PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jahnsen, ED; Trindade, A; Zaun, HC; Lehoux, S; Duarte, A; Jones, EAV				Jahnsen, Espen D.; Trindade, Alexandre; Zaun, Hans C.; Lehoux, Stephanie; Duarte, Antonio; Jones, Elizabeth A. V.			Notch1 Is Pan-Endothelial at the Onset of Flow and Regulated by Flow	PLOS ONE			English	Article							ARTERIAL-VENOUS DIFFERENTIATION; EMBRYONIC VASCULAR DEVELOPMENT; MOUSE YOLK-SAC; ALAGILLE-SYNDROME; PROGENITOR CELLS; HUMAN JAGGED1; BLOOD-FLOW; LIGAND; SHEAR; ANGIOGENESIS	Arteriovenous differentiation is a key event during vascular development and hemodynamic forces play an important role. Arteriovenous gene expression is present before the onset of flow, however it remains plastic and flow can alter arteriovenous identity. Notch signaling is especially important in the genetic determination of arteriovenous identity. Nevertheless, the effect of the onset of circulation on Notch expression and signaling has not been studied. The aim of this study is therefore to investigate the interaction of Notch1 signaling and hemodynamic forces during early vascular development. We find that the onset of Notch1 expression coincides with the onset of flow, and that expression is pan-endothelial at the onset of circulation in mouse embryos and only becomes arterial-specific after remodeling has occurred. When we ablate flow in the early embryo, endothelial cells fail to express Notch1. We show that low and disturbed flow patterns upregulate Notch1 expression in endothelial cells in vitro, but that higher shear stress levels do not (>= 10 dynes/cm(2)). Using siRNA, we knocked down Notch1 to investigate the role of Notch1 in mechanotransduction. When we applied shear stress levels similar to those found in embryonic arteries, we found an upregulation of Klf2, Dll1, Dll4, Jag1, Hey1, Nrp1 and CoupTFII but that only Dll4, Hey1, Nrp1 and EphB4 required Notch1 for flow-induced expression. Our results therefore indicate that Notch1 can modulate mechanotransduction but is not a critical mediator of the process since many genes mechanotransduce normally in the absence of Notch1, including genes involved in arteriovenous differentiation.	[Jahnsen, Espen D.; Zaun, Hans C.; Lehoux, Stephanie; Jones, Elizabeth A. V.] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Jahnsen, Espen D.; Jones, Elizabeth A. V.] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada; [Trindade, Alexandre; Duarte, Antonio] Univ Lisbon, Ctr Interdisciplinar Invest Sanidade Anim, Fac Med Vet, P-1699 Lisbon, Portugal; [Trindade, Alexandre; Duarte, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Jones, Elizabeth A. V.] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium	Lady Davis Institute; McGill University; McGill University; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; KU Leuven	Jones, EAV (corresponding author), McGill Univ, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ, Canada.	liz.jones@med.kuleuven.be	Trindade, Alexandre/AAC-9726-2019; Trindade, Alexandre/J-3606-2013; Jones, Elizabeth/B-3827-2010; Jones, Elizabeth AV/I-2180-2018; Duarte, Antonio/V-1178-2018	Trindade, Alexandre/0000-0002-3104-9259; Jones, Elizabeth/0000-0002-2006-7064; Jones, Elizabeth AV/0000-0002-2006-7064; Duarte, Antonio/0000-0002-9255-3635	Foundation des Maladies du Coeur du Quebec; Natural Science and Engineering Research Council Discovery Program [342134]; Canadian Foundation for Innovation; Sick Kids Foundation of Canada [NI12-029]; Eugenie Ulmer Lamothe Fund	Foundation des Maladies du Coeur du Quebec; Natural Science and Engineering Research Council Discovery Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); Sick Kids Foundation of Canada; Eugenie Ulmer Lamothe Fund	This work was supported by the Foundation des Maladies du Coeur du Quebec (http://www.fmcoeur.qc.ca), Natural Science and Engineering Research Council Discovery Program (No 342134, http://www.nserc-crsng.gc.ca), Canadian Foundation for Innovation (http://www.innovation.ca) and the Sick Kids Foundation of Canada (NI12-029, http://www.sickkidsfoundation.com) to EAVJ. EDJ was supported by the Eugenie Ulmer Lamothe Fund.	Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Chong DC, 2011, DEV DYNAM, V240, P2153, DOI 10.1002/dvdy.22706; Chouinard-Pelletier G, 2013, ANGIOGENESIS, V16, P71, DOI 10.1007/s10456-012-9300-2; CONLON RA, 1995, DEVELOPMENT, V121, P1533; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; Moyon D, 2001, DEVELOPMENT, V128, P3359; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nishii K, 2006, ANAT EMBRYOL, V211, P95, DOI 10.1007/s00429-005-0065-x; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; Rowlinson JM, 2010, BLOOD, V116, P2046, DOI 10.1182/blood-2009-11-252635; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2001, NATURE, V414, P163, DOI 10.1038/35102664; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Watson O, 2013, CARDIOVASC RES, V100, P252, DOI 10.1093/cvr/cvt170; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	44	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122622	10.1371/journal.pone.0122622	http://dx.doi.org/10.1371/journal.pone.0122622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830332	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600117
J	Bruinsma, BG; Wu, W; Ozer, S; Farmer, A; Markmann, JF; Yeh, H; Uygun, K				Bruinsma, Bote G.; Wu, Wilson; Ozer, Sinan; Farmer, Adam; Markmann, James F.; Yeh, Heidi; Uygun, Korkut			Warm Ischemic Injury Is Reflected in the Release of Injury Markers during Cold Preservation of the Human Liver	PLOS ONE			English	Article							CARDIAC DEATH; MACHINE PERFUSION; UNITED-STATES; DONOR LIVERS; TRANSPLANTATION; DONATION; VIABILITY; STORAGE; TIME; GRAFTS	Background Liver transplantation plays a pivotal role in the treatment of patients with end-stage liver disease. Despite excellent outcomes, the field is strained by a severe shortage of viable liver grafts. To meet high demands, attempts are made to increase the use of suboptimal livers by both pretransplant recovery and assessment of donor livers. Here we aim to assess hepatic injury in the measurement of routine markers in the post-ischemic flush effluent of discarded human liver with a wide warm ischemic range. Methods Six human livers discarded for transplantation with variable warm and cold ischemia times were flushed at the end of preservation. The liver grafts were flushed with NaCl or Lactated Ringer's, 2 L through the portal vein and 1 L through the hepatic artery. The vena caval effluent was sampled and analyzed for biochemical markers of injury; lactate dehydrogenase (LDH), alanine transaminase (ALT), and alkaline phosphatase (ALP). Liver tissue biopsies were analyzed for ATP content and histologically (H&E) examined. Results The duration of warm ischemia in the six livers correlated significantly to the concentration of LDH, ALT, and ALP in the effluent from the portal vein flush. No correlation was found with cold ischemia time. Tissue ATP content at the end of preservation correlated very strongly with the concentration of ALP in the arterial effluent (P<0.0007, R-2 = 0.96). Conclusion Biochemical injury markers released during the cold preservation period were reflective of the duration of warm ischemic injury sustained prior to release of the markers, as well as the hepatic energy status. As such, assessment of the flush effluent at the end of cold preservation may be a useful tool in evaluating suboptimal livers prior to transplantation, particularly in situations with undeterminable ischemic durations.	[Bruinsma, Bote G.; Wu, Wilson; Ozer, Sinan; Farmer, Adam; Uygun, Korkut] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Dept Surg, Boston, MA 02163 USA; [Bruinsma, Bote G.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Surg Lab, NL-1105 AZ Amsterdam, Netherlands; [Markmann, James F.; Yeh, Heidi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplant Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Harvard Medical School; Massachusetts General Hospital	Uygun, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Dept Surg, Boston, MA 02163 USA.	korkut.uygun@mgh.harvard.edu	Uygun, Korkut/AAH-3950-2020	Uygun, Korkut/0000-0003-2088-7860	National Institutes of Health [R00DK080942, R01DK096075]; Organ Solutions; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK080942, R01DK096075, K08DK094965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Organ Solutions; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from the National Institutes of Health (R00DK080942, R01DK096075) (KU) www.nih.gov. Organ Solutions provided support in the form of salaries for author KU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt PL, 2004, ANN SURG, V239, P87, DOI 10.1097/01.sla.0000103063.82181.2c; Berendsen TA, 2011, TRANSPL P, V43, P1484, DOI 10.1016/j.transproceed.2010.12.066; Bruinsma BG, 2014, AM J TRANSPLANT, V14, P1400, DOI 10.1111/ajt.12727; Bruinsma BG, 2013, INT J ARTIF ORGANS, V36, P775, DOI 10.5301/ijao.5000250; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Foley DP, 2014, LIVER TRANSPLANT, V20, P509, DOI 10.1002/lt.23859; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; HAMAMOTO I, 1995, TRANSPLANT INT, V8, P434; Dinh HL, 2012, WORLD J GASTROENTERO, V18, P4491, DOI 10.3748/wjg.v18.i33.4491; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; KAMIIKE W, 1988, TRANSPLANTATION, V45, P138, DOI 10.1097/00007890-198801000-00030; Kim WR, 2006, HEPATOLOGY, V43, P345, DOI 10.1002/hep.21025; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Lange R, 1996, TRANSPLANTATION, V62, P1255, DOI 10.1097/00007890-199611150-00013; Lange R, 1997, TRANSPL P, V29, P400, DOI 10.1016/S0041-1345(96)00136-4; LANIR A, 1988, HEPATOLOGY, V8, P471, DOI 10.1002/hep.1840080306; Markmann JF, 2001, TRANSPLANTATION, V72, P1113, DOI 10.1097/00007890-200109270-00023; McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f; Merion RM, 2006, ANN SURG, V244, P555, DOI 10.1097/01.sla.0000239006.33633.39; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; Perk Sinem, 2012, BMC Res Notes, V5, P325, DOI 10.1186/1756-0500-5-325; Perk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028518; Qing De-Ke, 2006, Hepatobiliary Pancreat Dis Int, V5, P515; Reddy SP, 2004, TRANSPLANTATION, V77, P1328, DOI 10.1097/01.TP.0000119206.63326.56; Reinders ME, 1996, TRANSPLANT INT, V9, P446, DOI 10.1111/j.1432-2277.1996.tb00987.x; Schenk M, 2000, Transpl Int, V13 Suppl 1, pS288; Schon MR, 1998, TRANSPLANT P, V30, P2318, DOI 10.1016/S0041-1345(98)00638-1; SHIMADA M, 1993, TRANSPLANT INT, V6, P4, DOI 10.1007/BF00336630; SHIMADA M, 1994, TRANSPLANT INT, V7, P233, DOI 10.1111/j.1432-2277.1994.tb01566.x; Suntharalingam C, 2009, AM J TRANSPLANT, V9, P2157, DOI 10.1111/j.1600-6143.2009.02758.x; Sutton ME, 2014, TRANSPL INT, V27, P11; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Verhoeven CJ, 2013, J HEPATOL, V59, P1231, DOI [10.1016/j.jhep.2013.07.034, 10.1016/j.jhep.2017.09.001]; Wakiyama S, 1996, TRANSPLANT INT, V9, P359; Wigmore SJ, 2010, TRANSPLANTATION, V90, P1048, DOI 10.1097/TP.0b013e3181f9962b	35	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123421	10.1371/journal.pone.0123421	http://dx.doi.org/10.1371/journal.pone.0123421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822248	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700224
J	Conrad, DJ; Bailey, BA				Conrad, Douglas J.; Bailey, Barbara A.			Multidimensional Clinical Phenotyping of an Adult Cystic Fibrosis Patient Population	PLOS ONE			English	Article							MUCOID PSEUDOMONAS-AERUGINOSA; METAGENOMIC ANALYSIS; SCORING SYSTEMS; LUNG-DISEASE; COMMUNITIES; INFECTION; FUNGAL	Background Cystic Fibrosis (CF) is a multi-systemic disease resulting from mutations in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene and has major manifestations in the sino-pulmonary, and gastro-intestinal tracts. Clinical phenotypes were generated using 26 common clinical variables to generate classes that overlapped quantiles of lung function and were based on multiple aspects of CF systemic disease. Methods The variables included age, gender, CFTR mutations, FEV1% predicted, FVC% predicted, height, weight, Brasfield chest xray score, pancreatic sufficiency status and clinical microbiology results. Complete datasets were compiled on 211 subjects. Phenotypes were identified using a proximity matrix generated by the unsupervised Random Forests algorithm and subsequent clustering by the Partitioning around Medoids (PAM) algorithm. The final phenotypic classes were then characterized and compared to a similar dataset obtained three years earlier. Findings Clinical phenotypes were identified using a clustering strategy that generated four and five phenotypes. Each strategy identified 1) a low lung health scores phenotype, 2) a younger, well-nourished, male-dominated class, 3) various high lung health score phenotypes that varied in terms of age, gender and nutritional status. This multidimensional clinical phenotyping strategy identified classes with expected microbiology results and low risk clinical phenotypes with pancreatic sufficiency. Interpretation This study demonstrated regional adult CF clinical phenotypes using non-parametric, continuous, ordinal and categorical data with a minimal amount of subjective data to identify clinically relevant phenotypes. These studies identified the relative stability of the phenotypes, demonstrated specific phenotypes consistent with published findings and identified others needing further study.	[Conrad, Douglas J.] Univ Calif San Diego, Dept Med, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92093 USA; [Bailey, Barbara A.] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA	University of California System; University of California San Diego; California State University System; San Diego State University	Conrad, DJ (corresponding author), Univ Calif San Diego, Dept Med, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92093 USA.	dconrad@ucsd.edu			NIH [RO1 1R01GM09534-01, NIH UL1 RR031980, NIH 1R01GM09534-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1107046] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	NIH RO1 1R01GM09534-01 supported the effort of both authors to obtain and analyze the data as indicated. The authors had full access to all data. The work in this manuscript was in part funded by two NIH grants: NIH UL1 RR031980 and NIH 1R01GM09534-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boase S, 2011, INT FORUM ALLERGY RH, V1, P340, DOI 10.1002/alr.20066; BRASFIELD D, 1980, AM J ROENTGENOL, V134, P1195, DOI 10.2214/ajr.134.6.1195; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burgel PR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/420134; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI 10.1016/j.biocel.2014.03.001; Cleveland RH, 2014, PEDIATR RADIOL, V44, P529, DOI 10.1007/s00247-013-2848-1; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; DOERSHUK CF, 1964, J PEDIATR-US, V65, P677, DOI 10.1016/S0022-3476(64)80152-9; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Hafen GM, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-44; Hafen GM, 2006, PEDIATR PULM, V41, P602, DOI 10.1002/ppul.20376; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Matouk E, 1997, EUR RESPIR J, V10, P2004, DOI 10.1183/09031936.97.10092004; Parad RB, 1999, INFECT IMMUN, V67, P4744, DOI 10.1128/IAI.67.9.4744-4750.1999; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002; TAUSSIG LM, 1973, J PEDIATR-US, V82, P380, DOI 10.1016/S0022-3476(73)80110-6; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370	26	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122705	10.1371/journal.pone.0122705	http://dx.doi.org/10.1371/journal.pone.0122705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822311	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700194
J	Damasceno, IZ; Melo, KRB; Nascimento, FD; Souza, DSP; Araujo, MS; Souza, SEG; Sampaio, MU; Nader, HB; Tersariol, ILS; Motta, G				Damasceno, Igor Z.; Melo, Katia R. B.; Nascimento, Fabio D.; Souza, Daianne S. P.; Araujo, Mariana S.; Souza, Sinval E. G.; Sampaio, Misako U.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara			Bradykinin Release Avoids High Molecular Weight Kininogen Endocytosis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ENDOTHELIAL-CELLS; CATHEPSIN-B; H-KININOGEN; SYSTEM; ANGIOGENESIS; PLASMA; GLYCOSAMINOGLYCANS; PREKALLIKREIN; ACTIVATION	Human H-kininogen (120 kDa) plays a role in many pathophysiological processes and interacts with the cell surface through protein receptors and proteoglycans, which mediate H-kininogen endocytosis. In the present work we demonstrate that H-kininogen containing bradykinin domain is internalized and different endogenous kininogenases are present in CHO-K1 cells. We used CHO-K1 (wild type) and CHO-745 (mutant deficient in proteoglycans biosynthesis) cell lines. H-kininogen endocytosis was studied using confocal microscopy, and its hydrolysis by cell lysate fraction was determined by immunoblotting. Bradykinin release was also measured by radioimmunoassay. H-kininogen interaction with the cell surface of CHO-745 cells resulted in bradykinin release by serine proteases. In CHO-K1 cells, which produce heparan and chondroitin sulfate proteoglycans, internalization of H-kininogen through its bradykinin domain can occur on lipid raft domains/caveolae. Nevertheless bradykinin-free H-kininogen was not internalized by CHO-K1 cells. The H-kininogen present in acidic endosomal vesicles in CHO-K1 was approximately 10-fold higher than the levels in CHO-745. CHO-K1 lysate fractions were assayed at pH 5.5 and intact H-kininogen was totally hydrolyzed into a 62 kDa fragment. By contrast, at an assay pH 7.4, the remained fragments were 115 kDa, 83 kDa, 62 kDa and 48 kDa in size. The anti-pain-Sepharose chromatography separated endogenous kininogenases from CHO-K1 lysate fraction. No difference was detected in the assays at pH 5.5 or 7.4, but the proteins in the fraction bound to the resin released bradykinin from H-kininogen. However, the proteins in the unbound fraction cleaved intact H-kininogen at other sites but did not release bradykinin. H-kininogen can interact with extravascular cells, and is internalized dependent on its bradykinin domain and cell surface proteoglycans. After internalization, H-kininogen is proteolytically processed by intracellular kininogenases. The present data also demonstrates that serine or cysteine proteases in lipid raft domains/caveolae on the CHO cell can hydrolyze H-kininogen, thus releasing kinins.	[Damasceno, Igor Z.; Melo, Katia R. B.; Souza, Daianne S. P.; Araujo, Mariana S.; Sampaio, Misako U.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Bioquim, Sao Paulo, SP, Brazil; [Nascimento, Fabio D.] Univ Anhanguera Sao Paulo UNIAN SP, Programa Biomat, Sao Paulo, SP, Brazil; [Nascimento, Fabio D.] Univ Anhanguera Sao Paulo UNIAN SP, Programa Biotecnol, Sao Paulo, SP, Brazil; [Souza, Sinval E. G.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Biofis, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Anhanguera; Universidade Anhanguera; Universidade Federal de Sao Paulo (UNIFESP)	Tersariol, ILS (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Bioquim, Sao Paulo, SP, Brazil.	ivarne.tersariol@gmail.com; guacyara.motta05@unifesp.br	Nascimento, Fabio Dupart/ABB-8295-2020; Nascimento, Fabio D/A-5115-2010; Nader, Helena Bonciani/D-9253-2012; MOTTA, GUACYARA/C-4429-2015; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; Araujo, Mariana/E-5434-2014	Nascimento, Fabio Dupart/0000-0001-6672-3373; Nascimento, Fabio D/0000-0001-6672-3373; MOTTA, GUACYARA/0000-0001-5427-1795; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; NADER, HELENA/0000-0002-7569-2166; Araujo, Mariana/0000-0001-5312-5075	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [CNPq 472403/2007-9]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP 13/05822-9, FAPESP 2012/50219-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Funding was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): grant to GM (CNPq 472403/2007-9) and ILST; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): grant to FDN (FAPESP 13/05822-9) and grant to ILST (FAPESP 2012/50219-6); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP. The Microscopy Center Facility at INFAR/EPM/UNIFESP was supported by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Barros NMT, 2004, BIOL CHEM, V385, P551, DOI 10.1515/BC.2004.066; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Cagliani R, 2013, MOL BIOL EVOL, V30, P1397, DOI 10.1093/molbev/mst054; Cavallo-Medved D, 2005, J CELL SCI, V118, P1493, DOI 10.1242/jcs.02278; Clapp C, 2009, PHYSIOL REV, V89, P1177, DOI 10.1152/physrev.00024.2009; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Durrant I, 1996, PROTEIN BLOTTING PRA, P141; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gozzo AJ, 2011, BIOCHIMIE, V93, P1839, DOI 10.1016/j.biochi.2011.07.003; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; HOOGEWERF AJ, 1991, J BIOL CHEM, V266, P16564; Ignatenko N, 2008, NEOPLASIA, V10, P140, DOI 10.1593/neo.07817; Kaplan AP, 1998, CLIN REV ALLERG IMMU, V16, P403, DOI 10.1007/BF02737659; Kashuba E, 2013, BIOMARKERS, V18, P279, DOI 10.3109/1354750X.2013.787544; Kolte D, 2011, J BIOL CHEM, V286, P24561, DOI 10.1074/jbc.M110.211557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Maurer M, 2011, ALLERGY, V66, P1397, DOI 10.1111/j.1398-9995.2011.02686.x; McCrae KR, 2005, CURR CANCER DRUG TAR, V5, P519, DOI 10.2174/156800905774574039; Melo KRB, 2009, BIOL CHEM, V390, P145, DOI 10.1515/BC.2009.016; Michaud D, 1998, ANAL CHIM ACTA, V372, P173, DOI 10.1016/S0003-2670(98)00349-3; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Moreira CR, 2003, INT IMMUNOPHARMACOL, V3, P293, DOI 10.1016/S1567-5769(02)00262-X; Motta G, 1992, Agents Actions Suppl, V36, P200; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Pathak M, 2013, THROMB HAEMOSTASIS, V110, P423, DOI 10.1160/TH12-11-0840; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2001, FEBS LETT, V500, P36, DOI 10.1016/S0014-5793(01)02570-4; Roycik MD, 2009, CURR PHARM DESIGN, V15, P1295, DOI 10.2174/138161209787846676; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schousboe I, 2004, EUR J BIOCHEM, V271, P2998, DOI 10.1111/j.1432-1033.2004.04229.x; SHIMAMOTO K, 1978, J LAB CLIN MED, V91, P721; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; TOYOOKA T, 1979, J MOL CELL CARDIOL, V11, P769, DOI 10.1016/0022-2828(79)90402-4; Veillard F, 2008, INT J BIOCHEM CELL B, V40, P1079, DOI 10.1016/j.biocel.2007.10.030; Veronez CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091280; VOGEL R, 1990, J BIOL CHEM, V265, P12494	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121721	10.1371/journal.pone.0121721	http://dx.doi.org/10.1371/journal.pone.0121721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822177	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700123
J	Drews, C; Galarneau, TJ				Drews, Carl; Galarneau, Thomas J., Jr.			Directional Analysis of the Storm Surge from Hurricane Sandy 2012, with Applications to Charleston, New Orleans, and the Philippines	PLOS ONE			English	Article							CUMULUS PARAMETERIZATION; MODEL; PREDICTION; FORECASTS; CLOUDS; SYSTEM	Hurricane Sandy in late October 2012 drove before it a storm surge that rose to 4.28 meters above mean lower low water at The Battery in lower Manhattan, and flooded the Hugh L. Carey automobile tunnel between Brooklyn and The Battery. This study examines the surge event in New York Harbor using the Weather Research and Forecasting (WRF) atmospheric model and the Coupled-Ocean-Atmosphere-Wave-Sediment Transport/Regional Ocean Modeling System (COAWST/ROMS). We present a new technique using directional analysis to calculate and display maps of a coastline's potential for storm surge; these maps are constructed from wind fields blowing from eight fixed compass directions. This analysis approximates the surge observed during Hurricane Sandy. The directional analysis is then applied to surge events at Charleston, South Carolina, New Orleans, Louisiana, and Tacloban City, the Philippines. Emergency managers could use these directional maps to prepare their cities for an approaching storm, on planning horizons from days to years.	[Drews, Carl; Galarneau, Thomas J., Jr.] Natl Ctr Atmospher Res, NCAR Earth Syst Lab, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Drews, C (corresponding author), Natl Ctr Atmospher Res, NCAR Earth Syst Lab, POB 3000, Boulder, CO 80307 USA.	drews@ucar.edu	Galarneau, Thomas J/AAR-7125-2020	Galarneau, Thomas J/0000-0002-2342-2594; Drews, Carl/0000-0002-0535-6538	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The NCAR Earth System Laboratory (NESL) at the National Center for Atmospheric Research provided computational support. NCAR is sponsored by the National Science Foundation. Any opinions, findings and conclusions or recommendations expressed in the publication are those of the author and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassill NP, 2014, GEOPHYS RES LETT, V41, P3274, DOI 10.1002/2014GL059839; Blake ES, 2013, ANN EST POP METR MIC; CHAPMAN DC, 1985, J PHYS OCEANOGR, V15, P1060, DOI 10.1175/1520-0485(1985)015<1060:NTOCSO>2.0.CO;2; Davis C, 2010, WEATHER FORECAST, V25, P1826, DOI 10.1175/2010WAF2222423.1; Dietrich JC, 2010, MON WEATHER REV, V138, P378, DOI 10.1175/2009MWR2907.1; Drews C, 2015, DIRECTIONAL ANAL STO; Drews C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072510; Drews C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012481; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Environmental Research Division's Data Access Program, 2013, TOP SRTM30 VERS 6 0; Flather R. A., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V10, P141; Galarneau TJ, 2013, MON WEATHER REV, V141, P4296, DOI 10.1175/MWR-D-13-00181.1; Grunwald M., 2005, WASHINGTON POST; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Hong SY, 2004, MON WEATHER REV, V132, P103, DOI 10.1175/1520-0493(2004)132<0103:ARATIM>2.0.CO;2; Knabb RD, 2005, TROPICAL CYCLONE REP, DOI [10.1177/0886260510365861, DOI 10.1177/0886260510365861]; Morss RE, 2010, WEATHER CLIM SOC, V2, P174, DOI 10.1175/2010WCAS1041.1; Munsell EB, 2014, J ADV MODEL EARTH SY, V6, P38, DOI 10.1002/2013MS000297; National Weather Service, 2015, SEA LAK OV SURG HURR; NOAA, 2013, NOAA REG ATL COAST; NOAA, 2014, HIST HURR TRACKS; NOAA, 2014, TID CURR; Oey LY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025873; Rappaport EN, 2009, WEATHER FORECAST, V24, P395, DOI 10.1175/2008WAF2222128.1; Rice Doyle, 2014, US TODAY; Schleifstein M, 2013, THE TIMES PICAY 1207; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Teves O, 2013, ASS PRESS; U.S. Census Bureau, 2012, ANN EST POP METR MIC; U.S. Geological Survey, 2013, SHUTTL RAD TOP MISS; US Army Corps of Engineers-Team New Orleans, 2013, IHNC LAK BORGN SURG; USGS, 2014, ENV ATLAS LAKE PONTC; Vickery PJ, 2000, J STRUCT ENG-ASCE, V126, P1203, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1203); Warner JC, 2010, OCEAN MODEL, V35, P230, DOI 10.1016/j.ocemod.2010.07.010; Zhang CX, 2011, MON WEATHER REV, V139, P3489, DOI 10.1175/MWR-D-10-05091.1	35	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122113	10.1371/journal.pone.0122113	http://dx.doi.org/10.1371/journal.pone.0122113			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822480	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700155
J	Grau, A; Tabib, A; Grau, I; Reiner, I; Mevorach, D				Grau, Amir; Tabib, Adi; Grau, Inna; Reiner, Inna; Mevorach, Dror			Apoptotic Cells Induce NF-kappa B and Inflammasome Negative Signaling	PLOS ONE			English	Article							NALP3 INFLAMMASOME; REACTIVE OXYGEN; EXPERIMENTAL COLITIS; NLRP3 INFLAMMASOME; IMMUNE-RESPONSE; DENDRITIC CELLS; MACROPHAGES; RECOGNITION; ACTIVATION; CLEARANCE	As they undergo phagocytosis, most early apoptotic cells negatively regulate proinflammatory signaling and were suggested as a major mechanism in the resolution of inflammation. The dextran sulfate sodium model is generally viewed as an epithelial damage model suited to investigate innate immune responses. Macrophages primed with LPS and subsequently exposed to DSS secrete high levels of IL-1 beta in an NLRP3-, ASC-, and caspase-1-dependent manner. The aim of this research was to test the therapeutic effect of a single dose of apoptotic cells in a DSS-colitis model and to explore possible mechanisms. Primary peritoneal macrophages, the DSS mice model, and Nlrp3-deficient mice, were used to assess the effect apoptotic cells on colitis. Immunohistochemistry, flow-cytometer, and western blots helped to explore the effect and mechanisms. Using a variety of NLRP3 triggering mechanisms, we show that apoptotic cells negatively regulate NF-kappa B and NLRP3 activation in primary peritoneal macrophages, at pre- and post-transcription levels, via inhibition of reactive oxygen species, lysosomal stabilization, and blocking K+ efflux. This property of apoptotic cells is demonstrated in a dramatic clinical, histological, and immunological amelioration of DSS colitis in Balb/c and B6 mice following a single administration of apoptotic cells.	[Grau, Amir; Tabib, Adi; Grau, Inna; Reiner, Inna; Mevorach, Dror] Hadassah Hebrew Univ Med Ctr, Lab Cellular & Mol Immunol, Rheumatol Res Ctr, Dept Med, Jerusalem, Israel	Hebrew University of Jerusalem	Mevorach, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Lab Cellular & Mol Immunol, Rheumatol Res Ctr, Dept Med, Jerusalem, Israel.	mevorachd@hadassah.org.il			Hadassah-Hebrew University Medical Center	Hadassah-Hebrew University Medical Center	This research was partially supported by a grant from the Hadassah-Hebrew University Medical Center. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hwang YS, 2004, ONCOGENE, V23, P6603, DOI 10.1038/sj.onc.1207867; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; Kwon KH, 2005, BIOCHEM BIOPH RES CO, V337, P647, DOI 10.1016/j.bbrc.2005.09.107; Kwon KH, 2007, LIFE SCI, V81, P362, DOI 10.1016/j.lfs.2007.05.022; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Podolsky DK, 2002, NEW ENGL J MED, P347; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Saas P, 2010, ANN NY ACAD SCI, V1209, P118, DOI 10.1111/j.1749-6632.2010.05741.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	42	19	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122440	10.1371/journal.pone.0122440	http://dx.doi.org/10.1371/journal.pone.0122440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822487	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700175
J	Lev, N; Barhum, Y; Lotan, I; Steiner, I; Offen, D				Lev, Nirit; Barhum, Yael; Lotan, Itay; Steiner, Israel; Offen, Daniel			DJ-1 Knockout Augments Disease Severity and Shortens Survival in a Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; G93A-SOD1 TRANSGENIC MICE; INCREASED OXIDATIVE DAMAGE; SUPEROXIDE DISMUTASE-1; PARKINSONS-DISEASE; LIPID-PEROXIDATION; MOTOR-NEURONS; SPINAL-CORD; EXPRESSION; MUTATIONS	Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, neurodegenerative disorder, characterized by the degeneration of motor neurons. Oxidative stress plays a central role in the disease progression, in concert with an enhanced glutamate excitotoxicity and neuro-inflammation. DJ-1 mutations, leading to the loss of functional protein, cause familial Parkinson's disease and motor neuron disease in several patients. DJ-1 responds to oxidative stress and plays an important role in the cellular defense mechanisms. We aimed to investigate whether loss of functional DJ-1 alters the disease course and severity in an ALS mouse model. To this end we used mice that express the human SOD1(G93A) mutation, the commonly used model of ALS and knockout of DJ-1 mice to generate SOD1 DJ-1 KO mice. We found that knocking out DJ-1in the ALS model led to an accelerated disease course and shortened survival time. DJ-1 deficiency was found to increase neuronal loss in the spinal cord associated with increased gliosis in the spinal cord and reduced antioxidant response that was regulated by the Nrf2 mechanism. The importance of DJ-1 in ALS was also illustrated in a motor neuron cell line that was exposed to glutamate toxicity and oxidative stress. Addition of the DJ-1 derived peptide, ND-13, enhanced the resistance to glutamate and SIN-1 induced toxicity. Thus, our results maintain that DJ-1 plays a role in the disease process and promotes the necessity of further investigation of DJ-1 as a therapeutic target for ALS.	[Lev, Nirit; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Felsenstein Med Res Ctr, Neurosci Lab, Petah Tiqwa, Israel; [Lev, Nirit; Lotan, Itay; Steiner, Israel] Tel Aviv Univ, Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel	Tel Aviv University; Rabin Medical Center; Tel Aviv University	Offen, D (corresponding author), Tel Aviv Univ, Felsenstein Med Res Ctr, Neurosci Lab, Petah Tiqwa, Israel.	danioffen@gmail.com	Lev, Nirit/AAA-1253-2020; lotan, Itay/Q-8028-2019	lotan, Itay/0000-0002-4015-9783	UGH Pharma; Lagacy Heritage Clinical Research Initiative of the Israel Science Foundation [1690/09]	UGH Pharma; Lagacy Heritage Clinical Research Initiative of the Israel Science Foundation	This research was supported by funding from UGH Pharma and the Lagacy Heritage Clinical Research Initiative of the Israel Science Foundation (grant 1690/09 to NL) (http://www.isf.org.il/english/path.asp?path_id=12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrus PK, 1998, J NEUROCHEM, V71, P2041; Annesi G, 2005, ANN NEUROL, V58, P803, DOI 10.1002/ana.20666; Badera V, 2005, BRAIN RES, V1041, P102, DOI 10.1016/j.brainres.2005.02.006; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Benkler C, 2013, GLIA, V61, P312, DOI 10.1002/glia.22428; Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Gurney ME, 1997, J NEUROL, V244, pS15, DOI 10.1007/BF03160575; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Knippenberg S, 2013, J NEUROPATH EXP NEUR, V72, P1052, DOI 10.1097/NEN.0000000000000004; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Lev N, 2013, MOVEMENT DISORD, V28, pS424; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2013, J GERONTOL A-BIOL, V68, P215, DOI 10.1093/gerona/gls147; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; Lo Coco D, 2009, MOVEMENT DISORD, V24, P1555, DOI 10.1002/mds.22629; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Petri S, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878030; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sejvar JJ, 2005, NEUROEPIDEMIOLOGY, V25, P144, DOI 10.1159/000086679; Shibata N, 2001, BRAIN RES, V917, P97, DOI 10.1016/S0006-8993(01)02926-2; Shibata N, 2007, NEUROPATHOLOGY, V27, P49, DOI 10.1111/j.1440-1789.2006.00746.x; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Tortarolo M, 2006, J NEUROSCI RES, V83, P134, DOI 10.1002/jnr.20715; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117190	10.1371/journal.pone.0117190	http://dx.doi.org/10.1371/journal.pone.0117190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822630	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700008
J	Ledesma, MMGL; Mojsiejczuk, LN; Rodrigo, B; Sevic, I; Mammana, L; Galdame, O; Gadano, A; Fainboim, H; Campos, R; Flichman, D				Lopez Ledesma, Maria Mora Gonzalez; Noelia Mojsiejczuk, Laura; Rodrigo, Belen; Sevic, Ina; Mammana, Lilia; Galdame, Omar; Gadano, Adrian; Fainboim, Hugo; Campos, Rodolfo; Flichman, Diego			Hepatitis B Virus Genotype Distribution and Genotype-Specific BCP/preCore Substitutions in Acute and Chronic Infections in Argentina	PLOS ONE			English	Article							NATURAL-HISTORY; E-ANTIGEN; CORE PROMOTER; VIROLOGICAL CHARACTERISTICS; HEPATOCELLULAR-CARCINOMA; PRECORE MUTATIONS; SUBGENOTYPES C2; REPLICATION; HBV; GENOME	Aim In order to assess Hepatitis B Virus genotype (g) and subgenotype (sg) implications in the course of infection, 234 HBsAg positive patients in different infection stages were characterized (66 acute infections, 63 HBeAg positive chronic infections and 105 anti-HBe positive chronic infections). Results Overall, sgA2 (17.9%), gD (20.9%), sgF1b (34.2%) and sgF4 (19.7%) were the most prevalent. Subgenotype F1b was overrepresented in acute and chronic HBeAg infections (56.1%), whereas gD was the most frequent (40.0%) in anti-HBe positive chronic infections. Among chronic infections, HBeAg positivity rates were 50.0, 12.5, 62.8 and 35.3% for sgA2, gD, sgF1b and sgF4, respectively (p < 0.05). A bias toward BCP/preCore mutations was observed among genotypes. In anti-HBe positive chronic infections, sgF1b was more prone to have A1762T/G1764A mutation than sgA2, sgF4 and gD (75.0, 40.0, 33.3 and 31.8%, p<0.005), whereas in the pC region, gD and sgF4 were more likely to have G1896A than sgA2 and sgF1b (81.0, 72.7, 0.0 and 31.3%, p < 0.001). The unexpected low frequency of the G1896A mutation in the sgF1b (despite carrying 1858T) prompted us to perform a further analysis in order to identify genotype-specific features that could justify the pattern mutations observed. A region encompassing nucleotides 1720 to 1920 showed the higher dissimilarity between sgF1b and sgF4. Genotypes and subgenotypes carrying the 1727G, 1740C and 1773T polymorphisms were prevented to mutate position 1896. Discussion HBeAg seroconversion is a critical event in the natural history of HBV infection. Differences in the HBeAg positivity rate might be relevant since different studies have observed that delayed HBeAg seroconversion is associated with a more severe clinical course of infection, highlighting the critical role that genotypes/subgenotypes might play in the progression of HBV infection. Polymorphisms in the regions 1720 to 1920 could be involved in the molecular mechanisms underlying seroconversion of each genotype/subgenotype.	[Lopez Ledesma, Maria Mora Gonzalez; Noelia Mojsiejczuk, Laura; Rodrigo, Belen; Sevic, Ina; Campos, Rodolfo; Flichman, Diego] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Mammana, Lilia; Fainboim, Hugo] Hosp Infecciosas F Muniz, Unidad Hepatol, Buenos Aires, DF, Argentina; [Galdame, Omar; Gadano, Adrian] Hosp Italiano Buenos Aires, Unidad Hepatol, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Ledesma, MMGL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	mgonzalezlopez@ffyb.uba.ar	Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; Rodrigo, Maria Belen/0000-0002-5741-2554; Mojsiejczuk, Laura/0000-0001-7170-8880; Gonzalez Lopez Ledesma, Maria Mora/0000-0002-2189-8388	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2012-112201101002 15]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2011-0705]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP 2012-112201101002 15) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2011-0705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2006, J VIROL, V80, P4380, DOI 10.1128/JVI.80.9.4380-4387.2006; Aike HAI, 1974, NEW LOOK STAT MODEL; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Bonino F, 2003, J HEPATOL, V39, pS160, DOI 10.1016/S0168-8278(03)00319-2; Chan HLY, 2006, J CLIN MICROBIOL, V44, P681, DOI 10.1128/JCM.44.3.681-687.2006; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; CHEN HS, 1992, J VIROL, V66, P5682, DOI 10.1128/JVI.66.9.5682-5684.1992; Chook JB, 2013, J MED VIROL, V85, P419, DOI 10.1002/jmv.23500; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; Crook PD, 2003, INT J EPIDEMIOL, V32, P118, DOI 10.1093/ije/dyg039; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Guarnieri M, 2006, J VIROL, V80, P587, DOI 10.1128/JVI.80.2.587-595.2006; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han YN, 2008, J GASTROEN HEPATOL, V23, P1728, DOI 10.1111/j.1440-1746.2008.05600.x; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Iloeje UH, 2012, LIVER INT, V32, P1333, DOI 10.1111/j.1478-3231.2012.02805.x; Imamura T, 2003, GUT, V52, P1630, DOI 10.1136/gut.52.11.1630; Jindal A, 2013, LIVER INT, V33, P164, DOI 10.1111/liv.12081; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kramvis A, MOL CHARACTERISATION; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li XD, 2010, J CLIN MICROBIOL, V48, P4363, DOI 10.1128/JCM.01518-10; Lindh M, 1997, J INFECT DIS, V175, P1285, DOI 10.1086/516458; Liu CJ, 2013, SEMIN LIVER DIS, V33, P97, DOI 10.1055/s-0033-1345716; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ledesma MMGL, 2011, INT J INFECT DIS, V15, pE314, DOI 10.1016/j.ijid.2010.12.009; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; MAYNARD JE, 1990, VACCINE, V8, pS18, DOI 10.1016/0264-410X(90)90209-5; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Mele A, 2008, CLIN INFECT DIS, V46, P868, DOI 10.1086/528687; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Oropeza CE, 2007, VIROLOGY, V359, P371, DOI 10.1016/j.virol.2006.08.036; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Panassie L, 2012, CLIN RES HEPATOL GAS, V36, pE1, DOI 10.1016/j.clinre.2011.09.002; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Leone FGPY, 2008, J CLIN VIROL, V42, P381, DOI 10.1016/j.jcv.2008.01.018; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sainokami S, 2007, J GASTROENTEROL, V42, P241, DOI 10.1007/s00535-006-1997-5; Sami H, 2013, ADV VIROL, V2013, DOI 10.1155/2013/846849; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Schalm S W, 1990, Prog Liver Dis, V9, P443; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Sugauchi F, 2003, GASTROENTEROLOGY, V124, P925, DOI 10.1053/gast.2003.50140; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Tong Shuping, 2005, Int J Med Sci, V2, P2; TONG SP, 1992, VIROLOGY, V191, P237, DOI 10.1016/0042-6822(92)90185-R; TONG SP, 1993, J VIROL, V67, P5651, DOI 10.1128/JVI.67.9.5651-5655.1993; Villeneuve JP, 2005, J CLIN VIROL, V34, pS139, DOI 10.1016/S1386-6532(05)80024-1; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x; Yuan J, 2007, J CLIN VIROL, V39, P87, DOI 10.1016/j.jcv.2007.03.005	71	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121436	10.1371/journal.pone.0121436	http://dx.doi.org/10.1371/journal.pone.0121436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822666	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700107
J	Luo, QL; Li, YJ; Wang, WQ; Fei, XW; Deng, XD				Luo, Qiulan; Li, Yajun; Wang, Wenquan; Fei, Xiaowen; Deng, Xiaodong			Genome-Wide Survey and Expression Analysis of Chlamydomonas reinhardtii U-box E3 Ubiquitin Ligases (CrPUBs) Reveal a Functional Lipid Metabolism Module	PLOS ONE			English	Article							ABSCISIC-ACID; CELL-DEATH; PHOSPHATE STARVATION; REPEAT PROTEIN; RING FINGER; ARABIDOPSIS; RECEPTOR; DEFENSE; GENE; TRIACYLGLYCEROL	E3 ubiquitin ligases determine the substrate specificity of ubiquitination. Plant U-box (PUB) E3 ligases, with a typical 70-amino acid U-box domain, participate in plant developmental processes and environmental responses. Thus far, 64 PUB proteins have been identified in Arabidopsis and 77 PUB proteins have been identified in Oryza. However, detailed studies on U-box genes in the model microalgae Chlamydomonas reinhardtii are lacking. Here, we present a comprehensive analysis of the genes encoding U-box family proteins in C. reinhardtii. Following BLASTP analysis, 30 full-length U-box genes were identified in the C. reinhardtii genome sequence. Bioinformatics analyses of CrPUB genes were performed to characterize the phylogenetic relationships, chromosomal locations and gene structures of each member. The 30 identified CrPUB proteins are clustered into 3 distinct subfamilies, and the genes for these proteins are unevenly distributed among 14 chromosomes. Furthermore, the quantitative real-time RT-PCR or semi-quantitative RT-PCR analysis of 30 CrPUB mRNA abundances under nitrogen starvation showed that 18 CrPUB genes were induced by N starvation and that 7 genes were repressed in the N-poor environment. We selected five CrPUB genes exhibiting marked changes in expression under N-free conditions for further analysis in RNAi experiments and examined the oil content of these gene-silenced transgenic strains. The silencing of CrPUB5 and CrPUB14, which are typically down-regulated under N starvation, induced 9.8%-45.0% and 14.4%-61.8% lipid accumulation, respectively. In contrast, the silencing of CrPUB11, CrPUB23 and CrPUB28, which are markedly up-regulated under N-free conditions, decreased the lipid content by 5.5%-27.8%, 8.1%-27.3% and 6.6%-27.9%, respectively. These results provide a useful reference for the identification and functional analysis of this gene family and fundamental information for microalgae lipid metabolism research.	[Luo, Qiulan; Li, Yajun; Wang, Wenquan; Deng, Xiaodong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou 571101, Peoples R China; [Fei, Xiaowen] Hainan Med Coll, Sch Sci, Haikou 571101, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan Medical University	Deng, XD (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou 571101, Peoples R China.	dengxiaodong@itbb.org.cn	fei, xiaowen/GRJ-8141-2022; Luo, Qiulan/AAT-7737-2021; Deng, Xiaodong/AAF-3261-2019	Deng, Xiaodong/0000-0002-6938-1214	National Natural Science Foundation of China [31160050, 31360051]; Major Technology Project of Hainan [ZDZX2013023-1]; National Nonprofit Institute Research Grants [CATAS-ITBB110507, 130305]; Funds of Hainan Engineering and Technological Research [GCZX2011006, GCZX2012004, GCZX2013004]; Natural Science Foundation of Hainan Province [313077, 314117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan; National Nonprofit Institute Research Grants; Funds of Hainan Engineering and Technological Research; Natural Science Foundation of Hainan Province	This work was supported by the National Natural Science Foundation of China (31160050, 31360051), the Major Technology Project of Hainan (ZDZX2013023-1), the National Nonprofit Institute Research Grants (CATAS-ITBB110507, 130305), the Funds of Hainan Engineering and Technological Research (GCZX2011006, GCZX2012004, GCZX2013004), and the Natural Science Foundation of Hainan Province (313077, 314117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador V, 2001, CELL, V106, P343, DOI 10.1016/S0092-8674(01)00445-7; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Bergler J, 2011, PLANT BIOLOGY, V13, P725, DOI 10.1111/j.1438-8677.2010.00431.x; Bono MS, 2013, BIORESOURCE TECHNOL, V143, P623, DOI 10.1016/j.biortech.2013.06.040; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Brunner M, 2008, GENE DEV, V22, P825, DOI 10.1101/gad.1664508; Chen LY, 2013, MOL PLANT, V6, P1388, DOI 10.1093/mp/sst005; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Deb S, 2014, PLANT PHYSIOL, V165, P1647, DOI 10.1104/pp.114.244376; Dhup S, 2014, BIORESOURCE TECHNOL, V152, P572, DOI 10.1016/j.biortech.2013.11.068; Gao TS, 2013, NUCLEIC ACIDS RES, V41, pD445, DOI 10.1093/nar/gks1103; Ghasemi Y, 2012, Prikl Biokhim Mikrobiol, V48, P150; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Herrera-Valencia VA, 2012, CURR MICROBIOL, V64, P477, DOI 10.1007/s00284-012-0095-6; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Hur YJ, 2012, MOL BIOL REP, V39, P5883, DOI 10.1007/s11033-011-1399-5; Kim M, 2003, BBA-PROTEINS PROTEOM, V1651, P50, DOI 10.1016/S1570-9639(03)00234-6; Kobayashi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049207; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kou Z, 2013, J APPL PHYCOL, V25, P1633, DOI 10.1007/s10811-013-0011-x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Li W, 2012, PLANT SIGNAL BEHAV, V7, P898, DOI 10.4161/psb.20703; Liu BS, 2013, BIORESOURCE TECHNOL, V146, P310, DOI 10.1016/j.biortech.2013.07.088; Liu JL, 2012, PLANT PHYSIOL, V160, P28, DOI 10.1104/pp.112.199430; Liu YC, 2011, MOL PLANT, V4, P938, DOI 10.1093/mp/ssr030; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Luo JH, 2006, PLANT J, V46, P649, DOI 10.1111/j.1365-313X.2006.02730.x; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; MARTIN NC, 1975, J CELL BIOL, V67, P587, DOI 10.1083/jcb.67.3.587; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Pringa E, 2001, J BIOL CHEM, V276, P19617, DOI 10.1074/jbc.M100192200; Raab S, 2009, PLANT J, V59, P39, DOI 10.1111/j.1365-313X.2009.03846.x; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Salt JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021321; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Seo DH, 2012, PLANT PHYSIOL, V160, P556, DOI 10.1104/pp.112.202143; Shen GX, 2007, PLANT J, V52, P309, DOI 10.1111/j.1365-313X.2007.03239.x; Shen GX, 2007, PLANT J, V49, P228, DOI 10.1111/j.1365-313X.2006.02963.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vogelmann K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00037; Wang H, 2013, PLANT J, V74, P511, DOI 10.1111/tpj.12146; Wase N, 2014, J PROTEOME RES, V13, P1373, DOI 10.1021/pr400952z; WETTERN M, 1990, EUR J BIOCHEM, V191, P571, DOI 10.1111/j.1432-1033.1990.tb19159.x; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yano K, 2009, PLANT J, V60, P168, DOI 10.1111/j.1365-313X.2009.03943.x; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; ZHANG H, 1992, PLANT CELL, V4, P1575, DOI 10.1105/tpc.4.12.1575; Zhang JF, 2014, PLANT REPROD, V27, P59, DOI 10.1007/s00497-014-0240-4; Zhang XC, 2010, MOL BIOL REP, V37, P653, DOI 10.1007/s11033-009-9507-5	70	21	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122600	10.1371/journal.pone.0122600	http://dx.doi.org/10.1371/journal.pone.0122600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822994	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700191
J	Novovic, K; Mihajlovic, S; Vasiljevic, Z; Filipic, B; Begovic, J; Jovcic, B				Novovic, Katarina; Mihajlovic, Sanja; Vasiljevic, Zorica; Filipic, Brankica; Begovic, Jelena; Jovcic, Branko			Carbapenem-Resistant Acinetobacter baumannii from Serbia: Revision of CarO Classification	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; METALLO-BETA-LACTAMASE; GENES; EPIDEMIOLOGY; MECHANISMS; EXPRESSION; DIVERSITY; EMERGENCE; SEQUENCE; PLASMID	Carbapenem-resistant A. baumannii present a significant therapeutic challenge for the treatment of nosocomial infections in many European countries. Although it is known that the gradient of A. baumannii prevalence increases from northern to southern Europe, this study provides the first data from Serbia. Twenty-eight carbapenem-resistant A. baumannii clinical isolates were collected at a Serbian pediatric hospital during a 2-year period. The majority of isolates (67.68%) belonged to the sequence type Group 1, European clonal complex II. All isolates harbored intrinsic OXA-51 and AmpC cephalosporinase. OXA-23 was detected in 16 isolates (57.14%), OXA-24 in 23 isolates (82.14%) and OXA-58 in 11 isolates (39.29%). Six of the isolates (21.43%) harbored all of the analyzed oxacillinases, except OXA-143 and OXA-235 that were not detected in this study. Production of oxacillinases was detected in different pulsotypes indicating the presence of horizontal gene transfer. NDM-1, VIM and IMP were not detected in analyzed clinical A. baumannii isolates. ISAba1 insertion sequence was present upstream of OXA-51 in one isolate, upstream of AmpC in 13 isolates and upstream of OXA-23 in 10 isolates. In silico analysis of carO sequences from analyzed A. baumannii isolates revealed the existence of two out of six highly polymorphic CarO variants. The phylogenetic analysis of CarO protein among Acinetobacter species revised the previous classification CarO variants into three groups based on strong bootstraps scores in the tree analysis. Group I comprises four variants (I-IV) while Groups II and III contain only one variant each. One half of the Serbian clinical isolates belong to Group I variant I, while the other half belongs to Group I variant III.	[Novovic, Katarina; Mihajlovic, Sanja; Filipic, Brankica; Begovic, Jelena; Jovcic, Branko] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Vasiljevic, Zorica] Inst Mother & Child Hlth Care Serbia Dr Vukan Cup, Belgrade, Serbia; [Filipic, Brankica] Univ Belgrade, Fac Pharm, Belgrade, Serbia; [Jovcic, Branko] Univ Belgrade, Fac Biol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Jovcic, B (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.	bjovcic@bio.bg.ac.rs	Filipić, Brankica/AFR-2112-2022; Vasiljevic, Zorica V/J-8389-2016	Filipić, Brankica/0000-0002-5747-9468; Vasiljevic, Zorica V/0000-0002-8864-1325; Novovic, Katarina/0000-0003-3727-4163; Jovcic, Branko/0000-0002-9500-3786; Begovic, Jelena/0000-0001-9599-3815	Ministry of Education, Science and Technological Development of the Republic of Serbia [173019]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by grant No. 173019 from the Ministry of Education, Science and Technological Development of the Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baang JH, 2012, AM J INFECT CONTROL, V40, P134, DOI 10.1016/j.ajic.2011.04.326; Bagos PG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-29; Beceiro A, 2009, ANTIMICROB AGENTS CH, V53, P1177, DOI 10.1128/AAC.00485-08; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Catel-Ferreira M, 2011, J ANTIMICROB CHEMOTH, V66, P2053, DOI 10.1093/jac/dkr267; Chung DR, 2011, AM J RESP CRIT CARE, V184, P1409, DOI 10.1164/rccm.201102-0349OC; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Fonseca EL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-245; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Jovcic B, 2009, ARCH BIOL SCI, V61, P159, DOI 10.2298/ABS0902159J; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Koh TH, 2010, LANCET INFECT DIS, V10, P828, DOI [10.1016/S1473-3099(10)70275-9, 10.1016/S1473-3099(10)70274-7]; Kojic M, 2005, CAN J MICROBIOL, V51, P305, DOI [10.1139/w05-009, 10.1139/W05-009]; Lee Y, 2011, ANTIMICROB AGENTS CH, V55, P361, DOI 10.1128/AAC.01672-09; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Mezzatesta ML, 2012, CLIN MICROBIOL INFEC, V18, P160, DOI 10.1111/j.1469-0691.2011.03527.x; Mirovic V, 2012, ANTIMICROB AGENTS CH, V56, P6062, DOI 10.1128/AAC.00838-12; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Mussi MA, 2007, FEBS LETT, V581, P5573, DOI 10.1016/j.febslet.2007.10.063; Mussi MA, 2011, J BACTERIOL, V193, P4736, DOI 10.1128/JB.01533-10; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Schreckenberg PC, 2003, MANUAL CLIN MICROBIO, P749; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Siroy A, 2005, ANTIMICROB AGENTS CH, V49, P4876, DOI 10.1128/AAC.49.12.4876-4883.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Teo J, 2012, WEST PAC SURVEILL RE, V3, P19, DOI [10.5365/wpsar.2011.2.4.010, 10.5365/WPSAR.2011.2.4.010]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Wolter DJ, 2009, ANTIMICROB AGENTS CH, V53, P1660, DOI 10.1128/AAC.01172-08; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Zarrilli R, 2007, CLIN MICROBIOL INFEC, V13, P481, DOI 10.1111/j.1469-0691.2006.01675.x; Zarrilli R, 2009, J INFECT DEV COUNTR, V3, P335, DOI 10.3855/jidc.240	44	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122793	10.1371/journal.pone.0122793	http://dx.doi.org/10.1371/journal.pone.0122793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822626	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700197
J	Postnikova, OA; Hull, M; Shao, J; Skantar, A; Nemchinov, LG				Postnikova, O. A.; Hull, M.; Shao, J.; Skantar, A.; Nemchinov, L. G.			Transcriptome Analysis of Resistant and Susceptible Alfalfa Cultivars Infected With Root-Knot Nematode Meloidogyne incognita (vol 10, e0118269, 2015)	PLOS ONE			English	Correction													Skantar, Andrea/V-1182-2018	Skantar, Andrea/0000-0001-8940-2580				Postnikova OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118269	1	3	3	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123157	10.1371/journal.pone.0123157	http://dx.doi.org/10.1371/journal.pone.0123157			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822722	Green Published, gold			2022-12-27	WOS:000352134700218
J	Stevens, K; Frank, KA; Kramer, DB				Stevens, Kara; Frank, Kenneth A.; Kramer, Daniel B.			Do Social Networks Influence Small-Scale Fishermen's Enforcement of Sea Tenure?	PLOS ONE			English	Article							MANAGEMENT EFFECTIVENESS; COMANAGEMENT; GOVERNANCE; EVOLUTION; FOOD; REGULATIONS; RECIPROCITY; SELECTION; TRAGEDY; COMMONS	Resource systems with enforced rules and strong monitoring systems typically have more predictable resource abundance, which can confer economic and social benefits to local communities. Co-management regimes demonstrate better social and ecological outcomes, but require an active role by community members in management activities, such as monitoring and enforcement. Previous work has emphasized understanding what makes fishermen comply with rules. This research takes a different approach to understand what influences an individual to enforce rules, particularly sea tenure. We conducted interviews and used multiple regression and Akaike's Information Criteria model selection to evaluate the effect of social networks, food security, recent catch success, fisherman's age and personal gear investment on individual's enforcement of sea tenure. We found that fishermen's enforcement of sea tenure declined between the two time periods measured and that social networks, age, food security, and changes in gear investment explained enforcement behavior across three different communities on Nicaragua's Atlantic Coast, an area undergoing rapid globalization.	[Stevens, Kara; Frank, Kenneth A.; Kramer, Daniel B.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Frank, Kenneth A.] Michigan State Univ, Dept Counseling Educ Psychol & Special Educ, E Lansing, MI 48824 USA; [Kramer, Daniel B.] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Stevens, K (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	stevenskara@yahoo.com			National Science Foundation (NSF) Coupled Human and Natural Systems Program [0815966]	National Science Foundation (NSF) Coupled Human and Natural Systems Program(National Science Foundation (NSF))	This research was funded by the National Science Foundation (NSF) Coupled Human and Natural Systems Program (#0815966). In addition, the authors thank the U.S. Student Fulbright program for providing support for fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson JM, 2010, OCEAN COAST MANAGE, V53, P524, DOI 10.1016/j.ocecoaman.2010.06.008; ACHESON JM, 1975, HUM ECOL, V3, P183, DOI 10.1007/BF01531640; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Velez MA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05721-180310; Ali J., 2010, INT J EC FINANCE, V2, P113, DOI [10.5539/ijef.v2n4p113, DOI 10.5539/IJEF.V2N4P113]; Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Barnes-Mauthe M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05295-180123; Basurto X, 2005, SOC NATUR RESOUR, V18, P643, DOI 10.1080/08941920590959631; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell SJ, 2013, MAR POLICY, V41, P72, DOI 10.1016/j.marpol.2012.12.022; Carpenter J, 2004, J EVOLUTIONARY EC, V14, P1; Cavalcanti C, 2010, ECOL ECON, V69, P613, DOI 10.1016/j.ecolecon.2009.09.009; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cox M, 2010, ECOL SOC, V15; Crawford BR, 2004, COAST MANAGE, V32, P39, DOI 10.1080/08920750490247481; Crona B, 2010, ECOL SOC, V15; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Curran S, 2002, POPUL DEV REV, V28, P89; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Eggert H, 2010, ENVIRON DEV ECON, V15, P197, DOI 10.1017/S1355770X09990106; Evans L, 2011, J ENVIRON MANAGE, V92, P1938, DOI 10.1016/j.jenvman.2011.03.010; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Frank K., 2011, SOCIAL NETWORKS NATU, P180, DOI DOI 10.1017/CBO9780511894985.009; Frank K, 2011, SOCIAL EMBEDDEDNESS; Frank KA, 2004, SOCIOL EDUC, V77, P148, DOI 10.1177/003804070407700203; Frank KA, 1996, SOC NETWORKS, V18, P93, DOI 10.1016/0378-8733(95)00257-X; FRANK KA, 1995, SOC NETWORKS, V17, P27, DOI 10.1016/0378-8733(94)00247-8; Frank KA, 1998, AM J SOCIOL, V104, P642, DOI 10.1086/210083; Gezelius SS, 2004, HUM ECOL, V32, P615, DOI 10.1007/s10745-004-6099-5; Gezelius SS, 2011, LAW SOC REV, V45, P435, DOI 10.1111/j.1540-5893.2011.00436.x; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goett J, 2006, THESIS U TEXAS AUSTI; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hahn T, 2006, BALLETTANZ, P34; Hatcher A, 2000, LAND ECON, V76, P448, DOI 10.2307/3147040; Hauck M, 2008, MAR POLICY, V32, P635, DOI 10.1016/j.marpol.2007.11.004; Hauck M, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P196, DOI 10.1079/9781845936075.0196; Hauzer M, 2013, MAR POLICY, V38, P346, DOI 10.1016/j.marpol.2012.06.012; Heckathorn D, 1989, RATION SOC, V1, P79; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Honneland G, 2000, MAR POLICY, V24, P11, DOI 10.1016/S0308-597X(98)00058-X; Hostetler M, 1998, THESIS S FRASER U; Isaac ME, 2007, ECOL SOC, V12; Jagers SC, 2012, MAR POLICY, V36, P969, DOI 10.1016/j.marpol.2012.02.004; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; Kramer DB, 2009, ECOL ECON, V68, P2897, DOI 10.1016/j.ecolecon.2009.06.026; Kuperan K, 1998, LAW SOC REV, V32, P309, DOI 10.2307/827765; Madrigal-Ballestero R, 2013, MAR POLICY, V37, P270, DOI 10.1016/j.marpol.2012.05.009; MANSKI CF, 1989, J HUM RESOUR, V24, P343, DOI 10.2307/145818; Matous P, 2013, INT J AGR SUSTAIN, V11, P301, DOI 10.1080/14735903.2012.751701; McClanahan TR, 2006, AQUAT CONSERV, V16, P147, DOI 10.1002/aqc.715; Melchior M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052615; Mertens F, 2012, SOC SCI MED, V75, P643, DOI 10.1016/j.socscimed.2011.10.016; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Paxton SJ, 1999, J ABNORM PSYCHOL, V108, P255, DOI 10.1037/0021-843X.108.2.255; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pomeroy RS, 1997, MAR POLICY, V21, P465, DOI 10.1016/S0308-597X(97)00017-1; Ramirez-Sanchez S, 2009, ECOL SOC, V14; Rice J, 2011, ICES J MARINE SCI; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Scholz JT, 2006, AM J POLIT SCI, V50, P81, DOI 10.1111/j.1540-5907.2006.00171.x; Slack KS, 2005, SOC SERV REV, V79, P511, DOI 10.1086/430894; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; SUTINEN JG, 1985, LAND ECON, V61, P387, DOI 10.2307/3146156; Turner RA, 2014, ECOL SOC, V19, DOI 10.5751/ES-06456-190238; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330	77	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121431	10.1371/journal.pone.0121431	http://dx.doi.org/10.1371/journal.pone.0121431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822364	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700105
J	Wakayo, T; Belachew, T; Vatanparast, H; Whiting, SJ				Wakayo, Tolassa; Belachew, Tefera; Vatanparast, Hassan; Whiting, Susan J.			Vitamin D Deficiency and Its Predictors in a Country with Thirteen Months of Sunshine: The Case of School Children in Central Ethiopia	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN-D CONCENTRATIONS; BONE-MINERAL DENSITY; LOW DIETARY CALCIUM; HIGH PREVALENCE; HEALTHY-CHILDREN; D INSUFFICIENCY; HYPOVITAMINOSIS-D; SUN EXPOSURE; RISK-FACTORS; WOMEN	Studies examining vitamin D status among children living in sunny climates indicated that children did not receive adequate vitamin D, however, this has not been looked at among children living in Ethiopia. In this study, we determined vitamin D deficiency and its predictors among school children aged 11-18 years, examining circulating 25-hydroxy vitamin D [25(OH)D]. The school-based cross-sectional study was conducted in schools in Adama Town (n = 89) and in rural Adama (n = 85) for a total sample of 174. Students were randomly selected using multi-stage stratified sampling method from both settings. Socioeconomic status of parents and demographic, anthropometric, sun exposure status and blood 25(OH)D levels were obtained. Vitamin D deficiency, defined as circulating levels of 25(OH)D < 50 nmol/L, was found in 42% of the entire study participants. Prevalence of deficiency was significantly higher among students in urban setting compared to rural (61.8% vs 21.2%, respectively, p< 0.001). After controlling for potential confounders using multivariable logistic regression model, duration of exposure to sunlight, amount of body part exposed to sunlight, place of residence, maternal education, body fatness, having TV/computer at home and socioeconomic status were significant predictors of vitamin D deficiency. The findings suggest that Vitamin D deficiency was prevalent in healthy school children living both in urban and rural areas of a country with abundant year round sunshine providing UVB, with the prevalence of deficiency being significantly higher among urban school children who were less exposed to sunlight. Behaviour change communication to enhance exposure to ultraviolet light is critical to prevent vitamin D deficiency in tropical country like Ethiopia. Further study is required to assess the deleterious effect of its deficiency on bone mineral homeostasis of growing children in Ethiopia during their most critical period of bone development.	[Wakayo, Tolassa; Belachew, Tefera] Jimma Univ, Jimma, Ethiopia; [Vatanparast, Hassan; Whiting, Susan J.] Univ Saskatchewan, Saskatoon, SK, Canada	Jimma University; University of Saskatchewan	Wakayo, T (corresponding author), Jimma Univ, Jimma, Ethiopia.	wakayotolassa@yahoo.com	Belachew, Tefera/AAO-5877-2020	Ushula, Tolassa Wakayo/0000-0001-6690-3489	College of Pharmacy and Nutrition, University of Saskatchewan	College of Pharmacy and Nutrition, University of Saskatchewan	Financial support was received from College of Pharmacy and Nutrition, University of Saskatchewan. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as Susan J Whiting and Hassan Vatanparast are from College of Pharmacy and Nutrition, University of Saskatchewan that funded this study.	Adams, 2011, VITAMIN D, P979, DOI DOI 10.1016/B978-0-12-381978-9.10054-X; Al-Musharaf S, 2012, EUR J PEDIATR, V171, P1081, DOI 10.1007/s00431-012-1686-8; Al-Othman A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-92; Andiran N, 2012, J CLIN RES PEDIATR E, V4, P25, DOI 10.4274/jcrpe.574; [Anonymous], 2006, Drug Ther Bull, V44, P12; Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Bener A, 2009, INT J FOOD SCI NUTR, V60, P60, DOI 10.1080/09637480802400487; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Cizmecioglu Filiz Mine, 2008, J Clin Res Pediatr Endocrinol, V1, P89, DOI 10.4008/jcrpe.v1i2.43; Egziabher TG, 2013, SO ETHIPIA FOOD NUTR, V34, P429; El-Hajj Fuleihan G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e53; Fares JE, 2003, BONE, V33, P242, DOI 10.1016/S8756-3282(03)00160-1; Garanty-Bogacka B, 2011, ENDOKRYNOL POL, V62, P506; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Goswami R, 2008, J Assoc Physicians India, V56, P755; Grant WB, 2006, J ORTHOMOLEC MED, V21, P37; Grant WB, 2005, ALTERN MED REV, V10, P94; Hanwell HEC, 2010, J STEROID BIOCHEM, V121, P334, DOI 10.1016/j.jsbmb.2010.03.023; Harinarayan CV, 2008, INDIAN J MED RES, V127, P211; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Harinarayan CV, 2004, ASIA PAC J CLIN NUTR, V13, P359; Hatun S, 2005, J NUTR, V135, P218, DOI 10.1093/jn/135.2.218; Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017/S0007114507842826; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Kruger MC, 2011, NUTR RES, V31, P748, DOI 10.1016/j.nutres.2011.09.012; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Maddah Mohsen, 2009, Journal of Nutrition for the Elderly, V28, P386, DOI 10.1080/01639360903393523; Manaseki-Holland S, 2008, INT J VITAM NUTR RES, V78, P16, DOI 10.1024/0300-9831.78.1.16; Marwaha RK, 2007, OSTEOPOROSIS INT, V18, P375, DOI 10.1007/s00198-006-0247-2; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; Moussavi M, 2005, HORM RES, V64, P144, DOI 10.1159/000088588; Neyestani TR, 2012, PUBLIC HEALTH NUTR, V15, P324, DOI 10.1017/S1368980011000188; Papandreou D, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/472173; Puri S, 2008, BRIT J NUTR, V99, P876, DOI 10.1017/S0007114507831758; Rajakumar K, 2011, J CLIN ENDOCR METAB, V96, P1560, DOI 10.1210/jc.2010-2388; Razzaghy-Azar M, 2010, ANN HUM BIOL, V37, P692, DOI 10.3109/03014460903527348; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Sahu M, 2009, CLIN ENDOCRINOL, V70, P680, DOI 10.1111/j.1365-2265.2008.03360.x; Schoenmakers I, 2008, BRIT J NUTR, V99, P1171, DOI 10.1017/S0007114508898662; Talaei A, 2010, INDIAN J ENDOCRINOL, V16, P786; Vatanparast H, 2013, NUTRIENTS, V5, P1561, DOI 10.3390/nu5051561; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Weng FL, 2007, AM J CLIN NUTR, V86, P150, DOI 10.1093/ajcn/86.1.150; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	50	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120963	10.1371/journal.pone.0120963	http://dx.doi.org/10.1371/journal.pone.0120963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822900	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700080
J	Eticha, T; Teklu, A; Ali, D; Solomon, G; Alemayehu, A				Eticha, Tadele; Teklu, Amha; Ali, Dagim; Solomon, Gebremedhin; Alemayehu, Adissu			Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia	PLOS ONE			English	Article							ANTIPSYCHOTIC MEDICATION; TREATMENT NONADHERENCE; PSYCHOTIC DISORDERS; BIPOLAR DISORDER; RELIABILITY; VALIDITY; SCALE; RISK; REHOSPITALIZATION; INTERVENTIONS	Background Non-adherence to antipsychotic medication has a negative impact on the course of illness resulting in increased risk of relapse, rehospitalization and suicide, and increased costs to healthcare systems. The objective of this study was to investigate factors associated with medication adherence among patients with schizophrenia at Ayder Referral Hospital and Mekelle Hospital in Mekelle, Tigray region, Northern Ethiopia. Methods The study was a cross-sectional survey in which sociodemographic characteristics, drug attitudes, insight and side effects were measured and explored in terms of their relationship with medication adherence. A structured questionnaire as a data collection tool was used. Data were analyzed with the help of SPSS Version 20.0. Results A total of 393 patients participated, 26.5% were non-adherent to their antipsychotic medication. The factors significantly associated with better adherence were positive treatment attitudes (AOR = 1.40, 95% CI: 1.26, 1.55), fewer side effects (AOR = 0.97, 95% CI: 0.94, 0.99), awareness of illness (AOR = 1.44, 95% CI: 1.12, 1.85) and the ability to relabel symptoms (AOR = 1.57, 95% CI: 1.19, 2.07). However, khat chewers (AOR = 0.24, 95% CI: 0.09, 0.68), being illiterate (AOR = 0.13, 95% CI: 0.03, 0.47) and older age group (AOR = 0.03, 95% CI: 0.01, 0.16) were associated with less medication adherence. Conclusions A high prevalence of medication non-adherence was found among patients with schizophrenia. Intervention strategies focused on educating the patients to better understand the illness, medications and their potential side effects might be useful in improving adherence to antipsychotic medication treatment.	[Eticha, Tadele; Teklu, Amha; Ali, Dagim; Solomon, Gebremedhin; Alemayehu, Adissu] Mekelle Univ, Dept Pharm, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Dept Pharm, Coll Hlth Sci, Mekelle, Ethiopia.	td.eticha@gmail.com		Hailu, Gebremedhin Solomon/0000-0001-8638-3214				BIRCHWOOD M, 1994, ACTA PSYCHIAT SCAND, V89, P62, DOI 10.1111/j.1600-0447.1994.tb01487.x; Birnbaum Michael, 2008, Patient Prefer Adherence, V2, P233; Buckley PF, 2007, CNS DRUGS, V21, P129, DOI 10.2165/00023210-200721020-00004; Dolder CR, 2002, AM J PSYCHIAT, V159, P103, DOI 10.1176/appi.ajp.159.1.103; Gibson S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-153; Higashi K, 2013, THER ADV PSYCHOPHARM, V70, P1; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; Hudson TJ, 2004, J CLIN PSYCHIAT, V65, P211; Janssen B, 2006, PSYCHOPHARMACOLOGY, V187, P229, DOI 10.1007/s00213-006-0413-4; Acosta FJ, 2012, WORLD J PSYCHIATR, V2, P74, DOI 10.5498/wjp.v2.i5.74; Jonsdottir H, 2013, ACTA PSYCHIAT SCAND, V127, P23, DOI 10.1111/j.1600-0447.2012.01911.x; Kane JM, 2013, WORLD PSYCHIATRY, V12, P216, DOI 10.1002/wps.20060; Kozma CM, 2009, AM HEALTH DRUG BENEF, V2, P31; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Magura Stephen, 2011, Open Addict J, V4, P58; Markowitz M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-246; Morken G, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-32; Mostafa A., 2014, ARAB J PSYCHIAT, V24, P60, DOI [10.12816/0000100, DOI 10.12816/0000100]; Nasrallah HA, 2005, PSYCHIAT SERV, V56, P273, DOI 10.1176/appi.ps.56.3.273; Nose M, 2003, BRIT J PSYCHIAT, V183, P197, DOI 10.1192/bjp.183.3.197; Ruzanna Z, 2010, MJP ONLINE EARLY; Taj Fawad, 2008, J Pak Med Assoc, V58, P432; Teferra S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-168; Tesfay K, 2013, ETHIOP J HEALTH SCI, V23, P227, DOI 10.4314/ejhs.v23i3.5; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; Valenstein M, 2002, MED CARE, V40, P630, DOI 10.1097/00005650-200208000-00002; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Weiden PJ, 2004, PSYCHIAT SERV, V55, P886, DOI 10.1176/appi.ps.55.8.886; Zygmunt A, 2002, AM J PSYCHIAT, V159, P1653, DOI 10.1176/appi.ajp.159.10.1653	29	36	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120560	10.1371/journal.pone.0120560	http://dx.doi.org/10.1371/journal.pone.0120560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816353	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600039
J	Pisoni, A; Turi, Z; Raithel, A; Ambrus, GG; Alekseichuk, I; Schacht, A; Paulus, W; Antal, A				Pisoni, Alberto; Turi, Zsolt; Raithel, Almuth; Ambrus, Geza Gergely; Alekseichuk, Ivan; Schacht, Annekathrin; Paulus, Walter; Antal, Andrea			Separating Recognition Processes of Declarative Memory via Anodal tDCS: Boosting Old Item Recognition by Temporal and New Item Detection by Parietal Stimulation	PLOS ONE			English	Article							EPISODIC MEMORY; FALSE RECOGNITION; MOTOR CORTEX; RETRIEVAL; LOBE; CONFIDENCE; SYSTEMS; NONOCCURRENCES; DISSOCIATION; BRAIN	There is emerging evidence from imaging studies that parietal and temporal cortices act together to achieve successful recognition of declarative information; nevertheless, the precise role of these regions remains elusive. To evaluate the role of these brain areas in declarative memory retrieval, we applied bilateral tDCS, with anode over the left and cathode over the right parietal or temporal cortices separately, during the recognition phase of a verbal learning paradigm using a balanced old-new decision task. In a parallel group design, we tested three different groups of healthy adults, matched for demographic and neurocognitive status: two groups received bilateral active stimulation of either the parietal or the temporal cortex, while a third group received sham stimulation. Accuracy, discriminability index (d') and reaction times of recognition memory performance were measurements of interest. The d' sensitivity index and accuracy percentage improved in both active stimulation groups, as compared with the sham one, while reaction times remained unaffected. Moreover, the analysis of accuracy revealed a different effect of tDCS for old and new item recognition. While the temporal group showed enhanced performance for old item recognition, the parietal group was better at correctly recognising new ones. Our results support an active role of both of these areas in memory retrieval, possibly underpinning different stages of the recognition process.	[Pisoni, Alberto; Turi, Zsolt; Raithel, Almuth; Ambrus, Geza Gergely; Alekseichuk, Ivan; Paulus, Walter; Antal, Andrea] Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Pisoni, Alberto] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Ambrus, Geza Gergely] Univ Jena, Inst Psychol, Jena, Germany; [Schacht, Annekathrin] Univ Gottingen, CRC Text Struct, D-37073 Gottingen, Germany	University of Gottingen; University of Milano-Bicocca; Friedrich Schiller University of Jena; University of Gottingen	Pisoni, A (corresponding author), Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany.	a.pisoni1@campus.unimib.it; zsoltturi@gmail.com	Ambrus, Géza Gergely/G-2716-2014; Paulus, Walter/A-3544-2009; Alekseichuk, Ivan/B-2340-2014; PISONI, ALBERTO/M-6958-2017	Ambrus, Géza Gergely/0000-0002-8400-8178; Paulus, Walter/0000-0001-5549-8377; Alekseichuk, Ivan/0000-0002-2205-4910; PISONI, ALBERTO/0000-0002-8231-9255; Turi, Zsolt/0000-0002-8130-7949	Bernstein Focus Neurotechnology [01GQ0810]	Bernstein Focus Neurotechnology	This study was supported by Bernstein Focus Neurotechnology (01GQ0810) (W.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Berryhill ME, 2007, J NEUROSCI, V27, P14415, DOI 10.1523/JNEUROSCI.4163-07.2007; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Davidson PSR, 2008, NEUROPSYCHOLOGIA, V46, P1743, DOI 10.1016/j.neuropsychologia.2008.01.011; De Rosario-Martinez Helios, 2013, PHIA POSTH INT AN R; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Ghetti S, 2003, J MEM LANG, V48, P722, DOI 10.1016/S0749-596X(03)00005-6; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Jacobson L, 2012, BRAIN RES, V1439, P66, DOI 10.1016/j.brainres.2011.12.036; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Leube DT, 2003, COGNITIVE BRAIN RES, V18, P97, DOI 10.1016/j.cogbrainres.2003.09.008; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Ofen N, 2012, J NEUROSCI, V32, P10012, DOI 10.1523/JNEUROSCI.1082-11.2012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Pergolizzi D, 2015, NEUROPSYCHOLOGIA, V66, P88, DOI 10.1016/j.neuropsychologia.2014.11.012; RCore Team, 2020, R LANG ENV STAT COMP; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Sandrini M, 2012, NEUROPSYCHOLOGIA, V50, P396, DOI 10.1016/j.neuropsychologia.2011.12.011; Schacter DL, 1999, J MEM LANG, V40, P1, DOI 10.1006/jmla.1998.2611; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Singmann H., 2014, AFEX ANAL FACTORIAL; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; STRACK F, 1994, J MEM LANG, V33, P203, DOI 10.1006/jmla.1994.1010; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van den Noort M, 2008, EUR J PSYCHOL ASSESS, V24, P35, DOI 10.1027/1015-5759.24.1.35; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Wolk DA, 2006, BRAIN RES, V1096, P148, DOI 10.1016/j.brainres.2006.04.050	58	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123085	10.1371/journal.pone.0123085	http://dx.doi.org/10.1371/journal.pone.0123085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816233	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600205
J	Dong, XL; Bollen, J				Dong, Xianlei; Bollen, Johan			Computational Models of Consumer Confidence from Large-Scale Online Attention Data: Crowd-Sourcing Econometrics	PLOS ONE			English	Article							TIME-SERIES; COMPLEX	Economies are instances of complex socio-technical systems that are shaped by the interactions of large numbers of individuals. The individual behavior and decision-making of consumer agents is determined by complex psychological dynamics that include their own assessment of present and future economic conditions as well as those of others, potentially leading to feedback loops that affect the macroscopic state of the economic system. We propose that the large-scale interactions of a nation's citizens with its online resources can reveal the complex dynamics of their collective psychology, including their assessment of future system states. Here we introduce a behavioral index of Chinese Consumer Confidence (C3I) that computationally relates large-scale online search behavior recorded by Google Trends data to the macroscopic variable of consumer confidence. Our results indicate that such computational indices may reveal the components and complex dynamics of consumer psychology as a collective socio-economic phenomenon, potentially leading to improved and more refined economic forecasting.	[Dong, Xianlei] Beijing Univ Technol, Sch Econ & Management, Beijing, Peoples R China; [Bollen, Johan] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Beijing University of Technology; Indiana University System; Indiana University Bloomington	Dong, XL (corresponding author), Beijing Univ Technol, Sch Econ & Management, Beijing, Peoples R China.	sddongxianlei@163.com		Dong, Xianlei/0000-0003-4090-8729	Chinese Scholarship Council; NSF [0914939]; Division of Computing and Communication Foundations [1101743] Funding Source: National Science Foundation	Chinese Scholarship Council(China Scholarship Council); NSF(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Xianlei Dong was supported by the Chinese Scholarship Council from 2013-2014. Johan Bollen was supported by NSF Award 0914939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, ENCY MEASUREMENT STA, P649; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Barberis N, 1998, J FINANC ECON, V49, P307, DOI 10.1016/S0304-405X(98)00027-0; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Center CEMA, 2010, CHINA MONTHLY EC FEB, P210; Cureton E.E., 1983, FACTOR ANAL APPL APP; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Deaton A., 1980, EC CONSUMER BEHAV, DOI DOI 10.1017/CBO9780511805653; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Frijda NH, 1994, VARIETIES AFFECT EMO, P197; Fuller W.A., 2009, INTRO STAT TIME SERI, V428; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gujarati D., 2008, MCGRAW HILL ED; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Kietzmann JH, 2011, BUS HORIZONS, V54, P241, DOI 10.1016/j.bushor.2011.01.005; King G, 2014, POLIT ANAL, P1; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pasinetti L. L., 1981, STRUCTURAL CHANGE EC; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Scott S, 2014, INT J MATH MODELLING, V5, P1; Shi Z, 2014, MIS QUART, V38, P123, DOI 10.25300/MISQ/2014/38.1.06; SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Webman J, 2014, 2014 MARKET OUTLOOK; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Yule GU, 1926, J R STAT SOC, V89, P1, DOI 10.2307/2341482	34	7	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120039	10.1371/journal.pone.0120039	http://dx.doi.org/10.1371/journal.pone.0120039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826692	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800012
J	He, PY; Yang, YJ; Qiao, SB; Xu, B; Yao, M; Wu, YJ; Yuan, JQ; Chen, J; Liu, HB; Dai, J; Yang, X; Tang, XR; Wang, Y; Li, W; Gao, RL				He, Peiyuan; Yang, Yuejin; Qiao, Shubin; Xu, Bo; Yao, Min; Wu, Yongjian; Yuan, Jinqing; Chen, Jue; Liu, Haibo; Dai, Jun; Yang, Xiao; Tang, Xinran; Wang, Yang; Li, Wei; Gao, Runlin			Comparison of Short- and Medium-Term Clinical Outcomes between Transradial Approach and Transfemoral Approach in a High-Volume PCI Heart Center in China	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACCESS; ANGIOGRAPHY; CATHETERIZATION; PREVALENCE; TRIALS	Background Transradial approach (TRA) outweighed transfemoral approach (TFA) in acute coronary syndrome patients because the former has better short-term outcomes in high-volume percutaneous coronary intervention (PCI) centers. Our study was one of the limited studies specifically in comparing the short-and medium-term effects of TRA and those of TFA in patients undergoing elective PCIs. Methods A total of 21,242 patients who underwent elective PCI with stent implantation were included. Using propensity score methodology, 1,634 patient pairs were matched. Major clinical outcomes and PCI-related complications between TRA and TFA were compared. Results In the propensity score-matched patients, the rates of in-hospital net adverse clinical events, which included death, myocardial infarction (MI), target vessel revascularization (TVR), stroke, and major bleeding, were much lower with TRA than with TFA (1.8% vs. 3.9%, P < 0.001). This difference was mainly due to the lower rate of major bleeding (0.6% vs. 1.8%, P < 0.001) and the decreased rate of MI (1.1% vs. 1.9%, P = 0.060). PCI-related dissection and thrombosis were similar between the TRA and TFA groups (both P > 0.05). Meanwhile, one-year incidence rates of major adverse cardiovascular events, which included death, MI, and TVR, were also similar (4.1% vs. 4.9%, P = 0.272) in TRA and TFA. Multivariable regression analyses showed that TRA was an independent predictor of the low rate of in-hospital net adverse clinical events (odds ratio, 0.53; 95% confidence interval, 0.40 to 0.71), but not of major adverse cardiovascular events at one-year follow-up (hazard ratio, 1.01; 95% confidence interval, 0.96 to 1.06). Conclusions In patients undergoing elective PCI, TRA patients had lower rates of in-hospital net adverse clinical outcomes compared with TFA patients. TRA might be recommended as a routine approach in high-volume PCI hospitals for elective PCIs.	[He, Peiyuan; Yang, Yuejin; Qiao, Shubin; Xu, Bo; Yao, Min; Wu, Yongjian; Yuan, Jinqing; Chen, Jue; Liu, Haibo; Dai, Jun; Gao, Runlin] Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiol, Beijing 100037, Peoples R China; [He, Peiyuan; Yang, Yuejin; Qiao, Shubin; Xu, Bo; Yao, Min; Wu, Yongjian; Yuan, Jinqing; Chen, Jue; Liu, Haibo; Dai, Jun; Yang, Xiao; Tang, Xinran; Wang, Yang; Li, Wei; Gao, Runlin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis China, Fuwai Hosp, Beijing 100037, Peoples R China; [He, Peiyuan; Yang, Yuejin; Qiao, Shubin; Xu, Bo; Yao, Min; Wu, Yongjian; Yuan, Jinqing; Chen, Jue; Liu, Haibo; Dai, Jun; Yang, Xiao; Tang, Xinran; Wang, Yang; Li, Wei; Gao, Runlin] Peking Union Med Coll, Beijing 100037, Peoples R China; [Yang, Xiao; Tang, Xinran; Wang, Yang; Li, Wei] Chinese Acad Med Sci, Cardiovasc Inst, Med Res & Biometr Ctr, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Yang, YJ (corresponding author), Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiol, Beijing 100037, Peoples R China.	yangyjfw@126.com	Xu, Bo/GQZ-1711-2022	Wu, Yongjian/0000-0002-5590-8396	National Health and Family Planning Commission of the People's Republic of China [201402001]	National Health and Family Planning Commission of the People's Republic of China	This work was supported by 2014 Special fund for scientific research in the public interest by National Health and Family Planning Commission of the People's Republic of China (No. 201402001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso G, 2010, HEART, V96, P1341, DOI 10.1136/hrt.2010.196824; Arzamendi D, 2010, AM J CARDIOL, V106, P148, DOI 10.1016/j.amjcard.2010.02.028; Ball WT, 2011, CIRC-CARDIOVASC INTE, V4, P336, DOI 10.1161/CIRCINTERVENTIONS.110.960864; Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015; Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013; Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; Johnman C, 2012, HEART, V98, P552, DOI 10.1136/heartjnl-2011-301032; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Joyal D, 2012, AM J CARDIOL, V109, P813, DOI 10.1016/j.amjcard.2011.11.007; Kanei Y, 2011, CATHETER CARDIO INTE, V78, P840, DOI 10.1002/ccd.22978; KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220; MEHRAN R, 2011, CIRCULATION, V123, P2736, DOI [10.1161/CIRCULATIONAHA.110.009449, DOI 10.1161/CIRCULATI0NAHA.110.009449]; Natsuaki M, 2012, CARDIOVASC INTERV TH, V27, P84, DOI 10.1007/s12928-012-0098-z; Pristipino C, 2009, HEART, V95, P476, DOI 10.1136/hrt.2008.150714; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P23, DOI 10.1016/j.jcin.2011.08.018; Wang L, 2010, INT J CARDIOL, V145, P246, DOI 10.1016/j.ijcard.2009.08.027; Yatskar L, 2007, CATHETER CARDIO INTE, V69, P961, DOI 10.1002/ccd.21087	21	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118491	10.1371/journal.pone.0118491	http://dx.doi.org/10.1371/journal.pone.0118491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826213	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800005
J	Paixao, L; Oliveira, J; Verissimo, A; Vinga, S; Lourenco, EC; Ventura, MR; Kjos, M; Veening, JW; Fernandes, VE; Andrew, PW; Yesilkaya, H; Neves, AR				Paixao, Laura; Oliveira, Joana; Verissimo, Andre; Vinga, Susana; Lourenco, Eva C.; Rita Ventura, M.; Kjos, Morten; Veening, Jan-Willem; Fernandes, Vitor E.; Andrew, Peter W.; Yesilkaya, Hasan; Neves, Ana Rute			Host Glycan Sugar-Specific Pathways in Streptococcus pneumonia: Galactose as a Key Sugar in Colonisation and Infection	PLOS ONE			English	Article							ACETYLGLUCOSAMINE UTILIZATION PATHWAY; N-ACETYLGLUCOSAMINE; RESPIRATORY-TRACT; GENE-EXPRESSION; BETA-GALACTOSIDASE; NASOPHARYNGEAL COLONIZATION; FUNCTIONAL-ANALYSIS; LACTOCOCCUS-LACTIS; GENOME SEQUENCE; VIRULENCE	The human pathogen Streptococcus pneumoniae is a strictly fermentative organism that relies on glycolytic metabolism to obtain energy. In the human nasopharynx S. pneumoniae encounters glycoconjugates composed of a variety of monosaccharides, which can potentially be used as nutrients once depolymerized by glycosidases. Therefore, it is reasonable to hypothesise that the pneumococcus would rely on these glycan-derived sugars to grow. Here, we identified the sugar-specific catabolic pathways used by S. pneumoniae during growth on mucin. Transcriptome analysis of cells grown on mucin showed specific upregulation of genes likely to be involved in deglycosylation, transport and catabolism of galactose, mannose and N acetylglucosamine. In contrast to growth on mannose and N-acetylglucosamine, S. pneumoniae grown on galactose re-route their metabolic pathway from homolactic fermentation to a truly mixed acid fermentation regime. By measuring intracellular metabolites, enzymatic activities and mutant analysis, we provide an accurate map of the biochemical pathways for galactose, mannose and N-acetylglucosamine catabolism in S. pneumoniae. Intranasal mouse infection models of pneumococcal colonisation and disease showed that only mutants in galactose catabolic genes were attenuated. Our data pinpoint galactose as a key nutrient for growth in the respiratory tract and highlights the importance of central carbon metabolism for pneumococcal pathogenesis.	[Paixao, Laura; Oliveira, Joana; Lourenco, Eva C.; Rita Ventura, M.; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Verissimo, Andre; Vinga, Susana] Univ Lisbon, Ctr Intelligent Syst, Inst Super Tecn, LAETA,IDMEC, P-1699 Lisbon, Portugal; [Kjos, Morten; Veening, Jan-Willem] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Ctr Synthet Biol, Groningen, Netherlands; [Fernandes, Vitor E.; Andrew, Peter W.; Yesilkaya, Hasan] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Universidade Nova de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; University of Groningen; University of Leicester	Neves, AR (corresponding author), Chr Hansen AS, Boge Alle 10-12, DK-2970 Horsholm, Denmark.	dkruns@chr-hansen.com	Andrew, Peter W/G-7526-2012; Paixão, Laura/F-2123-2015; Vinga, Susana/B-8450-2008; Ventura, Rita/B-8011-2008; Verissimo, Andre/H-7446-2017	Paixão, Laura/0000-0002-1697-4737; Vinga, Susana/0000-0002-1954-5487; Ventura, Rita/0000-0002-6854-7278; Verissimo, Andre/0000-0002-2212-339X; Veening, Jan-Willem/0000-0002-3162-6634; Kjos, Morten/0000-0003-4448-9082; E. Fernandes, Vitor/0000-0001-5179-2122; Lourenco, Eva/0000-0001-8370-3972	Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/SAU-MII/100964/2008, PEst-OE/EQB/LA0004/2011, Pest-OE/EME/LA0022]; FCT [SFRH/BD/46997/2008, SFRH/47702/2008, SFRH/BD/97415/2013, IF/00653/2012]; FEBS; European Research Council [337399-PneumoCell]; Netherlands Organisation for Scientific Research (NWO-ALW) [864.12.001]; European Social Fund (ESF) through the Operational Program Human Potential (POPH); MRC [G0501416] Funding Source: UKRI; Medical Research Council [G0501416] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEBS; European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); European Social Fund (ESF) through the Operational Program Human Potential (POPH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, project PTDC/SAU-MII/100964/2008, and through grants PEst-OE/EQB/LA0004/2011 and IDMEC, under LAETA Pest-OE/EME/LA0022. L. Paixao, E. C. Lourenco and A. Verissimo acknowledge FCT for the award of Ph.D. grants SFRH/BD/46997/2008, SFRH/47702/2008 and SFRH/BD/97415/2013, respectively. M. Kjos was supported by a FEBS Long-term fellowship. Work in the lab of J.-W. Veening was supported by European Research Council Starting grant (337399-PneumoCell) and a Vidi fellowship (864.12.001) from the Netherlands Organisation for Scientific Research (NWO-ALW). S. Vinga acknowledges support by Program Investigator FCT (IF/00653/2012) from FCT, co-funded by the European Social Fund (ESF) through the Operational Program Human Potential (POPH). The NMR spectrometers are part of The National NMR Facility, supported by Fundacao para a Ciencia e a Tecnologia (RECI/BBB-BQB/0230/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bortoni ME, 2009, MICROBIOL-SGM, V155, P4123, DOI 10.1099/mic.0.028282-0; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; Brittan JL, 2012, MOL ORAL MICROBIOL, V27, P270, DOI 10.1111/j.2041-1014.2012.00658.x; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Cai J, 2012, J BACTERIOL, V194, P3824, DOI 10.1128/JB.00156-12; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058492; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Chan PF, 2003, J BACTERIOL, V185, P2051, DOI 10.1128/JB.185.6.2051-2058.2003; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; CROW VL, 1982, J BACTERIOL, V151, P600, DOI 10.1128/JB.151.2.600-608.1982; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; EYRISCH O, 1993, CARBOHYD RES, V238, P287, DOI 10.1016/0008-6215(93)87020-S; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Gualdi L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-200; Hajaj B, 2012, INFECT IMMUN, V80, P4333, DOI 10.1128/IAI.00126-12; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; Higgins MA, 2014, J MOL BIOL, V426, P1469, DOI 10.1016/j.jmb.2013.12.006; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; HOMER KA, 1993, INFECT IMMUN, V61, P295, DOI 10.1128/IAI.61.1.295-302.1993; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Jenkinson SF, 2011, ORG LETT, V13, P4064, DOI 10.1021/ol201552q; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; JOHANSEN E, 1992, PLASMID, V27, P200, DOI 10.1016/0147-619X(92)90022-3; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Moye ZD, 2014, APPL ENVIRON MICROB, V80, P5053, DOI 10.1128/AEM.00820-14; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Neves AR, 2010, APPL ENVIRON MICROB, V76, P7048, DOI 10.1128/AEM.01195-10; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; SICARD AM, 1964, GENETICS, V50, P31; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Song JH, 2005, MOL CELLS, V19, P365; Song Xin-Ming, 2008, BMC Res Notes, V1, P64, DOI 10.1186/1756-0500-1-64; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Swiatek MA, 2012, J BACTERIOL, V194, P1136, DOI 10.1128/JB.06370-11; SZABO P, 1989, J CHEM SOC PERK T 1, P919, DOI 10.1039/p19890000919; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMAS TD, 1980, J BACTERIOL, V144, P672, DOI 10.1128/JB.144.2.672-682.1980; Tong HH, 2000, INFECT IMMUN, V68, P921, DOI 10.1128/IAI.68.2.921-924.2000; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; Verissimo A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-283; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WHITE RJ, 1967, BIOCHEM J, V105, P121, DOI 10.1042/bj1050121; Xiao X, 2002, MOL GENET GENOMICS, V267, P429, DOI 10.1007/s00438-002-0640-2; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Yeager AR, 2005, J ORG CHEM, V70, P1269, DOI 10.1021/jo0483670; Yesilkaya H, 2008, FEMS MICROBIOL LETT, V278, P231, DOI 10.1111/j.1574-6968.2007.01003.x; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Yuzenkova Y, 2014, NUCLEIC ACIDS RES, V42, P10987, DOI 10.1093/nar/gku790; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000; Zeng L, 2013, MOL ORAL MICROBIOL, V28, P292, DOI 10.1111/omi.12025; Zeng L, 2012, APPL ENVIRON MICROB, V78, P5597, DOI 10.1128/AEM.01393-12; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	89	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121042	10.1371/journal.pone.0121042	http://dx.doi.org/10.1371/journal.pone.0121042			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826206	Green Published, gold			2022-12-27	WOS:000352084800032
J	Prinzi, N; Sorrenti, S; Baldini, E; De Vito, C; Tuccilli, C; Catania, A; Coccaro, C; Bianchini, M; Nesca, A; Grani, G; Mocini, R; De Antoni, E; D'Armiento, M; Ulisse, S				Prinzi, Natalie; Sorrenti, Salvatore; Baldini, Enke; De Vito, Corrado; Tuccilli, Chiara; Catania, Antonio; Coccaro, Carmela; Bianchini, Marta; Nesca, Angela; Grani, Giorgio; Mocini, Renzo; De Antoni, Enrico; D'Armiento, Massimino; Ulisse, Salvatore			Association of Thyroid Diseases with Primary Extra-Thyroidal Malignancies in Women: Results of a Cross-Sectional Study of 6,386 Patients	PLOS ONE			English	Article							CHILDHOOD-CANCER SURVIVOR; 2ND PRIMARY MALIGNANCIES; BREAST-CANCER; AROMATASE-ACTIVITY; NATIONWIDE COHORT; GRAVES-DISEASE; RISK; HORMONE; CARCINOMA; HYPOTHYROIDISM	We here analyzed the prevalence of extra-thyroidal malignancies (EM) in 6,386 female patients affected by different thyroid disease (TD). At first, an age-matched analysis of EM in all patients was performed. We then evaluated EM prevalence in four TD diagnostic categories: non-nodular TD (n = 2,159); solitary nodule (n = 905); multinodular TD (n = 2,871); differentiated thyroid cancers (n = 451). Finally, patients were grouped based on the absence (n = 3,820) or presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase (TPOAb) (n = 2,369), or anti-Thyroid Stmulating Hormone (TSH) receptor autoantibodies (n = 197). A total of 673 EM were recorded. EM prevalence in TD patients was higher compared to the general population (Odds Ratio, OR 3.21) and the most frequent EM was breast cancer (OR 3.94), followed by colorectal (OR 2.18), melanoma (OR 6.71), hematological (OR 8.57), uterus (OR 2.52), kidney (OR 3.40) and ovary (OR 2.62) neoplasms. Age-matched analysis demonstrated that the risk of EM was maximal at age 0-44 yr (OR 11.28), remaining lower, but significantly higher that in the general population, in the 45-59 and 60-74 year age range. Breast and hematological malignancies showed an increased OR in all TD, while other cancers associated with specific TD. An increased OR for melanoma, breast and hematological malignancies was observed in both TPOAb and/or TgAb autoantibody negative and positive patients, while colorectal, uterus, kidney and ovary cancers showed an increased OR only in thyroid autoantibody negative patients. In conclusions, women affected by both benign and malignant TD, especially at a younger age and in absence of thyroid autoimmunity, have an increased risk of developing primary EM, thus requiring a careful follow-up and surveillance.	[Prinzi, Natalie; Baldini, Enke; Tuccilli, Chiara; Coccaro, Carmela; Bianchini, Marta; Nesca, Angela; Grani, Giorgio; D'Armiento, Massimino; Ulisse, Salvatore] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Sorrenti, Salvatore; Catania, Antonio; Mocini, Renzo; De Antoni, Enrico] Univ Roma La Sapienza, Dept Surg Sci, I-00185 Rome, Italy; [De Vito, Corrado] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Ulisse, S (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	salvatore.ulisse@uniroma1.it	Sorrenti, Salvatore/AGZ-2978-2022; Ulisse, Salvatore/H-5362-2019; Prinzi, Natalie/AAA-7518-2019; Grani, Giorgio/D-7968-2011	Sorrenti, Salvatore/0000-0003-0427-6648; Ulisse, Salvatore/0000-0002-7573-0759; Prinzi, Natalie/0000-0002-6261-7239; Grani, Giorgio/0000-0002-0388-1283; CATANIA, Antonio/0000-0003-0424-1189; DE VITO, CORRADO/0000-0002-7846-672X				AGHINILOMBARDI F, 1993, NATO ADV SCI INST SE, V241, P403; Armstrong GT, 2010, RADIAT RES, V174, P840, DOI 10.1667/RR1903.1; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Berthe E, 2004, EUR J NUCL MED MOL I, V31, P685, DOI 10.1007/s00259-003-1448-y; Bhatti P, 2010, RADIAT RES, V174, P741, DOI 10.1667/RR2240.1; Bonora E, 2010, J ONCOL, V2010, DOI 10.1155/2010/385206; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Canchola AJ, 2006, AM J EPIDEMIOL, V163, P521, DOI 10.1093/aje/kwj072; Cecconi S, 1999, ENDOCRINOLOGY, V140, P1783, DOI 10.1210/en.140.4.1783; Chen YK, 2013, BRIT J CANCER, V109, P2496, DOI 10.1038/bjc.2013.597; Chen YK, 2013, THYROID, V23, P880, DOI 10.1089/thy.2012.0568; Chuang SC, 2006, CANCER LETT, V238, P42, DOI 10.1016/j.canlet.2005.06.015; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; Danese D, 1997, J EXP CLIN CANC RES, V16, P337; De Remigis A, 2015, INT J CANCER, V136, P127, DOI 10.1002/ijc.28973; Ditsch N, 2010, ANTICANCER RES, V30, P1713; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gharib M, 2011, THYROID INT, V1, P3, DOI DOI 10.1186/1687-9856-2011-3; Hardefeldt PJ, 2012, BREAST CANCER RES TR, V133, P1169, DOI 10.1007/s10549-012-2019-3; Kuijpens JLP, 2005, THYROID, V15, P1253, DOI 10.1089/thy.2005.15.1253; Lal G, 2012, ANN SURG ONCOL, V19, P1887, DOI 10.1245/s10434-011-2193-2; Mehanna HM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b733; Nikiforov Y.E., 2009, DIAGNOSTIC PATHOLOGY; Nogueira CR, 1996, J STEROID BIOCHEM, V59, P271, DOI 10.1016/S0960-0760(96)00117-3; Paschke R, 2011, LANGENBECK ARCH SURG, V396, P1127, DOI 10.1007/s00423-011-0788-5; Pisani T, 2003, ANTICANCER RES, V23, P3323; Prinzi N, 2014, BREAST CANCER RES TR, V144, P683, DOI 10.1007/s10549-014-2893-y; Ronckers CM, 2005, INT J CANCER, V117, P281, DOI 10.1002/ijc.21064; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sandeep TC, 2006, J CLIN ENDOCR METAB, V91, P1819, DOI 10.1210/jc.2005-2009; Sandhu MK, 2009, BREAST CANCER RES TR, V115, P635, DOI 10.1007/s10549-008-0104-4; Sarlis Nicholas J, 2002, Hormones (Athens), V1, P35; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Shu X, 2010, BRIT J CANCER, V102, P1397, DOI 10.1038/sj.bjc.6605624; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Smyth PPA, 1998, J CLIN ENDOCR METAB, V83, P2711, DOI 10.1210/jc.83.8.2711; Subramanian S, 2007, THYROID, V17, P1277, DOI 10.1089/thy.2007.0171; Taylor AJ, 2009, INT J CANCER, V125, P2400, DOI 10.1002/ijc.24581; Terracini B, 2010, EPIDEMIOL PREV, V34, P1; Trimboli P, 2006, THYROID, V16, P1151, DOI 10.1089/thy.2006.16.1151; ULISSE S, 1994, J ENDOCRINOL, V140, P431, DOI 10.1677/joe.0.1400431; ULISSE S, 1994, MOL CELL ENDOCRINOL, V105, P45, DOI 10.1016/0303-7207(94)90034-5; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030	44	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122958	10.1371/journal.pone.0122958	http://dx.doi.org/10.1371/journal.pone.0122958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826596	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800101
J	Beier, JI; Jokinen, JD; Holz, GE; Whang, PS; Martin, AM; Warner, NL; Arteel, GE; Lukashevich, IS				Beier, Juliane I.; Jokinen, Jenny D.; Holz, Gretchen E.; Whang, Patrick S.; Martin, Amah M.; Warner, Nikole L.; Arteel, Gavin E.; Lukashevich, Igor S.			Novel Mechanism of Arenavirus-Induced Liver Pathology	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; BOLIVIAN HEMORRHAGIC-FEVER; FATAL LASSA FEVER; CELL-CYCLE ARREST; RHESUS MACAQUES; PARTIAL-HEPATECTOMY; ALPHA-DYSTROGLYCAN; MEDIATED HEPATITIS; VIRAL-HEPATITIS; INFECTION	Viral hemorrhagic fevers (VHFs) encompass a group of diseases with cardinal symptoms of fever, hemorrhage, and shock. The liver is a critical mediator of VHF disease pathogenesis and high levels of ALT/AST transaminases in plasma correlate with poor prognosis. In fact, Lassa Fever (LF), the most prevalent VHF in Africa, was initially clinically described as hepatitis. Previous studies in non-human primate (NHP) models also correlated LF pathogenesis with a robust proliferative response in the liver. The purpose of the current study was to gain insight into the mechanism of liver injury and to determine the potential role of proliferation in LF pathogenesis. C57Bl/6J mice were infected with either the pathogenic (for NHPs) strain of lymphocytic choriomeningitis virus (LCMV, the prototypic arenavirus), LCMV-WE, or with the non-pathogenic strain, LCMV-ARM. As expected, LCMV-WE, but not ARM, caused a hepatitis-like infection. LCMV-WE also induced a robust increase in the number of actively cycling hepatocytes. Despite this increase in proliferation, there was no significant difference in liver size between LCMV-WE and LCMV-ARM, suggesting that cell cycle was incomplete. Indeed, cells appeared arrested in the G(1) phase and LCMV-WE infection increased the number of hepatocytes that were simultaneously stained for proliferation and apoptosis. LCMV-WE infection also induced expression of a non-conventional virus receptor, AXL-1, from the TAM (TYRO3/AXL/MERTK) family of receptor tyrosine kinases and this expression correlated with proliferation. Taken together, these results shed new light on the mechanism of liver involvement in VHF pathogenesis. Specifically, it is hypothesized that the induction of hepatocyte proliferation contributes to expansion of the infection to parenchymal cells. Elevated levels of plasma transaminases are likely explained, at least in part, by abortive cell cycle arrest induced by the infection. These results may lead to the development of new therapies to prevent VHF progression.	[Beier, Juliane I.; Jokinen, Jenny D.; Holz, Gretchen E.; Martin, Amah M.; Arteel, Gavin E.; Lukashevich, Igor S.] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Whang, Patrick S.; Warner, Nikole L.; Lukashevich, Igor S.] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Beier, Juliane I.; Jokinen, Jenny D.; Holz, Gretchen E.; Whang, Patrick S.; Warner, Nikole L.; Lukashevich, Igor S.] Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY USA	University of Louisville; University of Louisville	Lukashevich, IS (corresponding author), Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	isluka01@louisville.edu	Arteel, Gavin/AAE-2440-2022	Arteel, Gavin/0000-0002-2253-5984; Warner, Nikole/0000-0002-2307-5529	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI093450];  [R01AA021978]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021978] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research reported in this publication was supported at least in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI093450 (to ISL). Additional funding has come from R01AA021978 (to GEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 2010, EMERG INFECT DIS, V16, P1093, DOI 10.3201/eid1607.091902; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Arteel GE, 2008, TOXICOL APPL PHARM, V226, P128, DOI 10.1016/j.taap.2007.08.020; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; Beier JI, 2008, J PHARMACOL EXP THER, V325, P801, DOI 10.1124/jpet.108.136721; Beier JI, 2009, HEPATOLOGY, V49, P1545, DOI 10.1002/hep.22847; Bergthaler A, 2007, J GEN VIROL, V88, P592, DOI 10.1099/vir.0.82428-0; Boehme KW, 2013, J VIROL, V87, P12967, DOI 10.1128/JVI.02080-13; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; CALLIS RT, 1982, AM J TROP MED HYG, V31, P1038, DOI 10.4269/ajtmh.1982.31.1038; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; CHILD PL, 1967, ARCH PATHOL, V83, P434; CORNELL RP, 1990, HEPATOLOGY, V11, P916, DOI 10.1002/hep.1840110603; CORNELL RP, 1985, AM J PHYSIOL, V249, pR563, DOI 10.1152/ajpregu.1985.249.5.R563; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; Djavani M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-20; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Dwyer EJC, 2000, J VIROL, V74, P3293, DOI 10.1128/JVI.74.7.3293-3300.2000; Dylla Douglas E, 2011, Genet Vaccines Ther, V9, P8, DOI 10.1186/1479-0556-9-8; EVARTS RP, 1989, CANCER RES, V49, P1541; Falzarano D, 2013, CURR OPIN VIROL, V3, P343, DOI 10.1016/j.coviro.2013.04.007; FARBER E, 1956, CANCER RES, V16, P142; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Fletcher NF, 2014, HEPATOLOGY, V59, P1320, DOI 10.1002/hep.26911; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Goncalves AR, 2013, J VIROL, V87, P11504, DOI 10.1128/JVI.01893-13; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Hayes MW, 2012, J VIROL, V86, P7216, DOI 10.1128/JVI.06508-11; Hensley LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-205; Higgins GM, 1931, ARCH PATHOL, V12, P186; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Kunz S, 2009, THROMB HAEMOSTASIS, V102, P1024, DOI 10.1160/TH09-06-0357; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Lang PA, 2010, CELL PHYSIOL BIOCHEM, V26, P263, DOI 10.1159/000320549; Li G, 2010, RETROVIROLOGY, V7, DOI [10.1186/1742-4690-1187-1159, DOI 10.1186/1742-4690-1187-1159]; Lukashevich IS, 2006, CURR GENOMICS, V7, P351, DOI 10.2174/138920206778948673; Lukashevich IS, 2013, EXPERT REV VACCINES, V12, P71, DOI [10.1586/erv.12.139, 10.1586/ERV.12.139]; Lukashevich IS, 2004, ARCH VIROL, V149, P2319, DOI 10.1007/s00705-004-0385-9; Lukashevich IS, 2003, J VIROL, V77, P1727, DOI 10.1128/JVI.77.3.1727-1737.2003; Lukashevich IS, 2002, J MED VIROL, V67, P171, DOI 10.1002/jmv.2206; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCCORMICK JB, 1986, AM J TROP MED HYG, V35, P401, DOI 10.4269/ajtmh.1986.35.401; McLay LJ, 2013, J GEN VIROLOGY; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MONTALI RJ, 1993, J INFECT DIS, V167, P946, DOI 10.1093/infdis/167.4.946; MONTALI RJ, 1989, J INFECT DIS, V160, P759, DOI 10.1093/infdis/160.5.759; Moraz ML, 2011, EXPERT REV ANTI-INFE, V9, P49, DOI 10.1586/ERI.10.142; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, P83; PETERS CJ, 1987, CURR TOP MICROBIOL, V134, P5; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; Salvato M.S., 2012, VIRUS TAXONOMY, P715; Shimojima M, 2012, J VET MED SCI, V74, P1363, DOI 10.1292/jvms.12-0176; Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; TERRELL TG, 1973, AM J PATHOL, V73, P477; von Montfort C, 2010, AM J PHYSIOL-GASTR L, V298, pG657, DOI 10.1152/ajpgi.00107.2009; WALKER DH, 1975, B WORLD HEALTH ORGAN, V52, P523; WALKER DH, 1982, AM J PATHOL, V107, P349; Wang T, 2000, TOXICOL APPL PHARM, V166, P92, DOI 10.1006/taap.2000.8952; WINN WC, 1975, ARCH PATHOL, V99, P599; Zapata JC, 2011, ANTIVIR RES, V92, P125, DOI 10.1016/j.antiviral.2011.07.015; Zapata JC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002406; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075; Zinkernagel RM, 2002, CURR TOP MICROBIOL, V263, P1	77	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122839	10.1371/journal.pone.0122839	http://dx.doi.org/10.1371/journal.pone.0122839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822203	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700203
J	Fuster-Parra, P; Bennasar-Veny, M; Tauler, P; Yanez, A; Lopez-Gonzalez, A; Aguilo, A				Fuster-Parra, Pilar; Bennasar-Veny, Miquel; Tauler, Pedro; Yanez, Aina; Lopez-Gonzalez, A.; Aguilo, Antoni			A Comparison between Multiple Regression Models and CUN-BAE Equation to Predict Body Fat in Adults	PLOS ONE			English	Article							MASS INDEX; RISK-FACTORS; SEX; AGE	Background Because the accurate measure of body fat (BF) is difficult, several prediction equations have been proposed. The aim of this study was to compare different multiple regression models to predict BF, including the recently reported CUN-BAE equation. Methods Multi regression models using body mass index (BMI) and body adiposity index (BAI) as predictors of BF will be compared. These models will be also compared with the CUN-BAE equation. For all the analysis a sample including all the participants and another one including only the overweight and obese subjects will be considered. The BF reference measure was made using Bioelectrical Impedance Analysis. Results The simplest models including only BMI or BAI as independent variables showed that BAI is a better predictor of BF. However, adding the variable sex to both models made BMI a better predictor than the BAI. For both the whole group of participants and the group of overweight and obese participants, using simple models (BMI, age and sex as variables) allowed obtaining similar correlations with BF as when the more complex CUN-BAE was used (rho = 0:87 vs rho= 0:86 for the whole sample and rho= 0:88 vs rho= 0:89 for overweight and obese subjects, being the second value the one for CUN-BAE). Conclusions There are simpler models than CUN-BAE equation that fits BF as well as CUN-BAE does. Therefore, it could be considered that CUN-BAE overfits. Using a simple linear regression model, the BAI, as the only variable, predicts BF better than BMI. However, when the sex variable is introduced, BMI becomes the indicator of choice to predict BF.	[Fuster-Parra, Pilar] Univ Illes Balears, Dept Math & Comp Sci, Palma De Mallorca, Baleares, Spain; [Fuster-Parra, Pilar; Bennasar-Veny, Miquel; Tauler, Pedro; Aguilo, Antoni] Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Baleares, Spain; [Yanez, Aina] Univ Hosp Son Espases, Inst Invest Sanitaria Palma IdISPa, Palma De Mallorca, Spain; [Lopez-Gonzalez, A.] Hosp Manacor, Balear Isl Hlth Serv, GESMA, Prevent Occupat Risks Hlth Serv, Manacor, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital de Manacor	Fuster-Parra, P (corresponding author), Univ Illes Balears, Dept Math & Comp Sci, Palma De Mallorca, Baleares, Spain.	pilar.fuster@uib.es	López, Ángel Arturo/AAN-2248-2021; Tauler, Pedro/M-4126-2018; Bennasar-Veny, Miquel/C-5881-2008; Yañez, Aina M/AAF-7087-2021; Fuster-Parra, Pilar/L-4662-2014	López, Ángel Arturo/0000-0002-7439-8117; Tauler, Pedro/0000-0003-0841-1720; Bennasar-Veny, Miquel/0000-0003-1668-2141; Yañez, Aina M/0000-0001-8527-3937; Fuster-Parra, Pilar/0000-0003-2929-1625	Spanish Ministry of Science and Innovation [PI 13/01477]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (PI 13/01477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, AM J CLIN NUTR, V64, P524, DOI DOI 10.1093/ajcn/64.3.524S; BAUMGARTNER RN, 1991, AM J CLIN NUTR, V53, P1345, DOI 10.1093/ajcn/53.6.1345; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; BURTON BT, 1985, INT J OBESITY, V9, P155; Dupler TL, 2000, J GERONTOL A-BIOL, V55, pM180, DOI 10.1093/gerona/55.3.M180; Ferguson T. S., 1996, COURSE LARGE SAMPLE; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Lopez AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035281; Martarelli D, 2008, EUR J NUTR, V47, P409, DOI 10.1007/s00394-008-0742-7; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; R Core Team, 2021, R LANGUAGE ENV STAT; Seber, 2012, LINEAR REGRESSION AN; St-Onge MP, 2005, CURR OPIN CLIN NUTR, V8, P523; VISSER M, 1994, BRIT J NUTR, V71, P823, DOI 10.1079/BJN19940189; World Health Organization, 1998, OB PREV ANDM GLOB EP	24	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122291	10.1371/journal.pone.0122291	http://dx.doi.org/10.1371/journal.pone.0122291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821960	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700162
J	Mousavi, SJ; Doweidar, MH				Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.			Three-Dimensional Numerical Model of Cell Morphology during Migration in Multi-Signaling Substrates	PLOS ONE			English	Article							CURRENT ELECTRIC-FIELD; SHAPE CHANGES; FIBROBLAST MOTILITY; HUMAN KERATINOCYTES; CANCER CELLS; MYOSIN-II; CHEMOTAXIS; MOVEMENT; SURFACE; ACTIN	Cell Migration associated with cell shape changes are of central importance in many biological processes ranging from morphogenesis to metastatic cancer cells. Cell movement is a result of cyclic changes of cell morphology due to effective forces on cell body, leading to periodic fluctuations of the cell length and cell membrane area. It is well-known that the cell can be guided by different effective stimuli such as mechanotaxis, thermotaxis, chemotaxis and/or electrotaxis. Regulation of intracellular mechanics and cell's physical interaction with its substrate rely on control of cell shape during cell migration. In this notion, it is essential to understand how each natural or external stimulus may affect the cell behavior. Therefore, a three-dimensional (3D) computational model is here developed to analyze a free mode of cell shape changes during migration in a multi-signaling micro-environment. This model is based on previous models that are presented by the same authors to study cell migration with a constant spherical cell shape in a multi-signaling substrates and mechanotaxis effect on cell morphology. Using the finite element discrete methodology, the cell is represented by a group of finite elements. The cell motion is modeled by equilibrium of effective forces on cell body such as traction, protrusion, electrostatic and drag forces, where the cell traction force is a function of the cell internal deformations. To study cell behavior in the presence of different stimuli, the model has been employed in different numerical cases. Our findings, which are qualitatively consistent with well-known related experimental observations, indicate that adding a new stimulus to the cell substrate pushes the cell to migrate more directionally in more elongated form towards the more effective stimuli. For instance, the presence of thermotaxis, chemotaxis and electrotaxis can further move the cell centroid towards the corresponding stimulus, respectively, diminishing the mechanotaxis effect. Besides, the stronger stimulus imposes a greater cell elongation and more cell membrane area. The present model not only provides new insights into cell morphology in a multi-signaling micro-environment but also enables us to investigate in more precise way the cell migration in the presence of different stimuli.	[Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Grp Struct Mech & Mat Modeling GEMM, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Univ Zaragoza, Sch Engn & Architecture EINA, Dept Mech Engn, Zaragoza, Spain; [Jamaleddin Mousavi, Seyed; Doweidar, Mohamed H.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Doweidar, MH (corresponding author), Univ Zaragoza, Grp Struct Mech & Mat Modeling GEMM, Aragon Inst Engn Res I3A, Zaragoza, Spain.	mohamed@unizar.es	Doweidar, Mohamed H./F-2140-2016; Doweidar, Mohamed H./HGF-0661-2022	Doweidar, Mohamed H./0000-0003-0088-7222; 	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2013-46467-C4-3-R]	Spanish Ministry of Economy and Competitiveness (MINECO)	The Spanish Ministry of Economy and Competitiveness (MINECO), https://sede.micinn.gob.es/, MAT2013-46467-C4-3-R, MHD. Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), http://www.ciber-bbn.es/es/quienes-somos, MHD.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; ALBRECHTBUEHLER G, 1981, COLD SPRING HARB SYM, V46, P45; Allena R, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P14; Allena R, 2013, B MATH BIOL, V75, P288, DOI 10.1007/s11538-012-9806-1; Allena R, 2012, J THEOR BIOL, V306, P15, DOI 10.1016/j.jtbi.2012.03.041; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Bahat A, 2006, MOL CELL ENDOCRINOL, V252, P115, DOI 10.1016/j.mce.2006.03.027; Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Chang PCT, 1996, J FORMOS MED ASSOC, V95, P623; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; COOPER MS, 1986, J CELL BIOL, V102, P1384, DOI 10.1083/jcb.102.4.1384; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Elliott CM, 2012, J R SOC INTERFACE, V9, P3027, DOI 10.1098/rsif.2012.0276; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fraser SP, 2002, BREAST CANCER RES TR, V76, pS142; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gao RC, 2011, EUKARYOT CELL, V10, P1251, DOI 10.1128/EC.05066-11; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; Grahn JC, 2003, WOUND REPAIR REGEN, V11, P64, DOI 10.1046/j.1524-475X.2003.11110.x; Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Han SJ, 2011, COMPUT METHOD BIOMEC, V14, P459, DOI 10.1080/10255842.2011.554412; Hannezo E, 2014, P NATL ACAD SCI USA, V111, P27, DOI 10.1073/pnas.1312076111; Hibbit Karlson, ABAQUS THEORY MANUAL; Higazi AAR, 1996, PLACENTA, V17, P683, DOI 10.1016/S0143-4004(96)80019-1; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; HONG CB, 1983, P NATL ACAD SCI-BIOL, V80, P5646, DOI 10.1073/pnas.80.18.5646; Huang YX, 2011, BIOSENS BIOELECTRON, V26, P2114, DOI 10.1016/j.bios.2010.09.016; Illingworth C. M., 1980, Clinical Physics and Physiological Measurement, V1, P87, DOI 10.1088/0143-0815/1/1/007; Jaffe L F, 1984, Clin Dermatol, V2, P34, DOI 10.1016/0738-081X(84)90025-7; Mousavi SJ, 2013, J THEOR BIOL, V329, P64, DOI 10.1016/j.jtbi.2013.03.021; JAMES DW, 1969, EXP CELL RES, V54, P107, DOI 10.1016/0014-4827(69)90299-7; Jimenez JA, 2003, J WATERW PORT C-ASCE, V129, P70, DOI 10.1061/(ASCE)0733-950X(2003)129:2(70); Kabaso D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001127; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim MC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002926; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lee YH, 2013, INTEGR BIOL-UK, V5, P1447, DOI 10.1039/c3ib40161h; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Long HY, 2011, CELL BIOCHEM BIOPHYS, V61, P481, DOI 10.1007/s12013-011-9231-3; Loth E, 2008, POWDER TECHNOL, V182, P342, DOI 10.1016/j.powtec.2007.06.001; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; MATSUDA M, 1985, INVEST OPHTH VIS SCI, V26, P443; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Mousavi SJ, 2014, COMPUT METHOD BIOMEC, V17, P678, DOI 10.1080/10255842.2012.710841; Mousavi SJ, 2013, MOL CELL BIOMECH, V10, P1; Mousavi SJ, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026002; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Neilson MP, 2011, SIAM J SCI COMPUT, V33, P1035, DOI 10.1137/100788938; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Ni Y, 2007, SOFT MATTER, V3, P1285, DOI 10.1039/b703376a; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; ONUMA EK, 1985, CELL CALCIUM, V6, P281, DOI 10.1016/0143-4160(85)90012-0; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; Palsson E, 2001, FUTURE GENER COMP SY, V17, P835, DOI 10.1016/S0167-739X(00)00062-5; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; Satulovsky J, 2008, BIOPHYS J, V94, P3671, DOI 10.1529/biophysj.107.117002; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Schafer A, 2005, ACTA BIOMATER, V1, P273, DOI 10.1016/j.actbio.2005.02.004; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Sheetz Michael P., 1999, P233; Sheridan DM, 1996, J INVEST DERMATOL, V106, P642, DOI 10.1111/1523-1747.ep12345456; Stokes GG., 1951, T CAMB PHIL SOC, V9; SULIK GL, 1992, ACTA OPHTHALMOL, V70, P115; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Tran-Cong S, 2004, POWDER TECHNOL, V139, P21, DOI 10.1016/j.powtec.2003.10.002; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Van Haastert PJM, 2010, J CELL SCI, V123, P3031, DOI 10.1242/jcs.071118; van Oers RFM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003774; Vermolen FJ, 2013, BIOMECH MODEL MECHAN, V12, P301, DOI 10.1007/s10237-012-0400-0; Verworn M, 1889, PFLUGERS ARCH GES PH, V45, P1, DOI [10.1007/BF01789713, DOI 10.1007/BF01789713]; Vroomans RMA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002763; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zhang S, 2008, CURR BIOL, V18, P1587, DOI 10.1016/j.cub.2008.08.069; Zhao M, 1997, CURR EYE RES, V16, P973, DOI 10.1076/ceyr.16.10.973.9014; Zhao M, 1996, INVEST OPHTH VIS SCI, V37, P2548; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	112	15	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122094	10.1371/journal.pone.0122094	http://dx.doi.org/10.1371/journal.pone.0122094			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822332	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700154
J	Lu, XL; Tong, YF; Liu, Y; Lixu, Y; Yang, H; Zhang, GY; Li, XH; Zhang, HG				Lu, Xiao Lan; Tong, Yang Fei; Liu, Ya; Lixu, Ya; Yang, Hua; Zhang, Guo Yuan; Li, Xiao-Hui; Zhang, Hai-Gang			Gaq Protein Carboxyl Terminus Imitation Polypeptide GCIP-27 Improves Cardiac Function in Chronic Heart Failure Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; KINASE-C; SARCOPLASMIC-RETICULUM; GENE-EXPRESSION; INDUCED HYPERTROPHY; SIGNALING PATHWAYS; MYOCYTE APOPTOSIS; CHLORAL HYDRATE; TASK-FORCE; ACTIVATION	Background Gaq protein carboxyl terminus imitation polypeptide (GCIP)-27 has been shown to alleviate pathological cardiomyocyte hypertrophy induced by various factors. Pathological cardiac hypertrophy increases the morbidity and mortality of cardiovascular diseases while it compensates for poor heart function. This study was designed to investigate the effects of GCIP-27 on heart function in rats with heart failure induced by doxorubicin. Methods and Results Forty-eight rats were randomly divided into the following six groups receiving vehicle (control), doxorubicin (Dox), losartan (6 mg/kg, i.g.) and three doses of GCIP-27 (10, 30, 90 mu g/kg; i.p., bid), respectively. Heart failure was induced by Dox, which was administered at a 20 mg/kg cumulative dose. After 10 weeks of treatment, we observed that GCIP-27 (30, 90 mu g/kg) significantly increased ejection fraction, fraction shortening, stroke volume and sarcoplasmic reticulum Ca2+ ATPase activity of Dox-treated hearts. Additionally, GCIP-27 decreased myocardial injury, heart weight index and left ventricular weight index, fibrosis and serum cardiac troponin-I concentration in Dox-treated mice. Immunohistochemistry, western blotting and real-time PCR experiments indicated that GCIP-27 (10-90 mu g/kg) could markedly upregulate the protein expression of myocardial alpha-myosin heavy chain (MHC), Bcl-2, protein kinase C (PKC) epsilon and phosphorylated extracellular signal-regulated kinase (p-ERK) 1/2 as well as the mRNA expression of alpha-MHC, but downregulated the expression of beta-MHC, Bax and PKC beta II, and the mRNA expression levels of beta-MHC in Doxtreated mice. It was also found that GCIP-27 (30, 90 mu g/L) decreased cell size and protein content of cardiomyocytes significantly in vitro by comparison of Dox group. Conclusions GCIP-27 could effectively ameliorate heart failure development induced by Dox. PKC-ERK1/2 signaling might represent the underlying mechanism of the beneficial effects of GCIP-27.	[Lu, Xiao Lan; Tong, Yang Fei; Yang, Hua; Zhang, Hai-Gang] Third Mil Med Univ, Coll Pharm, Dept Pharmacol, Chongqing 400038, Peoples R China; [Lu, Xiao Lan; Zhang, Guo Yuan] North Sichuan Med Coll, Affiliated Hosp 1, Dept Clin Lab, Nanchong 637000, Sichuan, Peoples R China; [Liu, Ya] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing 40038, Peoples R China; [Liu, Ya; Li, Xiao-Hui] Third Mil Med Univ, Dept Pharmaceut, Coll Pharm, Chongqing 40038, Peoples R China; [Lixu, Ya] Third Mil Med Univ, Dept Ultrasound, Affiliated Hosp 2, Chongqing 400037, Peoples R China	Army Medical University; North Sichuan Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, HG (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Pharmacol, Chongqing 400038, Peoples R China.	hg2ster@gmail.com	lu, xl/HDO-8340-2022		National Key New Drug Development Project of China [2009ZX09103-052]; National Natural Science Foundation of China [30973524]; Basic and Frontier Research Program of Natural Science Foundation of Chongqing, China [CSTC2013jcyjA10094]	National Key New Drug Development Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic and Frontier Research Program of Natural Science Foundation of Chongqing, China	This research was supported by grants from the National Key New Drug Development Project of China (2009ZX09103-052), the National Natural Science Foundation of China (No. 30973524), and the Basic and Frontier Research Program of Natural Science Foundation of Chongqing, China (No. CSTC2013jcyjA10094).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Baxter MG, 2009, ANESTHESIOLOGY, V111, P209, DOI 10.1097/ALN.0b013e3181a8617e; Benavides-Vallve C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041691; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Cahalin LP, 1996, PHYS THER, V76, P516, DOI 10.1093/ptj/76.5.516; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Cheng Y, 2011, AM J PHYSIOL-HEART C, V301, pH1438, DOI 10.1152/ajpheart.00440.2011; Dalal HM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000787; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DONG R, 1992, J CLIN INVEST, V90, P2022, DOI 10.1172/JCI116082; Farah VMA, 2000, BRAZ J MED BIOL RES, V33, P1491, DOI 10.1590/S0100-879X2000001200014; Francis Gary S., 2001, American Journal of Medicine, V110, p37S; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hartong R, 1996, J MOL CELL CARDIOL, V28, P2467, DOI 10.1006/jmcc.1996.0239; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hung KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091074; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Kjaer A, 2001, CLIN PHYSIOL, V21, P661, DOI 10.1046/j.1365-2281.2001.00371.x; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Liu JM, 2014, AM J PHYSIOL-HEART C, V307, pH987, DOI 10.1152/ajpheart.00990.2013; Maud P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/802539; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Merlo M, 2014, EUR J HEART FAIL, V16, P317, DOI 10.1002/ejhf.16; Migrino RQ, 2008, ULTRASOUND MED BIOL, V34, P208, DOI 10.1016/j.ultrasmedbio.2007.07.018; Monnerat-Cahli G, 2014, J MOL CELL CARDIOL, V76, P116, DOI 10.1016/j.yjmcc.2014.08.012; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Pass JM, 2001, AM J PHYSIOL-HEART C, V281, pH2500, DOI 10.1152/ajpheart.2001.281.6.H2500; Qi M, 1996, AM J PHYSIOL-HEART C, V271, pH1031, DOI 10.1152/ajpheart.1996.271.3.H1031; Qin FZ, 2005, BBA-MOL BASIS DIS, V1740, P499, DOI 10.1016/j.bbadis.2004.11.007; Rabelo E, 2001, HYPERTENSION, V38, P576, DOI 10.1161/hy09t1.096185; ROGERS TB, 1990, J BIOL CHEM, V265, P4302; Sankar V, 2012, CAN J PHYSIOL PHARM, V90, P627, DOI [10.1139/Y2012-047, 10.1139/y2012-047]; Sheng R, 2013, INT J CARDIOL, V162, P199, DOI 10.1016/j.ijcard.2011.07.083; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Sutsch G, 1997, CARDIOVASC DRUG THER, V10, P717, DOI 10.1007/BF00053029; Szuba A, 2011, ANN AGR ENV MED, V18, P260; Takahashi H, 2004, EUR J CLIN INVEST, V34, P85, DOI 10.1111/j.1365-2362.2004.01304.x; van Leeuwen BL, 2000, ANN ONCOL, V11, P1121, DOI 10.1023/A:1008352620870; Ventura Hector O, 2011, Congest Heart Fail, V17, P49, DOI 10.1111/j.1751-7133.2010.00197.x; Vijayan K, 2004, AM J PHYSIOL-HEART C, V287, pH2777, DOI 10.1152/ajpheart.00171.2004; WAAGSTEIN F, 1989, CIRCULATION, V80, P551, DOI 10.1161/01.CIR.80.3.551; Wakasaki H, 1997, P NATL ACAD SCI USA, V94, P9320, DOI 10.1073/pnas.94.17.9320; Wang HJ, 2001, CHIN J LAB ANIM SCI, V11, P202; Wang XQ, 2008, CLIN EXP PHARMACOL P, V35, P1215, DOI 10.1111/j.1440-1681.2008.04981.x; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wellman PJ, 2000, NUTRITION, V16, P837, DOI 10.1016/S0899-9007(00)00415-9; Xin W, 2011, MOL MED, V17, P201, DOI 10.2119/molmed.2010.00197; Yang DL, 2009, BIOL PHARM BULL, V32, P376, DOI 10.1248/bpb.32.376; Yang H, 2013, EUR J PHARM SCI, V49, P791, DOI 10.1016/j.ejps.2013.05.028; Zatonski WA, 2011, ANN AGR ENV MED, V18, P194; Zhang HG, 2007, CLIN EXP PHARMACOL P, V34, P1276, DOI 10.1111/j.1440-1681.2007.04716.x; Zhang HG, 2011, BIOL PHARM BULL, V34, P1527, DOI 10.1248/bpb.34.1527	63	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121007	10.1371/journal.pone.0121007	http://dx.doi.org/10.1371/journal.pone.0121007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822412	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700085
J	Lusi, EA; Di Ciommo, VM; Patrissi, T; Guarascio, P				Lusi, Elena Angela; Di Ciommo, Vincenzo Maria; Patrissi, Tommaso; Guarascio, Paolo			High Prevalence of Nickel Allergy in an Overweight Female Population: A Pilot Observational Analysis	PLOS ONE			English	Article							CONTACT-DERMATITIS; INDUCED HYPERGLYCEMIA; INSULIN; CHILDREN; CHLORIDE; ALPHA; CELLS; GAMMA; RATS	Context In our Allergy Unit, we incidentally observed that a low Nickel diet, prescribed for delayed allergy to Nickel sulfate, reduced body mass index (BMI) and waist circumference in overweight patients. Objectives This pilot cross-sectional analysis was undertaken to compare the prevalence of Nickel allergy of overweight individuals versus the general population. We also had the chance to report the efficacy of a low Nickel diet on BMI and waist circumference in Nickel-sensitive overweight subjects. Methods Eighty-seven overweight subjects, with a BMI >26 Kg/m(2), were consecutively enrolled in a health prevention program, and screened for the presence of Nickel allergy. The enrolled population was mostly females (72/87) (82.8%). Forty-three overweight women and two men showed a Nickel allergy and started a low Nickel diet. After 6-months of dieting, 24 overweight allergic women could be traced and changes in BMI and waist circumference were calculated. Main Outcome Measurements Prevalence of Nickel allergy in overweight. Results Prevalence of Nickel allergy in overweight female was 59.7%, compared with a prevalence rate of 12.5% in the general population. A significant reduction in BMI was observed in 24 out of 43 overweight females with Nickel allergy after 24 weeks of a low Nickel diet. Relative to baseline, mean BMI decrease was 4.2 +/- 0.5 (P <0.001) and the mean decline in waist circumference was 11.7 +/- 0.6 cm (P< 0.001). Conclusions This pilot observational analysis showed a substantially higher prevalence of Nickel allergy among overweight females, especially those with metabolic syndrome and fatty liver disease. A normocaloric low Nickel diet was effective in reducing BMI in this population. Further research is strongly needed to confirm these preliminary findings.	[Lusi, Elena Angela] St Vincent Private Hosp, Dublin, Ireland; [Di Ciommo, Vincenzo Maria] Osped Pediat Bambino Gesu, Epidemiol & Biostat Unit, Rome, Italy; [Patrissi, Tommaso] Italian Red Cross, Cardiol & Prevent Med Unit, Cent Lab, Rome, Italy; [Guarascio, Paolo] St Camillo Forlanini Hosp, Liver Unit, Rome, Italy	IRCCS Bambino Gesu; Azienda Ospedaliera San Camillo-Forlanini	Lusi, EA (corresponding author), St Vincent Private Hosp, Dublin, Ireland.	elenaangelalusi@yahoo.it						Admani S, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0421-0; Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Albanesi C, 1999, J IMMUNOL, V162, P494; Braga M, 2013, INT J IMMUNOPATH PH, V26, P707, DOI 10.1177/039463201302600314; Bwititi P T, 1998, Afr J Health Sci, V5, P198; Campanale M, 2014, DIGEST DIS SCI, V59, P1851, DOI 10.1007/s10620-014-3060-3; CARTANA J, 1992, TOXICOLOGY, V71, P181, DOI 10.1016/0300-483X(92)90065-M; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; DORMER RL, 1974, BIOCHEM J, V140, P135, DOI 10.1042/bj1400135; Dyring-Andersen B, 2013, CONTACT DERMATITIS, V68, P339, DOI 10.1111/cod.12043; ESKEW DL, 1983, SCIENCE, V222, P621, DOI 10.1126/science.222.4624.621; Essca Writing Grp, 2008, J EUR ACAD DERMATOL, V22, P174, DOI 10.1111/j.1468-3083.2007.02359.x; Gupta S, 2000, NITRIC OXIDE-BIOL CH, V4, P129, DOI 10.1006/niox.2000.0278; Jensen CS, 2003, CONTACT DERMATITIS, V49, P124, DOI 10.1111/j.0105-1873.2003.00157.x; Joneja JM, 1995, MANAGING FOOD ALLERG; KADOTA I, 1955, METABOLISM, V4, P337; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Krob HA, 2004, J AM ACAD DERMATOL, V51, P349, DOI 10.1016/j.jaad.2003.11.069; Kubrak OI, 2012, ECOTOX ENVIRON SAFE, V80, P231, DOI 10.1016/j.ecoenv.2012.03.006; MAYOR P, 1989, BIOL TRACE ELEM RES, V22, P63, DOI 10.1007/BF02917417; Monar I, 2014, MENOPAUSE, V21, P749, DOI [10.1097/GME.0000000000000125, DOI 10.1097/GME.0000000000000125]; NOVELLI ELB, 1988, BRAZ J MED BIOL RES, V21, P129; Pizzutelli S, 2011, EUR ANN ALLERGY CLIN, V43, P5; Ricciardi L, 2014, INT J IMMUNOPATH PH, V27, P131, DOI 10.1177/039463201402700118; SAGGERSON ED, 1976, BIOCHEM J, V154, P349, DOI 10.1042/bj1540349; Sharma Ashimav D, 2013, Indian J Dermatol, V58, P240, DOI 10.4103/0019-5154.110846; Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x; Tikare Swati N., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P89; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Yoshihisa Y, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/749561; Zirwas Matthew J, 2009, J Clin Aesthet Dermatol, V2, P39; Zug KA, 2014, DERMATITIS, V25, P345, DOI 10.1097/DER.0000000000000083	34	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123265	10.1371/journal.pone.0123265	http://dx.doi.org/10.1371/journal.pone.0123265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822975	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700220
J	Rim, D; Schiavon, S; Nazaroff, WW				Rim, Donghyun; Schiavon, Stefano; Nazaroff, William W.			Energy and Cost Associated with Ventilating Office Buildings in a Tropical Climate	PLOS ONE			English	Article							INDOOR AIR-QUALITY; PERSONALIZED VENTILATION; CONSERVATION MEASURES; COMMERCIAL BUILDINGS; THERMAL COMFORT; CHANGE IMPACTS; SUPPLY RATE; HOT; TEMPERATURE; SYMPTOMS	Providing sufficient amounts of outdoor air to occupants is a critical building function for supporting occupant health, well-being and productivity. In tropical climates, high ventilation rates require substantial amounts of energy to cool and dehumidify supply air. This study evaluates the energy consumption and associated cost for thermally conditioning outdoor air provided for building ventilation in tropical climates, considering Singapore as an example locale. We investigated the influence on energy consumption and cost of the following factors: outdoor air temperature and humidity, ventilation rate (L/s per person), indoor air temperature and humidity, air conditioning system coefficient of performance (COP), and cost of electricity. Results show that dehumidification of outdoor air accounts for more than 80% of the energy needed for building ventilation in Singapore's tropical climate. Improved system performance and/or a small increase in the indoor temperature set point would permit relatively large ventilation rates (such as 25 L/s per person) at modest or no cost increment. Overall, even in a thermally demanding tropical climate, the energy cost associated with increasing ventilation rate up to 25 L/s per person is less than 1% of the wages of an office worker in an advanced economy like Singapore's. This result implies that the benefits of increasing outdoor air ventilation rate up to 25 L/s per person-which is suggested to provide for productivity increases, lower sick building syndrome symptom prevalence, and reduced sick leave-can be much larger than the incremental cost of ventilation.	[Rim, Donghyun; Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Schiavon, Stefano] Univ Calif Berkeley, Dept Architecture, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rim, D (corresponding author), Penn State Univ, Dept Architectural Engn, University Pk, PA 16802 USA.	drim@psu.edu	Schiavon, Stefano/AAS-9673-2020; Nazaroff, William W/C-4106-2008; Nazaroff, William/AAJ-7352-2021	Schiavon, Stefano/0000-0003-1285-5682; Nazaroff, William W/0000-0001-5645-3357; Nazaroff, William/0000-0001-5645-3357	Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS)	Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS)(National Research Foundation, Singapore)	This research is funded by the Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore-Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) Program. BEARS has been established by the University of California, Berkeley as a center for intellectual excellence in research and education in Singapore.	Adnot J, 2012, FINAL REPORT TASK 2; *ASHRAE, 2002, INT WEATH EN CALC IW; ASHRAE, 2013, ASHRAE HDB FUND; Belzer DB, 1996, ENERG SOURCE, V18, P177, DOI 10.1080/00908319608908758; Bennett DH, 2012, INDOOR AIR, V22, P309, DOI 10.1111/j.1600-0668.2012.00767.x; Bernstein JA, 2008, J ALLERGY CLIN IMMUN, V121, P585, DOI 10.1016/j.jaci.2007.10.045; Candido C, 2010, BUILD ENVIRON, V45, P222, DOI 10.1016/j.buildenv.2009.06.005; CEN, 2007, 152512007 CEN EN; Cummings JB, 1996, UNCONTROLLED AIR FLO; Eang LS, 2008, ENERG POLICY, V36, P3982, DOI 10.1016/j.enpol.2008.07.014; EMA Singapore, 2014, SINGAPORE POWER TARI; ENV Ministry of the Environment, 1996, SING GUID GOOD IND A; Fisk WJ, 2011, INDOOR AIR, V21, P357, DOI 10.1111/j.1600-0668.2011.00719.x; Fisk WJ, 2009, INDOOR AIR, V19, P159, DOI 10.1111/j.1600-0668.2008.00575.x; Fisk WJ, 2012, BUILD ENVIRON, V47, P368, DOI 10.1016/j.buildenv.2011.07.001; Fisk WJ, 2007, P CLIM 2007 WELLB IN; Frank T, 2005, ENERG BUILDINGS, V37, P1175, DOI 10.1016/j.enbuild.2005.06.019; Fridley D.G., 2008, LBNL248E; Frontczak M, 2012, INDOOR AIR, V22, P119, DOI 10.1111/j.1600-0668.2011.00745.x; Harrison PTC, 2002, OCCUP ENVIRON MED, V59, P73, DOI 10.1136/oem.59.2.73; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Hodgson M, 2002, ENVIRON HEALTH PERSP, V110, P663, DOI 10.1289/ehp.02110s4663; Hwang RL, 2009, BUILD ENVIRON, V44, P1128, DOI 10.1016/j.buildenv.2008.08.001; Iqbal I, 2007, BUILD ENVIRON, V42, P2166, DOI 10.1016/j.buildenv.2006.04.011; Lam JC, 2000, BUILD ENVIRON, V35, P19, DOI 10.1016/S0360-1323(98)00067-5; Lam JC, 2008, ENERG CONVERS MANAGE, V49, P3170, DOI 10.1016/j.enconman.2008.05.022; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Lowe R, 2007, BUILD RES INF, V35, P343, DOI 10.1080/09613210701345873; Melikov AK, 2004, INDOOR AIR, V14, P157, DOI 10.1111/j.1600-0668.2004.00284.x; Mendell MJ, 2008, INDOOR AIR, V18, P301, DOI 10.1111/j.1600-0668.2008.00531.x; Menzies D, 1997, NEW ENGL J MED, V337, P1524, DOI 10.1056/NEJM199711203372107; Mundt E, 2004, VENTILATION EFFECTIV; Nazaroff WW, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015022; Nicol F, 2004, ENERG BUILDINGS, V36, P628, DOI 10.1016/j.enbuild.2004.01.016; Olesen BW, 2004, INDOOR AIR, V14, P18, DOI 10.1111/j.1600-0668.2004.00268.x; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Persily A, 2008, 7145 NISTIR NAT I ST; Persily AK, 2012, HVAC&R RES, V18, P4, DOI 10.1080/10789669.2011.592106; Refrigeratingand Air-Conditioning Engineers Inc American Society of Heating, 2019, 62 ANSI ASHRAE; Republic of Singapore, 2013, INC GROSS MONTHL INC; Rim D, 2008, ASHRAE TRAN, V114, P130; Saidur R, 2009, ENERG POLICY, V37, P4104, DOI 10.1016/j.enpol.2009.04.052; Schiavon S, 2008, ENERG BUILDINGS, V40, P1954, DOI 10.1016/j.enbuild.2008.05.001; Schiavon S, 2010, ENERG BUILDINGS, V42, P699, DOI 10.1016/j.enbuild.2009.11.009; Sekhar SC, 2005, HVAC&R RES, V11, P603, DOI 10.1080/10789669.2005.10391157; Sekhar SC, 2005, ENERG BUILDINGS, V37, P49, DOI 10.1016/j.enbuild.2004.05.003; Seppanen O, 2006, INDOOR AIR, V16, P28, DOI 10.1111/j.1600-0668.2005.00394.x; Singapore NEA, 2008, ANN REPORT; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Tham KW, 2004, INDOOR AIR, V14, P119, DOI 10.1111/j.1600-0668.2004.00280.x; USDOE, 2011, REP 1 QUADR TECHN RE; USEPA] United States Environmental Protection Agency, 2009, BUILD THEIR IMP ENV; Wargocki P, 2000, INDOOR AIR, V10, P222, DOI 10.1034/j.1600-0668.2000.010004222.x; Wargocki P, 2002, INDOOR AIR, V12, P113, DOI 10.1034/j.1600-0668.2002.01145.x; Wolkoff P, 2006, INDOOR AIR, V16, P7, DOI 10.1111/j.1600-0668.2005.00393.x; Zhang H, 2010, BUILD ENVIRON, V45, P29, DOI 10.1016/j.buildenv.2009.02.016	56	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122310	10.1371/journal.pone.0122310	http://dx.doi.org/10.1371/journal.pone.0122310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822504	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700165
J	Shang, YL				Shang, Yilun			Laplacian Estrada and Normalized Laplacian Estrada Indices of Evolving Graphs	PLOS ONE			English	Article							ENERGY; NETWORKS; SMALLEST	Large-scale time-evolving networks have been generated by many natural and technological applications, posing challenges for computation and modeling. Thus, it is of theoretical and practical significance to probe mathematical tools tailored for evolving networks. In this paper, on top of the dynamic Estrada index, we study the dynamic Laplacian Estrada index and the dynamic normalized Laplacian Estrada index of evolving graphs. Using linear algebra techniques, we established general upper and lower bounds for these graph-spectrum-based invariants through a couple of intuitive graph-theoretic measures, including the number of vertices or edges. Synthetic random evolving small-world networks are employed to show the relevance of the proposed dynamic Estrada indices. It is found that neither the static snapshot graphs nor the aggregated graph can approximate the evolving graph itself, indicating the fundamental difference between the static and dynamic Estrada indices.	Tongji Univ, Dept Math, Shanghai 200092, Peoples R China	Tongji University	Shang, YL (corresponding author), Tongji Univ, Dept Math, Shanghai 200092, Peoples R China.	shyl@tongji.edu.cn			Program for Young Excellent Talents in Tongji University [2014KJ036]	Program for Young Excellent Talents in Tongji University	This study is partly supported by Program for Young Excellent Talents in Tongji University under Grant No. 2014KJ036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Azami S, 2015, MATCH-COMMUN MATH CO, V74, P411; Bellman R., 1970, INTRODUCTION TO MATR; Bollobas B, 1998, ARS COMBINATORIA, V50, P225; Cavers M., 2010, NORMALIZED LAPLACIAN; Chen L, 2015, MATCH-COMMUN MATH CO, V73, P105; Chen XD, 2015, MATCH-COMMUN MATH CO, V73, P149; Chen XD, 2015, MATCH-COMMUN MATH CO, V73, P163; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Cvetkovic D, 1995, SPECTRA OF GRAPHS TH; de la Pena JA, 2007, LINEAR ALGEBRA APPL, V427, P70, DOI 10.1016/j.laa.2007.06.020; Estrada E, 2000, CHEM PHYS LETT, V319, P713, DOI 10.1016/S0009-2614(00)00158-5; Estrada E, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046105; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2006, INT J QUANTUM CHEM, V106, P823, DOI 10.1002/qua.20850; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; Estrada E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042811; Estrada E, 2012, PHYS REP, V514, P89, DOI 10.1016/j.physrep.2012.01.006; Fath-Tabar G.H., 2009, B ACAD MIE SERBE SCI, V34, P1; Gao N, 2015, MATCH-COMMUN MATH CO, V73, P133; Grindrod P, 2014, J COMPLEX NETW, V2, P60, DOI 10.1093/comnet/cnt015; Grindrod P, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2013.0835; Grindrod P, 2013, SIAM REV, V55, P118, DOI 10.1137/110855715; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Grindrod P, 2010, P ROY SOC A-MATH PHY, V466, P753, DOI 10.1098/rspa.2009.0456; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Gutman I, 2004, MATCH-COMMUN MATH CO, P83; Gutman I., 2011, SELECTED TOPICS APPL, P155; Gutman I, 2015, MATCH-COMMUN MATH CO, V73, P267; Hakimi-Nezhaad Mardjan, 2014, Journal of Applied Mathematics and Informatics, V32, P227; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu YM, 2005, MATCH-COMMUN MATH CO, V54, P425; Hu YM, 2007, DISCRETE APPL MATH, V155, P1044, DOI 10.1016/j.dam.2006.11.008; Huang F, 2015, MATCH-COMMUN MATH CO, V74, P419; Huo BF, 2011, EUR J COMBIN, V32, P662, DOI 10.1016/j.ejc.2011.02.011; Huo BF, 2011, LINEAR ALGEBRA APPL, V434, P1370, DOI 10.1016/j.laa.2010.11.025; Kuang J, 2004, APPLIED INEQUALITIES; Li JX, 2014, FILOMAT, V28, P365, DOI 10.2298/FIL1402365L; Li JX, 2009, APPL ANAL DISCR MATH, V3, P147, DOI 10.2298/AADM0901147L; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068423; Li X, 2012, GRAPH ENERGY; Li XL, 2008, MATCH-COMMUN MATH CO, V59, P127; Shang Y, 2012, INDIAN J PHYS, V86, P485, DOI 10.1007/s12648-012-0084-4; Shang YL, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/6/068903; Shang YL, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/7/070201; Shang YL, 2015, APPL MATH COMPUT, V250, P415, DOI 10.1016/j.amc.2014.10.129; Shang YL, 2015, LINEAR MULTILINEAR A, V63, P466, DOI 10.1080/03081087.2013.872640; Shang YL, 2012, APPL MATH E-NOTES, V12, P53; Shang YL, 2014, APPL ANAL DISCR MATH, V8, P346, DOI 10.2298/AADM140724011S; Shang YL, 2013, ROCKY MT J MATH, V43, P2009, DOI 10.1216/RMJ-2013-43-6-2009; Shang YL, 2013, B AUST MATH SOC, V88, P106, DOI 10.1017/S0004972712000676; Shang YL, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/7/075003; WANG CL, 1979, SIAM REV, V21, P550, DOI 10.1137/1021096; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu J, 2012, CHAOS, V22, DOI 10.1063/1.4754875; Wu J, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/7/078902; Zhou B, 2009, APPL ANAL DISCR MATH, V3, P371, DOI 10.2298/AADM0902371Z	58	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123426	10.1371/journal.pone.0123426	http://dx.doi.org/10.1371/journal.pone.0123426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822506	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700226
J	Vieira, VMNCS; Oppliger, LV; Engelen, AH; Correa, JA				Vieira, Vasco M. N. C. S.; Oppliger, Luz Valeria; Engelen, Aschwin H.; Correa, Juan A.			A New Method to Quantify and Compare the Multiple Components of Fitness-A Study Case with Kelp Niche Partition by Divergent Microstage Adaptations to Temperature	PLOS ONE			English	Article							LIFE-HISTORIES; RANGE LIMITS; PHAEOPHYCEAE; LAMINARIALES; RHODOPHYTA; SURVIVAL; SEAWEEDS; RELEASE; GAMETOPHYTES; VARIABILITY	Point 1 Management of crops, commercialized or protected species, plagues or life-cycle evolution are subjects requiring comparisons among different demographic strategies. The simpler methods fail in relating changes in vital rates with changes in population viability whereas more complex methods lack accuracy by neglecting interactions among vital rates. Point 2 The difference between the fitness (evaluated by the population growth rate.) of two alternative demographies is decomposed into the contributions of the differences between the pair-wised vital rates and their interactions. This is achieved through a full Taylor expansion (i.e. remainder = 0) of the demographic model. The significance of each term is determined by permutation tests under the null hypothesis that all demographies come from the same pool. Point 3 An example is given with periodic demographic matrices of the microscopic haploid phase of two kelp cryptic species observed to partition their niche occupation along the Chilean coast. The method provided clear and synthetic results showing conditional differentiation of reproduction is an important driver for their differences in fitness along the latitudinal temperature gradient. But it also demonstrated that interactions among vital rates cannot be neglected as they compose a significant part of the differences between demographies. Point 4 This method allows researchers to access the effects of multiple effective changes in a life-cycle from only two experiments. Evolutionists can determine with confidence the effective causes for changes in fitness whereas population managers can determine best strategies from simpler experimental designs.	[Vieira, Vasco M. N. C. S.] Univ Tecn Lisboa, Inst Super Tecn, MARETEC, P-1049001 Lisbon, Portugal; [Oppliger, Luz Valeria; Correa, Juan A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil, Santiago, Chile; [Engelen, Aschwin H.] Univ Algarve, CCMAR Ctr Marine Sci, P-8005139 Faro, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Pontificia Universidad Catolica de Chile; Universidade do Algarve	Vieira, VMNCS (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, MARETEC, Av Rovisco Pais, P-1049001 Lisbon, Portugal.	vasco.vieira@ist.utl.pt	Engelen, Aschwin H/M-3432-2013	Engelen, Aschwin H/0000-0002-9579-9606; Vieira, Vasco/0000-0001-9858-6254	CONICYT-FRENCH EMBASSADY Ph.D. grant	CONICYT-FRENCH EMBASSADY Ph.D. grant	LV Oppliger was supported by a CONICYT-FRENCH EMBASSADY Ph.D. grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol T., 1969, CALCULUS, VII; Apostol T., 1967, CALCULUS, V1; Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1987, MAR BIOL, V96, P293, DOI 10.1007/BF00427029; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Carmona R, 2006, J PHYCOL, V42, P259, DOI 10.1111/j.1529-8817.2006.00190.x; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Davis AS, 2004, ECOL APPL, V14, P655, DOI 10.1890/02-5385; Vieira VMNCS, 2012, J PHYCOL, V48, P1012, DOI 10.1111/j.1529-8817.2012.01192.x; Dieck T (Bartsch) I, 1993, MAR ECOL PROG SER, V100, P253; Dieck Tom, 1992, PHYCOLOGIA, V31, P147; Fierst J, 2005, J PHYCOL, V41, P238, DOI 10.1111/j.1529-8817.2005.04024.x; Garza-Sanchez F, 2000, BOT MAR, V43, P205, DOI 10.1515/BOT.2000.022; Gonzalez A, 2012, J PHYCOL, V48, P1153, DOI 10.1111/j.1529-8817.2012.01200.x; Gonzalez J, 1996, AQUACULTURE, V143, P91, DOI 10.1016/0044-8486(95)01203-6; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; Jahns H. M., 1995, ALGAE INTRO PHYCOLOG; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; LUNING K, 1978, Z PFLANZENPHYSIOL, V89, P333; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; Martinez Enrique A., 1999, Pacific Science, V53, P74; Matson PG, 2007, MAR BIOL, V151, P1941, DOI 10.1007/s00227-007-0630-3; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Munoz V, 2004, REV CHIL HIST NAT, V77, P639; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; Pacheco-Ruiz I, 2011, BOT MAR, V54, P127, DOI 10.1515/BOT.2011.019; PETERS AF, 1993, MAR BIOL, V115, P143, DOI 10.1007/BF00349396; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Sauvageau C, 1918, MEM ACAD SCI I FR, V56, P1; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Taylor AE, 1955, ADV CALCULUS; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Oppliger LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039289; Vieira VMNCS, 2013, OCEAN SCI, V9, P355, DOI 10.5194/os-9-355-2013; Vieira V.M.N.C.S., 2012, COMPUT ECOL SOFTW, P103; Viejo RM, 2011, ECOGRAPHY, V34, P75, DOI 10.1111/j.1600-0587.2010.06365.x	45	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119670	10.1371/journal.pone.0119670	http://dx.doi.org/10.1371/journal.pone.0119670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821954	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700042
J	Zang, HD; Yang, XC; Feng, XM; Qian, X; Hu, YG; Ren, CZ; Zeng, ZH				Zang, Huadong; Yang, Xuechao; Feng, Xiaomin; Qian, Xin; Hu, Yuegao; Ren, Changzhong; Zeng, Zhaohai			Rhizodeposition of Nitrogen and Carbon by Mungbean (Vigna radiata L.) and Its Contribution to Intercropped Oats (Avena nuda L.)	PLOS ONE			English	Article							ESTIMATING N RHIZODEPOSITION; BELOW-GROUND NITROGEN; PLANT-SOIL SYSTEM; LOLIUM-PERENNE; FIELD PEA; N-15; RHIZOSPHERE; ROOT; FIXATION; TURNOVER	Compounds released by mungbean roots potentially represent an enormous source of nitrogen (N) and carbon (C) in mungbean-oat intercropping systems. In this study, an in situ experiment was conducted using a N-15- C-13 double stem-feeding method to measure N and C derived from the rhizodeposition (NdfR and CdfR) of mungbean and their transfer to oats in an intercropping system. Mungbean plants were sole cropped (S) or intercropped (I) with oat. The plants were labeled 5 weeks after planting and were harvested at the beginning of pod setting (I-p and S-p) and at maturity (I-m and S-m). More than 60% and 50% of the applied N-15 and C-13, respectively, were recovered in each treatment, with N-15 and C-13 being quite uniformly distributed in the different plant parts. NdfR represented 9.8% (S-p), 9.2% (I-p), 20.1% (S-m), and 21.2%(I-m) of total mungbean plant N, whereas CdfR represented 13.3% (S-p), 42.0%(I-p), 15.4% (S-m), and 22.6% (I-m) of total mungbean plant C. When considering the part of rhizodeposition transferred to associated oat, intercropping mungbean released more NdfR and CdfR than mungbean alone. About 53.4-83.2% of below-ground plant N (BGP-N) and 58.4-85.9% of BGP-C originated from NdfR and CdfR, respectively. The N in oats derived from mungbean increased from 7.6% at the pod setting stage to 9.7% at maturity, whereas the C in oats increased from 16.2% to 22.0%, respectively. Only a small percentage of rhizodeposition from mungbean was transferred to oats in the intercropping systems, with a large percentage remaining in the soil. This result indicates that mungbean rhizodeposition might contribute to higher N and C availability in the soil for subsequent crops.	[Zang, Huadong; Yang, Xuechao; Feng, Xiaomin; Qian, Xin; Hu, Yuegao; Zeng, Zhaohai] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Ren, Changzhong] Baicheng Acad Agr Sci, Baicheng, Jilin, Peoples R China	China Agricultural University	Zeng, ZH (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	zengzhaohai@cau.edu.cn	Zang, Huadong/T-6447-2017	Zang, Huadong/0000-0002-2008-143X	China Agriculture Research System [CARS-08-B-1]; National Natural Science Foundation of China [31171509, 30871491]; Special Fund for Agro-scientific Research in the Public Interest [201103001]; National Key Technology R&D Program for the 12th five-year plan of China [2011BAD16B15]; Chinese University Scientific Fund [2013yj001]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology R&D Program for the 12th five-year plan of China(National Key Technology R&D Program); Chinese University Scientific Fund	The authors would like to acknowledge the financial support by the China Agriculture Research System (CARS-08-B-1), National Natural Science Foundation of China (No. 31171509, 30871491), Special Fund for Agro-scientific Research in the Public Interest (No. 201103001), the National Key Technology R&D Program for the 12th five-year plan of China (No. 2011BAD16B15) and the Chinese University Scientific Fund (2013yj001).	BROPHY LS, 1989, PLANT SOIL, V116, P77, DOI 10.1007/BF02327259; Chalk PM, 2002, BIOL FERT SOILS, V35, P387, DOI 10.1007/s00374-002-0460-x; Chu GX, 2004, PLANT SOIL, V263, P17, DOI 10.1023/B:PLSO.0000047722.49160.9e; DANSO SKA, 1987, SOIL BIOL BIOCHEM, V19, P411, DOI 10.1016/0038-0717(87)90031-9; de Graaff MA, 2007, NEW PHYTOL, V173, P778, DOI 10.1111/j.1469-8137.2006.01974.x; Domanski G, 2001, J PLANT NUTR SOIL SC, V164, P381, DOI 10.1002/1522-2624(200108)164:4<381::AID-JPLN381>3.0.CO;2-5; Francis CA, 1989, ADV AGRON, V42, P42, DOI DOI 10.1016/S0065-2113(08)60522-2; Gotz KP, 2000, ISOT ENVIRON HEALT S, V36, P111, DOI 10.1080/10256010008032937; Gregory PJ, 2006, EUR J SOIL SCI, V57, P2, DOI 10.1111/j.1365-2389.2005.00778.x; HELAL HM, 1984, PLANT SOIL, V76, P175, DOI 10.1007/BF02205578; Hertenberger G, 2004, RAPID COMMUN MASS SP, V18, P2415, DOI 10.1002/rcm.1615; Hogh-Jensen H, 2000, PLANT SOIL, V227, P171, DOI 10.1023/A:1026535401773; Hutsch BW, 2002, J PLANT NUTR SOIL SC, V165, P397, DOI 10.1002/1522-2624(200208)165:4<397::AID-JPLN397>3.0.CO;2-C; IZAURRALDE RC, 1992, BIOL FERT SOILS, V13, P11, DOI 10.1007/BF00337231; Jamont M, 2013, PLANT SOIL, V371, P641, DOI 10.1007/s11104-013-1712-2; JANZEN HH, 1990, SOIL BIOL BIOCHEM, V22, P1155, DOI 10.1016/0038-0717(90)90043-Y; JANZEN HH, 1989, SOIL BIOL BIOCHEM, V21, P189, DOI 10.1016/0038-0717(89)90094-1; Jensen ES, 1996, SOIL BIOL BIOCHEM, V28, P65, DOI 10.1016/0038-0717(95)00116-6; Jensen ES, 1996, SOIL BIOL BIOCHEM, V28, P159, DOI 10.1016/0038-0717(95)00134-4; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Khan DF, 2002, PLANT SOIL, V239, P277, DOI 10.1023/A:1015066323050; Khan WDF, 2002, PLANT SOIL, V245, P327, DOI 10.1023/A:1020407006212; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; Kuzyakov Y, 1999, PLANT SOIL, V213, P127, DOI 10.1023/A:1004566027237; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y., 2004, ARCH AGRON SOIL SCI, V50, P115, DOI [10.1080/03650340310001627658, DOI 10.1080/03650340310001627658]; Laberge G, 2011, PLANT SOIL, V340, P369, DOI 10.1007/s11104-010-0609-6; LEDGARD SF, 1985, SOIL BIOL BIOCHEM, V17, P575, DOI 10.1016/0038-0717(85)90028-8; Li M, 2009, CHINESE AGR SCI B, V11; Mahieu S, 2009, SOIL BIOL BIOCHEM, V41, P2236, DOI 10.1016/j.soilbio.2009.08.008; Mahieu S, 2007, PLANT SOIL, V295, P193, DOI 10.1007/s11104-007-9275-8; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mayer J, 2003, SOIL BIOL BIOCHEM, V35, P21, DOI 10.1016/S0038-0717(02)00212-2; MCNEILL AM, 1994, J EXP BOT, V45, P749, DOI 10.1093/jxb/45.6.749; Merbach W, 1999, J PLANT NUTR SOIL SC, V162, P373, DOI 10.1002/(SICI)1522-2624(199908)162:4<373::AID-JPLN373>3.0.CO;2-#; Merbach W, 2000, J PLANT NUTR SOIL SC, V163, P375, DOI 10.1002/1522-2624(200008)163:4<375::AID-JPLN375>3.0.CO;2-W; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Peoples M. B., 2002, Nitrogen fixation at the millennium, P357, DOI 10.1016/B978-044450965-9/50013-6; Rasmussen J, 2011, SOIL BIOL BIOCHEM, V43, P2213, DOI 10.1016/j.soilbio.2011.05.023; ROVIRA A. D., 1956, Plant and Soil, V7, P178, DOI 10.1007/BF01343726; Rroco E, 2000, EUR J AGRON, V13, P101, DOI 10.1016/S1161-0301(00)00068-X; Russell CA, 1996, AUST J AGR RES, V47, P1035, DOI 10.1071/AR9961035; Russell CA, 1996, AUST J AGR RES, V47, P1047, DOI 10.1071/AR9961047; SAWATSKY N, 1991, SOIL BIOL BIOCHEM, V23, P255, DOI 10.1016/0038-0717(91)90061-N; Schmidtke K, 2005, SOIL BIOL BIOCHEM, V37, P1893, DOI 10.1016/j.soilbio.2005.02.024; Schweinsberg-Mickan MSZ, 2012, J PLANT NUTR SOIL SC, V175, P750, DOI 10.1002/jpln.201100300; Warembourg FR, 2000, BIOL FERT SOILS, V30, P528, DOI 10.1007/s003740050032; Whipps J. M., 1990, The rhizosphere., P59; Wichern F, 2007, SOIL BIOL BIOCHEM, V39, P2829, DOI 10.1016/j.soilbio.2007.06.006; Wichern F, 2007, SOIL BIOL BIOCHEM, V39, P2527, DOI 10.1016/j.soilbio.2007.04.022; Xiao YB, 2004, PLANT SOIL, V262, P45, DOI 10.1023/B:PLSO.0000037019.34719.0d; Yang XC, 2012, THESIS CHINA AGR U; Yasmin K, 2006, SOIL BIOL BIOCHEM, V38, P397, DOI 10.1016/j.soilbio.2005.05.011; Yasmin K, 2010, PLANT SOIL, V327, P247, DOI 10.1007/s11104-009-0051-9	54	37	42	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121132	10.1371/journal.pone.0121132	http://dx.doi.org/10.1371/journal.pone.0121132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821975	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700092
J	Deng, L; Chen, J; Zhong, XR; Luo, T; Wang, YP; Huang, HF; Yin, LJ; Qiu, Y; Bu, H; Lv, Q; Zheng, H				Deng, Ling; Chen, Jie; Zhong, Xiao Rong; Luo, Ting; Wang, Yan Ping; Huang, Hui Fen; Yin, Li-Juan; Qiu, Yan; Bu, Hong; Lv, Qing; Zheng, Hong			Correlation between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women	PLOS ONE			English	Article							REDUCED PTEN EXPRESSION; PIK3CA MUTATIONS; CARCINOMA; RECEPTOR; GENE; INHIBITION; MTOR; CHEMOTHERAPY; TRASTUZUMAB; RESISTANCE	Background Abnormal activation of PI3K/AKT/mTOR (PAM) pathway, caused by PIK3CA mutation, KRAS mutation, PTEN loss, or AKT1 mutation, is one of the most frequent signaling abnormalities in breast carcinoma. However, distribution and frequencies of mutations in PAM pathway are unclear in breast cancer patients from the mainland of China and the correlation between these mutations and breast cancer outcome remains to be identified. Methods A total of 288 patients with invasive ductal breast cancer were recruited in this study. Mutations in PIK3CA (exons 4, 9 and 20), KRAS (exon 2) and AKT1 (exon 3) were detected using Sanger sequencing. PTEN loss was measured by immunohistochemistry assay. Correlations between these genetic aberrations and clinicopathological features were analyzed. Results The frequencies of PIK3CA mutation, KRAS mutation, AKT1 mutation and PTEN loss were 15.6%, 1.8%, 4.4% and 35.3%, respectively. However, except for PTEN loss, which was tied to estrogen receptor (ER) status, these alterations were not associated with other clinicopathological features. Survival analysis demonstrated that PIK3CA mutation, PTEN loss and PAM pathway activation were not associated with disease-free survival (DFS). Subgroup analysis of patients with ER positive tumors revealed that PIK3CA mutation more strongly reduced DFS compared to wild-type PIK3CA (76.2% vs. 54.2%; P = 0.011). PIK3CA mutation was also an independent factor for bad prognosis in ER positive patients. Conclusions AKT1, KRAS and PIK3CA mutations and PTEN loss all exist in women with breast cancer in the mainland China. PIK3CA mutation may contribute to the poor outcome of ER positive breast carcinomas, providing evidence for the combination of PI3K/AKT/mTOR inhibitors and endocrine therapy.	[Deng, Ling; Luo, Ting; Zheng, Hong] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan Provinc, Peoples R China; [Deng, Ling; Zhong, Xiao Rong; Luo, Ting; Wang, Yan Ping; Zheng, Hong] Sichuan Univ, Lab Mol Diag Canc, Natl Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy,West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Chen, Jie; Lv, Qing] Sichuan Univ, Dept Thyroid & Breast Surg, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Huang, Hui Fen; Yin, Li-Juan; Qiu, Yan; Bu, Hong] Sichuan Univ, Dept Pathol, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Zheng, H (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan Provinc, Peoples R China.	hong_zheng11@yahoo.com			Novartis Pharmaceuticals (China) [H1112149]	Novartis Pharmaceuticals (China)	Funding: The authors are grateful to Novartis Pharmaceuticals (China) Oncology for grant support (H1112149, http://www.novartisoncology.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Boulay A, 2005, CLIN CANCER RES, V11, P5319, DOI 10.1158/1078-0432.CCR-04-2402; Buzdar AU, 2009, ANN ONCOL, V20, P993, DOI 10.1093/annonc/mdn739; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Ellis MJ, 2010, BREAST CANCER RES TR, V119, P379, DOI 10.1007/s10549-009-0575-y; Faustino A, 2012, J CLIN ENDOCR METAB, V97, pE1139, DOI 10.1210/jc.2011-2748; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hernandez-Aya LF, 2011, ONCOLOGIST, V16, P404, DOI 10.1634/theoncologist.2010-0402; Iqbal J, 2012, HISTOPATHOLOGY, V61, P652, DOI 10.1111/j.1365-2559.2012.04255.x; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kita D, 2007, ACTA NEUROPATHOL, V113, P295, DOI 10.1007/s00401-006-0186-1; Lee JS, 2004, APPL IMMUNOHISTO M M, V12, P205, DOI 10.1097/00129039-200409000-00004; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Markman B, 2010, ANN ONCOL, V21, P683, DOI 10.1093/annonc/mdp347; Maruyama N, 2007, CLIN CANCER RES, V13, P408, DOI 10.1158/1078-0432.CCR-06-0267; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Populo H, 2011, PIGM CELL MELANOMA R, V24, P254, DOI 10.1111/j.1755-148X.2010.00796.x; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shoman N, 2005, MODERN PATHOL, V18, P250, DOI 10.1038/modpathol.3800296; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200	38	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120511	10.1371/journal.pone.0120511	http://dx.doi.org/10.1371/journal.pone.0120511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816324	gold, Green Submitted, Green Published			2022-12-27	WOS:000352133600038
J	Sahlen, V; Ordiz, A; Swenson, JE; Stoen, OG				Sahlen, Veronica; Ordiz, Andres; Swenson, Jon E.; Stoen, Ole Gunnar			Behavioural Differences between Single Scandinavian Brown Bears (Ursus arctos) and Females with Dependent Young When Experimentally Approached by Humans	PLOS ONE			English	Article							LARGE CARNIVORES; MODEL SELECTION; GRIZZLY BEARS; UNITED-STATES; ATTACKS; SIZE; CONSERVATION; POPULATION; DISTURBANCE; PREDATORS	Carnivore-human encounters that result in human injury present a conservation and management challenge and it is therefore important to understand under what conditions such incidents occur. Females with cubs are often involved when humans are injured by brown bears Ursus arctos. In Scandinavia, this is particularly true for unarmed recreational forest users. Our aim was to document behavioural differences between single bears and females with cubs in order to develop recommendations to minimize the risk of injuries to recreational forest users. We documented the reactions of GPS-collared females with cubs and single brown bears to experimental approaches by humans to 50 m from the bear on 42 and 108 occasions, respectively. The majority of females with cubs (95%) and single bears (89%) left when approached. Bears that left were passed at shorter distances and were in more open areas than those that stayed. Both groups had similar flight initiation distances, which were longer for bears that were active at the time of the disturbance. Females with cubs selected more open habitat than single bears, also for the new site they selected following disturbance. Females with cubs, particularly active females with cubs of the year, moved greater distances and spent more time active following the approach. Females with cubs and single bears were seen or heard in 26% and 14% of the approaches, respectively. None of the bears displayed any aggressive behaviour during the approaches. Females with cubs selected more open habitat, perhaps predisposing them to encountering people that are not involved in hunting activities, which might be the primary explanation why females with cubs are most frequently involved when unarmed people are injured by bears in Scandinavia. To mitigate injury risks, one must consider factors that bring bears closer to human activity in the first place.	[Sahlen, Veronica; Ordiz, Andres; Swenson, Jon E.; Stoen, Ole Gunnar] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Ordiz, Andres] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Stoen, Ole Gunnar] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research; Swedish University of Agricultural Sciences	Sahlen, V (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	v.sahlen@gmail.com	Swenson, Jon/AAE-2890-2019; Støen, Ole-Gunnar/AAY-6457-2020	Ordiz, Andres/0000-0002-6141-8457	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation; Research Council of Norway (RCN); Polish-Norwegian Research Program [POL-NOR/198352/85/2013]; program "Adaptive management of fish and wildlife populations"	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation(Austrian Science Fund (FWF)); Research Council of Norway (RCN)(Research Council of Norway); Polish-Norwegian Research Program; program "Adaptive management of fish and wildlife populations"	The Scandinavian Brown Bear Research Project (SBBRP) is funded by the Swedish Environmental Protection Agency, Norwegian Directorate for Nature Management, Swedish Association for Hunting and Wildlife Management, the Austrian Science Foundation and the Research Council of Norway (RCN). The research leading to these results has received funding from the Polish-Norwegian Research Program operated by the National Center for Research and Development under the Norwegian Financial Mechanism 20092014 in the frame of Project Contract No POL-NOR/198352/85/2013. VS and OGS were funded by the Norwegian Directorate for Nature Management, and O-G.S. was funded by the program "Adaptive management of fish and wildlife populations". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnemo J.M., 2011, BIOMEDICAL PROTOCOL; Bargali HS, 2005, URSUS, V16, P263, DOI 10.2192/1537-6176(2005)016[0263:COSBAA]2.0.CO;2; BEIER P, 1991, WILDLIFE SOC B, V19, P403; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ciuti S, 2008, BEHAV PROCESS, V77, P408, DOI 10.1016/j.beproc.2007.09.001; Conover M., 2002, RESOLVING HUMAN WILD; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; De Giorgio F, 2007, FORENSIC SCI INT, V173, P64, DOI 10.1016/j.forsciint.2006.08.026; Enserink M, 2006, SCIENCE, V314, P746, DOI 10.1126/science.314.5800.746; Esseen P-A, 2003, GEOMATIK IFSRO, P253; Fahlman A, 2011, J ZOO WILDLIFE MED, V42, P1, DOI 10.1638/2008-0117.1; Frid A, 2002, CONSERV ECOL, V6; Gore M. L., 2009, Human Dimensions of Wildlife, V14, P301, DOI 10.1080/10871200903160944; Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P69, DOI 10.1007/s00265-010-1036-7; Herrero S, 2003, URSUS-SERIES, V14, P44; Herrero S., 1990, BEARS THEIR BIOL MAN, V8, P25, DOI DOI 10.2307/3872659; Herrero S, 1976, BEARS THEIR BIOL MAN, P121; Herrero S, 2011, J WILDLIFE MANAGE, V75, P596, DOI 10.1002/jwmg.72; Herrero Stephen, 1999, Ursus, V11, P209; Hubbard Ryan D., 2009, Human-Wildlife Conflicts, V3, P129; Johansson Maria, 2012, Human Dimensions of Wildlife, V17, P58, DOI 10.1080/10871209.2012.619001; Johansson Maria, 2011, Human Dimensions of Wildlife, V16, P15, DOI 10.1080/10871209.2011.535240; KARLSSON C, 1991, SKOGSUPPSKATTNING SK; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Koskela E, 2000, EVOL ECOL, V14, P99, DOI 10.1023/A:1011051426666; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; MAESTRIPIERI D, 1992, CAN J ZOOL, V70, P1069, DOI 10.1139/z92-150; Miller SD, 1999, URSUS, P239; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Montgomery DC., 2019, INTRO STAT QUALITY C; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Nevin OT, 2005, BIOL CONSERV, V121, P611, DOI 10.1016/j.biocon.2004.06.011; Nielsen A, 2007, BASIC APPL ECOL, V8, P231, DOI 10.1016/j.baae.2006.05.009; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Ordiz A, 2009, URSUS, V20, P109, DOI 10.2192/08SC031.1; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Persson IL, 2001, WILDLIFE BIOL, V7, P27, DOI 10.2981/wlb.2001.006; Sahlen E, 2011, URSUS, V22, P152, DOI 10.2192/URSUS-D-10-00007.1; Sahlen V., 2013, THESIS NORWEGIAN U L; Sandstrom C., 2009, SVENSKARS INSTALLNIN; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Shewhart WA., 1931, EC CONTROL QUALITY M; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Steyaert SMJG, 2014, ECOL EVOL, V4, P300, DOI 10.1002/ece3.935; Steyaert SMJG, 2013, J ANIM ECOL, V82, P836, DOI 10.1111/1365-2656.12055; Swenson J. E., 1996, NORWEGIAN I NATURE R, V404; Swenson J.E., 1999, BIOSPH CONS, V2, P1; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; TT G, 2014, SVENSKA DAGBLADET; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wam HK, 2012, EUR J WILDLIFE RES, V58, P1001, DOI 10.1007/s10344-012-0670-y; White D, 1999, WILDLIFE SOC B, V27, P146; WIKLUND CG, 1990, BEHAV ECOL SOCIOBIOL, V26, P217; Garamszegi LZ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1, DOI 10.1007/s00265-010-1028-7	61	22	22	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121576	10.1371/journal.pone.0121576	http://dx.doi.org/10.1371/journal.pone.0121576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830333	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600076
J	Tietjen, I; Ntie-Kang, F; Mwimanzi, P; Onguene, PA; Scull, MA; Idowu, TO; Ogundaini, AO; Meva'a, LM; Abegaz, BM; Rice, CM; Andrae-Marobela, K; Brockman, MA; Brumme, ZL; Fedida, D				Tietjen, Ian; Ntie-Kang, Fidele; Mwimanzi, Philip; Onguene, Pascal Amoa; Scull, Margaret A.; Idowu, Thomas Oyebode; Ogundaini, Ablodun Oguntuga; Meva'a, Luc Mbaze; Abegaz, Berhanu M.; Rice, Charles M.; Andrae-Marobela, Kerstin; Brockman, Mark A.; Brumme, Zabrina L.; Fedida, David			Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ION-CHANNEL ACTIVITY; GALLOYL MOIETY; VPU; REPLICATION; P7; ANTIOXIDANT; FLAVONOIDS; CATECHINS; PROTEINS	The continued burden of HIV in resource-limited regions such as parts of sub-Saharan Africa, combined with adverse effects and potential risks of resistance to existing antiretroviral therapies, emphasize the need to identify new HIV inhibitors. Here we performed a virtual screen of molecules from the pan-African Natural Product Library, the largest collection of medicinal plant-derived pure compounds on the African continent. We identified eight molecules with structural similarity to reported interactors of Vpu, an HIV-1 accessory protein with reported ion channel activity. Using in vitro HIV-1 replication assays with a CD4+ T cell line and peripheral blood mononuclear cells, we confirmed antiviral activity and minimal cytotoxicity for two compounds, ixoratannin A-2 and boldine. Notably, ixoratannin A-2 retained inhibitory activity against recombinant HIV-1 strains encoding patient-derived mutations that confer resistance to protease, non-nucleoside reverse transcriptase, or integrase inhibitors. Moreover, ixoratannin A-2 was less effective at inhibiting replication of HIV-1 lacking Vpu, supporting this protein as a possible direct or indirect target. In contrast, boldine was less effective against a protease inhibitor-resistant HIV-1 strain. Both ixoratannin A-2 and boldine also inhibited in vitro replication of hepatitis C virus (HCV). However, BIT-225, a previously- reported Vpu inhibitor, demonstrated antiviral activity but also cytotoxicity in HIV-1 and HCV replication assays. Our work identifies pure compounds derived from African plants with potential novel activities against viruses that disproportionately afflict resource-limited regions of the world.	[Tietjen, Ian; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Tietjen, Ian; Mwimanzi, Philip; Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Ntie-Kang, Fidele] Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon; [Onguene, Pascal Amoa; Meva'a, Luc Mbaze] Univ Douala, Dept Chem, Fac Sci, Douala, Cameroon; [Scull, Margaret A.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Idowu, Thomas Oyebode; Ogundaini, Ablodun Oguntuga] Obafemi Awolowo Univ, Fac Pharm, Dept Pharmaceut Chem, Ife, Nigeria; [Abegaz, Berhanu M.] African Acad Sci, Nairobi, Kenya; [Andrae-Marobela, Kerstin] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Brockman, Mark A.] Simon Fraser Univ, Dept Mol Biol & Biochem, Fac Sci, Burnaby, BC V5A 1S6, Canada; [Brockman, Mark A.; Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada	University of British Columbia; Simon Fraser University; Rockefeller University; Obafemi Awolowo University; University of Botswana; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS	Tietjen, I (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	itietjen@mail.ubc.ca	Scull, Margaret/K-9963-2019; Ntie-Kang, Fidele/B-5877-2013; Brockman, Mark/D-1669-2016	Ntie-Kang, Fidele/0000-0003-0795-394X; Tietjen, Ian/0000-0002-8991-6490; Brumme, Zabrina/0000-0002-8157-1037; Scull, Margaret/0000-0002-6860-2468; Ogundaini, Abiodun/0000-0001-9356-497X; Idowu, Thomas/0000-0002-8154-7432; Brockman, Mark/0000-0001-6432-1426	Canadian Institutes for Health Research [HOP-115700]; Grand Challenges Canada; Canada-Sub Saharan Africa (CANSSA) HIV/AIDS Network through the Global Health Research Initiative (GHRI); Canadian Institutes of Health Research postdoctoral fellowship; Michael Smith Foundation for Health Research Postdoctoral fellowship; National Research Service Award from the National Institute of Allergy and Infectious Diseases [F32 AI091207]; National Institutes of Health [R01 AI099284, R01 AI075099]; Canadian Institutes of Health New Investigator Award; Michael Smith Foundation for Health Research Scholar Award; Canada Research Chair in Viral Pathogenesis and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099284, F32AI091207, R01AI075099] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Grand Challenges Canada(CGIAR); Canada-Sub Saharan Africa (CANSSA) HIV/AIDS Network through the Global Health Research Initiative (GHRI); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Postdoctoral fellowship(Michael Smith Foundation for Health Research); National Research Service Award from the National Institute of Allergy and Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); Canada Research Chair in Viral Pathogenesis and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by Canadian Institutes for Health Research (HOP-115700) to ZLB and MAB, http://www.cihr-irsc.gc.ca/e/193.html; Grand Challenges Canada (no grant number) to IT, http://www.grandchallenges.ca/grantee-stars/0487-01-10/; Canada-Sub Saharan Africa (CANSSA) HIV/AIDS Network through funding provided by the Global Health Research Initiative (GHRI), itself a collaborative research funding partnership of the Canadian Institutes of Health Research (CIHR), the Canadian International Development Agency (CIDA), and the International Development Research Centre (IDRC) (no grant number) to MAB and ZLB, http:// www.canssa.org/; Canadian Institutes of Health Research postdoctoral fellowship (no grant number) to PM, http://www.cihr-irsc.gc.ca/e/193.html; Michael Smith Foundation for Health Research Postdoctoral fellowship (no grant number) to PM, http://www.msfhr.org/role-hiv-nef-establishment-and-maintenance-hivlatency; National Research Service Award from the National Institute of Allergy and Infectious Diseases (F32 AI091207) to MAS, http://www.niaid.nih.gov/Pages/default.aspx; National Institutes of Health R01 AI099284, R01 AI075099 to CMR, http://www.niaid.nih.gov/Pages/default.aspx; Canadian Institutes of Health New Investigator Award (no grant number) to ZLB, http://www.cihr-irsc.gc.ca/e/193.html; Michael Smith Foundation for Health Research Scholar Award (no grant number) to ZLB, http://www.msfhr.org/zabrina-brumme; Canada Research Chair in Viral Pathogenesis and Immunity (no grant number) to MAB, http://www.chairs-chaires.gc.ca/chairholderstitulaires/profile-eng.aspx?profileId=2825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldersley M, RIMANTADINE ANTIVIRA; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Asami Y, 2003, J NAT PROD, V66, P729, DOI 10.1021/np030041j; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Bolduan S, 2011, VIROLOGY, V416, P75, DOI 10.1016/j.virol.2011.04.009; Boustie J, 1998, J NAT PROD, V61, P480, DOI 10.1021/np970382v; Bringmann G, 2008, NAT PROD REP, V25, P696, DOI 10.1039/b803784c; Brockman MA, 2006, J VIROL METHODS, V131, P134, DOI 10.1016/j.jviromet.2005.08.003; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Chang SS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002315; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Coady MJ, 1998, VIROLOGY, V244, P39, DOI 10.1006/viro.1998.9087; Daveu C, 1999, J CHEM INF COMP SCI, V39, P362, DOI 10.1021/ci980153u; Deeks SG, 2008, NAT REV DRUG DISCOV, V7, P117, DOI 10.1038/nrd2512; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2004, ANTIMICROB AGENTS CH, V48, P2325, DOI 10.1128/AAC.48.6.2325-2330.2004; Ewart GD, 1996, Hepatitis C antiviral compositions and methods, Patent No. [WO 2009018609 A1, 2009018609]; Farnet CM, 1998, ANTIMICROB AGENTS CH, V42, P2245, DOI 10.1128/AAC.42.9.2245; Fischer WB, 2014, BBA-BIOMEMBRANES, V1838, P1113, DOI 10.1016/j.bbamem.2013.08.017; Gazina EV, 2012, DRUG DISCOV TODAY, V17, P1039, DOI 10.1016/j.drudis.2012.05.002; Geary T.G., 2012, DRUG DISCOVERY AFRIC, P127; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hayeshi R, 2004, PHYTOTHER RES, V18, P877, DOI 10.1002/ptr.1481; Idowu TO, 2010, PHYTOCHEMISTRY, V71, P2092, DOI 10.1016/j.phytochem.2010.08.018; Iturriaga-Vasquez P, 2007, BIOORGAN MED CHEM, V15, P3368, DOI 10.1016/j.bmc.2007.03.023; IVORRA MD, 1993, EUR J PHARMACOL, V231, P165; Jiang F, 2010, CLIN IMMUNOL, V137, P347, DOI 10.1016/j.clim.2010.08.007; Kashiwada Y, 2005, BIOORGAN MED CHEM, V13, P443, DOI 10.1016/j.bmc.2004.10.020; Katerere DR, 2012, FITOTERAPIA, V83, P932, DOI 10.1016/j.fitote.2012.04.011; Khoury G, 2010, ANTIMICROB AGENTS CH, V54, P835, DOI 10.1128/AAC.01308-09; Kuhl BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027660; Kuroda M, 2003, J NAT PROD, V66, P894, DOI 10.1021/np030061l; Lau YS, 2014, J CARDIOVAS IN PRESS, DOI [10.1097/FJC.0185, DOI 10.1097/FJC.0185]; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SW, 2005, BBA-GEN SUBJECTS, V1723, P270, DOI 10.1016/j.bbagen.2005.02.012; Luscombe CA, 2010, ANTIVIR RES, V86, P144, DOI 10.1016/j.antiviral.2010.02.312; Meredith LW, 2013, ANTIVIR RES, V100, P636, DOI 10.1016/j.antiviral.2013.10.006; MONTANHA JA, 1995, PLANTA MED, V61, P419, DOI 10.1055/s-2006-958128; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Naithani R, 2008, MINI-REV MED CHEM, V8, P1106, DOI 10.2174/138955708785909943; Ntie-Kang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090655; Nutan, 2013, INDIAN J MED RES, V137, P540; O'Brien P, 2006, CHEM-BIOL INTERACT, V159, P1, DOI 10.1016/j.cbi.2005.09.002; Patargias G, 2010, ANAL BIOANAL CHEM, V396, P2559, DOI 10.1007/s00216-010-3498-x; Porrimer Y, 2014, NAT REV DRUG DISCOV, V4, P236; Rockstroh JK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-234; Sauter D, 2014, PLANTA MED, V80, P682, DOI 10.1055/s-0034-1368583; Schramm A, 2014, PLANTA MED, V80, P740, DOI 10.1055/s-0034-1368590; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Spasova M, 2008, BIOORGAN MED CHEM, V16, P7457, DOI 10.1016/j.bmc.2008.06.010; Stephens EB, 2002, VIROLOGY, V293, P252, DOI 10.1006/viro.2001.1244; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Tillekeratne LMV, 2001, BIOORG MED CHEM LETT, V11, P2763, DOI 10.1016/S0960-894X(01)00577-7; UNAIDS, UNAIDS ACC ANT THER; Walstab J, 2014, NEUROGASTROENT MOTIL, V26, P810, DOI 10.1111/nmo.12334; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Zhao YL, 2012, DRUG DISCOV TODAY, V17, P630, DOI 10.1016/j.drudis.2012.02.015	62	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121099	10.1371/journal.pone.0121099	http://dx.doi.org/10.1371/journal.pone.0121099			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830320	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600056
J	Henrion, MYR; Purdue, MP; Scelo, G; Broderick, P; Frampton, M; Ritchie, A; Meade, A; Li, P; McKay, J; Johansson, M; Lathrop, M; Larkin, J; Rothman, N; Wang, ZM; Chow, WH; Stevens, VL; Diver, WR; Albanes, D; Virtamo, J; Brennan, P; Eisen, T; Chanock, S; Houlston, RS				Henrion, Marc Y. R.; Purdue, Mark P.; Scelo, Ghislaine; Broderick, Peter; Frampton, Matthew; Ritchie, Alastair; Meade, Angela; Li, Peng; McKay, James; Johansson, Mattias; Lathrop, Mark; Larkin, James; Rothman, Nathaniel; Wang, Zhaoming; Chow, Wong-Ho; Stevens, Victoria L.; Diver, W. Ryan; Albanes, Demetrius; Virtamo, Jarmo; Brennan, Paul; Eisen, Timothy; Chanock, Stephen; Houlston, Richard S.			Common Variation at 1q24.1 (ALDH9A1) Is a Potential Risk Factor for Renal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL CARCINOMA; 2P21	So far six susceptibility loci for renal cell carcinoma (RCC) have been discovered by genome-wide association studies (GWAS). To identify additional RCC common risk loci, we performed a meta-analysis of published GWAS (totalling 2,215 cases and 8,566 controls of Western-European background) with imputation using 1000 Genomes Project and UK10K Project data as reference panels and followed up the most significant association signals [ 22 single nucleotide polymorphisms (SNPs) and 3 indels in eight genomic regions] in 383 cases and 2,189 controls from The Cancer Genome Atlas (TCGA). A combined analysis identified a promising susceptibility locus mapping to 1q24.1 marked by the imputed SNP rs3845536 (P-combined = 2.30x10(-8)). Specifically, the signal maps to intron 4 of the ALDH9A1 gene (aldehyde dehydrogenase 9 family, member A1). We further evaluated this potential signal in 2,461 cases and 5,081 controls from the International Agency for Research on Cancer (IARC) GWAS of RCC cases and controls from multiple European regions. In contrast to earlier findings no association was shown in the IARC series (P= 0.94; P-combined = 2.73x10(-5)). While variation at 1q24.1 represents a potential risk locus for RCC, future replication analyses are required to substantiate our observation.	[Henrion, Marc Y. R.; Broderick, Peter; Frampton, Matthew; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Purdue, Mark P.; Rothman, Nathaniel; Wang, Zhaoming; Chow, Wong-Ho; Albanes, Demetrius; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA; [Ritchie, Alastair; Meade, Angela] UCL, MRC, Clin Trials Unit, London, England; [Larkin, James] Royal Marsden NHS Fdn Trust, London, England; [Wang, Zhaoming] Leidos Biomed Res Inc, Canc Genom Res Lab, Gaithersburg, MD USA; [Stevens, Victoria L.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eisen, Timothy] Cambridge Univ Hlth Partners, Cambridge, England; [Scelo, Ghislaine; Li, Peng; McKay, James; Johansson, Mattias; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Medical Research Council Clinical Trials Unit; University of London; University College London; Royal Marsden NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; Finland National Institute for Health & Welfare; World Health Organization; International Agency for Research on Cancer (IARC); McGill University	Houlston, RS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England.	richard.houlston@icr.ac.uk	Purdue, Mark P/C-9228-2016; Wang, Zhaoming/R-5527-2018; Diver, Ryan/AAG-3469-2019; Henrion, Marc/AAT-7088-2020; Johansson, Mattias/ABF-3365-2020; Scelo, Ghislaine/CAF-8077-2022	Purdue, Mark P/0000-0003-1177-3108; Wang, Zhaoming/0000-0001-7556-3869; Diver, Ryan/0000-0002-5418-9000; Henrion, Marc/0000-0003-1242-839X; Johansson, Mattias/0000-0002-3116-5081; Houlston, Richard/0000-0002-5268-0242; Larkin, James/0000-0001-5569-9523	MRC CTU at UCL; Cancer Research UK [C490/A10124]; Bayer; Cancer Research UK - (Bobby Moore Fund) [C1298/A8362]; Leukaemia Lymphoma Research; RMH/ICR Biomedical Research Centre for Cancer; National Health Service (NHS); Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH); MRC CTU; Cancer Research UK [15116] Funding Source: researchfish	MRC CTU at UCL(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Bayer(Bayer AG); Cancer Research UK - (Bobby Moore Fund); Leukaemia Lymphoma Research; RMH/ICR Biomedical Research Centre for Cancer; National Health Service (NHS); Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH); MRC CTU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	SORCE is coordinated by the Medical Research Council (MRC) Clinical Trials Unit (CTU) at UCL and funded principally by the MRC CTU at UCL and Cancer Research UK with an educational grant from Bayer. Additional funding was provided by Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund). MYRH was supported by Leukaemia Lymphoma Research. JL is funded by the RMH/ICR Biomedical Research Centre for Cancer. National Health Service (NHS) funding for the Royal Marsden Biomedical Research Centre and Cambridge University Health Partners is acknowledged. Funding for the SEARCH team was provided by Cancer Research UK (C490/A10124). The NCI kidney GWAS was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH). The funders, except MRC CTU, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Broderick P, 2012, NAT GENET, V44, P58, DOI 10.1038/ng.993; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gudmundsson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3776; Han SS, 2012, HUM MOL GENET, V21, P1190, DOI 10.1093/hmg/ddr551; Henrion M, 2013, HUM MOL GENET, V22, P825, DOI 10.1093/hmg/dds489; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Izaguirre G, 1997, COMP BIOCHEM PHYS B, V118, P59, DOI 10.1016/S0305-0491(97)00022-9; Linehan WM, 2009, CANCER-AM CANCER SOC, V115, P2252, DOI 10.1002/cncr.24230; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Perroud B, 2009, MOL CELL PROTEOMICS, V8, P971, DOI 10.1074/mcp.M800252-MCP200; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Scales M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107497; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wu XF, 2012, HUM MOL GENET, V21, P456, DOI 10.1093/hmg/ddr479	25	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122589	10.1371/journal.pone.0122589	http://dx.doi.org/10.1371/journal.pone.0122589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826619	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800082
J	Lam, LCW; Chan, WC; Leung, T; Fung, AWT; Leung, EMF				Lam, Linda Chiu-wa; Chan, Wai Chi; Leung, Tony; Fung, Ada Wai-tung; Leung, Edward Man-fuk			Would Older Adults with Mild Cognitive Impairment Adhere to and Benefit from a Structured Lifestyle Activity Intervention to Enhance Cognition?: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; DEMENTIA; EXERCISE; VALIDATION; MEMORY; PREVALENCE; HEALTH; RISK	Background Epidemiologic evidence suggests that cognitive and physical activities are associated with better cognition in late life. The present study was conducted to examine the possible benefits of four structured lifestyle activity interventions and compare their effectiveness in optimizing cognition for older adults with mild cognitive impairment (MCI). Method and Findings This was a 12-month cluster randomized controlled trial. 555 community-dwelling Chinese older adults with MCI (295 with multiple-domain deficits (mdMCI), 260 with single-domain deficit (sdMCI)) were recruited. Participants were randomized into physical exercise (P), cognitive activity (C), integrated cognitive and physical exercise (CP), and social activity (S, active control) groups. Interventions comprised of one-hour structured activities three times per week. Primary outcome was Clinical Dementia Rating sum of boxes (CDR-SOB) scores. Secondary outcomes included Chinese versions of Alzheimer's Disease Assessment Scale Cognitive subscale (ADAS-Cog), delayed recall, Mini-Mental State Examination, Category Verbal Fluency Test (CVFT) and Disability Assessment for Dementia - Instrumental Activities of Daily Living (DAD-IADL). Percentage adherence to programs and factors affecting adherence were also examined. At 12th month, 423 (76.2%) completed final assessment. There was no change in CDR-SOB and DAD-IADL scores across time and intervention groups. Multilevel normal model and linear link function showed improvement in ADAS-Cog, delayed recall and CVFT with time (p<0.05). Post-hoc subgroup analyses showed that the CP group, compared with other intervention groups, had more significant improvements of ADAS-Cog, delayed recall and CVFT performance with sdMCI participants (p<0.05). Overall adherence rate was 73.3%. Improvements in ADAS-Cog and delayed recall scores were associated with adherence after controlling for age, education, and intervention groups (univariate analyses). Conclusions Structured lifestyle activity interventions were not associated with changes in everyday functioning, albeit with some improvements in cognitive scores across time. Higher adherence was associated with greater improvement in cognitive scores. Factors to enhance adherence should be specially considered in the design of psychosocial interventions for older adults with cognitive decline.	[Lam, Linda Chiu-wa; Leung, Tony; Fung, Ada Wai-tung] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chan, Wai Chi] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Leung, Edward Man-fuk] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; United Christian Hospital	Lam, LCW (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	cwlam@cuhk.edu.hk	FUNG, Ada Wai-Tung/K-7383-2019; Chan, Wai Chi/J-6947-2012	FUNG, Ada Wai-Tung/0000-0001-7439-3503; 	Simon KY Lee Fund for the Elderly in Hong Kong	Simon KY Lee Fund for the Elderly in Hong Kong	This project was funded by a donation from the Simon KY Lee Fund for the Elderly in Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Chiu HFK, 1998, NEUROLOGY, V50, P1002, DOI 10.1212/WNL.50.4.1002; Chu L. W., 2000, Annals Academy of Medicine Singapore, V29, P474; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Etgen T, 2011, DTSCH ARZTEBL INT, V108, P743, DOI 10.3238/arztebl.2011.0743; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Heo M, 2009, STAT MED, V28, P1017, DOI 10.1002/sim.3527; Lam CK, 2004, INT J GERIATR PSYCH, V19, P422, DOI 10.1002/gps.1098; Lam LC, 2001, ALZ DIS ASSOC DIS, V24, P343; Lam LCW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.008; Lam LCW, 2006, DEMENT GERIATR COGN, V22, P159, DOI 10.1159/000094543; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Legault C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-27; Leung Grace Tak Yu, 2011, East Asian Arch Psychiatry, V21, P123; Lui VWC, 2006, INT J GERIATR PSYCH, V21, P917, DOI 10.1002/gps.1580; Mok CCM, 2005, DEMENT GERIATR COGN, V20, P112, DOI 10.1159/000086612; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Murray DM, 2007, STAT MED, V26, P2297, DOI 10.1002/sim.2714; Nagamatsu Lindsay S, 2013, J Aging Res, V2013, P861893, DOI 10.1155/2013/861893; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Suzuki T, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-128; Valenzuela MJ, 2012, BIOL PSYCHIAT, V71, P783, DOI 10.1016/j.biopsych.2011.07.036; van Nimwegen M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f576; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	30	84	87	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118173	10.1371/journal.pone.0118173	http://dx.doi.org/10.1371/journal.pone.0118173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826620	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800002
J	Liu, WT; Jing, YY; Han, ZP; Li, XN; Liu, Y; Lai, FB; Li, R; Zhao, QD; Wu, MC; Wei, LX				Liu, Wen Ting; Jing, Ying Ying; Han, Zhi Peng; Li, Xiao Ning; Liu, Yan; Lai, Fo Bao; Li, Rong; Zhao, Qiu-Dong; Wu, Meng-Chao; Wei, Li-Xin			The Injured Liver Induces Hyperimmunoglobulinemia by Failing to Dispose of Antigens and Endotoxins in the Portal System	PLOS ONE			English	Article							SERUM IMMUNOGLOBULINS; CIRRHOSIS; IMMUNE; ACTIVATION; CELLS; IGE	Hyperimmunoglobulinemia is frequently observed in patients with chronic liver diseases. However, the exact mechanism underlying the high level of antibody formation is not fully understood. In our study, we provide evidence for the functional role of the liver and the stimulation of plasma cell proliferation in hyperimmunoglobulinemia. We collected sera from patients with chronic liver diseases, and the level of serum immunoglobulins in patients was examined; this was also investigated in animal models of liver cirrhosis and hepatocellular carcinoma. An end-to-side microsurgical portacaval shunt was used to mimic liver dysfunction in rats. We used portal vein serum and inferior vena cava serum to immunize healthy rats and mice in order to confirm the function of the healthy liver in disposing of antigens and endotoxins from the gut. For the analysis of the state of plasma cell activation, plasma cells from mice were stained with PE-conjugated anti-CD138 and FITC-conjugated anti-BrdU for flow cytometry analysis. Hyperimmunoglobulinemia was observed both in patients with chronic liver diseases and in related animal models, and high plasma LPS levels were also observed. There was a significant increase in the activation and proliferation of plasma cell in mice immunized with antigens or LPS-positive serum compared with controls that were immunized with antigens and LPS-negative serum. We confirmed that the healthy liver plays an important role in disposing of antigens and endotoxins derived from the gut. Hyperimmunoglobulinemia in chronic liver diseases mainly arises due to the collateral circulation secondary to portal hypertension, gut antigens and endotoxins that bypass the liver and reach the antibody-producing cells.	[Liu, Wen Ting; Jing, Ying Ying; Han, Zhi Peng; Liu, Yan; Lai, Fo Bao; Li, Rong; Zhao, Qiu-Dong; Wei, Li-Xin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China; [Wu, Meng-Chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Comprehens Treatment, Shanghai, Peoples R China; [Li, Xiao Ning] Fujian Entry Exit Inspectat & Quarantine Bur PRC, Hlth Quarantine & Supervis Dept, Fuzhou, Peoples R China	Naval Medical University; Naval Medical University	Wu, MC (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Comprehens Treatment, Shanghai, Peoples R China.	weilixin_smmu@163.com; lixinwei@smmu.edu.cn		Wei, Lixin/0000-0002-9526-5348	Key project of National Natural Science Foundation of China [81030041]; National Natural Science Foundation of China [31171321, 81101622, 81201584]; Special Funds for National key Sci-Tech Sepcial Project of China [2012ZX10002-016, 2012ZX10002011-011]; Shanghai Science and Technology Committee [12431900802, 12ZR1439800, 12ZR1454200]	Key project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for National key Sci-Tech Sepcial Project of China; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This project was supported by Key project of National Natural Science Foundation of China (Grant NO. 81030041); National Natural Science Foundation of China (Grant NO. 31171321, 81101622, 81201584); Special Funds for National key Sci-Tech Sepcial Project of China (Grant NO. 2012ZX10002-016, 2012ZX10002011-011); Shanghai Science and Technology Committee (Grant NO. 12431900802, 12ZR1439800, 12ZR1454200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott W, 2007, IMMUNOGENETICS, V59, P187, DOI 10.1007/s00251-006-0184-4; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; BEESON PB, 1945, J EXP MED, V81, P9, DOI 10.1084/jem.81.1.9; BENJAMIN IS, 1976, GASTROENTEROLOGY, V70, P661; BJORNEBOE M, 1972, LANCET, V1, P58; CLAGETT JA, 1978, DEV COMP IMMUNOL, V2, P235, DOI 10.1016/S0145-305X(78)80066-4; FEIZI T, 1968, GUT, V9, P193, DOI 10.1136/gut.9.2.193; Glaum MC, 2009, J ALLERGY CLIN IMMUN, V123, P224, DOI 10.1016/j.jaci.2008.09.018; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; HUSBY G, 1977, SCAND J GASTROENTERO, V12, P297, DOI 10.3109/00365527709180931; ITURRIAGA H, 1977, ANN CLIN RES, V9, P39; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KATZ DH, 1974, J IMMUNOL, V113, P974; KENT G, 1957, ARCH PATHOL, V64, P398; Liehr H, 1977, KUPFFER CELLS OTHER, P427; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; MARTIN DM, 1984, LIVER, V4, P214; Massonnet B, 2009, CLIN EXP IMMUNOL, V158, P115, DOI 10.1111/j.1365-2249.2009.04004.x; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; MOLLER G, 1973, J INFECT DIS, V128, pS52, DOI 10.1093/infdis/128.Supplement_1.S52; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; STOBO JD, 1979, DIGEST DIS SCI, V24, P737, DOI 10.1007/BF01317204; THOMAS HC, 1973, LANCET, V1, P1288; TOMASI TB, 1964, NATURE, V201, P834, DOI 10.1038/201834a0; TRIGER DR, 1973, LANCET, V1, P1494, DOI 10.1016/S0140-6736(73)91827-8; TSAI J-F, 1990, Gastroenterologia Japonica, V25, P388; Tsai JF, 1998, CLIN IMMUNOL IMMUNOP, V86, P246, DOI 10.1006/clin.1997.4477; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122739	10.1371/journal.pone.0122739	http://dx.doi.org/10.1371/journal.pone.0122739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826264	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800087
J	Zamuner, S; Rodriguez, A; Seno, F; Trovato, A				Zamuner, Stefano; Rodriguez, Alex; Seno, Flavio; Trovato, Antonio			An Efficient Algorithm to Perform Local Concerted Movements of a Chain Molecule	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; VARIABLE BOND ANGLES; LOOP CLOSURE; KINEMATICS; ROTATIONS; DYNAMICS	The devising of efficient concerted rotation moves that modify only selected local portions of chain molecules is a long studied problem. Possible applications range from speeding the uncorrelated sampling of polymeric dense systems to loop reconstruction and structure refinement in protein modeling. Here, we propose and validate, on a few pedagogical examples, a novel numerical strategy that generalizes the notion of concerted rotation. The usage of the Denavit-Hartenberg parameters for chain description allows all possible choices for the subset of degrees of freedom to be modified in the move. They can be arbitrarily distributed along the chain and can be distanced between consecutive monomers as well. The efficiency of the methodology capitalizes on the inherent geometrical structure of the manifold defined by all chain configurations compatible with the fixed degrees of freedom. The chain portion to be moved is first opened along a direction chosen in the tangent space to the manifold, and then closed in the orthogonal space. As a consequence, in Monte Carlo simulations detailed balance is easily enforced without the need of using Jacobian reweighting. Moreover, the relative fluctuations of the degrees of freedom involved in the move can be easily tuned. We show different applications: the manifold of possible configurations is explored in a very efficient way for a protein fragment and for a cyclic molecule; the "local backbone volume", related to the volume spanned by the manifold, reproduces the mobility profile of all-a helical proteins; the refinement of small protein fragments with different secondary structures is addressed. The presented results suggest our methodology as a valuable exploration and sampling tool in the context of bio-molecular simulations.	[Zamuner, Stefano; Seno, Flavio; Trovato, Antonio] Univ Padua, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Rodriguez, Alex] SISSA, I-34136 Trieste, Italy; [Seno, Flavio] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Trovato, Antonio] CNISM, Unita Padova, I-35131 Padua, Italy	University of Padua; International School for Advanced Studies (SISSA); Istituto Nazionale di Fisica Nucleare (INFN)	Trovato, A (corresponding author), Univ Padua, Dipartimento Fis & Astron G Galilei, Via Marzolo 8, I-35131 Padua, Italy.	antonio.trovato@unipd.it	Trovato, Antonio/A-3471-2009	Trovato, Antonio/0000-0002-1596-9477; Rodriguez, Alex/0000-0002-0213-6695; Zamuner, Stefano/0000-0003-1071-1829; Seno, Flavio/0000-0002-9095-4726	AIRC (Associazione Italiana per la Ricerca sul Cancro) [12214]; MIUR (Ministero Istruzione Universita' Ricerca) [RBAP11ETKA, 2012NNRKAF]; University of Padua (Universita' degli Studi di Padova) [CPDA121890]	AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero Istruzione Universita' Ricerca); University of Padua (Universita' degli Studi di Padova)	SZ, AR, FS, AT acknowledge financial support from AIRC (Associazione Italiana per la Ricerca sul Cancro, URL www.airc.it) through the grant AIRC 5 per mille, Rif. 12214. AR acknowledges financial support from MIUR (Ministero Istruzione Universita' Ricerca) through Fondo per gli Investimenti della Ricerca di Base-Accordo di Programma, Rif. RBAP11ETKA (URL firb.miur.it). FS acknowledges financial support from MIUR (Ministero Istruzione Universita' Ricerca) through Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale, Rif. 2012NNRKAF (URL prin.miur.it). SZ and AT acknowledge financial support from the University of Padua (Universita' degli Studi di Padova, URL www.unipd.it) through Progetto di Ateneo CPDA121890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt MR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2102896; Boomsma W, 2013, J COMPUT CHEM, V34, P1697, DOI 10.1002/jcc.23292; Bottaro S, 2012, J CHEM THEORY COMPUT, V8, P695, DOI 10.1021/ct200641m; BRUCCOLERI RE, 1985, MACROMOLECULES, V18, P2767, DOI 10.1021/ma00154a069; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coutsias EA, 2006, INT J QUANTUM CHEM, V106, P176, DOI 10.1002/qua.20751; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; Dinner AR, 2000, J COMPUT CHEM, V21, P1132, DOI 10.1002/1096-987X(200010)21:13<1132::AID-JCC2>3.0.CO;2-5; DODD LR, 1993, MOL PHYS, V78, P961, DOI 10.1080/00268979300100641; Favrin G, 2001, J CHEM PHYS, V114, P8154, DOI 10.1063/1.1364637; Go N., 1970, MACROMOLECULES, V3, P178, DOI DOI 10.1021/MA60014A012; Guuntert P, 1997, J MOL BIOL, V273, P283, DOI [10.1006/jmbi.1997.1284, DOI 10.1006/JMBI.1997.1284]; Hartenberg RS, 1955, J APLOID MECH    JUN, P215; Hartenberg RS, 1964, KINEMATIC SYNTHESIS; Hoffmann D, 1996, EUR BIOPHYS J BIOPHY, V24, P387, DOI 10.1007/BF00576711; HWANG WM, 1992, MECH MACH THEORY, V27, P189, DOI 10.1016/0094-114X(92)90008-6; JAIN A, 1993, J COMPUT PHYS, V106, P258; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MANOCHA D, 1995, COMPUT APPL BIOSCI, V11, P71; Noonan K, 2005, INT J ROBOT RES, V24, P971, DOI 10.1177/0278364905059108; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Ross KA., 1980, ELEMENTARY ANAL THEO; Rudin W., 1964, PRINCIPLES MATH ANAL, V3; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Ulmschneider JP, 2004, J PHYS CHEM B, V108, P16883, DOI 10.1021/jp047796z; Ulmschneider JP, 2003, J CHEM PHYS, V118, P4261, DOI 10.1063/1.1542611; Wang FG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056101	31	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118342	10.1371/journal.pone.0118342	http://dx.doi.org/10.1371/journal.pone.0118342			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825903	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800004
J	An, B; Zhang, LX; Liu, NF; Wang, Y				An, Bei; Zhang, Lixun; Liu, Naifa; Wang, Ying			Refugia Persistence of Qinghai-Tibetan Plateau by the Cold-Tolerant Bird Tetraogallus tibetanus (Galliformes: Phasianidae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGEOGRAPHIC STRUCTURE; ALLOPATRIC DIVERGENCE; EVOLUTIONARY HISTORY; DEMOGRAPHIC HISTORY; POPULATION-GROWTH; GENETIC-STRUCTURE; DNA POLYMORPHISM; ALPINE SHRUB; EXPANSION	Most of the temperate species are expected to have moved to lower altitudes during the glacial periods of the Quaternary. Here we tested this hypothesis in a cold-tolerant avian species Tibetan snowcock (Tetraogallus tibetanus) using two segments of mitochondrial gene (a 705bp Cytochrome-b; abbrev. Cyt-b and an 854 bp Control Region; abbrev. CR) and eight microsatellite loci by characterizing population differentiation and gene flow across its range. Combined (Cyt-b + CR) datasets detected several partially lineages with poor support. Microsatellite data, however, identified two distinct lineages congruent with the geographically separated western and central regions of Qinghai-Tibetan Plateau (QTP). The phylogeographic patterns that we observed might be explained by a combination of vicariance events that led to local isolation of T. tibetanus during warm periods and range expansions and population intermixing during cold periods. The results of this study add to our knowledge of population differentiation and connectivity in high altitude mountain ecosystems.	[An, Bei] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Lixun; Liu, Naifa] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhang, Lixun] Gansu Key Lab Biomonitoring & Bioremediat Environ, Lanzhou, Peoples R China; [Wang, Ying] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Shandong, Peoples R China	Lanzhou University; Lanzhou University; Shandong University	Zhang, LX (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	zhanglixun@lzu.edu.cn; naifaliu@sohu.com			National Natural Science Foundation of China (NSFC) [31101625, 30530130]; Lanzhou University Foundation of China [lzujbky-2010-131]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Lanzhou University Foundation of China	National Natural Science Foundation of China (NSFC No. 31101625 and 30530130) http://lifesc.lzu.edu.cn/t/zhanglixun_Lixun_Zhang_453.html. LZ design this study, collect data and prepare the manuscript and the Lanzhou University Foundation of China (lzujbky-2010-131).	An B, 2009, MOL PHYLOGENET EVOL, V50, P526, DOI 10.1016/j.ympev.2008.12.003; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barilani M, 2007, BIOL CONSERV, V137, P57, DOI 10.1016/j.biocon.2007.01.014; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P., 2002, MIGRATE DOCUMENTATIO; Belkhir K., 2004, GENETIX 4 05 POPULAT; Benzecri JP, 1973, ANAL DONNEES ANAL CO, VII; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Cheng T, 1978, FAUNA SINICA AVES, V4, P51; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Devitt TJ, 2013, MOL ECOL, V22, P1650, DOI 10.1111/mec.12196; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038184; Fu YX, 1997, GENETICS, V147, P915; Garcia JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-333; GOUDET J., 2001, FSTAT VERSION 2 9 3; Gould J, 1854, P ZOOL SOC, V47; Guo XG, 2012, ASIAN HERPETOL RES, V3, P52, DOI 10.3724/SP.J.1245.2012.00052; Hu Y, 2011, MOL ECOL, V20, P2662, DOI 10.1111/j.1365-294X.2011.05126.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; Li C, 2010, J PLANT ECOL, V3, P9, DOI 10.1093/jpe/rtp022; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maddison W, 2011, MESQUITE VERSION 2 7; Prance G, 1978, INTERCIENCIA, V4, P207; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozen S, 2000, Methods Mol Biol, V132, P365; SHEN XZ, 1963, CHIN J ZOOL, V5, P186; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Swofford D.L., 2002, PAUP VERSION 4 PHYLO; TAJIMA F, 1989, GENETICS, V123, P597; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wu Su-Gong, 1995, Acta Botanica Yunnanica, V17, P233; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang LX, 2014, BIOCHEM GENET, V52, P38, DOI 10.1007/s10528-013-9626-5	46	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121118	10.1371/journal.pone.0121118	http://dx.doi.org/10.1371/journal.pone.0121118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822918	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700090
J	Budgell, E; Cohen, AL; McAnerney, J; Walaza, S; Madhi, SA; Blumberg, L; Dawood, H; Kahn, K; Tempia, S; Venter, M; Cohen, C				Budgell, Eric; Cohen, Adam L.; McAnerney, Jo; Walaza, Sibongile; Madhi, Shabir A.; Blumberg, Lucille; Dawood, Halima; Kahn, Kathleen; Tempia, Stefano; Venter, Marietjie; Cohen, Cheryl			Evaluation of Two Influenza Surveillance Systems in South Africa	PLOS ONE			English	Article							CASE DEFINITIONS; ILLNESS; EPIDEMIOLOGY; PERFORMANCE; DIAGNOSIS	Background The World Health Organisation recommends outpatient influenza-like illness (ILI) and inpatient severe acute respiratory illness (SARI) surveillance. We evaluated two influenza surveillance systems in South Africa: one for ILI and another for SARI. Methodology The Viral Watch (VW) programme has collected virological influenza surveillance data voluntarily from patients with ILI since 1984 in private and public clinics in all 9 South African provinces. The SARI surveillance programme has collected epidemiological and virological influenza surveillance data since 2009 in public hospitals in 4 provinces by dedicated personnel. We compared nine surveillance system attributes from 2009-2012. Results We analysed data from 18,293 SARI patients and 9,104 ILI patients. The annual proportion of samples testing positive for influenza was higher for VW (mean 41%) than SARI (mean 8%) and generally exceeded the seasonal threshold from May to September (VW: weeks 21-40; SARI: weeks 23-39). Data quality was a major strength of SARI (most data completion measures > 90%; adherence to definitions: 88-89%) and a relative weakness of the VW programme (62% of forms complete, with limited epidemiologic data collected; adherence to definitions: 65-82%). Timeliness was a relative strength of both systems (e.g. both collected > 93% of all respiratory specimens within 7 days of symptom onset). ILI surveillance was more nationally representative, financially sustainable and expandable than the SARI system. Though the SARI programme is not nationally representative, the high quality and detail of SARI data collection sheds light on the local burden and epidemiology of severe influenza-associated disease. Conclusions To best monitor influenza in South Africa, we propose that both ILI and SARI should be under surveillance. Improving ILI surveillance will require better quality and more systematic data collection, and SARI surveillance should be expanded to be more nationally representative, even if this requires scaling back on information gathered.	[Budgell, Eric] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Cohen, Adam L.; Tempia, Stefano] Ctr Dis Control & Prevent South Africa, Influenza Program, Pretoria, South Africa; [McAnerney, Jo; Walaza, Sibongile; Madhi, Shabir A.; Blumberg, Lucille; Venter, Marietjie; Cohen, Cheryl] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp Complex, Dept Med, Kwa Zulu, South Africa; [Dawood, Halima] Univ KwaZulu Natal, Pietermaritzburg, South Africa; [Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Johannesburg, South Africa; [Tempia, Stefano] CTS Global Inc, Los Angeles, CA USA; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa	University of Oxford; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Research Foundation - South Africa; University of Witwatersrand; University of Kwazulu Natal; University of Witwatersrand; University of Pretoria; University of Witwatersrand; University of Witwatersrand	Budgell, E (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.	ebudgell@heroza.org	Dawood, Halima/AAO-6963-2020; Dawood, Halima/AAF-6045-2020; Venter, Marietjie/P-9604-2016	Dawood, Halima/0000-0001-8180-6791; Venter, Marietjie/0000-0003-2696-824X; Cohen, Cheryl/0000-0003-0376-2302; Kahn, Kathleen/0000-0003-3339-3931	National Institute for Communicable Diseases of the National Health Laboratory Service [U51/IP000155-04]; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa [U51/IP000155-04]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U51IP000155] Funding Source: NIH RePORTER	National Institute for Communicable Diseases of the National Health Laboratory Service; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the National Institute for Communicable Diseases of the National Health Laboratory Service and was supported in part by funds from the United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa (Cooperative Agreement Number: U51/IP000155-04). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. The funders had no role in study design, implementation, manuscript writing or the decision to submit for publication. The corresponding author had full access to all the data in the study and takes final responsibility for the decision to submit for publication.	Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Chen SY, 2012, AM J EMERG MED, V30, P1796, DOI 10.1016/j.ajem.2012.02.016; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; German R R, 2001, MMWR Recomm Rep, V50, P1; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Kasper MR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-320; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Ope MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020111; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Walaza S, 2013, OPT CONTR INFL 8 CAP; World Health Organization, 2014, GLOB EP SURV STAND I	20	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120226	10.1371/journal.pone.0120226	http://dx.doi.org/10.1371/journal.pone.0120226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822719	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700058
J	Della Pia, EA; Martinez, KL				Della Pia, Eduardo Antonio; Martinez, Karen L.			Single Domain Antibodies as a Powerful Tool for High Quality Surface Plasmon Resonance Studies	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NANOBODIES; FRAGMENTS; MUTANTS; IMMOBILIZATION; PURIFICATION; KINETICS; BINDING; CELLS	Single domain antibodies are recombinantly expressed functional antibodies devoid of light chains. These binding elements are derived from heavy chain antibodies found in camelids and offer several distinctive properties for applications in biotechnology such as small size, stability, solubility, and expression in high yields. In this study we demonstrated the potential of using single domain antibodies as capturing molecules in biosensing applications. Single domain antibodies raised against green fluorescent protein were anchored onto biosensor surfaces by using several immobilization strategies based on Ni2+: nitrilotriacetic acid-polyhistidine tag, antibody-antigen, biotin-streptavidin interactions and amine-coupling chemistry. The interaction with the specific target of the single domain antibodies was characterized by surface plasmon resonance. The immobilized single domain antibodies show high affinities for their antigens with K-D = 3-6 nM and outperform other antibody partners as capturing molecules facilitating also the data analysis. Furthermore they offer high resistance and stability to a wide range of denaturing agents. These unique biophysical properties and the production of novel single domain antibodies against affinity tags make them particularly attractive for use in biosensing and diagnostic assays.	[Della Pia, Eduardo Antonio] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Della Pia, EA (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	dellapiaea@nano.ku.dk; martinez@nano.ku.dk	Martinez, Karen/W-3709-2019; martinez, karen L/J-5933-2013	Martinez, Karen/0000-0003-0932-8080; martinez, karen L/0000-0003-0932-8080	Danish Research Council [FTP-12-132506]; Danish Ministry for Science, Technology and Innovation; Danish Agency for Science Technology and Innovation (The Danish Council for Strategic Research-ANaCell project)	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Ministry for Science, Technology and Innovation; Danish Agency for Science Technology and Innovation (The Danish Council for Strategic Research-ANaCell project)	E. D. P. was supported by a Danish Research Council fellowship award (FTP-12-132506). This work was supported by the Danish Ministry for Science, Technology and Innovation, the Danish Agency for Science Technology and Innovation (The Danish Council for Strategic Research-ANaCell project).	Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Broisat A, 2012, CIRC RES, V110, P927, DOI 10.1161/CIRCRESAHA.112.265140; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dejaegere A, 2005, BIOCHEMISTRY-US, V44, P14409, DOI 10.1021/bi050986v; Della Pia EA, 2014, ACS NANO, V8, P1844, DOI 10.1021/nn406252h; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Holz JB, 2012, TRANSFUS APHER SCI, V46, P343, DOI 10.1016/j.transci.2012.03.027; Huang L, 2005, BIOSENS BIOELECTRON, V21, P483, DOI 10.1016/j.bios.2004.11.016; Huang L, 2010, EXPERT REV MOL DIAGN, V10, P777, DOI 10.1586/ERM.10.62; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Kierny MR, 2012, NANO REV, V3, DOI [10.3402/nano.v3i0.18496, DOI 10.3402/NANO.V3I0.18496]; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pichler G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036967; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Saerens D, 2005, ANAL CHEM, V77, P7547, DOI 10.1021/ac051092j; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Van de Broek B, 2011, ACS NANO, V5, P4319, DOI 10.1021/nn1023363; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4	33	8	8	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0124303	10.1371/journal.pone.0124303	http://dx.doi.org/10.1371/journal.pone.0124303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822527	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700247
J	Huang, XL; Liu, DG; Wang, D; Shi, XQ; Simon, JC				Huang, Xianliang; Liu, Deguang; Wang, Da; Shi, Xiaoqin; Simon, Jean-Christophe			Molecular and Quantitative Genetic Differentiation in Sitobion avenae Populations from Both Sides of the Qinling Mountains	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; NATURAL-SELECTION; APHID; MARKERS; ARCHITECTURE; DIVERGENCE; EVOLUTION; SPECIALIZATION; PERFORMANCE; PLASTICITY	Quantitative trait differences are often assumed to be correlated with molecular variation, but the relationship is not certain, and empirical evidence is still scarce. To address this issue, we sampled six populations of the cereal aphid Sitobion avenae from areas north and south of the Qinling Mountains, and characterized their molecular variation at seven microsatellite loci and quantitative variation at nine life-history traits. Our results demonstrated that southern populations had slightly longer developmental times of nymphs but much higher lifetime fecundity, compared to northern populations. Of the nine tested quantitative characters, eight differed significantly among populations within regions, as well as between northern and southern regions. Genetic differentiation in neutral markers was likely to have been caused by founder events and drift. Increased subdivision for quantitative characters was found in northern populations, but reduced in southern populations. This phenomenon was not found for molecular characters, suggesting the decoupling between molecular and quantitative variation. The pattern of relationships between FST and Q(ST) indicated divergent selection and suggested that local adaptation play a role in the differentiation of life-history traits in tested S. avenae populations, particularly in those traits closely related to reproduction. The main role of natural selection over genetic drift was also supported by strong structural differences in G-matrices among S. avenae populations. However, cluster analyses did not result in two groups corresponding to northern and southern regions. Genetic differentiation between northern and southern populations in neutral markers was low, indicating considerable gene flow between them. The relationship between molecular and quantitative variation, as well as its implications for differentiation and evolution of S. avenae populations, was discussed.	[Huang, Xianliang; Liu, Deguang; Wang, Da] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China; [Huang, Xianliang; Liu, Deguang; Wang, Da] Minist Agr, Key Lab Integrated Pest Management Crops Northwes, Yangling, Shaanxi Provinc, Peoples R China; [Huang, Xianliang; Liu, Deguang; Wang, Da] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi Provinc, Peoples R China; [Shi, Xiaoqin] Northwest A&F Univ, Dept Foreign Languages, Yangling, Shaanxi Provinc, Peoples R China; [Simon, Jean-Christophe] INRA, UMR 1349, IGEPP, Domaine De La Motte, Le Rheu, France	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; INRAE	Liu, DG (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi Provinc, Peoples R China.	dgliu@nwsuaf.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China [20110204120001]	Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20110204120001) (http://www.moe.edu.cn/). DL received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白晶 Bai Jing], 2010, [陕西师范大学学报. 自然科学版, Journal of Shaanxi Normal University], V38, P98; Byers DL, 2005, GENETICA, V123, P107, DOI 10.1007/s10709-003-2721-5; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Cano JM, 2004, EVOLUTION, V58, P2013, DOI 10.1111/j.0014-3820.2004.tb00486.x; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; Chapuis E, 2007, MOL ECOL, V16, P3484, DOI 10.1111/j.1365-294X.2007.03386.x; Dai XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106179; Dedryver CA, 2008, B ENTOMOL RES, V98, P159, DOI 10.1017/S0007485307005500; Edmands S, 2003, EVOLUTION, V57, P2277; Endler J.A., 1977, Monographs in Population Biology, pi; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Gao SX, 2013, J ECON ENTOMOL, V106, P1294, DOI 10.1603/EC13017; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1999, PCA GEN WIND V 1 2; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; Jolivet C, 2007, ANN BOT-LONDON, V100, P119, DOI 10.1093/aob/mcm088; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lopez-Fanjul C, 2002, EVOLUTION, V56, P865; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Morgan KK, 2001, EVOLUTION, V55, P1753; Nei M., 1987, MOL EVOLUTIONARY GEN; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Neumaier A, 1998, GENET SEL EVOL, V30, P3, DOI 10.1051/gse:19980101; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Pfrender Michael E., 2000, Conservation Genetics, V1, P263, DOI 10.1023/A:1011518125488; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Pitchers WR, 2013, J EVOLUTION BIOL, V26, P1060, DOI 10.1111/jeb.12120; SAS, 1998, SAS SYST VERS 6 12; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; SPITZE K, 1993, GENETICS, V135, P367; Steinger T, 2002, MOL ECOL, V11, P2583, DOI 10.1046/j.1365-294X.2002.01653.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Vialatte A, 2007, AGR FOREST ENTOMOL, V9, P337, DOI 10.1111/j.1461-9563.2007.00347.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang B, 2012, MOL ECOL, V21, P2130, DOI 10.1111/j.1365-294X.2012.05517.x	39	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122343	10.1371/journal.pone.0122343	http://dx.doi.org/10.1371/journal.pone.0122343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822721	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700167
J	Ibrahim, GM; Cadotte, DW; Bernstein, M				Ibrahim, George M.; Cadotte, David W.; Bernstein, Mark			A Framework for the Monitoring and Evaluation of International Surgical Initiatives in Low- and Middle-Income Countries	PLOS ONE			English	Article							GLOBAL HEALTH; SIERRA-LEONE; LOGIC MODELS; CRANIOTOMY; TOOL	Background An estimated two billion people worldwide lack adequate access to surgical care. To address this humanitarian emergency, an increasing number of international surgical partnerships are emerging between developed and low-and middle-income countries (LMICs). At present, there are no clear indicators that may be used to assess the effectiveness of such initiatives. Study Design We conducted an international qualitative study of 31 surgeons from developed and LMICs involved in international partnerships across a variety of subspecialties. Thematic analysis and grounded theory were applied in order to develop a practical framework that may be applied to monitor and evaluate global surgical initiatives. Results Several themes emerged from the study: (i) there is a large unmet need to establish and maintain prospective databases in LMICs to inform the monitoring and evaluation of international surgical partnerships; (ii) assessment of initiatives must occur longitudinally over the span of several years; (ii) the domains of assessment are contextual and encompass cultural, institutional and regional factors; and (iv) evaluation strategies should explore broader impact within the community and country. Based on thematic analysis within the domains of inputs, outputs and outcomes, a framework for the monitoring and evaluation of international surgical initiatives, the Framework for the Assessment of InteRNational Surgical Success (FAIRNeSS) is proposed. Conclusions In response to the increasing number of surgical partnerships between developed and LMICs, we propose a framework to monitor and evaluate international surgical initiatives.	[Ibrahim, George M.; Cadotte, David W.; Bernstein, Mark] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Ibrahim, George M.; Cadotte, David W.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University of Toronto	Ibrahim, GM (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.	george.m.ibrahim@gmail.com						Barbour V, 2008, PLOS MED, V5, P1165, DOI 10.1371/journal.pmed.0050182; Bedada AG, 2014, ANN SURG; Bernstein M, 2004, CAN J SURG, V47, P170; Bramall A, 2014, WORLD NEUROSURG; Cadotte DW, 2010, WORLD NEUROSURG, V73, P270, DOI 10.1016/j.wneu.2010.02.017; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Hackenberg B, 2014, CAN J SURG S1, V57, pS9; Hartl R, 2010, WORLD NEUROSURG, V73, P259, DOI 10.1016/j.wneu.2010.02.047; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Holliman D, 2012, BRIT J NEUROSURG, V26, P326, DOI 10.3109/02688697.2011.633642; Howe KL, 2013, WORLD NEUROSURG, V80, pE171, DOI [10.1016/j.wneu.2013.07.003, 10.1016/j.wneu.2013.02.087]; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; McLaughlin JA, 1999, EVAL PROGRAM PLANN, V22, P65, DOI 10.1016/S0149-7189(98)00042-1; Meara JG, 2013, LANCET; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Millar A, 2001, EVAL PROGRAM PLANN, V24, P73, DOI 10.1016/S0149-7189(00)00048-3; Strauss A., 1990, BASICS QUALITATIVE R; WHO, 2004, MON EV TOOLK HIV AID; WK Kellogg Foundation, 2004, LOG MOD DEV GUID	22	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120368	10.1371/journal.pone.0120368	http://dx.doi.org/10.1371/journal.pone.0120368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821970	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700062
J	Jung, PP; Christian, N; Kay, DP; Skupin, A; Linster, CL				Jung, Paul P.; Christian, Nils; Kay, Daniel P.; Skupin, Alexander; Linster, Carole L.			Protocols and Programs for High-Throughput Growth and Aging Phenotyping in Yeast	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; POPULATION GENOMICS; PICHIA-SORBITOPHILA; ETHANOL TOLERANCE; GENOTOXIC AGENTS; PROTOPLOID YEAST; EXTENSION; COMPLEX	In microorganisms, and more particularly in yeasts, a standard phenotyping approach consists in the analysis of fitness by growth rate determination in different conditions. One growth assay that combines high throughput with high resolution involves the generation of growth curves from 96-well plate microcultivations in thermostated and shaking plate readers. To push the throughput of this method to the next level, we have adapted it in this study to the use of 384-well plates. The values of the extracted growth parameters (lag time, doubling time and yield of biomass) correlated well between experiments carried out in 384-well plates as compared to 96-well plates or batch cultures, validating the higher-throughput approach for phenotypic screens. The method is not restricted to the use of the budding yeast Saccharomyces cerevisiae, as shown by consistent results for other species selected from the Hemiascomycete class. Furthermore, we used the 384-well plate microcultivations to develop and validate a higher-throughput assay for yeast Chronological Life Span (CLS), a parameter that is still commonly determined by a cumbersome method based on counting "Colony Forming Units". To accelerate analysis of the large datasets generated by the described growth and aging assays, we developed the freely available software tools GATHODE and CATHODE. These tools allow for semi-automatic determination of growth parameters and CLS behavior from typical plate reader output files. The described protocols and programs will increase the time-and cost-efficiency of a number of yeast-based systems genetics experiments as well as various types of screens.	[Jung, Paul P.; Christian, Nils; Kay, Daniel P.; Skupin, Alexander; Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Skupin, Alexander] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	University of Luxembourg; University of California System; University of California San Diego	Linster, CL (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	carole.linster@uni.lu		SKUPIN, Alexander/0000-0002-8955-8304; Jung, Paul/0000-0001-5960-1327; Linster, Carole/0000-0001-7143-0719				Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cromie GA, 2013, G3-GENES GENOM GENET, V3, P2163, DOI 10.1534/g3.113.007492; DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fehrmann S, 2013, CELL REP, V5, P1589, DOI 10.1016/j.celrep.2013.11.013; Friedrich A, 2015, MOL BIOL EVOL, V32, P184, DOI 10.1093/molbev/msu295; Gagneur J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003803; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jung PP, 2012, G3-GENES GENOM GENET, V2, P1103, DOI 10.1534/g3.112.003152; Jung PP, 2010, CURR GENET, V56, P507, DOI 10.1007/s00294-010-0318-y; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kwan EX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003329; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 2012, SUBCELL BIOCHEM, V57, P101, DOI 10.1007/978-94-007-2561-4_5; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Maresova L, 2003, FOLIA MICROBIOL, V48, P211, DOI 10.1007/BF02930958; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Murakami C, 2009, J VIS EXP; Murakami CJ, 2008, J GERONTOL A-BIOL, V63, P113, DOI 10.1093/gerona/63.2.113; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Olsen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-141; Piper PW, 2012, SUBCELL BIOCHEM, V57, P145, DOI 10.1007/978-94-007-2561-4_7; Reisser C, 2013, GENETIC BASIS AMMONI; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stumpferl SW, 2012, GENOME RES, V22, P1963, DOI 10.1101/gr.136549.111; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Tan ZH, 2013, P NATL ACAD SCI USA, V110, P12367, DOI 10.1073/pnas.1301047110; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Voordeckers K, 2012, MOL MICROBIOL, V86, P225, DOI 10.1111/j.1365-2958.2012.08192.x; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wierman MB, 2014, FEMS YEAST RES, V14, P73, DOI 10.1111/1567-1364.12115; Woo DK, 2009, EXP GERONTOL, V44, P390, DOI 10.1016/j.exger.2009.03.001; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275	49	45	46	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119807	10.1371/journal.pone.0119807	http://dx.doi.org/10.1371/journal.pone.0119807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822370	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700045
J	Krizbai, IA; Gasparics, A; Nagyoszi, P; Fazakas, C; Molnar, J; Wilhelm, I				Krizbai, I. A.; Gasparics, A.; Nagyoszi, P.; Fazakas, C.; Molnar, J.; Wilhelm, I			Endothelial-Mesenchymal Transition of Brain Endothelial Cells: Possible Role during Metastatic Extravasation (vol 10, e0119655, 2015)	PLOS ONE			English	Correction													Sebe, Attila/K-2644-2017	Sebe, Attila/0000-0001-7814-5144				Krizbai IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119655	1	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123845	10.1371/journal.pone.0123845	http://dx.doi.org/10.1371/journal.pone.0123845			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822751	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700239
J	Morimoto, K; Suzuki, M; Ishifuji, T; Yaegashi, M; Asoh, N; Hamashige, N; Abe, M; Aoshima, M; Ariyoshi, K				Morimoto, Konosuke; Suzuki, Motoi; Ishifuji, Tomoko; Yaegashi, Makito; Asoh, Norichika; Hamashige, Naohisa; Abe, Masahiko; Aoshima, Masahiro; Ariyoshi, Koya		Adult Pneumonia Study Grp Japan	The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective Study	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; ACQUIRED PNEUMONIA; HEALTH-CARE; ASPIRATION PNEUMONIA; EPIDEMIOLOGY; ADULTS; MORTALITY; PATHOGENS; SEVERITY; SEROTYPE	Background The increasing burden of pneumonia in adults is an emerging health issue in the era of global population aging. This study was conducted to elucidate the burden of community-onset pneumonia (COP) and its etiologic fractions in Japan, the world's most aged society. Methods A multicenter prospective surveillance for COP was conducted from September 2011 to January 2013 in Japan. All pneumonia patients aged >= 15 years, including those with community- acquired pneumonia (CAP) and health care-associated pneumonia (HCAP), were enrolled at four community hospitals on four major islands. The COP burden was estimated based on the surveillance data and national statistics. Results A total of 1,772 COP episodes out of 932,080 hospital visits were enrolled during the surveillance. The estimated overall incidence rates of adult COP, hospitalization, and in-hospital death were 16.9 (95% confidence interval, 13.6 to 20.9), 5.3 (4.5 to 6.2), and 0.7 (0.6 to 0.8) per 1,000 person-years (PY), respectively. The incidence rates sharply increased with age; the incidence in people aged >= 85 years was 10-fold higher than that in people aged 15-64 years. The estimated annual number of adult COP cases in the entire Japanese population was 1,880,000, and 69.4% were aged >= 65 years. Aspiration-associated pneumonia (630,000) was the leading etiologic category, followed by Streptococcus pneumoniae-associated pneumonia (530,000), Haemophilus influenzae-associated pneumonia (420,000), and respiratory virus-associated pneumonia (420,000), including influenza-associated pneumonia (30,000). Conclusions A substantial portion of the COP burden occurs among elderly members of the Japanese adult population. In addition to the introduction of effective vaccines for S. pneumoniae and influenza, multidimensional approaches are needed to reduce the pneumonia burden in an aging society.	[Morimoto, Konosuke; Suzuki, Motoi; Ishifuji, Tomoko; Ariyoshi, Koya] Nagasaki Univ, Dept Clin Med, Inst Trop Med, Nagasaki 852, Japan; [Yaegashi, Makito] Kameda Med Ctr, Dept Gen Internal Med, Chiba, Japan; [Asoh, Norichika] Juzenkai Hosp, Dept Internal Med, Nagasaki, Japan; [Hamashige, Naohisa] Chikamori Hosp, Dept Internal Med, Kochi, Japan; [Abe, Masahiko] Ebetsu City Hosp, Dept Gen Internal Med, Ebetsu, Hokkaido, Japan; [Aoshima, Masahiro] Kameda Med Ctr, Dept Pulmonol, Chiba, Japan	Nagasaki University	Morimoto, K (corresponding author), Nagasaki Univ, Dept Clin Med, Inst Trop Med, Nagasaki 852, Japan.	komorimo@nagasaki-u.ac.jp		YOSHIDA, LAYMYINT/0000-0002-7567-3248; Suzuki, Motoi/0000-0002-8340-0880	JSPS KAKENHI Grant [25460761]; Pfizer; Nagasaki University; JSPS KAKENHI Grant [25460761]; Pfizer; Nagasaki University	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pfizer(Pfizer); Nagasaki University; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pfizer(Pfizer); Nagasaki University	This work was supported by JSPS KAKENHI Grant Number 25460761, Pfizer and Nagasaki University. Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University received financial support for this study from Pfizer. The funding source had no role in the design, data collection, analysis or interpretation of the study.	Ahmad OB., 2001, AGE STANDARDIZATION; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2011, PATIENT SURVEY 2011; [Anonymous], 2013, VIT STAT 2013; Barlow G, 2007, THORAX, V62, P253, DOI 10.1136/thx.2006.067371; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Capelastegui A, 2010, J INFECTION, V61, P364, DOI 10.1016/j.jinf.2010.07.015; Caram LB, 2009, J AM GERIATR SOC, V57, P482, DOI 10.1111/j.1532-5415.2008.02153.x; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P909; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Falsey AR, 2006, CLIN INFECT DIS, V42, P518, DOI 10.1086/499955; Grabenstein JD, 2014, CLIN INFECT DIS, V58, P854, DOI 10.1093/cid/cit800; Gross AE, 2014, ANTIMICROB AGENTS CH, V58, P5262, DOI 10.1128/AAC.02582-14; Gutierrez F, 2006, J INFECTION, V53, P166, DOI 10.1016/j.jinf.2005.11.006; Hak E, 2008, NETH J MED, V66, P378; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Ishiguro T, 2013, INTERNAL MED, V52, P317, DOI 10.2169/internalmedicine.52.8830; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jacups SP, 2011, VACCINE, V29, P5386, DOI 10.1016/j.vaccine.2011.05.082; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; MILLER DL, 1963, AM REV RESPIR DIS, V88, P473; Millett ERC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075131; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067; Naito T, 2014, J INFECT CHEMOTHER, V20, P450, DOI 10.1016/j.jiac.2014.03.004; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Shariatzadeh MR, 2006, J AM GERIATR SOC, V54, P296, DOI 10.1111/j.1532-5415.2005.00608.x; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Soto K, 2011, PUBLIC HEALTH REP, V126, P81, DOI 10.1177/00333549111260S313; Takaki M, 2014, JPN J INFECT DIS, V67, P269, DOI 10.7883/yoken.67.269; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; Vila-Corcoles A, 2009, RESP MED, V103, P309, DOI 10.1016/j.rmed.2008.08.006; Weinberger DM, 2014, HUMAN VACCINES IMMUN, V10; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9	47	110	112	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122247	10.1371/journal.pone.0122247	http://dx.doi.org/10.1371/journal.pone.0122247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822890	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700159
J	Parrello, D; Mustin, C; Brie, D; Miron, S; Billard, P				Parrello, Damien; Mustin, Christian; Brie, David; Miron, Sebastian; Billard, Patrick			Multicolor Whole-Cell Bacterial Sensing Using a Synchronous Fluorescence Spectroscopy-Based Approach	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; IRON HOMEOSTASIS; SIGMA-FACTOR; IN-SITU; PROTEINS; IDENTIFICATION; DECOMPOSITION; EXPRESSION; UNIQUENESS; DESIGN	The wide collection of currently available fluorescent proteins (FPs) offers new possibilities for multicolor reporter gene-based studies of bacterial functions. However, the simultaneous use of multiple FPs is often limited by the bleed-through of their emission spectra. Here we introduce an original approach for detection and separation of multiple overlapping fluorescent signals from mixtures of bioreporters strains. The proposed method relies on the coupling of synchronous fluorescent spectroscopy (SFS) with blind spectral decomposition achieved by the Canonical Polyadic (CP) decomposition (also known as Candecomp/Parafac) of three-dimensional data arrays. Due to the substantial narrowing of FP emission spectra and sensitive detection of multiple FPs in a one-step scan, SFS reduced spectral overlap and improved the selectivity of the CP unmixing procedure. When tested on mixtures of labeled E. coli strains, the SFS/CP approach could easily extract the contribution of at least four overlapping FPs. Furthermore, it allowed to simultaneously monitor the expression of three iron responsive genes and pyoverdine production in P. aeruginosa. Implemented in a convenient microplate format, this multiplex fluorescent reporter method provides a useful tool to study complex processes with different variables in bacterial systems.	[Parrello, Damien; Mustin, Christian; Billard, Patrick] Univ Lorraine, CNRS, LIEC, UMR 7360, Vandoeuvre Les Nancy, France; [Brie, David; Miron, Sebastian] Univ Lorraine, CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Billard, P (corresponding author), Univ Lorraine, CNRS, LIEC, UMR 7360, Vandoeuvre Les Nancy, France.	patrick.billard@univ-lorraine.fr		Billard, Patrick/0000-0001-8601-6270	French Agence Nationale de la Recherche (ANR) project HAESPRI [ANR-09-BLAN-0336-04]	French Agence Nationale de la Recherche (ANR) project HAESPRI(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche (ANR) project HAESPRI (ANR-09-BLAN-0336-04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ball DA, 2010, BIOCOMPUT-PAC SYM, P385; Bansal L, 2013, CHEM ENG SCI, V101, P191, DOI 10.1016/j.ces.2013.06.021; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox Robert Sidney 3rd, 2010, J Biol Eng, V4, P10, DOI 10.1186/1754-1611-4-10; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Ghim CM, 2010, BMB REP, V43, P451, DOI 10.5483/BMBRep.2010.43.7.451; Guo XJ, 2012, SIAM J MATRIX ANAL A, V33, P111, DOI 10.1137/110825765; Harshman R. A., 1970, 16 UCLA, P1; Hewitt BM, 2012, ENVIRON SCI TECHNOL, V46, P5414, DOI 10.1021/es300164p; Jouanneau S, 2011, ENVIRON SCI TECHNOL, V45, P2925, DOI 10.1021/es1031757; Larrainzar E, 2005, ANNU REV MICROBIOL, V59, P257, DOI 10.1146/annurev.micro.59.030804.121350; LLOYD JBF, 1971, NATURE-PHYS SCI, V231, P64, DOI 10.1038/physci231064a0; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Miron S, 2011, CHEMOMETR INTELL LAB, V105, P7, DOI 10.1016/j.chemolab.2010.10.005; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Patra D, 2002, TRAC-TREND ANAL CHEM, V21, P787, DOI 10.1016/S0165-9936(02)01201-3; Romanowski K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-212; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sidiropoulos ND, 2000, J CHEMOMETR, V14, P229, DOI 10.1002/1099-128X(200005/06)14:3<229::AID-CEM587>3.0.CO;2-N; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-32; Tiburzi F, 2008, MOL MICROBIOL, V67, P213, DOI 10.1111/j.1365-2958.2007.06051.x; Valeur B, 2012, STRUCTURAL EFFECTS O, P75; van der Meer JR, 2010, NAT REV MICROBIOL, V8, P511, DOI 10.1038/nrmicro2392; VISCA P, 1992, APPL ENVIRON MICROB, V58, P2886, DOI 10.1128/AEM.58.9.2886-2893.1992; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216	36	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122848	10.1371/journal.pone.0122848	http://dx.doi.org/10.1371/journal.pone.0122848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822488	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700205
J	Blazquez, R; Sanchez-Margallo, FM; Crisostomo, V; Baez, C; Maestre, J; Garcia-Lindo, M; Usoon, A; Alvarez, V; Casado, JG				Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Crisostomo, Veronica; Baez, Claudia; Maestre, Juan; Garcia-Lindo, Monica; Uson, Alejandra; Alvarez, Veronica; Casado, Javier G.			Intrapericardial Administration of Mesenchymal Stem Cells in a Large Animal Model: A Bio-Distribution Analysis	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; CARDIOVASCULAR-DISEASE; TECHNICAL FEASIBILITY; MYOCARDIAL-INFARCTION; HEART-FAILURE; DELIVERY; THERAPY; INTRACORONARY; INJECTION; ACCESS	The appropriate administration route for cardiovascular cell therapy is essential to ensure the viability, proliferative potential, homing capacity and implantation of transferred cells. At the present, the intrapericardial administration of pharmacological agents is considered an efficient method for the treatment of cardiovascular diseases. However, only a few reports have addressed the question whether the intrapericardial delivery of Mesenchymal Stem Cells (MSCs) could be an optimal administration route. This work firstly aimed to analyze the pericardial fluid as a cell-delivery vehicle. Moreover, the in vivo biodistribution pattern of intrapericardially administered MSCs was evaluated in a clinically relevant large animal model. Our in vitro results firstly showed that, MSCs viability, proliferative behavior and phenotypic profile were unaffected by exposure to pericardial fluid. Secondly, in vivo cell tracking by magnetic resonance imaging, histological examination and Y-chromosome amplification clearly demonstrated the presence of MSCs in pericardium, ventricles (left and right) and atrium (left and right) when MSCs were administered into the pericardial space. In conclusion, here we demonstrate that pericardial fluid is a suitable vehicle for MSCs and intrapericardial route provides an optimal retention and implantation of MSCs.	[Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Uson, Alejandra; Alvarez, Veronica; Casado, Javier G.] Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain; [Crisostomo, Veronica; Baez, Claudia; Maestre, Juan] Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain; [Garcia-Lindo, Monica] Minimally Invas Surg Ctr, Anaesthet Unit, Caceres, Spain		Casado, JG (corresponding author), Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain.	jgarcia@ccmijesususon.com	Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Pérez, Verónica Álvarez/AAP-1021-2020; Blazquez, Rebeca/D-9523-2017; Blazquez Duran, Rebeca/A-9008-2015; Garcia, Javier/X-4319-2018; Blázquez, Rebeca/Q-2588-2019; García, Javier/AAH-1330-2020; G Casado, Javier/ABE-9043-2021	Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Pérez, Verónica Álvarez/0000-0002-7319-6089; Blazquez, Rebeca/0000-0002-1149-8305; Blazquez Duran, Rebeca/0000-0002-1149-8305; Blázquez, Rebeca/0000-0002-1149-8305; Crisostomo, Veronica/0000-0003-1740-7029; Baez Diaz, Claudia/0000-0001-9031-2929; G Casado, Javier/0000-0001-6797-7287	Redes tematicas de investigacion cooperativa en salud [RD12/0042/0025, 242038]; GobEx; FSE [TE12066, TA13042]; FEDER [IB13123]	Redes tematicas de investigacion cooperativa en salud; GobEx; FSE(European Social Fund (ESF)); FEDER(European Commission)	This work was supported in part by two grants from Redes tematicas de investigacion cooperativa en salud (RD12/0042/0025 to FMSM and CB) and European FP7-HEALTH-2009-1.4-3 (Grant Agreement 242038). Two grants from GobEx cofinanced by FSE (TE12066 to RB and TA13042 to JGC). One grant from GobEx cofinanced by FEDER to JGC (IB13123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979; Casado JG, 2013, STEM CELL REV REP, V9, P184, DOI 10.1007/s12015-013-9430-y; Crisostomo V, 2013, ISRN CARDIOL; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Fei L, 1997, CIRCULATION, V96, P4044; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Fukushima S, 2013, FUTUR CARDIOL, V9, P215, DOI [10.2217/FCA.12.85, 10.2217/fca.12.85]; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Gomez-Mauricio RG, 2013, EUR J PHARM BIOPHARM, V84, P29, DOI 10.1016/j.ejpb.2012.11.028; Hoogduijn MJ, 2011, HUM GENE THER, V22, P1587, DOI 10.1089/hum.2011.039; Huang NF, 2009, REGEN MED, V4, P527, DOI 10.2217/RME.09.32; Hyun JS, 2013, BIOTECHNOL ADV, V31, P736, DOI 10.1016/j.biotechadv.2012.11.003; Ittrich H, 2013, ROFO-FORTSCHR RONTG, V185, P1149, DOI 10.1055/s-0033-1335438; Jasmin, 2012, Methods Mol Biol, V906, P239, DOI 10.1007/978-1-61779-953-2_18; Kornowski R, 2000, CIRCULATION, V101, P454, DOI 10.1161/01.CIR.101.4.454; Ladage D, 2011, GENE THER, V18, P979, DOI 10.1038/gt.2011.52; Laham RJ, 2003, CATHETER CARDIO INTE, V58, P375, DOI 10.1002/ccd.10378; Laham RJ, 2000, J PHARMACOL EXP THER, V292, P795; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Maisch B, 2012, HERZ, V37, P644, DOI 10.1007/s00059-012-3679-9; Mazo M, 2011, J CARDIOVASC TRANSL, V4, P145, DOI 10.1007/s12265-010-9246-y; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Plant AL, 2013, STEM CELLS DEV, V22, P2457, DOI 10.1089/scd.2013.0188; RIEMANN D, 1994, INT ARCH ALLERGY IMM, V104, P48, DOI 10.1159/000236708; Ruiz-Esparza GU, 2013, INT J NANOMED, V8, P629, DOI 10.2147/IJN.S30599; Rupp H, 2010, HERZ, V35, P458, DOI 10.1007/s00059-010-3382-7; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sharma R, 2007, STEM CELLS DEV, V16, P517, DOI 10.1089/scd.2006.0070; Sheng CC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/547902; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Sun F, 2006, RADIOLOGY, V238, P719, DOI 10.1148/radiol.2382042182; Sun F, 2012, J INVASIVE CARDIOL, V24, P210; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiao YF, 2008, AM J PHYSIOL-HEART C, V294, pH2212, DOI 10.1152/ajpheart.91502.2007; Yang Y, 2012, NMR BIOMED, V25, P227, DOI 10.1002/nbm.1735	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122377	10.1371/journal.pone.0122377	http://dx.doi.org/10.1371/journal.pone.0122377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816232	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600173
J	Li, SW; Wu, XL; Dong, CL; Xie, XY; Wu, JF; Zhang, X				Li, Shao-Wen; Wu, Xiao-Ling; Dong, Chun-Li; Xie, Xiu-Ying; Wu, Jin-Fang; Zhang, Xin			The Differential Expression of OCT4 Isoforms in Cervical Carcinoma	PLOS ONE			English	Article							CELL-LINES; STEM-CELLS; SPLICED VARIANT; CANCER; MARKER; ANGIOGENESIS; PSEUDOGENES; OCT3/4	OCT4 is a transcription factor involved in maintaining stem cell phenotype and pluripotential. However, it remains unclear the expression pattern and biological function of OCT4 iso-forms in cervical cancer. Here, we reported that both nuclear OCT4A and cytoplasmic OCT4B were overexpressed in CC. OCT4A was responsible for self-renewal of cervical cancer stem-like cells (CCSCs). Furthermore, OCT4B overexpression in SiHa cervical cancer cell line significantly increased cell proliferation and tumorigenesis by inhibiting apoptosis. Moreover, OCT4B enhanced angiogenesis by the upregulation of CD34, VEGF, HIF-1 alpha and IL-6, and promoted tumor cell mobility to the surrounding tissue by the upregulation of MMP2 and MMP9, and the induction of epithelial-mesenchymal transition (EMT). In conclusion, nuclear OCT4A may serve as a marker of CCSCs and the driving force for cervical cancer metastasis and recurrence, while cytoplasmic OCT4B may cooperate with OCT4A to regulate the progression of cervical cancer through inducing angiogenesis and EMT.	[Wu, Xiao-Ling; Dong, Chun-Li; Xie, Xiu-Ying; Wu, Jin-Fang; Zhang, Xin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Obstet & Gynecol, Xian 710049, Peoples R China; [Li, Shao-Wen] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Pediat, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, X (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Obstet & Gynecol, Xian 710049, Peoples R China.	zhangxin21521@163.com			Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by the Fundamental Research Funds for the Central Universities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acladious NN, 2002, INT J CANCER, V98, P435, DOI 10.1002/ijc.10080; Amin Rupen, 2008, Gastrointest Cancer Res, V2, pS27; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Canavan TP, 2000, AM FAM PHYSICIAN, V61, P1369; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Cortes-Dericks L, 2013, ANTICANCER RES, V33, P5365; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Ferlay J, 2010, IARC CANCERBASE, V10; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Gao Y, 2012, STEM CELLS, V30, P665, DOI 10.1002/stem.1034; Gao YA, 2010, J GENET GENOMICS, V37, P461, DOI 10.1016/S1673-8527(09)60065-5; Gu TT, 2012, AM J PATHOL, V181, P652, DOI 10.1016/j.ajpath.2012.04.008; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Liu CG, 2011, ANN SURG, V253, P1165, DOI 10.1097/SLA.0b013e318214c54e; Liu DB, 2011, TUMOR BIOL, V32, P941, DOI 10.1007/s13277-011-0196-z; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Monsef N, 2009, PROSTATE, V69, P909, DOI 10.1002/pros.20934; Mueller T, 2009, CELL MOL LIFE SCI, V66, P495, DOI 10.1007/s00018-008-8623-z; Papamichos SI, 2009, MOL HUM REPROD, V15, P269, DOI 10.1093/molehr/gap018; Resende MFd, 2013, TUMOR BIOL; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Wang YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3365; Wezel F, 2013, AM J PATHOL, V183, P1128, DOI 10.1016/j.ajpath.2013.06.025; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611	41	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0118033	10.1371/journal.pone.0118033	http://dx.doi.org/10.1371/journal.pone.0118033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816351	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600007
J	Wu, Q; Tan, C; Wang, B; Zhou, P				Wu, Qi; Tan, Chuan; Wang, Bo; Zhou, Ping			Behavioral Immune System and Ingroup Derogation: The Effects of Infectious Diseases on Ingroup Derogation Attitudes	PLOS ONE			English	Article							IN-GROUP; BLACK-SHEEP; GROUP BIAS; PATHOGEN PREVALENCE; SOCIAL CATEGORIZATION; ASSORTATIVE SOCIALITY; AVOIDANCE MECHANISMS; CULTURAL-DIFFERENCES; PERCEIVED THREAT; ETHNOCENTRISM	From evolutionary reasoning, we derived a novel hypothesis that ingroup derogation is an evolved response of behavioral immune system which follows the smoke detector principle and the functional flexibility principle. This hypothesis was tested and supported across three experiments. In Experiment 1, participants' group membership was manipulated by using a minimal group paradigm. The results indicated that mere social categorization alone-a heuristic cue that implies the differentiation between "us" and "them"-was sufficient to elicit ingroup derogation among Chinese participants, and, such an intergroup bias was positively associated with the perceived vulnerability to diseases, which was also more consistently associated with ingroup attitudes. Experiment 2 extended and partially replicated Experiment 1 by showing that when there were cues of diseases in the immediate physical environment, Chinese participants exaggerated their attitudes of ingroup derogation. The results also showed that this effect was mainly driven by outgroup attraction. Experiment 3 changed the method of disease manipulation, and found that Chinese participants responded more strongly to disease cues originating from ingroup members and that they endorsed more ingroup derogation attitudes even when the ingroup and outgroup members were both displaying cues of diseases. Taken together, these results reveal the previously unexplored effects of infectious diseases on ingroup derogation attitudes, and suggest an interesting linkage between the evolved behavioral immune system and the ingroup derogation.	[Wu, Qi; Tan, Chuan; Zhou, Ping] Hunan Normal Univ, Dept Psychol, Cognit & Human Behav Key Lab Hunan Prov, Changsha, Hunan, Peoples R China; [Wang, Bo] Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China	Hunan Normal University; Central University of Finance & Economics	Zhou, P (corresponding author), Hunan Normal Univ, Dept Psychol, Cognit & Human Behav Key Lab Hunan Prov, Changsha, Hunan, Peoples R China.	pingzhouhunnu@gmail.com	Wu, Qi/AHE-9532-2022		National Natural Science Foundation of China [31300870]; Hunan Normal University [13XQN01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Normal University	This work was supported by the National Natural Science Foundation of China (Grant 31300870) and the Hunan Normal University (Grant 13XQN01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G, 1958, THE NATURE OF PREJUD; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Cashdan E, 2013, HUM NATURE-INT BIOS, V24, P59, DOI 10.1007/s12110-012-9159-3; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Cottrell CA, 2013, FRONT SOC PSYCHOL, P29; Cuddy AJC, 2009, BRIT J SOC PSYCHOL, V48, P1, DOI 10.1348/014466608X314935; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; DIENER E, 1995, SOC INDIC RES, V34, P7, DOI 10.1007/BF01078966; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Endo Y, 2000, PERS SOC PSYCHOL B, V26, P1571, DOI 10.1177/01461672002612011; Eysenck HJ, 1975, MANUAL EYESENCK PERS; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P2587, DOI 10.1098/rspb.2008.0688; Fincher CL, 2008, OIKOS, V117, P1289, DOI 10.1111/j.0030-1299.2008.16684.x; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P99, DOI 10.1017/S0140525X11001774; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Heine SJ, 1997, J PERS SOC PSYCHOL, V72, P1268, DOI 10.1037/0022-3514.72.6.1268; HEWSTONE M, 1985, J PERS SOC PSYCHOL, V48, P614, DOI 10.1037/0022-3514.48.3.614; Hruschka DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063642; Huang JY, 2011, PSYCHOL SCI, V22, P1550, DOI 10.1177/0956797611417261; JAHODA G, 1972, EUR J SOC PSYCHOL, V2, P19, DOI 10.1002/ejsp.2420020104; Jost JT, 2002, J EXP SOC PSYCHOL, V38, P586, DOI 10.1016/S0022-1031(02)00505-X; Jost JT, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P89; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; LEE YT, 1993, J CROSS CULT PSYCHOL, V24, P298, DOI 10.1177/0022022193243003; LEE YT, 1995, PERS SOC PSYCHOL B, V21, P610, DOI 10.1177/0146167295216007; Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI DOI 10.1016/j.evolhumbehav.2011.12.005; Letendre K, 2010, BIOL REV, V85, P669, DOI 10.1111/j.1469-185X.2010.00133.x; Lewis AC, 2010, J SOC PSYCHOL, V150, P211, DOI 10.1080/00224540903366388; Lund EM, 2014, EVOL HUM BEHAV, V35, P336, DOI 10.1016/j.evolhumbehav.2014.03.004; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Ma-Kellams C, 2011, PERS SOC PSYCHOL B, V37, P15, DOI 10.1177/0146167210388193; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; Miller SL, 2012, J PERS SOC PSYCHOL, V102, P1198, DOI 10.1037/a0027198; Miller SL, 2011, PSYCHOL SCI, V22, P1467, DOI 10.1177/0956797611420166; Mortensen CR, 2010, PSYCHOL SCI, V21, P440, DOI 10.1177/0956797610361706; Murray DR, 2013, PERS INDIV DIFFER, V54, P103, DOI 10.1016/j.paid.2012.08.021; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451; Navarrete CD, 2007, EVOL HUM BEHAV, V28, P60, DOI 10.1016/j.evolhumbehav.2006.06.002; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; Park JH, 2003, J NONVERBAL BEHAV, V27, P65, DOI 10.1023/A:1023910408854; Park JH, 2007, EVOL HUM BEHAV, V28, P410, DOI 10.1016/j.evolhumbehav.2007.05.008; Park JH, 2013, J SOC PSYCHOL, V153, P212, DOI 10.1080/00224545.2012.721812; Pinto IR, 2010, J PERS SOC PSYCHOL, V99, P107, DOI 10.1037/a0018187; Rand DG, 2009, P NATL ACAD SCI USA, V106, P6187, DOI 10.1073/pnas.0811552106; Reese G, 2013, SOC COGNITION, V31, P482; Ruffle BJ, 2006, J ECON BEHAV ORGAN, V60, P147, DOI 10.1016/j.jebo.2004.07.007; Ryan S, 2012, EVOL HUM BEHAV, V33, P639, DOI 10.1016/j.evolhumbehav.2012.04.001; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2012, ADV EXP SOC PSYCHOL, V46, P1, DOI 10.1016/B978-0-12-394281-4.00001-5; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schaller M, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P243; Snibbe AC, 2003, J CROSS CULT PSYCHOL, V34, P581, DOI 10.1177/0022022103256480; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Terrizzi JA, 2013, EVOL HUM BEHAV, V34, P99, DOI 10.1016/j.evolhumbehav.2012.10.003; Thornhill R., 2014, PARASITE STRESS THEO, DOI DOI 10.1007/978-3-319-08040-6; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Tybur JM, 2011, PSYCHOL SCI, V22, P478, DOI 10.1177/0956797611400096; Van Vugt M, 2009, SOC PERSONAL PSYCHOL, V3, P927, DOI 10.1111/j.1751-9004.2009.00221.x; Wang SF, 2010, IEEE T MULTIMEDIA, V12, P682, DOI 10.1109/TMM.2010.2060716; Wong JJ, 2009, EXPERT SYST APPL, V36, P804, DOI 10.1016/j.eswa.2007.10.030; Wu BP, 2012, PERS INDIV DIFFER, V53, P50, DOI 10.1016/j.paid.2012.02.023; Yamagishi T, 2009, EVOL HUM BEHAV, V30, P229, DOI 10.1016/j.evolhumbehav.2009.02.004; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032932	70	12	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122794	10.1371/journal.pone.0122794	http://dx.doi.org/10.1371/journal.pone.0122794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816247	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600197
J	Basso, A; Richner, H				Basso, Alessandra; Richner, Heinz			Predator-Specific Effects on Incubation Behaviour and Offspring Growth in Great Tits	PLOS ONE			English	Article							NEST PREDATION; ANTIPREDATOR BEHAVIOR; TEMPERATURE AFFECTS; PRACTICAL GUIDE; PARUS-MAJOR; RISK; STRESS; SIZE; FOOD; EVOLUTIONARY	In birds, different types of predators may target adults or offspring differentially and at different times of the reproductive cycle. Hence they may also differentially influence incubation behaviour and thus embryonic development and offspring phenotype. This is poorly understood, and we therefore performed a study to assess the effects of the presence of either a nest predator or a predator targeting adults and offspring after fledging on female incubation behaviour in great tits (Parus major), and the subsequent effects on offspring morphological traits. We manipulated perceived predation risk during incubation using taxidermic models of two predators: the short-tailed weasel posing a risk to incubating females and nestlings, and the sparrowhawk posing a risk to adults and offspring after fledging. To disentangle treatment effects induced during incubation from potential carry-over effects of parental behaviour after hatching, we cross-fostered whole broods from manipulated nests with broods from unmanipulated nests. Both predator treatments lead to a reduced on- and off-bout frequency, to a slower decline in on-bout temperature as incubation advanced and showed a negative effect on nestling body mass gain. At the current state of knowledge on predator-induced variation in incubation patterns alternative hypotheses are feasible, and the findings of this study will be useful for guiding future research.	[Basso, Alessandra; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland	University of Bern	Basso, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	alessandra.basso@iee.unibe.ch	Richner, Heinz/B-1659-2008	Richner, Heinz/0000-0001-7390-0526	Swiss National Science Foundation [31003A_122566]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was funded by Swiss National Science Foundation (grant 31003A_122566 to H. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Badyaev AV, 2003, OECOLOGIA, V135, P386, DOI 10.1007/s00442-003-1203-x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cichon M, 2000, OECOLOGIA, V125, P453, DOI 10.1007/s004420000461; Conway CJ, 2000, EVOLUTION, V54, P670; Cooper CB, 2005, J FIELD ORNITHOL, V76, P352, DOI 10.1648/0273-8570-76.4.352; Coslovsky M, 2011, FUNCT ECOL, V25, P878, DOI 10.1111/j.1365-2435.2011.01834.x; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; CURIO E, 1983, OECOLOGIA, V60, P83, DOI 10.1007/BF00379324; de Heij ME, 2006, P ROY SOC B-BIOL SCI, V273, P2353, DOI 10.1098/rspb.2006.3584; DEBROT S, 1985, MAMMALIA, V49, P13, DOI 10.1515/mamm.1985.49.1.13; Deeming D.C., 2002, AVIAN INCUBATION BEH; DuRant SE, 2010, J EXP BIOL, V213, P45, DOI 10.1242/jeb.034488; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Ghalambor CK, 2000, ANIM BEHAV, V60, P263, DOI 10.1006/anbe.2000.1472; Ghalambor CK, 2002, BEHAV ECOL, V13, P101, DOI 10.1093/beheco/13.1.101; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Gosler A, 1993, GREAT TIT; Gotmark F, 2005, OECOLOGIA, V142, P177, DOI 10.1007/s00442-004-1715-z; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Ibanez-Alamo JD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1067, DOI 10.1007/s00265-012-1357-9; KORPIMAKI E, 1991, OECOLOGIA, V88, P552, DOI 10.1007/BF00317719; Kovarik P, 2011, ETHOLOGY, V117, P181, DOI 10.1111/j.1439-0310.2010.01865.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lubjuhn T, 1998, J FIELD ORNITHOL, V69, P595; LYON BE, 1987, BEHAV ECOL SOCIOBIOL, V20, P377, DOI 10.1007/BF00300684; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Nakagawa S, 2009, BIOL REV, V84, P515, DOI 10.1111/j.1469-185X.2009.00083.x; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nilsson JF, 2008, J AVIAN BIOL, V39, P553, DOI 10.1111/j.0908-8857.2008.04199.x; Nord A, 2012, ANIM BEHAV, V84, P427, DOI 10.1016/j.anbehav.2012.05.017; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Olioso G., 2004, MESANGES SENTIERS NA; Pitk M, 2012, HORM BEHAV, V62, P475, DOI 10.1016/j.yhbeh.2012.08.004; Rastogi AD, 2006, ANIM BEHAV, V72, P933, DOI 10.1016/j.anbehav.2006.03.006; Schneider NA, 2013, BEHAV ECOL, V24, P47, DOI 10.1093/beheco/ars134; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Silverin B, 1998, ANIM BEHAV, V55, P1411, DOI 10.1006/anbe.1997.0717; Smith PA, 2012, ANIM BEHAV, V84, P835, DOI 10.1016/j.anbehav.2012.07.004; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Tinbergen JM, 2002, AVIAN INCUBATION BEH; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	53	11	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121088	10.1371/journal.pone.0121088	http://dx.doi.org/10.1371/journal.pone.0121088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830223	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600054
J	Li, F; Bian, CS; Xu, JF; Pang, WF; Liu, J; Duan, SG; Lei, ZG; Jiwan, P; Jin, LP				Li, Fei; Bian, Chun Song; Xu, Jian Fei; Pang, Wan Fu; Liu, Jie; Duan, Shao Guang; Lei, Zun-Guo; Jiwan, Palta; Jin, Li-Ping			Cloning and Functional Characterization of SAD Genes in Potato	PLOS ONE			English	Article							CARRIER-PROTEIN DESATURASE; SOLANUM-TUBEROSUM L; COLD-ACCLIMATION; CHILLING TOLERANCE; FREEZING TOLERANCE; MEMBRANE-LIPIDS; FROST-HARDINESS; LOW-TEMPERATURE; HIGHER-PLANTS; CDNA CLONE	Stearoyl-acyl carrier protein desaturase (SAD), locating in the plastid stroma, is an important fatty acid biosynthetic enzyme in higher plants. SAD catalyzes desaturation of stearoyl-ACP to oleyl-ACP and plays a key role in determining the homeostasis between saturated fatty acids and unsaturated fatty acids, which is an important player in cold acclimation in plants. Here, four new full-length cDNA of SADs (ScoSAD, SaSAD, ScaSAD and StSAD) were cloned from four Solanum species, Solanum commersonii, S. acaule, S. cardiophyllum and S. tuberosum, respectively. The ORF of the four SADs were 1182 bp in length, encoding 393 amino acids. A sequence alignment indicated 13 amino acids varied among the SADs of three wild species. Further analysis showed that the freezing tolerance and cold acclimation capacity of S. commersonii are similar to S. acaule and their SAD amino acid sequences were identical but differed from that of S. cardiophyllum, which is sensitive to freezing. Furthermore, the sequence alignments between StSAD and ScoSAD indicated that only 7 different amino acids at residues were found in SAD of S. tuberosum (Zhongshu8) against the protein sequence of ScoSAD. A phylogenetic analysis showed the three wild potato species had the closest genetic relationship with the SAD of S. lycopersicum and Nicotiana tomentosiformis but not S. tuberosum. The SAD gene from S. commersonii (ScoSAD) was cloned into multiple sites of the pBI121 plant binary vector and transformed into the cultivated potato variety Zhongshu 8. A freeze tolerance analysis showed overexpression of the ScoSAD gene in transgenic plants significantly enhanced freeze tolerance in cv. Zhongshu 8 and increased their linoleic acid content, suggesting that linoleic acid likely plays a key role in improving freeze tolerance in potato plants. This study provided some new insights into how SAD regulates in the freezing tolerance and cold acclimation in potato.	[Li, Fei; Bian, Chun Song; Xu, Jian Fei; Pang, Wan Fu; Liu, Jie; Duan, Shao Guang; Jin, Li-Ping] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Li, Fei; Lei, Zun-Guo] Inst Potato Guizhou Prov, Guiyang, Peoples R China; [Jiwan, Palta] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Wisconsin System; University of Wisconsin Madison	Jin, LP (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	jinliping@caas.cn			China Agriculture Research System [CARS-10]; Key Laboratory of Biology and Genetic Improvement of Tuber and Root Crops, Ministry of Agriculture, P.R. China; Freezing Tolerance Wild Potato Genetic Improvement Research and Application	China Agriculture Research System; Key Laboratory of Biology and Genetic Improvement of Tuber and Root Crops, Ministry of Agriculture, P.R. China; Freezing Tolerance Wild Potato Genetic Improvement Research and Application	This study was supported by a fund from China Agriculture Research System (CARS-10, which had a role in data collection and analysis. The funding from the Key Laboratory of Biology and Genetic Improvement of Tuber and Root Crops, Ministry of Agriculture, P.R. China, has the role in study design and decision to publish. Additional funding was received from Freezing Tolerance Wild Potato Genetic Improvement Research and Application for preparation of the manuscript.	Abdallah A. Y, 1989, PLANT PHYSIOL, V87, P100; Bertin P, 1998, PLANT GROWTH REGUL, V24, P31, DOI 10.1023/A:1005950113741; Cui H, 2010, THESIS NE AGR U; Fei L., 2008, THESIS GRADUATE SCH; FLINT HL, 1967, CAN J PLANT SCI, V47, P229, DOI 10.4141/cjps67-043; Gang C, 2011, AFRICAN J BIOTECHNOL, V79, P18185; JEFFERSON RA, 1987, EMBO J, V6, P3901; John O, 1995, PLANT CELL, V7, P957; Kates M., 1984, Biomembranes, V12, P379; KNUTZON DS, 1992, P NATL ACAD SCI USA, V89, P2624, DOI 10.1073/pnas.89.7.2624; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lu CH, 2009, CROP, V1, P31; MCKEON TA, 1982, J BIOL CHEM, V257, P2141; Monica DP, 2008, MOL BREEDING, V21, P15; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; NISHIDA I, 1992, PLANT MOL BIOL, V19, P711, DOI 10.1007/BF00026799; Orlova IV, 2003, PLANT CELL PHYSIOL, V44, P447, DOI 10.1093/pcp/pcg047; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; PALTA JP, 1979, CROP SCI, V19, P665, DOI 10.2135/cropsci1979.0011183X001900050031x; Rorat T, 1998, PLANT SCI, V133, P57, DOI 10.1016/S0168-9452(98)00020-X; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; STONE JM, 1993, P NATL ACAD SCI USA, V90, P7869, DOI 10.1073/pnas.90.16.7869; Sutinen M.L., 1989, CURRENT TOPICS PLANT, P286; Tasseva G, 2004, PLANT PHYSIOL BIOCH, V42, P811, DOI 10.1016/j.plaphy.2004.10.001; TAYLOR MA, 1992, PLANT PHYSIOL, V100, P533, DOI 10.1104/pp.100.1.533; Teixeira MC, 2009, BIOTECHNOL LETT, V31, P1089, DOI 10.1007/s10529-009-9956-x; THOMPSON GA, 1991, P NATL ACAD SCI USA, V88, P2578, DOI 10.1073/pnas.88.6.2578; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; VANBERKEL J, 1994, PLANT PHYSIOL, V104, P445, DOI 10.1104/pp.104.2.445; VEGA SE, 1995, AM POTATO J, V72, P13, DOI 10.1007/BF02874375; Vega SE, 2000, J AM SOC HORTIC SCI, V125, P205, DOI 10.21273/JASHS.125.2.205; WANG SY, 1990, J AM SOC HORTIC SCI, V115, P462, DOI 10.21273/JASHS.115.3.462; YOSHIDA S, 1986, PLANT CELL PHYSIOL, V27, P83	34	18	22	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122036	10.1371/journal.pone.0122036	http://dx.doi.org/10.1371/journal.pone.0122036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825911	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800058
J	Reetz, K; Abbas, Z; Costa, AS; Gras, V; Tiffin-Richards, F; Mirzazade, S; Holschbach, B; Frank, RD; Vassiliadou, A; Kruger, T; Eitner, F; Gross, T; Schulz, JB; Floege, J; Shah, NJ				Reetz, Kathrin; Abbas, Zaheer; Costa, Ana Sofia; Gras, Vincent; Tiffin-Richards, Frances; Mirzazade, Shahram; Holschbach, Bernhard; Frank, Rolf Dario; Vassiliadou, Athina; Krueger, Thilo; Eitner, Frank; Gross, Theresa; Schulz, Joerg Bernhard; Floege, Juergen; Shah, Nadim Jon			Increased Cerebral Water Content in Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MONTREAL COGNITIVE ASSESSMENT; STAGE RENAL-DISEASE; WHITE-MATTER; DEFAULT-MODE; BRAIN; DIALYSIS; IMPAIRMENT; MRI; T-1	Little information is available on the impact of hemodialysis on cerebral water homeostasis and its distribution in chronic kidney disease. We used a neuropsychological test battery, structural magnetic resonance imaging (MRI) and a novel technique for quantitative measurement of localized water content using 3T MRI to investigate ten hemodialysis patients (HD) on a dialysis-free day and after hemodialysis (2.4 +/- 2.2 hours), and a matched healthy control group with the same time interval. Neuropsychological testing revealed mainly attentional and executive cognitive dysfunction in HD. Voxel-based-morphometry showed only marginal alterations in the right inferior medial temporal lobe white matter in HD compared to controls. Marked increases in global brain water content were found in the white matter, specifically in parietal areas, in HD patients compared to controls. Although the global water content in the gray matter did not differ between the two groups, regional increases of brain water content in particular in parieto-temporal gray matter areas were observed in HD patients. No relevant brain hydration changes were revealed before and after hemodialysis. Whereas longer duration of dialysis vintage was associated with increased water content in parieto-temporal-occipital regions, lower intradialytic weight changes were negatively correlated with brain water content in these areas in HD patients. Worse cognitive performance on an attention task correlated with increased hydration in frontal white matter. In conclusion, long-term HD is associated with altered brain tissue water homeostasis mainly in parietal white matter regions, whereas the attentional domain in the cognitive dysfunction profile in HD could be linked to increased frontal white matter water content.	[Reetz, Kathrin; Abbas, Zaheer; Costa, Ana Sofia; Tiffin-Richards, Frances; Mirzazade, Shahram; Schulz, Joerg Bernhard; Shah, Nadim Jon] RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany; [Reetz, Kathrin; Abbas, Zaheer; Gras, Vincent; Mirzazade, Shahram; Shah, Nadim Jon] Res Ctr Julich GmbH, Inst Neurosci & Med INM 4, Julich, Germany; [Reetz, Kathrin; Abbas, Zaheer; Costa, Ana Sofia; Tiffin-Richards, Frances; Mirzazade, Shahram; Schulz, Joerg Bernhard; Shah, Nadim Jon] JARA, Translat Brain Med, Julich, Germany; [Reetz, Kathrin; Abbas, Zaheer; Costa, Ana Sofia; Tiffin-Richards, Frances; Mirzazade, Shahram; Schulz, Joerg Bernhard; Shah, Nadim Jon] JARA, Translat Brain Med, Aachen, Germany; [Holschbach, Bernhard] KfH Kuratorium Dialyse & Nierentransplantat eV, Stolberg, Germany; [Frank, Rolf Dario] St Antonius Hosp Eschweiler, Dept Internal Med, Eschweiler, Germany; [Vassiliadou, Athina] Dialysezentrum Aachen, Praxis & Dialyse, Aachen, Germany; [Krueger, Thilo; Eitner, Frank; Gross, Theresa; Floege, Juergen] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Research Center Julich; Saint Antonius Hospital; RWTH Aachen University	Reetz, K (corresponding author), RWTH Aachen Univ Hosp, Dept Neurol, Aachen, Germany.	kreetz@ukaachen.de	Reetz, Kathrin/H-9510-2012; Costa, Ana Sofia/O-3913-2017; Schulz, Jörg B/D-9786-2012; Shah, N. Jon/H-5849-2013	Reetz, Kathrin/0000-0002-9730-9228; Costa, Ana Sofia/0000-0002-1999-6616; Schulz, Jörg B/0000-0002-8903-0593; Shah, N. Jon/0000-0002-8151-6169; Abbas, Zaheer/0000-0002-0650-8388; Gras, Vincent/0000-0002-4997-2738	Excellence Initiative of the German Research Foundation [DFG ZUK32/1]; German Federal Ministry of Education and Research [BMBF 01GQ1402]; Fundacao para a Ciencia e Tecnologia (FCT) -POPH - QREN Program [SFRH/BD/65743 2009]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association [HA-314]; Bayer Pharma AG	Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Fundacao para a Ciencia e Tecnologia (FCT) -POPH - QREN Program; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases through the Initiative and Network Fund of the Helmholtz Association; Bayer Pharma AG	Sources of support: This work was supported in part by the Excellence Initiative of the German Research Foundation [DFG ZUK32/1] and the German Federal Ministry of Education and Research [BMBF 01GQ1402] to KR; and by a PhD fellowship (SFRH/BD/65743 2009) from the Fundacao para a Ciencia e Tecnologia (FCT), financed by the POPH - QREN Program to ASC. NJS and JBS were in part funded by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases [HA-314], through the Initiative and Network Fund of the Helmholtz Association. The sponsors had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. Bayer Pharma AG provided support for the authors TK and FE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbas Z, 2015, NEUROIMAGE, V106, P404, DOI 10.1016/j.neuroimage.2014.11.017; Abbas Z, 2014, MAGN RESON MED, V72, P1735, DOI 10.1002/mrm.25086; Aebi C, 2002, VALIEDIRUNG NEUROPSY; [Anonymous], 2003, EUROPEAN HEART J; [Anonymous], 2000, MINI MENTAL STATUS T; Aschenbrenner S., 2000, REGENSBURG WORD FLUE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beddhu S, 2000, AM J MED, V108, P609, DOI 10.1016/S0002-9343(00)00371-5; Biernacki C, 2006, COMPUT STAT DATA AN, V51, P587, DOI 10.1016/j.csda.2005.12.015; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Buumler G., 1985, FARBE WORT INTERFERE; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Costa AS, 2014, AM J KIDNEY DIS, V64, P434, DOI 10.1053/j.ajkd.2014.02.012; Costa AS, 2012, DEMENT GERIATR COGN, V33, P379, DOI 10.1159/000340006; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Disabato BM, 2012, CURR PSYCHIAT REP, V14, P273, DOI 10.1007/s11920-012-0279-6; Drew DA, 2013, AM J KIDNEY DIS, V61, P271, DOI 10.1053/j.ajkd.2012.08.035; Eldehni MT, 2012, SEMIN DIALYSIS, V25, P253, DOI 10.1111/j.1525-139X.2012.01057.x; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Gras V, 2013, CONCEPT MAGN RESON A, V42, P89, DOI 10.1002/cmr.a.21264; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Griswold MA, 2005, MAGN RESON MED, V54, P1553, DOI 10.1002/mrm.20722; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Herrmann-Lingen C., 1995, HOSP ANXIETY DEPRESS; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Jahng GH, 2005, MED PHYS, V32, P1524, DOI 10.1118/1.1915014; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Keil F, 2012, NEUROIMAGE, V63, P1374, DOI 10.1016/j.neuroimage.2012.07.034; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kobayashi M, 2009, NEPHROL DIAL TRANSPL, V24, P201, DOI 10.1093/ndt/gfn419; Kong X, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000313; Kurt A, 2003, RIV NEURORADIOL, V16, P275, DOI 10.1177/197140090301600207; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; Madero M, 2011, SEMIN DIALYSIS, V24, P266, DOI 10.1111/j.1525-139X.2011.00857.x; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/306189; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Murray AM, 2007, AM J KIDNEY DIS, V50, P270, DOI 10.1053/j.ajkd.2007.05.010; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Neeb H, 2006, MAGN RESON MED, V56, P224, DOI 10.1002/mrm.20929; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; Neeb H, 2006, NEUROIMAGE, V29, P910, DOI 10.1016/j.neuroimage.2005.08.062; Niemann H., 2008, CALIFORNIA VERBAL LE; OBRIEN JT, 2003, LANCET NEUROL, V2, P89, DOI [10.1016/S1474-4422(03)00305-3, DOI 10.1016/S1474-4422(03)00305-3]; Oros-Peusquens AM KF, 2012, P INT SOC MAGN RESON, P20; Pereira AA, 2005, AM J KIDNEY DIS, V45, P448, DOI 10.1053/j.ajkd.2004.10.024; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Post JB, 2010, NEPHRON CLIN PRACT, V116, pC247, DOI 10.1159/000317206; Radbruch L, 2003, J PAIN SYMPTOM MANAG, V25, P449, DOI 10.1016/S0885-3924(03)00073-3; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sanchez-Roman S, 2011, J INT NEUROPSYCH SOC, V17, P80, DOI 10.1017/S1355617710001219; Sarnak MJ, 2013, NEUROLOGY, V80, P471, DOI 10.1212/WNL.0b013e31827f0f7f; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Shah NJ, 2008, NEUROIMAGE, V41, P706, DOI 10.1016/j.neuroimage.2008.02.057; Shah NJ, 2011, METHODS MOL BIOL, V711, P29, DOI 10.1007/978-1-61737-992-5_3; Shah NJ, 2003, HEPATOLOGY, V38, P1219, DOI 10.1053/jhep.2003.50477; Tofts PS, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P85; von Aste M, 2006, DEUTSCHSPRACHIGE BEA; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; Warrington E, 1992, TESTBATTERIE VISUELL; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Yakushiji Y, 2010, HYPERTENS RES, V33, P1232, DOI 10.1038/hr.2010.171; Zimmermann P, 2012, TESTBATTERIE AUFMERK	77	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122188	10.1371/journal.pone.0122188	http://dx.doi.org/10.1371/journal.pone.0122188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826269	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800060
J	Steele, LD; Coates, B; Valero, MC; Sun, W; Seong, KM; Muir, WM; Clark, JM; Pittendrigh, BR				Steele, Laura D.; Coates, Brad; Valero, M. Carmen; Sun, Weilin; Seong, Keon Mook; Muir, William M.; Clark, John M.; Pittendrigh, Barry R.			Selective Sweep Analysis in the Genomes of the 91-R and 91-C Drosophila melanogaster Strains Reveals Few of the 'Usual Suspects' in Dichlorodiphenyltrichloroethane (DDT) Resistance	PLOS ONE			English	Article							LONG TERMINAL REPEAT; INSECTICIDE RESISTANCE; CROSS-RESISTANCE; AEDES-AEGYPTI; CYTOCHROME-P-450 SYSTEM; SUSCEPTIBLE STRAINS; GENETIC-REGULATION; POINT MUTATIONS; WIDE ANALYSIS; EXPRESSION	Adaptation of insect phenotypes for survival after exposure to xenobiotics can result from selection at multiple loci with additive genetic effects. To the authors' knowledge, no selective sweep analysis has been performed to identify such loci in highly dichlorodiphenyltrichloroethane (DDT) resistant insects. Here we compared a highly DDT resistant phenotype in the Drosophila melanogaster (Drosophila) 91-R strain to the DDT susceptible 91-C strain, both of common origin. Whole genome re-sequencing data from pools of individuals was generated separately for 91-R and 91-C, and mapped to the reference Drosophila genome assembly (v. 5.72). Thirteen major and three minor effect chromosome intervals with reduced nucleotide diversity (pi) were identified only in the 91-R population. Estimates of Tajima's D (D) showed corresponding evidence of directional selection in these same genome regions of 91-R, however, no similar reductions in p or D estimates were detected in 91-C. An overabundance of non-synonymous proteins coding to synonymous changes were identified in putative open reading frames associated with 91-R. Except for NinaC and Cyp4g1, none of the identified genes were the 'usual suspects' previously observed to be associated with DDT resistance. Additionally, up-regulated ATP-binding cassette transporters have been previously associated with DDT resistance; however, here we identified a structurally altered MDR49 candidate resistance gene. The remaining fourteen genes have not previously been shown to be associated with DDT resistance. These results suggest hitherto unknown mechanisms of DDT resistance, most of which have been overlooked in previous transcriptional studies, with some genes having orthologs in mammals.	[Steele, Laura D.; Valero, M. Carmen; Sun, Weilin; Seong, Keon Mook; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Coates, Brad] Iowa State Univ, USDA, ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Clark, John M.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Massachusetts System; University of Massachusetts Amherst	Steele, LD (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	steele11@illinois.edu		Coates, Brad/0000-0001-8908-1529	United States Department of Agriculture, Agricultural Research Service (USDA-ARS; CRIS Project) [3625-22000-017-00]; Iowa Agriculture and Home Economics Experiment Station, Ames, IA [3543]; C.W. Kearns, C.L. Metcalf and W.P. Flint Endowment	United States Department of Agriculture, Agricultural Research Service (USDA-ARS; CRIS Project); Iowa Agriculture and Home Economics Experiment Station, Ames, IA; C.W. Kearns, C.L. Metcalf and W.P. Flint Endowment	The sequencing of the 91-R and 91-C genomes were paid for by the C.W. Kearns, C.L. Metcalf and W.P. Flint Endowment. A portion of research data analyses was supported by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS; CRIS Project 3625-22000-017-00) and the Iowa Agriculture and Home Economics Experiment Station, Ames, IA (Project 3543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Barnola F V, 1971, Int J Neurosci, V1, P309, DOI 10.3109/00207457109147430; Bastide H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003534; Ben Rhouma K, 2001, HUM EXP TOXICOL, V20, P393, DOI 10.1191/096032701682692946; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Brandt A, 2002, INSECT MOL BIOL, V11, P337, DOI 10.1046/j.1365-2583.2002.00344.x; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; Busvine J R, 1957, Bull World Health Organ, V16, P206; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Charlesworth B, 2012, GENETICS, V191, P233, DOI 10.1534/genetics.111.138073; Conis E, 2010, PUBLIC HEALTH REP, V125, P337, DOI 10.1177/003335491012500224; CROW JF, 1955, EVOLUTION, V9, P202, DOI 10.2307/2405589; CROW JF, 1954, J ECON ENTOMOL, V47, P393, DOI 10.1093/jee/47.3.393; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; DAPKUS D, 1992, J ECON ENTOMOL, V85, P340, DOI 10.1093/jee/85.2.340; DAPKUS D, 1977, GENETICS, V87, P685; DELPUECH JM, 1993, P NATL ACAD SCI USA, V90, P5643, DOI 10.1073/pnas.90.12.5643; Deus KM, 2012, J MED ENTOMOL, V49, P356, DOI 10.1603/ME11164; DEZELEE S, 1989, EMBO J, V8, P3437, DOI 10.1002/j.1460-2075.1989.tb08508.x; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R., 2005, P1; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Greenberg D S, 1963, Science, V140, P878, DOI 10.1126/science.140.3569.878; HALLSTROM I, 1985, CHEM-BIOL INTERACT, V56, P157, DOI 10.1016/0009-2797(85)90003-1; HALLSTROM I, 1985, CHEM-BIOL INTERACT, V56, P173, DOI 10.1016/0009-2797(85)90004-3; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Jeibmann A, 2009, INT J MOL SCI, V10, P407, DOI 10.3390/ijms10020407; Kamel F, 2000, AM J IND MED, V37, P618, DOI 10.1002/(SICI)1097-0274(200006)37:6&lt;618::AID-AJIM6&gt;3.0.CO;2-E; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; KING JC, 1954, J ECON ENTOMOL, V47, P387, DOI 10.1093/jee/47.3.387; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI [10.2307/2406613, 10.1111/j.1558-5646.1967.tb03408.x]; Kuruganti S, 2007, GENE, V388, P43, DOI 10.1016/j.gene.2006.09.019; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Maitra S, 1996, GENE, V180, P165, DOI 10.1016/S0378-1119(96)00446-5; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; MERRELL DJ, 1956, J ECON ENTOMOL, V49, P300, DOI 10.1093/jee/49.3.300; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Nolte V, 2013, GENOME RES, V23, P99, DOI 10.1101/gr.139873.112; Pant N, 2007, ENVIRON TOXICOL PHAR, V23, P135, DOI 10.1016/j.etap.2006.07.012; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pedra JHF, 2005, PROTEOMICS, V5, P258, DOI 10.1002/pmic.200400914; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PRASITTISUK C, 1977, PESTIC SCI, V8, P527, DOI 10.1002/ps.2780080516; Qiu XH, 2013, PEST MANAG SCI, V69, P930, DOI 10.1002/ps.3454; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Ribas-Fito N, 2006, AM J EPIDEMIOL, V164, P955, DOI 10.1093/aje/kwj299; Rose CJ, 2011, MOL BIOL EVOL, V28, P1835, DOI 10.1093/molbev/msr006; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; SCOTT JG, 1981, PESTIC BIOCHEM PHYS, V16, P21, DOI 10.1016/0048-3575(81)90068-7; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SHEPANSKI MC, 1977, J ECON ENTOMOL, V70, P539, DOI 10.1093/jee/70.5.539; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Steele LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098584; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Strycharz JP, 2010, PICOGRAM ABSTRACT BO, V78, P116; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Torres-Sanchez L, 2007, ENVIRON HEALTH PERSP, V115, P435, DOI 10.1289/ehp.9566; WATERS LC, 1992, P NATL ACAD SCI USA, V89, P4855, DOI 10.1073/pnas.89.11.4855; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Wilding CS, 2012, INSECT BIOCHEM MOLEC, V42, P699, DOI 10.1016/j.ibmb.2012.06.003; Wright S, 1931, GENETICS, V16, P0097; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	90	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123066	10.1371/journal.pone.0123066	http://dx.doi.org/10.1371/journal.pone.0123066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826265	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800105
J	Chen, YW; Wang, YY; Zhao, D; Yu, CG; Xin, Z; Cao, X; Shi, J; Yang, GR; Yuan, MX; Yang, JK				Chen, Yi-Wen; Wang, Ying-Ying; Zhao, Dong; Yu, Cai-Guo; Xin, Zhong; Cao, Xi; Shi, Jing; Yang, Guang-Ran; Yuan, Ming-Xia; Yang, Jin-Kui			High Prevalence of Lower Extremity Peripheral Artery Disease in Type 2 Diabetes Patients with Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TOE-BRACHIAL INDEX; CARDIOVASCULAR EVENTS; MEXICAN-AMERICANS; PART 1; RISK; COMPLICATIONS; ALBUMINURIA; MORTALITY; DIAGNOSIS	Little is known about the relationship between lower extremity peripheral arterial disease (PAD) and proliferative diabetic retinopathy (PDR) in type 2 diabetes (T2D). Here, we explored the relationship between sight-threatening PDR and PAD. We screened for diabetic retinopathy (DR) and PAD in hospitalized patients with T2D. Patients with a diabetic duration of more than 10 years, HbA1c >= 7.5%, eGFR >= 60mL/min/1.73m2 and with PDR or with no diabetic retinopathy (NDR) were eligible for this cross-sectional study. Severities of DR were graded by digital retinal photographs according to the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. We assessed PAD by measuring Ankle Brachial Index (ABI), Toe Brachial Index (TBI) and Doppler ultrasound. Statistical analyses were performed using SPSS 17.0 software. Of the 1544 patients, 169 patients with extreme eye (57 PDR and 112 NDR) phenotypes met the inclusion criteria. Patients with PDR had a significantly higher proportion of low ABI (<= 0.99) and high ABI (>= 1.3) than patients with NDR (28.1% and 15.8% vs. 14.3% and 6.2% respectively, P<0.05). PDR patients also had lower TBI than NDR patients (0.56 +/- 0.09 vs. 0.61 +/- 0.08, P<0.01). The proportion of patients with abnormal duplex ultrasound was higher in PDR than in NDR (21.1% vs. 9.8%, P<0.001). This showed that PDR associated with PAD could be defined in multiple ways: abnormal ABI (<= 0.9) (OR = 3.61, 95% CI: 1.15-11.26), abnormal TBI (OR = 2.84, 95% CI: 1.19-6.64), abnormal duplex (OR = 3.28, 95% CI: 1.00-10.71), and critical limb ischemia (OR = 5.52, 95% CI: 2.14-14.26). Moreover, PDR was a stronger independent correlation factor for PAD than a diabetic duration of 10 years. In conclusion, PAD is more common in PDR than in NDR. It implies that PDR and PAD are mostly concomitant in T2D. We should focus on screening PAD in patients with PDR in clinical practice.	[Chen, Yi-Wen; Wang, Ying-Ying; Yu, Cai-Guo; Xin, Zhong; Cao, Xi; Shi, Jing; Yang, Guang-Ran; Yuan, Ming-Xia; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China; [Chen, Yi-Wen] Capital Med Univ, Beijing Tongren Hosp, Dept Geriatr, Beijing, Peoples R China; [Zhao, Dong; Yu, Cai-Guo] Capital Med Univ, Beijing Tongzhou Dist Luhe Hosp, Dept Endocrinol, Beijing, Peoples R China; [Wang, Ying-Ying; Zhao, Dong; Xin, Zhong; Cao, Xi; Shi, Jing; Yang, Guang-Ran; Yuan, Ming-Xia; Yang, Jin-Kui] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China.	jinkui.yang@foxmail.com	wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	Yang, Jin-Kui/0000-0002-5430-2149	National Natural Science Foundation of China [81070644]; Beijing Municipal Science and Technology Project [D12110000412001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Project	This work was supported by the National Natural Science Foundation of China (81070644) and the Beijing Municipal Science and Technology Project (D12110000412001) to YJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; [Anonymous], 2011, VASC MED, V16, P452, DOI 10.1177/1358863X11424312; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Cunha-Vaz J, 2005, PROG RETIN EYE RES, V24, P355, DOI 10.1016/j.preteyeres.2004.07.004; Estacio RO, 1998, AM J KIDNEY DIS, V31, P947, DOI 10.1053/ajkd.1998.v31.pm9631838; Esteves J, 2008, ARQ BRAS ENDOCRINOL, V52, P431, DOI 10.1590/S0004-27302008000300003; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fukui M, 2012, HYPERTENS RES, V35, P745, DOI 10.1038/hr.2012.16; Gerstein HC, 2013, DIABETES CARE, V36, P1266, DOI 10.2337/dc12-1311; Gimeno-Orna JA, 2009, AM J CARDIOL, V103, P1364, DOI 10.1016/j.amjcard.2009.01.345; Hallman DM, 2005, DIABETES CARE, V28, P1163, DOI 10.2337/diacare.28.5.1163; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hoyer C, 2013, J VASC SURG, V58, P231, DOI 10.1016/j.jvs.2013.03.044; Katwal AB, 2011, CURR DIABETES REP, V11, P218, DOI 10.1007/s11892-011-0188-9; Kawasaki R, 2011, OPHTHALMOLOGY, V118, P860, DOI 10.1016/j.ophtha.2010.08.040; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Lau JF, 2011, NAT REV CARDIOL, V8, P405, DOI 10.1038/nrcardio.2011.66; Leeper NJ, 2012, CIRCULATION, V125, P3220, DOI 10.1161/CIRCULATIONAHA.111.033878; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mostaza J, 2008, EUR J INTERN MED, V19, P255, DOI 10.1016/j.ejim.2007.06.018; Petrovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/540416; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Reaven PD, 2008, DIABETES CARE, V31, P952, DOI 10.2337/dc07-1926; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Suominen V, 2008, EUR J VASC ENDOVASC, V35, P709, DOI 10.1016/j.ejvs.2008.01.013; Targher G, 2008, DIABETIC MED, V25, P45, DOI 10.1111/j.1464-5491.2007.02327.x; van Hecke MV, 2005, DIABETES CARE, V28, P1383, DOI 10.2337/diacare.28.6.1383; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yun Yong Woon, 2011, J Prev Med Public Health, V44, P260, DOI 10.3961/jpmph.2011.44.6.260	34	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122022	10.1371/journal.pone.0122022	http://dx.doi.org/10.1371/journal.pone.0122022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822410	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700145
J	Enochson, K; Culbertson, J				Enochson, Kelly; Culbertson, Jennifer			Collecting Psycholinguistic Response Time Data Using Amazon Mechanical Turk	PLOS ONE			English	Article							REPLICATION; ENGLISH	Researchers in linguistics and related fields have recently begun exploiting online crowd-sourcing tools, like Amazon Mechanical Turk (AMT), to gather behavioral data. While this method has been successfully validated for various offline measures-grammaticality judgment or other forced-choice tasks-its use for mainstream psycholinguistic research remains limited. This is because psycholinguistic effects are often dependent on relatively small differences in response times, and there remains some doubt as to whether precise timing measurements can be gathered over the web. Here we show that three classic psycholinguistic effects can in fact be replicated using AMT in combination with open-source software for gathering response times client-side. Specifically, we find reliable effects of subject definiteness, filler-gap dependency processing, and agreement attraction in self-paced reading tasks using approximately the same numbers of participants and/or trials as similar laboratory studies. Our results suggest that psycholinguists can and should be taking advantage of AMT and similar online crowd-sourcing marketplaces as a fast, low-resource alternative to traditional laboratory research.	[Enochson, Kelly; Culbertson, Jennifer] George Mason Univ, Linguist Program, Dept English, Fairfax, VA 22030 USA; [Culbertson, Jennifer] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland	George Mason University; University of Edinburgh	Enochson, K (corresponding author), George Mason Univ, Linguist Program, Dept English, Fairfax, VA 22030 USA.	kenochso@gmu.edu		Culbertson, Jennifer/0000-0002-1737-6296	George Mason University Libraries Open Access Publishing Fund	George Mason University Libraries Open Access Publishing Fund	Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel M., 1990, ACCESSING NOUN PHRAS; Baayen RH, 2010, INT J PSYCHOL RES, V3, P12; Badecker W, AGREEMENT WH Q UNPUB; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker M, 2012, LANGUAGE, V88, P231, DOI 10.1353/lan.2012.0049; BOCK K, 1991, COGNITIVE PSYCHOL, V23, P45, DOI 10.1016/0010-0285(91)90003-7; Crain S., 1985, CAN GRAMMARS HELP PA, P94, DOI [10.1017/CBO9780511597855.004, DOI 10.1017/CBO9780511597855.004]; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Culbertson J, 2014, P NATL ACAD SCI USA, V111, P5842, DOI 10.1073/pnas.1320525111; Demberg V, 2013, INTEGRATION COSTS AU; Drummond A, 2013, IBEX FARM; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gibson E, 2011, LANG LINGUIST COMPAS, V5, P509, DOI 10.1111/j.1749-818x.2011.00295.x; Gordon P. C., 1993, Cognitive Science, V17, P311, DOI 10.1207/s15516709cog1703_1; Gundel JK, 1993, COGNITIVE STATUS FOR, P274; Hawkins JA, 1999, LANGUAGE, V75, P244, DOI 10.2307/417261; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hofmeister P, 2010, LANGUAGE, V86, P366; Keller F, 2009, BEHAV RES METHODS, V41, P1, DOI 10.3758/BRM.41.1.12; Kimball J., 1971, LINGUIST INQ, V2, P241; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; MACWHINNEY B, 1984, J VERB LEARN VERB BE, V23, P127, DOI 10.1016/S0022-5371(84)90093-8; Munro R, 2010, P NAACL HLT 2010 WOR, P122; Pearlmutter NJ, 1999, J MEM LANG, V41, P427, DOI 10.1006/jmla.1999.2653; R Core Team, 2021, R LANGUAGE ENV STAT; Rohde D., 2003, LINGER FLEXIBLE PLAT; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schnoebelen T, 2010, PSIHOLOGIJA, V43, P441, DOI 10.2298/PSI1004441S; Schubert TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067769; Solomon ES, 2004, COGNITIVE PSYCHOL, V49, P1, DOI 10.1016/j.cogpsych.2003.10.001; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stowe Laurie A., 1986, LANG COGNITIVE PROC, V1, P227, DOI DOI 10.1080/01690968608407062; Vigliocco G, 1998, COGNITION, V68, pB13, DOI 10.1016/S0010-0277(98)00041-9; Wagers MW, 2009, J MEM LANG, V61, P206, DOI 10.1016/j.jml.2009.04.002; Wanner E, 1978, LINGUIST THEORY PSYC; Warren T, 2002, COGNITION, V85, P79, DOI 10.1016/S0010-0277(02)00087-2	41	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0116946	10.1371/journal.pone.0116946	http://dx.doi.org/10.1371/journal.pone.0116946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822348	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700005
J	Hampson, LV; Whitehead, J; Eleftheriou, D; Tudur-Smith, C; Jones, R; Jayne, D; Hickey, H; Beresford, MW; Bracaglia, C; Caldas, A; Cimaz, R; Dehoorne, J; Dolezalova, P; Friswell, M; Jelusic, M; Marks, SD; Martin, N; McMahon, AM; Peitz, J; van Royen-Kerkhof, A; Soylemezoglu, O; Brogan, PA				Hampson, Lisa V.; Whitehead, John; Eleftheriou, Despina; Tudur-Smith, Catrin; Jones, Rachel; Jayne, David; Hickey, Helen; Beresford, Michael W.; Bracaglia, Claudia; Caldas, Afonso; Cimaz, Rolando; Dehoorne, Joke; Dolezalova, Pavla; Friswell, Mark; Jelusic, Marija; Marks, Stephen D.; Martin, Neil; McMahon, Anne-Marie; Peitz, Joachim; van Royen-Kerkhof, Annet; Soylemezoglu, Oguz; Brogan, Paul A.			Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa	PLOS ONE			English	Article							CHURG-STRAUSS-SYNDROME; POOR-PROGNOSIS FACTORS; MICROSCOPIC POLYANGIITIS; PULSE CYCLOPHOSPHAMIDE; CLINICAL-TRIALS; VASCULITIS; BELIEFS	Objectives Definitive sample sizes for clinical trials in rare diseases are usually infeasible. Bayesian methodology can be used to maximise what is learnt from clinical trials in these circumstances. We elicited expert prior opinion for a future Bayesian randomised controlled trial for a rare inflammatory paediatric disease, polyarteritis nodosa (MYPAN, Mycophenolate mofetil for polyarteritis nodosa). Methods A Bayesian prior elicitation meeting was convened. Opinion was sought on the probability that a patient in the MYPAN trial treated with cyclophosphamide would achieve disease remission within 6-months, and on the relative efficacies of mycophenolate mofetil and cyclophosphamide. Expert opinion was combined with previously unseen data from a recently completed randomised controlled trial in ANCA associated vasculitis. Results A pan-European group of fifteen experts participated in the elicitation meeting. Consensus expert prior opinion was that the most likely rates of disease remission within 6 months on cyclophosphamide or mycophenolate mofetil were 74% and 71%, respectively. This prior opinion will now be taken forward and will be modified to formulate a Bayesian posterior opinion once the MYPAN trial data from 40 patients randomised 1: 1 to either CYC or MMF become available. Conclusions We suggest that the methodological template we propose could be applied to trial design for other rare diseases.	[Hampson, Lisa V.; Whitehead, John] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Eleftheriou, Despina; Brogan, Paul A.] UCL Inst Child Hlth, Dept Rheumatol, London, England; [Tudur-Smith, Catrin] Univ Liverpool, MRC North West Hub Trials Methodol Res, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Jones, Rachel] Addenbrookes Hosp, Dept Renal Med, Cambridge, England; [Jayne, David] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Hickey, Helen] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Medicines Children Res Network Clin Trials Unit, Liverpool L69 3BX, Merseyside, England; [Beresford, Michael W.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Bracaglia, Claudia] IRCCS Bambino Gesu Children Hosp, Dept Paediat Med, Div Rheumatol, I-00165 Rome, Italy; [Caldas, Afonso] Integrated Hosp S Joao, Oporto Med Sch, Oporto, Portugal; [Cimaz, Rolando] AOU Meyer, I-50139 Florence, Italy; [Dehoorne, Joke] Univ Hosp Ghent, Dept Pediat Rheumatol & Nephrol, Ghent, Belgium; [Dolezalova, Pavla] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Prague, Czech Republic; [Dolezalova, Pavla] Gen Univ Hosp, Prague, Czech Republic; [Friswell, Mark] Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Jelusic, Marija] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat Rheumatol, Zagreb 41001, Croatia; [Marks, Stephen D.] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Nephrol, London WC1N 3JH, England; [Martin, Neil] Yorkhill Hosp, Dept Paediat Rheumatol, Glasgow, Lanark, Scotland; [McMahon, Anne-Marie] Sheffield Childrens Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Peitz, Joachim] Univ Hosp Cologne, Hosp Children & Adolescents, Cologne, Germany; [van Royen-Kerkhof, Annet] Wilhelmina Childrens Hosp, Univ Med Ctr, Utrecht, Netherlands; [Soylemezoglu, Oguz] Gazi Univ Hosp, Dept Pediat Nephrol & Rheumatol, Ankara, Turkey	Lancaster University; University of London; University College London; University of Liverpool; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Liverpool; IRCCS Bambino Gesu; Universidade do Porto; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Ghent University; Ghent University Hospital; Charles University Prague; General University Hospital Prague; University of Zagreb; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Cologne; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Gazi University	Hampson, LV (corresponding author), Univ Lancaster, Dept Math & Stat, Lancaster, England.	l.v.hampson@lancaster.ac.uk	Beresford, Michael William/AAB-5261-2021; Dolezalova, Pavla/N-6408-2017; dehoorne, jo/C-6745-2018; Bracaglia, Claudia/K-6886-2016; Marks, Stephen/AAH-6303-2019; Bracaglia, Claudia/AAF-7969-2021; Jelusic, Marija/HDN-5509-2022; CIMAZ, Rolando/AAA-9058-2019	Beresford, Michael William/0000-0002-5400-9911; Dolezalova, Pavla/0000-0001-8375-661X; dehoorne, jo/0000-0003-4759-0717; Bracaglia, Claudia/0000-0002-9834-9619; Jelusic, Marija/0000-0002-1728-4260; CIMAZ, Rolando/0000-0002-3260-4226; Jayne, David/0000-0002-1712-0637; Jayne, David/0000-0002-8725-3283; Jones, Rachel/0000-0003-4790-283X; Brogan, Paul/0000-0001-6178-6893; Tudur Smith, Catrin/0000-0003-3051-1445	Arthritis Research UK [20094]; Medical Research Council North-West Hub for Trials Methodology Research [G0800792]; Medical Research Council [MR/J014079/1]; Medical Research Council [G0800792] Funding Source: researchfish; Rosetrees Trust [M465, M8-F1-CD1] Funding Source: researchfish; Versus Arthritis [20094] Funding Source: researchfish; MRC [G0800792, MR/J014079/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Medical Research Council North-West Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was available from the MYPAN trial budget (Arthritis Research UK grant 20094; http://www.arthritisresearchuk.org/ and the Medical Research Council North-West Hub for Trials Methodology Research (G0800792; https://www.liv.ac.uk/translational-medicine/departmentsandgroups/nwhtmr/about/; http://www.methodologyhubs.mrc.ac.uk/default.aspx. LVH was supported by Medical Research Council grant MR/J014079/1 http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGENSTOSS AH, 1951, AM J PATHOL, V27, P537; Department of Health, 2013, CONS UK PLAN RAR DIS; Dillon MJ, 2010, PEDIATR NEPHROL, V25, P1641, DOI 10.1007/s00467-009-1336-1; Dolezalova P, 2013, ANN RHEUM DIS, V72, P1628, DOI 10.1136/annrheumdis-2012-202111; Eleftheriou D, 2013, ARTHRITIS RHEUM-US, V65, P2476, DOI 10.1002/art.38024; Gayraud M, 1997, BRIT J RHEUMATOL, V36, P1290; GUILLEVIN L, 1995, ARTHRITIS RHEUM, V38, P1638, DOI 10.1002/art.1780381116; Guillevin L, 2003, ARTHRIT RHEUM-ARTHR, V49, P93, DOI 10.1002/art.10922; Gupta S, 2011, J CLIN EPIDEMIOL, V64, P1085, DOI 10.1016/j.jclinepi.2010.12.019; Hampson LV, 2014, STAT MED, V33, P4186, DOI 10.1002/sim.6225; Hiance A, 2009, J CLIN EPIDEMIOL, V62, P431, DOI 10.1016/j.jclinepi.2008.04.009; Hiemstra TF, 2010, NEPHRON CLIN PRACT, V116, pC1, DOI 10.1159/000314543; Johnson Sindhu R, 2011, J Rheumatol, V38, P462, DOI 10.3899/jrheum.100632; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; Morita S, 2008, BIOMETRICS, V64, P595, DOI 10.1111/j.1541-0420.2007.00888.x; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; R Core Team, 2021, R LANGUAGE ENV STAT; Ribi C, 2010, ARTHRITIS RHEUM-US, V62, P1186, DOI 10.1002/art.27340; RStudio Inc, 2013, SHIN WEB APPL FRAM R; Ruperto N, 2011, ARCH DIS CHILD, V96, P596, DOI 10.1136/adc.2010.188946; Tan SB, 2003, CONTROL CLIN TRIALS, V24, P110, DOI 10.1016/S0197-2456(02)00318-5	22	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120981	10.1371/journal.pone.0120981	http://dx.doi.org/10.1371/journal.pone.0120981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822991	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352134700081
J	Lee, CN; Ko, D; Suh, YW; Park, KW				Lee, Chan-Nyoung; Ko, Deokwon; Suh, Young-Woo; Park, Kun-Woo			Cognitive Functions and Stereopsis in Patients with Parkinson's Disease and Alzheimer's Disease Using 3-Dimensional Television: A Case Controlled Trial	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; DEPTH-PERCEPTION; CONTRAST SENSITIVITY; MOTION PARALLAX; SMOOTH-PURSUIT; RETINA; DYSFUNCTION; IMPAIRMENT; DISTANCE; PROGRESSION	Stereopsis or depth perception is an awareness of the distances of objects from the observer, and binocular disparity is a necessary component of recognizing objects through stereopsis. In the past studies, patients with neurodegenerative disease (Alzheimer dementia, AD; Parkinson's disease IPD) have problems of stereopsis but they did not have actual stimulation of stereopsis. Therefore in this study, we used a 3-dimensional (3D) movie on 3D television (TV) for actual stereopsis stimulation. We propose research through analyzing differences between the three groups (AD, IPD, and Controls), and identified relations between the results from the Titmus Stereo Fly Test, and the 3D TV test. The study also looked into factors that affect the 3D TV test. Before allowing the patients to watch TV, we examined Titmus stereo Fly Test and cognitive test. We used the 3D version of a movie, of 17 minutes 1 second duration, and carried out a questionnaire about stereopsis. The scores of the stereopsis questionnaire were decreased in AD patients, compared with in IPD and controls, although they did not have any difference of Titmus Stereo Fly Test scores. In IPD patients, cognitive function (Montreal cognitive assessment, MoCA) scores were correlated with the scores of the stereopsis questionnaire. We could conclude that Titmus fly test could not distinguish between the three groups and cognitive dysfunction contributes to actual stereopsis perception in IPD patients. Therefore the 3D TV test of AD and IPD patients was more effective than Titmus fly test.	[Lee, Chan-Nyoung; Ko, Deokwon; Park, Kun-Woo] Korea Univ, Coll Med, Dept Neurol, Seoul 136705, South Korea; [Suh, Young-Woo] Korea Univ, Coll Med, Dept Ophthalmol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Park, KW (corresponding author), Korea Univ, Coll Med, Dept Neurol, Seoul 136705, South Korea.	kunu@korea.ac.kr	Lee, Chan-Nyoung/AAP-8691-2020		Technology Innovation Program (or Industrial Strategic technology development program) - Ministry of Trade, industry & Energy (MI, Korea) [10049743]	Technology Innovation Program (or Industrial Strategic technology development program) - Ministry of Trade, industry & Energy (MI, Korea)	This work was supported by the Technology Innovation Program (or Industrial Strategic technology development program), (10049743, Establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication) funded by the Ministry of Trade, industry & Energy (MI, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CR, 2013, J NEURO-OPHTHALMOL, V33, P137, DOI 10.1097/WNO.0b013e31828c4e1a; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BODISWOLLNER I, 1987, BRAIN, V110, P1675, DOI 10.1093/brain/110.6.1675; Botha H, 2012, PARKINSONISM RELAT D, V18, P742, DOI 10.1016/j.parkreldis.2012.03.004; Cao YQ, 2012, NEURAL NETWORKS, V26, P75, DOI 10.1016/j.neunet.2011.10.010; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; de Leon JMRS, 2005, REV NEUROLOGIA, V40, P557, DOI 10.33588/rn.4009.2004568; DEES JW, 1966, J EXP PSYCHOL, V72, P466, DOI 10.1037/h0023629; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hasche H, 2001, KLIN MONATSBL AUGENH, V218, P38, DOI 10.1055/s-2001-11259; Heron S, 2012, VISION RES, V62, P228, DOI 10.1016/j.visres.2012.04.012; Hirayama Kazumi, 2007, Brain and Nerve (Tokyo), V59, P923; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hubel DH, 2013, CEREB CORTEX; JORDAN M, 1980, Z NATURFORSCH C, V35, P851; Kim SH, 2011, CAN J NEUROL SCI, V38, P299, DOI 10.1017/S0317167100011501; Koh SB, 2013, NEUROREPORT, V24, P229, DOI 10.1097/WNR.0b013e32835edbc5; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Krug K, 2011, J NEUROSCI, V31, P17892, DOI 10.1523/JNEUROSCI.2658-11.2011; Lee Se-Youp, 2005, Korean J Ophthalmol, V19, P136; Mandal PK, 2012, J ALZHEIMERS DIS, V31, pS117, DOI 10.3233/JAD-2012-120901; Mendez MF, 1996, PERCEPT MOTOR SKILL, V83, P987, DOI 10.2466/pms.1996.83.3.987; MENGOD G, 1992, NEUROCHEM INT, V20, pS33; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NGUYENLEGROS J, 1988, SURG RADIOL ANAT, V10, P137, DOI 10.1007/BF02307822; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; ONO ME, 1986, J EXP PSYCHOL HUMAN, V12, P331, DOI 10.1037/0096-1523.12.3.331; OSHEA RP, 1994, VISION RES, V34, P1595, DOI 10.1016/0042-6989(94)90116-3; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; PARKINSON D, 1989, NEUROSCIENCE, V30, P171, DOI 10.1016/0306-4522(89)90363-1; Pereira JB, 2009, MOVEMENT DISORD, V24, P1193, DOI 10.1002/mds.22560; Pigarev IN, 2011, EXP BRAIN RES, V214, P105, DOI 10.1007/s00221-011-2810-0; POGGIO GF, 1981, J PHYSIOL-LONDON, V315, P469, DOI 10.1113/jphysiol.1981.sp013759; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; PRICE MJ, 1992, NEUROLOGY, V42, P887, DOI 10.1212/WNL.42.4.887; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; Scholl B, 2013, J NEUROPHYSIOL, V109, P3013, DOI 10.1152/jn.01021.2012; SHARPE JA, 1987, NEUROLOGY, V37, P1389, DOI 10.1212/WNL.37.8.1389; SHIPLEY T, 1971, VISION RES, V11, P1491, DOI 10.1016/0042-6989(71)90070-8; Tian T, 2011, INT J OPHTHALMOL-CHI, V4, P433, DOI 10.3980/j.issn.2222-3959.2011.04.21; Ts'o DY, 2009, J PHYSIOL-LONDON, V587, P2791, DOI 10.1113/jphysiol.2009.171082; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; WHITE OB, 1983, BRAIN, V106, P571, DOI 10.1093/brain/106.3.571	45	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123229	10.1371/journal.pone.0123229	http://dx.doi.org/10.1371/journal.pone.0123229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822839	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700219
J	Liu, B; Fang, LY; Liu, FL; Wang, XL; Chen, JJ; Chou, KC				Liu, Bin; Fang, Longyun; Liu, Fule; Wang, Xiaolong; Chen, Junjie; Chou, Kuo-Chen			Identification of Real MicroRNA Precursors with a Pseudo Structure Status Composition Approach	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; MEMBRANE-PROTEIN TYPES; SEQUENCE-BASED PREDICTOR; GENERAL-FORM; RNA-INTERFERENCE; NUCLEAR EXPORT; BINDING PROTEIN; MODEL; FEATURES; PSEKNC	Containing about 22 nucleotides, a micro RNA (abbreviated miRNA) is a small non-coding RNA molecule, functioning in transcriptional and post-transcriptional regulation of gene expression. The human genome may encode over 1000 miRNAs. Albeit poorly characterized, miRNAs are widely deemed as important regulators of biological processes. Aberrant expression of miRNAs has been observed in many cancers and other disease states, indicating they are deeply implicated with these diseases, particularly in carcinogenesis. Therefore, it is important for both basic research and miRNA-based therapy to discriminate the real pre-miRNAs from the false ones (such as hairpin sequences with similar stem-loops). Particularly, with the avalanche of RNA sequences generated in the postgenomic age, it is highly desired to develop computational sequence-based methods in this regard. Here two new predictors, called "iMcRNA-PseSSC" and "iMcRNA-ExPseSSC", were proposed for identifying the human pre-microRNAs by incorporating the global or long-range structure-order information using a way quite similar to the pseudo amino acid composition approach. Rigorous cross-validations on a much larger and more stringent newly constructed benchmark dataset showed that the two new predictors (accessible at http://bioinformatics.hitsz.edu.cn/iMcRNA/) outperformed or were highly comparable with the best existing predictors in this area.	[Liu, Bin; Fang, Longyun; Liu, Fule; Wang, Xiaolong; Chen, Junjie] Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Liu, Bin; Wang, Xiaolong] Harbin Inst Technol, Key Lab Network Oriented Intelligent Computat, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Liu, Bin; Chou, Kuo-Chen] Gordon Life Sci Inst, Belmont, MA USA; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Gordon Life Science Institute; King Abdulaziz University	Liu, B (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen, Guangdong, Peoples R China.	bliu@insun.hit.edu.cn	Chou, Kuo-Chen/A-8340-2009; Chen, Junjie/HHM-8839-2022; Liu, Bin/E-9480-2013	Chen, Junjie/0000-0002-0483-303X; Liu, Bin/0000-0002-8520-8374	National Natural Science Foundation of China [61300112, 61272383]; Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2013103]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, and State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Innovation Foundation in Harbin Institute of Technology; Scientific Research Foundation for the Returned Overseas Chinese Scholars, and State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China (No. 61300112, 61272383), the Scientific Research Innovation Foundation in Harbin Institute of Technology (Project No. HIT.NSRIF.2013103), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, and State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; ALTHAUS IW, 1993, J BIOL CHEM, V268, P6119; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang C.- C., 2009, LIBSVM LIB SUPPORT V; Chen W, 2015, BIOINFORMATICS, V31, P119, DOI 10.1093/bioinformatics/btu602; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou K.C., 2011, NATUR SCI, V3, P862, DOI [10.4236/ns.2011.310111, DOI 10.4236/NS.2011.310111]; CHOU KC, 1980, BIOCHEM J, V187, P829, DOI 10.1042/bj1870829; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1997, PROTEINS, V28, P99, DOI 10.1002/(SICI)1097-0134(199705)28:1<99::AID-PROT10>3.0.CO;2-C; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Chou KC, 2015, MED CHEM; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dehzangi A, 2015, J THEOR BIOL, V364, P284, DOI 10.1016/j.jtbi.2014.09.029; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Gupta MK, 2013, SAR QSAR ENVIRON RES, V24, P597, DOI 10.1080/1062936X.2013.773378; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang C, 2010, J THEOR BIOL, V262, P750, DOI 10.1016/j.jtbi.2009.11.002; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JJ, 2004, LEUKEMIA, V18, P1539, DOI 10.1038/sj.leu.2403454; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S3; Liu Z, 2015, ANAL BIOCH; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Qiu WR, 2014, INT J MOL SCI, V15, P1746, DOI 10.3390/ijms15021746; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Vapnik V., 1998, STAT LEARNING THEORY; Wang T, 2008, PROTEIN PEPTIDE LETT, V15, P915, DOI 10.2174/092986608785849308; Wang YQ, 2011, GENOMICS, V98, P73, DOI 10.1016/j.ygeno.2011.04.011; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xiao X, 2006, BIOCHEM BIOPH RES CO, V342, P605, DOI 10.1016/j.bbrc.2006.01.166; Xiao X, 2005, J THEOR BIOL, V235, P555, DOI 10.1016/j.jtbi.2005.02.008; Xu R, 2014, J BIOMOLECULAR STRUC; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhong WZ, 2014, INT J MOL SCI, V15, P20072, DOI 10.3390/ijms151120072; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 2013, CURR TOP MED CHEM, V13, P1152, DOI 10.2174/15680266113139990003; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	90	173	173	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121501	10.1371/journal.pone.0121501	http://dx.doi.org/10.1371/journal.pone.0121501			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821974	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700112
J	Pizarro, C; Ahmadzadehfar, H; Essler, M; Tuleta, I; Fimmers, R; Nickenig, G; Skowasch, D				Pizarro, Carmen; Ahmadzadehfar, Hojjat; Essler, Markus; Tuleta, Izabela; Fimmers, Rolf; Nickenig, Georg; Skowasch, Dirk			Effect of Endobronchial Valve Therapy on Pulmonary Perfusion and Ventilation Distribution	PLOS ONE			English	Article							LUNG-VOLUME-REDUCTION; COPD ASSESSMENT TEST; SEVERE EMPHYSEMA; IMPORTANT DIFFERENCE; MEDICAL THERAPY; DISEASE; SURGERY	Introduction Endoscopic lung volume reduction (ELVR) is an emerging therapy for emphysematous COPD. However, any resulting changes in lung perfusion and ventilation remain undetermined. Here, we report ELVR-mediated adaptations in lung perfusion and ventilation, as investigated by means of pulmonary scintigraphy. Methods In this observational study, we enrolled 26 patients (64.9 +/- 9.4 yrs, 57.7% male) with COPD heterogeneous emphysema undergoing ELVR with endobronchial valves (Zephyr, Pulmonx, Inc.). Mean baseline FEV1 and RV were 32.9% and 253.8% predicted, respectively. Lung scintigraphy was conducted prior to ELVR and eight weeks thereafter. Analyses of perfusion and ventilation shifts were performed and complemented by correlation analyses between paired zones. Results After ELVR, target zone perfusion showed a mean relative reduction of 43.32% (p<0.001), which was associated with a significant decrease in target zone ventilation (p<0.001). Perfusion of the contralateral untreated zone and of the contralateral total lung exhibited significant increases post-ELVR (p = 0.002 and p = 0.005, respectively); both correlated significantly with the corresponding target zone perfusion adaptations. Likewise, changes in target zone ventilation correlated significantly with ventilatory changes in the contralateral untreated zone and the total contralateral lung (Pearson's r: -0.42, p = 0.04 and Pearson's r: -0.42, p = 0.03, respectively). These effects were observed in case of clinical responsiveness to ELVR, as assessed by changes in the six-minute walk test distance. Discussion ELVR induces a relevant decrease in perfusion and ventilation of the treated zone with compensatory perfusional and ventilatory redistribution to the contralateral lung, primarily to the non-concordant, contralateral zone.	[Pizarro, Carmen; Tuleta, Izabela; Nickenig, Georg; Skowasch, Dirk] Univ Hosp Bonn, Dept Internal Med Cardiol Pneumol & Angiol 2, Bonn, Germany; [Ahmadzadehfar, Hojjat; Essler, Markus] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany; [Fimmers, Rolf] Univ Hosp Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Pizarro, C (corresponding author), Univ Hosp Bonn, Dept Internal Med Cardiol Pneumol & Angiol 2, Bonn, Germany.	carmen.pizarro@ukb.uni-bonn.de		Ahmadzadehfar, Hojjat/0000-0002-0393-5309	Pulmonx, Inc., Redwood City, CA, USA	Pulmonx, Inc., Redwood City, CA, USA	This study has been funded by Pulmonx, Inc., Redwood City, CA, USA. None of the authors had any ownership interest in the company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argula RG, 2013, CHEST, V144, P1578, DOI 10.1378/chest.12-2826; Brown MS, 2012, EUR RADIOL, V22, P1547, DOI 10.1007/s00330-012-2393-6; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Chandra D, 2010, AM J RESP CRIT CARE, V182, P937, DOI 10.1164/rccm.201001-0043OC; Chung SCS, 2010, RESPIROLOGY, V15, P1079, DOI 10.1111/j.1440-1843.2010.01815.x; D'Andrilli A, 2009, EUR J CARDIO-THORAC, V35, P403, DOI 10.1016/j.ejcts.2008.10.045; Dykstra BJ, 1999, CHEST, V115, P68, DOI 10.1378/chest.115.1.68; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mantri S, 2009, J BRONCHOL INTERN PU, V16, P141, DOI 10.1097/LBR.0b013e3181a40a3e; Martin C, 2013, INT J CHRONIC OBSTR, V8, P7, DOI 10.2147/COPD.S28290; Martinez FJ, 2005, SEMIN RESP CRIT CARE, V26, P167, DOI 10.1055/s-2005-869537; Naunheim KS, 2006, ANN THORAC SURG, V82, P431, DOI 10.1016/j.athoracsur.2006.05.069; O'Donnell DE, 2008, J APPL PHYSIOL, V105, P753, DOI 10.1152/japplphysiol.90336.2008b; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Sommer N, 2008, EUR RESPIR J, V32, P1639, DOI 10.1183/09031936.00013908; Toma TP, 2003, LANCET, V361, P931, DOI 10.1016/S0140-6736(03)12762-6; Venuta F, 2005, ANN THORAC SURG, V79, P411, DOI 10.1016/j.athoracsur.2004.07.048; Wan IYP, 2006, CHEST, V129, P518, DOI 10.1378/chest.129.3.518	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118976	10.1371/journal.pone.0118976	http://dx.doi.org/10.1371/journal.pone.0118976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822624	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700028
J	Xia, CW; Wei, CT; Zhang, YY				Xia, Canwei; Wei, Chentao; Zhang, Yanyun			Territory Tenure Increases with Repertoire Size in Brownish-Flanked Bush Warbler	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; GREAT TIT PARUS; SONG REPERTOIRE; REPRODUCTIVE SUCCESS; SPARROWS; SURVIVAL; AGE; POPULATIONS; EVOLUTION	Song repertoire size is often cited as a classic example of a secondary sexual trait in birds. Models of sexual selection and empirical tests of their predictions have often related secondary sexual traits to longevity. However, the relationship between repertoire size and longevity is unclear. Using capture-mark-recapture studies in two populations of the brownish-flanked bush warbler Cettia fortipes, we found that males with a repertoire size of three maintained territory tenure for a longer duration than did males with a repertoire size of two. These results provide evidence that even a minimal difference in repertoire size can serve as a potential signal of territory tenure capability.	[Xia, Canwei; Wei, Chentao; Zhang, Yanyun] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, YY (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers & Ecol Engn, Beijing 100875, Peoples R China.	zhangyy@bnu.edu.cn	Wei, Chentao/GOK-2746-2022		National Natural Science Foundation of China [31172098]; China Postdoctoral Science Foundation [2014M550026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 31172098) and China Postdoctoral Science Foundation (No. 2014M550026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Beecher MD, 2000, ANIM BEHAV, V59, P29, DOI 10.1006/anbe.1999.1304; Brawn JD, 1999, P INT ORN C, V22, P297; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Forstmeier W, 2006, BEHAV ECOL SOCIOBIOL, V59, P634, DOI 10.1007/s00265-005-0090-z; Gil D, 2001, ANIM BEHAV, V62, P689, DOI 10.1006/anbe.2001.1812; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; HIEBERT SM, 1989, ANIM BEHAV, V37, P266, DOI 10.1016/0003-3472(89)90115-2; Hughes M, 2007, ANIM BEHAV, V73, P701, DOI 10.1016/j.anbehav.2006.09.013; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Kempenaers B, 2001, BEHAV ECOL SOCIOBIOL, V49, P251, DOI 10.1007/s002650000305; Kennerley P, 2010, REED BUSH WARBLERS; Kiefer S, 2009, J AVIAN BIOL, V40, P231, DOI 10.1111/j.1600-048X.2009.04500.x; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kroodsma Don, 2004, P108, DOI 10.1016/B978-012473070-0/50007-4; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; MacDougall-Shackleton SA, 1997, CURR ORNITHOL, V14, P81; MCGREGOR PK, 1981, AM NAT, V118, P149, DOI 10.1086/283811; NICE MARGARET M., 1941, AMER MIDLAND NAT, V26, P441, DOI 10.2307/2420732; Nowicki S, 2000, P ROY SOC B-BIOL SCI, V267, P2419, DOI 10.1098/rspb.2000.1300; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Reid JM, 2005, AM NAT, V165, P299, DOI 10.1086/428299; Ricklefs RE, 1997, ECOL MONOGR, V67, P23, DOI 10.1890/0012-9615(1997)067[0023:CDONWP]2.0.CO;2; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; Searcy William A., 1996, P454; Song C, 1996, SCI SURVEY DONGZHAI; Xia CW, 2014, ETHOLOGY, V120, P324, DOI 10.1111/eth.12205; Xia CW, 2013, ZOOL SCI, V30, P699, DOI 10.2108/zsj.30.699; Xia CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042528; Xia CW, 2010, CONDOR, V112, P591, DOI 10.1525/cond.2010.090021; Yu LS, 2004, SCI SURVEY KUANKUOSH	33	1	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122789	10.1371/journal.pone.0122789	http://dx.doi.org/10.1371/journal.pone.0122789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822524	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700196
J	Meng, MC; Wang, DM; Yao, JX				Meng, Mei-Cen; Wang, De-Ming; Yao, Jian-Xin			Vegetative Characters, Growth Habit and Microsporangiate Strobilus of Lycopsid Minostrobus chaohuensis	PLOS ONE			English	Article							GEN-NOV; EVOLUTIONARY; SUBLEPIDODENDRACEAE; DIAPHORODENDRACEAE; LEPIDOSTROBUS; PAURODENDRON; SEGREGATE; CHINA	Late Devonian Minostrobus chaohuensis is one of the earliest monosporangiate-strobilate isoetaleans. Based on new material of this plant, the vegetative axis and microsporangiate strobilus are studied in detail, and the whole plant knowledge is summarized. The vegetative axis is isotomously branched. The stem is up to 55 mm in diameter with helically arranged leaf cushions. Stems and thick branches bear long fusiform leaf cushions and interareas with vertical linear ornamentations. A ligule pit, oblanceolate leaf scar, and vascular bundle scar appear on the leaf cushion. Distal axes have persistent lanceolate leaves and rhombic leaf bases. The microsporangiate strobilus is cylindrical in shape, possesses sporophyll with alate pedicel and long triangular lamina, uniseriate sporangial wall, subarchesporial pad inside the sporangium, and microspore with cingulum. Based on comparisons with other isoetaleans, the usage of the terms "leaf cushion" and "leaf base" is discussed, and Minostrobus chaohuensis is considered as a tree-like lycopsid. It suggests that arborescent isoetaleans with monosporangiate strobili had appeared and diversified in the Late Devonian. The multi-dichotomous branching system of Minostrobus provides new data on the evolution of growth architecture in rhizomorphic lycopsids.	[Meng, Mei-Cen; Yao, Jian-Xin] Chinese Acad Geol Sci, Minist Land & Resources, Key Lab Stratig & Paleontol, Inst Geol, Beijing, Peoples R China; [Wang, De-Ming] Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China	Chinese Academy of Geological Sciences; Ministry of Natural Resources of the People's Republic of China; Peking University	Wang, DM (corresponding author), Peking Univ, Key Lab Orogen Belts & Crustal Evolut, Dept Geol, Beijing 100871, Peoples R China.	dmwang@pku.edu.cn; yaojianxin@gmail.com			National Basic Research Program of China (973 Program) [2012CB821900, 2011CB403002]; National Natural Science Foundation of China [41402023]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (973 Program, http://www.973.gov.cn/Default_3.aspx, no. 2012CB821900 and no. 2011CB403002) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, no. 41402023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman Richard M., 1992, Palaeontographica Abteilung B Palaeophytologie, V228, P29; BATEMAN RM, 1992, ANN MO BOT GARD, V79, P500, DOI 10.2307/2399752; BATEMAN RM, 1991, SYST BOT, V16, P195, DOI 10.2307/2418983; Bateman RM, 1988, PALAEOBOTANY PALAEOE; Berry CM, 2003, INT J PLANT SCI, V164, P263, DOI 10.1086/346170; BRACKHANES SD, 1983, BOT J LINN SOC, V86, P125, DOI 10.1111/j.1095-8339.1983.tb00720.x; Cai C.Y., 2000, STRATIGRAPHICAL STUD, P95; Cai Chongyang, 1996, Palaeontographica Abteilung B Palaeophytologie, V238, P1; Cai CY, 1986, ACTA PALAEONTOL SIN, V25, P516; Chaloner W.G., 1973, SPEC PAP PALAEONTOL, V12, P271; Dilcher D.L., 2004, FOREST CANOPIES, P118, DOI [DOI 10.1016/B978-012457553-0/50010-1, 10.1016/B978-012457553-0/50010-1]; DIMICHELE W A, 1981, Palaeontographica Abteilung B Palaeophytologie, V175, P85; DIMICHELE WA, 1983, SYST BOT, V8, P317, DOI 10.2307/2418485; DIMICHELE WA, 1985, SYST BOT, V10, P453, DOI 10.2307/2419138; DIMICHELE WA, 1992, AM J BOT, V79, P605, DOI 10.2307/2444876; DiMichele WA, 2013, AM J BOT, V100, P1604, DOI 10.3732/ajb.1200623; EGGERT DONALD ALAN, 1961, PALAEONTOGRAPHICA, V108, P43; FELIX CHARLES J., 1952, ANN MISSOURI BOT GARD, V39, P263, DOI 10.2307/2399093; Gu Zhi, 1974, FOSSIL PLANTS CHINA; [侯明金 HOU Mingjin], 2006, [地层学杂志, Journal of Stratigraphy], V30, P157; Jovet-Ast S., 1967, TRAITE PALEOBOTANIQU, V2, P435; Leisman GA, 1979, PALAEONTOGR ABT B, V168, P100; Li X.X., 1997, ACTA PALAEONTOL SIN, V36, P411; Li X-X., 1986, ACTA PALAEONTOL SIN, V25, P349; Liu L, 2013, NEUES JAHRB GEOL P-A, V268, P325, DOI 10.1127/0077-7749/2013/0331; LONG A G, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P127; [孟美岑 Meng Meicen], 2014, [古生物学报, Acta Palaeontologica Sinica], V53, P180; Meng MC, 2013, REV PALAEOBOT PALYNO, V190, P20, DOI 10.1016/j.revpalbo.2012.11.007; MENSAH M K, 1971, Palaeontology (Oxford), V14, P357; Meyen S V, 1976, PALAEONTOGR ABT B, V157, P112; PHILLIPS TL, 1966, AM J BOT, V53, P1086, DOI 10.2307/2440689; PIGG KB, 1983, BOT GAZ, V144, P132, DOI 10.1086/337354; REX GM, 1983, PALAEONTOLOGY, V26, P231; ROTHWELL GW, 1985, AM J BOT, V72, P86, DOI 10.2307/2443571; SCHLANKER CM, 1969, BOT GAZ, V130, P35, DOI 10.1086/336466; SCHOPF JM, 1975, REV PALAEOBOT PALYNO, V20, P27, DOI 10.1016/0034-6667(75)90005-6; Stewart W.N., 1993, PALEOBOTANY EVOLUTIO; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; THOMAS BA, 1984, REV PALAEOBOT PALYNO, V41, P273, DOI 10.1016/0034-6667(84)90049-6; THOMAS BA, 1984, PALAEONTOLOGY, V27, P707; Thomas BA, 1982, B BR MUS NAT HIS G, V36, P131; Thomas BA., 1970, PALAEONTOLOGY, V13, P145173; Thomas BA, 1976, LANCASHIRE GEOL J, V11, P15; Wang DM, 2014, REV PALAEOBOT PALYNO, V203, P35, DOI 10.1016/j.revpalbo.2014.01.003; Wang Q, 2005, AM J BOT, V92, P83, DOI 10.3732/ajb.92.1.83; Wang Q, 2003, BOT J LINN SOC, V143, P55, DOI 10.1046/j.1095-8339.2003.00200.x; Wang Q, 2003, REV PALAEOBOT PALYNO, V127, P269, DOI 10.1016/S0034-6667(03)00132-5; Wang Q, 2002, AM J BOT, V89, P1468, DOI 10.3732/ajb.89.9.1468; Wang Y, 2005, BOT J LINN SOC, V149, P299, DOI 10.1111/j.1095-8339.2005.00442.x; Wang Y, 2001, BOT J LINN SOC, V136, P439, DOI 10.1111/j.1095-8339.2001.tb00584.x; Wang Yi, 2012, Palaeoworld, V21, P20, DOI 10.1016/j.palwor.2011.10.001; WILLARD DA, 1989, AM J BOT, V76, P820, DOI 10.2307/2444538	52	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122167	10.1371/journal.pone.0122167	http://dx.doi.org/10.1371/journal.pone.0122167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816297	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600150
J	Viana, IMMN; de Almeida, MES; Lins, MP; Reis, MDD; Vieira, LFD; Smaniotto, S				Mendes Nicaclo Viana, Iana Mayane; Soares de Almeida, Maira Estanislau; Lins, Marvin Paulo; dos Santos Reis, Maria Danielma; de Araujo Vieira, Larissa Fernanda; Smaniotto, Salete			Combined Effect of Insulin-Like Growth Factor-1 and CC Chemokine Ligand 2 on Angiogenic Events in Endothelial Cells	PLOS ONE			English	Article							FACTOR-BINDING-PROTEINS; EPITHELIAL-CELLS; MIGRATION; MCP-1; FIBRONECTIN; EXPRESSION; ADHESION; VIVO; ACTIVATION; DIFFERENTIATION	Therapeutic angiogenesis may be applied in medical conditions to promote stimulation of angiogenesis. Angiogenesis is a multistep process, which includes endothelial cell proliferation, migration, and tube formation, which is mediated by various angiogenic polypeptides. Thus, studies that elucidate the cellular mechanisms involved in these processes are necessary to develop novel therapeutic strategies. This study investigated the in vitro effects of the pro-angiogenic factors, insulin-like growth factor-1 (IGF-1) and/or chemokine (CC motif) ligand 2 (CCL2), on endothelial cells. Flow cytometry analysis showed that IGF-1 and CCL2 treatment did not interfere with IGF-1 receptor (IGF-1R) expression, but CCL2 treatment increased CCL2 receptor (CCR2) expression. Immunofluorescence analysis revealed that the IGF-1/CCL2 combination induced a greater increase in fibronectin deposition, but the treatments did not alter the expression of the fibronectin receptors, CD49e and CD44. The interaction of fibronectin with cytokines demonstrated that IGF-1/CCL2 promoted changes in intermediate F-actin remodeling that may result in increased endothelial cell adhesion and cell migration mediated by fibronectin. Furthermore, IGF-1/CCL2 stimulated endothelial cells, grown on fibronectin, to form capillary-like structures and intercellular lumina with greater luminal area. These data suggest that IGF-1/CCL2 combination and a fibronectin matrix may contribute to the angiogenesis process to stimulate adhesion, migration, and tube formation by endothelial cells as a result of F-actin remodeling.	[Mendes Nicaclo Viana, Iana Mayane; Lins, Marvin Paulo; dos Santos Reis, Maria Danielma; de Araujo Vieira, Larissa Fernanda; Smaniotto, Salete] Univ Fed Alagoas, Inst Biol & Hlth Sci, Cell Biol Lab, Maceio, Alagoas, Brazil; [Soares de Almeida, Maira Estanislau] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade de Sao Paulo	Smaniotto, S (corresponding author), Univ Fed Alagoas, Inst Biol & Hlth Sci, Cell Biol Lab, Maceio, Alagoas, Brazil.	smaniotto@icbs.ufal.br	Smaniotto, Salete/AAT-4056-2020; Lins, Marvin/AAV-4044-2020; Almeida, Maira/F-7175-2013; Reis, Maria Danielma dos Santos/S-7334-2019; Smaniotto, Salete/T-3796-2017	Smaniotto, Salete/0000-0003-1527-5894; Lins, Marvin/0000-0003-4247-0345; dos Santos Reis, Maria Danielma/0000-0003-4119-4019	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL))	The study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Aplin AC, 2010, ANGIOGENESIS, V13, P219, DOI 10.1007/s10456-010-9179-8; ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; BUSSOLINO F, 1991, J IMMUNOL, V147, P2122; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Cines DB, 1998, BLOOD, V91, P3527; Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143; DAUGHADAY WH, 1987, J CLIN ENDOCR METAB, V65, P1075, DOI 10.1210/jcem-65-5-1075; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Divya P, 2007, BIOMOL ENG, V24, P593, DOI 10.1016/j.bioeng.2007.07.010; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Fischer C, 2006, Handb Exp Pharmacol, P157; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Hwang JS, 2004, FEBS LETT, V570, P47, DOI 10.1016/j.febslet.2004.06.023; Ikeo S, 2001, AM J PHYSIOL-CELL PH, V280, pC1255, DOI 10.1152/ajpcell.2001.280.5.C1255; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Jazayeri M, 2008, CELL BIOL INT, V32, P1183, DOI 10.1016/j.cellbi.2008.07.020; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim JH, 2008, MOL VIS, V14, P556; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maddala R, 2003, MOL VIS, V9, P329; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Murakami M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/293641; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Nitert MD, 2005, MOL CELL ENDOCRINOL, V229, P31, DOI 10.1016/j.mce.2004.10.003; Omari SMS, 2011, J BIOL SCI, V11, P64; Pepper MS, 1997, ARTERIOSCL THROM VAS, V17, P605, DOI 10.1161/01.ATV.17.4.605; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Rutanen EM, 2000, HUM REPROD, V15, P173, DOI 10.1093/humrep/15.suppl_3.173; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; TAMAROGLIO TA, 1994, EXP CELL RES, V215, P338, DOI 10.1006/excr.1994.1350; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Tsukuba T, 2009, J BIOCHEM, V145, P565, DOI 10.1093/jb/mvp016; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63; Yao HL, 2012, MOL CELL BIOCHEM, V366, P355, DOI 10.1007/s11010-012-1315-x; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17	58	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121249	10.1371/journal.pone.0121249	http://dx.doi.org/10.1371/journal.pone.0121249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830234	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600064
J	Cai, Y; Li, R; Zhu, JF; Na, L; He, YP; Redmon, P; Qiao, Y; Ma, J				Cai, Yong; Li, Rui; Zhu, Jingfen; Na, Li; He, Yaping; Redmon, Pam; Qiao, Yun; Ma, Jin			Personality, Perceived Environment, and Behavior Systems Related to Future Smoking Intentions among Youths: An Application of Problem-Behavior Theory in Shanghai, China	PLOS ONE			English	Article							TOBACCO USE; ADOLESCENT SMOKING; SOCIAL INFLUENCES; RISK BEHAVIOR; SUSCEPTIBILITY; PREVALENCE; PREDICTORS; SURVEILLANCE; CIGARETTES; MOTIVATION	Background Smoking among youths is a worldwide problem, particularly in China. Many endogenous and environmental factors influence smokers' intentions to smoke; therefore, a comprehensive model is needed to understand the significance and relationship of predictors. This study aimed to develop a prediction model based on problem-behavior theory (PBT) to interpret intentions to smoke among Chinese youths. Methods We conducted a cross-sectional study of 26,675 adolescents from junior, senior, and vocational high schools in Shanghai, China. Data on smoking status, smoking knowledge, attitude toward smoking, parents' and peers' smoking, and media exposure to smoking were collected from students. A structural equation model was used to assess the developed prediction model. Results The experimental smoking rate and current smoking rate among the students were 11.0% and 3%, respectively. Our constructed model showed an acceptable fit to the data (comparative fit index = 0.987, root-mean-square error of approximation = 0.034). Intention to smoke was predicted by perceived environment (beta = 0.455, P < 0.001) system consisting of peer smoking (beta = 0.599, P < 0.001), parent smoking (beta = 0.152, P < 0.001), and media exposure to smoking (beta = 0.226, P < 0.001), and behavior system (beta = 0.487, P < 0.001) consisting of tobacco experimentation (beta = 0.663, P < 0.001) and current smoking (beta = 0.755, P < 0.001). Smoking intention was irrelevant for personality system in students (beta = -0.113, P> 0.05) which consisted of acceptance of tobacco use (beta = 0.668, P < 0.001) and academic performance (beta = 0.171, P < 0.001). Conclusion The PBT-based model we developed provides a good understanding of the predictors of intentions to smoke and it suggests future interventions among youths should focus on components in perceived environment and behavior systems, and take into account the moderating effects of personality system.	[Cai, Yong; Li, Rui; Zhu, Jingfen; Na, Li; He, Yaping; Ma, Jin] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Redmon, Pam] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Qiao, Yun] Pudong Inst Hlth Dev, Shanghai, Peoples R China	Shanghai Jiao Tong University; Emory University	Cai, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.	caiyong202028@hotmail.com; majin@shsmu.edu.cn	Li, Rui/AAH-5039-2020	Li, Rui/0000-0001-8845-424X	Bill & Melinda Gates Foundation; Programs of Excellence in Tobacco Control, Emory University [1362-SJTU-S2]; Key Liberal Arts Innovative Project, Shanghai Municipal Education Commission [12ZS106]; General Program for Young Researchers of Humanities and Social Studies, China Ministry of Education [12YTC840001]; National Natural Science Funds [71403169]; National Natural Science Funds of China [71273174]; Shanghai Pujiang Program [14PJC076]; Social Cognitive and Behavioral Sciences program of Shanghai Jiao Tong University [14JCRY03]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Programs of Excellence in Tobacco Control, Emory University; Key Liberal Arts Innovative Project, Shanghai Municipal Education Commission; General Program for Young Researchers of Humanities and Social Studies, China Ministry of Education; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Social Cognitive and Behavioral Sciences program of Shanghai Jiao Tong University	This publication is based on research funded by (or in part by) the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. This publication is also supported by: Programs of Excellence in Tobacco Control, Emory University (1362-SJTU-S2); Key Liberal Arts Innovative Project, Shanghai Municipal Education Commission (12ZS106); General Program for Young Researchers of Humanities and Social Studies, China Ministry of Education (12YTC840001); National Natural Science Funds(71403169); The National Natural Science Funds of China (71273174), Shanghai Pujiang Program (14PJC076), Social Cognitive and Behavioral Sciences program of Shanghai Jiao Tong University (14JCRY03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bricker JB, 2006, NICOTINE TOB RES, V8, P217, DOI 10.1080/14622200600576339; Brown A, 2009, HEALTH EDUC RES, V24, P721, DOI 10.1093/her/cyp007; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cai Y, 2012, INT J ENV RES PUB HE, V9, P3421, DOI 10.3390/ijerph9103421; Carter OBJ, 2007, TOB CONTROL, V16, P368, DOI 10.1136/tc.2007.020446; Chen PL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-144; Chinese Center for Disease Control and Prevention, 2014, CHIN YOUTH TOB SURV; CONRAD KM, 1992, BRIT J ADDICT, V87, P1711; DEVRIES H, 1995, J APPL SOC PSYCHOL, V25, P237; ECKHARDT L, 1994, J SCHOOL HEALTH, V64, P67, DOI 10.1111/j.1746-1561.1994.tb06181.x; Fisher C., 2005, ENCY APPL DEV SCI, V1; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; GERBER RW, 1989, J YOUTH ADOLESCENCE, V18, P191, DOI 10.1007/BF02138800; Hassandra M, 2011, PSYCHOL HEALTH, V26, P1241, DOI 10.1080/08870446.2011.605137; Ingles CJ, 2013, ADICCIONES, V25, P63, DOI 10.20882/adicciones.73; Jackson C, 1998, PREV MED, V27, P129, DOI 10.1006/pmed.1997.0255; JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K; Jessor R, 1980, NIDA Res Monogr, V30, P102; Kremers SPJ, 2004, PATIENT EDUC COUNS, V55, P345, DOI 10.1016/j.pec.2003.04.004; Lai MK, 2004, ADDICTION, V99, P1195, DOI 10.1111/j.1360-0443.2004.00797.x; Lee Sungkyu, 2010, J Prev Med Public Health, V43, P283, DOI 10.3961/jpmph.2010.43.4.283; Lorenzo-Blanco EI, 2012, NICOTINE TOB RES, V14, P142, DOI 10.1093/ntr/ntr152; Markham WA, 2004, HEALTH EDUC RES, V19, P15, DOI 10.1093/her/cyg008; MCNEILL AD, 1989, J EPIDEMIOL COMMUN H, V43, P72, DOI 10.1136/jech.43.1.72; Ndugwa RP, 2011, J URBAN HEALTH, V88, P298, DOI 10.1007/s11524-010-9462-4; Olds R Scott, 2005, J Adolesc Health, V37, P75, DOI 10.1016/j.jadohealth.2004.09.020; Paavola M, 1996, HEALTH EDUC RES, V11, P309, DOI 10.1093/her/11.3.309; Paek HJ, 2008, HEALTH COMMUN, V23, P526, DOI 10.1080/10410230802460259; Park HK, 2012, MATERN CHILD HLTH J, V16, P1828, DOI 10.1007/s10995-011-0929-z; PEDERSON LL, 1987, PREV MED, V16, P432, DOI 10.1016/0091-7435(87)90042-9; Petersen, 1993, PROMOTING HLTH ADOLE, P13; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Qiu X, 2004, CHINA J PUB HLTH, V24, P1402; Scalici F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101275; Schultz ASH, 2010, CHRONIC DIS CAN, V30, P71; Shadel WG, 2008, J PEDIATR PSYCHOL, V33, P751, DOI 10.1093/jpepsy/jsn025; Smith KC, 2006, HEALTH COMMUN, V19, P19, DOI 10.1207/s15327027hc1901_3; Thrul J, 2013, HEALTH EDUC RES, V28, P683, DOI 10.1093/her/cyt062; Turbin M S, 2000, Prev Sci, V1, P115, DOI 10.1023/A:1010094221568; Tyc VL, 2004, ADDICT BEHAV, V29, P1143, DOI 10.1016/j.addbeh.2004.03.007; Wakefield M, 2004, ADDICTION, V99, P914, DOI 10.1111/j.1360-0443.2004.00742.x; Wang Q, 2011, CHIN J SCH HLTH, V32, P1434; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Warren CW, 2000, B WORLD HEALTH ORGAN, V78, P868; Wellman RJ, 2006, ARCH PEDIAT ADOL MED, V160, P1285, DOI 10.1001/archpedi.160.12.1285; Wu X, 2008, CHIN J HLTH ED, V24, P661; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; ZAMBOANGA BL, 2004, INTERAM J PSYCHOL, V38, P253; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x	55	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122276	10.1371/journal.pone.0122276	http://dx.doi.org/10.1371/journal.pone.0122276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826611	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800065
J	Hendriksen, MAH; van Raaij, JMA; Geleijnse, JM; Breda, J; Boshuizen, HC				Hendriksen, Marieke A. H.; van Raaij, Joop M. A.; Geleijnse, Johanna M.; Breda, Joao; Boshuizen, Hendriek C.			Health Gain by Salt Reduction in Europe: A Modelling Study	PLOS ONE			English	Article							DIETARY-SODIUM INTAKE; H URINARY SODIUM; COST-EFFECTIVENESS; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HEART-FAILURE; ADULTS; RISK; INTERVENTIONS; METAANALYSIS	Excessive salt intake is associated with hypertension and cardiovascular diseases. Salt intake exceeds the World Health Organization population nutrition goal of 5 grams per day in the European region. We assessed the health impact of salt reduction in nine European countries (Finland, France, Ireland, Italy, Netherlands, Poland, Spain, Sweden and United Kingdom). Through literature research we obtained current salt intake and systolic blood pressure levels of the nine countries. The population health modeling tool DYNAMO-HIA including country-specific disease data was used to predict the changes in prevalence of ischemic heart disease and stroke for each country estimating the effect of salt reduction through its effect on blood pressure levels. A 30% salt reduction would reduce the prevalence of stroke by 6.4% in Finland to 13.5% in Poland. Ischemic heart disease would be decreased by 4.1% in Finland to 8.9% in Poland. When salt intake is reduced to the WHO population nutrient goal, it would reduce the prevalence of stroke from 10.1% in Finland to 23.1% in Poland. Ischemic heart disease would decrease by 6.6% in Finland to 15.5% in Poland. The number of postponed deaths would be 102,100 (0.9%) in France, and 191,300 (2.3%) in Poland. A reduction of salt intake to 5 grams per day is expected to substantially reduce the burden of cardiovascular disease and mortality in several European countries.	[Hendriksen, Marieke A. H.; van Raaij, Joop M. A.; Boshuizen, Hendriek C.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands; [van Raaij, Joop M. A.; Geleijnse, Johanna M.; Boshuizen, Hendriek C.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [Breda, Joao] WHO, Reg Off Europe, Noncommunicable Dis & Hlth Promot, DK-2100 Copenhagen, Denmark	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; World Health Organization	Hendriksen, MAH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands.	marieke.hendriksen@rivm.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Boshuizen, Hendriek/M-3415-2014; Boshuizen, Hendriek C/B-3718-2014; Breda, Joao/J-9371-2014	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Boshuizen, Hendriek/0000-0002-3916-9095; Breda, Joao/0000-0002-8177-4926	World Health Organization - Regional Office for Europe by the EU	World Health Organization - Regional Office for Europe by the EU	The World Health Organization - Regional Office for Europe funded this work partially through a direct grant by the EU. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amcoff E, 2012, RIKSMATEN VUXNA 2010, DOI [10.1016/j.fct.2013.03.024, DOI 10.1016/J.FCT.2013.03.024]; [Anonymous], 2009, SPOZYCIE SOLI POLSCE; [Anonymous], 2008, AN ASSESSMENT OF DIE; Arcand J, 2012, AM J HYPERTENS, V25, P19, DOI 10.1038/ajh.2011.187; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Britton KA, 2009, EUR J HEART FAIL, V11, P1129, DOI 10.1093/eurjhf/hfp141; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Donfrancesco C, 2013, NUTR METAB CARDIOVAS, V23, P850, DOI 10.1016/j.numecd.2012.04.004; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; Giltinan M, 2011, REPORT SALT INTAKES; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; He J, 2002, ARCH INTERN MED, V162, P1619, DOI 10.1001/archinte.162.14.1619; Hendriksen MAH, 2014, PUBLIC HEALTH NUTR, V17, P1431, DOI 10.1017/S1368980013001481; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lhachimi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033317; Organization WH, 2009, GLOB HLTH RISKS MORT; Ortega RM, 2011, BRIT J NUTR, V105, P787, DOI 10.1017/S000711451000423X; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; Sadler K, 2011, NATL DIET NUTR SURVE; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; STAESSEN J, 1988, J HYPERTENS, V6, P965, DOI 10.1097/00004872-198812000-00003; Staessen JA, 1997, AM J CLIN NUTR, V65, P661; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sutherland J, 2013, BRIT J NUTR, V110, P552, DOI 10.1017/S0007114512005430; Teucher B, 2003, P NUTR SOC, V62, P859, DOI 10.1079/PNS2003300; TUOMILEHTO J, 1984, ANN CLIN RES, V16, P18; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; WHO, 2012, GUID SOD INT AD CHIL; World Health Organization, 2013, MAPP DIET SALT SOD R; World Health Organization, 2013, GLOB BRIEF HYP, P9; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	42	26	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118873	10.1371/journal.pone.0118873	http://dx.doi.org/10.1371/journal.pone.0118873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826317	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800007
J	Vettraino, A; Roques, A; Yart, A; Fan, JT; Sun, JH; Vannini, A				Vettraino, AnnaMaria; Roques, Alain; Yart, Annie; Fan, Jian-ting; Sun, Jiang-hua; Vannini, Andrea			Sentinel Trees as a Tool to Forecast Invasions of Alien Plant Pathogens	PLOS ONE			English	Article							OAK POWDERY MILDEW; PHYLOGENY; TAXONOMY; FUNGI	Recent disease outbreaks caused by alien invasive pathogens into European forests posed a serious threat to forest sustainability with relevant environmental and economic effects. Many of the alien tree pathogens recently introduced into Europe were not previously included on any quarantine lists, thus they were not subject to phytosanitary inspections. The identification and description of alien fungi potentially pathogenic to native European flora before their introduction in Europe, is a paramount need in order to limit the risk of invasion and the impact to forest ecosystems. To determine the potential invasive fungi, a sentinel trees plot was established in Fuyang, China, using healthy seedlings of European tree species including Quercus petreae, Q. suber, and Q. ilex. The fungal assemblage associated with symptomatic specimens was studied using the tag-encoded 454 pyrosequencing of the nuclear ribosomal internal transcribed spacer-1 (ITS 1). Taxa with probable Asiatic origin were identified and included plant pathogenic genera. These results indicate that sentinel plants may be a strategic tool to improve the prevention of bioinvasions.	[Vettraino, AnnaMaria; Vannini, Andrea] Univ Tuscia, DIBAF, Viterbo, Italy; [Roques, Alain; Yart, Annie] Ctr Rech Orleans, Zool Forestiere, INRA UR633, Orleans, France; [Fan, Jian-ting] Zhejiang A&F Univ, Sch Forestry & Biotechnol, Linan, Peoples R China; [Sun, Jiang-hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Tuscia University; INRAE; Zhejiang A&F University; Chinese Academy of Sciences; Institute of Zoology, CAS	Vannini, A (corresponding author), Univ Tuscia, DIBAF, Viterbo, Italy.	vannini@unitus.it	Vannini, Andrea/L-5071-2017	Vannini, Andrea/0000-0003-4318-9088; Diamandis, Stephanos/0000-0001-5650-0547; sun, jianghua/0000-0002-9465-3672	ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change - collaborative project) [245268]; COST PERMIT (Pathway Evaluation and pest Risk Management InTransport) [FP1002-181110-06882]	ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change - collaborative project); COST PERMIT (Pathway Evaluation and pest Risk Management InTransport)	This work was supported by ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change - collaborative project 245268) and COST PERMIT (Pathway Evaluation and pest Risk Management InTransport-FP1002-181110-06882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; [Anonymous], 2005, INVASIVE PLANTS ASIA; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Braun Uwe, 2003, Mycological Progress, V2, P3, DOI 10.1007/s11557-006-0039-2; Britton Kerry O., 2010, New Zealand Journal of Forestry Science, V40, P109; Brown AV, 2007, PLANT PATHOL, V56, P227, DOI 10.1111/j.1365-3059.2006.01511.x; Crous PW, 2009, FUNGAL DIVERS, V38, P1; Farr D.F., 1995, FUNGI PLANTS PLANT P; Feau N, 2012, FUNGAL ECOL, V5, P154, DOI 10.1016/j.funeco.2011.12.003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GILMAN JC, 1952, MYCOLOGIA, V44, P216, DOI 10.1080/00275514.1952.12024189; Green S, 2013, FOREST PATHOL, V43, P19, DOI 10.1111/j.1439-0329.2012.00788.x; Holland SM, ANAL RAREFACTION 200; Jeewon R, 2004, FUNGAL DIVERS, V17, P39; Kirschner R, 2014, MYCOSCIENCE, V55, P190, DOI 10.1016/j.myc.2013.08.004; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Landeras E, 2005, PLANT DIS, V89, P1015, DOI 10.1094/PD-89-1015A; Lombard L, 2010, PERSOONIA, V24, P1, DOI 10.3767/003158510X486568; Mohamed DJ, 2011, ISME J, V5, P379, DOI 10.1038/ismej.2010.137; Mougou A, 2008, FOREST PATHOL, V38, P275, DOI 10.1111/j.1439-0329.2008.00544.x; Nylander JAA., 2004, BIOINFORMATICS; Orgiazzi A., 2013, Diversity, V5, P73; Page RDM, 2001, TREEVIEW VERSION 166; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Rambaut A, 2009, TRACER V15 2009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques A, 2015, PLOS ONE IN PRESS; Roques A, 2013, ICBI INT C BIOL INV; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Smith ME, 2007, NEW PHYTOL, V174, P847, DOI 10.1111/j.1469-8137.2007.02040.x; Stonard JF, 2010, EUR J PLANT PATHOL, V126, P97, DOI 10.1007/s10658-009-9525-0; Takamatsu S, 2007, MYCOL RES, V111, P809, DOI 10.1016/j.mycres.2007.05.013; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Williamson B, 1991, COMPENDIUM RASPBERRY, P5; Yuan ZL, 2011, FUNGAL BIOL-UK, V115, P197, DOI 10.1016/j.funbio.2010.11.002; Zhao ZJ, 2013, INT J FOOD MICROBIOL, V164, P26, DOI 10.1016/j.ijfoodmicro.2013.03.018	38	33	35	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120571	10.1371/journal.pone.0120571	http://dx.doi.org/10.1371/journal.pone.0120571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826684	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800021
J	Chambers, CB; Halford, WP; Geltz, J; Villamizar, O; Gross, J; Embalabala, A; Gershburg, E; Wilber, A				Chambers, Christopher B.; Halford, William P.; Geltz, Joshua; Villamizar, Olga; Gross, Jeffrey; Embalabala, Alison; Gershburg, Edward; Wilber, Andrew			A System for Creating Stable Cell Lines that Express a Gene of Interest from a Bidirectional and Regulatable Herpes Simplex Virus Type 1 Promoter	PLOS ONE			English	Article							SLEEPING-BEAUTY; RESPONSIVE PROMOTERS; VECTORS; TETRACYCLINE; SELECTION; GENOME; INTERFERENCE; TRANSPOSASE; SEQUENCES; DESIGN	Expression systems used to study the biological function of a gene of interest can have limited utility due to three major factors: i) weak or heterogeneous gene expression; ii) poorly controlled gene expression; and iii) low efficiencies of stable integration and persistent expression. We envisioned that the ideal system should be tightly controlled and coupled with the ability to efficiently create and identify stable cell lines. Herein, we describe a system based upon a bidirectional Herpes simplex virus type 1 promoter that is naturally responsive to the VP16 transactivator and modified to permit tetracycline-regulated transcription on one side while maintaining constitutive activity on the other side. Incorporation of this element into the Sleeping Beauty transposon resulted in a novel bidirectional system with the capacity for high-efficiency stable integration. Using this system, we created stable cell lines in which expression of a gene of interest was tightly and uniformly controlled across a broad range of levels via a novel combination of doxycycline-sensitive de-repression and VP16-mediated sequence-specific induction. The unique characteristics of this system address major limitations of current methods and provide an excellent strategy to investigate the effects of gene dosing in mammalian models.	[Chambers, Christopher B.; Halford, William P.; Geltz, Joshua; Villamizar, Olga; Gross, Jeffrey; Embalabala, Alison; Gershburg, Edward; Wilber, Andrew] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Wilber, A (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA.	awilber@siumed.edu	Wilber, Andrew/I-9259-2019	Wilber, Andrew/0000-0002-8457-599X; Gershburg, Edward/0000-0003-3584-9947	Southern Illinois University School of Medicine; National Center for Research Resources [S10RR025674]; NATIONAL CANCER INSTITUTE [R15CA173657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025674] Funding Source: NIH RePORTER	Southern Illinois University School of Medicine; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Concept Development Grant from Southern Illinois University School of Medicine (WPH and AW), and the Southern Illinois University School of Medicine flow cytometry equipment was supported by Award Number S10RR025674 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Andrianaki A, 2010, GENE THER, V17, P380, DOI 10.1038/gt.2009.147; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; CHOU J, 1986, J VIROL, V57, P629, DOI 10.1128/JVI.57.2.629-637.1986; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; DAVIS MG, 1988, BIOTECHNOL APPL BIOC, V10, P6; EMERMAN M, 1986, MOL CELL BIOL, V6, P792, DOI 10.1128/MCB.6.3.792; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jacobs AH, 2003, HUM GENE THER, V14, P277, DOI 10.1089/10430340360535823; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Loew Rainer, 2006, J Mol Genet Med, V2, P107; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Orchard PJ, 2002, HUM GENE THER, V13, P979, DOI 10.1089/10430340252939087; Orekhova AS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P335, DOI 10.1134/S0006297913040020; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Payne Andrew J, 2013, Int J Biochem Mol Biol, V4, P201; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Takai Daiya, 2003, In Silico Biology, V3, P235; Turchiano G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112712; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; YEH L, 1993, J VIROL, V67, P7373, DOI 10.1128/JVI.67.12.7373-7382.1993	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122253	10.1371/journal.pone.0122253	http://dx.doi.org/10.1371/journal.pone.0122253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823013	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700161
J	Chen, W; Goff, MR; Kuang, HQ; Chen, GX				Chen, Wei; Goff, Matthew Ray; Kuang, Heqian; Chen, Guoxun			Higher Protein Kinase C zeta in Fatty Rat Liver and Its Effect on Insulin Actions in Primary Hepatocytes	PLOS ONE			English	Article							GLUCOKINASE GENE-EXPRESSION; ELEMENT-BINDING PROTEIN-1C; RECEPTOR SUBSTRATE-1 IRS-1; NF-KAPPA-B; HEPATIC GLUCONEOGENESIS; TRANSCRIPTIONAL REGULATION; ACID SYNTHESIS; X-RECEPTOR; ACTIVATION; PHOSPHORYLATION	We previously showed the impairment of insulin-regulated gene expression in the primary hepatocytes from Zucker fatty (ZF) rats, and its association with alterations of hepatic glucose and lipid metabolism. However, the molecular mechanism is unknown. A preliminary experiment shows that the expression level of protein kinase C zeta (PKC zeta), a member of atypical PKC family, is higher in the liver and hepatocytes of ZF rats than that of Zucker lean (ZL) rats. Herein, we intend to investigate the roles of atypical protein kinase C in the regulation of hepatic gene expression. The insulin-regulated hepatic gene expression was evaluated in ZL primary hepatocytes treated with atypical PKC recombinant adenoviruses. Recombinant adenovirus-mediated overexpression of PKC zeta, or the other atypical PKC member PKC iota/lambda, alters the basal and impairs the insulin-regulated expressions of glucokinase, sterol regulatory element-binding protein 1c, the cytosolic form of phosphoenolpyruvate carboxykinase, the catalytic subunit of glucose 6-phosphatase, and insulin like growth factorbinding protein 1 in ZL primary hepatocytes. PKC zeta or PKC iota/lambda overexpression also reduces the protein level of insulin receptor substrate 1, and the insulin-induced phosphorylation of AKT at Ser473 and Thr308. Additionally, PKC iota/lambda overexpression impairs the insulin-induced Prckz expression, indicating the crosstalk between PKC zeta and PKC iota/lambda. We conclude that the PKC zeta expression is elevated in hepatocytes of insulin resistant ZF rats. Overexpressions of aPKCs in primary hepatocytes impair insulin signal transduction, and in turn, the downstream insulin-regulated gene expression. These data suggest that elevation of aPKC expression may contribute to the hepatic insulin resistance at gene expression level.	[Chen, Wei; Goff, Matthew Ray; Kuang, Heqian; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Chen, GX (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu		Chen, Guoxun/0000-0001-6226-4050; Chen, Wei/0000-0002-6383-7540	Allen Foundation Inc; University of Tennessee at Knoxville; American Heart Association [09SDG2140003]; China Scholarship Council	Allen Foundation Inc; University of Tennessee at Knoxville; American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council)	This work was financially supported by research grant from Allen Foundation Inc (to GC), start-up fund from the University of Tennessee at Knoxville (to GC), and Scientist Development Grant from American Heart Association (09SDG2140003, to GC). WC received financial support from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100868; Farese RV, 2012, CURR OPIN LIPIDOL, V23, P175, DOI 10.1097/MOL.0b013e328352c4c7; Farese RV, 2010, AM J PHYSIOL-ENDOC M, V298, pE385, DOI 10.1152/ajpendo.00608.2009; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Guan HP, 2014, PROG MOL BIOL TRANSL, V121, P165, DOI 10.1016/B978-0-12-800101-1.00006-5; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Li R, 2014, J NUTR BIOCHEM, V25, P964, DOI 10.1016/j.jnutbio.2014.04.009; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Ribaux PG, 2003, BIOCHEM J, V376, P697, DOI 10.1042/BJ20031287; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Sajan MP, 2012, DIABETOLOGIA, V55, P1446, DOI 10.1007/s00125-012-2477-5; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Sajan MP, 2014, DIABETES, V63, P2690, DOI 10.2337/db13-1863; Sajan MP, 2013, DIABETOLOGIA, V56, P2507, DOI 10.1007/s00125-013-3010-1; Sajan MP, 2012, METABOLISM, V61, P459, DOI 10.1016/j.metabol.2011.12.008; Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200; Sajan MP, 2004, MOL ENDOCRINOL, V18, P2513, DOI 10.1210/me.2004-0045; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121890	10.1371/journal.pone.0121890	http://dx.doi.org/10.1371/journal.pone.0121890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822413	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700135
J	Khan, S; Ahmed, S				Khan, Saman; Ahmed, Shakil			Role of swi7H4 Mutant Allele of DNA Polymerase a in the DNA Damage Checkpoint Response	PLOS ONE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; REPLICATION CHECKPOINT; CHROMOSOME SEGREGATION; PROTEIN-KINASE; S-PHASE; ALPHA; COMPLEX; CHK1; STABILITY	Besides being a mediator of initiation of DNA replication, DNA polymerase a plays a key role in chromosome maintenance. Swi7H4, a novel temperature sensitive mutant of DNA polymerase a was shown to be defective in transcriptional silencing at the mating type centromere and telomere loci. It is also required for the establishment of chromatin state that can recruit the components of the heterochromatin machinery at these regions. Recently the role of DNA polymerase a in the S-phase alkylation damage response in S. pombe has also been studied. Here we investigate whether defects generated by swi7H4, a mutant allele of DNA polymerase a can activate a checkpoint response. We show that swi7H4 exhibit conditional synthetic lethality with chk1 null mutant and the double mutant of swi7H4 with chk1 deletion aggravate the chromosome segregation defects. More importantly swi7H4 mutant cells delay the mitotic progression at non permissive temperature that is mediated by checkpoint protein kinase Chk1. In addition we show that, in the swi7H4 mutant background, cells accumulate DNA damage at non permissive temperature activating the checkpoint kinase protein Chk1. Further, we observed synthetic lethality between swi7H4 and a number of genes involved in DNA repair pathway at semi permissive temperature. We summarize that defects in swi7H4 mutant results in DNA damage that delay mitosis in a Chk1 dependent manner that also require the damage repair pathway for proper recovery.	[Khan, Saman; Ahmed, Shakil] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ahmed, S (corresponding author), CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India.	shakil_ahmed@cdri.res.in		Khan, Saman/0000-0002-3191-4898	Department of Science and Technology, India [GAP0124]; Council of Scientific and Industrial Research [BSC0103, BSC0121]	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grant from Department of Science and Technology, India (GAP0124) and the Council of Scientific and Industrial Research (BSC0103 and BSC0121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Bisht KK, 2008, YEAST, V25, P537, DOI 10.1002/yea.1603; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; DURSO G, 1995, J CELL SCI, V108, P3109; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Koulintchenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047091; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Ranjan R, 2014, DNA REPAIR, V24, P98, DOI 10.1016/j.dnarep.2014.09.006; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Verma SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089587; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan S, 2001, CURR GENET, V38, P299, DOI 10.1007/s002940000172; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Yadav S, 2011, GENET RES, V93, P275, DOI 10.1017/S0016672311000188	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0124063	10.1371/journal.pone.0124063	http://dx.doi.org/10.1371/journal.pone.0124063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822347	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700245
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Argueso, M; Ramos, L; Sole-Violan, J; Caceres, JJ; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Argueso, Monica; Ramos, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum Levels of Caspase-Cleaved Cytokeratin-18 in Patients with Severe Traumatic Brain Injury Are Associated with Mortality: A Pilot Study	PLOS ONE			English	Article							CELL APOPTOSIS; BCL-2 FAMILY; DEATH; BIOMARKERS; EXPRESSION; FRAGMENTS; THERAPY; LIVER	Objective There have been found apoptotic changes in brain tissue samples from animals and humans after a traumatic brain injury (TBI). The protein cytokeratin 18 (CK-18), present in epithelial cells, is cleaved by the action of caspases during apoptosis, and the resulting fragments are released into the blood as caspase-cleaved CK (CCCK)-18. Circulating levels of CCCK-18, as biomarker of apoptosis, have been determined in patients with different processes; however, it has not been explored in TBI patients. Thus, the objective of this study was to determine whether there is an association between serum CCCK-18 levels and mortality and whether such levels could be used as a biomarker to predict outcomes in TBI patients. Methods A prospective, observational, multicenter study carried out in six Spanish Intensive Care Units. We included patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9; and were excluded those patients with Injury Severity Score (ISS) in non-cranial aspects higher than 9. We measured serum CCCK-18 levels at admission. The end-point of the study was 30-day mortality. Results Surviving patients (n = 73) showed lower serum CCCK-18 levels (P = 0.003) than non-survivors (n = 27). On ROC analysis, the area under the curve (AUC) for serum CCCK-18 levels as predictor of 30-day mortality was 0.69 (95% CI = 0.59-0.78; P = 0.006). We found in survival analysis that patients with serum CCCK-18 higher than 201 u/L had higher 30-day mortality than patients with lower levels (Hazard ratio = 3.9; 95% CI = 1.81-8.34; P< 0.001). Regression analyses showed that serum CCCK-18 levels higher than 201 u/L were associated with 30-day mortality (OR = 8.476; 95% CI = 2.087-34.434; P = 0.003) after controlling for age and GCS. Conclusions The novel finding of our study was that serum CCCK-18 levels are associated with 30-day mortality and could be used as a prognostic biomarker in patients with severe TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Deparment, Tenerife, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain.	lorentemartin@msn.com	Borreguero León, Juan María/ABQ-2161-2022; Martín, María/HDL-9512-2022	Borreguero León, Juan María/0000-0001-7414-5278; Argueso, Monica/0000-0001-5917-1056	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	This study was supported by fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen R, 2013, EXP THER MED, V6, P1463, DOI 10.3892/etm.2013.1342; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; TEASDALE G, 1974, LANCET, V2, P81; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764	31	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121739	10.1371/journal.pone.0121739	http://dx.doi.org/10.1371/journal.pone.0121739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822281	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700124
J	Singh, AK; Asoh, H; Takeda, Y; Phillips, S				Singh, Archana K.; Asoh, Hideki; Takeda, Yuji; Phillips, Steven			Statistical Detection of EEG Synchrony Using Empirical Bayesian Inference	PLOS ONE			English	Article							FALSE DISCOVERY RATE; NEURAL MASS MODEL; FUNCTIONAL CONNECTIVITY; PHASE SYNCHRONY; TOPOLOGICAL INFERENCE; BRAIN NETWORKS; ATTENTION; DYNAMICS; RATES; FMRI	There is growing interest in understanding how the brain utilizes synchronized oscillatory activity to integrate information across functionally connected regions. Computing phase-locking values (PLV) between EEG signals is a popular method for quantifying such synchronizations and elucidating their role in cognitive tasks. However, high-dimensionality in PLV data incurs a serious multiple testing problem. Standard multiple testing methods in neuroimaging research (e.g., false discovery rate, FDR) suffer severe loss of power, because they fail to exploit complex dependence structure between hypotheses that vary in spectral, temporal and spatial dimension. Previously, we showed that a hierarchical FDR and optimal discovery procedures could be effectively applied for PLV analysis to provide better power than FDR. In this article, we revisit the multiple comparison problem from a new Empirical Bayes perspective and propose the application of the local FDR method (locFDR; Efron, 2001) for PLV synchrony analysis to compute FDR as a posterior probability that an observed statistic belongs to a null hypothesis. We demonstrate the application of Efron's Empirical Bayes approach for PLV synchrony analysis for the first time. We use simulations to validate the specificity and sensitivity of locFDR and a real EEG dataset from a visual search study for experimental validation. We also compare locFDR with hierarchical FDR and optimal discovery procedures in both simulation and experimental analyses. Our simulation results showed that the locFDR can effectively control false positives without compromising on the power of PLV synchrony inference. Our results from the application locFDR on experiment data detected more significant discoveries than our previously proposed methods whereas the standard FDR method failed to detect any significant discoveries.	[Singh, Archana K.] ATR Neural Informat Anal Labs, Kyoto 6190288, Japan; [Asoh, Hideki; Takeda, Yuji; Phillips, Steven] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Singh, AK (corresponding author), ATR Neural Informat Anal Labs, Kyoto 6190288, Japan.	archana@mail.ecc.u-tokyo.ac.jp	Takeda, Yuji/Q-3406-2016; Singh, Archana K/U-7657-2018; Phillips, Steven/N-3425-2016; Asoh, Hideki/M-4313-2018	Takeda, Yuji/0000-0001-6950-087X; Singh, Archana K/0000-0003-1596-6572; Phillips, Steven/0000-0002-5694-0670; Asoh, Hideki/0000-0002-0891-3782	Japan Society for the Promotion of Science [26280051]; Ministry of Internal Affairs and Communications	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Internal Affairs and Communications	Funding provided by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) grant KAKENHI (26280051) to SP and Ministry of Internal Affairs and Communications (http://www.soumu.go.jp/english/) for a Project "Novel and innovative R & D making use of brain structures" which supported AS for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviyente S, 2011, HUM BRAIN MAPP, V32, P80, DOI 10.1002/hbm.21000; Aydore S, 2013, NEUROIMAGE, V74, P231, DOI 10.1016/j.neuroimage.2013.02.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya J, 2005, SIGNAL PROCESS, V85, P2161, DOI 10.1016/j.sigpro.2005.07.007; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chang YT, 2014, NEUROIMAGE, V91, P99, DOI 10.1016/j.neuroimage.2014.01.010; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Daly I, 2013, J COMPUT NEUROSCI, V34, P411, DOI 10.1007/s10827-012-0428-2; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fingelkurts A, 2003, NEUROIMAGE, V20, P529, DOI 10.1016/S1053-8119(03)00305-7; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Kiebel SJ, 2004, NEUROIMAGE, V22, P492, DOI 10.1016/j.neuroimage.2004.02.012; Kilner JM, 2010, ANN APPL STAT, V4, P1272, DOI 10.1214/10-AOAS337; Kilner JM, 2005, NEUROSCI LETT, V374, P174, DOI 10.1016/j.neulet.2004.10.052; Krieg J, 2011, NEUROIMAGE IN PRESS; Lachaux JP, 2000, INT J BIFURCAT CHAOS, V10, P2429, DOI 10.1142/S0218127400001560; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Phillips S, 2010, INT J PSYCHOPHYSIOL, V75, P39, DOI 10.1016/j.ijpsycho.2009.11.001; Ponten SC, 2010, NEUROIMAGE, V52, P985, DOI 10.1016/j.neuroimage.2009.10.049; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schwartzman A, 2009, NEUROIMAGE, V44, P71, DOI 10.1016/j.neuroimage.2008.04.182; Singh AK, 2011, NEUROIMAGE, V58, P148, DOI 10.1016/j.neuroimage.2011.05.082; Singh AK, 2010, NEUROIMAGE, V50, P40, DOI 10.1016/j.neuroimage.2009.12.030; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Stumpf K, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/48001; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Thatcher RW, 2008, NEUROIMAGE, V42, P1639, DOI 10.1016/j.neuroimage.2008.06.009; Woolrich MW, 2012, NEUROIMAGE, V62, P801, DOI 10.1016/j.neuroimage.2011.10.047; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121795	10.1371/journal.pone.0121795	http://dx.doi.org/10.1371/journal.pone.0121795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822617	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700127
J	Stantis, C; Kinaston, RL; Richards, MP; Davidson, JM; Buckley, HR				Stantis, Christina; Kinaston, Rebecca L.; Richards, Michael P.; Davidson, Janet M.; Buckley, Hallie R.			Assessing Human Diet and Movement in the Tongan Maritime Chiefdom Using Isotopic Analyses	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; BONE-COLLAGEN; STABLE-ISOTOPE; STRONTIUM ISOTOPES; PREHISTORIC MIGRATION; SOUTH COAST; NITROGEN; MOBILITY; MARINE; RATIOS	The rise of stratified societies fundamentally influences the interactions between status, movement, and food. Using isotopic analyses, we assess differences in diet and mobility of individuals excavated from two burial mounds located at the 'Atele burial site on Tongatapu, the main island of the Kingdom of Tonga (c. 500 -150 BP). The first burial mound (To-At-1) was classified by some archaeologists as a commoner's mound while the second burial mound (To-At-2) was possibly used for interment of the chiefly class. In this study, stable isotope analyses of diet (delta C-13, delta N-15, and delta S-34; n = 41) are used to asses paleodiet and Sr-87/Sr-86 ratios (n = 30) are analyzed to investigate individual mobility to test whether sex and social status affected these aspects of life. Our results show significant differences in diet between burial mounds and sexes. Those interred in To-At-2 displayed lower delta C-13 values, indicating they ate relatively more terrestrial plants (likely starchy vegetable staples) compared with To-At-1 individuals. Females displayed significantly lower delta N-15 values compared with males within the entire assemblage. No differences in delta S-34 values were observed between sexes or burial mound but it is possible that sea spray or volcanism may have affected these values. One individual displayed the strontium isotopic composition representative of a nonlocal immigrant (outside 2SD of the mean). This suggests the hege-monic control over interisland travel, may have prevented long-term access to the island by non-Tongans exemplifying the political and spiritual importance of the island of Tongatapu in the maritime chiefdom.	[Stantis, Christina; Kinaston, Rebecca L.; Buckley, Hallie R.] Univ Otago, Dept Anat, Div Hlth Sci, Dunedin, New Zealand; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Davidson, Janet M.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand	University of Otago; University of British Columbia; Max Planck Society	Stantis, C (corresponding author), Univ Otago, Dept Anat, Div Hlth Sci, Dunedin, New Zealand.	chris.stantis@anatomy.otago.ac.nz	Richards, Michael/O-3717-2016; Buckley, Hallie/Q-5458-2019	Richards, Michael/0000-0001-5274-8887; Stantis, Chris/0000-0001-7645-0233	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Max Planck Society provided funding. The Max Planck Society had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Ambrose SH, 1997, AM J PHYS ANTHROPOL, V104, P343; AMBROSE SH, 1992, CURR ANTHROPOL, V33, P401, DOI 10.1086/204088; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P193, DOI 10.1016/S0278-4165(03)00033-3; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; [Anonymous], 1996, BECOMING TONGAN ETHN; [Anonymous], [No title captured]; Aswani S., 1998, ASIAN PERSPECT, V37, P135; Bea-glehole J. G., 1967, J CAPTAIN J COOK HIS; Bentley RA, 2007, AM ANTIQUITY, V72, P645, DOI 10.2307/25470438; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Bentley RA, 2003, ARCHAEOMETRY, V45, P471, DOI 10.1111/1475-4754.00122; BEST S, 1992, J POLYNESIAN SOC, V101, P45; Bird, 1992, RECORDS AUSTR MUSE S, V42, P83; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; BOTT E, 1981, J POLYNESIAN SOC, V90, P7; BOUTTON T W, 1991, P173; Bromfield K, 2011, AUST J EARTH SCI, V58, P61, DOI 10.1080/08120099.2011.534816; Brown JA., 1981, ARCHAEOLOGY DEATH; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buckley HR, 2000, AM J PHYS ANTHROPOL, V113, P481, DOI 10.1002/1096-8644(200012)113:4<481::AID-AJPA4>3.0.CO;2-1; Buckley HR, 2001, HLTH DIS PREHISTORIC; Buikstra J. E., 1994, STANDARDS DATA COLLE; Burley DV, 1998, J WORLD PREHIST, V12, P337, DOI 10.1023/A:1022322303769; Burton JH, 1999, INT J OSTEOARCHAEOL, V9, P233, DOI 10.1002/(SICI)1099-1212(199907/08)9:4<233::AID-OA476>3.0.CO;2-S; Campbell IC, 1992, ISLAND KINGDOM TONGA; Chiaradia M, 2003, APPL GEOCHEM, V18, P353, DOI 10.1016/S0883-2927(02)00072-0; CHISHOLM BS, 1982, SCIENCE, V216, P1131, DOI 10.1126/science.216.4550.1131; Clark G, 2008, ANTIQUITY, V82, P994, DOI 10.1017/S0003598X00097738; Clark GR, 2014, P NATL ACAD SCI USA, V111, P10491, DOI 10.1073/pnas.1406165111; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Cook J, 1999, J CAPTAIN COOK PREPA; Curet LA, 2010, J ANTHROPOL ARCHAEOL, V29, P413, DOI 10.1016/j.jaa.2010.08.003; Danforth ME, 1999, ANNU REV ANTHROPOL, V28, P1, DOI 10.1146/annurev.anthro.28.1.1; DAVIDSON J M, 1969, Records of the Auckland Institute and Museum, V6, P251; Davidson J. M., 1979, PREHISTORY POLYNESIA, P82; DAVIDSON JM, 1977, WORLD ARCHAEOL, V9, P82, DOI 10.1080/00438243.1977.9979686; de Laeter JR, 1998, MASS SPECTROM REV, V17, P97, DOI 10.1002/(SICI)1098-2787(1998)17:2<97::AID-MAS2>3.0.CO;2-J; deFrance SD, 2009, J ARCHAEOL RES, V17, P105, DOI 10.1007/s10814-008-9027-1; Deniel C, 2001, ANAL CHIM ACTA, V426, P95, DOI 10.1016/S0003-2670(00)01185-5; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Evans Mike., 2001, PERSISTENCE GIFT TON; Ewart A, 1998, J PETROL, V39, P331, DOI 10.1093/petrology/39.3.331; Field JS, 2009, J ARCHAEOL SCI, V36, P1547, DOI 10.1016/j.jas.2009.03.016; FLANAGAN JG, 1989, ANNU REV ANTHROPOL, V18, P245; Foster AV, 2011, GENDERED DIVISIONS L; GILL JB, 1984, EARTH PLANET SC LETT, V68, P443, DOI 10.1016/0012-821X(84)90129-8; Green R.C., 1979, PREHISTORY POLYNESIA, P27; Greenhill SJ, 2011, OCEAN LINGUIST, V50, P551; Harris DavidR., 2007, RETHINKING AGR ARCHA, P16; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Helu F., 1995, J SOC OCEANISTES, V100-101, P191; Hezel FrancisX.S.J, 2001, NEW SHAPE OLD ISLAND; Hoefs J., 2009, STABLE ISOTOPE GEOCH, V6th; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Jaric J, 2004, USE PB SR ISOTOPES H; JELLIFFE DB, 1967, AM J CLIN NUTR, V20, P279, DOI 10.1093/ajcn/20.3.279; JOHNSON CM, 1990, CONTRIB MINERAL PETR, V104, P99, DOI 10.1007/BF00310649; Jones S., 2009, FOOD GENDER FIJI ETH; KAEPPLER AL, 1971, ETHNOLOGY, V10, P174, DOI 10.2307/3773008; Kaeppler AL., 1978, MEA FAKAEIKI TONGAN; KAEPPlER Riportato da A., 1978, MANKIND, V11, P246; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; Katzenberg MA, 2007, STABLE ISOTOPE ANAL, P411; Kendall EJ, 2013, AM J PHYS ANTHROPOL, V150, P210, DOI 10.1002/ajpa.22194; Kinaston R.L., 2013, PACIFIC ARCHAEOLOGY, P91; Kinaston R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104071; Kinaston R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090376; Kinaston R, 2013, J ARCHAEOL SCI, V40, P904, DOI 10.1016/j.jas.2012.09.002; Kinaston RL, 2013, AM J PHYS ANTHROPOL, V151, P589, DOI 10.1002/ajpa.22314; Kinaston RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064580; Kirch P.V., 1997, HIST ECOLOGY PACIFIC; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Kirch PV, 2003, WORLD ARCHAEOL, V34, P484, DOI 10.1080/0043824021000026468; KIRCH PV, 1979, J POLYNESIAN SOC, V88, P53; KIRCH PV, 1997, LAPITA PEOPLES ANCES; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kirch PV, 2001, ANCESRAL POLYNESIA E; Kirsch P., 2001, FEASTS ARCHAEOLOGICA, P168; Laffoon JE, 2012, J ARCHAEOL SCI, V39, P2371, DOI 10.1016/j.jas.2012.02.002; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Leach B, 2003, NZ J ARCHAEOL, V23, P31; Leach H, 2003, WORLD ARCHAEOL, V34, P442, DOI 10.1080/0043824021000026440; Levy R, 1988, FRENCH POLYNESIA BOO, P8; Lieber M, 1999, TRADITIONAL STORYTEL, P176; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lukacs J.R., 1989, RECONSTRUCTING LIFE, P261; Lukacs JR, 2012, BLACKW COMPANION ANT, P553; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; Martin J., 1827, ACCOUNT NATIVES TONG; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; McKern W.C, 1929, BISHOP MUSEUM B, V60; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Ohtsuka R, 1985, RECENT ADV INDO PACI, P343; Oliver D, 1989, OCEANIA NATIVE CULTU; Petchey F, 2011, QUAT GEOCHRONOL, V6, P539, DOI 10.1016/j.quageo.2011.08.001; Petersen G, 2000, J PAC HIST, V35, P5, DOI 10.1080/00223340050052275; PETERSON BJ, 1985, SCIENCE, V227, P1361, DOI 10.1126/science.227.4692.1361; PIETRUSEWSKY M, 1969, Records of the Auckland Institute and Museum, V6, P287; Pollock N., 1992, THESE ROOTS REMAIN F; POLLOCK NJ, 1986, ETHNOLOGY, V25, P107, DOI 10.2307/3773663; Poulson J., 1987, EARLY TONGAN PREHIST; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reitsema LJ, 2012, AM J PHYS ANTHROPOL, V148, P589, DOI 10.1002/ajpa.22085; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; ROGERS G, 1977, J POLYNESIAN SOC, V86, P157; SAHLINS MD, 1963, COMP STUD SOC HIST, V5, P285, DOI 10.1017/S0010417500001729; SAHLINS MD, 1958, SOCIAL STRATIFICATIO; Schoeninger M.J, 2010, DIET RECONSTRUCTION, P445; SCHOENINGER MJ, 1992, J WORLD PREHIST, V6, P247, DOI 10.1007/BF00975551; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Sealy J., 2005, HDB ARCHAEOLOGICAL S, P269; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sharp Z., 2007, PRINCIPLES STABLE IS; Shaw B, 2011, J ANTHROPOL ARCHAEOL, V30, P344, DOI 10.1016/j.jaa.2011.05.004; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Shaw BJ, 2009, J ARCHAEOL SCI, V36, P1079, DOI 10.1016/j.jas.2008.12.010; Taylor FW, 1977, P 3 INT COR REEF S; TERAKADO Y, 1988, CONTRIB MINERAL PETR, V99, P1, DOI 10.1007/BF00399360; Torrence R., 1986, PRODUCTION EXCHANGE; Valentin F, 2006, J ARCHAEOL SCI, V33, P1396, DOI 10.1016/j.jas.2006.01.012; Van der Veen M, 2003, WORLD ARCHAEOL, V34, P405, DOI 10.1080/0043824021000026422; Vika E, 2009, J ARCHAEOL SCI, V36, P2024, DOI 10.1016/j.jas.2009.05.022; Waldron T., 1994, COUNTING DEAD EPIDEM; West T, 1835, 10 YEARS S CENTRAL P; Whipkey CE, 2000, CHEM GEOL, V168, P37, DOI 10.1016/S0009-2541(00)00187-X; Whistler WA., 1991, ETHNOBOTANY TONGA PL; White CD, 1998, J ARCHAEOL SCI, V25, P643, DOI 10.1006/jasc.1997.0259; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; WRIGHT E, 1987, EARTH PLANET SC LETT, V81, P151, DOI 10.1016/0012-821X(87)90152-X; Zhang, 2013, ISOMAP ISOSCAPES MOD	142	34	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123156	10.1371/journal.pone.0123156	http://dx.doi.org/10.1371/journal.pone.0123156			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE9AD	25822619	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000352134700217
J	Roy, A; Dement, AD; Cho, KH; Kim, JH				Roy, Adhiraj; Dement, Angela D.; Cho, Kyu Hong; Kim, Jeong-Ho			Assessing Glucose Uptake through the Yeast Hexose Transporter 1 (Hxt1)	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; GLUT1; UBIQUITIN; BINDING; GENE; RGT1; ENDOCYTOSIS; REPRESSION	The transport of glucose across the plasma membrane is mediated by members of the glucose transporter family. In this study, we investigated glucose uptake through the yeast hexose transporter 1 (Hxt1) by measuring incorporation of 2-NBDG, a non-metabolizable, fluorescent glucose analog, into the yeast Saccharomyces cerevisiae. We find that 2-NBDG is not incorporated into the hxt null strain lacking all glucose transporter genes and that this defect is rescued by expression of wild type Hxt1, but not of Hxt1 with mutations at the putative glucose-binding residues, inferred from the alignment of yeast and human glucose transporter sequences. Similarly, the growth defect of the hxt null strain on glucose is fully complemented by expression of wild type Hxt1, but not of the mutant Hxt1 proteins. Thus, 2-NBDG, like glucose, is likely to be transported into the yeast cells through the glucose transport system. Hxt1 is internalized and targeted to the vacuole for degradation in response to glucose starvation. Among the mutant Hxt1 proteins, Hxt1(N370A) and HXT1(W473A) are resistant to such degradation. Hxt1(N370A), in particular, is able to neither uptake 2-NBDG nor restore the growth defect of the hxt null strain on glucose. These results demonstrate 2-NBDG as a fluorescent probe for glucose uptake in the yeast cells and identify N370 as a critical residue for the stability and function of Hxt1.	[Roy, Adhiraj; Kim, Jeong-Ho] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Dement, Angela D.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Cho, Kyu Hong] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	George Washington University; Virginia Polytechnic Institute & State University; Indiana State University	Kim, JH (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, 2300 Eye St NW, Washington, DC 20037 USA.	jh_kim@gwu.edu	Roy, Adhiraj/AAR-7311-2021	Roy, Adhiraj/0000-0001-7584-8872	National Institutes of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grant GM087470. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles J, 2004, CYTOM PART A, V61A, P88, DOI 10.1002/cyto.a.20035; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Krampe S, 1998, FEBS LETT, V441, P343, DOI 10.1016/S0014-5793(98)01583-X; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; LAGUNAS R, 1979, MOL CELL BIOCHEM, V27, P139, DOI 10.1007/BF00215362; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lloyd PG, 1999, PHYSIOL RES, V48, P401; Mandelkern M, 2002, TECHNOL CANCER RES T, V1, P423, DOI 10.1177/153303460200100603; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Palomino A, 2005, BIOCHEM J, V388, P697, DOI 10.1042/BJ20050160; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Roy A, 2014, BBA-GEN SUBJECTS, V1840, P2878, DOI 10.1016/j.bbagen.2014.05.004; Roy A, 2014, J BIOL CHEM, V289, P7247, DOI 10.1074/jbc.M113.539411; Roy A, 2014, FEBS OPEN BIO, V4, P105, DOI 10.1016/j.fob.2013.12.004; Roy A, 2013, MOL BIOL CELL, V24, P1493, DOI 10.1091/mbc.E13-01-0047; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Snowdon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050458; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; VINTERS HV, 1985, J NEUROPATH EXP NEUR, V44, P445, DOI 10.1097/00005072-198509000-00001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yoshioka K, 1996, APPL MICROBIOL BIOT, V46, P400	56	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121985	10.1371/journal.pone.0121985	http://dx.doi.org/10.1371/journal.pone.0121985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816250	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600133
J	Chandramouli, B; Di Maio, D; Mancini, G; Barone, V; Brancato, G				Chandramouli, Balasubramanian; Di Maio, Danilo; Mancini, Giordano; Barone, Vincenzo; Brancato, Giuseppe			Breaking the Hydrophobicity of the MscL Pore: Insights into a Charge-Induced Gating Mechanism	PLOS ONE			English	Article							BACTERIAL MECHANOSENSITIVE CHANNELS; MOLECULAR-DYNAMICS; LARGE-CONDUCTANCE; MYCOBACTERIUM-TUBERCULOSIS; ION-CHANNEL; FUNCTION MUTATIONS; ESCHERICHIA-COLI; FORCE-FIELD; MEMBRANE; PROTEIN	The mechanosensitive channel of large conductance (MscL) is a protein that responds to membrane tension by opening a transient pore during osmotic downshock. Due to its large pore size and functional reconstitution into lipid membranes, MscL has been proposed as a promising artificial nanovalve suitable for biotechnological applications. For example, site-specific mutations and tailored chemical modifications have shown how MscL channel gating can be triggered in the absence of tension by introducing charged residues at the hydrophobic pore level. Recently, engineered MscL proteins responsive to stimuli like pH or light have been reported. Inspired by experiments, we present a thorough computational study aiming at describing, with atomistic detail, the artificial gating mechanism and the molecular transport properties of a light-actuated bacterial MscL channel, in which a charge-induced gating mechanism has been enabled through the selective cleavage of photo-sensitive alkylating agents. Properties such as structural transitions, pore dimension, ion flux and selectivity have been carefully analyzed. Besides, the effects of charge on alternative sites of the channel with respect to those already reported have been addressed. Overall, our results provide useful molecular insights into the structural events accompanying the engineered MscL channel gating and the interplay of electrostatic effects, channel opening and permeation properties. In addition, we describe how the experimentally observed ionic current in a single-subunit charged MscL mutant is obtained through a hydrophobicity breaking mechanism involving an asymmetric inter-subunit motion.	[Chandramouli, Balasubramanian; Di Maio, Danilo; Mancini, Giordano; Barone, Vincenzo; Brancato, Giuseppe] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Di Maio, Danilo; Mancini, Giordano; Barone, Vincenzo; Brancato, Giuseppe] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy	Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN)	Brancato, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	giuseppe.brancato@sns.it	Brancato, Giuseppe/A-4346-2010; CHANDRAMOULI, BALASUBRAMANIAN/L-9556-2018; Brancato, Giuseppe/U-7083-2019; Barone, Vincenzo/C-7344-2008	CHANDRAMOULI, BALASUBRAMANIAN/0000-0002-6837-4709; Brancato, Giuseppe/0000-0001-8059-2517; Barone, Vincenzo/0000-0001-6420-4107	Ministero dell'Istruzione, dell'Universita e della Ricerca [RBFR10DAK6, 2012SK7ASN, RBFR12ETL5]; European Research Council [320951]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission)	GB was supported by: Ministero dell'Istruzione, dell'Universita e della Ricerca through the FIRB and PRIN projects (contract noRBFR10DAK6 and no2012SK7ASN). http://www.istruzione.it/. GM was supported by: Ministero dell'Istruzione, dell'Universita e della Ricerca through the FIRB project (contract noRBFR12ETL5). http://www.istruzione.it/. VB was supported by: European Research Council Advanced Grant 2012 (number 320951). http://erc.europa.eu/.	Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Anishkin A, 2005, J GEN PHYSIOL, V125, P155, DOI 10.1085/jgp.200409118; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Colombo G, 2003, BIOPHYS J, V84, P2331, DOI 10.1016/S0006-3495(03)75038-3; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Deplazes E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002683; Doerner JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1999; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Elmore DE, 2003, BIOPHYS J, V85, P1512, DOI 10.1016/S0006-3495(03)74584-6; Frisch G. W., 2013, GAUSSIAN 09; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Kocer A, 2006, ANGEW CHEM INT EDIT, V45, P3126, DOI 10.1002/anie.200503403; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinac B, 2011, CELL PHYSIOL BIOCHEM, V28, P1051, DOI 10.1159/000335842; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Meyer GR, 2006, BIOPHYS J, V91, P1630, DOI 10.1529/biophysj.106.080721; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mika JT, 2013, FASEB J, V27, P882, DOI 10.1096/fj.12-214361; Moe PC, 2000, J BIOL CHEM, V275, P31121, DOI 10.1074/jbc.M002971200; Oakley AJ, 1999, PROTEIN SCI, V8, P1915, DOI 10.1110/ps.8.10.1915; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pezeshki S, 2009, BIOPHYS J, V97, P1898, DOI 10.1016/j.bpj.2009.07.018; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Salvadori A, 2014, LECT NOTES COMPUT SC, V8853, P333, DOI 10.1007/978-3-319-13969-2_25; Shirvanyants D, 2014, BIOPHYS J, V106, P2375, DOI 10.1016/j.bpj.2014.04.023; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tang YY, 2008, BIOPHYS J, V95, P581, DOI 10.1529/biophysj.107.128496; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01834; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	66	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120196	10.1371/journal.pone.0120196	http://dx.doi.org/10.1371/journal.pone.0120196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825909	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800013
J	Hill, DJ; Griffiths, NJ; Borodina, E; Andreae, CA; Sessions, RB; Virji, M				Hill, Darryl J.; Griffiths, Natalie J.; Borodina, Elena; Andreae, Clio A.; Sessions, Richard B.; Virji, Mumtaz			Identification and Therapeutic Potential of a Vitronectin Binding Region of Meningococcal Msf	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MORAXELLA-CATARRHALIS; S-PROTEIN; NEISSERIA-GONORRHOEAE; USPA2 PROTEIN; COMPLEMENT; INTERNALIZATION; COLONIZATION; MECHANISMS; INTEGRINS	The human pathogen Neisseria meningitides (Nm) attains serum resistance via a number of mechanisms, one of which involves binding to the host complement regulator protein vitronectin. We have shown previously that the Meningococcal surface fibril (Msf), a trimeric autotransporter, binds to the activated form of vitronectin (aVn) to increase Nm survival in human serum. In this study, we aimed to identify the aVn-binding region of Msf to assess its potential as an antigen which can elicit antibodies that block aVn binding and/or possess bactericidal properties. Using several recombinant Msf fragments spanning its surface-exposed region, the smallest aVn-binding recombinants were found to span residues 1-86 and 39-124. The use of further deletion constructs and overlapping recombinant Msf fragments suggested that a region of Msf comprising residues 39-82 may be primarily important for aVn binding and that other regions may also be involved but to a lesser extent. Molecular modelling implicated K66 and K68, conserved in all available Msf sequences, to be involved in the interaction. Recombinant fragments which bound to aVn were able to reduce the survival advantage conveyed by aVn-interaction in serum bactericidal assays. Antibodies raised against one such fragment inhibited aVn binding to Msf. In addition, the antibodies enhanced specific killing of Msf-expressing Nm in a dose-dependent manner. Overall, this study identifies an aVn-binding region of Msf, an adhesin known to impart serum resistance properties to the pathogen; and shows that this region of Msf can elicit antibodies with dual properties which reduce pathogen survival within the host and thus has potential as a vaccine antigen.	[Hill, Darryl J.; Griffiths, Natalie J.; Borodina, Elena; Andreae, Clio A.; Virji, Mumtaz] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Sessions, Richard B.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Hill, DJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	Darryl.j.hill@bristol.ac.uk; m.virji@bristol.ac.uk		Sessions, Richard/0000-0003-0320-0895	GlaxoSmithKline Biologicals, Rixensart, Belgium; University of Bristol; Meningitis Now	GlaxoSmithKline Biologicals, Rixensart, Belgium(GlaxoSmithKline); University of Bristol; Meningitis Now	Financial support during this project was from GlaxoSmithKline Biologicals, Rixensart, Belgium, the University of Bristol and Meningitis Now. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, bacterial strains used in the study were provided by GlaxoSmithKline Biologicals.	[Anonymous], 2013, VACCINE; [Anonymous], 2013, LANCET INFECT DIS; ARKO RJ, 1991, J CLIN MICROBIOL, V29, P70, DOI 10.1128/JCM.29.1.70-75.1991; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Cotter SE, 2005, J BACTERIOL, V187, P4656, DOI 10.1128/JB.187.13.4656-4664.2005; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; Cunha CSE, 2009, CELL MICROBIOL, V11, P389, DOI 10.1111/j.1462-5822.2008.01262.x; Duensing TD, 1997, INFECT IMMUN, V65, P964, DOI 10.1128/IAI.65.3.964-970.1997; Feavers IM, 2009, VACCINE, V27, pB42, DOI 10.1016/j.vaccine.2009.05.001; Gasparini R, 2011, HUM VACCINES, V7, P170, DOI 10.4161/hv.7.2.13717; Gorringe AR, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18500; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Griffiths Natalie J., 2009, Vaccimonitor, V18, P90; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Harris SL, 2011, HUM VACCINES, V7, P68, DOI 10.4161/hv.7.0.14564; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; HOGASEN K, 1992, J BIOL CHEM, V267, P23076; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; JENNE D, 1985, EMBO J, V4, P3153, DOI 10.1002/j.1460-2075.1985.tb04058.x; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Jordan PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005198; LANE DA, 1987, J BIOL CHEM, V262, P16343; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Lynn GW, 2005, BIOCHEMISTRY-US, V44, P565, DOI 10.1021/bi048347s; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136/archdischild-2012-302036; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; POHL WR, 1991, AM REV RESPIR DIS, V143, P1369, DOI 10.1164/ajrccm/143.6.1369; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Radin JN, 2009, J BACTERIOL, V191, P5068, DOI 10.1128/JB.00395-09; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; StGeme JW, 1996, J BACTERIOL, V178, P6281, DOI 10.1128/jb.178.21.6281-6287.1996; Su YC, 2013, MICROBES INFECT, V15, P375, DOI 10.1016/j.micinf.2013.02.004; Su YC, 2013, MOL MICROBIOL, V87, P1245, DOI 10.1111/mmi.12164; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	56	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0124133	10.1371/journal.pone.0124133	http://dx.doi.org/10.1371/journal.pone.0124133			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826209	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800113
J	Park, Y; Kim, SU; Park, SY; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Tak, WY; Kweon, YO; Han, KH				Park, Yehyun; Kim, Seung Up; Park, Soo Young; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Tak, Won Young; Kweon, Young Oh; Han, Kwang-Hyub			A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography	PLOS ONE			English	Article							LIVER STIFFNESS MEASUREMENT; HCV-RELATED CIRRHOSIS; CHRONIC HEPATITIS-B; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; ARFI ELASTOGRAPHY; SPLEEN STIFFNESS; FIBROSIS; DIAGNOSIS; METAANALYSIS	Background & Aims Few noninvasive methods can accurately identify esophageal varices (EVs) in patients with compensated cirrhosis. We developed and validated a novel, acoustic radiation force impulse (ARFI) elastography-based prediction model for high-risk EVs (HEVs) in patients with compensated cirrhosis. Methods A total of 143 patients with compensated cirrhosis between February, 2010 and February, 2013 (training set) and 148 between June, 2010 and May, 2013 (validation set) who underwent ARFI elastography and endoscopy were prospectively recruited. Independent predictors of HEVs were used to construct a prediction model. Results Based on multivariate analysis, we developed two new statistical models, a varices risk score and ARFI-spleen diameter-to-platelet ratio score (ASPS), the latter of which was calculated as ARFI velocity x spleen diameter/platelet count. The area under receiver operating characteristic curve (AUROC) of the varices risk score and ASPS to predict HEVs were 0.935 (95% confidence interval [CI] 0.882-0.970) and 0.946 (95% CI 0.895-0.977), respectively. When ASPS, a simpler model with a higher AUROC, was applied in the validation set, acceptable diagnostic accuracy for HEVs was observed (AUROC = 0.814 [95% CI 0.743-0.885]). To detect HEVs, a negative predictive value of 98.3% was achieved at ASPS <2.83, whereas a positive predictive value of 100% was achieved at ASPS >5.28. Conclusions ASPS, a novel noninvasive ARFI-based prediction model, can accurately identify HEVs in patients with compensated cirrhosis. ASPS <2.83 may safely rule out the presence of HEVs, whereas patients with ASPS >5.28 should be considered for endoscopic examinations or appropriate prophylactic treatment.	[Park, Yehyun; Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul 120749, South Korea; [Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul 120749, South Korea; [Park, Soo Young; Tak, Won Young; Kweon, Young Oh] Kyungpook Natl Univ, Sch Med, Daegu, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kyungpook National University	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul 120749, South Korea.	ksukorea@yuhs.ac; psyoung0419@gmail.com	Park, Yehyun/AAC-8861-2022; Park, Jun Yong/H-7127-2019	Park, Yehyun/0000-0001-8811-0631; Kim, Beom Kyung/0000-0002-5363-2496; Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Seung Up/0000-0002-9658-8050; Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624	Liver Cirrhosis Clinical Research Center; Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Liver Cirrhosis Clinical Research Center; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter the authors' adherence to all the journal policies on sharing data and materials.	Aube C, 1999, J HEPATOL, V30, P472, DOI 10.1016/S0168-8278(99)80107-X; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Bota S, 2014, EUR J RADIOL, V83, P268, DOI 10.1016/j.ejrad.2013.11.019; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Bota S, 2012, ANN HEPATOL, V11, P519, DOI 10.1016/S1665-2681(19)31466-8; Castera L, 2013, GASTROENTEROLOGY, V144, P19, DOI 10.1053/j.gastro.2012.11.015; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; de Franchis R, 2006, AM J GASTROENTEROL, V101, P2520, DOI 10.1111/j.1572-0241.2006.00880.x; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; Kim BK, 2011, AM J GASTROENTEROL, V106, P1654, DOI 10.1038/ajg.2011.160; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Morishita N, 2014, J GASTROENTEROL, V49, P1175, DOI 10.1007/s00535-013-0877-z; Pritchett S, 2011, J Viral Hepat, V18, pe75, DOI 10.1111/j.1365-2893.2010.01375.x; Rifai K, 2011, Ultraschall Med, V32 Suppl 2, pE24, DOI 10.1055/s-0031-1281771; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Schepis F, 2001, HEPATOLOGY, V33, P333, DOI 10.1053/jhep.2001.21410; Shi KQ, 2013, LIVER INT, V33, P62, DOI 10.1111/liv.12003; Sporea I, 2011, WORLD J GASTROENTERO, V17, P2206, DOI 10.3748/wjg.v17.i17.2206; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; Takahashi H, 2010, LIVER INT, V30, P538, DOI 10.1111/j.1478-3231.2009.02130.x; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; Vermehren J, 2012, LIVER INT, V32, P852, DOI 10.1111/j.1478-3231.2011.02736.x; Ye XP, 2012, J ULTRAS MED, V31, P1245	30	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121009	10.1371/journal.pone.0121009	http://dx.doi.org/10.1371/journal.pone.0121009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826654	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800030
J	Dalton, KM; Frydman, J; Pande, VS				Dalton, Kevin M.; Frydman, Judith; Pande, Vijay S.			The Dynamic Conformational Cycle of the Group I Chaperonin C-Termini Revealed via Molecular Dynamics Simulation	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE PROTEIN; ESCHERICHIA-COLI; GROEL; CONFINEMENT; BINDING; MECHANISM; RESIDUES; FEATURES; CHAMBER	Chaperonins are large ring shaped oligomers that facilitate protein folding by encapsulation within a central cavity. All chaperonins possess flexible C-termini which protrude from the equatorial domain of each subunit into the central cavity. Biochemical evidence suggests that the termini play an important role in the allosteric regulation of the ATPase cycle, in substrate folding and in complex assembly and stability. Despite the tremendous wealth of structural data available for numerous orthologous chaperonins, little structural information is available regarding the residues within the C-terminus. Herein, molecular dynamics simulations are presented which localize the termini throughout the nucleotide cycle of the group I chaperonin, GroE, from Escherichia coli. The simulation results predict that the termini undergo a heretofore unappreciated conformational cycle which is coupled to the nucleotide state of the enzyme. As such, these results have profound implications for the mechanism by which GroE utilizes nucleotide and folds client proteins.	[Dalton, Kevin M.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pande, VS (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020	, judith/0000-0003-2302-6943; Dalton, Kevin/0000-0001-9396-085X	U. S. Department of Energy, Basic Energy Sciences [DE-FG02-12ER16334]; National Institutes of Health [5R01GM062868-11]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER	U. S. Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the U. S. Department of Energy, Basic Energy Sciences, under grant DE-FG02-12ER16334 to JF and by the National Institutes of Health under grant 5R01GM062868-11 to VP. KD is supported by a Stanford Graduate Fellowship (http://sgf.stanford.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; England JL, 2008, J AM CHEM SOC, V130, P11838, DOI 10.1021/ja802248m; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Lucent D, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015003; Luo HB, 2011, ARCH BIOCHEM BIOPHYS, V512, P111, DOI 10.1016/j.abb.2011.04.017; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Still W, 1990, SEMIANALYTICAL TREAT, P6127; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tyagi NK, 2011, FEBS LETT, V585, P1969, DOI 10.1016/j.febslet.2011.05.031; Voelz VA, 2012, J AM CHEM SOC, V134, P12565, DOI 10.1021/ja302528z; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Wang Y, 2013, 2012 INTERNATIONAL CONFERENCE ON EDUCATION REFORM AND MANAGEMENT INNOVATION (ERMI 2012), VOL 5, P3; Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205; Weber JK, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4801942; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117724	10.1371/journal.pone.0117724	http://dx.doi.org/10.1371/journal.pone.0117724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822285	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700014
J	Gathara, D; Nyamai, R; Were, F; Mogoa, W; Karumbi, J; Kihuba, E; Mwinga, S; Aluvaala, J; Mulaku, M; Kosgei, R; Todd, J; Allen, E; English, M				Gathara, David; Nyamai, Rachael; Were, Fred; Mogoa, Wycliffe; Karumbi, Jamlick; Kihuba, Elesban; Mwinga, Stephen; Aluvaala, Jalemba; Mulaku, Mercy; Kosgei, Rose; Todd, Jim; Allen, Elizabeth; English, Mike		SIRCLE Minist Hlth Hosp Survey Grp	Moving towards Routine Evaluation of Quality of Inpatient Pediatric Care in Kenya	PLOS ONE			English	Article							SERIOUS ILLNESS; HOSPITALS; HEALTH; GUIDELINES; COUNTRIES; CHILDREN; SYSTEMS	Background Regular assessment of quality of care allows monitoring of progress towards system goals and identifies gaps that need to be addressed to promote better outcomes. We report efforts to initiate routine assessments in a low-income country in partnership with government. Methods A cross-sectional survey undertaken in 22 'internship training' hospitals across Kenya that examined availability of essential resources and process of care based on review of 60 case-records per site focusing on the common childhood illnesses (pneumonia, malaria, diarrhea/dehydration, malnutrition and meningitis). Results Availability of essential resources was 75% (45/61 items) or more in 8/22 hospitals. A total of 1298 (range 54-61) case records were reviewed. HIV testing remained suboptimal at 12% (95% CI 7-19). A routinely introduced structured pediatric admission record form improved documentation of core admission symptoms and signs (median score for signs 22/22 and 8/22 when form used and not used respectively). Correctness of penicillin and gentamicin dosing was above 85% but correctness of prescribed intravenous fluid or oral feed volumes for severe dehydration and malnutrition were 54% and 25% respectively. Introduction of Zinc for diarrhea has been relatively successful (66% cases) but use of artesunate for malaria remained rare. Exploratory analysis suggests considerable variability of the quality of care across hospitals. Conclusion Quality of pediatric care in Kenya has improved but can improve further. The approach to monitoring described in this survey seems feasible and provides an opportunity for routine assessments across a large number of hospitals as part of national efforts to sustain improvement. Understanding variability across hospitals may help target improvement efforts.	[Gathara, David; English, Mike] KEMRI Wellcome Trust Res Programme, Nairobi, Kenya; [Nyamai, Rachael; Mogoa, Wycliffe; Karumbi, Jamlick; Kihuba, Elesban; Mwinga, Stephen; Aluvaala, Jalemba] Govt Kenya, Minist Hlth, Nairobi, Kenya; [Were, Fred; Aluvaala, Jalemba] Univ Nairobi, Dept Pediat & Child Hlth, Nairobi, Kenya; [Mulaku, Mercy] Univ Nairobi, Sch Pharm, Nairobi, Kenya; [Kosgei, Rose] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [English, Mike] Univ Oxford, Nuffield Dept Med, Oxford, England; [English, Mike] Univ Oxford, Dept Pediat, Oxford, England; [Todd, Jim] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Allen, Elizabeth] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	University of Nairobi; University of Nairobi; University of Nairobi; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Gathara, D (corresponding author), KEMRI Wellcome Trust Res Programme, Nairobi, Kenya.	dgathara@kemri-wellcome.org		Aluvaala, Jalemba/0000-0002-0851-3711; Mulaku, Mercy/0000-0003-2480-0814; English, Michael/0000-0002-7427-0826; Gathara, David/0000-0002-0958-0713; Todd, Jim/0000-0001-5918-4914; Were, Fred/0000-0001-7879-1883	Consortium for National Health Research (Kenya); Wellcome Trust [076827, 097170, 092654]; Wellcome Trust Strategic Award [084538]; University of Nairobi; Ministry of Health; London School of Hygiene and Tropical Medicine	Consortium for National Health Research (Kenya); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award(Wellcome Trust); University of Nairobi; Ministry of Health; London School of Hygiene and Tropical Medicine	This survey work was made possible by a grant from the Consortium for National Health Research (Kenya) to the SIRCLE Collaboration (http://cnhrkenya.org/). ME has been supported by funds from The Wellcome Trust (#076827 and #097170; http://www.wellcome.ac.uk/). Additional funds from a Wellcome Trust Strategic Award (#084538) and a Wellcome Trust core grant awarded to the KEMRI-Wellcome Trust Research Programme (#092654) supported DG and the contribution of JT and EA. These grants supplemented salary support from the University of Nairobi (FW, MM, RK), the Ministry of Health (RN, EK, SBM, JK) and London School of Hygiene and Tropical Medicine (to JT and EA). The Wellcome Trust and other funders had no role in developing this manuscript nor in the decision to submit for publication.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Aluvaala J, 2015, ARCH DIS CHILD, V100, P42, DOI 10.1136/archdischild-2014-306423; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2014, ARCH DIS CHILD, V99, P452, DOI 10.1136/archdischild-2013-305561; English M, 2011, ARCH DIS CHILD, V96, P285, DOI 10.1136/adc.2010.189126; Gathara D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-307; Idoc-africa, 2013, EM TRIAG ASS TREATM; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Leatherman S, 2010, INT J QUAL HEALTH C, V22, P237, DOI 10.1093/intqhc/mzq028; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mbindyo P, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-32; MoH, 2012, BAS PED PROT; Mwinga S TM, 2010, REPORT QUALITY PAEDI; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Ntoburi S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-90; RCPCH, 2014, IMPR QUAL HOSP CAR S; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Tuyisenge L, 2014, ARCH DIS CHILD, V99, P993, DOI 10.1136/archdischild-2014-306078; WHO, 2008, FRAM STAND COUNTR HL, V2	22	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117048	10.1371/journal.pone.0117048	http://dx.doi.org/10.1371/journal.pone.0117048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822492	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000352134700006
J	Hardman, JA; Haslam, IS; Farjo, N; Farjo, B; Paus, R				Hardman, Jonathan A.; Haslam, Iain S.; Farjo, Nilofer; Farjo, Bessam; Paus, Ralf			Thyroxine Differentially Modulates the Peripheral Clock: Lessons from the Human Hair Follicle	PLOS ONE			English	Article							CIRCADIAN CLOCK; THYROID-HORMONE; DNA-DAMAGE; EXPRESSION; BMAL1; GROWTH; GENES; CYCLE; PROLIFERATION; METABOLISM	The human hair follicle (HF) exhibits peripheral clock activity, with knock-down of clock genes (BMAL1 and PER1) prolonging active hair growth (anagen) and increasing pigmentation. Similarly, thyroid hormones prolong anagen and stimulate pigmentation in cultured human HFs. In addition they are recognized as key regulators of the central clock that controls circadian rhythmicity. Therefore, we asked whether thyroxine (T4) also influences peripheral clock activity in the human HF. Over 24 hours we found a significant reduction in protein levels of BMAL1 and PER1, with their transcript levels also decreasing significantly. Furthermore, while all clock genes maintained their rhythmicity in both the control and T4 treated HFs, there was a significant reduction in the amplitude of BMAL1 and PER1 in T4 (100 nM) treated HFs. Accompanying this, cell-cycle progression marker Cyclin D1 was also assessed appearing to show an induced circadian rhythmicity by T4 however, this was not significant. Contrary to short term cultures, after 6 days, transcript and/or protein levels of all core clock genes (BMAL1, PER1, clock, CRY1, CRY2) were up-regulated in T4 treated HFs. BMAL1 and PER1 mRNA was also up-regulated in the HF bulge, the location of HF epithelial stem cells. Together this provides the first direct evidence that T4 modulates the expression of the peripheral molecular clock. Thus, patients with thyroid dysfunction may also show a disordered peripheral clock, which raises the possibility that short term, pulsatile treatment with T4 might permit one to modulate circadian activity in peripheral tissues as a target to treat clock-related disease.	[Hardman, Jonathan A.; Haslam, Iain S.; Paus, Ralf] Univ Manchester, Dermatol Ctr, Inst Inflammat & Repair, Manchester, Lancs, England; [Hardman, Jonathan A.] Univ Manchester, Manchester Interdisciplinary Bio Ctr, Doctoral Training Ctr Integrat Syst Biol, Manchester, Lancs, England; [Farjo, Nilofer; Farjo, Bessam] Farjo Hair Inst, Manchester, Lancs, England; [Paus, Ralf] Univ Munster, Dept Dermatol, Munster, Germany	University of Manchester; University of Manchester; University of Munster	Paus, R (corresponding author), Univ Manchester, Dermatol Ctr, Inst Inflammat & Repair, Manchester, Lancs, England.	ralf.paus@manchester.ac.uk	Haslam, Iain/B-8299-2011; Paus, Ralf/B-5279-2015	Haslam, Iain/0000-0002-1008-2447; Hardman-Smart, Jonathan/0000-0002-1653-7908; Paus, Ralf/0000-0002-3492-9358	Biology and biotechnology research council (BBSRC); Biotechnology and Biological Sciences Research Council [972579] Funding Source: researchfish	Biology and biotechnology research council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant given to JH to complete his PhD studies from the Biology and biotechnology research council (BBSRC), however the authors received no specific funding for this work. Human tissue was stored in a registered biobank following human tissue act guidelines and stored with ethical and institutional approval from the University of Manchester.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Al-Nuaimi Y, 2014, J INVEST DERMATOL, V134, P610, DOI 10.1038/jid.2013.366; Al-Nuaimi Y, 2010, EXP DERMATOL, V19, P707, DOI 10.1111/j.1600-0625.2010.01114.x; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Aninye IO, 2014, J BIOL CHEM, V289, P17070, DOI 10.1074/jbc.M114.569723; Avitabile D, 2014, INT J BIOCHEM CELL B, V53, P24, DOI 10.1016/j.biocel.2014.04.024; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Baron KG, 2014, INT REV PSYCHIATR, V26, P139, DOI 10.3109/09540261.2014.911149; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Beasley L, 1982, CELL MOL LIFE SCI; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Chu GY, 2012, AM J PHYSIOL-ENDOC M, V302, pE645, DOI 10.1152/ajpendo.00470.2011; Cunningham F, 2014, NUCLEIC ACIDS RES, P1; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Dardente H, 2012, J NEUROENDOCRINOL, V24, P249, DOI 10.1111/j.1365-2826.2011.02250.x; Engelberth RCGJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/243825; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gerard C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002516; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Geyfman M, 2010, AGING-US, V2, P122, DOI 10.18632/aging.100130; Giebultowicz Jadwiga, 2004, Integr Comp Biol, V44, P266, DOI 10.1093/icb/44.3.266; Goriki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001839; Griniatsos J, 2006, WORLD J GASTROENTERO, V12, P2109, DOI 10.3748/wjg.v12.i13.2109; Hardman JA, 2014, J INVEST DERMATOL, P1; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Innominato PF, 2014, ANN MED, V46, P191, DOI 10.3109/07853890.2014.916990; Kalsbeek A, 2013, CIRCADIAN CLOCKS; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Karatsoreos IN, 2011, ENDOCRINOLOGY, V152, P1970, DOI 10.1210/en.2010-1398; Kloepper JE, 2010, EXP DERMATOL, V19, P305, DOI 10.1111/j.1600-0625.2009.00939.x; Kondratov RV, 2007, COLD SPRING HARB SYM, V72, P477, DOI 10.1101/sqb.2007.72.050; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Lippert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085255; Mazzoccoli G, 2014, WORLD J GASTROENTERO, V20, P4197, DOI 10.3748/wjg.v20.i15.4197; Mitchell AL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-132; Miyazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027168; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Orozco-Solis R, 2014, NEUROSCIENCE; Ortiz-Tudela E, 2014, INT J CANCER, V134, P2717, DOI 10.1002/ijc.28587; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Plikus MV, 2013, LOCAL CIRCADIAN CLOC; Preussner M, 2014, MOL CELL, V54, P651, DOI 10.1016/j.molcel.2014.04.015; Purba TS, 2014, BIOESSAYS, V36, P513, DOI 10.1002/bies.201300166; Rana S, 2014, MOL BIOL REP, V41, P95, DOI 10.1007/s11033-013-2841-7; Robinson I, 2014, FEBS LETT, P1; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Sandu C., 2012, CELL MOL LIFE SCI; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sheikh-Ali M, 2014, POWDER TECHNOL, P1; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Team RC, 2012, R LANG ENV STAT COMP; Tiede S, 2010, EUR J CELL BIOL, V89, P769, DOI 10.1016/j.ejcb.2010.06.002; Tonsfeldt KJ, 2012, MOL CELL ENDOCRINOL, V349, P3, DOI 10.1016/j.mce.2011.07.003; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vidali S, 2014, J INVEST DERMATOL, V134, P33, DOI 10.1038/jid.2013.286; Wood S, 2014, J ENDOCRINOL, V222, pR39, DOI 10.1530/JOE-14-0141; Wu YF, 2001, J BIOL CHEM, V276, P3929, DOI 10.1074/jbc.M006743200; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Yoshimura T, 2013, FRONT NEUROENDOCRIN, V34, P157, DOI 10.1016/j.yfrne.2013.04.002; Zanello SB, 2000, J INVEST DERMATOL, V115, P757, DOI 10.1046/j.1523-1747.2000.00121.x; Zeng ZL, 2010, J BIOCHEM, V148, P319, DOI 10.1093/jb/mvq069	69	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121878	10.1371/journal.pone.0121878	http://dx.doi.org/10.1371/journal.pone.0121878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822259	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000352134700134
J	Li, JN; Xie, ZJ; Wang, M; Ai, GM; Chen, YH				Li, Jine; Xie, Zhoujie; Wang, Min; Ai, Guomin; Chen, Yihua			Identification and Analysis of the Paulomycin Biosynthetic Gene Cluster and Titer Improvement of the Paulomycins in Streptomyces paulus NRRL 8115	PLOS ONE			English	Article							BRANCHED-CHAIN; ANTIBIOTIC BIOSYNTHESIS; SECONDARY METABOLITES; POLYKETIDE SYNTHASES; GLYCOSYLATION STEPS; ESCHERICHIA-COLI; BOND FORMATION; PATHWAY; ATTACHMENT; INSIGHTS	The paulomycins are a group of glycosylated compounds featuring a unique paulic acid moiety. To locate their biosynthetic gene clusters, the genomes of two paulomycin producers, Streptomyces paulus NRRL 8115 and Streptomyces sp. YN86, were sequenced. The paulomycin biosynthetic gene clusters were defined by comparative analyses of the two genomes together with the genome of the third paulomycin producer Streptomyces albus J1074. Subsequently, the identity of the paulomycin biosynthetic gene cluster was confirmed by inactivation of two genes involved in biosynthesis of the paulomycose branched chain (pau11) and the ring A moiety (pau18) in Streptomyces paulus NRRL 8115. After determining the gene cluster boundaries, a convergent biosynthetic model was proposed for paulomycin based on the deduced functions of the pau genes. Finally, a paulomycin high-producing strain was constructed by expressing an activator-encoding gene (pau13) in S. paulus, setting the stage for future investigations.	[Li, Jine; Xie, Zhoujie; Wang, Min; Ai, Guomin; Chen, Yihua] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Chen, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.	chenyihua@im.ac.cn	Li, Jine/ABB-8532-2020		National Natural Science Foundation of China [31200045, 31370095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China grants 31200045 (to J.L.) and 31370095 (to Y.C.) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON A, 1995, PROTEIN SCI, V4, P1648, DOI 10.1002/pro.5560040823; [Anonymous], 1987, USA Patent, Patent No. [1988002630 A2, 1988002630]; ARGOUDELIS AD, 1988, J ANTIBIOT, V41, P157, DOI 10.7164/antibiotics.41.157; ARGOUDELIS AD, 1987, J ANTIBIOT, V40, P419, DOI 10.7164/antibiotics.40.419; ARGOUDELIS AD, 1988, J ANTIBIOT, V41, P1212, DOI 10.7164/antibiotics.41.1212; ARGOUDELIS AD, 1988, J ANTIBIOT, V41, P1316, DOI 10.7164/antibiotics.41.1316; ARGOUDELIS AD, 1982, J ANTIBIOT, V35, P285, DOI 10.7164/antibiotics.35.285; Baczynskyj L, 1988, J ANTIBIOT TOKYO, V41, P157; Bihlmaier C, 2006, ANTIMICROB AGENTS CH, V50, P2113, DOI 10.1128/AAC.00007-06; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Borisova SA, 2004, J AM CHEM SOC, V126, P6534, DOI 10.1021/ja049967j; Borisova SA, 2010, BIOCHEMISTRY-US, V49, P8071, DOI 10.1021/bi1007657; Brana AF, 2014, ARCH MICROBIOL, V196, P345, DOI 10.1007/s00203-014-0977-z; Bretschneider T, 2012, NAT CHEM BIOL, V8, P154, DOI 10.1038/nchembio.746; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Chen HW, 1998, J AM CHEM SOC, V120, P11796, DOI 10.1021/ja983071v; Culbertson JE, 2013, BBA-PROTEINS PROTEOM, V1834, P240, DOI 10.1016/j.bbapap.2012.10.010; Erb A, 2009, CHEMBIOCHEM, V10, P1392, DOI 10.1002/cbic.200900054; Fernandez E, 1998, J BACTERIOL, V180, P4929; Gao XL, 2005, J BACTERIOL, V187, P7696, DOI 10.1128/JB.187.22.7696-7702.2005; Garrido LM, 2006, APPL MICROBIOL BIOT, V73, P122, DOI 10.1007/s00253-006-0453-z; Girish TS, 2011, FEBS LETT, V585, P2561, DOI 10.1016/j.febslet.2011.07.021; HANKA LJ, 1976, J ANTIBIOT, V29, P611, DOI 10.7164/antibiotics.29.611; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Huang SX, 2013, P NATL ACAD SCI USA, V110, P8069, DOI 10.1073/pnas.1304733110; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; Kaysser L, 2010, APPL ENVIRON MICROB, V76, P4008, DOI 10.1128/AEM.02740-09; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-71; Magarvey NA, 2006, ANTIMICROB AGENTS CH, V50, P2167, DOI 10.1128/AAC.01545-05; MAJER J, 1987, J GEN MICROBIOL, V133, P2503; MARSHALL VP, 1981, J ANTIBIOT, V34, P902, DOI 10.7164/antibiotics.34.902; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mitscher L A, 1965, Antimicrob Agents Chemother (Bethesda), V5, P828; Nelson DL, 2000, LEHNINGER PRINCIPLES, V3rd, P834; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Palaniaappan N, 2003, J BIOL CHEM, V278, P35552, DOI 10.1074/jbc.M305082200; Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Proschak A, 2014, CHEMBIOCHEM, V15, P369, DOI 10.1002/cbic.201300694; Rui Z, 2010, J BIOL CHEM, V285, P24915, DOI 10.1074/jbc.M110.128850; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZ MS, 1986, ANTIMICROB AGENTS CH, V29, P634, DOI 10.1128/AAC.29.4.634; Sasaki E, 2014, NATURE, V510, P427, DOI 10.1038/nature13256; SHEN B, 1994, J BIOL CHEM, V269, P30726; Siitonen V, 2012, CHEMBIOCHEM, V13, P120, DOI 10.1002/cbic.201100637; Silakowski B, 2000, EUR J BIOCHEM, V267, P6476, DOI 10.1046/j.1432-1327.2000.01740.x; Singh H, 2013, J BIOL CHEM, V288, P36189, DOI 10.1074/jbc.M113.525709; Singh S, 2013, ACS CHEM BIOL, V8, P1632, DOI 10.1021/cb400068k; Smanski MJ, 2011, P NATL ACAD SCI USA, V108, P13498, DOI 10.1073/pnas.1106919108; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Treede I, 2005, APPL ENVIRON MICROB, V71, P400, DOI 10.1128/AEM.71.1.400-406.2005; WILEY PF, 1976, J ANTIBIOT, V29, P587, DOI 10.7164/antibiotics.29.587; Winter JM, 2012, CURR OPIN BIOTECH, V23, P736, DOI 10.1016/j.copbio.2011.12.016; Wu XM, 2009, CHEMBIOCHEM, V10, P304, DOI 10.1002/cbic.200800527; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Yan Y, 2012, ORG LETT, V14, P4142, DOI 10.1021/ol301785x; Yang N, 2014, THESIS; Zhang YX, 1999, MICROBIOL-SGM, V145, P2323, DOI 10.1099/00221287-145-9-2323	66	39	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120542	10.1371/journal.pone.0120542	http://dx.doi.org/10.1371/journal.pone.0120542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822496	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700066
J	Ma, C; Chen, F; Zhang, YF; Sun, XY; Tong, PY; Si, Y; Zheng, SG				Ma, Chen; Chen, Feng; Zhang, Yifei; Sun, Xiangyu; Tong, Peiyuan; Si, Yan; Zheng, Shuguo			Comparison of Oral Microbial Profiles between Children with Severe Early Childhood Caries and Caries-Free Children Using the Human Oral Microbe Identification Microarray	PLOS ONE			English	Article							DIVERSITY	Objective Early childhood caries (ECC) has become a prevalent public health problem among Chinese preschool children. The bacterial microflora is considered to be an important factor in the formation and progress of dental caries. However, high-throughput and large-scale studies of the primary dentition are lacking. The present study aimed to compare oral microbial profiles between children with severe ECC (SECC) and caries-free children. Methods Both saliva and supragingival plaque samples were obtained from children with SECC (n = 20) and caries-free children (n = 20) aged 3 to 4 years. The samples were assayed using the Human Oral Microbe Identification Microarray (HOMIM). Results A total of 379 bacterial species were detected in both the saliva and supragingival plaque samples from all children. Thirteen (including Streptococcus) and two (Streptococcus and Actinomyces) bacterial species in supragingival plaque and saliva, respectively, showed significant differences in prevalence between the two groups. Of these, the frequency of Streptococcus mutans detection was significantly higher in both saliva (p = 0.026) and plaque (p = 0.006) samples from the SECC group than in those from the caries-free group. Conclusions The findings of our study revealed differences in the oral microbiota between the SECC and caries-free groups Several genera, including Streptococcus, Porphyromonas, and Actinomyces, are strongly associated with SECC and can be potential biomarkers of dental caries in the primary dentition.	[Ma, Chen; Sun, Xiangyu; Tong, Peiyuan; Si, Yan; Zheng, Shuguo] Peking Univ, Dept Prevent Dent, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Chen, Feng; Zhang, Yifei] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University	Si, Y (corresponding author), Peking Univ, Dept Prevent Dent, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	siyanyy@163.com; zhengsg86@gmail.com	Zheng, Shuguo/AAO-7612-2020; Sun, Xiangyu/T-8264-2019		National Natural Science Foundation of China [81200762, 81070815]; Peking University School of Stomatology [PKUSS20130210]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants 81200762 and 81070815 from National Natural Science Foundation of China, by the funding from Peking University School of Stomatology (PKUSS20130210), and by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy on Pediatric Dentistry, 2008, Pediatr Dent, V30, P40; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fabris AS, 2014, J APPL ORAL SCI, V22, P118, DOI 10.1590/1678-775720130358; Gomar-Vercher S, 2014, CLIN ORAL INVEST, V18, P2087, DOI 10.1007/s00784-014-1200-y; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Kononen E, 2000, ANN MED, V32, P107, DOI 10.3109/07853890009011759; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Li Y, 2002, J DENT RES, V81, P561, DOI 10.1177/154405910208100812; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rudney JD, 2012, J APPL MICROBIOL, V113, P1540, DOI 10.1111/j.1365-2672.2012.05439.x; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Tanner ACR, 2012, J DENT RES, V91, P853, DOI 10.1177/0022034512455031; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; Torlakovic Lino, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.16125; Xin BC, 2013, ORAL DIS, V19, P401, DOI 10.1111/odi.12018; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269	26	39	43	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122075	10.1371/journal.pone.0122075	http://dx.doi.org/10.1371/journal.pone.0122075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821962	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700152
J	Sonntag, R; Reinders, J; Gibmeier, J; Kretzer, JP				Sonntag, Robert; Reinders, Joern; Gibmeier, Jens; Kretzer, J. Philippe			Fatigue Performance of Medical Ti6Al4V Alloy after Mechanical Surface Treatments	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; MODULAR FEMORAL-NECK; CYCLIC DEFORMATION; RESIDUAL-STRESS; FRACTURE; FAILURE; CORROSION; BEHAVIOR; IMPLANT; STEMS	Mechanical surface treatments have a long history in traditional engineering disciplines, such as the automotive or aerospace industries. Today, they are widely applied to metal components to increase the mechanical performance of these. However, their application in the medical field is rather rare. The present study aims to compare the potential of relevant mechanical surface treatments on the high cycle fatigue (R = 0.1 for a maximum of 10 million cycles) performance of a Ti6Al4V standard alloy for orthopedic, spinal, dental and trauma surgical implants: shot peening, deep rolling, ultrasonic shot peening and laser shock peening. Hour-glass shaped Ti6Al4V specimens were treated and analyzed with regard to the material's microstructure, microhardness, residual stress depth profiles and the mechanical behavior during fatigue testing. All treatments introduced substantial compressive residual stresses and exhibited considerable potential for increasing fatigue performance from 10% to 17.2% after laser shock peening compared to non-treated samples. It is assumed that final mechanical surface treatments may also increase fretting wear resistance in the modular connection of total hip and knee replacements.	[Sonntag, Robert; Reinders, Joern; Kretzer, J. Philippe] Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany; [Gibmeier, Jens] Karlsruhe Inst Technol, Inst Appl Mat, D-76021 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Kretzer, JP (corresponding author), Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany.	philippe.kretzer@med.uni-heidelberg.de	Gibmeier, Jens/J-3488-2017	Gibmeier, Jens/0000-0002-5487-8025; Reinders, Jorn/0000-0002-8258-7735	Ministry of Art and Science of Baden-Wurttemberg, Germany; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Ministry of Art and Science of Baden-Wurttemberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The work was funded through the Ministry of Art and Science of Baden-Wurttemberg, Germany. (RS JR JPK). The authors acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6; Alvarez Diego Bertrand, 2004, Acta Orthop Belg, V70, P435; Arola DD, 2000, J BIOMED MATER RES, V53, P536, DOI 10.1002/1097-4636(200009)53:5<536::AID-JBM13>3.3.CO;2-M; Atwood SA, 2010, J BONE JOINT SURG AM, V92A, P1522, DOI 10.2106/JBJS.I.00980; Baleani M, 2000, ARTIF ORGANS, V24, P296, DOI 10.1046/j.1525-1594.2000.06486.x; Banovetz JM, 1996, J ORTHOP TRAUMA, V10, P389, DOI 10.1097/00005131-199608000-00005; Bergmann G, 2004, LANGENBECK ARCH SURG, V389, P53, DOI 10.1007/s00423-003-0434-y; Bothe RT, 1940, SURG GYNECOL OBSTET, V71, P592; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Busch CA, 2005, J BONE JOINT SURG BR, V87B, P1333, DOI 10.1302/0301-620X.87B10.16528; Dangles CJ, 2010, J ARTHROPLASTY, V25; Friske W.H., 1979, JMES, V1, P20, DOI [10.1007/BF02833987, DOI 10.1007/BF02833987]; Garellik G, 2011, SWEDISH HIP REGISTER; GILBERT JL, 1993, J BIOMED MATER RES, V27, P1533, DOI 10.1002/jbm.820271210; Graves S, 2012, AUSTR NATL JOINT REP; Grupp TM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-3; Hsu CC, 2010, MED ENG PHYS, V32, P454, DOI 10.1016/j.medengphy.2010.03.006; Iwakura T, 2013, CASE REP ORTHOP, V2013, P1, DOI [10. 1155/2013/172352, DOI 10.1155/2013/172352]; King A, 2006, MAT SCI ENG A-STRUCT, V435, P12, DOI 10.1016/j.msea.2006.07.020; Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013; Lakstein D, 2011, J BONE JOINT SURG AM, V93A, P57, DOI 10.2106/JBJS.I.01589; Lee H, 2006, MAT SCI ENG A-STRUCT, V420, P72, DOI 10.1016/j.msea.2006.01.031; Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012; LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021; Ludian T, 2008, ADV MATER SCI, V8, P44, DOI 10.2478/v10077-008-0030-5; Ludian T, 2006, INT J MATER RES, V97, P1425, DOI 10.3139/146.101387; Macherauch E, 1961, Z ANGEW PHYS, P305; Magnissalis EA, 2003, J BIOMED MATER RES B, V66B, P299, DOI 10.1002/jbm.b.10003; Mehran N, 2013, ORTHOPEDICS, V36, pE978, DOI 10.3928/01477447-20130624-33; Panagiotidou A, 2013, J ORTHOP RES, V31, P2032, DOI 10.1002/jor.22461; Patel A, 2009, J ARTHROPLASTY, V24; Petzow G, 2006, METALLOGRAPHISCHES K, P298; Ritchie RO, 1999, FATIGUE FRACT ENG M, V22, P621; Schuh A, 2005, ZBL CHIR, V130, P576, DOI 10.1055/s-2005-872558; Schuh A, 2004, BIOMED TECH, V49, P334, DOI 10.1515/BMT.2004.062; Schuh A, 2004, ZBL CHIR, V129, P225, DOI 10.1055/s-2004-822740; Schuh A, 2007, J BIOMED MATER RES B, V81B, P330, DOI 10.1002/jbm.b.30669; SIVASH KM, 1969, RECONS SURG, V11, P53; Sonntag R, 2013, FATIGUE FRACTURE MET, P98; Sotereanos NG, 2012, J ARTHROPLASTY, V28; Soyama H, 2004, TRIBOL LETT, V17, P501, DOI 10.1023/B:TRIL.0000044497.45014.f2; Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4; Umemoto M, 2003, MATER TRANS, V44, P1900, DOI 10.2320/matertrans.44.1900; Umemoto M, 2003, MATER TRANS, V44, P1488, DOI 10.2320/matertrans.44.1488; Wagner L, 1984, INFLUENCE SHOT PEENI, P201; Wilson DAJ, 2010, J BONE JOINT SURG AM, V92A, P1514, DOI 10.2106/JBJS.I.01107; Wolfstieg U., 1976, HTM J HEAT TREATM MA, V31, P23; Wright G, 2010, J BONE JOINT SURG AM, V92A, P1518, DOI 10.2106/JBJS.I.01033; Yukata K, 2009, J HAND SURG-AM, V34A, P907, DOI 10.1016/j.jhsa.2009.01.004	49	31	33	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121963	10.1371/journal.pone.0121963	http://dx.doi.org/10.1371/journal.pone.0121963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823001	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700141
J	Jewkes, R; Dunkle, K; Jama-Shai, N; Gray, G				Jewkes, Rachel; Dunkle, Kristin; Jama-Shai, Nwabisa; Gray, Glenda			Impact of Exposure to Intimate Partner Violence on CD4+and CD8+T Cell Decay in HIV Infected Women: Longitudinal Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; DECLINE; SEROCONVERTER; CORTISOL; ABUSE	Intimate partner violence (IPV) is a risk factor for HIV acquisition in many settings, but little is known about its impact on cellular immunity especially in HIV infected women, and if any impact differs according to the form of IPV. We tested hypotheses that exposure to IPV, non-partner rape, hunger, pregnancy, depression and substance abuse predicted change in CD4+ and CD8+ T-cell count in a dataset of 103 HIV infected young women aged 15-26 enrolled in a cluster randomised controlled trial. Multiple regression models were fitted to measure rate of change in CD4 and CD8 and including terms for age, person years of CD4+/CD8+ T-cell observation, HIV positivity at baseline, and stratum. Exposure variables included drug use, emotional, physical or sexual IPV exposure, non-partner rape, pregnancy and food insecurity. Mean CD4+ T-cell count at baseline (or first HIV+test) was 567.6 (range 1121-114). Participants were followed for an average of 1.3 years. The magnitude of change in CD4 T-cells was significantly associated with having ever experienced emotional abuse from a current partner at baseline or first HIV+ test (Coeff -132.9 95% CI - 196.4, -69.4 p<0.0001) and drug use (Coeff -129.9 95% CI -238.7, -21.2 p=0.02). It was not associated with other measures. The change in CD8 T-cells was associated with having ever experienced emotional abuse at baseline or prior to the first HIV+ test (Coeff -178.4 95% CI -330.2, -26.5 p= 0.02). In young ART-naive HIV positive women gender-based violence exposure in the form of emotional abuse is associated with a faster rate of decline in markers of cellular immunity. This highlights the importance of attending to emotional abuse when studying the physiological impact of IPV experience and the mechanisms of its impact on women's health.	[Jewkes, Rachel; Dunkle, Kristin; Jama-Shai, Nwabisa] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, Gauteng, South Africa; [Jewkes, Rachel; Jama-Shai, Nwabisa] Univ Witwatersrand, Sch Publ Hlth, Gauteng, South Africa; [Gray, Glenda] South African Med Res Council, Off President, Western Cape, South Africa	South African Medical Research Council; University of Witwatersrand; South African Medical Research Council	Jewkes, R (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, Gauteng, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	National Institute of Mental Health [MH 64882-01, MH 64882-04S1A1, 1R03MH085599]; South African Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085599, R01MH064882] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by National Institute of Mental Health grant No. MH 64882-01, MH 64882-04S1A1, 1R03MH085599 and the South African Medical Research Council. KD's participation was also partially facilitated by the Center for AIDS Research at Emory University (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Constantino R E, 2000, Biol Res Nurs, V1, P190, DOI 10.1177/109980040000100304; Heath NM, 2013, CYTOKINE, V63, P172, DOI 10.1016/j.cyto.2013.04.030; Inslicht SS, 2006, PSYCHONEUROENDOCRINO, V31, P825, DOI 10.1016/j.psyneuen.2006.03.007; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jina R, 2012, J INTERPERS VIOLENCE, V27, P862, DOI 10.1177/0886260511423247; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; McMahon JH, 2011, JAIDS-J ACQ IMM DEF, V58, P60, DOI 10.1097/QAI.0b013e318227f8dd; Meijerink H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18844; Organization WH, 2010, PREV INT PARTN SEX V, DOI [10.1136/ip.2010.029629, DOI 10.1136/IP.2010.029629]; Pico-Alfonso MA, 2004, BIOL PSYCHIAT, V56, P233, DOI 10.1016/j.biopsych.2004.06.001; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]	22	93	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122001	10.1371/journal.pone.0122001	http://dx.doi.org/10.1371/journal.pone.0122001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816336	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600135
J	Lykhmus, O; Voytenko, L; Koval, L; Mykhalskiy, S; Kholin, V; Peschana, K; Zouridakis, M; Tzartos, S; Komisarenko, S; Skok, M				Lykhmus, Olena; Voytenko, Larysa; Koval, Lyudmyla; Mykhalskiy, Sergiy; Kholin, Victor; Peschana, Kateryna; Zouridakis, Marios; Tzartos, Socrates; Komisarenko, Sergiy; Skok, Maryna			alpha 7 Nicotinic Acetylcholine Receptor-Specific Antibody Induces Inflammation and Amyloid beta(42) Accumulation in the Mouse Brain to Impair Memory	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; POSSIBLE RELEVANCE; HIGH-SENSITIVITY; RAT-BRAIN; ASTROCYTES; AGONIST; SUBUNIT; NEURONS; HIPPOCAMPUS; MECHANISMS	Nicotinic acetylcholine receptors (nAChRs) expressed in the brain are involved in regulating cognitive functions, as well as inflammatory reactions. Their density is decreased upon Alzheimer disease accompanied by accumulation of beta-amyloid (A beta(42)), memory deficit and neuroinflammation. Previously we found that alpha 7 nAChR-specific antibody induced proinflammatory interleukin-6 production in U373 glioblastoma cells and that such antibodies were present in the blood of humans. We raised a hypothesis that alpha 7 nAChR-specific antibody can cause neuroinflammation when penetrating the brain. To test this, C57Bl/6 mice were either immunized with extracellular domain of alpha 7 nAChR subunit alpha 7(1-208) or injected with bacterial lipopolysaccharide (LPS) for 5 months. We studied their behavior and the presence of alpha 3, alpha 4, alpha 7, beta 2 and beta 4 nAChR subunits, A beta(40) and A beta(42) and activated astrocytes in the brain by sandwich ELISA and confocal microscopy. It was found that either LPS injections or immunizations with alpha 7(1-208) resulted in region-specific decrease of alpha 7 and alpha 4 beta and increase of alpha 3 beta 4 nAChRs, accumulation of A beta(42) and activated astrocytes in the brain of mice and worsening of their episodic memory. Intravenously transferred alpha 7 nAChR-specific-antibodies penetrated the brain parenchyma of mice pre-injected with LPS. Our data demonstrate that (1) neuroinflammation is sufficient to provoke the decrease of alpha 7 and alpha 4 beta 2 nAChRs, A beta(42) accumulation and memory impairment in mice and (2) alpha 7(1-208) nAChR-specific antibodies can cause inflammation within the brain resulting in the symptoms typical for Alzheimer disease.	[Lykhmus, Olena; Koval, Lyudmyla; Komisarenko, Sergiy; Skok, Maryna] Palladin Inst Biochem, Kiev, Ukraine; [Voytenko, Larysa] Bogomoletz Inst Physiol, Kiev, Ukraine; [Mykhalskiy, Sergiy; Kholin, Victor; Peschana, Kateryna] Chebotaryov Inst Gerontol, Kiev, Ukraine; [Zouridakis, Marios; Tzartos, Socrates] Hellenic Pasteur Inst, Athens, Greece	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine	Skok, M (corresponding author), Palladin Inst Biochem, Kiev, Ukraine.	skok@biochem.kiev.ua	Skok, Maryna/AAQ-9939-2020; Komisarenko, Sergiy/AAT-3457-2020; Mykhalskiy, Sergiy/Q-6794-2019	Mykhalskiy, Sergiy/0000-0002-7232-4608; Skok, Maryna/0000-0002-5816-605X; Zouridakis, Marios/0000-0001-9760-1838; Komisarenko, Serhiy/0000-0002-3244-3194; Kholin, Viktor/0000-0002-0621-5569	Research Programme of Ukrainian Academy of Sciences "Fundamental bases of molecular and cellular biotechnologies"	Research Programme of Ukrainian Academy of Sciences "Fundamental bases of molecular and cellular biotechnologies"	The work was supported by the Research Programme of Ukrainian Academy of Sciences "Fundamental bases of molecular and cellular biotechnologies" (2010-2014) - MS, LK, OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Barucker C, 2014, J BIOL CHEM, V289, P20182, DOI 10.1074/jbc.M114.564690; Bian YQ, 2013, BEHAV BRAIN RES, V253, P253, DOI 10.1016/j.bbr.2013.07.028; Blamire AM, 2000, J NEUROSCI, V20, P8153; BRANDWEIN SR, 1987, J IMMUNOL, V138, P4263; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Carrero I, 2012, EXP NEUROL, V236, P215, DOI 10.1016/j.expneurol.2012.05.004; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grybko M, 2010, J MOL NEUROSCI, V40, P114, DOI 10.1007/s12031-009-9266-8; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P4541, DOI 10.1007/s00213-014-3596-0; Kalashnyk O, 2014, INT IMMUNOPHARMACOL, V23, P475, DOI 10.1016/j.intimp.2014.09.022; Kamynina AV, 2013, INT J BIOCHEM CELL B, V45, P899, DOI 10.1016/j.biocel.2013.01.011; Kedmi M, 2004, PHYSIOL GENOMICS, V17, P221, DOI 10.1152/physiolgenomics.00202.2003; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Komada M, 2008, JOVE, V22, DOI 10.3791/1088; Kondo Y, 2010, MOL CELL BIOCHEM, V333, P57, DOI 10.1007/s11010-009-0204-4; Koval L, 2011, J ALZHEIMERS DIS, V25, P747, DOI 10.3233/JAD-2011-101845; Koval OM, 2004, NEUROSCI LETT, V365, P143, DOI 10.1016/j.neulet.2004.04.071; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Liu Q, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-155; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Lykhmus O, 2011, J ALZHEIMERS DIS, V24, P693, DOI 10.3233/JAD-2011-101842; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Monson NL, 2014, J CEREBR BLOOD F MET, V34, P30, DOI 10.1038/jcbfm.2013.183; Ni RQ, 2013, J ALZHEIMERS DIS, V33, P841, DOI 10.3233/JAD-2012-121447; Niranjan R, 2012, FREE RADICAL RES, V46, P1167, DOI 10.3109/10715762.2012.697626; Oz M, 2013, CURR ALZHEIMER RES, V10, P618; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Richardson James A, 2002, ILAR J, V43, P89; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stuckenholz V, 2013, J PARKINSON DIS, V3, P161, DOI 10.3233/JPD-120157; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; WRIGHT RM, 1993, CIRC SHOCK, V41, P131; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	51	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122706	10.1371/journal.pone.0122706	http://dx.doi.org/10.1371/journal.pone.0122706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816313	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600190
J	Nocito, L; Kleckner, AS; Yoo, EJ; Jones, AR; Liesa, M; Corkey, BE				Nocito, Laura; Kleckner, Amber S.; Yoo, Elsia J.; Jones, Albert R.; Liesa, Marc; Corkey, Barbara E.			The Extracellular Redox State Modulates Mitochondrial Function, Gluconeogenesis, and Glycogen Synthesis in Murine Hepatocytes	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; THIOL/DISULFIDE REDOX; OXIDATIVE STRESS; RAT HEPATOCYTES; MALONYL-COA; LIVER; THERAPEUTICS; DYSFUNCTION; METABOLISM; DISEASE	Circulating redox state changes, determined by the ratio of reduced/oxidized pairs of different metabolites, have been associated with metabolic diseases. However, the pathogenic contribution of these changes and whether they modulate normal tissue function is unclear. As alterations in hepatic gluconeogenesis and glycogen metabolism are hallmarks that characterize insulin resistance and type 2 diabetes, we tested whether imposed changes in the extracellular redox state could modulate these processes. Thus, primary hepatocytes were treated with different ratios of the following physiological extracellular redox couples: beta-hydroxybutyrate (beta OHB)/acetoacetate (Acoc), reduced glutathione (GSH)/oxidized glutathione (GSSG), and cysteine/cystine. Exposure to a more oxidized ratio via extracellular beta OHB/Acoc, GSH/GSSG, and cysteine/cystine in hepatocytes from fed mice increased intracellular hydrogen peroxide without causing oxidative damage. On the other hand, addition of more reduced ratios of extracellular beta OHB/Acoc led to increased NAD(P) H and maximal mitochondrial respiratory capacity in hepatocytes. Greater beta OHB/Acoc ratios were also associated with decreased beta-oxidation, as expected with enhanced lipogenesis. In hepatocytes from fasted mice, a more extracellular reduced state of beta OHB/Acoc led to increased alanine-stimulated gluconeogenesis and enhanced glycogen synthesis capacity from added glucose. Thus, we demonstrated for the first time that the extracellular redox state regulates the major metabolic functions of the liver and involves changes in intracellular NADH, hydrogen peroxide, and mitochondrial respiration. Because redox state in the blood can be communicated to all metabolically sensitive tissues, this work confirms the hypothesis that circulating redox state may be an important regulator of whole body metabolism and contribute to alterations associated with metabolic diseases.	[Nocito, Laura; Kleckner, Amber S.; Yoo, Elsia J.; Jones, Albert R.; Liesa, Marc; Corkey, Barbara E.] Boston Univ, Dept Med, Boston, MA 02215 USA	Boston University	Corkey, BE (corresponding author), Boston Univ, Dept Med, Boston, MA 02215 USA.	bcorkey@bu.edu	Liesa, Marc/K-8590-2019	Liesa, Marc/0000-0002-5909-8570	NIH [DK35914, DK56690, 2P30DK046200]; USDA AFRI/NIFA [2012-67012-20658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK035914, R01DK056690, R01DK035914, P30DK046200, R37DK035914] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA AFRI/NIFA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH DK35914 (B.E.C) and DK56690 (B.E.C; www.nih.gov). A.S.K. is supported by USDA AFRI/NIFA fellowship 2012-67012-20658 (www.usda.gov). M.L. is funded by NIH 2P30DK046200 (BNORC Pilot and Feasibility grants; www.nih.gov; bnorc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos Alexis S, 2009, Recent Pat Cardiovasc Drug Discov, V4, P76; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; CLARK MG, 1981, COMP BIOCHEM PHYS B, V69, P775, DOI 10.1016/0305-0491(81)90383-7; CLARK MG, 1977, HORM METAB RES, V9, P213, DOI 10.1055/s-0028-1093539; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Corkey BE, 2012, TRENDS ENDOCRIN MET, V23, P594, DOI 10.1016/j.tem.2012.07.006; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; EISTETTER K, 1986, Drugs of the Future, V11, P1034; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hoshino Y, 2008, ANTIOXID REDOX SIGN, V10, P701, DOI 10.1089/ars.2007.1961; Ido Y, 2007, ANTIOXID REDOX SIGN, V9, P931, DOI 10.1089/ars.2007.1630; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; LATIPAA PM, 1986, BIOCHIM BIOPHYS ACTA, V875, P293, DOI 10.1016/0005-2760(86)90179-7; Livingstone C, 2007, BRIT J DIABETES VASC, V7, P258, DOI [10.1177/14746514070070060201, DOI 10.1177/14746514070070060201]; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Mann D V, 2013, HILAR CHOLANGIOCARCI, P75; Mooradian AD, 2011, FREE RADICAL BIO MED, V50, P1140, DOI 10.1016/j.freeradbiomed.2011.02.002; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON J, 1961, BIOCHEM J, V80, P540, DOI 10.1042/bj0800540; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	44	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122818	10.1371/journal.pone.0122818	http://dx.doi.org/10.1371/journal.pone.0122818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816337	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600199
J	Duan, JG; Chen, XY; Wang, L; Lau, A; Wong, A; Thomas, GN; Tomlinson, B; Liu, RX; Chan, JCN; Leung, TW; Mok, V; Wong, KS				Duan, Jian Gang; Chen, Xiang Yan; Wang, Li; Lau, Alex; Wong, Adrian; Thomas, G. Neil; Tomlinson, Brian; Liu, Roxanna; Chan, Juliana C. N.; Leung, Thomas W.; Mok, Vincent; Wong, Ka Sing			Sex Differences in Epidemiology and Risk Factors of Acute Coronary Syndrome in Chinese Patients with Type 2 Diabetes: A Long-Term Prospective Cohort Study	PLOS ONE			English	Article							SYNDROME EVALUATION WISE; CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; ARTERY-DISEASE; HEART-DISEASE; WOMEN; MELLITUS; MEN; POLYMORPHISMS; METAANALYSIS	Objective Diabetic patients with acute coronary syndrome (ACS) are at higher risk of poor outcome than are non-diabetic patients with ACS. Few studies have focused on sex-related ACS incidence, ACS-related mortality or risk factors to affects sex specific ACS in Chinese with Type 2 diabetes mellitus (T2DM). Based on a hospital-based cohort of Chinese patients with T2DM, we aimed to investigate whether there was sex difference in ACS or ACS-related mortality or risk factors of ACS. Methods Totally 2,135 Hong Kong Chinese with T2DM were recruited during 1994-1996 and followed up until August 2012. We systematically analyzed sex-related ACS incidence and ACS-related mortality and risk factors with. chi(2)-squared test, descriptive statistics and survival analysis. Results Regular follow-up was completed in 2,105 subjects (98.6%), with a median period of 14.53 years. The occurrence of ACS was recorded among 414 patients (19.7%) and ACS-related death among 104 patients (4.9%). ACS incidences increased with age in both men and women, and men had a higher prevalence of ACS than women across different age categories and different follow-up periods (log rank chi(2)=20.32, P<0.001). The transition of ACS incidences from slow to rapid increase were about 5 years earlier in men (at 51-55 years) than in women (55-60 years). Among ACS patients, cumulative ACS-related mortalities was similar between men and women (log rank chi(2)=0.063, P=0.802). Besides age and albuminuria, different profiles of risk factors accounted for the occurrence of ACS between men and women. Conclusions Our findings demonstrated sex differences in ACS incidence and risk factors, but not in ACS-related mortality in Chinese patients with T2DM. These findings suggest that screening and prevention campaigns should be optimized for men and women, which may help to identify diabetic patients at higher risk of coronary heart disease.	[Duan, Jian Gang] Capital Med Univ, Xuanwu Hosp, Dept Emergency, Beijing, Peoples R China; [Duan, Jian Gang; Chen, Xiang Yan; Wang, Li; Lau, Alex; Tomlinson, Brian; Liu, Roxanna; Chan, Juliana C. N.; Leung, Thomas W.; Mok, Vincent; Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Wong, Adrian] Hong Kong Inst Educ, Dept Psychol Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian] Hong Kong Inst Educ, Ctr Psychosocial Hlth & Aging, Hong Kong, Hong Kong, Peoples R China; [Thomas, G. Neil] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); University of Birmingham	Wong, KS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ks-wong@cuhk.edu.hk	Tomlinson, Brian/P-5365-2015; Wong, Ka Sing Lawrence/N-3434-2015; Lau, Alexander Y/N-2485-2015; Leung, Thomas W/AAU-6475-2021; Wong, Adrian/K-4859-2014; Leung, Thomas W. H./O-8567-2015; Tomlinson, Brian/AAD-9404-2019; Thomas, G. Neil/A-1879-2013; Chen, Xiang Yan/O-8602-2015; Chan, Juliana/B-7918-2016; Mok, Vincent/N-6421-2015	Wong, Ka Sing Lawrence/0000-0002-2031-9866; Lau, Alexander Y/0000-0002-5933-9290; Leung, Thomas W/0000-0001-8193-0709; Wong, Adrian/0000-0002-7859-3956; Tomlinson, Brian/0000-0001-6717-5444; Thomas, G. Neil/0000-0002-2777-1847; Chan, Juliana/0000-0003-1325-1194; Mok, Vincent/0000-0002-8102-8835	Direct Grant for Research [2005.1.082]; S.H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong; Croucher Senior Medical Research Fellowship	Direct Grant for Research; S.H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong; Croucher Senior Medical Research Fellowship	This study was partly funded by a Direct Grant for Research (reference no. 2005.1.082) and supported by the S.H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong. Professor KS Wong was supported in part by a Croucher Senior Medical Research Fellowship 2011-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2004, CIRCULATION, V110, P1572, DOI 10.1161/01.CIR.0000142047.28024.F2; Alexander KP, 2001, AM J MANAG CARE, V7, P951; Aronson D, 1997, ANN INTERN MED, V126, P296, DOI 10.7326/0003-4819-126-4-199702150-00006; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Cabrerizo-Garcia JL, 2015, REV PORT CARDIOL, V34, P43, DOI 10.1016/j.repc.2014.07.008; Chinese Society of Cardiology of Chinese Medical Association Editorial Board of Chinese Journal of Cardiology, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P3; Claassen M, 2012, WORLD J CARDIOL, V4, P36, DOI 10.4330/wjc.v4.i2.36; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365, DOI 10.1152/ajprenal.2001.280.3.F365; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Elsaesser A, 2004, CIRCULATION, V109, P565, DOI 10.1161/01.CIR.0000116022.77781.26; European Heart Network, EUROPEAN CARDIOVASCU; Gavin JR, 1997, DIABETES CARE, V20, P1183; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Katz P, 2014, DIABETES VASC DIS RE, V11, P395, DOI 10.1177/1479164114546854; Klempfner R, 2015, INT J CARDIOL, V179, P546, DOI 10.1016/j.ijcard.2014.10.116; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Lu HT, 2014, GLOB HEART, V9, P381, DOI 10.1016/j.gheart.2014.06.001; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Odeberg J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005077; Poon S, 2012, AM HEART J, V163, P66, DOI 10.1016/j.ahj.2011.09.025; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; Thomas GN, 2003, CEREBROVASC DIS, V16, P217, DOI 10.1159/000071119; Thomas GN, 2001, CLIN NEPHROL, V55, P7; Trichon Benjamin H, 2004, Diab Vasc Dis Res, V1, P23, DOI 10.3132/dvdr.2004.003; Vassalle C, 2012, GYNECOL ENDOCRINOL, V28, P746, DOI 10.3109/09513590.2011.652720; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; World Health Organization, 2004, GLOB BURD DIS 2004 U; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	35	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122031	10.1371/journal.pone.0122031	http://dx.doi.org/10.1371/journal.pone.0122031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830291	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600095
J	Qiu, P; Stevens, R; Wei, B; Lahser, F; Howe, AYM; Klappenbach, JA; Marton, MJ				Qiu, Ping; Stevens, Richard; Wei, Bo; Lahser, Fred; Howe, Anita Y. M.; Klappenbach, Joel A.; Marton, Matthew J.			HCV Genotyping from NGS Short Reads and Its Application in Genotype Detection from HCV Mixed Infected Plasma	PLOS ONE			English	Article							HEPATITIS-C; REVERSE HYBRIDIZATION; RESISTANCE ANALYSIS; WEIGHT MATRIX; BIAS; AMPLIFICATION; EPIDEMIOLOGY; SEQUENCE; SUBTYPE; LENGTH	Genotyping of hepatitis C virus (HCV) plays an important role in the treatment of HCV. As new genotype-specific treatment options become available, it has become increasingly important to have accurate HCV genotype and subtype information to ensure that the most appropriate treatment regimen is selected. Most current genotyping methods are unable to detect mixed genotypes from two or more HCV infections. Next generation sequencing (NGS) allows for rapid and low cost mass sequencing of viral genomes and provides an opportunity to probe the viral population from a single host. In this paper, the possibility of using short NGS reads for direct HCV genotyping without genome assembly was evaluated. We surveyed the publicly-available genetic content of three HCV drug target regions (NS3, NS5A, NS5B) in terms of whether these genes contained genotype-specific regions that could predict genotype. Six genotypes and 38 subtypes were included in this study. An automated phylogenetic analysis based HCV genotyping method was implemented and used to assess different HCV target gene regions. Candidate regions of 250-bp each were found for all three genes that have enough genetic information to predict HCV genotypes/ subtypes. Validation using public datasets shows 100% genotyping accuracy. To test whether these 250-bp regions were sufficient to identify mixed genotypes, we developed a random primer-based method to sequence HCV plasma samples containing mixtures of two HCV genotypes in different ratios. We were able to determine the genotypes without ambiguity and to quantify the ratio of the abundances of the mixed genotypes in the samples. These data provide a proof-of-concept that this random primed, NGS-based short-read genotyping approach does not need prior information about the viral population and is capable of detecting mixed viral infection.	[Qiu, Ping; Wei, Bo; Marton, Matthew J.] Merck Res Labs, Mol Biomarker & Diagnost, Rahway, NJ 07065 USA; [Stevens, Richard; Klappenbach, Joel A.] Merck Res Labs, Target & Pathway Biol, Boston, MA USA; [Lahser, Fred; Howe, Anita Y. M.] Merck Res Labs, Infect Dis & Clin Virol, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company	Qiu, P (corresponding author), Merck Res Labs, Mol Biomarker & Diagnost, Rahway, NJ 07065 USA.	ping.qiu@merck.com	Lahser, Frederick/A-3753-2016	Lahser, Frederick/0000-0003-4902-0435; Wei, Bo/0000-0002-9688-5442	Merck Research Labs	Merck Research Labs	This research study was sponsored by Merck Research Labs. The funder provided support in the form of salaries for authors PQ, RS, BW, FL, AH, JK, MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Al Balwi MA, 2011, SAUDI J KIDNEY DIS T, V22, P712; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bouchardeau F, 2007, J CLIN MICROBIOL, V45, P1140, DOI 10.1128/JCM.01982-06; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Ciotti M, 2010, J VIROL METHODS, V167, P205, DOI 10.1016/j.jviromet.2010.03.017; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Figlerowicz M, 2010, ARCH VIROL, V155, P1977, DOI 10.1007/s00705-010-0789-7; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Howe AYM, 2014, CLIN INFECT DIS, V59, P1657, DOI 10.1093/cid/ciu696; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marascio N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S5-S1; Martro E, 2008, J CLIN MICROBIOL, V46, P192, DOI 10.1128/JCM.01623-07; Qiu P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-29; Qiu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-62; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Sohn YH, 2010, CLIN CHEM LAB MED, V48, P469, DOI 10.1515/CCLM.2010.093; Stelzl E, 2007, CLIN CHEM LAB MED, V45, P167, DOI 10.1515/CCLM.2007.043; Sy Theodore, 2006, Int J Med Sci, V3, P41; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOKITA H, 1995, J GEN VIROL, V76, P2329, DOI 10.1099/0022-1317-76-9-2329; Touzet S, 2000, EUR J GASTROEN HEPAT, V12, P667, DOI 10.1097/00042737-200012060-00017; Verbeeck J, 2008, J CLIN MICROBIOL, V46, P1901, DOI 10.1128/JCM.02390-07; Yang YC, 2015, MICROB BIOTECHNOL, V8, P93, DOI 10.1111/1751-7915.12140; Zanini B, 2009, ANTIVIR THER, V14, P467	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122082	10.1371/journal.pone.0122082	http://dx.doi.org/10.1371/journal.pone.0122082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830316	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600097
J	Berecki-Gisolf, J; Yiengprugsawan, V; Kelly, M; McClure, R; Seubsman, SA; Sleigh, A				Berecki-Gisolf, Janneke; Yiengprugsawan, Vasoontara; Kelly, Matthew; McClure, Roderick; Seubsman, Sam-ang; Sleigh, Adrian		Thai Cohort Study Team	The Impact of the Thai Motorcycle Transition on Road Traffic Injury: Thai Cohort Study Results	PLOS ONE			English	Article							HELMET USE; MORTALITY	Objectives The aim of this study was to investigate the impact of motorcycle to car transitioning and urbanisation on traffic injury rates in Thailand. Design Analysis of two consecutive surveys of a large national cohort study. Setting Thailand. Participants The data derived from 57,154 Thai Cohort Study (TCS) participants who provided relevant data on both the 2005 and 2009 surveys. Primary and secondary outcome measures Motorcycle and car traffic crash injury self-reported in 2009, with twelve months' recall. Results In 2009, 5608(10%) participants reported a traffic crash injury. Most crashes involved a motorcycle (74%). Car access increased and motorcycle use decreased between 2005 and 2009. Among those who used a motorcycle at both time points, traffic injury incidence was 2.8 times greater compared to those who did not use a motorcycle at either time point. Multivariable logistic regression models were used to test longitudinal and cross sectional factors associated with traffic crash injury: in the adjusted model, cars were negatively and motorcycles positively associated with injury. Living in an urban area was not injury protective in the adjusted model of traffic crash injury. Conclusions Ongoing urbanisation in Thailand can be expected to lead to further reductions in road traffic injuries based on transition from motorcycles to cars in urban areas. Cities, however, do not provide an intrinsically safer traffic environment. To accommodate a safe transition to car use in Thailand, traffic infrastructural changes anticipating the growing car density in urban areas is warranted.	[Berecki-Gisolf, Janneke] Monash Univ, Monash Injury Res Inst, Melbourne, Vic 3004, Australia; [Yiengprugsawan, Vasoontara; Kelly, Matthew; Seubsman, Sam-ang; Sleigh, Adrian] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [McClure, Roderick] Harvard Univ, Sch Populat Hlth, Harvard Injury Control Res Ctr, Boston, MA USA; [Seubsman, Sam-ang] Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand	Monash University; Australian National University; Harvard University; Harvard T.H. Chan School of Public Health; Sukhothai Thammathirat Open University	Berecki-Gisolf, J (corresponding author), Monash Univ, Monash Injury Res Inst, Melbourne, Vic 3004, Australia.	janneke.berecki-gisolf@monash.edu	Yiengprugsawan, Vasoontara/N-7072-2013; Harley, David/B-4910-2017; Kelly, Matthew/ABC-1069-2020; sleigh, adrian/J-4540-2019; Yiengprugsawan, Vas Sbirakos/G-3176-2011	Yiengprugsawan, Vasoontara/0000-0001-9101-4704; Harley, David/0000-0001-6691-5420; Kelly, Matthew/0000-0001-7963-2139; sleigh, adrian/0000-0001-8443-7864; Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; McClure, Roderick/0000-0002-9067-8282; Seubsman, Sam-ang/0000-0002-7451-3218	International Collaborative Research Grants Scheme; Wellcome Trust UK [GR071587MA]; Australian National Health and Medical Research Council (NHMRC) [268055]; NHMRC [585426]	International Collaborative Research Grants Scheme; Wellcome Trust UK(Wellcome Trust); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The Thai Cohort Study is funded by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian National Health and Medical Research Council (NHMRC) (268055), and as a global health grant from the NHMRC (585426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; ASEAN-JAPAN Transport Partnership, 2013, DAT TEMPL ROAD TRANS; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; McClure R, 2012, J HLTH SAFETY RES PR, V4, P1; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Paulozzi LJ, 2007, ACCIDENT ANAL PREV, V39, P606, DOI 10.1016/j.aap.2006.10.007; Pitaktong Utit, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P232; Pomlaktong N, 2011, IMPACTS BENEFITS STR, P267; Porapakkham Y, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-14; Seubsman SA, 2010, ASEAN J OPEN DISTANC; Seubsman SA, 2010, J EPIDEMIOL, V20, P13, DOI 10.2188/jea.JE20090014; Siviroj P, 2012, INT J ENV RES PUB HE, V9, P3286, DOI 10.3390/ijerph9093286; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; van Beeck EF, 2000, INT J EPIDEMIOL, V29, P503, DOI 10.1093/ije/29.3.503; World Health Organization, 2013, ROAD SAF STAT WHO S; World Health Organization, 2013, GLOB STAT REP ROAD S	17	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120617	10.1371/journal.pone.0120617	http://dx.doi.org/10.1371/journal.pone.0120617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826214	Green Published, gold			2022-12-27	WOS:000352084800023
J	Favre, M; Sornette, D				Favre, Maroussia; Sornette, Didier			A Generic Model of Dyadic Social Relationships	PLOS ONE			English	Article							ELEMENTARY FORMS; ERRORS	We introduce a model of dyadic social interactions and establish its correspondence with relational models theory (RMT), a theory of human social relationships. RMT posits four elementary models of relationships governing human interactions, singly or in combination: Communal Sharing, Authority Ranking, Equality Matching, and Market Pricing. To these are added the limiting cases of asocial and null interactions, whereby people do not coordinate with reference to any shared principle. Our model is rooted in the observation that each individual in a dyadic interaction can do either the same thing as the other individual, a different thing or nothing at all. To represent these three possibilities, we consider two individuals that can each act in one out of three ways toward the other: perform a social action X or Y, or alternatively do nothing. We demonstrate that the relationships generated by this model aggregate into six exhaustive and disjoint categories. We propose that four of these categories match the four relational models, while the remaining two correspond to the asocial and null interactions defined in RMT. We generalize our results to the presence of N social actions. We infer that the four relational models form an exhaustive set of all possible dyadic relationships based on social coordination. Hence, we contribute to RMT by offering an answer to the question of why there could exist just four relational models. In addition, we discuss how to use our representation to analyze data sets of dyadic social interactions, and how social actions may be valued and matched by the agents.	[Favre, Maroussia; Sornette, Didier] ETH, Swiss Fed Inst Technol, Dept Management Technol & Econ, CH-8092 Zurich, Switzerland; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, CH-1211 Geneva 4, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Favre, M (corresponding author), ETH, Swiss Fed Inst Technol, Dept Management Technol & Econ, Scheuchzerstr 7, CH-8092 Zurich, Switzerland.	maroussiafavre@ethz.ch			Swiss National Foundation; ETH Zurich	Swiss National Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was partly supported by the Swiss National Foundation. The rest of the funding came from ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, SOC JUSTICE RES, DOI DOI 10.1023/A:1023295018444; Bolender J, 2010, THE SELF ORGANIZING; Brodbeck FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081558; Fiske A. P., 1995, J QUANTITATIVE ANTHR, V5, P305; FISKE AP, 1991, J PERS SOC PSYCHOL, V60, P656, DOI 10.1037/0022-3514.60.5.656; Fiske AP, 2005, INTERPERSONAL COGNITION, P267; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P3; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; FISKE AP, 1993, J CROSS CULT PSYCHOL, V24, P463, DOI 10.1177/0022022193244006; Fiske AP, 1997, EUR J SOC PSYCHOL, V27, P725, DOI 10.1002/(SICI)1099-0992(199711/12)27:6<725::AID-EJSP832>3.0.CO;2-A; Fiske AP, 1991, STRUCTURES OF SOCIAL; Fuchs B, 2014, SCIENTIFIC REPORTS, V4; Gigerenzer G, 2000, EVOLUTION AND COGNIT; GOLDMAN AI, 1993, ETHICS, V103, P337, DOI 10.1086/293500; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Haslam N, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P27; HASLAM N, 1994, COGNITION, V53, P59, DOI 10.1016/0010-0277(94)90077-9; Haslam N, 2002, PSYCHOL PSYCHOTHER-T, V75, P19, DOI 10.1348/147608302169526; HASLAM N, 1994, J PERS SOC PSYCHOL, V67, P575, DOI 10.1037/0022-3514.67.4.575; Haslam N, 1997, EVOLUTIONARY SOCIAL, P293; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; MARY DOUGLAS, 1978, CULTURAL BIAS; Mill John Stuart, 1906, UTILITARIANISM; Nettle D, 2011, CURR ANTHROPOL, V52, P747, DOI 10.1086/661521; Neumann J, 1953, THEORY OF GAMES AND; Senior TJ, 2013, PAPER PRESENTED AT T; Shaffer DM, 2004, PSYCHOL SCI, V15, P437, DOI 10.1111/j.0956-7976.2004.00698.x; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Thompson M, 1990, CULTURAL THEORY; Thurner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029796; Whitehead H, 2002, POWER AND THE SELF; Yukalov VI, 2011, THEOR DECIS, V70, P283, DOI 10.1007/s11238-010-9202-y; Yukalov VI, 2010, ADV COMPLEX SYST, V13, P659, DOI 10.1142/S0219525910002803	35	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120882	10.1371/journal.pone.0120882	http://dx.doi.org/10.1371/journal.pone.0120882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826403	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800028
J	Kozyrev, N; Coolen, LM				Kozyrev, Natalie; Coolen, Lique M.			Activation of Mu or Delta Opioid Receptors in the Lumbosacral Spinal Cord Is Essential for Ejaculatory Reflexes in Male Rats	PLOS ONE			English	Article							LUMBAR SPINOTHALAMIC CELLS; SEXUAL-BEHAVIOR; IN-VITRO; MECHANISMS; MUSCLES; NERVE; PENIS; HETERODIMERIZATION; IDENTIFICATION; TRANSMISSION	Ejaculation is controlled by a spinal ejaculation generator located in the lumbosacral spinal cord, consisting in male rats of lumbar spinothalamic (LSt) cells and their inter-spinal projections to autonomic and motor centers. LSt cells co-express several neuropeptides, including gastrin releasing peptide (GRP) and enkephalin. We previously demonstrated in rats that GRP regulates ejaculation by acting within the lumbosacral spinal cord. In the present study, the hypothesis was tested that enkephalin controls ejaculation by acting on mu (MOR) or delta opioid receptors (DOR) in LSt target areas. Adult male rats were anesthetized and spinalized and received intrathecal infusions of vehicle, MOR antagonist CTOP (0.4 or 4 nmol), DOR antagonist (TIPP (0.4, 4 or 40 nmol), MOR agonist DAMGO (0.1 or 10 nmol), or DOR agonist deltorphin II (1.3 or 13 nmol). Ejaculatory reflexes were triggered by stimulation of the dorsal penile nerve (DPN) and seminal vesicle pressure and rhythmic contractions of the bulbocavernosus muscle were analyzed. Intrathecal infusion of MOR or DOR antagonists effectively blocked ejaculatory reflexes induced by DPN stimulation. Intrathecal infusion of DAMGO, but not deltorphin II triggered ejaculation in absence of DPN stimulation. Both MOR and DOR agonists facilitated ejaculatory reflexes induced by subthreshold DPN stimulation in all animals. Overall, these results support the hypothesis that enkephalin plays a critical role in the control of ejaculation in male rats. Activation of either MOR or DOR in LSt target areas is required for ejaculation, while MOR activation is sufficient to trigger ejaculation in the absence of sensory stimulation.	[Kozyrev, Natalie; Coolen, Lique M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Kozyrev, Natalie; Coolen, Lique M.] Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; [Coolen, Lique M.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Coolen, Lique M.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Western University (University of Western Ontario); University of Michigan System; University of Michigan; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Coolen, LM (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	lcoolen@umc.edu		Coolen, Lique/0000-0003-2920-1116				AGMO A, 1992, PSYCHOPHARMACOLOGY, V107, P89, DOI 10.1007/BF02244971; Allard J, 2005, WORLD J UROL, V23, P119, DOI 10.1007/s00345-004-0494-9; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; BOHLEN J G, 1980, Archives of Sexual Behavior, V9, P503, DOI 10.1007/BF01542155; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; Carro-Juarez M, 2009, J SEX MED, V6, P3045, DOI 10.1111/j.1743-6109.2009.01470.x; CESSELIN F, 1995, FUND CLIN PHARMACOL, V9, P409, DOI 10.1111/j.1472-8206.1995.tb00517.x; Clement P, 2008, BRIT J PHARMACOL, V154, P1150, DOI 10.1038/bjp.2008.176; Coolen LM, 2005, J COMP NEUROL, V493, P39, DOI 10.1002/cne.20784; Coolen LM, 2004, PHYSIOL BEHAV, V83, P203, DOI 10.1016/j.physbeh.2004.08.023; Coolen LM, 2003, J COMP NEUROL, V463, P132, DOI 10.1002/cne.10739; GERSTENBERG TC, 1990, BRIT J UROL, V65, P395, DOI 10.1111/j.1464-410X.1990.tb14764.x; Giuliano F, 2005, ANN REV SEX RES, V16, P190; Giuliano F, 2011, J SEX MED, V8, P310, DOI 10.1111/j.1743-6109.2011.02450.x; Giuliano F, 2010, J SEX MED, V7, P2970, DOI 10.1111/j.1743-6109.2010.01960.x; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; HERBERT J, 1973, PHYSIOL BEHAV, V10, P293, DOI 10.1016/0031-9384(73)90313-2; HOLMES GM, 1991, PHYSIOL BEHAV, V49, P1235, DOI 10.1016/0031-9384(91)90357-T; HOLMES GM, 1991, NEUROSCI LETT, V125, P195, DOI 10.1016/0304-3940(91)90026-P; Ikoma M, 2007, ANESTHESIOLOGY, V107, P807, DOI 10.1097/01.anes.0000286985.80301.5e; JOHNSON RD, 1991, J COMP NEUROL, V312, P299, DOI 10.1002/cne.903120212; JU G, 1987, NEUROSCIENCE, V20, P439, DOI 10.1016/0306-4522(87)90103-5; Kozyrev N, 2012, J SEX MED, V9, P1303, DOI 10.1111/j.1743-6109.2012.02688.x; Marberger H., 1974, PHYSL GENETICS REPRO, P99; McKenna K., 1999, ENCY REPROD, P1002; McKenna K E, 2001, J Spinal Cord Med, V24, P148; NEWTON BW, 1993, PEPTIDES, V14, P955, DOI 10.1016/0196-9781(93)90072-O; Nicholas AP, 1999, NEUROSCI LETT, V270, P9, DOI 10.1016/S0304-3940(99)00446-2; PESCATORI ES, 1993, J UROLOGY, V149, P627, DOI 10.1016/S0022-5347(17)36168-2; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Pradhan AA, 2012, BRIT J PHARMACOL, V167, P960, DOI 10.1111/j.1476-5381.2012.02075.x; Russell J.A, 2007, OPIOID SYSTEMS, P11; Sakamoto H, 2008, NAT NEUROSCI, V11, P634, DOI 10.1038/nn.2126; Staudt MD, 2012, J SEX MED, V9, P2256, DOI 10.1111/j.1743-6109.2011.02574.x; Staudt MD, 2011, J SEX MED, V8, P1015, DOI 10.1111/j.1743-6109.2010.02168.x; Staudt MD, 2010, J SEX MED, V7, P2445, DOI 10.1111/j.1743-6109.2010.01741.x; Szentirmay AK, 2013, BRAIN RES BULL, V90, P66, DOI 10.1016/j.brainresbull.2012.09.006; Truitt WA, 2003, J NEUROSCI, V23, P325; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; Vaughan CW, 1997, J PHYSIOL-LONDON, V498, P463, DOI 10.1113/jphysiol.1997.sp021872; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Veening JG, 2014, PHARMACOL BIOCHEM BE, V121, P170, DOI 10.1016/j.pbb.2013.12.017; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wieder JA, 2000, UROLOGY, V55, P915, DOI 10.1016/S0090-4295(99)00608-1; WIESENFELDHALLIN Z, 1984, NATURE, V309, P257, DOI 10.1038/309257a0; Xu C, 2006, NEUROSCIENCE, V138, P561, DOI 10.1016/j.neuroscience.2005.11.016; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	48	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121130	10.1371/journal.pone.0121130	http://dx.doi.org/10.1371/journal.pone.0121130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826331	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800035
J	Tong, KL; Chan, KL; AbuBakar, S; Low, BS; Ma, HQ; Wong, PF				Tong, Kind Leng; Chan, Kit Lam; AbuBakar, Sazaly; Low, Bin Seng; Ma, Hai Qiu; Wong, Pooi Fong			The In Vitro and In Vivo Anti-Cancer Activities of a Standardized Quassinoids Composition from Eurycoma longifolia on LNCaP Human Prostate Cancer Cells	PLOS ONE			English	Article							SEX-HORMONE LEVELS; ANDROGEN RECEPTOR; POLY(ADP-RIBOSE) POLYMERASE; CYCLIN-E; APOPTOSIS; EXTRACT; JACK; EXPRESSION; GROWTH; SPERMATOGENESIS	Quassinoids are a group of diterpenoids found in plants from the Simaroubaceae family. They are also the major bioactive compounds found in Eurycoma longifolia which is commonly used as traditional medicine in South East Asia to treat various ailments including sexual dysfunction and infertility. These uses are attributed to its ability to improve testosterone level in men. Chronic consumption of E. longifolia extracts has been reported to increase testosterone level in men and animal model but its effect on prostate growth remains unknown. Therefore, the present study investigates the effects of a standardized total quassinoids composition (SQ40) containing 40% of the total quassinoids found in E. longifolia on LNCaP human prostate cancer cell line. SQ40 inhibited LNCaP cell growth at IC50 value of 5.97 mu g/mL while the IC50 on RWPE-1 human prostate normal cells was 59.26 mu g/mL. SQ40 also inhibited 5 alpha-dihydrotestosterone-stimulated growth in LNCaP cells dose-dependently. The inhibitory effect of SQ40 in anchorage-independent growth of LNCaP cells was also demonstrated using soft agar assay. SQ40 suppressed LNCaP cell growth via G(0)/G(1) phase arrest which was accompanied by the down-regulation of CDK4, CDK2, Cyclin D1 and Cyclin D3 and up-regulation of p21(Waf1/Cip1) protein levels. SQ40 at higher concentrations or longer treatment duration can cause G(2)M growth arrest leading to apoptotic cell death as demonstrated by the detection of poly(ADP-ribose) polymerase cleavage in LNCaP cells. Moreover, SQ40 also inhibited androgen receptor translocation to nucleus which is important for the transactivation of its target gene, prostate-specific antigen (PSA) and resulted in a significant reduction of PSA secretion after the treatment. In addition, intraperitoneal injection of 5 and 10 mg/kg of SQ40 also significantly suppressed the LNCaP tumor growth on mouse xenograft model. Results from the present study suggest that the standardized total quassinoids composition from E. longifolia promotes anti-prostate cancer activities in LNCaP human prostate cancer cells.	[Tong, Kind Leng; Wong, Pooi Fong] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Chan, Kit Lam; Low, Bin Seng; Ma, Hai Qiu] Univ Sci Malaysia, Sch Pharmaceut Sci, Minden 11800, Penang, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Sains Malaysia; Universiti Malaya	Wong, PF (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	wongpf@um.edu.my	WONG, POOI-FONG PF/B-5234-2010; abubakar, sazaly/B-3957-2010; , Bin Seng Low/Z-5135-2019	WONG, POOI-FONG PF/0000-0002-6705-2521; abubakar, sazaly/0000-0002-9267-1420; , Bin Seng Low/0000-0002-3660-7109	Ministry of Agriculture and Agro-Based Industry, Malaysia; NKEA Research Grant Scheme [(NRGS)-NH0711S001]; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (HIRG) [E00002-20001]	Ministry of Agriculture and Agro-Based Industry, Malaysia; NKEA Research Grant Scheme; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (HIRG)	This study was funded by Ministry of Agriculture and Agro-Based Industry, Malaysia, NKEA Research Grant Scheme (NRGS)-NH0711S001 and University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (HIRG) E00002-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salahi OSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083818; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bhat R, 2010, FITOTERAPIA, V81, P669, DOI 10.1016/j.fitote.2010.04.006; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; Cachet N, 2009, ANTIMICROB AGENTS CH, V53, P4393, DOI 10.1128/AAC.00951-09; Choo CY, 2002, PLANTA MED, V68, P382, DOI 10.1055/s-2002-26745; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Fiaschetti G, 2011, CURR MED CHEM, V18, P316, DOI 10.2174/092986711794839205; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Govindachari TR, 2001, FITOTERAPIA, V72, P568, DOI 10.1016/S0367-326X(00)00342-7; Guo Z, 2005, CURR MED CHEM, V12, P173, DOI 10.2174/0929867053363351; Haynes JM, 2001, CELL SIGNAL, V13, P703, DOI 10.1016/S0898-6568(01)00205-4; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HO SM, 1988, CANCER RES, V48, P609; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Houel E, 2013, NATURAL PRODUCTS, P3775; Imamoto T, 2009, FUTURE ONCOL, V5, P1005, DOI 10.2217/FON.09.82; KAIGHN ME, 1979, INVEST UROL, V17, P16; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lau ST, 2009, CANCER LETT, V281, P42, DOI 10.1016/j.canlet.2009.02.017; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Li CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/102987; Lin Lie-Chwen, 2001, Chinese Pharmaceutical Journal (Taipei), V53, P97; Low BS, 2013, J ETHNOPHARMACOL, V149, P201, DOI 10.1016/j.jep.2013.06.023; Low BS, 2013, J ETHNOPHARMACOL, V145, P706, DOI 10.1016/j.jep.2012.11.013; Low B, 2011, NAT PROD COMMUN, V6, P337; Low BS, 2004, PHYTOTHER RES, V28, P1022; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; Mahfudh N., 2008, CANC MOL, V4, P109; Garcia-Barrantes PM, 2011, J ETHNOPHARMACOL, V134, P904, DOI 10.1016/j.jep.2011.01.052; Miyake K, 2010, NAT PROD COMMUN, V5, P1009; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nicholson TM, 2011, DIFFERENTIATION, V82, P184, DOI 10.1016/j.diff.2011.04.006; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Okano M, 1996, BIOORG MED CHEM LETT, V6, P701, DOI 10.1016/0960-894X(96)00096-0; Rahman S, 1997, CHEM PHARM BULL, V45, P1527, DOI 10.1248/cpb.45.1527; Raji Y, 2012, AFR J TRADIT COMPLEM, V9, P112, DOI 10.4314/ajtcam.v9i1.16; Shuid AN, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-152; Silva ISB, 2001, ENDOCR RES, V27, P153, DOI 10.1081/ERC-100107177; Solomon MC, 2014, ANDROLOGIA, V46, P339, DOI 10.1111/and.12082; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Tambi MIB, 2010, ASIAN J ANDROL, V12, P376, DOI 10.1038/aja.2010.7; Tee TT, 2007, ANTICANCER RES, V27, P3425; Tee TT, 2005, ANTICANCER RES, V25, P2205; Teh CH, 2011, J CHROMATOGR A, V1218, P1861, DOI 10.1016/j.chroma.2011.02.014; Teh CH, 2011, PLANTA MED, V77, P128, DOI 10.1055/s-0030-1250159; Teh CH, 2010, FOOD CHEM, V120, P794, DOI 10.1016/j.foodchem.2009.11.012; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Verma N, 2010, MOL CELL BIOCHEM, V336, P127, DOI 10.1007/s11010-009-0263-6; Wong PF, 2012, PHYTOMEDICINE, V19, P138, DOI 10.1016/j.phymed.2011.07.001; Yang JH, 2013, J ETHNOPHARMACOL, V147, P442, DOI 10.1016/j.jep.2013.03.034; Zakaria Y, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-16; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	54	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121752	10.1371/journal.pone.0121752	http://dx.doi.org/10.1371/journal.pone.0121752			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826409	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800054
J	van den Berg, BA; Reinders, MJT; de Ridder, D; de Beer, TAP				van den Berg, Bastiaan A.; Reinders, Marcel J. T.; de Ridder, Dick; de Beer, Tjaart A. P.			Insight into Neutral and Disease-Associated Human Genetic Variants through Interpretable Predictors	PLOS ONE			English	Article							AMINO-ACID; PROTEIN MUTATIONS; SCORE; PATHOGENICITY; POLYMORPHISMS; FRAMEWORK	A variety of methods that predict human nonsynonymous single nucleotide polymorphisms (SNPs) to be neutral or disease-associated have been developed over the last decade. These methods are used for pinpointing disease-associated variants in the many variants obtained with next-generation sequencing technologies. The high performances of current sequence-based predictors indicate that sequence data contains valuable information about a variant being neutral or disease-associated. However, most predictors do not readily disclose this information, and so it remains unclear what sequence properties are most important. Here, we show how we can obtain insight into sequence characteristics of variants and their surroundings by interpreting predictors. We used an extensive range of features derived from the variant itself, its surrounding sequence, sequence conservation, and sequence annotation, and employed linear support vector machine classifiers to enable extracting feature importance from trained predictors. Our approach is useful for providing additional information about what features are most important for the predictions made. Furthermore, for large sets of known variants, it can provide insight into the mechanisms responsible for variants being disease-associated.	[van den Berg, Bastiaan A.; Reinders, Marcel J. T.; de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Dept Intelligent Syst, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands; [de Beer, Tjaart A. P.] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; [de Beer, Tjaart A. P.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [de Beer, Tjaart A. P.] SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [de Ridder, Dick] Wageningen Univ, Bioinformat Grp, NL-6708 PB Wageningen, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; de Ridder, Dick] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; de Ridder, Dick] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Delft University of Technology; European Molecular Biology Laboratory (EMBL); University of Basel; Swiss Institute of Bioinformatics; Wageningen University & Research	de Beer, TAP (corresponding author), European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	tjaart.debeer@unibas.ch	de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310; de Beer, Tjaart/0000-0001-5966-6091	Netherlands Bioinformatics Centre (NBIC)	Netherlands Bioinformatics Centre (NBIC)	This work was supported by the BioRange programme of the Netherlands Bioinformatics Centre (NBIC) and was part of the Kluyver Centre for Genomics of Industrial Fermentation, both subsidiaries of the Netherlands Genomics Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Care MA, 2007, BIOINFORMATICS, V23, P664, DOI 10.1093/bioinformatics/btl649; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Georgiev AG, 2009, J COMPUT BIOL, V16, P703, DOI 10.1089/cmb.2008.0173; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Yates CM, 2013, J MOL BIOL, V425, P1274, DOI 10.1016/j.jmb.2013.01.026; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zimmermann K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-4	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120729	10.1371/journal.pone.0120729	http://dx.doi.org/10.1371/journal.pone.0120729			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826299	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800025
J	Vranka, JA; Bradley, JM; Yang, YF; Keller, KE; Acott, TS				Vranka, Janice A.; Bradley, John M.; Yang, Yong-Feng; Keller, Kate E.; Acott, Ted S.			Mapping Molecular Differences and Extracellular Matrix Gene Expression in Segmental Outflow Pathways of the Human Ocular Trabecular Meshwork	PLOS ONE			English	Article							AQUEOUS-HUMOR OUTFLOW; CATIONIZED FERRITIN; INTRAOCULAR-PRESSURE; COLLECTOR CHANNELS; INNER-WALL; HUMAN EYES; FACILITY; CELLS; PERFUSION; MORPHOLOGY	Elevated intraocular pressure (IOP) is the primary risk factor for glaucoma, and lowering IOP remains the only effective treatment for glaucoma. The trabecular meshwork (TM) in the anterior chamber of the eye regulates IOP by generating resistance to aqueous humor outflow. Aqueous humor outflow is segmental, but molecular differences between high and low outflow regions of the TM are poorly understood. In this study, flow regions of the TM were characterized using fluorescent tracers and PCR arrays. Anterior segments from human donor eyes were perfused at physiological pressure in an ex vivo organ culture system. Fluorescently-labeled microspheres of various sizes were perfused into anterior segments to label flow regions. Actively perfused microspheres were segmentally distributed, whereas microspheres soaked passively into anterior segments uniformly labeled the TM and surrounding tissues with no apparent segmentation. Cell-tracker quantum dots (20 nm) were localized to the outer uveal and corneoscleral TM, whereas larger, modified microspheres (200 nm) localized throughout the TM layers and Schlemm's canal. Distribution of fluorescent tracers demonstrated a variable labeling pattern on both a macro-and microscale. Quantitative PCR arrays allowed identification of a variety of extracellular matrix genes differentially expressed in high and low flow regions of the TM. Several collagen genes (COL16A1, COL4A2, COL6A1 and 2) and MMPs (1, 2, 3) were enriched in high, whereas COL15A1, and MMP16 were enriched in low flow regions. Matrix metalloproteinase activity was similar in high and low regions using a quantitative FRET peptide assay, whereas protein levels in tissues showed modest regional differences. These gene and protein differences across regions of the TM provide further evidence for a molecular basis of segmental flow routes within the aqueous outflow pathway. New insight into the molecular mechanisms of segmental aqueous outflow may aid in the design and delivery of improved treatments for glaucoma patients.	[Vranka, Janice A.; Bradley, John M.; Yang, Yong-Feng; Keller, Kate E.; Acott, Ted S.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University	Vranka, JA (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	vranka@ohsu.edu		Keller, Kate/0000-0002-1616-972X	National Standard Glaucoma Award from the Bright Focus Foundation, Clarksburg, MD; NIH/National Eye Institute [EY019643, EY003279, EY008247, EY010572]; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY003279, P30EY010572, R01EY008247, R01EY019643, R01EY025721] Funding Source: NIH RePORTER	National Standard Glaucoma Award from the Bright Focus Foundation, Clarksburg, MD(BrightFocus Foundation); NIH/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funding sources for this work are: National Standard Glaucoma Award from the Bright Focus Foundation, Clarksburg, MD (JAV); NIH/National Eye Institute grants EY019643 (KEK), EY003279, EY008247, EY010572 (TSA); and an unrestricted grant to the Casey Eye Institute from Research to Prevent Blindness, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; BARANY EH, 1954, ACTA PHYSIOL SCAND, V30, P240, DOI 10.1111/j.1748-1716.1954.tb01092.x; Battista SA, 2008, INVEST OPHTH VIS SCI, V49, P5346, DOI 10.1167/iovs.08-1707; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Bradley JMB, 2001, INVEST OPHTH VIS SCI, V42, P1505; BULLER C, 1994, INVEST OPHTH VIS SCI, V35, P3841; Challa P, 2005, MOL VIS, V11, P425; Chang JY, 2014, J OCUL PHARM THER; DANON D, 1972, J ULTRA MOL STRUCT R, V38, P500, DOI 10.1016/0022-5320(72)90087-1; DEKATER AW, 1989, ARCH OPHTHALMOL-CHIC, V107, P572, DOI 10.1001/archopht.1989.01070010586035; DVORAKTHEOBALD G, 1955, AM J OPHTHALMOL, V39, P65; EPSTEIN DL, 1991, INVEST OPHTH VIS SCI, V32, P160; ERICKSONLAMY K, 1991, EXP EYE RES, V52, P723, DOI 10.1016/0014-4835(91)90024-9; Ethier CR, 2002, EXP EYE RES, V74, P161, DOI 10.1006/exer.2001.1144; Ethier CR, 2001, INVEST OPHTH VIS SCI, V42, P1795; FLOYD BB, 1985, INVEST OPHTH VIS SCI, V26, P797; FRANCOIS J, 1956, ARCH OPHTHALMOL-CHIC, V55, P193; Fuchshofer R, 2006, INVEST OPHTH VIS SCI, V47, P794, DOI 10.1167/iovs.05-0292; Gong HY, 2002, EXP EYE RES, V75, P347, DOI 10.1006/exer.2002.2010; Gottanka J, 2001, GRAEF ARCH CLIN EXP, V239, P138, DOI 10.1007/s004170000231; GRANT WM, 1963, ARCH OPHTHALMOL-CHIC, V69, P783; Hann CR, 2011, INVEST OPHTH VIS SCI, V52, P45, DOI 10.1167/iovs.10-5620; Hann CR, 2011, EXP EYE RES, V92, P104, DOI 10.1016/j.exer.2010.12.010; Hann CR, 2009, INVEST OPHTH VIS SCI, V50, P1692, DOI 10.1167/iovs.08-2375; Hann CR, 2005, INVEST OPHTH VIS SCI, V46, P1, DOI 10.1167/iovs.04-0800; Heimark RL, 2002, CURR EYE RES, V25, P299, DOI 10.1076/ceyr.25.5.299.13495; JOHNSON DH, 1989, ARCH OPHTHALMOL-CHIC, V107, P250, DOI 10.1001/archopht.1989.01070010256032; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Keller KE, 2008, INVEST OPHTH VIS SCI, V49, P2495, DOI 10.1167/iovs.07-0903; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Keller Kate E, 2013, J Ocul Biol, V1, P3; Keller KE, 2013, INVEST OPHTH VIS SCI, V54, P5613, DOI 10.1167/iovs.13-11620; Keller KE, 2013, MOL VIS, V19, P1639; Keller KE, 2012, INVEST OPHTH VIS SCI, V53, P4616, DOI 10.1167/iovs.12-9500; Keller KE, 2011, INVEST OPHTH VIS SCI, V52, P5049, DOI 10.1167/iovs.10-6948; Keller KE, 2009, INVEST OPHTH VIS SCI, V50, P5769, DOI 10.1167/iovs.09-3673; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Liton P, 2006, MOL VIS, V12, P774; Liu YT, 2013, INVEST OPHTH VIS SCI, V54, P6382, DOI 10.1167/iovs.13-12128; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; Lu ZZ, 2011, EXP EYE RES, V93, P397, DOI 10.1016/j.exer.2011.05.012; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; MELAMED S, 1986, EXP EYE RES, V43, P273, DOI 10.1016/S0014-4835(86)80096-3; O'Brien ET, 2014, J OCUL PHARMACOL TH, V30, P291, DOI 10.1089/jop.2013.0189; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; Overby DR, 2014, P NATL ACAD SCI US; Parc CE, 2000, INVEST OPHTH VIS SCI, V41, P2984; Perkumas KM, 2012, EXP EYE RES, V96, P82, DOI 10.1016/j.exer.2011.12.017; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V176, P309, DOI 10.1007/BF00421587; Santas AJ, 2003, INVEST OPHTH VIS SCI, V44, P4796, DOI 10.1167/iovs.02-1083; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Vranka JA, 2014, EXPT EYE RE IN PRESS; Wiggs JL, 2013, CLIN GENET, V84, P167, DOI 10.1111/cge.12176; Wiggs JL, 2013, JAMA OPHTHALMOL, V131, P1265, DOI 10.1001/jamaophthalmol.2013.4509; Wiggs JL, 2013, J GLAUCOMA, V22, P517, DOI 10.1097/IJG.0b013e31824d4fd8; Zhao XJ, 2005, MOL VIS, V11, P603; Zhu JY, 2013, CHINESE MED J-PEKING, V126, P1451, DOI 10.3760/cma.j.issn.0366-6999.20123656; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365; Zu JY, 2010, CHINESE MED J-PEKING, V123, P599, DOI 10.3760/cma.j.issn.0366-6999.2010.05.018	68	57	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122483	10.1371/journal.pone.0122483	http://dx.doi.org/10.1371/journal.pone.0122483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826404	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800073
J	Balsara, R; Dang, A; Donahue, DL; Snow, T; Castellino, FJ				Balsara, Rashna; Dang, Alexander; Donahue, Deborah L.; Snow, Tiffany; Castellino, Francis J.			Conantokin-G Attenuates Detrimental Effects of NMDAR Hyperactivity in an Ischemic Rat Model of Stroke	PLOS ONE			English	Article							RECEPTOR ANTAGONISTS; HIPPOCAMPAL-NEURONS; NR2B; EFFICACY; SUBUNIT; CGX-1007; PENUMBRA; INJURY; SAFETY; DEATH	The neuroprotective activity of conantokin-G (con-G), a naturally occurring antagonist of N-methyl-D-aspartate receptors (NMDAR), was neurologically and histologically compared in the core and peri-infarct regions after ischemia/reperfusion brain injury in male Sprague-Dawley rats. The contralateral regions served as robust internal controls. Intrathecal injection of con-G, post-middle carotid artery occlusion (MCAO), caused a dramatic decrease in brain infarct size and swelling at 4 hr, compared to 26 hr, and significant recovery of neurological deficits was observed at 26 hr. Administration of con-G facilitated neuronal recovery in the peri-infarct regions as observed by decreased neurodegeneration and diminished calcium microdeposits at 4 hr and 26 hr. Intact Microtubule Associated Protein (MAP2) staining and neuronal cytoarchitecture was observed in the peri-infarct regions of con-G treated rats at both timepoints. Con-G restored localization of GluN1 and GluN2B subunits in the neuronal soma, but not that of GluN2A, which was perinuclear in the peri-infarct regions at 4 hr and 26 hr. This suggests that molecular targeting of the GluN2B subunit has potential for reducing detrimental consequences of ischemia. Overall, the data demonstrated that stroke-induced NMDAR excitoxicity is ameliorated by con-G-mediated repair of neurological and neuroarchitectural deficits, as well as by reconstituting neuronal localization of GluN1 and GluN2B subunits in the peri-infarct region of the stroked brain.	[Balsara, Rashna; Dang, Alexander; Donahue, Deborah L.; Snow, Tiffany; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Balsara, Rashna; Snow, Tiffany; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Dang, Alexander/0000-0002-7964-7426	NIH from National Institutes of Health [HL019982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019982] Funding Source: NIH RePORTER	NIH from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH HL019982 to FJC from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong Heather, 1998, Epilepsia, V39, P39; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Balsara R, 2012, NEUROPHARMACOLOGY, V62, P2227, DOI 10.1016/j.neuropharm.2012.01.018; Baron JC, 2001, BRAIN, V124, P2, DOI 10.1093/brain/124.1.2; Barton ME, 2004, EPILEPSY RES, V59, P1, DOI 10.1016/j.eplepsyres.2003.12.010; Benchenane K, 2007, J CELL SCI, V120, P578, DOI 10.1242/jcs.03354; BENNETT SAL, 1995, ACTA NEUROPATHOL, V89, P126; Burzomato V, 2010, J PHYSIOL-LONDON, V588, P3403, DOI 10.1113/jphysiol.2010.195503; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Clayton DA, 2002, J NEUROSCI, V22, P3628; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Dos-Anjos S, 2009, NEUROCHEM INT, V54, P180, DOI 10.1016/j.neuint.2008.09.016; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; Dyker AG, 1999, STROKE, V30, P2038, DOI 10.1161/01.STR.30.10.2038; Dzamba D, 2013, CURR NEUROPHARMACOL, V11, P250, DOI 10.2174/1570159X11311030002; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Gardoni F, 2006, J NEUROSCI, V26, P2914, DOI 10.1523/JNEUROSCI.5326-05.2006; Geissler M, 2013, J NEUROSCI, V33, P7742, DOI 10.1523/JNEUROSCI.3275-12.2013; Gerriets T, 2003, J NEUROSCI METH, V122, P201, DOI 10.1016/S0165-0270(02)00322-9; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Hama A, 2009, NEUROPHARMACOLOGY, V56, P556, DOI 10.1016/j.neuropharm.2008.10.008; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hollmann MW, 2001, ANESTH ANALG, V92, P1182; HOSSMANN KA, 1985, ACTA NEUROPATHOL, V68, P230, DOI 10.1007/BF00690200; Jarzylo LA, 2012, J NEUROSCI, V32, P2552, DOI 10.1523/JNEUROSCI.3237-11.2012; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kunda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081405; Lekieffre D, 1997, BRAIN RES, V776, P88, DOI 10.1016/S0006-8993(97)00992-X; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Macrez R, 2010, STROKE, V41, P2950, DOI 10.1161/STROKEAHA.110.592360; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MINEMATSU K, 1993, NEUROLOGY, V43, P397, DOI 10.1212/WNL.43.2.397; Palmer GC, 1995, ANN NY ACAD SCI, V765, P236, DOI 10.1111/j.1749-6632.1995.tb16580.x; Petralia RS, 2009, FRONT NEUROSCI, P149; Picconi B, 2006, STROKE, V37, P1895, DOI 10.1161/01.STR.0000226981.57777.b0; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2007, CURR DRUG TARGETS, V8, P633, DOI 10.2174/138945007780618481; Saltarelli MD, 2004, STROKE, V35, P241; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Weilinger NL, 2013, ACTA PHARMACOL SIN, V34, P39, DOI 10.1038/aps.2012.95; Williams AJ, 2003, EXP BRAIN RES, V153, P16, DOI 10.1007/s00221-003-1566-6; Williams AJ, 2002, NEUROREPORT, V13, P821, DOI 10.1097/00001756-200205070-00017; Williams AJ, 2002, EUR J PHARMACOL, V452, P135, DOI 10.1016/S0014-2999(02)02327-0; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; Xiao C, 2008, NEUROPEPTIDES, V42, P601, DOI 10.1016/j.npep.2008.09.003; YANAGIHARA T, 1990, ACTA NEUROPATHOL, V80, P499, DOI 10.1007/BF00294610	57	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122840	10.1371/journal.pone.0122840	http://dx.doi.org/10.1371/journal.pone.0122840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822337	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700204
J	da Camara, SMA; Zunzunegui, MV; Pirkle, C; Moreira, MA; Maciel, ACC				da Camara, Saionara M. A.; Zunzunegui, Maria Victoria; Pirkle, Catherine; Moreira, Mayle A.; Maciel, Alvaro C. C.			Menopausal Status and Physical Performance in Middle Aged Women: A Cross-Sectional Community-Based Study in Northeast Brazil	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; SOCIAL-CLASS DIFFERENCES; LOWER-EXTREMITY FUNCTION; BRITISH BIRTH COHORT; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; MIDLIFE FINDINGS; GRIP STRENGTH; OLDER PERSONS; HEALTH	Objective To examine associations between menopausal status and physical performance in middle-aged women from the Northeast region of Brazil. Methods Cross-sectional study of women between 40 to 65 years old living in Parnamirim. Women were recruited by advertisements in primary care neighborhood centers across the city. Physical performance was assessed by grip strength, gait speed and chair stands. Menopausal status was determined using the Stages of Reproductive Aging Workshop classification and women were classified in: premenopausal, perimenopausal or postmenopausal. Multiple linear regression analyses were performed to model the effect of menopausal status on each physical performance measure, adjusting for covariates (age, family income, education, body mass index, parity and age at first birth). Results The premenopausal women were significantly stronger and performed better in chair stands than perimenopausal and postmenopausal women. Gait speed did not vary significantly by menopausal status. In multivariate analyses, menopausal status remained statistically significant only for grip strength. In fully adjusted analyses, premenopausal women had grip strength mean of 2.226 Kgf (95% CI: 0.361-4.091) higher than the postmenopausal group. Conclusions This study provides further evidence for the associations between menopause and physical performance in middle-aged women, since grip strength is weaker in peri and postmenopausal women compared to premenopausal, even adjusted for age and other covariates.	[da Camara, Saionara M. A.; Moreira, Mayle A.; Maciel, Alvaro C. C.] Univ Fed Rio Grande do Norte, Physiotherapy Dept, BR-59072970 Natal, RN, Brazil; [Zunzunegui, Maria Victoria] Univ Montreal, Sch Publ Hlth, Inst Rech Sante Publ, Quebec City, PQ, Canada; [Pirkle, Catherine] CHUQ, Ctr Rech, Axe Sante Publ & Prat Optimales Sante, Quebec City, PQ, Canada	Universidade Federal do Rio Grande do Norte; Universite de Montreal; Laval University	da Camara, SMA (corresponding author), Univ Fed Rio Grande do Norte, Physiotherapy Dept, BR-59072970 Natal, RN, Brazil.	saionaraaires@gmail.com	Maciel, Alvaro ACCM/M-4003-2017; Maciel, Álvaro Campos Cavalcanti/AAM-8606-2020; Camara, S MA/M-7513-2015	Maciel, Alvaro ACCM/0000-0002-8913-7868; Maciel, Álvaro Campos Cavalcanti/0000-0002-8913-7868; Camara, S MA/0000-0002-3054-7213; , Catherine/0000-0002-1528-5438; Zunzunegui, Maria-Victoria/0000-0003-0827-2804				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Bassey EJ, 1996, EUR J APPL PHYSIOL O, V73, P382, DOI 10.1007/BF02425503; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Cooper R, 2008, MENOPAUSE, V15, P1079, DOI 10.1097/gme.0b013e31816f63a3; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; El Khoudary SR, 2014, J GERONTOL A-BIOL, V69, P1011, DOI 10.1093/gerona/glt285; Fess E. E., 1992, GRIP STRENGTH; Gomes CD, 2014, ARCH GERONTOL GERIAT, V58, P214, DOI 10.1016/j.archger.2013.10.009; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, AGING-CLIN EXP RES, V6, P303, DOI 10.1007/BF03324256; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hansen AM, 2014, J AGING HEALTH, V26, P88, DOI 10.1177/0898264313508188; Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362; Hergenroeder Andrea L, 2011, Cardiopulm Phys Ther J, V22, P11; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kurina LM, 2004, AM J EPIDEMIOL, V160, P484, DOI 10.1093/aje/kwh244; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014; Murray ET, 2011, J GERONTOL A-BIOL, V66, P1350, DOI 10.1093/gerona/glr139; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Skelton DA, 1999, CLIN SCI, V96, P357, DOI 10.1042/CS19980318; Sowers M, 2001, J AM GERIATR SOC, V49, P1485, DOI 10.1046/j.1532-5415.2001.4911241.x; Strand BH, 2011, EUR J EPIDEMIOL, V26, P475, DOI 10.1007/s10654-011-9562-9; Tseng LA, 2012, MENOPAUSE, V19, P1186, DOI 10.1097/gme.0b013e3182565740; van Geel TACM, 2009, EUR J ENDOCRINOL, V160, P681, DOI 10.1530/EJE-08-0702; Velez MP, 2010, MENOPAUSE, V17, P552, DOI 10.1097/gme.0b013e3181ceca7a; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; World Health Organization, GLOB DAT BOD MASS IN	32	30	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119480	10.1371/journal.pone.0119480	http://dx.doi.org/10.1371/journal.pone.0119480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822526	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700037
J	Dong, YX; Tang, J; Chawla, NV; Lou, TC; Yang, Y; Wang, B				Dong, Yuxiao; Tang, Jie; Chawla, Nitesh V.; Lou, Tiancheng; Yang, Yang; Wang, Bai			Inferring Social Status and Rich Club Effects in Enterprise Communication Networks	PLOS ONE			English	Article								Social status, defined as the relative rank or position that an individual holds in a social hierarchy, is known to be among the most important motivating forces in social behaviors. In this paper, we consider the notion of status from the perspective of a position or title held by a person in an enterprise. We study the intersection of social status and social networks in an enterprise. We study whether enterprise communication logs can help reveal how social interactions and individual status manifest themselves in social networks. To that end, we use two enterprise datasets with three communication channels-voice call, short message, and email-to demonstrate the social-behavioral differences among individuals with different status. We have several interesting findings and based on these findings we also develop a model to predict social status. On the individual level, high-status individuals are more likely to be spanned as structural holes by linking to people in parts of the enterprise networks that are otherwise not well connected to one another. On the community level, the principle of homophily, social balance and clique theory generally indicate a "rich club" maintained by high-status individuals, in the sense that this community is much more connected, balanced and dense. Our model can predict social status of individuals with 93% accuracy.	[Dong, Yuxiao; Chawla, Nitesh V.; Yang, Yang] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Tang, Jie] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China; [Lou, Tiancheng] Google Inc, Mountain View, CA USA; [Wang, Bai] Beijing Univ Posts & Telecommun, Dept Comp Sci & Technol, Beijing 100088, Peoples R China	University of Notre Dame; Tsinghua University; Google Incorporated; Beijing University of Posts & Telecommunications	Chawla, NV (corresponding author), Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	nchawla@nd.edu	Yang, Yang/A-6288-2017; Chawla, Nitesh/F-2690-2016	Chawla, Nitesh/0000-0003-3932-5956	Army Research Laboratory; United States Air Force Office of Scientific Research; Defense Advanced Research Projects Agency [FA9550-12-1-0405]; National High-tech R D Program [2014AA015103]; National Basic Research Program of China [2014CB340500, 2012CB316006, 2013CB329603]; Natural Science Foundation of China [61222212]; Huawei Inc.; Beijing key lab of networked multimedia	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National High-tech R D Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huawei Inc.(Huawei Technologies); Beijing key lab of networked multimedia	YD, NVC and YY are supported by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-09-2-0053, the United States Air Force Office of Scientific Research and the Defense Advanced Research Projects Agency grant #FA9550-12-1-0405; JT is supported by the National High-tech R & D Program (No. 2014AA015103), National Basic Research Program of China (No. 2014CB340500, No. 2012CB316006), Natural Science Foundation of China (No. 61222212), a research fund supported by Huawei Inc. and Beijing key lab of networked multimedia; BW is supported by National Basic Research Program of China (2013CB329603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALBA RD, 1973, J MATH SOCIOL, V3, P113, DOI 10.1080/0022250X.1973.9989826; Brown C., 2014, CSCW14, DOI DOI 10.1145/2531602.2531641; Burt R.S., 2018, SOCIAL STRATIFICATIO, P659; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Cristian Danescu-Niculescu-Mizil, 2012, P 21 INT C WORLD WID, P699, DOI DOI 10.1145/2187836.2187931; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Dong YX, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P15, DOI 10.1145/2623330.2623703; Dong YX, 2012, IEEE DATA MINING, P181, DOI 10.1109/ICDM.2012.140; Easley D, 2010, NETWORKS CROWDS MARK; Freeman JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025107; Gilbert E., P ACM 2012 C COMP SU, P1037, DOI 10.1145/2145204.2145359; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Kleinberg J, 2008, EC'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON ELECTRONIC COMMERCE, P284; Kovanen L, 2013, P NATL ACAD SCI; Kraus MW, 2014, PLOS ONE, V01; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lafferty John, 2001, P INT C MACH LEARN, P282; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Lee C, 2011, COMMUNICATION NETW 1; Leskovec J., 2010, P INT C WORLD WID WE, P641, DOI DOI 10.1109/ICDE.2018.00077; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Lou TC, 2013, ACM T KNOWL DISCOV D, V7, DOI 10.1145/2499907.2499908; Lou Tiancheng, 2013, P 22 INT C WORLD WID, P825, DOI DOI 10.1145/2488388.2488461; Max W., 1946, CLASS STATUS PARTY E, P180; McAuley JJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773951; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILROY L, 1992, LANG SOC, V21, P1, DOI 10.1017/S0047404500015013; Palchykov V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00370; Rege M, 2008, J ECON BEHAV ORGAN, V66, P233, DOI 10.1016/j.jebo.2006.04.005; Rodkin PC, 2008, INT J BEHAV DEV, V32, P473, DOI 10.1177/0165025408093667; Salkind N., 2013, ENCY ED PSYCHOL; Szell M, 2013, SCI REPORTS      JUL, P3; Tang J., 2012, P 5 ACM INT C WEB SE, P743, DOI [http://doi.acm.org/10.1145/2124295.2124382, DOI 10.1145/2124295.2124382, 10.1145/2124295.2124382]; Tichy N. M., 1979, ACAD MANAGE REV, V4, P507, DOI [10.5465/AMR.1979.4498309, DOI 10.5465/AMR.1979.4498309]; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001; Zhao YC, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P695; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	41	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119446	10.1371/journal.pone.0119446	http://dx.doi.org/10.1371/journal.pone.0119446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822343	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700035
J	Kasuya, A; Ohta, I; Tokura, Y				Kasuya, Akira; Ohta, Isao; Tokura, Yoshiki			Structural and Immunological Effects of Skin Cryoablation in a Mouse Model	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; PROSTATIC CANCER; HISTAMINE; CRYOSURGERY; STIMULATION; RECEPTOR; INFLAMMATION; MECHANISMS; REGRESSION; ADJUVANTS	Cryoablation is therapeutically applied for various disorders in several organs, and skin diseases are typical targets as this cryotherapy has been widely used for viral warts, benign tumors, and actinic keratosis. The main mechanisms of cryoablation consist of direct freezing effect on skin constituents, thrombosis formation in microcirculation, and subsequent immunological responses. Among them, however, the immunological mechanism remains unelucidated, and it is an issue how the direct freezing injury induces immunological consequences. We established a mouse cryoablation model with liquid nitrogen applied to the shaved back skin, and used this system to study the immunological excitement. After application of liquid nitrogen, the thermal decrease ratio was -25 degrees C/sec or less and the lowest temperature was less than -100 degrees C, which was sufficient to induce ulceration. Destruction of cornified layer and necrosis of epidermal cells were observed in transmission electron microscopy image, and increased transepidermal water loss and skin permeability were detected by the functional measurements. By flow cytometry, antigen-presenting dendritic cells (DCs), including PDCA1(+)B220(+) CD19(-) plasmacytoid DCs (pDCs) and CD11c(+) myeloid DCs, as well as neutrophils and macrophages were increased in subcutaneous tissue. In parallel, the mRNA expressions of interferon alpha 1 which are known as pDC-producing cytokines, was elevated. We also found marked degranulation of mast cells, providing a possibility that released histamine attracts pDCs. Finally, FITC migration assay revealed that pDCs and CD11c(+) DCs emigrated from the cryoablated skin to the draining lymph nodes. Our study suggests that cryoablation induces destruction of the barrier/epidermis, accumulation of pDCs and CD11c(+) DCs to the skin, and migration of DCs to regional lymph nodes. Viral elements or tumor cell lysates released from damaged keratinocytes may stimulate the DCs, thereby leading to antiviral or antitumor effect.	[Kasuya, Akira; Tokura, Yoshiki] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan; [Ohta, Isao] Hamamatsu Univ, Sch Med, Ultrastruct Morphol Lab, Res Equipment Ctr, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Kasuya, A (corresponding author), Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan.	casuaki@hama-med.ac.jp						Amador-Molina A, 2013, VIRUSES-BASEL, V5, P2624, DOI 10.3390/v5112624; Baust JG, 2005, BJU INT, V95, P1187, DOI 10.1111/j.1464-410X.2005.05502.x; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Dawicki W, 2010, J IMMUNOL, V184, P2116, DOI 10.4049/jimmunol.0803894; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gittard SD, 2013, J ADHES SCI TECHNOL, V27, P227, DOI 10.1080/01694243.2012.705101; Gschwandtner M, 2011, J INVEST DERMATOL, V131, P1668, DOI 10.1038/jid.2011.72; GURSEL E, 1972, J UROLOGY, V108, P928, DOI 10.1016/S0022-5347(17)60909-1; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Ishii K, 2001, CURR BIOL, V11, pR569, DOI 10.1016/S0960-9822(01)00346-3; Kirschner N, 2012, ANN NY ACAD SCI, V1257, P158, DOI 10.1111/j.1749-6632.2012.06554.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V10, P414, DOI 10.1016/0006-3002(53)90273-X; Matin SF, 2010, J UROLOGY, V183, P333, DOI 10.1016/j.juro.2009.08.110; Muregi FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021251; OWEN DAA, 1980, BRIT J PHARMACOL, V69, P615, DOI 10.1111/j.1476-5381.1980.tb07912.x; Peh WL, 2002, J VIROL, V76, P10401, DOI 10.1128/JVI.76.20.10401-10416.2002; Sabel MS, 2009, CRYOBIOLOGY, V58, P1, DOI 10.1016/j.cryobiol.2008.10.126; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Simon T, 2012, INT IMMUNOL, V24, P107, DOI 10.1093/intimm/dxr107; SOANES WA, 1970, J UROLOGY, V104, P154, DOI 10.1016/S0022-5347(17)61690-2; Suzuki T, 2014, J DERMATOL SCI, V74, P116, DOI 10.1016/j.jdermsci.2013.12.013; TAGAMI H, 1977, ARCH DERMATOL, V113, P1209, DOI 10.1001/archderm.113.9.1209; TANAKA S, 1982, CRYOBIOLOGY, V19, P247, DOI 10.1016/0011-2240(82)90151-1; Tatsutani K, 1996, UROLOGY, V48, P441, DOI 10.1016/S0090-4295(96)00199-9; Tel J, 2012, CANCER IMMUNOL IMMUN, V61, P1279, DOI 10.1007/s00262-012-1210-z; Weber SM, 1997, SURGERY, V122, P742, DOI 10.1016/S0039-6060(97)90082-9; Yang G, 2011, CRYOBIOLOGY, V63, P38, DOI 10.1016/j.cryobiol.2011.04.007	33	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123906	10.1371/journal.pone.0123906	http://dx.doi.org/10.1371/journal.pone.0123906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821968	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700242
J	Ma, J; Lu, C; Liu, HM				Ma, Jian; Lu, Chen; Liu, Hongmei			Fault Diagnosis for the Heat Exchanger of the Aircraft Environmental Control System Based on the Strong Tracking Filter	PLOS ONE			English	Article								The aircraft environmental control system (ECS) is a critical aircraft system, which provides the appropriate environmental conditions to ensure the safe transport of air passengers and equipment. The functionality and reliability of ECS have received increasing attention in recent years. The heat exchanger is a particularly significant component of the ECS, because its failure decreases the system's efficiency, which can lead to catastrophic consequences. Fault diagnosis of the heat exchanger is necessary to prevent risks. However, two problems hinder the implementation of the heat exchanger fault diagnosis in practice. First, the actual measured parameter of the heat exchanger cannot effectively reflect the fault occurrence, whereas the heat exchanger faults are usually depicted by utilizing the corresponding fault-related state parameters that cannot be measured directly. Second, both the traditional Extended Kalman Filter (EKF) and the EKF-based Double Model Filter have certain disadvantages, such as sensitivity to modeling errors and difficulties in selection of initialization values. To solve the aforementioned problems, this paper presents a fault-related parameter adaptive estimation method based on strong tracking filter (STF) and Modified Bayes classification algorithm for fault detection and failure mode classification of the heat exchanger, respectively. Heat exchanger fault simulation is conducted to generate fault data, through which the proposed methods are validated. The results demonstrate that the proposed methods are capable of providing accurate, stable, and rapid fault diagnosis of the heat exchanger.	[Ma, Jian; Lu, Chen; Liu, Hongmei] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Ma, Jian; Lu, Chen] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China	Beihang University	Lu, C (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	luchen@buaa.edu.cn	Lu, Chen/B-6310-2016		National Natural Science Foundation of China [61074083, 50705005, 51105019]; Technology Foundation Program of National Defense [Z132010B004]; Innovation Foundation of BUAA for PhD Graduates	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation Program of National Defense; Innovation Foundation of BUAA for PhD Graduates	This study is supported by the National Natural Science Foundation of China (Grant Nos. 61074083, 50705005, and 51105019) and by the Technology Foundation Program of National Defense (Grant No. Z132010B004), as well as the Innovation Foundation of BUAA for PhD Graduates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jonsson GR, 2007, INT J HEAT MASS TRAN, V50, P2643, DOI 10.1016/j.ijheatmasstransfer.2006.11.025; Lin S., 2009, P IEEE WIR COMM NETW, P1, DOI DOI 10.1109/ICCE.2009.5012233; Mutambara A. G. O., 1999, Proceedings of the 1999 American Control Conference (Cat. No. 99CH36251), P3918, DOI 10.1109/ACC.1999.786251; Pang Liping, 2008, Acta Aeronautica et Astronautica Sinica, V29, P548; Perez-Grande I, 2002, APPL THERM ENG, V22, P1885, DOI 10.1016/S1359-4311(02)00130-8; Price DC, 2003, P IEEE SEMICOND THER, P341, DOI 10.1109/STHERM.2003.1194383; Tu Y, 2011, J AIRCRAFT, V48, P2031, DOI 10.2514/1.C031433; Wang D, 2004, CHINESE J CHEM ENG, V12, P60; Wright S, 2009, APPL THERM ENG, V29, P2596, DOI 10.1016/j.applthermaleng.2009.01.002; Zhou DH, 1998, IEEE T AERO ELEC SYS, V34, P420, DOI 10.1109/7.670324	10	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122829	10.1371/journal.pone.0122829	http://dx.doi.org/10.1371/journal.pone.0122829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823010	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700201
J	Wong, LL; Pye, QN; Chen, LJ; Seal, S; McGinnis, JF				Wong, Lily L.; Pye, Quentin N.; Chen, Lijuan; Seal, Sudipta; McGinnis, James F.			Defining the Catalytic Activity of Nanoceria in the P23H-1 Rat, a Photoreceptor Degeneration Model	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INTRAVITREAL INJECTION; OXIDATIVE STRESS; RETINAL DEGENERATION; TRANSGENIC RAT; TUBBY MICE; IN-SITU; APOPTOSIS; RHODOPSIN; NANOPARTICLES	Purpose Inorganic catalytic nanoceria or cerium oxide nanoparticles (CeNPs) are bona fide antioxidants that possess regenerative radical scavenging activities in vitro. Previously, we demonstrated that CeNPs had neuroprotective and anti-angiogenic properties in rodent retinal degeneration and neovascularization models. However, the cellular mechanisms and duration of the catalytic activity of CeNPs in preventing photoreceptor cell loss are still unknown. In this study, we sought to answer these questions using the P23H-1 rat, an autosomal dominant retinitis pigmentosa (adRP) model. Methods A single dose of either saline or CeNPs was delivered intravitreally into the eyes of P23H-1 rats at 2-3 weeks of age. Retinal functions were examined at 3 to 7 weeks post injection. We quantified retinal proteins by Western blot analyses and counted the number of apoptotic (TUNEL+) profiles in the outer nuclear layer (ONL) of retinal sections. We measured free 8-isoprostanes to quantify lipid peroxidation in retinal tissues. Results We observed increased rod and cone cell functions up to three weeks post injection. Apoptotic cells were reduced by 46%, 56%, 21%, and 24% at 3, 7, 14, 21 days, respectively, after CeNPs injection compared to saline. Additionally, reduction of lipid peroxidation in the retinas of CeNPs-treated vs saline-treated animals was detected 14 days post injection. Conclusions We validated that CeNPs were effective in delaying loss of photoreceptor cell function in an adRP rat model. This represents the fourth rodent retinal disease model that shows delay in disease progression after a single application of CeNPs. We further demonstrated that CeNPs slowed the rate of photoreceptor cell death. We deduced that the catalytic activity of CeNPs in vivo in this rat model to be undiminished for at least 7 days and then declined over the next 14 days after CeNPs administration.	[Wong, Lily L.; Pye, Quentin N.; Chen, Lijuan; McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Wong, Lily L.; Pye, Quentin N.; Chen, Lijuan; McGinnis, James F.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Seal, Sudipta] Univ Cent Florida, Coll Med, Mat Sci & Engn Nanosci & Technol Ctr, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Grad Coll, Dept Cell Biol, Oklahoma City, OK 73190 USA; [McGinnis, James F.] Univ Oklahoma, Hlth Sci Ctr, Grad Coll, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Central Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wong, LL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Ophthalmol, Oklahoma City, OK 73190 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019		National Institutes of Health (NIH) [R01 EY02211]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR11-04]; Presbyterian Health Foundation (PHF); Research to Prevent Blindness (RPB); NEI/DMEI Vision Core Facility grant at OUHSC (NIH) [P30-EY021725]; NATIONAL EYE INSTITUTE [P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology (OCAST); Presbyterian Health Foundation (PHF); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NEI/DMEI Vision Core Facility grant at OUHSC (NIH); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by grants from the National Institutes of Health (NIH): R01 EY02211 (JFM) (http://www.nei.nih.gov/), Oklahoma Center for the Advancement of Science and Technology (OCAST) HR11-04 (JFM) (http://www.ok.gov/ocast/), unrestricted funds from the Presbyterian Health Foundation (PHF) (http://www.phfokc.com/) and Research to Prevent Blindness (RPB) (http://www.rpbusa.org/rpb/), to the Dean McGee Eye Institute. This work was also supported in part by the NEI/DMEI Vision Core Facility grant at OUHSC (NIH: P30-EY021725) (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Aslan M, 2008, FREE RADICAL BIO MED, V45, P367, DOI 10.1016/j.freeradbiomed.2008.04.026; Cai X, 2014, BIOMATERIALS, V35, P249, DOI 10.1016/j.biomaterials.2013.10.022; Cai X, 2012, BIOMATERIALS, V33, P8771, DOI 10.1016/j.biomaterials.2012.08.030; Celardo Ivana, 2011, J Exp Ther Oncol, V9, P47; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen J, 2008, ADV EXP MED BIOL, V613, P53, DOI 10.1007/978-0-387-74904-4_5; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Falkenstein IA, 2007, RETINA-J RET VIT DIS, V27, P1044, DOI 10.1097/IAE.0b013e3180592ba6; Farrar GJ, 2012, GENE THER, V19, P137, DOI 10.1038/gt.2011.172; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLD R, 1994, LAB INVEST, V71, P219; Goldstein JC, 2000, ANN NY ACAD SCI, V926, P132; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Inohara N, 2000, CELL DEATH DIFFER, V7, P509, DOI 10.1038/sj.cdd.4400679; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kong L, 2006, NEUROBIOL DIS, V21, P468, DOI 10.1016/j.nbd.2005.08.017; Kong L, 2011, NEUROBIOL DIS, V42, P514, DOI 10.1016/j.nbd.2011.03.004; Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kyosseva SV, 2013, EXP EYE RES, V116, P63, DOI 10.1016/j.exer.2013.08.003; La Vail MM., 2005, RETINAL DEGENERATION; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Marc RE, RODENT HUMAN EYE MEA; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Perlman I., 2011, ELECTRORETINOGRAM ER; Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Roberts LJ, 2009, J LIPID RES, V50, pS219, DOI 10.1194/jlr.R800037-JLR200; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Vincent A, 2010, LANGMUIR, V26, P7188, DOI 10.1021/la904285g; Wong LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058431; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	47	39	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121977	10.1371/journal.pone.0121977	http://dx.doi.org/10.1371/journal.pone.0121977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822196	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700143
J	Zhang, ZH; Chen, L; Ni, HY				Zhang, Zhongheng; Chen, Lin; Ni, Hongying			Antipyretic Therapy in Critically Ill Patients with Sepsis: An Interaction with Body Temperature	PLOS ONE			English	Article							FEBRILE PATIENTS; FEVER; HYPERTHERMIA; MULTICENTER; MANAGEMENT; PHYSIOLOGY; MORTALITY; EXPOSURE	Background and Objective The effect of antipyretic therapy on mortality in patients with sepsis remains undetermined. The present study aimed to investigate the role of antipyretic therapy in ICU patients with sepsis by using a large clinical database. Methods The multiparameter intelligent monitoring in intensive care II (MIMIC-II) database was employed for the study. Adult patients with sepsis were included for analysis. Antipyretic therapy included antipyretic medication and external cooling. Multivariable model with interaction terms were employed to explore the association of antipyretic therapy and mortality risk. Main Results A total of 15,268 patients fulfilled inclusion criteria and were included in the study. In multivariable model by treating temperature as a continuous variable, there was significant interaction between antipyretic therapy and the maximum temperature (T-max). While antipyretic therapy had no significant effect on mortality in low temperature quintiles, antipyretic therapy was associated with increased risk of death in the quintile with body temperature >39 degrees C (OR: 1.29, 95% CI: 1.04-1.61). Conclusion Our study shows that there is no beneficial effect on reducing mortality risk with the use of antipyretic therapy in ICU patients with sepsis. External cooling may even be harmful in patients with sepsis.	[Zhang, Zhongheng; Chen, Lin; Ni, Hongying] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	Zhang, Zhongheng/E-1282-2011; zhang, zh/GWV-4677-2022	Zhang, Zhongheng/0000-0002-2336-5323; 	science and technology foundation of Jinhua city [2013-3-008]	science and technology foundation of Jinhua city	The study was funded by the science and technology foundation of Jinhua city (approval No. 2013-3-008)(http://www.zjjhst.gov.cn/kjzw/Default.aspx) HN received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod P, 2000, CLIN INFECT DIS, V31, pS224, DOI 10.1086/317516; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; BERNARD GR, 1991, AM REV RESPIR DIS, V144, P1095, DOI 10.1164/ajrccm/144.5.1095; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Drewry AM, 2013, CHEST, V144, P1098, DOI 10.1378/chest.13-0918; Greisman LA, 2002, CURR OPIN INFECT DIS, V15, P241, DOI 10.1097/00001432-200206000-00005; HAUPT MT, 1991, CRIT CARE MED, V19, P1339, DOI 10.1097/00003246-199111000-00006; Karnad DR, 2014, INTENS CARE MED, V40, P830, DOI 10.1007/s00134-014-3278-8; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; Launey Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10097; Laupland KB, 2008, CRIT CARE MED, V36, P1531, DOI 10.1097/CCM.0b013e318170efd3; Laupland KB, 2009, CRIT CARE MED, V37, pS273, DOI 10.1097/CCM.0b013e3181aa6117; Leligdowicz A, 2014, AM J RESP CRIT CARE, V189, P1204, DOI 10.1164/rccm.201310-1875OC; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; McPherson D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002586; Memis D, 2004, CRIT CARE, V8, pR474, DOI 10.1186/cc2969; Mohr N, 2012, INTERN EMERG MED, V7, P463, DOI 10.1007/s11739-012-0848-z; Mohr NM, 2013, CHEST, V144, P1096, DOI 10.1378/chest.13-0916; Neto AS, 2013, J CRIT CARE, V28, P681, DOI 10.1016/j.jcrc.2013.04.005; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Sund-Levander M, 2009, INT J NURS PRACT, V15, P241, DOI 10.1111/j.1440-172X.2009.01756.x; Tulapurkar ME, 2009, CELL STRESS CHAPERON, V14, P499, DOI 10.1007/s12192-009-0103-3; Wang Xiaoting, 2014, Zhonghua Nei Ke Za Zhi, V53, P293; Yang YL, 2013, CHINESE MED J-PEKING, V126, P1809, DOI 10.3760/cma.j.issn.0366-6999.20121880; Zhang ZH, 2014, J THORAC DIS, V6, P995, DOI 10.3978/j.issn.2072-1439.2014.07.01; Zhang ZH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-86; [No title captured]	32	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121919	10.1371/journal.pone.0121919	http://dx.doi.org/10.1371/journal.pone.0121919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822614	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700137
J	Mathew, DC; Ho, YN; Gicana, RG; Mathew, GM; Chien, MC; Huang, CC				Mathew, Dony Chacko; Ho, Ying-Ning; Gicana, Ronnie Gicaraya; Mathew, Gincy Marina; Chien, Mei-Chieh; Huang, Chieh-Chen			A Rhizosphere-Associated Symbiont, Photobacterium spp. Strain MELD1, and Its Targeted Synergistic Activity for Phytoprotection against Mercury	PLOS ONE			English	Article							CONTAMINATED SOIL; MINAMATA BAY; METAL UPTAKE; MERA GENE; SP-NOV.; RESISTANCE; BACTERIA; PLANTS; ACCUMULATION; SEDIMENT	Though heavy metal such as mercury is toxic to plants and microorganisms, the synergistic activity between them may offer benefit for surviving. In this study, a mercury-reducing bacterium, Photobacterium spp. strain MELD1, with an MIC of 33 mg. kg(-1) mercury was isolated from a severely mercury and dioxin contaminated rhizosphere soil of reed (Phragmites australis). While the whole genome sequencing of MELD1 confirmed the presence of a mer operon, the mercury reductase MerA gene showed 99% sequence identity to Vibrio shilloni AK1 and implicates its route resulted from the event of horizontal gene transfer. The efficiency of MELD1 to vaporize mercury (25 mg. kg(-1), 24 h) and its tolerance to toxic metals and xenobiotics such as lead, cadmium, pentachlorophenol, pentachloroethylene, 3-chlorobenzoic acid, 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxin is promising. Combination of a long yard bean (Vigna unguiculata ssp. Sesquipedalis) and strain MELD1 proved beneficial in the phytoprotection of mercury in vivo. The effect of mercury (Hg) on growth, distribution and tolerance was examined in root, shoot, leaves and pod of yard long bean with and without the inoculation of strain MELD1. The model plant inoculated with MELD1 had significant increases in biomass, root length, seed number, and increased mercury uptake limited to roots. Biolog plate assay were used to assess the sole-carbon source utilization pattern of the isolate and Indole-3-acetic acid (IAA) productivity was analyzed to examine if the strain could contribute to plant growth. The results of this study suggest that, as a rhizosphere-associated symbiont, the synergistic activity between the plant and MELD1 can improve the efficiency for phytoprotection, phytostabilization and phytoremediation of mercury.	[Mathew, Dony Chacko; Ho, Ying-Ning; Chien, Mei-Chieh; Huang, Chieh-Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Gicana, Ronnie Gicaraya] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Mathew, Gincy Marina] Mar Athanasios Coll Adv Studies MACFAST BIOCAMPUS, Sch Biosci, Tiruvalla, Kerala, India	National Chung Hsing University; National Chung Hsing University	Huang, CC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	cchuang@dragon.nchu.edu.tw	Huang, Chieh Chen/GMX-4191-2022; Mathew, Dony/I-6115-2015	Huang, Chieh Chen/0000-0002-3739-6315; Mathew, Dony/0000-0001-6822-2716	National Science Council [101-2622-E-006-010-CC1]	National Science Council(Ministry of Science and Technology, Taiwan)	Development of Integrated Phyto-Bioremediation Technology for Toxic Waste: Using An-Shun Site as a Model" project (101-2622-E-006-010-CC1) was funded by the National Science Council. The funders had a role in providing permits for data collection. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Allen RC, 2013, FEMS MICROBIOL ECOL, V83, P135, DOI 10.1111/j.1574-6941.2012.01460.x; Anderson CWN, 1999, J GEOCHEM EXPLOR, V67, P407, DOI 10.1016/S0375-6742(99)00055-2; Ast JC, 2007, INT J SYST EVOL MICR, V57, P2073, DOI 10.1099/ijs.0.65153-0; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BAUMANN P, 1983, ANNU REV MICROBIOL, V37, P369, DOI 10.1146/annurev.mi.37.100183.002101; Bidar G, 2009, ENVIRON SCI POLLUT R, V16, P42, DOI 10.1007/s11356-008-0021-4; Bogdanova ES, 1998, MICROBIOL-SGM, V144, P609, DOI 10.1099/00221287-144-3-609; Boyd ES, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00349; Bragato C, 2006, ENVIRON POLLUT, V144, P967, DOI 10.1016/j.envpol.2006.01.046; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; Bressan W, 2004, BIOCONTROL, V49, P315, DOI 10.1023/B:BICO.0000025372.51658.93; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Chadhain SMN, 2006, ENVIRON MICROBIOL, V8, P1746, DOI 10.1111/j.1462-2920.2006.01114.x; ChandraShekar CH, 2011, INT J PHARM BIOSCI, V2, P364, DOI [10.1016/j.ijpharm.2011.10.009, DOI 10.1016/J.IJPHARM.2011.10.009]; Chang HJ, 2010, J ENVIRON SCI HEAL A, V45, P923, DOI 10.1080/10934521003772303; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; de Andres F, 2007, SCI TOTAL ENVIRON, V378, P81, DOI 10.1016/j.scitotenv.2007.01.017; de Souza MP, 1999, PLANTA, V209, P259, DOI 10.1007/s004250050630; Deivanai S., 2014, Journal of Stress Physiology & Biochemistry, V10, P275; Domenico P.A., 1998, PHYS CHEM HYDROGEOLO, P506; Ebinghaus R, 1999, MERCURY CONTAMINATED, P1, DOI DOI 10.1007/978-3-662-03754-6_1; Glick BR, 2003, BIOTECHNOL ADV, V21, P383, DOI 10.1016/S0734-9750(03)00055-7; Ho CH, 2007, INT J PHYTOREMEDIAT, V9, P107, DOI 10.1080/15226510701232765; Ho YN, 2012, J HAZARD MATER, V15, P219; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Huang CC, 1999, GENE, V234, P361, DOI 10.1016/S0378-1119(99)00184-5; Huang HC., 2002, TAIWAN WATCH, V4, P80; Iohara K, 2001, APPL MICROBIOL BIOT, V56, P736, DOI 10.1007/s002530100734; Khanna Shibha, 1995, Indian Journal of Experimental Biology, V33, P766; Kibria MG, 2008, SOIL ENVRON, V27, P23; Lodewyckx C, 2001, INT J PHYTOREMEDIAT, V3, P173, DOI 10.1080/15226510108500055; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Nriagu J. O., 1979, BIOGEOCHEMISTRY MERC, P79; OKUZUMI M, 1994, INT J SYST BACTERIOL, V44, P631, DOI 10.1099/00207713-44-4-631; Pant P, 2011, INT J PHYTOREMEDIAT, V13, P168, DOI 10.1080/15226510903567489; Patra M, 2004, ENVIRON EXP BOT, V52, P199, DOI 10.1016/j.envexpbot.2004.02.009; Permina EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-49; Pichtel J, 2008, BIORESOURCE TECHNOL, V99, P1242, DOI 10.1016/j.biortech.2007.02.042; Research Development and Evaluation Commission., HIST AN SHUN PLANT; Resmi R., 2004, Journal of Tropical Agriculture, V42, P55; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; Salt DE, 1999, INT J PHYTOREMEDIAT, V1, P67, DOI 10.1080/15226519908500005; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Segura A, 2009, MICROB BIOTECHNOL, V2, P452, DOI 10.1111/j.1751-7915.2009.00113.x; Silvente S, 2008, J EXP BOT, V59, P1279, DOI 10.1093/jxb/ern034; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CH, 2012, ADV MATER RES-SWITZ, V343-344, P283, DOI 10.4028/www.scientific.net/AMR.343-344.283; U.S. Army Engineering Corp, 2000, IN SIT EL REM MET CO; Ueno A, 2007, WORLD J MICROB BIOT, V23, P1739, DOI 10.1007/s11274-007-9423-6; USEPA, 1997, EPA452R97009 OFF AIR; Vazquez S, 2006, WATER AIR SOIL POLL, V177, P349, DOI 10.1007/s11270-006-9178-y; Velasco-Alinsug MR, 2005, Z NATURFORSCH C, V60, P252; Villar-Salvador P, 2008, ENVIRON EXP BOT, V64, P145, DOI 10.1016/j.envexpbot.2008.04.005; Washington JA, 1980, DILUTION SUSCEPTIBIL, P453; Wilson JR, 2000, FEBS LETT, V472, P78, DOI 10.1016/S0014-5793(00)01430-7; Wireman J, 1997, APPL ENVIRON MICROB, V63, P4494, DOI 10.1128/AEM.63.11.4494-4503.1997; Wyszkowski Miroslaw, 2004, Polish Journal of Natural Sciences, V16, P123; Yoshizawa S, 2009, INT J SYST EVOL MICR, V59, P1438, DOI 10.1099/ijs.0.004309-0; Yurieva O, 1997, MOL MICROBIOL, V24, P321, DOI 10.1046/j.1365-2958.1997.3261688.x; Zeyaullah M, 2010, AFR J BIOTECHNOL, V9, P3510; Zhang F, 2005, CHEM ENG, V1, P14	68	22	25	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121178	10.1371/journal.pone.0121178	http://dx.doi.org/10.1371/journal.pone.0121178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816328	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600070
J	Mihaljevic, AL; Muller, TC; Kehl, V; Friess, H; Kleeff, J				Mihaljevic, Andre L.; Mueller, Tara C.; Kehl, Victoria; Friess, Helmut; Kleeff, Joerg			Wound Edge Protectors in Open Abdominal Surgery to Reduce Surgical Site Infections: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ELECTIVE COLORECTAL SURGERY; CIRCULAR POLYETHYLENE DRAPE; RANDOMIZED CONTROLLED-TRIAL; HOSPITAL STAY; RING DRAPE; PREVENTION; PROPHYLAXIS; MULTICENTER; CEFOTETAN; RATES	Importance Surgical site infections remain one of the most frequent complications following abdominal surgery and cause substantial costs, morbidity and mortality. Objective To assess the effectiveness of wound edge protectors in open abdominal surgery in reducing surgical site infections. Evidence Review A systematic literature search was conducted according to a prespecified review protocol in a variety of data-bases combined with hand-searches for randomized controlled trials on wound edge protectors in patients undergoing laparotomy. A qualitative and quantitative analysis of included trials was conducted. Findings We identified 16 randomized controlled trials including 3695 patients investigating wound edge protectors published between 1972 and 2014. Critical appraisal uncovered a number of methodological flaws, predominantly in the older trials. Wound edge protectors significantly reduced the rate of surgical site infections (risk ratio 0.65; 95% CI, 0.51-0.83; p = 0.0007; I-2 = 52%). The results were robust in a number of sensitivity analyses. A similar effect size was found in the subgroup of patients undergoing colorectal surgery (risk ratio 0.65; 95% CI, 0.44-0.97; p = 0.04; I-2 = 56%). Of the two common types of wound protectors double ring devices were found to exhibit a greater protective effect (risk ratio 0.29; 95% CI, 0.15-0.55) than single-ring devices (risk ratio 0.71; 95% CI, 0.54-0.92), but this might largely be due to the lower quality of available data for double-ring devices. Exploratory subgroup analyses for the degree of contamination showed a larger protective effect in contaminated cases (0.44; 95% CI, 0.28-0.67; p = 0.0002, I-2 = 23%) than in clean-contaminated surgeries (0.72, 95% CI, 0.57-0.91; p = 0.005; I-2 = 46%) and a strong effect on the reduction of superficial surgical site infections (risk ratio 0.45; 95% CI, 0.24-0.82; p = 0.001; I-2 = 72%). Conclusions and Relevance Wound edge protectors significantly reduce the rate of surgical site infections in open abdominal surgery. Further trials are needed to explore their effectiveness in different risk constellations.	[Mihaljevic, Andre L.; Mueller, Tara C.; Friess, Helmut; Kleeff, Joerg] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-81675 Munich, Germany; [Kehl, Victoria] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich	Kleeff, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	joerg.kleeff@tum.de	Kleeff, Jorg/B-2124-2009; Mueller, Tara/AAE-6774-2022	Kleeff, Jorg/0000-0003-3432-6669; Mihaljevic, Andre/0000-0003-1902-657X				ARNAUD JP, 1992, J HOSP INFECT, V22, P23, DOI 10.1016/S0195-6701(05)80004-0; Astagneau P, 2001, J HOSP INFECT, V48, P267, DOI 10.1053/jhin.2001.1003; Baier P, 2012, INT J COLORECTAL DIS, V27, P1223, DOI 10.1007/s00384-012-1484-9; BATZ W, 1987, AKTUEL CHIR, V22, P149; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035; Bennett-Guerrero E, 2010, NEW ENGL J MED, V363, P1038, DOI 10.1056/NEJMoa1000837; Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020; Bruce J, 2001, J HOSP INFECT, V49, P99, DOI 10.1053/jhin.2001.1045; Brunet P, 1994, LYON CHIR, V90, P438; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cheng KP, 2012, COLORECTAL DIS, V14, pE346, DOI 10.1111/j.1463-1318.2012.02943.x; COELLO R, 1993, J HOSP INFECT, V25, P239, DOI 10.1016/0195-6701(93)90110-L; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards JP, 2012, ANN SURG, V256, P53, DOI 10.1097/SLA.0b013e3182570372; European Centre for Disease Control and Prevention (ECDC), 2010, ANN EP REP COMM DIS; Fry Donald E, 2002, Surg Infect (Larchmt), V3 Suppl 1, pS37, DOI 10.1089/sur.2002.3.s1-37; Gamble S S, 1984, J R Coll Surg Edinb, V29, P232; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Gheorghe A, 2012, ANN SURG, V255, P1017, DOI 10.1097/SLA.0b013e31823e7411; HARROWER HW, 1968, AM J SURG, V116, P824, DOI 10.1016/0002-9610(68)90449-2; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Horiuchi T, 2007, J TRAUMA, V62, P212, DOI 10.1097/01.ta.0000196704.78785.ae; Horiuchi T, 2010, SURG INFECT, V11, P501, DOI 10.1089/sur.2009.072; Itani KMF, 2006, NEW ENGL J MED, V355, P2640, DOI 10.1056/NEJMoa054408; KAPPSTEIN I, 1992, THORAC CARDIOV SURG, V40, P148, DOI 10.1055/s-2007-1020134; Kercher KW, 2004, SURG ENDOSC, V18, P148, DOI 10.1007/s00464-003-8137-6; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Lee P, 2009, ARCH SURG-CHICAGO, V144, P872, DOI 10.1001/archsurg.2009.151; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Merle V, 2000, AM J INFECT CONTROL, V28, P109; Mihaljevic AL, 2014, MULTICENTER DOUBLE B, P31; Mihaljevic AL, 2014, ANN SURG, V260, P730, DOI 10.1097/SLA.0000000000000954; Mihaljevic AL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-57; Milsom JW, 1998, AM J SURG, V176, p46S, DOI 10.1016/S0002-9610(98)00220-7; Moayyedi P, 2004, AM J GASTROENTEROL, V99, P2297, DOI 10.1111/j.1572-0241.2004.40948.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NYSTROM PO, 1980, ACTA CHIR SCAND, V146, P65; NYSTROM PO, 1984, DIS COLON RECTUM, V27, P451, DOI 10.1007/BF02555535; Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; POULSEN KB, 1994, EPIDEMIOL INFECT, V113, P283, DOI 10.1017/S0950268800051712; PSAILA JV, 1977, BRIT J SURG, V64, P729, DOI 10.1002/bjs.1800641012; REDMOND HP, 1994, BRIT J SURG, V81, P1811; Reid K, 2010, DIS COLON RECTUM, V53, P1374, DOI 10.1007/DCR.0b013e3181ed3f7e; Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99; Sookhai S, 1999, LANCET, V353, P1585, DOI 10.1016/S0140-6736(99)00950-2; Sookhai S, 1999, LANCET, P353; Tanner J, 2009, J HOSP INFECT, V72, P243, DOI 10.1016/j.jhin.2009.03.021; The Nordic Cochrane Centre The Cochrane Collaboration, 2012, REVIEW MANAGER REVMA; Theodoridis TD, 2011, CLIN EXP OBSTET GYN, V38, P57; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; WILLIAMS JA, 1972, BRIT J SURG, V59, P142, DOI 10.1002/bjs.1800590218	54	37	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121187	10.1371/journal.pone.0121187	http://dx.doi.org/10.1371/journal.pone.0121187			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816365	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600071
J	Perez-Torrado, R; Llopis, S; Perrone, B; Gomez-Pastor, R; Hube, B; Querol, A				Perez-Torrado, Roberto; Llopis, Silvia; Perrone, Benedetta; Gomez-Pastor, Rocio; Hube, Bernhard; Querol, Amparo			Comparative Genomic Analysis Reveals a Critical Role of De Novo Nucleotide Biosynthesis for Saccharomyces cerevisiae Virulence	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; CANDIDA-ALBICANS; YEAST STRAINS; FOOD; ORIGIN; GENES; IDENTIFICATION; PATHOGENESIS; DEPENDS; GROWTH	In recent years, the number of human infection cases produced by the food related species Saccharomyces cerevisiae has increased. Whereas many strains of this species are considered safe, other 'opportunistic' strains show a high degree of potential virulence attributes and can cause infections in immunocompromised patients. Here we studied the genetic characteristics of selected opportunistic strains isolated from dietary supplements and also from patients by array comparative genomic hybridization. Our results show increased copy numbers of IMD genes in opportunistic strains, which are implicated in the de novo biosynthesis of the purine nucleotides pathway. The importance of this pathway for virulence of S. cerevisiae was confirmed by infections in immunodeficient murine models using a GUA1 mutant, a key gene of this pathway. We show that exogenous guanine, an end product of this pathway in its triphosphorylated form, increases the survival of yeast strains in ex vivo blood infections. Finally, we show the importance of the DNA damage response that activates dNTP biosynthesis in yeast cells during ex vivo blood infections. We conclude that opportunistic yeasts may use an enhanced de novo biosynthesis of the purine nucleotides pathway to increase survival and favor infections in the host.	[Perez-Torrado, Roberto; Llopis, Silvia; Perrone, Benedetta; Gomez-Pastor, Rocio; Querol, Amparo] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Perrone, Benedetta] Univ Turin, Dept Agr Forest & Food Sci Microbiol, Turin, Italy; [Perrone, Benedetta] Univ Turin, Food Technol Unit, Turin, Italy; [Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Turin; University of Turin; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Querol, A (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	aquerol@iata.csic.es	Querol, Amparo/AAW-7469-2020; Querol, Amparo/H-3782-2012; Perez Torrado, Roberto/E-7613-2012	Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845; Hube, Bernhard/0000-0002-6028-0425; Perez Torrado, Roberto/0000-0002-3118-6755	PROMETEO grant from the Generalitat Valenciana [PROMETEOII/2014/042]; FPU fellowship from the Spanish Ministry of Education and Science (MEC); JAEDOC postdoctoral program (CSIC)	PROMETEO grant from the Generalitat Valenciana; FPU fellowship from the Spanish Ministry of Education and Science (MEC)(National Health and Medical Research Council (NHMRC) of Australia); JAEDOC postdoctoral program (CSIC)	This work was supported by PROMETEO grant (Project PROMETEOII/2014/042) from the Generalitat Valenciana. S. Llopis was a recipient of a FPU fellowship from the Spanish Ministry of Education and Science (MEC). R. Perez-Torrado was supported by the JAEDOC postdoctoral program (CSIC) cofounded by ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson BL, 2010, NUCLEIC ACIDS RES, V38; Babrzadeh F, 2012, MOL GENET GENOMICS, V287, P485, DOI 10.1007/s00438-012-0695-7; Belloch C, 2009, APPL ENVIRON MICROB, V75; BYRON JK, 1995, INFECT IMMUN, V63, P478, DOI 10.1128/IAI.63.2.478-485.1995; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; Collins JD, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2497; de Llanos R, 2011, INT J FOOD MICROBIOL, V144, P393, DOI 10.1016/j.ijfoodmicro.2010.10.025; de Llanos R, 2006, ANTON LEEUW INT J G, V90, P221, DOI 10.1007/s10482-006-9077-7; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; ENG RHK, 1984, SABOURAUDIA, V22, P403; Escobar-Henriques M, 2001, J BIOL CHEM, V276, P1523, DOI 10.1074/jbc.M007926200; Fasullo M, 2010, NUCLEIC ACIDS RES, V38, P1195, DOI 10.1093/nar/gkp1064; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Iglesias-Gato D, 2011, GENETICS, V187, P105, DOI 10.1534/genetics.110.122135; JENSEN DP, 1976, ARCH INTERN MED, V136, P332, DOI 10.1001/archinte.136.3.332; Jiang LH, 2010, FEMS YEAST RES, V10, P199, DOI 10.1111/j.1567-1364.2009.00600.x; Kirdis E, 2007, MICROB PATHOGENESIS, V43, P179, DOI 10.1016/j.micpath.2007.05.008; Klingberg TD, 2008, FEMS YEAST RES, V8, P631, DOI 10.1111/j.1567-1364.2008.00365.x; Launhardt H, 1998, YEAST, V14, P935, DOI 10.1002/(SICI)1097-0061(199807)14:10<935::AID-YEA289>3.0.CO;2-9; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Leuschner RGK, 2010, TRENDS FOOD SCI TECH, V21, P425, DOI 10.1016/j.tifs.2010.07.003; Lin L, 2012, J INFECT DIS, V205, P337, DOI 10.1093/infdis/jir725; Llopis S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-419; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P2613, DOI 10.1128/JCM.36.9.2613-2617.1998; McCullough MJ, 1998, MED MYCOL, V36, P213; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916; Murphy A, 1999, ENZYME MICROB TECH, V25, P551, DOI 10.1016/S0141-0229(99)00086-1; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Ponton J, 2000, MED MYCOL, V38, P225, DOI 10.1080/mmy.38.s1.225.236; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Smalley D, 2002, J BACTERIOL, V184, P895, DOI 10.1128/jb.184.4.895-903.2002; Smith D, 2002, J CLIN MICROBIOL, V40, P2691, DOI 10.1128/JCM.40.7.2691-2692.2002; Stephens-Romero SD, 2005, INFECT IMMUN, V73, P114, DOI 10.1128/IAI.73.1.114-125.2005; WELCH JW, 1983, MOL CELL BIOL, V3, P1353, DOI 10.1128/MCB.3.8.1353; Yanez A., 2009, Open Mycology Journal, V3, P37, DOI 10.2174/1874437000903010037	47	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122382	10.1371/journal.pone.0122382	http://dx.doi.org/10.1371/journal.pone.0122382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816288	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600174
J	Traczyk, J; Sobkow, A; Zaleskiewicz, T				Traczyk, Jakub; Sobkow, Agata; Zaleskiewicz, Tomasz			Affect-Laden Imagery and Risk Taking: The Mediating Role of Stress and Risk Perception	PLOS ONE			English	Article							VISUAL-IMAGERY; EEG ALPHA; AFFECTIVE PSYCHOLOGY; DECISION-MAKING; MENTAL-IMAGERY; EMOTION; PROBABILITY; PERSPECTIVE; COGNITION; CHOICES	This paper investigates how affect-laden imagery that evokes emotional stress influences risk perception and risk taking in real-life scenarios. In a series of three studies, we instructed participants to imagine the consequences of risky scenarios and then rate the intensity of the experienced stress, perceived risk and their willingness to engage in risky behavior. Study 1 showed that people spontaneously imagine negative rather than positive risk consequences, which are directly related to their lower willingness to take risk. Moreover, this relationship was mediated by feelings of stress and risk perception. Study 2 replicated and extended these findings by showing that imagining negative risk consequences evokes psychophysiological stress responses observed in elevated blood pressure. Finally, in Study 3, we once again demonstrated that a higher intensity of mental images of negative risk consequences, as measured by enhanced brain activity in the parieto-occipital lobes, leads to a lower propensity to take risk. Furthermore, individual differences in creating vivid and intense negative images of risk consequences moderated the strength of the relationship between risk perception and risk taking. Participants who created more vivid and intense images of negative risk consequences paid less attention to the assessments of riskiness in rating their likelihood to take risk. To summarize, we showed that feelings of emotional stress and perceived riskiness mediate the relationship between mental imagery and risk taking, whereas individual differences in abilities to create vivid mental images may influence the degree to which more cognitive risk assessments are used in the risk-taking process.	[Traczyk, Jakub; Sobkow, Agata; Zaleskiewicz, Tomasz] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland	SWPS University of Social Sciences & Humanities	Traczyk, J (corresponding author), Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland.	jtraczyk@swps.edu.pl	Sobkow, Agata/K-1378-2016; Traczyk, Jakub/J-4532-2013; Traczyk, Jakub/I-9705-2019	Sobkow, Agata/0000-0002-5357-744X; Traczyk, Jakub/0000-0001-9145-1998; Traczyk, Jakub/0000-0001-9145-1998; Zaleskiewicz, Tomasz/0000-0002-4232-6151	National Science Centre, Poland [DEC-2011/01/N/HS6/03139]	National Science Centre, Poland(National Science Centre, Poland)	The research in this article was funded by the National Science Centre, Poland under grant number: DEC-2011/01/N/HS6/03139 to JT (http://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit E, 2012, PSYCHOL SCI, V23, P861, DOI 10.1177/0956797611434965; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2007, LME4 LINEAR MIXED EF; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Berry M., 2000, J PSYCHOL FINANCIAL, V1, P104, DOI DOI 10.1207/S15327760JPFM0102_2; Brandstatter E, 2006, PSYCHOL REV, V113, P409, DOI 10.1037/0033-295X.113.2.409; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V43, P623, DOI 10.1037/0022-3514.43.3.623; Christie I.C., 2011, HDB STRESS SCI BIOL, P515; Cremades JG, 2002, INT J PSYCHOPHYSIOL, V43, P261, DOI 10.1016/S0167-8760(01)00186-6; Cui X, 2007, VISION RES, V47, P474, DOI 10.1016/j.visres.2006.11.013; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAVIDSON RJ, 1977, PSYCHOPHYSIOLOGY, V14, P598, DOI 10.1111/j.1469-8986.1977.tb01207.x; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dowd H, 2010, INT J BEHAV MED, V17, P189, DOI 10.1007/s12529-009-9063-3; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; FARAH MJ, 1988, PSYCHOL REV, V95, P307, DOI 10.1037/0033-295X.95.3.307; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Holmes EA, 2005, EMOTION, V5, P489, DOI 10.1037/1528-3542.5.4.489; Hsee CK, 2004, J EXP PSYCHOL GEN, V133, P23, DOI 10.1037/0096-3445.133.1.23; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kosslyn SM, 1994, IMAGE BRAIN RESOLUTI, DOI [10.1162/jocn.1994.6.3.297, DOI 10.1162/JOCN.1994.6.3.297]; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LOPES LL, 1987, ADV EXP SOC PSYCHOL, V20, P255, DOI 10.1016/S0065-2601(08)60416-5; Luce MF, 1997, J EXP PSYCHOL LEARN, V23, P384, DOI 10.1037/0278-7393.23.2.384; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; MARKS DF, 1995, BRIT J PSYCHOL, V86, P271, DOI 10.1111/j.2044-8295.1995.tb02561.x; Mills B, 2008, PSYCHOL SCI, V19, P429, DOI 10.1111/j.1467-9280.2008.02104.x; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x; Preacher KJ, 2012, COMMUN METHODS MEAS, V6, P77, DOI 10.1080/19312458.2012.679848; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Schaefer RS, 2011, INT J PSYCHOPHYSIOL, V82, P254, DOI 10.1016/j.ijpsycho.2011.09.007; SLOVIC P, 1991, SCIENCE, V254, P1603, DOI 10.1126/science.254.5038.1603; Slovic P, 2000, LAW HUMAN BEHAV, V24, P271, DOI 10.1023/A:1005595519944; Slovic P., 1998, IMAGERY AFFECT DECIS; Slovic P, 2000, PERCEPTION RISK; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Traczyk J, 2015, J RISK RES; Tyszka T, 2006, RISK ANAL, V26, P1623, DOI 10.1111/j.1539-6924.2006.00847.x; Van Gelder JL, 2009, J BEHAV DECIS MAKING, V22, P45, DOI 10.1002/bdm.610; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Xu PF, 2013, J NEUROSCI, V33, P18641, DOI 10.1523/JNEUROSCI.1253-13.2013; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zaleskiewicz T, 2001, EUR J PERSONALITY, V15, pS105, DOI 10.1002/per.426	61	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122226	10.1371/journal.pone.0122226	http://dx.doi.org/10.1371/journal.pone.0122226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816238	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600157
J	Mariot, RF; de Oliveira, LA; Voorhuijzen, MM; Staats, M; Hutten, RCB; Van Dijk, JP; Kok, E; Frazzon, J				Mariot, Roberta Fogliatto; de Oliveira, Luisa Abruzzi; Voorhuijzen, Marleen M.; Staats, Martijn; Hutten, Ronald C. B.; Van Dijk, Jeroen P.; Kok, Esther; Frazzon, Jeverson			Selection of Reference Genes for Transcriptional Analysis of Edible Tubers of Potato (Solanum tuberosum L.)	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE-CHAIN-REACTION; SUPERIOR REFERENCE GENES; INTERNAL CONTROL GENES; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; ABIOTIC STRESS; NORMALIZATION; ARABIDOPSIS; IDENTIFICATION	Potato (Solanum tuberosum) yield has increased dramatically over the last 50 years and this has been achieved by a combination of improved agronomy and biotechnology efforts. Gene studies are taking place to improve new qualities and develop new cultivars. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) is a bench-marking analytical tool for gene expression analysis, but its accuracy is highly dependent on a reliable normalization strategy of an invariant reference genes. For this reason, the goal of this work was to select and validate reference genes for transcriptional analysis of edible tubers of potato. To do so, RT-qPCR primers were designed for ten genes with relatively stable expression in potato tubers as observed in RNA-Seq experiments. Primers were designed across exon boundaries to avoid genomic DNA contamination. Differences were observed in the ranking of candidate genes identified by geNorm, NormFinder and BestKeeper algorithms. The ranks determined by geNorm and NormFinder were very similar and for all samples the most stable candidates were C2, exocyst complex component sec3 (SEC3) and ATCUL3/ATCUL3A/CUL3/CUL3A (CUL3A). According to BestKeeper, the importin alpha and ubiquitin-associated/ts-n genes were the most stable. Three genes were selected as reference genes for potato edible tubers in RT-qPCR studies. The first one, called C2, was selected in common by NormFinder and geNorm, the second one is SEC3, selected by NormFinder, and the third one is CUL3A, selected by geNorm. Appropriate reference genes identified in this work will help to improve the accuracy of gene expression quantification analyses by taking into account differences that may be observed in RNA quality or reverse transcription efficiency across the samples.	[Mariot, Roberta Fogliatto; Frazzon, Jeverson] Univ Fed Rio Grande do Sul, Food Sci & Technol Inst, Dept Food Sci, Porto Alegre, RS, Brazil; [de Oliveira, Luisa Abruzzi] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Voorhuijzen, Marleen M.; Staats, Martijn; Van Dijk, Jeroen P.; Kok, Esther] Wageningen Univ R, RIKILT, Wageningen, Netherlands; [Hutten, Ronald C. B.] Wageningen UR, Plant Breeding, Wageningen, Netherlands	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Wageningen University & Research; Wageningen University & Research	Frazzon, J (corresponding author), Univ Fed Rio Grande do Sul, Food Sci & Technol Inst, Dept Food Sci, Porto Alegre, RS, Brazil.	jeverson.frazzon@ufrgs.br	Mariot, Roberta Fogliatto/J-8033-2019; Kok, Esther J/B-3919-2013	Mariot, Roberta Fogliatto/0000-0001-5784-3461; Kok, Esther J/0000-0003-1472-6710; Frazzon, Jeverson/0000-0002-0209-1466	National Council of Technological and Scientific Development of Brazil (CNPq) [300912/2012-9, 473181/2013-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil	National Council of Technological and Scientific Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by National Council of Technological and Scientific Development of Brazil (CNPq) (J.F.grant #300912/2012-9, #473181/2013-4) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hoenemann C, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-8; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060758; Perini P, 2014, MOL BREEDING, V34, P829, DOI 10.1007/s11032-014-0078-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2014, LANG ENV STAT COMP; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; van Dijk JP, 2009, J AGR FOOD CHEM, V57, P1612, DOI 10.1021/jf802815d; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatesh J, 2013, PLANT PHYSIOL BIOCH, V73, P392, DOI 10.1016/j.plaphy.2013.10.025; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Weber H, 2005, PLANT PHYSIOL, V137, P83, DOI 10.1104/pp.104.052654; Zarsky V, 2009, NEW PHYTOL, V183, P255, DOI 10.1111/j.1469-8137.2009.02880.x; Zhang DP, 2012, CELL CYCLE, V11, P3861, DOI 10.4161/cc.22068; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006	51	15	15	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120854	10.1371/journal.pone.0120854	http://dx.doi.org/10.1371/journal.pone.0120854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830330	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600046
J	Chen, SC; Ogata, A				Chen, Shu-Chuan; Ogata, Aaron			MixtureTree Annotator: A Program for Automatic Colorization and Visual Annotation of MixtureTree	PLOS ONE			English	Article							PHYLOGENETIC TREES; CLUSTERS; TOOL	The MixtureTree Annotator, written in JAVA, allows the user to automatically color any phylogenetic tree in Newick format generated from any phylogeny reconstruction program and output the Nexus file. By providing the ability to automatically color the tree by sequence name, the MixtureTree Annotator provides a unique advantage over any other programs which perform a similar function. In addition, the MixtureTree Annotator is the only package that can efficiently annotate the output produced by MixtureTree with mutation information and coalescent time information. In order to visualize the resulting output file, a modified version of FigTree is used. Certain popular methods, which lack good built-in visualization tools, for example, MEGA, Mesquite, PHY-FI, TreeView, treeGraph and Geneious, may give results with human errors due to either manually adding colors to each node or with other limitations, for example only using color based on a number, such as branch length, or by taxonomy. In addition to allowing the user to automatically color any given Newick tree by sequence name, the MixtureTree Annotator is the only method that allows the user to automatically annotate the resulting tree created by the MixtureTree program. The MixtureTree Annotator is fast and easy-to-use, while still allowing the user full control over the coloring and annotating process.	[Chen, Shu-Chuan] Idaho State Univ, Dept Math, Pocatello, ID 83209 USA; [Ogata, Aaron] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Ogata, Aaron] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Idaho; Idaho State University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Chen, SC (corresponding author), Idaho State Univ, Dept Math, Pocatello, ID 83209 USA.	scchen@isu.edu			National Science Foundation [DMS 0714949]	National Science Foundation(National Science Foundation (NSF))	The authors are thankful for National Science Foundation's funding - DMS 0714949 to Shu-Chuan Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2007, BIOINFORMATICS, V23, P2952, DOI 10.1093/bioinformatics/btm410; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Chen SC, 2011, MIXTURE TREE CONSTRU, P135; Chen SC, 2006, BIOMETRIKA, V93, P843, DOI 10.1093/biomet/93.4.843; Chen SC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-111; Chen SC, 2014, COMPUT STAT DATA AN, V74, P17, DOI 10.1016/j.csda.2013.11.010; Chen Wei-Hua, 2009, BMC Res Notes, V2, P155, DOI 10.1186/1756-0500-2-155; De Praetere P, 2004, HYPERGNEY GENT BIOIN; Dutheil J, 2002, BIOINFORMATICS, V18, P892, DOI 10.1093/bioinformatics/18.6.892; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Maddison WP, 2009, MESQUITE MODULAR SYS; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palidwor G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-79; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590	25	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118893	10.1371/journal.pone.0118893	http://dx.doi.org/10.1371/journal.pone.0118893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826378	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800009
J	Kim, SH; Jang, KM; Kim, MS				Kim, Seo-Hee; Jang, Kyoung-Mi; Kim, Myung-Sun			Deficits in Error-Monitoring by College Students with Schizotypal Traits: An Event-Related Potential Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SCHIZOPHRENIC-PATIENTS; UNAFFECTED SIBLINGS; ATTENTIONAL CONTROL; PERSONALITY-TRAITS; ANTISACCADE TASK; TIME PRESSURE; STROOP TASK; BRAIN; NEGATIVITY	The present study used event-related potentials (ERPs) to investigate deficits in error-monitoring by college students with schizotypal traits. Scores on the Schizotypal Personality Questionnaire (SPQ) were used to categorize the participants into schizotypal-trait (n = 17) and normal control (n = 20) groups. The error-monitoring abilities of the participants were evaluated using the Simon task, which consists of congruent (locations of stimulus and response are the same) and incongruent (locations of stimulus and response are different) conditions. The schizotypal-trait group committed more errors on the Simon task and exhibited smaller error-related negativity (ERN) amplitudes than did the control group. Additionally, ERN amplitude measured at FCz was negatively correlated with the error rate on the Simon task in the schizotypal-trait group but not in the control group. The two groups did not differ in terms of correct-related potentials (CRN), error positivity (Pe) and correct-related positivity (Pc) amplitudes. The present results indicate that individuals with schizotypal traits have deficits in error-monitoring and that reduced ERN amplitudes may represent a biological marker of schizophrenia.	[Kim, Seo-Hee; Jang, Kyoung-Mi; Kim, Myung-Sun] Sungshin Womens Univ, Dept Psychol, Seoul, South Korea	Sungshin Women's University	Kim, MS (corresponding author), Sungshin Womens Univ, Dept Psychol, Seoul, South Korea.	kimms@sungshin.ac.kr			Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Sciene, ICT and Future Planning [NRF-20062005055]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Sciene, ICT and Future Planning	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Sciene, ICT and Future Planning (NRF-20062005055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Asai T, 2007, J MOTOR BEHAV, V39, P162, DOI 10.3200/JMBR.39.3.162-168; Asai T, 2008, CONSCIOUS COGN, V17, P1131, DOI 10.1016/j.concog.2008.04.004; Bates AT, 2004, J PSYCHIATR RES, V38, P347, DOI 10.1016/j.jpsychires.2003.11.002; Becker TM, 2008, NEUROPSYCHOPHARMACOL, V33, P2619, DOI 10.1038/sj.npp.1301673; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Davies PL, 2001, BIOL PSYCHOL, V56, P191, DOI 10.1016/S0301-0511(01)00080-1; Dickey CC, 2002, HARVARD REV PSYCHIAT, V10, P1; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Farrer C, 2007, CURR PSYCHIATRY REV, V3, P243, DOI 10.2174/157340007782408897; First M.B., 2014, STRUCTURED CLIN INTE; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Ganushchak LY, 2006, BRAIN RES, V1125, P104, DOI 10.1016/j.brainres.2006.09.096; Gastaldo S, 2002, CORTEX, V38, P149, DOI 10.1016/S0010-9452(08)70647-6; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hommes J, 2012, PSYCHOL MED, V42, P235, DOI 10.1017/S0033291711001152; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Kerns JG, 2005, AM J PSYCHIAT, V162, P1833, DOI 10.1176/appi.ajp.162.10.1833; Kim MS, 2006, PSYCHIAT CLIN NEUROS, V60, P303, DOI 10.1111/j.1440-1819.2006.01506.x; Kim MS, 2011, COMPR PSYCHIAT, V52, P511, DOI 10.1016/j.comppsych.2010.10.010; Kopp B, 1999, J ABNORM PSYCHOL, V108, P337, DOI 10.1037/0021-843X.108.2.337; KOPP B, 1994, SCHIZOPHR RES, V13, P11, DOI 10.1016/0920-9964(94)90056-6; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Laurens KR, 2003, BRAIN, V126, P610, DOI 10.1093/brain/awg056; Leuthold H, 1999, CLIN NEUROPHYSIOL, V110, P342, DOI 10.1016/S1388-2457(98)00058-3; Lin HF, 2005, PSYCHOL MED, V35, P1589, DOI 10.1017/S0033291705005957; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Luck S.J., 2005, INTRO EVENT RELATED; Mathalon DH, 2009, INT J PSYCHOPHYSIOL, V73, P109, DOI 10.1016/j.ijpsycho.2009.02.005; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Moon H. O., 1997, J KOREAN NEUROPSYCHI, V36, P329; Morey RA, 2005, ARCH GEN PSYCHIAT, V62, P254, DOI 10.1001/archpsyc.62.3.254; Morris SE, 2006, J ABNORM PSYCHOL, V115, P239, DOI 10.1037/0021-843X.115.2.239; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; Noguchi H, 2008, PSYCHIAT RES, V161, P162, DOI 10.1016/j.psychres.2007.07.023; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Perez VB, 2012, J ABNORM PSYCHOL, V121, P372, DOI 10.1037/a0025487; Polli FE, 2008, BRAIN, V131, P971, DOI 10.1093/brain/awm307; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398; Simmonite M, 2012, INT J PSYCHOPHYSIOL, V84, P74, DOI 10.1016/j.ijpsycho.2012.01.012; SIMON JR, 1981, ACTA PSYCHOL, V47, P63, DOI 10.1016/0001-6918(81)90039-1; Takahashi T, 2002, EUR ARCH PSY CLIN N, V252, P268, DOI 10.1007/s00406-002-0392-3; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; van der Lubbe RHJ, 2001, J PSYCHOPHYSIOL, V15, P241, DOI 10.1027//0269-8803.15.4.241; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Yum TH, 1992, MANUAL KOREAN WECHSL	60	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122861	10.1371/journal.pone.0122861	http://dx.doi.org/10.1371/journal.pone.0122861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826220	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800095
J	Wei, XL; Li, HT; Yang, N; Wong, SYS; Owolabi, O; Xu, JG; Shi, LY; Tang, JL; Li, D; Griffiths, SM				Wei, Xiaolin; Li, Haitao; Yang, Nan; Wong, Samuel Y. S.; Owolabi, Onikepe; Xu, Jianguang; Shi, Leiyu; Tang, Jinling; Li, Donald; Griffiths, Sian M.			Comparing Quality of Public Primary Care between Hong Kong and Shanghai Using Validated Patient Assessment Tools	PLOS ONE			English	Article							COMMUNITY-HEALTH CENTERS; EXPERIENCES; CONTINUITY; SYSTEMS; REFORM; MANAGEMENT; MEDICINE; PROGRAM; CHINESE; IMPACT	Objectives Primary care is the key element of health reform in China. The objective of this study was to compare patient assessed quality of public primary care between Hong Kong, a city with established primary care environment influenced by its colonial history, and Shanghai, a city leading primary care reform in Mainland China; and to measure the equity of care in the two cities. Methods Cross sectional stratified random sampling surveys were conducted in 2011. Data were collected from 1,994 respondents in Hong Kong and 811 respondents in Shanghai. A validated Chinese version of the primary care assessment tool was employed to assess perceived quality of primary care with respect to socioeconomic characteristics and health status. Results We analyzed 391 and 725 respondents in Hong Kong and Shanghai, respectively, who were regular public primary care users. Respondents in Hong Kong reported significant lower scores in first contact accessibility (1.59 vs. 2.15), continuity of care (2.33 vs. 3.10), coordination of information (2.84 vs. 3.64), comprehensiveness service availability (2.43 vs. 3.31), comprehensiveness service provided (2.11 vs. 2.40), and the total score (23.40 vs. 27.40), but higher scores in first contact utilization (3.15 vs. 2.54) and coordination of services (2.67 vs. 2.40) when compared with those in Shanghai. Respondents with higher income reported a significantly higher total primary care score in Hong Kong, but not in Shanghai. Conclusions Respondents in Shanghai reported better quality of public primary care than those in Hong Kong, while quality of public primary care tended to be more equitable in Shanghai.	[Wei, Xiaolin; Li, Haitao; Yang, Nan; Wong, Samuel Y. S.; Tang, Jinling; Griffiths, Sian M.] Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China; [Owolabi, Onikepe] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Xu, Jianguang] Shanghai Commiss Hlth & Family Planning, Shanghai 200125, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of London; London School of Hygiene & Tropical Medicine	Wong, SYS (corresponding author), Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China.	yeungshanwong@cuhk.edu.hk	WONG, Samuel Yeung Shan/D-7311-2013; Tang, JL/G-1759-2013	WONG, Samuel Yeung Shan/0000-0003-0934-6385; 	Research Grants Council (RGC) of Hong Kong [CUHK 4002-SPPR-10]; Communicable Disease and Health Service Delivery (COMDIS HSD) Research Consortium of the Department for International Development of the UK Government (UKAID)	Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); Communicable Disease and Health Service Delivery (COMDIS HSD) Research Consortium of the Department for International Development of the UK Government (UKAID)	The study was funded by the Research Grants Council (RGC) of Hong Kong (CUHK 4002-SPPR-10) and the Communicable Disease and Health Service Delivery (COMDIS HSD) Research Consortium of the Department for International Development of the UK Government (UKAID). The funders had no roles in research design, data collection, interpretation of the data, writing and submitting the manuscript.	Bao Y, 2012, CHINESE JOURNAL OF G, V10, P997; Barber SL, 2011, INT J HEALTH PLAN M, V26, P339, DOI 10.1002/hpm.1109; Beaulieu Marie-Dominique, 2011, Healthc Policy, V7, P108; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bhattacharyya O, 2011, HEALTH POLICY, V100, P174, DOI 10.1016/j.healthpol.2010.11.005; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Chan MF, 2003, COMPLEMENT THER MED, V11, P103, DOI 10.1016/S0965-2299(03)00044-X; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chung VCH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/426360; Crawley D, 2009, J ROY SOC MED, V102, P103, DOI 10.1258/jrsm.2009.080389; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Griffiths SM, 2012, HONG KONG MED J, V18, P429; Jiang HL, 2009, HEALTH ECON, V18, pS107, DOI 10.1002/hec.1517; Lwaga S, 1991, SAMPLE SIZE DETERMIN; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Mercer SW, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-22; Owolabi O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-487; Raddish M, 1999, AM J MANAG CARE, V5, P727; Rowan MS, 2002, FAM MED, V34, P744; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Shanghai Statistical Bureau, 2011, REPORT OF INCOME GRO; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Shi LY, 2003, SOUTH MED J, V96, P787, DOI 10.1097/01.SMJ.0000066811.53167.2E; Shi LY, 2001, J FAM PRACTICE, V50, P161; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2007, J AM BOARD FAM MED, V20, P511, DOI 10.3122/jabfm.2007.06.070176; The Hong Kong Council of Social Science, 2013, STATISTICAL OVERVIEW; Tourigny A, 2010, CAN FAM PHYSICIAN, V56, pE273; Tsai J, 2010, J AM BOARD FAM MED, V23, P402, DOI 10.3122/jabfm.2010.03.090222; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; Wang HHX, 2013, ANN FAM MED, V11, P517, DOI 10.1370/afm.1545; Wei XL, 2008, J CLIN EPIDEMIOL, V61, P932, DOI 10.1016/j.jclinepi.2007.12.013; Wei XL, 2008, J CLIN EPIDEMIOL, V61, P925, DOI 10.1016/j.jclinepi.2007.12.010; Wei XL, 2005, INT J HEALTH PLAN M, V20, P269, DOI 10.1002/hpm.814; WHO, 2008, THE WORLD HEALTH REP; Williams B, 2008, INT J TUBERC LUNG D, V12, P1110; Wong MCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046309; Wong SYS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-397; Yang H, 2013, INT J QUAL HEALTH C, V25, P92, DOI 10.1093/intqhc/mzs072; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yu Y, 2011, INT J HEALTH PLAN M, V26, P379, DOI 10.1002/hpm.1117	42	33	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121269	10.1371/journal.pone.0121269	http://dx.doi.org/10.1371/journal.pone.0121269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826616	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000352084800038
J	Wiggins, IM; Hartley, DEH				Wiggins, Ian M.; Hartley, Douglas E. H.			A Synchrony-Dependent Influence of Sounds on Activity in Visual Cortex Measured Using Functional Near-Infrared Spectroscopy (fNIRS)	PLOS ONE			English	Article							DIFFUSE OPTICAL TOMOGRAPHY; MULTISENSORY INTERACTIONS; AUDIOVISUAL INTEGRATION; INVERSE EFFECTIVENESS; SELECTIVE ATTENTION; BRAIN; HUMANS; NIRS; RESPONSES; CORTICES	Evidence from human neuroimaging and animal electrophysiological studies suggests that signals from different sensory modalities interact early in cortical processing, including in primary sensory cortices. The present study aimed to test whether functional near-infrared spectroscopy (fNIRS), an emerging, non-invasive neuroimaging technique, is capable of measuring such multisensory interactions. Specifically, we tested for a modulatory influence of sounds on activity in visual cortex, while varying the temporal synchrony between trains of transient auditory and visual events. Related fMRI studies have consistently reported enhanced activation in response to synchronous compared to asynchronous audiovisual stimulation. Unexpectedly, we found that synchronous sounds significantly reduced the fNIRS response from visual cortex, compared both to asynchronous sounds and to a visual-only baseline. It is possible that this suppressive effect of synchronous sounds reflects the use of an efficacious visual stimulus, chosen for consistency with previous fNIRS studies. Discrepant results may also be explained by differences between studies in how attention was deployed to the auditory and visual modalities. The presence and relative timing of sounds did not significantly affect performance in a simultaneously conducted behavioral task, although the data were suggestive of a positive relationship between the strength of the fNIRS response from visual cortex and the accuracy of visual target detection. Overall, the present findings indicate that fNIRS is capable of measuring multisensory cortical interactions. In multisensory research, fNIRS can offer complementary information to the more established neuroimaging modalities, and may prove advantageous for testing in naturalistic environments and with infant and clinical populations.	[Wiggins, Ian M.; Hartley, Douglas E. H.] Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham, England; [Wiggins, Ian M.; Hartley, Douglas E. H.] Univ Nottingham, Div Clin Neurosci, Sch Med, Otol & Hearing Grp, Nottingham NG7 2RD, England; [Hartley, Douglas E. H.] MRC, Inst Hearing Res, Nottingham, England	University of Nottingham; University of Nottingham	Wiggins, IM (corresponding author), Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham, England.	ian.wiggins@nottingham.ac.uk		Wiggins, Ian/0000-0003-4613-8462; Hartley, Douglas/0000-0001-9803-4169	National Institute for Health Research; University of Nottingham	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Nottingham	This work was supported through intramural funding from the National Institute for Health Research and the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Baier B, 2006, J NEUROSCI, V26, P12260, DOI 10.1523/JNEUROSCI.1457-06.2006; Bastien D, 2012, BRAIN RES, V1431, P62, DOI 10.1016/j.brainres.2011.11.008; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Colier WNJM, 2001, VISION RES, V41, P97, DOI 10.1016/S0042-6989(00)00219-4; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Falchier A, 2002, J NEUROSCI, V22, P5749; Ferradal SL, 2014, NEUROIMAGE, V85, P117, DOI 10.1016/j.neuroimage.2013.03.069; Fiebelkorn IC, 2011, EXP BRAIN RES, V213, P167, DOI 10.1007/s00221-011-2670-7; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gleiss S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00052; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Holmes NP, 2009, BRAIN TOPOGR, V21, P168, DOI 10.1007/s10548-009-0097-2; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; James T. W., 2012, NEURAL BASES MULTISE; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Khan B, 2012, BIOMED OPT EXPRESS, V3, P878, DOI 10.1364/BOE.3.000878; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lawler Carly A, 2015, Cochlear Implants Int, V16 Suppl 1, pS30, DOI 10.1179/1467010014Z.000000000230; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Li XR, 2010, BEHAV RES METHODS, V42, P212, DOI 10.3758/BRM.42.1.212; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Marchant JL, 2013, CEREB CORTEX, V23, P1290, DOI 10.1093/cercor/bhs095; Marchant JL, 2012, HUM BRAIN MAPP, V33, P1212, DOI 10.1002/hbm.21278; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; McDonald JJ, 2013, J NEUROSCI, V33, P9194, DOI 10.1523/JNEUROSCI.5902-12.2013; Mercier MR, 2013, NEUROIMAGE, V79, P19, DOI 10.1016/j.neuroimage.2013.04.060; Meredith MA, 2009, HEARING RES, V258, P64, DOI 10.1016/j.heares.2009.03.005; Minati Ludovico, 2011, Journal of Medical Engineering & Technology, V35, P370, DOI 10.3109/03091902.2011.595533; Molavi B, 2012, PHYSIOL MEAS, V33, P259, DOI 10.1088/0967-3334/33/2/259; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Naue N, 2011, J NEUROSCI, V31, P7729, DOI 10.1523/JNEUROSCI.1076-11.2011; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Noesselt T, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00064; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Romei V, 2012, CURR BIOL, V22, P807, DOI 10.1016/j.cub.2012.03.025; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Sevy ABG, 2010, HEARING RES, V270, P39, DOI 10.1016/j.heares.2010.09.010; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Stein BE., 1993, MERGING SENSES; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Strangman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066319; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Toronov VY, 2007, NEUROIMAGE, V34, P1136, DOI 10.1016/j.neuroimage.2006.08.048; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tsuzuki D, 2014, NEUROIMAGE, V85, P92, DOI 10.1016/j.neuroimage.2013.07.025; Umeyama S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.047003; van Atteveldt N, 2014, NEURON, V81, P1240, DOI 10.1016/j.neuron.2014.02.044; van Zijl PCM, 2012, NEUROIMAGE, V62, P1092, DOI 10.1016/j.neuroimage.2012.01.029; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; [王跃年 WANG Yuenian], 2008, [桥梁建设, Bridge Construction], P9; Watanabe H, 2013, HUM BRAIN MAPP, V34, P543, DOI 10.1002/hbm.21453; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Welch RB, 1986, HDB PERCEPTION HUMAN, VI, P1; West B. T., 2006, LINEAR MIXED MODELS, P180; White BR, 2010, NEUROIMAGE, V49, P568, DOI 10.1016/j.neuroimage.2009.07.023; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050271; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00882; Zangenehpour S, 2010, NEUROPSYCHOLOGIA, V48, P591, DOI 10.1016/j.neuropsychologia.2009.10.022; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104	97	16	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122862	10.1371/journal.pone.0122862	http://dx.doi.org/10.1371/journal.pone.0122862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826284	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800096
J	da Silva, PG; Hernandez, MIM				da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel			Scale-Dependence of Processes Structuring Dung Beetle Metacommunities Using Functional Diversity and Community Deconstruction Approaches	PLOS ONE			English	Article							SCARABAEINAE COLEOPTERA SCARABAEIDAE; ATLANTIC FOREST FRAGMENTS; BETA DIVERSITY; TEMPORAL TURNOVER; PARTITIONING DIVERSITY; ECOSYSTEM FUNCTION; TROPICAL PRIMARY; LOCAL FACTORS; BIODIVERSITY; ASSEMBLAGES	Community structure is driven by mechanisms linked to environmental, spatial and temporal processes, which have been successfully addressed using metacommunity framework. The relative importance of processes shaping community structure can be identified using several different approaches. Two approaches that are increasingly being used are functional diversity and community deconstruction. Functional diversity is measured using various indices that incorporate distinct community attributes. Community deconstruction is a way to disentangle species responses to ecological processes by grouping species with similar traits. We used these two approaches to determine whether they are improvements over traditional measures (e.g., species composition, abundance, biomass) for identification of the main processes driving dung beetle (Scarabaeinae) community structure in a fragmented mainland-island landscape in southern Brazilian Atlantic Forest. We sampled five sites in each of four large forest areas, two on the mainland and two on the island. Sampling was performed in 2012 and 2013. We collected abundance and biomass data from 100 sampling points distributed over 20 sampling sites. We studied environmental, spatial and temporal effects on dung beetle community across three spatial scales, i.e., between sites, between areas and mainland-island. The.-diversity based on species abundance was mainly attributed to beta-diversity as a consequence of the increase in mean alpha- and beta-diversity between areas. Variation partitioning on abundance, biomass and functional diversity showed scale-dependence of processes structuring dung beetle metacommunities. We identified two major groups of responses among 17 functional groups. In general, environmental filters were important at both local and regional scales. Spatial factors were important at the intermediate scale. Our study supports the notion of scale-dependence of environmental, spatial and temporal processes in the distribution and functional organization of Scarabaeinae beetles. We conclude that functional diversity may be used as a complementary approach to traditional measures, and that community deconstruction allows sufficient disentangling of responses of different trait-based groups.	[da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	da Silva, PG (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	pedrogiovanidasilva@yahoo.com.br	Hernandez, Malva I. M./E-3485-2013; da Silva, Pedro Giovâni/F-7605-2014	Hernandez, Malva I. M./0000-0002-6820-5980; da Silva, Pedro Giovâni/0000-0002-0702-9186	Coordenacao de Pessoal de Nivel Superior [Process 001/2010 MEC/CAPES/PNPD]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Process 303800/2010-0]	Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Coordenacao de Pessoal de Nivel Superior for the scholarship to PGS and for research funding (Process 001/2010 MEC/CAPES/PNPD, Biodiversidade de artropodes terrestres e aquaticos em diferentes gradientes ambientais da Mata Atlantica do estado de Santa Catarina) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for the research grant to MIMH (Research Productivity/PQ/2010, Process 303800/2010-0, Comportamento de besouros Scarabaeinae e sua funcao no ciclo de decomposicao da materia organica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta J, 2014, ECOL COMPLEX, V20, P61, DOI 10.1016/j.ecocom.2014.08.003; Algarte VM, 2014, HYDROBIOLOGIA, V722, P279, DOI 10.1007/s10750-013-1711-6; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, J APPL ECOL, V47, P779, DOI 10.1111/j.1365-2664.2010.01825.x; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Campos RC, 2015, ECOL INDIC, V49, P216, DOI 10.1016/j.ecolind.2014.09.043; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Chown Steven L., 2011, P200; Colzani E, 2013, BIOTROPICA, V45, P343, DOI 10.1111/btp.12022; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; da Silva PG, 2013, AN ACAD BRAS CIENC, V85, P679, DOI 10.1590/S0001-37652013005000033; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; da Silva PG, 2012, ZOOL STUD, V51, P429; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Doube B.M., 1991, P133; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Duraes R, 2005, NEOTROP ENTOMOL, V34, P721, DOI 10.1590/S1519-566X2005000500003; Eros T, 2012, FRESHWATER BIOL, V57, P1914, DOI 10.1111/j.1365-2427.2012.02842.x; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston K. J, 1994, RARITY, V13, P1; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Gitay H., 1997, PLANT FUNCTIONAL TYP, P3; Halffter Gonzalo, 1991, Folia Entomologica Mexicana, V0, P195; Halffter Gonzalo, 1993, Biology International, V27, P15; Halffter Gonzalo, 2009, Boletin de la SEA, V45, P1; Hanski I., 1991, P305; Heino J, 2005, FRESHWATER BIOL, V50, P1578, DOI 10.1111/j.1365-2427.2005.01418.x; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2014, CURR OPIN INSECT SCI, V2, P7, DOI 10.1016/j.cois.2014.06.002; Heino J, 2013, FRESHWATER BIOL, V58, P1539, DOI 10.1111/fwb.12164; Heino J, 2010, LIMNOL OCEANOGR, V55, P2397, DOI 10.4319/lo.2010.55.6.2397; Hepp LU, 2013, HYDROBIOLOGIA, V703, P239, DOI 10.1007/s10750-012-1367-7; Hernández Malva Isabel Medina, 2002, Rev. Bras. entomol., V46, P597, DOI 10.1590/S0085-56262002000400015; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horgan FG, 2005, ECOL ENTOMOL, V30, P182, DOI 10.1111/j.0307-6946.2005.00673.x; HOWDEN HF, 1978, BIOTROPICA, V10, P43, DOI 10.2307/2388104; Hubbell Stephen P., 2001, V32, pi; Huttunen KL, 2014, ECOGRAPHY, V37, P599, DOI 10.1111/j.1600-0587.2013.00325.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Laliberte E, 2012, MEASURING FUNCTIONAL; Laliberte E, 2013, J VEG SCI, V24, P834, DOI 10.1111/jvs.12044; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Larsen TH, 2012, BIOTROPICA, V44, P82, DOI 10.1111/j.1744-7429.2011.00768.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Magurran A.E., 2004, MEASURING BIOL DIVER; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Marquez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054580; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2013, ECOLOGY, V94, P180, DOI 10.1890/12-0251.1; Passy SI, 2012, ECOL LETT, V15, P923, DOI 10.1111/j.1461-0248.2012.01809.x; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Quintero I, 2005, ECOLOGY, V86, P3303, DOI 10.1890/04-1960; R Core Team, 2014, LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; R-Forge Administration and Development Team, 2013, SPAT EC DAT AN R R D; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs Robert E., 1993, P350; Simmons LW, 2011, ECOLOGY EVOLUTION DU, P1, DOI DOI 10.1002/9781444342000; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Spector S, 2003, BIOTROPICA, V35, P394; Spector Sacha, 1998, Conservation Biology Series (Cambridge), V1, P181; Statzner B, 2004, ECOGRAPHY, V27, P470, DOI 10.1111/j.0906-7590.2004.03836.x; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Strecker AL, 2011, OECOLOGIA, V166, P819, DOI 10.1007/s00442-011-1924-1; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; Veloso HP, 1991, CLASSIFICACAO VEGETA, DOI [10.5681/joddd.2014.003, DOI 10.5681/JODDD.2014.003]; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007	119	39	41	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123030	10.1371/journal.pone.0123030	http://dx.doi.org/10.1371/journal.pone.0123030			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822150	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700213
J	Forner, J; Pfeiffer, A; Langenecker, T; Manavella, P; Lohmann, JU				Forner, Joachim; Pfeiffer, Anne; Langenecker, Tobias; Manavella, Pablo; Lohmann, Jan U.			Germline-Transmitted Genome Editing in Arabidopsis thaliana Using TAL-Effector-Nucleases	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; SHOOT APICAL MERISTEM; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; FUNCTIONAL GENOMICS; HIGHLY EFFICIENT; GENE-THERAPY; FLORAL DIP; CELL FATE; DNA	Transcription activator-like effector nucleases (TALENs) are custom-made bi-partite endonucleases that have recently been developed and applied for genome engineering in a wide variety of organisms. However, they have been only scarcely used in plants, especially for germline-modification. Here we report the efficient creation of small, germline-transmitted deletions in Arabidopsis thaliana via TALENs that were delivered by stably integrated transgenes. Using meristem specific promoters to drive expression of two TALEN arms directed at the CLV3 coding sequence, we observed very high phenotype frequencies in the T2 generation. In some instances, full CLV3 loss-of-function was already observed in the T1 generation, suggesting that transgenic delivery of TALENs can cause highly efficient genome modification. In contrast, constitutive TALEN expression in the shoot apical meristem (SAM) did not cause additional phenotypes and genome re-sequencing confirmed little offtarget effects, demonstrating exquisite target specificity.	[Forner, Joachim; Pfeiffer, Anne; Lohmann, Jan U.] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany; [Langenecker, Tobias; Manavella, Pablo] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Lohmann, JU (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.	jlohmann@meristemania.org	Lohmann, Jan/T-3776-2019	Lohmann, Jan/0000-0003-3667-187X; Manavella, Pablo/0000-0003-3589-4414; Forner, Joachim/0000-0002-6406-7066; Pfeiffer, Anne/0000-0001-6825-6297	ERC [282139]	ERC(European Research Council (ERC)European Commission)	ERC grant 282139; erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Belhaj K, 2013, PLANT; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bush SM, 2010, PLANT PHYSIOL, V154, P25, DOI 10.1104/pp.110.159897; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Chou ST, 2012, DRUG FUTURE, V37, P183, DOI 10.1358/dof.2012.037.03.1779022; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; FURNER IJ, 1992, DEVELOPMENT, V115, P755; Ge XC, 2008, PLANT CELL REP, V27, P1341, DOI 10.1007/s00299-008-0561-6; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katsuyama T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt638; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lieberman-Lazarovich M, 2011, METHODS MOL BIOL, V701, P51, DOI 10.1007/978-1-61737-957-4_3; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Pauwels K, 2014, NEW BIOTECHNOL, V31, P18, DOI 10.1016/j.nbt.2013.07.001; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sakuma T, 2014, DEV GROWTH DIFFER, V56, P2, DOI 10.1111/dgd.12111; Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sun N, 2014, MOL BIOSYST, V10, P446, DOI 10.1039/c3mb70412b; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Uhde-Stone C, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-3; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	51	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121056	10.1371/journal.pone.0121056	http://dx.doi.org/10.1371/journal.pone.0121056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822541	gold, Green Published			2022-12-27	WOS:000352134700087
J	Fouquet, C; Gilles, JF; Heck, N; Dos Santos, M; Schwartzmann, R; Cannaya, V; Morel, MP; Davidson, RS; Trembleau, A; Bolte, S				Fouquet, Coralie; Gilles, Jean-Francois; Heck, Nicolas; Dos Santos, Marc; Schwartzmann, Richard; Cannaya, Vidjeacoumary; Morel, Marie-Pierre; Davidson, Robert Stephen; Trembleau, Alain; Bolte, Susanne			Improving Axial Resolution in Confocal Microscopy with New High Refractive Index Mounting Media	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; OPTICAL MICROSCOPY; IN-VIVO; EXPRESSION; BRAIN; RECONSTRUCTION; PROTEINS; NEURONS; ROLES	Resolution, high signal intensity and elevated signal to noise ratio (SNR) are key issues for biologists who aim at studying the localisation of biological structures at the cellular and subcellular levels using confocal microscopy. The resolution required to separate sub-cellular biological structures is often near to the resolving power of the microscope. When optimally used, confocal microscopes may reach resolutions of 180 nm laterally and 500 nm axially, however, axial resolution in depth is often impaired by spherical aberration that may occur due to refractive index mismatches. Spherical aberration results in broadening of the point-spread function (PSF), a decrease in peak signal intensity when imaging in depth and a focal shift that leads to the distortion of the image along the z-axis and thus in a scaling error. In this study, we use the novel mounting medium CFM3 (Citifluor Ltd., UK) with a refractive index of 1.518 to minimize the effects of spherical aberration. This mounting medium is compatible with most common fluorochromes and fluorescent proteins. We compare its performance with established mounting media, harbouring refractive indices below 1.500, by estimating lateral and axial resolution with sub-resolution fluorescent beads. We show furthermore that the use of the high refractive index media renders the tissue transparent and improves considerably the axial resolution and imaging depth in immuno-labelled or fluorescent protein labelled fixed mouse brain tissue. We thus propose to use those novel high refractive index mounting media, whenever optimal axial resolution is required.	[Fouquet, Coralie; Gilles, Jean-Francois; Heck, Nicolas; Dos Santos, Marc; Schwartzmann, Richard; Cannaya, Vidjeacoumary; Morel, Marie-Pierre; Trembleau, Alain; Bolte, Susanne] Univ Paris 06, Univ Sorbonne, F-75005 Paris, France; [Fouquet, Coralie; Gilles, Jean-Francois; Heck, Nicolas; Dos Santos, Marc; Schwartzmann, Richard; Cannaya, Vidjeacoumary; Morel, Marie-Pierre; Trembleau, Alain; Bolte, Susanne] Inst Biol Paris Seine, CNRS FR3631, F-75005 Paris, France; [Fouquet, Coralie; Heck, Nicolas; Dos Santos, Marc; Cannaya, Vidjeacoumary; Morel, Marie-Pierre; Trembleau, Alain] CNRS, INSERM, U1130, Neurosci Paris Seine,UMR8246, F-75005 Paris, France; [Davidson, Robert Stephen] Citifluor Ltd, London N1 6LD, England	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bolte, S (corresponding author), Univ Paris 06, Univ Sorbonne, F-75005 Paris, France.	susanne.bolte@upmc.fr		DOS SANTOS, Marc/0000-0002-6101-5631; Trembleau, Alain/0000-0002-8290-0795	Citifluor Ltd.	Citifluor Ltd.	Citifluor Ltd provided support in the form of salaries for author RS Davidson, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. RS Davidson is the holder of UK patent 2419427 entitled "Mountant solution" which embraces the description of CFM3. The solution is marketed by Citifluor Ltd. of which RS Davidson is Managing director. Institute of Biology Paris-Seine Imaging Facility did not receive any financial support from Citifluor Ltd.	Akins MR, 2006, J COMP NEUROL, V499, P979, DOI 10.1002/cne.21147; Beecroft RA, 1983, TETRAHEDRON, V40, P4487; Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833; Booth MJ, 2002, P NATL ACAD SCI USA, V99, P5788, DOI 10.1073/pnas.082544799; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Diaspro A, 2002, APPL OPTICS, V41, P685, DOI 10.1364/AO.41.000685; Egner A, 2006, HDB BIOL CONFOCAL MI, P404, DOI DOI 10.1007/978-0-387-45524-2_20; Fremeau Jr RT, TRENDS NEUROSCI, V27, P98; GORHAM JD, 1991, NEURON, V7, P485, DOI 10.1016/0896-6273(91)90300-O; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Heck N, 2012, BRAIN STRUCT FUNCT, V217, P421, DOI 10.1007/s00429-011-0340-y; HELL S, 1993, J MICROSC-OXFORD, V169, P391, DOI 10.1111/j.1365-2818.1993.tb03315.x; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; HOFFMAN R, 1975, APPL OPTICS, V14, P1169, DOI 10.1364/AO.14.001169; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lue N, 2009, J PHYS CHEM A, V113, P13327, DOI 10.1021/jp904746r; Matthews C, 2010, IMAGE J USER DEV C P, V2010; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shapiro HM, 2005, PRACTICAL FLOW CYTOM, P303; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Strasser SD, 2012, OPT LETT, V37, P506, DOI 10.1364/OL.37.000506; Sun JJ, 2012, OPT EXPRESS, V20, P1084, DOI 10.1364/OE.20.001084; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Zhu D, 2013, LASER PHOTONICS REV, V7, P732, DOI 10.1002/lpor.201200056	28	37	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121096	10.1371/journal.pone.0121096	http://dx.doi.org/10.1371/journal.pone.0121096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822785	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700089
J	Jobst, BJ; Triphan, SMF; Sedlaczek, O; Anjorin, A; Kauczor, HU; Biederer, J; Ley-Zaporozhan, J; Ley, S; Wielputz, MO				Jobst, Bertram J.; Triphan, Simon M. F.; Sedlaczek, Oliver; Anjorin, Angela; Kauczor, Hans Ulrich; Biederer, Juergen; Ley-Zaporozhan, Julia; Ley, Sebastian; Wielpuetz, Mark O.			Functional Lung MRI in Chronic Obstructive Pulmonary Disease: Comparison of T1 Mapping, Oxygen-Enhanced T1 Mapping and Dynamic Contrast Enhanced Perfusion	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RESPIRATORY PHASE; VENTILATION; COPD; VISUALIZATION; PARENCHYMA; INHALATION; FIBROSIS	Purpose Monitoring of regional lung function in interventional COPD trials requires alternative end-points beyond global parameters such as FEV1. T1 relaxation times of the lung might allow to draw conclusions on tissue composition, blood volume and oxygen fraction. The aim of this study was to evaluate the potential value of lung Magnetic resonance imaging (MRI) with native and oxygen-enhanced T1 mapping for the assessment of COPD patients in comparison with contrast enhanced perfusion MRI. Materials and Methods 20 COPD patients (GOLD I-IV) underwent a coronal 2-dimensional inversion recovery snapshot flash sequence (8 slices/lung) at room air and during inhalation of pure oxygen, as well as dynamic contrast-enhanced first-pass perfusion imaging. Regional distribution of T1 at room air (T1), oxygen-induced T1 shortening (Delta T1) and peak enhancement were rated by 2 chest radiologists in consensus using a semi-quantitative 3-point scale in a zone-based approach. Results Abnormal T1 and Delta T1 were highly prevalent in the patient cohort. T1 and Delta T1 correlated positively with perfusion abnormalities (r = 0.81 and r = 0.80; p&0.001), and with each other (r = 0.80; p< 0.001). In GOLD stages I and II Delta T1 was normal in 16/29 lung zones with mildly abnormal perfusion (15/16 with abnormal T1). The extent of T1 (r = 0.45; p< 0.05),.T1 (r = 0.52; p< 0.05) and perfusion abnormalities (r = 0.52; p< 0.05) showed a moderate correlation with GOLD stage. Conclusion Native and oxygen-enhanced T1 mapping correlated with lung perfusion deficits and severity of COPD. Under the assumption that T1 at room air correlates with the regional pulmonary blood pool and that oxygen-enhanced T1 reflects lung ventilation, both techniques in combination are principally suitable to characterize ventilation-perfusion imbalance. This appears valuable for the assessment of regional lung characteristics in COPD trials without administration of i. v. contrast.	[Jobst, Bertram J.; Triphan, Simon M. F.; Sedlaczek, Oliver; Anjorin, Angela; Kauczor, Hans Ulrich; Biederer, Juergen; Ley-Zaporozhan, Julia; Ley, Sebastian; Wielpuetz, Mark O.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Jobst, Bertram J.; Triphan, Simon M. F.; Sedlaczek, Oliver; Anjorin, Angela; Kauczor, Hans Ulrich; Wielpuetz, Mark O.] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Jobst, Bertram J.; Kauczor, Hans Ulrich; Wielpuetz, Mark O.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Ley, Sebastian] Surg Hosp Dr Rinecker, Dept Diagnost & Intervent Radiol, Munich, Germany; [Triphan, Simon M. F.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Biederer, Juergen] Dept Radiol Hosp Gross Gerau, Radiol Darmstadt, Gross Gerau, Germany; [Ley-Zaporozhan, Julia] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Munich	Jobst, BJ (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	bertram.jobst@med.uni-heidelberg.de	Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021; Biederer, Juergen/E-4545-2010; Kauczor, Hans-Ulrich/AAU-5955-2021; Ley, Sebastian/I-3426-2013; Wielpütz, Mark Oliver/ADP-0499-2022	Wielpuetz, Mark/0000-0001-6962-037X; Ley, Sebastian/0000-0001-9269-2670; Wielpütz, Mark Oliver/0000-0001-6962-037X	Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany [01GI0870]	Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany(Federal Ministry of Education & Research (BMBF))	This work has been supported by the Competence Network on Asthma / COPD (ASCONET) through a grant from the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany (01GI0870, www.bmbf.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest with regard to the study at hand.	Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Euler Us V, 1946, ACTA PHYSL SCAND, V12, P301, DOI [10.1111/j.1748-1716.1946.tb00389.x, DOI 10.1111/J.1748-1716.1946.TB00389.X]; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hatabu H, 2001, EUR J RADIOL, V37, P172, DOI 10.1016/S0720-048X(00)00298-9; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Jakob PM, 2004, MAGN RESON MED, V51, P1009, DOI 10.1002/mrm.20051; Karlik SJ, 2003, AM J ROENTGENOL, V180, P47, DOI 10.2214/ajr.180.1.1800047; Kohlmann P, 2014, INT J COMPUT ASSIST; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ley-Zaporozhan Julia, 2007, COPD, V4, P55, DOI 10.1080/15412550701198719; Ley-Zaporozhan J, 2007, EUR J RADIOL, V63, P76, DOI 10.1016/j.ejrad.2007.01.020; Ley-Zaporozhan J, 2008, MAGN RESON IMAGING C, V16, P291, DOI 10.1016/j.mric.2008.02.014; Mai VM, 1999, MAGNET RESON MED, V41, P866, DOI 10.1002/(SICI)1522-2594(199905)41:5<866::AID-MRM2>3.0.CO;2-D; Marshall H, 2012, THORAX, V67, P613, DOI 10.1136/thoraxjnl-2011-200864; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakagawa T, 2001, J MAGN RESON IMAGING, V14, P419, DOI 10.1002/jmri.1202; Ohno Y, 2002, MAGN RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC; Ohno Y, 2012, EUR J RADIOL, V81, P1068, DOI 10.1016/j.ejrad.2011.02.004; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Renne J, 2015, J MAGN RESON IMAGING, V41, P60, DOI 10.1002/jmri.24535; Rodriguez-Roisin R, 2009, J APPL PHYSIOL, V106, P1902, DOI 10.1152/japplphysiol.00085.2009; Sergiacomi G, 2003, IN VIVO, V17, P319; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stadler A, 2005, P 91 RAD SOC N AM C, P242; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Stock KW, 1999, JMRI-J MAGN RESON IM, V9, P557, DOI 10.1002/(SICI)1522-2586(199904)9:4<557::AID-JMRI8>3.0.CO;2-Y; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WAGNER PD, 1977, J CLIN INVEST, V59, P203, DOI 10.1172/JCI108630; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0	40	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121520	10.1371/journal.pone.0121520	http://dx.doi.org/10.1371/journal.pone.0121520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822195	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700113
J	Liu, R; Dai, YY; Sun, LB				Liu, Rui; Dai, Yuanyuan; Sun, Libo			Effect of Rhizosphere Enzymes on Phytoremediation in PAH-Contaminated Soil Using Five Plant Species	PLOS ONE			English	Article							DEGRADATION; BIOREMEDIATION; HYDROCARBONS; CREOSOTE; REMOVAL; LOSSES	A pot experiment was performed to study the effectiveness of remediation using different plant species and the enzyme response involved in remediating PAH-contaminated soil. The study indicated that species Echinacea purpurea, Festuca arundinacea Schred, Fire Phoenix (a combined F. arundinacea), and Medicago sativa L. possess the potential for remediation in PAH-contaminated soils. The study also determined that enzymatic reactions of polyphenol oxidase (except Fire Phoenix), dehydrogenase (except Fire Phoenix), and urease (except Medicago sativa L.) were more prominent over cultivation periods of 60d and 120d than 150d. Urease activity of the tested species exhibited prominently linear negative correlations with alkali-hydrolyzable nitrogen content after the tested plants were cultivated for 150d (R-2 = 0.9592). The experiment also indicated that alkaline phosphatase activity in four of the five tested species (Echinacea purpurea, Callistephus chinensis, Festuca arundinacea Schred and Fire Phoenix) was inhibited during the cultivation process (at 60d and 120d). At the same time, the study determined that the linear relationship between alkaline phosphatase activity and effective phosphorus content in plant rhizosphere soil exhibited a negative correlation after a growing period of 120d (R-2 = 0.665). Phytoremediation of organic contaminants in the soil was closely related to specific characteristics of particular plant species, and the catalyzed reactions were the result of the action of multiple enzymes in the plant rhizosphere soil.	[Liu, Rui; Dai, Yuanyuan] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Liaoning, Peoples R China; [Dai, Yuanyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Libo] Hangzhou Wanxiang Polytech, Appl Engn Dept, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, R (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Liaoning, Peoples R China.	liurui@iae.ac.cn		Liu, Rui/0000-0002-1408-9443	National Natural Science Foundation of China [31170478, 31470547]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by Grant No. 31170478 and 31470547 from National Natural Science Foundation of China, (http://www.nsfc.gov.cn/publish/portal1/), to RL. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Andreoni V, 2004, CHEMOSPHERE, V57, P401, DOI 10.1016/j.chemosphere.2004.06.013; BANKS MK, 1999, PHYTOREMEDIATION HYD, P3; Baran S, 2004, GEODERMA, V118, P221, DOI 10.1016/S0016-7061(03)00205-2; Cheema SA, 2010, J HAZARD MATER, V177, P384, DOI 10.1016/j.jhazmat.2009.12.044; Chen Y, 2004, PLANT SOIL, V261, P189, DOI 10.1023/B:PLSO.0000035565.65775.3c; CHRISTENSENKIRS.KM, 1996, THESIS U OREGON; Cunningham SD, 1996, PLANT PHYSIOL, V110, P715, DOI 10.1104/pp.110.3.715; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; Frick CM, 1999, TECHN SEM CHEM SPILL, p105a; Gianfreda L, 2005, SCI TOTAL ENVIRON, V341, P265, DOI 10.1016/j.scitotenv.2004.10.005; Guan S., 1986, SOIL ENZYME ITS RES, V1986, P274; Hamdi H, 2012, INT BIODETER BIODEGR, V67, P40, DOI 10.1016/j.ibiod.2011.10.009; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Huang XD, 2004, ENVIRON POLLUT, V130, P453, DOI 10.1016/j.envpol.2003.12.018; Jagtap SS, 2014, FUEL, V116, P292, DOI 10.1016/j.fuel.2013.08.017; Khaziev FKH., 1980, SOIL ENZYME ACTIVITI, P125; Khaziev FKH, 1980, SOIL ENZYME ACTIVITI, P21; Kiss S, 1998, DEV SOIL SCI, V26; Lee SH, 2008, J HAZARD MATER, V153, P892, DOI 10.1016/j.jhazmat.2007.09.041; Liu R, 2014, SCI TOTAL ENVIRON, V473, P350, DOI 10.1016/j.scitotenv.2013.12.027; Liu SL, 2004, ENVIRON GEOCHEM HLTH, V26, P285, DOI 10.1023/B:EGAH.0000039592.80489.e5; Macek T, 2000, BIOTECHNOL ADV, V18, P23, DOI 10.1016/S0734-9750(99)00034-8; Mamutov AM, 1974, REPORT VASKHN ALL UN, V3, P5; Margesin R, 2000, CHEMOSPHERE, V40, P339, DOI 10.1016/S0045-6535(99)00218-0; McCutcheon S. C., 2003, PHYTOREMEDIATION TRA; McIntyre T, 1997, J SOIL CONTAM, V6, P227, DOI 10.1080/15320389709383562; McLellan SL, 2002, ENVIRON TOXICOL CHEM, V21, P253, DOI 10.1897/1551-5028(2002)021<0253:TEOPAH>2.0.CO;2; Meagher RB, 2000, CURR OPIN PLANT BIOL, V3, P153, DOI 10.1016/S1369-5266(99)00054-0; MENZIE CA, 1992, ENVIRON SCI TECHNOL, V26, P1278, DOI 10.1021/es00031a002; Nannipieri P, 1996, SOIL BIOL BIOCHEM, V28, P107, DOI 10.1016/0038-0717(95)00108-5; Oleszczuk P, 2005, POLYCYCL AROMAT COMP, V25, P245, DOI 10.1080/10406630591007170; Peng SW, 2009, J HAZARD MATER, V168, P1490, DOI 10.1016/j.jhazmat.2009.03.036; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Rasmussen G, 2004, ADV ENVIRON RES, V8, P313, DOI 10.1016/S1093-0191(02)00105-3; Reilley KA, 1996, J ENVIRON QUAL, V25, P212, DOI 10.2134/jeq1996.00472425002500020002x; Singer AC, 2004, CURR OPIN MICROBIOL, V7, P239, DOI 10.1016/j.mib.2004.04.007; Sun TR, 2010, J HAZARD MATER, V176, P919, DOI 10.1016/j.jhazmat.2009.11.124; Sun YB, 2008, BIORESOURCE TECHNOL, V99, P1103, DOI 10.1016/j.biortech.2007.02.035; Susarla S, 2002, ECOL ENG, V18, P647, DOI 10.1016/S0925-8574(02)00026-5; vanderWaarde JJ, 1995, SOIL ENVIRONM, V5, P1377; WALTON BT, 1994, BIOREMEDIATION RHIZO, P82; Wang X, 2012, BIOTECHNOL BIOENG, V109, P426, DOI 10.1002/bit.23351; Ward O, 2003, J IND MICROBIOL BIOT, V30, P260, DOI 10.1007/s10295-003-0042-4; WEST AW, 1988, AUST J SOIL RES, V26, P217, DOI 10.1071/SR9880217; Willey Neil, 2007, V23, P3; WILSON SC, 1993, ENVIRON POLLUT, V81, P229, DOI 10.1016/0269-7491(93)90206-4; Zhou L.K., 1987, SCI SOIL ENZYME, P267; Zhou Qixing, 2004, Yingyong Shengtai Xuebao, V15, P1698; Zhou QX, 2005, ENVIRON INT, V31, P835, DOI 10.1016/j.envint.2005.05.039; Zhou QX., 2004, PRINCIPLES METHODS C, P187	50	34	37	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120369	10.1371/journal.pone.0120369	http://dx.doi.org/10.1371/journal.pone.0120369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822167	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700063
J	Mecklenburg, KL; Freed, SA; Raval, M; Quintero, OA; Yengo, CM; O'Tousa, JE				Mecklenburg, Kirk L.; Freed, Stephanie A.; Raval, Manmeet; Quintero, Omar A.; Yengo, Christopher M.; O'Tousa, Joseph. E.			Invertebrate and Vertebrate Class III Myosins Interact with MORN Repeat-Containing Adaptor Proteins	PLOS ONE			English	Article							DROSOPHILA; LOCALIZATION; EXPRESSION; BINDING; TIPS; PHOTORECEPTORS; STEREOCILIA; COMPLEX; BUNDLES; CELLS	In Drosophila photoreceptors, the NINAC-encoded myosin III is found in a complex with a small, MORN-repeat containing, protein Retinophilin (RTP). Expression of these two proteins in other cell types showed NINAC myosin III behavior is altered by RTP. NINAC deletion constructs were used to map the RTP binding site within the proximal tail domain of NINAC. In vertebrates, the RTP ortholog is MORN4. Co-precipitation experiments demonstrated that human MORN4 binds to human myosin IIIA (MYO3A). In COS7 cells, MORN4 and MYO3A, but not MORN4 and MYO3B, co-localize to actin rich filopodia extensions. Deletion analysis mapped the MORN4 binding to the proximal region of the MYO3A tail domain. MYO3A dependent MORN4 tip localization suggests that MYO3A functions as a motor that transports MORN4 to the filopodia tips and MORN4 may enhance MYO3A tip localization by tethering it to the plasma membrane at the protrusion tips. These results establish conserved features of the RTP/MORN4 family: they bind within the tail domain of myosin IIIs to control their behavior.	[Mecklenburg, Kirk L.] Indiana Univ, Dept Biol, South Bend, IN 46615 USA; [Freed, Stephanie A.; O'Tousa, Joseph. E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Quintero, Omar A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Yengo, Christopher M.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Richmond; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yengo, CM (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	cyengo@hmc.psu.edu; jotousa@nd.edu	Raval, Manmeet H./J-5093-2019	Quintero-Carmona, Omar/0000-0002-9314-1704; O'Tousa, Joseph/0000-0001-9754-6816	NIH [R01EY06808, R01EY018141, K01CA160667]; National Center for Research Resources, Clinical and Translational Sciences Research; IUSB Research and Development; NATIONAL CANCER INSTITUTE [K01CA160667] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, Clinical and Translational Sciences Research; IUSB Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01EY06808 (JEO), R01EY018141 (CMY), K01CA160667 (OAQ), the Indiana Clinical and Translational Sciences Institute Grant from the National Center for Research Resources, Clinical and Translational Sciences Research (JEO), and an IUSB Research and Development grant (KLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dalal JS, 2011, J NEUROCHEM, V119, P772, DOI 10.1111/j.1471-4159.2011.07468.x; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Greenberg MJ, 2013, TRENDS CELL BIOL, V23, P81, DOI 10.1016/j.tcb.2012.10.008; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Manor Uri, 2012, Bioarchitecture, V2, P171, DOI 10.4161/bioa.21733; Mecklenburg KL, 2010, J NEUROSCI, V30, P1238, DOI 10.1523/JNEUROSCI.4464-09.2010; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.3.CO;2-H; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Venkatachalam K, 2010, J NEUROSCI, V30, P11337, DOI 10.1523/JNEUROSCI.2709-10.2010	23	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122502	10.1371/journal.pone.0122502	http://dx.doi.org/10.1371/journal.pone.0122502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822849	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700179
J	Schatzle, S; Specht, M; Waidner, B				Schaetzle, Sarah; Specht, Mara; Waidner, Barbara			Coiled Coil Rich Proteins (Ccrp) Influence Molecular Pathogenicity of Helicobacter pylori	PLOS ONE			English	Article							IV SECRETION SYSTEM; GASTRIC EPITHELIAL-CELLS; SITE-DIRECTED MUTAGENESIS; CAGA PROTEIN; RESPONSE REGULATORS; ACID RESISTANCE; UREASE; PHOSPHORYLATION; COLONIZATION; LOCALIZATION	Pathogenicity of the human pathogen Helicobacter pylori relies on its capacity to adapt to a hostile environment and to escape the host response. Although there have been great advances in our understanding of the bacterial cytoskeleton, major gaps remain in our knowledge of its contribution to virulence. In this study we have explored the influence of coiled coil rich proteins (Ccrp) cytoskeletal elements on pathogenicity factors of H. pylori. Deletion of any of the ccrp resulted in a strongly decreased activity of the main pathogenicity factor urease. We further investigated their role using in vitro co-culture experiments with the human gastric adenocarcinoma cell line AGS modeling H. pylori -host cell interactions. Intriguingly, host cell showed only a weak "scattering/hummingbird" phenotype, in which host cells are transformed from a uniform polygonal shape into a severely elongated state characterized by the formation of needle-like projections, after co-incubation with any ccrp deletion mutant. Furthermore, co-incubation with the ccrp59 mutant resulted in reduced type IV secretion system associated activities, e.g. IL-8 production and CagA translocation/phosphorylation. Thus, in addition to their role in maintaining the helical cell shape of H. pylori Ccrp proteins influence many cellular processes and are thereby crucial for the virulence of this human pathogen.	[Schaetzle, Sarah; Waidner, Barbara] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Dept Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Schaetzle, Sarah; Waidner, Barbara] Univ Freiburg, Fac Biol, Dept Microbiol, D-79104 Freiburg, Germany; [Specht, Mara; Waidner, Barbara] LOEWE Ctr Synthet Microbiol, D-35032 Marburg, Germany	University of Freiburg; University of Freiburg	Waidner, B (corresponding author), Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Dept Med Microbiol & Hyg, Hermann Herder Str 11, D-79104 Freiburg, Germany.	barbara.waidner@synmikro.uni-marburg.de			Deutsche Forschungsgemeinschaft [WA2574/1-1, WA2574/1-2, FOR 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft to Barbara Waidner WA2574/1-1, WA2574/1-2 and FOR 929.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, GUT MICROBES, V1, P94, DOI 10.4161/gmic.1.2.11437; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; Barrozo RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003189; Belogolova E, 2013, CELL MICROBIOL, V15, P1896, DOI 10.1111/cmi.12158; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Bulmer DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002500; Cameron TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042219; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chai Q, 2014, J BIOL CHEM, V289, P11342, DOI 10.1074/jbc.M114.557348; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Cowles KN, 2010, MOL MICROBIOL, V76, P1411, DOI 10.1111/j.1365-2958.2010.07132.x; Crabtree JE, 1996, SCAND J GASTROENTERO, V31, P3, DOI 10.3109/00365529609094526; Croxen MA, 2006, J BACTERIOL, V188, P2656, DOI 10.1128/JB.188.7.2656-2665.2006; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; FORMAN D, 1993, LANCET, V341, P1359; Gorrell RJ, 2012, CELL MICROBIOL, DOI 10.1111/cmi.12055; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2006, J IMMUNOL, V176, P3796, DOI 10.4049/jimmunol.176.6.3796; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman PS, 2003, INFECT IMMUN, V71, P2534, DOI 10.1128/IAI.71.5.2534-2541.2003; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Josenhans C, 2000, INFECT IMMUN, V68, P4598, DOI 10.1128/IAI.68.8.4598-4603.2000; Kahrs AF, 1995, GENE, V167, P53, DOI 10.1016/0378-1119(95)00671-0; Kumar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074620; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Labigne A, 1996, INFECT AGENT DIS, V5, P191; LEYING H, 1992, MOL MICROBIOL, V6, P2863, DOI 10.1111/j.1365-2958.1992.tb01466.x; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; MARSHALL BJ, 1984, LANCET, V1, P1311; MOBLEY HLT, 1991, SCAND J GASTROENTERO, V26, P39, DOI 10.3109/00365529109098223; Muller S, 2007, MICROBIOL RES, V162, P1, DOI 10.1016/j.micres.2006.01.003; Mukherjee A, 1998, METHOD ENZYMOL, V298, P296, DOI 10.1016/S0076-6879(98)98026-0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; PARSONNET J, 1994, WESTERN J MED, V161, P60; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Specht M, 2013, J BACTERIOL, V195, P1411, DOI 10.1128/JB.01490-12; Specht M, 2011, J BACTERIOL, V193, P4523, DOI 10.1128/JB.00231-11; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; van Vliet AHM, 2001, INFECT IMMUN, V69, P4891, DOI 10.1128/IAI.69.8.4891-4897.2001; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Voss BJ, 2014, J BACTERIOL; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; Wang HJ, 2012, MOL MICROBIOL, V83, P67, DOI 10.1111/j.1365-2958.2011.07910.x; Wirth HP, 1998, INFECT IMMUN, V66, P4856, DOI 10.1128/IAI.66.10.4856-4866.1998	73	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121463	10.1371/journal.pone.0121463	http://dx.doi.org/10.1371/journal.pone.0121463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822999	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700110
J	Patti, F; De Stefano, M; Lavorgna, L; Messina, S; Chisari, CG; Ippolito, D; Lanzillo, R; Vacchiano, V; Realmuto, S; Valentino, P; Coniglio, G; Buccafusca, M; Paolicelli, D; D'Ambrosio, A; Montella, P; Morra, VB; Savettieri, G; Alfano, B; Gallo, A; Simone, I; Viterbo, R; Zappia, M; Bonavita, S; Tedeschi, G				Patti, Francesco; De Stefano, Manuela; Lavorgna, Luigi; Messina, Silvia; Chisari, Clara Grazia; Ippolito, Domenico; Lanzillo, Roberta; Vacchiano, Veria; Realmuto, Sabrina; Valentino, Paola; Coniglio, Gabriella; Buccafusca, Maria; Paolicelli, Damiano; D'Ambrosio, Alessandro; Montella, Patrizia; Morra, Vincenzo Brescia; Savettieri, Giovanni; Alfano, Bruno; Gallo, Antonio; Simone, Isabella; Viterbo, Rosa; Zappia, Mario; Bonavita, Simona; Tedeschi, Gioacchino			Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients	PLOS ONE			English	Article							RELAPSING-REMITTING MS; MILDLY DISABLED PATIENTS; GREY-MATTER; DISEASE MEASURES; VOLUME CHANGES; BRAIN ATROPHY; IMPAIRMENT; ASSOCIATION; GRAY; POPULATION	Background Magnetic Resonance Imaging (MRI) techniques provided evidences into the understanding of cognitive impairment (CIm) in Multiple Sclerosis (MS). Objectives To investigate the role of white matter (WM) and gray matter (GM) in predicting long-term CIm in a cohort of MS patients. Methods 303 out of 597 patients participating in a previous multicenter clinical-MRI study were enrolled (49.4% were lost at follow-up). The following MRI parameters, expressed as fraction (f) of intracranial volume, were evaluated: cerebrospinal fluid (CSF-f), WM-f, GM-f and abnormal WM (AWM-f), a measure of lesion load. Nine years later, cognitive status was assessed in 241 patients using the Symbol Digit Modalities Test (SDMT), the Semantically Related Word List Test (SRWL), the Modified Card Sorting Test (MCST), and the Paced Auditory Serial Addition Test (PASAT). In particular, being SRWL a memory test, both immediate recall and delayed recall were evaluated. MCST scoring was calculated based on the number of categories, number of perseverative and non-perseverative errors. Results AWM-f was predictive of an impaired performance 9 years ahead in SDMT (OR 1.49, CI 1.12-1.97 p = 0.006), PASAT (OR 1.43, CI 1.14-1.80 p = 0.002), SRWL-immediate recall (OR 1.72 CI 1.35-2.20 p<0.001), SRWL-delayed recall (OR 1.61 CI 1.28-2.03 p<0.001), MCST-category (OR 1.52, CI 1.2-1.9 p<0.001), MCST-perseverative error(OR 1.51 CI 1.2-1.9 p = 0.001), MCST-non perseverative error (OR 1.26 CI 1.02-1.55 p = 0.032). Conclusion In our large MS cohort, focal WM damage appeared to be the most relevant predictor of the long-term cognitive outcome.	[Patti, Francesco; Messina, Silvia; Chisari, Clara Grazia; Zappia, Mario] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [De Stefano, Manuela; Lavorgna, Luigi; Ippolito, Domenico; D'Ambrosio, Alessandro; Montella, Patrizia; Gallo, Antonio; Bonavita, Simona; Tedeschi, Gioacchino] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Lanzillo, Roberta; Vacchiano, Veria; Morra, Vincenzo Brescia] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Realmuto, Sabrina; Savettieri, Giovanni] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Valentino, Paola] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, Catanzaro, Italy; [Coniglio, Gabriella] Madonna Grazie Hosp, Dept Neurol, Matera, Italy; [Buccafusca, Maria] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy; [Paolicelli, Damiano; Simone, Isabella; Viterbo, Rosa] Univ Bari, Dept Sci Med Base Neurosci & Organi Senso, Bari, Italy; [Alfano, Bruno] CNR, Biostruct & Bioimaging Inst, Naples, Italy; [Bonavita, Simona] Neurol Inst Diag & Care Hermitage Capodimonte, Naples, Italy	University of Catania; Universita della Campania Vanvitelli; University of Naples Federico II; University of Palermo; Magna Graecia University of Catanzaro; University of Messina; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Patti, F (corresponding author), Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy.	patti@unict.it	Vacchiano, Veria/AAC-5230-2022; Simone, sabella laura/K-9755-2018; Lavorgna, Luigi/AAG-9119-2021; VALENTINO, Paola/AAA-4243-2019; Lavorgna, Luigi/R-2696-2016; Messina, Silvia/ABC-8780-2020; Bonavita, Simona/AGN-5124-2022; Zappia, Mario/AAB-7800-2019; Lanzillo, Roberta/AFA-8874-2022	Vacchiano, Veria/0000-0002-3607-2394; Lavorgna, Luigi/0000-0003-4625-4236; VALENTINO, Paola/0000-0001-7863-9195; Lavorgna, Luigi/0000-0003-4625-4236; Bonavita, Simona/0000-0002-8561-9720; Alfano, Bruno/0000-0002-7315-3628; patti, francesco/0000-0002-6923-0846; Lanzillo, Roberta/0000-0001-6388-8180; Simone, Isabella Laura/0000-0002-7429-3091; chisari, clara grazia/0000-0003-1607-543X	Merck-Serono; Novartis; Biogen Idec; Bayer Schering; Merck Serono; Teva; Schering-Plough	Merck-Serono(Merck & Company); Novartis(Novartis); Biogen Idec(Biogen); Bayer Schering(Bayer AG); Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Schering-Plough(Merck & CompanySchering Plough Corporation)	The authors of this manuscript have the following competing interests: Dr. Patti has received honoraria for scientific lectures from Biogen Idec; Dr. De Stefano report no disclosure; Dr. Lavorgna has received travel payment from Merck-Serono, Novartis and Biogen Idec; Dr. Messina has received travel payment from Novartis, Biogen Idec, Bayer Schering, Merck Serono; report no disclosure; Drs Chisari, Ippolito, Vacchiano, Valentino, Buccafusca, Paolicelli, D'Ambrosio, Montella, Viterbo, Realmuto and Prof. Alfano report no disclosure; Dr Lanzillo has received travel payment from Merck-Serono, Novartis, Biogen Idec, Schering-Plough and Teva; Dr Coniglio has received funding for a trip from Novartis; Dr. Bresciamorra has received travel payment from Novartis, Biogen Idec, Schering-Plough and Teva. Prof. Savettieri has received travel payment from Teva and honoraria for scientific lectures from Biogen Idec; Dr. Gallo has received travel payment from Biogen Idec and Schering-Plough and honoraria for scientific lectures from Biogen Idec; Prof. Simone has received honoraria for educational lectures from Biogen Idec, Bayer, Sanofi Aventis-Genzyme and Teva; Prof. Zappia has received funding for a trip from Schering-Plough; Prof. Bonavita has received travel payment from Merck-Serono, Novartis, Biogen Idec and Teva and honoraria for scientific lectures from Novartis; Prof. Tedeschi has received travel payment from Merck-Serono, Novartis, Biogen Idec and Teva and honoraria for scientific lectures from Novartis, Teva and Biogen Idec. Francesco Patti declares, on behalf of all authors, all potential competing interests do not alter their adherence to PLOS ONE policies on sharing data and materials.	Alfano B, 2000, J MAGN RESON IMAGING, V12, P799, DOI 10.1002/1522-2586(200012)12:6<799::AID-JMRI2>3.0.CO;2-#; Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Bastianello S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-125; Bendfeldt K, 2010, HUM BRAIN MAPP, V31, P1542, DOI 10.1002/hbm.20951; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bomboi G, 2011, J NEUROIMAGING, V21, pe57, DOI 10.1111/j.1552-6569.2010.00488.x; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Deloire MSA, 2011, NEUROLOGY, V76, P1161, DOI 10.1212/WNL.0b013e318212a8be; Filippi M, 2013, NEUROLOGY, V81, P1759, DOI 10.1212/01.wnl.0000435551.90824.d0; Fischer M, 2014, J NEUROL SCI, V343, P91, DOI 10.1016/j.jns.2014.05.042; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guimaraes Joana, 2012, Front Neurol, V3, P74, DOI 10.3389/fneur.2012.00074; Lavorgna L, 2013, MULT SCLER; Leone C, 2014, MULT SCLER; Mauri M., 1997, ARCH PSICOL NEUROL P, V58, P621; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nocentini U, 2002, NUOVA RIV NEUROLOGIA; Papadopoulou A, 2013, MULT SCLER; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Prinster A, 2006, NEUROIMAGE, V29, P859, DOI 10.1016/j.neuroimage.2005.08.034; Rovaris M, 2006, J NEUROL SCI, V245, P111, DOI 10.1016/j.jns.2005.07.014; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Smith A, SYMBOL DIGIT MODALIT; Summers MM, 2008, MULT SCLER J, V14, P197, DOI 10.1177/1352458507082353; Tedeschi G, 2005, NEUROLOGY, V65, P280, DOI 10.1212/01.wnl.0000168837.87351.1f; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Wills S, 2004, APPL NEUROPSYCHOL, V11, P180; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	38	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120754	10.1371/journal.pone.0120754	http://dx.doi.org/10.1371/journal.pone.0120754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816303	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600045
J	Demanche, C; Deville, M; Michaux, J; Barriel, V; Pincon, C; Aliouat-Denis, CM; Pottier, M; Noel, C; Viscogliosi, E; Aliouat, E; Dei-Cas, E; Morand, S; Guillot, J				Demanche, Christine; Deville, Manjula; Michaux, Johan; Barriel, Veronique; Pincon, Claire; Aliouat-Denis, Cecile Marie; Pottier, Muriel; Noel, Christophe; Viscogliosi, Eric; Aliouat, El Moukhtar; Dei-Cas, Eduardo; Morand, Serge; Guillot, Jacques			What Do Pneumocystis Organisms Tell Us about the Phylogeography of Their Hosts? The Case of the Woodmouse Apodemus sylvaticus in Continental Europe and Western Mediterranean Islands	PLOS ONE			English	Article							F-SP HOMINIS; SP-NOV.; HELIGMOSOMOIDES-POLYGYRUS; CARINII; MITOCHONDRIAL; POPULATIONS; BATS; WAKEFIELDIAE; POLYMORPHISM; SPECIFICITY	Pneumocystis fungi represent a highly diversified biological group with numerous species, which display a strong host-specificity suggesting a long co-speciation process. In the present study, the presence and genetic diversity of Pneumocystis organisms was investigated in 203 lung samples from woodmice (Apodemus sylvaticus) collected on western continental Europe and Mediterranean islands. The presence of Pneumocystis DNA was assessed by nested PCR at both large and small mitochondrial subunit (mtLSU and mtSSU) rRNA loci. Direct sequencing of nested PCR products demonstrated a very high variability among woodmouse-derived Pneumocystisorganisms with a total number of 30 distinct combined mtLSU and mtSSU sequence types. However, the genetic divergence among these sequence types was very low (up to 3.87%) and the presence of several Pneumocystis species within Apodemus sylvaticus was considered unlikely. The analysis of the genetic structure of woodmouse-derived Pneumocystis revealed two distinct groups. The first one comprised Pneumocystis from woodmice collected in continental Spain, France and Balearic islands. The second one included Pneumocystis from woodmice collected in continental Italy, Corsica and Sicily. These two genetic groups were in accordance with the two lineages currently described within the host species Apodemus sylvaticus. Pneumocystis organisms are emerging as powerful tools for phylogeographic studies in mammals.	[Demanche, Christine; Aliouat-Denis, Cecile Marie; Pottier, Muriel; Aliouat, El Moukhtar] Univ Lille, Lab Parasitol EA4547, Fac Pharmacie, Lille, France; [Demanche, Christine; Aliouat-Denis, Cecile Marie; Pottier, Muriel; Viscogliosi, Eric; Aliouat, El Moukhtar; Dei-Cas, Eduardo] Univ Lille, Inst Pasteur Lille, Ctr Infect & Immunite Lille, Inserm UMR CNRS 8204 U1019,Biopole Alfort Biol &, Lille, France; [Michaux, Johan; Guillot, Jacques] Ecole Natl Vet Alfort, Res Grp Dynamyc, UPEC, ENVA, F-94704 Maisons Alfort, France; [Michaux, Johan] CBGP, UMR INRA IRD Cirad Montpellier SupAgro, F-34988 Montferrier Sur Lez, France; [Michaux, Johan] Univ Liege, Inst Botan B22, B-4000 Liege, Belgium; [Barriel, Veronique] Univ Paris 06, Museum Natl Hist Nat, CR2P UMR CNRS 7207, MNHN, Paris, France; [Pincon, Claire] Univ Lille, Dept Biostat EA2694, Lille, France; [Noel, Christophe] Geneius Labs Ltd, INEX Business Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Dei-Cas, Eduardo] Univ Lille, CHRU, Fac Med, Parasitol Mycol EA4547, Lille, France; [Morand, Serge] Univ Montpellier 2, Inst Sci Evolut, UMR CNRS IRD UM2, F-34093 Montpellier, France; [Morand, Serge] CNRS, CIRAD, Ctr Infectiol Christophe Merieux Laos, Viangchan, Laos	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of Liege; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD	Demanche, C (corresponding author), Univ Lille, Inst Pasteur Lille, Ctr Infect & Immunite Lille, Inserm UMR CNRS 8204 U1019,BRIPT, Lille, France.	christine.demanche@univ-lille2.fr	Aliouat, El Moukhtar/D-2859-2018; Pinçon, Claire/AAD-8448-2020; Guillot, Jacques/J-9428-2016; Morand, Serge/M-5433-2018; Aliouat-Denis, Cecile-Marie/P-1934-2016; Pincon, Claire/N-1607-2016	Aliouat, El Moukhtar/0000-0003-2905-7126; Guillot, Jacques/0000-0003-3577-6979; Morand, Serge/0000-0003-3986-7659; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Demanche, Christine/0000-0002-5425-8010; Pincon, Claire/0000-0002-5509-6199	French Ministry of Research (Lille Nord de France University) [EA4547]; French Ministry of Research (Lille Pasteur Institute); French Institute of Biodiversity (IFB)	French Ministry of Research (Lille Nord de France University); French Ministry of Research (Lille Pasteur Institute); French Institute of Biodiversity (IFB)	This work was supported by the French Ministry of Research (www.enseignementsuprecherche.gouv.fr) (EA4547 Lille Nord de France University and Lille Pasteur Institute) and by the French Institute of Biodiversity (IFB) (www.biodiversite-sbstta.org) in the framework of "Insularite et Parasitisme: diversite parasitaire et ecologie evolutive des populations de rongeurs insulaires". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2012, APPL ENVIRON MICROB, V78, P8122, DOI 10.1128/AEM.01791-12; ALIOUAT EM, 1994, J EUKARYOT MICROBIOL, V41, pS71; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; BARRIEL V, 1994, CR ACAD SCI III-VIE, V317, P693; Bruyndonckx N, 2010, MOL ECOL, V19, P2770, DOI 10.1111/j.1365-294X.2010.04699.x; Bruyndonckx N, 2009, MOL PHYLOGENET EVOL, V51, P227, DOI 10.1016/j.ympev.2009.02.005; Callejon R, 2010, PARASITOL RES, V107, P631, DOI 10.1007/s00436-010-1908-9; Chabe M, 2010, J EUKARYOT MICROBIOL, V57, P213, DOI 10.1111/j.1550-7408.2009.00465.x; Criscione CD, 2006, ECOLOGY, V87, P823, DOI 10.1890/0012-9658(2006)87[823:PGISPO]2.0.CO;2; Cushion MT, 2004, MYCOLOGIA, V96, P429, DOI 10.2307/3762163; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Bellocq JG, 2002, ECOGRAPHY, V25, P173, DOI 10.1034/j.1600-0587.2002.250205.x; Dei-Cas E, 1998, J MYCOL MED, V8, P1; Dei-Cas E, 2000, MED MYCOL, V38, P23, DOI 10.1080/mmy.38.s1.23.32; Dei-Cas E, 1998, FEMS IMMUNOL MED MIC, V22, P1; Dei-Cas E, 2006, FEMS MICROBIOL REV, V30, P853, DOI 10.1111/j.1574-6976.2006.00037.x; Demanche C, 2005, MICROBIOL-SGM, V151, P3117, DOI 10.1099/mic.0.28059-0; Demanche C, 2003, VET REC, V152, P811, DOI 10.1136/vr.152.26.811; Demanche C, 2001, J CLIN MICROBIOL, V39, P2126, DOI 10.1128/JCM.39.6.2126-2133.2001; Derouiche S, 2009, MEM I OSWALDO CRUZ, V104, P112, DOI 10.1590/S0074-02762009000100017; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Dumoulin A, 2000, EUR J CLIN MICROBIOL, V19, P671, DOI 10.1007/s100960000354; Durand-Joly I, 2002, J CLIN MICROBIOL, V40, P1862, DOI 10.1128/JCM.40.5.1862-1865.2002; Fromont E, 2001, PARASITOLOGY, V123, P143, DOI 10.1017/S0031182001008277; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GIGLIOTTI F, 1993, INFECT IMMUN, V61, P2886, DOI 10.1128/IAI.61.7.2886-2890.1993; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Guillot J, 2004, MOL PHYLOGENET EVOL, V31, P988, DOI 10.1016/j.ympev.2003.10.022; Guillot J, 2001, J EUK MICROBIOL S, P133; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugot JP, 2003, SYST BIOL, V52, P735, DOI 10.1080/10635150390250893; Keely SP, 2004, MICROBIOL-SGM, V150, P1153, DOI 10.1099/mic.0.26921-0; Laakkonen J, 1998, INT J PARASITOL, V28, P241, DOI 10.1016/S0020-7519(97)00155-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mazars E, 1997, J EUKARYOT MICROBIOL, V44, p39S, DOI 10.1111/j.1550-7408.1997.tb05763.x; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Michaux JR, 2004, MOL PHYLOGENET EVOL, V32, P788, DOI 10.1016/j.ympev.2004.02.018; Michaux JR, 2003, MOL ECOL, V12, P685, DOI 10.1046/j.1365-294X.2003.01752.x; Michaux JR, 2002, GLOBAL ECOL BIOGEOGR, V11, P427, DOI 10.1046/j.1466-822x.2002.00301.x; Nieberding C, 2006, J BIOGEOGR, V33, P1212, DOI 10.1111/j.1365-2699.2006.01503.x; Nieberding C, 2005, MOL ECOL, V14, P765, DOI 10.1111/j.1365-294X.2005.02440.x; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Nieberding CM, 2007, TRENDS ECOL EVOL, V22, P156, DOI 10.1016/j.tree.2006.11.012; Palmer RJ, 2000, APPL ENVIRON MICROB, V66, P4954, DOI 10.1128/AEM.66.11.4954-4961.2000; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Sara M, 2002, DIVERS DISTRIB, V8, P1, DOI 10.1046/j.1366-9516.2001.00119.x; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Taylor ML, 2005, FEMS IMMUNOL MED MIC, V45, P451, DOI 10.1016/j.femsim.2005.05.019; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsolaki AG, 1998, J CLIN MICROBIOL, V36, P90, DOI 10.1128/JCM.36.1.90-93.1998; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996	54	13	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120839	10.1371/journal.pone.0120839	http://dx.doi.org/10.1371/journal.pone.0120839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830289	Green Published, gold			2022-12-27	WOS:000352135600045
J	Haghighat-Khah, RE; Scaife, S; Martins, S; St John, O; Matzen, KJ; Morrison, N; Alphey, L				Haghighat-Khah, Roya Elaine; Scaife, Sarah; Martins, Sara; St John, Oliver; Matzen, Kelly Jean; Morrison, Neil; Alphey, Luke			Site-Specific Cassette Exchange Systems in the Aedes aegypti Mosquito and the Plutella xylostella Moth	PLOS ONE			English	Article							PHAGE PHI-C31-INTEGRASE; GENETIC-TRANSFORMATION; GENOMIC INTEGRATION; MAMMALIAN-CELLS; CRE RECOMBINASE; HIGH-EFFICIENCY; DNA-SEQUENCES; DROSOPHILA; EXPRESSION; PROMOTER	Genetically engineered insects are being evaluated as potential tools to decrease the economic and public health burden of mosquitoes and agricultural pest insects. Here we describe a new tool for the reliable and targeted genome manipulation of pest insects for research and field release using recombinase mediated cassette exchange (RMCE) mechanisms. We successfully demonstrated the established phi C31-RMCE method in the yellow fever mosquito, Aedes aegypti, which is the first report of RMCE in mosquitoes. A new variant of this RMCE system, called iRMCE, combines the phi C31-att integration system and Cre or FLP-mediated excision to remove extraneous sequences introduced as part of the site-specific integration process. Complete iRMCE was achieved in two important insect pests, Aedes aegypti and the diamondback moth, Plutella xylostella, demonstrating the transferability of the system across a wide phylogenetic range of insect pests.	[Haghighat-Khah, Roya Elaine; Martins, Sara; St John, Oliver; Alphey, Luke] Univ Oxford, Dept Zool, Oxford, England; [Haghighat-Khah, Roya Elaine; Scaife, Sarah; Martins, Sara; St John, Oliver; Matzen, Kelly Jean; Morrison, Neil; Alphey, Luke] Oxitec Ltd, Oxford, England	University of Oxford	Matzen, KJ (corresponding author), Oxitec Ltd, Oxford, England.	kelly.matzen@oxitec.com; luke.alphey@pirbright.ac.uk		Alphey, Luke/0000-0002-2916-3802; Haghighat-Khah, Roya/0000-0002-9741-5282; Matzen, Kelly/0000-0002-1167-7397				ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Anderson RP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks027; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Arimbasseri AG, 2008, MOL CELL BIOL, V28, P2598, DOI 10.1128/MCB.01953-07; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Bernardini F, 2014, P NATL ACAD SCI USA, V111, P7600, DOI 10.1073/pnas.1404996111; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Cox MM, 1983, BIOCHEMISTRY-US, V80, P4223; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Forsythe IJ, 1998, VIROLOGY, V252, P65, DOI 10.1006/viro.1998.9415; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; HOY MA, 1995, PARASITOL TODAY, V11, P229, DOI 10.1016/0169-4758(95)80086-7; Jasinskiene N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng148; Kapusi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045353; Kennett SB, 2002, J BIOL CHEM, V277, P9780, DOI 10.1074/jbc.M108661200; Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788; Lauth M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf114; Liu WY, 2007, MAR BIOTECHNOL, V9, P420, DOI 10.1007/s10126-007-9000-x; Long DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040150; Long DP, 2013, INSECT BIOCHEM MOLEC, V43, P997, DOI 10.1016/j.ibmb.2013.08.001; Louwerse JD, 2007, PLANT PHYSIOL, V145, P1282, DOI 10.1104/pp.107.108092; Macer DR., 2003, ETHICAL LEGAL SOCIAL; Martins S, 2012, INSECT MOL BIOL, V21, P414, DOI 10.1111/j.1365-2583.2012.01146.x; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Meza S, 2014, PLOS ONE, V9, P1; MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x; Mosimann C, 2013, DEV DYNAM, V242, P949, DOI 10.1002/dvdy.23989; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nuffield Council on Bioethics, 1999, ETH CLIN RES DEV COU; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Pfeifer TA, 1997, GENE, V188, P183, DOI 10.1016/S0378-1119(96)00756-1; SADOWSKI PD, 1984, COLD SPRING HARB SYM, V49, P789, DOI 10.1101/SQB.1984.049.01.089; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schetelig MF, 2013, G3-GENES GENOM GENET, V3, P687, DOI 10.1534/g3.112.005488; Schetelig MF, 2011, GENETICA, V139, P71, DOI 10.1007/s10709-010-9494-4; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Siegal ML, 1996, GENETICS, V144, P715; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; TIEDJE JM, 1989, ECOLOGY, V70, P298, DOI 10.2307/1937535; Tkachuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026422; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Wimmer EA, 2005, NAT METHODS, V2, P580, DOI 10.1038/nmeth0805-580; Yonemura N, 2013, APPL ENTOMOL ZOOL, V48, P265, DOI 10.1007/s13355-013-0182-6	63	19	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121097	10.1371/journal.pone.0121097	http://dx.doi.org/10.1371/journal.pone.0121097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830287	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600055
J	Papazi, A; Kastanaki, E; Pirintsos, S; Kotzabasis, K				Papazi, Aikaterini; Kastanaki, Elizabeth; Pirintsos, Stergios; Kotzabasis, Kiriakos			Lichen Symbiosis: Nature's High Yielding Machines for Induced Hydrogen Production	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; CARBON-DIOXIDE; ALGA TREBOUXIA; GREEN; TEMPERATURE; CHLORORESPIRATION; SELECTIVITY; REDUCTION; DIVERSITY	Hydrogen is a promising future energy source. Although the ability of green algae to produce hydrogen has long been recognized (since 1939) and several biotechnological applications have been attempted, the greatest obstacle, being the O-2-sensitivity of the hydrogenase enzyme, has not yet been overcome. In the present contribution, 75 years after the first report on algal hydrogen production, taking advantage of a natural mechanism of oxygen balance, we demonstrate high hydrogen yields by lichens. Lichens have been selected as the ideal organisms in nature for hydrogen production, since they consist of a mycobiont and a photobiont in symbiosis. It has been hypothesized that the mycobiont's and photobiont's consumption of oxygen (increase of COX and AOX proteins of mitochondrial respiratory pathways and PTOX protein of chrolorespiration) establishes the required anoxic conditions for the activation of the phycobiont's hydrogenase in a closed system. Our results clearly supported the above hypothesis, showing that lichens have the ability to activate appropriate bioenergetic pathways depending on the specific incubation conditions. Under light conditions, they successfully use the PSII-dependent and the PSII-independent pathways (decrease of D1 protein and parallel increase of PSaA protein) to transfer electrons to hydrogenase, while under dark conditions, lichens use the PFOR enzyme and the dark fermentative pathway to supply electrons to hydrogenase. These advantages of lichen symbiosis in combination with their ability to survive in extreme environments (while in a dry state) constitute them as unique and valuable hydrogen producing natural factories and pave the way for future biotechnological applications.	[Papazi, Aikaterini; Kastanaki, Elizabeth; Pirintsos, Stergios; Kotzabasis, Kiriakos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Pirintsos, Stergios] Univ Crete, Bot Garden, Rethimnon, Greece	University of Crete; University of Crete	Kotzabasis, K (corresponding author), Univ Crete, Dept Biol, Voutes Univ Campus, Iraklion, Crete, Greece.	kotzab@biology.uoc.gr	Kotzabasis, Kiriakos/AAP-1448-2021	Kotzabasis, Kiriakos/0000-0002-1002-6365				Ahmadjian V, 2002, CELL OR EX, V4, P373; AHMADJIAN V, 1988, PLANT SYST EVOL, V158, P243; Atkin OK, 2002, PLANT PHYSIOL, V128, P212, DOI 10.1104/pp.010326; Beck A, 1998, NEW PHYTOL, V139, P709, DOI 10.1046/j.1469-8137.1998.00231.x; Beck A, 2001, SYMBIOSIS, V31, P57; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Bishop NL, 1971, METHOD ENZYMOL, P130; Dahlkild A, 2001, BRYOLOGIST, V104, P527, DOI 10.1639/0007-2745(2001)104[0527:PDITPL]2.0.CO;2; Dal Grande F, 2014, MOL PHYLOGENET EVOL, V72, P54, DOI 10.1016/j.ympev.2013.12.010; de Vera JP, 2004, ADV SPACE RES, V33, P1236, DOI 10.1016/j.asr.2003.10.035; del Campo EM, 2013, FEMS MICROBIOL ECOL, V83, P310, DOI 10.1111/j.1574-6941.2012.01474.x; Friedl T, 2008, LICHEN BIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511790478.003; Friedl T., 1989, THESIS U BAYREUTH; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Gaffron H, 1940, AM J BOT, V27, P273, DOI 10.2307/2436697; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P241, DOI 10.1085/jgp.26.2.241; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; Gibbs M, 1986, PLANT PHYSIOL, V37, P649; Grube M, 2007, MYCOL RES, V111, P1116, DOI 10.1016/j.mycres.2007.04.008; Hallenbeck PC, 2002, INT J HYDROGEN ENERG, V27, P1185, DOI 10.1016/S0360-3199(02)00131-3; Hauck M, 2007, LICHENOLOGIST, V39, P195, DOI 10.1017/S0024282907006639; HONEGGER R, 1987, BOT HELV, V97, P147; Honegger R, 1998, LICHENOLOGIST, V30, P193; HONEGGER R, 2007, BR MYCOL SY, P185; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu F, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-92; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Palmqvist K, 2000, NEW PHYTOL, V148, P11, DOI 10.1046/j.1469-8137.2000.00732.x; Papazi A, 2014, INT J HYDROGEN ENERG, V39, P19452, DOI 10.1016/j.ijhydene.2014.09.096; Papazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061682; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Philipps G, 2012, PLANTA, V235, P729, DOI 10.1007/s00425-011-1537-2; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Ridka T., 2014, TERRICOLOUS LICHENS, P53, DOI DOI 10.1007/978; Rikkinen J, 2002, CYANOBACTERIA IN SYMBIOSIS, P31; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SCHEIDEGGER C, 1995, PLANTA, V197, P399; Shi XQ, 2013, BIORESOURCE TECHNOL, V144, P225, DOI 10.1016/j.biortech.2013.06.107; SIEDOW JN, 1995, PLANT CELL, V7, P821, DOI 10.1105/tpc.7.7.821; SIMINIS CI, 1993, PHYSIOL PLANTARUM, V87, P263, DOI 10.1111/j.1399-3054.1993.tb01729.x; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Taylor TN, 1997, AM J BOT, V84, P992, DOI 10.2307/2446290; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Timmins M, 2009, J EXP BOT, V60, P1691, DOI 10.1093/jxb/erp052; Wang JL, 2008, INT J HYDROGEN ENERG, V33, P5392, DOI 10.1016/j.ijhydene.2008.07.010; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	52	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121325	10.1371/journal.pone.0121325	http://dx.doi.org/10.1371/journal.pone.0121325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826211	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800041
J	Ulenberg, S; Belka, M; Krol, M; Herold, F; Hewelt-Belka, W; Kot-Wasik, A; Baczek, T				Ulenberg, Szymon; Belka, Mariusz; Krol, Marek; Herold, Franciszek; Hewelt-Belka, Weronika; Kot-Wasik, Agata; Baczek, Tomasz			Prediction of Overall In Vitro Microsomal Stability of Drug Candidates Based on Molecular Modeling and Support Vector Machines. Case Study of Novel Arylpiperazines Derivatives	PLOS ONE			English	Article							RECEPTOR; METABOLISM; LIGANDS; DESIGN; 5-HT7; SITES	Other than efficacy of interaction with the molecular target, metabolic stability is the primary factor responsible for the failure or success of a compound in the drug development pipeline. The ideal drug candidate should be stable enough to reach its therapeutic site of action. Despite many recent excellent achievements in the field of computational methods supporting drug metabolism studies, a well-recognized procedure to model and predict metabolic stability quantitatively is still lacking. This study proposes a workflow for developing quantitative metabolic stability-structure relationships, taking a set of 30 arylpiperazine derivatives as an example. The metabolic stability of the compounds was assessed in in vitro incubations in the presence of human liver microsomes and NADPH and subsequently quantified by liquid chromatography-mass spectrometry (LC-MS). Density functional theory (DFT) calculations were used to obtain 30 models of the molecules, and Dragon software served as a source of structure-based molecular descriptors. For modeling structure-metabolic stability relationships, Support Vector Machines (SVM), a non-linear machine learning technique, were found to be more effective than a regression technique, based on the validation parameters obtained. Moreover, for the first time, general sites of metabolism for arylpiperazines bearing the 4-aryl-2H-pyrido[1,2-c]pyrimidine-1,3-dione system were defined by analysis of Q-TOF-MS/MS spectra. The results indicated that the application of one of the most advanced chemometric techniques combined with a simple and quick in vitro procedure and LC-MS analysis provides a novel and valuable tool for predicting metabolic half-life values. Given the reduced time and simplicity of analysis, together with the accuracy of the predictions obtained, this is a valid approach for predicting metabolic stability using structural data. The approach presented provides a novel, comprehensive and reliable tool for investigating metabolic stability, factors that affect it, and the proposed structures of metabolites at the same time. The performance of the DFT-SVM-based approach provides an opportunity to implement it in a standard drug development pipeline.	[Ulenberg, Szymon; Belka, Mariusz; Baczek, Tomasz] Med Univ Gdansk, Dept Pharmaceut Chem, Fac Pharm, Gdansk, Poland; [Krol, Marek; Herold, Franciszek] Med Univ Warsaw, Dept Drug Technol & Pharmaceut Biotechnol, Warsaw, Poland; [Hewelt-Belka, Weronika; Kot-Wasik, Agata] Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Fahrenheit Universities; Gdansk University of Technology	Baczek, T (corresponding author), Med Univ Gdansk, Dept Pharmaceut Chem, Fac Pharm, Gdansk, Poland.	tbaczek@gumed.edu.pl	Król, Marek/P-1623-2018; Ulenberg, Szymon/M-7136-2018; Baczek, Tomasz/K-6467-2018; Hewelt-Belka, Weronika/X-9907-2019; Belka, Mariusz/AAQ-8911-2020; Kot-Wasik, Agata/GQZ-4091-2022; Hewelt-Belka, Weronika/ABF-1232-2021; Belka, Mariusz/M-6288-2018	Król, Marek/0000-0001-6962-6026; Ulenberg, Szymon/0000-0001-6599-5502; Baczek, Tomasz/0000-0001-6468-1974; Hewelt-Belka, Weronika/0000-0002-1990-2130; Belka, Mariusz/0000-0003-4413-1080; Kot-Wasik, Agata/0000-0002-2546-3779	Polish National Science Centre [UMO-2011/01/N/NZ1/00214, UMO-2011/03/B/NZ1/03113]	Polish National Science Centre	The project was funded by the Polish National Science Centre granted under decision no. UMO-2011/01/N/NZ1/00214 and UMO-2011/03/B/NZ1/03113. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248; Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; Caccia S, 2007, CURR DRUG METAB, V8, P612; Canale V, 2014, EUR J MED CHEM, V78, P10, DOI 10.1016/j.ejmech.2014.03.005; Chlon-Rzepa G, 2014, J MOL STRUCT, V1067, P243, DOI 10.1016/j.molstruc.2014.03.018; Fox T, 2006, CURR TOP MED CHEM, V6, P1579, DOI 10.2174/156802606778108915; Frisch M.J., 2003, GAUSSIAN 03 REVISION; Ghemtio L, 2014, J CHEM INF MODEL, V54, P1011, DOI 10.1021/ci400577a; Huang JJ, 2014, PHARMAZIE, V69, P578, DOI 10.1691/ph.2014.3971; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kowalski P, 2013, ARCH PHARM, V346, P339, DOI 10.1002/ardp.201300011; Kumar JSD, 2014, BIOORG MED CHEM LETT, P30; Mu FP, 2011, BIOINFORMATICS, V27, P1537, DOI 10.1093/bioinformatics/btr177; Plant N, 2004, DRUG DISCOV TODAY, V9, P328, DOI 10.1016/S1359-6446(03)03019-8; Salerno L, 2014, EUR J MED CHEM, V85, P716, DOI 10.1016/j.ejmech.2014.08.023; Sencanski M, 2014, CHEM BIOL DRUG DES, V83, P462, DOI 10.1111/cbdd.12261; Stanojevic M, 2014, J LIQ CHROMATOGR R T, V37, P2814, DOI 10.1080/10826076.2014.907112; Starr KR, 2007, NEUROPSYCHOPHARMACOL, V32, P2163, DOI 10.1038/sj.npp.1301341; Tandon M, 2004, BIOORG MED CHEM LETT, V14, P1709, DOI 10.1016/j.bmcl.2004.01.045; Vapnik V.N., 1995, NATURE STAT LEARNING; Zaretzki J, 2011, J CHEM INF MODEL, V51, P1667, DOI 10.1021/ci2000488; Zhang XL, 2014, CHINESE J STRUC CHEM, V33, P244; Zhu MS, 2005, DRUG METAB DISPOS, V33, P500, DOI 10.1124/dmd.104.000836; Zygmunt M, 2014, PHARMACOL REP, V66, P505, DOI 10.1016/j.pharep.2013.12.014	25	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122772	10.1371/journal.pone.0122772	http://dx.doi.org/10.1371/journal.pone.0122772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826401	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800090
J	Arapis, K; Cavin, JB; Gillard, L; Cluzeaud, F; Letteron, P; Ducroc, R; Le Beyec, J; Hourseau, M; Couvelard, A; Marmuse, JP; Le Gall, M; Bado, A				Arapis, Konstantinos; Cavin, Jean Baptiste; Gillard, Laura; Cluzeaud, Francoise; Letteron, Philippe; Ducroc, Robert; Le Beyec, Johanne; Hourseau, Muriel; Couvelard, Anne; Marmuse, Jean Pierre; Le Gall, Maude; Bado, Andre			Remodeling of the Residual Gastric Mucosa after Roux-En-Y Gastric Bypass or Vertical Sleeve Gastrectomy in Diet-Induced Obese Rats	PLOS ONE			English	Article							BARIATRIC SURGERY; WEIGHT-LOSS; ENERGY-EXPENDITURE; VAGAL INNERVATION; MEDICAL THERAPY; CELL; GHRELIN; HORMONES; MODELS; GLP-1	Whereas the remodeling of intestinal mucosa after bariatric surgeries has been the matter of numerous studies to our knowledge, very few reported on the remodeling of the residual gastric mucosa. In this study, we analyzed remodeling of gastric mucosa after Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) in rats. Diet-induced obese rats were subjected to RYGB, VSG or sham surgical procedures. All animals were assessed for food intake, body-weight, fasting blood, metabolites and hormones profiling, as well as insulin and glucose tolerance tests before and up to 5 weeks post-surgery. Remodeling of gastric tissues was analyzed by routine histology and immunohistochemistry studies, and qRT-PCR analyses of ghrelin and gastrin mRNA levels. In obese rats with impaired glucose tolerance, VSG and RYGB caused substantial weight loss and rats greatly improved their oral glucose tolerance. The remaining gastric mucosa after VSG and gastric pouch (GP) after RYGB revealed a hyperplasia of the mucous neck cells that displayed a strong immunoreactivity for parietal cell H+/K+-ATPase. Ghrelin mRNA levels were reduced by 2-fold in remaining fundic mucosa after VSG and 10-fold in GP after RYGB. In the antrum, gastrin mRNA levels were reduced after VSG in line with the reduced number of gastrin positive cells. This study reports novel and important observations dealing with the remaining gastric mucosa after RYGB and VSG. The data demonstrate, for the first time, a hyperplasia of the mucous neck cells, a transit cell population of the stomach bearing differentiating capacities into zymogenic and peptic cells.	[Arapis, Konstantinos; Cavin, Jean Baptiste; Gillard, Laura; Cluzeaud, Francoise; Letteron, Philippe; Ducroc, Robert; Le Beyec, Johanne; Couvelard, Anne; Marmuse, Jean Pierre; Le Gall, Maude; Bado, Andre] Univ Paris Diderot, Sorbonne Paris Cite, Inserm UMR 1149, UFR MEd Paris Diderot, Paris, France; [Arapis, Konstantinos; Cavin, Jean Baptiste; Gillard, Laura; Cluzeaud, Francoise; Letteron, Philippe; Ducroc, Robert; Le Beyec, Johanne; Hourseau, Muriel; Couvelard, Anne; Marmuse, Jean Pierre; Le Gall, Maude; Bado, Andre] Bichat Beaujon AP HP, DHU Unity, Paris, France; [Arapis, Konstantinos; Marmuse, Jean Pierre] Hop Bichat Claude Bernard, Serv Chirurg Gen & Digest, F-75877 Paris 18, France; [Hourseau, Muriel; Couvelard, Anne] Hop Bichat Claude Bernard, Dept Pathol, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Bado, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inserm UMR 1149, UFR MEd Paris Diderot, Paris, France.	andre.bado@inserm.fr	Le Gall, Maude/C-3917-2017; Le Gall, Maude/W-2593-2019	Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; BADO, Andre/0000-0002-8007-1460; Anne, Couvelard/0000-0002-6316-1210; Le Beyec - Le Bihan, johanne/0000-0002-5647-2002				Ashrafian H, 2011, OBES REV, V12, pe257, DOI 10.1111/j.1467-789X.2010.00802.x; Braghetto I, 2009, OBES SURG, V19, P1262, DOI 10.1007/s11695-009-9874-y; BRODIE DA, 1966, AM J DIG DIS, V11, P231, DOI 10.1007/BF02233904; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Bueter M, 2012, JOVE-J VIS EXP, DOI 10.3791/3940; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Bueter M, 2010, OBES SURG, V20, P616, DOI 10.1007/s11695-010-0075-5; Chambers AP, 2011, PHYSIOL BEHAV, V105, P120, DOI 10.1016/j.physbeh.2011.05.026; Chandarana K, 2011, DIABETES, V60, P810, DOI 10.2337/db10-0566; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Cummings DE, 2009, INT J OBESITY, V33, pS33, DOI 10.1038/ijo.2009.15; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Gagner M, 2013, NAT REV ENDOCRINOL, V9, P382, DOI 10.1038/nrendo.2013.100; Hanby AM, 1999, J PATHOL, V187, P331, DOI 10.1002/(SICI)1096-9896(199902)187:3<331::AID-PATH241>3.0.CO;2-S; Hao Z, 2014, OBES SURG, V24, P2145, DOI 10.1007/s11695-014-1338-3; Hao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052922; Hedberg J, 2011, SURG ENDOSC, V25, P2302, DOI 10.1007/s00464-010-1553-5; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Ionut V, 2013, OBESITY, V21, P1093, DOI 10.1002/oby.20364; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Martin M, 2012, OBES SURG, V22, P634, DOI 10.1007/s11695-012-0606-3; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nadreau E, 2006, INT J OBESITY, V30, P419, DOI 10.1038/sj.ijo.0803166; Papasavas PK, 2008, SURG OBES RELAT DIS, V4, P383, DOI 10.1016/j.soard.2007.08.014; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Rao RS, 2010, OBES SURG, V20, P1293, DOI 10.1007/s11695-010-0135-x; Saeidi N, 2012, INT J OBESITY, V36, P1396, DOI 10.1038/ijo.2012.167; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Safatle-Ribeiro AV, 2013, OBES SURG, V23, P1616, DOI 10.1007/s11695-013-0975-2; Salehi M, 2011, DIABETES, V60, P2308, DOI 10.2337/db11-0203; Sandoval D, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.148; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Seyfried F, 2011, OBESITY FACTS, V4, P3, DOI 10.1159/000327301; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Shin AC, 2012, ANN SURG, V255, P294, DOI 10.1097/SLA.0b013e31823e71b7; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Taqia E, 2010, J PEDIATR SURG, V45, P987, DOI 10.1016/j.jpedsurg.2010.02.036; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tymitz K, 2011, OBES SURG, V21, P125, DOI 10.1007/s11695-010-0311-z; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Ye JP, 2014, AM J PHYSIOL-REG I, V306, pR352, DOI 10.1152/ajpregu.00491.2013; Ying VWC, 2014, SURG ENDOSC, P1	51	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121414	10.1371/journal.pone.0121414	http://dx.doi.org/10.1371/journal.pone.0121414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822172	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700103
J	Hou, WW; Wang, SH; Wang, XL; Han, XA; Fan, HJ; Cao, SL; Yue, JP; Wang, Q; Jiang, W; Ding, C; Yu, SQ				Hou, Wanwan; Wang, Shaohui; Wang, Xiaolan; Han, Xiangan; Fan, Hongjie; Cao, Shoulin; Yue, Jiaping; Wang, Quan; Jiang, Wei; Ding, Chan; Yu, Shengqing			Development of Colloidal Gold Immunochromatographic Strips for Detection of Riemerella anatipestifer	PLOS ONE			English	Article							RAPID DETECTION; PASTEURELLA-ANATIPESTIFER; ESCHERICHIA-COLI; PCR ASSAY; SEROTYPES; VIRUS; GROEL; DUCKS	Riemerella anatipestifer is one of the most important bacterial pathogen of ducks and causes a contagious septicemia. R. anatipestifer infection causes serositis syndromes similar to other bacterial infections in ducks, including infection by Escherichia coli, Salmonella enterica and Pasteurella multocida. Clinically differentiating R. anatipestifer infections from other bacterial pathogen infections is usually difficult. In this study, MAb 1G2F10, a monoclonal antibody against R. anatipestifer GroEL, was used to develop a colloidal gold immunochromatographic strip. Colloidal gold particles were prepared by chemical synthesis to an average diameter of 20 +/- 5.26 nm by transmission electron microscope imaging. MAb 1G2F10 was conjugated to colloidal gold particles and the formation of antibody-colloidal gold conjugates was monitored by UV/Vis spectroscopy. Immunochromatographic strips were assembled in regular sequence through different accessories sticked on PVC plate. Strips specifically detected R. anatipestifer within 10 min, but did not detect E. coli, S. enterica and P. multocida. The detection limit for R. anatipestifer was 1x10(6) colony forming units, which was 500 times higher than a conventional agglutination test. Accuracy was 100% match to multiplex PCR. Assay stability and reproducibility were excellent after storage at 4 degrees C for 6 months. The immunochromatographic strips prepared in this study offer a specific, sensitive, and rapid detection method for R. anatipestifer, which is of great importance for the prevention and control of R. anatipestifer infections.	[Hou, Wanwan; Wang, Shaohui; Wang, Xiaolan; Han, Xiangan; Cao, Shoulin; Yue, Jiaping; Wang, Quan; Jiang, Wei; Ding, Chan; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Hou, Wanwan; Fan, Hongjie] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, SQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	Chinese Special Fund for Agro-scientific Research in the Public Interest [201003012]	Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the funds of Chinese Special Fund for Agro-scientific Research in the Public Interest (201003012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumner AJ, 2004, ANAL BIOANAL CHEM, V380, P15, DOI 10.1007/s00216-004-2726-7; BEGGS M, 1990, CLIN CHEM, V36, P1084; BISGAARD M, 1982, AVIAN PATHOL, V11, P341, DOI 10.1080/03079458208436109; Blazkova M, 2011, BIOSENS BIOELECTRON, V26, P2828, DOI 10.1016/j.bios.2010.10.001; Chen W., 2010, CHINESE J ANIMAL INF, V18, P34; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Han XA, 2012, APPL MICROBIOL BIOT, V93, P1197, DOI 10.1007/s00253-011-3635-2; Han XG, 2011, AVIAN DIS, V55, P379, DOI 10.1637/9602-112610-Reg.1; Heeschen C, 1998, CLIN CHEM, V44, P1925; Hou W, 2014, CHIN J ANIM INFECT D, V22, P7; Hu QH, 2011, J MICROBIOL METH, V87, P64, DOI 10.1016/j.mimet.2011.07.007; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; Huang B, 2002, VET MICROBIOL, V88, P339, DOI 10.1016/S0378-1135(02)00123-2; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kameyama K, 2006, J VIROL METHODS, V138, P140, DOI 10.1016/j.jviromet.2006.08.005; Kardos G, 2007, LETT APPL MICROBIOL, V44, P145, DOI 10.1111/j.1472-765X.2006.02053.x; Liu BH, 2008, ANAL CHEM, V80, P7029, DOI 10.1021/ac800951p; LOH H, 1992, AVIAN PATHOL, V21, P453, DOI 10.1080/03079459208418863; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Perfetti M, 2014, SMALL, V10, P323, DOI 10.1002/smll.201301617; Philip D, 2008, SPECTROCHIM ACTA A, V71, P80, DOI 10.1016/j.saa.2007.11.012; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Preechakasedkit P, 2012, BIOSENS BIOELECTRON, V31, P562, DOI 10.1016/j.bios.2011.10.031; Rouf M A, 2009, Mymensingh Med J, V18, pS1; Wang XJ, 2006, AQUACULTURE, V255, P196, DOI 10.1016/j.aquaculture.2006.01.021; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Watanabe T, 2001, CLIN BIOCHEM, V34, P257, DOI 10.1016/S0009-9120(01)00200-4; Zhai ZP, 2013, VET MICROBIOL, V162, P850, DOI 10.1016/j.vetmic.2012.11.002; Zhang DB ZX, 2005, CHINA POULTRY, P46; Zhang GP, 2006, VET PARASITOL, V137, P286, DOI 10.1016/j.vetpar.2006.01.026	30	9	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122952	10.1371/journal.pone.0122952	http://dx.doi.org/10.1371/journal.pone.0122952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822983	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700210
J	Pacheco, MLAF; Galante, D; Rodrigues, F; Leme, JD; Bidola, P; Hagadorn, W; Stockmar, M; Herzen, J; Rudnitzki, ID; Pfeiffer, F; Marques, AC				Pacheco, Mrian L. A. Forancelli; Galante, Douglas; Rodrigues, Fabio; Leme, Juliana de M.; Bidola, Pidassa; Hagadorn, Whitey; Stockmar, Marco; Herzen, Julia; Rudnitzki, Isaac D.; Pfeiffer, Franz; Marques, Antonio C.			Insights into the Skeletonization, Lifestyle, and Affinity of the Unusual Ediacaran Fossil Corumbella	PLOS ONE			English	Article							CLADISTIC-ANALYSIS; SOUTH-AMERICA; SCYPHOZOA; CLOUDINA; NAMACALATHUS; ORDOVICIAN; CORONATAE; SOLITARY; CNIDARIA; BASIN	The Ediacaran fossil Corumbella is important because it is hypothesized to be a scyphozoan cnidarian, and thus might be one of the rare examples of bona fide Neoproterozoic animals. Unfortunately, its mode of life, style of skeletonization, and taxonomic affinity have been very controversial. Here, we use X-ray micro-CT, SEM, and taphonomic analysis to compare preservational modes of Corumbella, in order to better understand the symmetry, mode of construction, preservational style, and taxonomy of this group. Results suggest that articulated and disarticulated specimens of Corumbella from the Ediacaran of Brazil, Paraguay, and the United States, although sometimes preserved very differently, represent the same taxon-Corumbella werneri. Corumbellids had a thick but flexible theca and probably lived with their basalmost part anchored in the sediment, much like Conotubus. When considered together, these results suggest that Corumbella was one of the first animals to build a skeleton, employing a lamellar microfabric similar to conulariids.	[Pacheco, Mrian L. A. Forancelli] Univ Fed Sao Carlos, Dept Biol, Sao Paulo, Brazil; [Galante, Douglas; Rodrigues, Fabio] Brazilian Synchrotron Light Lab, Sao Paulo, Brazil; [Leme, Juliana de M.] Univ Sao Paulo, Inst Geosci, Sao Paulo, Brazil; [Bidola, Pidassa; Stockmar, Marco; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Germany; [Bidola, Pidassa; Stockmar, Marco; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Hagadorn, Whitey] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO USA; [Herzen, Julia] Helmholtz Zentrum Geesthacht, Inst Mat Res, D-21502 Geesthacht, Germany; [Rudnitzki, Isaac D.] Fed Univ Para, Inst Geosci, BR-66059 Belem, Para, Brazil; [Marques, Antonio C.] Univ Sao Paulo, Inst Biosci, Sao Paulo, Brazil; [Marques, Antonio C.] Univ Sao Paulo, Ctr Marine Biol, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade de Sao Paulo; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Universidade Federal do Para; Universidade de Sao Paulo; Universidade de Sao Paulo	Pacheco, MLAF (corresponding author), Univ Fed Sao Carlos, Dept Biol, Sao Paulo, Brazil.	forancelli@ufscar.br	Marques, Antonio Carlos/E-8049-2011; de Moraes Leme, Juliana/C-3335-2012; Galante, Douglas/G-8752-2011; Pacheco, Mírian LAF/P-3074-2014; Fapesp, Biota/F-8655-2017; Rudnitzki, Isaac Daniel/I-5447-2015	Marques, Antonio Carlos/0000-0002-2884-0541; de Moraes Leme, Juliana/0000-0002-5833-4885; Galante, Douglas/0000-0002-3265-2527; Fapesp, Biota/0000-0002-9887-8449; Rudnitzki, Isaac Daniel/0000-0003-0969-3037; Alves Forancelli Pacheco, Mirian Liza/0000-0002-8810-2321	FAPESP [Proc. 2009/02312-4, Proc. 2011/50242-5]; NAP-Astrobio (PRP-USP); CNPq [562143/2010-6, 458555/2013-4]; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NAP-Astrobio (PRP-USP); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by research grants from FAPESP (Proc. 2009/02312-4) and NAP-Astrobio (PRP-USP). ACM had support from FAPESP (Proc. 2011/50242-5), CNPq (562143/2010-6, 458555/2013-4), and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida F.F.M., 1984, PRECAMBRIANO BRASIL, P265; Alvarenga CJS, 2009, NEOPROTEROZOIC CAMBR; Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Babcock LE, 2005, PALAEOGEOGR PALAEOCL, V220, P7, DOI 10.1016/j.palaeo.2003.01.001; Babinski M, 2006, S AM S ISOTOPE GEOLO, V1, P223; Babinski M., 2008, 6 S AM S IS GEOL SAN, P160; Boggiani PC, 2010, PRECAMBRIAN RES, V182, P382, DOI 10.1016/j.precamres.2010.06.003; Boggiani PC, 1998, THESIS U SAO PAULO; Chapman D. M., 1966, Symposia of the Zoological Society of London, VNo. 16, P51; CHAPMAN DM, 1972, HELGOLAND WISS MEER, V23, P393, DOI 10.1007/BF01625293; Leme JD, 2008, AMEGHINIANA, V45, P407; Dong XP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0071; Fairchild T.R., 1978, Boletim IG (Instituto de Geociencias) Universidade de Sao Paulo, V9, P74; Fairchild TR, 2012, INT J ASTROBIOL, V20, P1; Gaucher C, 2003, PRECAMBRIAN RES, V120, P241, DOI 10.1016/S0301-9268(02)00140-7; Glaessner M.F., 1984, DAWN ANIMAL LIFE; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; Grotzinger JP, 2000, PALEOBIOLOGY, V26, P334, DOI 10.1666/0094-8373(2000)026<0334:CMITSR>2.0.CO;2; Hagadorn JW, 2000, J PALEONTOL, V74, P349, DOI 10.1666/0022-3360(2000)074<0349:EFFTSG>2.0.CO;2; Hahn G., 1982, Geologica et Palaeontologica, V16, P1; HAHN G, 1985, Senckenbergiana Lethaea, V65, P413; Hofmann HJ, 2001, GEOLOGY, V29, P1091, DOI 10.1130/0091-7613(2001)029<1091:NCAINM>2.0.CO;2; Holst S, 2006, J EXP MAR BIOL ECOL, V329, P230, DOI 10.1016/j.jembe.2005.09.014; Jarms Gerhard, 2002, Biota Neotrop., V2, P1, DOI 10.1590/S1676-06032002000100004; Kerber Bruno Becker, 2013, Geologia USP Serie Cientifica, V13, P51; Leme J.M., 2010, PHYLOGENETIC SYSTEMA; Leme JDM, 2008, PALAEONTOLOGY, V51, P649, DOI 10.1111/j.1475-4983.2008.00775.x; Lucas SG, 2001, LETHAIA, V34, P30, DOI 10.1080/002411601300068198; Marques AC, 2004, INVERTEBR BIOL, V123, P23; MIERZEJEWSKA G, 1979, ACTA MED POL, V20, P35; MIERZEJEWSKI P., 1986, PALAEONTOLOGIA POLON, V47, P129; Morais LPC, 2013, THESIS U SAO PAULO; Oliveira RS, 2010, THESIS U FEDERAL PAR; Pacheco Miriam L. A. F., 2011, Journal of Taphonomy, V9, P269; RODRIGUES S, 2003, REV BRASILEIRA GEOCI, V33, P165; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; van Iten H., 1991, P145; Van Iten H, 2005, PALAEONTOLOGY, V48, P619, DOI 10.1111/j.1475-4983.2005.00471.x; Van Iten H, 2005, J PALEONTOL, V79, P400; Van Iten Heyo, 2006, Palaeoworld, V15, P294, DOI 10.1016/j.palwor.2006.10.006; VANITEN H, 1992, PALAEONTOLOGY, V35, P335; VANITEN H, 1992, PALAEONTOLOGY, V35, P359; VanIten H, 1996, PALAEONTOLOGY, V39, P1037; WALDE DHG, 1982, AN ACAD BRAS CIENC, V54, P461; Warren LV, 2012, GEOLOGY, V40, P691, DOI 10.1130/G33005.1; Warren LV, 2011, TERRA NOVA, V23, P382, DOI 10.1111/j.1365-3121.2011.01023.x; Wood RA, 2011, EARTH-SCI REV, V106, P184, DOI 10.1016/j.earscirev.2011.01.011; Zabini C, 2012, PALAEOGEOGR PALAEOCL, V326, P118, DOI 10.1016/j.palaeo.2012.02.010; Zaine MF, 1991, THESIS U SAO PAULO	49	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0114219	10.1371/journal.pone.0114219	http://dx.doi.org/10.1371/journal.pone.0114219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822998	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700001
J	Pappas, A; Chaiworapongsa, T; Romero, R; Korzeniewski, SJ; Cortez, JC; Bhatti, G; Gomez-Lopez, N; Hassan, SS; Shankaran, S; Tarca, AL				Pappas, Athina; Chaiworapongsa, Tinnakorn; Romero, Roberto; Korzeniewski, Steven J.; Cortez, Josef C.; Bhatti, Gaurav; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Shankaran, Seetha; Tarca, Adi L.			Transcriptomics of Maternal and Fetal Membranes Can Discriminate between Gestational-Age Matched Preterm Neonates with and without Cognitive Impairment Diagnosed at 18-24 Months	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; MAGNESIUM-SULFATE; NEURODEVELOPMENTAL OUTCOMES; APOLIPOPROTEIN-E; SELENOPROTEIN P; MESSENGER-RNA; ANTENATAL CORTICOSTEROIDS; DIFFERENTIAL FUNCTIONS; SCAVENGER RECEPTOR	Background Neurocognitive impairment among children born preterm may arise from complex interactions between genes and the intra-uterine environment. Objectives (1) To characterize the transcriptomic profiles of chorioamniotic membranes in preterm neonates with and without neurocognitive impairment via microarrays and (2) to determine if neonates with neurocognitive impairment can be identified at birth. Materials/Methods A retrospective case-control study was conducted to examine the chorioamniotic transcriptome of gestational-age matched very preterm neonates with and without neurocognitive impairment at 18-24 months' corrected-age defined by a Bayley-III Cognitive Composite Score < 80 (n = 14 each). Pathway analysis with down-weighting of overlapping genes (PADOG) was performed to identify KEGG pathways relevant to the phenotype. Select differentially expressed genes were profiled using qRT-PCR and a multi-gene disease prediction model was developed using linear discriminant analysis. The model's predictive performance was tested on a new set of cases and controls (n = 19 each). Results 1) 117 genes were differentially expressed among neonates with and without subsequent neurocognitive impairment (p<0.05 and fold change > 1.5); 2) Gene ontology analysis indicated enrichment of 19 biological processes and 3 molecular functions; 3)PADOG identified 4 significantly perturbed KEGG pathways: oxidative phosphorylation, Parkinson's disease, Alzheimer's disease and Huntington's disease (q-value < 0.1); 4) 48 of 90 selected differentially expressed genes were confirmed by qRT-PCR, including genes implicated in energy metabolism, neuronal signaling, vascular permeability and response to injury (e.g., up-regulation of SEPP1, APOE, DAB2, CD163, CXCL12, VWF; down-regulation of HAND1, OSR1) (p< 0.05); and 5) a multi-gene model predicted 18-24 month neurocognitive impairment (using the ratios of OSR1/VWF and HAND1/VWF at birth) in a larger, independent set (sensitivity = 74%, at specificity = 83%). Conclusions Gene expression patterns in the chorioamniotic membranes link neurocognitive impairment in preterm infants to neurodegenerative disease pathways and might be used to predict neurocognitive impairment. Further prospective studies are needed.	[Pappas, Athina; Chaiworapongsa, Tinnakorn; Romero, Roberto; Korzeniewski, Steven J.; Cortez, Josef C.; Bhatti, Gaurav; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Shankaran, Seetha; Tarca, Adi L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA; [Pappas, Athina; Chaiworapongsa, Tinnakorn; Romero, Roberto; Korzeniewski, Steven J.; Cortez, Josef C.; Bhatti, Gaurav; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Shankaran, Seetha; Tarca, Adi L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, DHHS, Detroit, MI USA; [Pappas, Athina; Cortez, Josef C.; Shankaran, Seetha] Wayne State Univ, Dept Pediat, Div Neonatal & Perinatal Med, Detroit, MI 48202 USA; [Chaiworapongsa, Tinnakorn; Korzeniewski, Steven J.; Gomez-Lopez, Nardhy; Hassan, Sonia S.; Tarca, Adi L.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto; Korzeniewski, Steven J.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Gomez-Lopez, Nardhy] Wayne State Univ, Dept Immunol & Microbiol, Detroit, MI USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Michigan State University; Wayne State University	Pappas, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA.	apappas@med.wayne.edu; atarca@med.wayne.edu	Gomez-Lopez, Nardhy/R-7664-2016; Korzeniewski, Steven J/U-6481-2017; Romero, Roberto/A-5268-2019	Gomez-Lopez, Nardhy/0000-0002-3406-5262; Korzeniewski, Steven J/0000-0002-8895-6052; bhatti, gaurav/0000-0002-8557-3347; Romero, Roberto/0000-0002-4448-5121	Division of Intramural Research, Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; Perinatal Initiative of the Wayne State University School of Medicine; Department of Obstetrics and Gynecology of Wayne State University	Division of Intramural Research, Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; Perinatal Initiative of the Wayne State University School of Medicine; Department of Obstetrics and Gynecology of Wayne State University	This research was supported, in part, by the Division of Intramural Research, Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. ALT, SJK and NGL were also supported by the Perinatal Initiative of the Wayne State University School of Medicine. ALT and SSH were also supported in part by Department of Obstetrics and Gynecology of Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; [Anonymous], 2013, STRING V 9 1 DATABAS; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barnes RM, 2010, DEV DYNAM, V239, P3086, DOI 10.1002/dvdy.22428; Bayley N., 2019, BAYLEY SCALES INFANT; Bekris LM, 2010, AM J MED GENET B, V153B, P409, DOI 10.1002/ajmg.b.30993; Bellinger FP, 2008, J ALZHEIMERS DIS, V15, P465; Bellinger FP, 2012, J PARKINSON DIS, V2, P115, DOI 10.3233/JPD-2012-11052; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benchoua A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00140; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breckenridge RA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001666; Brennand KJ, 2014, BIOL PSYCHIAT, V75, P936, DOI 10.1016/j.biopsych.2013.10.025; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Brownfoot FC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub2; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Caito SW, 2011, BRAIN RES, V1398, P1, DOI 10.1016/j.brainres.2011.04.046; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P57; Cheung Aaron Y L, 2012, Front Psychiatry, V3, P24, DOI 10.3389/fpsyt.2012.00024; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; COULTER DE, 1990, EMBO J, V9, P3795, DOI 10.1002/j.1460-2075.1990.tb07593.x; Crowther CA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub2; Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doxakis E, 2008, EMBO REP, V9, P1041, DOI 10.1038/embor.2008.161; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2010, DEV DYNAM, V239, P2748, DOI 10.1002/dvdy.22402; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guyon A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00065; Guyon A, 2014, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2014.00115; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hartfield EM, 2012, BIOCHEM SOC T, V40, P1152, DOI 10.1042/BST20120159; Hellstrom-Westas L, 2005, ACTA PAEDIATR, V94, P205, DOI 10.1080/08035250410023692; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Huang XM, 2006, ARCH NEUROL-CHICAGO, V63, P189, DOI 10.1001/archneur.63.2.189; Hutchinson EA, 2013, PEDIATRICS, V131, pE1053, DOI 10.1542/peds.2012-2311; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Jokubaitis VG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-32; Katoh M, 2002, INT J MOL MED, V10, P221; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Knickmeyer RC, 2014, CEREB CORTEX, V24, P1230, DOI 10.1093/cercor/bhs401; Kurz MW, 2009, J GERIATR PSYCH NEUR, V22, P166, DOI 10.1177/0891988709332945; Lee GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046592; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Mallon BS, 2014, STEM CELL RES, V12, P376, DOI 10.1016/j.scr.2013.11.010; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marret S, 2008, PEDIATRICS, V121, P225, DOI 10.1542/peds.2007-2971; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Martinez M, 2005, AM J MED GENET B, V136B, P72, DOI 10.1002/ajmg.b.30196; Masiulis I, 2009, BIOL CHEM, V390, P67, DOI 10.1515/BC.2009.011; Masterman T, 2004, LANCET NEUROL, V3, P331, DOI 10.1016/S1474-4422(04)00763-X; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moon C, 2005, NEUROSCI LETT, V378, P88, DOI 10.1016/j.neulet.2004.12.016; Morikawa Y, 2004, DEVELOPMENT, V131, P2195, DOI 10.1242/dev.01091; NELSON KB, 1995, PEDIATRICS, V95, P263; Ho NT, 2013, PEDIATR RES, V73, P450, DOI 10.1038/pr.2012.200; Nugent BM, 2012, J NEUROSCI, V32, P593, DOI 10.1523/JNEUROSCI.5415-11.2012; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957; Pey PX, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-21; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Qiao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053635; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; Rice DS, 1998, DEVELOPMENT, V125, P3719; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Rouse DJ, 2008, NEW ENGL J MED, V359, P895, DOI 10.1056/NEJMoa0801187; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Schmugge M, 2003, PEDIATR RES, V54, P474, DOI 10.1203/01.PDR.0000081294.26060.4B; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Sharaf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071091; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steinbrenner H, 2013, ARCH BIOCHEM BIOPHYS, V536, P152, DOI 10.1016/j.abb.2013.02.021; Stilund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098588; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Tarca AL, 2006, AM J OBSTET GYNECOL, V195, P373, DOI 10.1016/j.ajog.2006.07.001; Tarca AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079217; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tarca AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-136; Tavazzi E, 2014, CURR HIV RES; Than NG, 2009, J MATERN-FETAL NEO M, V22, P1000, DOI 10.3109/14767050903019676; Tran NN, 2013, SCHIZOPHRENIA BULL, V39, P4, DOI 10.1093/schbul/sbs127; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; UCHIHARA T, 1995, NEUROSCI LETT, V195, P5, DOI 10.1016/0304-3940(95)11763-M; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; WEINSTEIN MJ, 1989, BRIT J HAEMATOL, V72, P68, DOI 10.1111/j.1365-2141.1989.tb07654.x; Xu JY, 2014, DEVELOPMENT, V141, P1442, DOI 10.1242/dev.103283; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Yawno T, 2013, DEV NEUROSCI-BASEL, V35, P272, DOI 10.1159/000346683; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200	130	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118573	10.1371/journal.pone.0118573	http://dx.doi.org/10.1371/journal.pone.0118573			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822971	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700020
J	Rahman, MA; Hann, N; Wilson, A; Mnatzaganian, G; Worrall-Carter, L				Rahman, Muhammad Aziz; Hann, Nicholas; Wilson, Andrew; Mnatzaganian, George; Worrall-Carter, Linda			E-Cigarettes and Smoking Cessation: Evidence from a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NICOTINE REPLACEMENT THERAPY; ELECTRONIC CIGARETTE; REDUCTION; FEASIBILITY; BENEFITS; EFFICACY; SMOKERS	Background E-cigarettes are currently being debated regarding their possible role in smoking cessation and as they are becoming increasingly popular, the research to date requires investigation. Objectives To investigate whether the use of e-cigarettes is associated with smoking cessation or reduction, and whether there is any difference in efficacy of e-cigarettes with and without nicotine on smoking cessation. Data Sources A systematic review of articles with no limit on publication date was conducted by searching PubMed, Web of Knowledge and Scopus databases. Methods Published studies, those reported smoking abstinence or reduction in cigarette consumption after the use of e-cigarettes, were included. Studies were systematically reviewed, and meta-analyses were conducted using Mantel-Haenszel fixed-effect and random-effects models. Degree of heterogeneity among studies and quality of the selected studies were evaluated. Results Six studies were included involving 7,551 participants. Meta-analyses included 1,242 participants who had complete data on smoking cessation. Nicotine filled e-cigarettes were more effective for cessation than those without nicotine (pooled Risk Ratio 2.29, 95% CI 1.05-4.97). Amongst 1,242 smokers, 224 (18%) reported smoking cessation after using nicotine-enriched e-cigarettes for a minimum period of six months. Use of such e-cigarettes was positively associated with smoking cessation with a pooled Effect Size of 0.20 (95% CI 0.11-0.28). Use of e-cigarettes was also associated with a reduction in the number of cigarettes used. Limitations Included studies were heterogeneous, due to different study designs and gender variation. Whilst we were able to comment on the efficacy of nicotine vs. non-nicotine e-cigarettes for smoking cessation, we were unable to comment on the efficacy of e-cigarettes vs. other interventions for cessation, given the lack of comparator groups in the studies included in this meta-analysis. Conclusions Use of e-cigarettes is associated with smoking cessation and reduction. More randomised controlled trials are needed to assess effectiveness against other cessation methods.	[Rahman, Muhammad Aziz] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Rahman, Muhammad Aziz; Worrall-Carter, Linda] Australian Catholic Univ, SVCNR, Melbourne, Vic, Australia; [Rahman, Muhammad Aziz; Hann, Nicholas; Wilson, Andrew; Worrall-Carter, Linda] Australian Catholic Univ, Cardiovasc Res Ctr CvRC, Melbourne, Vic, Australia; [Hann, Nicholas; Wilson, Andrew] Univ Melbourne, Melbourne, Vic, Australia; [Wilson, Andrew; Worrall-Carter, Linda] St Vincents Hosp, Melbourne, Vic, Australia; [Mnatzaganian, George] Australian Catholic Univ, Fac Hlth Sci, Sch Allied Hlth, Melbourne, Vic, Australia	Australian Catholic University; Australian Catholic University; Australian Catholic University; University of Melbourne; St Vincent's Hospital Melbourne; Australian Catholic University	Rahman, MA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.	aziz.rahman@acu.edu.au	Rahman, Muhammad Aziz/B-3380-2009; Mnatzaganian, George/AAF-7753-2021	Rahman, Muhammad Aziz/0000-0003-1665-7966; Mnatzaganian, George/0000-0002-7698-5091				Apelberg BJ, 2010, AM J PUBLIC HEALTH, V100, P341, DOI 10.2105/AJPH.2008.147223; Balfour D, 2000, EUR HEART J, V21, P438, DOI 10.1053/euhj.1999.1949; Barbeau AM, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-5; Barth J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006886; Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Caponnetto P, 2013, Monaldi Arch Chest Dis, V79, P12; Caponnetto P, 2011, EUR RESPIR J, V38, P1005, DOI 10.1183/09031936.00109610; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Caponnetto P, 2013, INT J ENV RES PUB HE, V10, P446, DOI 10.3390/ijerph10020446; Chapman S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3840; Cooper H. M., 2009, HDB RES SYNTHESIS ME; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Etter JF, 2014, ADDICT BEHAV, V39, P491, DOI 10.1016/j.addbeh.2013.10.028; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hughes JR, 2005, ADDICTION, V100, P1074, DOI 10.1111/j.1360-0443.2005.01174.x; Kralikova E, 2013, CHEST, V144, P1609, DOI 10.1378/chest.12-2842; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Paradise Jordan, 2013, Yale J Health Policy Law Ethics, V13, P326; Pokhrel P, 2013, AM J PUBLIC HEALTH, V103, pE57, DOI 10.2105/AJPH.2013.301453; Polosa R, 2014, INTERN EMERG MED, V9, P537, DOI 10.1007/s11739-013-0977-z; Polosa R, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-19; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Rahman MA, 2014, TOB INDUC DIS, P12; Rennard SI, 2006, NICOTINE TOB RES, V8, P555, DOI 10.1080/14622200600789916; Saitta D, 2014, THER ADV CHRONIC DIS, V5, P50, DOI 10.1177/2040622314521271; Schivo M, 2014, CLIN REV ALLERG IMMU, V46, P34, DOI 10.1007/s12016-013-8372-0; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Syx E, 2014, EUR J HEALTH LAW, V21, P161, DOI 10.1163/15718093-12341312; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Walker N, 2009, NICOTINE TOB RES, V11, P1274, DOI 10.1093/ntr/ntp147; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300	41	104	104	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122544	10.1371/journal.pone.0122544	http://dx.doi.org/10.1371/journal.pone.0122544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822251	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700184
J	Jing, YW; Ni, ZY; Wu, JM; Higgins, L; Markowski, TW; Kaufman, DS; Walcheck, B				Jing, Yawu; Ni, Zhenya; Wu, Jianming; Higgins, LeeAnn; Markowski, Todd W.; Kaufman, Dan S.; Walcheck, Bruce			Identification of an ADAM17 Cleavage Region in Human CD16 (Fc gamma RIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PLURIPOTENT STEM-CELLS; ALPHA CONVERTING-ENZYME; MEMBRANE-PROXIMAL CLEAVAGE; L-SELECTIN; METALLOPROTEASE-17 ADAM17; SURFACE EXPRESSION; HUMAN-NEUTROPHILS; III CD16; IN-VITRO	CD16a and CD16b are IgG Fc receptors expressed by human natural killer (NK) cells and neutrophils, respectively. Both CD16 isoforms undergo a rapid down-regulation in expression by ADAM17-mediated proteolytic cleavage upon cell activation by various stimuli. We examined soluble CD16 released from activated NK cells and neutrophils by mass spectrometric analysis, and identified three separate cleavage sites in close proximity at P1/P10 positions alanine195/valine196, valine196/serine197, and threonine198/isoleucine199, revealing a membrane proximal cleavage region in CD16. Substitution of the serine at position 197 in the middle of the cleavage region for a proline (S197P) effectively blocked CD16a and CD16b cleavage in cell-based assays. We also show that CD16a/S197P was resistant to cleavage when expressed in the human NK cell line NK92 and primary NK cells derived fromgenetically-engineered human induced pluripotent stem cells. CD16a is a potent activating receptor and despite blocking CD16a shedding, the S197P mutation did not disrupt IgG binding by the receptor or its activation of NK92 cells by antibody-treated tumor cells. Our findings provide further characterization of CD16 cleavage by ADAM17 and they demonstrate that a non-cleavable version of CD16a can be expressed in engineered NK cells.	[Jing, Yawu; Wu, Jianming; Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA; [Jing, Yawu; Wu, Jianming; Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA; [Ni, Zhenya; Kaufman, Dan S.] Univ Minnesota, Dept Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Ni, Zhenya; Kaufman, Dan S.] Univ Minnesota, Dept Med, Stem Cell Inst, St Paul, MN 55108 USA; [Higgins, LeeAnn; Markowski, Todd W.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Higgins, LeeAnn; Markowski, Todd W.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Walcheck, B (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.	walch003@umn.edu		Kaufman, Dan/0000-0002-2003-2494	William Lawrence and Blanche Hughes Foundation; National Institutes of Health [R21-HL117652, R21-AI107543]; University of Minnesota Masonic Cancer Center, Brainstorm grant; University of Minnesota Comparative Medicine Signature Program grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL117652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107543] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Masonic Cancer Center, Brainstorm grant; University of Minnesota Comparative Medicine Signature Program grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the William Lawrence and Blanche Hughes Foundation, http://www.williamslaboratory.org/blanche-hughes-foundation.html (DSK); National Institutes of Health (R21-HL117652), http://www.nih.gov (JW); University of Minnesota Masonic Cancer Center, Brainstorm grant (DSK, BW); National Institutes of Health (R21-AI107543), http://www.nih.gov (BW); and University of Minnesota Comparative Medicine Signature Program grant (BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Dong CL, 2014, ARTHRITIS RHEUMATOL, V66, P1291, DOI 10.1002/art.38337; Eguizabal C, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00439; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Galon J, 1998, EUR J IMMUNOL, V28, P2101, DOI 10.1002/(SICI)1521-4141(199807)28:07<2101::AID-IMMU2101>3.0.CO;2-W; GONG JH, 1994, LEUKEMIA, V8, P652; HARRISON D, 1991, J IMMUNOL, V147, P3459; HUIZINGA TWJ, 1990, J CLIN INVEST, V86, P416, DOI 10.1172/JCI114727; Jewett A, 2011, J CANCER, V2, P443, DOI 10.7150/jca.2.443; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Knorr DA, 2013, STEM CELL TRANSL MED, V2, P274, DOI 10.5966/sctm.2012-0084; Lai P, 1996, CLIN CANCER RES, V2, P161; Lajoie L, 2014, J IMMUNOL, V192, P741, DOI 10.4049/jimmunol.1301024; Le Bouteiller P, 2002, P NATL ACAD SCI USA, V99, P16963, DOI 10.1073/pnas.012681099; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Long CM, 2012, J LEUKOCYTE BIOL, V92, P667, DOI 10.1189/jlb.0312112; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Mezyk R, 2003, ACTA BIOCHIM POL, V50, P625; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; Montaldo E, 2013, CYTOM PART A, V83A, P702, DOI 10.1002/cyto.a.22302; Ni ZY, 2014, STEM CELLS, V32, P1021, DOI 10.1002/stem.1611; ORY PA, 1989, J CLIN INVEST, V84, P1688, DOI 10.1172/JCI114350; Ott GR, 2008, BIOORG MED CHEM LETT, V18, P1577, DOI 10.1016/j.bmcl.2008.01.075; Peruzzi G, 2013, J IMMUNOL, V191, P1883, DOI 10.4049/jimmunol.1300313; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; SELVARAJ P, 1988, NATURE, V333, P565, DOI 10.1038/333565a0; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stawikowska R, 2013, J BIOL CHEM, V288, P22871, DOI 10.1074/jbc.M113.462267; TEILLAUD C, 1993, BLOOD, V82, P3081; Teillaud J L, 1994, Immunomethods, V4, P48, DOI 10.1006/immu.1994.1007; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Tian XH, 2009, STEM CELLS, V27, P2675, DOI 10.1002/stem.204; TOSI MF, 1992, J CLIN INVEST, V90, P462, DOI 10.1172/JCI115882; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Walcheck B, 2003, J LEUKOCYTE BIOL, V74, P389, DOI 10.1189/jlb.0403141; Wang Y, 2013, BBA-MOL CELL RES, V1833, P680, DOI 10.1016/j.bbamcr.2012.11.027; Wang Y, 2011, J BIOL CHEM, V286, P38980, DOI 10.1074/jbc.M111.277087; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wiernik A, 2013, CLIN CANCER RES, V19, P3844, DOI 10.1158/1078-0432.CCR-13-0505; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616	56	60	64	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121788	10.1371/journal.pone.0121788	http://dx.doi.org/10.1371/journal.pone.0121788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816339	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600119
J	Yoshida, A; Niki, M; Yamamoto, Y; Yasunaga, A; Ansai, T				Yoshida, Akihiro; Niki, Mamiko; Yamamoto, Yuji; Yasunaga, Ai; Ansai, Toshihiro			Proteome Analysis Identifies the Dpr Protein of Streptococcus mutans as an Important Factor in the Presence of Early Streptococcal Colonizers of Tooth Surfaces	PLOS ONE			English	Article							IRON-BINDING PROTEIN; OXYGEN TOLERANCE; BACTERIOCIN PRODUCTION; NADH OXIDASES; SANGUINIS; COLONIZATION; COEXISTENCE; MICROFLORA; RESISTANCE; SEQUENCE	Oral streptococci are primary colonizers of tooth surfaces and Streptococcus mutans is the principal causative agent of dental caries in humans. A number of proteins are involved in the formation of monospecies biofilms by S. mutans. This study analyzed the protein expression profiles of S. mutans biofilms formed in the presence or absence of S. gordonii, a pioneer colonizer of the tooth surface, by two-dimensional gel electrophoresis (2-DE). After identifying S. mutans proteins by Mass spectrometric analysis, their expression in the presence of S. gordonii was analyzed. S. mutans was inoculated with or without S. gordonii DL1. The two species were compartmentalized using 0.2-mu l Anopore membranes. The biofilms on polystyrene plates were harvested, and the solubilized proteins were separated by 2-DE. When S. mutans biofilms were formed in the presence of S. gordonii, the peroxide resistance protein Dpr of the former showed 4.3-fold increased expression compared to biofilms that developed in the absence of the pioneer colonizer. In addition, we performed a competition assay using S. mutans antioxidant protein mutants together with S. gordonii and other initial colonizers. Growth of the dpr-knockout S. mutans mutant was significantly inhibited by S. gordonii, as well as by S. sanguinis. Furthermore, a cell viability assay revealed that the viability of the dpr-defective mutant was significantly attenuated compared to the wild-type strain when co-cultured with S. gordonii. Therefore, these results suggest that Dpr might be one of the essential proteins for S. mutans survival on teeth in the presence of early colonizing oral streptococci.	[Yoshida, Akihiro] Matsumoto Dent Univ, Dept Oral Microbiol, Shiojiri, Japan; [Yoshida, Akihiro; Yasunaga, Ai; Ansai, Toshihiro] Kyushu Dent Univ, Div Community Oral Hlth Sci, Dept Oral Hlth Promot, Kitakyushu, Fukuoka, Japan; [Niki, Mamiko] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan; [Yamamoto, Yuji] Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori, Japan	Matsumoto Dental University; Kyushu Dental University; Osaka Metropolitan University; Kitasato University	Yoshida, A (corresponding author), Matsumoto Dent Univ, Dept Oral Microbiol, Shiojiri, Japan.	aki@po.mdu.ac.jp	Ansai, Toshihiro/AAM-2203-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [23463257]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid (C) 23463257 (to A.Yo.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; BREHM J, 1987, NUCLEIC ACIDS RES, V15, P3177, DOI 10.1093/nar/15.7.3177; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Heng NCK, 2007, J BACTERIOL, V189, P1468, DOI 10.1128/JB.01174-06; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Higuchi M, 2000, J BIOSCI BIOENG, V90, P484, DOI 10.1016/S1389-1723(01)80028-1; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kreth J, 2005, MOL MICROBIOL, V57, P392, DOI 10.1111/j.1365-2958.2005.04695.x; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; NAKAYAMA K, 1992, J BACTERIOL, V174, P4928, DOI 10.1128/JB.174.15.4928-4934.1992; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Perry JA, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P247; Petersen FC, 2010, METHODS MOL BIOL, V666, P167, DOI 10.1007/978-1-60761-820-1_12; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHIROZA T, 1993, INFECT IMMUN, V61, P3745, DOI 10.1128/IAI.61.9.3745-3755.1993; SUTTON HC, 1984, ARCH BIOCHEM BIOPHYS, V235, P106, DOI 10.1016/0003-9861(84)90259-5; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000; Yamamoto Y, 2004, J BACTERIOL, V186, P5997, DOI 10.1128/JB.186.18.5997-6002.2004; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Yoshida A, 2002, MICROBIOL-SGM, V148, P3385, DOI 10.1099/00221287-148-11-3385	41	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121176	10.1371/journal.pone.0121176	http://dx.doi.org/10.1371/journal.pone.0121176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816242	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600069
J	Bartsch, MS; Edwards, HS; Lee, D; Moseley, CE; Tew, KE; Renzi, RF; Van de Vreugde, JL; Kim, H; Knight, DL; Sinha, A; Branda, SS; Patel, KD				Bartsch, Michael S.; Edwards, Harrison S.; Lee, Daniel; Moseley, Caroline E.; Tew, Karen E.; Renzi, Ronald F.; Van de Vreugde, James L.; Kim, Hanyoup; Knight, Daniel L.; Sinha, Anupama; Branda, Steven S.; Patel, Kamlesh D.			The Rotary Zone Thermal Cycler: A Low-Power System Enabling Automated Rapid PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NUCLEIC-ACID AMPLIFICATION; FORENSIC DNA ANALYSIS; REAL-TIME PCR; ON-A-CHIP; CAPILLARY ELECTROPHORESIS MICROSYSTEM; OF-CARE DIAGNOSTICS; MICROFLUIDIC PLATFORM; TEMPERATURE CONTROL; QUANTITATIVE PCR	Advances in molecular biology, microfluidics, and laboratory automation continue to expand the accessibility and applicability of these methods beyond the confines of conventional, centralized laboratory facilities and into point of use roles in clinical, military, forensic, and field-deployed applications. As a result, there is a growing need to adapt the unit operations of molecular biology (e.g., aliquoting, centrifuging, mixing, and thermal cycling) to compact, portable, low-power, and automation-ready formats. Here we present one such adaptation, the rotary zone thermal cycler (RZTC), a novel wheel-based device capable of cycling up to four different fixed-temperature blocks into contact with a stationary 4-microliter capillary-bound sample to realize 1-3 second transitions with steady state heater power of less than 10 W. We demonstrate the utility of the RZTC for DNA amplification as part of a highly integrated rotary zone PCR (rzPCR) system that uses low-volume valves and syringe-based fluid handling to automate sample loading and unloading, thermal cycling, and between-run cleaning functionalities in a compact, modular form factor. In addition to characterizing the performance of the RZTC and the efficacy of different online cleaning protocols, we present preliminary results for rapid single-plex PCR, multiplex short tandem repeat (STR) amplification, and second strand cDNA synthesis.	[Bartsch, Michael S.; Edwards, Harrison S.; Lee, Daniel; Moseley, Caroline E.; Tew, Karen E.; Renzi, Ronald F.; Van de Vreugde, James L.; Kim, Hanyoup; Sinha, Anupama; Branda, Steven S.; Patel, Kamlesh D.] Sandia Natl Labs, Livermore, CA 94550 USA; [Knight, Daniel L.] SequoiaTek Corp, Logan, UT USA	United States Department of Energy (DOE); Sandia National Laboratories	Bartsch, MS (corresponding author), Sandia Natl Labs, Livermore, CA 94550 USA.	mbarts@sandia.gov		Branda, Steven/0000-0001-8763-1013; Bartsch, Michael/0000-0002-0409-5129	U.S. Department of Defense Rapid Reaction Technology Office on behalf of the U.S. Army Criminal Investigation Laboratory; Sandia National Laboratories internal Laboratory Directed Research and Development grants; Department of Homeland Security HS-STEM internship program; United States Department of Energy [DE-AC04-94AL85000]	U.S. Department of Defense Rapid Reaction Technology Office on behalf of the U.S. Army Criminal Investigation Laboratory; Sandia National Laboratories internal Laboratory Directed Research and Development grants; Department of Homeland Security HS-STEM internship program(United States Department of Homeland Security (DHS)); United States Department of Energy(United States Department of Energy (DOE))	This work was funded in part by the U.S. Department of Defense Rapid Reaction Technology Office on behalf of the U.S. Army Criminal Investigation Laboratory as part of the Battlefield Automated DNA Analysis and Sampling System project. Additional support was provided by Sandia National Laboratories internal Laboratory Directed Research and Development grants. Support for Harrison Edwards, Daniel Lee, Caroline Moseley, and Karen Tew was provided by the Department of Homeland Security HS-STEM internship program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Tayoun AN, 2012, EXP MOL PATHOL, V93, P261, DOI 10.1016/j.yexmp.2012.05.002; Aboud M, 2013, ELECTROPHORESIS, V34, P1539, DOI 10.1002/elps.201200570; Ahmad F, 2012, ANAL CHIM ACTA, V733, P1, DOI 10.1016/j.aca.2012.04.031; Angione SL, 2012, ANAL CHEM, V84, P2654, DOI 10.1021/ac202532a; Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Asplen C, 2014, EVID TECHNOL MAG, P8; Aw TG, 2012, CURR OPIN BIOTECH, V23, P422, DOI 10.1016/j.copbio.2011.11.016; Bartsch MS, 2013, U.S. Patent Application, Patent No. [13/945,153, 13945153]; Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; Brunklaus S, 2012, ELECTROPHORESIS, V33, P3222, DOI 10.1002/elps.201200259; Bu MQ, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/7/074002; Budowle Bruce, 2005, Legal Medicine, V7, P230, DOI 10.1016/j.legalmed.2005.01.001; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chang CM, 2013, LAB CHIP, V13, P1225, DOI 10.1039/c3lc41097h; Chen JF, 2005, ANAL CHEM, V77, P658, DOI 10.1021/ac048758e; Chen PC, 2008, BIOMED MICRODEVICES, V10, P141, DOI 10.1007/s10544-007-9119-6; Cheng JY, 2005, ANALYST, V130, P931, DOI 10.1039/b501061f; Chien CH, 2008, CHEM ENG J, V141, P327, DOI 10.1016/j.cej.2008.01.039; Wang CH, 2007, J MICROMECH MICROENG, V17, P367, DOI 10.1088/0960-1317/17/2/024; Chiou J, 2001, ANAL CHEM, V73, P2018, DOI 10.1021/ac001227f; Chou CF, 2002, MICROELECTRON ENG, V61-2, P921, DOI 10.1016/S0167-9317(02)00450-1; Christensen TB, 2007, J MICROMECH MICROENG, V17, P1527, DOI 10.1088/0960-1317/17/8/015; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Crews N, 2008, BIOMED MICRODEVICES, V10, P187, DOI 10.1007/s10544-007-9124-9; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Dougherty GM, 2007, PROC SPIE, V6540, DOI 10.1117/12.719841; Easley CJ, 2007, J MICROMECH MICROENG, V17, P1758, DOI 10.1088/0960-1317/17/9/002; Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103; Easley CJ, 2005, ANAL CHEM, V77, P1038, DOI 10.1021/ac048693f; Edwards C., 2006, Engineering & Technology, V1, P24, DOI 10.1049/et:20060201; El-Ali J, 2004, SENSOR ACTUAT A-PHYS, V110, P3, DOI 10.1016/j.sna.2003.09.022; Erill I, 2004, J MICROMECH MICROENG, V14, P1558, DOI 10.1088/0960-1317/14/11/018; Estes MD, 2012, ANALYST, V137, P5510, DOI 10.1039/c2an35768b; Evensen HT, 1998, REV SCI INSTRUM, V69, P519, DOI 10.1063/1.1148690; Ferguson BS, 2009, ANAL CHEM, V81, P6503, DOI 10.1021/ac900923e; Foudeh AM, 2012, LAB CHIP, V12, P3249, DOI 10.1039/c2lc40630f; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Friedman NA, 1998, ANAL CHEM, V70, P2997, DOI 10.1021/ac971303n; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Gonzalez A, 2007, BIOMED MICRODEVICES, V9, P261, DOI 10.1007/s10544-006-9030-6; Grover J, 2008, IEEE SENS J, V8, P476, DOI 10.1109/JSEN.2008.918248; Hagan KA, 2011, ANALYST, V136, P1928, DOI 10.1039/c0an00922a; Hagan KA, 2011, LAB CHIP, V11, P957, DOI 10.1039/c01c00136h; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Harrison OB, 2011, MICROBIOL-SGM, V157, P2181, DOI 10.1099/mic.0.050518-0; Hartung R, 2009, BIOMED MICRODEVICES, V11, P685, DOI 10.1007/s10544-008-9280-6; Hawkins KR, 2010, PROC SPIE, V7593, DOI 10.1117/12.845500; HAYATSU H, 1971, CHEM PHARM BULL, V19, P2189; Hellberg RSR, 2011, JALA-J LAB AUTOM, V16, P308, DOI 10.1016/j.jala.2010.07.004; Higgins JA, 2003, BIOSENS BIOELECTRON, V18, P1115, DOI 10.1016/S0956-5663(02)00252-X; Hindson BJ, 2005, ANAL CHEM, V77, P284, DOI 10.1021/ac0489014; Hopwood AJ, 2010, ANAL CHEM, V82, P6991, DOI 10.1021/ac101355r; Horsman KM, 2007, J FORENSIC SCI, V52, P784, DOI 10.1111/j.1556-4029.2007.00468.x; Hou CSJ, 2007, LAB CHIP, V7, P347, DOI 10.1039/b617082j; Hua ZS, 2010, ANAL CHEM, V82, P2310, DOI 10.1021/ac902510u; Hurth C, 2010, ELECTROPHORESIS, V31, P3510, DOI 10.1002/elps.201000305; Incropera FP, 2002, FUNDAMENTALS HEAT MA, P106; Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024; Jebrail MJ, 2012, LAB CHIP, V12, P2452, DOI 10.1039/c2lc40318h; Jha SK, 2012, LAB CHIP, V12, P4455, DOI 10.1039/c2lc40727b; Jiao ZJ, 2007, SENSOR ACTUAT A-PHYS, V140, P145, DOI 10.1016/j.sna.2007.06.025; Johnston MA, 2009, MILITARY POLICE 0501, V19-09-1, P5; Jung JH, 2012, LAB CHIP, V12, P1598, DOI 10.1039/c2lc21269b; Kantak C, 2014, LAB CHIP, V14, P841, DOI 10.1039/c3lc50980j; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; Kim H. S., 2013, PLOS ONE, V8; Kim H, 2011, JALA-J LAB AUTOM, V16, P405, DOI 10.1016/j.jala.2011.07.001; Kim H, 2009, OPT EXPRESS, V17, P218, DOI 10.1364/OE.17.000218; Kitpipit T, 2014, FORENSIC SCI MED PAT, V10, P29, DOI 10.1007/s12024-013-9521-8; Kodzius R, 2012, SENSOR ACTUAT B-CHEM, V161, P349, DOI 10.1016/j.snb.2011.10.044; Kolari K, 2008, SENSOR ACTUAT B-CHEM, V128, P442, DOI 10.1016/j.snb.2007.06.034; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Kricka LJ, 2003, ANAL BIOANAL CHEM, V377, P820, DOI 10.1007/s00216-003-2144-2; Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6; Lagally ET, 2001, LAB CHIP, V1, P102, DOI 10.1039/b109031n; Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Liao CS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni157; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Liu CN, 2005, ROY SOC CH, P297; Liu J, 2002, ELECTROPHORESIS, V23, P1531, DOI 10.1002/1522-2683(200205)23:10<1531::AID-ELPS1531>3.0.CO;2-D; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Liu P, 2011, LAB CHIP, V11, P1041, DOI 10.1039/c01c00533a; Liu P, 2011, FORENSIC SCI INT-GEN, V5, P484, DOI 10.1016/j.fsigen.2010.10.009; Liu P, 2009, TRENDS BIOTECHNOL, V27, P572, DOI 10.1016/j.tibtech.2009.07.002; Liu P, 2008, FORENSIC SCI INT-GEN, V2, P301, DOI 10.1016/j.fsigen.2008.03.009; Lounsbury JA, 2013, LAB CHIP, V13, P1384, DOI 10.1039/c3lc41326h; Lyon E, 2009, J MOL DIAGN, V11, P93, DOI 10.2353/jmoldx.2009.080094; Mafra I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/s00217-007-0782-x; Maltezos G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3530452; Maltezos G, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046789; MARIELLA R, 2001, PROC SPIE, V2, P58; Maurer JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/annurev.food.080708.100730; McCalla SE, 2011, ANNU REV BIOMED ENG, V13, P321, DOI 10.1146/annurev-bioeng-070909-105312; Miura M, 2013, REV INST MED TROP SP, V55, P401, DOI 10.1590/S0036-46652013000600005; Nagai H, 2001, BIOSENS BIOELECTRON, V16, P1015, DOI 10.1016/S0956-5663(01)00248-2; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P349, DOI 10.1271/bbb.58.349; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Njoroge SK, 2011, ELECTROPHORESIS, V32, P3221, DOI 10.1002/elps.201100274; Northrup MA, 1998, ANAL CHEM, V70, P918, DOI 10.1021/ac970486a; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Pal D, 2002, SENSOR ACTUAT A-PHYS, V102, P151, DOI 10.1016/S0924-4247(02)00300-X; Park DSW, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055003; Park N, 2003, ANAL CHEM, V75, P6029, DOI 10.1021/ac0346959; Poser S, 1997, SENSOR ACTUAT A-PHYS, V62, P672, DOI 10.1016/S0924-4247(97)01542-2; Potrich C, 2010, EUR BIOPHYS J BIOPHY, V39, P979, DOI 10.1007/s00249-009-0466-5; Pourahmadi F, 2000, MESA MG, P243; Prakash R, 2007, MICROFLUID NANOFLUID, V3, P177, DOI 10.1007/s10404-006-0114-7; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; Qiu XB, 2011, BIOMED MICRODEVICES, V13, P809, DOI 10.1007/s10544-011-9551-5; Ramasamy S, 2011, FORENSIC SCI INT, V210, P182, DOI 10.1016/j.forsciint.2011.03.006; Renzi RF, 2005, ANAL CHEM, V77, P435, DOI 10.1021/ac049214f; Ritzi-Lehnert M, 2011, BIOMED MICRODEVICES, V13, P819, DOI 10.1007/s10544-011-9552-4; Rodriguez I, 2003, ELECTROPHORESIS, V24, P172, DOI 10.1002/elps.200390010; Roper MG, 2005, ANAL CHEM, V77, P3887, DOI 10.1021/ac050756m; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sankar S, 2011, MOL DIAGN THER, V15, P1, DOI 10.2165/11586160-000000000-00000; Saunders DC, 2013, BIOSENS BIOELECTRON, V44, P222, DOI 10.1016/j.bios.2013.01.019; Schneegass I, 2001, J Biotechnol, V82, P101, DOI 10.1016/S1389-0352(01)00033-2; Schneegass I, 2001, LAB CHIP, V1, P42, DOI 10.1039/b103846j; Shaw KJ, 2010, LAB CHIP, V10, P1725, DOI 10.1039/c000357n; Shoffner MA, 1996, NUCLEIC ACIDS RES, V24, P375, DOI 10.1093/nar/24.2.375; Sim JE, 2013, J FORENSIC SCI, V58, P989, DOI 10.1111/1556-4029.12166; Sista R, 2008, LAB CHIP, V8, P2091, DOI 10.1039/b814922d; Stals A, 2013, CURR OPIN VIROL, V3, P69, DOI 10.1016/j.coviro.2012.11.003; Summers A, 2014, SPEEDING UP DNA ANAL; Sun Y, 2009, ANAL BIOANAL CHEM, V394, P1505, DOI 10.1007/s00216-009-2808-7; Taitz J, 2002, LANCET, V359, P794, DOI 10.1016/S0140-6736(02)07889-3; Tan Eugene, 2013, Investig Genet, V4, P16, DOI 10.1186/2041-2223-4-16; Taylor TB, 1997, NUCLEIC ACIDS RES, V25, P3164, DOI 10.1093/nar/25.15.3164; Terazono H, 2008, JPN J APPL PHYS, V47, P5212, DOI 10.1143/JJAP.47.5212; Terpe K, 2013, APPL MICROBIOL BIOT, V97, P10243, DOI 10.1007/s00253-013-5290-2; Thaitrong N, 2012, ELECTROPHORESIS, V33, P3506, DOI 10.1002/elps.201200441; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Verheij S, 2012, FORENSIC SCI INT-GEN, V6, P167, DOI 10.1016/j.fsigen.2011.03.014; Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8; Wang F, 2010, BIOMED MICRODEVICES, V12, P533, DOI 10.1007/s10544-010-9410-9; Wang J, 2006, LAB CHIP, V6, P46, DOI 10.1039/b511494b; Western L, 1999, CLIN CHEM, V45, pA161; Wheeler EK, 2011, ANALYST, V136, P3707, DOI 10.1039/c1an15365j; WITTWER CT, 1991, BIOTECHNIQUES, V10, P76; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q; Yang JN, 2002, LAB CHIP, V2, P179, DOI 10.1039/b208405h; Yoon DS, 2002, J MICROMECH MICROENG, V12, P813, DOI 10.1088/0960-1317/12/6/312; Yu YJ, 2012, ANAL CHEM, V84, P2825, DOI 10.1021/ac203307h; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhang CS, 2011, CHINESE J ANAL CHEM, V39, P645, DOI 10.1016/S1872-2040(10)60436-7; Zhang C, 2010, CHEM REV, V110, P4910, DOI 10.1021/cr900081z; Zhang YH, 2009, ANAL CHIM ACTA, V638, P115, DOI 10.1016/j.aca.2009.02.038; Zietkiewicz E, 2012, J APPL GENET, V53, P41, DOI 10.1007/s13353-011-0068-7	153	10	12	11	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118182	10.1371/journal.pone.0118182	http://dx.doi.org/10.1371/journal.pone.0118182			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826708	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800003
J	Chevalier, N; Gross, N; Widmann, C				Chevalier, Nadja; Gross, Nicole; Widmann, Christian			Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers	PLOS ONE			English	Article							NEUROBLASTOMA-CELL LINES; EWINGS-SARCOMA; TUMOR-CELLS; LEUKEMIA; THERAPY; FRAGMENT; PEPTIDE; GROWTH; RESISTANCE; MORTALITY	Although current anti-cancer protocols are reasonably effective, treatment-associated long-term side effects, induced by lack of specificity of the anti-cancer procedures, remain a challenging problem in pediatric oncology. TAT-RasGAP(317-326) is a RasGAP-derived cell-permeable peptide that acts as a sensitizer to various anti-cancer treatments in adult tumor cells. In the present study, we assessed the effect of TAT-RasGAP(317-326) in several childhood cancer cell lines. The RasGAP-derived peptide-induced cell death was analyzed in several neuroblastoma, Ewing sarcoma and leukemia cell lines (as well as in normal lymphocytes). Cell death was evaluated using flow cytometry methods in the absence or in the presence of the peptide in combination with various genotoxins used in the clinics (4-hydroperoxycyclo-phosphamide, etoposide, vincristine and doxorubicin). All tested pediatric tumors, in response to at least one genotoxin, were sensitized by TAT-RasGAP(317-326). The RasGAP-derived peptide did not increase cell death of normal lymphocytes, alone or in combination with the majority of the tested chemotherapies. Consequently, TAT-RasGAP(317-326) may benefit children with tumors by increasing the efficacy of anti-cancer therapies notably by allowing reductions in anti-cancer drug dosage and the associated drug-induced side effects.	[Chevalier, Nadja; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Gross, Nicole] Univ Hosp Ctr CHUV, Paediat Oncol Res Unit, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Widmann, C (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Christian.Widmann@unil.ch	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363	FORCE foundation; Swiss National Science Foundation [158116]	FORCE foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding provided by FORCE foundation http://www.force-fondation.ch/ (NC NG); MD-PhD fellowship from the Swiss National Science Foundation (no158116) (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibaldi A, 2014, APOPTOSIS, V19, P719, DOI 10.1007/s10495-013-0958-8; [Anonymous], 1973, JNCI-J NATL CANCER I, V51, P1417; Armenian SH, 2013, CURR OPIN PEDIATR, V25, P16, DOI 10.1097/MOP.0b013e32835b0b6a; AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Barras D, 2011, PROMISES APOPTOSIS I; Barras D, 2013, ONCOGENE; Barras D, 2014, J BIOL CHEM; Barras D, 2014, INT J CANCER, V135, P242, DOI 10.1002/ijc.28674; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Fulbright JM, 2011, CURR HEMATOL MALIG R, V6, P195, DOI 10.1007/s11899-011-0094-x; HAYES FD, 1972, P SOC EXP BIOL MED, V139, P417; Keshelava N, 1997, EUR J CANCER, V33, P2002, DOI 10.1016/S0959-8049(97)00213-X; Kilk K, 2009, TOXICOLOGY, V265, P87, DOI 10.1016/j.tox.2009.09.016; Lawlor ER, 2012, CLIN CANCER RES, V18, P2768, DOI 10.1158/1078-0432.CCR-11-1921; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Metayer C, 2013, CANCER EPIDEMIOL, V37, P336, DOI 10.1016/j.canep.2012.12.011; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2007, CRIT REV ONCOL HEMAT, V63, P160, DOI 10.1016/j.critrevonc.2007.04.003; Michod D, 2007, MOL CANCER RES, V5, P497, DOI 10.1158/1541-7786.MCR-06-0257; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Pittet O, 2007, J PHOTOCH PHOTOBIO B, V88, P29, DOI 10.1016/j.jphotobiol.2007.04.009; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; SEEGER RC, 1977, CANCER RES, V37, P1364; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shiozawa Y, 2014, ONCOL LETT, V7, P1169, DOI 10.3892/ol.2014.1822; Stiller CA, 2006, EUR J CANCER, V42, P1952, DOI 10.1016/j.ejca.2006.05.017; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; Vassal G, 2013, LANCET ONCOL, V14, pE117, DOI 10.1016/S1470-2045(13)70013-5; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Ward E., 2014, CA CANC J CLIN; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	46	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120487	10.1371/journal.pone.0120487	http://dx.doi.org/10.1371/journal.pone.0120487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826368	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800017
J	Friborg, J; Ross-Macdonald, P; Cao, J; Willard, R; Lin, BQ; Eggers, B; McPhee, F				Friborg, Jacques; Ross-Macdonald, Petra; Cao, Jian; Willard, Ryan; Lin, Baiqing; Eggers, Betsy; McPhee, Fiona			Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes	PLOS ONE			English	Article							CHRONIC HCV INFECTION; GENOTYPE 1 INFECTION; EMERGE PHASE IIB; INTERFERON-LAMBDA; PEGINTERFERON LAMBDA-1A; INNATE IMMUNITY; VIRAL DYNAMICS; EXPRESSION; ALPHA; LIVER	Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique receptor complex with limited cellular expression outside the liver which may result in a differentiated tolerability profile compared to peginterferon alfa (alfa). In Phase 2b clinical studies, Lambda administered in combination with ribavirin (RBV) was efficacious in patients with hepatitis C virus (HCV) infection representing genotypes 1 through 4, and was associated with more rapid declines in HCV RNA compared to alfa plus RBV. To gain insights into potential mechanisms for this finding, we investigated the effects of HCV replication on IFN signaling in primary human hepatocytes (PHH) and in induced hepatocyte-like cells (iHLCs). HCV infection resulted in rapid down-regulation of the type I IFN-alpha receptor subunit 1 (IFNAR1) transcript in hepatocytes while the transcriptional level of the unique IFN-lambda receptor subunit IL28RA was transiently increased. In line with this observation, IFN signaling was selectively impaired in infected cells upon stimulation with alfa but not in response to Lambda. Importantly, in contrast to alfa, Lambda was able to induce IFN-stimulated gene (ISG) expression in HCV-infected hepatocytes, reflecting the onset of innate responses. Moreover, global transcriptome analysis in hepatocytes indicated that Lambda stimulation prolonged the expression of various ISGs that are potentially beneficial to antiviral defense mechanisms. Collectively, these observed effects of HCV infection on IFN receptor expression and signaling within infected hepatocytes provide a possible explanation for the more pronounced early virologic responses observed in patients treated with Lambda compared to alfa.	[Friborg, Jacques; Willard, Ryan; Lin, Baiqing; Eggers, Betsy; McPhee, Fiona] Bristol Myers Squibb Res & Dev, Discovery Virol, Wallingford, CT 06340 USA; [Ross-Macdonald, Petra; Cao, Jian] Bristol Myers Squibb Res & Dev, Appl Genom, Hopewell, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Friborg, J (corresponding author), Bristol Myers Squibb Res & Dev, Discovery Virol, Wallingford, CT 06340 USA.	jacques.friborg@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was supported by Bristol-Myers Squibb. No other sources of funding were used. All authors of this manuscript are employees of Bristol-Myers Squibb. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Chevaliez S, 2011, CLIN RES HEPATOL GAS, V35, pS31, DOI [10.1016/S2210-7401(11)70005-5, 10.1016/S2210-7401(11)70007-9]; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Ding Q, 2012, EUR J IMMUNOL, V42, P2374, DOI 10.1002/eji.201242388; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Freeman J, 2014, J VIRAL HEPATITIS, V21, pE1, DOI 10.1111/jvh.12243; Freeman JA, 2010, HEPATOLOGY, V52, p721A; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; Goossens N, 2013, HEPATOLOGY; Gupta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041209; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lalle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093434; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Larrea E, 2006, GUT, V55, P1188, DOI 10.1136/gut.2005.070060; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee HC, 2014, J BIOL CHEM, V289, P11861, DOI 10.1074/jbc.A113.536102; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Meng XW, 2005, WORLD J GASTROENTERO, V11, P3962; Morita K, 1998, J CLIN GASTROENTEROL, V26, P135, DOI 10.1097/00004836-199803000-00010; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Neumann AU, 2000, J INFECT DIS, V182, P28, DOI 10.1086/315661; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Zeuzem S, 2012, J HEPATOL, V56, pS5, DOI 10.1016/S0168-8278(12)60024-5; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	62	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121734	10.1371/journal.pone.0121734	http://dx.doi.org/10.1371/journal.pone.0121734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826356	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800052
J	Sullivan, CR; Funk, AJ; Shan, D; Haroutunian, V; McCullumsmith, RE				Sullivan, Courtney R.; Funk, Adam J.; Shan, Dan; Haroutunian, Vahram; McCullumsmith, Robert E.			Decreased Chloride Channel Expression in the Dorsolateral Prefrontal Cortex in Schizophrenia	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INDUCED ORAL DYSKINESIAS; POSTMORTEM BRAIN; NA-K-2CL COTRANSPORTER; MESSENGER-RNAS; GABA; DEFICITS; MECHANISM; NKCC1; BENZODIAZEPINES	Alterations in GABAergic neurotransmission are implicated in several psychiatric illnesses, including schizophrenia. The Na-K-Cl and K-Cl cotransporters regulate intracellular chloride levels. Abnormalities in cotransporter expression levels could shift the chloride electrochemical gradient and impair GABAergic transmission. In this study, we performed Western blot analysis to investigate whether the Na-K-Cl and K-Cl cotransporter protein is abnormally expressed in the dorsal lateral prefrontal cortex and the anterior cingulate cortex in patients with schizophrenia versus a control group. We found decreased K-Cl cotransporter protein expression in the dorsal lateral prefrontal cortex, but not the anterior cingulate cortex, in subjects with schizophrenia, supporting the hypothesis of region level abnormal GABAergic function in the pathophysiology of schizophrenia. Subjects with schizophrenia off antipsychotic medication at the time of death had decreased K-Cl cotransporter protein expression compared to both normal controls and subjects with schizophrenia on antipsychotics. Our results provide evidence for KCC2 protein abnormalities in schizophrenia and suggest that antipsychotic medications might reverse deficits of this protein in the illness.	[Sullivan, Courtney R.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH USA; [Sullivan, Courtney R.; Funk, Adam J.; McCullumsmith, Robert E.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA; [Shan, Dan] Univ Alabama Birmingham, Dept Nephrol, Birmingham, AL USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Haroutunian, Vahram] James J Peters Vet Affairs Med Ctr, New York, NY USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai	McCullumsmith, RE (corresponding author), Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA.	robert.mccullumsmith@uc.edu	McCullumsmith, Robert/GYR-1547-2022		VA-MIRECC (Veterans Affairs Mental Illness Research, Education, and Clinical Center) [MH064673, MH066392, MH074016, MH094445]; Doris Duke Clinical Scientist Award (REM); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH064673, K08MH074016, R01MH094445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007453] Funding Source: NIH RePORTER	VA-MIRECC (Veterans Affairs Mental Illness Research, Education, and Clinical Center); Doris Duke Clinical Scientist Award (REM); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by VA-MIRECC (Veterans Affairs Mental Illness Research, Education, and Clinical Center), MH064673 and MH066392 (VH), MH074016, MH094445 and Doris Duke Clinical Scientist Award (REM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2011, ARCH GEN PSYCHIAT, V68, P21, DOI 10.1001/archgenpsychiatry.2010.114; Badcock JC, 2010, SCHIZOPHRENIA BULL, V36, P576, DOI 10.1093/schbul/sbn128; Bauer DE, 2009, J NEURAL TRANSM, V116, P487, DOI 10.1007/s00702-008-0143-3; Beeri MS, 2006, NEUROLOGY, V66, P1399, DOI 10.1212/01.wnl.0000210447.19748.0b; Benes F, 1998, SOC NEUROSCI ABSTRAC, V24; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Benes FM, 2000, BRAIN RES REV, V31, P251, DOI 10.1016/S0165-0173(99)00041-7; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COSTA E, 1975, LIFE SCI, V17, P167, DOI 10.1016/0024-3205(75)90501-9; Drummond JB, 2013, SCHIZOPHR RES, V147, P32, DOI 10.1016/j.schres.2013.03.010; Eastwood SL, 2005, SCHIZOPHR RES, V73, P159, DOI 10.1016/j.schres.2004.05.010; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Funk AJ, 2012, NEUROPSYCHOPHARMACOL, V37, P896, DOI 10.1038/npp.2011.267; Gaillard R, 2006, ENCEPHALE, V32, P1003; Harte MK, 2005, SCHIZOPHR RES, V75, P303, DOI 10.1016/j.schres.2004.11.001; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Kahle Kristopher T, 2008, Epilepsy Curr, V8, P51, DOI 10.1111/j.1535-7511.2008.00235.x; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; KASHIHARA K, 1986, BIOL PSYCHIAT, V21, P650, DOI 10.1016/0006-3223(86)90126-5; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; KAY SR, 1990, SCHIZOPHRENIA BULL, V16, P635, DOI 10.1093/schbul/16.4.635; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; LAUF PK, 1992, AM J PHYSIOL, V263, pC917, DOI 10.1152/ajpcell.1992.263.5.C917; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Markkanen M, 2014, J COMP NEUROL, V522, P1897, DOI 10.1002/cne.23510; McCullumsmith RE, 2014, NEUROPSYCHOPHARMACOL, V39, P65, DOI 10.1038/npp.2013.239; McCullumsmith RE, 2011, BIOL PSYCHIAT, V69, P127, DOI 10.1016/j.biopsych.2010.09.035; MITHANI S, 1987, PSYCHOPHARMACOLOGY, V93, P94, DOI 10.1007/BF02439593; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Nyberg S, 1997, ARCH GEN PSYCHIAT, V54, P953; Oni-Orisan A, 2008, BIOL PSYCHIAT, V63, P766, DOI 10.1016/j.biopsych.2007.10.020; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Powchik P, 1998, SCHIZOPHRENIA BULL, V24, P325, DOI 10.1093/oxfordjournals.schbul.a033330; PUROHIT DP, 1993, BIOL PSYCHIAT, V33, P255, DOI 10.1016/0006-3223(93)90291-K; Rajji TK, 2008, SCHIZOPHR RES, V102, P122, DOI 10.1016/j.schres.2008.03.015; Rinehart J, 2011, J BIOL CHEM, V286, P30171, DOI 10.1074/jbc.M111.222893; ROBERTS RC, 1995, SYNAPSE, V20, P234, DOI 10.1002/syn.890200307; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; SAWAGUCHI T, 1989, EXP BRAIN RES, V75, P457; Shan D, 2014, SCHIZOPHR RES, V154, P1, DOI 10.1016/j.schres.2014.01.028; Szoke A, 2008, EUR PSYCHIAT, V23, P20, DOI 10.1016/j.eurpsy.2007.10.006; Trivedi J K, 2006, Indian J Psychiatry, V48, P10, DOI 10.4103/0019-5545.31613; Vaughan CW, 1997, J PHYSIOL-LONDON, V498, P463, DOI 10.1113/jphysiol.1997.sp021872; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714; Zavitsanou K, 2002, NEUROSCIENCE, V109, P709, DOI 10.1016/S0306-4522(01)00533-4	56	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123158	10.1371/journal.pone.0123158	http://dx.doi.org/10.1371/journal.pone.0123158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826365	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800107
J	Gagnon, L; Ismaili, AA; Ptito, M; Kupers, R				Gagnon, Lea; Ismaili, Abd Rahman Alaoui; Ptito, Maurice; Kupers, Ron			Superior Orthonasal but Not Retronasal Olfactory Skills in Congenital Blindness	PLOS ONE			English	Article							COLOR; PERCEPTION; IDENTIFICATION; TASTE; CUES; SENSITIVITY; CHILDREN; DESIGN; EAT	Sight is undoubtedly important for finding and appreciating food, and cooking. Blind individuals are strongly impaired in finding food, limiting the variety of flavours they are exposed to. We have shown before that compared to sighted controls, congenitally blind individuals have enhanced olfactory but reduced taste perception. In this study we tested the hypothesis that congenitally blind subjects have enhanced orthonasal but not retronasal olfactory skills. Twelve congenitally blind and 14 sighted control subjects, matched in age, gender and body mass index, were asked to identify odours using grocery-available food powders. Results showed that blind subjects were significantly faster and tended to be better at identifying odours presented orthonasally. This was not the case when odorants were presented retronasally. We also found a significant group x route interaction, showing that although both groups performed better for retronasally compared to orthonasally presented odours, this gain was less pronounced for blind subjects. Finally, our data revealed that blind subjects were more familiar with the orthonasal odorants and used the retronasal odorants less often for cooking than their sighted counterparts. These results confirm that orthonasal but not retronasal olfactory perception is enhanced in congenital blindness, a result that is concordant with the reduced food variety exposure in this group.	[Gagnon, Lea; Ptito, Maurice; Kupers, Ron] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Gagnon, Lea; Ismaili, Abd Rahman Alaoui; Ptito, Maurice; Kupers, Ron] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Brain Res & Integrat Neurosci Lab, DK-2200 Copenhagen, Denmark; [Ptito, Maurice] Rigshosp, Lab Neuropsychiat, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark	Universite de Montreal; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kupers, R (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	kupers@sund.ku.dk	Ptito, Maurice/G-3422-2013	Ptito, Maurice/0000-0002-5173-5862; kupers, ron/0000-0001-7237-4245; Gagnon, Lea/0000-0002-5300-7578	Lundbeck Foundation [R 32-A2895]; Fonds de Recherche du Quebec en Sante; Harland Sanders Chair	Lundbeck Foundation(Lundbeckfonden); Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Harland Sanders Chair	This work was supported by the Lundbeck Foundation [R 32-A2895 to RK; http://www.lundbeckfonden.com/], the Fonds de Recherche du Quebec en Sante [LG; http://www.frqs.gouv.qc.ca/fr/index.shtml] and the Harland Sanders Chair [MP; http://www.opto.umontreal.ca/plasticity/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2006, TRENDS IN COGNITIVE, V15, P47; Barthomeuf L, 2010, OBESITY, V18, P719, DOI 10.1038/oby.2009.357; Beaulieu-Lefebvre M, 2011, BRAIN RES BULL, V84, P206, DOI 10.1016/j.brainresbull.2010.12.014; BERKSON G, 1975, J ABNORM PSYCHOL, V84, P519, DOI 10.1037/h0077062; Bilyk MC, 2009, CAN J DIET PRACT RES, V70, P13, DOI 10.3148/70.1.2009.13; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; CLYDESDALE FM, 1993, CRIT REV FOOD SCI, V33, P83, DOI 10.1080/10408399309527614; Delwiche J.F., 2003, FOODS FOOD INGRED J, V208, P349; Delwiche JF, 2012, PHYSIOL BEHAV, V107, P502, DOI 10.1016/j.physbeh.2012.07.007; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Dovey TM, 2012, BRIT J HEALTH PSYCH, V17, P258, DOI 10.1111/j.2044-8287.2011.02036.x; Gagnon L, 2013, CHEM SENSES, V38, P509, DOI 10.1093/chemse/bjt021; Gagnon L, 2010, NEUROREPORT, V21, P989, DOI 10.1097/WNR.0b013e32833eaaf9; Gilbert AN, 1996, AM J PSYCHOL, V109, P335, DOI 10.2307/1423010; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Harrar V, 2013, FLAVOUR, V2, P12; Harrar V, 2011, PERCEPTION, V40, P880, DOI 10.1068/p7040; Heilmann S, 2002, ARCH OTOLARYNGOL, V128, P414, DOI 10.1001/archotol.128.4.414; Koster EP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00064; Koutsoklenis A, 2011, J VISUAL IMPAIR BLIN, V105, P692, DOI 10.1177/0145482X1110501015; Koza BJ, 2005, CHEM SENSES, V30, P643, DOI 10.1093/chemse/bji057; Kulyukin V, 2008, ASSIST TECHNOL, V20, P86, DOI 10.1080/10400435.2008.10131935; Kupers R, 2011, NEUROPSYCHOLOGIA, V49, P2037, DOI 10.1016/j.neuropsychologia.2011.03.033; Kutintara B, 2013, DISABIL REHABIL-ASSI, V8, P136, DOI 10.3109/17483107.2012.737542; Levitan CA, 2008, CHEM SENSES, V33, P415, DOI 10.1093/chemse/bjn008; Linne V, 2002, OBES RES, V10, P92, DOI 10.1038/oby.2002.15; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; MURPHY C, 1986, PHYSIOL BEHAV, V37, P177, DOI 10.1016/0031-9384(86)90402-6; Ohla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032434; Parma V, 2011, APPETITE, V56, P249, DOI 10.1016/j.appet.2010.12.013; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Ptito M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/304045; Rombaux P, 2010, NEUROREPORT, V21, P1069, DOI 10.1097/WNR.0b013e32833fcb8a; Rosenbluth R, 2000, PERCEPTION, V29, P101, DOI 10.1068/p3001; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Sarafoleanu C, 2009, J Med Life, V2, P196; Seo HS, 2010, APPETITE, V54, P544, DOI 10.1016/j.appet.2010.02.011; Shankar M, 2010, ATTEN PERCEPT PSYCHO, V72, P1981, DOI 10.3758/APP.72.7.1981; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Tubaldi F, 2011, SOC NEUROSCI-UK, V6, P31, DOI 10.1080/17470911003691089; Wakefield CE, 2004, PERCEPTION, V33, P429, DOI 10.1068/p5001; Wansink B, 2007, PERCEPT MOTOR SKILL, V104, P273, DOI 10.2466/PMS.104.1.273-276; Wheatley J., 1973, MARKETING, V24-9, P67; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; WILSON JW, 1969, AM EDUC RES J, V6, P80; Yeomans MR, 2008, FOOD QUAL PREFER, V19, P565, DOI 10.1016/j.foodqual.2008.02.009; Zampini M, 2012, THE NEURAL BASIS OF, P17; Zhou W, 2011, SOC NEUROSCI-UK, V6, P270, DOI 10.1080/17470919.2010.523537	52	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122567	10.1371/journal.pone.0122567	http://dx.doi.org/10.1371/journal.pone.0122567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822780	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700189
J	George, AE; Chapman, DC				George, Amy E.; Chapman, Duane C.			Embryonic and Larval Development and Early Behavior in Grass Carp, Ctenopharyngodon idella: Implications for Recruitment in Rivers	PLOS ONE			English	Article							CATOSTOMUS-COMMERSONI; BIGHEAD CARP; WHITE SUCKER; TEMPERATURE; TRANSPORT; FISH; PREDICT; EGGS; RED	With recent findings of grass carp Ctenopharyngodon idella in tributaries of the Great Lakes, information on developmental rate and larval behavior is critical to efforts to assess the potential for establishment within the tributaries of that region. In laboratory experiments, grass carp were spawned and eggs and larvae reared at two temperature treatments, one "cold" and one "warm", and tracked for developmental rate, egg size, and behavior. Developmental rate was quantified using Yi's (1988) developmental stages and the cumulative thermal units method. Grass carp had a thermal minimum of 13.5 degrees C for embryonic stages and 13.3 degrees C for larval stages. Egg size was related to temperature and maternal size, with the largest eggs coming from the largest females, and eggs were generally larger in warmer treatments. Young grass carp larvae exhibited upward and downward swimming interspersed with long periods of lying on the bottom. Swimming capacity increased with ontogeny, and larvae were capable of horizontal swimming and position holding with gas bladder emergence. Developmental rates, behavior, and egg attributes can be used in combination with physical parameters of a river to assess the risk that grass carp are capable of reproduction and recruitment in rivers.	[George, Amy E.; Chapman, Duane C.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO 65201 USA	United States Department of the Interior; United States Geological Survey	George, AE (corresponding author), US Geol Survey, Columbia Environm Res Ctr, 4200 New Haven Rd, Columbia, MO 65201 USA.	ageorge@usgs.gov		Chapman, Duane/0000-0002-1086-8853	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	U.S. Geological Survey Base Funding to DCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdusamadov AS., 1987, J ICHTHYOL, V26, P41; Alderdice DF, 1978, J FISH RES BOARD CAN, V35, P65; BATTY RS, 1994, J EXP MAR BIOL ECOL, V177, P269, DOI 10.1016/0022-0981(94)90241-0; BETTOLI PW, 1985, J FISH BIOL, V27, P239, DOI 10.1111/j.1095-8649.1985.tb04024.x; BLAXTER JHS, 1992, NETH J ZOOL, V42, P336, DOI 10.1163/156854291X00379; BROWN D J, 1991, North American Journal of Fisheries Management, V11, P62, DOI 10.1577/1548-8675(1991)011<0062:GCLITL>2.3.CO;2; BULKOWSKI L, 1983, T AM FISH SOC, V112, P445, DOI 10.1577/1548-8659(1983)112<445:CIPDED>2.0.CO;2; Chapman D. C, 2006, US GEOLOGICAL SURVEY, V239; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Chapman DC, 2009, T AM FISH SOC, V138, P1226, DOI 10.1577/T09-004.1; CHILTON EW, 1992, REV FISH BIOL FISHER, V2, P283, DOI 10.1007/BF00043520; Conner J.V., 1980, 4 ANN LARV FISH C MI, P1; Cudmore B, 2004, CANADIAN MANUSCRIPT; Cudmore B, 2011, AM FISH S S, V74, P15; Deters JE, 2013, ENVIRON BIOL FISH, V96, P617, DOI 10.1007/s10641-012-0052-z; FUIMAN LA, 1980, COPEIA, P699, DOI 10.2307/1444446; FUIMAN LA, 1993, FISH B-NOAA, V91, P23; Galloway M.L., 1984, J ARK ACAD SCI, V38, P36; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; Geffen AJ, 2012, FISH RES, V117, P48, DOI 10.1016/j.fishres.2011.01.002; George AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073829; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Hamel P, 1997, CAN J FISH AQUAT SCI, V54, P2040, DOI 10.1139/f97-103; Hamel P, 1997, CAN J FISH AQUAT SCI, V54, P190, DOI 10.1139/cjfas-54-1-190; Hargrave CW, 2004, SOUTHWEST NAT, V49, P89, DOI 10.1894/0038-4909(2004)049<0089:EORBEG>2.0.CO;2; HASSLER TJ, 1970, T AM FISH SOC, V99, P369, DOI 10.1577/1548-8659(1970)99<369:EIOEDA>2.0.CO;2; Inaba D., 1957, Journal of the Tokyo University of Fisheries, V43, P81; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jhingran V., 1985, HATCHERY MANUAL COMM; Kawamura G., 1980, Memoirs Kagoshima University Research Center for the South Pacific, V1, P75; Knighton D., 1998, FLUVIAL FORMS PROCES; Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Konstantinov A. S., 1986, J ICHTHYOL+, V26, P65; Korwin-Kossakowski M., 2008, Archives of Polish Fisheries, V16, P231, DOI 10.2478/s10086-008-0020-6; Krykhtin M. L., 1981, J ICHTHYOL, V1, P109; LESLIE AJ, 1982, T AM FISH SOC, V111, P99, DOI 10.1577/1548-8659(1982)111<99:CVFTOG>2.0.CO;2; McDowall RM, 2009, REV FISH BIOL FISHER, V19, P1, DOI 10.1007/s11160-008-9085-y; Murphy EA., 2013, SCI INVESTIGATIONS R; Nico LG, 2005, POTENTIAL GEOGRAPHIC, P197; Piper R.G., 1982, FISH HATCHERY MANAGE, V1st ed.; Shireman JV, 1983, FISHERIES SYNOPSIS, V135; Soin SG, 1972, J ICHTHYOL, V12, P67; Southwick Associates Inc, 2008, TOD ANGL; STANLEY JG, 1978, T AM FISH SOC, V107, P119, DOI 10.1577/1548-8659(1978)107&lt;119:RRALFN&gt;2.0.CO;2; STEVENSO.JH, 1965, PROG FISH CULT, V27, P203, DOI 10.1577/1548-8640(1965)27[203:OOGCIA]2.0.CO;2; Taylor RM, 2005, FISHERIES MANAG ECOL, V12, P283, DOI 10.1111/j.1365-2400.2005.00446.x; Wallich C, 1901, METHOD RECORDING EGG, P185; Wittmann ME, 2014, CAN J FISH AQUAT SCI, V71, P992, DOI 10.1139/cjfas-2013-0537; Wu H, 2000, INLAND WATER FISHERI, V3, P7; Yi B, 1988, GEZHOUBA WATER CONTR, P69	51	33	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119023	10.1371/journal.pone.0119023	http://dx.doi.org/10.1371/journal.pone.0119023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822837	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700030
J	Lariviere, V; Haustein, S; Borner, K				Lariviere, Vincent; Haustein, Stefanie; Boerner, Katy			Long-Distance Interdisciplinarity Leads to Higher Scientific Impact	PLOS ONE			English	Article								Scholarly collaborations across disparate scientific disciplines are challenging. Collaborators are likely to have their offices in another building, attend different conferences, and publish in other venues; they might speak a different scientific language and value an alien scientific culture. This paper presents a detailed analysis of success and failure of interdisciplinary papers-as manifested in the citations they receive. For 9.2 million interdisciplinary research papers published between 2000 and 2012 we show that the majority (69.9%) of co-cited interdisciplinary pairs are "win-win" relationships, i.e., papers that cite them have higher citation impact and there are as few as 3.3% "lose-lose" relationships. Papers citing references from subdisciplines positioned far apart (in the conceptual space of the UCSD map of science) attract the highest relative citation counts. The findings support the assumption that interdisciplinary research is more successful and leads to results greater than the sum of its disciplinary parts.	[Lariviere, Vincent; Haustein, Stefanie] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Lariviere, Vincent] Univ Quebec, Ctr Interuniv Rech Sci & Technol, Observ Sci & Technol, Montreal, PQ H3C 3P8, Canada; [Boerner, Katy] Indiana Univ, Sch Informat & Comp, Cyberinfrastruct Network Sci Ctr, Bloomington, IN USA	Universite de Montreal; University of Quebec; University of Quebec Montreal; Indiana University System; Indiana University Bloomington	Lariviere, V (corresponding author), Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada.	vincent.lariviere@umontreal.ca	Haustein, Stefanie/C-6748-2011; Haustein, Stefanie/AAH-3636-2020; Lariviere, Vincent/AAF-3179-2019	Haustein, Stefanie/0000-0003-0157-1430; Haustein, Stefanie/0000-0003-0157-1430; 	Fonds Recherche Quebec - Societe et Culture; Social Sciences and Humanities Research Council of Canada; Canada Research Chairs program	Fonds Recherche Quebec - Societe et Culture; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs)	This research was funded by the Fonds Recherche Quebec - Societe et Culture, the Social Sciences and Humanities Research Council of Canada and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J., 2007, BIBLIOMETRIC ANAL IN; Borner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039464; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; COSEPUP, 2004, FAC INT RES; Frodeman Robert, 2010, OXFORD HDB INTERDISC; GIBBONS M., 1994, NEW PRODUCTION KNOWL; Klavans R., 2013, 18 INT C SCI TECHN I, P185; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Lariviere V, 2006, J AM SOC INF SCI TEC, V57, P997, DOI 10.1002/asi.20349; Lariviere V, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P187; Lariviere V, 2011, J INFORMETR, V5, P392, DOI 10.1016/j.joi.2011.02.001; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Levitt JM, 2008, J AM SOC INF SCI TEC, V59, P1973, DOI 10.1002/asi.20914; Moed HF., 2005, CITATION ANAL RES EV; OECD, 1972, INT PROB TEACH RES U; Rinia EJ, 2002, SCIENTOMETRICS, V53, P241, DOI 10.1023/A:1014856625623; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Weingart P., 2000, PRACTICING INTERDISC; Yegros-Yegros A, 2010, BOOK ABSTR 11 STI C, P304	22	72	81	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122565	10.1371/journal.pone.0122565	http://dx.doi.org/10.1371/journal.pone.0122565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822658	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700188
J	Liu, FL; Kuang, YQ; Mu, D; Zheng, HY; Zhu, JW; Zheng, YT				Liu, Feng Liang; Kuang, Yi Qun; Mu, Dan; Zheng, Hong Yi; Zhu, Jia Wu; Zheng, Yong Tang			The Effect of Exon 7 Deletion during the Evolution of TRIMCyp Fusion Proteins on Viral Restriction, Cytoplasmic Body Formation and Multimerization	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; CYCLOPHILIN-A; RHESUS TRIM5-ALPHA; MACACA-NEMESTRINA; HIV-1 INFECTION; CAPSID LATTICE; COILED-COIL; DOMAINS; BODIES	TRIMCyp is a fusion protein consisting of the TRIM5 gene product and retrotransposed Cyclophilin A (CypA). Two primate TRIMCyp fusion proteins with varying anti-HIV-1 activities independently evolved in owl monkeys and Old World monkeys. In addition, Old World monkey TRIMCyps lack exon7, which encodes amino acids in the Linker2 region. Previous studies on TRIM5 alpha indicated that this region affects anti-retroviral activity, cytoplasmic body formation, and multimerization. The effects of exon7 deletion on the functions of the TRIMCyp are unclear. In this study, we found that the cytoplasmic bodies and multimers of owl monkey TRIMCyp (omTRIMCyp) are different from those of northern pig-tailed macaque TRIMCyp (npmTRIMCyp). In addition, we demonstrated that exon7 deletion affected cytoplasmic body formation and multimerization. Moreover, we unexpectedly found two chimeric proteins of omTRIMCyp and npmTRIMCyp that failed to block HIV-1 replication, despite the presence of CypA in omTRIMCyp. Further studies indicated that the cytoplasmic bodies and spontaneous multimerization were not responsible for TRIMCyp anti-HIV-1 activity. Moreover, potent viral restriction is associated with higher amounts of monomeric TRIMCyp when the CypA domain is able to recognize and bind to the HIV-1 capsid. Our results suggested that the deletion of exon7 during the evolution of TRIMCyp affected its function.	[Liu, Feng Liang; Kuang, Yi Qun; Mu, Dan; Zheng, Hong Yi; Zhu, Jia Wu; Zheng, Yong Tang] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Kuang, Yi Qun; Mu, Dan; Zhu, Jia Wu] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zheng, Hong Yi] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zheng, YT (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	zhengyt@mail.kiz.ac.cn	Liu, Feng-Liang/O-4000-2019; Kuang, Yi-Qun/AAW-4884-2021	Liu, Feng-Liang/0000-0002-5038-5012; Kuang, Yi-Qun/0000-0002-1452-4388	National Natural Science Foundation of China [81172876, 81202366, U0832601, 31271322]; National Basic Research Program of China [2012CBA01305]; Knowledge Innovation Program of CAS [KSCX2-EW-R-13]; Twelfth Five-Year Key Scientific and Technological Program of China [2012ZX10001-006, 2012ZX10001-007, 2013ZX10001-002]; Twelfth Five-Year Key Scientific and Technological Program of Yunnan province [2013FB073]; "The Dawn of West China" Talent Training Program of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Twelfth Five-Year Key Scientific and Technological Program of China; Twelfth Five-Year Key Scientific and Technological Program of Yunnan province; "The Dawn of West China" Talent Training Program of CAS	This work was supported in part by grants from the National Natural Science Foundation of China (81172876, 81202366, U0832601, 31271322), the National Basic Research Program of China (2012CBA01305), the Knowledge Innovation Program of CAS (KSCX2-EW-R-13), the Twelfth Five-Year Key Scientific and Technological Program of China (2012ZX10001-006, 2012ZX10001-007, 2013ZX10001-002) and Yunnan province (2013FB073), and "The Dawn of West China" Talent Training Program of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGY MB, 1992, SCIENCE, V257, P103, DOI 10.1126/science.1621083; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Cao Guang, 2011, Zoological Research, V32, P40, DOI 10.3724/SP.J.1141.2011.01040; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diaz-Griffero F, 2007, VIROLOGY, V369, P400, DOI 10.1016/j.virol.2007.08.032; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Goldstone DC, 2014, P NATL ACAD SCI USA, V111, P9609, DOI 10.1073/pnas.1402448111; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht HN, 2007, VIROLOGY, V367, P19, DOI 10.1016/j.virol.2007.04.034; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Kuang YQ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-58; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Nepveu-Traversy ME, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-100; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sastri J, 2014, J VIROL, V88, P8911, DOI 10.1128/JVI.01134-14; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Yap MW, 2007, VIROLOGY, V365, P302, DOI 10.1016/j.virol.2007.04.005; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062	35	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121666	10.1371/journal.pone.0121666	http://dx.doi.org/10.1371/journal.pone.0121666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822622	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700117
J	Lu, W; Zheng, J; Pan, XD; Sun, LZ				Lu, Wei; Zheng, Jun; Pan, Xudong; Sun, Lizhong			Diagnostic Performance of Echocardiography for the Detection of Acute Cardiac Allograft Rejection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LEFT-VENTRICULAR FUNCTION; PRESSURE HALF-TIME; HEART-TRANSPLANT RECIPIENTS; ACUTE CELLULAR REJECTION; MYOCARDIAL PERFORMANCE; DOPPLER-ECHOCARDIOGRAPHY; TISSUE DOPPLER; ENDOMYOCARDIAL BIOPSY; NONINVASIVE DIAGNOSIS; DIASTOLIC FUNCTION	Objective Many studies have addressed the diagnostic performance of echocardiography to evaluate acute cardiac allograft rejection compared with endomyocardial biopsy. But the existence of heterogeneity limited its clinical application. Thus, we conducted a comprehensive, systematic literature review and meta-analysis for the purpose. Methods Studies prior to September 1, 2014 identified by Medline/PubMed, EMBASE and Cochrance were examined by two independent reviews. We conducted meta-analysis by using Meta-DiSc 1.4 software. An assessment tool of QUADAS-2 was applied to evaluate the risk of bias and applicability of the studies. Results Thirty studies met the inclusion criteria of meta-analysis. The four parameters of pressure half time, isovolumic relaxation time, index of myocardial performance and late diastolic mitral annular motion velocity were included in the meta-analysis, with a pooled diagnostic odds ratio of 10.43, 6.89, 15.95 and 5.68 respectively, and the area under the summary receiver operating characteristic curves value of 0.829, 0.599, 0.871 and 0.685 respectively. Conclusion The meta-analysis and systematic review demonstrate that no single parameter of echocardiography showed a reliable diagnostic performance for acute cardiac allograft rejection. A result of echocardiography for ACAR should be comprehensively considered by physicians in the context of clinical presentations and imaging feature.	[Lu, Wei; Zheng, Jun; Pan, Xudong; Sun, Lizhong] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China; [Lu, Wei] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China	Capital Medical University	Sun, LZ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China.	lizhongsun@outlook.com			"Standard Diagnosis and Treatment and Key Technology Research of Aortic Dissection" from the Research Special Fund for the Public Welfare Industry of Health [201402009]	"Standard Diagnosis and Treatment and Key Technology Research of Aortic Dissection" from the Research Special Fund for the Public Welfare Industry of Health	This study was supported by the "Standard Diagnosis and Treatment and Key Technology Research of Aortic Dissection" from the Research Special Fund for the Public Welfare Industry of Health (201402009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENDE I, 1990, CIRCULATION, V81, P66; Angermann CE, 1997, CIRCULATION, V95, P140, DOI 10.1161/01.CIR.95.1.140; APPLETON CP, 1988, J AM COLL CARDIOL, V12, P426, DOI 10.1016/0735-1097(88)90416-0; Asante-Korang A, 2004, J HEART LUNG TRANSPL, V23, P865, DOI 10.1016/j.healun.2003.08.004; Bader FM, 2011, TRANSPL P, V43, P3877, DOI 10.1016/j.transproceed.2011.09.039; BARALDIJUNKINS C, 1993, J HEART LUNG TRANSPL, V12, P63; Behera SK, 2008, PEDIATR TRANSPLANT, V12, P207, DOI 10.1111/j.1399-3046.2007.00812.x; Bloch KE, 1999, J CRIT CARE, V14, P177, DOI 10.1016/S0883-9441(99)90032-1; Boyd SYN, 1997, J AM SOC ECHOCARDIOG, V10, P526, DOI 10.1016/S0894-7317(97)70006-3; Burgess MI, 2003, AM J CARDIOL, V92, P308, DOI 10.1016/S0002-9149(03)00634-9; CHOONG CY, 1987, J AM COLL CARDIOL, V10, P800, DOI 10.1016/S0735-1097(87)80273-5; Ciliberto G R, 1996, J Am Soc Echocardiogr, V9, P306, DOI 10.1016/S0894-7317(96)90145-5; CILIBERTO GR, 1994, J AM COLL CARDIOL, V23, P1156, DOI 10.1016/0735-1097(94)90605-X; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; Dandel M, 2001, CIRCULATION, V104, pI184; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DESRUENNES M, 1988, J AM COLL CARDIOL, V12, P63, DOI 10.1016/0735-1097(88)90357-9; Eidem BW, 1998, J AM SOC ECHOCARDIOG, V11, P849, DOI 10.1016/S0894-7317(98)70004-5; Eun LY, 2005, AM J CARDIOL, V96, P857, DOI 10.1016/j.amjcard.2005.04.060; Fabregas RI, 1999, TRANSPLANT P, V31, P2545, DOI 10.1016/S0041-1345(99)00493-5; Fauchier L, 1997, TRANSPLANT P, V29, P2442, DOI 10.1016/S0041-1345(97)00442-9; Ferreira ML, 2010, PHYS THER, V90, P1383, DOI 10.2522/ptj.20090332; Flanagan R, 2013, PEDIATR TRANSPLANT, V17, P782, DOI 10.1111/petr.12153; HATLE L, 1979, CIRCULATION, V60, P1096, DOI 10.1161/01.CIR.60.5.1096; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Irwig I, 1995, J CLIN EPIDEMIOL, V48, P131; ISHIDA Y, 1986, CIRCULATION, V74, P187, DOI 10.1161/01.CIR.74.1.187; Kato TS, 2010, EUR J CARDIO-THORAC, V37, P1104, DOI 10.1016/j.ejcts.2009.11.037; Leonard GT, 2006, J HEART LUNG TRANSPL, V25, P61, DOI 10.1016/j.healun.2005.01.006; LIBANOFF AJ, 1968, CIRCULATION, V38, P144, DOI 10.1161/01.CIR.38.1.144; LIEBACK E, 1994, ANN THORAC SURG, V57, P1164, DOI 10.1016/0003-4975(94)91348-X; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P1298, DOI 10.1016/S0735-1097(86)80300-X; Lunze FI, 2013, J HEART LUNG TRANSPL, V32, P1027, DOI 10.1016/j.healun.2013.06.016; Mankad S, 1999, AM HEART J, V138, P721, DOI 10.1016/S0002-8703(99)70188-2; MANNAERTS HFJ, 1992, BRIT HEART J, V68, P356; Marciniak A, 2007, EUR J ECHOCARDIOGR, V8, P213, DOI 10.1016/j.euje.2006.03.014; Mena C, 2006, J AM SOC ECHOCARDIOG, V19, P1295, DOI 10.1016/j.echo.2006.04.029; Miller CA, 2013, HEART, V99, P445, DOI 10.1136/heartjnl-2012-302759; Moidl R, 1999, J HEART LUNG TRANSPL, V18, P194, DOI 10.1016/S1053-2498(98)00031-X; Moller JE, 1999, J AM SOC ECHOCARDIOG, V12, P1065, DOI 10.1016/S0894-7317(99)70103-3; Moran AM, 2000, J HEART LUNG TRANSPL, V19, P756, DOI 10.1016/S1053-2498(00)00145-5; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MoulyBandini A, 1996, TRANSPLANT INT, V9, P131, DOI 10.1007/BF00336390; Neuberger S, 1997, AM J CARDIOL, V79, P447, DOI 10.1016/S0002-9149(96)00784-9; Palka P, 1995, J Am Soc Echocardiogr, V8, P659, DOI 10.1016/S0894-7317(05)80380-3; Palka P, 2005, J AM SOC ECHOCARDIOG, V18, P107, DOI 10.1016/j.echo.2004.09.021; Pan CZ, 2011, ACTA CARDIOL, V66, P365, DOI 10.1080/AC.66.3.2114137; PARK JW, 1992, INT J CARDIOL, V37, P351, DOI 10.1016/0167-5273(92)90266-6; Pauliks LB, 2005, J HEART LUNG TRANSPL, V24, pS239, DOI 10.1016/j.healun.2004.07.008; Poulsen SH, 2000, J AM SOC ECHOCARDIOG, V13, P379, DOI 10.1016/S0894-7317(00)70007-1; Prakash A, 2004, J AM SOC ECHOCARDIOG, V17, P439, DOI 10.1016/j.echo.2004.02.002; Putzer GJB, 2000, J HEART LUNG TRANSPL, V19, P1166, DOI 10.1016/S1053-2498(00)00214-X; Resende Marcos Valério Coimbra, 2011, Arq. Bras. Cardiol., V97, P08; Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0; Rosenthal DN, 2004, J HEART LUNG TRANSPL, V23, P323, DOI 10.1016/S1053-2498(03)00209-2; Roshanali F, 2010, EUR J CARDIO-THORAC, V38, P176, DOI 10.1016/j.ejcts.2009.12.045; Sato T, 2011, J HEART LUNG TRANSPL, V30, P536, DOI 10.1016/j.healun.2010.10.014; Sera F, 2014, J CARD FAIL, V20, P359, DOI 10.1016/j.cardfail.2014.02.006; SPES CH, 1992, EUR HEART J, V13, P889, DOI 10.1093/oxfordjournals.eurheartj.a060288; Spiegelhalter D J, 1983, Stat Med, V2, P33, DOI 10.1002/sim.4780020105; Miguel GAS, 2012, ARQ BRAS CARDIOL, V99, P1031, DOI 10.1590/S0066-782X2012005000099; Stehlik J, 2010, J HEART LUNG TRANSPL, V29, P1089, DOI 10.1016/j.healun.2010.08.007; STEMPFLE HU, 1995, TRANSPLANT P, V27, P1981; Stengel SM, 2001, HEART, V86, P432, DOI 10.1136/heart.86.4.432; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; STORK T, 1991, J ULTRAS MED, V10, P569; Sun JP, 2005, J HEART LUNG TRANSPL, V24, P160, DOI 10.1016/j.healun.2003.11.400; Sutherland G R, 1994, J Am Soc Echocardiogr, V7, P441; Tang Z, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/236720; Tei C, 1995, J Cardiol, V26, P135; Tei C, 1995, J Cardiol, V26, P357; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; THOMAS JD, 1987, J AM COLL CARDIOL, V10, P923, DOI 10.1016/S0735-1097(87)80290-5; Toumanidis ST, 2004, CLIN CARDIOL, V27, P352, DOI 10.1002/clc.4960270611; Valantine H A, 1990, J Am Soc Echocardiogr, V3, P276; VALANTINE HA, 1987, CIRCULATION, V76, P86; Vivekananthan K, 2002, AM J CARDIOL, V90, P517, DOI 10.1016/S0002-9149(02)02525-0; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	80	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121228	10.1371/journal.pone.0121228	http://dx.doi.org/10.1371/journal.pone.0121228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822627	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700097
J	Millard, PS; Goldstuck, ND				Millard, Peter S.; Goldstuck, Norman D.			No-Needle, Single-Visit Adult Male Circumcision with Unicirc: A Multi-Centre Field Trial	PLOS ONE			English	Article							VOLUNTARY MALE CIRCUMCISION; RANDOMIZED-TRIAL	Background Voluntary medical male circumcision (VMMC) is a priority HIV preventive intervention. Current adult circumcision methods need improvement. Methods Field trial in 3 primary care centres. Minimally invasive VMMC using the Unicirc instrument following topical lidocaine/prilocaine anesthetic. Men were followed up at 1 and 4 weeks. Results We circumcised 110 healthy volunteers. Two men complained of transient burning pain during circumcision, but none required injectable anaesthesia. Median blood loss was 1ml and median procedure time was 9.0 min. There were 7 (6.3%) moderate complications (5 (4.5%) post-operative bleeds requiring suture and 2 (1.8%) post-operative infections) affecting 7 men. No men experienced significant wound dehiscence. 90.4% of men were fully healed at 4 weeks of follow-up and all were highly satisfied. Conclusions Use of topical anaesthesia obviates the need for injectable anesthetic and makes the Unicirc procedure nearly painless. Unicirc is rapid, easy to learn, heals by primary intention with excellent cosmetic results, obviates the need for a return visit for device removal, and is potentially cheaper and safer than other methods. Use of this method will greatly facilitate scale-up of mass circumcision programs.	[Millard, Peter S.] Univ New England, Portland, ME USA; [Goldstuck, Norman D.] Univ Stellenbosch, Fac Med & Hlth Sci, Cape Town, South Africa; [Goldstuck, Norman D.] Tygerberg Hosp, Dept Obstet & Gynaecol, Cape Town, South Africa	University of New England - Maine; Stellenbosch University; Tygerberg Hospital	Millard, PS (corresponding author), Univ New England, Portland, ME USA.	pmillard@mac.com	Goldstuck, Norman/Q-8856-2019	Goldstuck, Norman/0000-0002-6695-032X	Simunye Primary Health Care	Simunye Primary Health Care	This study was supported by Simunye Primary Health Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Millard PS, 2014, SAMJ S AFR MED J, V104, P52, DOI [10.7196/SAMJ.7357, 10.7196/samj.7357]; Millard PS, 2013, SAMJ S AFR MED J, V103, P736, DOI [10.7196/SAMJ.6856, 10.7196/samj.6856]; Millard PS, RANDOMIZED CONTROLLE; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; World Health Organization, 2011, FRAM CLIN EV DEV AD; World Health Organization, 2014, WHO PROGR BRIEF VOL; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	8	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121686	10.1371/journal.pone.0121686	http://dx.doi.org/10.1371/journal.pone.0121686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822727	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700118
J	Zhang, L; Li, P; Liu, RR; Zheng, MQ; Sun, Y; Wu, D; Hu, YD; Wen, J; Zhao, GP				Zhang, Lei; Li, Peng; Liu, Ranran; Zheng, Maiqing; Sun, Yan; Wu, Dan; Hu, Yaodong; Wen, Jie; Zhao, Guiping			The Identification of Loci for Immune Traits in Chickens Using a Genome-Wide Association Study	PLOS ONE			English	Article							RED-BLOOD-CELLS; ANTIBODY-RESPONSE; TRANSCRIPTIONAL REPRESSOR; LYMPHOCYTE RATIO; SELECTION; INNATE; HETEROPHIL; EXPRESSION; RESPONSIVENESS; STRESS	The genetic improvement of disease resistance in poultry continues to be a challenge. To identify candidate genes and loci responsible for these traits, genome-wide association studies using the chicken 60k high density single nucleotide polymorphism (SNP) array for six immune traits, total serum immunoglobulin Y (IgY) level, numbers of, and the ratio of heterophils and lymphocytes, and antibody responses against Avian Influenza Virus (AIV) and Sheep Red Blood Cell (SRBC), were performed. RT-qPCR was used to quantify the relative expression of the identified candidate genes. Nine significantly associated SNPs (P < 2.81E-06) and 30 SNPs reaching the suggestively significant level (P < 5.62E-05) were identified. Five of the 10 SNPs that were suggestively associated with the antibody response to SRBC were located within or close to previously reported QTL regions. Fifteen SNPs reached a suggestive significance level for AIV antibody titer and seven were found on the sex chromosome Z. Seven suggestive markers involving five different SNPs were identified for the numbers of heterophils and lymphocytes, and the heterophil/lymphocyte ratio. Nine significant SNPs, all on chromosome 16, were significantly associated with serum total IgY concentration, and the five most significant were located within a narrow region spanning 6.4kb to 253.4kb (P = 1.20E-14 to 5.33E-08). After testing expression of five candidate genes (IL4I1, CD1b, GNB2L1, TRIM27 and ZNF692) located in this region, changes in IL4I1, CD1b transcripts were consistent with the concentrations of IgY, while abundances of TRIM27 and ZNF692 showed reciprocal changes to those of IgY concentrations. This study has revealed 39 SNPs associated with six immune traits (total serumIgY level, numbers of, and the ratio of heterophils and lymphocytes, and antibody responses against AIV and SRBC) in Beijing-You chickens. The narrow region spanning 247kb on chromosome 16 is an important QTL for serum total IgY concentration. Five candidate genes related to IgY level validated here are novel and may play critical roles in the modulation of immune responses. Potentially useful candidate SNPs for marker-assisted selection for disease resistance are identified. It is highly likely that these candidate genes play roles in various aspects of the immune response in chickens.	[Zhang, Lei; Li, Peng; Liu, Ranran; Zheng, Maiqing; Sun, Yan; Wu, Dan; Hu, Yaodong; Wen, Jie; Zhao, Guiping] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Zhang, Lei; Li, Peng; Liu, Ranran; Zheng, Maiqing; Wen, Jie; Zhao, Guiping] Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Zhao, GP (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	zhaoguiping@caas.cn		Wen, Jie/0000-0001-7460-4219	National Key Technology RD Program [2011BAD28B03]; Agricultural Science and Technology Innovation Program [ASTIP-IAS04]; earmarked fund for modern agro-industry technology research system [CARS-42]	National Key Technology RD Program(National Key Technology R&D Program); Agricultural Science and Technology Innovation Program; earmarked fund for modern agro-industry technology research system	The research was supported by grants: the National Key Technology R&D Program (2011BAD28B03); the Agricultural Science and Technology Innovation Program (ASTIP-IAS04); the earmarked fund for modern agro-industry technology research system (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ali M, 2011, INVEST OPHTH VIS SCI, V52, P7432, DOI 10.1167/iovs.11-7872; AlMurrani WK, 1997, BRIT POULTRY SCI, V38, P159, DOI 10.1080/00071669708417962; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Bovenhuis H, 2002, POULTRY SCI, V81, P309, DOI 10.1093/ps/81.3.309; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Campo JL, 2002, POULTRY SCI, V81, P1448, DOI 10.1093/ps/81.10.1448; Delany ME, 2009, J HERED, V100, P507, DOI 10.1093/jhered/esp044; Dorshorst BJ, 2011, ANIM GENET, V42, P300, DOI 10.1111/j.1365-2052.2010.02146.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; GROSS WB, 1989, BRIT POULTRY SCI, V30, P919, DOI 10.1080/00071668908417218; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Jang JY, 2006, CELL IMMUNOL, V241, P14, DOI 10.1016/j.cellimm.2006.07.006; Jang JY, 2003, CELL IMMUNOL, V226, P11, DOI 10.1016/j.cellimm.2003.11.004; Jethanandani P, 2005, J BIOL CHEM, V280, P36037, DOI 10.1074/jbc.M508698200; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kaiser MG, 2002, POULTRY SCI, V81, P193, DOI 10.1093/ps/81.2.193; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Li DF, 2013, ANIM GENET, V44, P217, DOI 10.1111/j.1365-2052.2012.02395.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074846; Lucas AM, 1961, ATLAS AVIAN HEMATOLO, P271; Luo CL, 2014, INFECT GENET EVOL, V21, P351, DOI 10.1016/j.meegid.2013.12.004; Luo CL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-42; Ly N, 2010, DEV COMP IMMUNOL, V34, P123, DOI 10.1016/j.dci.2009.08.015; Man CL, 2011, MOL CELL BIOCHEM, V346, P117, DOI 10.1007/s11010-010-0598-z; MCFARLANE JM, 1989, POULTRY SCI, V68, P522, DOI 10.3382/ps.0680522; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; MULLER M, 1991, EXPERIENTIA, V47, P923, DOI 10.1007/BF01929883; Nagel J E, 2004, BMC Immunol, V5, P17, DOI 10.1186/1471-2172-5-17; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; PINARD MH, 1992, J ANIM SCI, V70, P2986, DOI 10.2527/1992.70102986x; Postigo AA, 1999, MOL CELL BIOL, V19, P7961; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu J, 2007, BIOCHEM BIOPH RES CO, V352, P469, DOI 10.1016/j.bbrc.2006.11.049; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Salomonsen J, 2005, P NATL ACAD SCI USA, V102, P8668, DOI 10.1073/pnas.0409213102; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; SHOOK GE, 1989, J DAIRY SCI, V72, P1349, DOI 10.3168/jds.S0022-0302(89)79242-0; Siwek M, 2003, POULTRY SCI, V82, P1845, DOI 10.1093/ps/82.12.1845; Siwek M, 2003, ANIM GENET, V34, P422, DOI 10.1046/j.0268-9146.2003.01047.x; Siwek M, 2006, DEV COMP IMMUNOL, V30, P659, DOI 10.1016/j.dci.2005.09.004; Siwek M, 2012, J APPL GENET, V53, P115, DOI 10.1007/s13353-011-0074-9; Slawinska A, 2011, POULTRY SCI, V90, P1909, DOI 10.3382/ps.2011-01465; Slawinska A, 2013, J APPL GENET, V54, P483, DOI 10.1007/s13353-013-0177-6; Stear MJ, 2001, RES VET SCI, V71, P1, DOI 10.1053/rvsc.2001.0496; Sun YF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-458; Swaggerty CL, 2009, FOODBORNE PATHOG DIS, V6, P777, DOI 10.1089/fpd.2009.0307; Tukaj S, 2010, CELL STRESS CHAPERON, V15, P555, DOI 10.1007/s12192-010-0168-z; Uhart M, 2004, MOL PSYCHIATR, V9, P998, DOI 10.1038/sj.mp.4001535; van der Poel Jan J, 2011, BMC Proc, V5 Suppl 4, pS18, DOI 10.1186/1753-6561-5-S4-S18; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; WARNER CM, 1987, J ANIM SCI, V64, P394, DOI 10.2527/jas1987.642394x; WEGMANN TG, 1968, TRANSFUSION, V8, P47, DOI 10.1111/j.1537-2995.1968.tb02388.x; Yang LP, 2010, MOL BIOL REP, V37, P2967, DOI 10.1007/s11033-009-9863-1; Yonash N, 2001, POULTRY SCI, V80, P22, DOI 10.1093/ps/80.1.22; Yunis R, 2002, ANIM GENET, V33, P407, DOI 10.1046/j.1365-2052.2002.00890.x; Zhao JH, 2007, J STAT SOFTW, V23; Zhao XL, 2012, POULTRY SCI, V91, P1047, DOI 10.3382/ps.2011-01892; Zhou H, 2003, POULTRY SCI, V82, P699, DOI 10.1093/ps/82.5.699; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	67	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117269	10.1371/journal.pone.0117269	http://dx.doi.org/10.1371/journal.pone.0117269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822738	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700009
J	Lo, E; Zhou, GF; Oo, W; Afrane, Y; Githeko, A; Yan, GY				Lo, Eugenia; Zhou, Guofa; Oo, Winny; Afrane, Yaw; Githeko, Andrew; Yan, Guiyun			Low Parasitemia in Submicroscopic Infections Significantly Impacts Malaria Diagnostic Sensitivity in the Highlands of Western Kenya	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; PLASMODIUM-FALCIPARUM; TRANSMISSION INTENSITY; PREGNANT-WOMEN; AGE-PATTERNS; MICROSCOPY; PREVALENCE; TESTS; BLOOD	Asymptomatic malaria infections represent a major challenge in malaria control and elimination in Africa. They are reservoirs of malaria parasite that can contribute to disease transmission. Therefore, identification and control of asymptomatic infections are important to make malaria elimination feasible. In this study, we investigated the extent and distribution of asymptomatic malaria in Western Kenya and examined how varying parasitemia affects performance of diagnostic methods including microscopy, conventional PCR, and quantitative PCR. In addition, we compared parasite prevalence rates and parasitemia levels with respect to topography and age in order to explore factors that influence malaria infection. Over 11,000 asymptomatic blood samples from children and adolescents up to 18 years old representing broad areas of Western Kenya were included. Quantitative PCR revealed the highest parasite positive rate among all methods and malaria prevalence in western Kenya varied widely from less than 1% to over 50%. A significantly lower parasitemia was detected in highland than in lowland samples and this contrast was also observed primarily among submicroscopic samples. Although we found no correlation between parasitemia level and age, individuals of younger age group (aged <14) showed significantly higher parasite prevalence. In the lowlands, individuals of aged 5-14 showed significantly higher prevalence than those under age 5. Our findings highlight the need for a more sensitive and time-efficient assay for asymptomatic malaria detection particularly in areas of low-transmission. Combining QPCR with microscopy can enhance the capacity of detecting submicroscopic asymptomatic malaria infections.	[Lo, Eugenia; Zhou, Guofa; Oo, Winny; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92697 USA; [Afrane, Yaw; Githeko, Andrew] Kenya Govt Med Res Ctr, Ctr Vector Biol & Control Res, Kisumu 40100, Kenya	University of California System; University of California Irvine; Kenya Medical Research Institute	Yan, GY (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92697 USA.	guiyuny@uci.edu			National Institutes of Health [R01 AI094580, D43 TW001505, R01 A1050243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243, R01AI094580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants from the National Institutes of Health (R01 AI094580, D43 TW001505 and R01 A1050243 to G.Y. and Y.A.). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arango EM, 2013, AM J TROP MED HYG, V89, P178, DOI 10.4269/ajtmh.12-0669; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bashir IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056828; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Boonma P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-124; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Fancony C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-284; Farcas GA, 2004, J CLIN MICROBIOL, V42, P636, DOI 10.1128/JCM.42.2.636-638.2004; Gediminas V, 2005, J PARASITOL, V94, P1395; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Jelinek T, 1996, AM J TROP MED HYG, V55, P647, DOI 10.4269/ajtmh.1996.55.647; Kaisar MMM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-169; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Khairnar K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-284; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Morassin B, 2002, AM J TROP MED HYG, V66, P503, DOI 10.4269/ajtmh.2002.66.503; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Pakalapati D, 2013, ASIAN PAC J TROP MED, V6, P346, DOI 10.1016/S1995-7645(13)60037-1; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Schachterle SE, 2011, J CLIN MICROBIOL, V49, P3885, DOI 10.1128/JCM.01157-11; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P2; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	44	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121763	10.1371/journal.pone.0121763	http://dx.doi.org/10.1371/journal.pone.0121763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816298	Green Published, gold			2022-12-27	WOS:000352133600118
J	Methy, N; Velter, A; Semaille, C; Bajos, N				Methy, Nicolas; Velter, Annie; Semaille, Caroline; Bajos, Nathalie			Sexual Behaviours of Homosexual and Bisexual Men in France: A Generational Approach	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; HIV PREVALENCE; GAY COMMUNITY; SAN-FRANCISCO; UNITED-STATES; YOUNG MEN; RISK; TRENDS; EPIDEMIOLOGY; INFECTION	Objective In high-income countries, the social and epidemiological contexts surrounding homosexuality and AIDS have changed profoundly in recent decades. This work sought to examine key indicators of the long-term sexual trajectories of successive generations of men who have sex with men (MSM) in France. Methods We performed a longitudinal analysis of the French Gay Press surveys, which were self-administered socio-behavioural questionnaires, repeated from 1985 to 2011 in the gay press, and on the internet in 2004 and 2011. An age-cohort analysis using graphical representations and multivariate logistic regressions was conducted among participants aged 18-59 (N= 38 821). Results First sexual intercourse occurred more often with a male partner in younger generations than in older ones: 76.0% in MSM who turned 18 in 1956-1959, 75.6% in 1980-1983, 83.7% in 2008-2011, p(overall)= 0.0002). Every generation showed the same pattern of sexual trajectory between 1985 and 2011: globally, the frequency of masturbation increased from the 1985 survey to the early 1990s and then decreased from the late 1990s to the end of the study period. Inversely, the frequency of oral and anal sex decreased in the mid-1980s and increased from 1990 to 2011. The frequency of both oral sex and anal intercourse is currently quite high, regardless of generation (> 95% and around 80%, respectively). Compared to their predecessors, recent generations of young MSM reported more frequent oral and anal sex, but fewer male partners in the previous 12 months. Discussion While the increased frequency of first intercourse with a man over successive generations since the 1970s may be related to reduced social pressure for heterosexuality, there is evidence that sexual norms among MSM are widespread, with practices spreading across age groups and generations. Although AIDS profoundly affected sexual practices in the 1980s, further AIDS-related events (discovery of HIV antiretroviral drugs and their use in prevention) do not appear to have accentuated ongoing trends in sexual practices.	[Methy, Nicolas; Bajos, Nathalie] INSERM, CESP, U1018, F-94275 Le Kremlin Bicetre, France; [Velter, Annie] Inst Veille Sanitaire, St Maurice, France; [Semaille, Caroline] Agence Natl Secur Medicamet & Prod Sante, St Denis, France; [Bajos, Nathalie] Inst Natl Etudes Demog, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute of Public Health Surveillance	Methy, N (corresponding author), INSERM, CESP, U1018, F-94275 Le Kremlin Bicetre, France.	nicolas.methy@inserm.fr	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Institute for Public Health Surveillance (InVS); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The Gay press surveys were funded by the French National Institute for Public Health Surveillance (InVS) and the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 2000, RECRUDESCENCE PRISES; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Andro A, 2012, SEXUALITY FRANCE PRA; Aouba A., 2008, B EPIDEMIOL HEBD, V45-46, P447; Bajos N., 2012, SEXUALITY FRANCE PRA; Bajos N, 2010, AIDS, V24, P1185, DOI 10.1097/QAD.0b013e328336ad52; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bochow M, 2003, HOMOSEXUALITES TEMPS; Bozon Michel, 2009, SOCIOLOGIE SEXUALITE; Broqua C., 2003, HOMOSEXUALITES TEMPS; Chauvin S., 2013, SOCIOLOGIE HOMOSEXUA; De Busscher PO, 2003, HOMOSEXUALITES TEMPS; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Hall HI, 2012, AIDS BEHAV, V16, P36, DOI 10.1007/s10461-011-9944-8; Holt M, 2011, CULT HEALTH SEX, V13, P857, DOI 10.1080/13691058.2011.581390; Janiec J, 2013, EUROPEAN COMMUNICABL, V18; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kellogg TA, 2013, SEX TRANSM DIS, V40, P689, DOI 10.1097/01.olq.0000431354.96087.50; Knussen C, 2011, SEX TRANSM INFECT, V87, P257, DOI 10.1136/sti.2010.045047; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Leichliter JS, 2013, JAIDS-J ACQ IMM DEF, V63, P254, DOI 10.1097/QAI.0b013e31828e0cfc; Lelutiu-Weinberger C, 2013, AIDS BEHAV, V17, P340, DOI 10.1007/s10461-011-0070-4; Lewnard JA, 2014, SEX TRANSM INFECT, V90, P290, DOI 10.1136/sextrans-2013-051332; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-826; Menza TW, 2011, AIDS BEHAV, V15, P319, DOI 10.1007/s10461-009-9626-y; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; MESSIAH A, 1993, POPULATION, V48, P1353, DOI 10.2307/1534181; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Oster AM, 2014, AIDS BEHAV, V18, pS237, DOI 10.1007/s10461-013-0566-1; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Prestage G, 2005, AUST NZ J PUBL HEAL, V29, P530, DOI 10.1111/j.1467-842X.2005.tb00245.x; Raymond HF, 2013, JAIDS-J ACQ IMM DEF, V62, P584, DOI 10.1097/QAI.0b013e318285febf; Reilly KH, 2014, AIDS EDUC PREV, V26, P134, DOI 10.1521/aeap.2014.26.2.134; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Schiltz M A, 1998, Popul, V10, P417; Schiltz MA., 1998, LES HOMOSEXUELS FACE; Schiltz MA, 1995, HOMOSEXUELS FACE SID; Schmidt AJ, 2009, TRENDS IN RISK TAKIN; Schwarcz S, 2007, AIDS BEHAV, V11, P596, DOI 10.1007/s10461-007-9232-9; Seng R, 2011, AIDS, V25, P977, DOI 10.1097/QAD.0b013e328345ef12; SOS homophobie, 2013, RAPP HOM 2013; Sullivan PS, 2014, CURR OPIN HIV AIDS, V9, P199, DOI 10.1097/COH.0000000000000039; van den Boom W, 2014, JAIDS-J ACQ IMM DEF, V65, P375, DOI 10.1097/QAI.0000000000000051; Velter A., 2007, ETAT DEPRESSIF CONDU; Velter A, 2004, RAPPORT ENQUETE PRES; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	51	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123151	10.1371/journal.pone.0123151	http://dx.doi.org/10.1371/journal.pone.0123151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816322	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600206
J	Poh, MSW; Yong, PVC; Viseswaran, N; Chia, YY				Poh, Melissa Su Wei; Yong, Phelim Voon Chen; Viseswaran, Navaratnam; Chia, Yoke Yin			Estrogenicity of Glabridin in Ishikawa Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; ALKALINE-PHOSPHATASE ACTIVITY; BIOIDENTICAL HORMONE-THERAPY; IN-VITRO; SYNTHETIC ESTROGENS; MCF-7 CELLS; LICORICE; ROOT; PHYTOESTROGENS; STIMULATION	Glabridin is an isoflavan from licorice root, which is a common component of herbal remedies used for treatment of menopausal symptoms. Past studies have shown that glabridin resulted in favorable outcome similar to 17 beta-estradiol (17 beta-E-2), suggesting a possible role as an estrogen replacement therapy (ERT). This study aims to evaluate the estrogenic effect of glabridin in an in-vitro endometrial cell line -Ishikawa cells via alkaline phosphatase (ALP) assay and ER-alpha-SRC-1-co-activator assay. Its effect on cell proliferation was also evaluated using Thiazoyl blue tetrazolium bromide (MTT) assay. The results showed that glabridin activated the ER-alpha-SRC-1-co-activator complex and displayed a dose-dependent increase in estrogenic activity supporting its use as an ERT. However, glabridin also induced an increase in cell proliferation. When glabridin was treated together with 17 beta-E-2, synergistic estrogenic effect was observed with a slight decrease in cell proliferation as compared to treatment by 17 beta-E-2 alone. This suggest that the combination might be better suited for providing high estrogenic effects with lower incidences of endometrial cancer that is associated with 17 beta-E-2.	[Poh, Melissa Su Wei; Yong, Phelim Voon Chen; Chia, Yoke Yin] Taylors Univ, Sch Biosci, Div Med Pharm & Hlth Sci, Subang Jaya 47500, Malaysia; [Viseswaran, Navaratnam] Taylors Univ, Postgrad Res & Strateg Dev, Subang Jaya 47500, Malaysia	Taylor's University; Taylor's University	Chia, YY (corresponding author), Taylors Univ, Sch Biosci, Div Med Pharm & Hlth Sci, 1 Jln Taylors, Subang Jaya 47500, Malaysia.	AdelineYokeYin.Chia@taylors.edu.my	Yong, Phelim VC/M-5961-2015	Yong, Phelim VC/0000-0002-5817-7381	Exploratory Research Grants Scheme [ERGS/1/2012/STG08/TAYLOR/03/2]; Fundamental Research Grant Scheme [FRGS/2/2010/SKK/TAYLOR/03/1]	Exploratory Research Grants Scheme; Fundamental Research Grant Scheme	This work was supported by Exploratory Research Grants Scheme (ERGS/1/2012/STG08/TAYLOR/03/2) to YYC, and Fundamental Research Grant Scheme (FRGS/2/2010/SKK/TAYLOR/03/1) to YYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JL, 1990, CANCER RES, V50, P3306; [Anonymous], 2011, TRADITIONAL HERBAL M; BEEBE SJ, 1984, J BIOL CHEM, V259, P3539; Bhat KPL, 2001, CANCER RES, V61, P6137; Cherng JM, 2006, EUR J PHARMACOL, V547, P10, DOI 10.1016/j.ejphar.2006.06.080; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Choi EM, 2005, BIOCHEM PHARMACOL, V70, P363, DOI 10.1016/j.bcp.2005.04.019; Cirigliano M, 2007, J WOMENS HEALTH, V16, P600, DOI 10.1089/jwh.2006.0311; Fukai T, 2003, FITOTERAPIA, V74, P624, DOI 10.1016/S0367-326X(03)00164-3; Harris DM, 2005, EXP BIOL MED, V230, P558, DOI 10.1177/153537020523000807; HOLINKA CF, 1986, CANCER RES, V46, P2771; Hsieh CY, 1998, CANCER RES, V58, P3833; Hu CY, 2009, J STEROID BIOCHEM, V113, P209, DOI 10.1016/j.jsbmb.2008.12.019; Kalita J, 2010, INDIAN J SCI TECHNOL, V3, P1142; Kayisli UA, 2002, J CLIN ENDOCR METAB, V87, P5539, DOI 10.1210/jc.2002-020716; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LITTLEFIELD BA, 1990, ENDOCRINOLOGY, V127, P2757, DOI 10.1210/endo-127-6-2757; Overk CR, 2005, J AGR FOOD CHEM, V53, P6246, DOI 10.1021/jf050448p; Pattimakiel L, 2011, CLEV CLIN J MED, V78, P829, DOI 10.3949/ccjm.78a.10114; Poh M., 2013, International Journal of Phytomedicine, V5, P119; Poh SWM., 2013, INT J PHARM PHARM SC, V5, P448; Simons R, 2011, ANAL BIOANAL CHEM, V401, P305, DOI 10.1007/s00216-011-5061-9; Somjen D, 2004, J STEROID BIOCHEM, V91, P241, DOI 10.1016/j.jsbmb.2004.04.008; Somjen D, 2004, J STEROID BIOCHEM, V91, P147, DOI 10.1016/j.jsbmb.2004.04.003; Tamir S, 2000, CANCER RES, V60, P5704; The North American Menopause Society, 2010, MENOP PRACT CLIN GUI; Tsai LC, 2000, EUR J BIOCHEM, V267, P1330, DOI 10.1046/j.1432-1327.2000.01100.x; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Wober J, 2002, J STEROID BIOCHEM, V83, P227, DOI 10.1016/S0960-0760(02)00252-2; Women's Health Initiative, QUEST ANSW WHI POSTM; Zava DT, 1997, ENVIRON HEALTH PERSP, V105, P637, DOI 10.2307/3433383	32	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121382	10.1371/journal.pone.0121382	http://dx.doi.org/10.1371/journal.pone.0121382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816349	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600087
J	Teng, C; Zhou, ZF; Molnar, I; Li, X; Tang, R; Chen, M; Wang, L; Su, SY; Zhang, W; Lin, M				Teng, Chao; Zhou, Zhengfu; Molnar, Istvan; Li, Xinna; Tang, Ran; Chen, Ming; Wang, Lin; Su, Shiyou; Zhang, Wei; Lin, Min			Whole-Genome Optical Mapping and Finished Genome Sequence of Sphingobacterium deserti sp nov., a New Species Isolated from the Western Desert of China	PLOS ONE			English	Article							TELLURITE RESISTANCE; IDENTIFICATION; PROTEIN; HYBRIDIZATION; SPIRITIVORUM; DAEJEONENSE; SIMILARITY; TREHALOSE; BACTERIA; STRAINS	A novel Gram-negative bacterium, designated ZW(T), was isolated from a soil sample of the Western Desert of China, and its phenotypic properties and phylogenetic position were investigated using a polyphasic approach. Growth occurred on TGY medium at 5-42 degrees C with an optimum of 30 degrees C, and at pH 7.0-11.0 with an optimum of pH 9.0. The predominant cellular fatty acids were summed feature 3 (C-16:1 omega 7c/C-16:1 omega 6c or C-16:1 omega 6c/C-16:1 omega 7c) (39.22%), iso-C-15:0 (27.91%), iso-C-17:0 3OH (15.21%), C-16:0 (4.98%), iso-C-15:0 3OH (3.03%), C16:0 3OH (5.39%) and C-14:0 (1.74%). The major polar lipid of strain ZW(T) is phosphatidylethanolamine. The only menaquinone observed was MK-7. The GC content of the DNA of strain ZWT is 44.9 mol%. rDNA phylogeny, genome relatedness and chemotaxonomic characteristics all indicate that strain ZW(T) represents a novel species of the genus Sphingobacterium. We propose the name S. deserti sp. nov., with ZW(T) (= KCTC 32092T = ACCC 05744T) as the type strain. Whole genome optical mapping and next-generation sequencing was used to derive a finished genome sequence for strain ZW(T), consisting of a circular chromosome of 4,615,818 bp in size. The genome of strain ZW(T) features 3,391 protein-encoding and 48 tRNA-encoding genes. Comparison of the predicted proteome of ZW(T) with those of other sphingobacteria identified 925 species-unique proteins that may contribute to the adaptation of ZW(T) to its native, extremely arid and inhospitable environment. As the first finished genome sequence for any Sphingobacterium, our work will serve as a useful reference for subsequent sequencing and mapping efforts for additional strains and species within this genus.	[Teng, Chao; Zhou, Zhengfu; Li, Xinna; Tang, Ran; Chen, Ming; Wang, Lin; Su, Shiyou; Zhang, Wei; Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Molnar, Istvan] Univ Arizona, Sch Nat Resources & Environm, Nat Prod Ctr, Tucson, AZ USA; [Wang, Lin] NW Univ Xian, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian 710069, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; University of Arizona; Northwest University Xi'an	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangwei01@caas.cn; linmin57@vip.163.com	teng, chao/GVU-5372-2022; Molnar, Istvan/GLV-3489-2022; min, lin/AAJ-7325-2020	Molnar, Istvan/0000-0002-3627-0454; 	Ministry of Science and Technology of China [2015CB755701, 2013CB733900, 2010CB126504, 2012AA063503]; National Natural Science Foundation of China [31170105]; Important National Science & Technology Specific Projects [2014ZX0800301B, 2013ZX08012-001, 2013ZX08009-003]; Special Fund for Agro-scientific Research in the Public Interest [201103007]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Ministry of Science and Technology of China (National Basic Research Program 2015CB755701, 2013CB733900, 2010CB126504 and National High-Tech Program 2012AA063503), the National Natural Science Foundation of China (grant No. 31170105), the Important National Science & Technology Specific Projects (2014ZX0800301B, 2013ZX08012-001, 2013ZX08009-003), and the Special Fund for Agro-scientific Research in the Public Interest (201103007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamala S, 2013, SCIENCE, V342, P1516, DOI 10.1126/science.1241130; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; Choi HA, 2012, INT J SYST EVOL MICR, V62, P2559, DOI 10.1099/ijs.0.024737-0; Cowan ST, 2003, COWAN STEELS MANUAL; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Duan SW, 2009, J MICROBIOL, V47, P693, DOI 10.1007/s12275-009-0296-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; He XA, 2010, INT J SYST EVOL MICR, V60, P2377, DOI 10.1099/ijs.0.018481-0; HOLMES B, 1982, INT J SYST BACTERIOL, V32, P157, DOI 10.1099/00207713-32-2-157; Jiang SJ, 2014, INT J SYST EVOL MICR, V64, P248, DOI 10.1099/ijs.0.051706-0; Kawai Y, 2011, CURRENT PROGRESS IN, P205; Kim KH, 2006, INT J SYST EVOL MICR, V56, P2031, DOI 10.1099/ijs.0.64406-0; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim YH, 2000, APPL ENVIRON MICROB, V66, P4620, DOI 10.1128/AEM.66.11.4620-4624.2000; Konings WN, 2002, ANTON LEEUW INT J G, V81, P61, DOI 10.1023/A:1020573408652; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee DH, 2013, INT J SYST EVOL MICR, V63, P755, DOI 10.1099/ijs.0.038844-0; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu J, 2012, INT J SYST EVOL MICR, V62, P1809, DOI 10.1099/ijs.0.033670-0; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Miller JM, 2013, J CLIN MICROBIOL, V51, P1066, DOI 10.1128/JCM.00093-13; OGara JP, 1997, APPL ENVIRON MICROB, V63, P4713, DOI 10.1128/AEM.63.12.4713-4720.1997; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Riley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027085; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saw JHW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076376; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sorokin DY, 2005, INT J SYST EVOL MICR, V55, P1405, DOI 10.1099/ijs.0.63737-0; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun ZZ, 2009, ANTIMICROB AGENTS CH, V53, P1964, DOI 10.1128/AAC.01382-08; Suprenant KA, 2007, J EXP BIOL, V210, P946, DOI 10.1242/jeb.001800; TURNER RJ, 1995, CAN J MICROBIOL, V41, P92, DOI 10.1139/m95-012; Vanderlinde EM, 2010, FEMS MICROBIOL ECOL, V71, P327, DOI 10.1111/j.1574-6941.2009.00824.x; Warren-Rhodes KA, 2007, FEMS MICROBIOL ECOL, V61, P470, DOI 10.1111/j.1574-6941.2007.00351.x; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; YABUUCHI E, 1983, INT J SYST BACTERIOL, V33, P580, DOI 10.1099/00207713-33-3-580; YABUUCHI E, 1979, J GEN APPL MICROBIOL, V25, P95, DOI 10.2323/jgam.25.95; Yoo SH, 2007, INT J SYST EVOL MICR, V57, P1590, DOI 10.1099/ijs.0.64948-0; Yuan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034458; Yuan ML, 2009, INT J SYST EVOL MICR, V59, P1513, DOI 10.1099/ijs.0.004523-0; Zhang J, 2012, INT J SYST EVOL MICR, V62, P683, DOI 10.1099/ijs.0.033118-0; Zhou ZF, 2012, INT J SYST EVOL MICR, V62, P791, DOI 10.1099/ijs.0.030429-0; Zhu HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050225	53	7	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122254	10.1371/journal.pone.0122254	http://dx.doi.org/10.1371/journal.pone.0122254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830331	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600106
J	Chang, EK; Eckert, MA; Ali, MM; Riazifar, H; Pone, EJ; Liu, LN; Zhao, WA				Chang, Elizabeth K.; Eckert, Mark A.; Ali, M. Monsur; Riazifar, Hamidreza; Pone, Egest J.; Liu, Linan; Zhao, Weian			Facile Supermolecular Aptamer Inhibitors of L-Selectin	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; SIALYL-LEWIS-X; MULTIVALENT LIGANDS; BINDING; MOLECULES; ADHESION; AFFINITY	Multivalent interactions occur frequently in nature, where they mediate high-affinity interactions between cells, proteins, or molecules. Here, we report on a method to generate multivalent aptamers (Multi-Aptamers) that target L-selectin function using rolling circle amplification (RCA). We find that the L-selectin Multi-Aptamers have increased affinity compared to the monovalent aptamer, are specific to L-selectin, and are capable of inhibiting interactions with endogenous ligands. In addition, the Multi-Aptamers efficiently inhibit L-selectin mediated dynamic adhesion in vitro and homing to secondary lymphoid tissues in vivo. Importantly, our method of generating multivalent materials using RCA avoids many of the challenges associated with current multivalent materials in that the Multi-Aptamers are high affinity, easily produced and modified, and biocompatible. We anticipate that the Multi-Aptamers can serve as a platform technology to modulate diverse cellular processes.	[Zhao, Weian] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Chao Family Comprehens Canc Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Biomed En, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Zhao, WA (corresponding author), Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Chao Family Comprehens Canc Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Biomed En, Irvine, CA 92697 USA.	weianz@uci.edu		Eckert, Mark/0000-0003-3166-3440; chang, elizabeth/0000-0002-4439-1854	Department of Pharmaceutical Sciences; Sue and Bill Gross Stem Cell Research Center; Chao Family Comprehensive Cancer Center at University of California Irvine; University of California, Cancer Research Coordinating Committee; California Institute for Regenerative Medicine (CIRM) [TG2-01152]	Department of Pharmaceutical Sciences; Sue and Bill Gross Stem Cell Research Center; Chao Family Comprehensive Cancer Center at University of California Irvine; University of California, Cancer Research Coordinating Committee(University of California System); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by the start-up fund from the Department of Pharmaceutical Sciences, Sue and Bill Gross Stem Cell Research Center and the Chao Family Comprehensive Cancer Center at University of California Irvine, and University of California, Cancer Research Coordinating Committee. MAE is supported by a California Institute for Regenerative Medicine (CIRM) Training Grant (TG2-01152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2014, CHEM SOC REV, V43, P3324, DOI 10.1039/c3cs60439j; Ali MM, 2007, CHEM COMMUN, P4459, DOI 10.1039/b709817k; Amiram M, 2011, NAT MATER, V10, P141, DOI [10.1038/nmat2942, 10.1038/NMAT2942]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Cheglakov Z, 2007, ORG BIOMOL CHEM, V5, P223, DOI 10.1039/b615450f; Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107; Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114; Gordon EJ, 2000, CHEM BIOL, V7, P9, DOI 10.1016/S1074-5521(00)00060-0; Green CE, 2003, AM J PHYSIOL-CELL PH, V284, pC705, DOI 10.1152/ajpcell.00331.2002; Hamblin GD, 2012, J AM CHEM SOC, V134, P2888, DOI 10.1021/ja2107492; Hicke BJ, 1996, J CLIN INVEST, V98, P2688, DOI 10.1172/JCI119092; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/nnano.2012.211, 10.1038/NNANO.2012.211]; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Liu S, 2011, POLYM CHEM-UK, V2, P1513, DOI 10.1039/c1py00063b; Liu WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024015; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; Mowery P, 2004, CHEM BIOL, V11, P725, DOI 10.1016/j.chembiol.2004.03.027; Rainer TH, 2002, RESUSCITATION, V52, P127, DOI 10.1016/S0300-9572(01)00444-0; Ringquist S, 1998, CYTOMETRY, V33, P394, DOI 10.1002/(SICI)1097-0320(19981201)33:4<394::AID-CYTO2>3.0.CO;2-0; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; Sanders WJ, 1999, J BIOL CHEM, V274, P5271, DOI 10.1074/jbc.274.9.5271; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; STOOLMAN LM, 1989, J CLIN INVEST, V84, P1196, DOI 10.1172/JCI114285; Tian Y, 2006, CHEMBIOCHEM, V7, P1862, DOI 10.1002/cbic.200600336; Toppila S, 1997, EUR J IMMUNOL, V27, P1360, DOI 10.1002/eji.1830270610; Watson SR, 2000, ANTISENSE NUCLEIC A, V10, P63, DOI 10.1089/oli.1.2000.10.63; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; Yamanashi Y, 2012, J BIOCHEM, V151, P353, DOI 10.1093/jb/mvs013; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang ZQ, 2014, CHEMBIOCHEM, V15, P1268, DOI 10.1002/cbic.201402100; Zhang ZQ, 2013, BIOMATERIALS, V34, P9728, DOI 10.1016/j.biomaterials.2013.08.079; Zhao WA, 2006, ANGEW CHEM INT EDIT, V45, P2409, DOI 10.1002/anie.200600061; Zhao WA, 2008, ANGEW CHEM INT EDIT, V47, P6330, DOI 10.1002/anie.200705982; Zhao WA, 2012, P NATL ACAD SCI USA, V109, P19626, DOI 10.1073/pnas.1211234109	37	7	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123034	10.1371/journal.pone.0123034	http://dx.doi.org/10.1371/journal.pone.0123034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826688	Green Published, gold			2022-12-27	WOS:000352084800102
J	Dattilo, W; Aguirre, A; Quesada, M; Dirzo, R				Dattilo, Wesley; Aguirre, Armando; Quesada, Mauricio; Dirzo, Rodolfo			Tropical Forest Fragmentation Affects Floral Visitors but Not the Structure of Individual-Based Palm-Pollinator Networks	PLOS ONE			English	Article							LOS-TUXTLAS; HABITAT FRAGMENTATION; RAIN-FOREST; REPRODUCTIVE SUCCESS; PLANT INTERACTIONS; NESTED DIETS; RESOURCE USE; SPECIALIZATION; DIVERSITY; PATTERN	Despite increasing knowledge about the effects of habitat loss on pollinators in natural landscapes, information is very limited regarding the underlying mechanisms of forest fragmentation affecting plant-pollinator interactions in such landscapes. Here, we used a network approach to describe the effects of forest fragmentation on the patterns of interactions involving the understory dominant palm Astrocaryum mexicanum (Arecaceae) and its floral visitors (including both effective and non-effective pollinators) at the individual level in a Mexican tropical rainforest landscape. Specifically, we asked: (i) Does fragment size affect the structure of individual-based plant-pollinator networks? (ii) Does the core of highly interacting visitor species change along the fragmentation size gradient? (iii) Does forest fragment size influence the abundance of effective pollinators of A. mexicanum? We found that fragment size did not affect the topological structure of the individual-based palm-pollinator network. Furthermore, while the composition of peripheral non-effective pollinators changed depending on fragment size, effective core generalist species of pollinators remained stable. We also observed that both abundance and variance of effective pollinators of male and female flowers of A. mexicanum increased with forest fragment size. These findings indicate that the presence of effective pollinators in the core of all forest fragments could keep the network structure stable along the gradient of forest fragmentation. In addition, pollination of A. mexicanum could be more effective in larger fragments, since the greater abundance of pollinators in these fragments may increase the amount of pollen and diversity of pollen donors between flowers of individual plants. Given the prevalence of fragmentation in tropical ecosystems, our results indicate that the current patterns of land use will have consequences on the underlying mechanisms of pollination in remnant forests.	[Dattilo, Wesley] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Aguirre, Armando] Inst Ecol AC, Red Interacc Multitrof, Xalapa, Veracruz, Mexico; [Quesada, Mauricio] Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Quesada, Mauricio] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidad Veracruzana; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Stanford University	Aguirre, A (corresponding author), Inst Ecol AC, Red Interacc Multitrof, Xalapa, Veracruz, Mexico.	armando.aguirre@inecol.mx	, WD/A-6371-2012; AGUIRRE-JAIMES, ARMANDO/Q-6713-2018	, WD/0000-0002-4758-4379; AGUIRRE-JAIMES, ARMANDO/0000-0002-6158-2919; Quesada, Mauricio/0000-0002-7776-9286	CNPq [237339/2012-9]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Los Tuxtlas-UNAM Biological Station provided all necessary facilities to conduct this study. We thank Jessica Falcao, Dulce Rodriguez, Stephen C. Pratt and one anonymous referee for their valuable improvements to this article. WD was supported by CNPq grant 237339/2012-9.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aguilar R, 2012, BIOL CONSERV, V152, P81, DOI 10.1016/j.biocon.2012.03.021; Aguirre A, 2008, BIOL CONSERV, V141, P375, DOI 10.1016/j.biocon.2007.09.014; Aguirre A, 2011, J TROP ECOL, V27, P25, DOI 10.1017/S0266467410000556; AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Ashworth L, 2009, BIOL CONSERV, V142, P1050, DOI 10.1016/j.biocon.2009.01.016; Askgaard Aino, 2008, Anales del Jardin Botanico de Madrid, V65, P197; Barfod AS, 2011, ANN BOT-LONDON, V108, P1503, DOI 10.1093/aob/mcr192; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J., 2013, MUTUALISTIC NETWORKS; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; BONGERS F, 1988, VEGETATIO, V74, P55, DOI 10.1007/BF00045614; BURQUEZ A, 1987, BOT J LINN SOC, V94, P407, DOI 10.1111/j.1095-8339.1987.tb01058.x; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Clemente MA, 2013, SOCIOBIOLOGY, V60, P337; Garcia-Aguirre MC, 2010, GEOMORPHOLOGY, V121, P245, DOI 10.1016/j.geomorph.2010.04.019; Cunningham SA, 2000, CONSERV BIOL, V14, P758, DOI 10.1046/j.1523-1739.2000.98609.x; Marquitti FMD, 2014, ECOGRAPHY, V37, P221, DOI 10.1111/j.1600-0587.2013.00506.x; Dattilo W, 2014, BIOTROPICA, V46, P712, DOI 10.1111/btp.12157; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; Dattilo W, 2014, AM J PRIMATOL, V76, P670, DOI 10.1002/ajp.22261; Dattilo W, 2014, ECOLOGY, V95, P475, DOI 10.1890/12-1647.1; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dattilo Wesley, 2012, Network Biology, V2, P127; Dattilo W, 2013, ARTHROPOD-PLANT INTE, V7, P455, DOI 10.1007/s11829-013-9256-1; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Dyer LA, 2010, BIOTROPICA, V42, P281, DOI 10.1111/j.1744-7429.2009.00624.x; Faegri K., 1980, PRINCIPLES POLLINATI, V3; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gomez JM, 2012, P ROY SOC B-BIOL SCI, V279, P1754, DOI 10.1098/rspb.2011.2244; Gomez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016143; Govaerts J, 2005, WORLD CHECKLIST PALM; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HENDERSON A, 1986, BOT REV, V52, P221, DOI 10.1007/BF02860996; Ibarra-Manruiquez G., 1997, HIST NATURAL TUXTLAS, P61; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kreft H, 2006, ECOGRAPHY, V29, P21, DOI 10.1111/j.2005.0906-7590.04203.x; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Marten-Rodriguez S, 2012, BIOTROPICA, V44, P680, DOI 10.1111/j.1744-7429.2012.00860.x; Mello MAR, 2013, BIOTROPICA, V45, P45, DOI 10.1111/j.1744-7429.2012.00899.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Mendoza E, 2005, REV CHIL HIST NAT, V78, P451; Morales CL, 2006, J ECOL, V94, P171, DOI 10.1111/j.1365-2745.2005.01069.x; NÚÑEZ-AVELLANEDA LUIS ALBERTO, 2008, Caldasia, V30, P101; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pinero D, 1977, B SOC BOT MEX, V37, P60; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Quero HJ, 1994, PALMAE, V81; R Development Core Team, R LANG ENV STAT COMP; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; Rudall P. J., 2007, ANATOMY FLOWERING PL; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Siefke Robert, 2004, Palms, V48, P33; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tur C, 2014, J ANIM ECOL, V83, P306, DOI 10.1111/1365-2656.12130; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; UHL NW, 1977, BIOTROPICA, V9, P170, DOI 10.2307/2387879; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vilela AA, 2014, FLORA, V209, P359, DOI 10.1016/j.flora.2014.04.004; Vormisto J, 2002, BIODIVERS CONSERV, V11, P1025, DOI 10.1023/A:1015873223350	79	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121275	10.1371/journal.pone.0121275	http://dx.doi.org/10.1371/journal.pone.0121275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826702	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800039
J	Deller, MC; Johnson, HA; Miller, MD; Spraggon, G; Elsliger, MA; Wilson, IA; Lesley, SA				Deller, Marc C.; Johnson, Hope A.; Miller, Mitchell D.; Spraggon, Glen; Elsliger, Marc-Andre; Wilson, Ian A.; Lesley, Scott A.			Crystal Structure of a Two-Subunit TrkA Octameric Gating Ring Assembly	PLOS ONE			English	Article							ESCHERICHIA-COLI; RCK DOMAIN; K+ TRANSPORTER; SALT BRIDGES; PROTEIN TRKA; ION-CHANNEL; POTASSIUM; MECHANISM; SEQUENCE; GENE	The TM1088 locus of T. maritima codes for two proteins designated TM1088A and TM1088B, which combine to form the cytosolic portion of a putative Trk K+ transporter. We report the crystal structure of this assembly to a resolution of 3.45 angstrom. The high resolution crystal structures of the components of the assembly, TM1088A and TM1088B, were also determined independently to 1.50 angstrom and 1.55 angstrom, respectively. The TM1088 proteins are structurally homologous to each other and to other K+ transporter proteins, such as TrkA. These proteins form a cytosolic gating ring assembly that controls the flow of K+ ions across the membrane. TM1088 represents the first structure of a two-subunit Trk assembly. Despite the atypical genetics and chain organization of the TM1088 assembly, it shares significant structural homology and an overall quaternary organization with other single-subunit K+ gating ring assemblies. This structure provides the first structural insights into what may be an evolutionary ancestor of more modern single-subunit K+ gating ring assemblies.	[Deller, Marc C.; Johnson, Hope A.; Elsliger, Marc-Andre; Wilson, Ian A.; Lesley, Scott A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Deller, Marc C.; Johnson, Hope A.; Elsliger, Marc-Andre; Wilson, Ian A.; Lesley, Scott A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Miller, Mitchell D.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA USA; [Miller, Mitchell D.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Spraggon, Glen; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Novartis	Deller, MC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA.	mdeller@scripps.edu; slesley@gnf.org		Elsliger, Marc Andre/0000-0002-1989-7626; Deller, Marc/0000-0001-8070-6502	Protein Structure Initiative of the National Institute of General Medical Sciences, National Institutes of Health (NIH) [U54 GM094586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586] Funding Source: NIH RePORTER	Protein Structure Initiative of the National Institute of General Medical Sciences, National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Protein Structure Initiative of the National Institute of General Medical Sciences, National Institutes of Health (NIH), grant number U54 GM094586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACHRICHTER L, 1987, SYST APPL MICROBIOL, V9, P34, DOI 10.1016/S0723-2020(87)80053-X; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; Cao Y, 2013, NATURE, V496, P317, DOI 10.1038/nature12056; Chayen NE, 1997, STRUCTURE, V5, P1269, DOI 10.1016/S0969-2126(97)00279-7; Cholo MC, 2006, J ANTIMICROB CHEMOTH, V57, P79, DOI 10.1093/jac/dki409; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; DEKKER K, 1991, J BACTERIOL, V173, P3078, DOI 10.1128/JB.173.10.3078-3083.1991; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hille B, 2001, ION CHANNELS EXCITAB; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson HA, 2009, J BACTERIOL, V191, P2276, DOI 10.1128/JB.01367-08; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kong CG, 2012, ELIFE, V1, DOI 10.7554/eLife.00184; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moroni A, 2006, NAT CHEM BIOL, V2, P572, DOI 10.1038/nchembio1106-572; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2006, APPL ENVIRON MICROB, V72, P5061, DOI 10.1128/AEM.00342-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; RHOADS DB, 1977, J BIOL CHEM, V252, P1394; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P2597, DOI 10.1021/bi951988q; Urzhumtsev A, 2009, ACTA CRYSTALLOGR D, V65, P1283, DOI 10.1107/S0907444909039638; Veneesha T, 2012, OPEN J RESP DIS, V2, P60; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	63	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122512	10.1371/journal.pone.0122512	http://dx.doi.org/10.1371/journal.pone.0122512			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826626	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800075
J	Malchenko, S; Sredni, ST; Hashimoto, H; Kasai, A; Nagayasu, K; Xie, JP; Margaryan, NV; Seiriki, K; Lulla, RR; Seftor, REB; Pachman, LM; Meltzer, HY; Hendrix, MJC; Soares, MB				Malchenko, Sergey; Sredni, Simone Treiger; Hashimoto, Hitoshi; Kasai, Atsushi; Nagayasu, Kazuki; Xie, Jianping; Margaryan, Naira V.; Seiriki, Kaoru; Lulla, Rishi R.; Seftor, Richard E. B.; Pachman, Lauren M.; Meltzer, Herbert Y.; Hendrix, Mary J. C.; Soares, Marcelo B.			A Mouse Model of Human Primitive Neuroectodermal Tumors Resulting from Microenvironmentally-Driven Malignant Transformation of Orthotopically Transplanted Radial Glial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; CHROMOSOMAL INSTABILITY; MEDULLOBLASTOMA; DIFFERENTIATION; EXPRESSION; ROLES	There is growing evidence and a consensus in the field that most pediatric brain tumors originate from stem cells, of which radial glial cells constitute a subtype. Here we show that orthotopic transplantation of human radial glial (RG) cells to the subventricular zone of the 3rd ventricle - but not to other transplantation sites - of the brain in immunocompromised NOD-SCID mice, gives rise to tumors that have the hallmarks of CNS primitive neuroectodermal tumors (PNETs). The resulting mouse model strikingly recapitulates the phenotype of PNETs. Importantly, the observed tumorigenic transformation was accompanied by aspects of an epithelial to mesenchymal transition (EMT)-like process. It is also noteworthy that the tumors are highly invasive, and that they effectively recruit mouse endothelial cells for angiogenesis. These results are significant for several reasons. First, they show that malignant transformation of radial glial cells can occur in the absence of specific mutations or inherited genomic alterations. Second, they demonstrate that the same radial glial cells may either give rise to brain tumors or differentiate normally depending upon the microenvironment of the specific region of the brain to which the cells are transplanted. In addition to providing a prospect for drug screening and development of new therapeutic strategies, the resulting mouse model of PNETs offers an unprecedented opportunity to identify the cancer driving molecular alterations and the microenvironmental factors that are responsible for committing otherwise normal radial glial cells to a malignant phenotype.	[Malchenko, Sergey; Sredni, Simone Treiger; Xie, Jianping; Margaryan, Naira V.; Seftor, Richard E. B.; Hendrix, Mary J. C.; Soares, Marcelo B.] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Canc Biol & Epigen Program, Chicago, IL 60611 USA; [Malchenko, Sergey; Lulla, Rishi R.; Seftor, Richard E. B.; Soares, Marcelo B.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Malchenko, Sergey; Sredni, Simone Treiger; Hendrix, Mary J. C.; Soares, Marcelo B.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Sredni, Simone Treiger] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Surg, Div Pediat Neurosurg, Chicago, IL 60611 USA; [Sredni, Simone Treiger] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Hashimoto, Hitoshi; Kasai, Atsushi; Nagayasu, Kazuki; Seiriki, Kaoru] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Brain Neuropharmacol &, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Kanazawa Univ, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Hamamatsu Univ Sch Med, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Chiba Univ, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, Fukui Univ, Suita, Osaka, Japan; [Hashimoto, Hitoshi; Margaryan, Naira V.] Osaka Univ, Inst Acad Initiat, Interdisciplinary Program Biomed Sci, Suita, Osaka, Japan; [Lulla, Rishi R.; Soares, Marcelo B.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Hematol Oncol, Chicago, IL 60611 USA; [Pachman, Lauren M.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Rheumatol, Cure Juvenile Myositis Program Excellence, Chicago, IL 60611 USA; [Pachman, Lauren M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Meltzer, Herbert Y.] Northwestern Univ, Feinberg Sch Med, Psychiat & Behav Sci, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Feinberg School of Medicine; Osaka University; Osaka University; Osaka University; Kanazawa University; Chiba University; Osaka University; Osaka University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Soares, MB (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Canc Biol & Epigen Program, Chicago, IL 60611 USA.	m-soares@northwestern.edu	Kasai, Atsushi/C-8073-2011; Pachman, Lauren/AAZ-6061-2021; Hashimoto, Hitoshi/D-1209-2010; xu, li/GNH-3667-2022; xu, li/AAO-4684-2021; Meltzer, Herbert Y/E-8131-2013	Kasai, Atsushi/0000-0002-1612-3078; Pachman, Lauren/0000-0001-8117-574X; Hashimoto, Hitoshi/0000-0001-6548-4016; Sredni, Simone/0000-0002-1715-3885; Lulla, Rishi/0000-0003-4109-2207	Dr. Ralph and Marian C. Falk Medical Research Trust; Maeve McNicholas Memorial Foundation; Children's Research Fund; Brain Tumor Research Fund; Northwestern University Flow Cytometry Facility, a Cancer Center Support Grant [NCI CA060553]; Japan Society for the Promotion of Science (JSPS), KAKENHI; Funding Program for Next Generation World-Leading Researchers; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Dr. Ralph and Marian C. Falk Medical Research Trust; Maeve McNicholas Memorial Foundation; Children's Research Fund; Brain Tumor Research Fund; Northwestern University Flow Cytometry Facility, a Cancer Center Support Grant; Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Dr. Ralph and Marian C. Falk Medical Research Trust, the Maeve McNicholas Memorial Foundation, the Children's Research Fund, and the Brain Tumor Research Fund (Soares, PI), the Northwestern University Flow Cytometry Facility, a Cancer Center Support Grant (NCI CA060553), the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research, KAKENHI, and the Funding Program for Next Generation World-Leading Researchers (Hashimoto).	Al-Romaih K, 2003, CANCER GENET CYTOGEN, V144, P91, DOI 10.1016/S0165-4608(02)00929-9; [Anonymous], 2007132146 CNS WHO; Bai RY, 2012, CANCER RES, V72, P5988, DOI 10.1158/0008-5472.CAN-12-0614; Barami K, 2007, J CLIN NEUROSCI, V14, P1143, DOI 10.1016/j.jocn.2007.04.009; Castillo M, 2010, AM J NEURORADIOL, V31, P389, DOI 10.3174/ajnr.A1674; Chen L, 2014, AM J CANCER RES, V4, P80; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Cruz M H, 2012, ISRN Oncol, V2012, P392647, DOI 10.5402/2012/392647; Dahiya S, 2011, J NEUROPATH EXP NEUR, V70, P622, DOI 10.1097/NEN.0b013e31822200aa; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gilbertson RJ, 2006, CELL CYCLE, V5, P135, DOI 10.4161/cc.5.2.2319; Gupta R, 2011, INT J ONCOL, V38, P733, DOI 10.3892/ijo.2010.883; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010; Knights Alexander J, 2012, Trends Cancer Res, V8, P61; Kyritsis AP, 2010, NEURO-ONCOLOGY, V12, P104, DOI 10.1093/neuonc/nop011; Malchenko S, 2014, GENE, V534, P400, DOI 10.1016/j.gene.2013.07.101; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Ortensi B, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt166; Philip B, 2013, CARCINOGENESIS, V34, P1699, DOI 10.1093/carcin/bgt209; Raffel C, 2004, NEOPLASIA, V6, P310, DOI 10.1593/neo.03454; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Stefanits H, 2014, CLIN NEUROPATHOL, V33, P122, DOI 10.5414/NP300675; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang XF, 2012, BRAIN TUMOR PATHOL, V29, P172, DOI 10.1007/s10014-011-0079-4; Zhang SJ, 2012, NEUROCHEM RES, V37, P2659, DOI 10.1007/s11064-012-0879-x	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121707	10.1371/journal.pone.0121707	http://dx.doi.org/10.1371/journal.pone.0121707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826270	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800051
J	Wu, XJ; Li, Y; Kurths, J				Wu, Xiangjun; Li, Yang; Kurths, Juergen			A New Color Image Encryption Scheme Using CML and a Fractional-Order Chaotic System	PLOS ONE			English	Article							ALGORITHM; CRYPTANALYSIS; SYNCHRONIZATION; PERMUTATION; HYPERCHAOS; STANDARD; MAP	The chaos-based image cryptosystems have been widely investigated in recent years to provide real-time encryption and transmission. In this paper, a novel color image encryption algorithm by using coupled-map lattices (CML) and a fractional-order chaotic system is proposed to enhance the security and robustness of the encryption algorithms with a permutation-diffusion structure. To make the encryption procedure more confusing and complex, an image division-shuffling process is put forward, where the plain-image is first divided into four sub-images, and then the position of the pixels in the whole image is shuffled. In order to generate initial conditions and parameters of two chaotic systems, a 280-bit long external secret key is employed. The key space analysis, various statistical analysis, information entropy analysis, differential analysis and key sensitivity analysis are introduced to test the security of the new image encryption algorithm. The cryptosystem speed is analyzed and tested as well. Experimental results confirm that, in comparison to other image encryption schemes, the new algorithm has higher security and is fast for practical image encryption. Moreover, an extensive tolerance analysis of some common image processing operations such as noise adding, cropping, JPEG compression, rotation, brightening and darkening, has been performed on the proposed image encryption technique. Corresponding results reveal that the proposed image encryption method has good robustness against some image processing operations and geometric attacks.	[Wu, Xiangjun; Li, Yang] Henan Univ, Coll Software, Kaifeng, Peoples R China; [Wu, Xiangjun; Kurths, Juergen] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Wu, Xiangjun; Kurths, Juergen] Humboldt Univ, Dept Phys, Berlin, Germany	Henan University; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin	Wu, XJ (corresponding author), Henan Univ, Coll Software, Kaifeng, Peoples R China.	xiangjung.wu@gmail.com			National Natural Science Foundation of China [61004006]; China Postdoctoral Science Foundation [2013M530181]; Natural Science Foundation of Henan Province, China [13230010254]; Program for Science & Technology Innovation Talents in Universities of Henan Province, China [14HASTIT042]; Foundation for University Young Key Teacher Program of Henan Province, China [2011GGJS-025]; Shanghai Postdoctoral Scientific Program [13R21410600]; Science & Technology Project Plan of Archives Bureau of Henan Province [2012-X-62]; Natural Science Foundation of Educational Committee of Henan Province, China [13A520082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Henan Province, China; Program for Science & Technology Innovation Talents in Universities of Henan Province, China; Foundation for University Young Key Teacher Program of Henan Province, China; Shanghai Postdoctoral Scientific Program; Science & Technology Project Plan of Archives Bureau of Henan Province; Natural Science Foundation of Educational Committee of Henan Province, China	This research was jointly supported by the National Natural Science Foundation of China (No. 61004006, http://www.nsfc.gov.cn), China Postdoctoral Science Foundation(No. 2013M530181, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), the Natural Science Foundation of Henan Province, China (No. 13230010254, http://www.hnkjt.gov.cn/, Program for Science & Technology Innovation Talents in Universities of Henan Province, China (Grant No 14HASTIT042, http://rcloud.edu.cn), the Foundation for University Young Key Teacher Program of Henan Province, China (No. 2011GGJS-025, http://www.haedu.gov.cn/), Shanghai Postdoctoral Scientific Program (No. 13R21410600, http://www.21cnhr.gov.cn/doctorarea/), the Science & Technology Project Plan of Archives Bureau of Henan Province (No. 2012-X-62, http://www.hada.gov.cn/) and the Natural Science Foundation of Educational Committee of Henan Province, China (No. 13A520082, http://www.haedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AH, 2012, AEU-INT J ELECTRON C, V66, P806, DOI 10.1016/j.aeue.2012.01.015; Baptista MS, 1998, PHYS LETT A, V240, P50, DOI 10.1016/S0375-9601(98)00086-3; Behnia S, 2008, CHAOS SOLITON FRACT, V35, P408, DOI 10.1016/j.chaos.2006.05.011; Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Deng WH, 2006, CHAOS, V16, DOI 10.1063/1.2401061; Enayatifar R, 2013, OPT LASER ENG, V51, P1066, DOI 10.1016/j.optlaseng.2013.03.010; Fridrich J, 1998, INT J BIFURCAT CHAOS, V8, P1259, DOI 10.1142/S021812749800098X; Fu C, 2012, OPT EXPRESS, V20, P2363, DOI 10.1364/OE.20.002363; Gao TG, 2008, PHYS LETT A, V372, P394, DOI 10.1016/j.physleta.2007.07.040; Gao TG, 2009, CHAOS SOLITON FRACT, V42, P548, DOI 10.1016/j.chaos.2009.01.017; Guan ZH, 2005, PHYS LETT A, V346, P153, DOI 10.1016/j.physleta.2005.08.006; HARTLEY TT, 1995, IEEE T CIRCUITS-I, V42, P485, DOI 10.1109/81.404062; Hermassi H, 2012, J SYST SOFTWARE, V85, P2133, DOI 10.1016/j.jss.2012.04.031; Huang CK, 2009, OPT COMMUN, V282, P2123, DOI 10.1016/j.optcom.2009.02.044; Kadir A, 2014, OPTIK, V125, P1671, DOI 10.1016/j.ijleo.2013.09.040; Kaneko K, 2001, COMPLEX SYSTEMS CHAO; Kiani-B A, 2009, COMMUN NONLINEAR SCI, V14, P863, DOI 10.1016/j.cnsns.2007.11.011; Kocarev L., 2001, IEEE Circuits and Systems Magazine, V1, P6, DOI 10.1109/7384.963463; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li CG, 2004, PHYSICA A, V341, P55, DOI 10.1016/j.physa.2004.04.113; Li CQ, 2012, NONLINEAR DYNAM, V70, P2383, DOI 10.1007/s11071-012-0626-5; Li CQ, 2004, LECT NOTES COMPUT SC, V3333, P418; Lian SG, 2005, CHAOS SOLITON FRACT, V26, P117, DOI 10.1016/j.chaos.2004.11.096; Liu HJ, 2014, AEU-INT J ELECTRON C, V68, P676, DOI 10.1016/j.aeue.2014.02.002; Liu HJ, 2011, OPT COMMUN, V284, P3895, DOI 10.1016/j.optcom.2011.04.001; Liu LL, 2012, COMPUT ELECTR ENG, V38, P1240, DOI 10.1016/j.compeleceng.2012.02.007; Mao YB, 2004, INT J BIFURCAT CHAOS, V14, P3613, DOI 10.1142/S021812740401151X; Matthews RAJ, 1989, CRYPTOLOGIA, VXIII, P29, DOI [10.1080/0161-118991863745, DOI 10.1080/0161-118991863745]; Ozkaynak F, 2012, OPT COMMUN, V285, P4946, DOI 10.1016/j.optcom.2012.07.106; Pareek NK, 2006, IMAGE VISION COMPUT, V24, P926, DOI 10.1016/j.imavis.2006.02.021; Patidar V, 2009, COMMUN NONLINEAR SCI, V14, P3056, DOI 10.1016/j.cnsns.2008.11.005; Petras I, 2008, CHAOS SOLITON FRACT, V38, P140, DOI 10.1016/j.chaos.2006.10.054; Rhouma R, 2009, CHAOS SOLITON FRACT, V40, P309, DOI 10.1016/j.chaos.2007.07.083; Rhouma R, 2008, PHYS LETT A, V372, P5973, DOI 10.1016/j.physleta.2008.07.057; Rhouma R, 2010, COMMUN NONLINEAR SCI, V15, P1887, DOI 10.1016/j.cnsns.2009.07.007; Seyedzadeh SM, 2012, SIGNAL PROCESS, V92, P1202, DOI 10.1016/j.sigpro.2011.11.004; Solak E, 2010, OPT COMMUN, V283, P232, DOI 10.1016/j.optcom.2009.09.070; Song CY, 2013, OPTIK, V124, P3329, DOI 10.1016/j.ijleo.2012.11.002; Stinson D.R., 2007, CRYPTOGRAPHY THEORY; Sun FY, 2008, CHAOS SOLITON FRACT, V38, P631, DOI 10.1016/j.chaos.2008.01.028; Teng L, 2012, OPT COMMUN, V285, P4048, DOI 10.1016/j.optcom.2012.06.004; Volos CK, 2013, SIGNAL PROCESS, V93, P1328, DOI 10.1016/j.sigpro.2012.11.008; Wang XY, 2012, SIGNAL PROCESS, V92, P1101, DOI 10.1016/j.sigpro.2011.10.023; Wei XP, 2012, J SYST SOFTWARE, V85, P290, DOI 10.1016/j.jss.2011.08.017; Wu XJ, 2014, COMMUN NONLINEAR SCI, V19, P1884, DOI 10.1016/j.cnsns.2013.10.025; Wu XJ, 2012, NONLINEAR ANAL-REAL, V13, P1441, DOI 10.1016/j.nonrwa.2011.11.008; Ye GD, 2012, NONLINEAR DYNAM, V69, P2079, DOI 10.1007/s11071-012-0409-z; Ye GD, 2010, PATTERN RECOGN LETT, V31, P347, DOI 10.1016/j.patrec.2009.11.008; Ye RS, 2011, OPT COMMUN, V284, P5290, DOI 10.1016/j.optcom.2011.07.070; Zhang GJ, 2011, OPT COMMUN, V284, P2775, DOI 10.1016/j.optcom.2011.02.039; Zhu CX, 2012, OPT COMMUN, V285, P29, DOI 10.1016/j.optcom.2011.08.079	51	45	45	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0119660	10.1371/journal.pone.0119660	http://dx.doi.org/10.1371/journal.pone.0119660			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826602	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800011
J	Ferreira-da-Silva, A; Valacca, C; Rios, E; Populo, H; Soares, P; Sobrinho-Simoes, M; Scorrano, L; Maximo, V; Campello, S				Ferreira-da-Silva, Andre; Valacca, Cristina; Rios, Elisabete; Populo, Helena; Soares, Paula; Sobrinho-Simoes, Manuel; Scorrano, Luca; Maximo, Valdemar; Campello, Silvia			Mitochondrial Dynamics Protein Drp1 Is Overexpressed in Oncocytic Thyroid Tumors and Regulates Cancer Cell Migration	PLOS ONE			English	Article							HURTHLE-CELL; DNA MUTATIONS; CARCINOMA; FISSION; EXPRESSION; PHENOTYPE; VARIANTS; EMPHASIS; REVEALS; LESIONS	Oncocytic cell tumors are characterized by the accumulation of morphologically abnormalmitochondria in their cells, suggesting a role for abnormal mitochondrial biogenesis in oncocytic cell transformation. Little is known about the reason for the dysmorphology of accumulated mitochondria. The proteins regulating the morphology of mitochondria, the "mitochondria-shaping" proteins, canmodulate their size and number; however, nothing is known hitherto about a possible involvement of mitochondrial dynamics in oncocytic cell transformation in tumors. Our aim was to assess the status of the mitochondria morphology and its role in oncocytic cell transformation. We therefore evaluated the expression pattern of the main mitochondrial fusion and fission proteins in a series of thyroid cell tumor samples, as well as in thyroid tumor cell lines, with and without oncocytic cell features. The expression of mitochondrial fusion (Opa1, Mfn1 andMfn2) and fission (Drp1 and Fis1) proteins were evaluated by immunohistochemistry (IHC) in a series of 88 human thyroid tumors. In vitro studies, for comparative purposes and to deepen the study, were performed using TPC1 - a papillary thyroid carcinoma derived cell line-and XTC. UC1, an oncocytic follicular thyroid carcinoma-derived cell line. Both IHC and in vitro protein analyses showed an overall increase in the levels of "mitochondrial- shaping" proteins in oncocytic thyroid tumors. Furthermore, overexpression of the pro-fission protein Drp1 was found to be associated with malignant oncocytic thyroid tumors. Interestingly, genetic and pharmacological blockage of Drp1 activity was able to influence thyroid cancer cells' migration/invasion ability, a feature of tumor malignancy. In this study we show that unbalanced mitochondrial dynamics characterize the malignant features of thyroid oncocytic cell tumors, and participate in the acquisition of the migrating phenotype.	[Ferreira-da-Silva, Andre; Rios, Elisabete; Populo, Helena; Soares, Paula; Sobrinho-Simoes, Manuel; Maximo, Valdemar] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Ferreira-da-Silva, Andre; Rios, Elisabete; Soares, Paula; Sobrinho-Simoes, Manuel; Maximo, Valdemar] Univ Porto, Dept Pathol, Fac Med, P-4100 Oporto, Portugal; [Valacca, Cristina; Campello, Silvia] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Rios, Elisabete; Sobrinho-Simoes, Manuel] Hosp Sao Joao, Dept Pathol, Oporto, Portugal; [Scorrano, Luca] Univ Padua, Dept Biol, Padua, Italy; [Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Scorrano, Luca; Campello, Silvia] IRCCS Fdn Santa Lucia, Rome, Italy	Universidade do Porto; Universidade do Porto; University of Rome Tor Vergata; Sao Joao Hospital; University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; IRCCS Santa Lucia	Campello, S (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	silvia.campello@uniroma2.it	Campello, Silvia/AAB-3399-2019; Maximo, Valdemar/E-7480-2011; Soares, Paula/B-6054-2008; Sobrinho-Simões, Manuel/J-8290-2013; Pópulo, Helena I M/K-2964-2013; Scorrano, Luca/K-3967-2019	Maximo, Valdemar/0000-0002-8631-8356; Soares, Paula/0000-0001-9607-6998; Pópulo, Helena I M/0000-0002-6353-6879; Scorrano, Luca/0000-0002-8515-8928; campello, silvia/0000-0003-0536-2484; Sobrinho-Simoes, Manuel/0000-0003-1613-1235	AIRC [PIC/IC/83037/2007, MFAG-12120]; Italian Ministry of Health [GR-2011-02351643]; project 'Microenvironment, metabolism and cancer' based at IPATIMUP; Programa Operacional Regional do Norte (ON. 2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional (FEDER); Portuguese Foundation for Science and Technology (FCT); FCT through a PhD grant [SFRH/BD/39104/2007]	AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); project 'Microenvironment, metabolism and cancer' based at IPATIMUP; Programa Operacional Regional do Norte (ON. 2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT through a PhD grant	This study was partially supported by the project PIC/IC/83037/2007 (to VM), the project MFAG-12120 from AIRC and GR-2011-02351643 from the Italian Ministry of Health (to SC). Further funding was obtained from the project 'Microenvironment, metabolism and cancer' based at IPATIMUP and partially supported by Programa Operacional Regional do Norte (ON. 2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional (QREN), and through the Fundo Europeu de Desenvolvimento Regional (FEDER). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology (FCT). The study was also FCT through a PhD grant to AFS (Ref.: SFRH/BD/39104/2007).	ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cheung CC, 2000, J CLIN ENDOCR METAB, V85, P878, DOI 10.1210/jc.85.2.878; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Corrado Mauro, 2012, Int J Cell Biol, V2012, P729290, DOI 10.1155/2012/729290; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Lellis R.A., 2004, WHO CLASSIFICATION T, V3rd; de Vries MM, 2012, HISTOPATHOLOGY, V61, P833, DOI 10.1111/j.1365-2559.2012.04276.x; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Evans HL, 1998, AM J SURG PATHOL, V22, P1512, DOI 10.1097/00000478-199812000-00008; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Goncalves AP, J BIOSCI, V36, P639; Gudbjartsson T, 2005, BJU INT, V96, P1275, DOI 10.1111/j.1464-410X.2005.05827.x; Heddi A, 1996, BBA-MOL BASIS DIS, V1316, P203, DOI 10.1016/0925-4439(96)00026-9; Hoos A, 2002, AM J PATHOL, V160, P175, DOI 10.1016/S0002-9440(10)64361-1; Ito K, 2000, ORL J OTO-RHINO-LARY, V62, P338, DOI 10.1159/000027766; Lima J, 2009, MITOCHONDRIA CANC; Maximo V, 2000, J PATHOL, V192, P561; Maximo V, 2002, AM J PATHOL, V160, P1857, DOI 10.1016/S0002-9440(10)61132-7; Maximo V, 2000, VIRCHOWS ARCH, V437, P107, DOI 10.1007/s004280000219; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; Maximo V, 2012, ENDOCR-RELAT CANCER, V19, pR131, DOI 10.1530/ERC-11-0354; Maximo V, 2009, VIRCHOWS ARCH, V454, P481, DOI 10.1007/s00428-009-0766-2; Meireles AM, 2007, THYROID, V17, P707, DOI 10.1089/thy.2007.0097; NESLAND JM, 1985, ULTRASTRUCT PATHOL, V8, P269, DOI 10.3109/01913128509141518; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Packeisen J, 2003, J CLIN PATHOL-MOL PA, V56, P198, DOI 10.1136/mp.56.4.198; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Pereira L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-53; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; ROTH SI, 1962, LAB INVEST, V11, P933; Sobrinho-Simoes M, 2008, ENDOCRIN METAB CLIN, V37, P333, DOI 10.1016/j.ecl.2008.02.004; SOBRINHOSIMOES MA, 1985, ULTRASTRUCT PATHOL, V8, P131, DOI 10.3109/01913128509142147; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tallini G, 1998, VIRCHOWS ARCH, V433, P5, DOI 10.1007/s004280050209; Trovisco V, 2004, J PATHOL, V202, P247, DOI 10.1002/path.1511; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	49	132	140	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122308	10.1371/journal.pone.0122308	http://dx.doi.org/10.1371/journal.pone.0122308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822260	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700163
J	Jullien, N; Roche, C; Brue, T; Figarella-Branger, D; Graillon, T; Barlier, A; Herman, JP				Jullien, Nicolas; Roche, Catherine; Brue, Thierry; Figarella-Branger, Dominique; Graillon, Thomas; Barlier, Anne; Herman, Jean-Paul			Dose-Dependent Dual Role of PIT-1 (POU1F1) in Somatolactotroph Cell Proliferation and Apoptosis	PLOS ONE			English	Article							PITUITARY-HORMONE DEFICIENCY; TRANSCRIPTION FACTOR PIT-1; ANTERIOR-PITUITARY; PROLACTIN PROMOTER; IN-VITRO; HOMEODOMAIN; DOMAIN; EXPRESSION; PROTEIN; LACTATION	To test the role of wtPIT-1 (PITWT) or PIT-1 (R271W) (PIT271) in somatolactotroph cells, we established, using inducible lentiviral vectors, sublines of GH4C1 somatotroph cells that allow the blockade of the expression of endogenous PIT-1 and/or the expression of PITWT or PIT271, a dominant negative mutant of PIT-1 responsible for Combined Pituitary Hormone Deficiency in patients. Blocking expression of endogenous PIT-1 induced a marked decrease of cell proliferation. Overexpressing PITWT twofold led also to a dose-dependent decrease of cell proliferation that was accompanied by cell death. Expression of PIT271 induced a strong dose-dependent decrease of cell proliferation accompanied by a very pronounced cell death. These actions of PIT271 are independent of its interaction/competition with endogenous PIT-1, as they were unchanged when expression of endogenous PIT-1 was blocked. All these actions are specific for somatolactotroph cells, and could not be observed in heterologous cells. Cell death induced by PITWT or by PIT271 was accompanied by DNA fragmentation, but was not inhibited by inhibitors of caspases, autophagy or necrosis, suggesting that this cell death is a caspase-independent apoptosis. Altogether, our results indicate that under normal conditions PIT-1 is important for the maintenance of cell proliferation, while when expressed at supra-normal levels it induces cell death. Through this dual action, PIT-1 may play a role in the expansion/regression cycles of pituitary lactotroph population during and after lactation. Our results also demonstrate that the so-called "dominant-negative" action of PIT271 is independent of its competition with PIT-1 or a blockade of the actions of the latter, and are actions specific to this mutant variant of PIT-1.	[Jullien, Nicolas; Roche, Catherine; Brue, Thierry; Barlier, Anne; Herman, Jean-Paul] Aix Marseille Univ, CNRS, UMR7286, F-13015 Marseille, France; [Roche, Catherine; Barlier, Anne] APHM Concept, Mol Biol Lab, F-13385 Marseille, France; [Brue, Thierry] APHM Timone, Dept Endocrinol, F-13385 Marseille, France; [Figarella-Branger, Dominique] APHM Timone, Neuropathol Lab, F-13385 Marseille, France; [Graillon, Thomas] APHM Timone, Dept Neurosurg, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Herman, JP (corresponding author), Aix Marseille Univ, CNRS, UMR7286, F-13015 Marseille, France.	jean-paul.herman@univ-amu.fr	Jullien, Nicolas/O-1947-2015; Brue, Thierry/AAI-2328-2019; Brue, Thierry/P-6571-2019	Jullien, Nicolas/0000-0001-8273-2106; Brue, Thierry/0000-0001-8482-6691; Brue, Thierry/0000-0001-8482-6691; Barlier, Anne/0000-0002-3740-6173; Graillon, Thomas/0000-0001-5627-8181	Agence Nationale de la Recherche [Genopath ANR-08-GENO-026-01]; Pfizer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Pfizer(Pfizer)	This work was supported by the following sources of funding: TB, JPH: Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), Genopath ANR-08-GENO-026-01; TB: Pfizer (http://www.pfizer.com/), Investigator Initiated Project "Novel molecular targets of the pituitary transcription factor Pit-1." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Aoki A, 1996, EXP CLIN ENDOCR DIAB, V104, P256, DOI 10.1055/s-0029-1211451; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; COHEN LE, 1995, J CLIN ENDOCR METAB, V80, P679, DOI 10.1210/jc.80.2.679; Diaz-Rodriguez E, 2012, ONCOGENE, V31, P2824, DOI 10.1038/onc.2011.458; Enwright JF, 2003, MOL ENDOCRINOL, V17, P209, DOI 10.1210/me.2001-0222; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guillou A, 2011, ENDOCRINOLOGY, V152, P515, DOI 10.1210/en.2010-0673; HAGGI ES, 1986, J ENDOCRINOL, V111, P367, DOI 10.1677/joe.0.1110367; Herman JP, 2012, MOL ENDOCRINOL, V26, P1455, DOI 10.1210/me.2011-1308; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Martinet W, 2006, AUTOPHAGY, V2, P312, DOI 10.4161/auto.2966; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Pellegrini I, 2006, MOL ENDOCRINOL, V20, P3212, DOI 10.1210/me.2006-0122; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Quentien MH, 2002, J BIOL CHEM, V277, P44408, DOI 10.1074/jbc.M207824200; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Roche C, 2004, J ENDOCRINOL, V183, P217, DOI 10.1677/joe.1.05759; Roche C, 2012, HUM GENE THER, V23, P104, DOI 10.1089/hum.2011.105; Romero CJ, 2009, TRENDS ENDOCRIN MET, V20, P506, DOI 10.1016/j.tem.2009.06.005; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Taniguchi Y, 2001, ANAT EMBRYOL, V204, P469, DOI 10.1007/s429-001-8003-x; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Ward RD, 2006, MOL ENDOCRINOL, V20, P1378, DOI 10.1210/me.2005-0409; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Yin P, 2000, NEUROENDOCRINOLOGY, V72, P72, DOI 10.1159/000054574	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120010	10.1371/journal.pone.0120010	http://dx.doi.org/10.1371/journal.pone.0120010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822178	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700053
J	Kumar, GR; Spurthi, KM; Kumar, GK; Kurapati, M; Saraswati, M; Aiyengar, TM; Chiranjeevi, P; Reddy, GS; Nivas, S; Kaushik, P; Sahu, KS; Rani, HS				Kumar, Rajesh G.; Spurthi, Mrudula K.; Kumar, Kishore G.; Kurapati, Mohanalatha; Saraswati, M.; Aiyengar, Mohini T.; Chiranjeevi, P.; Reddy, Srilatha G.; Nivas, S.; Kaushik, P.; Sahu, Sanjib K.; Rani, Surekha H.			Evaluation of Hs-CRP Levels and Interleukin 18 (-137G/C) Promoter Polymorphism in Risk Prediction of Coronary Artery Disease in First Degree Relatives	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; HEART-DISEASE; IL-18 GENE; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; FAMILY-HISTORY; ASSOCIATION; INFLAMMATION; VARIANTS	Background Coronary Artery Disease (CAD) is clearly a multifactorial disease that develops from childhood and ultimately leads to death. Several reports revealed having a First Degree Relatives (FDRS) with premature CAD is a significant autonomous risk factor for CAD development. C - reactive protein (CRP) is a member of the pentraxin family and is the most widely studied proinflammatory biomarker. IL-18 is a pleiotrophic and proinflammatory cytokine which is produced mainly by macrophages and plays an important role in the inflammatory cascade. Methods and Results Hs-CRP levels were estimated by ELISA and Genotyping of IL-18 gene variant located on promoter -137 (G/C) by Allele specific PCR in blood samples of 300 CAD patients and 300 controls and 100 FDRS. Promoter Binding sites and Protein interacting partners were identified by Alibaba 2.1 and Genemania online tools respectively. Hs-CRP levels were significantly high in CAD patients followed by FDRS when compared to controls. In IL-18 -137 (G/C) polymorphism homozygous GG is significantly associated with occurrence of CAD and Hs-CRP levels were significantly higher in GG genotype subjects when compared to GC and CC. IL-18 was found to be interacting with 100 protein interactants. Conclusion Our results indicate that Hs-CRP levels and IL-18-137(G/C) polymorphism may help to identify risk of future events of CAD in asymptomatic healthy FDRS.	[Kumar, Rajesh G.; Spurthi, Mrudula K.; Kumar, Kishore G.; Saraswati, M.; Aiyengar, Mohini T.; Chiranjeevi, P.; Reddy, Srilatha G.; Nivas, S.; Kaushik, P.; Rani, Surekha H.] Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India; [Kurapati, Mohanalatha] Bioclues Org, Hyderabad 500072, Telangana, India; [Sahu, Sanjib K.] Durgabai Deshmukh Hosp & Res Ctr, Hyderabad 500007, Telangana, India	Osmania University	Rani, HS (corresponding author), Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India.	surekharanih@gmail.com	G.Kumar, Dr.Rajesh/ABD-1925-2021; Hanumanth, SUREKHA/Z-5518-2019	G.Kumar, Dr.Rajesh/0000-0003-3042-5141; Shyamala, Nivas/0000-0003-3586-6050; Padala, Chiranjeevi/0000-0003-0662-7800	Indian Council of Medical Research; Centre For Advanced Study-Phase II; Department of Science and Technology - Promotion of University Research and Scientific Excellence	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Centre For Advanced Study-Phase II; Department of Science and Technology - Promotion of University Research and Scientific Excellence	1. http://icmr.nic.in/, Indian Council of Medical Research -Senior Research Fellowship-RKG, 2. Centre For Advanced Study-Phase II, CP, MAT, 3. Department of Science and Technology - Promotion of University Research and Scientific Excellence- KKG, NS, KP, SM, SRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; DEBEER FC, 1982, BRIT HEART J, V47, P239; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0; Glas J, 2005, INFLAMM BOWEL DIS, V11, P1031, DOI 10.1097/01.MIB.0000187574.41290.b1; Grabe N., 2002, SILICO BIOL, V2, P1; Gracie JA, 2005, GENES IMMUN, V6, P211, DOI 10.1038/sj.gene.6364183; Higgins M, 2000, AM J MED, V108, P387, DOI 10.1016/S0002-9343(99)00409-X; Ide A, 2004, J AUTOIMMUN, V22, P73, DOI 10.1016/j.jaut.2003.10.001; Jefferis BJMH, 2011, ATHEROSCLEROSIS, V217, P227, DOI 10.1016/j.atherosclerosis.2011.03.015; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kraus WE, 2000, AM HEART J, V140, pS27, DOI 10.1067/mhj.2000.109380; Kretowski A, 2002, DIABETES, V51, P3347, DOI 10.2337/diabetes.51.11.3347; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Leon MLA, 2005, INFLAMM RES, V54, P395, DOI 10.1007/s00011-005-1377-2; Liang XH, 2005, BIOCHEM BIOPH RES CO, V338, P736, DOI 10.1016/j.bbrc.2005.10.012; Liu WW, 2009, ANGIOLOGY, V60, P180, DOI 10.1177/0003319708319939; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Novak N, 2005, J ALLERGY CLIN IMMUN, V115, P828, DOI 10.1016/j.jaci.2005.01.030; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; PERKINS KA, 1986, AM J EPIDEMIOL, V124, P182, DOI 10.1093/oxfordjournals.aje.a114377; Rajeshwari R, 2005, NUTR RES, V25, P515, DOI 10.1016/j.nutres.2005.04.003; Ridker P, 2006, ARCH INTERN MED, V166, P1327, DOI 10.1001/archinte.166.12.1327-b; Rubin SA, 2000, CIRCULATION, V102, P19; Sawant A, 2011, CHOLESTEROL, P1, DOI [10.1155/2011/875307, DOI 10.1155/2011/875307]; Shayan S, 2009, INT CARDIOVASC RES J, V3, P158; Sivalingam SP, 2003, TISSUE ANTIGENS, V62, P498, DOI 10.1046/j.1399-0039.2003.00137.x; Stephens JW, 2003, J INTERN MED, V253, P120, DOI 10.1046/j.1365-2796.2003.01104.x; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Takada T, 2002, TISSUE ANTIGENS, V60, P36, DOI 10.1034/j.1399-0039.2002.600105.x; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Valdez R, 2007, PEDIATRICS, V120, pS78, DOI 10.1542/peds.2007-1010G; Yamaoka-Tojo M, 2003, HEART VESSELS, V18, P183, DOI 10.1007/s00380-003-0719-7; Yeh ETH, 2001, CIRCULATION, V104, P974, DOI 10.1161/01.CIR.104.9.974	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120359	10.1371/journal.pone.0120359	http://dx.doi.org/10.1371/journal.pone.0120359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822970	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700060
J	Liu, CY; Zhao, AC; Zhu, PP; Li, J; Han, L; Wang, XL; Fan, W; Lu, RH; Wang, CH; Li, ZG; Lu, C; Yu, MD				Liu, Changying; Zhao, Aichun; Zhu, Panpan; Li, Jun; Han, Leng; Wang, Xiling; Fan, Wei; Lu, Ruihua; Wang, Chuanhong; Li, Zhengang; Lu, Cheng; Yu, Maode			Characterization and Expression of Genes Involved in the Ethylene Biosynthesis and Signal Transduction during Ripening of Mulberry Fruit	PLOS ONE			English	Article							MORUS-ALBA L.; TOMATO FRUIT; PLANT DEVELOPMENT; OXIDASE GENE; ARABIDOPSIS; ETR1; FAMILY; MATURATION; RECEPTORS; KIWIFRUIT	Although ethylene is well known as an essential regulator of fruit development, little work has examined the role ethylene plays in the development and maturation of mulberry (Morus L.) fruit. To study the mechanism of ethylene action during fruit development in this species, we measured the ethylene production, fruit firmness, and soluble solids content (SSC) during fruit development and harvest. By comparing the results with those from other climacteric fruit, we concluded that Morus fruit are probably climacteric. Genes associated with the ethylene signal transduction pathway of Morus were characterized from M. notabilis Genome Database, including four ethylene receptor genes, a EIN2-like gene, a CTR1-like gene, four EIN3-like genes, and a RTE1-like gene. The expression patterns of these genes were analyzed in the fruit of M. atropurpurea cv. Jialing No. 40. During fruit development, transcript levels of MaETR2, MaERS, MaEIN4, MaRTE, and MaCTR1 were lower at the early stages and higher after 26 days after full bloom (DAF), while MaETR1, MaEIL1, MaEIL2, and MaEIL3 remained constant. In ripening fruit, the transcripts of MaACO1 and MaACS3 increased, while MaACS1 and MaACO2 decreased after harvest. The transcripts of MaACO1, MaACO2, and MaACS3 were inhibited by ethylene, and 1-MCP (1-methylcyclopropene) upregulated MaACS3. The transcripts of the MaETR-like genes, MaRTE, and MaCTR1 were inhibited by ethylene and 1-MCP, suggesting that ethylene may accelerate the decline of MaETRs transcripts. No significant changes in the expression of MaEIN2, MaEIL1, and MaEIL3 were observed during ripening or in response to ethylene, while the expressions of MaEIL2 and MaEIL4 increased rapidly after 24 h after harvest (HAH) and were upregulated by ethylene. The present study provides insights into ethylene biosynthesis and signal transduction in Morus plants and lays a foundation for the further understanding of the mechanisms underlying Morus fruit development and ripening.	[Liu, Changying; Zhao, Aichun; Zhu, Panpan; Li, Jun; Wang, Xiling; Fan, Wei; Lu, Ruihua; Wang, Chuanhong; Lu, Cheng; Yu, Maode] Southwest Univ, Coll Biotechnol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Han, Leng] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China; [Li, Zhengang] Yunnan Acad Agr Sci, Inst Sericulture & Apiculture, Kunming, Yunnan, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Yunnan Academy of Agricultural Sciences	Yu, MD (corresponding author), Southwest Univ, Coll Biotechnol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	yumd@163.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102; , liu zhang ying/0000-0002-5573-236X	Special Fund for Agro-scientific Research in the Public Interest of China [201403064]; China Agriculture Research System [CARS-22]; National Natural Science Foundation of China [31360190]	Special Fund for Agro-scientific Research in the Public Interest of China; China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	AZ and MY are funded by the Special Fund for Agro-scientific Research in the Public Interest of China (No. 201403064), and China Agriculture Research System (No. CARS-22). Part of this research was funded by the National Natural Science Foundation of China (No. 31360190) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dal Cin V, 2006, POSTHARVEST BIOL TEC, V42, P125, DOI 10.1016/j.postharvbio.2006.06.008; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; El-Sharkawy I, 2007, J EXP BOT, V58, P3631, DOI 10.1093/jxb/erm213; El-Sharkawy I, 2003, J EXP BOT, V54, P1615, DOI 10.1093/jxb/erg158; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Hayama H, 2006, J EXP BOT, V57, P4071, DOI 10.1093/jxb/erl178; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Hiwasa K, 2003, J EXP BOT, V54, P771, DOI 10.1093/jxb/erg073; Hu ZL, 2010, RUSS J PLANT PHYSL+, V57, P554, DOI 10.1134/S102144371004014X; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Liu CY, 2014, J ZHEJIANG UNIV-SC B, V15, P611, DOI 10.1631/jzus.B1300320; Liu ChangYing, 2014, Acta Agronomica Sinica, V40, P1205; Mbeguie-A-Mbeguie D, 2008, PHYSIOL PLANTARUM, V133, P435, DOI 10.1111/j.1399-3054.2008.01083.x; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Owino WO, 2006, PLANT PHYSIOL BIOCH, V44, P335, DOI 10.1016/j.plaphy.2006.03.009; Pan G, 2008, J PLANT PHYSIOL, V165, P1204, DOI 10.1016/j.jplph.2007.02.012; Pang JH, 2007, POSTHARVEST BIOL TEC, V44, P195, DOI 10.1016/j.postharvbio.2006.12.017; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; Trainotti L, 2005, J EXP BOT, V56, P2037, DOI 10.1093/jxb/eri202; Wang A, 2009, PLANT PHYSIOL, V151, P391, DOI 10.1104/pp.109.135822; Xie YH, 2006, POSTHARVEST BIOL TEC, V42, P8, DOI 10.1016/j.postharvbio.2006.04.016; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yu MD, 1996, SCI SERICULT, V22, P67; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zhu HL, 2006, J INTEGR PLANT BIOL, V48, P1478, DOI 10.1111/j.1744-7909.2006.00366.x	37	16	23	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122081	10.1371/journal.pone.0122081	http://dx.doi.org/10.1371/journal.pone.0122081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822202	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700153
J	Read, EK; Bell, C; Rhind, S; Hecker, KG				Read, Emma K.; Bell, Catriona; Rhind, Susan; Hecker, Kent G.			The Use of Global Rating Scales for OSCEs in Veterinary Medicine	PLOS ONE			English	Article							STRUCTURED CLINICAL EXAMINATION; SKILLS; CHECKLISTS; RELIABILITY; COMPETENCE	OSCEs (Objective Structured Clinical Examinations) are widely used in health professions to assess clinical skills competence. Raters use standardized binary checklists (CL) or multi-dimensional global rating scales (GRS) to score candidates performing specific tasks. This study assessed the reliability of CL and GRS scores in the assessment of veterinary students, and is the first study to demonstrate the reliability of GRS within veterinary medical education. Twelve raters from two different schools (6 from University of Calgary [UCVM] and 6 from Royal (Dick) School of Veterinary Studies [R(D)SVS] were asked to score 12 students (6 from each school). All raters assessed all students (video recordings) during 4 OSCE stations (bovine haltering, gowning and gloving, equine bandaging and skin suturing). Raters scored students using a CL, followed by the GRS. Novice raters (6 R(D) SVS) were assessed independently of expert raters (6 UCVM). Generalizability theory (G theory), analysis of variance (ANOVA) and t-tests were used to determine the reliability of rater scores, assess any between school differences (by student, by rater), and determine if there were differences between CL and GRS scores. There was no significant difference in rater performance with use of the CL or the GRS. Scores from the CL were significantly higher than scores from the GRS. The reliability of checklist scores were .42 and .76 for novice and expert raters respectively. The reliability of the global rating scale scores were .7 and .86 for novice and expert raters respectively. A decision study (D-study) showed that once trained using CL, GRS could be utilized to reliably score clinical skills in veterinary medicine with both novice and experienced raters.	[Read, Emma K.; Hecker, Kent G.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [Bell, Catriona; Rhind, Susan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	University of Calgary; University of Edinburgh	Read, EK (corresponding author), Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada.	ekread@ucalgary.ca		Hecker, Kent/0000-0001-9129-6166; Bell, Catriona/0000-0001-8501-1697	University of Calgary Faculty of Veterinary Medicine; Higher Education Academy, UK	University of Calgary Faculty of Veterinary Medicine; Higher Education Academy, UK	This study was funded by the University of Calgary Faculty of Veterinary Medicine (EKR, KGH) and the Higher Education Academy, UK (CB, SR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler MD, 2011, SIMUL HEALTHC, V6, P18, DOI 10.1097/SIH.0b013e318201aa90; Crossley J, 2012, MED EDUC, V46, P28, DOI 10.1111/j.1365-2923.2011.04166.x; Cunnington JPW, 1996, ADV HEALTH SCI EDUC, V1, P227, DOI [10.1023/A:1018369124027, 10.1007/BF00162920]; Friedman Z, 2006, REGION ANESTH PAIN M, V31, P304, DOI 10.1016/j.rapm.2006.04.006; Harasym P, 2008, ADV HEALTH SCI EDUC, V13, P617, DOI 10.1007/s10459-007-9068-0; HARDEN RM, 1975, BRIT MED J, V1, P447, DOI 10.1136/bmj.1.5955.447; Hecker K, 2010, J VET MED EDUC, V37, P395, DOI 10.3138/jvme.37.4.395; Hecker KG, 2012, J VET MED EDUC, V39, P304, DOI 10.3138/jvme.0312.022R; Hodges B, 1999, ACAD MED, V74, P1129, DOI 10.1097/00001888-199910000-00017; Hodges B, 2003, MED EDUC, V37, P1012, DOI 10.1046/j.1365-2923.2003.01674.x; Hodges BD, 2006, J VET MED EDUC, V33, P571, DOI 10.3138/jvme.33.4.571; Ma IWY, 2012, ADV HEALTH SCI EDUC, V17, P457, DOI 10.1007/s10459-011-9322-3; May SA, 2010, J VET MED EDUC, V37, P258, DOI 10.3138/jvme.37.3.258; McGill DA, 2011, ADV HEALTH SCI EDUC, V16, P405, DOI 10.1007/s10459-011-9296-1; Read EK, 2013, J VET SCI TECHNOL; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Reznick R, 1997, AM J SURG, V173, P226, DOI 10.1016/S0002-9610(97)89597-9; Schnabel LV, 2013, VET SURG, V42, P488, DOI 10.1111/j.1532-950X.2013.12006.x; Tavares W, 2013, PREHOSP EMERG CARE, V17, P57, DOI 10.3109/10903127.2012.702194; van Luijk SJ, 1992, CURRENT DEV ASSESSIN, P357	20	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121000	10.1371/journal.pone.0121000	http://dx.doi.org/10.1371/journal.pone.0121000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822258	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700084
J	Soderquist, F; Hellstrom, PM; Cunningham, JL				Soderquist, Fanny; Hellstrom, Per M.; Cunningham, Janet L.			Human Gastroenteropancreatic Expression of Melatonin and Its Receptors MT1 and MT2	PLOS ONE			English	Article							PARS TUBERALIS CELLS; ACID-INDUCED COLITIS; PROTEIN-KINASE-C; GASTROINTESTINAL MELATONIN; ENTEROCHROMAFFIN CELLS; ULCERATIVE-COLITIS; OXIDATIVE STRESS; IDENTIFIES GENES; MESSENGER-RNA; FOOD-INTAKE	Background and Aim The largest source of melatonin, according to animal studies, is the gastrointestinal (GI) tract but this is not yet thoroughly characterized in humans. This study aims to map the expression of melatonin and its two receptors in human GI tract and pancreas using microarray analysis and immunohistochemistry. Method Gene expression data from normal intestine and pancreas and inflamed colon tissue due to ulcerative colitis were analyzed for expression of enzymes relevant for serotonin and melatonin production and their receptors. Sections from paraffin-embedded normal tissue from 42 individuals, representing the different parts of the GI tract (n= 39) and pancreas (n= 3) were studied with immunohistochemistry using antibodies with specificity for melatonin, MT1 and MT2 receptors and serotonin. Results Enzymes needed for production of melatonin are expressed in both GI tract and pancreas tissue. Strong melatonin immunoreactivity (IR) was seen in enterochromaffin (EC) cells partially co-localized with serotonin IR. Melatonin IR was also seen in pancreas islets. MT1 and MT2 IR were both found in the intestinal epithelium, in the submucosal and myenteric plexus, and in vessels in the GI tract as well as in pancreatic islets. MT1 and MT2 IR was strongest in the epithelium of the large intestine. In the other cell types, both MT2 gene expression and IR were generally elevated compared to MT1. Strong MT2, IR was noted in EC cells but not MT1 IR. Changes in gene expression that may result in reduced levels of melatonin were seen in relation to inflammation. Conclusion Widespread gastroenteropancreatic expression of melatonin and its receptors in the GI tract and pancreas is in agreement with the multiple roles ascribed to melatonin, which include regulation of gastrointestinal motility, epithelial permeability as well as enteropancreatic cross-talk with plausible impact on metabolic control.	[Soderquist, Fanny; Cunningham, Janet L.] Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden; [Hellstrom, Per M.] Uppsala Univ, Dept Med Sci, Gastroenterol Hepatol, Uppsala, Sweden	Uppsala University; Uppsala University	Cunningham, JL (corresponding author), Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden.	janet.cunningham@neuro.uu.se	Cunningham, Janet/C-4719-2013	Cunningham, Janet/0000-0001-7876-7779; Hellstrom, Per/0000-0001-8428-0772	Stiftelsen Soderstrom-Konigska sjukhemmet; Marta och Nicke Nasvells fond; Swedish Society of Medicine; Uppsala University Hospital; Erik, Karin and Gosta Selanders Stiftelse	Stiftelsen Soderstrom-Konigska sjukhemmet; Marta och Nicke Nasvells fond; Swedish Society of Medicine; Uppsala University Hospital; Erik, Karin and Gosta Selanders Stiftelse	This work was funded by grants from Erik, Karin and Gosta Selanders Stiftelse, Stiftelsen Soderstrom-Konigska sjukhemmet (JLC), Marta och Nicke Nasvells fond (JLC), The Swedish Society of Medicine (JLC), and ALF Funds from Uppsala University Hospital (JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bahr I, 2011, J PINEAL RES, V50, P336, DOI 10.1111/j.1600-079X.2010.00848.x; Barrett P, 1998, ENDOCRINOLOGY, V139, P163, DOI 10.1210/en.139.1.163; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bazwinsky-Wutschke I, 2012, J PINEAL RES, V53, P344, DOI 10.1111/j.1600-079X.2012.01004.x; BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bubenik GA, 2008, J PHYSIOL PHARMACOL, V59, P33; Bubenik GA, 2001, BIOL SIGNAL RECEPT, V10, P350; BUBENIK GA, 1992, J PINEAL RES, V12, P7, DOI 10.1111/j.1600-079X.1992.tb00020.x; Bubenik GA, 2000, J PINEAL RES, V28, P9, DOI 10.1034/j.1600-079x.2000.280102.x; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Chojnacki C, 2013, WORLD J GASTROENTERO, V19, P3602, DOI 10.3748/wjg.v19.i23.3602; Cucina A, 2009, J PINEAL RES, V46, P172, DOI 10.1111/j.1600-079X.2008.00645.x; Das A, 2010, J PINEAL RES, V48, P157, DOI 10.1111/j.1600-079X.2009.00739.x; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Espino J, 2010, FERTIL STERIL, V94, P1915, DOI 10.1016/j.fertnstert.2009.12.082; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Fan LL, 2013, J PINEAL RES, V55, P174, DOI 10.1111/jpi.12060; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; HUETHER G, 1994, ANN NY ACAD SCI, V719, P146, DOI 10.1111/j.1749-6632.1994.tb56826.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; Jaworek J, 2007, J PHYSIOL PHARMACOL, V58, P65; Jaworek J, 2004, J PINEAL RES, V37, P161, DOI 10.1111/j.1600-079X.2004.00153.x; Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P381; Lanfumey L, 2013, PHARMACOL THERAPEUT, V138, P176, DOI 10.1016/j.pharmthera.2013.01.005; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lungwitz E, 2009, BRAIN RES, V1250, P157, DOI 10.1016/j.brainres.2008.11.010; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Masana M I, 2001, Sci STKE, V2001, ppe39; Masana MI, 2002, J PHARMACOL EXP THER, V302, P1295, DOI 10.1124/jpet.302.3.1295; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Meliska CJ, 2013, CHRONOBIOL INT, V30, P1160, DOI 10.3109/07420528.2013.808652; Messner M, 1998, J PINEAL RES, V25, P251, DOI 10.1111/j.1600-079X.1998.tb00395.x; Mustonen AM, 2001, ENDOCRINE, V16, P43, DOI 10.1385/ENDO:16:1:43; Nemeth C, 2011, J BIOL REG HOMEOS AG, V25, P531; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Radogna F, 2010, BIOCHEM PHARMACOL, V80, P1844, DOI 10.1016/j.bcp.2010.07.041; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; ROJDMARK S, 1989, CLIN ENDOCRINOL, V30, P451, DOI 10.1111/j.1365-2265.1989.tb00445.x; Ross AW, 1998, ENDOCRINOLOGY, V139, P1723, DOI 10.1210/en.139.4.1723; Sallinen P, 2005, LIFE SCI, V76, P1123, DOI 10.1016/j.lfs.2004.08.016; Sayyed HG, 2013, DIGEST DIS SCI, V58, P3156, DOI 10.1007/s10620-013-2811-x; Sjoblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002; Sjoblom M, 2003, J PINEAL RES, V34, P288; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Smirnov AN, 2001, BIOCHEMISTRY-MOSCOW+, V66, P19, DOI 10.1023/A:1002821427018; Sommansson A, 2012, J PINEAL RES; Sotak M, 2006, J PINEAL RES, V41, P183, DOI 10.1111/j.1600-079X.2006.00355.x; Stebelova K, 2010, ACTA HISTOCHEM, V112, P26, DOI 10.1016/j.acthis.2008.03.004; Tahan G, 2011, DIGEST DIS SCI, V56, P715, DOI 10.1007/s10620-010-1364-5; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Thor PJ, 2007, J PHYSIOL PHARMACOL, V58, P97; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; Wu CC, 2012, J PINEAL RES, V52, P460, DOI 10.1111/j.1600-079X.2011.00960.x	63	46	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120195	10.1371/journal.pone.0120195	http://dx.doi.org/10.1371/journal.pone.0120195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822611	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700057
J	Zelcbuch, L; Razo-Mejia, M; Herz, E; Yahav, S; Antonovsky, N; Kroytoro, H; Milo, R; Bar-Even, A				Zelcbuch, Lior; Razo-Mejia, Manuel; Herz, Elad; Yahav, Sagit; Antonovsky, Niv; Kroytoro, Hagar; Milo, Ron; Bar-Even, Arren			An In Vivo Metabolic Approach for Deciphering the Product Specificity of Glycerate Kinase Proves that Both E. coli's Glycerate Kinases Generate 2-Phosphoglycerate	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECONSTRUCTION; 3-KINASE; PATHWAY; ENZYME	Apart from addressing humanity's growing demand for fuels, pharmaceuticals, plastics and other value added chemicals, metabolic engineering of microbes can serve as a powerful tool to address questions concerning the characteristics of cellular metabolism. Along these lines, we developed an in vivo metabolic strategy that conclusively identifies the product specificity of glycerate kinase. By deleting E. coli's phosphoglycerate mutases, we divide its central metabolism into an 'upper' and 'lower' metabolism, each requiring its own carbon source for the bacterium to grow. Glycerate can serve to replace the upper or lower carbon source depending on the product of glycerate kinase. Using this strategy we show that while glycerate kinase from Arabidopsis thaliana produces 3-phosphoglycerate, both E. coli's enzymes generate 2-phosphoglycerate. This strategy represents a general approach to decipher enzyme specificity under physiological conditions.	[Zelcbuch, Lior; Razo-Mejia, Manuel; Herz, Elad; Yahav, Sagit; Antonovsky, Niv; Kroytoro, Hagar; Milo, Ron; Bar-Even, Arren] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel; [Razo-Mejia, Manuel] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Bar-Even, Arren] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Weizmann Institute of Science; California Institute of Technology; Max Planck Society	Bar-Even, A (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel.	Bar-Even@mpimp-golm.mpg.de	Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299; Bar-Even, Arren/0000-0002-1039-4328	European Research Council [260392]	European Research Council(European Research Council (ERC)European Commission)	European Research Council (Project SYMPAC 260392, http://erc.europa.eu/synthetic-metabolic-pathways-carbon-fixation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN KB, 1980, J BACTERIOL, V144, P114, DOI 10.1128/JB.144.1.114-123.1980; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartsch O, 2008, FEBS LETT, V582, P3025, DOI 10.1016/j.febslet.2008.07.038; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; DOUGHTY CC, 1966, J BIOL CHEM, V241, P568; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Gandia-Herrero F, 2014, APPL MICROBIOL BIOT, V98, P1165, DOI 10.1007/s00253-013-4961-3; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; IRANI MH, 1977, J BACTERIOL, V132, P398, DOI 10.1128/JB.132.2.398-410.1977; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; ORNSTON MK, 1969, J BACTERIOL, V97, P1227, DOI 10.1128/JB.97.3.1227-1233.1969; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Vinokur JM, 2014, BIOCHEMISTRY-US, V53, P4161, DOI 10.1021/bi500566q; Wellner A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003665; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151	27	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122957	10.1371/journal.pone.0122957	http://dx.doi.org/10.1371/journal.pone.0122957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823014	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000352134700211
J	Cherry, JBC; Bruce, JM; Lusk, JL; Crespi, JM; Lim, SL; Bruce, AS				Cherry, J. Bradley C.; Bruce, Jared M.; Lusk, Jayson L.; Crespi, John M.; Lim, Seung-Lark; Bruce, Amanda S.			Neurofunctional Correlates of Ethical, Food-Related Decision-Making	PLOS ONE			English	Article							ANIMAL FEEDING OPERATIONS; GREENHOUSE-GAS; NEURAL BASIS; HEALTH; CORTEX; VMPFC; FMRI; EMISSIONS; VALUATION; PARIETAL	For consumers today, the perceived ethicality of a food's production method can be as important a purchasing consideration as its price. Still, few studies have examined how, neurofunctionally, consumers are making ethical, food-related decisions. We examined how consumers' ethical concern about a food's production method may relate to how, neurofunctionally, they make decisions whether to purchase that food. Forty-six participants completed a measure of the extent to which they took ethical concern into consideration when making food-related decisions. They then underwent a series of functional magnetic resonance imaging (fMRI) scans while performing a food-related decision-making (FRDM) task. During this task, they made 56 decisions whether to purchase a food based on either its price (i.e., high or low, the "price condition") or production method (i.e., with or without the use of cages, the "production method condition"), but not both. For 23 randomly selected participants, we performed an exploratory, whole-brain correlation between ethical concern and differential neurofunctional activity in the price and production method conditions. Ethical concern correlated negatively and significantly with differential neurofunctional activity in the left dorsolateral prefrontal cortex (dlPFC). For the remaining 23 participants, we performed a confirmatory, region-of-interest (ROI) correlation between the same variables, using an 8-mm3 volume situated in the left dlPFC. Again, the variables correlated negatively and significantly. This suggests, when making ethical, food-related decisions, the more consumers take ethical concern into consideration, the less they may rely on neurofunctional activity in the left dlPFC, possibly because making these decisions is more routine for them, and therefore a more perfunctory process requiring fewer cognitive resources.	[Cherry, J. Bradley C.; Bruce, Jared M.; Lim, Seung-Lark] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Lusk, Jayson L.] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA; [Crespi, John M.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA; [Bruce, Amanda S.] Univ Kansas, Med Ctr, Joint Dept Pediat, Kansas City, KS 66103 USA; [Bruce, Amanda S.] Childrens Mercy Hosp, Kansas City, KS USA	University of Missouri System; University of Missouri Kansas City; Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University; University of Kansas; University of Kansas Medical Center	Bruce, AS (corresponding author), Univ Kansas, Med Ctr, Joint Dept Pediat, Kansas City, KS 66103 USA.	amandasbruce@gmail.com	Lim, Seung-Lark/D-2664-2011	Lim, Seung-Lark/0000-0002-0360-6361	United States Department of Agriculture [2011-67023-30047]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The present study was funded by a grant from the United States Department of Agriculture (Grant No. 2011-67023-30047, http://www.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado CS, 2012, J ENVIRON HEALTH, V74, P22; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Boyle LA, 2002, APPL ANIM BEHAV SCI, V76, P119, DOI 10.1016/S0168-1591(01)00211-8; Bruce AS, 2014, J NEUROSCI PSYCHOL E, V7, P164, DOI 10.1037/npe0000023; Bruce AS, 2013, J PEDIATR-US, V162, P759, DOI 10.1016/j.jpeds.2012.10.003; Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839; Cikara M, 2010, SOC COGN AFFECT NEUR, V5, P404, DOI 10.1093/scan/nsq011; D'Silva J, 2006, INTEGR ZOOL, V1, P53, DOI 10.1111/j.1749-4877.2006.00013.x; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fiala N, 2008, ECOL ECON, V67, P412, DOI 10.1016/j.ecolecon.2007.12.021; Frewer LJ, 2005, J AGR ENVIRON ETHIC, V18, P345, DOI 10.1007/s10806-005-1489-2; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green CF, 2006, J OCCUP ENVIRON HYG, V3, P9, DOI 10.1080/15459620500430615; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greger Michael, 2010, FAM COMMUNITY HEALTH, V33, P373, DOI DOI 10.1097/FCH; Gurian-Sherman D.., 2008, CAFOS UNCOVERED UNTO; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Harper G. C., 2002, British Food Journal, V104, P287, DOI 10.1108/00070700210425723; Harrison BJ, 2012, ARCH GEN PSYCHIAT, V69, P741, DOI 10.1001/archgenpsychiatry.2011.2165; Heederik D, 2007, ENVIRON HEALTH PERSP, V115, P298, DOI 10.1289/ehp.8835; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Holt DM, 2008, AGR HUM VALUES, V25, P169, DOI 10.1007/s10460-008-9122-4; Hribar C., 2010, UNDERSTANDING CONCEN; Huk AC, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00086; Hurley SP, 2006, J AGR RESOUR ECON, V31, P301; Hutcherson CA, 2012, J NEUROSCI, V32, P13543, DOI 10.1523/JNEUROSCI.6387-11.2012; Ilea RC, 2009, J AGR ENVIRON ETHIC, V22, P153, DOI 10.1007/s10806-008-9136-3; Jensen TB, 2012, PREV VET MED, V103, P31, DOI 10.1016/j.prevetmed.2011.09.009; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; Key N, 2007, 52 US DEP AGR; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kolbe EA, 2013, IOWA LAW REV, V99, P415; Koneswaran G, 2008, ENVIRON HEALTH PERSP, V116, P578, DOI 10.1289/ehp.11034; Lindeman M, 2000, APPETITE, V34, P55, DOI 10.1006/appe.1999.0293; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; Lusk JL, 2007, ENVIRON RESOUR ECON, V36, P499, DOI 10.1007/s10640-006-9039-6; MacDonald JM, 2009, B US DEP AGR; MacDonald JM, 2007, 47 US DEP AGR; MacDonald JM, 2008, B US DEP AGR; Marsh JM, 2001, J AGR RESOUR ECON, V26, P463; McLeod-Kilmurray H., 2012, Bulletin of Science, Technology and Society, V32, P71, DOI 10.1177/0270467612444585; Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Norwood FB, 2011, J ENVIRON ECON MANAG, V62, P80, DOI 10.1016/j.jeem.2011.04.001; Norwood FB, 2011, COMPASSION BY THE PO; Ollinger M, 2005, 3 US DEP AGR; Pascual L, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00065; Patel P, 2010, DESALIN WATER TREAT, V19, P12, DOI 10.5004/dwt.2010.1890; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; PCIFAP (Pew Commission on Industrial Farm Animal Production), 2008, PUTT MEAT TABL IND F; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Pollan M, 2002, OMNIVORES DILEMMA NA; Pollan M, 2008, DEFENSE FOOD EATERS; Prickett RW, 2010, ANIM WELFARE, V19, P335; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Saja K, 2013, AGR HUM VALUES, V30, P193, DOI 10.1007/s10460-012-9402-x; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Schleim S, 2011, SOC COGN AFFECT NEUR, V6, P48, DOI 10.1093/scan/nsq010; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Sokol-Hessner P, 2012, EUR J NEUROSCI, V35, P1065, DOI 10.1111/j.1460-9568.2012.08076.x; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Talairach J, 1988, CO PLANAR STEREOTAXI; Thompson PB, 2010, J VET MED EDUC, V37, P13, DOI 10.3138/jvme.37.1.13; Thorne PS, 2007, ENVIRON HEALTH PERSP, V115, P296, DOI 10.1289/ehp.8831; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tonsor G. T., 2009, Journal of Agricultural and Applied Economics, V41, P713; Tonsor GT, 2009, FOOD POLICY, V34, P492, DOI 10.1016/j.foodpol.2009.06.008; Trewavas A, 2002, NATURE, V418, P668, DOI 10.1038/nature01013; Verheul J, 2011, NAT RESOUR J, V51, P163; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Walker P, 2005, PUBLIC HEALTH NUTR, V8, P348, DOI 10.1079/PHN2005727; West BM, 2011, WATER AIR SOIL POLL, V217, P473, DOI 10.1007/s11270-010-0602-y; Yoon C, 2012, MARKET LETT, V23, P473, DOI 10.1007/s11002-012-9188-z	83	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120541	10.1371/journal.pone.0120541	http://dx.doi.org/10.1371/journal.pone.0120541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830288	Green Published, gold			2022-12-27	WOS:000352135600035
J	El-Hawaz, RF; Bridges, WC; Adelberg, JW				El-Hawaz, Rabia F.; Bridges, William C.; Adelberg, Jeffrey W.			In Vitro Growth of Curcuma longa L. in Response to Five Mineral Elements and Plant Density in Fed-Batch Culture Systems	PLOS ONE			English	Article							MICROPROPAGATION; OPTIMIZATION; BIOREACTORS; MEDIA	Plant density was varied with P, Ca, Mg, and KNO3 in a multifactor experiment to improve Curcuma longa L. micropropagation, biomass and microrhizome development in fed-batch liquid culture. The experiment had two paired D-optimal designs, testing sucrose fed-batch and nutrient sucrose fed-batch techniques. When sucrose became depleted, volume was restored to 5% m/v sucrose in 200 ml of modified liquid MS medium by adding sucrose solutions. Similarly, nutrient sucrose fed-batch was restored to set points with double concentration of treatments' macronutrient and MS micronutrient solutions, along with sucrose solutions. Changes in the amounts of water and sucrose supplementations were driven by the interaction of P and KNO3 concentrations. Increasing P from 1.25 to 6.25 mM increased both multiplication and biomass. The multiplication ratio was greatest in the nutrient sucrose fed-batch technique with the highest level of P, 6 buds/vessel, and the lowest level of Ca and KNO3. The highest density (18 buds/vessel) produced the highest fresh biomass at the highest concentrations of KNO3 and P with nutrient sucrose fed-batch, and moderate Ca and Mg concentrations. However, maximal rhizome dry biomass required highest P, sucrose fed-batch, and a moderate plant density. Different media formulations and fed-batch techniques were identified to maximize the propagation and storage organ responses. A single experimental design was used to optimize these dual purposes.	[El-Hawaz, Rabia F.; Adelberg, Jeffrey W.] Clemson Univ, Sch Agr Forestry & Environm Sci, Clemson, SC 29634 USA; [Bridges, William C.] Clemson Univ, Dept Math Sci, Clemson, SC USA	Clemson University; Clemson University	Adelberg, JW (corresponding author), Clemson Univ, Sch Agr Forestry & Environm Sci, Clemson, SC 29634 USA.	jadlbrg@clemson.edu			Libyan ministry of education and scientific research	Libyan ministry of education and scientific research	The authors thank Dr. Kathy Moore and Clemson University's Agricultural Chemical Service for media analysis. We also thank the Libyan ministry of education and scientific research for the graduate stipend of the senior author.	Adelberg J, 2006, HORTSCIENCE, V41, P539, DOI 10.21273/HORTSCI.41.3.539; Adelberg JW, 2007, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.2007.756.11; Adelberg J, 2005, PLANT CELL TISS ORG, V81, P359, DOI 10.1007/s11240-004-6657-y; Adelberg J, 2013, IN VITRO CELL DEV-PL, V49, P724, DOI 10.1007/s11627-013-9576-y; Adelberg J, 2010, PROPAG ORNAM PLANTS, V10, P205; Adelberg JW, 2010, IN VITRO CELL DEV-PL, V46, P95, DOI 10.1007/s11627-009-9247-1; Anderson-Cook CM, 2009, J STAT PLAN INFER, V139, P629, DOI 10.1016/j.jspi.2008.04.004; Arigita L, 2010, IN VITRO CELL DEV-PL, V46, P312, DOI 10.1007/s11627-009-9267-x; Chang YH, 2013, FUEL, V105, P711, DOI 10.1016/j.fuel.2012.10.033; Cousins M. M., 2009, Journal of Herbs, Spices & Medicinal Plants, V15, P303, DOI 10.1080/10496470903507841; Cousins MM, 2008, PLANT CELL TISS ORG, V93, P283, DOI 10.1007/s11240-008-9375-z; De Klerk GJ, 2011, SCI HORTIC-AMSTERDAM, V127, P542, DOI 10.1016/j.scienta.2010.11.015; Etienne H, 2002, PLANT CELL TISS ORG, V69, P215, DOI 10.1023/A:1015668610465; Ferri M, 2011, FOOD CHEM, V124, P1473, DOI 10.1016/j.foodchem.2010.07.114; Halloran SM, 2011, IN VITRO CELL DEV-PL, V47, P257, DOI 10.1007/s11627-011-9364-5; Kim EK, 2004, J HORTIC SCI BIOTECH, V79, P818, DOI 10.1080/14620316.2004.11511848; Madan M.S., 2007, TURMERIC GENUS CURCU, P369; Mazri M. A., 2013, Notulae Scientia Biologicae, V5, P332; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Paek KY, 2001, IN VITRO CELL DEV-PL, V37, P149, DOI 10.1007/s11627-001-0027-9; Payne GF., 1992, PLANT CELL TISSUE CU; Preil W., 2005, LIQUID CULTURE SYSTE, P6, DOI [10.1007/ 1-4020-3200-5_4, DOI 10.1007/1-4020-3200-5_4]; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P343, DOI [10.1007/s11627-013-9556-2, 10.1007/s11627-013-9504-1]; SIM SJ, 1999, BIOTECHNOL BIOPROC E, V4, P106, DOI DOI 10.1007/BF02932379; Sluis CJ, 2006, FOCUS BIOTECHNOL, V6, P231; WALKER PN, 1991, T ASAE, V34, P2609, DOI 10.13031/2013.31913; Wu JY, 2008, APPL MICROBIOL BIOT, V78, P441, DOI 10.1007/s00253-007-1332-y; Yunque DAT, 2011, J APPL PHYCOL, V23, P433, DOI 10.1007/s10811-010-9594-7; ZIV M, 1991, In Vitro Cellular and Developmental Biology Plant, V27P, P64	30	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118912	10.1371/journal.pone.0118912	http://dx.doi.org/10.1371/journal.pone.0118912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830292	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600005
J	Jaffe, R; Pope, N; Carvalho, AT; Maia, UM; Blochtein, B; de Carvalho, CAL; Carvalho-Zilse, GA; Freitas, BM; Menezes, C; Ribeiro, MD; Venturieri, GC; Imperatriz-Fonseca, VL				Jaffe, Rodolfo; Pope, Nathaniel; Carvalho, Airton Torres; Maia, Ulysses Madureira; Blochtein, Betina; Lopes de Carvalho, Carlos Alfredo; Carvalho-Zilse, Gislene Almeida; Freitas, Breno Magalhaes; Menezes, Cristiano; Ribeiro, Marcia de Fatima; Venturieri, Giorgio Cristino; Imperatriz-Fonseca, Vera Lucia			Bees for Development: Brazilian Survey Reveals How to Optimize Stingless Beekeeping	PLOS ONE			English	Article							HONEY; MELIPONICULTURE; CONSERVATION; POLLINATION; SELECTION; IMPACTS; APIDAE	Stingless bees are an important asset to assure plant biodiversity in many natural ecosystems, and fulfill the growing agricultural demand for pollination. However, across developing countries stingless beekeeping remains an essentially informal activity, technical knowledge is scarce, and management practices lack standardization. Here we profited from the large diversity of stingless beekeepers found in Brazil to assess the impact of particular management practices on productivity and economic revenues from the commercialization of stingless bee products. Our study represents the first large-scale effort aiming at optimizing stingless beekeeping for honey/colony production based on quantitative data. Survey data from 251 beekeepers scattered across 20 Brazilian States revealed the influence of specific management practices and other confounding factors over productivity and income indicators. Specifically, our results highlight the importance of teaching beekeepers how to inspect and feed their colonies, how to multiply them and keep track of genetic lineages, how to harvest and preserve the honey, how to use vinegar traps to control infestation by parasitic flies, and how to add value by labeling honey containers. Furthermore, beekeeping experience and the network of known beekeepers were found to be key factors influencing productivity and income. Our work provides clear guidelines to optimize stingless beekeeping and help transform the activity into a powerful tool for sustainable development.	[Jaffe, Rodolfo; Imperatriz-Fonseca, Vera Lucia] Univ Sao Paulo, Dept Ecol, Rua Matao 321, Sao Paulo, SP, Brazil; [Pope, Nathaniel] Univ Texas Austin, Dept Integrat Biol, Biol Labs 401, Austin, TX 78712 USA; [Carvalho, Airton Torres; Maia, Ulysses Madureira; Imperatriz-Fonseca, Vera Lucia] Univ Fed Rural Semi Arido, Dept Ciencias Anim, Mossoro, RN, Brazil; [Blochtein, Betina] Pontificia Univ Catolica Rio Grande do Sul, Entomol Lab, Porto Alegre, RS, Brazil; [Lopes de Carvalho, Carlos Alfredo] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Insecta Res Grp, Cruz das Almas, BA, Brazil; [Carvalho-Zilse, Gislene Almeida] Inst Nacl de Pesquisas da Amazonia, Grp Pesquisas Abelhas, Manaus, Amazonas, Brazil; [Freitas, Breno Magalhaes] Univ Fed Ceara, Dept Zootecnia CCA, Fortaleza, Ceara, Brazil; [Menezes, Cristiano; Venturieri, Giorgio Cristino] Empresa Brasileira Pesquisa Agr, Embrapa Amazonia Oriental, Belem, Para, Brazil; [Ribeiro, Marcia de Fatima] Empresa Brasileira Pesquisa Agr, Embrapa Semiarido, Petrolina, PE, Brazil	Universidade de Sao Paulo; University of Texas System; University of Texas Austin; Universidade Federal Rural do Semi-Arido (UFERSA); Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Reconcavo da Bahia; Institute Nacional de Pesquisas da Amazonia; Universidade Federal do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Jaffe, R (corresponding author), Univ Sao Paulo, Dept Ecol, Rua Matao 321, Sao Paulo, SP, Brazil.	r.jaffe@ib.usp.br	Carvalho, Airton Torres/S-5448-2019; Carvalho, Carlos A L/N-3321-2016; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Menezes, Cristiano/D-9881-2014; Maia, Ulysses Madureira/ABG-3304-2020; Blochtein, Betina/B-9412-2014; Jaffé, Rodolfo/K-3230-2013; Freitas, Breno M/F-9509-2012; de Carvalho, Carlos Alfredo Lopes/N-6717-2019; Carvalho-Zilse, Gislene GACZ/M-2275-2013; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021	Carvalho, Airton Torres/0000-0003-3395-4444; Carvalho, Carlos A L/0000-0002-3306-3003; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Maia, Ulysses Madureira/0000-0003-0940-9331; Blochtein, Betina/0000-0001-8452-1716; Jaffé, Rodolfo/0000-0002-2101-5282; Freitas, Breno M/0000-0002-9932-2207; de Carvalho, Carlos Alfredo Lopes/0000-0002-3306-3003; Carvalho-Zilse, Gislene GACZ/0000-0003-1933-8899; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2012/13200-5]; Empresa Brasileira de Pesquisa Agropecuaria-EMBRAPA [02.11.01.029.00.00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; National Science Foundation-NSF	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Empresa Brasileira de Pesquisa Agropecuaria-EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation-NSF(National Science Foundation (NSF)National Research Foundation of Korea)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (RJ, 2012/13200-5), funded the study design, some data collection, data analysis, and the preparation and publication of this manuscript. Empresa Brasileira de Pesquisa Agropecuaria-EMBRAPA (02.11.01.029.00.00), funded some data collection. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, supported ATC and BMF, while the National Science Foundation-NSF, supported NP.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Alves R, 2006, CRIACAO ABELHAS NATI; Bienefeld K, 2008, AM BEE J, V148, P739; Biesmeijer JC, 2006, APIDOLOGIE, V37, P121, DOI 10.1051/apido:2006020; Borst PL, 2012, AM BEE J, V152, P679; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Bruening H., 2006, ABELHA JANDAIRA; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camargo MF, 2012, CATALOGUE BEES HYMEN; Carvalho C. A. L., 2013, STINGLESS BEES PROCE, P1; Carvalho-Zilse G.A., 2012, MELIPONICULTURA AMAZ; Cortopassi-Laurino M, 2006, APIDOLOGIE, V37, P275, DOI 10.1051/apido:2006027; Costa L, 2009, J APICULT RES, V48, P38, DOI 10.3896/IBRA.1.48.1.09; Crane E, 1990, BEES BEEKEEPING SCI; de Oliveira Alves R.M., 2013, POT HONEY LEGACY STI, P541, DOI [DOI 10.1007/978-1-4614-4960-7, https://doi.org/10.1007/978-1-4614-4960-7_40, DOI 10.1007/978-1-4614-4960-7_40]; Dias VHP, 2008, REV VERDE AGROECOLOG, V3; Ferreira EA, 2013, ENSINO SAUDE AMBIENT, V6, DOI [10.1002/jeab.93, DOI 10.1002/JEAB.93]; Frazao RF, 2013, ABELHAS NATIVAS AMAZ; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giannini TC, 2015, APIDOLOGIE, V46, P209, DOI 10.1007/s13592-014-0316-z; Gonzalez-Acereto JA, 2006, J APICULT RES, V45, P234, DOI 10.1080/00218839.2006.11101356; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Gupta R.K., 2014, BEEKEEPING POVERTY A, VVolume 1; Halcroft MT, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.01; Heard TA, 2000, BEE WORLD, V81, P116, DOI 10.1080/0005772X.2000.11099481; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; IBCE, 2010, PERF MERC MIEL AB NA; Jaffe R, 2013, MENSAGEM DOCE, V120, P7; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jalil A.H., 2014, BEESCAPE MELIPONINES; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Lobato T, 2010, ASPECTOS EC CRIACAO; Menezes C, 2013, POT HONEY LEGACY STI, P153, DOI [DOI 10.1007/978-1-4614-4960-7, 10.1007/978-1-4614-4960-7_10]; Menezes C, 2013, APIDOLOGIE, V44, P491, DOI 10.1007/s13592-013-0197-6; Michener C.D., 1986, Contributions of the American Entomological Institute, V22, P1; Michener C.D., 2013, POT HONEY, V1st, P3, DOI 10.1007/978-1-4614-4960-7; Nogueira-Neto P.N., 1997, VIDA CRIACAO ABELHAS; Oliveira RC, 2013, APIDOLOGIE, V44, P29, DOI 10.1007/s13592-012-0152-y; Pereira D. S., 2011, Acta Veterinaria Brasilica, V5, P81; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Quezada-Euan JJG, 2001, BEE WORLD, V82, P160, DOI 10.1080/0005772X.2001.11099523; R Core T, 2014, R LANG ENV STAT COMP; Roubik D.W., 1992, ECOLOGY NATURAL HIST; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; Silveira F.A., 2002, ABELHAS BRASILEIRAS, V1; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Souza B, 2006, INTERCIENCIA, V31, P867; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Venturieri G.C., 2012, POLINIZADORES BRASIL; Venturieri GC, 2008, CRIACAO ABELHAS INDI, P60; Verma L. R, 1990, BEEKEEPING INTEGRATE; Villanueva-Gutierrez R, 2013, J KANSAS ENTOMOL SOC, V86, P352, DOI 10.2317/JKES130131.1; Villas-B?as, 2012, CPT CTR PRODU ES T C; Wenseleers T, 2011, BIOL LETTERS, V7, P173, DOI 10.1098/rsbl.2010.0819	58	81	87	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121157	10.1371/journal.pone.0121157	http://dx.doi.org/10.1371/journal.pone.0121157			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826402	Green Published, gold			2022-12-27	WOS:000352084800036
J	Li, MY; Qiu, JG; Hou, Q; Wang, DJ; Huang, WT; Hu, C; Li, K; Gao, X				Li, Maoyin; Qiu, Jianguang; Hou, Qi; Wang, Dejuan; Huang, Wentao; Hu, Cheng; Li, Ke; Gao, Xin			Endoscopic Enucleation versus Open Prostatectomy for Treating Large Benign Prostatic Hyperplasia: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							HOLMIUM LASER ENUCLEATION; URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; TRANSVESICAL OPEN PROSTATECTOMY; FOLLOW-UP; PLASMAKINETIC ENUCLEATION; TRANSURETHRAL ENUCLEATION; CONTEMPORARY SERIES; CLINICAL-TRIALS; RESECTION	Objectives To evaluate the overall efficacy and safety of endoscopic enucleation of the prostate (EP) vs open prostatectomy (OP) for large benign prostatic hyperplasia (BPH). Methods We conducted an electronic search of PubMed/Medline, EMBASE, The Cochrane Library, and Web of Science to detect all relevant randomized controlled trials (RCTs) comparing EP with OP. A meta-analysis was performed using Review Manager 5.3. Results Seven RCTs (735 patients) were included. At the 3-, 6- and 12-month follow-up, there were no significant differences in the International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), quality of life (QoL) score and post-void residual urine volume (PVR) between EP and OP. The International Index of Erectile Function (IIEF-5) was higher with EP (weighted mean difference [WMD]: 1.00, 95% confidence interval [CI]: 0.21 to 1.78, p=0.01) at the 12-month follow-up. The catheterization time (WMD: 3.80 d, 95% CI: -5.11 to -2.48, P<0.00001) and hospital stay (WMD: 4.93 d, 95% CI: -5.96 to -3.89, P<0.00001) were shorter with EP. The duration of operation was longer for EP compared with OP (WMD: 16.21 min, 95% CI: 3.72 to 28.70, P=0.01). The resected tissue weight (WMD: -9.63 g, 95% CI: -14.46 to -4.81, P<0.0001) and decrease in hemoglobin (WMD: -1.14 g/dL, 95% CI: -1.81 to -0.47, P=0.0008) were less with EP. EP was associated with fewer blood transfusions (risk ratio: 0.22, 95% CI: 0.10 to 0.47, P=0.0001). There were no significant differences between EP and OP when comparing other complications. Conclusions Although only a limited number of RCTs with relatively limited follow-up are available, EP is shown to have a similar postoperative profile and comparable safety to OP. By contrast, EP may have a more desirable perioperative profile. EP appears to be an effective and safe minimally invasive option for treating large prostates that requires only brief convalescence.	[Li, Maoyin; Qiu, Jianguang; Wang, Dejuan; Huang, Wentao; Hu, Cheng; Li, Ke; Gao, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Qi] Cent Hosp Longgang Dist, Dept Urol, Shenzhen, Peoples R China	Sun Yat Sen University	Gao, X (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	gaoxin44@vip.163.com	; Li, Ke/W-5181-2017	Hou, Qi/0000-0002-4597-7013; Li, Ke/0000-0002-0391-521X				Ahlstrand C, 1996, SCAND J UROL NEPHROL, V30, P37, DOI 10.3109/00365599609182347; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; [Anonymous], 2005, DI YI JUN YI DA XUE; Bruskewitz R, 1999, EUR UROL, V36, P7, DOI 10.1159/000052343; Carmignani L, 2013, J UROLOGY, V189, pE892, DOI 10.1016/j.juro.2013.02.2083; Chen SS, 2014, EUR UROL, V66, P284, DOI 10.1016/j.eururo.2014.01.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; El-Hakim A, 2002, BJU INT, V90, P863, DOI 10.1046/j.1464-410X.2002.03071.x; Freyer PJ, 1919, BRIT MED J, V1919, P121; Geavlete B, 2013, BJU INT, V111, P793, DOI 10.1111/j.1464-410X.2012.11730.x; Gilling P, 1996, UROLOGY, V47, P48, DOI 10.1016/S0090-4295(99)80381-1; Gilling PJ, 2000, J ENDOUROL, V14, P529, DOI 10.1089/end.2000.14.529; Girman CJ, 1998, UROLOGY, V51, P428, DOI 10.1016/S0090-4295(97)00717-6; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kuntz RM, 2008, EUR UROL, V53, P160, DOI 10.1016/j.eururo.2007.08.036; Kuntz RM, 2004, J ENDOUROL, V18, P189, DOI 10.1089/089277904322959851; Kuntz RM, 2002, J UROLOGY, V168, P1465, DOI 10.1016/S0022-5347(05)64475-8; Liu CX, 2010, J UROLOGY, V184, P2440, DOI 10.1016/j.juro.2010.08.037; Lukacs B, 1999, EUR UROL, V36, P14, DOI 10.1159/000052344; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCCONNELL JD, 1991, J ANDROL, V12, P356; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Mozes B, 1996, J UROLOGY, V155, P191, DOI 10.1016/S0022-5347(01)66591-1; Naspro R, 2006, EUR UROL, V50, P563, DOI 10.1016/j.eururo.2006.04.003; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Ou RB, 2013, BJU INT, V112, P239, DOI 10.1111/bju.12181; Rao JM, 2013, UROLOGY, V82, P176, DOI 10.1016/j.urology.2013.02.032; Serretta V, 2002, UROLOGY, V60, P623, DOI 10.1016/S0090-4295(02)01860-5; Suer E, 2008, UROLOGY, V72, P90, DOI 10.1016/j.urology.2008.03.015; Tan AHH, 2003, J UROLOGY, V170, P1270, DOI 10.1097/01.ju.0000086948.55973.00; Varkarakis I, 2004, UROLOGY, V64, P306, DOI 10.1016/j.urology.2004.03.033; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Xu AA, 2013, J ENDOUROL, V27, P1254, DOI 10.1089/end.2013.0107; Zhang Yong, 2007, Zhonghua Nan Ke Xue, V13, P1091; Zheng Shao-bo, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P734	36	48	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121265	10.1371/journal.pone.0121265	http://dx.doi.org/10.1371/journal.pone.0121265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826453	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800037
J	Sheinman, M; Massip, F; Arndt, PF				Sheinman, Michael; Massip, Florian; Arndt, Peter F.			Statistical Properties of Pairwise Distances between Leaves on a Random Yule Tree	PLOS ONE			English	Article							PHYLOGENETIC TREES; EXTINCTION RATES; DISTRIBUTIONS; MODELS; SPECIATION; EVOLUTION; GENOMES; GENE	A Yule tree is the result of a branching process with constant birth and death rates. Such a process serves as an instructive null model of many empirical systems, for instance, the evolution of species leading to a phylogenetic tree. However, often in phylogeny the only available information is the pairwise distances between a small fraction of extant species representing the leaves of the tree. In this article we study statistical properties of the pairwise distances in a Yule tree. Using a method based on a recursion, we derive an exact, analytic and compact formula for the expected number of pairs separated by a certain time distance. This number turns out to follow a increasing exponential function. This property of a Yule tree can serve as a simple test for empirical data to be well described by a Yule process. We further use this recursive method to calculate the expected number of the n-most closely related pairs of leaves and the number of cherries separated by a certain time distance. To make our results more useful for realistic scenarios, we explicitly take into account that the leaves of a tree may be incompletely sampled and derive a criterion for poorly sampled phylogenies. We show that our result can account for empirical data, using two families of birds species.	[Sheinman, Michael; Massip, Florian; Arndt, Peter F.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Massip, Florian] INRA, Unite Math Informat & Genome UR1077, Jouy En Josas, France	Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sheinman, M (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	mishashe@gmail.com		massip, Florian/0000-0001-5855-0935; Arndt, Peter F/0000-0003-1762-9836				Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Hohna S, 2011, MOL BIOL EVOL, V28, P2577, DOI 10.1093/molbev/msr095; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Karlin S., 1975, 1 COURSE STOCHASTIC; KENDALL DG, 1949, J R STAT SOC B, V11, P230; KENDALL DG, 1948, BIOMETRIKA, V35, P6, DOI 10.2307/2332624; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Massip F, 2015, MOL BIOL EVOL, V32, P524, DOI 10.1093/molbev/msu313; McKenzie A, 2000, MATH BIOSCI, V164, P81, DOI 10.1016/S0025-5564(99)00060-7; Mooers A, 2012, SYST BIOL, V61, P195, DOI 10.1093/sysbio/syr090; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mulder WH, 2011, J THEOR BIOL, V280, P139, DOI 10.1016/j.jtbi.2011.04.009; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; Reed WJ, 2004, MATH BIOSCI, V189, P97, DOI 10.1016/j.mbs.2003.11.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2006, ANN COMB, V10, P129, DOI 10.1007/s00026-006-0278-6; SLATKIN M, 1991, GENETICS, V129, P555; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Steel M, 2010, APPL MATH LETT, V23, P1315, DOI 10.1016/j.aml.2010.06.021; Tambovtsev Y., 2007, SKASE J THEORETICAL, V4, P1; Yanai I, 2000, PHYS REV LETT, V85, P2641, DOI 10.1103/PhysRevLett.85.2641; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120206	10.1371/journal.pone.0120206	http://dx.doi.org/10.1371/journal.pone.0120206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826216	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800014
J	Bu, SH; Zhao, XW; Can, Y; Jia, W; Tu, JX; Yuan, MZ				Bu, Su Hong; Zhao Xinwang; Can Yi; Jia Wen; Tu Jinxing; Yuan Ming Zhang			Interacted QTL Mapping in Partial NCII Design Provides Evidences for Breeding by Design	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BRASSICA-NAPUS-L.; MAXIMUM-LIKELIHOOD METHOD; YIELD-RELATED TRAITS; NEAR-ISOGENIC LINES; ELITE RICE HYBRID; GENETIC-BASIS; OILSEED RAPE; GENERAL-METHOD; TESTCROSS PROGENIES	The utilization of heterosis in rice, maize and rapeseed has revolutionized crop production. Although elite hybrid cultivars are mainly derived from the F-1 crosses between two groups of parents, named NCII mating design, little has been known about the methodology of how interacted effects influence quantitative trait performance in the population. To bridge genetic analysis with hybrid breeding, here we integrated an interacted QTL mapping approach with breeding by design in partial NCII mating design. All the potential main and interacted effects were included in one full model. If the number of the effects is huge, bulked segregant analysis were used to test which effects were associated with the trait. All the selected effects were further shrunk by empirical Bayesian, so significant effects could be identified. A series of Monte Carlo simulations was performed to validate the new method. Furthermore, all the significant effects were used to calculate genotypic values of all the missing F-1 hybrids, and all these F-1 phenotypic or genotypic values were used to predict elite parents and parental combinations. Finally, the new method was adopted to dissect the genetic foundation of oil content in 441 rapeseed parents and 284 F-1 hybrids. As a result, 8 main-effect QTL and 37 interacted QTL were found and used to predict 10 elite restorer lines, 10 elite sterile lines and 10 elite parental crosses. Similar results across various methods and in previous studies and a high correlation coefficient (0.76) between the predicted and observed phenotypes validated the proposed method in this study.	[Bu, Su Hong; Can Yi; Jia Wen; Yuan Ming Zhang] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhao Xinwang; Tu Jinxing; Yuan Ming Zhang] Huazhong Agr Univ, Stat Genom Lab, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Nanjing Agricultural University; Huazhong Agricultural University	Yuan, MZ (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AAT-2899-2021; Zhang, Yuan-Ming/AFQ-8637-2022	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109306]; Specialized Research Fund for the Doctoral Program of Higher Education [20120097110023]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2014RC020]	National Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Huazhong Agricultural University Scientific & Technological Self-innovation Foundation	This work was supported by grant 2011CB109306 from the National Basic Research Program of China; grant 20120097110023 from Specialized Research Fund for the Doctoral Program of Higher Education; and Program No. 2014RC020 from Huazhong Agricultural University Scientific & Technological Self-innovation Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Calus MPL, 2013, ANIMAL, V7, P183, DOI 10.1017/S1751731112001450; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; COCKERHAM CC, 1954, GENETICS, V39, P859; Comstock R. E., 1952, Heterosis., P494; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Feng JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059541; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Gai J., 2003, GENETIC SYSTEM QUANT; GARRETSEN F, 1978, EUPHYTICA, V27, P49, DOI 10.1007/BF00039119; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; He XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024575; He XH, 2011, THEOR APPL GENET, V122, P33, DOI 10.1007/s00122-010-1420-8; He XH, 2012, CHINESE SCI BULL, V57, P2655, DOI 10.1007/s11434-012-5127-x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; [胡文明 Hu Wenming], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P3305; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang A, 2015, HEREDITY, V114, P107, DOI 10.1038/hdy.2014.79; Huang J, 2013, GENETICA, V141, P453, DOI 10.1007/s10709-013-9744-3; JANSEN RC, 1993, GENETICS, V135, P205; Jones DF, 1917, GENETICS, V2, P466; JONES DF, 1922, J AM SOC AGRON, V14, P242, DOI DOI 10.2134/AGRONJ1922.00021962001400060006X; Kao CH, 1999, GENETICS, V152, P1203; Kao CH, 2002, GENETICS, V160, P1243; KEARSEY MJ, 1968, HEREDITY, V23, P403, DOI 10.1038/hdy.1968.52; KEMPTHORNE O, 1961, BIOMETRICS, V17, P229, DOI 10.2307/2527989; KEULS M, 1977, EUPHYTICA, V26, P537, DOI 10.1007/BF00021679; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; LANDER ES, 1989, GENETICS, V121, P185; Lenarcic AB, 2012, GENETICS, V190, P413, DOI 10.1534/genetics.111.132563; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li LZ, 2013, J GENET, V92, P529, DOI 10.1007/s12041-013-0311-6; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; Lu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017773; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Martinez EA, 1999, MOL ECOL, V8, P1533, DOI 10.1046/j.1365-294x.1999.00721.x; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Meuwissen THE, 2001, GENETICS, V157, P1819; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qi HH, 2013, THEOR APPL GENET, V126, P369, DOI 10.1007/s00122-012-1985-5; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Qu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028463; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Rebai A, 2000, GENET RES, V75, P243, DOI 10.1017/S0016672399004358; Reif JC, 2009, GENETICS, V181, P247, DOI 10.1534/genetics.108.093047; Rutkoski JE, 2011, EUPHYTICA, V179, P161, DOI 10.1007/s10681-010-0301-1; Sax K, 1923, GENETICS, V8, P552; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Schrag TA, 2009, THEOR APPL GENET, V118, P741, DOI 10.1007/s00122-008-0934-9; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Sun MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047037; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TILLMANN P, 1997, CGIRC B, V13, P84; Townsend T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061989; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang XF, 2009, J HERED, V100, P496, DOI 10.1093/jhered/esp009; Wen J., 2014, THESIS NANJING AGR U; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 1996, GENET RES, V68, P175, DOI 10.1017/S0016672300034066; Xu SZ, 2003, GENETICS, V163, P789; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Yi NJ, 2009, GENETICS, V181, P1101, DOI 10.1534/genetics.108.099556; Yu ChuanYuan, 2008, Acta Agronomica Sinica, V34, P1308, DOI 10.1016/S1875-2780(08)60044-9; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang J, 2012, HEREDITY, V108, P396, DOI 10.1038/hdy.2011.86; Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084750; Zhang YM, 2005, HEREDITY, V95, P96, DOI 10.1038/sj.hdy.6800702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang YM, 2004, GENETICS, V166, P1981, DOI 10.1534/genetics.166.4.1981; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; Zhao JY, 2005, CROP SCI, V45, P51; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	84	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121034	10.1371/journal.pone.0121034	http://dx.doi.org/10.1371/journal.pone.0121034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822501	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700086
J	Chen, H; Liu, L; Qi, XS; He, CY; Yin, ZX; Wu, FF; Fan, DM; Han, GH				Chen, Hui; Liu, Lei; Qi, Xingshun; He, Chuangye; Yin, Zhanxin; Wu, Feifei; Fan, Daiming; Han, Guohong			Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis	PLOS ONE			English	Article							PROTHROMBIN GENE MUTATION; FACTOR-VIII; PROTEIN-C; PROCOAGULANT IMBALANCE; RISK-FACTORS; THROMBOPHILIA; DEFICIENCIES	Background and Aim The coagulation abnormalities in non-cirrhotic Budd-Chiari syndrome (NC-BCS) and noncirrhotic portal vein thrombosis (NC-PVT) are unclear. We conducted this case-control study to investigate the coagulation profile of NC-BCS and NC-PVT in Chinese patients. Methods We measured the levels of factors II, V, VII, VIII, IX, X, XI, XII, protein C (PC), protein S (PS) and antithrombin (AT) in blood samples from 37 NC-BCS patients, 74 NC-PVT patients, and 100 healthy controls. The levels and ratios of pro-and anti-coagulation factors were compared between patients with NC-BCS and healthy controls, between different types of NC-BCS and between NC-PVT and healthy controls. Results In patients with NC-BCS, factor VIII (P< 0.001) was significantly elevated; factor V (P< 0.001), VII (P< 0.001), IX (P = 0.003), X (P< 0.001), XI (P< 0.001), XII (P< 0.001), PC (P< 0.001) and AT (P< 0.001) were significantly decreased; and no difference was observed for factor II (P = 0.088) and PS (P = 0.199) compared with healthy controls. Factor VIII-to-PC (P = 0.008), factor VIII-to-PS (P = 0.037) and factor VIII-to-AT (P = 0.001) were significantly increased; other ratios were significantly reduced or did not show any difference. No differences were observed between different types of NC-BCS for individual pro-and anticoagulation factors or the ratios between them. Among patients with NC-PVT, factor VIII (P< 0.001) was significantly elevated and other factors were significantly decreased. Factor II-to-PC (P< 0.001), factor VIII-to-PC (P< 0.001), factor IX-to-PC (P< 0.001), factor VIII-to-PS (P< 0.001), factor II-to-AT (P< 0.001), factor VIII-to-AT (P< 0.001) and factor IX-to-AT (P< 0.001) were significantly increased; all other ratios for NC-PVT were significantly reduced or did not show any significant difference. Conclusions NC-BCS and NC-PVT are associated with elevated levels of factor VIII and the decreased levels of PC and AT were probably the most significant features of coagulation imbalance. Additionally, NC-PVT was associated with decreased levels of PS.	[Chen, Hui; Liu, Lei; Qi, Xingshun; He, Chuangye; Yin, Zhanxin; Wu, Feifei; Han, Guohong] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University	Han, GH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian 710032, Peoples R China.	guohhan@126.com	Qi, Xingshun/M-7063-2013	Qi, Xingshun/0000-0002-9448-6739; Liu, Lei/0000-0002-3570-2219	National Natural Science Foundation of China [81172145]; Xijing Hospital, Fourth Military Medical University, Xi'an, China [XJZT11ZO5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xijing Hospital, Fourth Military Medical University, Xi'an, China	This work was supported by grant 81172145 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) and this study was also funded by a translational research project (XJZT11ZO5) of the Xijing Hospital, Fourth Military Medical University, Xi'an, China. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandenburg VM, 2001, GASTROENTEROLOGY, V120, P1563; Garcia-Pagan JC, 2009, J HEPATOL, V51, P632, DOI 10.1016/j.jhep.2009.06.009; Chaireti R, 2014, THROMB RES, V134, P455, DOI 10.1016/j.thromres.2014.05.012; Chen H, 2013, THROMB RES, V131, P173, DOI 10.1016/j.thromres.2012.11.003; De Stefano V, 2010, INTERN EMERG MED, V5, P487, DOI 10.1007/s11739-010-0413-6; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Deltenre P, 2001, GUT, V48, P264, DOI 10.1136/gut.48.2.264; Denninger MH, 2000, HEPATOLOGY, V31, P587, DOI 10.1002/hep.510310307; Han GH, 2013, RADIOLOGY, V266, P657, DOI 10.1148/radiol.12120856; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Jagtap Amit, 2003, Indian Journal of Pediatrics, V70, P1003, DOI 10.1007/BF02723831; Janssen HLA, 2003, J HEPATOL, V38, P364, DOI 10.1016/S0168-8278(02)00434-8; Janssen HLA, 2000, BLOOD, V96, P2364; Koshy A, 2004, J CLIN GASTROENTEROL, V38, P723, DOI 10.1097/01.mcg.0000135375.89760.dc; Koshy A, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.016; Kumar A, 2015, ALIMENT PHARM THER, V41, P276, DOI 10.1111/apt.13019; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Madonna P, 2001, GASTROENTEROLOGY, V120, P1059, DOI 10.1053/gast.2001.23083; Marlar RA, 2011, AM J HEMATOL, V86, P418, DOI 10.1002/ajh.21992; Menon KVN, 2004, NEW ENGL J MED, V350, P578, DOI 10.1056/NEJMra020282; Mohanty D, 2001, HEPATOLOGY, V34, P666, DOI 10.1053/jhep.2001.27948; Murad SD, 2009, ANN INTERN MED, V151, P167, DOI 10.7326/0003-4819-151-3-200908040-00004; Nishida N, 2013, DIGEST DIS, V31, P408, DOI 10.1159/000355237; PABINGER I, 1992, THROMB HAEMOSTASIS, V68, P470; Primignani M, 2005, HEPATOLOGY, V41, P603, DOI 10.1002/hep.20591; Qi XS, 2014, CLIN GASTROENTEROL H, V12, P1801, DOI 10.1016/j.cgh.2014.04.026; Qi XS, 2014, LIVER INT, V34, P1164, DOI 10.1111/liv.12355; Qi XS, 2013, THROMB HAEMOSTASIS, V109, P878, DOI 10.1160/TH12-10-0784; Qi XS, 2013, J GASTROEN HEPATOL, V28, P432, DOI 10.1111/jgh.12085; Qi XS, 2011, J HEPATOL, V54, P1080, DOI 10.1016/j.jhep.2010.10.034; Raffa S, 2012, CLIN GASTROENTEROL H, V10, P72, DOI 10.1016/j.cgh.2011.09.010; Shetty S, 2011, THROMB RES, V127, P505, DOI 10.1016/j.thromres.2010.09.019; Tripodi A, 2014, J HEPATOL, V61, P148, DOI 10.1016/j.jhep.2014.03.013; Tripodi A, 2013, J HEPATOL, V59, P265, DOI 10.1016/j.jhep.2013.03.036; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Valla DC, 2003, HEPATOLOGY, V38, P793, DOI 10.1053/jhep.2003.50415	37	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119909	10.1371/journal.pone.0119909	http://dx.doi.org/10.1371/journal.pone.0119909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823002	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700051
J	Li, L; Xu, ZP; Liu, GP; Xu, C; Wang, ZH; Li, XG; Liu, EJ; Zeng, J; Chai, DM; Yao, WL; Wang, JZ				Li, Li; Xu, Zhi-Peng; Liu, Gong-Ping; Xu, Cheng; Wang, Zhi-Hao; Li, Xiao-Guang; Liu, En-Jie; Zeng, Juan; Chai, Da-Min; Yao, Wen-Long; Wang, Jian-Zhi			Expression of 1N3R-Tau Isoform Inhibits Cell Proliferation by Inducing S Phase Arrest in N2a Cells	PLOS ONE			English	Article							HUMAN TAU ISOFORMS; MESSENGER-RNA; CYCLE REENTRY; PROTEIN-TAU; PHOSPHORYLATION; DEATH; DIFFERENTIATION; NEUROGENESIS; HIPPOCAMPUS; ANTAGONIZES	Tau is a microtubule-associated protein implicated in neurodegenerative tauopathies. Six tau isoforms are generated from a single gene through alternative splicing of exons 2, 3 and 10 in human brain. Differential expression of tau isoforms has been detected in different brain areas, during neurodevelopment and in neurodegenerative disorders. However, the biological significance of different tau isoforms is not clear. Here, we investigated the individual effect of six different isoforms of tau on cell proliferation and the possible mechanisms by transient expression of eGFP-labeled tau isoform plasmid in N2a cells. Our study showed the transfection efficiency was comparable between different isoforms of tau by examining GFP expression. Compared with other isoforms, we found expression of 1N3R-tau significantly inhibited cell proliferation by Cell Counting Kit-8 assay and BrdU incorporation. Flow cytometry analysis further showed expression of 1N3R-tau induced S phase arrest. Compared with the longest isoform of tau, expression of 1N3R-tau induced cyclin E translocation from the nuclei to cytoplasm, while it did not change the level of cell cycle checkpoint proteins. These data indicate that 1N3R-tau inhibits cell proliferation through inducing S phase arrest.	[Li, Li; Xu, Zhi-Peng; Liu, Gong-Ping; Xu, Cheng; Wang, Zhi-Hao; Li, Xiao-Guang; Liu, En-Jie; Zeng, Juan; Chai, Da-Min; Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Dept Pathophysiol, Key Lab, Educ Minist China Neurol Disorders,Tongji Med Col, Wuhan 430074, Peoples R China; [Wang, Jian-Zhi] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Yao, Wen-Long] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Nantong University; Huazhong University of Science & Technology	Wang, JZ (corresponding author), Huazhong Univ Sci & Technol, Dept Pathophysiol, Key Lab, Educ Minist China Neurol Disorders,Tongji Med Col, Wuhan 430074, Peoples R China.	wangjz@mails.tjmu.edu.cn	Liu, Enjie/AHD-1743-2022		Natural Science Foundation of China [81261120570, 91132305, 81171195]; Ministry of Science and Technology [2013DFG32670]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Natural Science Foundation of China (81261120570, 91132305, 81171195), and the Ministry of Science and Technology (2013DFG32670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Cho GW, 2011, ASSAY DRUG DEV TECHN, V9, P503, DOI 10.1089/adt.2010.0343; Collet J, 1997, EUR J NEUROSCI, V9, P2723, DOI 10.1111/j.1460-9568.1997.tb01701.x; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; Dawson HN, 2001, J CELL SCI, V114, P1179; Duan DX, 2013, J ALZHEIMERS DIS, V37, P795, DOI 10.3233/JAD-130377; Hernandez Felix, 2008, Curr Aging Sci, V1, P56; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; LARCHER JC, 1992, DEV BIOL, V154, P195, DOI 10.1016/0012-1606(92)90059-P; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Majounie E, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.01.017; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Pristera A, 2013, NEUROBIOL AGING, V34, P2551, DOI 10.1016/j.neurobiolaging.2013.05.010; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Sennvik K, 2007, FASEB J, V21, P2149, DOI 10.1096/fj.06-7735com; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Singh TJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P43, DOI 10.1006/abbi.1996.0140; SMITH CJ, 1995, FEBS LETT, V375, P243, DOI 10.1016/0014-5793(95)01221-Y; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Voss K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-18; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076057; Wang XC, 2008, NEUROCHEM RES, V33, P1138, DOI 10.1007/s11064-007-9563-y; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067; Zilka N, 2011, NEUROSCIENCE, V193, P330, DOI 10.1016/j.neuroscience.2011.06.088; Zilkova M, 2011, J ALZHEIMERS DIS, V23, P161, DOI 10.3233/JAD-2010-101434	39	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119865	10.1371/journal.pone.0119865	http://dx.doi.org/10.1371/journal.pone.0119865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822823	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700049
J	Longley, RJ; Bauza, K; Ewer, KJ; Hill, AVS; Spencer, AJ				Longley, Rhea J.; Bauza, Karolis; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.			Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8(+) T Cells	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; SPOROZOITE INVASION; GLIDING MOTILITY; HEPATIC STAGES; EXPRESSES GFP; FALCIPARUM; MALARIA; YOELII; ANTIBODIES; RECOMBINANT	The development of an efficacious vaccine against the Plasmodium parasite remains a top priority. Previous research has demonstrated the ability of a prime-boost virally vectored sub-unit vaccination regimen, delivering the liver-stage expressed malaria antigen TRAP, to produce high levels of antigen-specific T cells. The liver-stage of malaria is the main target of T cell-mediated immunity, yet a major challenge in assessing new T cell inducing vaccines has been the lack of a suitable pre-clinical assay. We have developed a flow-cytometry based in vitro T cell killing assay using a mouse hepatoma cell line, Hepa1-6, and Plasmodium berghei GFP expressing sporozoites. Using this assay, P. berghei TRAP-specific CD8(+) T cell enriched splenocytes were shown to inhibit liver-stage parasites in an effector-to-target ratio dependent manner. Further development of this assay using human hepatocytes and P. falciparum would provide a new method to pre-clinically screen vaccine candidates and to elucidate mechanisms of protection in vitro.	[Longley, Rhea J.; Bauza, Karolis; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Spencer, AJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	longley.r@wehi.edu.au; alex.spencer@ndm.ox.ac.uk	Longley, Rhea J/C-9573-2018; Spencer, Alexandra/AAE-6494-2019; Ewer, Katie J/B-4328-2011	Longley, Rhea J/0000-0002-4510-5602; Spencer, Alexandra/0000-0001-7958-6961; Ewer, Katie J/0000-0001-9827-9836	Wellcome Trust [095540/Z/11/Z]; Rhodes Trust; Nuffield Department of Medicine	Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust; Nuffield Department of Medicine	Funding was provided by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number 095540/Z/11/Z. Additional funding was provided by the Rhodes Trust and a Nuffield Department of Medicine Studentship to support RJL. AVSH is a Jenner Institute Investigator; AJS is a James Martin Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauza K, 2014, INFECT IMMUN, V82, P1277, DOI 10.1128/IAI.01187-13; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Cottingham MG, 2012, BIOTECHNOL BIOENG, V109, P719, DOI 10.1002/bit.24342; Doolan DL, 1999, J IMMUNOL, V163, P884; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Finney OC, 2014, VACCINE, V32, P2135, DOI 10.1016/j.vaccine.2014.02.055; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Grimm CF, 2000, GASTROENTEROLOGY, V119, P1104, DOI 10.1053/gast.2000.18157; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Harimoto H, 2013, IMMUNOL CELL BIOL, V91, P545, DOI 10.1038/icb.2013.38; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; HOLLINGDALE MR, 1990, T ROY SOC TROP MED H, V84, P325, DOI 10.1016/0035-9203(90)90303-V; HOLLINGDALE MR, 1987, EXP PARASITOL, V63, P345, DOI 10.1016/0014-4894(87)90182-2; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Karnasuta C, 1995, AM J TROP MED HYG, V53, P607, DOI 10.4269/ajtmh.1995.53.607; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; MAZIER D, 1986, SCIENCE, V231, P156, DOI 10.1126/science.3510455; MELLOUK S, 1990, B WORLD HEALTH ORGAN, V68, P52; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Muller H.M., 1993, Parassitologia (Rome), V35, P69; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Pradel G, 2002, MOL MICROBIOL, V45, P637, DOI 10.1046/j.1365-2958.2002.03057.x; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; RENIA L, 1993, J IMMUNOL, V150, P1471; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; Sheehy SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065960; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; Sinnis Photini, 2013, Methods Mol Biol, V923, P385; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; World Health Organisation, 2012, WORLD MALARIA REPORT; Zimmermann M, 2008, J HEPATOL, V48, P51, DOI 10.1016/j.jhep.2007.08.008; Zou XY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-394	53	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119880	10.1371/journal.pone.0119880	http://dx.doi.org/10.1371/journal.pone.0119880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822951	Green Published, gold			2022-12-27	WOS:000352134700050
J	Meshaal, MS; Kassem, HH; Samir, A; Zakaria, A; Baghdady, Y; Rizk, HH				Meshaal, Marwa Sayed; Kassem, Hussein Heshmat; Samir, Ahmad; Zakaria, Ayman; Baghdady, Yasser; Rizk, Hussein Hassan			Impact of Routine Cerebral CT Angiography on Treatment Decisions in Infective Endocarditis	PLOS ONE			English	Article							PERIPHERAL VASCULAR-DISEASE; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; INTRACRANIAL ANEURYSMS; MR-ANGIOGRAPHY; STROKE COUNCIL; INTERDISCIPLINARY COUNCIL; CARDIOVASCULAR RADIOLOGY; PROSPECTIVE MULTICENTER; ENDOVASCULAR TREATMENT	Background Infective endocarditis (IE) is commonly complicated by cerebral embolization and hemorrhage secondary to intracranial mycotic aneurysms (ICMAs). These complications are associated with poor outcome and may require diagnostic and therapeutic plans to be modified. However, routine screening by brain CT and CT angiography (CTA) is not standard practice. We aimed to study the impact of routine cerebral CTA on treatment decisions for patients with IE. Methods From July 2007 to December 2012, we prospectively recruited 81 consecutive patients with definite left-sided IE according to modified Duke's criteria. All patients had routine brain CTA conducted within one week of admission. All patients with ICMA underwent four-vessel conventional angiography. Invasive treatment was performed for ruptured aneurysms, aneurysms >= 5 mm, and persistent aneurysms despite appropriate therapy. Surgical clipping was performed for leaking aneurysms if not amenable to intervention. Results: The mean age was 30.43 +/- 8.8 years and 60.5% were males. Staph aureus was the most common organism (32.3%). Among the patients, 37% had underlying rheumatic heart disease, 26% had prosthetic valves, 23.5% developed IE on top of a structurally normal heart and 8.6% had underlying congenital heart disease. Brain CT/CTA revealed that 51 patients had evidence of cerebral embolization, of them 17 were clinically silent. Twenty-six patients (32%) had ICMA, of whom 15 were clinically silent. Among the patients with ICMAs, 11 underwent endovascular treatment and 2 underwent neurovascular surgery. The brain CTA findings prompted different treatment choices in 21 patients (25.6%). The choices were aneurysm treatment before cardiac surgery rather than at follow-up, valve replacement by biological valve instead of mechanical valve, and withholding anticoagulation in patients with prosthetic valve endocarditis for fear of aneurysm rupture. Conclusions Routine brain CT/CTA resulted in changes in the treatment plan in a significant proportion of patients with IE, even those without clinically evident neurological disease. Routine brain CT/CTA may be indicated in all hospitalized patients with IE.	[Meshaal, Marwa Sayed; Kassem, Hussein Heshmat; Samir, Ahmad; Baghdady, Yasser; Rizk, Hussein Hassan] Cairo Univ, Dept Cardiovasc Med, Cairo, Egypt; [Zakaria, Ayman] Cairo Univ, Dept Radiol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Meshaal, MS (corresponding author), Cairo Univ, Dept Cardiovasc Med, Cairo, Egypt.	marwamashaal@kasralainy.edu.eg	Meshaal, Marwa/AAY-6946-2021; SAMIR, AHMAD/S-6357-2019	Meshaal, Marwa/0000-0003-1632-3026; SAMIR, AHMAD/0000-0003-4401-4976; Rizk, Hussien/0000-0001-5791-2359	Kasr Al Ainy School of Medicine	Kasr Al Ainy School of Medicine	This work was supported by Kasr Al Ainy School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almandoz JED, 2012, J NEUROSURG, V117, P309, DOI 10.3171/2012.4.JNS112306; Baddour LM, 2005, CIRCULATION; Bederson JB, 2000, CIRCULATION, V102, P2300; CAMARATA PJ, 1993, INVEST RADIOL, V28, P373, DOI 10.1097/00004424-199304000-00020; Chapot R, 2002, ENDOVASCULAR TREATME, P222; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Erdogan HB, 2004, TEX HEART I J, V31, P165; Garg N, 2005, INT J CARDIOL, V98, P253, DOI 10.1016/j.ijcard.2003.10.043; Goto M, 2014, CLIN NEUROL NEUROSUR, V126, P177, DOI 10.1016/j.clineuro.2014.09.003; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; Hiratsuka Yoshiyasu, 2008, Magn Reson Med Sci, V7, P169; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Iung B, 2013, STROKE, V44, P3056, DOI 10.1161/STROKEAHA.113.001470; Karamessini MT, 2004, EUR J RADIOL, V49, P212, DOI 10.1016/S0720-048X(03)00173-6; Kassem HH, 2012, HEAR J, V6, P213; Lerner PI, 1985, MED CLIN NORTH AM, P69; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lung B, 2012, EUR HEART J-CARD IMG, V13, P703, DOI 10.1093/ehjci/jes023; Meyers PM, 2010, J NEUROINTERV SURG, V2, P177, DOI 10.1161/CIRCULATIONAHA.109.192217; Numminen J, 2011, ACTA RADIOL, V52, P670, DOI 10.1258/ar.2011.100421; Nunes MCP, 2010, INT J INFECT DIS, P14; Patel FM, 2001, NEUROL INDIA, V49, P41; Piotin M, 2003, NEURORADIOLOGY, V45, P404, DOI 10.1007/s00234-002-0922-8; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Trabelsi I, 2008, AM J CARDIOL, V102, P1247, DOI 10.1016/j.amjcard.2008.06.052; Uysal Ender, 2005, Diagn Interv Radiol, V11, P77; Wajnberg E, 2008, ARQ NEURO-PSIQUIAT, V66, P790, DOI 10.1590/S0004-282X2008000600002; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Yildirimturk O, 2009, TURK KARDIYOL DERN A, V37, P91	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118616	10.1371/journal.pone.0118616	http://dx.doi.org/10.1371/journal.pone.0118616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823006	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700021
J	Sun, DD; Hou, CJ; Yuan, LJ; Duan, YY; Hou, Y; Zhou, FP				Sun, Dan Dan; Hou, Chuan Ju; Yuan, Li Jun; Duan, Yun You; Hou, Ying; Zhou, Fang Ping			Hemodynamic Changes of the Middle Hepatic Vein in Patients with Pulmonary Hypertension Using Echocardiography	PLOS ONE			English	Article							DOPPLER WAVE-FORM; INFERIOR VENA-CAVA; SPECTRAL DOPPLER; DISEASE; FLOW; SONOGRAPHY; DIAGNOSIS; PRESSURE	The aim of this study was to analyze the changes of the middle hepatic vein (MHV) spectra in patients with pulmonary hypertension (PH) caused by congenital heart disease (CHD) and determine the proper parameters of MHV to predict PH. Eighty patients with CHD were included, whose pulmonary artery pressure was measured via right heart catheterization, and the MHV spectra were detected via echocardiography. The peak value of velocity (V) and velocity time integral (VTI) of the waves, including S wave, D wave and A wave, were measured at the end of inspiration. The values of the MHV parameters that were predictive of PH were evaluated and their cut-off points were determined. Compared with the control group, V of S wave (S), VTI of S wave (SVTI), V of D wave (D), VTI of D wave (DVTI) decreased and V of A wave (A), VTI of A wave (AVTI), A/S, AVTI/SVTI, A/(S+D), AVTI/(SVTI + DVTI) increased in the PH group. These differences were statistically significant (P<0.05). A correlation analysis determined that the ratios of A/S, A/(S+D), AVTI/(SVTI+DVTI) were positively correlated with pulmonary artery mean pressure (r= 0.529,0.575,0.438, P<0.001). An ROC curve analysis determined that the diagnostic effect of A/(S+D) was superior to the other two parameters. On the ROC curve, when the ratio of A/(S+D) was 0.30, the sensitivity was 85.37% and specificity was 75.00% for predicting PH. The spectral parameters of MHV, including the ratios of A/S, A/(S+D) and AVTI/(SVTI+DVTI), increased with increasing pulmonary pressure in CHD patients. When the ratio of A/(S+D) was 0.30 in MHV spectra, it had sufficient sensitivity and specificity for diagnosing PH, and this method could be used as a new non-invasive complementary echocardiographic parameter for predicting PH.	[Sun, Dan Dan] Jilin Med Coll, Dept Stomatol & Med Imaging, Changchun, Jilin Province, Peoples R China; [Sun, Dan Dan; Yuan, Li Jun; Duan, Yun You; Hou, Ying] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diag, Xian 710032, Shaanxi Provinc, Peoples R China; [Hou, Chuan Ju] Shenyang Mil Area Command, Gen Hosp, Dept Congenital Heart Dis Internal, Shenyang, Liaoning Provin, Peoples R China; [Zhou, Fang Ping] Jilin Med Coll, Affiliated Hosp, Dept Ultrasound Diag, Changchun, Jilin Province, Peoples R China	Jilin Medical University; Air Force Military Medical University; Jilin Medical University	Duan, YY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diag, Xian 710032, Shaanxi Provinc, Peoples R China.	duanyy@fmmu.edu.cn; 1046501@qq.com	sun, dandan/GZG-6540-2022		National Nature Science Foundation of China [81171349]; Science and Technology Development Program of Jilin Province of China [20130522016JH]; Science and Technology Program of Jilin City of China [201464046]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Jilin Province of China; Science and Technology Program of Jilin City of China	This work was supported by the National Nature Science Foundation of China (81171349) to YYD, the Science and Technology Development Program of Jilin Province of China (20130522016JH) DDS, and the Science and Technology Program of Jilin City of China (201464046) to DDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Z, 1992, JPN CIRC J, V56, P317, DOI 10.1253/jcj.56.317; BOLONDI L, 1991, RADIOLOGY, V178, P513, DOI 10.1148/radiology.178.2.1987617; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Cabrita IZ, 2013, EUR HEART J-CARD IMG, V14, P51, DOI 10.1093/ehjci/jes093; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Er F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015670; Fadel BM, 2015, ECHOCARDIOGR-J CARD, V32, P170, DOI 10.1111/echo.12710; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Jiang X, 2013, CURR HYPERTENS REP, V15, P638, DOI 10.1007/s11906-013-0397-5; Kruskal JB, 2004, RADIOGRAPHICS, V24, P657, DOI 10.1148/rg.243035139; LAABAN JP, 1989, THORAX, V44, P396, DOI 10.1136/thx.44.5.396; McGoon MD, 2009, MAYO CLIN PROC, V84, P191, DOI 10.1016/S0025-6196(11)60828-8; Pedersen JF, 2005, BRIT J RADIOL, V78, P242, DOI 10.1259/bjr/15227254; Scheinfeld MH, 2009, RADIOGRAPHICS, V29, P2081, DOI 10.1148/rg.297095715; Teichgraber UKM, 1997, ULTRASCHALL MED, V18, P267, DOI 10.1055/s-2007-1000440; Zhang LZ, 1995, CHIN J ULTRASONOGR, V4, P15	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121408	10.1371/journal.pone.0121408	http://dx.doi.org/10.1371/journal.pone.0121408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821961	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700102
J	Wu, HN; Zhang, YQ; Zhang, WB; Pei, XW; Zhang, C; Jia, SR; Li, WM				Wu, Huanian; Zhang, Yongqiang; Zhang, Wangbin; Pei, Xinwu; Zhang, Chao; Jia, Shirong; Li, Weimin			Transcriptomic Analysis of the Primary Roots of Alhagi sparsifolia in Response to Water Stress	PLOS ONE			English	Article							RNA-SEQ DATA; DIFFERENTIAL EXPRESSION; OSMOTIC-STRESS; DROUGHT STRESS; PLANT; GENES; SALT; TOLERANCE; GLUTATHIONE; SALINITY	Background Alhagi sparsifolia is a typical desert phreatophyte and has evolved to withstand extreme dry, cold and hot weather. While A. sparsifolia represents an ideal model to study the molecular mechanism of plant adaption to abiotic stress, no research has been done in this aspect to date. Here we took advantage of Illumina platform to survey transcriptome in primary roots of A. sparsifolia under water stress conditions in aim to facilitate the exploration of its genetic basis for drought tolerance. Methodology and Principal Findings We sequenced four primary roots samples individually collected at 0, 6, 24 and 30h from the A. sparsifolia seedlings in the course of 24h of water stress following 6h of rehydration. The resulting 38,763,230, 67,511,150, 49,259,804 and 54,744,906 clean reads were pooled and assembled into 33,255 unigenes with an average length of 1,057 bp. All-unigenes were subjected to functional annotation by searching against the public databases. Based on the established transcriptome database, we further evaluated the gene expression profiles in the four different primary roots samples, and identified numbers of differently expressed genes (DEGs) reflecting the early response to water stress (6h vs. 0h), the late response to water stress (24h vs. 0h) and the response to post water stress rehydration (30h vs. 24h). Moreover, the DEGs specifically regulated at 6, 24 and 30h were captured in order to depict the dynamic changes of gene expression during water stress and subsequent rehydration. Functional categorization of the DEGs indicated the activation of oxidoreductase system, and particularly emphasized the significance of the 'Glutathione metabolism pathway' in response to water stress. Conclusions This is the first description of the genetic makeup of A. sparsifolia, thus providing a substantial contribution to the sequence resources for this species. The identified DEGs offer a deep insight into the molecular mechanism of A. sparsifolia in response to water stress, and merit further investigation.	[Wu, Huanian; Zhang, Yongqiang; Pei, Xinwu; Zhang, Chao; Jia, Shirong; Li, Weimin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China; [Zhang, Wangbin] Tarim Univ, Coll Plant Sci, Alar 843300, Xinjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Tarim University	Li, WM (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, 12 Zhongguancun South St, Beijing 100081, Peoples R China.	liweimin01@caas.cn	pei, xinwu/O-7083-2019; Jia, Shirong/L-8788-2019; Pei, Xinwu/AAI-1736-2019	Pei, Xinwu/0000-0001-7828-3037	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2011ZX08001-002, 2011ZX08004-004]	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms	The National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2011ZX08001-002, 2011ZX08004-004).	Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Bowman MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082634; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Bustos D, 2008, ANN BOT-LONDON, V102, P551, DOI 10.1093/aob/mcn141; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Colotti G, 2011, AMINO ACIDS, V40, P269, DOI 10.1007/s00726-010-0630-3; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cui MH, 2013, FEBS LETT, V587, P1773, DOI 10.1016/j.febslet.2013.04.028; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Fujii H, 2012, CELL MOL LIFE SCI, V69, P3165, DOI 10.1007/s00018-012-1087-1; Garg R, 2013, METHODS MOL BIOL, V1069, P43, DOI 10.1007/978-1-62703-613-9_4; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui DW, 2013, J ARID LAND, V5, P542, DOI 10.1007/s40333-013-0186-7; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; Hubbard KE, 2012, ANN BOT-LONDON, V109, P5, DOI 10.1093/aob/mcr252; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Jaradat MR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-192; Kar RK, 2011, PLANT SIGNAL BEHAV, V6, P1741, DOI 10.4161/psb.6.11.17729; Kim JH, 2013, J PLANT PHYSIOL, V170, P1461, DOI 10.1016/j.jplph.2013.05.011; Koffler BE, 2014, PLANT SCI, V227, P133, DOI 10.1016/j.plantsci.2014.08.002; Kollist H, 2014, NEW PHYTOL, V203, P44, DOI 10.1111/nph.12832; Kosova K, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00711, 10.3389/fpls.2014.00343]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu B, 2013, S AFR J BOT, V86, P56, DOI 10.1016/j.sajb.2013.02.003; Liu XN, 2003, CROP SCI, V43, P678; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz WW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-264; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Micheletto S, 2007, PLANT SCI, V173, P510, DOI 10.1016/j.plantsci.2007.08.003; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Passioura JB, 1996, PLANT GROWTH REGUL, V20, P79, DOI 10.1007/BF00024003; Rabara RC, 2014, OMICS, V18, P601, DOI 10.1089/omi.2013.0177; Rabello AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-485; Ranjan A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-680; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tardieu F, 1998, J EXP BOT, V49, P419, DOI 10.1093/jexbot/49.suppl_1.419; Tausz M, 2004, J EXP BOT, V55, P1955, DOI 10.1093/jxb/erh194; Thomas FM, 2000, J APPL BOT-ANGEW BOT, V74, P212; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Veerabagu M, 2014, MOL PLANT, V7, P1560, DOI 10.1093/mp/ssu074; Vonlanthen B, 2011, FLORA, V206, P100, DOI 10.1016/j.flora.2010.01.013; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Xian LH, 2014, PLANTA, V239, P61, DOI 10.1007/s00425-013-1963-4; Xue GP, 2014, J EXP BOT, V65, P539, DOI 10.1093/jxb/ert399; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeng FJ, 2006, PLANT SOIL, V279, P129, DOI 10.1007/s11104-005-0498-2; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	75	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120791	10.1371/journal.pone.0120791	http://dx.doi.org/10.1371/journal.pone.0120791			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822368	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700075
J	Chang, YJ; Hsu, SL; Liu, YT; Lin, YH; Lin, MH; Huang, SJ; Ho, JAA; Wu, LC				Chang, Ya Ju; Hsu, Shih Lan; Liu, Yi Ting; Lin, Yu Hsuan; Lin, Ming Hui; Huang, Shu Jung; Ho, Ja-an Annie; Wu, Li-Chen			Gallic Acid Induces Necroptosis via TNF-alpha Signaling Pathway in Activated Hepatic Stellate Cells	PLOS ONE			English	Article							CATALASE GENE-EXPRESSION; OXIDATIVE STRESS; PROGRAMMED NECROSIS; NEGATIVE REGULATION; DEATH; APOPTOSIS; ANTIOXIDANT; CARCINOMA; NETWORK	Gallic acid (3, 4, 5-trihydroxybenzoic acid, GA), a natural phenolic acid widely found in gallnuts, tea leaves and various fruits, possesses several bioactivities against inflammation, oxidation, and carcinogenicity. The beneficial effect of GA on the reduction of animal hepatofibrosis has been indicated due to its antioxidative property. However, the cytotoxicity of GA autoxidation causing cell death has also been reported. Herein, we postulated that GA might target activated hepatic stellate cells (aHSCs), the cell type responsible for hepatofibrosis, to mitigate the process of fibrosis. The molecular cytotoxic mechanisms that GA exerted on aHSCs were then analyzed. The results indicated that GA elicited aHSC programmed cell death through TNF-alpha-mediated necroptosis. GA induced significant oxidative stress through the suppression of catalase activity and the depletion of glutathione (GSH). Elevated oxidative stress triggered the production of TNF-alpha facilitating the undergoing of necroptosis through the up-regulation of key necroptotic regulatory proteins TRADD and receptor-interacting protein 3 (RIP3), and the inactivation of caspase-8. Calmodulin and calpain-1 activation were engaged, which promoted subsequent lysosomal membrane permeabilization (LMP). The TNF-alpha antagonist (SPD-304) and the RIP1 inhibitor (necrostatin-1, Nec-1) confirmed GA-induced TNFR1-mediated necroptosis. The inhibition of RIP1 by Nec-1 diverted the cell death from necroptosis to apoptosis, as the activation of caspase 3 and the increase of cytochrome c. Collectively, this is the first report indicating that GA induces TNF signaling-triggered necroptosis in aHSCs, which may offer an alternative strategy for the amelioration of liver fibrosis.	[Chang, Ya Ju; Ho, Ja-an Annie] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Hsu, Shih Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Liu, Yi Ting; Lin, Yu Hsuan; Lin, Ming Hui; Huang, Shu Jung; Wu, Li-Chen] Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan	National Taiwan University; Taichung Veterans General Hospital; National Chi Nan University	Wu, LC (corresponding author), Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan.	lw25@ncnu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Ho, Annie/0000-0001-6684-1118	Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU) [1027902, 1017901]; National Science Council of Taiwan (NSC) [101-2627-M-260-001, 101-2113-M-260-002-MY2]; National Chi Nan University; Taichung Veterans General Hospital; National Science Council Taiwan	Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU); National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Chi Nan University; Taichung Veterans General Hospital; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU) 1027902, National Science Council of Taiwan (NSC) 101-2627-M-260-001, National Science Council of Taiwan (NSC) 101-2113-M-260-002-MY2, and Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU)-1017901. National Chi Nan University, http://www.ncnu.edu.tw/ncnuweb/; Taichung Veterans General Hospital, http://www.vghtc.gov.tw/home/index.html; National Science Council Taiwan, http://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bors W, 2000, ARCH BIOCHEM BIOPHYS, V374, P347, DOI 10.1006/abbi.1999.1606; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chia YC, 2010, MOLECULES, V15, P8377, DOI 10.3390/molecules15118377; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Chuang CY, 2010, J AGR FOOD CHEM, V58, P2943, DOI 10.1021/jf9043265; Georgiadis Vassilis, 2012, JAKSTAT, V1, P200, DOI 10.4161/jkst.20968; Guimaraes ELM, 2006, LIVER INT, V26, P477, DOI 10.1111/j.1478-3231.2006.01245.x; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Hentze H, 2002, J BIOL CHEM, V277, P5588, DOI 10.1074/jbc.M110766200; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hynes MJ, 2001, J INORG BIOCHEM, V85, P131, DOI 10.1016/S0162-0134(01)00205-7; Inoue M, 2000, BIOL PHARM BULL, V23, P1153, DOI 10.1248/bpb.23.1153; INOUE M, 1994, BIOCHEM BIOPH RES CO, V204, P898, DOI 10.1006/bbrc.1994.2544; Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; Min JY, 2010, FEBS LETT, V584, P2427, DOI 10.1016/j.febslet.2010.04.048; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Nabavi SM, 2013, MOL CELL BIOCHEM, V372, P233, DOI 10.1007/s11010-012-1464-y; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Ohno Y, 1999, ANTI-CANCER DRUG, V10, P845, DOI 10.1097/00001813-199910000-00008; Pourahmad J, 2012, TOXICOL IN VITRO, V26, P545, DOI 10.1016/j.tiv.2012.01.020; Qiu XB, 2000, HEART VESSELS, V15, P90, DOI 10.1007/s003800070038; Quan X, 2011, FEBS LETT, V585, P3436, DOI 10.1016/j.febslet.2011.09.035; Rasool MK, 2010, J PHARM PHARMACOL, V62, P638, DOI 10.1211/jpp.62.05.0012; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Russell LH, 2012, ANTICANCER RES, V32, P1595; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; SATO K, 1992, MOL CELL BIOL, V12, P2525, DOI 10.1128/MCB.12.6.2525; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Takeuchi T, 2000, J BIOCHEM-TOKYO, V128, P1025, DOI 10.1093/oxfordjournals.jbchem.a022830; Traister A, 2005, SCAND J GASTROENTERO, V40, P1226, DOI 10.1080/00365520510023341; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Yanez J, 2004, NUTR CANCER, V49, P191, DOI 10.1207/s15327914nc4902_11; You BR, 2011, MOL CELL BIOCHEM, V357, P295, DOI 10.1007/s11010-011-0900-8; You BR, 2011, DRUG CHEM TOXICOL, V34, P38, DOI 10.3109/01480545.2010.494182; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005	42	34	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120713	10.1371/journal.pone.0120713	http://dx.doi.org/10.1371/journal.pone.0120713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816210	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600044
J	Konieczna, P; Schiavi, E; Ziegler, M; Groeger, D; Healy, S; Grant, R; O'Mahony, L				Konieczna, Patrycja; Schiavi, Elisa; Ziegler, Mario; Groeger, David; Healy, Selena; Grant, Ray; O'Mahony, Liam			Human Dendritic Cell DC-SIGN and TLR-2 Mediate Complementary Immune Regulatory Activities in Response to Lactobacillus rhamnosus JB-1	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; HISTAMINE-RECEPTOR 2; T-CELLS; GUT MICROBIOTA; BACTERIUM; COMMENSAL; SYSTEM; ACIDOPHILUS; RECOGNITION; HOMEOSTASIS	The microbiota is required for optimal host development and ongoing immune homeostasis. Lactobacilli are common inhabitants of the mammalian large intestine and immunoregulatory effects have been described for certain, but not all, strains. The mechanisms underpinning these protective effects are beginning to be elucidated. One such protective organism is Lactobacillus rhamnosus JB-1 (Lb. rhamnosus JB-1). Lb. murinus has no such anti-inflammatory protective effects and was used as a comparator organism. Human monocyte-derived dendritic cells (MDDCs) were co-incubated with bacteria and analysed over time for bacterial adhesion and intracellular processing, costimulatory molecule expression, cytokine secretion and induction of lymphocyte polarization. Neutralising antibodies were utilized to identify the responsible MDDC receptors. Lb. rhamnosus JB-1 adhered to MDDCs, but internalization and intracellular processing was significantly delayed, compared to Lb. murinus which was rapidly internalized and processed. Lb. murinus induced CD80 and CD86 expression, accompanied by high levels of cytokine secretion, while Lb. rhamnosus JB-1 was a poor inducer of costimulatory molecule expression and cytokine secretion. Lb. rhamnosus JB-1 primed MDDCs induced Foxp3 expression in autologous lymphocytes, while Lb. murinus primed MDDCs induced Foxp3, T-bet and Ror-.t expression. DC-SIGN was required for Lb. rhamnosus JB-1 adhesion and influenced IL-12 secretion, while TLR-2 influenced IL-10 and IL-12 secretion. Here we demonstrate that the delayed kinetics of bacterial processing by MDDCs correlates with MDDC activation and stimulation of lymphocytes. Thus, inhibition or delay of intracellular processing may be a novel strategy by which certain commensals may avoid the induction of proinflammatory responses.	[Konieczna, Patrycja; Schiavi, Elisa; Ziegler, Mario; O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland; [Groeger, David; Healy, Selena] Alimentary Hlth Ltd, Cork, Ireland; [Grant, Ray] Alimentary Hlth Pharma Davos, Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	O'Mahony, L (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland.	liam.omahony@siaf.uzh.ch	O'Mahony, Liam/AAG-5838-2019	O'Mahony, Liam/0000-0003-4705-3583	Swiss National Foundation [310030-127356, 310030 144219]; Allergiestiftung Ulrich Muller-Gierok; European Union; EU	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Allergiestiftung Ulrich Muller-Gierok; European Union(European Commission); EU(European Commission)	Funding: The authors are supported by Swiss National Foundation grants (project numbers 310030-127356 and 310030 144219), Allergiestiftung Ulrich Muller-Gierok, European Union research grants and EU Marie Curie grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akdis M, 2009, NAT REV DRUG DISCOV, V8, P645, DOI 10.1038/nrd2653; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Ferstl R, 2014, J ALLERGY CLIN IMMUN, V134, P744, DOI 10.1016/j.jaci.2014.04.034; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Karimi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047556; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Khan MW, 2012, IMMUNOTHERAPY-UK, V4, P151, DOI [10.2217/IMT.11.163, 10.2217/imt.11.163]; Konieczna P, 2012, GUT MICROBES, V3, P261, DOI 10.4161/gmic.20358; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; O'Mahony L, 2010, AUTOIMMUNITY, V43, P493, DOI 10.3109/08916931003674725; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pluznick JL, 2014, GUT MICROBES, V5, P202, DOI 10.4161/gmic.27492; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schiavi E, 2015, CURR OPIN GASTROEN, V31, P98, DOI 10.1097/MOG.0000000000000155; Shanahan F, 2010, AM J GASTROENTEROL, V105, P275, DOI 10.1038/ajg.2009.729; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	40	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120261	10.1371/journal.pone.0120261	http://dx.doi.org/10.1371/journal.pone.0120261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816321	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000352133600031
J	Sato, Y; Hayashida, N; Orita, M; Urata, H; Shinkawa, T; Fukushima, Y; Nakashima, Y; Kudo, T; Yamashita, S; Takamura, N				Sato, Yoshinobu; Hayashida, Naomi; Orita, Makiko; Urata, Hideko; Shinkawa, Tetsuko; Fukushima, Yoshiko; Nakashima, Yumiko; Kudo, Takashi; Yamashita, Shunichi; Takamura, Noboru			Factors Associated with Nurses' Intention to Leave Their Jobs after the Fukushima Daiichi Nuclear Power Plant Accident	PLOS ONE			English	Article							SATISFACTION; HOSPITALS; PRIVATE; TAIWAN	We conducted a survey among nurses who were working at the Fukushima Medical University Hospital at the time of the Fukushima Daiichi Nuclear Power Plant accident to clarify the factors associated with their intention to leave their jobs during the radiation emergency. We asked 345 nurses (17 men and 328 women) about their intention to leave their jobs after the accident. We also asked about relevant factors including the participants' demographic factors, living situation, working status, and knowledge of radiation health effects. We found that living with preschoolers (OR = 1.87, 95% CI: 1.02-3.44, p = 0.042), anxiety about life in Fukushima City after the accident (OR = 5.55, 95% CI: 1.18-26.13, p = 0.030), consideration of evacuation from Fukushima after the accident (OR = 2.42, 95% CI: 1.45-4.06, p = 0.001), consideration of the possible radiation health effects in children (OR = 1.90, 95% CI: 1.02-3.44, p = 0.042), and anxiety about relationships with colleagues in the hospital after the accident (OR = 3.23, p = 0.001) were independently associated with the nurses' intention to leave their jobs after the accident. On the other hand, the percentage of nurses with knowledge on radiation health effects was relatively low among those who had the intention to leave the job and among those who did not have the intention to leave the job after the accident, with no significant differences between the two groups. Our results suggest the need for an education program for nurses regarding radiation health effects.	[Sato, Yoshinobu; Hayashida, Naomi; Orita, Makiko; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Sato, Yoshinobu; Nakashima, Yumiko] Fukushima Med Univ Hosp, Fukushima, Japan; [Orita, Makiko; Urata, Hideko; Shinkawa, Tetsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki 852, Japan; [Fukushima, Yoshiko] Hirosaki Univ, Sch Hlth Sci, Hirosaki, Aomori, Japan; [Kudo, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 852, Japan	Nagasaki University; Fukushima Medical University; Nagasaki University; Hirosaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234	Grants-in-Aid for Scientific Research [25282042, 26305025, 15K00540] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		AbuAlRub RF, 2009, INT NURS REV, V56, P326, DOI 10.1111/j.1466-7657.2009.00718.x; [Anonymous], 2014, 16 REV BOARD M FUK P; Chen HC, 2008, INT J NURS STUD, V45, P277, DOI 10.1016/j.ijnurstu.2006.08.010; El-Jardali F, 2009, BMC NURS, V8, DOI 10.1186/1472-6955-8-3; Estryn-Behar M, 2007, MED CARE, V45, P939, DOI 10.1097/MLR.0b013e31806728d8; Fukushima International Association, INF RAD RAD MAT Q A; Hart SE, 2005, J NURS SCHOLARSHIP, V37, P173, DOI 10.1111/j.1547-5069.2005.00030.x; Kudo Y, 2006, J OCCUP HEALTH, V48, P504, DOI 10.1539/joh.48.504; Liou SR, 2010, J CLIN NURS, V19, P1635, DOI 10.1111/j.1365-2702.2009.03080.x; Ma JC, 2009, NURS ECON, V27, P178; Mrayyan Majd Tawfeeq, 2005, J Nurs Manag, V13, P40, DOI 10.1111/j.1365-2834.2004.00453.x; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Nuclear Emergency Response Headquarters of Japanese Government, 2 NUCL EM RESP HEADQ; Nuclear Emergency Response Headquarters of Japanese Government, JAP GOV IAEA MIN C N; Ohno K, 2011, RADIAT PROT DOSIM, V147, P343, DOI 10.1093/rpd/ncr342; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Reconstruction Agency, NUMB EV IW MIYAG FUK; Sourdif Jacynthe, 2004, Nurs Health Sci, V6, P59, DOI 10.1111/j.1442-2018.2003.00174.x; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2013, UNSCEAR 2013 REP ANN; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105	21	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122389	10.1371/journal.pone.0122389	http://dx.doi.org/10.1371/journal.pone.0122389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816345	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600175
J	Xu, MY; Chen, XH; Yin, H; Yin, LQ; Liu, F; Fu, YC; Yao, JW; Deng, XL				Xu, Mingyan; Chen, Xihe; Yin, Hao; Yin, Liqin; Liu, Fan; Fu, Yucai; Yao, Jiangwu; Deng, Xiaoling			Cloning and Characterization of the Human Integrin beta 6 Gene Promoter	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; EXPRESSION; ALPHA-V-BETA-6; ACTIVATION; MOTILITY; CANCER; CELLS; STAT3	The integrin beta 6 (ITGB6) gene, which encodes the limiting subunit of the integrin av beta 6 heterodimer, plays an important role in wound healing and carcinogenesis. The mechanism underlying ITGB6 regulation, including the identification of DNA elements and cognate transcription factors responsible for basic transcription of human ITGB6 gene, remains unknown. This report describes the cloning and characterization of the human ITGB6 promoter. Using 50-RACE (rapid amplification of cDNA ends) analysis, the transcriptional initiation site was identified. Promoter deletion analysis identified and functionally validated a TATA box located in the region -24 to -18 base pairs upstream of the ITGB6 promoter. The regulatory elements for transcription of the ITGB6 gene were predominantly located -289 to -150 from the ITGB6 promoter and contained putative binding sites for transcription factors such as STAT3 and C/EBP alpha. Using chromatin immunoprecipitation assays, this study has demonstrated, for the first time, that transcription factors STAT3 and C/EBP alpha are involved in the positive regulation of ITGB6 transcription in oral squamous cell carcinoma cells. These findings have important implications for unraveling the mechanism of abnormal ITGB6 activation in tissue remodeling and tumorigenesis.	[Xu, Mingyan; Yao, Jiangwu] Xiamen Stomatol Hosp, Xiamen Stomatol Res Inst, Dept Oral Biol & Biomat, Xiamen, Fujian, Peoples R China; [Xu, Mingyan; Liu, Fan; Deng, Xiaoling] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Chen, Xihe; Yin, Hao; Yin, Liqin; Fu, Yucai] Shantou Univ, Coll Med, Lab Cell Senescence, Shantou, Guangdong, Peoples R China	Xiamen University; Shantou University	Yao, JW (corresponding author), Xiamen Stomatol Hosp, Xiamen Stomatol Res Inst, Dept Oral Biol & Biomat, Xiamen, Fujian, Peoples R China.	dentyjw@126.com; xiaolingdeng@xmu.edu.cn			National Natural Sciences Foundation of China [81072208, 30900661, 81370160]; Medical Innovation Project of Fujian Province [2014CXB-47]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Innovation Project of Fujian Province	This work was supported by the National Natural Sciences Foundation of China (81072208 to MX, 30900661 and 81370160 to XD) and Medical Innovation Project of Fujian Province (2014CXB-47 to MX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1997, CANCER LETT, V118, P101, DOI 10.1016/S0304-3835(97)00234-6; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bansal M, 2014, CURR OPIN STRUC BIOL, V25, P77, DOI 10.1016/j.sbi.2014.01.007; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Breous E, 2005, MOL CELL ENDOCRINOL, V245, P169, DOI 10.1016/j.mce.2005.11.009; BREUSS JM, 1995, J CELL SCI, V108, P2241; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Deng XL, 2013, INT J BIOCHEM CELL B, V45, P1366, DOI 10.1016/j.biocel.2013.04.003; Duran EM, 2005, FRONT BIOSCI-LANDMRK, V10, P2955, DOI 10.2741/1751; Ganguly KK, 2013, CELL ADH MIGR, V7; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kumar M, 2013, INT J CANCER, V132, P2032, DOI 10.1002/ijc.27880; Li DR, 2012, BIOTECHNIQUES, V52, P173, DOI 10.2144/000113821; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; LopezRodriguez C, 1997, J BIOL CHEM, V272, P29120, DOI 10.1074/jbc.272.46.29120; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; STARR DB, 1995, J MOL BIOL, V250, P434; Sullivan BP, 2011, J PHARMACOL EXP THER, V337, P471, DOI 10.1124/jpet.110.177337; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaragoza K, 2010, MOL CELL BIOL, V30, P2293, DOI 10.1128/MCB.01619-09; Zhao Y, 2012, CELL BIOCHEM FUNCT, V30, P340, DOI 10.1002/cbf.2810	33	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121439	10.1371/journal.pone.0121439	http://dx.doi.org/10.1371/journal.pone.0121439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816241	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600093
J	Weber, AM; Fernald, LCH; Galasso, E; Ratsifandrihamanana, L				Weber, Ann M.; Fernald, Lia C. H.; Galasso, Emanuela; Ratsifandrihamanana, Lisy			Performance of a Receptive Language Test among Young Children in Madagascar	PLOS ONE			English	Article							SOCIOECONOMIC GRADIENTS; IMPROVING MEASUREMENT; HEALTH-EDUCATION; LOW-INCOME; VOCABULARY; GROWTH; OUTCOMES; WEALTH	Language tests developed and validated in one country may lose their desired properties when translated for use in another, possibly resulting in misleading estimates of ability. Using Item Response Theory (IRT) methodology, we assess the performance of a test of receptive vocabulary, the U.S.-validated Peabody Picture Vocabulary Test-Third Edition (PPVT-III), when translated, adapted, and administered to children 3 to 10 years of age in Madagascar (N = 1372), in the local language (Malagasy). Though Malagasy is considered a single language, there are numerous dialects spoken in Madagascar. Our findings were that test scores were positively correlated with age and indicators of socio-economic status. However, over half (57/96) of items evidenced unexpected response variation and/or bias by local dialect spoken. We also encountered measurement error and reduced differentiation among person abilities when we used the publishers' recommended stopping rules, largely because we lost the original item ordering by difficulty when we translated test items into Malagasy. Our results suggest that bias and testing inefficiency introduced from the translation of the PPVT can be significantly reduced with the use of methods based on IRT at both the pre-testing and analysis stages. We explore and discuss implications for cross-cultural comparisons of internationally recognized tests, such as the PPVT.	[Weber, Ann M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Galasso, Emanuela] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Ratsifandrihamanana, Lisy] Le Ctr Med Educ Des Orchidees Blanches, Antananarivo, Madagascar	Stanford University; University of California System; University of California Berkeley; The World Bank	Weber, AM (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	annweber@stanford.edu		Fernald, Lia C.H./0000-0003-1555-4607	Knowledge for Change Program (KCP) of the World Bank	Knowledge for Change Program (KCP) of the World Bank	AMW acknowledges financial support from the Knowledge for Change Program (KCP) of the World Bank (http://www.worldbank.org/) for the analysis of the data used for this manuscript. The World Bank was responsible for the design and data collection of a larger scale study that generated the data used for this paper, however the KCP had no role in this secondary data analysis, decision to publish, or preparation of the manuscript. Any opinion, findings, and recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the World Bank.	[Anonymous], EXAMINING CHILD DEV; Baranowski T, 2006, HEALTH EDUC RES, V21, P98, DOI 10.1093/her/cyl087; BrooksGunn J, 1996, CHILD DEV, V67, P396; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cueto S, 2009, 15 YOUNG LIV DEP INT; Dahl O., 2011, N S CONTRIBUTIONS AF, P51, DOI Cologne; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Dunn L. M., 1986, TEST VOCABULARIO IM; Dunn L.M., 1981, PEABODY PICTURE VOCA; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2012, P NATL ACAD SCI USA, V109, P17273, DOI 10.1073/pnas.1121241109; Fernald LCH, 2011, DEVELOPMENTAL SCI, V14, P832, DOI 10.1111/j.1467-7687.2010.01032.x; FERNANDEZ MC, 1992, HISPANIC J BEHAV SCI, V14, P268, DOI 10.1177/07399863920142006; Ferne T., 2007, LANG ASSESS Q, V4, P113, DOI [10.1080/15434300701375923, DOI 10.1080/15434300701375923]; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; GranthamMcGregor SM, 1997, AM J CLIN NUTR, V66, P247, DOI 10.1093/ajcn/66.2.247; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; Kuhl P, 2008, ANNU REV NEUROSCI, V31, P511, DOI 10.1146/annurev.neuro.30.051606.094321; Lewis Paul, 2015, ETHNOLOGUE LANGUAGES; Macours K., 2008, CASH TRANSFERS BEHAV; Marchman VA, 2008, DEVELOPMENTAL SCI, V11, pF9, DOI 10.1111/j.1467-7687.2008.00671.x; Muchinsky PM, 1996, EDUC PSYCHOL MEAS, V56, P63, DOI 10.1177/0013164496056001004; National Scientific Council on the Developing Child, 2007, 5 NAT SCI COUNC DEV; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Pack I., 2002, THESIS U CALIFORNIA; Paek I, 2011, EDUC PSYCHOL MEAS, V71, P1023, DOI 10.1177/0013164411400734; Paxson C, 2008, EC DEV CULTURAL CHAN, V59, P187; Paxson C, 2007, J HUM RESOUR, V42, P49, DOI 10.3368/jhr.XLII.1.49; Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x; Pollitt E, 1999, FOOD NUTR B, V20; Sharp M, 2011, HLTH NUTR POPULATION; Simos PG, 2011, ASSES EFF INTERV, V37, P34, DOI 10.1177/1534508411413254; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; The American Educational Research Association The American Psychological Association & The National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Traub RE., 1997, ED MEAS ISS PRACT, V16, P8, DOI [10.1111/j.1745-3992.1997.tb00603.x, DOI 10.1111/J.1745-3992.1997.TB00603.X]; UN General Assembly, 1989, CONV RIGHTS CHILD; UNICEF MICS, 1995, SER COUNTR SURV; USAID, EDDATA 2 ED DAT DEC; Williams K.T., 1997, TECHNICAL REFERENCES, V3rd; Wilson M., 2005, CONSTRUCTING MEASURE; Wilson M, 2006, HEALTH EDUC RES, V21, P19, DOI 10.1093/her/cyl053; Wilson M, 2006, HEALTH EDUC RES, V21, P4, DOI 10.1093/her/cyl108; Wu MargaretL., 2007, ACER CONQUEST VERSIO	48	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121767	10.1371/journal.pone.0121767	http://dx.doi.org/10.1371/journal.pone.0121767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830221	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600084
J	Dodbiba, L; Teichman, J; Fleet, A; Thai, H; Starmans, MHW; Navab, R; Chen, Z; Girgis, H; Eng, L; Espin-Garcia, O; Shen, XW; Bandarchi, B; Schwock, J; Tsao, MS; El-Zimaity, H; Der, SD; Xu, W; Bristow, RG; Darling, GE; Boutros, PC; Ailles, LE; Liu, G				Dodbiba, Lorin; Teichman, Jennifer; Fleet, Andrew; Thai, Henry; Starmans, Maud H. W.; Navab, Roya; Chen, Zhuo; Girgis, Hala; Eng, Lawson; Espin-Garcia, Osvaldo; Shen, Xiaowei; Bandarchi, Bizhan; Schwock, Joerg; Tsao, Ming-Sound; El-Zimaity, Hala; Der, Sandy D.; Xu, Wei; Bristow, Robert G.; Darling, Gail E.; Boutros, Paul C.; Ailles, Laurie E.; Liu, Geoffrey			Appropriateness of Using Patient-Derived Xenograft Models for Pharmacologic Evaluation of Novel Therapies for Esophageal/Gastro-Esophageal Junction Cancers	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SQUAMOUS-CELL CARCINOMA; INTRATUMOR HETEROGENEITY; ADENOCARCINOMA CELL; GENE-EXPRESSION; LINES; GROWTH; EXPLORATION; EVOLUTION	The high morbidity and mortality of patients with esophageal (E) and gastro-esophageal junction (GEJ) cancers, warrants new pre-clinical models for drug testing. The utility of primary tumor xenografts (PTXGs) as pre-clinical models was assessed. Clinicopathological, immunohistochemical markers (p53, p16, Ki-67, Her-2/neu and EGFR), and global mRNA abundance profiles were evaluated to determine selection biases of samples implanted or engrafted, compared with the underlying population. Nine primary E/GEJ adenocarcinoma xenograft lines were further characterized for the spectrum and stability of gene/protein expression over passages. Seven primary esophageal adenocarcinoma xenograft lines were treated with individual or combination chemotherapy. Tumors that were implanted (n= 55) in NOD/SCID mice had features suggestive of more aggressive biology than tumors that were never implanted (n= 32). Of those implanted, 21/55 engrafted; engraftment was associated with poorly differentiated tumors (p= 0.04) and older patients (p= 0.01). Expression of immunohistochemical markers were similar between patient sample and corresponding xenograft. mRNA differences observed between patient tumors and first passage xenografts were largely due to loss of human stroma in xenografts. mRNA patterns of early vs late passage xenografts and of small vs large tumors of the same passage were similar. Complete resistance was present in 2/7 xenografts while the remaining tumors showed varying degrees of sensitivity, that remained constant across passages. Because of their ability to recapitulate primary tumor characteristics during engraftment and across serial passaging, PTXGs can be useful clinical systems for assessment of drug sensitivity of human E/GEJ cancers.	[Dodbiba, Lorin; Teichman, Jennifer; Chen, Zhuo; Bristow, Robert G.; Boutros, Paul C.; Ailles, Laurie E.; Liu, Geoffrey] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Dodbiba, Lorin] Wayne State Univ, Sch Med, Detroit, MI USA; [Fleet, Andrew; Navab, Roya; Eng, Lawson; Bandarchi, Bizhan; Tsao, Ming-Sound; Der, Sandy D.; Bristow, Robert G.; Ailles, Laurie E.; Liu, Geoffrey] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Thai, Henry; Tsao, Ming-Sound; El-Zimaity, Hala] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada; [Starmans, Maud H. W.; Espin-Garcia, Osvaldo; Shen, Xiaowei; Xu, Wei; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Starmans, Maud H. W.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol Maastro, Maastricht, Netherlands; [Girgis, Hala; Schwock, Joerg; Tsao, Ming-Sound; El-Zimaity, Hala] Toronto Gen Hosp, Dept Anat Pathol, Toronto, ON, Canada; [Darling, Gail E.] Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Liu, Geoffrey] Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Xu, Wei] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Wayne State University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Maastricht University; Maastricht University Medical Centre (MUMC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Liu, G (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	geoffrey.liu@uhn.ca	Liu, Geoffrey/N-4421-2016; Eng, Lawson/AAB-8539-2020; Navab, Roya/AGD-7380-2022; Teichman, Jennifer/AHE-5052-2022; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Teichman, Jennifer/0000-0002-7538-5772; Tsao, Ming Sound/0000-0002-9160-5405; Schwock, Joerg/0000-0001-8889-5600; Bristow, Robert/0000-0002-8553-9544; Boutros, Paul/0000-0003-0553-7520; Liu, Geoffrey/0000-0002-2603-7296; Eng, Lawson/0000-0002-4816-8385	Alan B. Brown Chair in Molecular Genomics, Posluns Family Fund; CCO Chair in Experimental Therapeutics and Population Studies; Ontario Institute for Cancer Research through Government of Ontario; Ontario Institute for Cancer Research New Investigator Award; Terry Fox Research Institute New Investigator Award	Alan B. Brown Chair in Molecular Genomics, Posluns Family Fund; CCO Chair in Experimental Therapeutics and Population Studies; Ontario Institute for Cancer Research through Government of Ontario; Ontario Institute for Cancer Research New Investigator Award; Terry Fox Research Institute New Investigator Award	GL was supported by the Alan B. Brown Chair in Molecular Genomics, Posluns Family Fund and CCO Chair in Experimental Therapeutics and Population Studies. This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. LEA was supported by an Ontario Institute for Cancer Research New Investigator Award. PCB was supported by a Terry Fox Research Institute New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele M, 1999, CANCER GENET CYTOGEN, V110, P94, DOI 10.1016/S0165-4608(98)00205-2; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonstra JJ, 2012, GENE CHROMOSOME CANC, V51, P272, DOI 10.1002/gcc.20952; Chen JC, 1996, ORAL SURG ORAL MED O, V81, P197, DOI 10.1016/S1079-2104(96)80415-X; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Delpisheh Ali, 2014, Gastroenterol Hepatol Bed Bench, V7, P101; Dodbiba L, 2013, LAB INVEST, V93, P397, DOI 10.1038/labinvest.2013.8; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Fiebig H H, 1984, Behring Inst Mitt, P343; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeuken JWM, 2000, J NEUROSURG, V92, P652, DOI 10.3171/jns.2000.92.4.0652; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Kim T, 2011, J SURG ONCOL, V103, P179, DOI 10.1002/jso.21784; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Pertschuk Louis P., 1999, Breast J, V5, P369, DOI 10.1046/j.1524-4741.1999.97088.x; Raju U, 2006, RADIOTHER ONCOL, V80, P185, DOI 10.1016/j.radonc.2006.07.027; Reyal F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3095; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Sakamoto Y, 1993, Gan To Kagaku Ryoho, V20, P447; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Santander S, 2012, INT J ONCOL, V40, P527, DOI 10.3892/ijo.2011.1219; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Situ DR, 2013, J THORAC CARDIOV SUR, V146, P45, DOI 10.1016/j.jtcvs.2013.01.034; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Taddei A, 2014, DIGEST DIS SCI, V59, P949, DOI 10.1007/s10620-013-2975-4; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121872	10.1371/journal.pone.0121872	http://dx.doi.org/10.1371/journal.pone.0121872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826681	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800056
J	Fernandez-de-Una, L; Canellas, I; Gea-Izquierdo, G				Fernandez-de-Una, Laura; Canellas, Isabel; Gea-Izquierdo, Guillermo			Stand Competition Determines How Different Tree Species Will Cope with a Warming Climate	PLOS ONE			English	Article							SCOTS PINE; GROWTH-RESPONSE; INTRASPECIFIC COMPETITION; DROUGHT; DECLINE; OAK; VARIABILITY; ADAPTATION; MORTALITY; FORESTS	Plant-plant interactions influence how forests cope with climate and contribute to modulate species response to future climate scenarios. We analysed the functional relationships between growth, climate and competition for Pinus sylvestris, Quercus pyrenaica and Quercus faginea to investigate how stand competition modifies forest sensitivity to climate and simulated how annual growth rates of these species with different drought tolerance would change throughout the 21st century. Dendroecological data from stands subjected to thinning were modelled using a novel multiplicative nonlinear approach to overcome biases related to the general assumption of a linear relationship between covariates and to better mimic the biological relationships involved. Growth always decreased exponentially with increasing competition, which explained more growth variability than climate in Q. faginea and P. sylvestris. The effect of precipitation was asymptotic in all cases, while the relationship between growth and temperature reached an optimum after which growth declined with warmer temperatures. Our growth projections indicate that the less drought-tolerant P. sylvestris would be more negatively affected by climate change than the studied sub-Mediterranean oaks. Q. faginea and P. sylvestris mean growth would decrease under all the climate change scenarios assessed. However, P. sylvestris growth would decline regardless of the competition level, whereas this decrease would be offset by reduced competition in Q. faginea. Conversely, Q. pyrenaica growth would remain similar to current rates, except for the warmest scenario. Our models shed light on the nature of the species-specific interaction between climate and competition and yield important implications for management. Assuming that individual growth is directly related to tree performance, trees under low competition would better withstand the warmer conditions predicted under climate change scenarios but in a variable manner depending on the species. Thinning following an exponential rule may be desirable to ensure long-term conservation of high-density Mediterranean woodlands, particularly in drought-limited sites.	[Fernandez-de-Una, Laura; Canellas, Isabel; Gea-Izquierdo, Guillermo] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr, Madrid, Spain; [Gea-Izquierdo, Guillermo] Univ Aix Marseille, CNRS, UMR 7330, CEREGE, Aix En Provence, France	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite	Fernandez-de-Una, L (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr, Madrid, Spain.	fernandez.laura@inia.es	Gea-Izquierdo, Guillermo/AAZ-2645-2021; Canellas, Isabel/B-7658-2008; Fernández-de-Uña, Laura/AAU-1785-2020	Gea-Izquierdo, Guillermo/0000-0003-0148-3721; Canellas, Isabel/0000-0002-9716-7776; Fernandez de Una, Laura/0000-0001-8136-2545	Spanish Ministry of Economy and Competitiveness [AGL2010-21153-C02-01, AGL2013-46028R]; Madrid Regional Government (projects REGENFOR); Madrid Regional Government [S2013/MAE-2760]; INIA [AT2013-0004]; FPI fellowship [BES-2011-047651]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Madrid Regional Government (projects REGENFOR); Madrid Regional Government; INIA(Instituto de Investigacion Agropecuaria (INIA)); FPI fellowship(Spanish Government)	Funding was provided by the Spanish Ministry of Economy and Competitiveness (projects AGL2010-21153-C02-01 and AGL2013-46028R), Madrid Regional Government (projects REGENFOR and S2013/MAE-2760) and INIA (project AT2013-0004). LFU was supported by a FPI fellowship (BES-2011-047651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; [Anonymous], 2003, TIME SERIES ANAL PRE; Benavides R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059824; Bigler C, 2004, FOREST ECOL MANAG, V199, P183, DOI 10.1016/j.foreco.2004.04.019; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; BREDA N, 1995, TREE PHYSIOL, V15, P295, DOI 10.1093/treephys/15.5.295; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canellas I, 2004, ANN FOREST SCI, V61, P243, DOI 10.1051/forest:2004017; Canellas I., 1996, Annali dell'Istituto Sperimentale per la Selvicoltura, V27, P143; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Chen PY, 2010, GLOBAL CHANGE BIOL, V16, P3374, DOI 10.1111/j.1365-2486.2010.02166.x; Corcuera L, 2002, TREES-STRUCT FUNCT, V16, P465, DOI 10.1007/s00468-002-0187-1; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Duursma RA, 2008, TREE PHYSIOL, V28, P265, DOI 10.1093/treephys/28.2.265; Eilmann B, 2009, TREE PHYSIOL, V29, P1011, DOI 10.1093/treephys/tpp035; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Fichtner A, 2012, J APPL ECOL, V49, P1306, DOI 10.1111/j.1365-2664.2012.02196.x; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Gea-Izquierdo G, 2014, FOREST ECOL MANAG, V320, P70, DOI 10.1016/j.foreco.2014.02.025; Gea-Izquierdo G, 2013, FOREST ECOL MANAG, V305, P282, DOI 10.1016/j.foreco.2013.05.058; Gea-Izquierdo G, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009080; Gea-Izquierdo G, 2009, FOREST SCI, V55, P310; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Herrera S, 2012, INT J CLIMATOL, V32, P74, DOI 10.1002/joc.2256; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056758; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Camarero JJ, 2011, FOREST ECOL MANAG, V262, P759, DOI 10.1016/j.foreco.2011.05.009; Kirchner M, 2013, INT J CLIMATOL, V33, P539, DOI 10.1002/joc.3444; Kouba Y, 2012, FOREST ECOL MANAG, V274, P143, DOI 10.1016/j.foreco.2012.02.033; Landsberg J, 2011, TERR ECOL SER, V4, P13, DOI 10.1016/S1936-7961(11)04002-4; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loehle C, 2009, CLIMATIC CHANGE, V94, P233, DOI 10.1007/s10584-008-9488-8; Martin-Benito D, 2011, FOREST ECOL MANAG, V262, P1030, DOI 10.1016/j.foreco.2011.05.038; Martin-Benito D, 2010, FOREST ECOL MANAG, V259, P967, DOI 10.1016/j.foreco.2009.12.001; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2012, OECOLOGIA, V168, P877, DOI 10.1007/s00442-011-2132-8; McDowell N, 2003, PLANT CELL ENVIRON, V26, P631, DOI 10.1046/j.1365-3040.2003.00999.x; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Misson L, 2011, GLOBAL CHANGE BIOL, V17, P1036, DOI 10.1111/j.1365-2486.2010.02348.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Montserrat-Marti G, 2009, TREES-STRUCT FUNCT, V23, P787, DOI 10.1007/s00468-009-0320-5; Moreno-Gutierrez C, 2012, PLANT CELL ENVIRON, V35, P1026, DOI 10.1111/j.1365-3040.2011.02469.x; Mugica FF, 1998, HOLOCENE, V8, P69, DOI 10.1191/095968398675691171; Murphy L, 2012, LIKELIHOOD METHODS M; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Piutti E, 1997, CAN J FOREST RES, V27, P277, DOI 10.1139/x96-176; Pretzsch H, 2005, FOREST SCI, V51, P304; R Core Team, 2021, R LANGUAGE ENV STAT; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Rozas V, 2012, GLOBAL PLANET CHANGE, V94-95, P62, DOI 10.1016/j.gloplacha.2012.07.004; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; de Dios RS, 2009, PLANT ECOL, V204, P189, DOI 10.1007/s11258-009-9584-5; Sarris D, 2007, GLOBAL CHANGE BIOL, V13, P1187, DOI 10.1111/j.1365-2486.2007.01348.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tolwinski-Ward SE, 2011, CLIM DYNAM, V36, P2419, DOI 10.1007/s00382-010-0945-5; Vaganov E. A., 2006, GROWTH DYNAMICS CONI; Valbuena-Carabana M, 2008, FOREST ECOL MANAG, V254, P225, DOI 10.1016/j.foreco.2007.08.001; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747	69	57	58	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122255	10.1371/journal.pone.0122255	http://dx.doi.org/10.1371/journal.pone.0122255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826446	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800064
J	Liang, X; Liu, Y; Mei, SY; Zhang, MM; Xin, JX; Zhang, Y; Yang, RC				Liang, Xue; Liu, Yu; Mei, Shiyue; Zhang, Miaomiao; Xin, Jiaxuan; Zhang, Yuan; Yang, Rongcun			MicroRNA-22 Impairs Anti-Tumor Ability of Dendritic Cells by Targeting p38	PLOS ONE			English	Article							DIFFERENTIATION; IMMUNITY; MODULATE; T(H)17; KINASE; ALPHA	Dendritic cells (DCs) play a critical role in triggering anti-tumor immune responses. Their intracellular p38 signaling is of great importance in controlling DC activity. In this study, we identified microRNA-22 (miR-22) as a microRNA inhibiting p38 protein expression by directly binding to the 3' untranslated region (3'UTR) of its mRNA. The p38 down-regulation further interfered with the synthesis of DC-derived IL-6 and the differentiation of DC-driven Th17 cells. Moreover, overexpression of miR-22 in DCs impaired their tumor-suppressing ability while miR-22 inhibitor could reverse this phenomenon and improve the curative effect of DC-based immunotherapy. Thus, our results highlight a suppressive role for miR-22 in the process of DC-invoked anti-tumor immunity and that blocking this microRNA provides a new strategy for generating potent DC vaccines for patients with cancer.	[Liang, Xue; Liu, Yu; Mei, Shiyue; Zhang, Miaomiao; Xin, Jiaxuan; Zhang, Yuan; Yang, Rongcun] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China; [Liang, Xue] Tianjin Med Univ, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Tianjin Inst Cardiol, Dept Cardiol,Hosp 2, Tianjin, Peoples R China; [Yang, Rongcun] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Tianjin Medical University; Nankai University; Nankai University	Yang, RC (corresponding author), Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China.	ryang@nankai.edu.cn			NSFC [31470876, 91029736, 91442111]; ISF-NSFC program [31461143010]; Ministry of Science and Technology grant (863 program) [2008AA02Z129]; National Key Scientific Program [2011CB964902]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; State Key Laboratory of Medicinal Chemical Biology	NSFC(National Natural Science Foundation of China (NSFC)); ISF-NSFC program; Ministry of Science and Technology grant (863 program); National Key Scientific Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Key Laboratory of Medicinal Chemical Biology	This research was supported by NSFC grants 31470876, 91029736, 91442111 and ISF-NSFC program 31461143010; a Ministry of Science and Technology grant (863 program, 2008AA02Z129); the National Key Scientific Program (2011CB964902); the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13023) and State Key Laboratory of Medicinal Chemical Biology.	Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028; Dubois B, 1999, J LEUKOCYTE BIOL, V66, P224, DOI 10.1002/jlb.66.2.224; Feng Y, 2014, PLOS ONE; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Huang ZP, 2014, TRENDS CARDIOVAS MED, V24, P267, DOI 10.1016/j.tcm.2014.07.005; Jena BP, 2008, MOL CELLS, V26, P517; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HYS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052341; Lin C-C, 2014, J MICROBIOLOGY IMMUN; Min SP, 2013, J IMMUNOL, V190, P2437, DOI 10.4049/jimmunol.1202282; Nunez S, 2013, IMMUNOLOGY, V139, P61, DOI 10.1111/imm.12055; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; SUN WH, 1992, CANCER RES, V52, P5412; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Wang SQ, 2006, BLOOD, V107, P2432, DOI 10.1182/blood-2005-06-2486; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu J, 2015, MOL MED REP, V11, P865, DOI 10.3892/mmr.2014.2807; Yang RC, 2004, J VIROL, V78, P11152, DOI 10.1128/JVI.78.20.11152-11160.2004; Yu H, 2014, J CELLULAR BIOCH	32	30	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121510	10.1371/journal.pone.0121510	http://dx.doi.org/10.1371/journal.pone.0121510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826372	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800045
J	Poudel, S; Aryal, N; Lu, CF				Poudel, Saroj; Aryal, Niranjan; Lu, Chaofu			Identification of MicroRNAs and Transcript Targets in Camelina sativa by Deep Sequencing and Computational Methods	PLOS ONE			English	Article							BIOFUEL CROP; EXPRESSION; MECHANISMS; PREDICTION; ALIGNMENT; GENOME	Camelina sativa is an annual oilseed crop that is under intensive development for renewable resources of biofuels and industrial oils. MicroRNAs, or miRNAs, are endogenously encoded small RNAs that play key roles in diverse plant biological processes. Here, we conducted deep sequencing on small RNA libraries prepared from camelina leaves, flower buds and two stages of developing seeds corresponding to initial and peak storage products accumulation. Computational analyses identified 207 known miRNAs belonging to 63 families, as well as 5 novel miRNAs. These miRNAs, especially members of the miRNA families, varied greatly in different tissues and developmental stages. The predicted miRNA target genes are involved in a broad range of physiological functions including lipid metabolism. This report is the first step toward elucidating roles of miRNAs in C. sativa and will provide additional tools to improve this oilseed crop for biofuels and biomaterials.	[Poudel, Saroj] Montana State Univ, Dept Comp Sci, Bozeman, MT 59717 USA; [Poudel, Saroj; Aryal, Niranjan; Lu, Chaofu] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lu, CF (corresponding author), Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.	clu@montana.edu	Lu, Chaofu/AAE-5839-2019	Lu, Chaofu/0000-0001-6901-7490; Poudel, Saroj/0000-0001-7147-1836	National Science Foundation [IOS-1339385]; Department of Energy of the United States [DE-AR0000202]; Division Of Integrative Organismal Systems [1339385] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy of the United States(United States Department of Energy (DOE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (No. IOS-1339385), and the Department of Energy (DE-AR0000202) of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Belide S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00168; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Collins-Silva J.E., 2011, INFORM, V22, P610; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Rodriguez-Rodriguez MF, 2013, IND CROP PROD, V50, P673, DOI 10.1016/j.indcrop.2013.07.042; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galli V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083727; Gehringer A, 2006, GENOME, V49, P1555, DOI 10.1139/G06-117; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kim D, 2012, PHYTOPATHOLOGY, V103, P74; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Moser B.R., 2010, LIPID TECHNOL, V22, P270, DOI [10.1002/lite.201000068, DOI 10.1002/LITE.201000068]; Mudalkar S, 2014, PLANT MOL BIOL, V84, P159, DOI 10.1007/s11103-013-0125-1; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; Pilgeram A.L., 2007, ISSUES NEW CROPS NEW; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Stief A, 2014, PLANT CELL, DOI [10.1105/tpc.1114.123851, DOI 10.1105/TPC.1114.123851]; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Vollmann J, 2007, IND CROP PROD, V26, P270, DOI 10.1016/j.indcrop.2007.03.017; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zubr J, 1997, IND CROP PROD, V6, P113, DOI 10.1016/S0926-6690(96)00203-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	15	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121542	10.1371/journal.pone.0121542	http://dx.doi.org/10.1371/journal.pone.0121542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826400	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800046
J	Sanchez, A; Malak, DA; Guelmami, A; Perennou, C				Sanchez, Antonio; Malak, Dania Abdul; Guelmami, Anis; Perennou, Christian			Development of an Indicator to Monitor Mediterranean Wetlands	PLOS ONE			English	Article							EARTH OBSERVATION; THEMATIC MAPPER; LANDSAT; LIMITATIONS; VEGETATION; INVENTORY; CAMARGUE	Wetlands are sensitive ecosystems that are increasingly subjected to threats from anthropogenic factors. In the last decades, coastal Mediterranean wetlands have been suffering considerable pressures from land use change, intensification of urban growth, increasing tourism infrastructure and intensification of agricultural practices. Remote sensing (RS) and Geographic Information Systems (GIS) techniques are efficient tools that can support monitoring Mediterranean coastal wetlands on large scales and over long periods of time. The study aims at developing a wetland indicator to support monitoring Mediterranean coastal wetlands using these techniques. The indicator makes use of multi-temporal Landsat images, land use reference layers, a 50m numerical model of the territory (NMT) and Corine Land Cover (CLC) for the identification and mapping of wetlands. The approach combines supervised image classification techniques making use of vegetation indices and decision tree analysis to identify the surface covered by wetlands at a given date. A validation process is put in place to compare outcomes with existing local wetland inventories to check the results reliability. The indicator's results demonstrate an improvement in the level of precision of change detection methods achieved by traditional tools providing reliability up to 95% in main wetland areas. The results confirm that the use of RS techniques improves the precision of wetland detection compared to the use of CLC for wetland monitoring and stress the strong relation between the level of wetland detection and the nature of the wetland areas and the monitoring scale considered.	[Sanchez, Antonio; Malak, Dania Abdul] Univ Malaga, European Top Ctr, E-29071 Malaga, Spain; [Guelmami, Anis; Perennou, Christian] Tour Valat Res Ctr Conservat Mediterranean Wetlan, Arles, France	Universidad de Malaga	Malak, DA (corresponding author), Univ Malaga, European Top Ctr, E-29071 Malaga, Spain.	daniaabdulmalak@uma.es		Sanchez Espinosa, Antonio/0000-0003-0283-2532				Avitabile V, 2012, REMOTE SENS ENVIRON, V117, P366, DOI 10.1016/j.rse.2011.10.012; Aznar JC, 2003, WETLANDS, V23, P149, DOI 10.1672/0277-5212(2003)023[0149:ABAVAL]2.0.CO;2; Camathias L, 2013, APPL VEG SCI, V16, P539, DOI 10.1111/avsc.12028; Davidson NC, 2007, AQUAT CONSERV, V17, P219, DOI 10.1002/aqc.846; Davranche A, 2013, REMOTE SENS ENVIRON, V138, P165, DOI 10.1016/j.rse.2013.07.015; Davranche A, 2010, REMOTE SENS ENVIRON, V114, P552, DOI 10.1016/j.rse.2009.10.009; Dervieux A., 2005, VERTIGO, P6, DOI [10.4000/vertigo.2411, DOI 10.4000/VERTIGO.2411]; Finlayson CM, 1999, MAR FRESHWATER RES, V50, P717, DOI 10.1071/MF99098; Giles PT, 2001, PHOTOGRAMM ENG REM S, V67, P833; Halverson M., 2014, HYDROLOGY EARTH SYST, V11, P13663; Ju JC, 2008, REMOTE SENS ENVIRON, V112, P1196, DOI 10.1016/j.rse.2007.08.011; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Liu YS, 2005, PEDOSPHERE, V15, P778; MacKay H, 2009, J ENVIRON MANAGE, V90, P2234, DOI 10.1016/j.jenvman.2008.01.019; Mahavir D, 2000, INT ARCH PHOTOGRAMME, V33, pB7; Ozesmi Stacy L., 2002, Wetlands Ecology and Management, V10, P381, DOI 10.1023/A:1020908432489; Perennou Christian, 2012, Ecologia Mediterranea, V38, P53; Ramsey  E., 1998, REMOTE SENSING CHANG, P211; Rebelo LM, 2009, J ENVIRON MANAGE, V90, P44; Rodhe A, 1999, AGR FOREST METEOROL, V98-9, P325, DOI 10.1016/S0168-1923(99)00104-5; TAYLOR ARD, 1995, VEGETATIO, V118, P57, DOI 10.1007/BF00045191; Thomas G.S, 1976, S MACH PROC REM SENS, p4B41; Tourenq C, 2001, BIOL CONSERV, V100, P335, DOI 10.1016/S0006-3207(01)00037-4; Toyra J, 2005, REMOTE SENS ENVIRON, V97, P174, DOI 10.1016/j.rse.2005.03.012; Vogelmann JE, 2001, REMOTE SENS ENVIRON, V78, P55, DOI 10.1016/S0034-4257(01)00249-8; Weiss DJ, 2009, GEOGR COMPASS, V3, P1, DOI 10.1111/j.1749-8198.2008.00200.x; Wijedasa LS, 2012, REMOTE SENS-BASEL, V4, P2595, DOI 10.3390/rs4092595; Wimmer A, 2000, INT ARCH PHOTOGRAMME, V33, pB7; Xie ZL, 2010, ESTUAR COAST SHELF S, V86, P379, DOI 10.1016/j.ecss.2009.03.040; Zhang YL, 2011, INT J REMOTE SENS, V32, P545, DOI 10.1080/01431160903475241	30	4	4	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122694	10.1371/journal.pone.0122694	http://dx.doi.org/10.1371/journal.pone.0122694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826210	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800086
J	Ayuso, MI; Martinez-Alonso, E; Salvador, N; Bonova, P; Regidor, I; Alcazar, A				Ayuso, Maria I.; Martinez-Alonso, Emma; Salvador, Nelida; Bonova, Petra; Regidor, Ignacio; Alcazar, Alberto			Dissociation of eIF4E-Binding Protein 2 (4E-BP2) from eIF4E Independent of Thr(37)/Thr(46) Phosphorylation in the Ischemic Stress Response	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; FACTOR 4E-BINDING PROTEINS; MESSENGER-RNA TRANSLATION; CELL-DEATH; NEURONAL CELLS; BRAIN ISCHEMIA; INITIATION; REPERFUSION; MECHANISMS; INSULIN	Eukaryotic initiation factor (eIF) 4E-binding proteins (4E-BPs) are translational repressors that bind specifically to eIF4E and are critical in the control of protein translation. 4E-BP2 is the predominant 4E-BP expressed in the brain, but their role is not well known. Here, we characterized four forms of 4E-BP2 detected by two-dimensional gel electrophoresis (2-DGE) in brain. The form with highest electrophoretic mobility was the main form susceptible to phosphorylation at Thr(37)/Thr(46) sites, phosphorylation that was detected in acidic spots. Cerebral ischemia and subsequent reperfusion induced dephosphorylation and phosphorylation of 4E-BP2 at Thr(37)/Thr(46), respectively. The induced phosphorylation was in parallel with the release of 4E-BP2 from eIF4E, although two of the phosphorylated 4E-BP2 forms were bound to eIF4E. Upon long-term reperfusion, there was a decrease in the binding of 4E-BP2 to eIF4E in cerebral cortex, demonstrated by cap binding assays and 4E-BP2-immunoprecipitation experiments. The release of 4E-BP2 from eIF4E was without changes in 4E-BP2 phosphorylation or other post-translational modification recognized by 2-DGE. These findings demonstrated specific changes in 4E-BP2/eIF4E association dependent and independent of 4E-BP2 phosphorylation. The last result supports the notion that phosphorylation may not be the uniquely regulation for the binding of 4E-BP2 to eIF4E under ischemic stress.	[Ayuso, Maria I.; Martinez-Alonso, Emma; Salvador, Nelida; Alcazar, Alberto] Hosp Ramon & Cajal, Dept Invest, IRYCIS, E-28034 Madrid, Spain; [Bonova, Petra] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Regidor, Ignacio] Hosp Ramon & Cajal, Dept Neurophysiol, IRYCIS, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal; Slovak Academy of Sciences; Hospital Universitario Ramon y Cajal	Alcazar, A (corresponding author), Hosp Ramon & Cajal, Dept Invest, IRYCIS, E-28034 Madrid, Spain.	alberto.alcazar@hrc.es	Bonova, Petra/F-2887-2018; Ayuso, Maria Irene/C-9435-2015	Bonova, Petra/0000-0002-5427-8126; Ayuso, Maria Irene/0000-0003-0046-3657; Salvador, Nelida/0000-0002-6772-3647	Institute of Health Carlos III from the Spanish Ministry of Economy and Competitiveness with the grant numbers [PI11/00334, PI14/00705]; FEDER grant	Institute of Health Carlos III from the Spanish Ministry of Economy and Competitiveness with the grant numbers; FEDER grant	This work was supported by the Institute of Health Carlos III (http://www.isciii.es/) from the Spanish Ministry of Economy and Competitiveness with the grant numbers PI11/00334 (National Plan) and PI14/00705 (State Plan), and the funding from FEDER grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso MI, 2010, J BIOL CHEM, V285, P34355, DOI 10.1074/jbc.M110.135103; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Cid C, 2003, FASEB J, V17, P409, DOI 10.1096/fj.03-0606fje; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; de la Vega CM, 2001, BIOCHEM J, V357, P819; Dobrikov M, 2011, MOL CELL BIOL, V31, P2947, DOI 10.1128/MCB.05589-11; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Hermann DM, 2001, NEUROSCIENCE, V104, P947, DOI 10.1016/S0306-4522(01)00125-7; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Ayuso MI, 2013, J CEREBR BLOOD F MET, V33, P1173, DOI 10.1038/jcbfm.2013.60; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; Quevedo C, 2002, BIOCHEM BIOPH RES CO, V291, P560, DOI 10.1006/bbrc.2002.6479; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Srivastava T, 2012, J NEUROSCI, V32, P5620, DOI 10.1523/JNEUROSCI.0030-12.2012; TsukiyamaKohara K, 1996, GENOMICS, V38, P353, DOI 10.1006/geno.1996.0638; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5	26	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121958	10.1371/journal.pone.0121958	http://dx.doi.org/10.1371/journal.pone.0121958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822952	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700140
J	Costa, JM; Ferreira, SM; Protzek, AO; Santos, GJ; Cappelli, AP; Silveira, LR; Zoppi, C; de Oliveira, CAM; Boschero, AC; Carneiro, EM; Rezende, LF				Costa-Junior, Jose M.; Ferreira, Sandra M.; Protzek, Andre O.; Santos, Gustavo J.; Cappelli, Ana P.; Silveira, Leonardo R.; Zoppi, Claudio; de Oliveira, Camila A. M.; Boschero, Antonio C.; Carneiro, Everardo M.; Rezende, Luiz F.			Endurance Training Inhibits Insulin Clearance and IDE Expression in Swiss Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCAGON-LIKE PEPTIDE-1; SKELETAL-MUSCLE; EXERCISE; RESISTANCE; METABOLISM; RAT; HOMEOSTASIS; PREVENTION; SECRETION	Introduction Endurance training improves peripheral insulin sensitivity in the liver and the skeletal muscle, but the mechanism for this effect is poorly understood. Recently, it was proposed that insulin clearance plays a major role in both glucose homeostasis and insulin sensitivity. Therefore, our goal was to determine the mechanism by which endurance training improves insulin sensitivity and how it regulates insulin clearance in mice. Methods Mice were treadmill-trained for 4 weeks at 70-80% of maximal oxygen consumption (VO2 max) for 60 min, 5 days a week. The glucose tolerance and the insulin resistance were determined using an IPGTT and an IPITT, respectively, and the insulin decay rate was calculated from the insulin clearance. Protein expression and phosphorylation in the liver and the skeletal muscle were ascertained by Western blot. Results Trained mice exhibited an increased VO2 max, time to exhaustion, glucose tolerance and insulin sensitivity. They had smaller fat pads and lower plasma concentrations of insulin and glucose. Endurance training inhibited insulin clearance and reduced expression of IDE in the liver, while also inhibiting insulin secretion by pancreatic islets. There was increased phosphorylation of both the canonical (IR-AKT) and the non-canonical (CaMKII-AMPK-ACC) insulin pathways in the liver of trained mice, whereas only the CaMKII-AMPK pathway was increased in the skeletal muscle. Conclusion Endurance training improved glucose homeostasis not only by increasing peripheral insulin sensitivity but also by decreasing insulin clearance and reducing IDE expression in the liver.	[Costa-Junior, Jose M.; Ferreira, Sandra M.; Protzek, Andre O.; Santos, Gustavo J.; Cappelli, Ana P.; Zoppi, Claudio; Boschero, Antonio C.; Carneiro, Everardo M.; Rezende, Luiz F.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, BR-13083865 Campinas, SP, Brazil; [Silveira, Leonardo R.] Univ Sao Paulo, Dept Biochem & Immunol, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [de Oliveira, Camila A. M.] Fed Univ Sao Paulo Unifesp, Dept Biosci, BR-11060001 Santos, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Rezende, LF (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, POB 6109, BR-13083865 Campinas, SP, Brazil.	luizbio@gmail.com	Cappelli, Ana Paula Gameiro/I-1357-2015; Santos, Gustavo/L-6419-2013; Oliveira, Camila/P-9574-2018; costa, jose maria/L-9753-2016; Boschero, Antonio/O-7525-2014; Ferreira, Sandra/L-3844-2014; Carneiro, Everardo/D-4758-2012; Ferreira, Sandra M/C-6771-2015	Cappelli, Ana Paula Gameiro/0000-0002-8018-0579; Santos, Gustavo/0000-0001-9135-7184; Oliveira, Camila/0000-0001-6666-166X; costa, jose maria/0000-0002-7789-3180; Boschero, Antonio/0000-0003-3829-8570; Ferreira, Sandra M/0000-0003-2642-2802	FAPESP; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESP (http://www.fapesp.br/) and CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, NAT MED, V12, P511, DOI 10.1038/nm0506-511; Ahren B, 2005, DIABETOLOGIA, V48, P2140, DOI 10.1007/s00125-005-1915-z; Authier F, 1996, CLIN INVEST MED, V19, P149; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; Chandra J, 2001, DIABETES, V50, pS44, DOI 10.2337/diabetes.50.2007.S44; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; Cordes CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018138; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; DELA F, 1992, AM J PHYSIOL, V263, pE1134; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1988, AM J MED, V85, P71, DOI 10.1016/0002-9343(88)90399-3; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; GARETTO LP, 1984, AM J PHYSIOL, V246, pE471, DOI 10.1152/ajpendo.1984.246.6.E471; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hansen B C, 1993, Obes Res, V1, P252; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Ivy J L, 1997, Sports Med, V24, P321; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lean MEJ, 2000, DRUGS TODAY, V36, P773, DOI 10.1358/dot.2000.36.11.601531; Lean MEJ, 2000, P NUTR SOC, V59, P331, DOI 10.1017/S0029665100000379; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Maarbjerg SJ, 2011, ACTA PHYSIOL, V202, P323, DOI 10.1111/j.1748-1716.2011.02267.x; MCKEIGUE PM, 1991, LANCET, V338, P1270, DOI 10.1016/0140-6736(91)92135-O; Meier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE849, DOI 10.1152/ajpendo.00289.2007; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; NESTLER JE, 1988, AM J MED SCI, V295, P15, DOI 10.1097/00000441-198801000-00005; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; POLONSKY KS, 1994, DIABETES, V43, P871, DOI 10.2337/diabetes.43.7.871; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; RABKIN R, 1986, AM J PHYSIOL, V250, pE530, DOI 10.1152/ajpendo.1986.250.5.E530; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Rezende LF, 2012, DIABETOLOGIA, V55, P1495, DOI 10.1007/s00125-012-2493-5; Rezende LF, 2007, J ENDOCRINOL, V195, P157, DOI 10.1677/JOE-07-0016; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; SRERE PA, 1963, BIOCHIM BIOPHYS ACTA, V73, P523, DOI 10.1016/0926-6569(63)90146-9; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; STROMBLAD G, 1986, METABOLISM, V35, P323, DOI 10.1016/0026-0495(86)90148-4; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yuan HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053887	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118809	10.1371/journal.pone.0118809	http://dx.doi.org/10.1371/journal.pone.0118809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822220	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700024
J	Cuevas, I; Layman, H; Coussens, L; Boudreau, N				Cuevas, Ileana; Layman, Hans; Coussens, Lisa; Boudreau, Nancy			Sustained Endothelial Expression of HoxA5 In Vivo Impairs Pathological Angiogenesis And Tumor Progression	PLOS ONE			English	Article							MARROW-DERIVED CELLS; TRANSGENIC MICE; VESSEL FORMATION; GENE-EXPRESSION; MUTANT MICE; CARCINOGENESIS; SPECIFICATION; MYELOPOIESIS; PROGENITORS; INDUCTION	HoxA5 is expressed in quiescent endothelial cells ( EC), but absent in activated angiogenic EC. To examine the efficacy of targeting HoxA5 therapeutically to quell pathologic or tumor angiogenesis, we generated an inducible, transgenic mouse model of sustained HoxA5 expression in ECs. During pathologic angiogenesis, sustained HoxA5 regulates expression several angiogenic effector molecules, notably increased expression of TSP-2 and reduced expression of VEGF, thus leading to inhibition of pathological angiogenesis in tissues. To evaluate if this impressive reduction of vascularization could also impact tumor angiogenesis, HoxA5 mice were bred with a mouse model of de novo squamous carcinogenesis, e.g., K14-HPV16 mice. Activation of EC-HoxA5 significantly reduced infiltration by mast cells into neoplastic skin, an early hallmark of progression to dysplasia, reduced angiogenic vasculature, and blunted characteristics of tumor progression. To evaluate HoxA5 as a therapeutic, topical application of a HoxA5 transgene onto early neoplastic skin of K14-HPV16 mice similarly resulted in a significant impairment of angiogenic vasculature and progression to dysplasia to a similar extent as observed with genetic delivery of HoxA5. Together these data indicate that HoxA5 represents a novel molecule for restricting pathological and tumorigenic angiogenesis.	[Cuevas, Ileana; Layman, Hans; Boudreau, Nancy] Univ Calif San Francisco, Dept Surg, Surg Res Lab, San Francisco, CA 94143 USA; [Coussens, Lisa] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Coussens, Lisa] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University	Boudreau, N (corresponding author), Univ Calif San Francisco, Dept Surg, Surg Res Lab, San Francisco, CA 94143 USA.	NBoudreau@sfghsurg.ucsf.edu	Coussens, Lisa/ABH-9834-2020		National Institutes of Health/National Cancer Institute [CA140943, CA140655]; NATIONAL CANCER INSTITUTE [R01CA140655, R01CA140943] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute grants CA140943 (LM and NB) and CA140655. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agah A, 2004, MATRIX BIOL, V22, P539, DOI 10.1016/j.matbio.2003.09.004; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Arderiu G, 2007, CELL ADHES MIGR, V1, P185, DOI 10.4161/cam.1.4.5448; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Aubin J, 2002, DEVELOPMENT, V129, P4075; Aubin J, 1997, AM J PHYSIOL, V277, pC965; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Boudreau NJ, 2004, J BIOL CHEM, V279, P4862, DOI 10.1074/jbc.M305190200; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 1996, AM J PATHOL, V149, P1899; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; de Visser KE, 2004, NEOPLASIA, V6, P768, DOI 10.1593/neo.04250; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Eichten A, 2007, CANCER RES, V67, P5211, DOI 10.1158/0008-5472.CAN-06-4676; Fuller JF, 1999, BLOOD, V93, P3391, DOI 10.1182/blood.V93.10.3391.410k26_3391_3400; Garin E, 2006, DEV DYNAM, V235, P1858, DOI 10.1002/dvdy.20822; Golpon HA, 2001, AM J PATHOL, V158, P955, DOI 10.1016/S0002-9440(10)64042-4; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hansen SL, 2003, AM J PATHOL, V163, P2421, DOI 10.1016/S0002-9440(10)63597-3; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Jacobi J, 2004, GENE THER, V11, P302, DOI 10.1038/sj.gt.3302162; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krieger KE, 2004, DEV BRAIN RES, V150, P125, DOI 10.1016/j.devbrainres.2004.03.005; Liang YM, 2012, J DERMATOL SCI, V66, P197, DOI 10.1016/j.jdermsci.2012.02.019; Mace KA, 2005, J CELL SCI, V118, P2567, DOI 10.1242/jcs.02399; Mace KA, 2009, STEM CELLS, V27, P1654, DOI 10.1002/stem.90; Meunier D, 2003, DEV DYNAM, V227, P367, DOI 10.1002/dvdy.10325; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Myers C, 2000, J CELL BIOL, V148, P343, DOI 10.1083/jcb.148.2.343; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5	44	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121720	10.1371/journal.pone.0121720	http://dx.doi.org/10.1371/journal.pone.0121720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821967	Green Published, gold			2022-12-27	WOS:000352134700122
J	Pinzon-Florez, CE; Fernandez-Nino, JA; Ruiz-Rodriguez, M; Idrovo, AJ; Lopez, AAA				Eduardo Pinzon-Florez, Carlos; Alfredo Fernandez-Nino, Julian; Ruiz-Rodriguez, Myriam; Idrovo, Alvaro J.; Arredondo Lopez, Abel Armando			Determinants of Performance of Health Systems Concerning Maternal and Child Health: A Global Approach	PLOS ONE			English	Article							INFANT-MORTALITY RATES; INCOME INEQUALITY; ECONOMETRIC-ANALYSIS; LIFE EXPECTANCY; RESOURCES; AFRICA; CARE; FRACTIONALIZATION; CORRUPTION; EFFICIENCY	Aims To assess the association of social determinants on the performance of health systems around the world. Methods A transnational ecological study was conducted with an observation level focused on the country. In order to research on the strength of the association between the annual maternal and child mortality in 154 countries and social determinants: corruption, democratization, income inequality and cultural fragmentation, we used a mixed linear regression model for repeated measures with random intercepts and a conglomerate-based geographical analysis, between 2000 and 2010. Results Health determinants with a significant association on child mortality(< 1year): higher access to water (beta a Quartile 4(Q4) vs Quartile 1(Q1) = -6,14; 95% CI: -11,63 to -0,73), sanitation systems, (Q4 vs Q1 = -25,58; 95% CI: -31,91 to -19,25),% measles vaccination coverage (Q4 vs Q1 = -7.35; 95% CI: -10,18 to -4,52), % of births attended by a healthcare professional (Q4 vs Q1 = -7,91; 95% CI: -11,36 to -4,52) and a % of the total health expenditure (Q3 vs Q1 = -2,85; 95% CI: -4,93 to -0,7). Ethnic fragmentation (Q4 vs Q1 = 9,93; 95% CI: -0.03 to 19.89) had a marginal effect. For child mortality< 5 years, an association was found for these variables and democratization (not free vs free = 11,23; 95% CI: -0,82 to 23,29), out-of-pocket expenditure (Q1 vs Q4 = 17,71; 95% CI: 5,86 to 29,56). For MMR (Maternal mortality ratio), % of access to water for all the quartiles,% of access to sanitation systems, (Q3 vs Q1 = -171,15; 95% CI: -281,29 to -61), birth attention by a healthcare professional (Q4 vs Q1 = -231,23; 95% CI: -349,32 to -113,15), and having corrupt government (Q3 vs Q1 = 83,05; 95% CI: 33,10 to 133). Conclusions Improving access to water and sanitation systems, decreasing corruption in the health sector must become priorities in health systems. The ethno-linguistic cultural fragmentation and the detriment of democracy turn out to be two factors related to health results.	[Eduardo Pinzon-Florez, Carlos; Arredondo Lopez, Abel Armando] Inst Nacl Salud Publ Mexico, Ctr Res Hlth Syst CISS, Cuernavaca, Morelos, Mexico; [Alfredo Fernandez-Nino, Julian] Inst Nacl Salud Publ Mexico, Informat Ctr Publ Hlth Decis CENIDSP, Cuernavaca, Morelos, Mexico; [Ruiz-Rodriguez, Myriam; Idrovo, Alvaro J.] Univ Ind Santander, Sch Hlth, Dept Publ Hlth, Sch Med, Bucaramanga, Colombia	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Industrial de Santander	Lopez, AAA (corresponding author), Inst Nacl Salud Publ Mexico, Ctr Res Hlth Syst CISS, Cuernavaca, Morelos, Mexico.	armando.arredondo@insp.mx	Fernández-Niño, Julián Alfredo/AHE-6038-2022	Fernández-Niño, Julián Alfredo/0000-0002-8948-8481; Ruiz-Rodriguez, Myriam/0000-0002-8598-3354; Idrovo, Alvaro J/0000-0001-9579-1463	CONACYT (Mexico) [CVU 444131]	CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by CONACYT (Mexico), grant number: CVU 444131.	Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Adams O, 2003, HUMAN RESOURCES HLTH; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alba Richard, 2003, REMAKING AM MAINSTRE; Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; Alvarez-Dardet C, 2006, J EPIDEMIOL COMMUN H, V60, P669, DOI 10.1136/jech.2005.038273; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Bean Frank D., 2003, AM NEWCOMERS DYNAMIC; Beck T, 2005, J ECON GROWTH, V10, P199, DOI 10.1007/s10887-005-3533-5; Besley T, 2006, AM ECON REV, V96, P313, DOI 10.1257/000282806777212053; Botting MJ, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-12; Buykx P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-81; Caldwell JC, 1989, WHAT WE KNOW HLTH TR; Davies HTO, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1305; de Savigny Don, 2008, FIXING HLTH SYSTEMS; de Sousa MF, 2014, CIENC SAUDE COLETIVA, V19, P331, DOI 10.1590/1413-81232014192.08182012; Dolea C, 2002, J EPIDEMIOL COMMUN H, V56, P444, DOI 10.1136/jech.56.6.444; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; EIU, 2013, DEM IND 2012 DEM STA; El-Jardali Fadi, 2007, Hum Resour Health, V5, P9, DOI 10.1186/1478-4491-5-9; Elzinga G, 2005, B WORLD HEALTH ORGAN, V83, P242; Ensor T, 2002, REGULATING ENTREPREN; Evans DB, 2001, BRIT MED J, V323, P307, DOI 10.1136/bmj.323.7308.307; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Gini C., 1936, GEN SERIES, V208; HERTZ E, 1994, SOC SCI MED, V39, P105, DOI 10.1016/0277-9536(94)90170-8; Hsiao William C., 2004, HARVARD CHINA REV, V5, P64; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Idrovo AJ, 2010, REV SAUDE PUBL, V44, P695, DOI 10.1590/S0034-89102010005000020; Inglehart R., 2005, MODERNIZATION CULTUR; International Transparency, 2010, GLOB CORR REP; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; KIM KK, 1992, SOC SCI MED, V34, P837, DOI 10.1016/0277-9536(92)90253-M; Ko K, 2010, SOC SCI J, V47, P508, DOI 10.1016/j.soscij.2010.03.001; Krastev I., 2004, SHIFTING OBSESSIONS; Krupp K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-18; Leipziger D., 2003, 3163 WORLD BANK; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Levine R., 2007, SHOULD ALL VERTICAL; Lind JT, 2007, J PUBLIC ECON, V91, P51, DOI 10.1016/j.jpubeco.2006.09.006; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Mackenbach JP, 2009, J EPIDEMIOL COMMUN H, V63, P181, DOI 10.1136/jech.2008.077032; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mckeown T, 1975, POPULATION STUDIES, V1975, P391; MILLS A, 1983, SOC SCI MED, V17, P1971, DOI 10.1016/0277-9536(83)90137-5; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; OOMS G, 2008, GLOBALIZATION HEALTH, V4, P97979, DOI DOI 10.1186/1744-8603-4-1; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Osimen GU, 2013, IOSR J HUMANITIES SO, V16, P79; Paldam M., 2002, EUR J POLIT ECON, V18, P215, DOI [10.1016/S0176-2680(02)00078-2, DOI 10.1016/S0176-2680(02)00078-2]; Florez CEP, 2014, REV PANAM SALUD PUBL, V35, P1; Piwoz EG, 2005, J NUTR, V135, P1113, DOI 10.1093/jn/135.5.1113; Population Division of the Department of Economic and Social Affairs of the UN Secretariat, 2004, WORLD POP PROSP 2004; Postero Nancy Grey, 2006, NOW WE ARE CITIZENS; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; Roberts R., 2003, 210 CTR AID PUBL EXP; Robinson J, 2000, J ADV NURS, V32, P28, DOI 10.1046/j.1365-2648.2000.01458.x; Robst J, 1997, APPL ECON LETT, V4, P45, DOI 10.1080/758521831; Robst J, 2001, APPL ECON LETT, V8, P737, DOI 10.1080/13504850110036328; Schein E. H., 2006, ORG CULTURE LEADERSH; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; UN, 2005, UN MILL PROJ WHOS GO; UNICEF, 2009, STAT WORLDS CHILDR; United Nations Office on Drugs and Crime, 2004, UN CONV CORR; Varshney A, 1997, COMP POLIT, V30, P1, DOI 10.2307/422190; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; WHO, 2000, WORLD HLTH REP HLTH; WHO, 2007, EV BUS STRENGTH HLTH, V44, P44; WHO, 2004, MAT MORT 2000 EST DE; Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637; Zakir M, 1999, APPL ECON LETT, V6, P271, DOI 10.1080/135048599353203	77	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120747	10.1371/journal.pone.0120747	http://dx.doi.org/10.1371/journal.pone.0120747			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822246	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700074
J	Neirynck, N; Glorieux, G; Schepers, E; Verbeke, F; Vanholder, R				Neirynck, Nathalie; Glorieux, Griet; Schepers, Eva; Verbeke, Francis; Vanholder, Raymond			Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MURINE TNF RECEPTORS; CARDIOVASCULAR MORTALITY; FACTOR-ALPHA; MYOCARDIAL-INFARCTION; HEMODIALYSIS-PATIENTS; ALL-CAUSE; IN-VITRO; INTERLEUKIN-6; INFLAMMATION	Background Soluble tumor necrosis factor receptors 1 (sTNFR1) and 2 (sTNFR2) have been associated to progression of renal failure, end stage renal disease and mortality in early stages of chronic kidney disease (CKD), mostly in the context of diabetic nephropathy. The predictive value of these markers in advanced stages of CKD irrespective of the specific causes of kidney disease has not yet been defined. In this study, the relationship between sTNFR1 and sTNFR2 and the risk for adverse cardiovascular events (CVE) and all-cause mortality was investigated in a population with CKD stage 4-5, not yet on dialysis, to minimize the confounding by renal function. Patients and methods In 131 patients, CKD stage 4-5, sTNFR1, sTNFR2 were analysed for their association to a composite endpoint of all-cause mortality or first non-fatal CVE by univariate and multivariate Cox proportional hazards models. In the multivariate models, age, gender, CRP, eGFR and significant comorbidities were included as covariates. Results During a median follow-up of 33 months, 40 events (30.5%) occurred of which 29 deaths (22.1%) and 11 (8.4%) first non-fatal CVE. In univariate analysis, the hazard ratios (HR) of sTNFR1 and sTNFR2 for negative outcome were 1.49 (95% confidence interval (CI): 1.28-1.75) and 1.13 (95% CI: 1.06-1.20) respectively. After adjustment for clinical covariables (age, CRP, diabetes and a history of cardiovascular disease) both sTNFRs remained independently associated to outcomes (HR: sTNFR1: 1.51, 95% CI: 1.30-1.77; sTNFR2: 1.13, 95% CI: 1.06-1.20). A subanalysis of the non-diabetic patients in the study population confirmed these findings, especially for sTNFR1. Conclusion sTNFR1 and sTNFR2 are independently associated to all-cause mortality or an increased risk for cardiovascular events in advanced CKD irrespective of the cause of kidney disease.	[Neirynck, Nathalie; Glorieux, Griet; Schepers, Eva; Verbeke, Francis; Vanholder, Raymond] Ghent Univ Hosp, Nephrol Sect, Dept Internal Med, Ghent, Belgium	Ghent University; Ghent University Hospital	Neirynck, N (corresponding author), Ghent Univ Hosp, Nephrol Sect, Dept Internal Med, Ghent, Belgium.	n.neirynck@ugent.be			FWO (Fonds voor Wetensschappelijk Onderzoek) - Vlaanderen [G016210N]	FWO (Fonds voor Wetensschappelijk Onderzoek) - Vlaanderen	This research is funded by FWO (Fonds voor Wetensschappelijk Onderzoek) - Vlaanderen, project number: G016210N (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Aderka D, 1998, J CLIN INVEST, V101, P650, DOI 10.1172/JCI694; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; BEMELMANS MHA, 1994, CYTOKINE, V6, P608, DOI 10.1016/1043-4666(94)90048-5; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Goicoechea M, 2012, RENAL FAILURE, V34, P1002, DOI 10.3109/0886022X.2012.696469; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331; LEEUWENBERG JFM, 1994, J IMMUNOL, V152, P4036; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Luna JM, 2013, AGE AGEING, V42, P385, DOI 10.1093/ageing/afs175; Meuwese CL, 2011, NEPHROL DIAL TRANSPL, V26, P1313, DOI 10.1093/ndt/gfq557; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nilsson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055477; Obregon C, 2009, AM J PATHOL, V175, P696, DOI 10.2353/ajpath.2009.080716; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pinckard JK, 1997, J IMMUNOL, V158, P3869; Saulnier PJ, 2014, DIABETES CARE, V37, P1425, DOI 10.2337/dc13-2580; Schnabel RB, 2013, ARTERIOSCL THROM VAS, V33, P1728, DOI 10.1161/ATVBAHA.112.301174; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Soriano S, 2007, CLIN NEPHROL, V67, P352; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Ueland T, 2005, J AM COLL CARDIOL, V46, P2018, DOI 10.1016/j.jacc.2005.08.039; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435	31	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122073	10.1371/journal.pone.0122073	http://dx.doi.org/10.1371/journal.pone.0122073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823004	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700151
J	Strang, AC; Knetsch, MLW; Koole, LH; de Winter, RJ; van der Wal, AC; de Vries, CJM; Tak, PP; Bisoendial, RJ; Stroes, ESG; Rotmans, JI				Strang, Aart C.; Knetsch, Menno L. W.; Koole, Leo H.; de Winter, Robbert J.; van der Wal, Allard C.; de Vries, Carlie J. M.; Tak, Paul P.; Bisoendial, Radjesh J.; Stroes, Erik S. G.; Rotmans, Joris I.			Effect of Anti-ApoA-I Antibody-Coating of Stents on Neointima Formation in a Rabbit Balloon-Injury Model	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; COLLABORATIVE NETWORK METAANALYSIS; APOLIPOPROTEIN-A-I; BARE-METAL STENTS; ENDOTHELIAL-CELLS; ELUTING STENTS; VENOUS THROMBOEMBOLISM; ARTERY STENT; HDL; ATHEROSCLEROSIS	Background and Aims Since high-density lipoprotein (HDL) has pro-endothelial and anti-thrombotic effects, a HDL recruiting stent may prevent restenosis. In the present study we address the functional characteristics of an apolipoprotein A-I (ApoA-I) antibody coating in vitro. Subsequently, we tested its biological performance applied on stents in vivo in rabbits. Materials and Methods The impact of anti ApoA-I-versus apoB-antibody coated stainless steel discs were evaluated in vitro for endothelial cell adhesion, thrombin generation and platelet adhesion. In vivo, response to injury in the iliac artery of New Zealand white rabbits was used as read out comparing apoA-I-coated versus bare metal stents. Results ApoA-I antibody coated metal discs showed increased endothelial cell adhesion and proliferation and decreased thrombin generation and platelet adhesion, compared to control discs. In vivo, no difference was observed between ApoA-I and BMS stents in lumen stenosis (23.3 +/- 13.8% versus 23.3 +/- 11.3%, p=0.77) or intima surface area (0.81 +/- 0.62 mm(2) vs 0.84 +/- 0.55 mm(2), p=0.85). Immunohistochemistry also revealed no differences in cell proliferation, fibrin deposition, inflammation and endothelialization. Conclusion ApoA-I antibody coating has potent pro-endothelial and anti-thrombotic effects in vitro, but failed to enhance stent performance in a balloon injury rabbit model in vivo.	[Strang, Aart C.; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Knetsch, Menno L. W.; Koole, Leo H.] Maastricht Univ, Dept Biomed Engn Biomat Sci, NL-6200 MD Maastricht, Netherlands; [de Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Bisoendial, Radjesh J.] Heart Res Inst, Newtown, NSW 2042, Australia; [Bisoendial, Radjesh J.] Centenary Inst, Newtown, NSW 2042, Australia; [Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; Heart Research Institute; University of Sydney; Centenary Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Stroes, ESG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.s.stroes@amc.uva.nl	Rotmans, Joris I./G-8866-2014	Rotmans, Joris I./0000-0001-9682-6234; van der Wal, Allard/0000-0001-5590-3758	OrbusNeich Medical, Leek, The Netherlands; Dutch Heart association [2008B070]	OrbusNeich Medical, Leek, The Netherlands; Dutch Heart association	This work was supported by a grant from OrbusNeich Medical, Leek, The Netherlands, and supported in part by a grant from the Dutch Heart association (2008B070). OrbusNeich and the Dutch Heart association had no role in the study design, the collection, analysis and interpretation of the data, and in the writing of the report. Authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Braekkan SK, 2009, J THROMB HAEMOST, V7, P1428, DOI 10.1111/j.1538-7836.2009.03481.x; Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chamberlain AM, 2008, BLOOD, V112, P2675, DOI 10.1182/blood-2008-05-157412; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Danenberg HD, 2003, CIRCULATION, V108, P2798, DOI 10.1161/01.CIR.0000097002.69209.CD; Edelman ER, 1998, AM J CARDIOL, V81, p4E, DOI 10.1016/S0002-9149(98)00189-1; Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037; FLEISHER LN, 1982, J BIOL CHEM, V257, P6653; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589; Jang HS, 2009, CATHETER CARDIO INTE, V74, P881, DOI 10.1002/ccd.22047; John MC, 2008, JACC-CARDIOVASC INTE, V1, P535, DOI 10.1016/j.jcin.2008.08.004; Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195; KO TM, 1993, BIOMATERIALS, V14, P657; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; LEBLOND L, 1991, J BIOL CHEM, V266, P6058; Li DY, 1999, ARTERIOSCL THROM VAS, V19, P378, DOI 10.1161/01.ATV.19.2.378; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; MURUGESAN G, 1994, CIRC RES, V74, P1149, DOI 10.1161/01.RES.74.6.1149; Nakazawa G, 2011, CIRC-CARDIOVASC INTE, V4, P38, DOI 10.1161/CIRCINTERVENTIONS.110.957654; Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Patel S, 2010, ATHEROSCLEROSIS, V212, P392, DOI 10.1016/j.atherosclerosis.2010.05.035; Ribichini F, 2007, J AM COLL CARDIOL, V50, P176, DOI 10.1016/j.jacc.2007.03.031; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Spieker Lukas E., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P51, DOI 10.2174/1568008043340044; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stevens KN, 2009, ACS APPL MATER INTER, V1, P2049, DOI 10.1021/am900390h; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; TAUBER JP, 1980, J CLIN INVEST, V66, P696, DOI 10.1172/JCI109907; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Wang SH, 2010, CLIN EXP IMMUNOL, V160, P137, DOI 10.1111/j.1365-2249.2009.04068.x; Wilson GJ, 2009, CIRCULATION, V120, P141, DOI 10.1161/CIRCULATIONAHA.107.730010; WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979; ZEIHER AM, 1994, CIRCULATION, V89, P2525, DOI 10.1161/01.CIR.89.6.2525; Zhang Q, 2009, INT J CARDIOL, V133, P286, DOI 10.1016/j.ijcard.2008.11.034	44	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122836	10.1371/journal.pone.0122836	http://dx.doi.org/10.1371/journal.pone.0122836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821966	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700202
J	Tsai, CY; Peh, MT; Feng, W; Dymock, BW; Moore, PK				Tsai, Chin-Yi; Peh, Meng Teng; Feng, Wei; Dymock, Brian William; Moore, Philip Keith			Hydrogen Sulfide Promotes Adipogenesis in 3T3L1 Cells	PLOS ONE			English	Article							ACID-BINDING PROTEIN; METABOLIC SYNDROME; LIPID-METABOLISM; GLUCOSE-UTILIZATION; INSULIN-RESISTANCE; LINKING OBESITY; ADIPOSE-TISSUE; FATTY-ACIDS; LYASE CSE; LIPOLYSIS	The effect of hydrogen sulfide (H2S) on differentiation of 3T3L1-derived adipocytes was examined. Endogenous H2S was increased after 3T3L1 differentiation. The expression of the H2S-synthesising enzymes, cystathionine gamma-lyase (CSE), cystathionine beta-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST), was increased in a time-dependent manner during 3T3L1 differentiation. Expression of genes associated with adipogenesis related genes including fatty acid binding protein 4 (FABP4/aP2), a key regulator of this process, was increased by GYY4137 (a slow-releasing H2S donor compound) and sodium hydrosulfide (NaHS, a classical H2S donor) but not by ZYJ1122 or time-expired NaHS. Furthermore expression of these genes were reduced by aminooxyacetic acid (AOAA, CBS inhibitor), DL-propargylglycine (PAG, CSE inhibitor) as well as by CSE small interference RNA (siCSE) and siCBS. The size and number of lipid droplets in mature adipocytes was significantly increased by both GYY4137 and NaHS, which also impaired the ability of CL316,243 (beta 3-agonist) to promote lipolysis in these cells. In contrast, AOAA and PAG had the opposite effect. Taken together, we show that the H2S-synthesising enzymes CBS, CSE and 3-MST are endogenously expressed during adipogenesis and that both endogenous and exogenous H2S modulate adipogenesis and adipocyte maturation.	[Tsai, Chin-Yi; Peh, Meng Teng; Moore, Philip Keith] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Neurobiol Grp,Life Sci Inst, Singapore 117595, Singapore; [Feng, Wei; Dymock, Brian William] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Tsai, CY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Neurobiol Grp,Life Sci Inst, Singapore 117595, Singapore.	tsai.jinie@gmail.com		Dymock, Brian/0000-0002-2374-5756	Biomedical Research Council in National University of Singapore; Agency for Science, Technology and Research (A*STAR) Singapore	Biomedical Research Council in National University of Singapore(National University of Singapore); Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR))	This work is funded by Biomedical Research Council in National University of Singapore and the Agency for Science, Technology and Research (A*STAR) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chiang JK, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-78; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Grasselli E, 2010, INT J MOL MED, V25, P505, DOI 10.3892/ijmm_00000370; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; RUSSELL TR, 1979, P NATL ACAD SCI USA, V76, P4451, DOI 10.1073/pnas.76.9.4451; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Skovgaard N, 2011, CURR PHARM BIOTECHNO, V12, P1385, DOI 10.2174/138920111798280956; Srilatha B, 2007, J SEX MED, V4, P1304, DOI 10.1111/j.1743-6109.2007.00561.x; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan EH, 2005, CANCER RES, V65, P10330, DOI 10.1158/0008-5472.CAN-04-4486; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Volpato GP, 2008, ANESTHESIOLOGY, V108, P659, DOI 10.1097/ALN.0b013e318167af0d; Wang K, 2014, J FLUORESC, V24, P1, DOI 10.1007/s10895-013-1296-5; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yanai H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-10; Zaheer S, 2013, NEUROCHEM RES, V38, P218, DOI 10.1007/s11064-012-0913-z	52	52	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119511	10.1371/journal.pone.0119511	http://dx.doi.org/10.1371/journal.pone.0119511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822632	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700038
J	Verhougstraete, MP; Brothers, S; Litaker, W; Blackwood, AD; Noble, R				Verhougstraete, Marc Paul; Brothers, Sydney; Litaker, Wayne; Blackwood, A. Denene; Noble, Rachel			Lessons Learned from Implementing a Wet Laboratory Molecular Training Workshop for Beach Water Quality Monitoring	PLOS ONE			English	Article							RAPIDLY MEASURED INDICATORS; ILLNESS; ENTEROCOCCUS; SCIENCE; ENUMERATION; CALIFORNIA; LITERACY; MODEL	Rapid molecular testing methods are poised to replace many of the conventional, culture-based tests currently used in fields such as water quality and food science. Rapid qPCR methods have the benefit of being faster than conventional methods and provide a means to more accurately protect public health. However, many scientists and technicians in water and food quality microbiology laboratories have limited experience using these molecular tests. To ensure that practitioners can use and implement qPCR techniques successfully, we developed a week long workshop to provide hands-on training and exposure to rapid molecular methods for water quality management. This workshop trained academic professors, government employees, private industry representatives, and graduate students in rapid qPCR methods for monitoring recreational water quality. Attendees were immersed in these new methods with hands-on laboratory sessions, lectures, and one-on-one training. Upon completion, the attendees gained sufficient knowledge and practice to teach and share these new molecular techniques with colleagues at their respective laboratories. Key findings from this workshop demonstrated: 1) participants with no prior experience could be effectively trained to conduct highly repeatable qPCR analysis in one week; 2) participants with different desirable outcomes required exposure to a range of different platforms and sample processing approaches; and 3) the collaborative interaction amongst newly trained practitioners, workshop leaders, and members of the water quality community helped foster a cohesive cohort of individuals which can advocate powerful cohort for proper implementation of molecular methods.	[Verhougstraete, Marc Paul] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA; [Brothers, Sydney] Univ N Carolina, Wilmington, NC 28401 USA; [Litaker, Wayne] Ctr Coastal Fisheries & Habitat Res, Natl Ocean Serv, Natl Ocean & Atmospher Adm, Beaufort, NC USA; [Blackwood, A. Denene; Noble, Rachel] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA	University of Arizona; University of North Carolina; University of North Carolina Wilmington; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of North Carolina; University of North Carolina Chapel Hill	Verhougstraete, MP (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA.	mverhougstraete@arizona.email.edu		Verhougstraete, Marc/0000-0003-4154-7531; Noble, Rachel/0000-0001-9071-8312	North Carolina Biotechnology Center President Initiative Award	North Carolina Biotechnology Center President Initiative Award	Partial funding of this workshop was provided by North Carolina Biotechnology Center President Initiative Award [http://www.ncbiotech.org/content/training-workshops-molecular-training-facility-eastern-north-carolina]. The remaining workshop funding came from participant registration and fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso PJ, 2003, PREV MED, V36, P250, DOI 10.1016/S0091-7435(02)00061-0; [Anonymous], 2001, REPORT, V1, P288; [Anonymous], 1999, GUIDELINES DEFINING, P13; Black FM, 2008, QUALITY ENHANCEMENT, P80; Boud D, 2014, PEER LEARNING HIGHER, P190; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao YP, 2013, WATER RES, V47, P233, DOI 10.1016/j.watres.2012.09.056; Capstick S., 2004, PEER ASS LEARN C INT, P53; Carver CA, 1999, IEEE T EDUC, V42, P33, DOI 10.1109/13.746332; Colford JM, 2012, WATER RES, V46, P2176, DOI 10.1016/j.watres.2012.01.033; Commission E, 2006, OFF J EUR UNION, V64, P37; Fang ZH, 2013, J ADOLESC ADULT LIT, V57, P274, DOI 10.1002/jaal.250; Frick WE, 2008, ENVIRON SCI TECHNOL, V42, P4818, DOI 10.1021/es703185p; Griffith JF, 2011, MAR TECHNOL SOC J, V45, P65, DOI 10.4031/MTSJ.45.2.13; HOLLIDAY WG, 1994, J RES SCI TEACH, V31, P877, DOI 10.1002/tea.3660310905; Kim JH, 2004, ENVIRON SCI TECHNOL, V38, P2497, DOI 10.1021/es034382v; Krajcik JS, 2010, SCIENCE, V328, P456, DOI 10.1126/science.1182593; Lavender JS, 2009, WATER RES, V43, P4967, DOI 10.1016/j.watres.2009.08.010; Leecaster MK, 2001, MAR POLLUT BULL, V42, P1150, DOI 10.1016/S0025-326X(01)00130-8; Marra RM, 1997, PROC FRONT EDUC CONF, P109, DOI 10.1109/FIE.1997.644821; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Stewart JR, 2013, WATER RES, V47, P6829, DOI 10.1016/j.watres.2013.04.063; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; U.S. Environmental Protection Agency, 2012, RECR WAT QUAL CRIT; USEPA, 2012, EPA821R12008; Vokurka S, 2013, J CLIN NURS, P1; Wade TJ, 2008, EPIDEMIOLOGY, V19, P375, DOI 10.1097/EDE.0b013e318169cc87; Wade TJ, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-66; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Webb S, 2013, BIOTECHNIQUES, V55, P165, DOI 10.2144/000114085; WHO, 2003, WHO GUID SAF RECR WA, V1; Xiao S, 2008, ENG SUBJECT CTR REPO, P26	32	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121214	10.1371/journal.pone.0121214	http://dx.doi.org/10.1371/journal.pone.0121214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822486	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700095
J	Rozado, D; Duenser, A; Howell, B				Rozado, David; Duenser, Andreas; Howell, Ben			Improving the Performance of an EEG-Based Motor Imagery Brain Computer Interface Using Task Evoked Changes in Pupil Diameter	PLOS ONE			English	Article							SINGLE-TRIAL EEG; BCI; CLASSIFICATION; PUPILLOMETRY; COMPONENTS	For individuals with high degrees of motor disability or locked-in syndrome, it is impractical or impossible to use mechanical switches to interact with electronic devices. Brain computer interfaces (BCIs) can use motor imagery to detect interaction intention from users but lack the accuracy of mechanical switches. Hence, there exists a strong need to improve the accuracy of EEG-based motor imagery BCIs attempting to implement an on/off switch. Here, we investigate how monitoring the pupil diameter of a person as a psycho-physiological parameter in addition to traditional EEG channels can improve the classification accuracy of a switch-like BCI. We have recently noticed in our lab (work not yet published) how motor imagery is associated with increases in pupil diameter when compared to a control rest condition. The pupil diameter parameter is easily accessible through video oculography since most gaze tracking systems report pupil diameter invariant to head position. We performed a user study with 30 participants using a typical EEG based motor imagery BCI. We used common spatial patterns to separate motor imagery, signaling movement intention, from a rest control condition. By monitoring the pupil diameter of the user and using this parameter as an additional feature, we show that the performance of the classifier trying to discriminate motor imagery from a control condition improves over the traditional approach using just EEG derived features. Given the limitations of EEG to construct highly robust and reliable BCIs, we postulate that multi-modal approaches, such as the one presented here that monitor several psycho-physiological parameters, can be a successful strategy in making BCIs more accurate and less vulnerable to constraints such as requirements for long training sessions or high signal to noise ratio of electrode channels.	[Rozado, David; Duenser, Andreas; Howell, Ben] CSIRO Digital Product Flagship, Sandy Bay, Tas 7005, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rozado, D (corresponding author), CSIRO Digital Product Flagship, 15 Coll Rd, Sandy Bay, Tas 7005, Australia.	drozado@gmail.com	, AndreasDuenser/I-9279-2014; Rozado, David/O-6934-2014	, AndreasDuenser/0000-0002-7423-0736; Rozado, David/0000-0001-6849-4746	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	CSIRO internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Beatty J, 1977, TECHNICAL REPORT; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Curran EA, 2003, BRAIN COGNITION, V51, P326, DOI 10.1016/S0278-2626(03)00036-8; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demberg V, 2013, P 35 ANN M COGN SCI; Fujisawa J, 2008, IEEE VIRTUAL REALITY 2008, PROCEEDINGS, P251; GARRETT JC, 1989, ARCH SEX BEHAV, V18, P191, DOI 10.1007/BF01543194; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hartmann M, 2014, CURR BIOL, V24, pR281, DOI 10.1016/j.cub.2014.02.028; Hill NJ, 2006, IEEE T NEUR SYS REH, V14, P183, DOI 10.1109/TNSRE.2006.875548; Hochberg LR, 2006, IEEE ENG MED BIOL, V25, P32, DOI 10.1109/MEMB.2006.1705745; KOLES ZJ, 1991, ELECTROEN CLIN NEURO, V79, P440, DOI 10.1016/0013-4694(91)90163-X; Kothe CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056014; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Makeig S, 2012, P IEEE, V100, P1567, DOI 10.1109/JPROC.2012.2185009; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Obermaier B, 2001, PATTERN RECOGN LETT, V22, P1299, DOI 10.1016/S0167-8655(01)00075-7; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; PEAVLER WS, 1974, PSYCHOPHYSIOLOGY, V11, P559, DOI 10.1111/j.1469-8986.1974.tb01114.x; Pedrotti M, 2014, INT J HUM-COMPUT INT, V30, P220, DOI 10.1080/10447318.2013.848320; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1998, IEEE Trans Rehabil Eng, V6, P316, DOI 10.1109/86.712230; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Rosas-Cholula G, 2010, ELECT ROBOT AUTO MEC, P360, DOI 10.1109/CERMA.2010.48; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wolpaw J, 2011, BRAIN COMPUTER INTER; Wubbels P, 2007, LECT NOTES ARTIF INT, V4565, P23	33	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121262	10.1371/journal.pone.0121262	http://dx.doi.org/10.1371/journal.pone.0121262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816285	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600077
J	Uehara, K; Coxon, JP; Byblow, WD				Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.			Transcranial Direct Current Stimulation Improves Ipsilateral Selective Muscle Activation in a Frequency Dependent Manner	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ANTAGONIST MUSCLES; MAGNETIC STIMULATION; EXCITABILITY; INHIBITION; MOVEMENTS; SUPPRESSION; SYNERGIES; FACILITATION; MODULATION	Failure to suppress antagonist muscles can lead to movement dysfunction, such as the abnormal muscle synergies often seen in the upper limb after stroke. A neurophysiological surrogate of upper limb synergies, the selectivity ratio (SR), can be determined from the ratio of biceps brachii (BB) motor evoked potentials to transcranial magnetic stimulation prior to forearm pronation versus elbow flexion. Surprisingly, cathodal transcranial direct current stimulation (c-TDCS) over ipsilateral primary motor cortex (M1) reduces (i.e. improves) the SR in healthy adults, and chronic stroke patients. The ability to suppress antagonist muscles may be exacerbated at high movement rates. The aim of the present study was to investigate whether the selective muscle activation of the biceps brachii (BB) is dependent on altering frequency demands, and whether the c-tDCS improvement of SR is dependent on task frequency. Seventeen healthy participants performed repetitive isometric elbow flexion and forearm pronation at three rates, before and after c-tDCS or sham delivered to ipsilateral left M1. Ipsilateral c-tDCS improved the SR in a frequency dependent manner by selectively suppressing BB antagonist excitability. Our findings confirm that c-tDCS is an effective tool for improving selective muscle activation, and provide novel evidence for its efficacy at rates of movement where it is most likely to benefit task performance.	[Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.] Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand; [Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Uehara, Kazumasa] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Div Human Sci, Human Motor Control Lab, Higashihiroshima, Hiroshima 724, Japan	University of Auckland; University of Auckland; Hiroshima University	Byblow, WD (corresponding author), Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand.	w.byblow@auckland.ac.nz	Byblow, Winston/D-3579-2009; Coxon, James/S-1286-2019	Byblow, Winston/0000-0001-8347-6730; Coxon, James/0000-0003-2351-8489; Uehara, Kazumasa/0000-0003-2350-8694	Aotearoa Foundation of New Zealand [9133-3627269]; Faculty Research Development Fund (FRDF) grant [3704166]; Japan Society for the Promotion of Science [24-393]	Aotearoa Foundation of New Zealand; Faculty Research Development Fund (FRDF) grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KU is supported by a postdoctoral fellow from Japan Society for the Promotion of Science (24-393). JPC is supported by a postdoctoral fellowship from the Aotearoa Foundation of New Zealand (9133-3627269). This study was financially supported by a Faculty Research Development Fund (FRDF) grant awarded to WDB (3704166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Bradnam LV, 2012, CEREB CORTEX, V22, P2662, DOI 10.1093/cercor/bhr344; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; Bradnam LV, 2010, J NEUROPHYSIOL, V104, P2594, DOI 10.1152/jn.00365.2010; Bradnam LV, 2010, J NEUROPHYSIOL, V103, P2382, DOI 10.1152/jn.01046.2009; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P805, DOI 10.1152/jn.1985.53.3.805; d'Avella A, 2008, J NEUROPHYSIOL, V100, P1433, DOI 10.1152/jn.01377.2007; DE LUCA CJ, 1987, J NEUROPHYSIOL, V58, P525, DOI 10.1152/jn.1987.58.3.525; Furuya S, 2012, HUM MOVEMENT SCI, V31, P26, DOI 10.1016/j.humov.2011.01.002; Gerachshenko T, 2008, CLIN NEUROPHYSIOL, V119, P683, DOI 10.1016/j.clinph.2007.11.004; Gerachshenko T, 2007, EXP BRAIN RES, V183, P531, DOI 10.1007/s00221-007-1071-4; Gerard MJ, 2002, HUM FACTORS, V44, P51, DOI 10.1518/0018720024494757; GOWLAND C, 1992, PHYS THER, V72, P624, DOI 10.1093/ptj/72.9.624; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; Hayashi MJ, 2008, CEREB CORTEX, V18, P2932, DOI 10.1093/cercor/bhn053; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; Kuxhaus L, 2014, J BIOMECH, V47, P1234, DOI 10.1016/j.jbiomech.2013.12.008; Levin MF, 2000, BRAIN RES, V853, P352, DOI 10.1016/S0006-8993(99)02298-2; MARSDEN CD, 1983, J PHYSIOL-LONDON, V335, P1; McCambridge AB, 2011, J NEUROPHYSIOL, V105, P2937, DOI 10.1152/jn.00171.2011; Monte-Silva K, 2010, J NEUROPHYSIOL, V103, P1735, DOI 10.1152/jn.00924.2009; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Simkins M, 2013, EXP BRAIN RES, V229, P517, DOI 10.1007/s00221-013-3613-2; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Uehara K, 2013, BEHAV BRAIN RES, V240, P33, DOI 10.1016/j.bbr.2012.10.053; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073; van den Berg FE, 2011, J COGNITIVE NEUROSCI, V23, P3456, DOI 10.1162/jocn_a_00018; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Welmer AK, 2006, AM J PHYS MED REHAB, V85, P112, DOI 10.1097/01.phm.0000197587.78140.17; WIERZBICKA MM, 1986, EXP BRAIN RES, V63, P331	40	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122434	10.1371/journal.pone.0122434	http://dx.doi.org/10.1371/journal.pone.0122434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816204	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600180
J	Wang, B; Chen, Y; Mu, CY; Su, YH; Liu, R; Huang, ZY; Li, Y; Yu, QM; Chang, GB; Xu, Q; Chen, GH				Wang, Bin; Chen, Yang; Mu, Chunyu; Su, Yanhui; Liu, Ran; Huang, Zhengyang; Li, Yang; Yu, Qingming; Chang, Guobin; Xu, Qi; Chen, Guohong			Identification and Expression Analysis of the Interferon-Induced Protein with Tetratricopeptide Repeats 5 (IFIT5) Gene in Duck (Anas platyrhynchos domesticus)	PLOS ONE			English	Article							MOLECULAR ANALYSIS; CRYSTAL-STRUCTURE; IMMUNITY	The interferon-induced proteins with tetratricopeptide repeats (IFITs) protein family mediates antiviral effects by inhibiting translation initiation, cell proliferation, and migration in the interferon (IFN) dependent innate immune system. Several members of this family, including IFIT1, IFIT2, IFIT3 and IFIT5, have been heavily studied in mammals. Avian species contain only one family member, IFIT5, and little is known about the role of this protein in birds. In this study, duck IFIT5 (duIFIT5) full-length mRNA was cloned by reverse transcription polymerase chain reaction (RT-PCR) and rapid amplification of the cDNA ends (RACE). Based on the sequence obtained, we performed a series of bioinformatics analyses, and found that duIFIT5 was most similar to homologs in other avian species. Also, duIFIT5 contained eight conserved TPR motifs and two conserved multi-domains (TPR_11 and TPR_12). Finally, we used duck hepatitis virus type 1 (DHV-1) and polyriboinosinicpolyribocytidylic acid (poly (I:C)) as a pathogen or a pathogen-associated molecular pattern induction to infect three-day-old domestic ducklings. The liver and spleen were collected to detect the change in duIFIT5 transcript level upon infection by quantitative real-time PCR (qRT-PCR). DuIFIT5 expression rapidly increased after DHV-1 infection and maintained a high level, while the transcripts of duIFIT5 peaked at 8h after poly (I: C) infection and then returned to normal. Taken together, these results provide a greater understanding of avian IFIT5.	[Wang, Bin; Chen, Yang; Mu, Chunyu; Su, Yanhui; Liu, Ran; Huang, Zhengyang; Li, Yang; Yu, Qingming; Chang, Guobin; Xu, Qi; Chen, Guohong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou 225009, Jiangsu, Peoples R China		Chen, GH (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou 225009, Jiangsu, Peoples R China.	ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022; Huang, Zhengyang/J-6297-2013	Huang, Zhengyang/0000-0001-9197-6700	National Waterfowl Industrial Technology System [CARS-43-3]; Excellent PhD Dissertation Foundation of Yangzhou University; Priority Academic Program Development of Jiangsu Higher Education Institutions [[2011]137]	National Waterfowl Industrial Technology System; Excellent PhD Dissertation Foundation of Yangzhou University; Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by the National Waterfowl Industrial Technology System (No. CARS-43-3), the Excellent PhD Dissertation Foundation of Yangzhou University and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions ([2011]137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; Chen Y, 2013, DEV COMP IMMUNOL, V41, P766, DOI 10.1016/j.dci.2013.07.018; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Ding CY, 2007, VIROLOGY, V361, P9, DOI 10.1016/j.virol.2007.01.007; Feng F, 2013, CELL RES, V23, P1055, DOI 10.1038/cr.2013.80; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Gu CQ, 2012, POULTRY SCI, V91, P583, DOI 10.3382/ps.2011-01743; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Sen GC, 2012, CELL RES, V22, P1407, DOI 10.1038/cr.2012.130; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Ullah MO, 1399, TLR SIGNALLING ADAPT; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Woolcock P., 2003, DIS POULTRY, V10, P661; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	30	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121065	10.1371/journal.pone.0121065	http://dx.doi.org/10.1371/journal.pone.0121065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816333	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600063
J	Pho, MT; Deo, S; Palamountain, KM; Joloba, ML; Bajunirwe, F; Katamba, A				Pho, Mai T.; Deo, Sarang; Palamountain, Kara M.; Joloba, Moses Lutaakome; Bajunirwe, Francis; Katamba, Achilles			Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda	PLOS ONE			English	Article							TOOLS; TECHNOLOGIES; RESISTANCE	Background Xpert MTB/RIF (Xpert) is being widely adopted in high TB burden countries. Analysis is needed to guide the placement of devices within health systems to optimize the tuberculosis (TB) case detection rate (CDR). Methods We used epidemiological and operational data from Uganda (139 sites serving 87,600 individuals tested for TB) to perform a model-based comparison of the following placement strategies for Xpert devices: 1) Health center level (sites ranked by size from national referral hospitals to health care level III centers), 2) Smear volume (sites ranked from highest to lowest volume of smear microscopy testing), 3) Antiretroviral therapy (ART) volume (sites ranked from greatest to least patients on ART), 4) External equality assessment (EQA) performance (sites ranked from worst to best smear microscopy performance) and 5) TB prevalence (sites ranked from highest to lowest). We compared two clinical algorithms, one where Xpert was used only for smear microscopy negative samples versus another replacing smear microscopy. The primary outcome was TB CDR; secondary outcomes were detection of multi-drug resistant TB, number of sites requiring device placement to achieve specified rollout coverage, and cost. Results Placement strategies that prioritized sites with higher TB prevalence maximized CDR, with an incremental rate of 6.2-12.6% compared to status quo (microscopy alone). Diagnosis of MDR-TB was greatest in the TB Prevalence strategy when Xpert was used in place of smear microscopy. While initial implementation costs were lowest in the Smear Volume strategy, cost per additional TB case detected was lowest in the TB prevalence strategy. Conclusion In Uganda, placement of Xpert devices in sites with high TB prevalence yielded the highest TB CDR at the lowest cost per additional case diagnosed. These results represent novel use of program level data to inform the optimal placement of new technology in resource-constrained settings.	[Pho, Mai T.] Univ Chicago, Dept Med, Sect Hosp Med, Chicago, IL 60637 USA; [Pho, Mai T.] Univ Chicago, Sect Infect Dis & Global Hlth, Chicago, IL 60637 USA; [Deo, Sarang] Indian Sch Business, Hyderabad, Andhra Pradesh, India; [Palamountain, Kara M.] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA; [Joloba, Moses Lutaakome] Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Katamba, Achilles] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda	University of Chicago; University of Chicago; Indian School of Business (ISB); Northwestern University; Makerere University; Mbarara University of Science & Technology; Makerere University	Pho, MT (corresponding author), Univ Chicago, Dept Med, Sect Hosp Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mpho@bsd.uchicago.edu	Deo, Sarang/B-5895-2015	Deo, Sarang/0000-0002-3233-6014; Joloba, Moses/0000-0002-0334-9983	Grand Challenges Canada [0004-02]	Grand Challenges Canada(CGIAR)	Grand Challenges Canada #0004-02, grandchallenges.ca (MTP SD KMP FB AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimbola TO, 2012, JAIDS-J ACQ IMM DEF, V60, pE1, DOI 10.1097/QAI.0b013e318246538f; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cohen G DP, 2013, DIAGNOSTIC DELAYS AS; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Gane EJ SC, 2012, 47 ANN M EUR ASS ST; Khan MS, 2009, TROP MED INT HEALTH, V14, P1437, DOI 10.1111/j.1365-3156.2009.02406.x; Laboratory NTR, 2011, UG TB LAB NEW SPUT S; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Mugambi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078891; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P423, DOI 10.1586/14737159.6.3.423; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Programme NTaLC, 2012, DRAFT PLANN IMPL XP; STD/AIDS Control Programme MoH, 2011, ST ANT THER SERV UG; Stevens W, 2012, LESS LEARNT 4 ANN WH; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2021, 10 THREATS GLOB HLTH	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122574	10.1371/journal.pone.0122574	http://dx.doi.org/10.1371/journal.pone.0122574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830297	Green Published, gold			2022-12-27	WOS:000352135600115
J	Kleino, I; Jarviluoma, A; Hepojoki, J; Huovila, AP; Saksela, K				Kleino, Iivari; Jarviluoma, Annika; Hepojoki, Jussi; Huovila, Ari Pekka; Saksela, Kalle			Preferred SH3 Domain Partners of ADAM Metalloproteases Include Shared and ADAM-Specific SH3 Interactions	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ALTERNATIVE EXON USE; TEC FAMILY KINASES; CYTOPLASMIC DOMAIN; ECTODOMAIN CLEAVAGE; PROMOTE MIGRATION; TYROSINE KINASE; MOLECULAR-BASIS; LIGAND RELEASE; HB-EGF	A disintegrin and metalloproteinases (ADAMs) constitute a protein family essential for extracellular signaling and regulation of cell adhesion. Catalytic activity of ADAMs and their predicted potential for Src-homology 3 (SH3) domain binding show a strong correlation. Here we present a comprehensive characterization of SH3 binding capacity and preferences of the catalytically active ADAMs 8, 9, 10, 12, 15, 17, and 19. Our results revealed several novel interactions, and also confirmed many previously reported ones. Many of the identified SH3 interaction partners were shared by several ADAMs, whereas some were ADAM-specific. Most of the ADAM-interacting SH3 proteins were adapter proteins or kinases, typically associated with sorting and endocytosis. Novel SH3 interactions revealed in this study include TOCA1 and CIP4 as preferred partners of ADAM8, and RIMBP1 as a partner of ADAM19. Our results suggest that common as well as distinct mechanisms are involved in regulation and execution of ADAM signaling, and provide a useful framework for addressing the pathways that connect ADAMs to normal and aberrant cell behavior.	[Kleino, Iivari; Jarviluoma, Annika; Hepojoki, Jussi; Saksela, Kalle] Univ Helsinki, Dept Virol, Helsinki, Finland; [Kleino, Iivari; Jarviluoma, Annika; Hepojoki, Jussi; Saksela, Kalle] Helsinki Univ Hosp, Helsinki, Finland; [Huovila, Ari Pekka] Univ Tampere, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University	Saksela, K (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.	kalle.saksela@helsinki.fi	Huovila, Ari-Pekka/O-1650-2017; Hepojoki, Jussi/W-4667-2017	Huovila, Ari-Pekka/0000-0002-4853-7160; Hepojoki, Jussi/0000-0001-5699-214X; Kleino, Iivari/0000-0001-6219-8575; Saksela, Kalle/0000-0003-0827-122X	Jenny and Antti Wihuri Foundation; Academy of Finland; Helsinki University Central Hospital Research Council; Biocentrum Helsinki; Sigrid Juselius Foundation	Jenny and Antti Wihuri Foundation; Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Council; Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants to IK from The Jenny and Antti Wihuri Foundation and to KS from the Academy of Finland, Helsinki University Central Hospital Research Council, Biocentrum Helsinki, and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bohm BB, 2013, ARTHRITIS RHEUM-US, V65, P2826, DOI 10.1002/art.38109; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Deng W, 2014, P NATL ACAD SCI USA, V111, P15987, DOI 10.1073/pnas.1409354111; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Ebsen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102899; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fried D, 2012, J BIOL CHEM, V287, P21214, DOI 10.1074/jbc.M112.347120; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Galiegue S, 1999, J BIOL CHEM, V274, P2938, DOI 10.1074/jbc.274.5.2938; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hartmann M, 2013, TRENDS BIOCHEM SCI, V38, P111, DOI 10.1016/j.tibs.2012.12.002; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Koprulu AD, 2009, CRIT REV IMMUNOL, V29, P317, DOI 10.1615/CritRevImmunol.v29.i4.30; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Maretzky T, 2009, CANCER RES, V69, P4573, DOI 10.1158/0008-5472.CAN-08-4766; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Micocci KC, 2013, BIOCHIMIE, V95, P1371, DOI 10.1016/j.biochi.2013.03.001; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moro N, 2014, EUR J CELL BIOL, V93, P23, DOI 10.1016/j.ejcb.2014.01.002; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Ortiz RM, 2004, GENE CHROMOSOME CANC, V41, P366, DOI 10.1002/gcc.20102; PAWSON T, 1994, ADV CANCER RES, V64, P87, DOI 10.1016/S0065-230X(08)60835-0; Poghosyan Z, 2002, J BIOL CHEM, V277, P4999, DOI 10.1074/jbc.M107430200; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Romagnoli M, 2014, EMBO MOL MED, V6, P278, DOI 10.1002/emmm.201303373; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sun CX, 2010, CARDIOVASC RES, V87, P348, DOI 10.1093/cvr/cvq060; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Xu Q, 2010, TUMOR BIOL, V31, P217, DOI 10.1007/s13277-010-0034-8; Yasui A, 2004, PATHOBIOLOGY, V71, P185, DOI 10.1159/000078672; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Yumoto N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003322; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028	75	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121301	10.1371/journal.pone.0121301	http://dx.doi.org/10.1371/journal.pone.0121301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825872	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800040
J	Baumlisberger, M; Youssar, L; Schilhabel, MB; Jonas, D				Baeumlisberger, Mathias; Youssar, Loubna; Schilhabel, Markus B.; Jonas, Daniel			Influence of a Non-Hospital Medical Care Facility on Antimicrobial Resistance in Wastewater	PLOS ONE			English	Article							RNA GENE DATABASE; 16S RIBOSOMAL-RNA; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; TREATMENT-PLANT; SEQUENCE-ANALYSIS; NURSING-HOMES; PREVALENCE; BACTERIA; DIVERSITY	The global widespread use of antimicrobials and accompanying increase in resistant bacterial strains is of major public health concern. Wastewater systems and wastewater treatment plants are considered a niche for antibiotic resistance genes (ARGs), with diverse microbial communities facilitating ARG transfer via mobile genetic element (MGE). In contrast to hospital sewage, wastewater from other health care facilities is still poorly investigated. At the instance of a nursing home located in south-west Germany, in the present study, shotgun metagenomics was used to investigate the impact on wastewater of samples collected up-and down-stream in different seasons. Microbial composition, ARGs and MGEs were analyzed using different annotation approaches with various databases, including Antibiotic Resistance Ontologies (ARO), integrons and plasmids. Our analysis identified seasonal differences in microbial communities and abundance of ARG and MGE between samples from different seasons. However, no obvious differences were detected between up-and downstream samples. The results suggest that, in contrast to hospitals, sewage from the nursing home does not have a major impact on ARG or MGE in wastewater, presumably due to much less intense antimicrobial usage. Possible limitations of metagenomic studies using high-throughput sequencing for detection of genes that seemingly confer antibiotic resistance are discussed.	[Baeumlisberger, Mathias; Youssar, Loubna; Jonas, Daniel] Univ Freiburg, Med Ctr, Inst Environm Hlth Sci, Freiburg, Germany; [Baeumlisberger, Mathias; Youssar, Loubna; Jonas, Daniel] Univ Freiburg, Med Ctr, Hosp Infect Control, Freiburg, Germany; [Schilhabel, Markus B.] Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Kiel, Germany	University of Freiburg; University of Freiburg; University of Kiel; Schleswig Holstein University Hospital	Jonas, D (corresponding author), Univ Freiburg, Med Ctr, Inst Environm Hlth Sci, Freiburg, Germany.	daniel.jonas@uniklinik-freiburg.de			German Federal Ministry of Education and Research [02WRS1280A - J]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was funded by the German Federal Ministry of Education and Research (02WRS1280A - J) as part of the research program "Risk Management of Emerging Compounds and Pathogens in the Water Cycle (RiSKWa)".	Arvand M, 2013, J ANTIMICROB CHEMOTH, V68, P2686, DOI 10.1093/jac/dkt226; ATV, 2006, ATV WORKING SHEET A1; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061011; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Brechet C, 2014, CLIN INFECT DIS, V58, P1658, DOI 10.1093/cid/ciu190; Cai L, 2014, APPL MICROBIOL BIOT, V98, P3317, DOI 10.1007/s00253-013-5402-z; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chao YQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03550; Cock PJA, 2013, PEERJ, V1, DOI 10.7717/peerj.167; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Conejo MC, 2003, ANTIMICROB AGENTS CH, V47, P2313, DOI 10.1128/AAC.47.7.2313-2315.2003; Cuccuru G, 2014, BIOINFORMATICS, V30, P1928, DOI 10.1093/bioinformatics/btu135; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gilmour MW, 2004, PLASMID, V52, P182, DOI 10.1016/j.plasmid.2004.06.006; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Hewson I, 2014, APPL ENVIRON MICROB, V80, P328, DOI 10.1128/AEM.02680-13; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Jakobsen L, 2008, ENVIRON INT, V34, P108, DOI 10.1016/j.envint.2007.07.011; Jury KL., 2010, CURRENT RES TECHNOLO, P509; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lemarchand K, 2005, J MICROBIOL METH, V63, P115, DOI 10.1016/j.mimet.2005.02.021; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Ma LP, 2014, APPL MICROBIOL BIOT, V98, P5195, DOI 10.1007/s00253-014-5511-3; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; da Costa PMM, 2006, J ENVIRON SCI HEAL B, V41, P1393, DOI 10.1080/03601230600964258; Martins VV, 2014, ENVIRON SCI POLLUT R, V21, P5873, DOI 10.1007/s11356-014-2509-4; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McClean P, 2011, J ANTIMICROB CHEMOTH, V66, P1609, DOI 10.1093/jac/dkr183; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Meyer E, 2013, INT J MED MICROBIOL, V303, P388, DOI 10.1016/j.ijmm.2013.04.004; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mokrousov I, 2003, ANTIMICROB AGENTS CH, V47, P2231, DOI 10.1128/AAC.47.7.2231-2235.2003; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; O'Driscoll J, 2006, J BACTERIOL, V188, P6629, DOI 10.1128/JB.00672-06; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pop-Vicas A, 2008, J AM GERIATR SOC, V56, P1276, DOI 10.1111/j.1532-5415.2008.01787.x; Port JA, 2014, ENVIRON HEALTH PERSP, V122, P222, DOI 10.1289/ehp.1307009; Port JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048000; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabate M, 2008, RES MICROBIOL, V159, P288, DOI 10.1016/j.resmic.2008.02.001; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; Wang ZH, 2014, GENET MOL RES, V13, P7542, DOI 10.4238/2014.September.12.21; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y	66	25	25	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122635	10.1371/journal.pone.0122635	http://dx.doi.org/10.1371/journal.pone.0122635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821977	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700192
J	Han, YJ; Park, JD; Lee, B; Choi, YH; Suh, DI; Lim, BC; Chae, JH				Han, Young Joo; Park, June Dong; Lee, Bongjin; Choi, Yu Hyeon; Suh, Dong In; Lim, Byung Chan; Chae, Jong-Hee			Home Mechanical Ventilation in Childhood-Onset Hereditary Neuromuscular Diseases: 13 Years' Experience at a Single Center in Korea	PLOS ONE			English	Article							MUSCULAR-ATROPHY TYPE-1; FIBER-TYPE DISPROPORTION; RESPIRATORY MANAGEMENT; CHILDREN; SURVIVAL; COMPLICATIONS; TRACHEOSTOMY; CARE	Introduction Children with hereditary neuromuscular diseases (NMDs) are at a high risk of morbidity and mortality related to respiratory failure. The use of home mechanical ventilation (HMV) has saved the lives of many children with NMD but, due to a lack of studies, dependable guidelines are not available. We drew upon our experience to compare the various underlying NMDs and to evaluate HMV with regard to respiratory morbidity, the proper indications and timing for its use, and to develop a policy to improve the quality of home noninvasive ventilation (NIV). Methods We retrospectively analyzed the medical records of 57 children with childhood-onset hereditary NMDs in whom HMV was initiated between January 2000 and May 2013 at Seoul National University Children's Hospital. The degree of respiratory morbidity was estimated by the frequency and duration of hospitalizations caused by respiratory distress. Results The most common NMD was spinal muscular atrophy (SMA, n = 33). Emergent mechanical ventilation was initiated in 44% of the patients before the confirmed diagnosis, and the indicators of pre-HMV respiratory morbidity (e.g., extubation trials, hypoxia, hospitalizations, and intensive care unit stay) were greater in these patients than in others. The proportion of post-HMV hospitalizations (range, 0.00-0.52; median, 0.01) was lower than that of pre-HMV hospitalizations (0.02-1.00; 0.99) (P < 0.001). Eight patients were able to maintain home NIV. The main causes of NIV failure were air leakage and a large amount of airway secretions. Conclusions The application of HMV helped reduce respiratory morbidity in children with childhood-onset hereditary NMD. Patients with SMA type I can benefit from an early diagnosis and the timely application of HMV. The choice between invasive and noninvasive HMV should be based on the patient's age and NIV trial tolerance. Systematic follow-up guidelines provided by a multidisciplinary team are needed.	[Han, Young Joo; Park, June Dong; Lee, Bongjin; Choi, Yu Hyeon; Suh, Dong In; Lim, Byung Chan; Chae, Jong-Hee] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Lim, Byung Chan; Chae, Jong-Hee] Seoul Natl Univ, Childrens Hosp, Pediat Clin Neurosci Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, JD (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	jdparkmd@snu.ac.kr		Lee, Bongjin/0000-0001-7878-9644; Lim, Byung Chan/0000-0002-8509-4135; CHOI, YU HYEON/0000-0002-3057-0886; Park, June Dong/0000-0001-8113-1384				Ahn JJ, 2000, TUBERC RESPIR DIS SE, V49, P624, DOI [10.4046/trd.2000.49.5.624, DOI 10.4046/TRD.2000.49.5.624]; Amin Raouf S, 2003, Semin Neonatol, V8, P127, DOI 10.1016/S1084-2756(02)00220-8; Bach JR, 2008, PAEDIATR RESPIR REV, V9, P45, DOI 10.1016/j.prrv.2007.11.003; Bach JR, 2007, AM J PHYS MED REHAB, V86, P339, DOI 10.1097/PHM.0b013e31804a8505; Bach JR, 2000, CHEST, V117, P1100, DOI 10.1378/chest.117.4.1100; Bach JR, 2003, AM J PHYS MED REHAB, V82, P137, DOI 10.1097/00002060-200302000-00009; Bach JR, 2002, PEDIATR PULM, V34, P16, DOI 10.1002/ppul.10110; BANWELL BL, 1994, PEDIATR NEUROL, V10, P335; Barreiro TJ, 2007, CRIT CARE CLIN, V23, P201, DOI 10.1016/j.ccc.2006.11.015; Bartholomeus MGT, 2000, CLIN NEUROL NEUROSUR, V102, P97, DOI 10.1016/S0303-8467(00)00066-4; Brillante R, 2012, RESPIROLOGY, V17, P933, DOI 10.1111/j.1440-1843.2012.02209.x; Carr MM, 2001, LARYNGOSCOPE, V111, P1925, DOI 10.1097/00005537-200111000-00010; D'Amico A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-71; Deutsch ES, 2010, RESP CARE, V55, P1082; Duynstee MLG, 2002, INT J PEDIATR OTORHI, V62, P1, DOI 10.1016/S0165-5876(01)00545-6; Edwards JD, 2010, J PEDIATR-US, V157, P955, DOI 10.1016/j.jpeds.2010.06.012; Farre R, 2006, THORAX, V61, P400, DOI 10.1136/thx.2005.052647; Farre R, 2005, EUR RESPIR J, V26, P86, DOI 10.1183/09031936.05.00066904; Fauroux B, 2003, PEDIATR PULM, V35, P119, DOI 10.1002/ppul.10237; Graham RJ, 2007, PEDIATRICS, V119, pE1280, DOI 10.1542/peds.2006-2471; Gregoretti C, 2013, PEDIATRICS, V131, pE1509, DOI 10.1542/peds.2012-2278; Hill NS, 2002, SEM RESP CRIT CARE M, V23, P293, DOI 10.1055/s-2002-33038; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Mah JK, 2008, NEUROMUSCULAR DISORD, V18, P983, DOI 10.1016/j.nmd.2008.09.001; Manzur Adnan Y, 2003, Neuromuscul Disord, V13, P184, DOI 10.1016/S0960-8966(02)00212-2; Navalesi P, 2000, CRIT CARE MED, V28, P1785, DOI 10.1097/00003246-200006000-00015; Noyes J, 2006, J ADV NURS, V56, P392, DOI 10.1111/j.1365-2648.2006.04014.x; Ottonello G, 2007, PEDIATR INT, V49, P801, DOI 10.1111/j.1442-200X.2007.02463.x; Perrin C, 2004, MUSCLE NERVE, V29, P5, DOI 10.1002/mus.10487; Racca F, 2011, PEDIATR PULM, V46, P566, DOI 10.1002/ppul.21401; Racca F, 2010, MINERVA ANESTESIOL, V76, P51; Robert D, 2007, CRIT CARE, V11, DOI 10.1186/cc5714; Simonds AK, 2003, EUR RESPIR J, V22, p38S, DOI 10.1183/09031936.03.00029803; Simonds Anita K, 2005, Paediatr Respir Rev, V6, P209, DOI 10.1016/j.prrv.2005.06.003; Simonds AK, 2006, CHEST, V130, P1879, DOI 10.1378/chest.130.6.1879; Sritippayawan S, 2003, J PEDIATR-US, V142, P481, DOI 10.1067/mpd.2003.157; Tsuji M, 1999, PEDIATR NEUROL, V21, P658, DOI 10.1016/S0887-8994(99)00056-9; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788	38	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122346	10.1371/journal.pone.0122346	http://dx.doi.org/10.1371/journal.pone.0122346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822836	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700168
J	Higashi, T; Katsuno, T; Kitajiri, S; Furuse, M				Higashi, Tomohito; Katsuno, Tatsuya; Kitajiri, Shin-ichiro; Furuse, Mikio			Deficiency of Angulin-2/ILDR1, a Tricellular Tight Junction-Associated Membrane Protein, Causes Deafness with Cochlear Hair Cell Degeneration in Mice	PLOS ONE			English	Article							CLAUDINS; BARRIER; EXPRESSION; MUTATIONS; OCCLUDIN	Tricellular tight junctions seal the extracellular spaces of tricellular contacts, where the vertices of three epithelial cells meet, and are required for the establishment of a strong barrier function of the epithelial cellular sheet. Angulins and tricellulin are known as specific protein components of tricellular tight junctions, where angulins recruit tricellulin. Mutations in the genes encoding angulin-2/ILDR1 and tricellulin have been reported to cause human hereditary deafness DFNB42 and DFNB49, respectively. To investigate the pathogenesis of DFNB42, we analyzed mice with a targeted disruption of Ildr1, which encodes angulin-2/ILDR1. Ildr1 null mice exhibited profound deafness. Hair cells in the cochlea of Ildr1 null mice develop normally, but begin to degenerate by two weeks after birth. Tricellulin localization at tricellular contacts of the organ of Corti in the cochlea was retained in Ildr1 null mice, but its distribution along the depth of tricellular contacts was affected. Interestingly, compensatory tricellular contact localization of angulin-1/LSR was observed in the organ of Corti in Ildr1 null mice although it was hardly detected in the organ of Corti in wild-type mice. The onset of hair cell degeneration in Ildr1 null mice was earlier than that in the reported Tric mutant mice, which mimic one of the tricellulin mutations in DFNB49 deafness. These results indicate that the angulin-2/ILDR1 deficiency causes the postnatal degenerative loss of hair cells in the cochlea, leading to human deafness DFNB42. Our data also suggest that angulin family proteins have distinct functions in addition to their common roles of tricellulin recruitment and that the function of angulin-2/ILDR1 for hearing cannot be substituted by angulin-1/LSR.	[Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 657, Japan; [Katsuno, Tatsuya; Kitajiri, Shin-ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Furuse, Mikio] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan	Kobe University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Kitajiri, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan.	kitajiri@ent.kuhp.kyoto-u.ac.jp; furuse@nips.ac.jp	Higashi, Tomohito/AHE-7942-2022	Higashi, Tomohito/0000-0001-5616-1477; Furuse, Mikio/0000-0003-2847-8156	Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) [LS084]; JSPS [26291043]; Takeda Science Foundation;  [23-0990]; Grants-in-Aid for Scientific Research [26293369] Funding Source: KAKEN	Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html) [LS084 to M.F.]; the Grant-in-Aid for Scientific Research (B) from JSPS [26291043 to M.F.]; the Grant-in-Aid for JSPS Fellows [23-0990 to T.H.]; and the second step of Visionary Research Grant (a stepwise encouraging program) by Takeda Science Foundation (http://www.takeda-sci.or.jp/) to S.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28960; Furuse M, 2009, BBA-BIOMEMBRANES, V1788, P813, DOI 10.1016/j.bbamem.2008.07.017; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Gunzel D, 2012, COMPR PHYSIOL, V2, P1819, DOI 10.1002/cphy.c110045; Higashi T, 2013, J CLIN INVEST, V123, P3712, DOI 10.1172/JCI69651; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kitajiri S, 2004, HEARING RES, V187, P25, DOI 10.1016/S0378-5955(03)00338-1; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meyers JR, 2003, J NEUROSCI, V23, P4054; Morozko EL, 2014, HUM MOL GEN IN PRESS; Nakano Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000610; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8	28	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120674	10.1371/journal.pone.0120674	http://dx.doi.org/10.1371/journal.pone.0120674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822906	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700070
J	Kumar, D; Datta, R; Hazra, S; Sultana, A; Mukhopadhyay, R; Chattopadhyay, S				Kumar, Deepak; Datta, Riddhi; Hazra, Saptarshi; Sultana, Asma; Mukhopadhyay, Ria; Chattopadhyay, Sharmila			Transcriptomic Profiling of Arabidopsis thaliana Mutant pad2.1 in Response to Combined Cold and Osmotic Stress	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; DISEASE RESISTANCE; SALICYLIC-ACID; FUNCTIONAL-ANALYSIS; HYDROGEN-PEROXIDE; REDOX HOMEOSTASIS; OXIDATIVE STRESS; GENE-EXPRESSION; DEFENSE; BIOSYNTHESIS	The contribution of glutathione (GSH) in stress tolerance, defense response and antioxidant signaling is an established fact. In this study transcriptome analysis of pad2.1, an Arabidopsis thaliana mutant, after combined osmotic and cold stress treatment has been performed to explore the intricate position of GSH in the stress and defense signaling network in planta. Microarray data revealed the differential regulation of about 1674 genes in pad2.1 amongst which 973 and 701 were significantly up-and down-regulated respectively. Gene enrichment, functional pathway analysis by DAVID and MapMan analysis identified various stress and defense related genes viz. members of heat shock protein family, peptidyl prolyl isomerase (PPIase), thioredoxin peroxidase (TPX2), glutathione-S-transferase (GST), NBS-LRR type resistance protein etc. as down-regulated. The expression pattern of the above mentioned stress and defense related genes and APETALA were also validated by comparative proteomic analysis of combined stress treated Col-0 and pad2.1. Functional annotation noted down-regulation of UDP-glycosyl transferase, 4-coumarate CoA ligase 8, cinnamyl alcohol dehydrogenase 4 (CAD4), ACC synthase and ACC oxidase which are the important enzymes of phenylpropanoid, lignin and ethylene (ET) biosynthetic pathway respectively. Since the only difference between Col-0 (Wild type) and pad2.1 is the content of GSH, so, this study suggested that in addition to its association with specific stress responsive genes and proteins, GSH provides tolerance to plants by its involvement with phenylpropanoid, lignin and ET biosynthesis under stress conditions.	[Kumar, Deepak; Datta, Riddhi; Hazra, Saptarshi; Sultana, Asma; Mukhopadhyay, Ria; Chattopadhyay, Sharmila] CSIR, Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, Plant Biol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, S (corresponding author), CSIR, Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, Plant Biol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	sharmila@iicb.res.in	Sultana, Asma/AAS-1199-2021	Sultana, Asma/0000-0002-7739-1025; Chattopadhyay, Sharmila/0000-0002-9058-9415; Kumar, Deepak/0000-0002-2914-592X; Datta, Riddhi/0000-0001-7490-190X; Kumar, Deepak/0000-0002-5816-5129	Department of Science and Technology (DST) [GAP-302]; Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC-0117/0107]	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by Department of Science and Technology (DST; Grant No. GAP-302), and Council of Scientific and Industrial Research (CSIR; Grant No. BSC-0117/0107), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Bechtold U, 2013, J EXP BOT, V64, P3467, DOI 10.1093/jxb/ert185; BOLTER C, 1993, PHYSIOL MOL PLANT P, V42, P321, DOI 10.1016/S0885-5765(05)80009-8; Bossio E, 2013, PLANT CELL TISS ORG, V112, P239, DOI 10.1007/s11240-012-0228-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; De Vos M, 2006, PLANT SIGNAL BEHAV, V1, P305, DOI 10.4161/psb.1.6.3512; DRON M, 1988, P NATL ACAD SCI USA, V85, P6738, DOI 10.1073/pnas.85.18.6738; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Dubreuil-Maurizi C, 2012, PLANT SIGNAL BEHAV, V7, P210, DOI 10.4161/psb.18831; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Ghanta S., 2011, PLANT SIGNAL BEHAV, V6, P1, DOI DOI 10.4161/PSB.6.4.15402; Ghanta S, 2014, J PLANT PHYSIOL, V171, P940, DOI 10.1016/j.jplph.2014.03.002; Ghanta S, 2011, PLANTA, V233, P895, DOI 10.1007/s00425-011-1349-4; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Gomez LD, 2004, J EXP BOT, V55, P1851, DOI 10.1093/jxb/erh202; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung KT, 2008, J PLANT PHYSIOL, V165, P1280, DOI 10.1016/j.jplph.2007.10.008; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; KETTERER B, 1990, GLUTATHIONE S-TRANSFERASES AND DRUG RESISTANCE, P97; KIYOSUE T, 1993, FEBS LETT, V335, P189, DOI 10.1016/0014-5793(93)80727-C; Kocsy G, 2001, PLANT PHYSIOL, V127, P1147, DOI 10.1104/pp.010107; Kumar A, 2009, PLANT CELL TISS ORG, V96, P117, DOI 10.1007/s11240-008-9467-9; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Lim B, 2014, PLANT BIOLOGY, V16, P58, DOI 10.1111/plb.12033; Link G, 1996, BIOESSAYS, V18, P465, DOI 10.1002/bies.950180608; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittova V, 2003, FEBS LETT, V554, P417, DOI 10.1016/S0014-5793(03)01214-6; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nandety RS, 2013, PLANT PHYSIOL, V162, P1459, DOI 10.1104/pp.113.219162; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Queval G, 2012, PHILOS T R SOC B, V367, P3475, DOI 10.1098/rstb.2012.0068; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rokutan K, 1996, J CLIN INVEST, V97, P2242, DOI 10.1172/JCI118665; Rouhier N, 2003, ANTIOXID REDOX SIGN, V5, P15, DOI 10.1089/152308603321223504; Sharma AD, 2003, BIOL PLANTARUM, V47, P367, DOI 10.1023/B:BIOP.0000023879.74558.48; Sinha R, 2011, J PROTEOMICS, V74, P327, DOI 10.1016/j.jprot.2010.11.009; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Tsakraklides G, 2002, PLANT J, V32, P879, DOI 10.1046/j.1365-313X.2002.01477.x; Wang HB, 1999, J NAT PROD, V62, P294, DOI 10.1021/np980501m; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Weaver LM, 2006, PLANT J, V47, P829, DOI 10.1111/j.1365-313X.2006.02834.x; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Xiang CB, 2001, PLANT PHYSIOL, V126, P564, DOI 10.1104/pp.126.2.564; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanagisawa S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-50; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x; Zou JY, 1998, CELL STRESS CHAPERON, V3, P130, DOI 10.1379/1466-1268(1998)003<0130:CBGOAT>2.3.CO;2	76	8	10	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122690	10.1371/journal.pone.0122690	http://dx.doi.org/10.1371/journal.pone.0122690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822199	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700193
J	Hruschka, DJ; Hadley, C; Brewis, AA; Stojanowski, CM				Hruschka, Daniel J.; Hadley, Craig; Brewis, Alexandra A.; Stojanowski, Christopher M.			Genetic Population Structure Accounts for Contemporary Ecogeographic Patterns in Tropic and Subtropic-Dwelling Humans	PLOS ONE			English	Article							BODY-SURFACE AREA; WEIGHT; SIZE; MASS; PROPORTIONS; CLIMATE; HEIGHT; BIRTH; SELECTION; CHILDREN	Contemporary human populations conform to ecogeographic predictions that animals will become more compact in cooler climates and less compact in warmer ones. However, it remains unclear to what extent this pattern reflects plastic responses to current environments or genetic differences among populations. Analyzing anthropometric surveys of 232,684 children and adults from across 80 ethnolinguistic groups in sub-Saharan Africa, Asia and the Americas, we confirm that body surface-to-volume correlates with contemporary temperature at magnitudes found in more latitudinally diverse samples (Adj. R-2 = 0.14-0.28). However, far more variation in body surface-to-volume is attributable to genetic population structure (Adj. R-2 = 0.50-0.74). Moreover, genetic population structure accounts for nearly all of the observed relationship between contemporary temperature and body surface-to-volume among children and adults. Indeed, after controlling for population structure, contemporary temperature accounts for no more than 4% of the variance in body form in these groups. This effect of genetic affinity on body form is also independent of other ecological variables, such as dominant mode of subsistence and household wealth per capita. These findings suggest that the observed fit of human body surface-to-volume with current climate in this sample reflects relatively large effects of existing genetic population structure of contemporary humans compared to plastic response to current environments.	[Hruschka, Daniel J.; Brewis, Alexandra A.; Stojanowski, Christopher M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Hadley, Craig] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Arizona State University; Arizona State University-Tempe; Emory University	Hruschka, DJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	Daniel.Hruschka@asu.edu						Auerbach BM, 2012, AM J PHYS ANTHROPOL, V149, P525, DOI 10.1002/ajpa.22154; Beall CM, 2012, HUMAN BIOL EVOLUTION, P177; Betti L, 2012, HUM BIOL, V84, P139, DOI 10.3378/027.084.0203; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2002, AM J HUM BIOL, V14, P753, DOI 10.1002/ajhb.10092; Cowgill LW, 2012, AM J PHYS ANTHROPOL, V148, P557, DOI 10.1002/ajpa.22072; CROGNIER E, 1981, ANN HUM BIOL, V8, P99, DOI 10.1080/03014468100004841; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; Foster F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072269; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Hadley C, 2014, AM J PHYS ANTHROPOL, V154, P232, DOI 10.1002/ajpa.22496; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hayes A. F., 2013, INTRODUCTION TO MEDI; Higgins RW, 2011, AM J PHYS ANTHROPOL, V146, P336, DOI 10.1002/ajpa.21575; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Hruschka DJ, 2014, AM J PHYS ANTHROPOL, V153, P542, DOI 10.1002/ajpa.22452; Hruschka DJ, 2013, ECON HUM BIOL, V11, P337, DOI 10.1016/j.ehb.2012.01.001; Hruschka DJ, 2013, AM J PHYS ANTHROPOL, V151, P68, DOI 10.1002/ajpa.22258; Hruschka DJ, ESTIMATING ABSOLUTE; IBM Corp, 2011, IBM SPSS STATISTICS; ICF Macro, DEMOGRAPHIC AND HEAL; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Leonard W.R., 2010, HUMAN EVOLUTIONARY B, P157; Lewin R., 1998, PRINCIPLES OF HUMAN; Long JC, 2009, AM J PHYS ANTHROPOL, V139, P23, DOI 10.1002/ajpa.21011; MALINA RM, 1975, AM J CLIN NUTR, V28, P1061, DOI 10.1093/ajcn/28.9.1061; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; ROBERTS DF, 1969, J BIOSOC SCI, VS, P43, DOI 10.1017/S002193200002321X; Roberts DF, 1978, CLIMATE AND HUMAN VA; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Ruff C, 2005, J HUM EVOL, V48, P381, DOI 10.1016/j.jhevol.2004.11.009; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Stock JT, 2006, AM J PHYS ANTHROPOL, V131, P194, DOI 10.1002/ajpa.20398; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Ulijaszek SJ, 1993, NUTRITIONAL ANTHROPO; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; von Cramon-Taubadel N, 2013, PROCEEDINGS OF THE R, V280, DOI [10.1098/rspb.2013.1629, DOI 10.1098/RSPB.2013.1629]; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122301	10.1371/journal.pone.0122301	http://dx.doi.org/10.1371/journal.pone.0122301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816235	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600165
J	Khuroo, MS; Khuroo, NS; Khuroo, MS				Khuroo, Mehnaaz Sultan; Khuroo, Naira Sultan; Khuroo, Mohammad Sultan			Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RAPID TEST; BLOOD-DONORS; SCREENING-TESTS; ANTIBODY ASSAYS; HIGH PREVALENCE; HCV; PERFORMANCE; HIV; HISTORY; RISK	Background Point-of-care tests provide a plausible diagnostic strategy for hepatitis C infection in economically impoverished areas. However, their utility depends upon the overall performance of individual tests. Methods A literature search was conducted using the metasearch engine Metta, a query interface for retrieving articles from five leading medical databases. Studies were included if they employed point-of-care tests to detect antibodies of hepatitis C virus and compared the results with reference tests. Two reviewers performed a quality assessment of the studies and extracted data for estimating test accuracy. Findings Thirty studies that had evaluated 30 tests fulfilled the inclusion criteria. The overall pooled sensitivity, specificity, positive likelihood-ratio, negative likelihood-ratio and diagnostic odds ratio for all tests were 97.4% (95% CI: 95.9-98.4), 99.5% (99.2-99.7), 80.17 (55.35-116.14), 0.03 (0.02-0.04), and 3032.85 (1595.86-5763.78), respectively. This suggested a high pooled accuracy for all studies. We found substantial heterogeneity between studies, but none of the subgroups investigated could account for the heterogeneity. Genotype diversity of HCV had no or minimal influence on test performance. Of the seven tests evaluated in the meta-regression model, OraQuick had the highest test sensitivity and specificity and showed better performance than a third generation enzyme immunoassay in seroconversion panels. The next highest test sensitivities and specificities were from TriDot and SDBioline, followed by Genedia and Chembio. The Spot and Multiplo tests produced poor test sensitivities but high test specificities. Nine of the remaining 23 tests produced poor test sensitivities and specificities and/or showed poor performances in seroconversion panels, while 14 tests had high test performances with diagnostic odds ratios ranging from 590.70 to 28822.20. Conclusions Performances varied widely among individual point-of-care tests for diagnosis of hepatitis C virus infection. Physicians should consider this while using specific tests in clinical practice.	[Khuroo, Mehnaaz Sultan] Govt Med Coll, Srinagar, Jammu & Kashmir, India; [Khuroo, Naira Sultan; Khuroo, Mohammad Sultan] Dr Khuroo Med Clin, Ctr Digest Dis, Srinagar, Jammu & Kashmir, India		Khuroo, MS (corresponding author), Govt Med Coll, Srinagar, Jammu & Kashmir, India.	khuroo@yahoo.com	Khuroo, Mohammad Sultan/N-3571-2014	Khuroo, Mehnaaz sultan/0000-0001-9441-1430; Khuroo, Mohammad Sultan/0000-0003-2823-8814				Al-Tahish G, 2013, J VIROL METHODS, V189, P370, DOI 10.1016/j.jviromet.2013.03.013; Bornschlegel K, 2013, MMWR-MORBID MORTAL W, V62, P357; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Buti M, 2000, REV ESP ENFERM DIG, V92, P144; Centers for Disease Control and Prevention, 2013, MMWR, V52; Cha YJ, 2013, ANN LAB MED, V33, P184, DOI 10.3343/alm.2013.33.3.184; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; da Rosa L, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.12274; Daniel HDJ, 2005, J CLIN MICROBIOL, V43, P1977, DOI 10.1128/JCM.43.4.1977-1978.2005; Department of Blood Safety and Clinical Technology, 2001, 1 WHO DEP BLOOD SAF; Department of Blood Safety and Clinical Technology, 2002, WHO EV PHAS IN PRESS; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hui AY, 2002, ACTA VIROL, V46, P47; Jewett A, 2012, J CLIN VIROL, V54, P213, DOI 10.1016/j.jcv.2012.04.003; Kamili S., 2012, Clinical Infectious Diseases, V55, P43, DOI 10.1093/cid/cis368; Kant J, 2013, EUR J GASTROEN HEPAT, V25, P416, DOI 10.1097/MEG.0b013e32835c502d; Kaur H, 2000, Indian J Med Sci, V54, P432; Khuroo MS, 2014, J CLIN EXP HEPATOL, V4, P226, DOI 10.1016/j.jceh.2014.07.008; Kim MH, 2013, J VIROL METHODS, V193, P379, DOI 10.1016/j.jviromet.2013.07.005; Lee MH, 2014, WORLD J GASTROENTERO, V20, P9270, DOI 10.3748/wjg.v20.i28.9270; Lee SR, 2010, J CLIN VIROL, V48, P15, DOI 10.1016/j.jcv.2010.02.018; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Maity S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-290; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montebugnoli L, 1999, CLIN CHIM ACTA, V288, P91, DOI 10.1016/S0009-8981(99)00146-1; Mvere D, 1996, B WORLD HEALTH ORGAN, V74, P19; Nantachit N, 2007, TRANSFUSION, V47, P1803, DOI 10.1111/j.1537-2995.2007.01395.x; Nelson DR, 2009, HEPATOLOGY, V50, P997, DOI 10.1002/hep.23208; Njouom R, 2006, J VIROL METHODS, V133, P223, DOI 10.1016/j.jviromet.2005.11.001; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; O'Connell RJ, 2013, TRANSFUSION, V53, P505, DOI 10.1111/j.1537-2995.2012.03770.x; Ivantes CAP, 2010, BRAZ J INFECT DIS, V14, P483, DOI 10.1590/S1413-86702010000500010; Poovorawan Yong, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P647; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Scheiblauer H, 2006, TRANSFUSION, V46, P708, DOI 10.1111/j.1537-2995.2006.00789.x; Shinkins B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2778; Shivkumar S, 2012, ANN INTERN MED, V157, P558, DOI 10.7326/0003-4819-157-8-201210160-00006; Smalheiser NR, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-1; Smith BD, 2012, ANTIVIR THER, V17, P1409, DOI 10.3851/IMP2470; Smith BD, 2011, CLIN INFECT DIS, V53, P780, DOI 10.1093/cid/cir499; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; St John Andrew, 2013, Clin Biochem Rev, V34, P61; Tagny CT, 2014, J VIROL METHODS, V199, P119, DOI 10.1016/j.jviromet.2014.01.002; Torane VP, 2008, INDIAN J MED MICROBI, V26, P284, DOI 10.4103/0255-0857.42071; Vamvakas E C, 2001, Am J Clin Pathol, V116 Suppl, pS47; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Ward JW, 2012, ANTIVIR THER, V17, P1397, DOI 10.3851/IMP2477; Ward R, 2011, 0018 HOR SCAN; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yeh Chih-Ko, 2010, Tex Dent J, V127, P651; Yuen MF, 2001, AM J GASTROENTEROL, V96, P838, DOI 10.1111/j.1572-0241.2001.03628.x	56	57	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121450	10.1371/journal.pone.0121450	http://dx.doi.org/10.1371/journal.pone.0121450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816332	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600095
J	Kim, JH; Lee, KS; Yoo, KB; Park, EC				Kim, Jae-Hyun; Lee, Kwang-Soo; Yoo, Ki-Bong; Park, Eun-Cheol			The Differences in Health Care Utilization between Medical Aid and Health Insurance: A Longitudinal Study Using Propensity Score Matching	PLOS ONE			English	Article							SOUTH-KOREA; SERVICES; OVERUSE	Study Objectives Health care utilization has progressively increased, especially among Medical Aid beneficiaries in South Korea. The Medical Aid classifies beneficiaries into two categories, type 1 and 2, on the basis of being incapable (those under 18 or over 65 years of age, or disabled) or capable of working, respectively. Medical Aid has a high possibility for health care utilization due to high coverage level. In South Korea, the national health insurance (NHI) achieved very short time to establish coverage for the entire Korean population. However there there remaine a number of problems to be solved. Therefore, the objective of this study was to investigate the differences in health care utilization between Medical Aid beneficiaries and Health Insurance beneficiaries. Methods & Design Data were collected from the Korean Welfare Panel Study from 2008 to 2012 using propensity score matching. Of the 2,316 research subjects, 579 had Medical Aid and 1,737 had health insurance. We also analyzed three dependent variables: days spent in the hospital, number of outpatient visits, and hospitalizations per year. Analysis of variance and longitudinal data analysis were used. Results The number of outpatient visits was 1.431 times higher (p< 0.0001) in Medical Aid beneficiaries, the number of hospitalizations per year was 1.604 times higher (p< 0.0001) in Medical Aid beneficiaries, and the number of days spent in the hospital per year was 1.282 times higher (p< 0.268) for Medical Aid beneficiaries than in individuals with Health Insurance. Medical Aid patients had a 0.874 times lower frequency of having an unmet needs due to economic barrier (95% confidence interval: 0.662-1.156). Conclusions Health insurance coverage has an impact on health care utilization. More health care utilization among Medical Aid beneficiaries appears to have a high possibility of a moral hazard risk under the Health Insurance program. Therefore, the moral hazard for Medical Aid beneficiaries should be avoided.	[Kim, Jae-Hyun] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Kim, Jae-Hyun; Park, Eun-Cheol] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea; [Lee, Kwang-Soo] Yonsei Univ, Coll Hlth Sci, Dept Hlth Adm, Wonju, Gwangwondo, South Korea; [Yoo, Ki-Bong] Eulji Univ, Dept Healthcare Management, Songnam, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Eulji University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019; Kim, Jae Hyun/AAY-8167-2020	Park, Eun-Cheol/0000-0002-2306-5398; Kim, Jae Hyun/0000-0003-2824-0113				Ahn YH, 2011, J COMMUN HEALTH NURS, V28, P190, DOI 10.1080/07370016.2011.614837; [Anonymous], 2011, HLTH WELF MIN WHIT P; Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002; GOLD M, 1984, HEALTH SERV RES, V19, P383; Hadley J, 2003, INQUIRY-J HEALTH CAR, V40, P323, DOI 10.5034/inquiryjrnl_40.4.323; Jeon B, 2013, HEALTH POLICY, V113, P69, DOI 10.1016/j.healthpol.2013.05.007; Jeong HS, 2011, HEALTH AFFAIR, V30, P136, DOI 10.1377/hlthaff.2008.0816; Kang MS, 2012, J KOREAN MED SCI, V27, pS21, DOI 10.3346/jkms.2012.27.S.S21; Kim E. S., 2007, CURRENT SITUATION ME; Kim JY, 2005, HEALTH POLICY, V72, P293, DOI 10.1016/j.healthpol.2004.09.002; Linden A, 2007, DIS MANAGE, V10, P266, DOI 10.1089/dis.2007.105711; Organisation for Economic Co-operation and Development (OECD), 2014, SOURC SYMB STAT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shin SM, 2010, J ADV NURS, V66, P2257, DOI 10.1111/j.1365-2648.2010.05364.x	14	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119939	10.1371/journal.pone.0119939	http://dx.doi.org/10.1371/journal.pone.0119939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816234	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600021
J	Koren, Y; Sznitman, R; Arratia, PE; Carls, C; Krajacic, P; Brown, AEX; Sznitman, J				Koren, Yelena; Sznitman, Raphael; Arratia, Paulo E.; Carls, Christopher; Krajacic, Predrag; Brown, Andre E. X.; Sznitman, Josue			Model-Independent Phenotyping of C. elegans Locomotion Using Scale-Invariant Feature Transform	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BEHAVIOR; SEARCH; SYSTEM; GENES; GAIT	To uncover the genetic basis of behavioral traits in the model organism C. elegans, a common strategy is to study locomotion defects in mutants. Despite efforts to introduce (semi-) automated phenotyping strategies, current methods overwhelmingly depend on worm-specific features that must be hand-crafted and as such are not generalizable for phenotyping motility in other animal models. Hence, there is an ongoing need for robust algorithms that can automatically analyze and classify motility phenotypes quantitatively. To this end, we have developed a fully-automated approach to characterize C. elegans' phenotypes that does not require the definition of nematode-specific features. Rather, we make use of the popular computer vision Scale-Invariant Feature Transform (SIFT) from which we construct histograms of commonly-observed SIFT features to represent nematode motility. We first evaluated our method on a synthetic dataset simulating a range of nematode crawling gaits. Next, we evaluated our algorithm on two distinct datasets of crawling C. elegans with mutants affecting neuromuscular structure and function. Not only is our algorithm able to detect differences between strains, results capture similarities in locomotory phenotypes that lead to clustering that is consistent with expectations based on genetic relationships. Our proposed approach generalizes directly and should be applicable to other animal models. Such applicability holds promise for computational ethology as more groups collect high-resolution image data of animal behavior.	[Koren, Yelena; Sznitman, Josue] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel; [Sznitman, Raphael] Univ Bern, ARTORG Ctr, Ophthalm Technol Grp, CH-3012 Bern, Switzerland; [Arratia, Paulo E.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Carls, Christopher; Krajacic, Predrag] West Virginia Sch Osteopath Med, Dept Biomed Sci, Lewisburg, WV USA; [Brown, Andre E. X.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, London SW7 2AZ, England	Technion Israel Institute of Technology; University of Bern; University of Pennsylvania; Imperial College London	Sznitman, J (corresponding author), Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel.	sznitman@bm.technion.ac.il		Sznitman, Raphael/0000-0001-6791-4753; Brown, Andre/0000-0002-1324-8764	US-Israel Binational Science Foundation (BSF) [2011323]; European Commission [PCIG09-GA-2011-293604]; Medical Research Council [MC-A658-5TY30]; Coleman-Cohen fund (British Technion Society); National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]	US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coleman-Cohen fund (British Technion Society); National Institutes of Health (NIH) Office of Research Infrastructure Programs	PEA and JS were supported by a US-Israel Binational Science Foundation grant (BSF Nr. 2011323). JS was supported by the European Commission (FP7 Program) through a Career Integration Grant (PCIG09-GA-2011-293604). AEXB was supported by the Medical Research Council (grant MC-A658-5TY30) and in part by Coleman-Cohen fund (British Technion Society). Some strains were provided by the CGC, which is funded by National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Aslan B, 2005, NUCL INSTRUM METH A, V537, P626, DOI 10.1016/j.nima.2004.08.071; Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; Belongie S., 2000, NIPS, P3; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; Boyle JH, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00010; BRENNER S, 1974, GENETICS, V77, P71; Brown AEX, 2013, ARXIV13011017; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Combes D, 2001, INT REV CYTOL, V209, P207; Cronin Christopher J., 2006, V351, P241; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Deselaers T, 2010, PROC CVPR IEEE, P1633, DOI 10.1109/CVPR.2010.5539775; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Geng W, 2003, CONF REC ASILOMAR C, P2063; Geng W, 2003, GENETICS, V165, P1117; Gjorgjieva J, 2014, BIOSCIENCE, V64, P476, DOI 10.1093/biosci/biu058; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Greenblum A, 2014, IEEE T BIO-MED ENG, V61, P2278, DOI 10.1109/TBME.2014.2298612; Greenblum A, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-74; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; HODGKIN J, 1983, GENETICS, V103, P43; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Korta J, 2007, J EXP BIOL, V210, P2383, DOI 10.1242/jeb.004572; Krajacic P, 2012, GENETICS, V191, P1015, DOI 10.1534/genetics.112.141176; Kuo WJ, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4872061; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mongan NP, 1998, RECEPTOR CHANNEL, V6, P213; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Rankin CH, 2002, NAT REV GENET, V3, P622, DOI 10.1038/nrg864; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shechtman E, 2007, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2007.383198; Shen XN, 2012, BIOPHYS J, V102, P2772, DOI 10.1016/j.bpj.2012.05.012; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Sivic J, 2009, IEEE T PATTERN ANAL, V31, P591, DOI 10.1109/TPAMI.2008.111; Sokal RR, 1966, NUMERICAL TAXONOMY; SQUIRE MD, 1995, RECEPTOR CHANNEL, V3, P107; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Sznitman J, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3529236; Sznitman J, 2010, EXP MECH, V50, P1303, DOI 10.1007/s11340-010-9339-1; Sznitman J, 2010, BIOPHYS J, V98, P617, DOI 10.1016/j.bpj.2009.11.010; Sznitman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011631; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Wei Geng, 2003, Proceedings of the Fifth IASTED International Conference on Signal and Image Processing, P342; Wood WB, 1988, COLD SPRING HARBOR M; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Yu H, 2013, P NATL ACAD SCI USA, V110, P11940, DOI 10.1073/pnas.1310468110; Zhou X, 2008, P 16 ACM INT C MULT, P229, DOI DOI 10.1145/1459359.1459391.ISBN; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	55	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122326	10.1371/journal.pone.0122326	http://dx.doi.org/10.1371/journal.pone.0122326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816290	gold, Green Published			2022-12-27	WOS:000352133600166
J	Matos, LMO; Neves, AJR; Pratas, D; Pinho, AJ				Matos, Luis M. O.; Neves, Antonio J. R.; Pratas, Diogo; Pinho, Armando J.			MAFCO: A Compression Tool for MAF Files	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT; SOFTWARE; MODEL	In the last decade, the cost of genomic sequencing has been decreasing so much that researchers all over the world accumulate huge amounts of data for present and future use. These genomic data need to be efficiently stored, because storage cost is not decreasing as fast as the cost of sequencing. In order to overcome this problem, the most popular general-purpose compression tool, gzip, is usually used. However, these tools were not specifically designed to compress this kind of data, and often fall short when the intention is to reduce the data size as much as possible. There are several compression algorithms available, even for genomic data, but very few have been designed to deal with Whole Genome Alignments, containing alignments between entire genomes of several species. In this paper, we present a lossless compression tool, MAFCO, specifically designed to compress MAF (Multiple Alignment Format) files. Compared to gzip, the proposed tool attains a compression gain from 34% to 57%, depending on the data set. When compared to a recent dedicated method, which is not compatible with some data sets, the compression gain of MAFCO is about 9%. Both source-code and binaries for several operating systems are freely available for non-commercial use at: http://bioinformatics.ua.pt/software/mafco.	[Matos, Luis M. O.; Neves, Antonio J. R.; Pratas, Diogo; Pinho, Armando J.] Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3810193 Aveiro, Portugal	Universidade de Aveiro	Matos, LMO (corresponding author), Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3810193 Aveiro, Portugal.	luismatos@ua.pt	Pratas, Diogo/AAG-8710-2020; Pinho, Armando J/A-2309-2012; Matos, Luis/HDL-7321-2022; Neves, Antonio J. R./AAF-9857-2019	Pratas, Diogo/0000-0003-1176-552X; Neves, Antonio J. R./0000-0001-5433-6667; Pinho, Armando/0000-0002-9164-0016	FEDER through Operational Program Competitiveness Factors-COMPETE; National Funds through FCT-Foundation for Science and Technology [SFRH/BD/86531/2012]; FCT [FCOMP-01-0124-FEDER-022682, PEst-C/EEI/UI0127/2011]	FEDER through Operational Program Competitiveness Factors-COMPETE; National Funds through FCT-Foundation for Science and Technology; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding: This work was partially supported by FEDER through the Operational Program Competitiveness Factors-COMPETE and by National Funds through FCT-Foundation for Science and Technology in a context of a PhD Grant (FCT reference SFRH/BD/86531/2012) and the project FCOMP-01-0124-FEDER-022682 (FCT reference PEst-C/EEI/UI0127/2011).	Bonfield JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059190; Bonnal RJP, 2012, BIOINFORMATICS, V28, P1035, DOI 10.1093/bioinformatics/bts080; Canovas R., 2013, P 36 AUST COMP SCI C, P51; Cao MD, 2007, IEEE DATA COMPR CONF, P43; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Deorowicz S, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-25; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giancarlo R, 2014, BRIEF BIOINFORM, V15, P390, DOI 10.1093/bib/bbt088; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Hach F, 2012, BIOINFORMATICS, V28, P3051, DOI 10.1093/bioinformatics/bts593; Hanus P, 2010, IEEE T INFORM THEORY, V56, P696, DOI 10.1109/TIT.2009.2037052; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Haussler, 2004, P 8 ANN INT C RES CO, P177, DOI DOI 10.1145/974614.974638; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jones DC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks754; Korodi G, 2007, IEEE DATA COMPR CONF, P33; Matos LMO, 2013, IEEE T INFORM THEORY, V59, P3189, DOI 10.1109/TIT.2012.2236605; Matos LMO, 2012, LECT NOTES COMPUT SC, V7324, P359, DOI 10.1007/978-3-642-31295-3_42; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pinho AJ, 2014, BIOINFORMATICS, V30, P117, DOI 10.1093/bioinformatics/btt594; Pinho AJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1124; Popitsch N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks939; Wandelt S, 2013, IEEE ACM T COMPUT BI, V10, P1275, DOI 10.1109/TCBB.2013.122; Wheeler C, BIORUBY MAF	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0116082	10.1371/journal.pone.0116082	http://dx.doi.org/10.1371/journal.pone.0116082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816229	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600005
J	Schappacher-Tilp, G; Leonard, T; Desch, G; Herzog, W				Schappacher-Tilp, Gudrun; Leonard, Timothy; Desch, Gertrud; Herzog, Walter			A Novel Three-Filament Model of Force Generation in Eccentric Contraction of Skeletal Muscles	PLOS ONE			English	Article							PEVK DOMAIN; TITIN ELASTICITY; ISOMETRIC FORCE; ACTIN-BINDING; STRETCH; ENHANCEMENT; FILAMENTS; TENSION; FIBERS; DEPENDENCE	We propose and examine a three filament model of skeletal muscle force generation, thereby extending classical cross-bridge models by involving titin-actin interaction upon active force production. In regions with optimal actin-myosin overlap, the model does not alter energy and force predictions of cross-bridge models for isometric contractions. However, in contrast to cross-bridge models, the three filament model accurately predicts history-dependent force generation in half sarcomeres for eccentric and concentric contractions, and predicts the activation-dependent forces for stretches beyond actin-myosin filament overlap.	[Schappacher-Tilp, Gudrun; Desch, Gertrud] Graz Univ, Dept Math & Sci Comp, A-8010 Graz, Austria; [Leonard, Timothy; Herzog, Walter] Univ Calgary, Human Performance Lab, Calgary, AB, Canada	University of Graz; University of Calgary	Schappacher-Tilp, G (corresponding author), Graz Univ, Dept Math & Sci Comp, A-8010 Graz, Austria.	gudrun.schappacher-tilp@uni-graz.at	Herzog, Walter/AAG-7188-2020	Herzog, Walter/0000-0002-5341-0033; Schappacher-Tilp, Gudrun/0000-0001-9078-0044	Austrian Science Fund; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Programme; Killam Foundation; Austrian Science Fund (FWF) [T 478] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Programme(Canada Research Chairs); Killam Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: Funding provided by the Austrian Science Fund: www.fwf.ac.at, Natural Sciences and Engineering Research Council of Canada: www.nserc-crsng.gc.ca, the Canada Research Chair Programme: www.chairs-chaires.gc.ca/home-accueileng.aspx, and the Killam Foundation: http://killamlaureates.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PM, 1997, J STRUCT BIOL, V120, P93, DOI 10.1006/jsbi.1997.3898; Bianco P, 2007, BIOPHYS J, V93, P2102, DOI [10.1529/biophysj.107.106153, 10.1529/biophysj.l07.106153]; Campbell KS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000560; Campbell SG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002156; Chung CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/310791; DuVall MM, 2013, EUR BIOPHYS J BIOPHY, V42, P301, DOI 10.1007/s00249-012-0875-8; Freiburg A, 2000, CIRC RES, V86, P1114; Fukushima H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/727239; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Herzog JA, 2012, J BIOMECH, V45, P1893, DOI 10.1016/j.jbiomech.2012.05.021; HERZOG W, 1992, J BIOMECH, V25, P945, DOI 10.1016/0021-9290(92)90235-S; Herzog W, 2006, J PHYSIOL-LONDON, V574, P635, DOI 10.1113/jphysiol.2006.107748; Herzog W, 2000, J BIOMECH, V33, P531, DOI 10.1016/S0021-9290(99)00221-3; Herzog W, 2013, J APPL PHYSL; Herzog Walter, 2012, Mol Cell Biomech, V9, P175; Herzog W, 2012, EXERC SPORT SCI REV, V40, P50, DOI 10.1097/JES.0b013e31823cd75b; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Huxley AF, 1980, REFLECTIONS MUSCLE S; Joumaa V, 2008, AM J PHYSIOL-CELL PH, V294, pC74, DOI 10.1152/ajpcell.00218.2007; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Labeit D, 2003, P NATL ACAD SCI USA, V100, P13716, DOI 10.1073/pnas.2235652100; Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC1398, DOI 10.1152/ajpcell.00222.2010; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC14, DOI 10.1152/ajpcell.00049.2010; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; LI QN, 1995, BIOPHYS J, V69, P1508, DOI 10.1016/S0006-3495(95)80021-4; Linari M, 2000, J PHYSIOL-LONDON, V526, P589, DOI 10.1111/j.1469-7793.2000.00589.x; Linari M, 2003, J PHYSIOL-LONDON, V548, P461, DOI 10.1113/jphysiol.2002.032185; Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468; Linke WA, 2000, ADV EXP MED BIOL, V481, P179; Linke WA, 1998, P NATL ACAD SCI USA, V95, P8052, DOI 10.1073/pnas.95.14.8052; Linke WA, 2000, HISTOL HISTOPATHOL, V15, P799, DOI 10.14670/HH-15.799; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Minozzo FC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02320; MORGAN DL, 1994, EXP PHYSIOL, V79, P831, DOI 10.1113/expphysiol.1994.sp003811; Nagy A, 2004, J CELL SCI, V117, P5781, DOI 10.1242/jcs.01501; Nishikawa KC, 2012, P ROY SOC B-BIOL SCI, V279, P981, DOI 10.1098/rspb.2011.1304; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; Rassier DE, 2003, J BIOMECH, V36, P1309, DOI 10.1016/S0021-9290(03)00155-6; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Schachar R, 2002, J BIOMECH, V35, P1299, DOI 10.1016/S0021-9290(02)00188-4; Schappacher-Tilp G, 2012, ESMC 2012 8 EUR SOL; Tilp M, 2011, J APPL BIOMECH, V27, P64, DOI 10.1123/jab.27.1.64; Ting LYM, 2012, BIOPHYS J, V102, p154A, DOI 10.1016/j.bpj.2011.11.841; TRINICK JA, 1981, J MOL BIOL, V151, P309, DOI 10.1016/0022-2836(81)90517-9; Walcott S, 2008, MATH BIOSCI, V216, P172, DOI 10.1016/j.mbs.2008.10.005; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Yamasaki R, 2001, BIOPHYS J, V81, P2297, DOI 10.1016/S0006-3495(01)75876-6	52	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0117634	10.1371/journal.pone.0117634	http://dx.doi.org/10.1371/journal.pone.0117634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816319	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600006
J	Abdollahi, A; Abu Talib, M; Yaacob, SN; Ismail, Z				Abdollahi, Abbas; Abu Talib, Mansor; Yaacob, Siti Nor; Ismail, Zanariah			Problem-Solving Skills Appraisal Mediates Hardiness and Suicidal Ideation among Malaysian Undergraduate Students	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; COLLEGE-STUDENTS; RISK-FACTORS; PERSONALITY; HEALTH; STRESS; DISTINCTIVENESS; RESILIENCE; BEHAVIOR	Objectives Recent evidence suggests that suicidal ideation is increased among university students, it is essential to increase our knowledge concerning the etiology of suicidal ideation among university students. This study was conducted to examine the relationships between problem- solving skills appraisal, hardiness, and suicidal ideation among university students. In addition, this study was conducted to examine problem-solving skills appraisal (including the three components of problem-solving confidence, approach-avoidance style, and personal control of emotion) as a potential mediator between hardiness and suicidal ideation. Methods The participants consisted of 500 undergraduate students from Malaysian public universities. Results Structural Equation Modelling (SEM) estimated that undergraduate students with lower hardiness, poor problem-solving confidence, external personal control of emotion, and avoiding style was associated with higher suicidal ideation. Problem-solving skills appraisal (including the three components of problem-solving confidence, approach-avoidance style, and personal control of emotion) partially mediated the relationship between hardiness and suicidal ideation. Conclusion These findings underline the importance of studying mediating processes that explain how hardiness affects suicidal ideation.	[Abdollahi, Abbas; Abu Talib, Mansor; Ismail, Zanariah] Univ Putra Malaysia, Fac Human Ecol, Serdang 43400, Selangor, Malaysia; [Yaacob, Siti Nor] Univ Putra Malaysia, Fac Human Ecol, Family Adolescent & Child Res Ctr Excellent FACE, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Abdollahi, A (corresponding author), Univ Putra Malaysia, Fac Human Ecol, Serdang 43400, Selangor, Malaysia.	abdollahi.abbas58@gmail.com; mansorat@gmail.com	Abdollahi, Abbas/W-9987-2019; Abu Talib, Mansor/ABD-7552-2021	Abdollahi, Abbas/0000-0002-8346-5043				Abdollahi a., 2014, JOURNAL OF HUMANISTI; Abdollahi A, 2014, ASIAN SOCIAL SCI, V10, P165, DOI DOI 10.5539/ASS.V10N8P165; Abdollahi A, 2015, J DUAL DIAGN, V11, P12, DOI 10.1080/15504263.2014.988558; Abdollahi A, 2014, ISSUES MENT HEALTH N, V35, P100, DOI 10.3109/01612840.2013.843621; Bahamin G, 2012, PROCD SOC BEHV, V46, P4236, DOI 10.1016/j.sbspro.2012.06.233; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Becker-Weidman EG, 2010, BEHAV RES THER, V48, P11, DOI 10.1016/j.brat.2009.08.006; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bolton C, 2007, CLIN PSYCHOL REV, V27, P511, DOI 10.1016/j.cpr.2006.12.001; Bryan CJ, 2013, J AFFECT DISORDERS, V148, P37, DOI 10.1016/j.jad.2012.11.044; Chinaveh M, 2010, PROCD SOC BEHV, V7, P302, DOI 10.1016/j.sbspro.2010.10.042; Ciarrochi J, 2003, PERS INDIV DIFFER, V34, P1477, DOI 10.1016/S0191-8869(02)00129-0; Cunningham CJL, 2008, J OCCUP HEALTH PSYCH, V13, P271, DOI 10.1037/1076-8998.13.3.271; D'Zurilla TJ, 2007, PROBLEM SOLVING THER; Davis J. W., 2008, AM STAT, V62, P268, DOI DOI 10.1198/000313008X332287; Delahaij R, 2010, PERS INDIV DIFFER, V49, P386, DOI 10.1016/j.paid.2010.04.002; Erbes CR, 2011, J RES PERS, V45, P508, DOI 10.1016/j.jrp.2011.07.001; Eschleman KJ, 2010, INT J STRESS MANAGE, V17, P277, DOI 10.1037/a0020476; Foo XY, 2014, J RELIG HEALTH, V53, P731, DOI 10.1007/s10943-012-9667-9; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Garrosa E, 2008, INT J NURS STUD, V45, P418, DOI 10.1016/j.ijnurstu.2006.09.003; Gau SSF, 2008, J AM COLL HEALTH, V57, P135, DOI 10.3200/JACH.57.2.135-142; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Heppner MJ, 2004, J VOCAT BEHAV, V65, P217, DOI 10.1016/S0001-8791(03)00100-3; Heppner PP, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P127; Heppner PP, 1988, THE PROBLEM SOLVING; Judkins S, 2005, J PROF NURS, V21, P314, DOI 10.1016/j.profnurs.2005.07.003; Klag S, 2004, BRIT J HEALTH PSYCH, V9, P137, DOI 10.1348/135910704773891014; Kline R.B., 2010, PRINCIPLES PRACTICE; Kline RB, 2005, PRINCIPLES PRACTICE; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; KOBASA SC, 1981, J HEALTH SOC BEHAV, V22, P368, DOI 10.2307/2136678; KOBASA SC, 1982, J PERS SOC PSYCHOL, V42, P168, DOI 10.1037/0022-3514.42.1.168; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Lee HS, 2008, PSYCHIAT INVEST, V5, P86, DOI 10.4306/pi.2008.5.2.86; Maddi S. R., 2006, J POSIT PSYCHOL, V1, P160, DOI DOI 10.1080/17439760600619609; Maddi SR, 2009, J POSIT PSYCHOL, V4, P566, DOI 10.1080/17439760903157133; Maddi SR, 2006, J PERS, V74, P575, DOI 10.1111/j.1467-6494.2006.00385.x; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; Nezhad MAS, 2010, PROCD SOC BEHV, V5, P757, DOI 10.1016/j.sbspro.2010.07.180; OKUN MA, 1988, PERS INDIV DIFFER, V9, P101, DOI 10.1016/0191-8869(88)90035-9; Pengilly JW, 2000, J CLIN PSYCHOL, V56, P813, DOI 10.1002/(SICI)1097-4679(200006)56:6<813::AID-JCLP10>3.0.CO;2-Q; Phillips J, 2011, J EMERG NURS, V37, P125, DOI 10.1016/j.jen.2010.10.012; Polanco-Roman L, 2013, BEHAV THER, V44, P75, DOI 10.1016/j.beth.2012.07.002; Rutter PA, 2008, DEATH STUD, V32, P142, DOI 10.1080/07481180701801295; Schreurs B, 2010, WORK STRESS, V24, P56, DOI 10.1080/02678371003718733; Speckens AEM, 2005, SUICIDE LIFE-THREAT, V35, P365, DOI 10.1521/suli.2005.35.4.365; Vidrine JI, 2011, MOTIVATION AND PROBL; World Health Organization, 2012, SUIC PREV SUPRE; Wu M.L, 2010, STRUCTURAL EQUATION	51	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122222	10.1371/journal.pone.0122222	http://dx.doi.org/10.1371/journal.pone.0122222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830229	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600104
J	De Spiegelaere, W; Dern-Wieloch, J; Weigel, R; Schumacher, V; Schorle, H; Nettersheim, D; Bergmann, M; Brehm, R; Kliesch, S; Vandekerckhove, L; Fink, C				De Spiegelaere, Ward; Dern-Wieloch, Jutta; Weigel, Roswitha; Schumacher, Valerie; Schorle, Hubert; Nettersheim, Daniel; Bergmann, Martin; Brehm, Ralph; Kliesch, Sabine; Vandekerckhove, Linos; Fink, Cornelia			Reference Gene Validation for RT-qPCR, a Note on Different Available Software Packages	PLOS ONE			English	Article							REAL-TIME PCR; MESSENGER-RNA EXPRESSION; RELIABLE REFERENCE GENES; HEPARG CELL-LINE; HOUSEKEEPING GENES; QUANTITATIVE PCR; NORMALIZATION; QUANTIFICATION; INTEGRITY; SELECTION	Background An appropriate normalization strategy is crucial for data analysis from real time reverse transcription polymerase chain reactions (RT-qPCR). It is widely supported to identify and validate stable reference genes, since no single biological gene is stably expressed between cell types or within cells under different conditions. Different algorithms exist to validate optimal reference genes for normalization. Applying human cells, we here compare the three main methods to the online available RefFinder tool that integrates these algorithms along with R-based software packages which include the NormFinder and GeNorm algorithms. Results 14 candidate reference genes were assessed by RT-qPCR in two sample sets, i.e. a set of samples of human testicular tissue containing carcinoma in situ (CIS), and a set of samples from the human adult Sertoli cell line (FS1) either cultured alone or in co-culture with the seminoma like cell line (TCam-2) or with equine bone marrow derived mesenchymal stem cells (eBM-MSC). Expression stabilities of the reference genes were evaluated using geNorm, NormFinder, and BestKeeper. Similar results were obtained by the three approaches for the most and least stably expressed genes. The R-based packages NormqPCR, SLqPCR and the NormFinder for R script gave identical gene rankings. Interestingly, different outputs were obtained between the original software packages and the RefFinder tool, which is based on raw Cq values for input. When the raw data were reanalysed assuming 100% efficiency for all genes, then the outputs of the original software packages were similar to the RefFinder software, indicating that RefFinder outputs may be biased because PCR efficiencies are not taken into account. Conclusions This report shows that assay efficiency is an important parameter for reference gene validation. New software tools that incorporate these algorithms should be carefully validated prior to use.	[De Spiegelaere, Ward; Vandekerckhove, Linos] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Dern-Wieloch, Jutta; Weigel, Roswitha; Bergmann, Martin; Fink, Cornelia] Univ Giessen, Dept Vet Anat Histol & Embryol, D-35390 Giessen, Germany; [Schumacher, Valerie] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Schorle, Hubert; Nettersheim, Daniel] Univ Bonn, Dept Dev Pathol, Sch Med, Bonn, Germany; [Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Kliesch, Sabine] Univ Munster, Ctr Androl & Reprod Med, D-48149 Munster, Germany	Ghent University; Justus Liebig University Giessen; Harvard University; Harvard Medical School; University of Bonn; University of Veterinary Medicine Hannover, Foundation; University of Munster	De Spiegelaere, W (corresponding author), Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium.	Ward.DeSpiegelaere@UGent.be	De Spiegelaere, Ward/C-6245-2008; Schorle, Hubert/M-5001-2016; Schorle, Hubert/S-1713-2019; Vandekerckhove, Linos/J-6420-2013; Nettersheim, Daniel/M-9249-2013	De Spiegelaere, Ward/0000-0003-2097-8439; Schorle, Hubert/0000-0001-8272-0076; Vandekerckhove, Linos/0000-0002-8600-1631; Nettersheim, Daniel/0000-0002-4483-845X	Deutsche Forschungsgemeinschaft (DFG) [FI 1729/1-1]; FWO research foundation - Flanders (FWO) [1.8.020.09.N.00]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FWO research foundation - Flanders (FWO)	The study was supported by the Deutsche Forschungsgemeinschaft (DFG), Project FI 1729/1-1. LV is Senior clinical investigator supported by the FWO research foundation - Flanders (FWO, Grant # 1.8.020.09.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Bergmann M, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P155, DOI 10.1007/978-3-540-78355-8_11; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Ceelen L, 2014, CLIN CHEM, V60, P451, DOI 10.1373/clinchem.2013.209478; Ceelen L, 2011, BIOCHEM PHARMACOL, V81, P1255, DOI 10.1016/j.bcp.2011.03.004; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; De Spiegelaere W, 2011, HISTOL HISTOPATHOL, V26, P267, DOI 10.14670/HH-26.267; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Fink C, 2006, NEOPLASIA, V8, P1019, DOI 10.1593/neo.06559; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Kohl M, 2007, SLQPCR FUNCTIONS ANA; Meyer FRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063125; Neuvians TAP, 2005, J BIOTECHNOL, V117, P163, DOI 10.1016/j.jbiotec.2005.01.011; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rachatasumrit N, 2012, 2012 28TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE MAINTENANCE (ICSM), P357, DOI 10.1109/ICSM.2012.6405293; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Soetens QD, 2013, PROC IEEE INT CONF S, P384, DOI 10.1109/ICSM.2013.53; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Taki FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094311; Taki FA, 2013, PSYCHOPHARMACOLOGY, V230, P77, DOI 10.1007/s00213-013-3139-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xu J, 2014, CURR MICROBIOL, V68, P120, DOI 10.1007/s00284-013-0442-2; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	31	145	146	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122515	10.1371/journal.pone.0122515	http://dx.doi.org/10.1371/journal.pone.0122515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825906	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800076
J	Lee, ES; Akef, A; Mahadevan, K; Palazzo, AF				Lee, Eliza S.; Akef, Abdalla; Mahadevan, Kohila; Palazzo, Alexander F.			The Consensus 5 ' Splice Site Motif Inhibits mRNA Nuclear Export	PLOS ONE			English	Article							LOCALIZATION; EXPRESSION; SEQUENCES; PROTEINS; RETENTION; COMPLEX; COMPONENTS; HELICASES; IDENTITY; ELEMENTS	In eukaryotes, mRNAs are synthesized in the nucleus and then exported to the cytoplasm where they are translated into proteins. We have mapped an element, which when present in the 3' terminal exon or in an unspliced mRNA, inhibits mRNA nuclear export. This element has the same sequence as the consensus 5' splice site motif that is used to define the start of introns. Previously it was shown that when this motif is retained in the mRNA, it causes defects in 3' cleavage and polyadenylation and promotes mRNA decay. Our new data indicates that this motif also inhibits nuclear export and promotes the targeting of transcripts to nuclear speckles, foci within the nucleus which have been linked to splicing. The motif, however, does not disrupt splicing or the recruitment of UAP56 or TAP/Nxf1 to the RNA, which are normally required for nuclear export. Genome wide analysis of human mRNAs, lncRNA and eRNAs indicates that this motif is depleted from naturally intronless mRNAs and eRNAs, but less so in lncRNAs. This motif is also depleted from the beginning and ends of the 3' terminal exons of spliced mRNAs, but less so for lncRNAs. Our data suggests that the presence of the 5' splice site motif in mature RNAs promotes their nuclear retention and may help to distinguish mRNAs from misprocessed transcripts and transcriptional noise.	[Lee, Eliza S.; Akef, Abdalla; Mahadevan, Kohila; Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Palazzo, AF (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle,MSB Room 5336, Toronto, ON M5S 1A8, Canada.	alex.palazzo@utoronto.ca	Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995; Akef, Abdalla/0000-0001-6416-0538	Canadian Institutes of Health Research [FRN 102725]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research to AFP (FRN 102725), http://www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad X, 2008, NUCLEIC ACIDS RES, V36, P2338, DOI 10.1093/nar/gkn068; Akef A, 2013, NUCLEUS-PHILA, V4, P326, DOI 10.4161/nucl.26052; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cui XYA, 2014, WIRES RNA, V5, P481, DOI 10.1002/wrna.1225; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; FURTH PA, 1994, MOL CELL BIOL, V14, P5278, DOI 10.1128/MCB.14.8.5278; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; Gueroussov Serge, 2010, J Vis Exp, DOI 10.3791/2387; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Langemeier J, 2012, EMBO J, V31, P4035, DOI 10.1038/emboj.2012.252; Lei HX, 2013, NUCLEIC ACIDS RES, V41, P2517, DOI 10.1093/nar/gks1314; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Li BJ, 1996, P NATL ACAD SCI USA, V93, P1596, DOI 10.1073/pnas.93.4.1596; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Mahadevan K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001545; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Palazzo AF, PLOS GENET IN PRESS; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Palazzo AF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00002; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Palazzo AF, 2013, WIRES RNA, V4, P523, DOI 10.1002/wrna.1176; Palazzo AF, 2012, BBA-GENE REGUL MECH, V1819, P566, DOI 10.1016/j.bbagrm.2011.12.012; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Shibayama Y, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28658; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Takemura R, 2011, GENES CELLS, V16, P1035, DOI 10.1111/j.1365-2443.2011.01548.x; Taniguchi I, 2008, MOL CELL BIOL, V28, P601, DOI 10.1128/MCB.01341-07; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Vagner S, 2000, RNA, V6, P178, DOI 10.1017/S1355838200991854; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Volanakis A, 2013, GENE DEV, V27, P2025, DOI 10.1101/gad.221960.113; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Zhang B, 2014, MOL CELL BIOL, V34, P2318, DOI 10.1128/MCB.01673-13	57	24	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122743	10.1371/journal.pone.0122743	http://dx.doi.org/10.1371/journal.pone.0122743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826302	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800088
J	Li, HB; Chen, GD; Yan, W				Li, Haobing; Chen, Guangdeng; Yan, Wei			Molecular Characterization of Barley 3H Semi-Dwarf Genes	PLOS ONE			English	Article							DWARFING GENES; PLANT; BRASSINOSTEROID-INSENSITIVE1; ELONGATION; HOMOLOG	The barley chromosome 3H accommodates many semi-dwarfing genes. To characterize these genes, the two-rowed semi-dwarf Chinese barley landrace 'TX9425' was crossed with the Australian barley variety 'Franklin' to generate a doubled haploid (DH) population, and major QTLs controlling plant height have been identified in our previous study. The major QTL derived from 'TX9425' was targeted to investigate the allelism of the semi-dwarf gene uzu in barley. Twelve sets of near-isogenic lines and a large NILF2 fine mapping population segregating only for the dwarfing gene from 'TX9425' were developed. The semi-dwarfing gene in 'TX9425' was located within a 2.8 cM region close to the centromere on chromosome 3H by fine mapping. Molecular cloning and sequence analyses showed that the 'TX9425'-derived allele contained a single nucleotide substitution from A to G at position 2612 of the HvBRI1 gene. This was apparently the same mutation as that reported in six-rowed uzu barley. Markers co-segregating with the QTL were developed from the sequence of the HvBRI1 gene and were validated in the 'TX9425'/'Franklin' DH population. The other major dwarfing QTL derived from the Franklin variety was distally located on chromosome 3HL and co-segregated with the sdw1 diagnostic marker hv20ox2. A third dwarfing gene, expressed only in winter-sown trials, was identified and located on chromosome 3HS. The effects and interactions of these dwarfing genes under different growing conditions are discussed. These results improve our understanding of the genetic mechanisms controlling semi-dwarf stature in barley and provide diagnostic markers for the selection of semi-dwarfness in barley breeding programs.	[Li, Haobing] Univ Tasmania, Tasmanian Inst Agr Res, Hobart, Tas, Australia; [Li, Haobing] Univ Tasmania, Sch Agr Sci, Hobart, Tas, Australia; [Li, Haobing; Chen, Guangdeng; Yan, Wei] CSIRO Agr Flagship, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Li, Haobing] Dept Environm & Primary Ind, Biosci Res Div, Horsham, Vic, Australia; [Chen, Guangdeng] Sichuan Agr Univ, Inst Ecol & Environm Sci, Chengdu, Peoples R China; [Yan, Wei] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	University of Tasmania; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University; Jiangsu Academy of Agricultural Sciences	Li, HB (corresponding author), Univ Tasmania, Tasmanian Inst Agr Res, Hobart, Tas, Australia.	haobing.li@depi.vic.gov.au			Australian GRDC [UT8]	Australian GRDC(Grains R&D Corp)	UT8 Project funded by Australian GRDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, MAPQTL VERSION 5 0 S; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; Caesar K, 2011, PLANT J, V66, P528, DOI 10.1111/j.1365-313X.2011.04510.x; Chen ZW, 2012, GENET MOL RES, V11, P644, DOI 10.4238/2012.March.16.2; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Doyle J. J., 1987, PHYTOCHEM B, P11; FETTELL NA, 2001, P 10 AUSTR BARL TECH; Foster AE, 1987, P 5 INT BARL GEN S 1, P979; Gale MD, 1985, PROGR PLANT BREEDING, P1, DOI DOI 10.1016/B978-0-407-00780-2.50005-9; Gallagher LW, 1996, CROP SCI, V36, P466, DOI 10.2135/cropsci1996.0011183X003600020044x; Garza-Falcon E, 1960, THESIS COLORADO STAT; Gruszka D., 2006, Barley Genetics Newsletter, V36, P1; Gruszka D, 2011, J APPL GENET, V52, P257, DOI 10.1007/s13353-011-0031-7; Hellewell KB, 2000, CROP SCI, V40, P352, DOI 10.2135/cropsci2000.402352x; Holton N, 2007, PLANT CELL, V19, P1709, DOI 10.1105/tpc.106.047795; Ivandic V, 1999, THEOR APPL GENET, V98, P728, DOI 10.1007/s001220051127; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Khodayari H, 2012, INT J BIOSCI BIOCH B, V2, P1; KHUSH GS, 1993, INTERNATIONAL CROP SCIENCE I, P189; Leonard WH, 1957, COLORADO AGR EXP STA, V60, P1; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Ma J, 2012, EUPHYTICA, V183, P147, DOI 10.1007/s10681-011-0414-1; Mano Y, 2001, GENOME, V44, P284, DOI 10.1139/gen-44-2-284; Michaels SD, 1998, PLANT J, V14, P381, DOI 10.1046/j.1365-313X.1998.00123.x; MICKELSON HR, 1994, CROP SCI, V34, P1180, DOI 10.2135/cropsci1994.0011183X003400050007x; Milach SCK, 2001, ADV AGRON, V73, P35, DOI 10.1016/S0065-2113(01)73004-0; Nomura T, 2003, PLANT J, V36, P291, DOI 10.1046/j.1365-313X.2003.01863.x; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; RASMUSSON DC, 1991, FIELD CROP RES, V26, P191, DOI 10.1016/0378-4290(91)90035-T; ROBERTSON D. W., 1965, CROP SCI, V5, P33, DOI 10.2135/cropsci1965.0011183X000500010013x; Saisho D, 2004, BREEDING SCI, V54, P409, DOI 10.1270/jsbbs.54.409; SEARS RG, 1981, CROP SCI, V21, P828, DOI 10.2135/cropsci1981.0011183X002100060008x; TAKAHASHI R., 1964, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V12, P217; TAKAHASHI R., 1942, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V9, P71; TAKAHASHI R, 1951, BER OHARA I LANDWIRT, V9, P399; Tsuchiya T., 1972, BARLEY GENET NEWSL, P87; Tsuchiya T, 1972, BARLEY GENET NEWSL, V2, P80; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Vagner Haahr D.v.W., 1976, P 3 INT BARL GEN S V, P215; Van Ooijen J. W, 2006, JOINMAP 4 SOFTWARE F; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Zhang J, 2003, EUPHYTICA, V131, P285, DOI 10.1023/A:1024032732443; Zhang J., 2000, PLANT BREEDING, V119, P523, DOI 10.1046/j.1439-0523.2000.00543.x; Zhang J., 1994, BARLEY SCI, V4, P11; Zhang Jing, 2006, Agricultural Sciences in China, V5, P643, DOI 10.1016/S1671-2927(06)60105-3	48	6	7	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120558	10.1371/journal.pone.0120558	http://dx.doi.org/10.1371/journal.pone.0120558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826380	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800018
J	Lippman, SA; Koester, KA; Amico, KR; Lama, JR; Fernandes, NM; Gonzales, P; Grinsztejn, B; Liu, A; Buchbinder, S; Koblin, BA				Lippman, Sheri A.; Koester, Kimberly A.; Amico, K. Rivet; Lama, Javier R.; Fernandes, Nilo Martinez; Gonzales, Pedro; Grinsztejn, Beatriz; Liu, Al; Buchbinder, Susan; Koblin, Beryl A.			Client and Provider Perspectives on New HIV Prevention Tools for MSM in the Americas	PLOS ONE			English	Article							MALE CIRCUMCISION; MEN; SEX; BRAZIL; RISK; INFECTION; AIDS; PROPHYLAXIS; HIV/AIDS; ACCESS	Men who have sex with men (MSM) in the Americas require targeted, combination HIV prevention approaches. We solicited client and provider perspectives on emerging prevention interventions including HIV pre-exposure prophylaxis (PrEP) and HIV self-tests through focus groups and in-depth interviews with 130 MSM and 41 providers across four sites: New York, San Francisco, Lima, and Rio de Janeiro. Among the MSM participants, we identified three prevention typologies: non-condom users, inconsistent condom users, and consistent condom users. Northern and Southern MSM differed in the variety of harm reduction strategies utilized: where U.S. MSM relied on condom use as well as disclosure and seroadaptive behaviors for prevention, condom use without disclosure or serostatus discussions was the norm in South America. Interest in new prevention technologies was shaped by the social context. U.S. MSM preferences differed by typology, such that non-condom users were interested in taking PrEP and using home HIV tests. MSM in Brazil, regardless of typology, were interested in exploring new prevention options. MSM in Peru demonstrated moderate interest but were less comfortable with adopting new strategies. MSM and providers' opinions differed substantially with respect to new prevention options. Across sites, most providers were reticent to engage with new prevention options, though some NGO-based providers were more supportive of exploring new prevention tools. Both clients and providers will need to be engaged in developing integrated prevention strategies for MSM.	[Lippman, Sheri A.; Koester, Kimberly A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Amico, K. Rivet] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Lama, Javier R.; Gonzales, Pedro] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Fernandes, Nilo Martinez; Grinsztejn, Beatriz] Fiocruz MS, HIV AIDS Clin Res Ctr, BR-21045900 Rio De Janeiro, Brazil; [Liu, Al; Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Koblin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA	University of California System; University of California San Francisco; University of Connecticut; Fundacao Oswaldo Cruz; San Francisco Department of Public Health; New York Blood Center	Lippman, SA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	sheri.lippman@ucsf.edu	/AAE-4700-2020	Amico, K Rivet/0000-0002-4458-6934; Lippman, Sheri/0000-0003-3152-9372	National Institute of Allergy and Infectious Diseases [R01AI083060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069476, R01AI083060, UM1AI069476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The data collection for this study was funded by the National Institute of Allergy and Infectious Diseases R01AI083060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034972; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Berkman A, 2005, AM J PUBLIC HEALTH, V95, P1162, DOI 10.2105/AJPH.2004.054593; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Caceres C, 2014, POLICY DIALOGUE ENHA, pA256; California HIV/AIDS Policy Research Centers, 2014, US HIV OV THE COUNT; Carballo-Dieguez A, 2011, J SEX RES; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Celum C, 2013, JAIDS-J ACQ IMM DEF, V63, pS213, DOI 10.1097/QAI.0b013e3182986f3a; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen SE, 2014, C RETR OPP INF CROI; Galvao J, 2005, AM J PUBLIC HEALTH, V95, P1110, DOI 10.2105/AJPH.2004.044313; Grangeiro A, 2009, REV PANAM SALUD PUBL, V26, P87, DOI 10.1590/S1020-49892009000700013; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hirshfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046252; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Lippman SA, 2014, CAD SAUDE PUBLICA, V30, P724, DOI 10.1590/0102-311X00008913; Liu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Nagaraj S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-181; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pines HA, 2013, J ACQUIR IMMUNE DEFI; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Sandoval C, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-23; Smith JH, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-47; Snowden JM, 2009, SEX TRANSM INFECT, V85, P469, DOI 10.1136/sti.2009.036269; Sturges JE., 2004, QUAL RES, V4, P107, DOI [DOI 10.1177/1468794104041110, 10.1177/1468794104041110]; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tang EC, 2014, AIDS RES HUM RETROVI; UNAIDS, 2010, GLOB REP UNAIDS REP, DOI [10.1189/jlb.0811394, DOI 10.1189/JLB.0811394]; US Food and Drug Administration (USFDA), 2012, ORAQUICK IN HOM HIV; Vallabhaneni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055397; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121044	10.1371/journal.pone.0121044	http://dx.doi.org/10.1371/journal.pone.0121044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826246	gold, Green Published			2022-12-27	WOS:000352084800033
J	Zust, MA; Colella, P; Reber, TP; Vuilleumier, P; Hauf, M; Ruch, S; Henke, K				Zuest, Marc Alain; Colella, Patrizio; Reber, Thomas Peter; Vuilleumier, Patrik; Hauf, Martinus; Ruch, Simon; Henke, Katharina			Hippocampus Is Place of Interaction between Unconscious and Conscious Memories	PLOS ONE			English	Article							SEMANTIC ASSOCIATIONS; TEMPORAL-LOBE; FACE; NEUROPHYSIOLOGY; PERCEPTION; ACTIVATION; CORRELATE; SYSTEMS; SLEEP	Recent evidence suggests that humans can form and later retrieve new semantic relations unconsciously by way of hippocampus-the key structure also recruited for conscious relational (episodic) memory. If the hippocampus subserves both conscious and unconscious relational encoding/retrieval, one would expect the hippocampus to be place of unconscious-conscious interactions during memory retrieval. We tested this hypothesis in an fMRI experiment probing the interaction between the unconscious and conscious retrieval of face-associated information. For the establishment of unconscious relational memories, we presented subliminal (masked) combinations of unfamiliar faces and written occupations ("actor" or "politician"). At test, we presented the former subliminal faces, but now supraliminally, as cues for the reactivation of the unconsciously associated occupations. We hypothesized that unconscious reactivation of the associated occupation-actor or politician-would facilitate or inhibit the subsequent conscious retrieval of a celebrity's occupation, which was also actor or politician. Depending on whether the reactivated unconscious occupation was congruent or incongruent to the celebrity's occupation, we expected either quicker or delayed conscious retrieval process. Conscious retrieval was quicker in the congruent relative to a neutral baseline condition but not delayed in the incongruent condition. fMRI data collected during subliminal face-occupation encoding confirmed previous evidence that the hippocampus was interacting with neocortical storage sites of semantic knowledge to support relational encoding. fMRI data collected at test revealed that the facilitated conscious retrieval was paralleled by deactivations in the hippocampus and neocortical storage sites of semantic knowledge. We assume that the unconscious reactivation has pre-activated overlapping relational representations in the hippocampus reducing the neural effort for conscious retrieval. This finding supports the notion of synergistic interactions between conscious and unconscious relational memories in a common, cohesive hippocampal-neocortical memory space.	[Zuest, Marc Alain; Colella, Patrizio; Reber, Thomas Peter; Ruch, Simon; Henke, Katharina] Univ Bern, Dept Psychol, Div Expt Psychol & Neuropsychol, Bern, Switzerland; [Zuest, Marc Alain; Colella, Patrizio; Reber, Thomas Peter; Ruch, Simon; Henke, Katharina] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Dept Neurosci & Clin Neurol, Geneva, Switzerland; [Hauf, Martinus] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Geneva; University of Bern; University Hospital of Bern	Zust, MA (corresponding author), Univ Bern, Dept Psychol, Div Expt Psychol & Neuropsychol, Bern, Switzerland.	marc.zuest@psy.unibe.ch	Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Ruch, Simon/0000-0002-5796-4543; Reber, Thomas/0000-0002-3969-9782; Zust, Marc Alain/0000-0003-3043-2106	Swiss National Science Foundation [320000-114012]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by Swiss National Science Foundation (http://www.snf.ch/de/Seiten/default.aspx) grant 320000-114012 to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Ciranni MA, 1999, J EXP PSYCHOL LEARN, V25, P1403, DOI 10.1037/0278-7393.25.6.1403; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Dehaene S, 2014, CURR OPIN NEUROBIOL, V25, P76, DOI 10.1016/j.conb.2013.12.005; Drosopoulos S, 2011, BIOL PSYCHOL, V86, P168, DOI 10.1016/j.biopsycho.2010.11.005; Duss SB, 2014, BRAIN, V137, P3355, DOI 10.1093/brain/awu270; Duss SB, 2011, CONSCIOUS COGN, V20, P928, DOI 10.1016/j.concog.2011.03.018; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Gainotti G, 2012, NEUROPSYCHOLOGIA, V50, P205, DOI 10.1016/j.neuropsychologia.2011.12.005; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Harand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043495; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henke K, 2003, NEUROPSYCHOLOGIA, V41, P863, DOI 10.1016/S0028-3932(03)00035-6; Henke K, 2003, CONSCIOUS COGN, V12, P31, DOI 10.1016/S1053-8100(02)00006-5; Henke K, 1999, SOC NEUR ABSTR, P647; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Martin A, 1999, HIPPOCAMPUS, V9, P62, DOI 10.1002/(SICI)1098-1063(1999)9:1<62::AID-HIPO7>3.0.CO;2-K; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; McKenzie S, 2013, J NEUROSCI, V33, P10243, DOI 10.1523/JNEUROSCI.0879-13.2013; Moscovitch M, 2008, CAN J EXP PSYCHOL, V62, P62, DOI 10.1037/1196-1961.62.1.62; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Reber TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00009; Reber TP, 2012, CONSCIOUS COGN, V21, P953, DOI 10.1016/j.concog.2012.02.013; Reber TP, 2012, J NEUROSCI, V32, P6138, DOI 10.1523/JNEUROSCI.5639-11.2012; Reber TP, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00343; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Saletin JM, 2011, CEREB CORTEX, V21, P2534, DOI 10.1093/cercor/bhr034; Snodgrass M, 2006, COGNITION, V101, P43, DOI 10.1016/j.cognition.2005.06.006; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Todorov A, 2012, MOTIV EMOTION, V36, P16, DOI 10.1007/s11031-011-9238-5; Tsukiura T, 2006, NEUROIMAGE, V30, P617, DOI 10.1016/j.neuroimage.2005.09.043; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Yordanova J, 2012, J COGNITIVE NEUROSCI, V24, P119, DOI 10.1162/jocn_a_00097	52	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122459	10.1371/journal.pone.0122459	http://dx.doi.org/10.1371/journal.pone.0122459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826338	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800071
J	Allegrucci, G; Sbordoni, V; Cesaroni, D				Allegrucci, Giuliana; Sbordoni, Valerio; Cesaroni, Donatella			Is Radon Emission in Caves Causing Deletions in Satellite DNA Sequences of Cave-Dwelling Crickets?	PLOS ONE			English	Article							DOLICHOPODA-SCHIAVAZZII ORTHOPTERA; GEOGRAPHIC-VARIATION; GENETIC-STRUCTURE; RHAPHIDOPHORIDAE; GENOTOXICITY; POLYMORPHISM; POPULATIONS; PATTERNS; EXPOSURE; FAMILY	The most stable isotope of radon, Rn-222, represents the major source of natural radioactivity in confined environments such as mines, caves and houses. In this study, we explored the possible radon-related effects on the genome of Dolichopoda cave crickets (Orthoptera, Rhaphidophoridae) sampled in caves with different concentrations of radon. We analyzed specimens from ten populations belonging to two genetically closely related species, D. geniculata and D. laetitiae, and explored the possible association between the radioactivity dose and the level of genetic polymorphism in a specific family of satellite DNA (pDo500 satDNA). Radon concentration in the analyzed caves ranged from 221 to 26000 Bq/m(3). Specimens coming from caves with the highest radon concentration showed also the highest variability estimates in both species, and the increased sequence heterogeneity at pDo500 satDNA level can be explained as an effect of the mutation pressure induced by radon in cave. We discovered a specific category of nuclear DNA, the highly repetitive satellite DNA, where the effects of the exposure at high levels of radon-related ionizing radiation are detectable, suggesting that the satDNA sequences might be a valuable tool to disclose harmful effects also in other organisms exposed to high levels of radon concentration.	[Allegrucci, Giuliana; Sbordoni, Valerio; Cesaroni, Donatella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Rome Tor Vergata	Allegrucci, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	allegrucci@uniroma2.it	Allegrucci, Giuliana/AAZ-2217-2021; Sbordoni, Valerio/L-8889-2013	Sbordoni, Valerio/0000-0002-9510-1925; CESARONI, DONATELLA/0000-0001-9787-7148	Regione Lazio (Dipartimento del Territorio), Italy [B4886/05]	Regione Lazio (Dipartimento del Territorio), Italy	This work was supported by the Regione Lazio (Dipartimento del Territorio), Italy, grant number: B4886/05. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERING HJ, 1992, LANCET, V340, P739, DOI 10.1016/0140-6736(92)92287-P; Allegrucci G, 1997, HEREDITY, V78, P665, DOI 10.1038/hdy.1997.106; Allegrucci G, 2005, MOL PHYLOGENET EVOL, V37, P153, DOI 10.1016/j.ympev.2005.04.022; ALLEGRUCCI G, 1987, BIOL J LINN SOC, V31, P151, DOI 10.1111/j.1095-8312.1987.tb01986.x; Allegrucci G, 2011, MOL PHYLOGENET EVOL, V60, P108, DOI 10.1016/j.ympev.2011.04.002; Allegrucci G, 2009, J BIOGEOGR, V36, P1785, DOI 10.1111/j.1365-2699.2009.02130.x; Angeletti D, 2014, CURR ZOOL, V60, P252, DOI 10.1093/czoolo/60.2.252; Aytekin H, 2006, RADIAT PROT DOSIM, V118, P117, DOI 10.1093/rpd/nci326; Bachmann L, 1996, J MOL EVOL, V43, P135, DOI 10.1007/BF02337358; BACHMANN L, 1994, J MOL EVOL, V39, P274, DOI 10.1007/BF00160151; BAUBRON JC, 1991, J GEOL SOC LONDON, V148, P571, DOI 10.1144/gsjgs.148.3.0571; Bellocchi E, 2009, SPELEOLOGIA VENETA, V17, P77; Benzecri JP, 1973, ANAL DONNEES 2 ANAL; Bilban M, 2001, HEALTH PHYS, V80, P157, DOI 10.1097/00004032-200102000-00008; Cesaroni D, 1997, J BIOGEOGR, V24, P419, DOI 10.1111/j.1365-2699.1997.00104.x; Cigna A.A., 2004, INT J SPELEOL, V32, P8, DOI [10.5038/1827-806X.32.1.8, DOI 10.5038/1827-806X.32.1.8]; Cristaldi M, 2004, MUTAT RES-GEN TOX EN, V559, P1, DOI 10.1016/j.mrgentox.2003.10.021; De Pasquale L, 1998, THESIS U STUDI AQUIL; DEPASQUALE L, 1995, ECOGRAPHY, V18, P217; Dixon DR, 2002, MUTAGENESIS, V17, P495, DOI 10.1093/mutage/17.6.495; Gustavino B, 2014, CURR ZOOL, V60, P299, DOI 10.1093/czoolo/60.2.299; Hakl J., 1997, RADON MEASUREMENTS E, P261; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Iyengar MAR, 1990, TECH REP SERIES, P310; Jostes RF, 1996, MUTAT RES-REV GENET, V340, P125, DOI 10.1016/S0165-1110(96)90044-5; KHAN MA, 1995, MUTAT RES-ENVIR MUTA, V334, P131, DOI 10.1016/0165-1161(95)90003-9; Lacaze E, 2010, MUTAT RES-GEN TOX EN, V700, P32, DOI 10.1016/j.mrgentox.2010.04.025; Lewis C, 2008, MUTAT RES-GEN TOX EN, V654, P69, DOI 10.1016/j.mrgentox.2008.05.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinsen L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-3; Martinsen L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-301; Palomeque T, 2008, HEREDITY, V100, P564, DOI 10.1038/hdy.2008.24; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Sbordoni V., 1987, P514; SBORDONI V, 1976, Z ZOOL SYST EVOL, V14, P292; SBORDONI V, 1985, B ZOOL, V52, P139, DOI 10.1080/11250008509440347; Sperrin M, 2001, ENV MANAGE HLTH, V12, P476; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	38	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122456	10.1371/journal.pone.0122456	http://dx.doi.org/10.1371/journal.pone.0122456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822625	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700177
J	Chou, CH; Lai, SL; Ho, CM; Lin, WH; Chen, CN; Lee, PH; Peng, FC; Kuo, SH; Wu, SY; Lai, HS				Chou, Chia-Hung; Lai, Shou-Lun; Ho, Cheng-Maw; Lin, Wen-Hsi; Chen, Chiung-Nien; Lee, Po-Huang; Peng, Fu-Chuo; Kuo, Sung-Hsin; Wu, Szu-Yuan; Lai, Hong-Shiee			Lysophosphatidic Acid Alters the Expression Profiles of Angiogenic Factors, Cytokines, and Chemokines in Mouse Liver Sinusoidal Endothelial Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPATIC REGENERATION; PARTIAL-HEPATECTOMY; PROLIFERATION; DEFICIENT; MICE	Background and Aims Lysophosphatidic acid (LPA) is a multi-function glycerophospholipid. LPA affects the proliferation of hepatocytes and stellate cells in vitro, and in a partial hepatectomy induced liver regeneration model, the circulating LPA levels and LPA receptor (LPAR) expression levels in liver tissue are significantly changed. Liver sinusoidal endothelial cells (Lsecs) play an important role during liver regeneration. However, the effects of LPA on Lsecs are not well known. Thus, we investigated the effects of LPA on the expression profiles of angiogenic factors, cytokines, and chemokines in Lsecs. Methods Mouse Lsecs were isolated using CD31-coated magnetic beads. The mRNA expression levels of LPAR's and other target genes were determined by quantitative RT-PCR. The protein levels of angiogenesis factors, cytokines, and chemokines were determined using protein arrays and enzyme immunoassay (EIA). Critical LPAR related signal transduction was verified by using an appropriate chemical inhibitor. Results LPAR1 and LPAR3 mRNA's were expressed in mouse LPA-treated Lsecs. Treating Lsecs with a physiological level of LPA significantly enhanced the protein levels of angiogenesis related proteins (cyr61 and TIMP-1), cytokines (C5/C5a, M-CSF, and SDF-1), and chemokines (MCP-5, gp130, CCL28, and CXCL16). The LPAR1 and LPAR3 antagonist ki16425 significantly inhibited the LPA-enhanced expression of cyr61, TIMP-1, SDF-1, MCP-5, gp130, CCL28, and CXCL16, but not that of C5/C5a or M-CSF. LPA-induced C5/C5a and M-CSF expression may have been through an indirect regulation mechanism. Conclusion LPA regulated the expression profiles of angiogenic factors, cytokines, and chemokines in Lsecs that was mediated via LPAR1 and LPAR3 signaling. Most of the factors that were enhanced by LPA have been found to play critical roles during liver regeneration. Thus, these results may prove useful for manipulating LPA effects on liver regeneration.	[Chou, Chia-Hung; Lai, Shou-Lun; Ho, Cheng-Maw; Lin, Wen-Hsi; Chen, Chiung-Nien; Lee, Po-Huang; Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chou, Chia-Hung; Lai, Shou-Lun; Ho, Cheng-Maw; Lin, Wen-Hsi; Chen, Chiung-Nien; Lee, Po-Huang; Kuo, Sung-Hsin; Lai, Hong-Shiee] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Peng, Fu-Chuo] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Kuo, Sung-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Wu, Szu-Yuan] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	hslai@ntu.edu.tw	Ho, Cheng-Maw/H-5366-2019	Ho, Cheng-Maw/0000-0003-1874-7615; Lai, Hong-Shiee/0000-0002-7958-2183; PENG, FU-CHUO/0000-0003-4385-8499; LEE, PO-HUANG/0000-0001-5831-035X; Lai, Shuo-Lun/0000-0002-2480-4252; Kuo, Sung-Hsin/0000-0003-0054-887X; CHEN, CHIUNG-NIEN/0000-0003-1192-5220; Wu, Szu-Yuan/0000-0001-5637-558X	Taiwan National Science Council [NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3]; National Taiwan University Hospital [NTUH100-S1491]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by Taiwan National Science Council grants NSC 96-2314-B-002-079-MY3, NSC 100-2314-B-002-019-MY3, and the National Taiwan University Hospital Grant NTUH100-S1491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Amemiya H, 2011, J SURG RES, V165, P59, DOI 10.1016/j.jss.2009.08.008; Chen P, 2006, ARCH MED RES, V37, P576, DOI 10.1016/j.arcmed.2005.12.004; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066268; Coulon S, 2013, HEPATOLOGY, V57, P1793, DOI 10.1002/hep.26219; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Dierssen U, 2008, J BIOL CHEM, V283, P9886, DOI 10.1074/jbc.M705483200; Duarte S, 2012, HEPATOLOGY, V56, P1074, DOI 10.1002/hep.25710; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; El Filali E, 2013, CELL TRANSPLANT, V22, P1801, DOI 10.3727/096368912X657594; FEINGOLD KR, 1988, BIOCHEM BIOPH RES CO, V153, P576, DOI 10.1016/S0006-291X(88)81134-3; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; KUMA S, 1990, IMMUNOBIOLOGY, V180, P235, DOI 10.1016/S0171-2985(11)80331-1; Lai HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067868; Lai HS, 2009, AM SURGEON, V75, P49; Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lehwald N, 2014, LIVER INT, V34, P89, DOI 10.1111/liv.12195; Lin CH, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/351010; Manka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102351; Masana MI, 1995, RECEPTOR CHANNEL, V3, P255; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Mavier P, 2004, AM J PATHOL, V165, P1969, DOI 10.1016/S0002-9440(10)63248-8; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Mochida S, 1996, BIOCHEM BIOPH RES CO, V226, P176, DOI 10.1006/bbrc.1996.1329; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Ohkubo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105533; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Oude Elferink RP, 2014, BIOCH BIOPHYS ACTA; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Schulze C, 1997, J NEUROCHEM, V68, P991; Simo KA, 2014, HPB, V16, P534, DOI 10.1111/hpb.12176; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Uda Y, 2013, SURGERY, V153, P70, DOI 10.1016/j.surg.2012.06.021; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; Zhu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071612	41	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122060	10.1371/journal.pone.0122060	http://dx.doi.org/10.1371/journal.pone.0122060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822713	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700148
J	Kujala, M; Nevalainen, J; Marz, W; Laaksonen, R; Datta, S				Kujala, Maiju; Nevalainen, Jaakko; Maerz, Winfried; Laaksonen, Reijo; Datta, Susmita			Differential Network Analysis with Multiply Imputed Lipidomic Data	PLOS ONE			English	Article							SPHINGOLIPID METABOLISM; CHAINED EQUATIONS; MICROARRAY DATA; IMPUTATION; BIOINFORMATICS; INTEGRATION	The importance of lipids for cell function and health has been widely recognized, e.g., a disorder in the lipid composition of cells has been related to atherosclerosis caused cardiovascular disease (CVD). Lipidomics analyses are characterized by large yet not a huge number of mutually correlated variables measured and their associations to outcomes are potentially of a complex nature. Differential network analysis provides a formal statistical method capable of inferential analysis to examine differences in network structures of the lipids under two biological conditions. It also guides us to identify potential relationships requiring further biological investigation. We provide a recipe to conduct permutation test on association scores resulted from partial least square regression with multiple imputed lipidomic data from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study, particularly paying attention to the left-censored missing values typical for a wide range of data sets in life sciences. Left-censored missing values are low-level concentrations that are known to exist somewhere between zero and a lower limit of quantification. To make full use of the LURIC data with the missing values, we utilize state of the art multiple imputation techniques and propose solutions to the challenges that incomplete data sets bring to differential network analysis. The customized network analysis helps us to understand the complexities of the underlying biological processes by identifying lipids and lipid classes that interact with each other, and by recognizing the most important differentially expressed lipids between two subgroups of coronary artery disease (CAD) patients, the patients that had a fatal CVD event and the ones who remained stable during two year follow-up.	[Kujala, Maiju] Univ Turku, Dept Math & Stat, Turku 20014, Finland; [Nevalainen, Jaakko] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth, Heidelberg, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Clin Lab Diagnost, Graz, Austria; [Laaksonen, Reijo] Zora Biosci, Espoo, Finland; [Laaksonen, Reijo] Tampere Univ Hosp, Tampere, Finland; [Datta, Susmita] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Turku; Tampere University; Ruprecht Karls University Heidelberg; SYNLAB Group; Medical University of Graz; Tampere University; Tampere University Hospital; University of Louisville	Kujala, M (corresponding author), Univ Turku, Dept Math & Stat, Assistentinkatu 7, Turku 20014, Finland.	mekuja@utu.fi	Nevalainen, Jaakko/X-1828-2019	Nevalainen, Jaakko/0000-0001-6295-0245	National Institutes of Health [CA 170091-01A1]; EU [201668]; NATIONAL CANCER INSTITUTE [R15CA170091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research work was partially supported by National Institutes of Health grant CA 170091-01A1 (Susmita Datta). The lipidomic studies were supported by EU grant (201668) to AtheroRemo consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2010, BRIEF BIOINFORM, V11, P253, DOI 10.1093/bib/bbp059; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Datta S, 2001, GENE EXPRESSION, V9, P249, DOI 10.3727/000000001783992498; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gill R, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-427, 10.1186/1471-2105-11-95]; Gopalacharyulu PV, 2008, INT J DATA MIN BIOIN, V2, P54, DOI 10.1504/IJDMB.2008.016756; Gupta S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-26; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Jornsten R, 2005, BIOINFORMATICS, V21, P4155, DOI 10.1093/bioinformatics/bti638; Lee M, 2012, STAT MED, V31, P1838, DOI 10.1002/sim.4503; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; MENG XL, 1994, STAT SCI, V9, P538, DOI 10.1214/ss/1177010269; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Niemela PS, 2009, J CHROMATOGR B, V877, P2855, DOI 10.1016/j.jchromb.2009.01.025; Oresic M, 2009, EUR J LIPID SCI TECH, V111, P99, DOI 10.1002/ejlt.200800144; Pihur V, 2008, BIOINFORMATICS, V24, P561, DOI 10.1093/bioinformatics/btm640; Podbielska M, 2012, NEUROCHEM RES, V37, P1154, DOI 10.1007/s11064-012-0728-y; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Tarasov K, 2014, J CLIN ENDOCR METAB, V99, pE45, DOI 10.1210/jc.2013-2559; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van Buuren S, 2011, J STAT SOFTW, V45, P1; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Winkelmann BR, 2001, PHARMACOGENOMICS, V2, pS7; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	45	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121449	10.1371/journal.pone.0121449	http://dx.doi.org/10.1371/journal.pone.0121449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822937	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700109
J	Liu, M; Jin, X; He, XG; Pan, L; Zhang, XM; Zhao, YX				Liu, Min; Jin, Xing; He, Xigan; Pan, Ling; Zhang, Xiumei; Zhao, Yunxue			Macrophages Support Splenic Erythropoiesis in 4T1 Tumor-Bearing Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PRIMARY PROPHYLAXIS; MOUSE MODEL; HSC NICHES; G-CSF; CANCER; ANEMIA; MECHANISMS	Anemia is a common complication of cancer; a role of spleen in tumor-stress erythropoiesis has been suggested. However, the molecular mechanisms involved in the splenic erythropoiesis following tumor maintenance remain poorly understood. Here we show that tumor development blocks medullar erythropoiesis by granulocyte colony-stimulating factor (G-CSF) and then causes anemia in murine 4T1 breast tumor-bearing mice. Meanwhile, tumor-stress promotes splenic erythropoiesis. Splenectomy worsened tumor-induced anemia, and reduced tumor volume and tumor weight, indicating the essential role of spleen in tumor-stress erythropoiesis and tumor growth. Tumor progression of these mice led to increased amounts of bone morphogenetic protein 4 (BMP4) in spleen. The in vivo role of macrophages in splenic erythropoiesis under tumor-stress conditions was investigated. Macrophage depletion by injecting liposomal clodronate decreased the expression of BMP4, inhibited splenic erythropoiesis, aggravated the tumor-induced anemia and suppressed tumor growth. Our results provide insight that macrophages and BMP4 are positive regulators of splenic erythropoiesis in tumor pathological situations. These findings reveal that during the tumor-stress period, the microenvironment of the spleen is undergoing changes, which contributes to adopt a stress erythropoietic fate and supports the expansion and differentiation of stress erythroid progenitors, thereby replenishing red blood cells and promoting tumor growth.	[Liu, Min; Jin, Xing; Pan, Ling; Zhang, Xiumei; Zhao, Yunxue] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250012, Peoples R China; [He, Xigan] Shandong Univ, Qilu Hosp, Jinan 250012, Peoples R China	Shandong University; Shandong University	Zhang, XM (corresponding author), Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250012, Peoples R China.	zhangxm@sdu.edu.cn; zhaoyunxue@sdu.edu.cn			National Natural Science Foundation of China [81102468, 81272351]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81102468 and 81272351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Azoitei N, 2014, CANCER RES, V74, P7125, DOI 10.1158/0008-5472.CAN-14-1017; Chan KKW, 2012, J CLIN ONCOL, V30, P1064, DOI 10.1200/JCO.2011.36.8647; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; de Bruin AM, 2013, BLOOD, V121, P3578, DOI 10.1182/blood-2012-05-432906; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Gilreath JA, 2014, AM J HEMATOL, V89, P203, DOI 10.1002/ajh.23628; Glaspy J, 2012, J NATL COMPR CANC NE, V10, P659, DOI 10.6004/jnccn.2012.0065; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hohaus S, 2010, J CLIN ONCOL, V28, P2538, DOI 10.1200/JCO.2009.27.6873; Jacobsen RN, 2014, EXP HEMATOL, V42, P547, DOI 10.1016/j.exphem.2014.03.009; Kautz L, 2014, BLOOD, V124, P479, DOI 10.1182/blood-2014-05-516252; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Langdon JM, 2014, AM J HEMATOL, V89, P470, DOI 10.1002/ajh.23670; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Maccio A, 2005, BLOOD, V106, P362, DOI 10.1182/blood-2005-01-0160; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Papaldo P, 2006, J CLIN ONCOL, V24, P3048, DOI 10.1200/JCO.2005.02.9488; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Peslak SA, 2012, BLOOD, V120, P2501, DOI 10.1182/blood-2011-11-394304; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Sio A, 2013, CANCER RES, V73, P5892, DOI 10.1158/0008-5472.CAN-13-0842; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Tesio M, 2013, J EXP MED, V210, P2337, DOI 10.1084/jem.20122768; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Winkler IG, 2012, LEUKEMIA, V26, P1594, DOI 10.1038/leu.2012.17; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Xue L, 2014, DEVELOPMENT, V141, P2245, DOI 10.1242/dev.103960; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575	40	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121921	10.1371/journal.pone.0121921	http://dx.doi.org/10.1371/journal.pone.0121921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822717	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700138
J	Paczkowska, M; Mizera, M; Piotrowska, H; Szymanowska-Powalowska, D; Lewandowska, K; Goscianska, J; Pietrzak, R; Bednarski, W; Majka, Z; Cielecka-Piontek, J				Paczkowska, Magdalena; Mizera, Mikolaj; Piotrowska, Hanna; Szymanowska-Powalowska, Daria; Lewandowska, Kornelia; Goscianska, Joanna; Pietrzak, Robert; Bednarski, Waldemar; Majka, Zbigniew; Cielecka-Piontek, Judyta			Complex of Rutin with beta-Cyclodextrin as Potential Delivery System	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; QUERCETIN; DEGRADATION	This study aimed to obtain and characterize an RU-beta-CD complex in the context of investigating the possibility of changes in the solubility, stability, antioxidative and microbiological activity as well as permeability of complexated rutin as against its free form. The formation of the RU-beta-CD complex via a co-grinding technique was confirmed by using DSC, SEM, FT-IR and Raman spectroscopy, and its geometry was assessed through molecular modeling. It was found that the stability and solubility of the so-obtained complex were greater compared to the free form; however, a slight decrease was observed inits antibacterial potency. An examination of changes in the EPR spectra of thecomplex excluded any reducing effect of complexation on the antioxidative activity of rutin. Considering the prospect of preformulation studies involving RU-beta-CD complexes, of significance is also the observed possibility of prolongedly releasing rutin from the complex at a constant level over along period of 20 h, and the fact that twice as much complexated rutin was able topermeate compared to its free form.	[Paczkowska, Magdalena; Mizera, Mikolaj; Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Fac Pharm, Dept Pharmaceut Chem, Poznan, Poland; [Piotrowska, Hanna] Poznan Univ Med Sci, Fac Pharm, Dept Toxicol, Poznan, Poland; [Szymanowska-Powalowska, Daria] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland; [Lewandowska, Kornelia] Polish Acad Sci, Inst Mol Phys, Dept Mol Crystals, Poznan, Poland; [Goscianska, Joanna; Pietrzak, Robert] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland; [Bednarski, Waldemar] Polish Acad Sci, Inst Mol Phys, Dept Solid State Radiospect, Poznan, Poland; [Majka, Zbigniew] Adamed Sp Zoo, Czosnow, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences	Paczkowska, M (corresponding author), Poznan Univ Med Sci, Fac Pharm, Dept Pharmaceut Chem, Poznan, Poland.	magda.paczkowska@gmail.com	Goscianska, Joanna/AAJ-2478-2020; Lewandowska, Kornelia/AAE-4630-2019; Bednarski, Waldemar/U-8837-2018	Goscianska, Joanna/0000-0002-4202-652X; Lewandowska, Kornelia/0000-0002-2063-7805; Bednarski, Waldemar/0000-0003-1956-7501; Cielecka-Piontek, Judyta/0000-0003-0891-5419; Paczkowska-Walendowska, Magdalena/0000-0002-0418-9336; Mizera, Mikolaj/0000-0001-5465-1990; Pietrzak, Robert/0000-0003-1394-3078	Ministry of Science and Higher Education, Poland [DI2012 024342]; Adamed Sp. z o.o.	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Adamed Sp. z o.o.	This work was supported by Ministry of Science and Higher Education, Poland, No DI2012 024342, (http://www.nauka.gov.pl/en/). Grant allowed to pay the charge of the manuscript. Co-author Zbigniew Majka is employed by Adamed Sp. z o. o. Adamed Sp. z o.o. provided support in the form of salary for author ZM, but did not have anyadditional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Chamani J, 2005, THERMOCHIM ACTA, V432, P106, DOI 10.1016/j.tca.2005.04.014; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Ding HY, 2003, SPECTROCHIM ACTA A, V59, P3421, DOI 10.1016/S1386-1425(03)00176-8; Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e; FERRARO JR, 1965, INORG CHEM, V4, P1382, DOI 10.1021/ic50032a002; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gong AQ, 2014, SPECTROCHIM ACTA A, V122, P331, DOI 10.1016/j.saa.2013.11.050; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Iacopini P, 2008, J FOOD COMPOS ANAL, V21, P589, DOI 10.1016/j.jfca.2008.03.011; LETELLIER S, 1995, ANAL CHIM ACTA, V315, P357, DOI 10.1016/0003-2670(95)00263-Y; Makris DP, 2000, J AGR FOOD CHEM, V48, P3830, DOI 10.1021/jf0001280; Muankaew C, 2014, INT J PHARMACEUT, V474, P80, DOI 10.1016/j.ijpharm.2014.08.013; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Savic S, 2013, FOOD CHEM, V141, P4194, DOI 10.1016/j.foodchem.2013.07.010; Takahama U, 2009, FOOD CHEM, V116, P214, DOI 10.1016/j.foodchem.2009.02.036; Nguyen TA, 2013, FOOD CHEM, V136, P186, DOI 10.1016/j.foodchem.2012.07.104; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010; Zhao J, 2012, CARBOHYD POLYM, V90, P1764, DOI 10.1016/j.carbpol.2012.07.066; Zielinska Danuta, 2010, Polish Journal of Food and Nutrition Sciences, V60, P315; Zvezdanovic JB, 2012, J SERB CHEM SOC, V77, P297, DOI 10.2298/JSC110618180Z	22	42	44	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120858	10.1371/journal.pone.0120858	http://dx.doi.org/10.1371/journal.pone.0120858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822535	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700077
J	Persson, S; Jensen, TH; Blomstrom, AL; Appelberg, MT; Magnusson, U				Persson, Sara; Jensen, Trine H.; Blomstrom, Anne-Lie; Appelberg, Mia Tjernstrom; Magnusson, Ulf			Aleutian Mink Disease Virus in Free-Ranging Mink from Sweden	PLOS ONE			English	Article							FERAL AMERICAN MINK; EXPERIMENTAL TRANSMISSION; SPLEEN MASS; PARVOVIRUS; ANTIBODIES; WILD; PATHOGENICITY; CARNIVORES; INFECTION; PASTEL	Aleutian mink disease (AMD) is a chronic viral disease in farmed mink and the virus (AMDV) has been found in many free-ranging mink (Neovison vison) populations in Europe and North America. In this study, AMDV DNA and AMDV antibodies were analysed in 144 free-ranging mink hunted in Sweden. Associations between being AMDV infected (defined as positive for both viral DNA and antibodies) and the weight of the spleen, liver, kidneys, adrenal glands and body condition were calculated and the sequences of ten AMDV isolates were analysed in order to characterize the genetic relationships. In total, 46.1% of the mink were positive for AMDV antibodies and 57.6% were positive for AMDV DNA. Twenty-two percent of the mink tested on both tests (n = 133) had dissimilar results. The risk of having AMDV antibodies or being positive for AMDV DNA clearly increased with age and the majority of the mink that were two years or older were infected. Few macroscopic changes were found upon necropsy. However, the relative weight of the spleen was sexually dimorphic and was found to be slightly, but significantly (rho = 0.006), heavier in AMDV infected male mink than uninfected. No association between AMDV infection and body condition, weight of the kidneys, liver or adrenal glands were found. Several different strains of AMDV were found across the country. Two of the AMDV sequences from the very north of Sweden did not group with any of the previously described groups of strains. In summary, AMDV seems to be prevalent in wild mink in Sweden and may subtly influence the weight of the spleen.	[Persson, Sara; Appelberg, Mia Tjernstrom; Magnusson, Ulf] Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, Uppsala, Sweden; [Jensen, Trine H.] Tech Univ Denmark, Natl Vet Inst, Aarhus, Denmark; [Blomstrom, Anne-Lie] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences; Technical University of Denmark; Swedish University of Agricultural Sciences	Persson, S (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Div Reprod, Uppsala, Sweden.	sara.persson@slu.se	Persson, Sara/C-1620-2015	Persson, Sara/0000-0003-4700-0553; Magnusson, Ulf/0000-0002-7087-6820; Blomstrom, Anne-Lie/0000-0003-4455-311X	Evidensia Djurkliniken Ojebyn	Evidensia Djurkliniken Ojebyn	This work was supported by the Evidensia Djurkliniken Ojebyn, affiliation for author MTA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDERSEN S, 1985, ACTA PATH MICRO IM B, V93, P195; ALEXANDERSEN S, 1988, J VIROL, V62, P3684, DOI 10.1128/JVI.62.10.3684-3694.1988; BLOOM ME, 1994, INFECT AGENT DIS, V3, P279; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; CHRISTENSEN J, 1993, J VIROL, V67, P229, DOI 10.1128/JVI.67.1.229-238.1993; Christensen LS, 2011, VET MICROBIOL, V149, P64, DOI 10.1016/j.vetmic.2010.10.016; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; EKLUND CM, 1968, J INFECT DIS, V118, P510, DOI 10.1093/infdis/118.5.510; Farid AH, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-10; Farid AH, 2010, CAN VET J, V51, P75; Fournier-Chambrillon C, 2004, J WILDLIFE DIS, V40, P394, DOI 10.7589/0090-3558-40.3.394; Gerell R., 1967, DISPERSAL ACCLIMATIZ; GORHAM JR, 1964, J INFECT DIS, V114, P341, DOI 10.1093/infdis/114.4.341; HAAS L, 1988, J GEN VIROL, V69, P705, DOI 10.1099/0022-1317-69-3-705; HADLOW WJ, 1983, INFECT IMMUN, V41, P1016, DOI 10.1128/IAI.41.3.1016-1023.1983; HADLOW WJ, 1984, J VIROL, V50, P38, DOI 10.1128/JVI.50.1.38-41.1984; HANSEN M, 1988, ACTA VET SCAND, V29, P271; Harrington LA, 2012, EUR J WILDLIFE RES, V58, P875, DOI 10.1007/s10344-012-0652-0; Henson J B, 1976, Front Biol, V44, P175; Jensen TH, 2012, J WILDLIFE DIS, V48, P497, DOI 10.7589/0090-3558-48.2.497; Jensen TH, 2011, J VIROL METHODS, V171, P81, DOI 10.1016/j.jviromet.2010.10.004; Jensen TH, 2014, VET MICROBIOL, V168, P420, DOI 10.1016/j.vetmic.2013.11.041; KENYON AJ, 1978, AM J VET RES, V39, P1011; Knuuttila A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-141; Knuuttila A, 2009, CLIN VACCINE IMMUNOL, V16, P1360, DOI 10.1128/CVI.00148-09; Manas S, 2001, J WILDLIFE DIS, V37, P138, DOI 10.7589/0090-3558-37.1.138; Matson G.M., 1981, WORKBOOK CEMENTUM AN; Nituch LA, 2012, EVOL APPL, V5, P330, DOI 10.1111/j.1752-4571.2011.00224.x; Nituch LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021693; Oie KL, 1996, J VIROL, V70, P852, DOI 10.1128/JVI.70.2.852-861.1996; Olofsson A, 1999, J CLIN MICROBIOL, V37, P4145, DOI 10.1128/JCM.37.12.4145-4149.1999; PADGETT GA, 1967, J INFECT DIS, V117, P35, DOI 10.1093/infdis/117.1.35; Persson S, 2011, EUR J WILDLIFE RES, V57, P1057, DOI 10.1007/s10344-011-0519-9; PRIDHAM T. J., 1958, CANADIAN JOUR COMP MED AND VET SCI, V22, P99; Reichert M, 2014, B VET I PULAWY, V58, P369, DOI 10.2478/bvip-2014-0057; Schulte-Hostedde AI, 2012, BIOL J LINN SOC, V107, P624, DOI 10.1111/j.1095-8312.2012.01961.x; Schulte-Hostedde AI, 2011, J MAMMAL, V92, P221, DOI 10.1644/10-MAMM-A-020.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tjernstrom M., 2010, PLASMACYTOS ALEUTIAN; Yamaguchi N, 2001, VET REC, V149, P485, DOI 10.1136/vr.149.16.485	40	23	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122194	10.1371/journal.pone.0122194	http://dx.doi.org/10.1371/journal.pone.0122194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822750	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700158
J	Powell-Jackson, T; Acharya, R; Filippi, V; Ronsmans, C				Powell-Jackson, Timothy; Acharya, Rajib; Filippi, Veronique; Ronsmans, Carine			Delivering Medical Abortion at Scale: A Study of the Retail Market for Medical Abortion in Madhya Pradesh, India	PLOS ONE			English	Article							MISOPROSTOL; AVAILABILITY; INTERVENTIONS; CONTRACEPTION; MIFEPRISTONE; PHARMACIES; MORBIDITY; PROVISION; EFFICACY; QUALITY	Background Medical abortion (mifepristone and misoprostol) has the potential to contribute to reduced maternal mortality but little is known about the provision or quality of advice for medical abortion through the private retail sector. We examined the availability of medical abortion and the practices of pharmacists in India, where abortion has been legal since 1972. Methods We interviewed 591 pharmacists in 60 local markets in city, town and rural areas of Madhya Pradesh. One month later, we returned to 359 pharmacists with undercover patients who presented themselves unannounced as genuine customers seeking a medical abortion. Results Medical abortion was offered to undercover patients by 256 (71.3%) pharmacists and 24 different brands were identified. Two thirds (68.5%) of pharmacists stated that abortion was illegal in India. Only 106 (38.5%) pharmacists asked clients the timing of the last menstrual period and 38 (13.8%) requested to see a doctor's prescription - a legal requirement in India. Only 59 (21.5%) pharmacists correctly advised patients on the gestational limit for medical abortion, 97 (35.3%) provided correct information on how many and when to take the tablets in a combination pack, and 78 (28.4%) gave accurate advice on where to seek care in case of complications. Advice on post-abortion family planning was almost nonexistent. Conclusions The retail market for medical abortion is extensive, but the quality of advice given to patients is poor. Although the contribution of medical abortion to women's health in India is poorly understood, there is an urgent need to improve the practices of pharmacists selling medical abortion.	[Powell-Jackson, Timothy] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Acharya, Rajib] Populat Council, New Delhi, India; [Filippi, Veronique; Ronsmans, Carine] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Powell-Jackson, T (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England.	Timothy.Powell-Jackson@lshtm.ac.uk		Acharya, Rajib/0000-0003-4586-0859	UK aid from the UK government; STEP-UP, a Research Programme Consortium on "Strengthening Evidence for Programming on Unintended Pregnancy"; Department for International Development (DFID) [201398] Funding Source: researchfish	UK aid from the UK government(CGIAR); STEP-UP, a Research Programme Consortium on "Strengthening Evidence for Programming on Unintended Pregnancy"; Department for International Development (DFID)	The work was funded by UK aid from the UK government. VF received support from STEP-UP, a Research Programme Consortium on "Strengthening Evidence for Programming on Unintended Pregnancy". STEP-UP is funded by UK aid from the UK government. The sponsors of the study had no role in designing the study, data analysis, data interpretation, or writing of the article. All authors had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of data analysis.	Adler AJ, 2012, TROP MED INT HEALTH, V17, P177, DOI 10.1111/j.1365-3156.2011.02896.x; [Anonymous], 2005, REPROD HEALTH MATTER, V13, P20; Billings DL, 2009, CONTRACEPTION, V79, P445, DOI 10.1016/j.contraception.2008.12.011; Boler T., 2009, MED ABORTION INDIA M MED ABORTION INDIA M; Bongaarts J, 2000, STUD FAMILY PLANN, V31, P193, DOI 10.1111/j.1728-4465.2000.00193.x; Bongaarts J, 1978, STUDIES FAMILY PLANN, V13; Bracken H, 2010, INT J GYNECOL OBSTET, V108, P228, DOI 10.1016/j.ijgo.2009.09.027; Costa SH, 1998, INT J GYNECOL OBSTET, V63, pS131, DOI 10.1016/S0020-7292(98)00195-7; Coyaji K, 2007, BJOG-INT J OBSTET GY, V114, P271, DOI 10.1111/j.1471-0528.2006.01208.x; Coyaji K, 2001, LANCET, V357, P120, DOI 10.1016/S0140-6736(00)03549-2; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Dragoman M, 2014, BJOG-INT J OBSTET GY, V121, P25, DOI 10.1111/1471-0528.12689; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; Ganatra B, 2005, REPROD HEALTH MATTER, V13, P65, DOI 10.1016/S0968-8080(05)26215-8; Ganatra B, 2014, B WORLD HEALTH ORGAN, V92, P155, DOI 10.2471/BLT.14.136333; Huda FA, 2014, INT J GYNECOL OBSTET, V124, P164, DOI 10.1016/j.ijgo.2013.07.037; Jejeebhoy SJ, 2012, INT PERSPECT SEX R H, V38, P133, DOI 10.1363/3813312; Kahn JG, 2000, CONTRACEPTION, V61, P29, DOI 10.1016/S0010-7824(99)00115-8; Kahn M, 2001, AVAILABILITY ACCESS; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Lara D, 2006, CONTRACEPTION, V74, P394, DOI 10.1016/j.contraception.2006.05.068; Lara D, 2011, INT PERSPECT SEX R H, V37, P75, DOI 10.1363/3707511; Leela Visaria, 2008, Economic and Political Weekly, V43, P35; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; MALHOTRA A, 2003, REALIZING REPROD CHO; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; Miller S, 2005, BJOG-INT J OBSTET GY, V112, P1291, DOI 10.1111/j.1471-0528.2005.00704.x; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Office of Registrar General, 2013, ANN HLTH SURV 2011 1; Office of Registrar General, 2014, REP MED CERT CAUS DE; Office of Registrar General, 2014, CENS 2011 PRIM CENS; Okonofua FE, 2011, STUD FAMILY PLANN, V42, P41, DOI 10.1111/j.1728-4465.2011.00263.x; Ramachandar L, 2005, REPROD HEALTH MATTER, V13, P54, DOI 10.1016/S0968-8080(05)26195-5; Santhya K.G., 2003, CHANGING FAMILY PLAN; Say L, 2014, LANCET GLOBAL HLTH; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Smith F, 2009, TROP MED INT HEALTH, V14, P362, DOI 10.1111/j.1365-3156.2009.02232.x; Subha B, 2012, INT J GYNECOL OBSTET, V118, pS33, DOI 10.1016/j.ijgo.2012.05.008; Turner KL, 2013, MED ABORTION TRAININ; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Wafula FN, 2010, INT J QUAL HEALTH C, V22, P316, DOI 10.1093/intqhc/mzq022	42	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120637	10.1371/journal.pone.0120637	http://dx.doi.org/10.1371/journal.pone.0120637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822656	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000352134700068
J	Samuel, MS; Abigail, MEA; Ramalingam, C				Samuel, Melvin S.; Abigail, M. E. A.; Ramalingam, Chidambaram			Biosorption of Cr(VI) by Ceratocystis paradoxa MSR2 Using Isotherm Modelling, Kinetic Study and Optimization of Batch Parameters Using Response Surface Methodology	PLOS ONE			English	Article							AQUEOUS-SOLUTION; HEXAVALENT CHROMIUM; ADSORPTION-ISOTHERMS; WASTE-WATER; REMOVAL; EQUILIBRIUM; BIOMASS; PB(II); CR(III); CD(II)	This study is focused on the possible use of Ceratocystis paradoxa MSR2 native biomass for Cr(VI) biosorption. The influence of experimental parameters such as initial pH, temperature, biomass dosage, initial Cr(VI) concentration and contact time were optimized using batch systems as well as response surface methodology (RSM). Maximum Cr(VI) removal of 68.72% was achieved, at an optimal condition of biomass dosage 2g L-1, initial Cr(VI) concentration of 62.5 mg L-1 and contact time of 60 min. The closeness of the experimental and the predicted values exhibit the success of RSM. The biosorption mechanism of MSR2 biosorbent was well described by Langmuir isotherm and a pseudo second order kinetic model, with a high regression coefficient. The thermodynamic study also revealed the spontaneity and exothermic nature of the process. The surface characterization using FT-IR analysis revealed the involvement of amine, carbonyl and carboxyl groups in the biosorption process. Additionally, desorption efficiency of 92% was found with 0.1 M HNO3. The Cr(VI) removal efficiency, increased with increase in metal ion concentration, biomass concentration, temperature but with a decrease in pH. The size of the MSR2 biosorbent material was found to be 80 mu m using particle size analyzer. Atomic force microscopy (AFM) visualizes the distribution of Cr(VI) on the biosorbent binding sites with alterations in the MSR2 surface structure. The SEM-EDAX analysis was also used to evaluate the binding characteristics of MSR2 strain with Cr(VI) metals. The mechanism of Cr(VI) removal of MSR2 biomass has also been proposed.	[Samuel, Melvin S.; Abigail, M. E. A.; Ramalingam, Chidambaram] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Ramalingam, C (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	cramalingam@vit.ac.in	Chidambaram, Ramalingam/U-7922-2019	Chidambaram, Ramalingam/0000-0001-9549-7686	VIT University	VIT University	The authors are thankful to VIT University for providing laboratory facility and financial assistance. The isolated fungus was identified by Yaazh Xenomics, Chennai, India.	Adamson A. W., 1967, PHYS CHEM SURFACES; Anayurt RA, 2009, CHEM ENG J, V151, P255, DOI 10.1016/j.cej.2009.03.002; Anwar J, 2010, BIORESOURCE TECHNOL, V101, P1752, DOI 10.1016/j.biortech.2009.10.021; Arica MY, 2005, COLLOID SURFACE A, V253, P203, DOI 10.1016/j.colsurfa.2004.11.012; Baral A, 2002, ENVIRON SCI POLICY, V5, P121; Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7; Colica G, 2010, J BIOTECHNOL, V150, pS55, DOI 10.1016/j.jbiotec.2010.08.145; Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gupta VK, 2010, J COLLOID INTERF SCI, V342, P135, DOI 10.1016/j.jcis.2009.09.065; HALSEY G, 1948, J CHEM PHYS, V16, P931, DOI 10.1063/1.1746689; Harkins WD, 1944, J CHEM PHYS, V12, P112, DOI 10.1063/1.1723913; Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034; Karaoglu MH, 2010, CHEM ENG J, V159, P98, DOI 10.1016/j.cej.2010.02.047; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Li ZH, 2011, COMP BIOCHEM PHYS C, V153, P402, DOI 10.1016/j.cbpc.2011.01.005; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032; Moussavi G, 2009, J HAZARD MATER, V168, P806, DOI 10.1016/j.jhazmat.2009.02.097; Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060; Nomanbhay SM, 2005, ELECTRON J BIOTECHN, V8, P43; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002; Perez-Marin AB, 2007, J HAZARD MATER, V139, P122, DOI 10.1016/j.jhazmat.2006.06.008; Prakasham RS, 1999, ENVIRON POLLUT, V104, P421, DOI 10.1016/S0269-7491(98)00174-2; RICHARD FC, 1991, WATER RES, V25, P807, DOI 10.1016/0043-1354(91)90160-R; Sanghi R, 2009, J HAZARD MATER, V169, P1074, DOI 10.1016/j.jhazmat.2009.04.056; Sari A, 2008, CHEM ENG J, V144, P1, DOI 10.1016/j.cej.2007.12.020; Sari A, 2009, J HAZARD MATER, V164, P1004, DOI 10.1016/j.jhazmat.2008.09.002; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Say R, 2004, ENG LIFE SCI, V4, P276, DOI 10.1002/elsc.200420032; Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018; Temkin M, 1940, ACTA PHYSICOCHIM URS, V12, P327; Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011; Uluozlu OD, 2008, BIORESOURCE TECHNOL, V99, P2972, DOI 10.1016/j.biortech.2007.06.052; Vieira Regine H. S. F., 2000, International Microbiology, V3, P17; Wahab MA, 2010, BIORESOURCE TECHNOL, V101, P5070, DOI 10.1016/j.biortech.2010.01.121; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021	40	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118999	10.1371/journal.pone.0118999	http://dx.doi.org/10.1371/journal.pone.0118999			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822726	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700029
J	Sohn, YS; Shin, HC; Park, WS; Ge, JN; Kim, CH; Lee, BL; Heo, WD; Jung, JU; Rigden, DJ; Oh, BH				Sohn, Young-Sik; Shin, Ho-Chul; Park, Wei Sun; Ge, Jianning; Kim, Chan-Hee; Lee, Bok Luel; Heo, Won Do; Jung, Jae U.; Rigden, Daniel John; Oh, Byung-Ha			Lpg0393 of Legionella pneumophila Is a Guanine-Nucleotide Exchange Factor for Rab5, Rab21 and Rab22	PLOS ONE			English	Article							EFFECTOR PROTEIN DRRA; STRUCTURAL BASIS; PLASMA-MEMBRANE; GTPASE FUNCTION; X-RAY; CELL; ACTIVATION; RABEX-5; SYSTEM; VPS9	Legionella pneumophila, a human intracellular pathogen, encodes about 290 effector proteins that are translocated into host cells through a secretion machinery. Some of these proteins have been shown to manipulate or subvert cellular processes during infection, but functional roles of a majority of them remain unknown. Lpg0393 is a newly identified Legionella effector classified as a hypothetical protein. Through X-ray crystallographic analysis, we show that Lpg0393 contains a Vps9-like domain, which is structurally most similar to the catalytic core of human Rabex-5 that activates the endosomal Rab proteins Rab5, Rab21 and Rab22. Consistently, Lpg0393 exhibited a guanine-nucleotide exchange factor activity toward the endosomal Rabs. This work identifies the first example of a bacterial guanine-nucleotide exchange factor that is active towards the Rab5 sub-cluster members, implying that the activation of these Rab proteins might be advantageous for the intracellular survival of Legionella.	[Sohn, Young-Sik; Shin, Ho-Chul; Park, Wei Sun; Heo, Won Do; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Canc Metastasis Control Ctr, Daejeon 305701, South Korea; [Shin, Ho-Chul] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Daejeon 305600, South Korea; [Ge, Jianning; Jung, Jae U.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Kim, Chan-Hee; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab Insect Symbiosis, Busan 609735, South Korea; [Rigden, Daniel John] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Southern California; Pusan National University; University of Liverpool	Rigden, DJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.	drigden@liverpool.ac.uk; bhoh@kaist.ac.kr	Kim, Chan-Hee/C-6849-2016; Oh, Byung-Ha/C-2061-2011; Heo, Won-Do/C-1696-2011	Kim, Chan-Hee/0000-0002-5315-4981; Rigden, Daniel/0000-0002-7565-8937	GRL Program from National Research Foundation of Korea [K20815000001]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099] Funding Source: NIH RePORTER	GRL Program from National Research Foundation of Korea(National Research Foundation of Korea); Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the the GRL Program (K20815000001) from National Research Foundation of Korea and by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (No. 2011-0031955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; HODGKIN EE, 1987, INT J QUANTUM CHEM, V14, P105; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ku B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003082; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Lucas M, 2014, P NATL ACAD SCI USA, V111, pE3514, DOI 10.1073/pnas.1405391111; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2011, FEBS LETT, V585, P2749, DOI 10.1016/j.febslet.2011.08.006; Schoebel S, 2011, P NATL ACAD SCI USA, V108, P17945, DOI 10.1073/pnas.1113133108; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stein M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034870; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Tilney LG, 2001, J CELL SCI, V114, P4637; Uejima T, 2010, J BIOL CHEM, V285, P36689, DOI 10.1074/jbc.M110.152132; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu L, 2013, MICROBES INFECT, V15, P157, DOI 10.1016/j.micinf.2012.11.001; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	41	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118683	10.1371/journal.pone.0118683	http://dx.doi.org/10.1371/journal.pone.0118683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821953	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700022
J	Vallez Garcia, D; Casteels, C; Schwarz, AJ; Dierckx, RAJO; Koole, M; Doorduin, J				Vallez Garcia, David; Casteels, Cindy; Schwarz, Adam J.; Dierckx, Rudi A. J. O.; Koole, Michel; Doorduin, Janine			A Standardized Method for the Construction of Tracer Specific PET and SPECT Rat Brain Templates: Validation and Implementation of a Toolbox	PLOS ONE			English	Article							ATLAS; MRI; MICROPET; IMAGES	High-resolution anatomical image data in preclinical brain PET and SPECT studies is often not available, and inter-modality spatial normalization to an MRI brain template is frequently performed. However, this procedure can be challenging for tracers where substantial anatomical structures present limited tracer uptake. Therefore, we constructed and validated strain-and tracer-specific rat brain templates in Paxinos space to allow intra-modal registration. PET [F-18]FDG, [C-11]flumazenil, [C-11]MeDAS, [C-11]PK11195 and [C-11]raclopride, and SPECT [Tc-99m]HMPAO brain scans were acquired from healthy male rats. Tracer-specific templates were constructed by averaging the scans, and by spatial normalization to a widely used MRI-based template. The added value of tracer-specific templates was evaluated by quantification of the residual error between original and realigned voxels after random misalignments of the data set. Additionally, the impact of strain differences, disease uptake patterns (focal and diffuse lesion), and the effect of image and template size on the registration errors were explored. Mean registration errors were 0.70 +/- 0.32mm for [F-18] FDG (n = 25), 0.23 +/- 0.10mm for [C-11]flumazenil (n = 13), 0.88 +/- 0.20 mm for [C-11]MeDAS (n = 15), 0.64 +/- 0.28mm for [C-11]PK11195 (n = 19), 0.34 +/- 0.15mm for [C-11] raclopride (n = 6), and 0.40 +/- 0.13mm for [Tc-99m] HMPAO (n = 15). These values were smallest with tracer-specific templates, when compared to the use of [F-18] FDG as reference template (p&0.001). Additionally, registration errors were smallest with strain-specific templates (p&0.05), and when images and templates had the same size (p <= 0.001). Moreover, highest registration errors were found for the focal lesion group (p&0.005) and the diffuse lesion group (p = n.s.). In the voxel-based analysis, the reported coordinates of the focal lesion model are consistent with the stereotaxic injection procedure. The use of PET/SPECT strain-and tracer-specific templates allows accurate registration of functional rat brain data, independent of disease specific uptake patterns and with registration error below spatial resolution of the cameras. The templates and the SAMIT package will be freely available for the research community.	[Vallez Garcia, David; Dierckx, Rudi A. J. O.; Koole, Michel; Doorduin, Janine] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Casteels, Cindy] Katholieke Univ Leuven, Mol Small Anim Imaging Ctr MoSAIC, Leuven, Belgium; [Schwarz, Adam J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Groningen; KU Leuven; Indiana University System; Indiana University Bloomington	Doorduin, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	j.doorduin@umcg.nl	García, David Vállez/N-2348-2015	García, David Vállez/0000-0003-3308-3167; Koole, Michel/0000-0001-5862-640X; Doorduin, Janine/0000-0003-2925-9959				Casteels C, 2006, J NUCL MED, V47, P1858; Casteels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065286; Coello C, 2011, J NEUROSCI METH, V199, P166, DOI 10.1016/j.jneumeth.2011.04.026; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Faria DD, 2014, MULT SCLER J, V20, P1443, DOI 10.1177/1352458514526941; Faria DD, 2014, NEUROIMAGE, V87, P395, DOI 10.1016/j.neuroimage.2013.10.057; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Hardin JW, 2012, GEN ESTIMATING EQUAT; Karger CP, 2003, PHYS MED BIOL, V48, P211, DOI 10.1088/0031-9155/48/2/305; Larsen P, 1997, APPL RADIAT ISOTOPES, V48, P153, DOI 10.1016/S0969-8043(96)00177-7; Majka P, 2012, NEUROINFORMATICS, V10, P181, DOI 10.1007/s12021-011-9138-6; Nagren K, 1998, J LABELLED COMPD RAD, V41, P831; Nie B, 2013, HUM BRAIN MAPP, V34, P1306, DOI 10.1002/hbm.21511; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Paxinos G., 2004, J CHEM INF MODEL, V5th; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Van Laere K, 2001, J NUCL MED, V42, P361; WEISNER PS, 1993, EUR J NUCL MED, V20, P661	22	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122363	10.1371/journal.pone.0122363	http://dx.doi.org/10.1371/journal.pone.0122363			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823005	Green Published, gold			2022-12-27	WOS:000352134700170
J	Van Doorn-Klomberg, AL; Braspenning, JCC; Atsma, F; Jansen, B; Bouma, M; Wolters, RJ; Wensing, M				Van Doorn-Klomberg, Arna L.; Braspenning, Joze C. C.; Atsma, Femke; Jansen, Birgit; Bouma, Margriet; Wolters, Rene J.; Wensing, Michel			Patient Characteristics Associated with Measurement of Routine Diabetes Care: An Observational Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE MANAGEMENT; CASE-MIX; COMORBIDITY TYPE; QUALITY; IMPACT; PREVENTION; DEPRESSION	Background Non-modifiable patient characteristics, including age, gender, ethnicity as well as the occurrence of multi-morbidities, are associated with processes and outcomes of diabetes care. Information on these factors can be used in case mix adjustment of performance measures. However, the practical relevance of such adjustment is not clear. The aim of this study was to assess the strength of associations between patient factors and diabetes care processes and outcomes. Methods We performed an observational study based on routinely collected data of 12,498 diabetes patients in 59 Dutch primary care practices. Data were collected on patient age, gender, whether the patient lived in a deprived area, body mass index and the co-occurrence of cardiovascular disease, chronic obstructive pulmonary disease, depression or anxiety. Outcomes included 6 dichotomous measures (3 process and 3 outcome related) regarding glycosylated hemoglobin, systolic blood pressure and low density lipoprotein-cholesterol. We performed separate hierarchical logistic mixed model regression models for each of the outcome measures. Results Each of the process measure models showed moderate effect sizes, with pooled areas under the curve that varied between 0.66 and 0.76. The frequency of diabetes related consultations as a measure of patient compliance to treatment showed the strongest association with all process measures (odds ratios between 5.6 and 14.5). The effect sizes of the outcome measure models were considerably smaller than the process measure models, with pooled areas under the curve varying from 0.57 to 0.61. Conclusions Several non-modifiable patient factors could be associated with processes and outcomes of diabetes care. However, associations were small. These results suggest that case-mix correction or stratification in assessing diabetes care has limited practical relevance.	[Van Doorn-Klomberg, Arna L.; Braspenning, Joze C. C.; Atsma, Femke; Jansen, Birgit; Wolters, Rene J.; Wensing, Michel] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Bouma, Margriet] Dutch Coll Gen Practitioners NHG, Utrecht, Netherlands	Radboud University Nijmegen	Van Doorn-Klomberg, AL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands.	Arna.vanDoorn-Klomberg@radboudumc.nl	Wolters, R.J./L-4770-2015; Wensing, Michel/H-8113-2014; Atsma, F./L-4178-2015; Braspenning, Jozé/AAG-7612-2021; Braspenning, Jozé CC/D-4268-2009	Wensing, Michel/0000-0001-6569-8137; Braspenning, Jozé/0000-0003-0800-0630; Braspenning, Jozé CC/0000-0003-0800-0630				Bae S, 2008, J GEN INTERN MED, V23, P1933, DOI 10.1007/s11606-008-0784-9; Beaton SJ, 2004, DIABETES CARE, V27, P694, DOI 10.2337/diacare.27.3.694; Bentsen B G, 1986, Scand J Prim Health Care, V4, P43, DOI 10.3109/02813438609013970; Campbell JA, 2012, ENDOCRINE, V42, P471, DOI 10.1007/s12020-012-9744-6; Chin MH, 2000, DIABETES CARE, V23, P884, DOI 10.2337/diacare.23.7.884; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; Malik S, 2007, DIABETES RES CLIN PR, V77, P126, DOI 10.1016/j.diabres.2006.10.016; Marceau L, 2011, J EVAL CLIN PRACT, V17, P1122, DOI 10.1111/j.1365-2753.2010.01489.x; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Nouwens E, 2012, NETH J MED, V70, P298; Paddison C, 2012, BMJ QUAL SAF, V21, P634, DOI 10.1136/bmjqs-2011-000737; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rutten G.E.H.M., 2013, HUISARTS WETENSCHAP, V56, P512; Schaars CF, 2004, DIABETES CARE, V27, P123, DOI 10.2337/diacare.27.1.123; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Doorn-Klomberg AL, 2013, MED CARE, V51, P115, DOI 10.1097/MLR.0b013e3182726bf1; Voorham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038707; Williams JLS, 2014, DIABETES TECHNOL THE, V16, P421, DOI 10.1089/dia.2013.0329; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121845	10.1371/journal.pone.0121845	http://dx.doi.org/10.1371/journal.pone.0121845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822978	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700130
J	von Lassberg, C; Rapp, W				von Lassberg, Christoph; Rapp, Walter			The Punctum Fixum-Punctum Mobile Model: A Neuromuscular Principle for Efficient Movement Generation?	PLOS ONE			English	Article							MECHANICAL ENERGETIC PROCESSES; INTER-SEGMENTAL COORDINATION; HIGH BAR; SHOULDER MUSCLES; VARIABILITY; PERFORMANCE; ELEMENTS	According to the "punctum fixum-punctum mobile model" that was introduced in prior studies, for generation of the most effective intentional acceleration of a body part the intersegmental neuromuscular onset succession has to spread successively from the rotation axis (punctum fixum) toward the body part that shall be accelerated (punctum mobile). The aim of the present study was to investigate whether this principle is, indeed, fundamental for any kind of efficient rotational accelerations in general, independent of the kind of movements, type of rotational axis, the current body position, or movement direction. Neuromuscular onset succession was captured by surface electromyography of relevant muscles of the anterior and posterior muscle chain in 16 high-level gymnasts during intentional accelerating movement phases while performing 18 different gymnastics elements (in various body positions to forward and backward, performed on high bar, parallel bars, rings and trampoline), as well as during non-sport specific pivot movements around the longitudinal axis. The succession patterns to generate the acceleration phases during these movements were described and statistically evaluated based on the onset time difference between the muscles of the corresponding muscle chain. In all the analyzed movement phases, the results clearly support the hypothesized succession pattern from punctum fixum to punctum mobile. This principle was further underlined by the finding that the succession patterns do change their direction running through the body when the rotational axis (punctum fixum) has been changed (e.g., high bar or rings [hands] vs. floor or trampoline [feet]). The findings improve our understanding of intersegmental neuromuscular coordination patterns to generate intentional movements most efficiently. This could help to develop more specific methods to facilitate such patterns in particular contexts, thus allowing for shorter motor learning procedures of context-specific key movement sequences in different disciplines of sports, as well as during non-sport specific movements.	[von Lassberg, Christoph] Univ Leipzig, Inst Gen Kinesiol & Athlet Training, D-04109 Leipzig, Germany; [von Lassberg, Christoph; Rapp, Walter] Univ Tubingen, Med Clin, Dept Sports Med, Tubingen, Germany	Leipzig University; Eberhard Karls University of Tubingen	von Lassberg, C (corresponding author), Univ Leipzig, Inst Gen Kinesiol & Athlet Training, D-04109 Leipzig, Germany.	cvl-lassberg@t-online.de			Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science) [AZ: IIA1-070603/11]	Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science)	This study was supported by the Bundesinstitut fur Sportwissenschaft in Bonn (German Institute for Sport Science; AZ: IIA1-070603/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All measurements were conducted according to the principles expressed in the Declaration of Helsinki and were undertaken with the understanding and written informed consent of each subject or their parents, in case of juvenile participants.	Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; Arampatzis A, 2001, J BIOMECH, V34, P505, DOI 10.1016/S0021-9290(00)00212-8; Arampatzis A, 1999, J BIOMECH, V32, P811, DOI 10.1016/S0021-9290(99)00065-2; BARTLETT LR, 1989, AM J SPORT MED, V17, P89, DOI 10.1177/036354658901700115; Bartonietz K., 2000, BIOMECHANICS SPORT P, P401, DOI [10.1002/9780470693797.ch20, DOI 10.1002/9780470693797.CH20]; Bauer WL, 1983, BIOMECHANICS B, P801; Bernasconi SM, 2006, J STRENGTH COND RES, V20, P53; Bizzi E., 1981, HDB PHYSL, V1, P1321; Frere J, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00099; Frere J, 2012, HUM MOVEMENT SCI, V31, P472, DOI 10.1016/j.humov.2012.02.002; Heinen T, 2011, SCI GYMNAST J, V3, P7; Hiley MJ, 2013, HUM MOVEMENT SCI, V32, P171, DOI 10.1016/j.humov.2012.11.007; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Irwin G, 2007, SPORT BIOMECH, V6, P131, DOI 10.1080/14763140701323117; Kearney J. K., 1993, Models and Techniques in Computer Animation, P270; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; MEDVED V, 1995, MED PROG TECHNOL, V21, P77; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P3; Morriss C, 1996, SPORTS MED, V21, P438, DOI 10.2165/00007256-199621060-00005; Qian JG, 2012, J HUM KINET, V31, P45, DOI 10.2478/v10078-012-0005-9; Tsuchiya J, 2004, INT J SPORT HLTH SCI, V2, P211; von Lassberg C, 2009, P 14 ANN C EUR COLL, P402; von Lassberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095450; von Lassberg C, 2014, J ELECTROMYOGR KINES, V24, P359, DOI 10.1016/j.jelekin.2014.03.003; von Lassberg C, 2013, J ELECTROMYOGR KINES, V23, P1124, DOI 10.1016/j.jelekin.2013.07.006; Yeadon MR, 2000, HUM MOVEMENT SCI, V19, P153, DOI 10.1016/S0167-9457(00)00008-7	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120193	10.1371/journal.pone.0120193	http://dx.doi.org/10.1371/journal.pone.0120193			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822498	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700056
J	Dong, HN; Liu, YF; Zu, X; Li, N; Li, FR; Zhang, DW				Dong, Huina; Liu, Yongfei; Zu, Xin; Li, Ning; Li, Feiran; Zhang, Dawei			An Enzymatic Assay for High-Throughput Screening of Cytidine-Producing Microbial Strains	PLOS ONE			English	Article							BACILLUS-SUBTILIS; GLUTAMATE-DEHYDROGENASE; AMMONIA; INDOPHENOL; BERTHELOT; DEAMINASE; SYNTHETASE; MUTANTS; SERUM	Cytidine is an industrially useful precursor for the production of antiviral compounds and a variety of industrial compounds. Interest in the microbial production of cytidine has grown recently and high-throughput screening of cytidine over-producers is an important approach in large-scale industrial production using microorganisms. An enzymatic assay for cytidine was developed combining cytidine deaminase (CDA) and indophenol method. CDA catalyzes the cleavage of cytidine to uridine and NH3, the latter of which can be accurately determined using the indophenol method. The assay was performed in 96-well plates and had a linear detection range of cytidine of 0.058 - 10 mM. This assay was used to determine the amount of cytidine in fermentation flasks and the results were compared with that of High Perfomance Liquid Chromatography (HPLC) method. The detection range of the CDA method is not as wide as that of the HPLC, furthermore the correlation factor of CDA method is not as high as that of HPLC. However, it was suitable for the detection of large numbers of crude samples and was applied to high-throughput screening for high cytidine-producing strains using 96-well deep-hole culture plates. This assay was proved to be simple, accurate, specific and suitable for cytidine detection and high-throughput screening of cytidine-producing strains in large numbers of samples (96 well or more).	[Dong, Huina; Liu, Yongfei; Zu, Xin; Li, Ning; Li, Feiran; Zhang, Dawei] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Dong, Huina; Liu, Yongfei; Zhang, Dawei] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Zhang, Dawei] Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Zu, Xin] Dalian Polytech Univ, Sch Biol Engn, Light Ind Technol & Engn, Dalian 116034, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Dalian Polytechnic University	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	zhang_dw@tib.cas.cn	Li, Feiran/GNP-2168-2022	Li, Feiran/0000-0001-9155-5260	State Key Development Program for Basic Research of China (973 Program) [2013CB733600]; National Nature Science Foundation of China [31200036, 31370089]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from State Key Development Program for Basic Research of China (973 Program, 2013CB733600), National Nature Science Foundation of China (31200036, 31370089).	Asahi S, 1996, BIOSCI BIOTECH BIOCH, V60, P353, DOI 10.1271/bbb.60.353; ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P915, DOI 10.1271/bbb.59.915; ASAHI S, 1994, BIOSCI BIOTECH BIOCH, V58, P1399, DOI 10.1271/bbb.58.1399; Baumgartner M, 2002, ACTA VET HUNG, V50, P263, DOI 10.1556/AVet.50.2002.3.2; BOLLETER WT, 1961, ANAL CHEM, V33, P592, DOI 10.1021/ac60172a034; Carlow DC, 1999, BIOCHEMISTRY-US, V38, P12258, DOI 10.1021/bi990819t; CARTER CW, 1995, BIOCHIMIE, V77, P92, DOI 10.1016/0300-9084(96)88110-7; DAFONSECAWOLLHEIM F, 1992, EUR J CLIN CHEM CLIN, V30, P537; DIAZ J, 1995, CLIN CHEM, V41, P1048; DIENST SG, 1961, J LAB CLIN MED, V58, P149; Fang HT, 2013, BIOTECHNOL LETT, V35, P245, DOI 10.1007/s10529-012-1068-3; HALL A, 1993, APPL GEOCHEM, V8, P101, DOI 10.1016/0883-2927(93)90059-P; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; IOSEFSOHN M, 1985, CLIN CHEM, V31, P2012; Johansson E, 2004, BIOCHEMISTRY-US, V43, P6020, DOI 10.1021/bi035893x; Kameya M, 2014, ANAL BIOCHEM, V447, P33, DOI 10.1016/j.ab.2013.11.002; Kashyap Rajpal S, 2006, Cerebrospinal Fluid Res, V3, P5, DOI 10.1186/1743-8454-3-5; KILLEEN GF, 1993, ANAL BIOCHEM, V215, P284, DOI 10.1006/abio.1993.1588; Lee YB, 2011, J MICROBIOL, V49, P53, DOI 10.1007/s12275-011-0195-1; Liu YF, 2014, ENZYME MICROB TECH, V67, P1, DOI 10.1016/j.enzmictec.2014.08.008; MROZ EA, 1982, KIDNEY INT, V21, P524, DOI 10.1038/ki.1982.56; NGO TT, 1982, ANAL CHEM, V54, P46, DOI 10.1021/ac00238a015; PARK JM, 1994, KOREAN J MICROBIOL, V32, P545; POTVIN BW, 1975, J BACTERIOL, V123, P604, DOI 10.1128/JB.123.2.604-615.1975; Rao Z, 2013, FINE CHEM INTERMEDIA, V43, P29; Richards D A, 1987, Biomed Chromatogr, V2, P148, DOI 10.1002/bmc.1130020404; ROLAND KL, 1985, J BACTERIOL, V163, P991, DOI 10.1128/JB.163.3.991-999.1985; SEARLE PL, 1984, ANALYST, V109, P549, DOI 10.1039/an9840900549; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; TANGANELLI E, 1982, CLIN CHEM, V28, P1461; TAYLOR S, 1974, ANAL BIOCHEM, V60, P153, DOI 10.1016/0003-2697(74)90140-7; Thomas DH, 2002, J CHROMATOGR A, V956, P181, DOI 10.1016/S0021-9673(02)00141-3; THOMPSON PW, 1986, ANN RHEUM DIS, V45, P9, DOI 10.1136/ard.45.1.9; Uezer A, 2008, ANAL CHIM ACTA, V612, P53, DOI 10.1016/j.aca.2008.02.015; WAKISAKA S, 1987, ANAL BIOCHEM, V163, P117, DOI 10.1016/0003-2697(87)90101-1; Yamaguchi F, 2005, CLIN CHIM ACTA, V352, P165, DOI 10.1016/j.cccn.2004.09.011	36	6	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121612	10.1371/journal.pone.0121612	http://dx.doi.org/10.1371/journal.pone.0121612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816248	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600109
J	Ercumen, A; Naser, AM; Unicomb, L; Arnold, BF; Colford, JM; Luby, SP				Ercumen, Ayse; Naser, Abu Mohd.; Unicomb, Leanne; Arnold, Benjamin F.; Colford, John M., Jr.; Luby, Stephen P.			Effects of Source- versus Household Contamination of Tubewell Water on Child Diarrhea in Rural Bangladesh: A Randomized Controlled Trial	PLOS ONE			English	Article							DICHLOROISOCYANURATE NADCC TABLETS; SAFE DRINKING-WATER; DEVELOPING-COUNTRIES; FECAL CONTAMINATION; ROUTINE TREATMENT; ESCHERICHIA-COLI; WELL-WATER; QUALITY; DISEASE; RISK	Background Shallow tubewells are the primary drinking water source for most rural Bangladeshis. Fecal contamination has been detected in tubewells, at low concentrations at the source and at higher levels at the point of use. We conducted a randomized controlled trial to assess whether improving the microbiological quality of tubewell drinking water by household water treatment and safe storage would reduce diarrhea in children <2 years in rural Bangladesh. Methods We randomly assigned 1800 households with a child aged 6-18 months (index child) into one of three arms: chlorine plus safe storage, safe storage and control. We followed households with monthly visits for one year to promote the interventions, track their uptake, test participants' source and stored water for fecal contamination, and record caregiver-reported child diarrhea prevalence (primary outcome). To assess reporting bias, we also collected data on health outcomes that are not expected to be impacted by our interventions. Findings Both interventions had high uptake. Safe storage, alone or combined with chlorination, reduced heavy contamination of stored water. Compared to controls, diarrhea in index children was reduced by 36% in the chlorine plus safe storage arm (prevalence ratio, PR = 0.64, 0.55-0.73) and 31% in the safe storage arm (PR = 0.69, 0.60-0.80), with no difference between the two intervention arms. One limitation of the study was the non-blinded design with self-reported outcomes. However, the prevalence of health outcomes not expected to be impacted by water interventions did not differ between study arms, suggesting minimal reporting bias. Conclusions Safe storage significantly improved drinking water quality at the point of use and reduced child diarrhea in rural Bangladesh. There was no added benefit from combining safe storage with chlorination. Efforts should be undertaken to implement and evaluate long-term efforts for safe water storage in Bangladesh.	[Ercumen, Ayse; Arnold, Benjamin F.; Colford, John M., Jr.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Naser, Abu Mohd.; Unicomb, Leanne; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Luby, Stephen P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of California System; University of California Berkeley; International Centre for Diarrhoeal Disease Research (ICDDR); Stanford University; Centers for Disease Control & Prevention - USA	Ercumen, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	aercumen@berkeley.edu	Unicomb, Leanne Elizabeth/AAW-4900-2021; Arnold, Benjamin/AAE-9656-2020	Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Arnold, Benjamin/0000-0001-6105-7295; Luby, Stephen/0000-0001-5385-899X; Ercumen, Ayse/0000-0001-6002-1514; Colford, John/0000-0002-3288-6956	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was funded by the United States Agency for International Development (USAID). *icddr,b acknowledges with gratitude the commitment of USAID to its research efforts. The contents of this manuscript are the sole responsibility of icddr,b and do not necessarily reflect the views of USAID, CDC or the United States Government. *Medentech provided the NaDCC tablets used in the study free of charge. USAID or Medentech had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR JG, 1984, J APPL PSYCHOL, V69, P334, DOI 10.1037/0021-9010.69.2.334; Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Albert J, 2010, ENVIRON SCI TECHNOL, V44, P4426, DOI 10.1021/es1000566; Albert MJ, 1999, J CLIN MICROBIOL, V37, P3458, DOI 10.1128/JCM.37.11.3458-3464.1999; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Arnold BF, 2013, AM J EPIDEMIOL, V177, P361, DOI 10.1093/aje/kws281; Austin CJ, 1993, TTHESIS TULANE U; BBS-UNICEF, 2010, MULT IND CLUST SURV; Bhargava A, 2003, AM J HUM BIOL, V15, P209, DOI 10.1002/ajhb.10141; BLACK RE, 1981, LANCET, V1, P141; Boisson S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001497; BRISCOE J, 1978, AM J CLIN NUTR, V31, P2100, DOI 10.1093/ajcn/31.11.2100; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Clasen T, 2006, INT J HYG ENVIR HEAL, V209, P173, DOI 10.1016/j.ijheh.2005.11.004; Clasen T, 2007, AM J TROP MED HYG, V76, P187, DOI 10.4269/ajtmh.2007.76.187; DEB BC, 1986, B WORLD HEALTH ORGAN, V64, P127; Enger KS, 2012, ENVIRON SCI TECHNOL, V46, P5160, DOI 10.1021/es204381e; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Ferguson AS, 2011, J WATER HEALTH, V9, P708, DOI 10.2166/wh.2011.106; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Gunther I, 2013, HEALTH ECON, V22, P757, DOI 10.1002/hec.2852; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; Huda TMN, 2012, SOC SCI MED, V75, P604, DOI 10.1016/j.socscimed.2011.10.042; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Islam MS, 2001, APPL ENVIRON MICROB, V67, P3328, DOI 10.1128/AEM.67.7.3328-3330.2001; Jain S, 2010, AM J TROP MED HYG, V82, P16, DOI 10.4269/ajtmh.2010.08-0584; KHAN MU, 1981, INT J EPIDEMIOL, V10, P23, DOI 10.1093/ije/10.1.23; Kinniburgh D.G., 2001, BRITISH GEOGRAPHICAL; KIRCHHOFF LV, 1985, J HYG-CAMBRIDGE, V94, P173, DOI 10.1017/S0022172400061374; Knappett PSK, 2012, J WATER HEALTH, V10, P565, DOI 10.2166/wh.2012.102; Knappett PSK, 2012, ENVIRON SCI TECHNOL, V46, P1361, DOI 10.1021/es202773w; Knappett PSK, 2011, SCI TOTAL ENVIRON, V409, P3174, DOI 10.1016/j.scitotenv.2011.04.043; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Leber J, 2011, GROUND WATER, V49, P111, DOI 10.1111/j.1745-6584.2010.00689.x; LEVINE RJ, 1976, LANCET, V2, P86; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; LLOYD BJ, 1991, WATER SCI TECHNOL, V24, P61, DOI 10.2166/wst.1991.0031; LOEVINSOHN BP, 1990, INT J EPIDEMIOL, V19, P788, DOI 10.1093/ije/19.4.788; Luby S, 2006, J APPL MICROBIOL, V100, P1154, DOI 10.1111/j.1365-2672.2006.02940.x; Luby SP, 2008, J APPL MICROBIOL, V105, P1002, DOI 10.1111/j.1365-2672.2008.03826.x; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Raina PS, 1999, CAN J PUBLIC HEALTH, V90, P172, DOI 10.1007/BF03404501; Roberts L, 2001, B WORLD HEALTH ORGAN, V79, P280; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; SOMMER A, 1972, LANCET, V2, P985; Steiner TS, 1997, ANNU REV MED, V48, P329, DOI 10.1146/annurev.med.48.1.329; Strauss B, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-8; Tanaka G, 2007, PEDIATR INFECT DIS J, V26, P1014, DOI 10.1097/INF.0b013e318125721c; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; USEPA, 2002, 1604 USEPA; van Geen A, 2011, ENVIRON SCI TECHNOL, V45, P1199, DOI 10.1021/es103192b; WALKER CF, 1990, IEEE ENG MED BIOL, V9, P12; WHO (World Health Organisation), 1997, GUID DRINK WAT QUAL; Wood Angela M, 2004, Clin Trials, V1, P368; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029593	56	62	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121907	10.1371/journal.pone.0121907	http://dx.doi.org/10.1371/journal.pone.0121907			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816342	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600126
J	Ripperger, SP; Kalko, EKV; Rodriguez-Herrera, B; Mayer, F; Tschapka, M				Ripperger, Simon P.; Kalko, Elisabeth K. V.; Rodriguez-Herrera, Bernal; Mayer, Frieder; Tschapka, Marco			Frugivorous Bats Maintain Functional Habitat Connectivity in Agricultural Landscapes but Rely Strongly on Natural Forest Fragments	PLOS ONE			English	Article							PHYLLOSTOMID BATS; HOME-RANGE; SPECIES RICHNESS; ATLANTIC FOREST; MOVEMENT; SELECTION; SERVICES; BIRDS; CONSEQUENCES; INFORMATION	Anthropogenic changes in land use threaten biodiversity and ecosystem functioning by the conversion of natural habitat into agricultural mosaic landscapes, often with drastic consequences for the associated fauna. The first step in the development of efficient conservation plans is to understand movement of animals through complex habitat mosaics. Therefore, we studied ranging behavior and habitat use in Dermanura watsoni (Phyllostomidae), a frugivorous bat species that is a valuable seed disperser in degraded ecosystems. Radio-tracking of sixteen bats showed that the animals strongly rely on natural forest. Day roosts were exclusively located within mature forest fragments. Selection ratios showed that the bats foraged selectively within the available habitat and positively selected natural forest. However, larger daily ranges were associated with higher use of degraded habitats. Home range geometry and composition of focal foraging areas indicated that wider ranging bats performed directional foraging bouts from natural to degraded forest sites traversing the matrix over distances of up to three hundred meters. This behavior demonstrates the potential of frugivorous bats to functionally connect fragmented areas by providing ecosystem services between natural and degraded sites, and highlights the need for conservation of natural habitat patches within agricultural landscapes that meet the roosting requirements of bats.	[Ripperger, Simon P.; Mayer, Frieder] Leibniz Inst Evolut & Biodivers Forschung, Museum Nat Kunde, Berlin, Germany; [Ripperger, Simon P.; Kalko, Elisabeth K. V.; Tschapka, Marco] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Kalko, Elisabeth K. V.; Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Rodriguez-Herrera, Bernal] Univ Costa Rica, Escuela Biol, San Pedro, Costa Rica; [Mayer, Frieder] Berlin Brandenburg Inst Adv Biodivers Res, Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica	Ripperger, SP (corresponding author), Leibniz Inst Evolut & Biodivers Forschung, Museum Nat Kunde, Berlin, Germany.	simon.ripperger@mfn-berlin.de			"Deutscher Akademischer Austauschdienst" (DAAD) [D0948581]; "German Science Foundation" (DFG, Research Unit BATS "Dynamic Adaptable Applications for Bats Tracking by Embedded Communicating Systems" ) [FOR 1508]	"Deutscher Akademischer Austauschdienst" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); "German Science Foundation" (DFG, Research Unit BATS "Dynamic Adaptable Applications for Bats Tracking by Embedded Communicating Systems" )(German Research Foundation (DFG))	Funding for field work was provided to SPR by a grant of the "Deutscher Akademischer Austauschdienst" (DAAD grant number D0948581), https://www.daad.de/de/. Funding to FM by the "German Science Foundation" allowed for the preparation of this manuscript (DFG grant FOR 1508, Research Unit BATS "Dynamic Adaptable Applications for Bats Tracking by Embedded Communicating Systems"), http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Amelon Sybill K., 2009, P57; [Anonymous], 2007, NEOTROPICAL TENT ROO; Barton K., 2013, MUMIN MULTI MODEL IN; Bernard E, 2003, BIOTROPICA, V35, P262, DOI 10.1111/j.1744-7429.2003.tb00285.x; Brunet-Rossinni Anja K., 2009, P315; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2013, PACKAGE ADEHABITAT R; CHARLESDOMINIQUE P, 1991, J TROP ECOL, V7, P243, DOI 10.1017/S026646740000540X; Chaverri G, 2007, J MAMMAL, V88, P477, DOI 10.1644/05-MAMM-A-260R2.1; Cordeiro NJ, 2009, ECOLOGY, V90, P1030, DOI 10.1890/07-1208.1; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Durant KA, 2013, J MAMMAL, V94, P1438, DOI 10.1644/13-MAMM-A-103.1; Estrada A, 2001, ECOGRAPHY, V24, P94, DOI 10.1034/j.1600-0587.2001.240111.x; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Faries D, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-26; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Franzreb KE, 2006, FOREST ECOL MANAG, V228, P274, DOI 10.1016/j.foreco.2006.03.007; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Ghanem SJ, 2012, ADV STUD BEHAV, V44, P279, DOI 10.1016/B978-0-12-394288-3.00007-1; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Henry M, 2007, J MAMMAL, V88, P81, DOI 10.1644/06-MAMM-A-001R1.1; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Loayza AP, 2008, BIOTROPICA, V40, P630, DOI 10.1111/j.1744-7429.2008.00422.x; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Lopez JE, 2004, ACTA CHIROPTEROL, V6, P111, DOI 10.3161/001.006.0109; Lopez JE, 2007, REV BIOL TROP, V55, P301; Manly B.F.J., 2002, RESOURCE SELECTION A; Medina A, 2007, BIOTROPICA, V39, P120, DOI 10.1111/j.1744-7429.2006.00240.x; Melo FPL, 2009, BIOTROPICA, V41, P737, DOI 10.1111/j.1744-7429.2009.00528.x; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Montiel S, 2006, J TROP ECOL, V22, P267, DOI 10.1017/S026646740500307X; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neubaum DJ, 2005, J MAMMAL, V86, P95, DOI 10.1644/1545-1542(2005)086<0095:SACOBB>2.0.CO;2; Palminteri S, 2012, INT J PRIMATOL, V33, P401, DOI 10.1007/s10764-011-9573-0; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; R Core Team, 2012, R LANG ENV STAT COMP; Ripperger SP, 2013, CONSERV GENET, V14, P925, DOI 10.1007/s10592-012-0434-y; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Rodriguez-Perez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033246; Rothenwohrer C, 2011, J ZOOL, V283, P108, DOI 10.1111/j.1469-7998.2010.00748.x; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Sagot M, 2013, BIOTROPICA, V45, P511, DOI 10.1111/btp.12034; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sarmento R, 2014, ZOOLOGIA-CURITIBA, V31, P245, DOI 10.1590/S1984-46702014000300006; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Sesnie SE, 2008, REMOTE SENS ENVIRON, V112, P2145, DOI 10.1016/j.rse.2007.08.025; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; STILES FG, 1989, FIELD GUIDE BIRDS CO; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Trevelin LC, 2013, FOREST ECOL MANAG, V291, P136, DOI 10.1016/j.foreco.2012.11.013; Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zuur Alain F., 2009, P1	64	37	39	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120535	10.1371/journal.pone.0120535	http://dx.doi.org/10.1371/journal.pone.0120535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830222	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600034
J	Habib, M; Shaker, S; El-Gayar, N; Aboul-Fotouh, S				Habib, Mohamed; Shaker, Safaa; El-Gayar, Nesreen; Aboul-Fotouh, Sawsan			The Effects of Antidepressants "Fluoxetine and Imipramine" on Vascular Abnormalities and Toll Like Receptor-4 Expression in Diabetic and Non-Diabetic Rats Exposed to Chronic Stress	PLOS ONE			English	Article							CHRONIC MILD-STRESS; NECROSIS-FACTOR-ALPHA; COMORBID DEPRESSION; TLR LIGANDS; RISK; ATHEROSCLEROSIS; SYNTHASE; ADULTS; ASSOCIATION; DISORDERS	Several studies reveal that diabetes doubles the odds of comorbid depression with evidence of a pro-inflammatory state underlying its vascular complications. Indeed, little information is available about vascular effects of antidepressant drugs in diabetes. Method: We investigated the effect of chronic administration of fluoxetine "FLU" and imipramine "IMIP" on behavioral, metabolic and vascular abnormalities in diabetic and non-diabetic rats exposed to chronic restraint stress (CRS). Results: Both diabetes and CRS induced depressive-like behavior which was more prominent in diabetic/depressed rats; this was reversed by chronic treatment with FLU and IMIP in a comparable manner. Diabetic and non-diabetic rats exposed to CRS exhibited abnormalities in glucose homeostasis, lipid profile and vascular function, manifested by decreased endothelium-dependent relaxation, increased systolic blood pressure and histopathological atherosclerotic changes. Vascular and metabolic dysfunctions were associated with significant increase in aortic expression of TLR-4, and pro-inflammatory cytokines (TNF-alpha and IL-1 beta). FLU ameliorated these metabolic, vascular and inflammatory abnormalities, while IMIP induced either no change or even worsening of some parameters. Conclusion: FLU has favorable effect over IMIP on metabolic, vascular and inflammatory aberrations associated with DM and CRS in Wistar rats, clarifying the preference of FLU over IMIP in management of comorbid depression in diabetic subjects.	[Habib, Mohamed; El-Gayar, Nesreen; Aboul-Fotouh, Sawsan] Ain Shams Univ, Fac Med, Dept Pharmacol, Cairo, Egypt; [Shaker, Safaa] Ain Shams Univ, Fac Med, Dept Histol, Cairo, Egypt; [Aboul-Fotouh, Sawsan] Ain Shams Univ, Fac Med, Clin Pharmacol Unit, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Aboul-Fotouh, S (corresponding author), Ain Shams Univ, Fac Med, Dept Pharmacol, Cairo, Egypt.	sawsanaf2005@yahoo.com	Habib, Mohamed Z./GRO-6836-2022; HABIB, MOHAMED Z./AAN-9490-2020	Habib, Mohamed Z./0000-0001-7161-8121; 				Aboul-Fotouh S, 2014, PSYCHOPHARMACOLOGY B; Aboul-Fotouh S, 2013, CAN J PHYSIOL PHARM, V91, P1119, DOI 10.1139/cjpp-2013-0185; Aboul-Fotouh S, 2013, BEHAV PHARMACOL, V24, P552, DOI 10.1097/FBP.0b013e3283654029; Aboul-Fotouh S, 2013, PHARMACOL BIOCHEM BE, V104, P105, DOI 10.1016/j.pbb.2012.12.027; Amsterdam JD, 1999, J CLIN PSYCHOPHARM, V19, P9, DOI 10.1097/00004714-199902000-00004; Ananloo ES, 2013, DARU, V21, DOI 10.1186/2008-2231-21-4; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Anderson RJ, 2010, DIABETES CARE, V33, P485, DOI 10.2337/dc09-1466; [Anonymous], 1986, OFF J EUR COMM L, V358, P1; Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breum L, 1995, METABOLISM, V44, P1570, DOI 10.1016/0026-0495(95)90077-2; Caruso C, 2010, J NEUROIMMUNOL, V227, P52, DOI 10.1016/j.jneuroim.2010.06.013; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Ceretta LB, 2012, DIABETES-METAB RES, V28, P139, DOI 10.1002/dmrr.1285; Chrapko W, 2006, NEUROPSYCHOPHARMACOL, V31, P1286, DOI 10.1038/sj.npp.1300961; Crestani CC, 2011, EUR J PHARMACOL, V670, P527, DOI 10.1016/j.ejphar.2011.09.030; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Dredge K, 1999, INT J IMMUNOPHARMACO, V21, P663, DOI 10.1016/S0192-0561(99)00042-9; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Elgarf AS, 2014, PHARM BIOCH BEHAV; Garate I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-151; Ghaeli P, 2004, J CLIN PSYCHOPHARM, V24, P386, DOI 10.1097/01.jcp.0000132441.27854.0d; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Gomez R, 2001, BRAZ J MED BIOL RES, V34, P57, DOI 10.1590/S0100-879X2001000100007; GOODNICK PJ, 1995, J CLIN PSYCHIAT, V56, P128; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; Haider S, 2013, ACTA NEUROL BELG, V113, P35, DOI 10.1007/s13760-012-0121-2; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466; Isingrini E, 2012, PSYCHOSOM MED, V74, P63, DOI 10.1097/PSY.0b013e31823a43e0; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Ismail B, 2014, CAN J PHYSIOL PHARM, V92, P375, DOI 10.1139/cjpp-2013-0446; Jindal RD, 2009, AM J PSYCHIAT, V166, P1065, DOI 10.1176/appi.ajp.2009.09050629; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; KISHIKAWA H, 1993, VIRCHOWS ARCH A, V423, P433, DOI 10.1007/BF01606532; Kubera M, 2006, INT J NEUROPSYCHOPH, V9, P297, DOI 10.1017/S1461145705005663; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lu ZY, 2013, J ENDOCRINOL, V216, P61, DOI 10.1530/JOE-12-0338; Mansi KS, 2007, INT J ZOOLOGICAL RES, V3, P33; MASSOL J, 1989, DIABETES, V38, P1161, DOI 10.2337/diabetes.38.9.1161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mohamed BM, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S41020; Mooradian A D, 2001, Growth Horm IGF Res, V11 Suppl A, pS79, DOI 10.1016/S1096-6374(01)80013-7; Neves VJ, 2012, STRESS, V15, P138, DOI 10.3109/10253890.2011.601369; Paile-Hyvarinen M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-34; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; Reus GZ, 2013, BEHAV BRAIN RES, V242, P40, DOI 10.1016/j.bbr.2012.11.044; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Richardson SM, 2003, CELL MOL BIOL, V49, P1385; Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35; Rubin RR, 2008, DIABETES CARE, V31, P420, DOI 10.2337/dc07-1827; Ruengsakulrach P, 1999, CIRCULATION, V100, P139; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Salehi B, 2009, SCI J KURDISTAN U ME, V14, P45; Takano K, 2012, J PHARMACOL SCI, V120, P176, DOI 10.1254/jphs.12039FP; Taylor V, 2010, CAN J PSYCHIAT, V55, P362, DOI 10.1177/070674371005500605; Tonissaar M, 2008, PROG NEURO-PSYCHOPH, V32, P164, DOI 10.1016/j.pnpbp.2007.08.001; VANHOUTTE PM, 1994, TEX HEART I J, V21, P62; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Wang SH, 2009, TOXICOL SCI, V111, P72, DOI 10.1093/toxsci/kfp126; Xie P, 2010, CLIN MED INSIGHTS-CA, V4, P89, DOI 10.4137/CMC.S5659; Yasui T, 2007, J REPROD IMMUNOL, V75, P56, DOI 10.1016/j.jri.2007.02.004; Zafir A, 2007, EUR J PHARMACOL, V572, P23, DOI 10.1016/j.ejphar.2007.05.062	69	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120559	10.1371/journal.pone.0120559	http://dx.doi.org/10.1371/journal.pone.0120559			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826421	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800019
J	Lee, RH; Vazquez, G				Lee, Robert H.; Vazquez, Guillermo			Reduced Size and Macrophage Content of Advanced Atherosclerotic Lesions in Mice with Bone Marrow Specific Deficiency of Alpha 7 Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							PROGRESSION; MONOCYTES; PATHWAYS; SURVIVAL	In macrophages the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) modulates production of inflammatory cytokines, cholesterol accumulation and lipoprotein uptake. Recently, our laboratory showed that selective stimulation of the alpha 7nAChR protects macrophages from apoptosis, an effect that is absent in alpha 7nAChR-deficient macrophages. All these observations are suggestive of a potential role of macrophage alpha 7nAChR in atherosclerosis. Mouse models of the disease with bone marrow deletion of alpha 7nAChR represent an attractive approach to address the in vivo relevance of these in vitro findings. However, recent studies that focused on the impact of hematopoietic deficiency of alpha 7ZnAChR on early atherosclerotic lesions of low density lipoprotein receptor knockout (LDLRKO) mice, yielded controversial results. The question also remained whether macrophage alpha 7nAChR modulates the characteristics of advanced lesions. Here we used LDLR knockout mice transplanted with bone marrow from wild-type or alpha 7nAChR knockout animals to revisit the effect of hematopoietic deficiency of alpha 7nAChR on early lesions and to examine, for the first time, its impact on advanced plaques. Aortic sinus atherosclerotic lesions were analyzed following 8 and 14 weeks on a high fat diet. Early lesions in mice with alpha 7nAChR deficient bone marrow were not different from those in control animals. However, advanced lesions of mice with bone marrow deletion of alpha 7nAChR exhibited reduction in size, macrophage content and cell proliferation. These studies are the first in examining the impact of hematopoietic deficiency of alpha 7nAChR on the characteristics of advanced atherosclerotic lesions in a mouse model of the disease and provide novel evidence underscoring a potential pro-atherogenic role of macrophage alpha 7nAChR.	[Lee, Robert H.; Vazquez, Guillermo] Univ Toledo, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, Coll Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Vazquez, G (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, Coll Med, Hlth Sci Campus,3000 Transverse Dr, Toledo, OH 43614 USA.	Guillermo.Vazquez@utoledo.edu			National Institutes of Health (NIH) [R01HL111877-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111877] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01HL111877-03 (to G.V.). The sponsoring agency had no role in collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Aparicio-Vergara M, 2012, CURR OPIN LIPIDOL, V23, P111, DOI 10.1097/MOL.0b013e3283508c4f; Ayari H, 2013, J BIOSCIENCES, V38, P311, DOI 10.1007/s12038-013-9310-2; Cagnin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-13; Cooke JP, 2008, TRENDS CARDIOVAS MED, V18, P247, DOI 10.1016/j.tcm.2008.11.007; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Hernandez CM, 2014, J PHYSIOL-LONDON, V592, P3201, DOI 10.1113/jphysiol.2014.272054; Johansson ME, 2014, ARTERIOSCL THROM VAS, V34, P2632, DOI 10.1161/ATVBAHA.114.303892; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; KALSNER S, 1989, CIRC RES, V65, P237, DOI 10.1161/01.RES.65.2.237; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kooijman S, 2015, J THROMB HAEMOST, V13, P126, DOI 10.1111/jth.12765; KOVACH JA, 1995, CIRCULATION, V92, P2291, DOI 10.1161/01.CIR.92.8.2291; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lee RH, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.189; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Schiller NK, 2004, J LIPID RES, V45, P1398, DOI 10.1194/jlr.M400036-JLR200; Schirmer SH, 2009, J MOL CELL CARDIOL, V46, P177, DOI 10.1016/j.yjmcc.2008.10.029; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Smedlund K, 2011, J CELL BIOCHEM, V112, P1978, DOI 10.1002/jcb.23169; Smedlund K, 2010, CIRC RES, V106, P1479, DOI 10.1161/CIRCRESAHA.109.213314; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tano JY, 2014, CARDIOVASC RES, V101, P138, DOI 10.1093/cvr/cvt231; Tano JYK, 2012, CHANNELS, V6, P141, DOI 10.4161/chan.20292; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wilund KR, 2009, BIOCHEM BIOPH RES CO, V390, P148, DOI 10.1016/j.bbrc.2009.09.088; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou MS, 2013, AM J PHYSIOL-HEART C, V305, pH563, DOI 10.1152/ajpheart.00042.2013	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0124584	10.1371/journal.pone.0124584	http://dx.doi.org/10.1371/journal.pone.0124584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826262	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800114
J	Li, XK; Ding, SM; Cameron, SL; Kang, ZH; Wang, YY; Yang, D				Li, Xuankun; Ding, Shuangmei; Cameron, Stephen L.; Kang, Zehui; Wang, Yuyu; Yang, Ding			The First Mitochondrial Genome of the Sepsid Fly Nemopoda mamaevi Ozerov, 1997 (Diptera: Sciomyzoidea: Sepsidae), with Mitochondrial Genome Phylogeny of Cyclorrhapha	PLOS ONE			English	Article							RNA PUNCTUATION MODEL; NUCLEOTIDE-SEQUENCE; DROSOPHILA-YAKUBA; CONTROL REGION; FRUIT-FLY; EVOLUTION; DNA; GENES; FLIES; TRANSCRIPTION	Sepsid flies (Diptera: Sepsidae) are important model insects for sexual selection research. In order to develop mitochondrial (mt) genome data for this significant group, we sequenced the first complete mt genome of the sepsid fly Nemopoda mamaevi Ozerov, 1997. The circular 15,878 bp mt genome is typical of Diptera, containing all 37 genes usually present in bilaterian animals. We discovered inaccurate annotations of fly mt genomes previously deposited on GenBank and thus re-annotated all published mt genomes of Cyclorrhapha. These re-annotations were based on comparative analysis of homologous genes, and provide a statistical analysis of start and stop codon positions. We further detected two 18 bp of conserved intergenic sequences from tRNA(Glu)-tRNA(Phe) and ND1-tRNA(Ser(UCN)) across Cyclorrhapha, which are the mtTERM binding site motifs. Additionally, we compared automated annotation software MITOS with hand annotation method. Phylogenetic trees based on the mt genome data from Cyclorrhapha were inferred by Maximum-likelihood and Bayesian methods, strongly supported a close relationship between Sepsidae and the Tephritoidea.	[Li, Xuankun; Ding, Shuangmei; Kang, Zehui; Wang, Yuyu; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Cameron, Stephen L.] Queensland Univ Technol, Fac Sci & Engn, Earth Environm & Biol Sci Sch, Brisbane, Qld 4001, Australia	China Agricultural University; Queensland University of Technology (QUT)	Yang, D (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	dyangcau@126.com	Cameron, Stephen L/A-3742-2008; Wang, Yuyu/J-3117-2019	Cameron, Stephen L/0000-0002-6694-4130; Kang, Zehui/0000-0003-1961-9578	National Natural Science Foundation of China [31320103902]; National "Twelfth Five-Year" Plan for Science and Technology Support [2012BAD19B00]; Australian Research Council [FT120100746]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology Support; Australian Research Council(Australian Research Council)	DY was funded by the National Natural Science Foundation of China (31320103902) and the National "Twelfth Five-Year" Plan for Science and Technology Support (2012BAD19B00). SLC was funded by an Australian Research Council Future Fellowship (FT120100746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov B, 2010, TRENDS EVOL BIOL, V2, pe4, DOI DOI 10.4081/EB.2010.E4; Ang Y, 2008, SYST ENTOMOL, V33, P552, DOI 10.1111/j.1365-3113.2008.00422.x; Baena ML, 2007, ETHOL ECOL EVOL, V19, P27; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 2006, OMICS, V10, P119, DOI 10.1089/omi.2006.10.119; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boore JL, 2001, MOL BIOL EVOL, V18, P1413, DOI 10.1093/oxfordjournals.molbev.a003925; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMING JM, 1995, ENTOMOL SCAND, V26, P121; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Griffiths GCD, 1972, THE PHYLOGENETIC CLA; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ingram KK, 2008, BIOL J LINN SOC, V93, P227, DOI 10.1111/j.1095-8312.2007.00922.x; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Koehler C. M., 2004, MITOCHONDRIAL FUNCTI; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li Xiaomin, 2014, ScientificWorldJournal, V2014, P608231, DOI 10.1155/2014/608231; Llopart A, 2014, MOL ECOL, V23, P1124, DOI 10.1111/mec.12678; Logue K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-64; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Melicher D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-188; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; OZEROV AL, 2005, ZOOLOGICHESKIE ISSLE, V8, P1; Ozerov AL, 1997, INT J DIPTEROL RES, V8, P159; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pont Adrian C., 2002, Fauna Entomologica Scandinavica, V37, P1; Puniamoorthy N, 2009, J EVOLUTION BIOL, V22, P2146, DOI 10.1111/j.1420-9101.2009.01826.x; Puniamoorthy N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-155; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao YJ, 2012, MOL BIOL REP, V39, P11023, DOI 10.1007/s11033-012-2005-1; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; WADA S, 1991, J NAT HIST, V25, P1531, DOI 10.1080/00222939100770971; Wang HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-401; Wang SY, 2011, MOL BIOL REP, V38, P687, DOI 10.1007/s11033-010-0155-6; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang F, 2013, GENE, V529, P1, DOI 10.1016/j.gene.2013.08.010; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Ye Jun, 2010, Plant Quarantine (Shanghai), V24, P11; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zatwarnicki T., 1996, GENUS, V3, P103; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100558; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	77	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123594	10.1371/journal.pone.0123594	http://dx.doi.org/10.1371/journal.pone.0123594			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826648	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800111
J	Zhang, YW; Yu, ZQ; Jiang, F; Fu, P; Shen, JJ; Wu, WX; Li, JX				Zhang, Yuewei; Yu, Ziqiang; Jiang, Fei; Fu, Ping; Shen, Junjun; Wu, Wenxue; Li, Jinxiang			Two DNA Aptamers against Avian Influenza H9N2 Virus Prevent Viral Infection in Cells	PLOS ONE			English	Article							RECEPTOR-BINDING REGION; IN-VITRO SELECTION; CAPILLARY-ELECTROPHORESIS; A VIRUS; MEMBRANE-FUSION; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; RNA APTAMER; HEMAGGLUTININ; LIGANDS	New antiviral therapy for pandemic influenza mediated by the H9N2 avian influenza virus (AIV) is increasingly in demand not only for the poultry industry but also for public health. Aptamers are confirmed to be promising candidates for treatment and prevention of influenza viral infections. Thus, we studied two DNA aptamers, A9 and B4, selected by capillary electrophoresis-based systemic evolution of ligands by exponential enrichment (CE-SELEX) procedure using H9N2 AIV purified haemagglutinin (HA) as target. Both aptamers had whole-virus binding affinity. Also, an enzyme-linked aptamer assay (ELAA) confirmed binding affinity and specificity against other AIV subtypes. Finally, we studied aptamer-inhibitory effects on H9N2 AIV infection in Madin-Darby canine kidney (MDCK) cells and quantified viral load in supernatant and in cell with quantitative PCR (qPCR). Our data provide a foundation for future development of innovative anti-influenza drugs.	[Zhang, Yuewei; Yu, Ziqiang; Jiang, Fei; Fu, Ping; Shen, Junjun; Wu, Wenxue] China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100094, Peoples R China; [Zhang, Yuewei; Yu, Ziqiang; Jiang, Fei; Fu, Ping; Shen, Junjun; Wu, Wenxue] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China; [Li, Jinxiang] Chinese Acad Agr Sci, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences	Wu, WX (corresponding author), China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100094, Peoples R China.	wuwenxue@cau.edu.cn; labboard@126.com			Agricultural Finance, Ministry of Agriculture of the People's Republic of China; Chinese Universities Scientific Fund [2013BH027]	Agricultural Finance, Ministry of Agriculture of the People's Republic of China; Chinese Universities Scientific Fund	This work was supported by the project supported by Agricultural Finance, Ministry of Agriculture of the People's Republic of China and by Chinese Universities Scientific Fund 2013BH027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cabral TM, 2012, J VIROL METHODS, V183, P25, DOI 10.1016/j.jviromet.2012.03.016; Capua I, 2006, AVIAN PATHOL, V35, P189, DOI 10.1080/03079450600717174; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; Choi JG, 2008, J VET SCI, V9, P67, DOI 10.4142/jvs.2008.9.1.67; Choi S, 2011, MOL CELLS, V32, P527, DOI 10.1007/s10059-011-0156-x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fischer N, 2007, CURR OPIN CHEM BIOL, V11, P316, DOI 10.1016/j.cbpa.2007.05.017; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GAO XM, 1989, J IMMUNOL, V143, P3007; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2006, J BIOCHEM, V139, P837, DOI 10.1093/jb/mvj095; Gopinath Subash C B, 2005, Nucleic Acids Symp Ser (Oxf), P85, DOI 10.1093/nass/49.1.85; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; Jiang Fei, 2011, Journal of Agricultural Biotechnology, V19, P191; Jin Y, 2011, J GENE MED, V13, P243, DOI 10.1002/jgm.1558; KAWASAKI K, 1983, BIOCHIM BIOPHYS ACTA, V733, P286, DOI 10.1016/0005-2736(83)90534-5; Kwon HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097574; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Mendonsa SD, 2005, J AM CHEM SOC, V127, P9382, DOI 10.1021/ja052406n; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Mosing RK, 2005, ANAL CHEM, V77, P6107, DOI 10.1021/ac050836q; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Ong AK, 2007, J INFECT DIS, V196, P181, DOI 10.1086/518939; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suenaga E, 2014, ACTA BIOMATER, V10, P1314, DOI 10.1016/j.actbio.2013.12.034; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Torres-Chavolla E, 2009, BIOSENS BIOELECTRON, V24, P3175, DOI 10.1016/j.bios.2008.11.010; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wongphatcharachai M, 2013, J CLIN MICROBIOL, V51, P46, DOI 10.1128/JCM.02118-12; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang YW, 2013, ANAL BIOANAL CHEM, V405, P5549, DOI 10.1007/s00216-013-6968-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	22	22	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123060	10.1371/journal.pone.0123060	http://dx.doi.org/10.1371/journal.pone.0123060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826217	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800104
J	Anton, G; Wilson, R; Yu, ZH; Prehn, C; Zukunft, S; Adamski, J; Heier, M; Meisinger, C; Romisch-Margl, W; Wang-Sattler, R; Hveem, K; Wolffenbuttel, B; Peters, A; Kastenmuller, G; Waldenberger, M				Anton, Gabriele; Wilson, Rory; Yu, Zhong-hao; Prehn, Cornelia; Zukunft, Sven; Adamski, Jerzy; Heier, Margit; Meisinger, Christa; Roemisch-Margl, Werner; Wang-Sattler, Rui; Hveem, Kristian; Wolffenbuttel, Bruce; Peters, Annette; Kastenmueller, Gabi; Waldenberger, Melanie			Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples	PLOS ONE			English	Article							WHOLE-BLOOD; GENOME-WIDE; STABILITY; PLASMA; METABOLOMICS; SEPARATION; ANALYTES; PROTEIN	Advances in the "omics" field bring about the need for a high number of good quality samples. Many omics studies take advantage of biobanked samples to meet this need. Most of the laboratory errors occur in the pre-analytical phase. Therefore evidence-based standard operating procedures for the pre-analytical phase as well as markers to distinguish between 'good' and 'bad' quality samples taking into account the desired downstream analysis are urgently needed. We studied concentration changes of metabolites in serum samples due to pre-storage handling conditions as well as due to repeated freeze-thaw cycles. We collected fasting serum samples and subjected aliquots to up to four freeze-thaw cycles and to pre-storage handling delays of 12, 24 and 36 hours at room temperature (RT) and on wet and dry ice. For each treated aliquot, we quantified 127 metabolites through a targeted metabolomics approach. We found a clear signature of degradation in samples kept at RT. Storage on wet ice led to less pronounced concentration changes. 24 metabolites showed significant concentration changes at RT. In 22 of these, changes were already visible after only 12 hours of storage delay. Especially pronounced were increases in lysophosphatidylcholines and decreases in phosphatidylcholines. We showed that the ratio between the concentrations of these molecule classes could serve as a measure to distinguish between 'good' and 'bad' quality samples in our study. In contrast, we found quite stable metabolite concentrations during up to four freeze-thaw cycles. We concluded that pre-analytical RT handling of serum samples should be strictly avoided and serum samples should always be handled on wet ice or in cooling devices after centrifugation. Moreover, serum samples should be frozen at or below -80 degrees C as soon as possible after centrifugation.	[Anton, Gabriele; Wilson, Rory; Yu, Zhong-hao; Heier, Margit; Meisinger, Christa; Wang-Sattler, Rui; Peters, Annette; Waldenberger, Melanie] Helmholtz Ctr Munich, Inst Epidemiol 2, Munich, Germany; [Prehn, Cornelia; Zukunft, Sven; Adamski, Jerzy] Helmholtz Ctr Munich, Inst Expt Genet, Munich, Germany; [Heier, Margit; Meisinger, Christa] KORA Myocardial Infarct Registry, Cent Hosp Augsburg, Augsburg, Germany; [Roemisch-Margl, Werner; Kastenmueller, Gabi] Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Munich, Germany; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Wolffenbuttel, Bruce] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9713 AV Groningen, Netherlands	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Norwegian University of Science & Technology (NTNU); University of Groningen	Anton, G (corresponding author), Helmholtz Ctr Munich, Inst Epidemiol 2, Munich, Germany.	gabriele.anton@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Waldenberger, Melanie/B-5355-2014; Hveem, Kristian/AFV-4683-2022; Kastenmüller, Gabi/ABF-5987-2020; Meisinger, Christine/B-5358-2014; Wang-Sattler, Rui/B-5354-2014; Peters, Annette/A-6117-2011	Waldenberger, Melanie/0000-0003-0583-5093; Wang-Sattler, Rui/0000-0002-8794-8229; Peters, Annette/0000-0001-6645-0985; Prehn, Cornelia/0000-0002-1274-4715; Kastenmuller, Gabi/0000-0002-2368-7322; Meisinger, Christa/0000-0002-9026-6544; Adamski, Jerzy/0000-0001-9259-0199	European Union [261433]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 261433 (Biobank Standardisation and Harmonisation for Research Excellence in the European Union - BioSHaRE-EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Bernini P, 2011, J BIOMOL NMR, V49, P231, DOI 10.1007/s10858-011-9489-1; Bhatnagar BS, 2007, PHARM DEV TECHNOL, V12, P505, DOI 10.1080/10837450701481157; Boyanton BL, 2002, CLIN CHEM, V48, P2242; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1983, CART CLASSIFICATION, P156; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Clark S, 2004, INT J EPIDEMIOL, V33, P518, DOI 10.1093/ije/dyh064; Clark S, 2003, INT J EPIDEMIOL, V32, P125, DOI 10.1093/ije/dyg023; Cuhadar S, 2013, BIOCHEM MEDICA, V23, P70, DOI 10.11613/BM.2013.009; Fliniaux O, 2011, J BIOMOL NMR, V51, P457, DOI 10.1007/s10858-011-9574-5; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kamlage B, 2014, CLIN CHEM, V60, P399, DOI 10.1373/clinchem.2013.211979; LaBaer J, 2012, J PROTEOME RES, V11, P5592, DOI 10.1021/pr300796m; Lippi G, 2006, CLIN CHEM LAB MED, V44, P358, DOI 10.1515/CCLM.2006.073; Narayanan S, 2000, AM J CLIN PATHOL, V113, P429, DOI 10.1309/C0NM-Q7R0-LL2E-B3UY; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Silberman S., 2010, LIB FLESH SORRY STAT; van Eijsden M, 2005, CLIN CHEM, V51, P230; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wichmann HE, 2011, NAT BIOTECHNOL, V29, P795, DOI 10.1038/nbt.1958; Wood JT, 2008, CLIN CHEM LAB MED, V46, P1289, DOI 10.1515/CCLM.2008.242; Yang W, 2013, ANAL CHEM, V85, P2606, DOI 10.1021/ac303576b; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230; Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	29	69	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121495	10.1371/journal.pone.0121495	http://dx.doi.org/10.1371/journal.pone.0121495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823017	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700111
J	Bleuel, J; Zaucke, F; Bruggemann, GP; Niehoff, A				Bleuel, Judith; Zaucke, Frank; Brueggemann, Gert-Peter; Niehoff, Anja			Effects of Cyclic Tensile Strain on Chondrocyte Metabolism: A Systematic Review	PLOS ONE			English	Review							NECROSIS-FACTOR-ALPHA; PROINFLAMMATORY GENE INDUCTION; ARTICULAR-CARTILAGE; GROWTH-FACTOR; NITRIC-OXIDE; II COLLAGEN; PROTEOGLYCAN SYNTHESIS; BOVINE CHONDROCYTES; MECHANICAL STRAIN; TISSUE STRAIN	Chondrocytes reorganize the extracellular matrix of articular cartilage in response to externally applied loads. Thereby, different loading characteristics lead to different biological responses. Despite of active research in this area, it is still unclear which parts of the extracellular matrix adapt in what ways, and how specific loading characteristics affect matrix changes. This review focuses on the influence of cyclic tensile strain on chondrocyte metabolism in vitro. It also aimed to identify anabolic or catabolic chondrocyte responses to different loading protocols. The key findings show that loading cells up to 3% strain, 0.17 Hz, and 2 h, resulted in weak or no biological responses. Loading between 3-10% strain, 0.17-0.5 Hz, and 2-12 h led to anabolic responses; and above 10% strain, 0.5 Hz, and 12 h catabolic events predominated. However, this review also discusses that various other factors are involved in the remodeling of the extracellular matrix in response to loading, and that parameters like an inflammatory environment might influence the biological response.	[Bleuel, Judith; Brueggemann, Gert-Peter; Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Zaucke, Frank] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Zaucke, Frank; Brueggemann, Gert-Peter; Niehoff, Anja] Univ Cologne, Cologne Ctr Musculoskeletal Biomech, Fac Med, D-50931 Cologne, Germany	German Sport University Cologne; University of Cologne; University of Cologne	Bleuel, J (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany.	j.bleuel@dshs-koeln.de	Zaucke, Frank/AAT-2688-2021; Zaucke, Frank/E-2077-2012; Niehoff, Anja/K-6626-2015	Niehoff, Anja/0000-0002-4165-0929	German Sport University Cologne; Deutsche Forschungsgemeinschaft [ZA561/2-1]	German Sport University Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant of the German Sport University Cologne and by the Deutsche Forschungsgemeinschaft (grant ZA561/2-1 to FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Aigner T, 2006, EUR CELLS MATER, V12, P49, DOI 10.22203/eCM.v012a06; Akagi M, 2006, J ORTHOP RES, V24, P1782, DOI 10.1002/jor.20211; ARMSTRONG CG, 1980, J BIOMECH ENG-T ASME, V102, P214, DOI 10.1115/1.3149576; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; BENES AJ, 1985, J CELL SCI, V75, P35; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025; Bieler FH, 2009, J BIOMECH, V42, P1692, DOI 10.1016/j.jbiomech.2009.04.013; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Brown TD, 1998, AM J MED SCI, V316, P162, DOI 10.1097/00000441-199809000-00003; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; BUCKLEY MJ, 1988, BONE MINER, V4, P225; CHEVALIER X, 1993, SEMIN ARTHRITIS RHEU, V22, P307, DOI 10.1016/S0049-0172(05)80010-1; Colombo A, 2008, P I MECH ENG H, V222, P1235, DOI 10.1243/09544119JEIM428; Das RHJ, 2008, OSTEOARTHR CARTILAGE, V16, P385, DOI 10.1016/j.joca.2007.07.014; Dodge GR, 1998, ARTHRITIS RHEUM-US, V41, P274; Doi H, 2008, ACTA MED OKAYAMA, V62, P119; Dossumbekova A, 2007, ARTHRITIS RHEUM, V56, P3284, DOI 10.1002/art.22933; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; FREEMAN PM, 1994, J ORTHOPAED RES, V12, P311, DOI 10.1002/jor.1100120303; Fukuda K, 1997, J LAB CLIN MED, V130, P209, DOI 10.1016/S0022-2143(97)90098-6; Gassner R, 1999, J IMMUNOL, V163, P2187; Gassner R, 2000, Mund Kiefer Gesichtschir, V4 Suppl 2, pS479, DOI 10.1007/PL00012696; Gassner RJ, 2000, INT J ORAL MAX SURG, V29, P389; Gilchrist CL, 2007, J BIOMECH, V40, P786, DOI 10.1016/j.jbiomech.2006.03.013; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; GUENTHER HL, 1982, EXPERIENTIA, V38, P979, DOI 10.1007/BF01953688; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; HOLMVALL K, 1995, EXP CELL RES, V221, P496, DOI 10.1006/excr.1995.1401; Honda K, 2000, EUR J CELL BIOL, V79, P601, DOI 10.1078/0171-9335-00089; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Huang J, 2007, GENE, V404, P101, DOI 10.1016/j.gene.2007.09.007; Iimoto S, 2005, INT J MOL MED, V16, P1083; Iscru DF, 2008, J STRUCT BIOL, V162, P397, DOI 10.1016/j.jsb.2008.02.005; Kamiya T, 2010, J BIOMED MATER RES A, V92A, P801, DOI 10.1002/jbm.a.32295; Kammermann JR, 1996, OSTEOARTHR CARTILAGE, V4, P23, DOI 10.1016/S1063-4584(96)80004-5; Kawakita K, 2012, OSTEOARTHR CARTILAGE, V20, P1603, DOI 10.1016/j.joca.2012.08.022; KIM YJ, 1995, J BIOMECH, V28, P1055, DOI 10.1016/0021-9290(94)00159-2; Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1; Lahiji K, 2004, IN VITRO CELL DEV-AN, V40, P138, DOI 10.1290/1543-706X(2004)40<138:CSSPCA>2.0.CO;2; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Little CB, 1997, OSTEOARTHR CARTILAGE, V5, P49, DOI 10.1016/S1063-4584(97)80031-3; LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Long P, 2001, J DENT RES, V80, P1416, DOI 10.1177/00220345010800050601; Long P, 2001, ARTHRITIS RHEUM, V44, P2311, DOI 10.1002/1529-0131(200110)44:10<2311::AID-ART393>3.0.CO;2-Q; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; Madden R, 2013, J BIOMECH, V46, P554, DOI 10.1016/j.jbiomech.2012.09.021; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Marlovits S, 2004, J BONE JOINT SURG BR, V86B, P286, DOI 10.1302/0301-620X.86B2.14918; Marques MR, 2008, J DENT RES, V87, P153, DOI 10.1177/154405910808700210; Matheson LA, 2006, BIOMATERIALS, V27, P226, DOI 10.1016/j.biomaterials.2005.05.070; Matsukawa M, 2004, INFLAMM RES, V53, P239, DOI 10.1007/s00011-004-1254-4; Middleton J, 1996, J HISTOCHEM CYTOCHEM, V44, P133, DOI 10.1177/44.2.8609369; Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48; Moo EK, 2014, J BIOMECH, V47, P1004, DOI 10.1016/j.jbiomech.2014.01.003; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Obbink-Huizer C, 2014, BIOMECH MODEL MECHAN, V13, P227, DOI 10.1007/s10237-013-0501-4; Ohno S, 2005, CONNECT TISSUE RES, V46, P227, DOI 10.1080/03008200500346111; Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; Ru-song Z, 2012, CHIN J TISSUE ENG RE, V16, P3649; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Shi SL, 2012, J ORTHOP RES, V30, P1026, DOI 10.1002/jor.22036; Shimizu Akira, 2004, Mod Rheumatol, V14, P296, DOI 10.3109/s10165-004-0312-7; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Tanaka N, 2005, J DENT RES, V84, P64, DOI 10.1177/154405910508400111; Tanimoto K, 2011, CELL TISSUE RES, V344, P333, DOI 10.1007/s00441-011-1156-z; Tanimoto K, 2010, J BIOMED MATER RES A, V93A, P373, DOI 10.1002/jbm.a.32540; Thomas RS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3536; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Ueki M, 2008, ANN BIOMED ENG, V36, P793, DOI 10.1007/s10439-008-9462-7; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; Vande Geest Jonathan P, 2004, J Biomech, V37, P1923, DOI 10.1016/j.jbiomech.2004.02.022; Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032; Wang D, 2011, OSTEOARTHR CARTILAGE, V19, P213, DOI 10.1016/j.joca.2010.11.003; Wilkins RJ, 2000, BIORHEOLOGY, V37, P67; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; Xu HG, 2011, MOL MED REP, V4, P831, DOI 10.3892/mmr.2011.508; Xu ZF, 2000, J IMMUNOL, V165, P453, DOI 10.4049/jimmunol.165.1.453; Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781; Yamazaki K, 2003, ARTHRITIS RHEUM, V48, P3151, DOI 10.1002/art.11305; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yokota Hiroki, 2011, Curr Osteoporos Rep, V9, P237, DOI 10.1007/s11914-011-0067-y; Yorimitsu M, 2008, OSTEOARTHR CARTILAGE, V16, P764, DOI 10.1016/j.joca.2007.11.006	96	58	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119816	10.1371/journal.pone.0119816	http://dx.doi.org/10.1371/journal.pone.0119816			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822615	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700047
J	Cao, XC; Wang, X; Jin, D; Guo, XJ; Tang, XC				Cao, Xiaochun; Wang, Xiao; Jin, Di; Guo, Xiaojie; Tang, Xianchao			A Stochastic Model for Detecting Overlapping and Hierarchical Community Structure	PLOS ONE			English	Article							COMPLEX NETWORKS	Community detection is a fundamental problem in the analysis of complex networks. Recently, many researchers have concentrated on the detection of overlapping communities, where a vertex may belong to more than one community. However, most current methods require the number (or the size) of the communities as a priori information, which is usually unavailable in real-world networks. Thus, a practical algorithm should not only find the overlapping community structure, but also automatically determine the number of communities. Furthermore, it is preferable if this method is able to reveal the hierarchical structure of networks as well. In this work, we firstly propose a generative model that employs a non-negative matrix factorization (NMF) formulization with a l(2,1) norm regularization term, balanced by a resolution parameter. The NMF has the nature that provides overlapping community structure by assigning soft membership variables to each vertex; the l(2,1) regularization term is a technique of group sparsity which can automatically determine the number of communities by penalizing too many nonempty communities; and hence the resolution parameter enables us to explore the hierarchical structure of networks. Thereafter, we derive the multiplicative update rule to learn the model parameters, and offer the proof of its correctness. Finally, we test our approach on a variety of synthetic and real-world networks, and compare it with some state-of-the-art algorithms. The results validate the superior performance of our new method.	[Cao, Xiaochun; Wang, Xiao; Jin, Di; Tang, Xianchao] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Cao, Xiaochun; Guo, Xiaojie] Chinese Acad Sci, Inst Informat Engn, State Key Lab Informat Secur, Beijing 100093, Peoples R China	Tianjin University; Chinese Academy of Sciences; Institute of Information Engineering, CAS	Wang, X (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China.	wangxiao_cv@tju.edu.cn	Jin, Di/AAC-3716-2019; Guo, Xiaojie/AAC-3114-2022		National Natural Science Foundation of China [61332012, 61303110]; National Basic Research Program of China [2013CB329305]; National High-tech R & D Program of China [2013AA01A601]; Chinese Academy of Sciences; PhD Programs Foundation of Ministry of Education of China [20130032120043]; Key Laboratory of Symbolic Computation and knowledge Engineering of Ministry of Education [93K172013K02]; Innovation Foundation of Tianjin University [60302034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech R & D Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Key Laboratory of Symbolic Computation and knowledge Engineering of Ministry of Education; Innovation Foundation of Tianjin University	This work was supported by National Natural Science Foundation of China (No. 61332012), National Basic Research Program of China (2013CB329305), National High-tech R & D Program of China (2013AA01A601), 100 Talents Programme of The Chinese Academy of Sciences, National Natural Science Foundation of China (61303110), PhD Programs Foundation of Ministry of Education of China (20130032120043), Open Project Program of Key Laboratory of Symbolic Computation and knowledge Engineering of Ministry of Education (93K172013K02), and Innovation Foundation of Tianjin University (60302034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyd S., 2004, CONVEX OPTIMIZATION; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cao XC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02993; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Huang WT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023049, 10.1371/journal.pone.0023829]; Jin D, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/09/P09013; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kim J., 2012, IEEE INT C DATA MINI, P851, DOI DOI 10.1137/1.9781611972825.73; Knuth DE., 1993, STANFORD GRAPH BASE; Lambiotte Renaud, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P546; LAMBIOTTE R, 2008, ARXIV08121770; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee H, 2009, ARTIF INTELL, P320; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OJA E, 1992, NEURAL NETWORKS, V5, P927, DOI 10.1016/S0893-6080(05)80089-9; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Ren W, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036111; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Tan VYF, 2013, IEEE T PATTERN ANAL, V35, P1592, DOI 10.1109/TPAMI.2012.240; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xie J., 2013, ACM COMPUT SURV, V45, P1, DOI DOI 10.1145/2501654.2501657; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zarei M, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/11/P11013; Zhang Y., 2012, P 18 ACM SIGKDD INT, P606, DOI [DOI 10.1145/2339530.2339629, 10.1145/2339530.2339629]; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803	44	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119171	10.1371/journal.pone.0119171	http://dx.doi.org/10.1371/journal.pone.0119171			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822148	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700033
J	Gopinath, B; Flood, VM; Kifley, A; Liew, G; Mitchell, P				Gopinath, Bamini; Flood, Victoria M.; Kifley, Annette; Liew, Gerald; Mitchell, Paul			Smoking, Antioxidant Supplementation and Dietary Intakes among Older Adults with Age-Related Macular Degeneration over 10 Years	PLOS ONE			English	Article							10-YEAR INCIDENCE; GLYCEMIC INDEX; EYE DISEASE; RISK; MACULOPATHY; ADHERENCE; QUESTIONNAIRE; PROGRESSION; PREVALENCE; AUSTRALIA	We aimed to compare the micronutrient usage and other lifestyle behaviors over 10 years among those with and without age-related macular degeneration (AMD). 1612 participants aged 49+ years at baseline were re-examined over 10 years, west of Sydney, Australia. AMD was assessed from retinal photographs. Dietary data were collected using a semi-quantitative food frequency questionnaire. Smoking status was self-reported. 56 participants had any AMD at baseline, of these 25% quit smoking at 5 years and were still not smoking at 10-year follow-up. Among participants who had below the recommended intake of vitamins A, C or E supplements at baseline, those who did compared to those who did not develop late AMD over 10 years were more likely to report vitamins A (total), C or E supplement intake above the recommended intake at 10-year follow-up: multivariable-adjusted OR 4.21 (95% CI 1.65-10.73); OR 6.52 (95% CI 2.76-15.41); and OR 5.71 (95% CI 2.42-13.51), respectively. Participants with compared to without AMD did not appreciably increase fish, fruit and vegetable consumption and overall diet quality. Adherence to smoking and dietary recommendations was poor among older adults with AMD. However, uptake of antioxidant supplements increased significantly among those with late AMD.	[Gopinath, Bamini; Kifley, Annette; Liew, Gerald; Mitchell, Paul] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Gopinath, Bamini; Kifley, Annette; Liew, Gerald; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Flood, Victoria M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Flood, Victoria M.] St Vincents Hosp, Sydney, NSW 2010, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; St Vincents Hospital Sydney	Gopinath, B (corresponding author), Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia.	bamini.gopinath@sydney.edu.au	Liew, Gerald/AAB-6870-2022; Gopinath, Bamini/K-4286-2019; Mitchell, Paul/P-1498-2014; Flood, Victoria M/A-8732-2016	Gopinath, Bamini/0000-0003-3573-359X; Flood, Victoria M/0000-0001-5310-7221	Australian National Health and Medical Research Council [974159, 991407, 211069, 262120]; Westmead Millennium Institute; Macular Degeneration Foundation; Blackmores Dr Paul Beaumont Fellowship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute; Macular Degeneration Foundation; Blackmores Dr Paul Beaumont Fellowship	The Blue Mountains Eye Study was funded by the Australian National Health and Medical Research Council (Grant Nos. 974159, 991407, 211069, 262120), and Westmead Millennium Institute. Bamini Gopinath is supported by a Macular Degeneration Foundation and Blackmores Dr Paul Beaumont Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-related Eye Disease Study, 2011, AB AREDS2; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; [Anonymous], 2005, ARCH OPHTHALMOL-CHIC, V123, P1570, DOI DOI 10.1001/ARCHOPHT.123.11.1570; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Australian Institute of Health and Welfare, 2007, AUSTR DIET QUAL IND; Barclay AW, 2008, PUBLIC HEALTH NUTR, V11, P573, DOI 10.1017/S1368980007001103; Bourla DH, 2006, J AM GERIATR SOC, V54, P1130, DOI 10.1111/j.1532-5415.2006.00771.x; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Charkoudian LD, 2008, OPHTHALMOLOGY, V115, P1032, DOI 10.1016/j.ophtha.2007.08.003; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Christen WG, 2009, ARCH INTERN MED, V169, P335, DOI 10.1001/archinternmed.2008.574; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Department of Community Services and Health, 1995, NUTTAB95 NUTR DAT TA; Department of Community Services and Health, 1990, NUTTAB90 NUTR DATA T; Health National and Medical Research Council, 2003, DIET GUID AUSTR AD; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Hochstetler BS, 2010, RETINA-J RET VIT DIS, V30, P1166, DOI 10.1097/IAE.0b013e3181cea5c6; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaushik S, 2008, AM J CLIN NUTR, V88, P1104, DOI 10.1093/ajcn/88.4.1104; Kennedy RD, 2012, CLIN EXP OPTOM, V95, P590, DOI 10.1111/j.1444-0938.2012.00789.x; KLEIN BEK, 1989, INVEST OPHTH VIS SCI, V30, P304; McLennan W, 1995, 48070 AUSTR BUR STAT; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Ng WT, 2006, CLIN EXP OPHTHALMOL, V34, P9, DOI 10.1111/j.1442-9071.2006.01141.x; Russell J, 2013, BRIT J NUTR, V109, P547, DOI 10.1017/S0007114512001377; Shah SU, 2013, CAN J OPHTHALMOL, V48, P204, DOI 10.1016/j.jcjo.2013.01.013; Sin HPY, 2013, ACTA OPHTHALMOL, V91, P6, DOI 10.1111/j.1755-3768.2011.02357.x; Smith A, 1998, AUSTR GUIDE HLTH EAT, P1; Smith W, 1998, AUST NZ J PUBL HEAL, V22, P456, DOI 10.1111/j.1467-842X.1998.tb01414.x; Tan JSL, 2009, ARCH OPHTHALMOL-CHIC, V127, P656, DOI 10.1001/archophthalmol.2009.76; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wang JJ, 2009, AM J EPIDEMIOL, V169, P633, DOI 10.1093/aje/kwn358; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; Yu X. Q., 1999, Australian Journal of Nutrition and Dietetics, V56, P69	38	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122548	10.1371/journal.pone.0122548	http://dx.doi.org/10.1371/journal.pone.0122548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822372	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700185
J	Hehre, EJ; Meeuwig, JJ				Hehre, E. James; Meeuwig, J. J.			Differential Response of Fish Assemblages to Coral Reef-Based Seaweed Farming	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; MULTIVARIATE-ANALYSIS; MARINE RESERVES; HABITAT LOSS; LONG-TERM; PHILIPPINES; DIVERSITY; BIODIVERSITY; RECOVERY; LANDSCAPE	As the global demand for seaweed-derived products drives the expansion of seaweed farming onto shallow coral ecosystems, the effects of farms on fish assemblages remain largely unexplored. Shallow coral reefs provide food and shelter for highly diverse fish assemblages but are increasingly modified by anthropogenic activities. We hypothesized that the introduction of seaweed farms into degraded shallow coral reefs had potential to generate ecological benefits for fish by adding structural complexity and a possible food source. We conducted 210 transects at 14 locations, with sampling stratified across seaweed farms and sites adjacent to and distant from farms. At a seascape scale, locations were classified by their level of exposure to human disturbance. We compared sites where (1) marine protected areas (MPAs) were established, (2) neither MPAs nor blast fishing was present (hence "unprotected"), and (3) blast fishing occurred. We observed 80,186 fish representing 148 species from 38 families. The negative effects of seaweed farms on fish assemblages appeared stronger in the absence of blast fishing and were strongest when MPAs were present, likely reflecting the positive influence of the MPAs on fish within them. Species differentiating fish assemblages with respect to seaweed farming and disturbance were typically small but also included two key target species. The propensity for seaweed farms to increase fish diversity, abundance, and biomass is limited and may reduce MPA benefits. We suggest that careful consideration be given to the placement of seaweed farms relative to MPAs.	[Hehre, E. James] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V5Z 1M9, Canada; [Meeuwig, J. J.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Meeuwig, J. J.] Univ Western Australia, Ctr Marine Futures, Oceans Inst, Crawley, WA, Australia	University of British Columbia; University of Western Australia; University of Western Australia	Hehre, EJ (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V5Z 1M9, Canada.	Jhehre@gmail.com		Meeuwig, Jessica/0000-0003-1169-8785	University of British Columbia (UBC) Four Year Fellowship; Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship	University of British Columbia (UBC) Four Year Fellowship; Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship	Funding for this research was provided to EJH by: the University of British Columbia (UBC) Four Year Fellowship, the Jerry and Jan Barto Foundation, and the Craig and Gigi Barto Foundation. The authors also wish to thank the Endeavour Fellowship to EJH for support while in Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Armada N, 2009, COAST MANAGE, V37, P308, DOI 10.1080/08920750902851609; Barrett NS, 2009, J EXP MAR BIOL ECOL, V370, P104, DOI 10.1016/j.jembe.2008.12.005; BELLWOOD DR, 1988, J FISH BIOL, V32, P881, DOI 10.1111/j.1095-8649.1988.tb05431.x; Bergman KC, 2001, MAR POLLUT BULL, V42, P1379, DOI 10.1016/S0025-326X(01)00168-0; Burke L, REEFS RISK REVISITED; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; CHRISTIE P, 2006, COASTAL ENV FISHERIE, V28, P1; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Crawford B, 2002, SPE ISRM ROCK MECH C, P1, DOI DOI 10.2118/78189-MS; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Eklof JS, 2006, MAR ECOL PROG SER, V325, P73, DOI 10.3354/meps325073; Eklof JS, 2005, ESTUAR COAST SHELF S, V63, P385, DOI 10.1016/j.ecss.2004.11.014; English S., 1997, SURVEY MANUAL TROPIC; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Fox HE, 2003, MAR POLLUT BULL, V46, P1024, DOI 10.1016/S0025-326X(03)00246-7; Fox HE, 2006, ECOL APPL, V16, P1631, DOI 10.1890/1051-0761(2006)016[1631:RFBFOC]2.0.CO;2; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Fujii T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102508; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2003, ECOL APPL, V13, pS117; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hill NAO, 2012, CONSERV BIOL, V26, P324, DOI 10.1111/j.1523-1739.2011.01796.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hughes A., 2012, NAT ED KNOWL, V3, P48; Hughes RM, 1998, CAN J FISH AQUAT SCI, V55, P1618, DOI 10.1139/cjfas-55-7-1618; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Julian CM, 2001, ECOLOGY, V82, P3435, DOI [10.1890/0012-9658(2001)082[3435:SEEOHF]2.0.CO;2, DOI 10.1890/0012-9658(2001)082[3435:SEEOHF]2.0.CO;2]; Lyimo Thomas J., 2006, Western Indian Ocean Journal of Marine Science, V5, P141; Mathieson AM, 2012, THE STATE OF WORLD F; Mathieson AM, 2010, STATE WORLD FISHERIE; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2001, CORAL REEFS, V19, P367, DOI 10.1007/s003380000131; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pinchon M, 1977, P 3 INT COR REEF S G, P261; Pusey JB, 1993, ENVIRON BIOL FISH, V37, P335; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ricketts TH, 2001, CONSERV BIOL, V15, P378, DOI 10.1046/j.1523-1739.2001.015002378.x; Robinson R, 2008, PLOS BIOL, V6, DOI 10.1371/journal.pbio.0060039; SALE PF, 1972, ECOLOGY, V53, P741, DOI 10.2307/1934795; Sale PF, 1998, AUST J ECOL, V23, P202, DOI 10.1111/j.1442-9993.1998.tb00721.x; Sale PF, ECOLOGY CORAL REEF F; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; Smart SM, 2006, P ROY SOC B-BIOL SCI, V273, P2659, DOI 10.1098/rspb.2006.3630; SOLIMAN VS, 2008, KUROSHIO SCI, V2, P67; SPALING H, 1993, ENVIRON MANAGE, V17, P587, DOI 10.1007/BF02393721; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; SWEATMAN HPA, 1983, MAR BIOL, V75, P225, DOI 10.1007/BF00406006; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vlach P, 2005, FOLIA ZOOL, V54, P421; White PJT, 2007, GLOBAL ECOL BIOGEOGR, V16, P290, DOI 10.1111/j.1466-8238.2007.00298.x	66	12	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118838	10.1371/journal.pone.0118838	http://dx.doi.org/10.1371/journal.pone.0118838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822342	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700025
J	Lindeberg, T; Friberg, A				Lindeberg, Tony; Friberg, Anders			Idealized Computational Models for Auditory Receptive Fields	PLOS ONE			English	Article							SCALE-SPACE; TIME-DOMAIN; SPEECH; FILTER; RESPONSES; NEURONS; ARCHITECTURE; SELECTIVITY; PLASTICITY; PATTERNS	We present a theory by which idealized models of auditory receptive fields can be derived in a principled axiomatic manner, from a set of structural properties to (i) enable invariance of receptive field responses under natural sound transformations and (ii) ensure internal consistency between spectro-temporal receptive fields at different temporal and spectral scales. For defining a time-frequency transformation of a purely temporal sound signal, it is shown that the framework allows for a new way of deriving the Gabor and Gammatone filters as well as a novel family of generalized Gammatone filters, with additional degrees of freedom to obtain different trade-offs between the spectral selectivity and the temporal delay of time-causal temporal window functions. When applied to the definition of a second-layer of receptive fields from a spectrogram, it is shown that the framework leads to two canonical families of spectro-temporal receptive fields, in terms of spectro-temporal derivatives of either spectro-temporal Gaussian kernels for non-causal time or a cascade of time-causal first-order integrators over the temporal domain and a Gaussian filter over the log-spectral domain. For each filter family, the spectro-temporal receptive fields can be either separable over the time-frequency domain or be adapted to local glissando transformations that represent variations in logarithmic frequencies over time. Within each domain of either non-causal or time-causal time, these receptive field families are derived by uniqueness from the assumptions. It is demonstrated how the presented framework allows for computation of basic auditory features for audio processing and that it leads to predictions about auditory receptive fields with good qualitative similarity to biological receptive fields measured in the inferior colliculus (ICC) and primary auditory cortex (A1) of mammals.	[Lindeberg, Tony] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden; [Friberg, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Speech Mus & Hearing, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology	Lindeberg, T (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden.	tony@csc.kth.se	Friberg, Anders K/A-2490-2012; Lindeberg, Tony/G-3580-2011	Lindeberg, Tony/0000-0002-9081-2170	Swedish Research Council [2010-4766, 2012-4685, 2014-4083]; KTH School of Computer Science and Communication Small Visionary Project; EU project SkAT-VG by Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open [618067]	Swedish Research Council(Swedish Research CouncilEuropean Commission); KTH School of Computer Science and Communication Small Visionary Project; EU project SkAT-VG by Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open	This work has been supported by the Swedish Research Council contracts 2010-4766, 2012-4685 and 2014-4083, a KTH School of Computer Science and Communication Small Visionary Project and the EU project SkAT-VG supported by the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission under FET-Open grant number 618067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Ambikairajah E, 2001, INT CONF ACOUST SPEE, P773, DOI 10.1109/ICASSP.2001.941029; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; [Anonymous], [No title captured]; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031537; BAER T, 1993, J REHABIL RES DEV, V30, P49; Bleeck S, 2004, ACTA ACUST UNITED AC, V90, P781; BROWN JC, 1992, J ACOUST SOC AM, V92, P2698, DOI 10.1121/1.404385; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen ZL, 2011, HEARING RES, V282, P204, DOI 10.1016/j.heares.2011.08.001; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; Conway BR, 2006, J NEUROSCI, V26, P10826, DOI 10.1523/JNEUROSCI.2091-06.2006; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; DeAngelis G.C., 2004, VISUAL NEUROSCIENCES, V1, P704; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Domont X, 2008, INT CONF ACOUST SPEE, P4417, DOI 10.1109/ICASSP.2008.4518635; Eggermont JJ, 2011, HEARING RES, V271, P123, DOI 10.1016/j.heares.2010.01.014; Elhilali M, 2007, J NEUROSCI, V27, P10372, DOI 10.1523/JNEUROSCI.1462-07.2007; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Ezzat T., 2007, P INTERSPEECH, P506; Fletcher H, 1934, J ACOUSTICAL SOC AM; Florack L., 1997, IMAGE STRUCTURE, DOI [10.1007/978-94-015-8845-4, DOI 10.1007/978-94-015-8845-4]; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARTMANN WM, 1990, J ACOUST SOC AM, V88, P1712, DOI 10.1121/1.400246; Hartmann WM, 1996, J ACOUST SOC AM, V100, P3491, DOI 10.1121/1.417248; He L., 2009, 2009 3 INT C AFFECTI, P1; Heckmann M, 2011, SPEECH COMMUN, V53, P736, DOI 10.1016/j.specom.2010.08.006; HEWITT MJ, 1994, J ACOUST SOC AM, V95, P2145, DOI 10.1121/1.408676; Hirschmann II, 1955, CONVOLUTION TRANSFOR; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Iijima T., 1962, TECHNICAL REPORT; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; Johannesma PIM, 1972, IPO S HEAR THEOR EIN, P58; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kandel E., 2000, PRINCIPLES NEURAL SC; Kleinschmidt M, 2002, ACTA ACUST UNITED AC, V88, P416; Kleinschmidt M., 2002, INTERSPEECH; Koch C., 1999, BIOPHYSICS OF COMPUT; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; KOENDERINK JJ, 1992, IEEE T PATTERN ANAL, V14, P597, DOI 10.1109/34.141551; KOENDERINK JJ, 1988, BIOL CYBERN, V58, P159, DOI 10.1007/BF00364135; KOENDERINK JJ, 1987, BIOL CYBERN, V55, P367, DOI 10.1007/BF00318371; Laptev I, 2004, IMAGE VISION COMPUT, V22, P105, DOI 10.1016/j.imavis.2003.07.002; Laptev I, 2007, COMPUT VIS IMAGE UND, V108, P207, DOI 10.1016/j.cviu.2006.11.023; Laudanski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050539; LINDEBERG T, 1990, IEEE T PATTERN ANAL, V12, P234, DOI 10.1109/34.49051; Lindeberg T, 2003, LECT NOTES COMPUT SC, V2695, P148; Lindeberg T., 1993, Journal of Mathematical Imaging and Vision, V3, P349, DOI 10.1007/BF01664794; Lindeberg T, 1998, INT J COMPUT VISION, V30, P117, DOI 10.1023/A:1008097225773; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; LINDEBERG T, 1993, IEEE T PATTERN ANAL, V15, P1068, DOI 10.1109/34.254063; Lindeberg T., 1994, SCALE SPACE THEORY C; Lindeberg T, 1996, GAUSSIAN SCALE SPACE, P75; Lindeberg T., 1996, LNCS, V1064, P229; Lindeberg T., 2008, WILEY ENCY COMPUTER, VIV, P2495, DOI DOI 10.1002/9780470050118.ECSE609; Lindeberg T, 2014, ARXIV14042037V1CSSD; Lindeberg T, 2013, BIOL CYBERN, V107, P589, DOI 10.1007/s00422-013-0569-z; Lindeberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066990; Lindeberg T, 2011, J MATH IMAGING VIS, V40, P36, DOI 10.1007/s10851-010-0242-2; Lobo AP, 2003, P AC SPEECH SIGN PRO, V1, P820, DOI [10.1109/ICASSP.2003.1198907, DOI 10.1109/ICASSP.2003.1198907]; Lopez-Poveda EA, 2001, J ACOUST SOC AM, V110, P3107, DOI 10.1121/1.1416197; Lukas BD, 1981, IM UND WORKSH; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Meddis R, 2010, SPRINGER HANDB AUDIT, V35, P1, DOI 10.1007/978-1-4419-5934-8; Meyer BT, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P906; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Moore B. C. J., 2013, INTRO PSYCHOL HEARIN, V6th; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Muller M, 2011, IEEE J-STSP, V5, P1088, DOI 10.1109/JSTSP.2011.2112333; Ngamkham W, 2010, IEEE INT SYMP CIRC S, P969, DOI 10.1109/ISCAS.2010.5537383; Palmer S., 1999, VISION SCI PHOTONS P; Patterson R.D., 1996, ADV SPEECH HEARING L, V3, P547; Patterson R.D., 1986, FREQUENCY SELECTIVIT, P123; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; Patterson RD, 2003, J ACOUST SOC AM, V114, P1529, DOI 10.1121/1.1600720; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Pienkowski M, 2005, J NEUROPHYSIOL, V93, P454, DOI 10.1152/jn.00569.2004; Qiu AQ, 2003, J NEUROPHYSIOL, V90, P456, DOI 10.1152/jn.00851.2002; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; Sameh S, 2013, INT J SPEECH TECHNOL, V16, P203, DOI 10.1007/s10772-012-9174-0; Schadler MR, 2012, J ACOUST SOC AM, V131, P4134, DOI 10.1121/1.3699200; Schluter R, 2007, INT CONF ACOUST SPEE, P649; Schorkhuber C., 2010, P 7 SOUND MUS COMP C, P3; Slaney M, 1998, TECH REP; Sporring J, 1996, SERIES MATH IMAGING; STORK DG, 1990, J OPT SOC AM A, V7, P1362, DOI 10.1364/JOSAA.7.001362; ter Haar Romeny B, 2003, FRONT END VISION MUL; Theunissen FE, 2000, J NEUROSCI, V20, P2315; van de Boogart CG, 2006, P AC SPEECH SIGN PRO, VIII, P161; Van Immerseel L, 2003, ACOUST RES LETT ONL, V4, P59, DOI 10.1121/1.1573131; Weickert J, 1999, J MATH IMAGING VIS, V10, P237, DOI 10.1023/A:1008344623873; Witkin A.P., 1983, P 8 INT JOINT C ART, P1019, DOI DOI 10.1007/978-3-8348-9190-729; Wolfe PJ, 2001, PROCEEDINGS OF THE 2001 IEEE WORKSHOP ON THE APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS, P43, DOI 10.1109/ASPAA.2001.969538; Wu QA, 2011, IEEE T AUDIO SPEECH, V19, P927, DOI 10.1109/TASL.2010.2070495; YOUNG R A, 1987, Spatial Vision, V2, P273, DOI 10.1163/156856887X00222; Young RA, 2001, SPATIAL VISION, V14, P261, DOI 10.1163/156856801753253582; Young RW, 1939, J ACOUST SOC AM, V11, P134, DOI 10.1121/1.1916017; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630	111	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119032	10.1371/journal.pone.0119032	http://dx.doi.org/10.1371/journal.pone.0119032			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822973	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700031
J	Machado, GC; Ferreira, PH; Harris, IA; Pinheiro, MB; Koes, BW; van Tulder, M; Rzewuska, M; Maher, CG; Ferreira, ML				Machado, Gustavo C.; Ferreira, Paulo H.; Harris, Ian A.; Pinheiro, Marina B.; Koes, Bart W.; van Tulder, Maurits; Rzewuska, Magdalena; Maher, Chris G.; Ferreira, Manuela L.			Effectiveness of Surgery for Lumbar Spinal Stenosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COFLEX INTERLAMINAR STABILIZATION; PROCESS-SPLITTING LAMINECTOMY; UNITED-STATES TRENDS; UNILATERAL LAMINOTOMY; CANAL STENOSIS; BILATERAL DECOMPRESSION; DEGENERATIVE SPONDYLOLISTHESIS; SURGICAL DECOMPRESSION; MIDLINE DECOMPRESSION; RATING QUALITY	Background The management of spinal stenosis by surgery has increased rapidly in the past two decades, however, there is still controversy regarding the efficacy of surgery for this condition. Our aim was to investigate the efficacy and comparative effectiveness of surgery in the management of patients with lumbar spinal stenosis. Methods Electronic searches were performed on MEDLINE, EMBASE, AMED, CINAHL, Web of Science, LILACS and Cochrane Library from inception to November 2014. Hand searches were conducted on included articles and relevant reviews. We included randomised controlled trials evaluating surgery compared to no treatment, placebo/sham, or to another surgical technique in patients with lumbar spinal stenosis. Primary outcome measures were pain, disability, recovery and quality of life. The PEDro scale was used for risk of bias assessment. Data were pooled with a random-effects model, and the GRADE approach was used to summarise conclusions. Results Nineteen published reports (17 trials) were included. No trials were identified comparing surgery to no treatment or placebo/sham. Pooling revealed that decompression plus fusion is not superior to decompression alone for pain (mean difference -3.7, 95% confidence interval -15.6 to 8.1), disability (mean difference 9.8, 95% confidence interval -9.4 to 28.9), or walking ability (risk ratio 0.9, 95% confidence interval 0.4 to 1.9). Interspinous process spacer devices are slightly more effective than decompression plus fusion for disability (mean difference 5.7, 95% confidence interval 1.3 to 10.0), but they resulted in significantly higher reoperation rates when compared to decompression alone (28% v 7%, P < 0.001). There are no differences in the effectiveness between other surgical techniques for our main outcomes. Conclusions The relative efficacy of various surgical options for treatment of spinal stenosis remains uncertain. Decompression plus fusion is not more effective than decompression alone. Interspinous process spacer devices result in higher reoperation rates than bony decompression.	[Machado, Gustavo C.; Rzewuska, Magdalena; Maher, Chris G.; Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Ferreira, Paulo H.; Pinheiro, Marina B.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Harris, Ian A.] Univ New S Wales, Ingham Inst Appl Med Res, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Koes, Bart W.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [van Tulder, Maurits] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Inst Bone & Joint Res, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney; University of Sydney; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; University of Sydney	Machado, GC (corresponding author), Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2006, Australia.	gmachado@georgeinstitute.org.au	Maher, Christopher/AAC-6267-2019; Koes, Bart w/K-4614-2016; Machado, Gustavo/H-5453-2016; Ferreira, Manuela/AAQ-5446-2020; Ferreira, Paulo H/N-3061-2017; van Tulder, Maurits/AAB-9785-2022	Maher, Christopher/0000-0002-1628-7857; Koes, Bart w/0000-0002-0450-9969; Machado, Gustavo/0000-0002-8544-0448; Ferreira, Manuela/0000-0002-3479-0683; Ferreira, Paulo H/0000-0002-5861-7770; van Tulder, Maurits/0000-0002-7589-8471; Rzewuska, Magdalena/0000-0003-4642-1196; Pinheiro, Marina/0000-0001-7459-5105				ARYANPUR J, 1988, NEUROSURGERY, V23, P111, DOI 10.1227/00006123-198807000-00021; Azzazi A, 2010, NEUROSURG QUART, V20, P165, DOI 10.1097/WNQ.0b013e3181ebb0ea; Benoist M, 2002, JOINT BONE SPINE, V69, P450, DOI 10.1016/S1297-319X(02)00429-3; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461, DOI 10.1097/00002517-199306060-00001; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Cavusoglu H, 2007, TURK NEUROSURG, V17, P100; Celik SE, 2010, J SPINAL DISORD TECH, V23, P229, DOI 10.1097/BSD.0b013e3181a3d889; Chou Dean, 2011, Evid Based Spine Care J, V2, P45, DOI 10.1055/s-0030-1267086; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; DAVIS H, 1994, SPINE, V19, P1117, DOI 10.1097/00007632-199405001-00003; Davis R, 2013, J NEUROSURG-SPINE, V19, P174, DOI 10.3171/2013.4.SPINE12636; Davis RJ, 2013, SPINE, V38, P1529, DOI 10.1097/BRS.0b013e31829a6d0a; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Deyo RA, 2013, SPINE, V38, P865, DOI 10.1097/BRS.0b013e31828631b8; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Elkins MR, 2013, BRIT J SPORT MED, V47, P188, DOI 10.1136/bjsports-2012-091804; Flum DR, 2006, JAMA-J AM MED ASSOC, V296, P2483, DOI 10.1001/jama.296.20.2483; Gibson JNA, 2005, SPINE, V30, P2312, DOI 10.1097/01.brs.0000182315.88558.9c; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; GROB D, 1995, J BONE JOINT SURG AM, V77A, P1036, DOI 10.2106/00004623-199507000-00009; GROB D, 1993, ORTHOPADE, V22, P243; Gurelik M, 2012, J NEUROL SCI-TURK, V29, P744; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hallett A, 2007, SPINE, V32, P1375, DOI 10.1097/BRS.0b013e318064520f; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horng S, 2003, CRIT CARE MED, V31, pS126, DOI 10.1097/01.CCM.0000054906.49187.67; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Jansson KA, 2003, EUR SPINE J, V12, P535, DOI 10.1007/s00586-003-0544-9; JOHNSSON KE, 1989, SPINE, V14, P591, DOI 10.1097/00007632-198906000-00008; JOHNSSON KE, 1992, CLIN ORTHOP RELAT R, P82; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Kovacs FM, 2011, SPINE, V36, pE1335, DOI 10.1097/BRS.0b013e31820c97b1; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu XY, 2013, SPINE, V38, pE732, DOI 10.1097/BRS.0b013e31828fc84c; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Martin CR, 2007, SPINE, V32, P1791, DOI 10.1097/BRS.0b013e3180bc219e; May S, 2013, PHYSIOTHERAPY, V99, P12, DOI 10.1016/j.physio.2011.12.004; Mirza SK, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-53; Moojen WA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6415; Moojen WA, 2011, EUR SPINE J, V20, P1596, DOI 10.1007/s00586-011-1873-8; NASCA RJ, 1989, SPINE, V14, P451, DOI 10.1097/00007632-198904000-00023; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; POSTACCHINI F, 1993, J BONE JOINT SURG BR, V75, P386, DOI 10.1302/0301-620X.75B3.8496205; Rajasekaran S, 2013, SPINE, V38, P1737, DOI 10.1097/BRS.0b013e3182a056c1; Resnick DK, 2005, J NEUROSURG-SPINE, V2, P679, DOI 10.3171/spi.2005.2.6.0679; RUBIN DB, 1990, J STAT PLAN INFER, V25, P279, DOI 10.1016/0378-3758(90)90077-8; Ruetten S, 2009, J NEUROSURG-SPINE, V10, P476, DOI 10.3171/2008.7.17634; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Spetzger U, 1997, ACTA NEUROCHIR, V139, P392, DOI 10.1007/BF01808872; Spetzger U, 1997, ACTA NEUROCHIR, V139, P397, DOI 10.1007/BF01808874; Stromqvist BH, 2013, SPINE, V38, P1436, DOI 10.1097/BRS.0b013e31828ba413; Stromqvist F, 2012, EUR SPINE J, V21, P825, DOI 10.1007/s00586-011-2101-2; TAYLOR VM, 1994, SPINE, V19, P1207, DOI 10.1097/00007632-199405310-00002; Thome C, 2005, J NEUROSURG-SPINE, V3, P129, DOI 10.3171/spi.2005.3.2.0129; TURNER JA, 1992, SPINE, V17, P1, DOI 10.1097/00007632-199201000-00001; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; Watanabe K, 2005, J NEUROSURG-SPINE, V3, P405, DOI 10.3171/spi.2005.3.5.0405; Watanabe K, 2011, J NEUROSURG-SPINE, V14, P51, DOI 10.3171/2010.9.SPINE09933; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Wu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097142; Yagi M, 2009, J NEUROSURG-SPINE, V10, P293, DOI 10.3171/2009.1.SPINE08288; You JJ, 2013, SPINE, V38, P51, DOI 10.1097/BRS.0b013e3182611182	65	62	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122800	10.1371/journal.pone.0122800	http://dx.doi.org/10.1371/journal.pone.0122800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822730	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700198
J	Ohkuma, T; Iwase, M; Fujii, H; Kaizu, S; Ide, H; Jodai, T; Kikuchi, Y; Idewaki, Y; Hirakawa, Y; Nakamura, U; Kitazono, T				Ohkuma, Toshiaki; Iwase, Masanori; Fujii, Hiroki; Kaizu, Shinako; Ide, Hitoshi; Jodai, Tamaki; Kikuchi, Yohei; Idewaki, Yasuhiro; Hirakawa, Yoichiro; Nakamura, Udai; Kitazono, Takanari			Dose- and Time-Dependent Association of Smoking and Its Cessation with Glycemic Control and Insulin Resistance in Male Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; CIGARETTE-SMOKING; GLUCOSE-TOLERANCE; RISK-FACTORS; SMOKERS; WOMEN; MICROALBUMINURIA; INFLAMMATION; METAANALYSIS; POPULATION	Objective Cigarette smoking is an important modifiable risk factor for cardiovascular diseases. However, the effect of smoking and its cessation on glycemic control in diabetic patients has not been fully examined yet. The aim of the present study was to examine the association of smoking status with glycemic level and markers of insulin resistance and secretion in patients with type 2 diabetes mellitus. Research Design and Methods A total of 2,490 Japanese male patients with type 2 diabetes mellitus aged >= 20 years were divided according to smoking status, amount of cigarettes smoked and years since quitting. The associations with glycemic level and markers of insulin resistance and secretion were examined cross-sectionally. Results HbA(1c) levels increased progressively with increases in both number of cigarettes per day and pack-years of cigarette smoking compared with never smokers (P for trend = 0.001 and < 0.001, respectively), whereas fasting plasma glucose did not. On the other hand, HbA(1c), but not fasting plasma glucose, decreased linearly with increase in years after smoking cessation (P for trend < 0.001). These graded relationships persisted significantly after controlling for the confounders, including total energy intake, current drinking, regular exercise, depressive symptoms, and BMI. In addition, a homeostasis model assessment of insulin resistance and high-sensitivity C-reactive protein also showed similar trends. Conclusions Smoking and its cessation showed dose- and time-dependent relationship with glycemic control and insulin resistance in patients with type 2 diabetes mellitus. These findings may highlight the importance of smoking cessation in the clinical management of diabetes mellitus.	[Ohkuma, Toshiaki; Iwase, Masanori; Kaizu, Shinako; Ide, Hitoshi; Jodai, Tamaki; Kikuchi, Yohei; Nakamura, Udai; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Ohkuma, Toshiaki] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Fukuoka 812, Japan; [Iwase, Masanori; Idewaki, Yasuhiro] Hakujyuji Hosp, Ctr Diabet, Fukuoka, Japan; [Hirakawa, Yoichiro] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Fujii, Hiroki] Kyushu Dent Univ, Sch Oral Hlth Sci, Div Gen Internal Med, Kitakyushu, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu Dental University	Iwase, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.	iwase@intmed2.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI; Japan Diabetes Foundation; Japan Heart Foundation; Astellas/Pfizer Grant for Research	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Japan Heart Foundation; Astellas/Pfizer Grant for Research	Financial support for this study was provided by Japan Society for the Promotion of Science KAKENHI, a grant from the Japan Diabetes Foundation, and Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan F, 2006, EUR J CLIN INVEST, V36, P459, DOI 10.1111/j.1365-2362.2006.01650.x; USA Pooling Project Research Group, 1978, Journal of Chronic Diseases, V31, P201; Baggio B, 2002, J AM SOC NEPHROL, V13, P2730, DOI 10.1097/01.ASN.0000032422.81130.68; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Bermudez EA, 2002, AM J CARDIOL, V89, P1117, DOI 10.1016/S0002-9149(02)02284-1; BEUTLER E, 1975, BLOOD, V46, P253; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; GRIMES D, 1978, BRIT MED J, V2, P460, DOI 10.1136/bmj.2.6135.460; HANSON M, 1987, SCAND J GASTROENTERO, V22, P1102, DOI 10.3109/00365528708991965; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P644; Hokanson JM, 2006, DIABETES EDUCATOR, V32, P562, DOI 10.1177/0145721706289914; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Mackay J, 2002, TOBACCO ATLAS; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Narkiewicz K, 1998, CIRCULATION, V98, P528, DOI 10.1161/01.CIR.98.6.528; Nilsson PM, 2004, DIABETES METAB, V30, P261, DOI 10.1016/S1262-3636(07)70117-9; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; SMITH RJ, 1982, J CLIN INVEST, V69, P1164, DOI 10.1172/JCI110552; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; van Geenen EJM, 2011, AM J GASTROENTEROL, V106, P1161, DOI 10.1038/ajg.2011.43; Voulgari C, 2011, METABOLISM, V60, P1456, DOI 10.1016/j.metabol.2011.02.014; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WILKINS JN, 1982, PSYCHOPHARMACOLOGY, V78, P305, DOI 10.1007/BF00433730; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	37	38	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122023	10.1371/journal.pone.0122023	http://dx.doi.org/10.1371/journal.pone.0122023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822499	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700146
J	Portet, S; Madzvamuse, A; Chung, A; Leube, RE; Windoffer, R				Portet, Stephanie; Madzvamuse, Anotida; Chung, Andy; Leube, Rudolf E.; Windoffer, Reinhard			Keratin Dynamics: Modeling the Interplay between Turnover and Transport	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; NETWORK; ACTIN; PHOSPHORYLATION; ORGANIZATION; MECHANISMS; PRECURSORS; MICROSCOPY; INSIGHTS	Keratin are among the most abundant proteins in epithelial cells. Functions of the keratin network in cells are shaped by their dynamical organization. Using a collection of experimentally-driven mathematical models, different hypotheses for the turnover and transport of the keratin material in epithelial cells are tested. The interplay between turnover and transport and their effects on the keratin organization in cells are hence investigated by combining mathematical modeling and experimental data. Amongst the collection of mathematical models considered, a best model strongly supported by experimental data is identified. Fundamental to this approach is the fact that optimal parameter values associated with the best fit for each model are established. The best candidate among the best fits is characterized by the disassembly of the assembled keratin material in the perinuclear region and an active transport of the assembled keratin. Our study shows that an active transport of the assembled keratin is required to explain the experimentally observed keratin organization.	[Portet, Stephanie] Univ Manitoba, Dept Math, Winnipeg, MB R3T 2N2, Canada; [Madzvamuse, Anotida; Chung, Andy] Univ Sussex, Sch Math & Phys Sci, Dept Math, Brighton, E Sussex, England; [Leube, Rudolf E.; Windoffer, Reinhard] Univ Aachen, Rhein Westfal Tech Hsch, Inst Mol & Cellular Anat, Aachen, Germany	University of Manitoba; University of Sussex; RWTH Aachen University	Portet, S (corresponding author), Univ Manitoba, Dept Math, Winnipeg, MB R3T 2N2, Canada.	portets@cc.umanitoba.ca	Madzvamuse, Anotida/F-9270-2012	Madzvamuse, Anotida/0000-0002-9511-8903; Windoffer, Reinhard/0000-0003-1403-5880; Portet, Stephanie/0000-0002-8802-8184; Leube, Rudolf/0000-0002-5519-7379	RWTH Aachen University; Durham University (Durham, UK); Natural Sciences and Engineering Research Council of Canada [RGPIN/315119-2013]; Engineering and Physical Sciences Research Council [EP/J016780/1]; Leverhulme Trust [RPG-2014-149]; German Research Council [LE 566/18, LE 566/20, WI 1731/6, WI 1731/8]; ERS grant by RWTH Aachen University; IZKF grant; EPSRC [EP/J016780/1] Funding Source: UKRI	RWTH Aachen University; Durham University (Durham, UK); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); German Research Council(German Research Foundation (DFG)); ERS grant by RWTH Aachen University; IZKF grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was initiated in June 2013 while SP was visiting the Institute of Molecular and Cellular Biology at RWTH Aachen University (Aachen, Germany). AM and SP thank RWTH Aachen University for the Theodore von Karmam Fellowships in 2013 and 2014 respectively, that supported their research stay. The work was finalized while SP was holding a Fellowship at the Institute of Advanced Study at Durham University (Durham, UK) from October to December 2014. SP is also supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (RGPIN/315119-2013). AM acknowledges support from the Engineering and Physical Sciences Research Council Grant(EP/J016780/1) and the Leverhulme Trust Research Project Grant (RPG-2014-149). The work of RL and RW was supported by the German Research Council (LE 566/18, LE 566/20, WI 1731/6, WI 1731/8), an ERS grant by RWTH Aachen University and an IZKF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MATLAB STAT TOOLB RE; Beil M, 2009, J THEOR BIOL, V256, P518, DOI 10.1016/j.jtbi.2008.09.044; Brown A, 2005, MOL BIOL CELL, V16, P4243, DOI 10.1091/mbc.E05-02-0141; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHOU CF, 1993, J CELL SCI, V105, P433; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; DORSEY RE, 1995, J BUS ECON STAT, V13, P53, DOI 10.2307/1392521; Feng X, 2013, J INVEST DERMATOL, V133, P850, DOI 10.1038/jid.2012.397; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herberich G, 2011, IEEE ENG MED BIO, P7751, DOI 10.1109/IEMBS.2011.6091910; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kim JS, 2010, BIOPHYS J, V99, P2748, DOI 10.1016/j.bpj.2010.09.023; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Leube Rudolf E, 2011, Bioarchitecture, V1, P39; Li YY, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026001; Madzvamuse A, 2003, J COMPUT PHYS, V190, P478, DOI 10.1016/S0021-9991(03)00294-8; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Portet S, 2003, J THEOR BIOL, V223, P313, DOI 10.1016/s0022-5193(03)00101-2; Portet S, 2009, MATH BIOSCI ENG, V6, P117, DOI 10.3934/mbe.2009.6.117; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Sun CJ, 2015, IMA J APPL MATH, V80, P100, DOI 10.1093/imamat/hxt030; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Windoffer R, 1999, J CELL SCI, V112, P4521; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121090	10.1371/journal.pone.0121090	http://dx.doi.org/10.1371/journal.pone.0121090			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822661	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700088
J	Radin, JM; Hawksworth, AW; Ortiguerra, RG; Brice, GT				Radin, Jennifer M.; Hawksworth, Anthony W.; Ortiguerra, Ryan G.; Brice, Gary T.			Seroprotective Antibodies to 2011 Variant Influenza A(H3N2v) and Seasonal Influenza A(H3N2) among Three Age Groups of US Department of Defense Service Members	PLOS ONE			English	Article							LONG-TERM IMMUNOGENICITY; UNITED-STATES; HUMAN INFECTIONS; IMMUNE-RESPONSE; H1N1 2009; VACCINE; VIRUS; ADULTS; EFFICACY; H3N2V	Background In 2011, a new variant of influenza A(H3N2) emerged that contained a recombination of genes from swine H3N2 viruses and the matrix (M) gene of influenza A(H1N1)pdm09 virus. New combinations and variants of pre-existing influenza viruses are worrisome if there is low or nonexistent immunity in a population, which increases chances for an outbreak or pandemic. Methods Sera collected in 2011 were obtained from US Department of Defense service members in three age groups: 19-21 years, 32-33 years, and 47-48 years. Pre- and post-vaccination samples were available for the youngest age group, and postvaccination samples for the two older groups. Specimens were tested using microneutralization assays for antibody titers against H3N2v (A/Indiana/10/2011) and seasonal H3N2 virus (A/Perth/16/2009). Results The youngest age group had significantly (p<0.05) higher geometric mean titers for H3N2v with 165 (95% confidence interval [CI]: 105-225) compared with the two older groups, aged 32-33 and 47-48 years, who had geometric mean titers of 68 (95% CI: 55-82) and 46 (95% CI: 24-65), respectively. Similarly, the youngest age group also had the highest geometric mean titers for seasonal H3N2. In the youngest age group, the proportion of patients who seroconverted after vaccination was 12% for H3N2v and 27% for seasonal H3N2. Discussion Our results were similar to previous studies that found highest seroprotection among young adults and decreasing titers among older adults. The proportion of 19- to 21-year-olds who seroconverted after seasonal vaccination was low and similar to previous findings. Improving our understanding of H3N2v immunity among different age groups in the United States can help inform vaccination plans if H3N2v becomes more transmissible in the future.	[Radin, Jennifer M.; Hawksworth, Anthony W.; Ortiguerra, Ryan G.; Brice, Gary T.] Naval Hlth Res Ctr, Operat Infect Dis Dept, San Diego, CA 92106 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Radin, JM (corresponding author), Naval Hlth Res Ctr, Operat Infect Dis Dept, San Diego, CA 92106 USA.	jennifer.radin@med.navy.mil		Radin, Jennifer/0000-0003-3843-0842	Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit [60805]; US Government	Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit; US Government	Report number 14-29, supported by Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit No. 60805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Jennifer Radin, Mr. Anthony Hawksworth, and Mr. Ryan Ortiguerra are employed by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and are funded to do this work by the US Government. CDR Gary Brice is a military service member. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. Approved for public release; distribution is unlimited. US Government Work (17 USC 105). Not copyrighted in the US. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (Protocol NHRC.2013.0025).	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; BLACK SC, 2011, AM POETRY REV, V40, P30, DOI DOI 10.1097/INF.0B013E3182367662; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V16, P237; Chan KH, 2011, CLIN VACCINE IMMUNOL, V18, P867, DOI 10.1128/CVI.00555-10; Epperson S, 2013, CLIN INFECT DIS, V57, pS4, DOI 10.1093/cid/cit272; Faix DJ, 2012, PLOS ONE, V7, pe3481; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Kelly H, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0UMAL.P0NE.0021828; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Phillips CJ, 2013, CLIN INFECT DIS, V56, P11, DOI 10.1093/cid/cis860; Richards S., 2011, Morbidity and Mortality Weekly Report, V60, P1741; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Skowronski DM, 2012, EUROSURVEILLANCE, V17, P2; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Song JY, 2013, CLIN VACCINE IMMUNOL, V20, P513, DOI 10.1128/CVI.00725-12; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Waalen K, 2012, EUROSURVEILLANCE, V17, P5; Word Health Organization, 2010, REC VIR INFL VACC US	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121037	10.1371/journal.pone.0121037	http://dx.doi.org/10.1371/journal.pone.0121037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816244	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600061
J	Baranowski, P; Jedryczka, M; Mazurek, W; Babula-Skowronska, D; Siedliska, A; Kaczmarek, J				Baranowski, Piotr; Jedryczka, Malgorzata; Mazurek, Wojciech; Babula-Skowronska, Danuta; Siedliska, Anna; Kaczmarek, Joanna			Hyperspectral and Thermal Imaging of Oilseed Rape (Brassica napus) Response to Fungal Species of the Genus Alternaria	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS INFECTION; OPTICAL-PROPERTIES; DISEASE SEVERITY; PLANT-DISEASES; BIOTIC STRESS; DOWNY MILDEW; LEAVES; CLASSIFICATION; REFLECTANCE; INDEXES	In this paper, thermal (8-13 mu m) and hyperspectral imaging in visible and near infrared (VNIR) and short wavelength infrared (SWIR) ranges were used to elaborate a method of early detection of biotic stresses caused by fungal species belonging to the genus Alternaria that were host (Alternaria alternata, Alternaria brassicae, and Alternaria brassicicola) and non-host (Alternaria dauci) pathogens to oilseed rape (Brassica napus L.). The measurements of disease severity for chosen dates after inoculation were compared to temperature distributions on infected leaves and to averaged reflectance characteristics. Statistical analysis revealed that leaf temperature distributions on particular days after inoculation and respective spectral characteristics, especially in the SWIR range (1000-2500 nm), significantly differed for the leaves inoculated with A. dauci from the other species of Alternaria as well as from leaves of non-treated plants. The significant differences in leaf temperature of the studied Alternaria species were observed in various stages of infection development. The classification experiments were performed on the hyperspectral data of the leaf surfaces to distinguish days after inoculation and Alternaria species. The second-derivative transformation of the spectral data together with back-propagation neural networks (BNNs) appeared to be the best combination for classification of days after inoculation (prediction accuracy 90.5%) and Alternaria species (prediction accuracy 80.5%).	[Baranowski, Piotr; Mazurek, Wojciech; Siedliska, Anna] Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland; [Jedryczka, Malgorzata; Babula-Skowronska, Danuta; Kaczmarek, Joanna] Polish Acad Sci, Inst Plant Genet, Poznan, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences	Baranowski, P (corresponding author), Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland.	pbaranow@ipan.lublin.pl	Babula-Skowronska, Danuta/ABC-3243-2020	Siedliska, Anna/0000-0002-7510-8863; Babula-Skowronska, Danuta/0000-0002-5641-5227; Baranowski, Piotr/0000-0003-0979-177X; Mazurek, Wojciech/0000-0002-7816-3243	Polish National Centre for Research and Development in frame of the FACCE JPI Knowledge Hub project "Modelling European Agriculture with Climate Change for Food Safety" (MACSUR)	Polish National Centre for Research and Development in frame of the FACCE JPI Knowledge Hub project "Modelling European Agriculture with Climate Change for Food Safety" (MACSUR)	This work was partially supported by the Polish National Centre for Research and Development in frame of the FACCE JPI Knowledge Hub project "Modelling European Agriculture with Climate Change for Food Safety" (MACSUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SJ, 1983, ANN APPL BIOL, V102, P413, DOI 10.1111/j.1744-7348.1983.tb02714.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Baranowski P., 2009, Rosliny Oleiste, V30, P21; Baranowski P, 2013, POSTHARVEST BIOL TEC, V86, P249, DOI 10.1016/j.postharvbio.2013.07.005; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; Belin E, 2011, COMPUT ELECTRON AGR, V77, P188, DOI 10.1016/j.compag.2011.05.002; Berger S, 2004, PHYSIOL PLANTARUM, V122, P419, DOI 10.1111/j.1399-3054.2004.00433.x; Boccara M, 2001, PLANT J, V28, P663, DOI 10.1046/j.1365-313x.2001.01186.x; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Bravo C, 2003, BIOSYST ENG, V84, P137, DOI 10.1016/S1537-5110(02)00269-6; Camargo A, 2009, COMPUT ELECTRON AGR, V66, P121, DOI 10.1016/j.compag.2009.01.003; Carroll MW, 2008, J ECON ENTOMOL, V101, P1614, DOI 10.1603/0022-0493(2008)101[1614:UOSVID]2.0.CO;2; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Chaerle L, 2000, TRENDS PLANT SCI, V5, P495, DOI 10.1016/S1360-1385(00)01781-7; Chaerle L, 2004, PLANT CELL PHYSIOL, V45, P887, DOI 10.1093/pcp/pch097; Chou HM, 2000, MOL PLANT PATHOL, V1, P99, DOI 10.1046/j.1364-3703.2000.00013.x; Delalieux S, 2009, INT J REMOTE SENS, V30, P1887, DOI 10.1080/01431160802541556; Delalieux S, 2007, EUR J AGRON, V27, P130, DOI 10.1016/j.eja.2007.02.005; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Graeff S, 2006, CENT EUR J BIOL, V1, P275, DOI 10.2478/s11535-006-0020-8; Gutierrez PA, 2008, COMPUT ELECTRON AGR, V60, P122, DOI 10.1016/j.compag.2007.07.011; HALL MA, 1998, THESIS U WAIKATO; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hatfield JL, 2008, AGRON J, V100, pS117, DOI 10.2134/agronj2006.0370c; Hellebrand H. J., 2006, International Agrophysics, V20, P1; Jones HG, 2004, ADV BOT RES, V41, P107; Karimi Y, 2006, COMPUT ELECTRON AGR, V51, P99, DOI 10.1016/j.compag.2005.12.001; Knogge W, 1996, PLANT CELL, V8, P1711, DOI 10.1105/tpc.8.10.1711; Lagopodi AL, 2010, EUR J PLANT PATHOL, V128, P311, DOI 10.1007/s10658-010-9665-2; Larsolle A, 2007, PRECIS AGRIC, V8, P37, DOI 10.1007/s11119-006-9027-4; Lindenthal M, 2005, PHYTOPATHOLOGY, V95, P233, DOI 10.1094/PHYTO-95-0233; Logrieco A, 2009, WORLD MYCOTOXIN J, V2, P129, DOI 10.3920/WMJ2009.1145; MAGAN N, 1984, APPL ENVIRON MICROB, V47, P1113, DOI 10.1128/AEM.47.5.1113-1117.1984; Mahlein AK, 2010, PRECIS AGRIC, V11, P413, DOI 10.1007/s11119-010-9180-7; Mahlein AK, 2012, EUR J PLANT PATHOL, V133, P197, DOI 10.1007/s10658-011-9878-z; MITCHELL MT, 1998, MACHINE LEARNING; Naidu RA, 2009, COMPUT ELECTRON AGR, V66, P38, DOI 10.1016/j.compag.2008.11.007; Oerke EC, 2006, J EXP BOT, V57, P2121, DOI 10.1093/jxb/erj170; Oerke EC, 2011, PRECIS AGRIC, V12, P699, DOI 10.1007/s11119-010-9212-3; Otani H, 1992, ALTERNARIA BIOL PLAN, P573; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Saharan G. S., 1983, Indian Phytopathology, V36, P503; Siedliska A, 2014, COMPUT ELECTRON AGR, V106, P66, DOI 10.1016/j.compag.2014.05.012; Steddom K, 2005, PLANT DIS, V89, P153, DOI 10.1094/PD-89-0153; Steddom K, 2003, PHYTOPATHOLOGY, V93, P720, DOI 10.1094/PHYTO.2003.93.6.720; Wang X, 2008, INT J REMOTE SENS, V29, P1693, DOI 10.1080/01431160701281007; Witten I.H., 2005, MORGAN KAUFMAN SERIE; Wolf PFJ, 2002, PLANT DIS, V86, P336, DOI 10.1094/PDIS.2002.86.4.336; Wu D, 2008, T ASABE, V51, P1133, DOI 10.13031/2013.24504; Zhang M, 2002, INT J REMOTE SENS, V23, P1095, DOI 10.1080/01431160110106078	51	65	69	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122913	10.1371/journal.pone.0122913	http://dx.doi.org/10.1371/journal.pone.0122913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826369	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800098
J	Ishii, A; Karasuyama, T; Kikuchi, T; Tanaka, M; Yamano, E; Watanabe, Y				Ishii, Akira; Karasuyama, Takuma; Kikuchi, Taiki; Tanaka, Masaaki; Yamano, Emi; Watanabe, Yasuyoshi			The Neural Mechanisms of Re-Experiencing Mental Fatigue Sensation: A Magnetoencephalography Study	PLOS ONE			English	Article							BRAIN ACTIVITY; AMYGDALA RESPONSES; SYNCHRONIZATION; HAPPINESS; DYNAMICS; SADNESS; EVENTS; MEG	There have been several studies which have tried to clarify the neural mechanisms of fatigue sensation; however fatigue sensation has multiple aspects. We hypothesized that past experience related to fatigue sensation is an important factor which contributes to future formation of fatigue sensation through the transfer to memories that are located within specific brain structures. Therefore, we aimed to investigate the neural mechanisms of fatigue sensation related to memory. In the present study, we investigated the neural activity caused by re-experiencing the fatigue sensation that had been experienced during a fatigue-inducing session. Thirteen healthy volunteers participated in fatigue and non-fatigue experiments in a crossover fashion. In the fatigue experiment, they performed a 2-back test session for 40 min to induce fatigue sensation, a rest session for 15 min to recover from fatigue, and a magnetoencephalography (MEG) session in which they were asked to re-experience the state of their body with fatigue that they had experienced in the 2-back test session. In the non-fatigue experiment, the participants performed a free session for 15 min, a rest session for 15 min, and an MEG session in which they were asked to re-experience the state of their body without fatigue that they had experienced in the free session. Spatial filtering analyses of oscillatory brain activity showed that the delta band power in the left Brodmann's area (BA) 39, alpha band power in the right pulvinar nucleus and the left BA 40, and beta band power in the left BA 40 were lower when they re-experienced the fatigue sensation than when they re-experienced the fatigue-free sensation, indicating that these brain regions are related to re-experiencing the fatigue sensation. Our findings may help clarify the neural mechanisms underlying fatigue sensation.	[Ishii, Akira; Karasuyama, Takuma; Kikuchi, Taiki; Tanaka, Masaaki; Yamano, Emi; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 5458585, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Osaka Metropolitan University; RIKEN	Ishii, A (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	a.ishii@med.osaka-cu.ac.jp	Yamano, Emi/AAL-6201-2020	Yamano, Emi/0000-0003-3907-5360	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Health Labour Science Research Grant of Japan [KAKENHI: 25750351]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [25750351] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Health Labour Science Research Grant of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI: 25750351) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Health Labour Science Research Grant of Japan, and by a grant from the Ministry of Health, Labour and Welfare of Japan (URLs: http://www.jsps.go.jp/j-grantsinaid/index.html; http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal Y, 2007, P ANN INT IEEE EMBS, P4937, DOI 10.1109/IEMBS.2007.4353448; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cornwell BR, 2008, BRAIN RES, V1244, P103, DOI 10.1016/j.brainres.2008.09.068; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Denkova E, 2006, BRAIN RES, V1078, P143, DOI 10.1016/j.brainres.2006.01.061; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Ishii A, 2014, NEUROSCIENCE, V261, P60, DOI 10.1016/j.neuroscience.2013.12.049; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095763; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Kitani T., 2011, NIHON HIROUGAKKAISHI, V6, P1; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otto T, 2013, SOCIAL COGNITIVE AFF; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Papadelis C, 2007, INT J BIOELECTROMAGN, V9, P163; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Sekihara K, 2008, SER BIOMED ENG, P1; Styliadis C, 2014, INT J PSYCHOPHYSIOL, V93, P121, DOI 10.1016/j.ijpsycho.2013.05.006; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tanaka M, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-46; Tanaka M, 2008, PSYCHOL REP, V103, P682, DOI 10.2466/PR0.103.3.682-690; Tanaka M, 2009, LIFE SCI, V84, P235, DOI 10.1016/j.lfs.2008.12.004; van Wijk BCM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00187	34	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122455	10.1371/journal.pone.0122455	http://dx.doi.org/10.1371/journal.pone.0122455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826300	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800070
J	Siegel, EM; Riggs, BM; Delmas, AL; Koch, A; Hakam, A; Brown, KD				Siegel, Erin M.; Riggs, Bridget M.; Delmas, Amber L.; Koch, Abby; Hakam, Ardeshir; Brown, Kevin D.			Quantitative DNA Methylation Analysis of Candidate Genes in Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; PROMOTER HYPERMETHYLATION; INTRAEPITHELIAL NEOPLASIA; PROGNOSTIC MARKER; POSITIVE WOMEN; UTERINE CERVIX; CPG ISLANDS; DAP-KINASE; SLIT-ROBO; PROTEIN	Aberrant DNA methylation has been observed in cervical cancer; however, most studies have used non-quantitative approaches to measure DNA methylation. The objective of this study was to quantify methylation within a select panel of genes previously identified as targets for epigenetic silencing in cervical cancer and to identify genes with elevated methylation that can distinguish cancer from normal cervical tissues. We identified 49 women with invasive squamous cell cancer of the cervix and 22 women with normal cytology specimens. Bisulfite-modified genomic DNA was amplified and quantitative pyrosequencing completed for 10 genes (APC, CCNA, CDH1, CDH13, WIF1, TIMP3, DAPK1, RARB, FHIT, and SLIT2). A Methylation Index was calculated as the mean percent methylation across all CpG sites analyzed per gene (similar to 4-9 CpG site) per sequence. A binary cut-point was defined at > 15% methylation. Sensitivity, specificity and area under ROC curve (AUC) of methylation in individual genes or a panel was examined. The median methylation index was significantly higher in cases compared to controls in 8 genes, whereas there was no difference in median methylation for 2 genes. Compared to HPV and age, the combination of DNA methylation level of DAPK1, SLIT2, WIF1 and RARB with HPV and age significantly improved the AUC from 0.79 to 0.99 (95% CI: 0.97-1.00, p-value = 0.003). Pyrosequencing analysis confirmed that several genes are common targets for aberrant methylation in cervical cancer and DNA methylation level of four genes appears to increase specificity to identify cancer compared to HPV detection alone. Alterations in DNA methylation of specific genes in cervical cancers, such as DAPK1, RARB, WIF1, and SLIT2, may also occur early in cervical carcinogenesis and should be evaluated.	[Siegel, Erin M.; Riggs, Bridget M.; Koch, Abby] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Div Populat Sci, Tampa, FL 33612 USA; [Delmas, Amber L.; Brown, Kevin D.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Delmas, Amber L.; Brown, Kevin D.] Univ Florida, Coll Med, UF Shands Canc Ctr, Gainesville, FL 32610 USA; [Hakam, Ardeshir] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute	Siegel, EM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Div Populat Sci, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Erin.Siegel@moffitt.org		Eliason, Amber/0000-0001-8765-686X	University of Florida-Moffitt Collaborative Grant [UF09060]; National Cancer Institute [1RO3 CA143980-01]; Tissue Core Facility at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA76292]; Collaborative Data Services Core Facility at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA76292]; NATIONAL CANCER INSTITUTE [R25CA174664, R03CA143980, P30CA076292] Funding Source: NIH RePORTER	University of Florida-Moffitt Collaborative Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tissue Core Facility at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; Collaborative Data Services Core Facility at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this study was provided by a University of Florida-Moffitt Collaborative Grant (UF09060) and National Cancer Institute 1RO3 CA143980-01 grant to EMS and KDB. This work was supported in part by the Tissue Core Facility and the Collaborative Data Services Core Facility at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center, under grant number P30-CA76292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL C, 1991, CANCER RES, V51, P3982; Benbrook DM, 1997, GYNECOL ONCOL, V66, P114, DOI 10.1006/gyno.1997.4736; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; Chaopatchayakul P, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.037; Choi CH, 2007, CANCER LETT, V255, P26, DOI 10.1016/j.canlet.2007.03.015; Chung MT, 2009, GYNECOL ONCOL, V112, P301, DOI 10.1016/j.ygyno.2008.10.004; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Delmas AL, 2011, CARCINOGENESIS, V32, P1625, DOI 10.1093/carcin/bgr193; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Geisen C, 1997, CANCER RES, V57, P1460; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hernandez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050533; Hesselink AT, 2011, CLIN CANCER RES, V17, P2459, DOI 10.1158/1078-0432.CCR-10-2548; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Iliopoulos D, 2009, ONCOL REP, V22, P199, DOI 10.3892/or_00000425; Janes H, 2009, STATA J, V9, P17, DOI 10.1177/1536867X0900900102; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Jo H, 2007, J OBSTET GYNAECOL RE, V33, P236, DOI 10.1111/j.1447-0756.2007.00517.x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Leonard SM, 2012, CARCINOGENESIS, V33, P1286, DOI 10.1093/carcin/bgs157; Lin TS, 2005, CANCER LETT, V226, P77, DOI 10.1016/j.canlet.2004.12.031; Lorincz Attila T, 2011, Expert Opin Med Diagn, V5, P375; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Mitra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038342; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Pepe MS, 2009, STATA J, V9, P1; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Reesink-Peters N, 2004, MOL CANCER RES, V2, P289; Sahasrabuddhe VV, 2011, FUTURE MICROBIOL, V6, P1083, DOI [10.2217/FMB.11.87, 10.2217/fmb.11.87]; Shivapurkar N, 2007, GYNECOL ONCOL, V107, P549, DOI 10.1016/j.ygyno.2007.08.057; Steinau M, 2014, J INFECT DIS, V209, P1739, DOI 10.1093/infdis/jit799; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; van der Meide WF, 2011, GYNECOL ONCOL, V123, P116, DOI 10.1016/j.ygyno.2011.06.015; Vasiljevic N, 2014, GYNECOL ONCOL, V132, P709, DOI 10.1016/j.ygyno.2014.02.001; Virmani AK, 2001, CLIN CANCER RES, V7, P584; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; Widschwendter A, 2004, INT J CANCER, V109, P163, DOI 10.1002/ijc.11706; Widschwendter A, 2004, CLIN CANCER RES, V10, P3396, DOI 10.1158/1078-0432.CCR-03-0143; Wisman GBA, 2006, INT J CANCER, V119, P1908, DOI 10.1002/ijc.22060; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Yang N, 2009, CANCER EPIDEM BIOMAR, V18, P3000, DOI 10.1158/1055-9965.EPI-09-0405	55	40	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122495	10.1371/journal.pone.0122495	http://dx.doi.org/10.1371/journal.pone.0122495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826459	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800074
J	Torstveit, MK; Aagedal-Mortensen, K; Stea, TH				Torstveit, Monica Klungland; Aagedal-Mortensen, Kjersti; Stea, Tonje Holte			More than Half of High School Students Report Disordered Eating: A Cross Sectional Study among Norwegian Boys and Girls	PLOS ONE			English	Article							FEMALE ATHLETE TRIAD; RISK-FACTORS; BODY-MASS; INTERNATIONAL SURVEY; ADOLESCENT GIRLS; YOUNG ADULTHOOD; SECULAR TRENDS; PREVALENCE; BEHAVIORS; ATTITUDES	Disordered eating and eating disorders are of great concern due to their associations with physical and mental health risks. Even if adolescence has been identified as the most vulnerable time for developing disordered eating, few studies have used a broad spectrum of criteria to investigate the prevalence of disordered eating among high school students of both genders, in different programs of study, nor assessed correlates of disordered eating among this important target group. The purposes of this study were therefore to investigate the prevalence and correlates of disordered eating among both male and female high school students in sport-, general and vocational programs. A comprehensive questionnaire was completed by 2,451 students (98.7%), aged 15-17 years. The total prevalence of disordered eating was 54.9%, with 64.3% among girls and 45.0% among boys (p< 0.001). The highest prevalence of disordered eating was found among vocational students (60.7%), followed by students in general programs (49.8%) and sport students (38.3%) (p< 0.001). Female gender, school program (vocational and general), overweight/obesity and weight regulation were positively associated with disordered eating. The high prevalence indicates the importance of tailored prevention efforts directed at high school students, particularly in vocational programs. Furthermore, a smaller girls-boys ratio than expected indicates that the efforts to identify and manage disordered eating among high school students should include both genders.	[Torstveit, Monica Klungland; Aagedal-Mortensen, Kjersti; Stea, Tonje Holte] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway	University of Agder	Torstveit, MK (corresponding author), Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway.	monica.k.torstveit@uia.no			Norwegian Olympic and Paralympic Committee and Confederation of Sports; Aust-Agder County in the south of Norway; Vest-Agder County in the south of Norway	Norwegian Olympic and Paralympic Committee and Confederation of Sports; Aust-Agder County in the south of Norway; Vest-Agder County in the south of Norway	The main project was supported with funding partly by the Norwegian Olympic and Paralympic Committee and Confederation of Sports and partly by the Aust-Agder and Vest-Agder Counties in the south of Norway. No grant numbers are included in the allocation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe DS, 2014, INT J BEHAV DEV, V38, P128, DOI 10.1177/0165025413514871; Anderson DA, 2004, BEHAV MODIF, V28, P763, DOI 10.1177/0145445503259851; Austin S Bryn, 2008, Prev Chronic Dis, V5, pA114; Bratland-Sanda S, 2012, EUR EAT DISORD REV, V20, P287, DOI 10.1002/erv.1156; Cafri G, 2005, CLIN PSYCHOL REV, V25, P215, DOI 10.1016/j.cpr.2004.09.003; Cafri G, 2004, ASSESSMENT, V11, P224, DOI 10.1177/1073191104267652; Chamay-Weber C, 2005, J ADOLESCENT HEALTH, V37, P417, DOI 10.1016/j.jadohealth.2004.09.014; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Croll J, 2002, J ADOLESCENT HEALTH, V31, P166, DOI 10.1016/S1054-139X(02)00368-3; Crow S, 2008, J CONSULT CLIN PSYCH, V76, P887, DOI 10.1037/a0012783; Coelho GMD, 2010, APPETITE, V55, P379, DOI 10.1016/j.appet.2010.08.003; Ferreira JED, 2008, APPETITE, V51, P249, DOI 10.1016/j.appet.2008.02.015; Ferreiro F, 2011, J CLIN CHILD ADOLESC, V40, P500, DOI 10.1080/15374416.2011.563465; FISHER M, 1995, J ADOLESCENT HEALTH, V16, P420, DOI 10.1016/1054-139X(95)00069-5; Forman-Hoffman Valerie, 2004, Eat Behav, V5, P325, DOI 10.1016/j.eatbeh.2004.04.003; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Gonsalves D, 2013, MATERN CHILD HLTH J, P20; Hadjigeorgiou C, 2012, PUBLIC HEALTH, V126, P690, DOI 10.1016/j.puhe.2012.04.014; Hautala LA, 2008, J CLIN NURS, V17, P1803, DOI 10.1111/j.1365-2702.2007.02143.x; Herpertz-Dahlmann B, 2011, NERVENARZT, V82, P1093, DOI 10.1007/s00115-010-3231-1; Herpertz-Dahlmann B, 2008, EUR CHILD ADOLES PSY, V17, P82, DOI 10.1007/s00787-008-1009-9; HOEK HW, 1995, AM J PSYCHIAT, V152, P1272; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Holm-Denoma JM, 2009, INT J EAT DISORDER, V42, P47, DOI 10.1002/eat.20560; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Jalali-Farahani S, 2014, CHILD PSYCHIAT HUM D; Joiner TE, 1998, INT J EAT DISORDER, V23, P189, DOI 10.1002/(SICI)1098-108X(199803)23:2<189::AID-EAT9>3.0.CO;2-G; Jonat L M, 2004, Eat Weight Disord, V9, P285; Kjelsas Einar, 2004, Eat Behav, V5, P13, DOI 10.1016/S1471-0153(03)00057-6; Liechty JM, 2013, INT J EAT DISORDER, V46, P790, DOI 10.1002/eat.22174; Litt D, 2008, BODY IMAGE, V5, P346, DOI 10.1016/j.bodyim.2008.04.002; MALONEY MJ, 1989, PEDIATRICS, V84, P482; Martinsen M, 2010, BRIT J SPORT MED, V44, P70, DOI 10.1136/bjsm.2009.068668; Martinsen M, 2013, MED SCI SPORT EXER, V45, P1188, DOI 10.1249/MSS.0b013e318281a939; McCarthy DM, 2002, ASSESSMENT, V9, P382, DOI 10.1177/1073191102238196; McCreary DR, 2000, J AM COLL HEALTH, V48, P297, DOI 10.1080/07448480009596271; McCreary DR., 2004, PSYCHOL MEN MASC, V5, P49, DOI [10.1037/1524-9220.5.1.49, DOI 10.1037/1524-9220.5.1.49]; Meltzer LJ, 2001, DIABETES CARE, V24, P678, DOI 10.2337/diacare.24.4.678; Monthuy-Blanc J, 2010, REV EPIDEMIOL SANTE, V58, P415, DOI 10.1016/j.respe.2010.07.003; Morande G, 1999, J ADOLESCENT HEALTH, V24, P212, DOI 10.1016/S1054-139X(98)00025-1; Musaiger AO, 2013, APPETITE, V60, P162, DOI 10.1016/j.appet.2012.10.012; Neumark-Sztainer D, 2006, J AM DIET ASSOC, V106, P559, DOI 10.1016/j.jada.2006.01.003; Neumark-Sztainer D, 2000, ARCH PEDIAT ADOL MED, V154, P569, DOI 10.1001/archpedi.154.6.569; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Neumark-Sztainer D, 2011, J AM DIET ASSOC, V111, P1004, DOI 10.1016/j.jada.2011.04.012; Nevonen L, 2006, NORD J PSYCHIAT, V60, P44, DOI 10.1080/08039480500504537; OLIVARDIA R, 1995, AM J PSYCHIAT, V152, P1279; Otis CL, 1997, MED SCI SPORT EXER, V29, pR1, DOI 10.1097/00005768-199705000-00037; Palma-Coca O, 2011, J ADOLESCENT HEALTH, V49, P400, DOI 10.1016/j.jadohealth.2011.01.019; Patton GC, 1999, BRIT MED J, V318, P765, DOI 10.1136/bmj.318.7186.765; Presnell K, 2009, CLIN PSYCHOL PSYCHOT, V16, P357, DOI 10.1002/cpp.630; Reinking MF, 2005, J ATHL TRAINING, V40, P47; Rodgers RF, 2012, BODY IMAGE, V9, P318, DOI 10.1016/j.bodyim.2012.03.002; Rosendahl J, 2009, SCAND J MED SCI SPOR, V19, P731, DOI 10.1111/j.1600-0838.2008.00821.x; SHISSLAK CM, 1995, INT J EAT DISORDER, V18, P209, DOI 10.1002/1098-108X(199511)18:3&lt;209::AID-EAT2260180303&gt;3.0.CO;2-E; Smolak L, 2000, INT J EAT DISORDER, V27, P371, DOI 10.1002/(SICI)1098-108X(200005)27:4&lt;371::AID-EAT1&gt;3.0.CO;2-Y; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Striegel-Moore RH, 2007, AM PSYCHOL, V62, P181, DOI 10.1037/0003-066X.62.3.181; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; SUNDGOTBORGEN J, 1993, INT J SPORT NUTR, V3, P29, DOI 10.1123/ijsn.3.1.29; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tam CK, 2007, J PAEDIATR CHILD H, V43, P811, DOI 10.1111/j.1440-1754.2007.01195.x; THELEN MH, 1992, J CLIN CHILD PSYCHOL, V21, P41, DOI 10.1207/s15374424jccp2101_7; Thiel A, 2006, J PSYCHOSOM RES, V61, P567, DOI 10.1016/j.jpsychores.2006.02.015; Torstveit MK, 2008, SCAND J MED SCI SPOR, V18, P108, DOI 10.1111/j.1600-0838.2007.00657.x; Torstveit MK, 2005, MED SCI SPORT EXER, V37, P184, DOI 10.1249/01.MSS.0000152677.60545.3A; Torstveit MK, 2005, MED SCI SPORT EXER, V37, P1449, DOI 10.1249/01.mss.0000177678.73041.38; Toselli AL, 2005, EPIDEMIOL PSICHIAT S, V14, P91, DOI 10.1017/S1121189X00006291; von Soest T, 2014, INT J EAT DISORDER, V47, P448, DOI 10.1002/eat.22271; White J H, 2000, J Child Adolesc Psychiatr Nurs, V13, P76, DOI 10.1111/j.1744-6171.2000.tb00081.x	72	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122681	10.1371/journal.pone.0122681	http://dx.doi.org/10.1371/journal.pone.0122681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25825877	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800085
J	Bull, SC; Doig, AJ				Bull, Simon C.; Doig, Andrew J.			Properties of Protein Drug Target Classes	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; COUPLED RECEPTORS; ALLOSTERIC MODULATION; THERAPEUTIC TARGETS; CANCER; GENE; EXPRESSION; DISCOVERY; OPINION; DESIGN	Accurate identification of drug targets is a crucial part of any drug development program. We mined the human proteome to discover properties of proteins that may be important in determining their suitability for pharmaceutical modulation. Data was gathered concerning each protein's sequence, post-translational modifications, secondary structure, germline variants, expression profile and drug target status. The data was then analysed to determine features for which the target and non-target proteins had significantly different values. This analysis was repeated for subsets of the proteome consisting of all G-protein coupled receptors, ion channels, kinases and proteases, as well as proteins that are implicated in cancer. Machine learning was used to quantify the proteins in each dataset in terms of their potential to serve as a drug target. This was accomplished by first inducing a random forest that could distinguish between its targets and non-targets, and then using the random forest to quantify the drug target likeness of the non-targets. The properties that can best differentiate targets from non-targets were primarily those that are directly related to a protein's sequence (e.g. secondary structure). Germline variants, expression levels and interactions between proteins had minimal discriminative power. Overall, the best indicators of drug target likeness were found to be the proteins' hydrophobicities, in vivo half-lives, propensity for being membrane bound and the fraction of non-polar amino acids in their sequences. In terms of predicting potential targets, datasets of proteases, ion channels and cancer proteins were able to induce random forests that were highly capable of distinguishing between targets and non-targets. The non-target proteins predicted to be targets by these random forests comprise the set of the most suitable potential future drug targets, and should therefore be prioritised when building a drug development programme.	[Bull, Simon C.; Doig, Andrew J.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Doig, AJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	andrew.doig@manchester.ac.uk	Doig, Andrew/AAD-7456-2019	Doig, Andrew/0000-0003-0346-2270	Biotechnology & Biological Sciences Research Council (BBSRC) (UK)	Biotechnology & Biological Sciences Research Council (BBSRC) (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology & Biological Sciences Research Council (BBSRC) (UK) supported SCB with a PhD Studenship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Andersen OS, 2008, J GEN PHYSIOL, V131, P395, DOI 10.1085/jgp.200810012; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Bull SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055484; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cavanaugh A, 2012, BRIT J PHARMACOL, V165, P1670, DOI 10.1111/j.1476-5381.2011.01403.x; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen XP, 2007, DRUG DISCOV THER, V1, P23; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dilly S, 2011, CHEMBIOCHEM, V12, P1808, DOI 10.1002/cbic.201100236; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ekman D, 2006, GENOME BIOLOGY, V7, P13; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Eshelman L., 1991, FDN GENETIC ALGORITH, P265, DOI DOI 10.1016/B978-0-08-050684-5.50020-3; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kinsella RJ, 2011, DATABASE THE JOURNAL, V9, DOI [10.1093/database/bar013, DOI 10.1093/DATABASE/BAR013]; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lane JR, 2013, ACS CHEM NEUROSCI, V4, P527, DOI 10.1021/cn400005t; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; McNulty MM, 2007, J PHYSIOL-LONDON, V581, P741, DOI 10.1113/jphysiol.2007.130161; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Perner S, 2013, INT J CANCER, V132, P807, DOI 10.1002/ijc.27733; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shen A, 2010, MOL BIOSYST, V6, P1431, DOI 10.1039/c003913f; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xu H, 2001, AM J PHYSIOL-CELL PH, V280, pC628, DOI 10.1152/ajpcell.2001.280.3.C628; Xu H, 2007, PROTEOMICS, V7, P4255, DOI 10.1002/pmic.200700062; Yin M, 2007, DIAGN PATHOL, V2, P2; Zheng CJ, 2006, PHARMACOL REV, V58, P259, DOI 10.1124/pr.58.2.4; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	68	60	62	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117955	10.1371/journal.pone.0117955	http://dx.doi.org/10.1371/journal.pone.0117955			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822509	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700016
J	Fujisawa, M; Kobayashi, K; Johnston, P; New, M				Fujisawa, Mariko; Kobayashi, Kazuhiko; Johnston, Peter; New, Mark			What Drives Farmers to Make Top-Down or Bottom-Up Adaptation to Climate Change and Fluctuations? A Comparative Study on 3 Cases of Apple Farming in Japan and South Africa	PLOS ONE			English	Article							FRUIT-QUALITY; VULNERABILITY; VARIABILITY; TRENDS; POLICY	Agriculture is one of the most vulnerable sectors to climate change. Farmers have been exposed to multiple stressors including climate change, and they have managed to adapt to those risks. The adaptation actions undertaken by farmers and their decision making are, however, only poorly understood. By studying adaptation practices undertaken by apple farmers in three regions: Nagano and Kazuno in Japan and Elgin in South Africa, we categorize the adaptation actions into two types: farmer initiated bottom-up adaptation and institution led top-down adaptation. We found that the driver which differentiates the type of adaptation likely adopted was strongly related to the farmers' characteristics, particularly their dependence on the institutions, e.g. the farmers' cooperative, in selling their products. The farmers who rely on the farmers' cooperative for their sales are likely to adopt the institution-led adaptation, whereas the farmers who have established their own sales channels tend to start innovative actions by bottom-up. We further argue that even though the two types have contrasting features, the combinations of the both types of adaptations could lead to more successful adaptation particularly in agriculture. This study also emphasizes that more farm-level studies for various crops and regions are warranted to provide substantial feedbacks to adaptation policy.	[Fujisawa, Mariko; Kobayashi, Kazuhiko] Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan; [Fujisawa, Mariko; New, Mark] Univ Cape Town, ACDI, ZA-7701 Rondebosch, South Africa; [Johnston, Peter] Univ Cape Town, CSAG, ZA-7701 Cape Town, South Africa	University of Tokyo; University of Cape Town; University of Cape Town	Kobayashi, K (corresponding author), Univ Tokyo, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	k.kobayashi.ut@gmail.com	New, Mark/A-7684-2008; Kobayashi, Kazuhiko/AAN-7096-2020	New, Mark/0000-0001-6082-8879; Johnston, Peter/0000-0003-3329-0334	Research Program on Climate Change, Agriculture and Food Security (CCAFS); Consultative Group on International Agricultural Research (CGIAR)	Research Program on Climate Change, Agriculture and Food Security (CCAFS); Consultative Group on International Agricultural Research (CGIAR)(CGIAR)	The grant is in 'Theme 4.2-Activity 261' (http://activities.ccafs.cgiar.org/activity.do?id=261), Research Program on Climate Change, Agriculture and Food Security (CCAFS) (http://ccafs.cgiar.org/), the Consultative Group on International Agricultural Research (CGIAR). MN got the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger W. N., 2007, CLIMATE CHANGE 2007, P717, DOI DOI 10.1017/CB09781107415324.004; Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Amaru S, 2013, APPL GEOGR, V39, P128, DOI 10.1016/j.apgeog.2012.12.006; [Anonymous], 2011, KEY DECIDUOUS FRUIT; Arakawa O, 2000, REGUL PLANT GROWTH D, V35, P149; Asari M., 2010, Japanese Journal of Phytopathology, V76, P85; Belliveau S, 2006, GLOBAL ENVIRON CHANG, V16, P364, DOI 10.1016/j.gloenvcha.2006.03.003; Bradshaw B, 2004, CLIMATIC CHANGE, V67, P119, DOI 10.1007/s10584-004-0710-z; Burton I, 2005, CLIMATIC CHANGE, V70, P191, DOI 10.1007/s10584-005-5942-z; Cook NC, 2000, J HORTIC SCI BIOTECH, V75, P233; Darnhofer I, 2010, ENVIRON POLICY GOV, V20, P212, DOI 10.1002/eet.547; Department of Agriculture, 2013, TRENDS AGR SECT 2012; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; FAO, 2011, FAO STAT APPL PROD W; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Fujisawa M, 2013, IMPACTS WORLD, V2013, P815, DOI [10.2312/pik.2013.001, DOI 10.2312/PIK.2013.001]; Fujisawa M, 2013, REG ENVIRON CHANGE, V13, P1211, DOI 10.1007/s10113-013-0434-6; Fujisawa M, 2011, MITIG ADAPT STRAT GL, V16, P865, DOI 10.1007/s11027-011-9299-5; Fujisawa M, 2010, GLOBAL CHANGE BIOL, V16, P2651, DOI 10.1111/j.1365-2486.2009.02126.x; Grab S, 2011, AGR FOREST METEOROL, V151, P406, DOI 10.1016/j.agrformet.2010.11.001; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Iglesias I, 2008, SCI HORTIC-AMSTERDAM, V119, P32, DOI 10.1016/j.scienta.2008.07.004; Japan Meteorological Agency, 2011, STAT CLIM INF JAP; Ju ZQ, 1999, SCI HORTIC-AMSTERDAM, V82, P47, DOI 10.1016/S0304-4238(99)00038-2; Kawano S, 1998, J JPN SOC HORTIC SCI, V67, P1176, DOI 10.2503/jjshs.67.1176; Klein RJT, 2005, ENVIRON SCI POLICY, V8, P579, DOI 10.1016/j.envsci.2005.06.010; Mertz O, 2009, ENVIRON MANAGE, V43, P804, DOI 10.1007/s00267-008-9197-0; Midgley SJE, 2011, ACTA HORTIC, V903, P1127, DOI 10.17660/ActaHortic.2011.903.157; Ministry of Agriculture Forestry and Fisheries, 2005, CENS AGR FOR 2005; Ministry of Agriculture Forestry and Fisheries, 2010, BAS POL FRUITS PROD; Ministry of Agriculture Forestry and Fishery, 2010, FOR FISH APPL PROD J; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Nicholas KA, 2012, GLOBAL ENVIRON CHANG, V22, P483, DOI 10.1016/j.gloenvcha.2012.01.001; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Osanai Y., 1990, Bulletin of the Aomori Apple Experiment Station, V26, P159; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Salinari F, 2006, GLOBAL CHANGE BIOL, V12, P1299, DOI 10.1111/j.1365-2486.2006.01175.x; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Sugiura T, 2004, J JPN SOC HORTIC SCI, V73, P72, DOI 10.2503/jjshs.73.72; Sugiura Toshihiko, 2007, Horticultural Research (Japan), V6, P257, DOI 10.2503/hrj.6.257; Sugiura T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02418; Thomas DSG, 2007, CLIMATIC CHANGE, V83, P301, DOI 10.1007/s10584-006-9205-4; Tompkins EL, 2010, GLOBAL ENVIRON CHANG, V20, P627, DOI 10.1016/j.gloenvcha.2010.05.001; Tucker CM, 2010, GLOBAL ENVIRON CHANG, V20, P23, DOI 10.1016/j.gloenvcha.2009.07.006; Veberic R, 2007, J SCI FOOD AGR, V87, P593, DOI 10.1002/jsfa.2726; Wilby RL, 2010, WEATHER, V65, P180, DOI 10.1002/wea.543	46	14	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120563	10.1371/journal.pone.0120563	http://dx.doi.org/10.1371/journal.pone.0120563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822534	Green Published, Green Accepted, gold			2022-12-27	WOS:000352134700067
J	Hiong, KC; Ip, YK; Wong, WP; Chew, SF				Hiong, Kum C.; Ip, Yuen K.; Wong, Wai P.; Chew, Shit F.			Differential Gene Expression in the Liver of the African Lungfish, Protopterus annectens, after 6 Months of Aestivation in Air or 1 Day of Arousal from 6 Months of Aestivation	PLOS ONE			English	Article							BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; MESSENGER-RNA EXPRESSION; PHOSPHATE SYNTHETASE-III; INCREASED UREA SYNTHESIS; NITROGEN-METABOLISM; MOLECULAR CHARACTERIZATION; METHIONINE METABOLISM; AMMONIA PRODUCTION; HYDROGEN-PEROXIDE; SKELETAL-MUSCLE	The African lungfish, Protopterus annectens, can undergo aestivation during drought. Aestivation has three phases: induction, maintenance and arousal. The objective of this study was to examine the differential gene expression in the liver of P. annectens after 6 months (the maintenance phase) of aestivation as compared with the freshwater control, or after 1 day of arousal from 6 months aestivation as compared with 6 months of aestivation using suppression subtractive hybridization. During the maintenance phase of aestivation, the mRNA expression of argininosuccinate synthetase 1 and carbamoyl phosphate synthetase III were up-regulated, indicating an increase in the ornithine-urea cycle capacity to detoxify ammonia to urea. There was also an increase in the expression of betaine homocysteine-S-transferase 1 which could reduce and prevent the accumulation of hepatic homocysteine. On the other hand, the down-regulation of superoxide dismutase 1 expression could signify a decrease in ROS production during the maintenance phase of aestivation. In addition, the maintenance phase was marked by decreases in expressions of genes related to blood coagulation, complement fixation and iron and copper metabolism, which could be strategies used to prevent thrombosis and to conserve energy. Unlike the maintenance phase of aestivation, there were increases in expressions of genes related to nitrogen, carbohydrate and lipid metabolism and fatty acid transport after 1 day of arousal from 6 months aestivation. There were also up-regulation in expressions of genes that were involved in the electron transport system and ATP synthesis, indicating a greater demand for metabolic energy during arousal. Overall, our results signify the importance of sustaining a low rate of waste production and conservation of energy store during the maintenance phase, and the dependence on internal energy store for repair and structural modification during the arousal phase, of aestivation in the liver of P. annectens.	[Hiong, Kum C.; Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore 639798, Singapore; [Ip, Yuen K.; Wong, Wai P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; National University of Singapore	Chew, SF (corresponding author), Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore 639798, Singapore.	sfun.chew@nie.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	Ministry of Education of the Republic of Singapore [R-154-000-429-112, R154-000-470-112, RI 9/08 CSF, RI 4/12 CSF]	Ministry of Education of the Republic of Singapore(Ministry of Education, Singapore)	This project was supported by the Ministry of Education of the Republic of Singapore through grants (R-154-000-429-112 and R154-000-470-112) and (RI 9/08 CSF and RI 4/12 CSF), administered to Y. K. Ip and S. F. Chew, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abu-Amara M, 2012, LIVER INT, V32, P531, DOI 10.1111/j.1478-3231.2012.02755.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Cammack R, 1990, IRON TRANSPORT STORA, P17; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Carnovale CE, 2012, ANN HEPATOL, V11, P636, DOI 10.1016/S1665-2681(19)31436-X; Chasteen ND, 1998, MET IONS BIOL SYST, V35, P479; Chew SF, 2003, J EXP BIOL, V206, P3615, DOI 10.1242/jeb.00619; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; Chng YR, 2014, J COMP PHYSIOL B, V184, P835, DOI 10.1007/s00360-014-0842-z; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; DELANEY RG, 1976, COPEIA, P423; DELANEY RG, 1977, AM J PHYSIOL, V233, pR181, DOI 10.1152/ajpregu.1977.233.5.R181; DELANEY RG, 1974, J EXP BIOL, V61, P111; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; FINKELSTEIN JD, 1971, ARCH BIOCHEM BIOPHYS, V146, P84, DOI 10.1016/S0003-9861(71)80044-9; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; FISHMAN AP, 1986, J MORPHOL, P237; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; GUBLER CJ, 1953, J CLIN INVEST, V32, P405, DOI 10.1172/JCI102752; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Henkin R, 1974, PROTEIN METAL INTERA, ppp; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; HERMESLIMA M, 1995, AM J PHYSIOL-REG I, V268, pR1386, DOI 10.1152/ajpregu.1995.268.6.R1386; Ip YK, 2010, PROG MOL SUBCELL BIO, V49, P63, DOI 10.1007/978-3-642-02421-4_4; Ip YK, 2005, J EXP ZOOL PART A, V303A, P1054, DOI 10.1002/jez.a.237; JANSSENS PA, 1968, COMP BIOCHEM PHYSIOL, V24, P887, DOI 10.1016/0010-406X(68)90800-1; JANSSENS PA, 1968, COMP BIOCHEM PHYSIOL, V24, P879, DOI 10.1016/0010-406X(68)90799-8; Kalani A, 2013, MOL NEUROBIOL, V48, P157, DOI 10.1007/s12035-013-8421-y; KETTERER B, 1983, ENVIRON HEALTH PERSP, V49, P59, DOI 10.2307/3429581; KIKUCHI K, 1995, J BIOL CHEM, V270, P17087, DOI 10.1074/jbc.270.29.17087; Linn S, 1998, DRUG METAB REV, V30, P313, DOI 10.3109/03602539808996315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loong AM, 2008, J COMP PHYSIOL B, V178, P853, DOI 10.1007/s00360-008-0273-9; Loong AM, 2007, AQUAT TOXICOL, V85, P76, DOI 10.1016/j.aquatox.2007.08.002; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Loong AM, 2012, J COMP PHYSIOL B, V182, P231, DOI 10.1007/s00360-011-0613-z; Loong AM, 2008, J COMP PHYSIOL B, V178, P351, DOI 10.1007/s00360-007-0228-6; Loong AM, 2005, J EXP ZOOL PART A, V303A, P354, DOI 10.1002/jez.a.147; MANNERVIK B, 1985, METHOD ENZYMOL, V113, P490; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Miller A, 2000, HEART VESSELS, V15, P135, DOI 10.1007/s003800070030; Miller JW, 1999, NUTR REV, V57, P126; Millian NS, 1998, ARCH BIOCHEM BIOPHYS, V356, P93, DOI 10.1006/abbi.1998.0757; Muller- Eberhard U, 1974, STRUCTURE FUNCTION P, V1, ppp; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Ong JLY, 2015, COMP BIOCHEM PHYS B, V183, P30, DOI 10.1016/j.cbpb.2014.12.007; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; PROHASKA JR, 1980, BIOCHIM BIOPHYS ACTA, V611, P87, DOI 10.1016/0005-2744(80)90045-5; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; ROGERS JT, 1990, J BIOL CHEM, V265, P14572; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Sha Z, 2008, MOL IMMUNOL, V45, P1458, DOI 10.1016/j.molimm.2007.08.012; Smith HW, 1931, ECOLOGY, V12, P164, DOI 10.2307/1932938; STEEGERSTHEUNISSEN RPM, 1991, NEW ENGL J MED, V324, P199; Storey KB, 1996, BRAZ J MED BIOL RES, V29, P1715; THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TORTI SV, 1988, J BIOL CHEM, V263, P12638; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; Veeranki S, 2013, INT J MOL SCI, V14, P15074, DOI 10.3390/ijms140715074; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Yogev O, 2010, PLOS BIOL, V8, p[e1000328, doi], DOI [doi: 10.1371/ journal. pbio. 1000328 PMID: 20231875, DOI 10.1371/J0URNAL.PBI0.1000328]; [No title captured]	71	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121224	10.1371/journal.pone.0121224	http://dx.doi.org/10.1371/journal.pone.0121224			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822522	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700096
J	Huang, Y; Deng, HJ; Shan, XF; Gong, XY; Li, XS; Tu, Z; Long, QX; Huang, AL				Huang, Yong; Deng, Haijun; Shan, Xuefeng; Gong, Xuyang; Li, Xiaosong; Tu, Zen; Long, Quanxin; Huang, Ailong			Lower Mutation Frequency of BCP/Precore Regions in e Antigen-Negative Chronic HBV-Infected Children instead of Adults Patients	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BASAL CORE PROMOTER; PRECORE REGION; VIRAL REPLICATION; HBEAG SEROCONVERSION; LIVER-DISEASE; GENE; MUTANTS; ASSOCIATION; EXPRESSION	To describe the Hepatitis B e antigen(HBeAg) seroconversion related mutation profiles of the basal core promoter(BCP)/precore regions in e antigen seroconverted child patients, a cohort of 245 child patients with CHB and a control patients group of 92 adult patients with CHB were recruited. The mutation frequencies of six nucleotides or nucleotide combinations including nucleotide (nt) 1896, nt1762/1764, nt1752, nt1846, nt1899 and nt1753 showed significant differences between HBeAg positive and HBeAg-negative child patients groups. The frequencies of these HBeAg seroconversion-related mutations were significantly lower in HBeAg-negative children with CHB than in HBeAg-negative adults with CHB, especially for the mutation G1896A (41.1% vs 91.7%, P< 0.001), and the average number of BCP/precore region mutations in samples from HBeAg-negative child patients was also obviously lower than in HBeAg-negative adult patients(3.62 +/- 3.03 vs 4.89 +/- 2.09, P< 0.001), suggesting less impact of mutations in the BCP/precore region on HBeAg seroconversion in child patients than adult patients.	[Huang, Yong; Deng, Haijun; Gong, Xuyang; Li, Xiaosong; Tu, Zen; Long, Quanxin; Huang, Ailong] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Huang, Yong; Deng, Haijun; Gong, Xuyang; Li, Xiaosong; Tu, Zen; Long, Quanxin; Huang, Ailong] Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China; [Huang, Yong] Chongqing Med Univ, Affiliated Hosp 2, Dept Clin Lab, Chongqing, Peoples R China; [Shan, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China; [Long, Quanxin; Huang, Ailong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Long, QX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.	longquanxin@gmail.com; ahuang1964@163.com	LI, XIAOSONG/GLT-3551-2022; Long, Quanxin/AAK-6199-2021	Long, Quanxin/0000-0003-1857-2798; Li, Xiaosong/0000-0001-5533-7995	National Science and Technology Major Project [2013ZX10002002]; Chongqing Science and Technology Commission [cstc2013jcyjC10002]; National Natural Science Foundation of China [81301394]	National Science and Technology Major Project; Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded in full by National Science and Technology Major Project (2013ZX10002002), Chongqing Science and Technology Commission (cstc2013jcyjC10002), and National Natural Science Foundation of China (81301394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113, DOI 10.1016/0016-5085(90)90632-B; [Anonymous], 2009, J HEPATOL, V50, P227, DOI [10.1016/j.jhep.2008., 10.001S0168-8278(08)00637-5, DOI 10.1016/J.JHEP.2008]; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1053/jhep.1996.v24.pm0008707278; Buckwold VE, 1996, J VIROL, V70, P5845, DOI 10.1128/JVI.70.9.5845-5851.1996; CARMAN WF, 1989, LANCET, V2, P588; Chauhan R, 2006, J MED VIROL, V78, P1047, DOI 10.1002/jmv.20661; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chen WN, 2000, EUR J CLIN INVEST, V30, P787; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chun YK, 2000, HEPATOLOGY, V32, P1154; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fang ZL, 2009, J HEPATOL, V50, P273, DOI 10.1016/j.jhep.2008.09.014; Gunther S, 1998, J GEN VIROL, V79, P375; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kang HS, 2011, J KOREAN MED SCI, V26, P546, DOI 10.3346/jkms.2011.26.4.546; Kitab B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042891; Kurosaki M, 1996, J MED VIROL, V49, P115; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2010, DIGEST DIS SCI, V55, P2727, DOI 10.1007/s10620-010-1179-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Milich DR, 1998, J IMMUNOL, V160, P2013; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2000, HEPATOLOGY, V32, P124, DOI 10.1053/jhep.2000.8529; Nie H, 2012, J HEPATOL, V56, P795, DOI 10.1016/j.jhep.2011.11.012; Nordin M, 2014, J MED VIROL, V86, P437, DOI 10.1002/jmv.23839; OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990; OKAMOTO H, 1994, J VIROL, V68, P8102, DOI 10.1128/JVI.68.12.8102-8110.1994; Pang A, 2004, J HEPATOL, V40, P1008, DOI 10.1016/j.jhep.2004.02.024; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Song BC, 2006, INTERVIROLOGY, V49, P266, DOI 10.1159/000093456; Yan T, 2011, J MED VIROL, V83, P996, DOI 10.1002/jmv.22067; Yang HC, 2013, HEPATOLOGY, V57, P934, DOI 10.1002/hep.26121; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yong-Ping Yan H-XS, 2014, J CLIN TRANSLATIONAL, V2, P7, DOI 10.14218/JCTH.2013.00027; Yoo BC, 2003, J HEPATOL, V38, P98, DOI 10.1016/S0168-8278(02)00349-5; YUAN TTT, 1995, VIROLOGY, V211, P144, DOI 10.1006/viro.1995.1387; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	45	2	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120733	10.1371/journal.pone.0120733	http://dx.doi.org/10.1371/journal.pone.0120733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822176	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700073
J	Jia, DW; Duan, FF; Peng, PK; Sun, LL; Ruan, YY; Gu, JX				Jia, Dongwei; Duan, Fangfang; Peng, Peike; Sun, Linlin; Ruan, Yuanyuan; Gu, Jianxin			Pyrroloquinoline-Quinone Suppresses Liver Fibrogenesis in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; OXIDATIVE STRESS; KINASE ACTIVATION; RAT-LIVER; TGF-BETA; FIBROSIS; GROWTH; INJURY; MACROPHAGES; APOPTOSIS	Liver fibrosis represents the consequences of a sustained wound healing response to chronic liver injuries, and its progression toward cirrhosis is the major cause of liver-related morbidity and mortality worldwide. However, anti-fibrotic treatment remains an unconquered area for drug development. Accumulating evidence indicate that oxidative stress plays a critical role in liver fibrogenesis. In this study, we found that PQQ, a natural anti-oxidant present in a wide variety of human foods, exerted potent anti-fibrotic and ROS-scavenging activity in Balb/C mouse models of liver fibrosis. The antioxidant activity of PQQ was involved in the modulation of multiple steps during liver fibrogenesis, including chronic liver injury, hepatic inflammation, as well as activation of hepatic stellate cells and production of extracellular matrix. PQQ also suppressed the up-regulation of RACK1 in activated HSCs in vivo and in vitro. Our data suggest that PQQ suppresses oxidative stress and liver fibrogenesis in mice, and provide rationale for the clinical application of PQQ in the prevention and treatment of liver fibrosis.	[Jia, Dongwei; Peng, Peike; Sun, Linlin; Ruan, Yuanyuan; Gu, Jianxin] Fudan Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Duan, Fangfang; Gu, Jianxin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ruan, YY (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai 200433, Peoples R China.	yuanyuanruan@fudan.edu.cn; jxgu@shmu.edu.cn			State Key Project Specialized for Infectious Diseases of China [2012ZX10002-008]; National Basic Research Program of China (973 Program) [2012CB822104]; National High-tech R&D Program (863 Program) [2012AA020203]; National Natural Science Fund [31170766, 31370808]; China Postdoctoral Science Foundation [2014M551321]	State Key Project Specialized for Infectious Diseases of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the State Key Project Specialized for Infectious Diseases of China (2012ZX10002-008), the National Basic Research Program of China (973 Program) (2012CB822104), the National High-tech R&D Program (863 Program) (2012AA020203), the National Natural Science Fund (31170766, 31370808), and the China Postdoctoral Science Foundation (2014M551321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar AM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/761450; Baroni GS, 1998, HEPATOLOGY, V27, P720; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chen W, 2012, ASIAN AUSTRAL J ANIM, V25, P1190, DOI 10.5713/ajas.2012.12019; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; Friedman SL, 2013, J HEPATOL, V58, P1, DOI 10.1016/j.jhep.2012.10.014; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2005, J CLIN INVEST, V115, P29, DOI 10.1172/JCI200523928; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Jia DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060115; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Klemmer I, 2011, HEPATOL RES, V41, P1094, DOI 10.1111/j.1872-034X.2011.00856.x; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; LEDDACOLUMBANO GM, 1991, AM J PATHOL, V139, P1099; Marra F, 1999, HEPATOLOGY, V30, P951, DOI 10.1002/hep.510300406; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Muriel P, 2009, HEPATOL INT, V3, P526, DOI 10.1007/s12072-009-9158-6; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Poli G, 1997, FREE RADICAL BIO MED, V22, P287, DOI 10.1016/S0891-5849(96)00327-9; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Rucker R, 2005, NATURE, V433, pE10, DOI 10.1038/nature03323; Rucker R, 2009, ALTERN MED REV, V14, P268; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Song SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107685; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Suzuki T, 2007, J APPL PHYSIOL, V102, P163, DOI 10.1152/japplphysiol.00964.2006; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083; Urakami T, 1997, J NUTR SCI VITAMINOL, V43, P19, DOI 10.3177/jnsv.43.19; Uskokovic-Markovic S, 2007, J PHARM PHARM SCI, V10, P340; WESTERLING J, 1979, BIOCHEM BIOPH RES CO, V87, P719, DOI 10.1016/0006-291X(79)92018-7; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	50	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121939	10.1371/journal.pone.0121939	http://dx.doi.org/10.1371/journal.pone.0121939			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822822	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700139
J	Li, F; Xie, YH; Zhu, LL; Jiang, L; Chen, XS; Pan, BH; Deng, ZM				Li, Feng; Xie, Yonghong; Zhu, Lianlian; Jiang, Li; Chen, Xinsheng; Pan, Baihan; Deng, Zhengmiao			Changed Clonal Growth Form Induced by Sand Burial Facilitates the Acclimation of Carex brevicuspis to Competition	PLOS ONE			English	Article							POSITIVE SPECIES INTERACTIONS; BIOMASS ALLOCATION; WETLAND SEDGE; STRESS; GUERRILLA; PHALANX; GRASS; SEDIMENTATION; METAANALYSIS; INTEGRATION	Both competition and burial are important factors that influence plant growth and structuring plant communities. Competition intensity may decline with increased burial stress. However, experimental evidence is scarce. The aim of this study was to elucidate the role of burial stress in influencing plant competition by investigating biomass accumulation, biomass allocation, and clonal growth performance of Carex brevicuspis, one of the dominant species in the Dongting Lake wetland in China. The experiment was conducted with two typical wetland species, C. brevicuspis (target plant) and Polygonum hydropiper (neighbor plant), in a target-neighbor design containing three densities (0, 199, and 398 neighbor plants m-2) and two burial depths (0 and 12 cm). The biomass accumulation of C. brevicuspis decreased with increment of P. hydropiper density in the 0 cm burial treatment. However, in the 12 cm burial treatment, biomass accumulation of C. brevicuspis did not change under medium and high P. hydropiper densities. The relative neighbor effect index (RNE) increased with enhancement of P. hydropiper density but decreased with increasing burial depth. The shoot mass fraction decreased with P. hydropiper density in the 12 cm burial treatments, but the root mass fraction was only affected by burial depth. However, the rhizome mass fraction increased with both P. hydropiper density and burial depth. The number of ramets decreased with increasing P. hydropiper density. With increasing burial depth and density, the proportion of spreading ramets increased from 34.23% to 80.44%, whereas that of clumping ramets decreased from 65.77% to 19.56%. Moreover, increased P. hydropiper density and burial depth led to greater spacer length. These data indicate that the competitive effect of P. hydropiper on C. brevicuspis was reduced by sand burial, which was reflected by different patterns of biomass accumulation and RNE at the two burial depth treatments. A change from a phalanx to a guerrilla growth form and spacer elongation induced by sand burial helped C. brevicuspis to acclimate to competition.	[Li, Feng; Xie, Yonghong; Zhu, Lianlian; Jiang, Li; Chen, Xinsheng; Pan, Baihan; Deng, Zhengmiao] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China; [Li, Feng; Xie, Yonghong; Zhu, Lianlian; Jiang, Li; Chen, Xinsheng; Pan, Baihan; Deng, Zhengmiao] Inst Subtrop Agr, Dongting Lake Stn Wetland Ecosyst Res, Changsha 410125, Hunan, Peoples R China; [Zhu, Lianlian; Pan, Baihan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, YH (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China.	yonghongxie@163.com	LI, feng/HIR-1703-2022	, Xinsheng/0000-0002-3720-247X	National Basic Research Program of China [2012CB417005]; National Natural Science Foundation of China [31200271]; Science and Technology Project of Hunan Province [2014NK2009]; Knowledge Innovation Program of the Chinese Academy of Sciences [ISACX-LYQY-QN-1208]; Youth Innovation Promotion Association of CAS	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Hunan Province; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Youth Innovation Promotion Association of CAS	This study was supported by the National Basic Research Program of China (2012CB417005), the National Natural Science Foundation of China (31200271), the Science and Technology Project of Hunan Province (2014NK2009), the Knowledge Innovation Program of the Chinese Academy of Sciences (ISACX-LYQY-QN-1208), and the Youth Innovation Promotion Association of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELCHER JW, 1995, J ECOL, V83, P673, DOI 10.2307/2261635; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BISHOP GF, 1985, OECOLOGIA, V66, P417, DOI 10.1007/BF00378308; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brose U, 2005, PLANT ECOL, V178, P51, DOI 10.1007/s11258-004-2487-6; Cabaco S, 2007, J EXP MAR BIOL ECOL, V340, P204, DOI 10.1016/j.jembe.2006.09.003; Chen XS, 2014, NORD J BOT, V32, P251, DOI 10.1111/j.1756-1051.2013.00094.x; Chen XS, 2011, FLORA, V206, P347, DOI 10.1016/j.flora.2010.07.006; Corcket E, 2003, ECOSCIENCE, V10, P186, DOI 10.1080/11956860.2003.11682766; Dai LK, 2010, FLORA CHINA, V23; Davis CA, 2009, AQUAT BOT, V91, P267, DOI 10.1016/j.aquabot.2009.07.005; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Franks SJ, 2003, PLANT ECOL, V168, P13, DOI 10.1023/A:1024450623205; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hou Zhi-yong, 2009, Yingyong Shengtai Xuebao, V20, P1323; Humphrey LD, 1998, J ECOL, V86, P854, DOI 10.1046/j.1365-2745.1998.8650854.x; Humphrey LD, 2001, CAN J BOT, V79, P1122, DOI 10.1139/cjb-79-9-1122; Kawai T, 2007, P R SOC B, V274, P2503, DOI 10.1098/rspb.2007.0871; Li F, 2014, LIMNOLOGICA, V45, P33, DOI 10.1016/j.limno.2013.09.004; Li F, 2009, AQUAT BOT, V91, P219, DOI 10.1016/j.aquabot.2009.06.005; [李景保 LI Jingbao], 2008, [地理学报, Acta Geographica Sinica], V63, P514; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Luo WB, 2010, WETLANDS, V30, P525, DOI 10.1007/s13157-010-0064-4; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Mainiero R, 2005, PLANT SOIL, V270, P311, DOI 10.1007/s11104-004-1724-z; Markham JH, 1996, FUNCT ECOL, V10, P548; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Pan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05612; Pan Y, 2012, AQUAT BOT, V100, P35, DOI 10.1016/j.aquabot.2012.03.008; Price EAC, 1996, OIKOS, V75, P279, DOI 10.2307/3546251; SCHMID B, 1986, PROC R SOC SER B-BIO, V228, P173, DOI 10.1098/rspb.1986.0049; Suzuki JI, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P311; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Xie YongHong, 2008, Research of Agricultural Modernization, V29, P684; Ye XH, 2006, ANN BOT-LONDON, V98, P187, DOI 10.1093/aob/mcl086; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x	38	6	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121270	10.1371/journal.pone.0121270	http://dx.doi.org/10.1371/journal.pone.0121270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822734	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700098
J	Moriya, M; Miyajima, M; Nakajima, M; Ogino, I; Arai, H				Moriya, Masao; Miyajima, Masakazu; Nakajima, Madoka; Ogino, Ikuko; Arai, Hajime			Impact of Cerebrospinal Fluid Shunting for Idiopathic Normal Pressure Hydrocephalus on the Amyloid Cascade	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SURROGATE MARKER; BETA OLIGOMERS; PATHOPHYSIOLOGY; HYPOTHESIS; PREVALENCE; A-BETA-42; DIAGNOSIS; DRAINAGE; PEPTIDE	The aim of this study was to determine whether the improvement of cerebrospinal fluid (CSF) flow dynamics by CSF shunting, can suppress the oligomerization of amyloid beta-peptide (A beta), by measuring the levels of Alzheimer's disease (AD)-related proteins in the CSF before and after lumboperitoneal shunting. Lumbar CSF from 32 patients with idiopathic normal pressure hydrocephalus (iNPH) (samples were obtained before and 1 year after shunting), 15 patients with AD, and 12 normal controls was analyzed for AD-related proteins and APLP1-derived A beta-like peptides (APL1 beta) (a surrogate marker for A beta). We found that before shunting, individuals with iNPH had significantly lower levels of soluble amyloid precursor proteins (sAPP) and A beta 38 compared to patients with AD and normal controls. We divided the patients with iNPH into patients with favorable (improvement >= 1 on the modified Rankin Scale) and unfavorable (no improvement on the modified Rankin Scale) outcomes. Compared to the unfavorable outcome group, the favorable outcome group showed significant increases in A beta 38, 40, 42, and phosphorylated-tau levels after shunting. In contrast, there were no significant changes in the levels of APL1 beta 25, 27, and 28 after shunting. After shunting, we observed positive correlations between sAPPa and sAPP beta, A beta 38 and 42, and APL1 beta 25 and 28, with shifts from sAPP beta to sAPPa, from APL1 beta 28 to 25, and from A beta 42 to 38 in all patients with iNPH. Our results suggest that A beta production remained unchanged by the shunt procedure because the levels of sAPP and APL1 beta were unchanged. Moreover, the shift of A beta from oligomer to monomer due to the shift of A beta 42 (easy to aggregate) to A beta 38 (difficult to aggregate), and the improvement of interstitial-fluid flow, could lead to increased A beta levels in the CSF. Our findings suggest that the shunting procedure can delay intracerebral deposition of A beta in patients with iNPH.	[Moriya, Masao; Miyajima, Masakazu; Nakajima, Madoka; Ogino, Ikuko; Arai, Hajime] Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan	Juntendo University	Moriya, M (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan.	m-moriya@shoikai.com	Nakajima, Madoka/AAU-6505-2021		Ministry of Health, Labour and Welfare of Japan [KAKENHI 23592106, 23592142]; Grants-in-Aid for Scientific Research [26293326] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids for Scientific Research (KAKENHI 23592106, 23592142), and a Research Grant from the Ministry of Health, Labour and Welfare of Japan (2012-Nanchi www.mhlw.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Cage TA, 2011, J CLIN NEUROSCI, V18, P649, DOI 10.1016/j.jocn.2010.08.028; Choi YJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01921; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Davson H., 1987, PHYS PATHO PHYS CERE, V24, P106; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Hamlat A, 2006, MED HYPOTHESES, V67, P115, DOI 10.1016/j.mehy.2006.01.029; Handoko M, 2013, JAMA NEUROL, V70, P594, DOI 10.1001/jamaneurol.2013.48; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; Kakuda N, 2013, NEUROBIOL AGING, V34, P1101, DOI 10.1016/j.neurobiolaging.2012.08.017; Klinge P, 2012, ACTA NEUROL SCAND, V126, P145, DOI 10.1111/j.1600-0404.2012.01676.x; Kubo Y, 2008, DEMENT GERIATR COGN, V25, P37, DOI 10.1159/000111149; Lai SM, 2001, NEUROEPIDEMIOLOGY, V20, P26, DOI 10.1159/000054754; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyajima M, 2013, EUR J NEUROL, V20, P236, DOI 10.1111/j.1468-1331.2012.03781.x; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Okochi M, 2010, NEURODEGENER DIS, V7, P42, DOI 10.1159/000283481; Ray B, 2011, J PSYCHIATR RES, V45, P539, DOI 10.1016/j.jpsychires.2010.07.011; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Silverberg GD, 2008, NEUROLOGY, V71, P202, DOI 10.1212/01.wnl.0000316197.04157.6f; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Tarnaris A, 2009, J NEUROL NEUROSUR PS, V80, P1130, DOI 10.1136/jnnp.2008.171686; Tarnaris Andrew, 2011, Alzheimers Dement, V7, P501, DOI 10.1016/j.jalz.2011.01.003; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; Tullberg M, 2007, EUR J NEUROL, V14, P248, DOI 10.1111/j.1468-1331.2006.01553.x; Tullberg M, 2008, CEREBROSPINAL FLUID, V5, P9, DOI DOI 10.1186/1743-8454-5-9; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Wostyn P., 2011, INT J ALZHEIMERS DIS, V2011; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026	38	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119973	10.1371/journal.pone.0119973	http://dx.doi.org/10.1371/journal.pone.0119973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821958	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700052
J	Puukila, S; Bryan, S; Laakso, A; Abdel-Malak, J; Gurney, C; Agostino, A; Bello-Klein, A; Prasad, K; Khaper, N				Puukila, Stephanie; Bryan, Sean; Laakso, Anna; Abdel-Malak, Jessica; Gurney, Carli; Agostino, Adrian; Bello-Klein, Adriane; Prasad, Kailash; Khaper, Neelam			Secoisolariciresinol Diglucoside Abrogates Oxidative Stress-Induced Damage in Cardiac Iron Overload Condition	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CARDIOMYOCYTES; HYPERTROPHY; TRANSFERRIN; MECHANISM; APOPTOSIS; FLAXSEED; PATHWAY; RATS	Cardiac iron overload is directly associated with cardiac dysfunction and can ultimately lead to heart failure. This study examined the effect of secoisolariciresinol diglucoside (SDG), a component of flaxseed, on iron overload induced cardiac damage by evaluating oxidative stress, inflammation and apoptosis in H9c2 cardiomyocytes. Cells were incubated with 50 mu 5M iron for 24 hours and/or a 24 hour pre-treatment of 500 mu M SDG. Cardiac iron overload resulted in increased oxidative stress and gene expression of the inflammatory mediators tumor necrosis factor-a, interleukin-10 and interferon gamma, as well as matrix metalloproteinases-2 and -9. Increased apoptosis was evident by increased active caspase 3/7 activity and increased protein expression of Forkhead box O3a, caspase 3 and Bax. Cardiac iron overload also resulted in increased protein expression of p70S6 Kinase 1 and decreased expression of AMP-activated protein kinase. Pre-treatment with SDG abrogated the iron-induced increases in oxidative stress, inflammation and apoptosis, as well as the increased p70S6 Kinase 1 and decreased AMP-activated protein kinase expression. The decrease in superoxide dismutase activity by iron treatment was prevented by pre-treatment with SDG in the presence of iron. Based on these findings we conclude that SDG was cytoprotective in an in vitro model of iron overload induced redox-inflammatory damage, suggesting a novel potential role for SDG in cardiac iron overload.	[Puukila, Stephanie; Abdel-Malak, Jessica; Gurney, Carli; Agostino, Adrian] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Bryan, Sean; Laakso, Anna; Khaper, Neelam] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada; [Bello-Klein, Adriane] Univ Fed Rio Grande do Sul, Dept Physiol, Porto Alegre, RS, Brazil; [Prasad, Kailash] Univ Saskatchewan, Coll Med, Dept Physiol, Saskatoon, SK S7N 0W0, Canada	Lakehead University; Lakehead University; Northern Ontario School of Medicine; Universidade Federal do Rio Grande do Sul; University of Saskatchewan	Khaper, N (corresponding author), Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada.	nkhaper@nosm.ca			Northern Ontario School of Medicine Faculty Association RD	Northern Ontario School of Medicine Faculty Association RD	Funding support from the Northern Ontario School of Medicine Faculty Association RD (NK) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Bolger A, 2009, AM J CARDIOL, V90, P384; Bryan S, 2013, CAN J PHYSIOL PHARM, V91, P22, DOI 10.1139/cjpp-2012-0295; Cario H, 2003, EUR J PEDIATR, V162, P139, DOI 10.1007/s00431-002-1121-7; Del Vecchio GC, 2002, ACTA HAEMATOL-BASEL, V108, P144, DOI 10.1159/000064705; Deng W, 2013, MOL NUTR FOOD RES, V57, P1680, DOI 10.1002/mnfr.201300012; Dolinsky VW, 2013, BBA-MOL BASIS DIS, V1832, P1723, DOI 10.1016/j.bbadis.2013.05.018; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Haddad JJ, 2002, BIOCHEM BIOPH RES CO, V297, P163, DOI 10.1016/S0006-291X(02)02094-6; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Kandasamy AD, 2009, CARDIOVASC RES, V83, P698, DOI 10.1093/cvr/cvp175; Kaur K, 2006, J MOL CELL CARDIOL, V41, P1023, DOI 10.1016/j.yjmcc.2006.08.005; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Knobel Y, 2006, TOXICOL IN VITRO, V20, P793, DOI 10.1016/j.tiv.2005.11.009; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; LIU P, 1994, CARDIOVASC DRUG THER, V8, P101, DOI 10.1007/BF00877096; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Ovechkin AV, 2005, J APPL PHYSIOL, V99, P2398, DOI 10.1152/japplphysiol.00442.2005; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Penumathsa SV, 2007, J PHARMACOL EXP THER, V320, P951, DOI 10.1124/jpet.106.114165; Prasad K, 2000, MOL CELL BIOCHEM, V209, P89, DOI 10.1023/A:1007079802459; Prasad K, 1997, MOL CELL BIOCHEM, V168, P117, DOI 10.1023/A:1006847310741; Prasad K, 1997, ATHEROSCLEROSIS, V132, P69, DOI 10.1016/S0021-9150(97)06110-8; Prasad K, 2001, J LAB CLIN MED, V138, P32, DOI 10.1067/mlc.2001.115717; Prasad K, 2009, J CARDIOVASC PHARM, V54, P369, DOI 10.1097/FJC.0b013e3181af04e5; Qi XF, 2013, EXP MOL PATHOL, V95, P242, DOI 10.1016/j.yexmp.2013.08.003; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Shawky M, 2003, BENCH BEDSIDE OXIDAT, P129; Shvartsman M, 2007, AM J PHYSIOL-CELL PH, V293, pC1383, DOI 10.1152/ajpcell.00054.2007; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487; Tu VC, 2002, J PHARMACOL EXP THER, V300, P1101, DOI 10.1124/jpet.300.3.1101; Vasdev Sudesh, 2006, Exp Clin Cardiol, V11, P206	42	13	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122852	10.1371/journal.pone.0122852	http://dx.doi.org/10.1371/journal.pone.0122852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822525	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700206
J	Simon, P; Feuerstacke, C; Kaese, M; Saboor, F; Middendorff, R; Galuska, SP				Simon, Peter; Feuerstacke, Caroline; Kaese, Miriam; Saboor, Farhan; Middendorff, Ralf; Galuska, Sebastian P.			Polysialylation of NCAM Characterizes the Proliferation Period of Contractile Elements during Postnatal Development of the Epididymis	PLOS ONE			English	Article							CELL-ADHESION-MOLECULE; POLYSIALIC ACID; N-CAM; PSA-NCAM; EXPRESSION; SYSTEM; SPERMATOGENESIS; DIFFERENTIATION; NEUROTROPHINS; NEUROPILIN-2	Polysialic acid (polySia) attached to the neural cell adhesion molecule (NCAM) regulates inter alia the proliferation and differentiation via the interactions with neurotrophins. Since in postnatal epididymis neurotrophins and their receptors like the Low-Affinity Nerve Growth Factor Receptor p75 and TrK B receptor are expressed, we wanted to analyze if the polysialylation of NCAM is also involved during the development of the epididymis. To this end, we monitored the developmental changes in the expression of the polysialyltransferases and NCAM polysialylation using murine epididymis at different time points during postnatal development. Our results revealed that during postnatal development of the epididymis both polysialyltransferases, ST8SiaII and ST8SiaIV, were expressed and that the expression levels dropped with increasing age. In agreement with the expression levels of the polysialyltransferases the highest content of polysialylated NCAM was present during the first 10 days after birth. Interestingly, proliferating smooth muscle cell populations prevalently expressed polysialylated NCAM. Furthermore, we observed that inverse to the decrease in polysialylation of smooth muscle cells a strong up-regulation of collagen takes place suggesting a functional relationship since collagen was recently described to induce the turnover of polysialylated NCAM via an induction of endocytosis in cellulo. The same time course of polySia and collagen synthesis was also observed in other regions of the male reproductive system e.g. vas deferens and tunica albuginea (testis). Together, we identified a spatio-temporal expression pattern of polySia-NCAM characterized by high proliferation rate of smooth muscle cells and low collagen content.	[Simon, Peter; Kaese, Miriam; Galuska, Sebastian P.] Univ Giessen, Inst Biochem, Fac Med, D-35392 Giessen, Germany; [Simon, Peter; Feuerstacke, Caroline; Saboor, Farhan; Middendorff, Ralf] Univ Giessen, Fac Med, Dept Anat & Cell Biol, D-35385 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Middendorff, R (corresponding author), Univ Giessen, Fac Med, Dept Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	ralf.middendorff@anatomie.med.uni-giessen.de; sebastian.galuska@biochemie.med.uni-giessen.de	Saboor, Farhan/GWQ-7441-2022		Deutsche Forschungsgemeinschaft [GA 1755/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft to SPG (GA 1755/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Eddy EM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.110189; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Hansch M, 2014, GLYCOBIOLOGY, V24, P488, DOI 10.1093/glycob/cwu023; Hromatka BS, 2013, GLYCOBIOLOGY, V23, P593, DOI 10.1093/glycob/cws162; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; LACKIE PM, 1990, DEVELOPMENT, V110, P933; LACKIE PM, 1991, DIFFERENTIATION, V47, P85, DOI 10.1111/j.1432-0436.1991.tb00226.x; Lantuejoul S, 2000, HUM PATHOL, V31, P415, DOI 10.1053/hp.2000.6552; Li CJ, 2013, REPRODUCTION, V145, pR89, DOI 10.1530/REP-12-0466; Middendorff R, 2002, J CLIN ENDOCR METAB, V87, P3486, DOI 10.1210/jc.87.7.3486; MOLLER CJ, 1991, ANAT EMBRYOL, V184, P541, DOI 10.1007/BF00942576; Monzo HJ, 2013, J NEUROCHEM, V126, P758, DOI 10.1111/jnc.12363; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Russo MA, 1999, BIOL REPROD, V61, P1123, DOI 10.1095/biolreprod61.4.1123; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Simon P, 2013, J BIOL CHEM, V288, P18825, DOI 10.1074/jbc.M113.451112; Stamatos NM, 2014, GLYCOBIOLOGY, V24, P864, DOI 10.1093/glycob/cwu050; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Ulm C, 2013, CELL MOL LIFE SCI, V70, P3695, DOI 10.1007/s00018-013-1342-0; Volkmann J, 2011, HUM REPROD, V26, P1450, DOI 10.1093/humrep/der077; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123960	10.1371/journal.pone.0123960	http://dx.doi.org/10.1371/journal.pone.0123960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822229	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700244
J	Sun, Y; Florer, J; Mayhew, CN; Jia, ZF; Zhao, ZY; Xu, K; Ran, HM; Liou, B; Zhang, WJ; Setchell, KDR; Gu, JG; Grabowski, GA				Sun, Ying; Florer, Jane; Mayhew, Christopher N.; Jia, Zhanfeng; Zhao, Zhiying; Xu, Kui; Ran, Huimin; Liou, Benjamin; Zhang, Wujuan; Setchell, Kenneth D. R.; Gu, Jianguo; Grabowski, Gregory A.			Properties of Neurons Derived from Induced Pluripotent Stem Cells of Gaucher Disease Type 2 Patient Fibroblasts: Potential Role in Neuropathology	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; HUMAN GLUCOCEREBROSIDASE GENE; MOUSE MODEL; PARKINSONS-DISEASE; GLUCOSYLSPHINGOSINE; MUTATIONS; ACCUMULATION; PHENOTYPE; INFANTILE; DEFECTS	Gaucher disease (GD) is caused by insufficient activity of acid beta-glucosidase (GCase) resulting from mutations in GBA1. To understand the pathogenesis of the neuronopathic GD, induced pluripotent stem cells (iPSCs) were generated from fibroblasts isolated from three GD type 2 (GD2) and 2 unaffected (normal and GD carrier) individuals. The iPSCs were converted to neural precursor cells (NPCs) which were further differentiated into neurons. Parental GD2 fibroblasts as well as iPSCs, NPCs, and neurons had similar degrees of GCase deficiency. Lipid analyses showed increases of glucosylsphingosine and glucosylceramide in the GD2 cells. In addition, GD2 neurons showed increased a-synuclein protein compared to control neurons. Whole cell patch-clamping of the GD2 and control iPSCs-derived neurons demonstrated excitation characteristics of neurons, but intriguingly, those from GD2 exhibited consistently less negative resting membrane potentials with various degree of reduction in action potential amplitudes, sodium and potassium currents. Culture of control neurons in the presence of the GCase inhibitor (conduritol B epoxide) recapitulated these findings, providing a functional link between decreased GCase activity in GD and abnormal neuronal electrophysiological properties. To our knowledge, this study is first to report abnormal electrophysiological properties in GD2 iPSC-derived neurons that may underlie the neuropathic phenotype in Gaucher disease.	[Sun, Ying; Florer, Jane; Xu, Kui; Ran, Huimin; Liou, Benjamin; Grabowski, Gregory A.] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45267 USA; [Mayhew, Christopher N.] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Pathol & Lab Med, Cincinnati, OH USA; [Sun, Ying; Mayhew, Christopher N.; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati Coll Med, Dept Pediat, Cincinnati, OH USA; [Jia, Zhanfeng; Zhao, Zhiying; Gu, Jianguo] Univ Cincinnati Coll Med, Dept Anesthesiol, Cincinnati, OH USA; [Jia, Zhanfeng; Zhao, Zhiying] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Grabowski, Gregory A.] Synageva BioPharma Corp, Lexington, MA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Hebei Medical University	Sun, Y (corresponding author), Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45267 USA.	ying.sun@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Mayhew, Chris/0000-0002-7408-1726	NIH [DK 36729]; Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Synageva; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the NIH (DK 36729) to GAG. Synageva provided support in the form of a salary for author GAG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2013, ADV DIFFER EQU, DOI DOI 10.1371/J0URNAL.P0NE.0057560; Antonchuk Jennifer, 2013, Methods Mol Biol, V946, P523, DOI 10.1007/978-1-62703-128-8_32; Ben-David O, 2010, NEUROMOL MED, V12, P341, DOI 10.1007/s12017-010-8114-x; BERGMANN JE, 1989, AM J HUM GENET, V44, P741; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; BEUTLER E, 1991, P NATL ACAD SCI USA, V88, P10544, DOI 10.1073/pnas.88.23.10544; Beutler E., 2001, METABOLIC MOL BASES, VIII, P3635; Budde T, 1998, EUR J NEUROSCI, V10, P2309, DOI 10.1046/j.1460-9568.1998.00242.x; Burrow TA, 2014, MOL GENET METAB; Cabrera-Salazar MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043310; CERVOSNAVARRO J, 1990, CLIN NEUROPATHOL, V9, P310; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; DePaolo J, 2009, MOVEMENT DISORD, V24, P1571, DOI 10.1002/mds.22538; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Gornati R, 2002, J INHERIT METAB DIS, V25, P47, DOI 10.1023/A:1015137917508; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 2010, ONLINE METABOLIC MOL; GRAFE M, 1988, ANN NEUROL, V23, P300, DOI 10.1002/ana.410230315; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; KAYE EM, 1986, ANN NEUROL, V20, P223, DOI 10.1002/ana.410200208; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Liu J, 2012, P NATL ACAD SCI USA, V109, P10018, DOI 10.1073/pnas.1200941109; Maor G, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-140; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mignot C, 2006, BRAIN DEV-JPN, V28, P39, DOI 10.1016/j.braindev.2005.04.005; NILSSON O, 1982, CLIN GENET, V22, P274; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; NILSSON O, 1982, BIOCHIM BIOPHYS ACTA, V712, P453, DOI 10.1016/0005-2760(82)90272-7; NILSSON O, 1985, CLIN GENET, V27, P443; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055856; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pandey MK, 2012, MOL GENET METAB, V106, P310, DOI 10.1016/j.ymgme.2012.04.020; Panicker LM, 2014, STEM CELLS, V32, P2338, DOI 10.1002/stem.1732; Panicker LM, 2012, P NATL ACAD SCI USA, V109, P18054, DOI 10.1073/pnas.1207889109; Park H, 2010, J LIPID RES, V51, P480, DOI 10.1194/jlr.M000984; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Stone DL, 2000, HUM MUTAT, V15, P181, DOI 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.3.CO;2-J; Sun Y, 2006, J LIPID RES, V47, P2161, DOI 10.1194/jlr.M600239-JLR200; Sun Y, 2013, HUM MOL GENET, V22, P2435, DOI 10.1093/hmg/ddt096; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; SUOMI WD, 1965, J LIPID RES, V6, P211; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069147; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2013, HUM MOL GENET, V22, P633, DOI 10.1093/hmg/dds471; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; Wang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061418; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; YAMAGUCHI Y, 1994, J BIOCHEM-TOKYO, V116, P704, DOI 10.1093/oxfordjournals.jbchem.a124584	72	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118771	10.1371/journal.pone.0118771	http://dx.doi.org/10.1371/journal.pone.0118771			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822147	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700023
J	Uno, T; Kawai, K; Sakai, K; Wakebe, T; Ibaraki, T; Kunii, N; Matsuo, T; Saito, N				Uno, Takeshi; Kawai, Kensuke; Sakai, Katsuyuki; Wakebe, Toshihiro; Ibaraki, Takuya; Kunii, Naoto; Matsuo, Takeshi; Saito, Nobuhito			Dissociated Roles of the Inferior Frontal Gyrus and Superior Temporal Sulcus in Audiovisual Processing: Top-Down and Bottom-Up Mismatch Detection	PLOS ONE			English	Article							SPEECH-PERCEPTION; VISUAL-ATTENTION; GAMMA ACTIVITY; AUDITORY INFORMATION; MACAQUE MONKEY; HEARING LIPS; CORTEX; INTEGRATION; MCGURK; LANGUAGE	Visual inputs can distort auditory perception, and accurate auditory processing requires the ability to detect and ignore visual input that is simultaneous and incongruent with auditory information. However, the neural basis of this auditory selection from audiovisual information is unknown, whereas integration process of audiovisual inputs is intensively researched. Here, we tested the hypothesis that the inferior frontal gyrus (IFG) and superior temporal sulcus (STS) are involved in top-down and bottom-up processing, respectively, of target auditory information from audiovisual inputs. We recorded high gamma activity (HGA), which is associated with neuronal firing in local brain regions, using electrocorticography while patients with epilepsy judged the syllable spoken by a voice while looking at a voice-congruent or -incongruent lip movement from the speaker. The STS exhibited stronger HGA if the patient was presented with information of large audiovisual incongruence than of small incongruence, especially if the auditory information was correctly identified. On the other hand, the IFG exhibited stronger HGA in trials with small audiovisual incongruence when patients correctly perceived the auditory information than when patients incorrectly perceived the auditory information due to the mismatched visual information. These results indicate that the IFG and STS have dissociated roles in selective auditory processing, and suggest that the neural basis of selective auditory processing changes dynamically in accordance with the degree of incongruity between auditory and visual information.	[Uno, Takeshi; Kawai, Kensuke; Kunii, Naoto; Matsuo, Takeshi; Saito, Nobuhito] Univ Tokyo, Dept Neurosurg, Grad Sch Med, Bunkyo Ku, Tokyo 113, Japan; [Sakai, Katsuyuki; Wakebe, Toshihiro; Ibaraki, Takuya] Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Kawai, K (corresponding author), NTT Med Ctr Tokyo, Dept Neurosurg, Shinagawa Ku, Tokyo, Japan.	kenkawai-tky@umin.net	Kunii, Naoto/AGH-2837-2022	Kunii, Naoto/0000-0002-8992-380X; Ibaraki, Takuya/0000-0001-7552-5686	Japan Epilepsy Research Foundation; Japan Society for the Promotion of Science [14441825, 21390405, 26462221]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [26462221] Funding Source: KAKEN	Japan Epilepsy Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Epilepsy Research Foundation, Grant-in-Aid No. 14441825 for Young Scientists (B) from the Japan Society for the Promotion of Science, Grant-in-Aid No. 21390405 for Scientific Research (B) and Grant-in-Aid No. 26462221 for Scientific Research (C) from the Japan Society for the Promotion of Science, and a Grant H23-Nervous and Muscular-General-003 for Comprehensive Research on Disability, Health and Welfare from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal LH, 2011, NAT NEUROSCI, V14, P797, DOI 10.1038/nn.2810; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Axmacher N, 2008, J NEUROSCI, V28, P7304, DOI 10.1523/JNEUROSCI.1778-08.2008; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Blank H, 2013, NEUROIMAGE, V65, P109, DOI 10.1016/j.neuroimage.2012.09.047; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Burke JF, 2014, NEUROIMAGE, V85, P834, DOI 10.1016/j.neuroimage.2013.06.067; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; Chang EF, 2013, P NATL ACAD SCI USA, V110, P2653, DOI 10.1073/pnas.1216827110; Conner CR, 2014, CEREB CORTEX, V24, P2741, DOI 10.1093/cercor/bht130; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Cusick CG, 1997, CEREBR CORT, V12, P435; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eliades SJ, 2014, J NEUROPHYSIOL, V112, P2147, DOI 10.1152/jn.00207.2014; Flinker A, 2010, J NEUROSCI, V30, P16643, DOI 10.1523/JNEUROSCI.1809-10.2010; Friston KJ, 2015, CURR OPIN NEUROBIOL, V31, P1, DOI 10.1016/j.conb.2014.05.004; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Hocking J, 2008, CEREB CORTEX, V18, P2439, DOI 10.1093/cercor/bhn007; Irwin JR, 2011, J NEUROLINGUIST, V24, P611, DOI 10.1016/j.jneuroling.2011.05.001; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kayser C, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.007.2009; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Kunii N, 2013, NEUROIMAGE, V65, P242, DOI 10.1016/j.neuroimage.2012.09.059; Kunii N, 2011, NEUROSURGERY, V69, P590, DOI 10.1227/NEU.0b013e3182181be1; Lifshitz M, 2013, CORTEX, V49, P463, DOI 10.1016/j.cortex.2012.08.007; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Matsuo T, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00034; McGettigan C, 2012, J COGNITIVE NEUROSCI, V24, P636, DOI 10.1162/jocn_a_00161; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mottonen R, 2004, NEUROSCI LETT, V363, P112, DOI 10.1016/j.neulet.2004.03.076; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Ogata S, 2001, MODEL BASED LIP SYNC, P28; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Olson IR, 2002, COGNITIVE BRAIN RES, V14, P129, DOI 10.1016/S0926-6410(02)00067-8; Perrone-Bertolotti M, 2012, J NEUROSCI, V32, P17554, DOI 10.1523/JNEUROSCI.2982-12.2012; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Smith E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073148; Sohoglu E, 2012, J NEUROSCI, V32, P8443, DOI 10.1523/JNEUROSCI.5069-11.2012; Speier W, 2013, CLIN NEUROPHYSIOL, V124, P1321, DOI 10.1016/j.clinph.2013.02.002; Spence C, 2000, NEUROREPORT, V11, P2057, DOI 10.1097/00001756-200006260-00049; Staff I. P. A., 1999, HDB INT PHONETIC ASS; Stefanics G, 2007, PSYCHOPHYSIOLOGY, V44, P697, DOI 10.1111/j.1469-8986.2007.00540.x; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Szycik GR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00095; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034; Zekveld AA, 2006, NEUROIMAGE, V32, P1826, DOI 10.1016/j.neuroimage.2006.04.199	69	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122580	10.1371/journal.pone.0122580	http://dx.doi.org/10.1371/journal.pone.0122580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822912	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700190
J	Wang, LY; Wee, CY; Suk, HI; Tang, XY; Shen, DG				Wang, Liye; Wee, Chong-Yaw; Suk, Heung-Il; Tang, Xiaoying; Shen, Dinggang			MRI-Based Intelligence Quotient (IQ) Estimation with Sparse Learning	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; LOGISTIC-REGRESSION; FEATURE-SELECTION; CLASSIFICATION; ACTIVATION; DISEASE; MEMORY; GYRUS	In this paper, we propose a novel framework for IQ estimation using Magnetic Resonance Imaging (MRI) data. In particular, we devise a new feature selection method based on an extended dirty model for jointly considering both element-wise sparsity and group-wise sparsity. Meanwhile, due to the absence of large dataset with consistent scanning protocols for the IQ estimation, we integrate multiple datasets scanned from different sites with different scanning parameters and protocols. In this way, there is large variability in these different datasets. To address this issue, we design a two-step procedure for 1) first identifying the possible scanning site for each testing subject and 2) then estimating the testing subject's IQ by using a specific estimator designed for that scanning site. We perform two experiments to test the performance of our method by using the MRI data collected from 164 typically developing children between 6 and 15 years old. In the first experiment, we use a multi-kernel Support Vector Regression (SVR) for estimating IQ values, and obtain an average correlation coefficient of 0.718 and also an average root mean square error of 8.695 between the true IQs and the estimated ones. In the second experiment, we use a single-kernel SVR for IQ estimation, and achieve an average correlation coefficient of 0.684 and an average root mean square error of 9.166. All these results show the effectiveness of using imaging data for IQ prediction, which is rarely done in the field according to our knowledge.	[Wang, Liye; Tang, Xiaoying] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, Dept Radiol, IDEA Lab, Chapel Hill, NC 27599 USA; [Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA; [Suk, Heung-Il; Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Beijing Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, IDEA Lab, CB 7510, Chapel Hill, NC 27599 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698; Suk, Heung-Il/0000-0001-7019-8962	NIH [EB006733, EB008374, EB009634, AG041721, MH100217, AG042599]; National Natural Science Foundation of China [81271568]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721, R01AG042599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB006733, EB008374, EB009634, AG041721, MH100217, and AG042599. Also, this work was partially funded by the National Natural Science Foundation of China (No. 81271568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Argyriou A., 2007, NEURAL INFORM PROCES, V19, P41, DOI DOI 10.1007/S10994-007-5040-8; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Chai KMA, 2008, MULTITASK GAUSSIAN P, P265; Chen R, 2013, P RAD SOC N AM CHIC; Chen X, 2009, IEEE DATA MINING, P746, DOI 10.1109/ICDM.2009.128; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Grindrod CM, 2008, BRAIN RES, V1229, P167, DOI 10.1016/j.brainres.2008.07.017; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Jalali A., 2010, ADV NEURAL INF PROCE, V23, P964; Kim SE, 2014, EUR J NEUROL, V21, P708, DOI 10.1111/ene.12301; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu J., 2010, ARXIV10094766; Liu J., 2009, P 25 C UNCERTAINTY A, P339, DOI DOI 10.5555/1795114.1795154; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 1997, J NEUROSCI, V17, P7103; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Meyer M, 2000, COGNITIVE BRAIN RES, V9, P19, DOI 10.1016/S0926-6410(99)00039-7; Navas-Sanchez FJ, 2014, HUM BRAIN MAPP, V35, P2619, DOI 10.1002/hbm.22355; Obozinski G., 2009, J STAT COMPUT, V20, P231; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Robey A, 2014, J EXP CHILD PSYCHOL, V127, P144, DOI 10.1016/j.jecp.2014.01.008; Ryali S, 2010, NEUROIMAGE, V51, P752, DOI 10.1016/j.neuroimage.2010.02.040; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Wee CY, 2012, LECT NOTES COMPUT SC, V7511, P212, DOI 10.1007/978-3-642-33418-4_27; Welcome SE, 2014, NEUROIMAGE, V96, P261, DOI 10.1016/j.neuroimage.2014.03.069; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Xue Y, 2007, J MACH LEARN RES, V8, P35; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang TZ, 2013, INT J COMPUT VISION, V101, P367, DOI 10.1007/s11263-012-0582-z; Zhou JY, 2013, NEUROIMAGE, V78, P233, DOI 10.1016/j.neuroimage.2013.03.073; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117295	10.1371/journal.pone.0117295	http://dx.doi.org/10.1371/journal.pone.0117295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822851	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700010
J	Wang, N; He, YL; Pang, LJ; Zou, H; Liu, CX; Zhao, J; Hu, JM; Zhang, WJ; Qi, Y; Li, F				Wang, Ning; He, Yong-Lai; Pang, Li-Juan; Zou, Hong; Liu, Chun-Xia; Zhao, Jin; Hu, Jian-Ming; Zhang, Wen-Jie; Qi, Yan; Li, Feng			Down-Regulated E-Cadherin Expression Is Associated with Poor Five-Year Overall Survival in Bone and Soft Tissue Sarcoma: Results of a Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SYNOVIAL SARCOMA; ADHESION MOLECULES; PROGNOSTIC VALUE; EWINGS-SARCOMA; OVARIAN-CANCER; BETA-CATENIN; LEIOMYOSARCOMAS; OSTEOSARCOMA; DETERMINANT	Purpose To conduct a meta-analysis to evaluate the prognostic role of E-cadherin expression in bone and soft tissue sarcomas. Methods The PubMed, EMBASE, and Web of Science databases were searched using terms related to E-cadherin, sarcoma, and prognosis for all articles published in English before March 2014. Pooled effect was calculated from the available data to evaluate the association between negative E-cadherin expression and 5-year overall survival and tumor clinicopathological features in sarcoma patients. Pooled odds ratios (OR) and risk ratios (RR) with 95% confidence intervals (CI) were calculated using a fixed-effects model. Result Eight studies met the selection criteria and reported on 812 subjects. A total of 496 subjects showed positive E-cadherin expression (59.9%). Negative E-cadherin expression in bone and soft tissue sarcomas was correlated with lower 5-year overall survival (OR = 3.831; 95% CI: 2.246-6.534), and was associated with higher clinical stage (RR = 1.446; 95% CI: 1.030-2.028) and with male sex (RR = 0.678; 95% CI: 0.493-0.933). Conclusion In the E-cadherin negative group, 5-year overall survival was significantly worse than in the E-cadherin positive group. However, further studies are required to confirm these results.	[Wang, Ning; Pang, Li-Juan; Zou, Hong; Liu, Chun-Xia; Zhao, Jin; Hu, Jian-Ming; Zhang, Wen-Jie; Qi, Yan; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Wang, Ning; Pang, Li-Juan; Zou, Hong; Liu, Chun-Xia; Zhao, Jin; Hu, Jian-Ming; Zhang, Wen-Jie; Qi, Yan; Li, Feng] Shihezi Univ, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Wang, Ning; Pang, Li-Juan; Zou, Hong; Liu, Chun-Xia; Zhao, Jin; Hu, Jian-Ming; Zhang, Wen-Jie; Qi, Yan; Li, Feng] Chinese Minist Educ, Shihezi, Xinjiang, Peoples R China; [He, Yong-Lai] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept ICU Intens Care, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Qi, Y (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.	qiyanyan-2004@126.com; lifeng7855@126.com	zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022		National Natural Science Foundation of China [81202120]; Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University [2013ZRKXJQ05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University	This work was supported by a grant from the National Natural Science Foundation of China (no. 81202120), and Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University (2013ZRKXJQ05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chen HP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-16; Dian D, 2011, ARCH GYNECOL OBSTET, V284, P437, DOI 10.1007/s00404-010-1657-0; Gogou P, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-28; Gogou PN, 2009, CLIN TRANSL ONCOL, V11, P548, DOI 10.1007/s12094-009-0401-3; He X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070858; Irwig L, 1998, BRIT MED J, V316, P470; Izumi T, 2007, AM J SURG PATHOL, V31, P85, DOI 10.1097/01.pas.0000213413.33558.85; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang H, 2011, ANN SURG ONCOL, V18, P711, DOI 10.1245/s10434-010-1338-z; Koo JS, 2009, JPN J CLIN ONCOL, V39, P560, DOI 10.1093/jjco/hyp065; Luo SL, 2014, TUMOR BIOL, V35, P5533, DOI 10.1007/s13277-014-1728-0; Machado I, 2012, VIRCHOWS ARCH, V461, P333, DOI 10.1007/s00428-012-1288-x; Peng HL, 2012, ASIAN PAC J CANCER P, V13, P2003, DOI 10.7314/APJCP.2012.13.5.2003; PRESANT CA, 1986, J CLIN ONCOL, V4, P1658, DOI 10.1200/JCO.1986.4.11.1658; Qi Y, 2013, INT J CLIN EXP PATHO, V6, P2787; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Saito T, 2001, PATHOL INT, V51, P532, DOI 10.1046/j.1440-1827.2001.01232.x; Saito T, 2001, AM J PATHOL, V159, P2117, DOI 10.1016/S0002-9440(10)63063-5; Sampson VB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102041; Sato H, 1999, HUM PATHOL, V30, P1344, DOI 10.1016/S0046-8177(99)90066-7; Sekar P, 2014, J ONCOL, V2014, DOI 10.1155/2014/702527; Skubitz KM, 2007, MAYO CLIN PROC, V82, P1409, DOI 10.4065/82.11.1409; Smith MEF, 1998, HISTOPATHOLOGY, V33, P425, DOI 10.1046/j.1365-2559.1998.00544.x; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0401-y; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101330; Wardelmann E, 2010, ANN ONCOL, V21, P265, DOI 10.1093/annonc/mdq381; Wisanuyotin T, 2013, ASIA-PAC J CLIN ONCO, V9, P80, DOI 10.1111/j.1743-7563.2012.01563.x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang JL, 2010, MOL CELL PROTEOMICS, V9, P2405, DOI 10.1074/mcp.M110.000240; Yin K, 2012, MED ONCOL, V29, P3449, DOI 10.1007/s12032-012-0317-6; Yoo J, 2002, ARCH PATHOL LAB MED, V126, P33	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121448	10.1371/journal.pone.0121448	http://dx.doi.org/10.1371/journal.pone.0121448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822802	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700108
J	Zheng, GD; Lin, LZ; Zhong, SS; Zhang, QF; Li, DM				Zheng, Guodong; Lin, Lezhen; Zhong, Shusheng; Zhang, Qingfeng; Li, Dongming			Effects of Puerarin on Lipid Accumulation and Metabolism in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; ENERGY-METABOLISM; OXIDATIVE STRESS; STEM-CELL; LIPASE; ACID; MECHANISMS; EXTRACT; OBESITY; LEPTIN	In order to investigate the mechanisms by which puerarin from kudzu root extract regulates lipid metabolism, fifty mice were randomly assigned to five groups: normal diet, high-fat diet (HFD), and HFD containing 0.2%, 0.4% or 0.8% puerarin for 12 weeks. Body weight, intra-peritioneal adipose tissue (IPAT) weight, serum biochemical parameters, and hepatic and feces lipids were measured. Activity and mRNA and protein expressions of hepatic lipid metabolism-related enzymes were analyzed. Compared with HFD, 0.4% and 0.8% puerarin significantly decreased body and IPAT weight. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, triglycerides and leptin in mice fed the 0.4% and 0.8% puerarin diets compared with HFD. Fatty acid synthase activity was suppressed in mice fed the 0.4% and 0.8% puerarin diets, while the activities of AMP-activated protein kinase (AMPK), carnitine acyltransferase (CAT) and hormone-sensitive lipase (HSL) were increased. mRNA expression of peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) was down-regulated in liver of mice fed the 0.8% diet compared with HFD, while mRNA expression of CAT and HSL was considerably up-regulated by 0.4% and 0.8% puerarin diets. The protein expression of PPAR gamma 2 in liver was decreased and those of p-AMPK, HSL and p-HSL were increased in mice fed 0.4% and 0.8% puerarin diets. These results suggest that > 0.4% puerarin influenced the activity, mRNA and protein levels of hepatic lipid metabolism-related enzymes, decreasing serum and liver lipids, body weight gain and fat accumulation. Puerarin might be beneficial to prevent lifestyle-related diseases.	[Zheng, Guodong; Zhong, Shusheng; Zhang, Qingfeng; Li, Dongming] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang, Peoples R China; [Lin, Lezhen] Lib Jiangxi Agr Univ, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University	Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang, Peoples R China.	zrs150716@aliyun.com	Zhang, Qing-FENG/F-6875-2015	Zhang, Qing-FENG/0000-0002-1277-042X	National Natural Science Foundation of China [31160320]; National High Technology Research and Development Program (863 Program) of China [2013BDA10B04]; Jiangxi Province Natural Science Foundation of China [20142BAB204003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Jiangxi Province Natural Science Foundation of China	This work was kindly supported by the National Natural Science Foundation of China (No. 31160320), the National High Technology Research and Development Program (863 Program) of China (No. 2013BDA10B04) and the Jiangxi Province Natural Science Foundation of China (No. 20142BAB204003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Chen G, 2014, ACTA PHARMACOL SIN, V35, P463, DOI 10.1038/aps.2013.185; Chen X, 2013, PHYTOMEDICINE, V20, P849, DOI 10.1016/j.phymed.2013.04.001; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Guerra MC, 2000, LIFE SCI, V67, P2997, DOI 10.1016/S0024-3205(00)00885-7; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Janeckova R, 2001, PHYSIOL RES, V50, P443; Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984; Lee CE, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/759143; Li M, 1999, BIOCHEM MOL BIOL INT, V47, P63; Li R, 2013, INT IMMUNOPHARMACOL, V17, P71, DOI 10.1016/j.intimp.2013.05.023; Liang XL, 2012, J ETHNOPHARMACOL, V144, P677, DOI 10.1016/j.jep.2012.10.011; Liang YZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/796890; Liu M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/485927; Lord CC, 2012, ADIPOCYTE, V1, P123, DOI 10.4161/adip.20035; Ma JQ, 2014, BASIC CLIN PHARMACOL; Marrelli M, 2014, J SCI FOOD AGR, V94, P2217, DOI 10.1002/jsfa.6544; Meezan E, 2005, J AGR FOOD CHEM, V53, P8760, DOI 10.1021/jf058105e; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Peng JH, 2013, J PHARMACOL EXP THER, V344, P646, DOI 10.1124/jpet.112.201137; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; She SY, 2014, FOOD FUNCT, V5, P944, DOI 10.1039/c3fo60565e; SONG XP, 1988, ACTA PHARM SINIC, V9, P55; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang L, 2014, CELL PHYSIOL BIOCHEM, V34, P383, DOI 10.1159/000363007; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yan LP, 2006, LIFE SCI, V79, P324, DOI 10.1016/j.lfs.2006.01.016; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang SY, 2006, BIOL PHARM BULL, V29, P945, DOI 10.1248/bpb.29.945; Zhang Z, 2013, J CLIN PHARMACOL, V53, P787, DOI 10.1002/jcph.96; Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652; Zhu W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-35	40	33	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122925	10.1371/journal.pone.0122925	http://dx.doi.org/10.1371/journal.pone.0122925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822741	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700208
J	Huang, YH; Ching-Chang, I; Kuo, CH; Hsu, YY; Lee, FT; Shi, GY; Tseng, SH; Wu, HL				Huang, Yi-Hsun; Ching-Chang, I; Kuo, Cheng-Hsiang; Hsu, Yun-Yan; Lee, Fang-Tzu; Shi, Guey-Yueh; Tseng, Sung-Huei; Wu, Hua-Lin			Thrombomodulin Promotes Corneal Epithelial Wound Healing	PLOS ONE			English	Article							BB-INDUCED THROMBOMODULIN; GROWTH-FACTORS; PDGF-BB; CELLS; INFLAMMATION; DOMAIN; LOCALIZATION; MAINTENANCE; MIGRATION; REPAIR	Purpose To determine the role of thrombomodulin (TM) in corneal epithelial wound healing, and to investigate whether recombinant TM epidermal growth factor-like domain plus serine/threonine-rich domain (rTMD23) has therapeutic potential in corneal epithelial wound healing. Methods TM localization and expression in the murine cornea were examined by immunofluorescence staining. TM expression after injury was also studied. The effect of rTMD23 on corneal wound healing was evaluated by in vitro and in vivo assays. Results TM was expressed in the cornea in normal adult mice. TM expression increased in the early phase of wound healing and decreased after wound recovery. In the in vitro study, platelet-derived growth factor-BB (PDGF-BB) induced TM expression in murine corneal epithelial cells by mediating E26 transformation-specific sequence-1 (Ets-1) via the mammalian target of rapamycin (mTOR) signaling pathway. The administration of rTMD23 increased the rate of corneal epithelial wound healing. Conclusions TM expression in corneal epithelium was modulated during the corneal wound healing process, and may be regulated by PDGF-BB. In addition, rTMD23 has therapeutic potential in corneal injury.	[Huang, Yi-Hsun] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Huang, Yi-Hsun; Tseng, Sung-Huei] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Ophthalmol, Tainan 70101, Taiwan; [Ching-Chang, I; Kuo, Cheng-Hsiang; Hsu, Yun-Yan; Lee, Fang-Tzu; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Cardiovasc Res Ctr, Tainan 70101, Taiwan; [Ching-Chang, I; Kuo, Cheng-Hsiang; Hsu, Yun-Yan; Lee, Fang-Tzu; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Wu, HL (corresponding author), Natl Cheng Kung Univ, Coll Med, Cardiovasc Res Ctr, Tainan 70101, Taiwan.	jackhyh@gmail.com	Kuo, Cheng-Hsiang/GRJ-7463-2022	Kuo, Cheng-Hsiang/0000-0002-4885-9020	National Cheng Kung University Hospital Research Fund [NCKUH-10406017]	National Cheng Kung University Hospital Research Fund	This work was supported by the National Cheng Kung University Hospital Research Fund (NCKUH-10406017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Vinay B, 2003, Indian J Ophthalmol, V51, P5; Bazan HEP, 2005, EXP EYE RES, V80, P453, DOI 10.1016/j.exer.2004.12.023; BUCK RC, 1979, INVEST OPHTH VIS SCI, V18, P767; Cheng TL, 2013, J INVEST DERMATOL, V133, P1638, DOI 10.1038/jid.2013.8; Cheng TL, 2011, J INVEST DERMATOL, V131, P2486, DOI 10.1038/jid.2011.230; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; DUA HS, 1994, BRIT J OPHTHALMOL, V78, P401, DOI 10.1136/bjo.78.5.401; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001; Haber M, 2003, VET OPHTHALMOL, V6, P211, DOI 10.1046/j.1463-5224.2003.00296.x; HAMADA H, 1995, BLOOD, V86, P225, DOI 10.1182/blood.V86.1.225.bloodjournal861225; Ikeda T, 2000, INVEST OPHTH VIS SCI, V41, P3383; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kamiyama K, 1998, CORNEA, V17, P315, DOI 10.1097/00003226-199805000-00013; Kenchegowda S, 2010, J LIPID RES, V51, P879, DOI 10.1194/jlr.R001347; Klenkler B, 2007, OCUL SURF, V5, P228, DOI 10.1016/S1542-0124(12)70613-4; Kobayashi T, 2009, MOL VIS, V15, P1589; LAGER DJ, 1995, AM J PATHOL, V146, P933; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Lo IC, 2009, CARDIOVASC RES, V81, P771, DOI 10.1093/cvr/cvn351; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Namba H, 2010, INVEST OPHTH VIS SCI, V51, P5460, DOI 10.1167/iovs.10-5578; Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x; Shi CS, 2005, CIRCULATION, V111, P1627, DOI 10.1161/01.CIR.0000160364.05405.B5; Vesaluoma M, 1997, CURR EYE RES, V16, P825, DOI 10.1076/ceyr.16.8.825.8984; Wei HJ, 2011, CARDIOVASC RES, V92, P317, DOI 10.1093/cvr/cvr220; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Yoshioka R, 2010, INVEST OPHTH VIS SCI, V51, P5630, DOI 10.1167/iovs.10-5158; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P2414, DOI 10.1167/iovs.11-8869; Zieske JD, 2001, CURR OPIN OPHTHALMOL, V12, P237, DOI 10.1097/00055735-200108000-00001	32	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122491	10.1371/journal.pone.0122491	http://dx.doi.org/10.1371/journal.pone.0122491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816372	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600183
J	Kolliopoulou, A; Van Nieuwerburgh, F; Stravopodis, DJ; Deforce, D; Swevers, L; Smagghe, G				Kolliopoulou, Anna; Van Nieuwerburgh, Filip; Stravopodis, Dimitrios J.; Deforce, Dieter; Swevers, Luc; Smagghe, Guy			Transcriptome Analysis of Bombyx mori Larval Midgut during Persistent and Pathogenic Cytoplasmic Polyhedrosis Virus Infection	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; INDUCED APOPTOSIS REQUIRES; XYLULOSE REDUCTASE DCXR; ANTIVIRAL DEFENSE; SMALL RNAS; SILKWORM; PROTEIN; IMMUNITY; PATHWAYS; RESISTANCE	Many insects can be persistently infected with viruses but do not show any obvious adverse effects with respect to physiology, development or reproduction. Here, Bombyx mori strain Daizo, persistently infected with cytoplasmic polyhedrosis virus (BmCPV), was used to study the host's transcriptional response after pathogenic infection with the same virus in midgut tissue of larvae persistently and pathogenically infected as 2nd and 4th instars. Next generation sequencing revealed that from 13,769 expressed genes, 167 were upregulated and 141 downregulated in both larval instars following pathogenic infection. Several genes that could possibly be involved in B. mori immune response against BmCPV or that may be induced by the virus in order to increase infectivity were identified, whereas classification of differentially expressed transcripts (confirmed by qRT-PCR) resulted in gene categories related to physical barriers, immune responses, proteolytic /metabolic enzymes, heat-shock proteins, hormonal signaling and uncharacterized proteins. Comparison of our data with the available literature (pathogenic infection of persistently vs. non-persistently infected larvae) unveiled various similarities of response in both cases, which suggests that pre-existing persistent infection does not affect in a major way the transcriptome response against pathogenic infection. To investigate the possible host's RNAi response against BmCPV challenge, the differential expression of RNAi-related genes and the accumulation of viral small RNAs (vsRNAs) were studied. During pathogenic infection, siRNA-like traces like the 2-fold up-regulation of the core RNAi genes Ago-2 and Dcr-2 as well as a peak of 20 nt small RNAs were observed. Interestingly, vsRNAs of the same size were detected at lower rates in persistently infected larvae. Collectively, our data provide an initial assessment of the relative significance of persistent infection of silkworm larvae on the host response following pathogenic infection with CPV, while they also highlight the relative importance of RNAi as an antiviral mechanism.	[Kolliopoulou, Anna; Swevers, Luc] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol, Athens, Greece; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Dept Pharmaceut, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Stravopodis, Dimitrios J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece; [Smagghe, Guy] Univ Ghent, Lab Agrozool, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium	National Centre of Scientific Research "Demokritos"; Ghent University; National & Kapodistrian University of Athens; Ghent University	Swevers, L (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol, Athens, Greece.	swevers@bio.demokritos.gr; guy.smagghe@ugent.be	Van Nieuwerburgh, Filip/H-9697-2015; Smagghe, Guy/AAE-8914-2019; Kolliopoulou, Anna/AAU-4656-2021; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Smagghe, Guy/0000-0001-8334-3313; Kolliopoulou, Anna/0000-0002-5514-9617; Deforce, Dieter LD/0000-0002-0635-661X; Stravopodis, Dimitrios/0000-0002-9535-2134	Research Council of Ghent University (BOF-UGent, Belgium); Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium); General Secretariat for Research and Technology, Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; NCSR "Demokritos"; BBSRC [BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740, MR/K001744/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [G0900740, MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	Research Council of Ghent University (BOF-UGent, Belgium); Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium)(FWO); General Secretariat for Research and Technology, Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; NCSR "Demokritos"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge support by the Research Council of Ghent University (BOF-UGent, Belgium) (www.ugent.be, Belgium), the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium) (www.fwo.be), and the General Secretariat for Research and Technology, Hellenic Republic Ministry of National Education and Religious Affairs, in Greece (www.gsrt.gr). Anna Kolliopoulou is a recipient of a PhD fellowship from NCSR "Demokritos". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstein M, 2010, ADV EXP MED BIOL, V692, P155; Bao YY, 2008, INSECT BIOCHEM MOLEC, V38, P853, DOI 10.1016/j.ibmb.2008.06.004; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; C ore Team R, 2012, R LANG ENV STAT COMP; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Chen Y, 2011, LUNG CANCER, V73, P38, DOI 10.1016/j.lungcan.2010.10.015; Chevignon G, 2015, INSECT BIOCH MOL BIO; Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021; Field LM, 1998, BIOCHEM J, V330, P169; Gan L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-8; Gao K, 2014, GENE, V539, P230, DOI 10.1016/j.gene.2014.01.073; Gao K, 2014, J INVERTEBR PATHOL, V115, P8, DOI 10.1016/j.jip.2013.10.016; Gao K, 2012, J INVERTEBR PATHOL, V110, P83, DOI 10.1016/j.jip.2012.02.011; Girardin SE, 2006, IMMUNITY, V24, P363, DOI 10.1016/j.immuni.2006.04.001; Giuliano John S Jr, 2011, Open Inflamm J, V4, P49; Goic B, 2012, CURR OPIN MICROBIOL, V15, P531, DOI 10.1016/j.mib.2012.06.002; Gu J, 2013, INSECT BIOCHEM MOLEC, V43, P794, DOI 10.1016/j.ibmb.2013.06.001; Hill CL, 1999, J VIROL METHODS, V78, P177, DOI 10.1016/S0166-0934(98)00181-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Iwanaga M, 2013, VIRUS RES; Izumi N, 2013, RNA, V19, P896, DOI 10.1261/rna.037200.112; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Kolliopoulou A, 2013, INSECT BIOCHEM MOLEC, V43, P654, DOI 10.1016/j.ibmb.2013.05.001; Kominsky DJ, 2002, CELL DEATH DIFFER, V9, P926, DOI 10.1038/sj.cdd.4401045; Kominsky DJ, 2002, J VIROL, V76, P11414, DOI 10.1128/JVI.76.22.11414-11424.2002; Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06; Lee SK, 2013, INT J BIOCHEM CELL B, V45, P2563, DOI 10.1016/j.biocel.2013.08.010; Li LN, 2010, J PROTEOME RES, V9, P2460, DOI 10.1021/pr901151k; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Liu J, 2013, VIROLOGY, V447, P52, DOI 10.1016/j.virol.2013.08.025; Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Mori H, 2010, INSECT VIROLOGY, P307; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7; Niu J, 2014, CURR OPIN INSECT SCI, V3, P1; Ponnuvel KM, 2012, ARCH INSECT BIOCHEM, V81, P90, DOI 10.1002/arch.21046; Ruan Wen-jing, 2006, J Zhejiang Univ Sci B, V7, P929, DOI 10.1631/jzus.2006.B0929; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Shimomura M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-486; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Son LT, 2011, FEBS LETT, V585, P1310, DOI 10.1016/j.febslet.2011.03.062; Stewart ME, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-362; Subbaiah EV, 2013, GENETICS, V193, P63, DOI 10.1534/genetics.112.144402; Swevers L, 2013, INSECT MOL BIOL, V22, P668, DOI 10.1111/imb.12054; Tyler KL, 2001, TRENDS MICROBIOL, V9, P560, DOI 10.1016/S0966-842X(01)02103-5; Villarreal LP, 2011, VIRUSES-BASEL, V3, P1933, DOI 10.3390/v3101933; Vodovar N, 2012, ADV INSECT PHYSIOL, V42, P1, DOI 10.1016/B978-0-12-387680-5.00001-X; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068209; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Wu P, 2009, AFR J BIOTECHNOL, V8, P3711; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhang F, 2014, TOXINS, V6, P3187, DOI 10.3390/toxins6113187; Zhu L, 2013, INSECT BIOCHEM MOLEC, V43, P664, DOI 10.1016/j.ibmb.2013.04.004	69	41	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121447	10.1371/journal.pone.0121447	http://dx.doi.org/10.1371/journal.pone.0121447			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816294	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600094
J	Matuschek, H; Kliegl, R; Holschneider, M				Matuschek, Hannes; Kliegl, Reinhold; Holschneider, Matthias			Smoothing Spline ANOVA Decomposition of Arbitrary Splines: An Application to Eye Movements in Reading	PLOS ONE			English	Article								The Smoothing Spline ANOVA (SS-ANOVA) requires a specialized construction of basis and penalty terms in order to incorporate prior knowledge about the data to be fitted. Typically, one resorts to the most general approach using tensor product splines. This implies severe constraints on the correlation structure, i.e. the assumption of isotropy of smoothness can not be incorporated in general. This may increase the variance of the spline fit, especially if only a relatively small set of observations are given. In this article, we propose an alternative method that allows to incorporate prior knowledge without the need to construct specialized bases and penalties, allowing the researcher to choose the spline basis and penalty according to the prior knowledge of the observations rather than choosing them according to the analysis to be done. The two approaches are compared with an artificial example and with analyses of fixation durations during reading.	[Matuschek, Hannes; Holschneider, Matthias] Univ Potsdam, Focus Area Dynam Complex Syst, D-14476 Potsdam, Germany; [Matuschek, Hannes; Kliegl, Reinhold] Univ Potsdam, Dept Psychol, D-14476 Potsdam, Germany	University of Potsdam; University of Potsdam	Matuschek, H (corresponding author), Univ Potsdam, Focus Area Dynam Complex Syst, Karl Liebknecht Str 24, D-14476 Potsdam, Germany.	hannes.matuschek@uni-potsdam.de	Kliegl, Reinhold/A-1276-2009; Kliegl, Reinhold/AAD-3463-2019	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Holschneider, Matthias/0000-0003-3987-105X	CLARIN, BMBF-FKZ [01UG1120A]; Deutsche Forschungsgemeinschaft [FOR-868]	CLARIN, BMBF-FKZ; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was funded by CLARIN, BMBF-FKZ: 01UG1120A and the Deutsche Forschungsgemeinschaft FOR-868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2010, AMST STUD THEORY HIS, V311, P257; Demidenko E, 2004, MIXED MODELS THEORY, V518; Gu C, 2013, PACKAGE GSS; Gu C., 2002, SPR S STAT, DOI 10.1007/978-1-4757-3683-0; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Heister J, 2012, VISUAL WORD RECOGNIT, V2; KIMELDOR.GS, 1970, ANN MATH STAT, V41, P495, DOI 10.1214/aoms/1177697089; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kliegl R, 2007, J EXP PSYCHOL GEN, V136, P530, DOI 10.1037/0096-3445.136.3.530; Kosling K, 2012, PROMINENCE TRICONSTI; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; R Core Team, 2021, R LANGUAGE ENV STAT; Ruppert D., 2003, SEMIPARAMETRIC REGRE, V12; Tremblay Antoine, 2010, PERSPECTIVES FORMULA, P151; WAHBA G., 1990, SPLINE MODELS OBSERV, V59, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; Wieling M, 2014, LANG DYN CHANG, V4, P253, DOI 10.1163/22105832-00402001; Wieling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023613; Wood S, 2012, PACKAGE GAMM4; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood S. N., 2012, PACKAGE MGCV; Wotschack C, 2013, Q J EXP PSYCHOL, V66, P548, DOI 10.1080/17470218.2011.625094	21	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119165	10.1371/journal.pone.0119165	http://dx.doi.org/10.1371/journal.pone.0119165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816246	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600013
J	Van den Broeck, G; Maertens, M				Van den Broeck, Goedele; Maertens, Miet			Female Employment Reduces Fertility in Rural Senegal	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; WOMENS EMPLOYMENT; POPULATION; TRANSITION; MODEL	Economic growth and modernization of society are generally associated with fertility rate decreases but which forces trigger this is unclear. In this paper we assess how fertility changes with increased labor market participation of women in rural Senegal. Evidence from high-income countries suggests that higher female employment rates lead to reduced fertility rates but evidence from developing countries at an early stage of demographic transition is largely absent. We concentrate on a rural area in northern Senegal where a recent boom in horticultural exports has been associated with a sudden increase in female off-farm employment. Using survey data we show that employed women have a significantly higher age at marriage and at first childbirth, and significantly fewer children. As causal identification strategy we use instrumental variable and difference-in-differences estimations, combined with propensity score matching. We find that female employment reduces the number of children per woman by 25%, and that this fertility-reducing effect is as large for poor as for non-poor women and larger for illiterate than for literate women. Results imply that female employment is a strong instrument for empowering rural women, reducing fertility rates and accelerating the demographic transition in poor countries. The effectiveness of family planning programs can increase if targeted to areas where female employment is increasing or to female employees directly because of a higher likelihood to reach women with low-fertility preferences. Our results show that changes in fertility preferences not necessarily result from a cultural evolution but can also be driven by sudden and individual changes in economic opportunities.	[Van den Broeck, Goedele; Maertens, Miet] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium	KU Leuven	Maertens, M (corresponding author), Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium.	miet.maertens@kuleuven.be	Maertens, Miet/A-5509-2013; Van Den Broeck, Goedele/AAD-3865-2020	Van Den Broeck, Goedele/0000-0002-8480-3526; Maertens, Miet/0000-0001-7245-0375	IWT (Agency for Innovation by Science and Technology in Flanders); KU Leuven Research Foundation (Methusalem fund)	IWT (Agency for Innovation by Science and Technology in Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven Research Foundation (Methusalem fund)	We acknowledge research funding from IWT (Agency for Innovation by Science and Technology in Flanders - www.iwt.be) and KU Leuven Research Foundation (Methusalem fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 1974, WORLD DEV, V2, P23; Ahn N, 2002, J POPUL ECON, V15, P667, DOI 10.1007/s001480100078; Alkire S, 2010, 11 UNDP; Barrett CB, 2010, APPL ECON PERSPECT P, V32, P515, DOI 10.1093/aepp/ppq023; Basu K, 2006, ECON J, V116, P558, DOI 10.1111/j.1468-0297.2006.01092.x; Becker S, 1960, U NBER C SERIES, V11; Beguy D, 2009, DEMOGR RES, V20, P97, DOI 10.4054/DemRes.2009.20.7; Boserup E, 1970, WOMANS ROLE EC DEV; Brewster KL, 2000, ANNU REV SOCIOL, V26, P271, DOI 10.1146/annurev.soc.26.1.271; Budig MJ, 2003, SOC SCI RES, V32, P376, DOI 10.1016/S0049-089X(03)00012-7; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; CRAMER JC, 1980, AM SOCIOL REV, V45, P167, DOI 10.2307/2095117; Dollar D, 2004, ECON J, V114, pF22, DOI 10.1111/j.0013-0133.2004.00186.x; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Fang H, 2013, WORKING PAPER SERIES, V2; Foley EE, 2007, MED ANTHROPOL, V26, P323, DOI 10.1080/01459740701619830; Galor O, 2000, AM ECON REV, V90, P806, DOI 10.1257/aer.90.4.806; Garenne M, 2002, WORLD DEV, V30, P1835, DOI 10.1016/S0305-750X(02)00069-4; Kalwij AS, 2000, J POPUL ECON, V13, P221, DOI 10.1007/s001480050135; Maertens M, 2013, FOOD POLICY, V43, P118, DOI 10.1016/j.foodpol.2013.07.006; Maertens M, 2012, DEV POLICY REV, V30, P473, DOI 10.1111/j.1467-7679.2012.00585.x; Maertens M, 2011, EUR REV AGRIC ECON, V38, P31, DOI 10.1093/erae/jbq053; Mason KO, 1997, DEMOGRAPHY, V34, P443, DOI 10.2307/3038299; Munshi K, 2006, J DEV ECON, V80, P1, DOI 10.1016/j.jdeveco.2005.01.002; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; Osili UO, 2008, J DEV ECON, V87, P57, DOI 10.1016/j.jdeveco.2007.10.003; Republique du Senegal, 2012, PLAN ACT NAT PLAN FA; Shapiro D, 1997, POPUL RES POLICY REV, V16, P259, DOI 10.1023/A:1005761504449; Shenk MK, 2013, P NATL ACAD SCI USA, V110, P8045, DOI 10.1073/pnas.1217029110; TEITELBAUM MS, 1975, SCIENCE, V188, P420, DOI 10.1126/science.1124392; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Upadhay UD, 2010, WORKING PAPER SERIES, V80; World Bank, 2014, WORLD DEV IND 2014	34	22	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122086	10.1371/journal.pone.0122086	http://dx.doi.org/10.1371/journal.pone.0122086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816301	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600142
J	Handel, N; Otte, S; Jonker, M; Brul, S; ter Kuile, BH				Handel, Nadine; Otte, Sarah; Jonker, Martijs; Brul, Stanley; ter Kuile, Benno H.			Factors That Affect Transfer of the IncI1 beta-Lactam Resistance Plasmid pESBL-283 between E-coli Strains	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; CONJUGATIVE PLASMID; GENE-EXPRESSION; EVOLUTION; EPIDEMIOLOGY; ADAPTATION; PRESSURE; BACTERIA	The spread of antibiotic resistant bacteria worldwide presents a major health threat to human health care that results in therapy failure and increasing costs. The transfer of resistance conferring plasmids by conjugation is a major route by which resistance genes disseminate at the intra-and interspecies level. High similarities between resistance genes identified in foodborne and hospital-acquired pathogens suggest transmission of resistance conferring and transferrable mobile elements through the food chain, either as part of intact strains, or through transfer of plasmids from foodborne to human strains. To study the factors that affect the rate of plasmid transfer, the transmission of an extended-spectrum beta-lactamase (ESBL) plasmid from a foodborne Escherichia colistrain to the beta-lactam sensitive E. coli MG1655 strain was documented as a function of simulated environmental factors. The foodborne E. coli isolate used as donor carried a CTX-M-1 harboring IncI1 plasmid that confers resistance to beta-lactam antibiotics. Cell density, energy availability and growth rate were identified as factors that affect plasmid transfer efficiency. Transfer rates were highest in the absence of the antibiotic, with almost every acceptor cell picking up the plasmid. Raising the antibiotic concentrations above the minimum inhibitory concentration (MIC) resulted in reduced transfer rates, but also selected for the plasmid carrying donor and recombinant strains. Based on the mutational pattern of transconjugant cells, a common mechanism is proposed which compensates for fitness costs due to plasmid carriage by reducing other cell functions. Reducing potential fitness costs due to maintenance and expression of the plasmid could contribute to persistence of resistance genes in the environment even without antibiotic pressure. Taken together, the results identify factors that drive the spread and persistence of resistance conferring plasmids in natural isolates and shows how these can contribute to transmission of resistance genes through the food chain.	[Handel, Nadine; Otte, Sarah; Brul, Stanley; ter Kuile, Benno H.] Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Jonker, Martijs] Univ Amsterdam, Swammerdam Inst Life Sci, MicroArray Dept, Amsterdam, Netherlands; [Jonker, Martijs] Univ Amsterdam, Swammerdam Inst Life Sci, Integrat Bioinformat Unit, Amsterdam, Netherlands; [ter Kuile, Benno H.] Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment & Res, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	ter Kuile, BH (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.	B.H.terKuile@uva.nl	Kuile, Benno Ter/AAD-1699-2021		Netherlands Food and Consumer Product safety Authority	Netherlands Food and Consumer Product safety Authority	This study was supported by the Netherlands Food and Consumer Product safety Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al Naiemi N, 2006, J CLIN MICROBIOL, V44, P3012, DOI 10.1128/JCM.01112-06; Andersen PS, 2013, GENOME ANNOUNC, P1; [Anonymous], 1991, COEVOLUTION BACTERIA, V45, P656; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brouwer MS, 2014, GENOME ANNOUNC, P2; Burian J, 1997, PLASMID, V37, P2, DOI 10.1006/plas.1996.1273; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Caboche S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-264; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carman RJ, 2005, REGUL TOXICOL PHARM, V43, P168, DOI 10.1016/j.yrtph.2005.06.005; Cottell JL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-168; Cottell JL, 2012, ANTIMICROB AGENTS CH, V56, P4703, DOI 10.1128/AAC.00848-12; Coudron PE, 1997, J CLIN MICROBIOL, V35, P2593, DOI 10.1128/JCM.35.10.2593-2597.1997; Dahlberg C, 2003, GENETICS, V165, P1641; Dahlberg C, 1998, APPL ENVIRON MICROB, V64, P2670; Dionisio F, 2005, BIOL LETT-UK, V1, P250, DOI 10.1098/rsbl.2004.0275; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Evans CGT, 1970, CONTINUOUS CULTURE M; Fabich AJ, 2011, INFECT IMMUN, V79, P2430, DOI 10.1128/IAI.01199-10; Feld L, 2008, J ANTIMICROB CHEMOTH, V61, P845, DOI 10.1093/jac/dkn033; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Frost LS, 2010, FUTURE MICROBIOL, V5, P1057, DOI 10.2217/FMB.10.70; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Gniadkowski M, 2001, CLIN MICROBIOL INFEC, V7, P597, DOI 10.1046/j.1198-743x.2001.00330.x; Goren MG, 2010, EMERG INFECT DIS, V16, P1014, DOI 10.3201/eid1606.091671; Handel N, 2014, ANTIMICROB AGENTS CH, V58, P4371, DOI 10.1128/AAC.02892-14; Handel N, 2013, ANTIMICROB AGENTS CH, V57, P3752, DOI 10.1128/AAC.02096-12; Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hobman JL, 2007, J BACTERIOL, V189, P8786, DOI 10.1128/JB.00977-07; KRUSE H, 1994, APPL ENVIRON MICROB, V60, P4015, DOI 10.1128/AEM.60.11.4015-4021.1994; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; LEVY SB, 1976, NATURE, V260, P40, DOI 10.1038/260040a0; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; MACDONALD JA, 1992, WATER RES, V26, P461, DOI 10.1016/0043-1354(92)90046-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; NCBI Resource Coordinators, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI [10.1093/nar/gks1189, DOI 10.1093/NAR/GKS1189]; Normander B, 1998, APPL ENVIRON MICROB, V64, P1902; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pruss BM, 2003, J BACTERIOL, V185, P534, DOI 10.1128/JB.185.2.534-543.2003; Rupp ME, 2003, DRUGS, V63, P353, DOI 10.2165/00003495-200363040-00002; Schuurmans JM, 2009, J MICROBIOL METH, V79, P44, DOI 10.1016/j.mimet.2009.07.017; Schuurmans JM, 2014, PLASMID, V72, P1, DOI 10.1016/j.plasmid.2014.01.002; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao K, 2007, NUCLEIC ACIDS RES, V35, P4441, DOI 10.1093/nar/gkm456; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460	56	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123039	10.1371/journal.pone.0123039	http://dx.doi.org/10.1371/journal.pone.0123039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830294	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600135
J	Cheng, ZL; Bown, L; Tahlan, K; Bignell, DRD				Cheng, Zhenlong; Bown, Luke; Tahlan, Kapil; Bignell, Dawn R. D.			Regulation of Coronafacoyl Phytotoxin Production by the PAS-LuxR Family Regulator CfaR in the Common Scab Pathogen Streptomyces scabies	PLOS ONE			English	Article							THAXTOMIN-A; CELLULOSE SYNTHESIS; POSITIVE REGULATOR; BIOSYNTHESIS; DIMERIZATION; DOMAINS; TRANSCRIPTION; PEPTIDE; GENES; IDENTIFICATION	Potato common scab is an economically important crop disease that is characterized by the formation of superficial, raised or pitted lesions on the potato tuber surface. The most widely distributed causative agent of the disease is Streptomyces scabies, which produces the phytotoxic secondary metabolite thaxtomin A that serves as a key virulence factor for the organism. Recently, it was demonstrated that S. scabies can also produce the phytotoxic secondary metabolite coronafacoyl-L-isoleucine (CFA-L-Ile) as well as other related metabolites in minor amounts. The expression of the biosynthetic genes for CFA-L-Ile production is dependent on a PAS-LuxR family transcriptional regulator, CfaR, which is encoded within the phytotoxin biosynthetic gene cluster in S. scabies. In this study, we show that CfaR activates coronafacoyl phytotoxin production by binding to a single site located immediately upstream of the putative -35 hexanucleotide box within the promoter region for the biosynthetic genes. The binding activity of CfaR was shown to require both the LuxR and PAS domains, the latter of which is involved in protein homodimer formation. We also show that CFA-L-Ile production is greatly enhanced in S. scabies by overexpression of both cfaR and a downstream co-transcribed gene, orf1. Our results provide important insight into the regulation of coronafacoyl phytotoxin production, which is thought to contribute to the virulence phenotype of S. scabies. Furthermore, we provide evidence that CfaR is a novel member of the PAS-LuxR family of regulators, members of which are widely distributed among actinomycete bacteria.	[Cheng, Zhenlong; Bown, Luke; Tahlan, Kapil; Bignell, Dawn R. D.] Mem Univ Newfoundland, Dept Biol, St John, NF A1B 3X9, Canada	Memorial University Newfoundland	Bignell, DRD (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF A1B 3X9, Canada.	dbignell@mun.ca		Bignell, Dawn/0000-0003-1731-5669	Natural Sciences and Engineering Research Council of Canada [386696-2010]; Research & Development Corporation of Newfoundland [5404.1207.102, 5404.1218.103]; Labrador Ignite RD Program [5404.1207.102, 5404.1218.103]; Canadian Foundation of Innovation Leaders Opportunity Fund [30482]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research & Development Corporation of Newfoundland; Labrador Ignite RD Program; Canadian Foundation of Innovation Leaders Opportunity Fund	The described work was funded by the Natural Sciences and Engineering Research Council of Canada Discovery Grants Program (386696-2010 to DRDB). Equipment used in this study was purchased with financial assistance from the Research & Development Corporation of Newfoundland and Labrador Ignite R&D Program (5404.1207.102 to DRDB), the Research & Development Corporation of Newfoundland and Labrador Leverage R&D Program (5404.1218.103 to KT and DRDB) and the Canadian Foundation of Innovation Leaders Opportunity Fund (30482 to KT and DRDB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bignell DRD, 2014, J APPL MICROBIOL, V116, P223, DOI 10.1111/jam.12369; Bignell DRD, 2014, MOL PLANT MICROBE IN, V27, P875, DOI 10.1094/MPMI-02-14-0037-R; Bignell DRD, 2010, MOL PLANT MICROBE IN, V23, P161, DOI 10.1094/MPMI-23-2-0161; Bischoff V, 2009, J EXP BOT, V60, P955, DOI 10.1093/jxb/ern344; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dees MW, 2012, POTATO RES, V55, P249, DOI 10.1007/s11540-012-9206-9; Duval I, 2009, PLANT CELL REP, V28, P811, DOI 10.1007/s00299-009-0670-x; Fry BA, 2002, PHYSIOL MOL PLANT P, V60, P1, DOI 10.1006/pmpp.2001.0371; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Fyans JK, 2015, MOL PLANT MICROBE IN, V28, P443, DOI 10.1094/MPMI-09-14-0255-R; Goyer C, 1998, PHYTOPATHOLOGY, V88, P442, DOI 10.1094/PHYTO.1998.88.5.442; Healy FG, 2000, MOL MICROBIOL, V38, P794, DOI 10.1046/j.1365-2958.2000.02170.x; Hill J, 2005, CAN J PLANT PATHOL, V27, P46; Hiltunen LH, 2005, ANN APPL BIOL, V146, P395, DOI 10.1111/j.1744-7348.2005.040083.x; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Johnson EG, 2009, MOL MICROBIOL, V73, P409, DOI 10.1111/j.1365-2958.2009.06780.x; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; KING RR, 1991, AM POTATO J, V68, P675, DOI 10.1007/BF02853743; King RR, 2009, PHYTOCHEMISTRY, V70, P833, DOI 10.1016/j.phytochem.2009.04.013; Kinkel LL, 1998, CAN J MICROBIOL, V44, P768, DOI 10.1139/cjm-44-8-768; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; LORIA R, 1995, PHYTOPATHOLOGY, V85, P537, DOI 10.1094/Phyto-85-537; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Niedziela-Majka A, 1998, PROTEIN EXPRES PURIF, V14, P208, DOI 10.1006/prep.1998.0932; Palmer GC, 2010, J BACTERIOL, V192, P2722, DOI 10.1128/JB.00112-10; Pongratz I, 1998, MOL CELL BIOL, V18, P4079, DOI 10.1128/MCB.18.7.4079; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Sambrook J., 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, METAB ENG, V13, P756, DOI 10.1016/j.ymben.2011.09.011; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Vicente CM, 2014, APPL MICROBIOL BIOT, V98, P9311, DOI 10.1007/s00253-014-5998-7; Wei J, 2011, LETT APPL MICROBIOL, V52, P322, DOI 10.1111/j.1472-765X.2011.03003.x; Wilson CR, 2004, P INT POT SCAB S SEP; Wu HL, 2014, J IND MICROBIOL BIOT, V41, P163, DOI 10.1007/s10295-013-1370-7; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321	50	8	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122450	10.1371/journal.pone.0122450	http://dx.doi.org/10.1371/journal.pone.0122450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826255	Green Published, gold, Green Accepted			2022-12-27	WOS:000352084800069
J	He, XQ; Guan, J; Liu, F; Li, J; He, MR				He, Xiao-qing; Guan, Jing; Liu, Fang; Li, Jing; He, Mei-rong			Identification of the sAPRIL Binding Peptide and Its Growth Inhibition Effects in the Colorectal Cancer Cells	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; B-CELL; IN-VITRO; MULTIPLE-MYELOMA; HEPARAN-SULFATE; GOLGI-APPARATUS; MEMBER APRIL; TUMOR; APOPTOSIS; LIGAND	Background A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) super family. It binds to its specific receptors and is involved in multiple processes during tumorigenesis and tumor cells proliferation. High levels of APRIL expression are closely correlated to the growth, metastasis, and 5-FU drug resistance of colorectal cancer. The aim of this study was to identify a specific APRIL binding peptide (BP) able to block APRIL activity that could be used as a potential treatment for colorectal cancer. Methods A phage display library was used to identify peptides that bound selectively to soluble recombinant human APRIL (sAPRIL). The peptides with the highest binding affinity for sAPRIL were identified using ELISA. The effects of sAPRIL-BP on cell proliferation and cell cycle/apoptosis in vitro were evaluated using the CCK-8 assay and flow cytometry, respectively. An in vivo mouse model of colorectal cancer was used to determine the anti-tumor efficacy of the sAPRIL-BP. Results Three candidate peptides were characterized from eight phage clones with high binding affinity for sAPRIL. The peptide with the highest affinity was selected for further characterization. The identified sAPRIL-BP suppressed tumor cell proliferation and cell cycle progression in LOVO cells in a dose-dependent manner. In vivo in a mouse colorectal challenge model, the sAPRIL-BP reduced the growth of tumor xenografts in nude mice by inhibiting proliferation and inducing apoptosis intratumorally. Moreover, in an in vivo metastasis model, sAPRIL-BP reduced liver metastasis of colorectal cancer cells. Conclusions sAPRIL-BP significantly suppressed tumor growth in vitro and in vivo and might be a candidate for treating colorectal cancers that express high levels of APRIL.	[He, Xiao-qing; Guan, Jing; Liu, Fang; Li, Jing; He, Mei-rong] Southern Med Univ, Nanfang Hosp, Inst Digest Dis, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [He, Xiao-qing] Wuzhou Red Cross Hosp, Dept Oncol, Wuzhou 543002, Guangxi Provinc, Peoples R China; [Guan, Jing] Army Reserve Antiaircraft Artillery Hosp, Zhengzhou 450002, Henan Province, Peoples R China	Southern Medical University - China	He, MR (corresponding author), Southern Med Univ, Nanfang Hosp, Inst Digest Dis, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China.	hemr@263.net	刘, 芳华/H-7907-2014	刘, 芳华/0000-0002-1934-3674	Subject of Guangzhou Science and Technology Planned Projects [2012J4300091]	Subject of Guangzhou Science and Technology Planned Projects	This work was supported by the Subject of Guangzhou Science and Technology Planned Projects (2012J4300091).	Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Bonci D, 2008, HAEMATOL-HEMATOL J, V93, P1899, DOI 10.3324/haematol.13035; Borghouts C, 2005, J PEPT SCI, V11, P713, DOI 10.1002/psc.717; Cazal CM, 2010, ANTI-CANCER AGENT ME, V10, P769; Corti A, 2011, CURR PHARM BIOTECHNO, V12, P1128, DOI 10.2174/138920111796117373; Cui JW, 2012, ASIAN PAC J CANCER P, V13, P633, DOI 10.7314/APJCP.2012.13.2.633; Dai SS, 2009, ACTA BIOCHIM POL, V56, P703; Ding WF, 2009, CLIN BIOCHEM, V42, P1694, DOI 10.1016/j.clinbiochem.2009.06.019; Gao Q, 2013, CURR MOL MED, V13, P464; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Guan Jing, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1600; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Janin YL, 2003, AMINO ACIDS, V25, P1, DOI 10.1007/s00726-002-0349-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lascano V, 2012, CELL DEATH DIFFER, V19, P1826, DOI 10.1038/cdd.2012.68; Liu WG, 2010, J CONTROL RELEASE, V144, P2, DOI 10.1016/j.jconrel.2010.01.032; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Medema JP, 2003, CELL DEATH DIFFER, V10, P1121, DOI 10.1038/sj.cdd.4401291; Moller I, 2011, RAPID COMMUN MASS SP, V25, P2115, DOI 10.1002/rcm.5109; Moreaux J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-83; Munari F, 2011, BLOOD, V117, P6612, DOI 10.1182/blood-2010-06-293266; Norikura T, 2008, BIOSCI BIOTECH BIOCH, V72, P1183, DOI 10.1271/bbb.70586; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Pelekanou V, 2011, ANAL CELL PATHOL, V34, P49, DOI [10.3233/ACP-2011-0001, 10.1155/2011/108631]; Petty RD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-434; Quinn J, 2011, BLOOD, V117, P890, DOI 10.1182/blood-2010-01-264424; Rabiee Atoosa, 2011, J Diabetes Sci Technol, V5, P1521; Rastelli L, 2011, INT J ONCOL, V39, P401, DOI 10.3892/ijo.2011.1040; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Roth W, 2001, CELL DEATH DIFFER, V8, P403, DOI 10.1038/sj.cdd.4400827; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Tu XA, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-105; Vessillier S, 2012, ANN RHEUM DIS, V71, P143, DOI 10.1136/annrheumdis-2011-200100; Wang F, 2011, CANCER GENE THER, V18, P500, DOI 10.1038/cgt.2011.19; Wang F, 2008, ONCOL REP, V20, P135; Wang F, 2013, MOL CELL BIOCHEM, V383, P179, DOI 10.1007/s11010-013-1766-8; Wang F, 2011, CLIN CHEM LAB MED, V49, P1715, DOI 10.1515/CCLM.2011.608; Wang Gui-hua, 2013, Zhonghua Zhong Liu Za Zhi, V35, P249, DOI 10.3760/cma.j.issn.0253-3766.2013.04.003; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Wang JC, 2012, MOL CELL BIOCHEM, V363, P1, DOI 10.1007/s11010-011-1151-4; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137	49	5	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120564	10.1371/journal.pone.0120564	http://dx.doi.org/10.1371/journal.pone.0120564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826583	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800020
J	Itoga, M; Konno, Y; Moritoki, Y; Saito, Y; Ito, W; Tamaki, M; Kobayashi, Y; Kayaba, H; Kikuchi, Y; Chihara, J; Takeda, M; Ueki, S; Hirokawa, M				Itoga, Masamichi; Konno, Yasunori; Moritoki, Yuki; Saito, Yukiko; Ito, Wataru; Tamaki, Mami; Kobayashi, Yoshiki; Kayaba, Hiroyuki; Kikuchi, Yuta; Chihara, Junichi; Takeda, Masahide; Ueki, Shigeharu; Hirokawa, Makoto			G-Protein-Coupled Estrogen Receptor Agonist Suppresses Airway Inflammation in a Mouse Model of Asthma through IL-10	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC LUNG INFLAMMATION; INNATE LYMPHOID-CELLS; CYTOKINE PRODUCTION; SEX-HORMONES; MURINE MODEL; T-CELLS; MICE; EXPRESSION; HYPERRESPONSIVENESS	Estrogen influences the disease severity and sexual dimorphism in asthma, which is caused by complex mechanisms. Besides classical nuclear estrogen receptors (ER alpha beta), G-protein-coupled estrogen receptor (GPER) was recently established as an estrogen receptor on the cell membrane. Although GPER is associated with immunoregulatory functions of estrogen, the pathophysiological role of GPER in allergic inflammatory lung disease has not been examined. We investigated the effect of GPER-specific agonist G-1 in asthmatic mice. GPER expression in asthmatic lung was confirmed by immunofluorescent staining. OVA-sensitized BALB/c and C57BL/6 mice were treated with G-1 by daily subcutaneous injections during an airway challenge phase, followed by histological and biochemical examination. Strikingly, administration of G-1 attenuated airway hyperresponsiveness, accumulation of inflammatory cells, and levels of Th2 cytokines (IL-5 and IL-13) in BAL fluid. G-1 treatment also decreased serum levels of anti-OVA IgE antibodies. The frequency of splenic Foxp3(+) CD4(+) regulatory T cells and IL-10-producing GPER(+) CD4(+) T cells was significantly increased in G-1-treated mice. Additionally, splenocytes isolated from G-1-treated mice showed greater IL-10 production. G-1-induced amelioration of airway inflammation and IgE production were abolished in IL-10-deficient mice. Taken together, these results indicate that extended GPER activation negatively regulates the acute asthmatic condition by altering the IL-10-producing lymphocyte population. The current results have potential importance for understanding the mechanistic aspects of function of estrogen in allergic inflammatory response.	[Itoga, Masamichi; Konno, Yasunori; Moritoki, Yuki; Saito, Yukiko; Ito, Wataru; Tamaki, Mami; Kobayashi, Yoshiki; Kayaba, Hiroyuki; Kikuchi, Yuta; Takeda, Masahide; Ueki, Shigeharu; Hirokawa, Makoto] Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 0108543, Japan; [Itoga, Masamichi; Kayaba, Hiroyuki] Hirosaki Univ, Dept Clin Lab Med, Grad Sch Med, Hirosaki, Aomori 0368562, Japan; [Konno, Yasunori] Akita Univ, Div Dent & Oral Surg, Grad Sch Med, Akita 0108543, Japan; [Ito, Wataru] Nagareyama Tobu Clin, Chiba 2700145, Japan; [Kobayashi, Yoshiki] Kansai Med Univ, Dept Otolaryngol, Hirakata, Osaka 5731010, Japan; [Chihara, Junichi] Soseikai Gen Hosp, Fushimi Ku, Kyoto 6128473, Japan; [Takeda, Masahide] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita 0108543, Japan	Akita University; Hirosaki University; Akita University; Kansai Medical University; Akita University	Takeda, M (corresponding author), Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, 1-1-1 Hondo, Akita 0108543, Japan.	takeda-56@hos.akita-u.ac.jp; ueki-shige@nifty.com	Ueki, Shigeharu/I-3566-2019	Ueki, Shigeharu/0000-0002-3537-7735; Itoga, Masamichi/0000-0002-9400-5245	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590952, 23791097, 13383320, 26860743, 24790547]; Grants-in-Aid for Scientific Research [25460670] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided in part by Grants-in-Aid for Scientific Research (C) (24590952 [Y. Moritoki], 13383320 [S. Ueki]) and Grants-in-Aid for Young Scientists (23791097 and 26860743 [M. Takeda], 24790547 [Y. Kobayashi]) supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brunsing RL, 2011, IMMUNOLOGY, V134, P93, DOI 10.1111/j.1365-2567.2011.03471.x; Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; DELPRETE G, 1993, J IMMUNOL, V150, P353; Dimitropoulou C, 2005, AM J RESP CELL MOL, V32, P239, DOI 10.1165/rcmb.2004-0331OC; Dimitropoulou C, 2009, LUNG, V187, P116, DOI 10.1007/s00408-008-9129-z; Engdahl C, 2010, ARTHRITIS RHEUM-US, V62, P524, DOI 10.1002/art.25055; Ensom MHH, 2003, ANN PHARMACOTHER, V37, P1610, DOI 10.1345/aph.1D090; Feng Y, 1997, BIOCHEM BIOPH RES CO, V231, P651, DOI 10.1006/bbrc.1997.6161; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Hamano N, 1998, ALLERGY ASTHMA PROC, V19, P263, DOI 10.2500/108854198778557773; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Intapad S, 2012, J CELL PHYSIOL, V227, P3036, DOI 10.1002/jcp.23045; Isensee J, 2009, ENDOCRINOLOGY, V150, P1722, DOI 10.1210/en.2008-1488; Jensen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014409; Kanehiro A, 2000, AM J RESP CRIT CARE, V162, P1132, DOI 10.1164/ajrccm.162.3.9910100; Kramer PR, 2004, ARTHRITIS RHEUM, V50, P1967, DOI 10.1002/art.20309; Kuhn C, 2000, AM J RESP CELL MOL, V22, P289, DOI 10.1165/ajrcmb.22.3.3690; Kvingedal AM, 1997, FEBS LETT, V407, P59, DOI 10.1016/S0014-5793(97)00278-0; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; Li BWS, 2013, IMMUNOLOGY, V140, P281, DOI 10.1111/imm.12153; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; Lim RH, 2008, AM J RESP CELL MOL, V38, P499, DOI 10.1165/rcmb.2008-0002ED; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; MYERS JR, 1994, CHEST, V106, P318, DOI 10.1378/chest.106.1.318; Okuyama K, 2008, CLIN EXP ALLERGY, V38, P1212, DOI 10.1111/j.1365-2222.2008.03015.x; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; PIETRAS RJ, 1975, NATURE, V253, P357, DOI 10.1038/253357a0; Polanczyk MJ, 2007, INT IMMUNOL, V19, P337, DOI 10.1093/intimm/dxl151; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Riffo-Vasquez Y, 2007, CLIN EXP ALLERGY, V37, P459, DOI 10.1111/j.1365-2222.2007.02670.x; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Takeda M, 2013, RESPIROLOGY, V18, P797, DOI 10.1111/resp.12078; Tamaki M, 2014, IMMUNOL LETT, V160, P72, DOI 10.1016/j.imlet.2014.03.012; Ueki S, 2003, IMMUNOL LETT, V86, P183, DOI 10.1016/S0165-2478(03)00003-8; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Windahl SH, 2009, AM J PHYSIOL-ENDOC M, V296, pE490, DOI 10.1152/ajpendo.90691.2008; Wise JT, 1999, J IMMUNOL, V162, P5592; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Yamamoto R, 2013, J ASTHMA, V50, P828, DOI 10.3109/02770903.2013.816725; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20; ZuanyAmorim C, 1996, J IMMUNOL, V157, P377	56	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123210	10.1371/journal.pone.0123210	http://dx.doi.org/10.1371/journal.pone.0123210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826377	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800108
J	Johansson, DP; Lee, I; Riserus, U; Langton, M; Landberg, R				Johansson, Daniel P.; Lee, Isabella; Riserus, Ulf; Langton, Maud; Landberg, Rikard			Effects of Unfermented and Fermented Whole Grain Rye Crisp Breads Served as Part of a Standardized Breakfast, on Appetite and Postprandial Glucose and Insulin Responses: A Randomized Cross-over Trial	PLOS ONE			English	Article							MOLECULAR-WEIGHT DISTRIBUTION; IN-VITRO; METABOLOMICS REVEALS; GLYCEMIC RESPONSE; TEMPORAL TRACKING; HEALTHY-SUBJECTS; DIETARY-FIBERS; RATING SYSTEM; ENERGY-INTAKE; BETA-GLUCAN	Background Whole grain rye products have been shown to increase satiety and elicit lower postprandial insulin response without a corresponding change in glucose response compared with soft refined wheat bread. The underlying mechanisms for these effects have not been fully determined The primary aim of the study was to investigate if whole grain rye crisp bread compared to refined wheat crisp bread, elected beneficial effects on appetite and postprandial insulin response, similarly as for other rye products. Methods In a randomized cross-over trial, 23 healthy volunteers, aged 27-70 years, BMI 18-31.4 kg/m(2), were served a standardized breakfast with unfermented whole grain rye crisp bread (uRCB), fermented whole grain rye crisp bread (RCB) or refined wheat crisp bread (WCB), Appetite was measured using a visual analogue scale (VAS) until 4 h after breakfast. Postprandial glucose and insulin were measured at 0-230 min. Breads were chemically characterized including macronutrients, energy, dietary fiber components, and amino acid composition, and microstructure was characterized with light microscopy. Results Reported fullness was 16% higher (P< 0.001), and hunger 11% and 12% lower (P< 0.05) after ingestion of uRCB and RCB, respectively, compared with WCB. Postprandial glucose response did not differ significantly between treatments. Postprandial insulin was 10% lower (P< 0.007) between 0-120 min but not significantly lower between 0-230 min for RCB compared with WCB. uRCB induced 13% (P< 0.002) and 17% (P< 0.001) lower postprandial insulin response between 0-230 min compared with RCB and WCB respectively. Conclusion Whole grain rye crisp bread induces higher satiety and lower insulin response compared with refined wheat crisp bread. Microstructural characteristics, dietary fiber content and composition are probable contributors to the increased satiety after ingestion of rye crisp breads. Higher insulin secretion after ingestion of RCB and WCB compared with uRCB may be due to differences in fiber content and composition, and higher availability of insulinogenic branched chain amino acids.	[Johansson, Daniel P.; Lee, Isabella; Langton, Maud; Landberg, Rikard] Swedish Univ Agr Sci SLU, Dept Food Sci, Bioctr, Uppsala, Sweden; [Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci Clin Nutr & Metab, Uppsala, Sweden; [Landberg, Rikard] Karolinska Insitutet, Inst Environm Med, Nutr Epidemiol Unit, Stockholm, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Karolinska Institutet	Johansson, DP (corresponding author), Swedish Univ Agr Sci SLU, Dept Food Sci, Bioctr, Uppsala, Sweden.	daniel.p.johansson@slu.se		Johansson, Daniel/0000-0002-9677-8233; Langton, Maud/0000-0003-1565-6996	Barilla	Barilla	RL holds a research grant from Barilla for the financing of the current study (http://www.barillagroup.com/). RL did not get salary or any other financial compensation for conducting the present study or for any other purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, J AGR FOOD CHEM, V57, P2004, DOI 10.1021/jf801280f; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; Bondia-Pons I, 2009, J CEREAL SCI, V49, P323, DOI 10.1016/j.jcs.2009.01.007; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Burton P, 2006, BRIT J NUTR, V96, P877, DOI 10.1017/BJN20061900; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Christensen KL, 2013, J AGR FOOD CHEM, V61, P7760, DOI 10.1021/jf400965j; Clark MJ, 2013, J AM COLL NUTR, V32, P200, DOI 10.1080/07315724.2013.791194; Croon L.-B., 1980, Var Foeda, V32, P425; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Eelderink C, 2012, J NUTR, V142, P258, DOI 10.3945/jn.111.147884; ELLIS PR, 1995, BRIT J NUTR, V74, P539, DOI 10.1079/BJN19950157; Fabek H, 2014, FOOD HYDROCOLLOID, V35, P718, DOI 10.1016/j.foodhyd.2013.08.007; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Forsberg T, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-26; Gunnerud UJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044731; Hartvigsen ML, 2014, EUR J CLIN NUTR, V68, P84, DOI 10.1038/ejcn.2013.236; HEATON KW, 1988, AM J CLIN NUTR, V47, P675, DOI 10.1093/ajcn/47.4.675; Hetherington MM, 2013, NUTR RES REV, V26, P22, DOI 10.1017/S0954422413000012; HOLM J, 1988, AM J CLIN NUTR, V47, P1010, DOI 10.1093/ajcn/47.6.1010; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Isaksson H, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.18519; Isaksson Hanna, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1809; Isaksson H, 2012, PHYSIOL BEHAV, V105, P877, DOI 10.1016/j.physbeh.2011.10.023; Isaksson H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-31; Isaksson H, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-39; Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1; Juntunen KS, 2003, AM J CLIN NUTR, V78, P957, DOI 10.1093/ajcn/78.5.957; Juntunen KS, 2002, AM J CLIN NUTR, V75, P254, DOI 10.1093/ajcn/75.2.254; Katina K, 2007, J CEREAL SCI, V46, P348, DOI 10.1016/j.jcs.2007.07.006; Knudsen KEB, 2005, J NUTR, V135, P1696, DOI 10.1093/jn/135.7.1696; Le Gall M, 2009, BRIT J NUTR, V102, P1590, DOI 10.1017/S0007114509990924; Leinonen K, 1999, EUR J CLIN NUTR, V53, P262, DOI 10.1038/sj.ejcn.1600716; Lentle RG, 2008, J COMP PHYSIOL B, V178, P257, DOI 10.1007/s00360-007-0217-9; Lightowler HJ, 2009, NUTR RES, V29, P551, DOI 10.1016/j.nutres.2009.06.004; Loosveld AMA, 1997, J AGR FOOD CHEM, V45, P1998, DOI 10.1021/jf960901k; Lu ZX, 2004, EUR J CLIN NUTR, V58, P621, DOI 10.1038/sj.ejcn.1601857; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; Marciani L, 2001, AM J PHYSIOL-GASTR L, V280, pG1227, DOI 10.1152/ajpgi.2001.280.6.G1227; MCCLEARY BV, 1991, J SCI FOOD AGR, V55, P303, DOI 10.1002/jsfa.2740550215; McCleary BV, 2000, J AOAC INT, V83, P356; Moazzami AA, 2014, J NUTR, V144, P807, DOI 10.3945/jn.113.188912; Moazzami AA, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-88; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nilsson M, 2004, AM J CLIN NUTR, V80, P1246, DOI 10.1093/ajcn/80.5.1246; NILSSON U, 1987, J CEREAL SCI, V6, P53, DOI 10.1016/S0733-5210(87)80040-1; Nordlund E, 2013, J CEREAL SCI, V58, P200, DOI 10.1016/j.jcs.2013.05.006; Ostman E, 2006, J CEREAL SCI, V43, P230, DOI 10.1016/j.jcs.2005.11.001; Rakha A, 2010, FOOD CHEM, V119, P859, DOI 10.1016/j.foodchem.2009.09.090; Rakha A, 2011, INT J MOL SCI, V12, P3381, DOI 10.3390/ijms12053381; Rolls BJ, 1998, AM J CLIN NUTR, V67, P1170, DOI 10.1093/ajcn/67.6.1170; Rosen LAH, 2011, J AGR FOOD CHEM, V59, P12149, DOI 10.1021/jf2019837; Rosen LAH, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-42; Rosen LA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-7; Rosenfeld MJ, 2009, Patent No. [US 7, 507,731 B2, 7507731]; Shelat KJ, 2011, CARBOHYD POLYM, V86, P1732, DOI 10.1016/j.carbpol.2011.07.004; Shelat KJ, 2010, CARBOHYD POLYM, V82, P46, DOI 10.1016/j.carbpol.2010.04.019; Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221; Stratton RJ, 1998, EUR J CLIN NUTR, V52, P737, DOI 10.1038/sj.ejcn.1600636; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Stubbs RJ, 2001, PHYSIOL BEHAV, V72, P615, DOI 10.1016/S0031-9384(00)00440-6; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Theander O, 1995, J AOAC INT, V78, P1030; Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715; Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x; Wanders AJ, 2013, BRIT J NUTR, V109, P1330, DOI 10.1017/S0007114512003145; Wirfalt E, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20523	68	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122241	10.1371/journal.pone.0122241	http://dx.doi.org/10.1371/journal.pone.0122241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826373	gold, Green Published, Green Accepted			2022-12-27	WOS:000352084800062
J	Schwedt, A; Seidel, M; Dittmar, T; Simon, M; Bondarev, V; Romano, S; Lavik, G; Schulz-Vogt, HN				Schwedt, Anne; Seidel, Michael; Dittmar, Thorsten; Simon, Meinhard; Bondarev, Vladimir; Romano, Stefano; Lavik, Gaute; Schulz-Vogt, Heide N.			Substrate Use of Pseudovibrio sp Growing in Ultra-Oligotrophic Seawater	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; FREE AMINO-ACIDS; ESCHERICHIA-COLI; MARINE-BACTERIA; GROWTH-KINETICS; MASS-SPECTRA; CARBON; OCEAN; RELEASE; PROTEIN	Marine planktonic bacteria often live in habitats with extremely low concentrations of dissolved organic matter (DOM). To study the use of trace amounts of DOM by the facultatively oligotrophic Pseudovibrio sp. FO-BEG1, we investigated the composition of artificial and natural seawater before and after growth. We determined the concentrations of dissolved organic carbon (DOC), total dissolved nitrogen (TDN), free and hydrolysable amino acids, and the molecular composition of DOM by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI FT-ICR-MS). The DOC concentration of the artificial seawater we used for cultivation was 4.4 mu mol C L-1, which was eight times lower compared to the natural oligotrophic seawater we used for parallel experiments (36 mu mol C L-1). During the three-week duration of the experiment, cell numbers increased from 40 cells mL(-1) to 2x10(4) cells mL(-1) in artificial and to 3x10(5) cells mL(-1) in natural seawater. No nitrogen fixation and minor CO2 fixation (< 1% of cellular carbon) was observed. Our data show that in both media, amino acids were not the main substrate for growth. Instead, FT-ICR-MS analysis revealed usage of a variety of different dissolved organic molecules, belonging to a wide range of chemical compound groups, also containing nitrogen. The present study shows that marine heterotrophic bacteria are able to proliferate with even lower DOC concentrations than available in natural ultra-oligotrophic seawater, using unexpected organic compounds to fuel their energy, carbon and nitrogen requirements.	[Schwedt, Anne; Bondarev, Vladimir; Romano, Stefano; Lavik, Gaute] Max Planck Inst Marine Microbiol, Bremen, Germany; [Seidel, Michael; Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, ICBM MPI Bridging Grp, D-26111 Oldenburg, Germany; [Simon, Meinhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Schulz-Vogt, Heide N.] Leibniz Inst Balt Sea Res Warnemunde, Rostock, Germany	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Leibniz Institut fur Ostseeforschung Warnemunde	Schwedt, A (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	aschwedt@mpi-bremen.de	Dittmar, Thorsten/L-7796-2013; Romano, Stefano/J-3756-2013; Schulz-Vogt, Heide/I-1397-2012	Dittmar, Thorsten/0000-0002-3462-0107; Romano, Stefano/0000-0002-7600-1953; Schulz-Vogt, Heide/0000-0003-1445-0291	European Research Council [203364-ELNOX]; Max Planck Society	European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the European Research Council (No 203364-ELNOX) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN JW, 1984, MAR ECOL PROG SER, V18, P31, DOI 10.3354/meps018031; BADA JL, 1977, MAR CHEM, V5, P523, DOI 10.1016/0304-4203(77)90038-X; Bondarev V, 2013, ENVIRON MICROBIOL, V15, P2095, DOI 10.1111/1462-2920.12123; Brock J, 2011, ISME J, V5, P497, DOI 10.1038/ismej.2010.135; Dittmar T., 2009, PRACTICAL GUIDELINES, P67; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dittmar T, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P369, DOI 10.1016/B978-0-12-405940-5.00007-8; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; FUHRMAN JA, 1990, MAR ECOL PROG SER, V66, P197, DOI 10.3354/meps066197; FUHRMAN JA, 1987, MAR ECOL PROG SER, V37, P45, DOI 10.3354/meps037045; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Ihssen J, 2005, ENVIRON MICROBIOL, V7, P1568, DOI 10.1111/j.1462-2920.2005.00846.x; Kamp A, 2008, MICROB ECOL, V56, P484, DOI 10.1007/s00248-008-9367-x; Keil RG, 1999, AQUAT MICROB ECOL, V18, P293, DOI 10.3354/ame018293; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Lechtenfeld OJ, 2013, MAR CHEM, V150, P25, DOI 10.1016/j.marchem.2013.01.006; Lendenmann U, 1996, APPL ENVIRON MICROB, V62, P1493, DOI 10.1128/AEM.62.5.1493-1499.1996; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; Lunau M, 2006, LIMNOL OCEANOGR, V51, P847, DOI 10.4319/lo.2006.51.2.0847; Romano S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096038; Schut F, 1997, AQUAT MICROB ECOL, V12, P177, DOI 10.3354/ame012177; Schwedt A, 2012, FRONTIERS MICROBIOLO, V2, P1; Schwedt A., 2011, THESIS U BREMEN GERM; Simon M, 2007, LIMNOL OCEANOGR, V52, P85, DOI 10.4319/lo.2007.52.1.0085; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Soule MCK, 2010, ORG GEOCHEM, V41, P725, DOI 10.1016/j.orggeochem.2010.05.017; STANLEY SO, 1987, MAR CHEM, V22, P13, DOI 10.1016/0304-4203(87)90045-4; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0; ZWEIFEL UL, 1993, MAR ECOL PROG SER, V101, P23, DOI 10.3354/meps101023	34	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121675	10.1371/journal.pone.0121675	http://dx.doi.org/10.1371/journal.pone.0121675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826215	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800050
J	Althabe, F; Berrueta, M; Hemingway-Foday, J; Mazzoni, A; Bonorino, CA; Gowdak, A; Gibbons, L; Bellad, MB; Metgud, MC; Goudar, S; Kodkany, BS; Derman, RJ; Saleem, S; Iqbal, S; Ala, SH; Goldenberg, RL; Chomba, E; Manasyan, A; Chiwila, M; Imenda, E; Mbewe, F; Tshefu, A; Lokomba, V; Bose, CL; Moore, J; Meleth, S; McClure, EM; Koso-Thomas, M; Buekens, P; Belizan, JM				Althabe, Fernando; Berrueta, Mabel; Hemingway-Foday, Jennifer; Mazzoni, Agustina; Astoul Bonorino, Carolina; Gowdak, Andrea; Gibbons, Luz; Bellad, M. B.; Metgud, M. C.; Goudar, Shivaprasad; Kodkany, Bhalchandra S.; Derman, Richard J.; Saleem, Sarah; Iqbal, Samina; Ala, Syed Hasan; Goldenberg, Robert L.; Chomba, Elwyn; Manasyan, Albert; Chiwila, Melody; Imenda, Edna; Mbewe, Florence; Tshefu, Antoinette; Lokomba, Victor; Bose, Carl L.; Moore, Janet; Meleth, Sreelatha; McClure, Elizabeth M.; Koso-Thomas, Marion; Buekens, Pierre; Belizan, Jose M.			A Color-Coded Tape for Uterine Height Measurement: A Tool to Identify Preterm Pregnancies in Low Resource Settings	PLOS ONE			English	Article							SYMPHYSIS-FUNDAL HEIGHT; GESTATIONAL-AGE; ANTENATAL CORTICOSTEROIDS; DEVELOPING-COUNTRIES; NEONATAL SURVIVAL; BIRTH; ULTRASOUND	Introduction Neonatal mortality associated with preterm birth can be reduced with antenatal corticosteroids (ACS), yet < 10% of eligible pregnant women in low-middle income countries. The inability to accurately determine gestational age (GA) leads to under-identification of high-risk women who could receive ACS or other interventions. To facilitate better identification in low-resource settings, we developed a color-coded tape for uterine height (UH) measurement and estimated its accuracy identifying preterm pregnancies. Methods We designed a series of colored-coded tapes with segments corresponding to UH measurements for 20-23.6 weeks, 24.0-35.6 weeks, and > 36.0 weeks GA. In phase 1, UH measurements were collected prospectively in the Democratic Republic of Congo, India and Pakistan, using distinct tapes to address variation across regions and ethnicities. In phase 2, we tested accuracy in 250 pregnant women with known GA from early ultrasound enrolled at prenatal clinics in Argentina, India, Pakistan and Zambia. Providers masked to the ultrasound GA measured UH. Receiver operating characteristics (ROC) analysis was conducted. Results 1,029 pregnant women were enrolled. In all countries the tapes were most effective identifying pregnancies between 20.0-35.6 weeks, compared to the other GAs. The ROC areas under the curves and 95% confidence intervals were: Argentina 0.69 (0.63, 0.74); Zambia 0.72 (0.66, 0.78), India 0.84 (0.80, 0.89), and Pakistan 0.83 (0.78, 0.87). The sensitivity and specificity (and 95% confidence intervals) for identifying pregnancies between 20.0-35.6 weeks, respectively, were: Argentina 87% (82%-92%) and 51% (42%-61%); Zambia 91% (86%-95%) and 50% (40%-60%); India 78% (71%-85%) and 89% (83%-94%); Pakistan 63% (55%-70%) and 94% (89%-99%). Conclusions We observed moderate-good accuracy identifying pregnancies <= 35.6 weeks gestation, with potential usefulness at the community level in low-middle income countries to facilitate the preterm identification and interventions to reduce preterm neonatal mortality. Further research is needed to validate these findings on a population basis.	[Althabe, Fernando; Berrueta, Mabel; Mazzoni, Agustina; Astoul Bonorino, Carolina; Gowdak, Andrea; Gibbons, Luz; Belizan, Jose M.] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Hemingway-Foday, Jennifer; Moore, Janet; Meleth, Sreelatha; McClure, Elizabeth M.] RTI Int, Durham, NC USA; [Bellad, M. B.; Metgud, M. C.; Goudar, Shivaprasad; Kodkany, Bhalchandra S.] KLE Univ Jawaharlal Nehru Med Coll, Belgaum, Karnataka, India; [Derman, Richard J.] Christiana Care, Newark, DC USA; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Samina] Sobhraj Matern Hosp, Dept Obstet, Karachi, Pakistan; [Ala, Syed Hasan] Sindh Govt Qatar Hosp, Dept Obstet, Karachi, Pakistan; [Goldenberg, Robert L.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Chomba, Elwyn; Chiwila, Melody; Imenda, Edna; Mbewe, Florence] Univ Teaching Hosp, Lusaka, Zambia; [Manasyan, Albert] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Tshefu, Antoinette; Lokomba, Victor] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Manasyan, Albert; Bose, Carl L.] Univ N Carolina, Chapel Hill, NC USA; [Koso-Thomas, Marion] Eunice Kennedy Shriver NICHD, Bethesda, MD USA; [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Research Triangle Institute; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Christiana Care Health System; Aga Khan University; Columbia University; University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tulane University	Althabe, F (corresponding author), Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina.	falthabe@iecs.org.ar	Metgud, Mrityunjay/R-6612-2019; GOUDAR, SHIVAPRASAD S/S-1217-2019; Bellad, Mrutyunjaya/R-6494-2019; Hemingway-Foday, Jennifer/HHN-4777-2022	Metgud, Mrityunjay/0000-0002-0844-8569; GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; Bellad, Mrutyunjaya/0000-0003-0460-1439; Manasyan, Albert/0000-0001-6275-245X; Hemingway-Foday, Jennifer/0000-0001-9776-5306; Belizan, Jose/0000-0002-8412-3010; McClure, Elizabeth/0000-0001-8659-5444; Gibbons, Luz/0000-0002-0235-1635; Moore, Janet/0000-0003-1750-8794; Derman, Richard/0000-0003-1148-1594	National Institute of Child Health and Human Development as part of the Global Network for Women's and Children's Health Research [U01 HD40477, U01 HD043475, U01 HD042372, U01 HD040607, U01 HD040636, U01 HD043464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD042372, U01HD040607, U10HD076465, U01HD040636, U10HD076457, U01HD040477, U01HD043464] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043475] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development as part of the Global Network for Women's and Children's Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the National Institute of Child Health and Human Development as part of the Global Network for Women's and Children's Health Research (http://www.nichd.nih.gov/research/supported/Pages/globalnetwork.aspx) Grant numbers include: U01 HD40477 [Tulane], U01 HD043475 [UNC], U01 HD042372 [Christiana Care], U01 HD040607 [Columbia University], U01 HD040636 (RTI), U01 HD043464 [UAB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althabe F, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-22; ANDERSSON R, 1995, J TROP MED HYG, V98, P169; BELIZAN JM, 1978, AM J OBSTET GYNECOL, V131, P643, DOI 10.1016/0002-9378(78)90824-4; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; FAUSTIN D, 1991, J NATL MED ASSOC, V83, P425; Garces A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-34; Geerts Lut, 2013, S Afr Med J, V103, P552, DOI 10.7196/samj.6751; Goto E, 2013, J EPIDEMIOL COMMUN H, V67, P999, DOI 10.1136/jech-2012-202141; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Habbema J. D. F., 2009, EVIDENCE BASE CLIN D, P118; Harris RD, 2009, J ULTRAS MED, V28, P1067, DOI 10.7863/jum.2009.28.8.1067; Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Knottnerus JA, 2009, EVIDENCE BASE CLIN D, P42; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; McClure EM, 2011, INT J GYNECOL OBSTET, V115, P215, DOI 10.1016/j.ijgo.2011.07.017; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Villar J, 1979, Bull Pan Am Health Organ, V13, P117; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; World Health Organization, 2013, BORN TOO SOON THE GL	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117134	10.1371/journal.pone.0117134	http://dx.doi.org/10.1371/journal.pone.0117134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822529	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700007
J	Caillet, P; Klemm, S; Ducher, M; Aussem, A; Schott, AM				Caillet, Pascal; Klemm, Sarah; Ducher, Michel; Aussem, Alexandre; Schott, Anne-Marie			Hip Fracture in the Elderly: A Re-Analysis of the EPIDOS Study with Causal Bayesian Networks	PLOS ONE			English	Article							FALL-RELATED FACTORS; RISK-ASSESSMENT; IDENTIFY WOMEN; OLDER WOMEN; STRENGTH; HEALTH; TOOLS; SCORE	Objectives Hip fractures commonly result in permanent disability, institutionalization or death in elderly. Existing hip-fracture predicting tools are underused in clinical practice, partly due to their lack of intuitive interpretation. By use of a graphical layer, Bayesian network models could increase the attractiveness of fracture prediction tools. Our aim was to study the potential contribution of a causal Bayesian network in this clinical setting. A logistic regression was performed as a standard control approach to check the robustness of the causal Bayesian network approach. Setting EPIDOS is a multicenter study, conducted in an ambulatory care setting in five French cities between 1992 and 1996 and updated in 2010. The study included 7598 women aged 75 years or older, in which fractures were assessed quarterly during 4 years. A causal Bayesian network and a logistic regression were performed on EPIDOS data to describe major variables involved in hip fractures occurrences. Results Both models had similar association estimations and predictive performances. They detected gait speed and mineral bone density as variables the most involved in the fracture process. The causal Bayesian network showed that gait speed and bone mineral density were directly connected to fracture and seem to mediate the influence of all the other variables included in our model. The logistic regression approach detected multiple interactions involving psychotropic drug use, age and bone mineral density. Conclusion Both approaches retrieved similar variables as predictors of hip fractures. However, Bayesian network highlighted the whole web of relation between the variables involved in the analysis, suggesting a possible mechanism leading to hip fracture. According to the latter results, intervention focusing concomitantly on gait speed and bone mineral density may be necessary for an optimal prevention of hip fracture occurrence in elderly people.	[Caillet, Pascal; Schott, Anne-Marie] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, France; [Klemm, Sarah; Aussem, Alexandre] Univ Lyon 1, CNRS, Data Min & Machine Learning DM2L Team, LIRIS UMR 5205, Villeurbanne, France; [Ducher, Michel] Hosp Civils Lyon, Grp Hosp Geriatrie, Francheville, France; [Caillet, Pascal; Schott, Anne-Marie] Univ Lyon 1, F-69365 Lyon, France; [Caillet, Pascal; Schott, Anne-Marie] INSERM, U1033, F-69008 Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Caillet, P (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, France.	p.caillet@yahoo.fr; anne-marie.schott-pethelaz@chu-lyon.fr	Schott, Anne-Marie/V-7580-2018; Caillet, Pascal/K-5299-2019	Schott, Anne-Marie/0000-0003-3337-4474; Caillet, Pascal/0000-0001-5667-7887	Rhone Alpes Complex Systems Institute; Hospices Civils de Lyon	Rhone Alpes Complex Systems Institute(Region Auvergne-Rhone-Alpes); Hospices Civils de Lyon	This work was funded by the Rhone Alpes Complex Systems Institute and the Hospices Civils de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; Aussem A, 2012, ARTIF INTELL MED, V54, P53, DOI 10.1016/j.artmed.2011.09.002; Charitos T, 2009, EXPERT SYST APPL, V36, P1249, DOI 10.1016/j.eswa.2007.11.065; Clark EM, 2012, AGE AGEING, V41, P46, DOI 10.1093/ageing/afr132; Cuaya G, 2013, MED BIOL ENG COMPUT, V51, P29, DOI 10.1007/s11517-012-0960-2; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Detilleux J, 2012, STAT METHODS MED RES; Edwards MH, 2013, BONE, V52, P541, DOI 10.1016/j.bone.2012.11.006; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forsberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019956; Goldberg A, 2012, ARCH GERONTOL GERIAT, V54, P434, DOI 10.1016/j.archger.2011.06.017; Jorgensen Niklas R, 2011, Curr Osteoporos Rep, V9, P149, DOI 10.1007/s11914-011-0065-0; Flores MJ, 2011, ARTIF INTELL MED, V53, P181, DOI 10.1016/j.artmed.2011.08.004; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; KOLLER D., 2009, PROBABILISTIC GRAPHI; Lalande L, 2013, MED BIOL ENG COMPUT, V51, P657, DOI 10.1007/s11517-013-1035-8; Lappenschaar M, 2013, ARTIF INTELL MED, V57, P171, DOI 10.1016/j.artmed.2012.12.007; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lewis FI, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-4; McGee S, 2002, J GEN INTERN MED, V17, P646; MENZIES P, 1993, BRIT J PHILOS SCI, V44, P187, DOI 10.1093/bjps/44.2.187; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Rubin KH, 2013, BONE, V56, P16, DOI 10.1016/j.bone.2013.05.002; Sambrook PN, 2007, OSTEOPOROSIS INT, V18, P603, DOI 10.1007/s00198-006-0290-z; Scott D, 2014, ARCH GERONTOL GERIAT, V58, P308, DOI 10.1016/j.archger.2013.11.004; Scutari M, 2013, BAYESIAN NETWORKS R; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Silverman S, 2012, OSTEOPOROSIS INT, V23, P797, DOI 10.1007/s00198-011-1775-y; Stojadinovic A, 2011, AM SURGEON, V77, P221; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Thompson VA, 2002, J EXP PSYCHOL LEARN, V28, P1154, DOI 10.1037//0278-7393.28.6.1154; Visscher S, 2009, ARTIF INTELL MED, V46, P251, DOI 10.1016/j.artmed.2008.11.006; Welsch R. E, 2004, REGRESSION DIAGNOSTI; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	38	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120125	10.1371/journal.pone.0120125	http://dx.doi.org/10.1371/journal.pone.0120125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822373	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700055
J	Hakon, J; Ruscher, K; Romner, B; Tomasevic, G				Hakon, Jakob; Ruscher, Karsten; Romner, Bertil; Tomasevic, Gregor			Preservation of the Blood Brain Barrier and Cortical Neuronal Tissue by Liraglutide, a Long Acting Glucagon-Like-1 Analogue, after Experimental Traumatic Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTERCELLULAR-ADHESION MOLECULE-1; PEPTIDE-1 RECEPTOR AGONIST; ENDOTHELIAL-CELLS; GENE-EXPRESSION; EDEMA FORMATION; RATS; IMPACT; MICE; HYPERGLYCEMIA	Cerebral edema is a common complication following moderate and severe traumatic brain injury (TBI), and a significant risk factor for development of neuronal death and deterioration of neurological outcome. To this date, medical approaches that effectively alleviate cerebral edema and neuronal death after TBI are not available. Glucagon-like peptide-1 (GLP-1) has anti-inflammatory properties on cerebral endothelium and exerts neuroprotective effects. Here, we investigated the effects of GLP-1 on secondary injury after moderate and severe TBI. Male Sprague Dawley rats were subjected either to TBI by Controlled Cortical Impact (CCI) or sham surgery. After surgery, vehicle or a GLP-1 analogue, Liraglutide, were administered subcutaneously twice daily for two days. Treatment with Liraglutide (200 mu g/kg) significantly reduced cerebral edema in pericontusional regions and improved sensorimotor function 48 hours after CCI. The integrity of the blood-brain barrier was markedly preserved in Liraglutide treated animals, as determined by cerebral extravasation of Evans blue conjugated albumin. Furthermore, Liraglutide reduced cortical tissue loss, but did not affect tissue loss and delayed neuronal death in the thalamus on day 7 post injury. Together, our data suggest that the GLP-1 pathway might be a promising target in the therapy of cerebral edema and cortical neuronal injury after moderate and severe TBI.	[Hakon, Jakob; Ruscher, Karsten; Tomasevic, Gregor] Lund Univ, Wallenberg Neurosci Ctr, Expt Brain Res Lab, Lund, Sweden; [Hakon, Jakob; Romner, Bertil] Copenhagen Univ Hosp, Risgshosp, Dept Neurosurg, Copenhagen, Denmark; [Romner, Bertil; Tomasevic, Gregor] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden	Lund University; University of Copenhagen; Lund University; Skane University Hospital	Hakon, J (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Expt Brain Res Lab, BMC A13, Lund, Sweden.	jakobhakon@gmail.com		Hakon, Jakob/0000-0003-1079-0141				Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Ceriello A, 2013, DIABETES CARE, P1; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Conti AC, 1998, J NEUROSCI, V18, P5663; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; DeFronzo R, 2014, EFFECTS LIRAGLUTIDE; DellaValle B, 2014, ANN CLIN TRANSL NEUR, V1, P721, DOI 10.1002/acn3.99; DERYCK M, 1992, BRAIN RES, V573, P44; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Fukui S, 2003, J CEREBR BLOOD F MET, V23, P1212, DOI 10.1097/01.WCB.0000088762.02615.30; Gejl Michael, 2013, Front Neuroenergetics, V5, P2, DOI 10.3389/fnene.2013.00002; Gejl M, 2012, J CEREBR BLOOD F MET, V32, P2146, DOI 10.1038/jcbfm.2012.118; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; Hou J, 2012, J INEQUAL APPL, P1, DOI 10.1186/1029-242X-2012-60; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Krasner NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097554; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Rachmany L, 2012, AGE; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; [Services USDoHaH Food and Drug Adminstration CfDEaR], 2005, GUID IND EST MAX SAF; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; SZTRIHA L, 1986, ACTA NEUROPATHOL, V70, P169, DOI 10.1007/BF00691435; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yrjanheikki J, 2005, BRAIN RES, V1052, P174, DOI 10.1016/j.brainres.2005.06.004; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	76	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120074	10.1371/journal.pone.0120074	http://dx.doi.org/10.1371/journal.pone.0120074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822252	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700054
J	Jespersen, D; Yu, JJ; Huang, BR				Jespersen, David; Yu, Jingjin; Huang, Bingru			Metabolite Responses to Exogenous Application of Nitrogen, Cytokinin, and Ethylene Inhibitors in Relation to Heat-Induced Senescence in Creeping Bentgrass	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; INDUCED LEAF SENESCENCE; PLANT-RESPONSES; ENVIRONMENTAL-STRESS; FOLIAR APPLICATION; THERMAL BENTGRASS; SUGAR ALCOHOLS; DROUGHT STRESS; AMINO-ACIDS; TOLERANCE	The exogenous application of ethylene inhibitors, cyotkinins, or nitrogen has previously been shown to suppress heat-induced senescence and improve heat tolerance in cool -season grasses. The objectives of this study were to examine metabolic profiles altered by exogenous treatment of creeping bentgrass with an ethylene inhibitor, cytokinin or nitrogen under heat stress and to determine metabolic pathways regulated by those compounds in association with their effectiveness for improving heat tolerance. Creeping bentgrass (Agostis stolonifera) plants (cv. Penncross) were foliar sprayed with 18 mM carbonyldiamide (N source), 25 mu M aminoethoxyvinylglycine (AVG, ethylene inhibitor), 25 mu M zeatin riboside (ZR, cytokinin), or a water control, and then exposed to 20/15 degrees C (day/night) or 35/30 degrees C (heat stress) in growth chambers. All three exogenous treatments suppressed leaf senescence, as manifested by increased turf quality and chlorophyll content, and reduced electrolyte leakage under heat stress. Polar metabolite profiling identified increases in the content of certain organic acids (i.e. citric and malic acid), sugar alcohols, disaccharides (sucrose), and decreased accumulations of monosaccharides (i.e. glucose and fructose) with exogenous treatment of N, AVG, or ZR at the previously mentioned concentrations when compared to the untreated control under heat stress. Nitrogen stimulated amino acid accumulation whereas AVG and ZR reduced amino acid accumulation compared to the untreated control under heat stress. These results revealed that the alleviation of heat-induced leaf senescence by N, AVG, and ZR could be due to changes in the accumulation of metabolites involved in osmoregulation, antioxidant metabolism, carbon and nitrogen metabolism, as well as stress signaling molecules.	[Jespersen, David; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Yu, Jingjin] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China	Rutgers State University New Brunswick; Nanjing Agricultural University	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	huang@aesop.rutgers.edu			Rutgers Center for Turfgrass Science	Rutgers Center for Turfgrass Science	This work was supported by the Rutgers Center for Turfgrass Science to BH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Balota M, 2004, CROP SCI, V44, P812, DOI 10.2135/cropsci2004.0812; BARNEIX AJ, 1984, PLANTA, V162, P469, DOI 10.1007/BF00393461; BEALE SI, 1975, P NATL ACAD SCI USA, V72, P2719, DOI 10.1073/pnas.72.7.2719; Beard J. B., 1972, TURFGRASS SCI CULTUR; Beltrano J, 1999, J PLANT GROWTH REGUL, V18, P59, DOI 10.1007/PL00007049; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; DARRALL NM, 1981, J EXP BOT, V32, P369, DOI 10.1093/jxb/32.2.369; DRACUP M, 1986, J EXP BOT, V37, P1079, DOI 10.1093/jxb/37.7.1079; Du HM, 2011, PHYSIOL PLANTARUM, V141, P251, DOI 10.1111/j.1399-3054.2010.01432.x; EVENCHEN Z, 1982, PLANT PHYSIOL, V69, P385, DOI 10.1104/pp.69.2.385; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Fu J, 2007, J PLANT NUTR, V26, P81; GEPSTEIN S, 1981, PLANT PHYSIOL, V68, P349, DOI 10.1104/pp.68.2.349; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hare PD, 1997, PLANT GROWTH REGUL, V23, P79, DOI 10.1023/A:1005954525087; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Heckathorn SA, 1996, OECOLOGIA, V105, P413, DOI 10.1007/BF00328745; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jespersen D, 2015, PROTEOMICS, V15, P798, DOI 10.1002/pmic.201400393; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Kirma M, 2012, J EXP BOT, V63, P4995, DOI 10.1093/jxb/ers119; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Leshem YY, 1996, BIOL PLANTARUM, V38, P1, DOI 10.1007/BF02879625; Lyons EM, 2007, ENVIRON EXP BOT, V59, P307, DOI 10.1016/j.envexpbot.2006.04.002; Meister A., 2012, BIOCH AMINO ACIDS; Merewitz EB, 2010, J AM SOC HORTIC SCI, V135, P230, DOI 10.21273/JASHS.135.3.230; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Nilsen ET, 1996, FIELD CROP RES, P192; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noctor G, 1997, PHYSIOL PLANTARUM, V100, P255, DOI 10.1034/j.1399-3054.1997.1000206.x; Qiu Y, 2007, ANAL CHIM ACTA, V583, P277, DOI 10.1016/j.aca.2006.10.025; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SARADADEVI K, 1992, PLANT PHYSIOL, V99, P1232, DOI 10.1104/pp.99.3.1232; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tawfik AA, 1996, AM POTATO J, V73, P261, DOI 10.1007/BF02849276; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; WANG ZC, 1992, J AM SOC HORTIC SCI, V117, P816, DOI 10.21273/JASHS.117.5.816; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467, DOI 10.21273/JASHS.127.4.467; Wold S, 1994, CHEMOMETRIC METHODS; Xu Y, 2007, J AM SOC HORTIC SCI, V132, P185, DOI 10.21273/JASHS.132.2.185; Xu Y, 2013, CROP SCI, V53, P1626, DOI 10.2135/cropsci2013.01.0045; Xu Y, 2009, CROP SCI, V49, P1876, DOI 10.2135/cropsci2008.07.0441; Xu Y, 2009, PLANT GROWTH REGUL, V57, P281, DOI 10.1007/s10725-008-9346-8; Yu JJ, 2012, J AM SOC HORTIC SCI, V137, P221, DOI 10.21273/JASHS.137.4.221; Zhao WY, 2008, BIOL PLANTARUM, V52, P113, DOI 10.1007/s10535-008-0021-8	64	30	33	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123744	10.1371/journal.pone.0123744	http://dx.doi.org/10.1371/journal.pone.0123744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822363	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700235
J	Mahittikorn, A; Mori, H; Popruk, S; Roobthaisong, A; Sutthikornchai, C; Koompapong, K; Siri, S; Sukthana, Y; Nacapunchai, D				Mahittikorn, Aongart; Mori, Hirotake; Popruk, Supaluk; Roobthaisong, Amonrattana; Sutthikornchai, Chantira; Koompapong, Khuanchai; Siri, Sukhontha; Sukthana, Yaowalark; Nacapunchai, Duangporn			Development of a Rapid, Simple Method for Detecting Naegleria fowleri Visually in Water Samples by Loop-Mediated Isothermal Amplification (LAMP)	PLOS ONE			English	Article							REAL-TIME PCR; FREE-LIVING AMEBAS; DIAGNOSTIC METHOD; NESTED PCR; IDENTIFICATION; ASSAY; COST; SPP.	Naegleria fowleri is the causative agent of the fatal disease primary amebic meningoencephalitis. Detection of N. fowleri using conventional culture and biochemical-based assays is time-consuming and laborious, while molecular techniques, such as PCR, require laboratory skills and expensive equipment. We developed and evaluated a novel loop-mediated isothermal amplification (LAMP) assay targeting the virulence-related gene for N. fowleri. Time to results is about 90 min and amplification products were easily detected visually using hydroxy naphthol blue. The LAMP was highly specific after testing against related microorganisms and able to detect one trophozoite, as determined with spiked water and cerebrospinal fluid samples. The assay was then evaluated with a set of 80 water samples collected during the flooding crisis in Thailand in 2011, and 30 natural water samples from border areas of northern, eastern, western, and southern Thailand. N. fowleri was detected in 13 and 10 samples using LAMP and PCR, respectively, with a Kappa coefficient of 0.855. To the best of our knowledge, this is the first report of a LAMP assay for N. fowleri. Due to its simplicity, speed, and high sensitivity, the LAMP method described here might be useful for quickly detecting and diagnosing N. fowleri in water and clinical samples, particularly in resource-poor settings.	[Mahittikorn, Aongart; Mori, Hirotake; Popruk, Supaluk; Sutthikornchai, Chantira; Koompapong, Khuanchai; Sukthana, Yaowalark] Mahidol Univ, Fac Trop Med, Dept Protozool, Bangkok, Thailand; [Roobthaisong, Amonrattana] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan; [Roobthaisong, Amonrattana] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan; [Siri, Sukhontha] Mahidol Univ, Fac Publ Hlth, Dept Epidemiol, Bangkok 10700, Thailand; [Nacapunchai, Duangporn] Mahidol Univ, Fac Med Technol, Dept Parasitol, Bangkok 10700, Thailand	Mahidol University; Tokyo Medical & Dental University (TMDU); Kyoto University; Mahidol University; Mahidol University	Mahittikorn, A (corresponding author), Mahidol Univ, Fac Trop Med, Dept Protozool, Bangkok, Thailand.	aongart.mah@mahidol.ac.th; duangporn.nac@mahidol.ac.th	Mori, Hirotake/AAG-8989-2021; MORI, HIROTAKE/AAZ-2591-2021	MORI, HIROTAKE/0000-0002-7988-5758	Faculty of Tropical Medicine, Mahidol University; ICTM grant of the Faculty of Tropical Medicine, Mahidol University	Faculty of Tropical Medicine, Mahidol University; ICTM grant of the Faculty of Tropical Medicine, Mahidol University	This study was supported by a Research Grant from the Faculty of Tropical Medicine, Mahidol University, Fiscal Year 2011, and by an ICTM grant of the Faculty of Tropical Medicine, Mahidol University, year 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2010, AM J TROP MED HYG, V82, P591, DOI 10.4269/ajtmh.2010.09-0369; Ahmad AF, 2011, WATER RES, V45, P5211, DOI 10.1016/j.watres.2011.07.025; Armitage P, 2001, STAT METHODS MED RES, V4th; Bearinger JP, 2011, IEEE T BIO-MED ENG, V58, P805, DOI 10.1109/TBME.2010.2089054; Behets J, 2007, PARASITOL RES, V100, P1249, DOI 10.1007/s00436-006-0399-1; Behets J, 2007, WATER RES, V41, P118, DOI 10.1016/j.watres.2006.10.003; Chaturongkasumrit Y, 2013, SCI TOTAL ENVIRON, V463-464, P959, DOI DOI 10.1016/J.SCIT0TENV.2013.06.071; Cope J, 2014, IDWEEK          1010; da Rocha-Azevedo Bruno, 2009, Interdiscip Perspect Infect Dis, V2009, P251406, DOI 10.1155/2009/251406; Eiken Chemical Co. Ltd, GUID LAMP PRIM DES P; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Heggie TW, 2010, TRAVEL MED INFECT DI, V8, P201, DOI 10.1016/j.tmaid.2010.06.001; Hodgetts J, 2011, B INSECTOL, V64, pS41; HU WN, 1992, INFECT IMMUN, V60, P2418, DOI 10.1128/IAI.60.6.2418-2424.1992; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Jariya P., 1997, Siriraj Hospital Gazette, V49, P222; Jariya P, 1988, J PARASITOLOGY TROPI, V11, P40; Koloren Zeynep, 2010, Turkiye Parazitoloji Dergisi, V34, P207, DOI 10.5152/tpd.2010.16; Lek-Uthai U, 2009, EXP PARASITOL, V121, P342, DOI 10.1016/j.exppara.2008.12.009; Lekkla Amorn, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P5; Li J, 2015, BIOSENS BIOELECTRON, V64, P196, DOI 10.1016/j.bios.2014.08.069; Liang SY, 2009, J CLIN MICROBIOL, V47, P1892, DOI 10.1128/JCM.00105-09; Maclean RC, 2004, PARASITOL RES, V93, P211, DOI 10.1007/s00436-004-1104-x; Madarova L, 2010, EXP PARASITOL, V126, P37, DOI 10.1016/j.exppara.2009.11.001; Marciano-Cabral F, 2003, APPL ENVIRON MICROB, V69, P5864, DOI 10.1128/AEM.69.10.5864-5869.2003; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nacapunchai D, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P179; Nacapunchai D, 1999, J TROP MED PARASITOL, V22, P22; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; Preston TM, 2003, J EUKARYOT MICROBIOL, V50, P245, DOI 10.1111/j.1550-7408.2003.tb00128.x; Puzon GJ, 2009, ENVIRON SCI TECHNOL, V43, P6691, DOI 10.1021/es900432m; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Reveiller FL, 2002, PARASITOL RES, V88, P443, DOI 10.1007/s00436-002-0591-x; Robinson BS, 2006, APPL ENVIRON MICROB, V72, P5857, DOI 10.1128/AEM.00113-06; Schild M, 2007, J CLIN MICROBIOL, V45, P564, DOI 10.1128/JCM.01357-06; Skotarczak B, 2009, PARASITE, V16, P183, DOI 10.1051/parasite/2009163183; SPARAGANO O, 1993, FEMS MICROBIOL LETT, V110, P325, DOI 10.1111/j.1574-6968.1993.tb06343.x; Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902; Tiewcharoen Supathra, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P275; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Trabelsi H, 2012, PATHOL BIOL, V60, P399, DOI 10.1016/j.patbio.2012.03.002; Tung MC, 2013, INT J PARASITOL, V43, P691, DOI 10.1016/j.ijpara.2013.01.012; USEPA (U.S. Environmental Protection Agency), 2005, 1623 USEPA OFF WAT; Viera AJ, 2005, FAM MED, V37, P360; Wannasan A, 2013, REV INST MED TROP SP, V55, P411, DOI 10.1590/S0036-46652013000600007; Yoder JS, 2012, CLIN INFECT DIS, V55, pE79, DOI 10.1093/cid/cis626	47	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120997	10.1371/journal.pone.0120997	http://dx.doi.org/10.1371/journal.pone.0120997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822175	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700083
J	Nagpal, L; Panda, K				Nagpal, Latika; Panda, Koustubh			Characterization of Calmodulin-Free Murine Inducible Nitric-Oxide Synthase	PLOS ONE			English	Article							ELECTRON-TRANSFER; ACIDIC RESIDUES; BINDING; DIMER; DOMAIN; HEME; TETRAHYDROBIOPTERIN; APOCALMODULIN; PURIFICATION; DIMERIZATION	Nitric-Oxide Synthase (NOS), that produces the biological signal molecule Nitric-Oxide (NO), exists in three different isoforms called, neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). All NOS isoforms require post-translational interaction with the calcium-binding protein, calmodulin (CaM) for manifesting their catalytic activity. However, CaM has been suggested to control the translational assembly of the enzyme as well, particularly in helping its inducible isoform, iNOS assume a stable, heme-replete, dimeric and active form. Expression of recombinant murine iNOS in E. coli in the absence of CaM has been previously shown to give extremely poor yield of the enzyme which was claimed to be absolutely heme-free, devoid of flavins, completely monomeric and catalytically inactive when compared to the heme-replete, active, dimeric iNOS, generated through co-expression with CaM. In contrast, we found that although iNOS expressed without CaM does produce significantly low amounts of the CaM-free enzyme, the iNOS thus produced, is not completely devoid of heme and is neither entirely monomeric nor absolutely bereft of catalytic activity as reported before. In fact, iNOS synthesized in the absence of CaM undergoes compromised heme incorporation resulting in extremely poor dimerization and activity compared to its counterpart co-expressed with CaM. Moreover, such CaM-free iNOS has similar flavin content and reductase activity as iNOS co-expressed with CaM, suggesting that CaM may not be as much required for the functional assembly of the iNOS reductase domain as its oxygenase domain. LC-MS/MS-based peptide mapping of the CaM-free iNOS confirmed that it had the same full-length sequence as the CaM-replete iNOS. Isothermal calorimetric measurements also revealed high affinity for CaM binding in the CaM-free iNOS and thus the possible presence of a CaM-binding domain. Thus CaM is essential but not indispensible for the assembly of iNOS and such CaM-free iNOS may help in elucidating the role of CaM on iNOS catalysis.	[Panda, Koustubh] Univ Calcutta, Dept Biotechnol, Kolkata, India; Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata, India	University of Calcutta; University of Calcutta	Panda, K (corresponding author), Univ Calcutta, Dept Biotechnol, Kolkata, India.	pandak66@yahoo.co			Research Grant for Teachers by the University of Calcutta	Research Grant for Teachers by the University of Calcutta	Funded by Research Grant for Teachers by the University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Censarek P, 2004, FEBS LETT, V577, P465, DOI 10.1016/j.febslet.2004.10.048; Censarek P, 2002, BIOCHEMISTRY-US, V41, P8598, DOI 10.1021/bi025681k; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Forstermann U, 2000, HANDB EXP PHARMACOL, V143, P71; FORSTERMANN U, 1995, BIOCHEM PHARMACOL, V50, P1321, DOI 10.1016/0006-2952(95)00181-6; Gachhui R, 1997, BIOCHEMISTRY-US, V36, P5097, DOI 10.1021/bi970331x; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Nagpal L, 2013, J BIOL CHEM, V288, P19685, DOI 10.1074/jbc.M112.446542; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Spratt DE, 2007, BIOCHEMISTRY-US, V46, P8288, DOI 10.1021/bi062130b; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763; XIE QW, 1994, J BIOL CHEM, V269, P28500	22	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121782	10.1371/journal.pone.0121782	http://dx.doi.org/10.1371/journal.pone.0121782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822458	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700125
J	Noureen, A; Fresser, F; Utermann, G; Schmidt, K				Noureen, Asma; Fresser, Friedrich; Utermann, Gerd; Schmidt, Konrad			Sequence Variation within the KIV-2 Copy Number Polymorphism of the Human LPA Gene in African, Asian, and European Populations	PLOS ONE			English	Article							KRINGLE-IV REPEATS; HUMAN GENOME; LIPOPROTEIN(A) CONCENTRATIONS; HUMAN APOLIPOPROTEIN(A); PLASMA-CONCENTRATIONS; DNA-POLYMERASES; MOLECULAR-BASIS; ETHNIC-GROUPS; LP(A); CAUCASIANS	Amazingly little sequence variation is reported for the kringle IV 2 copy number variation (KIV 2 CNV) in the human LPA gene. Apart from whole genome sequencing projects, this region has only been analyzed in some detail in samples of European populations. We have performed a systematic resequencing study of the exonic and flanking intron regions within the KIV 2 CNV in 90 alleles from Asian, European, and four different African populations. Alleles have been separated according to their CNV length by pulsed field gel electrophoresis prior to unbiased specific PCR amplification of the target regions. These amplicons covered all KIV 2 copies of an individual allele simultaneously. In addition, cloned amplicons from genomic DNA of an African individual were sequenced. Our data suggest that sequence variation in this genomic region may be higher than previously appreciated. Detection probability of variants appeared to depend on the KIV 2 copy number of the analyzed DNA and on the proportion of copies carrying the variant. Asians had a high frequency of so-called KIV 2 type B and type C (together 70% of alleles), which differ by three or two synonymous substitutions respectively from the reference type A. This is most likely explained by the strong bottleneck suggested to have occurred when modern humans migrated to East Asia. A higher frequency of variable sites was detected in the Africans. In particular, two previously unreported splice site variants were found. One was associated with non-detectable Lp(a). The other was observed at high population frequencies (10% to 40%). Like the KIV 2 type B and C variants, this latter variant was also found in a high proportion of KIV 2 repeats in the affected alleles and in alleles differing in copy numbers. Our findings may have implications for the interpretation of SNP analyses in other repetitive loci of the human genome.	[Noureen, Asma; Schmidt, Konrad] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Noureen, Asma; Fresser, Friedrich; Utermann, Gerd; Schmidt, Konrad] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Human Genet, A-6020 Innsbruck, Austria; [Fresser, Friedrich] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Translat Cell Genet, A-6020 Innsbruck, Austria; [Schmidt, Konrad] Albert Schweitzer Hosp, Ctr Rech Med Lambarene, Lambarene, Gabon; [Schmidt, Konrad] Univ Tubingen, Dept Trop Med, Tubingen, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Eberhard Karls University of Tubingen	Schmidt, K (corresponding author), Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	konrad.schmidt@afrigene.com			Innsbruck Medical University [P5030-011-011]	Innsbruck Medical University	The study was funded by Research Project Fund P5030-011-011 "Clinical Genetics" of Innsbruck Medical University to the Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brunner C, 1996, J BIOL CHEM, V271, P32403, DOI 10.1074/jbc.271.50.32403; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Crawford DC, 2008, HUM HERED, V66, P199, DOI 10.1159/000143403; Deo RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014581; Dumitrescu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016604; Erdel M, 1999, NAT GENET, V21, P357, DOI 10.1038/7681; Fawcett JA, 2013, TRENDS GENET, V29, P561, DOI 10.1016/j.tig.2013.07.002; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; Gaw A, 1998, ARTERIOSCL THROM VAS, V18, P1870, DOI 10.1161/01.ATV.18.12.1870; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Kraft HG, 1996, EUR J HUM GENET, V4, P74; KRAFT HG, 1992, HUM GENET, V90, P220; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; KRONENBERG F, 1994, J LIPID RES, V35, P1318; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Lavebratt C, 2004, HUM MUTAT, V23, P92, DOI 10.1002/humu.10292; Li Y, 1999, P NATL ACAD SCI USA, V96, P9491, DOI 10.1073/pnas.96.17.9491; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Ogorelkova M, 1999, HUM MOL GENET, V8, P2087, DOI 10.1093/hmg/8.11.2087; Ogorelkova M, 2001, HUM MOL GENET, V10, P815, DOI 10.1093/hmg/10.8.815; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; RADER DJ, 1993, J CLIN INVEST, V91, P443, DOI 10.1172/JCI116221; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosby O, 2000, ATHEROSCLEROSIS, V148, P353, DOI 10.1016/S0021-9150(99)00285-3; Rosby O, 1997, CLIN GENET, V52, P293; SANDHOLZER C, 1991, HUM GENET, V86, P607; Schmidt K, 2006, EUR J HUM GENET, V14, P190, DOI 10.1038/sj.ejhg.5201512; Scholz M, 1999, EUR J HUM GENET, V7, P169, DOI 10.1038/sj.ejhg.5200290; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	41	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121582	10.1371/journal.pone.0121582	http://dx.doi.org/10.1371/journal.pone.0121582			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822457	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700115
J	Rautiainen, S; Kononen, M; Sironen, R; Masarwah, A; Sudah, M; Hakumaki, J; Vanninen, R; Sutela, A				Rautiainen, Suvi; Kononen, Mervi; Sironen, Reijo; Masarwah, Amro; Sudah, Mazen; Hakumaki, Juhana; Vanninen, Ritva; Sutela, Anna			Preoperative Axillary Staging with 3.0-T Breast MRI: Clinical Value of Diffusion Imaging and Apparent Diffusion Coefficient	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; MAGNETIC-RESONANCE; SENTINEL NODE; CANCER PATIENTS; NEEDLE-BIOPSY; METAANALYSIS; METASTASIS; ULTRASOUND; ACCURACY; DISSECTION	The axillary staging in newly diagnosed breast cancer is under major evolution. The aims of this study were to define the diagnostic performance of 3.0-T diffusion-weighted imaging (DWI) in the detection of axillary metastases in newly diagnosed breast cancer, to assess apparent diffusion coefficients (ADCs) for histopathologically confirmed metastatic lymph nodes in a clinical setting. Altogether 52 consecutive breast cancer patients underwent magnetic resonance imaging and DWI in addition to axillary ultrasound. ADCs of axillary lymph nodes were analysed by two breast radiologists and ultrasound-guided core biopsies were taken. In a separate reading by one radiologist two types of region of interests were used for a smaller group of patients. Altogether 56 axillae (121 lymph nodes) were included in the statistical analysis. Metastatic axillae (51.8%) had significantly lower ADCs (p<0.001). Mean ADCs were 0.663-0.676 x 10(-3) mm(2)/s for the histologically confirmed metastatic LNs and 1.100-1.225 x 10(-3) mm(2)/s for the benign. The sensitivity, specificity, and accuracy of DWI were 72.4%, 79.6%, and 75.9%, respectively with threshold ADC 0.812 x 10(-3) mm(2)/s. Region of interest with information on the minimum value increased the diagnostic performance (area under the curve 0.794 vs. 0.619). Even though ADCs are significantly associated with histopathologically confirmed axillary metastases the diagnostic performance of axillary DWI remains moderate and ultrasound-guided core biopsies or sentinel lymph node biopsies cannot be omitted.	[Rautiainen, Suvi; Kononen, Mervi; Masarwah, Amro; Sudah, Mazen; Hakumaki, Juhana; Vanninen, Ritva; Sutela, Anna] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Sironen, Reijo] Kuopio Univ Hosp, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Radiol Unit, Inst Clin Med, Kuopio, Finland; [Sironen, Reijo] Univ Eastern Finland, Inst Clin Med, Unit Pathol & Forens Med, Kuopio, Finland; [Rautiainen, Suvi; Sironen, Reijo; Vanninen, Ritva] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Rautiainen, S (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	suvi.rautiainen@kuh.fi	Hakumäki, Juhana/AAH-1058-2021	Hakumaki, Juhana/0000-0001-7341-5440; Kononen, Mervi/0000-0002-9622-2796	Mauri and Sirkka Wiljasalo Foundation; Finnish Cultural Foundation; Cancer Centre of Eastern Finland by the University of Eastern Finland [5053129]; Finnish government [506 3532]	Mauri and Sirkka Wiljasalo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Centre of Eastern Finland by the University of Eastern Finland; Finnish government	Mauri and Sirkka Wiljasalo Foundation (SR), Finnish Cultural Foundation (A. A. Laaksonen fund) (SR), Strategic funding of the Cancer Centre of Eastern Finland provided by the University of Eastern Finland (grant number 5053129) (SR, AM), Finnish government research funding (grant number 506 3532) (SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Cakir O, 2013, EUR J RADIOL, V82, pE801, DOI 10.1016/j.ejrad.2013.09.001; Chung J, 2013, ACTA RADIOL; Cooper KL, 2011, EJSO-EUR J SURG ONC, V37, P187, DOI 10.1016/j.ejso.2011.01.003; D'Orsi C, 2003, BREAST IMAGING REPOR; Diepstraten SCE, 2014, ANN SURG ONCOL, V21, P51, DOI 10.1245/s10434-013-3229-6; Dong H, 2013, CLIN BREAST CANC; Fletcher R.H., 2005, CLIN EPIDEMIOLOGY ES, V4th ed., P45; Fornasa F, 2012, J MAGN RESON IMAGING, V36, P858, DOI 10.1002/jmri.23706; Ganott Marie A, 2014, ISRN Oncol, V2014, P703160, DOI 10.1155/2014/703160; Gentilini O, 2012, BREAST, V21, P678, DOI 10.1016/j.breast.2012.06.013; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hahn SY, 2014, EUR J RADIOL, V83, P283, DOI 10.1016/j.ejrad.2013.10.023; Harnan SE, 2011, EJSO-EUR J SURG ONC, V37, P928, DOI 10.1016/j.ejso.2011.07.007; He N, 2012, EUR J RADIOL, V81, P2602, DOI 10.1016/j.ejrad.2012.03.019; Houssami N, 2011, ANN SURG, V254, P243, DOI 10.1097/SLA.0b013e31821f1564; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Li B, 2014, EUR J RADIOL, V83, P338, DOI 10.1016/j.ejrad.2013.11.017; Luo NB, 2013, J MAGN RESON IMAGING, V38, P824, DOI 10.1002/jmri.24031; Mariani G, 2001, J NUCL MED, V42, P1198; Matsuoka A, 2008, RADIAT MED, V26, P15, DOI 10.1007/s11604-007-0187-6; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; NICE, 2009, EARL LOC ADV BREAST; Nogueira L, 2014, CLIN RADIOL, V69, P378, DOI 10.1016/j.crad.2013.11.005; Park SH, 2013, J MAGN RESON IMAGING; Rautiainen S, 2013, RADIOLOGY, V269, P54, DOI 10.1148/radiol.13122637; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Weiser MR, 2001, ANN SURG ONCOL, V8, P145, DOI 10.1007/s10434-001-0145-y	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122516	10.1371/journal.pone.0122516	http://dx.doi.org/10.1371/journal.pone.0122516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823016	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700181
J	Vivek, S; Weeks, ER				Vivek, Skanda; Weeks, Eric R.			Measuring and Overcoming Limits of the Saffman-Delbruck Model for Soap Film Viscosities	PLOS ONE			English	Article							COLLOIDAL PARTICLES; LIQUID INTERFACES; LIPID-MEMBRANES; BROWNIAN-MOTION; DIFFUSION; HYDRODYNAMICS; MICRORHEOLOGY; TURBULENCE; FILAMENTS; FLUID	We observe tracer particles diffusing in soap films to measure the two-dimensional (2D) viscous properties of the films. Saffman-Delbruck type models relate the single-particle diffusivity to parameters of the film (such as thickness h) for thin films, but the relation breaks down for thicker films. Notably, the diffusivity is faster than expected for thicker films, with the crossover at h/d = 5.2 +/- 0.9 using the tracer particle diameter d. This indicates a crossover from purely 2D diffusion to diffusion that is more three-dimensional. We demonstrate that measuring the correlations of particle pairs as a function of their separation overcomes the limitations of the Saffman-Delbruck model and allows one to measure the viscosity of a soap film for any thickness.	[Vivek, Skanda; Weeks, Eric R.] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Emory University	Weeks, ER (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	erweeks@emory.edu	Weeks, Eric R/I-8960-2019	Weeks, Eric R/0000-0003-1503-3633; Vivek, Skanda/0000-0003-3158-5702	National Science Foundation [CBET-1336401]; Div Of Chem, Bioeng, Env, & Transp Sys [1336401] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding provided by National Science Foundation under Grant No. CBET-1336401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Bechhoefer J, 1997, PHYS REV LETT, V79, P4922, DOI 10.1103/PhysRevLett.79.4922; Burgess JM, 1999, PHYS REV E, V60, P715, DOI 10.1103/PhysRevE.60.715; Cheung C, 1996, PHYS REV LETT, V76, P2531, DOI 10.1103/PhysRevLett.76.2531; COUDER Y, 1989, PHYSICA D, V37, P384, DOI 10.1016/0167-2789(89)90144-9; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; Di Leonardo R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.106103; Di Leonardo R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031406; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fischer TM, 2006, J FLUID MECH, V558, P451, DOI 10.1017/S002211200600022X; Gibbs JW, 1931, COLLECTED WORKS; HUGHES BD, 1981, J FLUID MECH, V110, P349, DOI 10.1017/S0022112081000785; Kaz DM, 2012, NAT MATER, V11, P138, DOI [10.1038/NMAT3190, 10.1038/nmat3190]; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; Martin BK, 1998, PHYS REV LETT, V80, P3964, DOI 10.1103/PhysRevLett.80.3964; Nguyen ZH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268304; Nikolaides MG, 2002, NATURE, V420, P299, DOI 10.1038/nature01113; Parthasarathy R, 2012, NAT METHODS, V9, P724, DOI [10.1038/NMETH.2071, 10.1038/nmeth.2071]; Petrov EP, 2008, BIOPHYS J, V94, pL41, DOI 10.1529/biophysj.107.126565; Petrov EP, 2012, SOFT MATTER, V8, P7552, DOI 10.1039/c2sm25796c; Plateau J., 1873, STATIQUE EXPT THEORI; Prasad V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026309; Prasad V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178302; Rutgers MA, 1998, PHYS REV LETT, V81, P2244, DOI 10.1103/PhysRevLett.81.2244; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511; Samaniuk JR, 2014, SOFT MATTER, V10, P7023, DOI 10.1039/c4sm00646a; Stone HA, 1998, J FLUID MECH, V369, P151, DOI 10.1017/S0022112098001980; Stone HA, 2010, J FLUID MECH, V645, P1, DOI 10.1017/S0022112009994186; Sur J, 2001, PHYS REV LETT, V86, P4326, DOI 10.1103/PhysRevLett.86.4326; Sutherland W, 1905, PHILOS MAG, V9, P781, DOI 10.1080/14786440509463331; Tien HT, 2001, J MEMBRANE SCI, V189, P83, DOI 10.1016/S0376-7388(01)00394-5; Trapeznikov AA, 1957, P 2 INT C SURF ACT, P242; Vestergaard CL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022726; Wu XL, 2001, REV SCI INSTRUM, V72, P2467, DOI 10.1063/1.1366634; Zhang J, 2000, NATURE, V408, P835, DOI 10.1038/35048530	37	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121981	10.1371/journal.pone.0121981	http://dx.doi.org/10.1371/journal.pone.0121981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822262	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700144
J	Wang, XW; Guan, Z; Chen, Y; Dong, YT; Niu, YH; Wang, JH; Zhang, T; Niu, B				Wang, Xiuwei; Guan, Zhen; Chen, Yan; Dong, Yanting; Niu, Yuhu; Wang, Jianhua; Zhang, Ting; Niu, Bo			Genomic DNA Hypomethylation Is Associated with Neural Tube Defects Induced by Methotrexate Inhibition of Folate Metabolism	PLOS ONE			English	Article							METHYLATION CYCLE; PREVENTION; IDENTIFICATION; SUPPRESSION; DEFICIENT; MUTATION; ELEMENTS; COMMON; P53	DNA methylation is thought to be involved in the etiology of neural tube defects (NTDs). However, the exact mechanism between DNA methylation and NTDs remains unclear. Herein, we investigated the change of methylation in mouse model of NTDs associated with folate dysmetabolism by use of ultraperformance liquid chromatography tandem mass spectrometry (UPLC/MS/MS), liquid chromatography-electrospray ionization tandem mass spectrometry (LC-MS/MS), microarray, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and Real time quantitative PCR. Results showed that NTD neural tube tissues had lower concentrations of 5-methyltetrahydrofolate (5-MeTHF, P = 0.005), 5-formyltetrahydrofolate (5-FoTHF, P = 0.040), S-adenosylmethionine (SAM, P = 0.004) and higher concentrations of folic acid (P = 0.041), homocysteine (Hcy, P = 0.006) and S-adenosylhomocysteine (SAH, P = 0.045) compared to control. Methylation levels of genomic DNA decreased significantly in the embryonic neural tube tissue of NTD samples. 132 differentially methylated regions (35 low methylated regions and 97 high methylated regions) were selected by microarray. Two genes (Siah1b, Prkx) in Wnt signal pathway demonstrated lower methylated regions (peak) and higher expression in NTDs (P<0.05; P<0.05). Results suggest that DNA hypomethylation was one of the possible epigenetic variations correlated with the occurrence of NTDs induced by folate dysmetabolism and that Siah1b, Prkx in Wnt pathway may be candidate genes for NTDs.	[Wang, Xiuwei; Dong, Yanting; Niu, Yuhu; Niu, Bo] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Peoples R China; [Guan, Zhen; Wang, Jianhua; Zhang, Ting; Niu, Bo] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing, Peoples R China; [Chen, Yan] Shanxi Med Univ, Hosp 2, Dept Resp, Taiyuan, Peoples R China	Shanxi Medical University; Capital Institute of Pediatrics (CIP); Shanxi Medical University	Zhang, T (corresponding author), Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing, Peoples R China.	zhangtingcv@yahoo.com; niub2004@126.com			Ministry of Science and Technology of China; National "973" Project on Population and Health [2013CB945404]; National Natural Science Foundation of China [81370312]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National "973" Project on Population and Health(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The Ministry of Science and Technology of China, National "973" Project on Population and Health (Project 2013CB945404) and the National Natural Science Foundation of China (Project 81370312).	Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Cogram P, 2004, HUM MOL GENET, V13, P7, DOI 10.1093/hmg/ddh003; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dunlevy LPE, 2006, FEBS LETT, V580, P2803, DOI 10.1016/j.febslet.2006.04.020; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li XH, 2011, DEV BIOL, V356, P475, DOI 10.1016/j.ydbio.2011.05.673; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; van der Linden IJM, 2008, BIRTH DEFECTS RES A, V82, P676, DOI 10.1002/bdra.20509; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wang X, 2013, J APPL TOXICOL; Wang XW, 2014, J CHROMATOGR B, V962, P9, DOI 10.1016/j.jchromb.2014.05.023; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Zhang M, 2012, ANAL METHODS-UK, V4, P2515, DOI 10.1039/c2ay25140j; Zhao J, 2013, J APPL TOXICOL, V33, P915, DOI 10.1002/jat.2769	30	23	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121869	10.1371/journal.pone.0121869	http://dx.doi.org/10.1371/journal.pone.0121869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822193	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700133
J	Konuma, K; Itoh, M; Suganami, T; Kanai, S; Nakagawa, N; Sakai, T; Kawano, H; Hara, M; Kojima, S; Izumi, Y; Ogawa, Y				Konuma, Kuniha; Itoh, Michiko; Suganami, Takayoshi; Kanai, Sayaka; Nakagawa, Nobutaka; Sakai, Takeru; Kawano, Hiroyuki; Hara, Mitsuko; Kojima, Soichi; Izumi, Yuichi; Ogawa, Yoshihiro			Eicosapentaenoic Acid Ameliorates Non-Alcoholic Steatohepatitis in a Novel Mouse Model Using Melanocortin 4 Receptor-Deficient Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIET-INDUCED OBESITY; FISH-OIL; LIVER-DISEASE; ADIPONECTIN SECRETION; HEPATIC STEATOSIS; FIBROSIS; ACTIVATION; EXPRESSION; LEPTIN	Many attempts have been made to find novel therapeutic strategies for non-alcoholic steatohepatitis (NASH), while their clinical efficacy is unclear. We have recently reported a novel rodent model of NASH using melanocortin 4 receptor-deficient (MC4R-KO) mice, which exhibit the sequence of events that comprise hepatic steatosis, liver fibrosis, and hepatocellular carcinoma with obesity-related phenotypes. In the liver of MC4R-KO mice, there is a unique histological feature termed hepatic crown-like structures (hCLS), where macrophages interact with dead hepatocytes and fibrogenic cells, thereby accelerating inflammation and fibrosis. In this study, we employed MC4R-KO mice to examine the effect of highly purified eicosapentaenoic acid (EPA), a clinically available n-3 polyunsaturated fatty acid, on the development of NASH. EPA treatment markedly prevented the development of hepatocyte injury, hCLS formation and liver fibrosis along with lipid accumulation. EPA treatment was also effective even after MC4R-KO mice developed NASH. Intriguingly, improvement of liver fibrosis was accompanied by the reduction of hCLS formation and plasma kallikrein-mediated transforming growth factor-beta activation. Moreover, EPA treatment increased the otherwise reduced serum concentrations of adiponectin, an adipocytokine with anti-inflammatory and anti-fibrotic properties. Collectively, EPA treatment effectively prevents the development and progression of NASH in MC4R-KO mice along with amelioration of hepatic steatosis. This study unravels a novel anti-fibrotic mechanism of EPA, thereby suggesting a clinical implication for the treatment of NASH.	[Konuma, Kuniha; Itoh, Michiko; Kanai, Sayaka; Nakagawa, Nobutaka; Sakai, Takeru; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Konuma, Kuniha; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Tokyo, Japan; [Suganami, Takayoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Kawano, Hiroyuki] Mochida Pharmaceut, Pharmaceut Res Ctr, Dev Res, Shizuoka, Japan; [Hara, Mitsuko; Kojima, Soichi] RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama, Japan; [Ogawa, Yoshihiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Mochida Pharmaceutical Co Ltd; RIKEN; Japan Science & Technology Agency (JST)	Suganami, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Tokyo, Japan.	suganami.mem@tmd.ac.jp	SUGANAMI, Takayoshi/A-9475-2016; Kojima, Soichi/N-7104-2015	Kojima, Soichi/0000-0002-5252-1612; Ogawa, Yoshihiro/0000-0002-0834-2836	Mochida Pharmaceutical Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ono Medical Research Foundation; Yokoyama Foundation for Clinical Pharmacology; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [14J40047] Funding Source: KAKEN	Mochida Pharmaceutical Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ono Medical Research Foundation; Yokoyama Foundation for Clinical Pharmacology(Yokoyama Foundation for Clinical Pharmacology); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Mochida Pharmaceutical Co. Ltd. who also provided highly purified EPA ethyl ester. Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan, Japan Science and Technology Agency, Japan Society for the Promotion of Science, and research grants from Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Ono Medical Research Foundation, Yokoyama Foundation for Clinical Pharmacology, and The Uehara Memorial Foundation. Michiko Itoh was supported by Research Fellowship of Japan Society for the Promotion of Science. Co-author Hiroyuki Kawano is employed by Mochida Pharmaceutical Co. Ltd. Mochida Pharmaceutical Co. Ltd. provided support in the form of salary for Hiroyuki Kawano, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akita K, 2002, GASTROENTEROLOGY, V123, P352, DOI 10.1053/gast.2002.34234; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Argo CK, 2015, J HEPATOL, V62, P190, DOI 10.1016/j.jhep.2014.08.036; Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Dasarathy S, 2015, J CLIN GASTROENTEROL, V49, P137, DOI 10.1097/MCG.0000000000000099; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Di Minno MND, 2012, WORLD J GASTROENTERO, V18, P5839, DOI 10.3748/wjg.v18.i41.5839; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Gautron L, 2010, J COMP NEUROL, V518, P6, DOI 10.1002/cne.22221; Hara M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-221; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Ishii H, 2009, J HEPATOL, V50, P562, DOI 10.1016/j.jhep.2008.10.031; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Itoh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082163; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kajikawa S, 2011, DIGEST DIS SCI, V56, P1065, DOI 10.1007/s10620-010-1400-5; Kajikawa S, 2010, DIGEST DIS SCI, V55, P631, DOI 10.1007/s10620-009-1020-0; Kakisaka K, 2012, AM J PHYSIOL-GASTR L, V302, pG77, DOI 10.1152/ajpgi.00301.2011; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Larter CZ, 2008, J HEPATOL, V48, P638, DOI 10.1016/j.jhep.2007.12.011; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P267, DOI 10.1111/j.1440-1746.2007.05157.x; Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Okuno M, 2001, GASTROENTEROLOGY, V120, P1784, DOI 10.1053/gast.2001.24832; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	54	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121528	10.1371/journal.pone.0121528	http://dx.doi.org/10.1371/journal.pone.0121528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816330	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600103
J	Lyu, XF; Yu, JB; Zhou, M; Ma, B; Wang, GM; Zhan, C; Han, GX; Guan, B; Wu, HF; Li, YZ; Wang, D				Lyu, Xiaofei; Yu, Junbao; Zhou, Mo; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De			Changes of Soil Particle Size Distribution in Tidal Flats in the Yellow River Delta	PLOS ONE			English	Article							LAND-USE TYPES; FRACTAL FEATURES; SPATIAL-PATTERNS; CHINA; SEDIMENT; WETLAND; FRAGMENTATION; VARIABILITY; ACCRETION; SALINITY	Background The tidal flat is one of the important components of coastal wetland systems in the Yellow River Delta (YRD). It can stabilize shorelines and protect coastal biodiversity. The erosion risk in tidal flats in coastal wetlands was seldom been studied. Characterizing changes of soil particle size distribution (PSD) is an important way to quantity soil erosion in tidal flats. Method/Principal findings Based on the fractal scale theory and network analysis, we determined the fractal characterizations (singular fractal dimension and multifractal dimension) soil PSD in a successional series of tidal flats in a coastal wetland in the YRD in eastern China. The results showed that the major soil texture was from silt loam to sandy loam. The values of fractal dimensions, ranging from 2.35 to 2.55, decreased from the low tidal flat to the high tidal flat. We also found that the percent of particles with size ranging between 0.4 and 126 mu m was related with fractal dimensions. Tide played a great effort on soil PSD than vegetation by increasing soil organic matter (SOM) content and salinity in the coastal wetland in the YRD. Conclusions/Significance Tidal flats in coastal wetlands in the YRD, especially low tidal flats, are facing the risk of soil erosion. This study will be essential to provide a firm basis for the coast erosion control and assessment, as well as wetland ecosystem restoration.	[Lyu, Xiaofei; Yu, Junbao; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China; [Lyu, Xiaofei; Yu, Junbao; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De] YICCAS, Shandong Prov Key Lab Coastal Environm Proc, Yantai, Shandong, Peoples R China; [Lyu, Xiaofei; Wang, Guangmei; Zhan, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Mo] NE Normal Univ, Environm Coll, Changchun 130024, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Normal University - China	Yu, JB (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China.	junbao.yu@gmail.com	wang, gm/GWV-1237-2022; Wu, Huifeng/E-4886-2016	马, 斌/0000-0001-8625-1676; Yu, Junbao/0000-0002-3433-3538; Ma, Bin/0000-0003-3666-7862	Project of National Science & Technology Pillar Program in "12th Five Year'' period [2011BAC02B01]; National Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201114]; National Science Foundation of China [41301333]	Project of National Science & Technology Pillar Program in "12th Five Year'' period; National Natural Science Foundation for Distinguished Young Scholar of Shandong Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of National Science & Technology Pillar Program in "12th Five Year'' period (2011BAC02B01), National Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201114), and the National Science Foundation of China (41301333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2009, VADOSE ZONE J, V8, P202, DOI 10.2136/vzj2008.0038; Baker RC, 2013, ACTA ARITH, V157, P37, DOI 10.4064/aa157-1-3; Billingsley Patrick, 1965, ERGODIC THEORY INFOR; Biswas A, 2012, NONLINEAR PROC GEOPH, V19, P227, DOI 10.5194/npg-19-227-2012; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Chen M, 2013, BIOGEOCHEMISTRY, V115, P167, DOI 10.1007/s10533-013-9826-4; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Fan XM, 2011, ECOHYDROLOGY, V4, P744, DOI 10.1002/eco.164; Fu H, 2009, ARID LAND RES MANAG, V23, P137, DOI 10.1080/15324980902813658; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Ghorbani N, 2012, NUTR CYCL AGROECOSYS, V93, P15, DOI 10.1007/s10705-012-9496-y; Gulser C, 2006, GEODERMA, V131, P33, DOI 10.1016/j.geoderma.2005.03.004; Nguyen HYT, 2013, J COAST CONSERV, V17, P93, DOI 10.1007/s11852-012-0221-4; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Mavi MS, 2012, SOIL BIOL BIOCHEM, V45, P8, DOI 10.1016/j.soilbio.2011.10.003; Montero E, 2003, GEODERMA, V112, P197, DOI 10.1016/S0016-7061(02)00306-3; Peng G, 2014, J SOIL SEDIMENT, V14, P1116, DOI 10.1007/s11368-014-0876-6; Perfect E, 1997, ENG GEOL, V48, P185, DOI 10.1016/S0013-7952(97)00040-9; Pye K, 2007, FORENSIC SCI INT, V167, P30, DOI 10.1016/j.forsciint.2006.06.005; Renyi A., 1970, PROBABILITY THEORY; Salako FK, 1999, GEODERMA, V91, P103, DOI 10.1016/S0016-7061(99)00006-3; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Schulte E.E, 1995, RECOMMENDED SOIL TES, Vsecond; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P1908, DOI 10.1016/j.soilbio.2011.05.013; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P667, DOI 10.1016/j.soilbio.2010.12.004; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; Wissing L., 2014, Geoderma, V228/229, P90, DOI 10.1016/j.geoderma.2013.12.012; Xie XJ, 2013, J MT SCI-ENGL, V10, P437, DOI 10.1007/s11629-013-2500-3; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Yu J, 2011, BIOGEOSCIENCES, V8, P2427, DOI 10.5194/bg-8-2427-2011; Yu JB, 2014, ENVIRON EARTH SCI, V72, P589, DOI 10.1007/s12665-013-2980-0; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092839; Zhang YN, 2013, ECOL ENG, V52, P308, DOI 10.1016/j.ecoleng.2012.10.002	36	24	25	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121368	10.1371/journal.pone.0121368	http://dx.doi.org/10.1371/journal.pone.0121368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816240	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600085
J	Sato, S; Saisho, Y; Kou, K; Meguro, S; Tanaka, M; Irie, J; Kawai, T; Itoh, H				Sato, Seiji; Saisho, Yoshifumi; Kou, Kinsei; Meguro, Shu; Tanaka, Masami; Irie, Junichiro; Kawai, Toshihide; Itoh, Hiroshi			Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; GLYCEMIC CONTROL; TREATMENT SATISFACTION; THERAPY; INCRETIN; VILDAGLIPTIN; METAANALYSIS; SENSITIVITY	Aims To clarify the efficacy and safety of adding sitagliptin to insulin therapy in Japanese patients with suboptimally controlled type 2 diabetes (T2DM). Study Design and Methods This was a 24-week, prospective, randomized, open-labeled, controlled trial. Patients with T2DM who were suboptimally controlled despite receiving at least twice daily injection of insulin were enrolled in the study. The patients were randomized to continuation of insulin treatment (Insulin group) or addition of sitagliptin 50 to 100 mg daily to insulin treatment (Ins+Sita group). The primary outcome was change in HbA1c at week 24. Results Adding sitagliptin to insulin significantly reduced HbA1c from 7.9 +/- 1.0% at baseline to 7.0 +/- 0.8% at week 24 (P <0.0001), while there was no significant change in HbA1c in the Insulin group (7.8 +/- 0.7% vs. 7.8 +/- 1.1%, P = 0.32). The difference in HbA1c reduction between the groups was 0.9% (95% confidence interval, 0.4 to 1.5, P = 0.01). There was no significant weight gain in either group. Incidence of hypoglycemia was significantly reduced in the Ins+Sita group compared with the Insulin group. Treatment satisfaction was improved in the Ins+Sita group. Baseline HbA1c level and beta cell function were associated with the magnitude of reduction in HbA1c in the Ins+Sita group. Conclusion Adding sitagliptin to insulin reduced HbA1c without weight gain or increase in hypoglycemia, and improved treatment satisfaction in Japanese patients with T2DM who were suboptimally controlled despite at least twice daily injection of insulin.	[Sato, Seiji; Saisho, Yoshifumi; Kou, Kinsei; Meguro, Shu; Tanaka, Masami; Irie, Junichiro; Kawai, Toshihide; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Keio University	Saisho, Y (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	ysaisho@z5.keio.jp	Irie, Junichiro/H-7795-2019; Saisho, Yoshifumi/H-2925-2019; Meguro, Shu/AAE-7261-2020	Irie, Junichiro/0000-0003-2662-4121; Saisho, Yoshifumi/0000-0002-6071-4393; 	Research Foundation for Community Medicine	Research Foundation for Community Medicine	This study was supported by funding from the Research Foundation for Community Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslanian S, 2013, DIABETES CARE, V36, P1749, DOI 10.2337/dc12-2393; Ashwell SG, 2008, DIABETES CARE, V31, P1112, DOI 10.2337/dc07-1183; Bak MJ, 2014, EUR J ENDOCRINOL, V170, P529, DOI 10.1530/EJE-13-0941; Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530; Cooperberg BA, 2009, DIABETES CARE, V32, P2275, DOI 10.2337/dc09-0798; Davies M, 2005, DIABETES CARE, V28, P1282, DOI 10.2337/diacare.28.6.1282; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x; Eurich DT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2267; Farngren J, 2014, DIABETES OBES METAB, V16, P812, DOI 10.1111/dom.12284; Fonseca V, 2007, DIABETOLOGIA, V50, P1148, DOI 10.1007/s00125-007-0633-0; Giugliano D, 2011, DIABETES CARE, V34, P510, DOI 10.2337/dc10-1710; Goossen K, 2012, DIABETES OBES METAB, V14, P1061, DOI 10.1111/j.1463-1326.2012.01610.x; Harris SB, 2014, DIABETES CARE, V37, P604, DOI 10.2337/dc13-1636; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Home P, 2014, DIABETES CARE, V37, P1499, DOI 10.2337/dc13-2743; Home PD, 2014, DIABETES CARE, V37, P1237, DOI 10.2337/dc13-2413; Hong ES, 2012, DIABETES OBES METAB, V14, P795, DOI 10.1111/j.1463-1326.2012.01600.x; Ishii H, 2011, CURR MED RES OPIN, V27, P643, DOI 10.1185/03007995.2010.551760; Japan Diabetes Society, 2014, GUID TREATM DIAB; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kahn SE, 2011, DIABETES, V60, P1552, DOI 10.2337/db10-1392; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Kodani N, 2013, CLIN DRUG INVEST, V33, P563, DOI 10.1007/s40261-013-0098-5; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; Muscelli E, 2012, J CLIN ENDOCR METAB, V97, P2818, DOI 10.1210/jc.2012-1205; Rosenstock J, 2009, DIABETES OBES METAB, V11, P1145, DOI 10.1111/j.1463-1326.2009.01124.x; Saisho Y, 2014, ENDOCR J, V61, P149, DOI 10.1507/endocrj.EJ13-0376; Saisho Y, 2013, ENDOCR J, V60, P517; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Solis-Herrera C, 2013, DIABETES CARE, V36, P2756, DOI 10.2337/dc12-2072; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; Vilsboll T, 2009, DIABETES OBES METAB, V11, P11, DOI 10.1111/j.1463-1326.2009.01073.x; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x	41	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121988	10.1371/journal.pone.0121988	http://dx.doi.org/10.1371/journal.pone.0121988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816296	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600134
J	Meijerink, H; Indrati, A; Utami, F; Soedarmo, S; Alisjahbana, B; Netea, MG; van Crevel, R; Wisaksana, R; van der Ven, AJ				Meijerink, Hinta; Indrati, Agnes; Utami, Fitri; Soedarmo, Suharyani; Alisjahbana, Bachti; Netea, Mihai G.; van Crevel, Reinout; Wisaksana, Rudi; van der Ven, Andre Jam			Heroin Use Is Associated with Suppressed Pro-Inflammatory Cytokine Response after LPS Exposure in HIV-Infected Individuals	PLOS ONE			English	Article							MORPHINE-INDUCED ALTERATIONS; TUMOR-NECROSIS-FACTOR; C VIRUS COINFECTION; RECEPTOR 4; BACTERIAL TRANSLOCATION; PROGRESSION; TOLERANCE; PAIN; TNF; CYTOTOXICITY	Background Opioid use is associated with increased incidence of infectious diseases. Although experimental studies have shown that opioids affect various functions of immune cells, only limited data are available from human studies. Drug use is an important risk factor for HIV transmission; however no data are available whether heroin and/or methadone modulate immune response. Therefore, we examined the effect of heroin and methadone use among HIV-infected individuals on the production of cytokines after ex vivo stimulation with various pathogens. Methods Treatment naive HIV-infected individuals from Indonesia were recruited. Several cohorts of individuals were recruited: 1) using heroin 2) receiving methadone opioid substitution 3) using heroin over 1 year ago and 4) controls (never used opioids). Whole blood was stimulated with Mycobacterium tuberculosis, Candida albicans and LPS for 24 to 48 hours. Cytokine production (IL-1 beta, IL-6, IL-10, IFN-alpha, IFN-gamma and TNF-alpha) was determined using multiplex beads assay. Results Among 82 individuals, the cytokine levels in unstimulated samples did not differ between groups. Overall, heroin users had significantly lower cytokine response after exposure to LPS (p<0.05). After stimulation with either M. tuberculosis or C. albicans the cytokine production of all groups were comparable. Conclusion The cytokine production after exposure to LPS is significantly down-regulated in HIV-infected heroin users. Interesting, methadone use did not suppress cytokine response, which could have implications guidelines of opioid substitution.	[Meijerink, Hinta; Netea, Mihai G.; van Crevel, Reinout; van der Ven, Andre Jam] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Indrati, Agnes; Utami, Fitri; Soedarmo, Suharyani; Alisjahbana, Bachti; Wisaksana, Rudi] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia	Radboud University Nijmegen; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran	van der Ven, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Andre.vanderVen@radboudumc.nl	van der Ven, A.J.A.M./H-8102-2014; Netea, Mihai/N-5155-2014; van Crevel, reinout/A-6636-2010	van der Ven, A.J.A.M./0000-0003-1833-3391; van Crevel, reinout/0000-0002-6233-6410	Radboud University Medical Centre Nijmegen; Radboud University; VIDI grant from the Netherlands Foundation of Scientific Research (NWO); Royal Dutch Academy of Arts and Sciences (KNAW)	Radboud University Medical Centre Nijmegen; Radboud University; VIDI grant from the Netherlands Foundation of Scientific Research (NWO); Royal Dutch Academy of Arts and Sciences (KNAW)	Hinta Meijerink has a fellowship from Radboud University Medical Centre Nijmegen; Rudi Wisaksana has a fellowship from the Radboud University; Reinout van Crevel has a VIDI grant from the Netherlands Foundation of Scientific Research (NWO); Bachti Alisjahbana has a post-doc fellowship from the Royal Dutch Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkov N, 2005, BIOCHEM BIOPH RES CO, V333, P1295, DOI 10.1016/j.bbrc.2005.06.035; Azarang A, 2007, EUR CYTOKINE NETW, V18, P210, DOI 10.1684/ecn.2007.0107; Bastami S, 2013, ACTA ONCOL, V52, P1022, DOI 10.3109/0284186X.2012.737932; Beilin B, 2003, ANESTH ANALG, V97, P822, DOI 10.1213/01.ANE.0000078586.82810.3B; BHARGAVA HN, 1994, BRAIN RES, V642, P1, DOI 10.1016/0006-8993(94)90899-0; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Bonnet MP, 2008, ANESTH ANALG, V106, P1142, DOI 10.1213/ane.0b013e318165de89; CARMODY JJ, 1987, ANAESTH INTENS CARE, V15, P27, DOI 10.1177/0310057X8701500106; CHAO CC, 1993, INT J IMMUNOPHARMACO, V15, P447, DOI 10.1016/0192-0561(93)90057-6; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; COUSSONS ME, 1992, J NEUROIMMUNOL, V39, P219, DOI 10.1016/0165-5728(92)90256-K; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Donahoe RM, 1998, J NEUROIMMUNOL, V83, P77, DOI 10.1016/S0165-5728(97)00224-5; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Dutta R, 2012, J NEUROSCI, V32, P9917, DOI 10.1523/JNEUROSCI.0870-12.2012; Eidson LN, 2013, J NEUROSCI, V33, P15952, DOI 10.1523/JNEUROSCI.1609-13.2013; Fernandez-Botran R, 2014, J INTERFERON CYTOKIN; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; FOWLER CJ, 1994, NEUROCHEM INT, V24, P401, DOI 10.1016/0197-0186(94)90089-2; Franchi S, 2012, BRAIN BEHAV IMMUN, V26, P480, DOI 10.1016/j.bbi.2011.12.010; Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x; Gein S V, 2009, Neurosci Behav Physiol, V39, P591, DOI 10.1007/s11055-009-9166-y; Greub G, 2000, VACCINE, V19, P1113, DOI 10.1016/S0264-410X(00)00332-7; Hashiguchi S, 2005, J CLIN ANESTH, V17, P575, DOI 10.1016/j.jclinane.2005.03.004; Kapadia F, 2005, CLIN INFECT DIS, V41, P1027, DOI 10.1086/433175; KUEPPERS PM, 1993, ANN SURG, V217, P286, DOI 10.1097/00000658-199303000-00011; LORENZO P, 1987, IMMUNOPHARMACOLOGY, V14, P93, DOI 10.1016/0162-3109(87)90033-6; LYSLE DT, 1993, J PHARMACOL EXP THER, V265, P1071; Madera-Salcedo IK, 2013, J IMMUNOL, V191, P3400, DOI 10.4049/jimmunol.1202658; MANDLER RN, 1986, J IMMUNOL, V136, P934; Martin JC, 2004, HIV CLIN TRIALS, V5, P125, DOI 10.1310/YFV8-FE5K-5LN9-DQ4C; MATHEWS PM, 1983, J IMMUNOL, V130, P1658; Mattioli TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097361; Meijerink H, 2014, AIDS 2014; Meijerink H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18844; Meng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054040; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Neri S, 2005, PSYCHOPHARMACOLOGY, V179, P700, DOI 10.1007/s00213-005-2239-x; Nieuwenhuijs VB, 1998, ANN SURG, V228, P188, DOI 10.1097/00000658-199808000-00007; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V64, P425, DOI 10.1097/QAI.0b013e31829f919d; PETERSON PK, 1987, J CLIN INVEST, V80, P824, DOI 10.1172/JCI113140; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Piroth L, 2000, J VIRAL HEPATITIS, V7, P302; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Regan PM, 2012, J CELL PHYSIOL, V227, P2832, DOI 10.1002/jcp.24004; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; Sacerdote P, 2000, ANESTH ANALG, V90, P1411, DOI 10.1097/00000539-200006000-00028; Sauer RS, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-10; Schwarz JM, 2013, J NEUROSCI, V33, P961, DOI 10.1523/JNEUROSCI.2516-12.2013; Smith AP, 2003, LIFE SCI, V73, P1873, DOI 10.1016/S0024-3205(03)00549-6; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Steele AD, 2003, VIROLOGY, V309, P99, DOI 10.1016/S0042-6822(03)00015-1; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Wang J, 2008, ARCH IMMUNOL THER EX, V56, P299, DOI 10.1007/s00005-008-0035-0; Wang JH, 2011, J BIOL CHEM, V286, P10225, DOI 10.1074/jbc.M110.188680; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang ZY, 2006, CLIN CHIM ACTA, V369, P40, DOI 10.1016/j.cca.2006.01.008; Wisaksana R, 2010, ADDICTION, V105, P1055, DOI 10.1111/j.1360-0443.2010.02898.x; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Yokota Tetsuya, 2004, J Anesth, V18, P190; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	65	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122822	10.1371/journal.pone.0122822	http://dx.doi.org/10.1371/journal.pone.0122822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830312	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600125
J	Bouwer, MC; Slippers, B; Degefu, D; Wingfield, MJ; Lawson, S; Rohwer, ER				Bouwer, Marc Clement; Slippers, Bernard; Degefu, Dawit; Wingfield, Michael John; Lawson, Simon; Rohwer, Egmont Richard			Identification of the Sex Pheromone of the Tree Infesting Cossid Moth Coryphodema tristis (Lepidoptera: Cossidae)	PLOS ONE			English	Article							COMPONENTS; FEMALE; ELECTROANTENNOGRAM; ACETATES	The cossid moth (Coryphodema tristis) has a broad range of native tree hosts in South Africa. The moth recently moved into non-native Eucalyptus plantations in South Africa, on which it now causes significant damage. Here we investigate the chemicals involved in pheromone communication between the sexes of this moth in order to better understand its ecology, and with a view to potentially develop management tools for it. In particular, we characterize female gland extracts and headspace samples through coupled gas chromatography electro-antennographic detection (GC-EAD) and two dimensional gas chromatography mass spectrometry (GCxGC-MS). Tentative identities of the potential pheromone compounds were confirmed by comparing both retention time and mass spectra with authentic standards. Two electrophysiologically active pheromone compounds, tetradecyl acetate (14:OAc) and Z9-tetradecenyl acetate (Z9-14:OAc) were identified from pheromone gland extracts, and an additional compound (Z9-14: OH) from headspace samples. We further determined dose response curves for the identified compounds and six other structurally similar compounds that are common to the order Cossidae. Male antennae showed superior sensitivity toward Z9-14: OAc, Z7-tetradecenyl acetate (Z7-14: OAc), E9-tetradecenyl acetate (E9-14:OAc), Z9-tetradecenol (Z9-14: OH) and Z9-tetradecenal (Z9-14:Ald) when compared to female antennae. While we could show electrophysiological responses to single pheromone compounds, behavioral attraction of males was dependent on the synergistic effect of at least two of these compounds. Signal specificity is shown to be gained through pheromone blends. A field trial showed that a significant number of males were caught only in traps baited with a combination of Z9-14: OAc (circa 95% of the ratio) and Z9-14: OH. Addition of 14: OAc to this mixture also improved the number of males caught, although not significantly. This study represents a major step towards developing a useful attractant to be used in management tools for C. tristis and contributes to the understanding of chemical communication and biology of this group of insects.	[Bouwer, Marc Clement] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Chem, ZA-0002 Pretoria, Gauteng, South Africa; [Slippers, Bernard; Degefu, Dawit; Wingfield, Michael John] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, Gauteng, South Africa; [Lawson, Simon] Univ Sunshine Coast, Dept Agr Fisheries & Forestry Ecosci Precinct, Brisbane, Qld 4001, Australia; [Rohwer, Egmont Richard] Univ Pretoria, Ctr Chromatog, Dept Chem, ZA-0002 Pretoria, Gauteng, South Africa	University of Pretoria; University of Pretoria; University of the Sunshine Coast; University of Pretoria	Bouwer, MC (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Chem, ZA-0002 Pretoria, Gauteng, South Africa.	marc.bouwer@fabi.up.ac.za	Wingfield, Michael J/A-9473-2008; Slippers, Bernard/A-9351-2008; Lawson, Simon/L-6095-2019	Slippers, Bernard/0000-0003-1491-3858; Bouwer, Marc/0000-0002-0435-0919	Tree Protection Cooperative Program (TPCP); THRIP initiative of the Department of Trade and Industry; DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB); National Research Foundation [65891]	Tree Protection Cooperative Program (TPCP); THRIP initiative of the Department of Trade and Industry; DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India)); National Research Foundation	Members of the Tree Protection Cooperative Program (TPCP), the THRIP initiative of the Department of Trade and Industry and the DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB) are acknowledged for financial support. Grant 65891, National Research Foundation, http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; CAPIZZI A, 1983, J CHEM ECOL, V9, P191, DOI 10.1007/BF00988036; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Chen X, 2006, J CHEM ECOL, V32, P669, DOI 10.1007/s10886-005-9025-4; Davis Steven R., 2006, Journal of the Lepidopterists' Society, V60, P194; Fang YL, 2005, J CHEM ECOL, V31, P39, DOI 10.1007/s10886-005-0972-6; Fang YL, 2003, ACTA ENTOMOL SINICA, P5; Gebeyehu S, 2005, S AFR J SCI, V101, P26; HANSSON BS, 1989, PHYSIOL ENTOMOL, V14, P147, DOI 10.1111/j.1365-3032.1989.tb00946.x; Hegazi E, 2009, ANN ENTOMOL SOC AM, V102, P809, DOI 10.1603/008.102.0507; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Ma Peter W.K., 2003, P19, DOI 10.1016/B978-012107151-6/50004-9; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; MAYER MS, 1984, J INSECT PHYSIOL, V30, P757, DOI 10.1016/0022-1910(84)90041-6; MAYER MS, 1993, J INSECT PHYSIOL, V39, P401, DOI 10.1016/0022-1910(93)90028-P; Meyer AJ, 1965, THESIS STELLENBOSCH; Petty F., 1917, B DEP AGR, V2; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; SCHNEIDER D, 1957, Z VERGL PHYSIOL, V40, P8, DOI 10.1007/BF00298148; Slone DH, 2007, J CHEM ECOL, V33, P1748, DOI 10.1007/s10886-007-9338-6; Struble D.L., 1984, Springer Series in Experimental Entomology, V1984, P161	21	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118575	10.1371/journal.pone.0118575	http://dx.doi.org/10.1371/journal.pone.0118575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826254	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352084800006
J	Cai, ZQ; Si, SB; Chen, C; Zhao, Y; Ma, YY; Wang, L; Geng, ZM				Cai, Zhi-qiang; Si, Shu-bin; Chen, Chen; Zhao, Yaling; Ma, Yong-yi; Wang, Lin; Geng, Zhi-min			Analysis of Prognostic Factors for Survival after Hepatectomy for Hepatocellular Carcinoma Based on a Bayesian Network	PLOS ONE			English	Article							MANAGEMENT; INVASION; SYSTEM	Background The prognosis of hepatocellular carcinoma (HCC) after hepatectomy involves many factors. Previous studies have evaluated the separate influences of single factors; few have considered the combined influence of various factors. This paper combines the Bayesian network (BN) with importance measures to identify key factors that have significant effects on survival time. Methods A dataset of 299 patients with HCC after hepatectomy was studied to establish a BN using a tree-augmented naive Bayes algorithm that could mine relationships between factors. The composite importance measure was applied to rank the impact of factors on survival time. Results 124 patients (>10 months) and 77 patients (<= 10 months) were correctly classified. The accuracy of BN model was 67.2%. For patients with long survival time (>10 months), the true-positive rate of the model was 83.22% and the false-positive rate was 48.67%. According to the model, the preoperative alpha fetoprotein (AFP) level and postoperative performance of transcatheter arterial chemoembolization (TACE) were independent factors for survival of HCC patients. The grade of preoperative liver function reflected the tendency for postoperative complications. Intraoperative blood loss, tumor size, portal vein tumor thrombosis (PVTT), time of clamping the porta hepatis, tumor number, operative method, and metastasis were dependent variables in survival time prediction. PVTT was considered the most significant for the prognosis of survival time. Conclusions Using the BN and importance measures, PVTT was identified as the most significant predictor of survival time for patients with HCC after hepatectomy.	[Cai, Zhi-qiang; Chen, Chen; Ma, Yong-yi; Wang, Lin; Geng, Zhi-min] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China; [Cai, Zhi-qiang; Si, Shu-bin] Northwestern Polytech Univ, Sch Mech Engn, Dept Ind Engn, Xian 710072, Shaanxi, Peoples R China; [Zhao, Yaling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University; Northwestern Polytechnical University; Xi'an Jiaotong University	Geng, ZM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China.	gengzhimin@mail.xjtu.edu.cn						Aguiar-Pulido V, 2012, MOL BIOSYST, V8, P1716, DOI 10.1039/c2mb25039j; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bellazzi R, 2001, LECT NOTES ARTIF INT, V2101, P40; Birnbaum ZW., 1969, IMPORTANCE DIFFERENT; Borgonovo E, 2007, RELIAB ENG SYST SAFE, V92, P771, DOI 10.1016/j.ress.2006.04.015; Cai ZQ, 2011, EXPERT SYST APPL, V38, P5036, DOI 10.1016/j.eswa.2010.09.146; Chen DC, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P723, DOI 10.1109/ICMLA.2008.40; Chen DC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/632786; Cheng-Mei Chen, 2011, 2011 Seventh International Conference on Natural Computation (ICNC 2011), P811, DOI 10.1109/ICNC.2011.6022187; Cure S, 2012, CURR MED RES OPIN, V28, P1841, DOI 10.1185/03007995.2012.734798; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; FUSSELL JB, 1975, IEEE T RELIAB, V24, P169, DOI 10.1109/TR.1975.5215142; Huang ZY, 2012, ANN SURG ONCOL, V19, P2515, DOI 10.1245/s10434-012-2269-7; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Minagawa M, 2006, WORLD J GASTROENTERO, V12, P7561, DOI 10.3748/wjg.v12.i47.7561; Nouso K, 2008, BRIT J CANCER, V98, P1161, DOI 10.1038/sj.bjc.6604282; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Ramirez-Marquez JE, 2005, IEEE T RELIAB, V54, P517, DOI 10.1109/TR.2005.853444; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Shindoh J, 2013, ANN SURG ONCOL, V20, P1223, DOI 10.1245/s10434-012-2739-y; Si SB, 2011, IN C IND ENG ENG MAN, P1826, DOI 10.1109/IEEM.2011.6118231; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Wan-Ting Hung, 2012, Proceedings of the 2012 Third International Conference on Innovations in Bio-Inspired Computing and Applications (IBICA), P241, DOI 10.1109/IBICA.2012.28; Yi Y, 2013, ANN SURG ONCOL, V20, P267, DOI 10.1245/s10434-012-2487-z	25	25	27	0	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120805	10.1371/journal.pone.0120805	http://dx.doi.org/10.1371/journal.pone.0120805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826337	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800026
J	Gu, ZR; Imai, F; Kim, IJ; Fujita, H; Katayama, KI; Mori, K; Yoshihara, Y; Yoshida, Y				Gu, Zirong; Imai, Fumiyasu; Kim, In Jung; Fujita, Hiroko; Katayama, Kei Ichi; Mori, Kensaku; Yoshihara, Yoshihiro; Yoshida, Yutaka			Expression of the Immunoglobulin Superfamily Cell Adhesion Molecules in the Developing Spinal Cord and Dorsal Root Ganglion	PLOS ONE			English	Article							MOTOR CIRCUITS; CONNECTIVITY; SPECIFICITY; IDENTIFICATION; TRANSMISSION; ORGANIZATION; PROTEINS; NEURONS; MEMBER; AXONS	Cell adhesion molecules belonging to the immunoglobulin superfamily (IgSF) control synaptic specificity through hetero- or homophilic interactions in different regions of the nervous system. In the developing spinal cord, monosynaptic connections of exquisite specificity form between proprioceptive sensory neurons and motor neurons, however, it is not known whether IgSF molecules participate in regulating this process. To determine whether IgSF molecules influence the establishment of synaptic specificity in sensory-motor circuits, we examined the expression of 157 IgSF genes in the developing dorsal root ganglion (DRG) and spinal cord by in situ hybridization assays. We find that many IgSF genes are expressed by sensory and motor neurons in the mouse developing DRG and spinal cord. For instance, Alcam, Mcam, and Ocam are expressed by a subset of motor neurons in the ventral spinal cord. Further analyses show that Ocam is expressed by obturator but not quadriceps motor neurons, suggesting that Ocam may regulate sensory-motor specificity in these sensory- motor reflex arcs. Electrophysiological analysis shows no obvious defects in synaptic specificity of monosynaptic sensory-motor connections involving obturator and quadriceps motor neurons in Ocam mutant mice. Since a subset of Ocam(+) motor neurons also express Alcam, Alcam or other functionally redundant IgSF molecules may compensate for Ocam in controlling sensory-motor specificity. Taken together, these results reveal that IgSF molecules are broadly expressed by sensory and motor neurons during development, and that Ocam and other IgSF molecules may have redundant functions in controlling the specificity of sensory-motor circuits.	[Gu, Zirong; Imai, Fumiyasu; Katayama, Kei Ichi; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Kim, In Jung] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Kim, In Jung] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Fujita, Hiroko; Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Saitama, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan	Cincinnati Children's Hospital Medical Center; Yale University; Yale University; RIKEN; University of Tokyo	Yoshida, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	yutaka.yoshida@cchmc.org	Katayama, Kei-ichi/J-4699-2013; Yoshihara, Yoshihiro/N-6481-2015	Katayama, Kei-ichi/0000-0003-0527-4644; Yoshihara, Yoshihiro/0000-0002-0319-7166; Mori, Kensaku/0000-0001-7853-9370	March of Dimes Foundation [5-FY09-106]; NINDS [NS065048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25115005] Funding Source: KAKEN	March of Dimes Foundation(March of Dimes); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the March of Dimes Foundation (5-FY09-106) and NINDS (NS065048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Brown AG, 1981, ORGANIZATION IN THE; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Fukuhara K, 2013, CELL REP, V5, P748, DOI 10.1016/j.celrep.2013.10.005; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Garcia S, 2007, HUM PATHOL, V38, P830, DOI 10.1016/j.humpath.2006.11.015; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Mears SC, 1997, J NEUROSCI, V17, P3128; MENDELSON B, 1991, J NEUROSCI, V11, P1390; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; Tu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074124; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	40	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121550	10.1371/journal.pone.0121550	http://dx.doi.org/10.1371/journal.pone.0121550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826454	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800047
J	Huang, YW; Chiu, CC; Liang, JD; Chiou, LL; Huang, GT; Yu, MJ; Lee, HS				Huang, Yu-Wen; Chiu, Chien-Chang; Liang, Ja-Der; Chiou, Ling-Ling; Huang, Guan-Tarn; Yu, Ming-Jiun; Lee, Hsuan-Shu			Brain Isoform Glycogen Phosphorylase as a Novel Hepatic Progenitor Cell Marker	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; HEPATOCYTE GROWTH-FACTOR; COLLECTING DUCT CELLS; WB-F344 RAT-LIVER; STEM-LIKE CELLS; OVAL CELLS; ISOZYME PATTERN; DIFFERENTIATION; TISSUES; REGENERATION	An appropriate liver-specific progenitor cell marker is a stepping stone in liver regenerative medicine. Here, we report brain isoform glycogen phosphorylase (GPBB) as a novel liver progenitor cell marker. GPBB was identified in a protein complex precipitated by a monoclonal antibody Ligab generated from a rat liver progenitor cell line Lig-8. Immunoblotting results show that GPBB was expressed in two liver progenitor cell lines Lig-8 and WB-F344. The levels of GPBB expression decreased in the WB-F344 cells under sodium butyrate (SB)-induced cell differentiation, consistent with roles of GPBB as a liver progenitor cell marker. Short hairpin RNA (shRNA)-mediated GPBB knockdown followed by glucose deprivation test shows that GPBB aids in liver progenitor cell survival under low glucose conditions. Furthermore, shRNA-mediated GPBB knockdown followed by SB-induced cell differentiation shows that reducing GPBB expression delayed liver progenitor cell differentiation. We conclude that GPBB is a novel liver progenitor cell marker, which facilitates liver progenitor cell survival under low glucose conditions and cell differentiation.	[Huang, Yu-Wen; Chiu, Chien-Chang; Lee, Hsuan-Shu] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Huang, Yu-Wen] Minist Hlth & Welf, Div Med Devices & Cosmet, Food & Drug Adm, Taipei, Taiwan; [Liang, Ja-Der; Huang, Guan-Tarn; Lee, Hsuan-Shu] Natl Taiwan Univ, Dept Internal Med, Taipei, Taiwan; [Chiou, Ling-Ling] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Yu, Ming-Jiun] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Lee, Hsuan-Shu] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Yu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan.	mjyu@ntu.edu.tw; benlee@ntu.edu.tw		LEE, HSUAN-SHU/0000-0002-8017-0434; YU, MING-JIUN/0000-0003-0393-4696; Huang, Guan-Tarn/0000-0001-7004-826X; LIANG, JA-DER/0000-0002-4532-0118	National Science Council of Taiwan [NSC 102-2313-B-002-014]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant number of NSC 102-2313-B-002-014 from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2011, GUT LIVER, V5, P367, DOI 10.5009/gnl.2011.5.3.367; Best DH, 2010, EXP MOL PATHOL, V89, P92, DOI 10.1016/j.yexmp.2010.06.007; Chiu CC, 2009, HYBRIDOMA, V28, P435, DOI 10.1089/hyb.2009.0051; Chiu CC, 2009, HISTOCHEM CELL BIOL, V132, P479, DOI 10.1007/s00418-009-0634-9; COLEMAN WB, 1993, AM J PATHOL, V142, P1373; Coleman WB, 1997, AM J PATHOL, V151, P353; COLEMAN WB, 1994, J CELL PHYSIOL, V161, P463, DOI 10.1002/jcp.1041610309; Darwiche H, 2011, HEPATIC MED-EVID RES, V3, P89, DOI 10.2147/HMER.S12368; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; Kadyk LC, 2015, STEM CELL TRANSL MED, V4, P207, DOI 10.5966/sctm.2014-0276; KASSNER G, 1987, BIOMED BIOCHIM ACTA, V46, P357; KOST DP, 1991, J CELL PHYSIOL, V147, P274, DOI 10.1002/jcp.1041470212; Lee HS, 2003, BIOTECHNOL BIOENG, V83, P760, DOI 10.1002/bit.10727; Lee HS, 2003, J BIOMED SCI, V10, P757, DOI 10.1159/000073963; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149; Muller-Borer BJ, 2004, AM J PATHOL, V165, P135, DOI 10.1016/S0002-9440(10)63282-8; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Ogden GR, 1996, BRIT J ORAL MAX SURG, V34, P461, DOI 10.1016/S0266-4356(96)90109-6; Ott M, 1999, J PATHOL, V187, P365, DOI 10.1002/(SICI)1096-9896(199902)187:3<365::AID-PATH237>3.0.CO;2-Z; PFEIFFER B, 1995, HISTOCHEM CELL BIOL, V103, P69, DOI 10.1007/BF01464477; Pfeiffer-Guglielmi B, 2007, BRAIN RES, V1136, P20, DOI 10.1016/j.brainres.2006.12.037; Poulsen RC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.52; RICHTER F, 1983, BIOMED BIOCHIM ACTA, V42, P1229; RICHTER F, 1988, BIOMED BIOCHIM ACTA, V47, P743; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; SATO K, 1976, CANCER RES, V36, P487; Stolzing A, 2006, REJUV RES, V9, P31, DOI 10.1089/rej.2006.9.31; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200	34	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122528	10.1371/journal.pone.0122528	http://dx.doi.org/10.1371/journal.pone.0122528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826279	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800078
J	Katono, K; Sato, Y; Jiang, SX; Kobayashi, M; Nagashio, R; Ryuge, S; Fukuda, E; Goshima, N; Satoh, Y; Saegusa, M; Masuda, N				Katono, Ken; Sato, Yuichi; Jiang, Shi-Xu; Kobayashi, Makoto; Nagashio, Ryo; Ryuge, Shinichiro; Fukuda, Eriko; Goshima, Naoki; Satoh, Yukitoshi; Saegusa, Makoto; Masuda, Noriyuki			Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NONMUSCLE MYOSIN-II; POOR-PROGNOSIS; TUMORS; STAGE; CYTOKINESIS; METASTASIS; MIGRATION; CHEMORESISTANCE; PREDICTOR; INVASION	Introduction Myosin-9 (MYH9) belongs to the myosin superfamily of actin-binding motor protein. Recently, MYH9 has been thought to be associated with cancer cell migration, invasion, and metastasis. The aims of this study were to immunohistochemically examine MYH9 expression in surgically resected non-small cell lung cancer (NSCLC), and evaluate its correlations with clinicopathological parameters and the prognosis of patients. Methods MYH9 expression was immunohistochemically studied in 266 consecutive resected NSCLCs, and its associations with clinicopathological parameters were evaluated. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of MYH9 expression on survival. Results MYH9 expression was detected in 102 of 266 (38.3%) NSCLCs. MYH9 expression was significantly correlated with the adenocarcinoma histology (P = 0.014), poorer differentiation ((P = 0.033), intratumoral vascular invasion and lymphatic invasion ((P = 0.013 and P = 0.045 respectively), and a poorer prognosis ((P = 0.032). In addition, multivariable analysis revealed that MYH9 expression independently predicted a poorer survival (HR, 2.15; 95% CI, 1.17-3.92; (P = 0.01). Conclusion The present study revealed that MYH9 is expressed in a subset of NSCLC with a more malignant nature, and its expression is an indicator of a poorer survival probability.	[Katono, Ken; Ryuge, Shinichiro; Masuda, Noriyuki] Kitasato Univ, Sch Med, Dept Resp Med, Shiroganedai, Kanagawa, Japan; [Sato, Yuichi; Kobayashi, Makoto; Nagashio, Ryo] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan; [Jiang, Shi-Xu; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Shiroganedai, Kanagawa, Japan; [Fukuda, Eriko; Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Div Quantitat Prote Team, Tokyo, Japan; [Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University; National Institute of Advanced Industrial Science & Technology (AIST); Kitasato University	Sato, Y (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan.	yuichi@med.kitasato-u.ac.jp	Fukuda, Eriko/M-2854-2018	Fukuda, Eriko/0000-0003-3086-3707; Kobayashi, Makoto/0000-0001-7176-7207				Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Derycke L, 2011, INT J DEV BIOL, V55, P835, DOI 10.1387/ijdb.113336ld; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang SX, 2004, MODERN PATHOL, V17, P222, DOI 10.1038/modpathol.3800038; Kageyama T, 2011, ASIAN PAC J CANCER P, V12, P3457; Kivela A, 2000, AM J PATHOL, V156, P577, DOI 10.1016/S0002-9440(10)64762-1; Liu DN, 2012, INT J MOL SCI, V13, P15291, DOI 10.3390/ijms131115291; Maeda J, 2008, BRIT J CANCER, V98, P596, DOI 10.1038/sj.bjc.6604197; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; SATO Y, 1986, AM J PATHOL, V125, P431; Travis W, 2004, WHO CLASSIFICATION T; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wei Y, 2009, CELL CYCLE, V8, P2132; Xia ZK, 2012, DIS ESOPHAGUS, V25, P427, DOI 10.1111/j.1442-2050.2011.01261.x; Xiong D, 2012, ONCOL REP, V28, P1625, DOI 10.3892/or.2012.1965; Xu J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-200; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	28	36	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121460	10.1371/journal.pone.0121460	http://dx.doi.org/10.1371/journal.pone.0121460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826333	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800044
J	Zaidi, AH; Saldin, LT; Kelly, LA; Bergal, L; Londono, R; Kosovec, JE; Komatsu, Y; Kasi, PM; Shetty, AA; Keane, TJ; Thakkar, SJ; Huleihel, L; Landreneau, RJ; Badylak, SF; Jobe, BA				Zaidi, Ali H.; Saldin, Lindsey T.; Kelly, Lori A.; Bergal, Linda; Londono, Ricardo; Kosovec, Juliann E.; Komatsu, Yoshihiro; Kasi, Pashtoon M.; Shetty, Amit A.; Keane, Timothy J.; Thakkar, Shyam J.; Huleihel, Luai; Landreneau, Rodney J.; Badylak, Stephen F.; Jobe, Blair A.			MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BARRETTS-ESOPHAGUS; BREAST-CANCER; EXPRESSION; REFLUX; INVASION; INFLAMMATION; ACTIVATION; PREVENTION; METAPLASIA	Objective To establish a miRNA signature for metastasis in an animal model of esophageal adenocarcinoma (EAC). Background The incidence of esophageal adenocarcinoma (EAC) has dramatically increased and esophageal cancer is now the sixth leading cause of cancer deaths worldwide. Mortality rates remain high among patients with advanced stage disease and esophagectomy is associated with high complication rates. Hence, early identification of potentially metastatic disease would better guide treatment strategies. Methods The modified Levrat's surgery was performed to induce EAC in Sprague-Dawley rats. Primary EAC and distant metastatic sites were confirmed via histology and immunofluorescence. miRNA profiling was performed on primary tumors with or without metastasis. A unique subset of miRNAs expressed in primary tumors and metastases was identified with Ingenuity Pathway Analysis (IPA) along with upstream and downstream targets. miRNA-linked gene expression analysis was performed on a secondary cohort of metastasis positive (n= 5) and metastasis negative (n= 28) primary tumors. Results The epithelial origin of distant metastasis was established by IF using villin (VIL1) and mucin 5AC (MUC5AC) antibodies. miRNome analysis identified four down-regulated miRNAs in metastasis positive primary tumors compared to metastasis negative tumors: miR-92a-3p (p= 0.0001), miR-141-3p (p= 0.0022), miR-451-1a (p= 0.0181) and miR133a-3p (p= 0.0304). Six target genes identified in the top scoring networks by IPA were validated as significantly, differentially expressed in metastasis positive primary tumors: Ago2, Akt1, Kras, Bcl2L11, CDKN1B and Zeb2. Conclusion In vivo metastasis was confirmed in the modified Levrat's model. Analysis of the primary tumor identified a distinctive miRNA signature for primary tumors that metastasized.	[Zaidi, Ali H.; Kelly, Lori A.; Bergal, Linda; Kosovec, Juliann E.; Komatsu, Yoshihiro; Shetty, Amit A.; Landreneau, Rodney J.; Jobe, Blair A.] Allegheny Hlth Network, Esophageal & Lung Inst, Pittsburgh, PA 15212 USA; [Saldin, Lindsey T.; Londono, Ricardo; Keane, Timothy J.; Huleihel, Luai; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kasi, Pashtoon M.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Thakkar, Shyam J.] Allegheny Hlth Network, Div Gastroenterol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jobe, BA (corresponding author), Allegheny Hlth Network, Esophageal & Lung Inst, Pittsburgh, PA 15212 USA.	bjobe1@wpahs.org	Kasi, Pashtoon Murtaza/M-2569-2019	Kasi, Pashtoon Murtaza/0000-0002-5169-7085; Keane, Timothy/0000-0002-7975-0538; Badylak, Stephen/0000-0003-3555-0689	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER; NIBIB NIH HHS [T32 EB001026] Funding Source: Medline; NIGMS NIH HHS [T32 GM008208] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTWOOD SEA, 1992, SURGERY, V111, P503; Blandino G, 2014, FEBS LETT; Blecker D, 1999, AM J GASTROENTEROL, V94, P3427, DOI 10.1111/j.1572-0241.1999.01604.x; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen ZL, 2014, CANCER LETT, V350, P34, DOI 10.1016/j.canlet.2014.04.013; Chen Z, 2013, CANCER-AM CANCER SOC, V119, P1985, DOI 10.1002/cncr.28002; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dubecz A, 2013, J GASTROINTEST SURG; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Fu CR, 2014, BIOCHEM BIOPH RES CO, V446, P1197, DOI 10.1016/j.bbrc.2014.03.087; Gibson MK, 2013, ANN SURG, V258, P82, DOI 10.1097/SLA.0b013e318270500d; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hong L, 2014, EXPERT OPIN BIOL TH, V14, P483, DOI 10.1517/14712598.2014.882896; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Jeffrey SS, 2008, NAT BIOTECHNOL, V26, P400, DOI 10.1038/nbt0408-400; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Keeley SB, 2007, ANN SURG ONCOL, V14, P2406, DOI 10.1245/s10434-007-9392-x; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; King TJ, 2005, ONCOGENE, V24, P1718, DOI 10.1038/sj.onc.1208355; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li SQ, 2014, MOL MED REPROTS; Lin ML, 2014, MOL CARCINOGEN, V53, P360, DOI 10.1002/mc.21984; Liu YQ, 2014, J BIOL CHEM, V289, P4116, DOI 10.1074/jbc.M113.533505; Luketich JD, 1999, ANN THORAC SURG, V68, P1133; Mariette C, 2011, LANCET ONCOL, V12, P296, DOI 10.1016/S1470-2045(10)70125-X; Matsuda Y, 2006, MED MOL MORPHOL, V39, P169, DOI 10.1007/s00795-006-0339-2; Miyashita T, 2013, DIGESTION, V87, P6, DOI 10.1159/000343896; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pacurari M, 2013, INT J ONCOL, V43, P548, DOI 10.3892/ijo.2013.1963; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pera M, 2000, CARCINOGENESIS, V21, P1587, DOI 10.1093/carcin/21.8.1587; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Raggi M, 2010, LANGENBECK ARCH SURG, V395, P347, DOI 10.1007/s00423-010-0607-4; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Redova M, 2011, BIOCHEM BIOPH RES CO, V405, P153, DOI 10.1016/j.bbrc.2011.01.019; Rubenstein JH, 2014, GASTROENTEROL CLIN N, V43, P1, DOI 10.1016/j.gtc.2013.11.006; Shaheen NJ, 2005, GASTROENTEROLOGY, V128, P1554, DOI 10.1053/j.gastro.2005.03.032; Shang QJ, 2012, MOL MED REP, V5, P1401, DOI 10.3892/mmr.2012.844; Sharma VK, 2007, GASTROINTEST ENDOSC, V65, P185, DOI 10.1016/j.gie.2006.09.033; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sui GP, 2006, J SURG RES, V134, P1, DOI 10.1016/j.jss.2005.12.029; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Yoo NJ, 2010, APMIS, V118, P271, DOI 10.1111/j.1600-0463.2010.02588.x; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531	53	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122375	10.1371/journal.pone.0122375	http://dx.doi.org/10.1371/journal.pone.0122375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826212	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800068
J	Davis, KE; Eleftheriou, CG; Allen, AE; Procyk, CA; Lucas, RJ				Davis, Katherine E.; Eleftheriou, Cyril G.; Allen, Annette E.; Procyk, Christopher A.; Lucas, Robert J.			Melanopsin-Derived Visual Responses under Light Adapted Conditions in the Mouse dLGN	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CIRCADIAN CLOCK; MICE; VISION; CONE; ADAPTATION; ROD; PHOTORECEPTORS; DISCRIMINATION; PHOTOPIGMENT	A direct projection from melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs) reaches the primary visual thalamus (dorsal lateral geniculate nucleus; dLGN). The significance of this melanopsin input to the visual system is only recently being investigated. One unresolved question is the degree to which neurons in the dLGN could use melanopsin to track dynamic changes in light intensity under light adapted conditions. Here we set out to address this question. We were able to present full field steps visible only to melanopsin by switching between rod-isoluminant 'yellow' and 'blue' lights in a mouse lacking cone function (Cnga3(-/-)). In the retina these stimuli elicited melanopsin-like responses from a subset of ganglion cells. When presented to anaesthetised mice, we found that similar to 25-30% of visually responsive neurones in the contralateral dLGN responded to these melanopsin-isolating steps with small increases in firing rate. Such responses could be elicited even with fairly modest increases in effective irradiance (32% Michelson contrast for melanopsin). These melanopsin-driven responses were apparent at bright backgrounds (corresponding to twilight-daylight conditions), but their threshold irradiance was strongly dependent upon prior light exposure when stimuli were superimposed on a spectrally neutral ramping background light. While both onset and offset latencies were long for melanopsin-derived responses compared to those evoked by rods, there was great variability in these parameters with some cells responding to melanopsin steps in <1 s. These data indicate that a subset of dLGN units can employ melanopsin signals to detect modest changes in irradiance under photopic conditions.	[Davis, Katherine E.; Eleftheriou, Cyril G.; Allen, Annette E.; Procyk, Christopher A.; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Davis, KE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Katherine.davis-2@manchester.ac.uk; Robert.Lucas@manchester.ac.uk	Procyk, Christopher Anthony/ABB-3253-2021	Procyk, Christopher Anthony/0000-0002-6754-4665; Allen, Annette/0000-0003-0214-7076; Eleftheriou, Cyril/0000-0002-5931-996X	European Research Council; BBSRC [BB/1007296/1]	European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council (Grant MeloVision) and BBSRC (BB/1007296/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2014, CURR BIOL, V24, P2481, DOI 10.1016/j.cub.2014.09.015; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brown TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053583; Brown TM, 2012, CURR BIOL, V22, P1134, DOI 10.1016/j.cub.2012.04.039; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davis KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091203; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Jacobs GH, 2007, DOC OPHTHALMOL, V115, P137, DOI 10.1007/s10633-007-9055-z; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Lucas RJ, 2012, PROG BRAIN RES, V199, P1, DOI 10.1016/B978-0-444-59427-3.00001-0; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Paxinos G, 2004, THE MOUSE BRAIN IN S; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Renna JM, 2011, NAT NEUROSCI, V14, P827, DOI 10.1038/nn.2845; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Townsend G, 2002, BRAIN RES PROTOC, V9, P122, DOI 10.1016/S1385-299X(02)00139-3; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zhao XW, 2014, J PHYSIOL-LONDON, V592, P1619, DOI 10.1113/jphysiol.2013.262782	39	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123424	10.1371/journal.pone.0123424	http://dx.doi.org/10.1371/journal.pone.0123424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822371	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700225
J	Hayashi, M; Fukuhara, H; Inoue, K; Shuin, T; Hagiya, Y; Nakajima, M; Tanaka, T; Ogura, S				Hayashi, Maiko; Fukuhara, Hideo; Inoue, Keiji; Shuin, Taro; Hagiya, Yuichiro; Nakajima, Motowo; Tanaka, Tohru; Ogura, Shun-ichiro			The Effect of Iron Ion on the Specificity of Photodynamic Therapy with 5-Aminolevulinic Acid	PLOS ONE			English	Article							ABC TRANSPORTER ABCG2; PROTOPORPHYRIN-IX; (ALA)-INDUCED PHOTOSENSITIVITY; MITOCHONDRIAL IRON; ACCUMULATION; CANCER; ALA; ROLES; CELLS; FERROCHELATASE	Recently, photodynamic therapy using 5-aminolevulinic acid (ALA-PDT) has been widely used in cancer therapy. ALA administration results in tumor-selective accumulation of the photosensitizer protoporphyrin IX (PpIX) via the heme biosynthetic pathway. Although ALA-PDT has selectivity for tumor cells, PpIX is accumulated into cultured normal cells to a small extent, causing side effects. The mechanism of tumor-selective PpIX accumulation is not well understood. The purpose of the present study was to identify the mechanism of tumor-selective PpIX accumulation after ALA administration. We focused on mitochondrial labile iron ion, which is the substrate for metabolism of PpIX to heme. We investigated differences in iron metabolism between tumor cells and normal cells and found that the amount of mitochondrial labile iron ion in cancer was lower than that in normal cells. This finding could be because of the lower expression of mitoferrins, which are the mitochondrial iron transporters. Accordingly, we added sodium ferrous citrate (SFC) with ALA as a source of iron. As a result, we observed the accumulation of PpIX only in tumor cells, and only these cells showed sensitivity to ALA-PDT. Taken together, these results suggest that the uptake abilities of iron ion into mitochondria play a key role in tumor-selective PpIX accumulation. Using SFC as a source of iron might thus increase the specificity of ALA-PDT effects.	[Hayashi, Maiko; Hagiya, Yuichiro; Ogura, Shun-ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Fukuhara, Hideo; Inoue, Keiji; Shuin, Taro] Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan; [Nakajima, Motowo; Tanaka, Tohru] SBI Pharma CO LTD, Minato Ku, Tokyo 1066020, Japan	Tokyo Institute of Technology; Kochi University; SBI Pharmaceuticals	Ogura, S (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B47 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	sogura@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26430141, 26462414]; SBI Pharma CO., LTD.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SBI Pharma CO., LTD.	The studies in the authors' laboratories were supported by the Grant-in-Aid for Scientific Research (C) (No. 26430141 and No. 26462414) from the Ministry of Education, Culture, Sports, Science and Technology. SBI Pharma CO., LTD., provided support in the form of salaries for authors MN and TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Berg K, 1996, BRIT J CANCER, V74, P688, DOI 10.1038/bjc.1996.423; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Choudry K, 2003, BRIT J DERMATOL, V149, P124, DOI 10.1046/j.1365-2133.2003.05351.x; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Inoue K, 2013, PHOTODIAGN PHOTODYN, V10, P484, DOI 10.1016/j.pdpdt.2013.05.002; Ishizuka M, 2011, PHOTODIAGN PHOTODYN, V8, P328, DOI 10.1016/j.pdpdt.2011.04.004; KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9; KRAMMER B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI DOI 10.1039/B712847A; Mrozek-Wilczkiewicz A, 2014, ACS MED CHEM LETT, V5, P336, DOI 10.1021/ml400422a; Ohgari Y, 2005, BIOCHEM PHARMACOL, V71, P42, DOI 10.1016/j.bcp.2005.10.019; Ohgari Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P1138, DOI 10.1111/j.1751-1097.2011.00950.x; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Sawamoto M, 2013, PHOTOCHEM PHOTOBIOL, V89, P163, DOI 10.1111/j.1751-1097.2012.01215.x; Serda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110291; Tran TT, 2014, PHOTOCHEM PHOTOBIOL, V90, P1136, DOI 10.1111/php.12290; Tamura A, 2007, DRUG METAB PHARMACOK, V22, P428, DOI 10.2133/dmpk.22.428; Yamamoto F, 2007, BIOCHEM BIOPH RES CO, V353, P541, DOI 10.1016/j.bbrc.2006.12.007; Yamashita K, 2014, FEBS OPEN BIO, V4, P347, DOI 10.1016/j.fob.2014.03.010; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	24	22	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122351	10.1371/journal.pone.0122351	http://dx.doi.org/10.1371/journal.pone.0122351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822972	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700169
J	Pieters, BCH; Arntz, OJ; Bennink, MB; Broeren, MGA; van Caam, APM; Koenders, MI; van Lent, PLEM; van den Berg, WB; de Vries, M; van der Kraan, PM; van de Loo, FAJ				Pieters, Bartijn C. H.; Arntz, Onno J.; Bennink, Miranda B.; Broeren, Mathijs G. A.; van Caam, Arjan P. M.; Koenders, Marije I.; van Lent, Peter L. E. M.; van den Berg, Wim B.; de Vries, Marieke; van der Kraan, Peter M.; van de Loo, Fons A. J.			Commercial Cow Milk Contains Physically Stable Extracellular Vesicles Expressing Immunoregulatory TGF-beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-DERIVED EXOSOMES; BREAST-MILK; T-CELLS; NEUTROPHIL RECRUITMENT; MEDIATED TRANSFER; INTERLEUKIN-17; MICRORNAS; DISEASE; RNA	Scope Extracellular vesicles, including exosomes, have been identified in all biological fluids and rediscovered as an important part of the intercellular communication. Breast milk also contains extracellular vesicles and the proposed biological function is to enhance the antimicrobial defense in newborns. It is, however, unknown whether extracellular vesicles are still present in commercial milk and, more importantly, whether they retained their bioactivity. Here, we characterize the extracellular vesicles present in semi-skimmed cow milk available for consumers and study their effect on T cells. Methods and Results Extracellular vesicles from commercial milk were isolated and characterized. Milk-derived extracellular vesicles contained several immunomodulating miRNAs and membrane protein CD63, characteristics of exosomes. In contrast to RAW 267.4 derived extracellular vesicles the milk-derived extracellular vesicles were extremely stable under degrading conditions, including low pH, boiling and freezing. Milk-derived extracellular vesicles were easily taken up by murine macrophages in vitro. Furthermore, we found that they can facilitate T cell differentiation towards the pathogenic Th17 lineage. Using a (CAGA) 12-luc reporter assay we showed that these extracellular vesicles carried bioactive TGF-beta, and that anti-TGF-beta antibodies blocked Th17 differentiation. Conclusion Our findings show that commercial milk contains stable extracellular vesicles, including exosomes, and carry immunoregulatory cargo. These data suggest that the extracellular vesicles present in commercial cow milk remains intact in the gastrointestinal tract and exert an immunoregulatory effect.	[Pieters, Bartijn C. H.; Arntz, Onno J.; Bennink, Miranda B.; Broeren, Mathijs G. A.; van Caam, Arjan P. M.; Koenders, Marije I.; van Lent, Peter L. E. M.; van den Berg, Wim B.; de Vries, Marieke; van der Kraan, Peter M.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Med Ctr, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van de Loo, FAJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands.	Fons.vandeLoo@radboudumc.nl	van den Berg, W.B./H-8010-2014; Broeren, Mathijs/P-8612-2015; Arntz, Onno J/A-2354-2016; de Vries, Marieke/P-6000-2015; van de Loo, Fons AJ/A-3425-2014; Pieters, Bartijn CH/T-1996-2018; van Caam, Arjan P.M./E-2235-2016; van der Kraan, Peter M/D-9115-2011; Koenders, Marije I/A-1341-2012; van Lent, Peter/A-4047-2014	Arntz, Onno J/0000-0001-7064-6067; van de Loo, Fons AJ/0000-0002-5851-099X; van Caam, Arjan P.M./0000-0001-5473-4884; Koenders, Marije I/0000-0001-5845-8362; Broeren, Mathijs/0000-0002-0749-1063	Dutch Arthritis Association [RF 12-2-201, RF 11-1-49]; Netherlands Organization for Health Research and Development (ZonMw) [114021001]; Innovative Medicines Initiative Joint Undertaking, project BeTheCure [115142-2]	Dutch Arthritis Association; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Innovative Medicines Initiative Joint Undertaking, project BeTheCure	This work was supported by Dutch Arthritis Association (RF 12-2-201 and RF 11-1-49), FAJL (http://www.reumafonds.nl/); Netherlands Organization for Health Research and Development (ZonMw, project no. 114021001), MV (http://www.zonmw.nl/en/); and Innovative Medicines Initiative Joint Undertaking, project BeTheCure (no. 115142-2), MIK (http://www.imi.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Donnet-Hughes A, 2000, IMMUNOL CELL BIOL, V78, P74, DOI 10.1046/j.1440-1711.2000.00882.x; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Field CJ, 2005, J NUTR, V135, P1; Freitas A, 2009, CRITICAL CARE, V13, P8; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Jorgensen M, 2013, J EXTRACELL VESICLES, V18, P2, DOI DOI 10.3402/JEV.V2I0.20920; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Melnik BC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-103; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nakamura Y, 2009, J NUTR, V139, P1463, DOI 10.3945/jn.109.108761; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Ogawa J, 2004, EARLY HUM DEV, V77, P67, DOI 10.1016/j.earlhumdev.2004.01.005; Orlov SN, 2005, CELL CALCIUM, V38, P53, DOI 10.1016/j.ceca.2005.03.006; Ozawa T, 2009, J NUTR, V139, P69, DOI 10.3945/jn.108.092528; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Penttila IA, 2010, J PEDIATR-US, V156, pS21, DOI 10.1016/j.jpeds.2009.11.016; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rogers ML, 1996, J ENDOCRINOL, V151, P77, DOI 10.1677/joe.0.1510077; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skogberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067554; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C., 2011, F1000 BIOL REPORTS, V3; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	58	124	128	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121123	10.1371/journal.pone.0121123	http://dx.doi.org/10.1371/journal.pone.0121123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822997	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700091
J	Shi, ZH; Zhang, C; Xu, XF; Zhu, J; Zhou, Q; Ma, LJ; Niu, J; Yang, ZN				Shi, Zhi-Hao; Zhang, Cheng; Xu, Xiao-Feng; Zhu, Jun; Zhou, Que; Ma, Li-Juan; Niu, Jin; Yang, Zhong-Nan			Overexpression of AtTTP Affects ARF17 Expression and Leads to Male Sterility in Arabidopsis	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; PATTERN-FORMATION; SEED-GERMINATION; WALL FORMATION; POLLEN; MICRORNA; GENE; CALLOSE; KINASE; RNA	Callose synthesis is critical for the formation of the pollen wall pattern. CalS5 is thought to be the major synthethase for the callose wall. In the Arabidopsis anther, ARF17 regulates the expression of CalS5 and is the target of miR160. Plants expressing miR160-resistant ARF17 (35S:5mARF17 lines) with increased ARF17 mRNA levels display male sterility. Here we report a zinc finger family gene, AtTTP, which is involved in miR160 maturation and callose synthesis in Arabidopsis. AtTTP is expressed in microsporocytes, tetrads and tapetal cells in the anther. Over-expression lines of AtTTP (AtTTP-OE line) exhibited reduced male fertility. CalS5 expression was tremendously reduced and the tetrad callose wall became much thinner in the AtTTP-OE line. Northern blotting hybridization and quantitative RT-PCR analysis revealed that miR160 was decreased, while the expression of ARF17 was increased in the AtTTP-OE line. Based on these results, we propose that AtTTP associates with miR160 in order to regulate the ARF17 expression needed for callose synthesis and pollen wall formation.	[Shi, Zhi-Hao; Zhang, Cheng; Xu, Xiao-Feng; Zhu, Jun; Zhou, Que; Ma, Li-Juan; Niu, Jin; Yang, Zhong-Nan] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	Shanghai Normal University	Yang, ZN (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China.	znyang@shnu.edu.cn	Yang, Zhong-nan/O-2025-2019; Yang, Zhong-Nan/F-5570-2012	Yang, Zhong-nan/0000-0002-5918-2385; Yang, Zhong-Nan/0000-0002-5918-2385; Xu, Xiaofeng/0000-0002-5718-8927	National Science Foundation of China [30925007]; Shanghai Municipal Education Commission [12YZ087, J50401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from the National Science Foundation of China (30925007) and Shanghai Municipal Education Commission (12YZ087, J50401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Borges F, 2011, J EXP BOT, V62, P1611, DOI 10.1093/jxb/erq452; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Chang HS, 2012, PLANT PHYSIOL, V158, P264, DOI 10.1104/pp.111.184853; DICKINSON HG, 1968, NATURE, V220, P926, DOI 10.1038/220926a0; Dong XY, 2005, PLANT J, V42, P315, DOI 10.1111/j.1365-313X.2005.02379.x; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Grant-Downton R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-643; Heslop-Harrison J, 1971, Symp Soc Exp Biol, V25, P277; HESLOPHARRISON J, 1968, NATURE, V220, P605, DOI 10.1038/220605a0; HESLOPHARRISON J, 1968, SCIENCE, V161, P230, DOI 10.1126/science.161.3838.230; HIRD DL, 1993, PLANT J, V4, P1023, DOI 10.1046/j.1365-313X.1993.04061023.x; Huang XY, 2013, PLANT CELL, V25, P637, DOI 10.1105/tpc.112.107896; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim DH, 2008, PLANT CELL, V20, P1260, DOI 10.1105/tpc.108.058859; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Lu PL, 2014, PLANT PHYSIOL, V164, P1893, DOI 10.1104/pp.113.233387; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Nishikawa SI, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-22; OWEN HA, 1995, PROTOPLASMA, V185, P7, DOI 10.1007/BF01272749; Park JI, 2010, PLANT CELL PHYSIOL, V51, P981, DOI 10.1093/pcp/pcq057; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Pomeranz M, 2010, PLANT SIGNAL BEHAV, V5, P190, DOI 10.4161/psb.5.2.10988; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003521; WATERKEYN L, 1970, Grana, V10, P13; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xu J, 2011, CURR OPIN PLANT BIOL, V14, P88, DOI 10.1016/j.pbi.2010.10.003; Yang J, 2013, PLANT PHYSIOL, V162, P720, DOI 10.1104/pp.113.214940; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Zhang CH, 2002, PROTOPLASMA, V219, P59, DOI 10.1007/s007090200006; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu J, 2011, J INTEGR PLANT BIOL, V53, P892, DOI 10.1111/j.1744-7909.2011.01078.x; Zinkl GM, 1999, DEVELOPMENT, V126, P5431	54	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117317	10.1371/journal.pone.0117317	http://dx.doi.org/10.1371/journal.pone.0117317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822980	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700011
J	Tsao, CW; Liu, CY; Chou, YC; Cha, TL; Chen, SC; Hsu, CY				Tsao, Chih-Wei; Liu, Chin-Yu; Chou, Yu-Ching; Cha, Tai-Lung; Chen, Shih-Chang; Hsu, Chien-Yeh			Exploration of the Association between Obesity and Semen Quality in a 7630 Male Population	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; REPRODUCTIVE HORMONES; WAIST CIRCUMFERENCE; IMPACT; MEN; INFERTILITY; INTEGRITY; BMI	This study aimed to explore the association between body mass index (BMI), other anthropometric indexes and semen quality in a general male population in Taiwan. In this cross-sectional cohort study, the study cohort consisted of 7941 healthy male individuals aged 18 years or older who participated in a standard medical screening program run by a private firm from January 2008 to May 2013. Semen parameters including sperm concentration (SC), total sperm motility (TSM), progressive motility (PRM), and normal sperm morphology (NSM) were recorded. Anthropometric indexes including BMI, waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and body fat percentage were measured. A total of 7630 men were enrolled for the final analysis, of whom 68.5% had a normal weight distribution and 31.4% were overweight or obese. Total sperm motility, progressive motility, normal sperm morphology and sperm concentration showed a statistically linear decline with increasing age (p < 0.001, p < 0.001, p < 0.001 and p = 0.004). Sperm concentration showed a significantly negatively linear association with BMI (p = 0.005), and normal sperm morphology showed an inverse association with BMI and waist-to-height ratio (p < 0.001 and p = 0.004). The prevalence of abnormal total sperm motility, progressive motility, normal sperm morphology and sperm concentration increased with increasing age (p = 0.011, p < 0.001, p < 0.001 and p = 0.002). Lower normal sperm morphology and sperm concentration were associated with increasing body adiposity (p< 0.05). No relationship between obesity and sperm motility was identified.	[Tsao, Chih-Wei; Cha, Tai-Lung] Triserv Gen Hosp, Div Urol, Dept Surg, Natl Def Med Ctr, Taipei, Taiwan; [Liu, Chin-Yu] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Shih-Chang] Natl Taiwan Univ Sci & Technol, Grad Inst Patent, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, Master Program Global Hlth & Dev, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Fu Jen Catholic University; National Defense Medical Center; National Taiwan University of Science & Technology; Taipei Medical University	Hsu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan.	weisurger228@yahoo.com.tw		Tsao, Chih-Wei/0000-0001-7214-8766				Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Belloc Stephanie, 2014, HIGH BODY MASS INDEX; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Colaci DS, 2012, FERTIL STERIL, V98, P1193, DOI 10.1016/j.fertnstert.2012.07.1102; Collodel G, 2010, J ANDROL, V31, P108, DOI 10.2164/jandrol.109.007773; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Duale N, 2014, ANDROLOGY-US, V2, P234, DOI 10.1111/j.2047-2927.2013.00178.x; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Hakonsen LB, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-24; Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Kuhnert B, 2004, HUM REPROD UPDATE, V10, P327, DOI 10.1093/humupd/dmh030; MacDonald AA, 2013, HUM REPROD, V28, P3178, DOI 10.1093/humrep/det379; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; MENKVELD R, 1990, HUM REPROD, V5, P586, DOI 10.1093/oxfordjournals.humrep.a137150; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1400, DOI 10.1016/j.fertnstert.2012.07.1146; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Shao J, 2010, J NUTR HEALTH AGING, V14, P782, DOI 10.1007/s12603-010-0106-x; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Zhang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070893	35	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119458	10.1371/journal.pone.0119458	http://dx.doi.org/10.1371/journal.pone.0119458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822490	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700036
J	Xu, J; Wu, B; Wang, JH; Huang, L; Wang, DY; Zhao, L; Zhao, GP; Wang, Y				Xu, Jie; Wu, Biao; Wang, Jing-Hui; Huang, Ling; Wang, Deng-yu; Zhao, Ling; Zhao, Guo-ping; Wang, Ying			Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B	PLOS ONE			English	Article							LAMIVUDINE-RESISTANCE; GENOTYPIC RESISTANCE; REPLICATION CAPACITY; ADEFOVIR DIPIVOXIL; HBV POLYMERASE; E-ANTIGEN; ADD-ON; THERAPY; INFECTION; MUTANTS	High rate of viral replication and lacking of proofreading activity in hepatitis B virus (HBV) polymerase lead to the generation of mutations in HBV virus. Mutations in the reverse transcriptase (RT) region of HBV polymerase are demonstrated to be strongly associated with drug resistance during antiviral treatment. However, the presence of mutations as well as its clinical significance in treatment-naive hepatitis patients (defined as pre-existing mutations) need to be further investigated. In the present study, a total of 168 serum samples from treatment-naive chronic hepatitis B (CHB) patients were collected, and the RT region of HBV polymerase was sequenced. The results showed that pre-existing mutations in the RT region of HBV polymerase were detected in 43 of 168 (25.6%) treatment-naive CHB patients within which there were no well-characterized primary nucleotide analogs (NAs) resistance sites. Three dominant sites at rt191, rt207 and rt226 were found mutant in 7(16.28%), 8(18.60%), and 14(32.56%) samples respectively among these 43 patients. No significant correlation was found between pre-existing mutations and gender, age, HBV genotype, ALT, HBeAg or HBV DNA loads. However, patients with pre-existing RT mutations under HBeAg sero-negative status exhibited decreased HBV DNA loads, which contributed to the decreased HBV DNA loads in the total HBeAg sero-negative patients. The above investigation indicated that there was a prevalence of pre-existing mutations in RT region of HBV polymerase which might affect the serum HBV DNA level in treatment-naive CHB patients. Its effects on the occurrence of NAs resistance and the prognosis after treatment need to be further investigated.	[Xu, Jie; Huang, Ling; Zhao, Ling] Shanghai Jiao Tong Univ Sch Med, Dept Infect Dis, Peoples Hosp 3, Shanghai, Peoples R China; [Wu, Biao; Wang, Jing-Hui; Wang, Ying] Shanghai Jiao Tong Univ Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Wu, Biao; Wang, Deng-yu; Zhao, Guo-ping; Wang, Ying] Shanghai Acad Sci & Technol, Shanghai Key Lab Hlth & Dis Genom, Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, Y (corresponding author), Shanghai Jiao Tong Univ Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.	ywang@sibs.ac.cn		Zhao, Guo-Ping/0000-0002-7621-6620	Shanghai Jiaotong University School of Medicine [12XJ10048]; Shanghai Municipal Education Commission [J50207]; Science and Technology Commission of Baoshan District [11-E-2]	Shanghai Jiaotong University School of Medicine; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Baoshan District	This work was supported by grants from Shanghai Jiaotong University School of Medicine (12XJ10048), Shanghai Municipal Education Commission (J50207) and Science and Technology Commission of Baoshan District (11-E-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Cento V, 2013, J INFECTION, V67, P303, DOI 10.1016/j.jinf.2013.05.008; Ciftci S, 2014, DIAGN MICR INFEC DIS, V79, P25, DOI 10.1016/j.diagmicrobio.2014.01.005; Ciupe SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039591; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Fan JY, 2014, J GEN VIROL, V95, P2523, DOI 10.1099/vir.0.066886-0; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Han KH, 2011, ANTIVIR THER, V16, P77, DOI 10.3851/IMP1702; Huang ZM, 2005, WORLD J GASTROENTERO, V11, P867, DOI 10.3748/wjg.v11.i6.867; Ji D, 2012, J CLIN VIROL, V54, P66, DOI 10.1016/j.jcv.2012.02.003; Leung N, 2002, J GASTROEN HEPATOL, V17, P409, DOI 10.1046/j.1440-1746.2002.02767.x; Liu BM, 2010, ANTIVIR RES, V85, P512, DOI 10.1016/j.antiviral.2009.12.006; Liu Y, 2015, J VIRAL HEPATITIS, V22, P328, DOI 10.1111/jvh.12298; Liu Y, 2011, J VIRAL HEPATITIS, V18, pe29, DOI 10.1111/j.1365-2893.2010.01360.x; Liu Y, 2014, J VIRAL HEPAT; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; Milich DR, 1998, J IMMUNOL, V160, P2013; Milich DR, 1997, J VIROL, V71, P2192, DOI 10.1128/JVI.71.3.2192-2201.1997; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; Pollicino T, 2009, ANTIVIR THER, V14, P649; Rodriguez C, 2013, HEPATOLOGY, V58, P890, DOI 10.1002/hep.26383; Ryu SH, 2006, B KOREAN J HEPATOL, V12, P484; Sayan M, 2011, HEPAT MON, V11, P835, DOI 10.5812/kowsar.1735143X.775; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Singla B, 2013, J MED VIROL, V85, P1155, DOI 10.1002/jmv.23608; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Wang FF, 2009, CLIN THER, V31, P360, DOI 10.1016/j.clinthera.2009.02.016; WANG J, 1991, J VIROL, V65, P5080, DOI 10.1128/JVI.65.9.5080-5083.1991; Wang YX, 2007, J MED VIROL, V79, P676, DOI 10.1002/jmv.20835; Yang HL, 2002, HEPATOLOGY, V36, P464, DOI 10.1053/jhep.2002.34740; Zhang MS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-292; Zhang Y, 2013, EUR J GASTROEN HEPAT, V25, P814, DOI 10.1097/MEG.0b013e32835ee516; Zhu Yuao, 2011, Antiviral Chemistry & Chemotherapy, V22, P13, DOI 10.3851/IMP1791; Zollner B, 2005, J CLIN MICROBIOL, V43, P2503, DOI 10.1128/JCM.43.5.2503-2505.2005; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	43	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117429	10.1371/journal.pone.0117429	http://dx.doi.org/10.1371/journal.pone.0117429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821965	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700012
J	Chen, W; Brehm, JM; Lin, J; Wang, T; Forno, E; Acosta-Perez, E; Boutaoui, N; Canino, G; Celedon, JC				Chen, Wei; Brehm, John M.; Lin, Jerome; Wang, Ting; Forno, Erick; Acosta-Perez, Edna; Boutaoui, Nadia; Canino, Glorisa; Celedon, Juan C.			Expression Quantitative Trait Loci (eQTL) Mapping in Puerto Rican Children	PLOS ONE			English	Article							GLOBAL GENE-EXPRESSION; CHILDHOOD ASTHMA; ATOPY	Background Expression quantitative trait loci (eQTL) have been identified using tissue or cell samples from diverse human populations, thus enhancing our understanding of regulation of gene expression. However, few studies have attempted to identify eQTL in racially admixed populations such as Hispanics. Methods We performed a systematic eQTL study to identify regulatory variants of gene expression in whole blood from 121 Puerto Rican children with (n = 63) and without (n = 58) asthma. Genome-wide genotyping was conducted using the Illumina Omni2.5M Bead Chip, and gene expression was assessed using the Illumina HT-12 microarray. After completing quality control, we performed a pair-wise genome analysis of similar to 15 K transcripts and similar to 1.3 M SNPs for both local and distal effects. This analysis was conducted under a regression framework adjusting for age, gender and principal components derived from both genotypic and mRNA data. We used a false discovery rate (FDR) approach to identify significant eQTL signals, which were next compared to top eQTL signals from existing eQTL databases. We then performed a pathway analysis for our top genes. Results We identified 36,720 local pairs in 3,391 unique genes and 1,851 distal pairs in 446 unique genes at FDR <0.05, corresponding to unadjusted P values lower than 1.5x10(-4) and 4.5x10(-9), respectively. A significant proportion of genes identified in our study overlapped with those identified in previous studies. We also found an enrichment of disease-related genes in our eQTL list. Conclusions We present results from the first eQTL study in Puerto Rican children, who are members of a unique Hispanic cohort disproportionately affected with asthma, prematurity, obesity and other common diseases. Our study confirmed eQTL signals identified in other ethnic groups, while also detecting additional eQTLs unique to our study population. The identified eQTLs will help prioritize findings from future genome-wide association studies in Puerto Ricans.	[Chen, Wei; Brehm, John M.; Wang, Ting; Forno, Erick; Boutaoui, Nadia; Celedon, Juan C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA; [Lin, Jerome] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Acosta-Perez, Edna; Canino, Glorisa] Univ Puerto Rico, Behav Sci Res Inst, San Juan, PR 00936 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Celedon, JC (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA.	juan.celedon@chp.edu	Forno, Erick/I-1476-2019; Pérez, Edna Acosta/AAW-6672-2021; Chen, Wei/AAX-5994-2020; Wang, Ting/L-8427-2017	Forno, Erick/0000-0001-6497-9885; Chen, Wei/0000-0001-7196-8703; Wang, Ting/0000-0003-4712-6658; acosta, edna/0000-0001-7101-3157	U.S. National Institutes of Health [HL117191, HL079966]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117191, R01HL079966] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by U.S. National Institutes of Health, grants HL117191 and HL079966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm JM, 2012, J ALLERGY CLIN IMMUN, V129, P1484, DOI 10.1016/j.jaci.2012.03.035; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Forno E, 2014, J ALLERGY CLIN IMMUN, V133, P1308, DOI 10.1016/j.jaci.2013.09.041; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Liang L., 2013, GENOME RES; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rosas-Salazar C, 2014, J ALLERGY CLIN IMMUN, V133, P357, DOI 10.1016/j.jaci.2013.09.003; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	14	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122464	10.1371/journal.pone.0122464	http://dx.doi.org/10.1371/journal.pone.0122464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816334	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352133600182
J	Forsstrom, B; Axnas, BB; Rockberg, J; Danielsson, H; Bohlin, A; Uhlen, M				Forsstrom, Bjorn; Axnas, Barbara Bislawska; Rockberg, Johan; Danielsson, Hanna; Bohlin, Anna; Uhlen, Mathias			Dissecting Antibodies with Regards to Linear and Conformational Epitopes	PLOS ONE			English	Article							POLYCLONAL ANTIBODIES; GENERATION; THERAPEUTICS	An important issue for the performance and specificity of an antibody is the nature of the binding to its protein target, including if the recognition involves linear or conformational epitopes. Here, we dissect polyclonal sera by creating epitope-specific antibody fractions using a combination of epitope mapping and an affinity capture approach involving both synthesized peptides and recombinant protein fragments. This allowed us to study the relative amounts of antibodies to linear and conformational epitopes in the polyclonal sera as well as the ability of each antibody-fraction to detect its target protein in Western blot assays. The majority of the analyzed polyclonal sera were found to have most of the target-specific antibodies directed towards linear epitopes and these were in many cases giving Western blot bands of correct molecular weight. In contrast, many of the antibodies towards conformational epitopes did not bind their target proteins in the Western blot assays. The results from this work have given us insights regarding the nature of the antibody response generated by immunization with recombinant protein fragments and has demonstrated the advantage of using antibodies recognizing linear epitopes for immunoassay involving wholly or partially denatured protein targets.	[Forsstrom, Bjorn; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Axnas, Barbara Bislawska; Rockberg, Johan; Danielsson, Hanna; Bohlin, Anna; Uhlen, Mathias] Royal Inst Technol KTH, AlbaNova Univ Ctr, Sch Biotechnol, Dept Prote, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology	Uhlen, M (corresponding author), KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; 	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Funding was provided by the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/Kaw/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaton C, 2004, J CHROMATOGR A, V1043, P33, DOI 10.1016/j.chroma.2004.06.008; Alm T, 2014, J PROTEOME RES, V13, P1669, DOI 10.1021/pr4011525; Berglund L, 2008, PROTEOMICS, V8, P2832, DOI 10.1002/pmic.200800203; Brown MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028718; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Carter John Mark, 2003, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0903s55; Edfors F, 2014, MOL CELL PROTEOMICS, V13, P1611, DOI 10.1074/mcp.M113.034140; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Forsstrom B, 2014, MOL CELL PROTEOMICS, V13, P1585, DOI 10.1074/mcp.M113.033308; Hjelm B, 2011, PROTEIN SCI, V20, P1824, DOI 10.1002/pro.716; Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001; Hurn B A, 1980, Methods Enzymol, V70, P104; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; SELA M, 1967, COLD SPRING HARB SYM, V32, P537, DOI 10.1101/SQB.1967.032.01.065; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248	18	58	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121673	10.1371/journal.pone.0121673	http://dx.doi.org/10.1371/journal.pone.0121673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816293	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600110
J	Gateau, T; Durantin, G; Lancelot, F; Scannella, S; Dehais, F				Gateau, Thibault; Durantin, Gautier; Lancelot, Francois; Scannella, Sebastien; Dehais, Frederic			Real-Time State Estimation in a Flight Simulator Using fNIRS	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BRAIN-COMPUTER INTERFACE; PREFRONTAL CORTEX; WORKING-MEMORY; MOTOR IMAGERY; CLASSIFICATION; SIGNALS; NIRS; ACTIVATION; BCI	Working memory is a key executive function for flying an aircraft. This function is particularly critical when pilots have to recall series of air traffic control instructions. However, working memory limitations may jeopardize flight safety. Since the functional near-infrared spectroscopy (fNIRS) method seems promising for assessing working memory load, our objective is to implement an on-line fNIRS-based inference system that integrates two complementary estimators. The first estimator is a real-time state estimation MACD-based algorithm dedicated to identifying the pilot's instantaneous mental state (not-on-task vs. on-task). It does not require a calibration process to perform its estimation. The second estimator is an online SVM-based classifier that is able to discriminate task difficulty (low working memory load vs. high working memory load). These two estimators were tested with 19 pilots who were placed in a realistic flight simulator and were asked to recall air traffic control instructions. We found that the estimated pilot's mental state matched significantly better than chance with the pilot's real state (62% global accuracy, 58% specificity, and 72% sensitivity). The second estimator, dedicated to assessing single trial working memory loads, led to 80% classification accuracy, 72% specificity, and 89% sensitivity. These two estimators establish reusable blocks for further fNIRS-based passive brain computer interface development.	[Gateau, Thibault; Durantin, Gautier; Lancelot, Francois; Scannella, Sebastien; Dehais, Frederic] ISAE, Toulouse, France	Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO)	Gateau, T (corresponding author), ISAE, Toulouse, France.	thibault.gateau@isae.fr		Dehais, frederic/0000-0003-0854-7919; Durantin, Gautier/0000-0003-4421-2091	French Defence Agency (Direction Generale de l'Armement -Mission pour la Recherche et l'Innovation Scientifique-" Modelisation de l'Attention pour une Interaction Adaptative" project)	French Defence Agency (Direction Generale de l'Armement -Mission pour la Recherche et l'Innovation Scientifique-" Modelisation de l'Attention pour une Interaction Adaptative" project)	This work was funded by the French Defence Agency (Direction Generale de l'Armement -Mission pour la Recherche et l'Innovation Scientifique-" Modelisation de l'Attention pour une Interaction Adaptative" project). http://www.defense.gouv.fr/dga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Afergan D, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3797, DOI 10.1145/2556288.2557230; [Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNALP0NE.0037791; Appel, 2005, TECHNICAL ANAL POWER; Ayaz H, 2005, THESIS DREXEL U; Ayaz H, 2011, JOVE-J VIS EXP, DOI 10.3791/3443; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Billings CE, 1981, 1875 NASA, P89; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Causse M, 2011, AGING NEUROPSYCHOL C, V18, P544, DOI 10.1080/13825585.2011.586018; Causse M, 2011, INT J AVIAT PSYCHOL, V21, P217, DOI 10.1080/10508414.2011.582441; Chan J, 2012, J NEAR INFRARED SPEC, V20, P107, DOI 10.1255/jnirs.971; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Cui X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015474; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Derosiere G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092045; Derosiere G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00583; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Durantin G, 2014, BEHAV BRAIN RES, V259, P16, DOI 10.1016/j.bbr.2013.10.042; Durantin G, 2014, IEEE ENG MED BIO, P2107, DOI 10.1109/EMBC.2014.6944032; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gagnon JF, 2012, P HUM FACT ERG SOC C; George L., 2010, INT C APPL BION BIOM; Girouard Audrey, 2013, International Journal of Autonomous and Adaptive Communications Systems, V6, P26, DOI 10.1504/IJAACS.2013.050689; Girouard A, 2009, LECT NOTES COMPUT SC, V5726, P440, DOI 10.1007/978-3-642-03655-2_50; Gratton G, 2006, OXFORD SERIES HUMAN, P65; Guirgis M, 2010, P ISSNIP BIOS BIOR C, P59; Hirshfield LM, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P373; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Khan MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00244; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Kubler A, 2006, IEEE T NEUR SYS REH, V14, P131, DOI 10.1109/TNSRE.2006.875585; Kuhn ME, 2008, FOOD TECHNOL-CHICAGO, V62, P28; Li CJ, 2005, PROC SPIE, V5696, P33, DOI 10.1117/12.590222; Lin WH, 2003, LECT NOTES ARTIF INT, V2797, P217; Mackey JR, 2013, EFFECTS VARYING GRAV; Matsuyama H., 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P775, DOI 10.1109/ROMAN.2009.5326215; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Morrow D.G., 1993, INT J AVIATION PSYCH, V3, P285, DOI DOI 10.1207/S15327108IJAP0304_; Naseer N, 2015, NAME FRONTIERS HUMAN, V9; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Parasuraman R, 2008, HUM FACTORS, V50, P511, DOI 10.1518/001872008X312198; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Reegis N, 2014, IEEE T HUMAN MACHIN; Risser M.R., 2006, INTERFERENCE TIMING, V50, P11, DOI [10.1177/154193120605000103, DOI 10.1177/154193120605000103]; Sato H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1960907; Scerbo MW, 2003, P HUM FACT ERG SOC A, V47, P95; Schreppel T, 2008, NEUROPSYCHOBIOLOGY, V57, P188, DOI 10.1159/000147473; Schudlo LC, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016003; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Solovey E, 2012, P SIGCHI C HUM FACT, P2193, DOI DOI 10.1145/2207676.2208372; Solovey ET, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P383; St John M, 2004, INT J HUM-COMPUT INT, V17, P131, DOI 10.1207/s15327590ijhc1702_2; Strait M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00117; Strait Megan, 2014, CHI 14 HUM FACT COMP, P619; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Takeuchi Y, 2000, J OCCUP HEALTH, V42, P60, DOI 10.1539/joh.42.60; Taylor JL, 2005, PSYCHOL AGING, V20, P117, DOI 10.1037/0882-7974.20.1.117; TAYLOR JL, 1994, J GERONTOL, V49, pP191, DOI 10.1093/geronj/49.5.P191; Tomita Y, 2013, C HUM SYST INTERACT, P495, DOI 10.1109/HSI.2013.6577871; Tsirogiannis GL, 2004, LECT NOTES COMPUT SC, V3025, P154; Utsugi K, 2007, P ANN INT IEEE EMBS, P5338, DOI 10.1109/IEMBS.2007.4353547; Villringer K, 1997, ADV EXP MED BIOL, V413, P149; Yamamoto D, 2007, EUR C BIOM OPT INT S; Zhang J, 2013, INT J PHOTOENERGY, V2013, DOI [10.1155/2013/986076, 10.4018/978-1-4666-1939-5.ch001]	77	94	94	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121279	10.1371/journal.pone.0121279	http://dx.doi.org/10.1371/journal.pone.0121279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816347	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600079
J	Pialoux, V; Genevois, C; Capoen, A; Forbes, SC; Thomas, J; Rogowski, I				Pialoux, Vincent; Genevois, Cyril; Capoen, Arnaud; Forbes, Scott C.; Thomas, Jordan; Rogowski, Isabelle			Playing vs. Nonplaying Aerobic Training in Tennis: Physiological and Performance Outcomes	PLOS ONE			English	Article							ELECTROMYOGRAPHIC ANALYSIS; SOCCER PLAYERS; HEART-RATE; INTENSITY; COMPETITION; EXERCISE; FATIGUE; DRILLS	This study compared the effects of playing and nonplaying high intensity intermittent training (HIIT) on physiological demands and tennis stroke performance in young tennis players. Eleven competitive male players (13.4 +/- 1.3 years) completed both a playing and nonplaying HIIT session of equal distance, in random order. During each HIIT session, heart rate (HR), blood lactate, and ratings of perceived exertion (RPE) were monitored. Before and after each HIIT session, the velocity and accuracy of the serve, and forehand and backhand strokes were evaluated. The results demonstrated that both HIIT sessions achieved an average HR greater than 90% HRmax. The physiological demands (average HR) were greater during the playing session compared to the nonplaying session, despite similar lactate concentrations and a lower RPE. The results also indicate a reduction in shot velocity after both HIIT sessions; however, the playing HIIT session had a more deleterious effect on stroke accuracy. These findings suggest that 1) both HIIT sessions may be sufficient to develop maximal aerobic power, 2) playing HIIT sessions provide a greater physiological demand with a lower RPE, and 3) playing HIIT has a greater deleterious effect on stroke performance, and in particular on the accuracy component of the ground stroke performance, and should be incorporated appropriately into a periodization program in young male tennis players.	[Pialoux, Vincent; Genevois, Cyril; Capoen, Arnaud; Rogowski, Isabelle] Univ Lyon 1, Ctr Rech & Innovat Sport EA 647, F-69622 Villeurbanne, France; [Pialoux, Vincent; Genevois, Cyril; Capoen, Arnaud; Rogowski, Isabelle] UFRSTAPS, Villeurbanne, France; [Pialoux, Vincent] Inst Univ France, Paris, France; [Capoen, Arnaud; Thomas, Jordan] Ligue Essonne Tennis, St Genevieve Des Bois, France; [Forbes, Scott C.] Okanagan Coll, Human Kinet, Penticton, BC, Canada	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Rogowski, I (corresponding author), Univ Lyon 1, Ctr Rech & Innovat Sport EA 647, F-69622 Villeurbanne, France.	isabelle.rogowski@univ-lyon1.fr						Bekraoui N, 2012, APPL PHYSIOL NUTR ME, V37, P982, DOI [10.1139/h2012-082, 10.1139/H2012-082]; Botton F, 2011, J STRENGTH COND RES, V25, P3022, DOI 10.1519/JSC.0b013e318234e613; Cohen J., 1998, STAT POWER ANAL BEHA; Crespo M, 1998, ITF MANUAL ADV COACH; Davey PR, 2002, J SPORT SCI, V20, P311, DOI 10.1080/026404102753576080; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; Fernandez-Fernandez J, 2001, J SPORT SCI MED, V10, P540; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; Fernandez-Fernandez J, 2010, J STRENGTH COND RES, V24, P3255, DOI 10.1519/JSC.0b013e3181e8745f; Ferrauti A, 2001, J SPORT SCI, V19, P235, DOI 10.1080/026404101750158277; Ferrauti A, 2011, J SPORT SCI, V29, P485, DOI 10.1080/02640414.2010.539247; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Genevois C, 2013, J STRENGTH COND RES, V27, P677, DOI 10.1519/JSC.0b013e31825c3290; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Hill-Haas SV, 2009, INT J SPORTS MED, V30, P636, DOI 10.1055/s-0029-1220730; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; MORRIS M, 1989, AM J SPORT MED, V17, P241, DOI 10.1177/036354658901700215; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Rogowski I, 2011, J APPL BIOMECH, V27, P15, DOI 10.1123/jab.27.1.15; Rota S, 2014, J ELECTROMYOGR KINES, V24, P90, DOI 10.1016/j.jelekin.2013.10.007; RYU RKN, 1988, AM J SPORT MED, V16, P481, DOI 10.1177/036354658801600509; Sperlich B, 2011, J STRENGTH COND RES, V25, P1271, DOI 10.1519/JSC.0b013e3181d67c38; Sperlich B, 2010, EUR J APPL PHYSIOL, V110, P1029, DOI 10.1007/s00421-010-1586-4; Srihirun K, 2014, J EXERC PHYSL ONLINE, V17, P11; Torres-Luque G, 2011, EUR J SPORT SCI, V11, P39, DOI 10.1080/17461391003770533	28	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122718	10.1371/journal.pone.0122718	http://dx.doi.org/10.1371/journal.pone.0122718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816346	Green Submitted, gold, Green Published			2022-12-27	WOS:000352133600191
J	van Hemel-Ruiter, ME; de Jong, PJ; Ostafin, BD; Oldehinkel, AJ				van Hemel-Ruiter, Madelon E.; de Jong, Peter J.; Ostafin, Brian D.; Oldehinkel, Albertine J.			Reward-Related Attentional Bias and Adolescent Substance Use: A Prognostic Relationship?	PLOS ONE			English	Article							ALCOHOL-USE; INCENTIVE-SENSITIZATION; CANNABIS USE; EARLY-ONSET; AGE; ADDICTION; TRAILS; CONSUMPTION; DEPENDENCE; DRINKING	Current cognitive-motivational addiction theories propose that prioritizing appetitive, reward-related information (attentional bias) plays a vital role in substance abuse behavior. Previous cross-sectional research has shown that adolescent substance use is related to reward-related attentional biases. The present study was designed to extend these findings by testing whether these reward biases have predictive value for adolescent substance use at three-year follow-up. Participants (N = 657, mean age = 16.2 yrs at baseline) were a sub-sample of Tracking Adolescents' Individual Lives Survey (TRAILS), a large longitudinal community cohort study. We used a spatial orienting task as a behavioral index of appetitive-related attentional processes at baseline and a substance use questionnaire at both baseline and three years follow-up. Bivariate correlational analyses showed that enhanced attentional engagement with cues that predicted potential reward and nonpunishment was positively associated with substance use (alcohol, tobacco, and cannabis) three years later. However, reward bias was not predictive of changes in substance use. A post-hoc analysis in a selection of adolescents who started using illicit drugs (other than cannabis) in the follow-up period demonstrated that stronger baseline attentional engagement toward cues of nonpunishment was related to a higher level of illicit drug use three years later. The finding that reward bias was not predictive for the increase in substance use in adolescents who already started using substances at baseline, but did show prognostic value in adolescents who initiated drug use in between baseline and follow-up suggests that appetitive bias might be especially important in the initiation stages of adolescent substance use.	[van Hemel-Ruiter, Madelon E.; de Jong, Peter J.; Ostafin, Brian D.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	University of Groningen; University of Groningen	van Hemel-Ruiter, ME (corresponding author), Verslavingszorg Noord Nederland, Groningen, Netherlands.	m.vanhemel@vnn.nl	de Jong, Peter/E-9095-2014; de Jong, Peter/ABB-1750-2020	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663	Netherlands Organization for Scientific Research NWO (Medical Research Council program) [GB-MW 940-38-011 AJO]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004 AJO]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-98-018 AJO, 60-60600-97-118 AJO, 60-60600-97-202 PJdJ]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710 AJO]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006 AJO, GB-MaGW 480-07-001 AJO]; Netherlands Organization for Scientific Research NWO (Social Sciences Council) [GB-MaGW 457-03-018 AJO, GB-MaGW 452-04-314 AJO, GB-MaGW 452-06-004 AJO]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005 AJO]; Sophia Foundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]	Netherlands Organization for Scientific Research NWO (Medical Research Council program)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Sophia Foundation for Medical Research; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project)	This work was supported by the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011 AJO; ZonMW Brainpower grant 100-001-004 AJO; ZonMw Risk Behavior and Dependence grants 60-60600-98-018 AJO, 60-60600-97-118 AJO and 60-60600-97-202 PJdJ; ZonMw Culture and Health grant 261-98-710 AJO; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 AJO and GB-MaGW 480-07-001 AJO; Social Sciences Council project grants GB-MaGW 457-03-018 AJO, GB-MaGW 452-04-314 AJO, and GB-MaGW 452-06-004 AJO; NWO large-sized investment grant 175.010.2003.005 AJO) www.nwo.nl. The authors also received support from the Sophia Foundation for Medical Research (projects 301 and 393) www.sophiafoundation.org (AJO); the Dutch Ministry of Justice (WODC) www.wodc.nl (AJO); and the European Science Foundation (EuroSTRESS project FP-006) www.esf.org (AJO). Participating universities include: University Medical Center and University of Groningen www.umcg.nl; Erasmus University Medical Center Rotterdam www.erasmusmc.nl; University of Utrecht www.uu.nl; Radboud Medical Center Nijmegen www.ru.nl and the Parnassia Bavo group www.parnassiagroep.nl; University of Groningen www.rug.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colder CR, 2002, PSYCHOL ADDICT BEHAV, V16, P325, DOI 10.1037//0893-164X.16.325; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Houben K, 2012, BEER NO GO LEARNING; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Huizink AC, 2006, ADDICTION, V101, P1581, DOI 10.1111/j.1360-0443.2006.01570.x; Knyazev GG, 2004, DRUG ALCOHOL DEPEN, V75, P309, DOI 10.1016/j.drugalcdep.2004.03.007; Lopez-Vergara HI, 2012, AM J DRUG ALCOHOL AB, V38, P130, DOI 10.3109/00952990.2011.643973; Lubman DI, 2000, PSYCHOL MED, V30, P169, DOI 10.1017/S0033291799001269; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Monshouwer K., 2008, JEUGD RISKANT GEDRAG; Nederhof E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-93; O'Connor RM, 2005, PSYCHOL ADDICT BEHAV, V19, P10, DOI 10.1037/0893-164X.19.1.10; Pardo Y, 2007, ADDICT BEHAV, V32, P2398, DOI 10.1016/j.addbeh.2007.02.010; Pratt NL, 2009, DISS ANSTR INT B, V69; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; van Hemel-Ruiter MLE, 2013, PSYCHOL ADDICT BEHAV, V27, P142, DOI 10.1037/a0028271; Winters KC, 2008, DRUG ALCOHOL DEPEN, V92, P239, DOI 10.1016/j.drugalcdep.2007.08.005	29	9	9	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121058	10.1371/journal.pone.0121058	http://dx.doi.org/10.1371/journal.pone.0121058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816295	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600062
J	Adler, NRL; Stevens, MP; Dean, RE; Saint, RJ; Pankhania, D; Prior, JL; Atkins, TP; Kessler, B; Nithichanon, A; Lertmemongkolchai, G; Galyov, EE				Adler, Natalie R. Lazar; Stevens, Mark P.; Dean, Rachel E.; Saint, Richard J.; Pankhania, Depesh; Prior, Joann L.; Atkins, Timothy P.; Kessler, Bianca; Nithichanon, Arnone; Lertmemongkolchai, Ganjana; Galyov, Edouard E.			Systematic Mutagenesis of Genes Encoding Predicted Autotransported Proteins of Burkholderia pseudomallei Identifies Factors Mediating Virulence in Mice, Net Intracellular Replication and a Novel Protein Conferring Serum Resistance	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; OPRB EFFLUX PUMP; FUNCTIONAL-CHARACTERIZATION; TRIMERIC AUTOTRANSPORTERS; CAPSULAR POLYSACCHARIDE; BORDETELLA-PERTUSSIS; ESCHERICHIA-COLI; COMPLEMENT; BINDING; MALLEI	Burkholderia pseudomallei is the causative agent of the severe tropical disease melioidosis, which commonly presents as sepsis. The B. pseudomallei K96243 genome encodes eleven predicted autotransporters, a diverse family of secreted and outer membrane proteins often associated with virulence. In a systematic study of these autotransporters, we constructed insertion mutants in each gene predicted to encode an autotransporter and assessed them for three pathogenesis-associated phenotypes: virulence in the BALB/c intra-peritoneal mouse melioidosis model, net intracellular replication in J774.2 murine macrophage-like cells and survival in 45% (v/v) normal human serum. From the complete repertoire of eleven autotransporter mutants, we identified eight mutants which exhibited an increase in median lethal dose of 1 to 2-log(10) compared to the isogenic parent strain (bcaA, boaA, boaB, bpaA, bpaC, bpaE, bpaF and bimA). Four mutants, all demonstrating attenuation for virulence, exhibited reduced net intracellular replication in J774.2 macrophage-like cells (bimA, boaB, bpaC and bpaE). A single mutant (bpaC) was identified that exhibited significantly reduced serum survival compared to wild-type. The bpaC mutant, which demonstrated attenuation for virulence and net intracellular replication, was sensitive to complement-mediated killing via the classical and/or lectin pathway. Serum resistance was rescued by in trans complementation. Subsequently, we expressed recombinant proteins of the passenger domain of four predicted autotransporters representing each of the phenotypic groups identified: those attenuated for virulence (BcaA), those attenuated for virulence and net intracellular replication (BpaE), the BpaC mutant with defects in virulence, net intracellular replication and serum resistance and those displaying wild-type phenotypes (BatA). Only BcaA and BpaE elicited a strong IFN-gamma response in a restimulation assay using whole blood from seropositive donors and were recognised by seropositive human sera from the endemic area. To conclude, several predicted autotransporters contribute to B. pseudomallei virulence and BpaC may do so by conferring resistance against complement-mediated killing.	[Adler, Natalie R. Lazar; Pankhania, Depesh; Galyov, Edouard E.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Stevens, Mark P.] Univ Edinburgh, Sch Vet Studies, Roslin Inst & Royal Dick, Easter Bush, Scotland; [Dean, Rachel E.; Saint, Richard J.; Prior, Joann L.; Atkins, Timothy P.] Def Sci & Technol Lab, Biomed Sci, Porton Down, Scotland; [Atkins, Timothy P.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Kessler, Bianca; Nithichanon, Arnone; Lertmemongkolchai, Ganjana] Khon Kaen Univ, Fac Assoc Med Sci, Ctr Res & Dev Med Diagnost Labs CMDL, Khon Kaen, Thailand	University of Leicester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Defence Science & Technology Laboratory; University of Exeter; Khon Kaen University	Galyov, EE (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	eg98@leicester.ac.uk	Lazar Adler, Natalie/I-2099-2014	Lazar Adler, Natalie/0000-0001-5775-7627; Galyov, Edouard/0000-0003-2609-0748; Stevens, Mark/0000-0003-2174-5039; nithichanon, arnone/0000-0001-5617-8746; Lertmemongkolchai, Ganjana/0000-0001-6972-585X	Wellcome Trust [085972]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/E021212/1] Funding Source: researchfish; BBSRC [BBS/E/D/20231761, BB/E021212/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Wellcome Trust grant 085972. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079461; Adler NRL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00151; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; Balder R, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-1110-1250, DOI 10.1186/1471-2180-1110-1250]; Barnes MG, 2001, INFECT IMMUN, V69, P3067, DOI 10.1128/IAI.69.5.3067-3072.2001; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Campos CG, 2013, INFECT IMMUN, V81, P2788, DOI 10.1128/IAI.00526-13; Campos CG, 2013, INFECT IMMUN, V81, P1121, DOI 10.1128/IAI.01453-12; Chan YY, 2005, J BACTERIOL, V187, P4707, DOI 10.1128/JB.187.14.4707-4719.2005; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Egan AM, 1996, INFECT IMMUN, V64, P4952, DOI 10.1128/IAI.64.12.4952-4959.1996; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Hallstrom T, 2011, J IMMUNOL, V186, P3120, DOI 10.4049/jimmunol.1002621; Hallstrom T, 2010, J CLIN MICROBIOL, V48, P921, DOI 10.1128/JCM.01654-09; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Lafontaine ER, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-92; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Leduc I, 2009, INFECT IMMUN, V77, P657, DOI 10.1128/IAI.00819-08; LERTMEMONGKOLCHAI G, 1991, ASIAN PAC J ALLERGY, V9, P5; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Mack K, 1998, FEMS MICROBIOL LETT, V162, P69, DOI 10.1016/S0378-1097(98)00104-9; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mil-Homens D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041747; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Noofeli M, 2011, MICROB PATHOGENESIS, V51, P169, DOI 10.1016/j.micpath.2011.04.004; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Sandt CH, 2001, INFECT IMMUN, V69, P7293, DOI 10.1128/IAI.69.12.7293-7203.2001; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Tippayawat P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000407; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI [10.1186/1471-2180-1187-1119, DOI 10.1186/1471-2180-1187-1119]; Wikraiphat C, 2009, FEMS IMMUNOL MED MIC, V56, P253, DOI 10.1111/j.1574-695X.2009.00574.x; Woodman ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052276	54	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121271	10.1371/journal.pone.0121271	http://dx.doi.org/10.1371/journal.pone.0121271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830295	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600065
J	Ang, SF; Ng, ESH; Li, HH; Ong, YH; Choo, SP; Ngeow, J; Toh, HC; Lim, KH; Yap, HY; Tan, CK; Ooi, LLPJ; Chung, AYF; Chow, PKH; Foo, KF; Tan, MH; Cheow, PC				Ang, Soo Fan; Ng, Elizabeth Shu-Hui; Li, Huihua; Ong, Yu-Han; Choo, Su Pin; Ngeow, Joanne; Toh, Han Chong; Lim, Kiat Hon; Yap, Hao Yun; Tan, Chee Kiat; Ooi, London Lucien Peng Jin; Chung, Alexander Yaw Fui; Chow, Pierce Kah Hoe; Foo, Kian Fong; Tan, Min-Han; Cheow, Peng Chung			The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; CURATIVE RESECTION; STAGING-SYSTEM; PROGNOSIS; SURVIVAL; NOMOGRAM	Background and Aims Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of primarily patients with advanced cancer, and may be less relevant to resectable HCC. We developed a postoperative nomogram, the Singapore Liver Cancer Recurrence (SLICER) Score, to predict outcomes of HCC patients who have undergone surgical resection. Methods Records for 544 consecutive patients undergoing first-line curative surgery for HCC in one institution from 1992-2007 were reviewed, with 405 local patients selected for analysis. Freedom from relapse (FFR) was the primary outcome measure. An outcome-blinded modeling strategy including clustering, data reduction and transformation was used. We compared the performance of SLICER in estimating FFR with other HCC prognostic models using concordance-indices and likelihood analysis. Results A nomogram predicting FFR was developed, incorporating non-neoplastic liver cirrhosis, multifocality, preoperative alpha-fetoprotein level, Child-Pugh score, vascular invasion, tumor size, surgical margin and symptoms at presentation. Our nomogram outperformed other HCC prognostic models in predicting FFR by means of log-likelihood ratio statistics with good calibration demonstrated at 3 and 5 years post-resection and a concordance index of 0.69. Using decision curve analysis, SLICER also demonstrated superior net benefit at higher threshold probabilities. Conclusion The SLICER score enables well-calibrated individualized predictions of relapse following curative HCC resection, and may represent a novel tool for biomarker research and individual counseling.	[Ang, Soo Fan; Ng, Elizabeth Shu-Hui; Ong, Yu-Han; Choo, Su Pin; Ngeow, Joanne; Toh, Han Chong; Foo, Kian Fong; Tan, Min-Han] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Li, Huihua] Singapore Gen Hosp, Hlth Serv Res, Singapore, Singapore; [Li, Huihua] Duke Natl Univ Singapore, Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Yap, Hao Yun] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Chee Kiat] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore; [Ooi, London Lucien Peng Jin; Chung, Alexander Yaw Fui; Cheow, Peng Chung] Singapore Gen Hosp, Dept Hepatobiliary & Transplant Surg, Singapore, Singapore; [Chow, Pierce Kah Hoe] Natl Canc Ctr, Div Surg Oncol, Singapore, Singapore; [Chow, Pierce Kah Hoe] Duke Natl Univ Singapore, Grad Sch Med, Off Clin Sci, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; Singapore General Hospital; Singapore General Hospital; Singapore General Hospital; Singapore General Hospital; National Cancer Centre Singapore (NCCS); National University of Singapore	Ang, SF (corresponding author), Natl Canc Ctr, Div Med Oncol, Singapore, Singapore.	Ang.S.F@nccs.com.sg; tan.min.han@nccs.com.sg	Ngeow, Joanne/O-1250-2013; CHOO, Su Pin/ABB-3892-2020; Joanne, Ngeow/G-9610-2019; Tan, Chee-Kiat/AAF-6443-2019; Tan, Chee-Kiat/AAN-3888-2020; Tan, Min/GQQ-2702-2022; Ooi, London Lucien/AGK-1395-2022	Ngeow, Joanne/0000-0003-1558-3627; Joanne, Ngeow/0000-0003-1558-3627; Tan, Chee-Kiat/0000-0001-6992-2319; Tan, Chee-Kiat/0000-0001-6992-2319; Ong, Yu Han/0000-0001-9300-573X; Chow, Pierce/0000-0003-0584-2584				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cho CS, 2008, J AM COLL SURGEONS, V206, P281, DOI 10.1016/j.jamcollsurg.2007.07.031; Edge SB, 2009, AJCC CANC STAGING MA, P237; Fu SJ, 2013, SURGERY, V154, P536, DOI 10.1016/j.surg.2013.02.014; Harrell FE, 2001, REGRESSION MODELING; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Li J, 2014, BRIT J CANCER, V110, P1110, DOI 10.1038/bjc.2014.19; Liu CL, 2002, WORLD J SURG, V26, P348, DOI 10.1007/s00268-001-0231-0; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Manghisi G, 1998, HEPATOLOGY, V28, P751; MATSUMATA T, 1989, HEPATOLOGY, V9, P457, DOI 10.1002/hep.1840090320; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Perrone F, 2000, HEPATOLOGY, V31, P840; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Schwartz JD, 2002, LANCET ONCOL, V3, P593, DOI 10.1016/S1470-2045(02)00873-2; Shimozawa N, 2004, J AM COLL SURGEONS, V198, P356, DOI 10.1016/j.jamcollsurg.2003.10.017; Stipa F, 2006, CANCER-AM CANCER SOC, V106, P1331, DOI 10.1002/cncr.21703; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Tamura Y, 2013, DIGEST DIS SCI, V58, P2406, DOI 10.1007/s10620-013-2661-6; Toyosaka A, 1996, HPB Surg, V10, P97, DOI 10.1155/1996/75210; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Villanueva Augusto, 2011, Gastroenterology, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015	36	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118658	10.1371/journal.pone.0118658	http://dx.doi.org/10.1371/journal.pone.0118658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830231	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600004
J	Brudzynski, K; Sjaarda, C				Brudzynski, Katrina; Sjaarda, Calvin			Honey Glycoproteins Containing Antimicrobial Peptides, Jelleins of the Major Royal Jelly Protein 1, Are Responsible for the Cell Wall Lytic and Bactericidal Activities of Honey	PLOS ONE			English	Article							CONCANAVALIN-A; FAMILY; QUANTIFICATION; IDENTIFICATION; CHROMATOGRAPHY; ANIMALS; PLANTS	We have recently identified the bacterial cell wall as the cellular target for honey antibacterial compounds; however, the chemical nature of these compounds remained to be elucidated. Using Concavalin A-affinity chromatography, we found that isolated glycoprotein fractions (glps), but not flow-through fractions, exhibited strong growth inhibitory and bactericidal properties. The glps possessed two distinct functionalities: (a) specific binding and agglutination of bacterial cells, but not rat erythrocytes and (b) non-specific membrane permeabilization of both bacterial cells and erythrocytes. The isolated glps induced concentration-and time-dependent changes in the cell shape of both E. coli and B. subtilis as visualized by light and SEM microscopy. The appearance of filaments and spheroplasts correlated with growth inhibition and bactericidal effects, respectively. The time-kill kinetics showed a rapid, >5-log(10) reduction of viable cells within 15 min incubation at 1xMBC, indicating that the glps-induced damage of the cell wall was lethal. Unexpectedly, MALDI-TOF and electrospray quadrupole time of flight mass spectrometry, (ESI-Q-TOF-MS/MS) analysis of glps showed sequence identity with the Major Royal Jelly Protein 1 (MRJP1) precursor that harbors three antimicrobial peptides: Jelleins 1, 2, and 4. The presence of high-mannose structures explained the lectin-like activity of MRJP1, while the presence of Jelleins in MRJP1 may explain cell wall disruptions. Thus, the observed damages induced by the MRJP1 to the bacterial cell wall constitute the mechanism by which the antibacterial effects were produced. Antibacterial activity of MRJP1 glps directly correlated with the overall antibacterial activity of honey, suggesting that it is honey's active principle responsible for this activity.	[Brudzynski, Katrina; Sjaarda, Calvin] Bee Biomed Inc, Drug Discovery & Dev Dept, St Catharines, ON, Canada		Brudzynski, K (corresponding author), Bee Biomed Inc, Drug Discovery & Dev Dept, St Catharines, ON, Canada.	beebio@sympatico.ca			Bee-Biomedicals Inc.	Bee-Biomedicals Inc.	Bee-Biomedicals Inc. provided support in the form of salaries for authors KB and CS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Albert S, 1999, J MOL EVOL, V49, P290, DOI 10.1007/PL00006551; Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Bilikova K, 2010, J AGR FOOD CHEM, V58, P8776, DOI 10.1021/jf101583s; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brudzynski K, 2006, CAN J MICROBIOL, V52, P1228, DOI 10.1139/W06-086; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00036; Brudzynski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106967; Brudzynski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072897; Brudzynski K, 2012, FOOD CHEM, V133, P329, DOI 10.1016/j.foodchem.2012.01.035; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Brudzynski K, 2011, FOOD CHEM, V127, P1023, DOI 10.1016/j.foodchem.2011.01.075; Charroux B, 2009, MICROBES INFECT, V11, P631, DOI 10.1016/j.micinf.2009.03.004; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL; Di Girolamo F, 2012, J PROTEOMICS, V75, P3688, DOI 10.1016/j.jprot.2012.04.029; DOYLE RJ, 1972, J BACTERIOL, V109, P652, DOI 10.1128/JB.109.2.652-658.1972; EHRENSTEIN G, 1977, Q REV BIOPHYS, V10, P1, DOI 10.1017/S0033583500000123; Esko J, 1999, ESSENTIALS GLYCOBIOL, pChapter 21; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung S, 2012, J BIOL CHEM, V287, P14246, DOI 10.1074/jbc.M111.336495; Kato Y, 2012, J AGR FOOD CHEM, V60, P3418, DOI 10.1021/jf300068w; Kimura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P2109, DOI 10.1271/bbb.64.2109; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Michalek M, 2013, ANTIMICROB AGENTS CH, V57, P2955, DOI 10.1128/AAC.02498-12; NARASIMHAN S, 1979, CAN J BIOCHEM CELL B, V57, P83, DOI 10.1139/o79-011; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Romanelli A, 2011, J PEPT SCI, V17, P348, DOI 10.1002/psc.1316; Rossano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049164; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Won SR, 2008, FOOD RES INT, V41, P952, DOI 10.1016/j.foodres.2008.07.014; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	45	59	60	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120238	10.1371/journal.pone.0120238	http://dx.doi.org/10.1371/journal.pone.0120238			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830314	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600025
J	Narvaez, J; Diaz-Torne, C; Magallares, B; Hernandez, MV; Reina, D; Corominas, H; Sanmart, R; de la Serna, AR; Llobet, JM; Nolla, JM				Narvaez, Javier; Diaz-Torne, Cesar; Magallares, Berta; Victoria Hernandez, Maria; Reina, Delia; Corominas, Hector; Sanmart, Raimon; Rodriguez de la Serna, Arturo; Maria Llobet, Josep; Nolla, Joan M.			Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; INADEQUATE RESPONSE; RECEPTOR INHIBITION; ADDING TOCILIZUMAB; DISEASE-ACTIVITY; MONOTHERAPY; COMBINATION; INTERLEUKIN-6; RITUXIMAB; UPDATE	Objective In agreement with EULAR recommendations, a DMARD in combination with a biotherapy is the reference treatment because of the superior long-term clinical and radiographic outcomes. Methotrexate (MTX) is the cornerstone of combination therapy but is in some cases contra-indicated or poorly tolerated. This observational study aimed to compare the effectiveness and safety of TCZ in combination with either MTX or leflunomide (LEF) in the treatment of patients with active rheumatoid arthritis (RA) and an inadequate response to one or more DMARDs and/or biological agents in a real-world setting. Methods We performed an ambispective review of 91 patients with active RA who were routinely treated with TCZ plus MTX or LEF. A comparative study between the two combinations of treatment was performed at 6 months of follow-up considering 3 outcomes: improvement of RA disease activity, evolution of functional disability, and tolerability and side effect profile. Results Of the 91 patients, 62 received TCZ with MTX and 29 received TCZ with LEF. Eighty-one patients were followed for 6 months, and the remaining 10 patients discontinued treatment due to serious adverse events. At baseline, there were no significant differences between the groups in terms of the main clinical and laboratory data or in the number of previous DMARDs and biological agents used. At 6 months, there were no significant differences between the combinations in terms of disease activity and functional disability. Serious adverse events occurred in 11% and 10% of the patients treated in combination with MTX and LEF, respectively. Conclusion Our preliminary data support the argument that LEF is an effective and safe (equivalent) alternative to MTX for combination treatment with TCZ.	[Narvaez, Javier; Nolla, Joan M.] Hosp Univ Bellvitge IDIBELL, Dept Rheumatol, Barcelona, Spain; [Diaz-Torne, Cesar; Magallares, Berta; Rodriguez de la Serna, Arturo; Maria Llobet, Josep] Hosp Santa Creu & Sant Pau, Rheumatol Unit, Barcelona, Spain; [Victoria Hernandez, Maria; Sanmart, Raimon] Hosp Clin Barcelona, IDIBAPS, Dept Rheumatol, Barcelona, Spain; [Reina, Delia; Corominas, Hector] Hosp St Joan Despi, Dept Rheumatol, Consorci Sanitari Integral, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Narvaez, J (corresponding author), Hosp Univ Bellvitge IDIBELL, Dept Rheumatol, Barcelona, Spain.	fjnarvaez@bellvitgehospital.cat	Narvaez, Javier/AAD-7434-2020; Narvaez, Javier/AAD-7456-2020; Hernandez, María/GYU-3543-2022; Díaz-Torné, César/AAG-2419-2020; Sanmarti, Raimon/M-4434-2017; Corominas, Hèctor/P-5045-2019	Narvaez, Javier/0000-0002-1614-8064; Díaz-Torné, César/0000-0001-6275-7699; Sanmarti, Raimon/0000-0002-8864-3806; Corominas, Hèctor/0000-0002-7738-6787; Hernandez, Maria Victoria/0000-0001-6657-2333				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Behrens F, 2011, CURR OPIN RHEUMATOL, V23, P282, DOI 10.1097/BOR.0b013e328344fddb; Burmester GR, 2011, ANN RHEUM DIS, V70, P755, DOI 10.1136/ard.2010.139725; Chatzidionysiou K, 2012, ANN RHEUM DIS, V71, P374, DOI 10.1136/annrheumdis-2011-200003; De Stefano R, 2010, CLIN RHEUMATOL, V29, P517, DOI 10.1007/s10067-009-1349-y; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; EMA, ROACTEMRA TOC SUMM P; Finckh A, 2009, ANN RHEUM DIS, V68, P33, DOI 10.1136/ard.2007.085696; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kojima T, 2014, RHEUMATOLOGY; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Narvaez J, 2011, SEMIN ARTHRITIS RHEU, V41, P401, DOI 10.1016/j.semarthrit.2011.06.005; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Pers YM, 2014, RHEUMATOLOGY, V53, P76, DOI 10.1093/rheumatology/ket301; Richter A, 2014, ARTHRIT CARE RES, V66, P1627, DOI 10.1002/acr.22327; Schoels MM, 2013, ANN RHEUM DIS, V72, P583, DOI 10.1136/annrheumdis-2012-202470; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Takeuchi T, 2013, ANN RHEUM DIS, V72, P62; Takeuchi T, 2014, ANN RHEUM DIS S2, V73; Molina JT, 2010, REUMATOL CLIN, V6, P23, DOI 10.1016/j.reuma.2009.10.006	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123392	10.1371/journal.pone.0123392	http://dx.doi.org/10.1371/journal.pone.0123392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830224	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600144
J	Song, HK; Kim, J; Lee, JS; Nho, KJ; Jeong, HC; Kim, J; Ahn, Y; Park, WJ; Kim, DH				Song, Hong Ki; Kim, Jiyeon; Lee, Jong Sub; Nho, Kyoung Jin; Jeong, Hae Chang; Kim, Jihwa; Ahn, Youngkeun; Park, Woo Jin; Kim, Do Han			Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; SIGNALING PATHWAYS; PRESSURE-OVERLOAD; EXPRESSION; GROWTH; SIZE; CONTRACTILITY; ACTIVATION; INDUCTION	Cardiac hypertrophy is an adaptive response to various physiological and pathological stimuli. Phosphoinositide-3 kinase (PI3K) is a highly conserved lipid kinase involved in physiological cardiac hypertrophy (PHH). PI3K interacting protein1 (Pik3ip1) shares homology with the p85 regulatory subunit of PI3K and is known to interact with the p110 catalytic subunit of PI3K, leading to attenuation of PI3K activity in liver and immune cells. However, the role of Pik3ip1 in the heart remains unknown. In the present study, the effects of Pik3ip1 on cardiac hypertrophy were examined. We found that the expression level of Pik3ip1 was markedly higher in cardiomyocytes than in fibroblasts. The interaction of Pik3ip1 with the p110a subunit of PI3K in the heart was identified by immunoprecipitation using neonatal rat cardiomyocytes (NRCM). Approximately 35% knockdown of Pik3ip1 was sufficient to induce myocardial hypertrophy. Pik3ip1 deficiency was shown to lead to activation of PI3K/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway, increasing protein synthesis and cell size. However, adenovirus-mediated overexpression of Pik3ip1 attenuated PI3K-mediated cardiac hypertrophy. Pik3ip1 was upregulated by PHH due to swimming training, but not by pathological cardiac hypertrophy (PAH) due to pressure-overload, suggesting that Pik3ip1 plays a compensatory negative role for PHH. Collectively, our results elucidate the mechanisms for the roles of Pik3ip1 in PI3K/AKT signaling pathway.	[Song, Hong Ki; Kim, Jiyeon; Lee, Jong Sub; Nho, Kyoung Jin; Kim, Jihwa; Park, Woo Jin; Kim, Do Han] GIST, Sch Life Sci, Gwangju, South Korea; [Song, Hong Ki; Kim, Jiyeon; Lee, Jong Sub; Nho, Kyoung Jin; Kim, Jihwa; Park, Woo Jin; Kim, Do Han] GIST, Syst Biol Res Ctr, Gwangju, South Korea; [Jeong, Hae Chang; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University Hospital	Kim, DH (corresponding author), GIST, Sch Life Sci, Gwangju, South Korea.	dhkim@gist.ac.kr		Nho, Kyoung Jin/0000-0003-4478-4647	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning [2013M3A9A7046297]	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning	This work was supported by the 2014 GIST Systems Biology Infrastructure Establishment Grant and the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2013M3A9A7046297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Aoyagi T, 2011, CURR PHARM DESIGN, V17, P1818, DOI 10.2174/138161211796390976; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bisping E, 2012, J BIOL CHEM, V287, P9827, DOI 10.1074/jbc.M111.338749; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Cui XB, 2012, CARDIOVASC RES, V93, P69, DOI 10.1093/cvr/cvr273; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeFrances MC, 2012, EUR J IMMUNOL, V42, P2754, DOI 10.1002/eji.201141653; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gao Peng, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P572; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heusch G, 2011, J AM COLL CARDIOL, V57, P310, DOI 10.1016/j.jacc.2010.06.057; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Lorell BH, 2000, CIRCULATION, V102, P470; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Ma ZC, 2013, EUR J APPL PHYSIOL, V113, P2473, DOI 10.1007/s00421-013-2685-9; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Schmidt-Strassburger U, 2012, FASEB J, V26, P4990, DOI 10.1096/fj.12-208587; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Velagaleti Raghava S, 2010, Heart Fail Clin, V6, P115, DOI 10.1016/j.hfc.2009.08.002; Wong CC, 2014, NAT GENET, V46, P33, DOI 10.1038/ng.2846; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	41	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122251	10.1371/journal.pone.0122251	http://dx.doi.org/10.1371/journal.pone.0122251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826393	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800063
J	Bajocco, S; Dragoz, E; Gitas, I; Smiraglia, D; Salvati, L; Ricotta, C				Bajocco, Sofia; Dragoz, Eleni; Gitas, Ioannis; Smiraglia, Daniela; Salvati, Luca; Ricotta, Carlo			Mapping Forest Fuels through Vegetation Phenology: The Role of Coarse-Resolution Satellite Time-Series	PLOS ONE			English	Article							SPATIAL-PATTERNS; CLIMATE-CHANGE; IGNITION RISK; FIRE; MODIS; CLASSIFICATION; WILDFIRES; DYNAMICS; IDENTIFICATION; SEASONALITY	Traditionally fuel maps are built in terms of 'fuel types', thus considering the structural characteristics of vegetation only. The aim of this work is to derive a phenological fuel map based on the functional attributes of coarse-scale vegetation phenology, such as seasonality and productivity. MODIS NDVI 250m images of Sardinia (Italy), a large Mediterranean island with high frequency of fire incidence, were acquired for the period 2000-2012 to construct a mean annual NDVI profile of the vegetation at the pixel-level. Next, the following procedure was used to develop the phenological fuel map: (i) image segmentation on the Fourier components of the NDVI profiles to identify phenologically homogeneous landscape units, (ii) cluster analysis of the phenological units and post-hoc analysis of the fire-proneness of the phenological fuel classes (PFCs) obtained, (iii) environmental characterization (in terms of land cover and climate) of the PFCs. Our results showed the ability of coarse-resolution satellite time-series to characterize the fire-proneness of Sardinia with an adequate level of accuracy. The remotely sensed phenological framework presented may represent a suitable basis for the development of fire distribution prediction models, coarsescale fuel maps and for various biogeographic studies.	[Bajocco, Sofia; Smiraglia, Daniela] Consiglio Ric Agr & Anal Econ Agr, Res Unit Climatol & Meteorol Appl Agr CRA CMA, Rome, Italy; [Dragoz, Eleni; Gitas, Ioannis] Aristotle Univ Thessaloniki, Sch Forestry & Nat Environm, GR-54006 Thessaloniki, Greece; [Salvati, Luca] Consiglio Ric Agr & Anal Econ, Res Ctr Soil Plant Syst Studies CRA RPS, Rome, Italy; [Ricotta, Carlo] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Aristotle University of Thessaloniki; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome	Bajocco, S (corresponding author), Consiglio Ric Agr & Anal Econ Agr, Res Unit Climatol & Meteorol Appl Agr CRA CMA, Rome, Italy.	sofia.bajocco@entecra.it	Bajocco, Sofia/F-7701-2013; Gitas, Ioannis Z./C-3329-2008; Salvati, Luca/AAS-6179-2021; Smiraglia, Daniela/O-2429-2016	Bajocco, Sofia/0000-0003-2301-9188; Gitas, Ioannis Z./0000-0003-0056-5629; Smiraglia, Daniela/0000-0002-0427-248X; RICOTTA, Carlo/0000-0003-0818-3959	Italian Ministry of Agriculture and Forestry [DM 8608/7303/08]	Italian Ministry of Agriculture and Forestry	This research was funded within the Research Project "Agroscenari-Adaptation scenarios of Italian agriculture to climate change" by the Italian Ministry of Agriculture and Forestry with DM 8608/7303/08, 07 August 2008 (http://www.agroscenari.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl DE, 2006, REMOTE SENS ENVIRON, V104, P88, DOI 10.1016/j.rse.2006.05.003; Alcaraz-Segura D, 2006, GLOBAL ECOL BIOGEOGR, V15, P200, DOI 10.1111/j.1466-822x.2006.00215.x; Anderson H.E., 1982, USDA FOREST SERVICE; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arroyo LA, 2008, FOREST ECOL MANAG, V256, P1239, DOI 10.1016/j.foreco.2008.06.048; Azzali S, 2000, INT J REMOTE SENS, V21, P973, DOI 10.1080/014311600210380; Baatz M., 2000, MULTIRESOLUTION SEGM, VXII, P12, DOI DOI 10.1016/J.ISPRSJPRS.2003.10.002; Bajocco S, 2010, ECOL MODEL, V221, P59, DOI 10.1016/j.ecolmodel.2008.12.024; Bajocco S, 2008, LANDSCAPE ECOL, V23, P241, DOI 10.1007/s10980-007-9176-5; Bajocco S, 2012, ECOL INDIC, V23, P578, DOI 10.1016/j.ecolind.2012.05.013; Bajocco S, 2011, PROG PHYS GEOG, V35, P3, DOI 10.1177/0309133310380768; Bajocco S, 2010, ENVIRON MONIT ASSESS, V164, P445, DOI 10.1007/s10661-009-0905-x; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Brown ME, 2010, REMOTE SENS ENVIRON, V114, P2286, DOI 10.1016/j.rse.2010.05.005; Burgan RE, 1984, INT167 USDA FOR SERV; Catry FX, 2009, INT J WILDLAND FIRE, V18, P921, DOI 10.1071/WF07123; Clerici N, 2012, REMOTE SENS-BASEL, V4, P1781, DOI 10.3390/rs4061781; Conedera M, 2011, FOREST ECOL MANAG, V261, P2179, DOI 10.1016/j.foreco.2010.08.013; Curt T, 2013, J ENVIRON MANAGE, V117, P150, DOI 10.1016/j.jenvman.2012.12.006; De Angelis A, 2012, LANDSCAPE ECOL, V27, P1535, DOI 10.1007/s10980-012-9808-2; European Environment Agency, 2007, 172007 EEA, P66; Fensholt R, 2012, REMOTE SENS ENVIRON, V121, P144, DOI 10.1016/j.rse.2012.01.017; Fiorucci P, 2007, EARTH INTERACT, V11, DOI 10.1175/EI199.1; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Gu YX, 2010, REMOTE SENS-BASEL, V2, P526, DOI 10.3390/rs2020526; Guglietta D, 2011, REMOTE SENS LETT, V2, P213, DOI 10.1080/01431161.2010.512927; Hargrove WW, 2009, PHOTOGRAMM ENG REM S, V75, P1150; Ivits E, 2012, GLOBAL PLANET CHANGE, V88-89, P85, DOI 10.1016/j.gloplacha.2012.03.010; Jakubauskas ME, 2002, COMPUT ELECTRON AGR, V37, P127, DOI 10.1016/S0168-1699(02)00116-3; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Julien Y, 2006, REMOTE SENS ENVIRON, V103, P43, DOI 10.1016/j.rse.2006.03.011; Lanorte A, 2008, IFOREST, V1, P60, DOI 10.3832/ifor0451-0010060; Lasaponara R, 2005, INT J REMOTE SENS, V26, P853, DOI 10.1080/0143116042000274131; Legendre P, 1998, NUMERICAL ECOLOGY, P673; Li CG, 2012, INT J REMOTE SENS, V33, P922, DOI 10.1080/01431161.2010.536183; Lowe SH, 2011, IEEE J-STARS, V4, P890, DOI 10.1109/JSTARS.2011.2157659; Ma XL, 2013, REMOTE SENS ENVIRON, V139, P97, DOI 10.1016/j.rse.2013.07.030; Mallinis G, 2008, ISPRS J PHOTOGRAMM, V63, P237, DOI 10.1016/j.isprsjprs.2007.08.007; Manes F, 2010, PLANT BIOSYST, V144, P202, DOI 10.1080/11263500903560801; Merrill D.F., 1987, GLOSSARY FOREST FIRE; Moreira F, 2001, LANDSCAPE ECOL, V16, P557, DOI 10.1023/A:1013130528470; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; Nemani R, 2009, REMOTE SENS ENVIRON, V113, P1497, DOI 10.1016/j.rse.2008.06.017; Nunes MCS, 2005, LANDSCAPE ECOL, V20, P661, DOI 10.1007/s10980-005-0070-8; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Paruelo JM, 2004, GLOBAL ECOL BIOGEOGR, V13, P385, DOI 10.1111/j.1466-822X.2004.00118.x; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pereira MG, 2005, AGR FOREST METEOROL, V129, P11, DOI 10.1016/j.agrformet.2004.12.007; Pezzatti GB, 2009, PLANT BIOSYST, V143, P609, DOI 10.1080/11263500903233292; Pollard KS, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1404; Ricotta C, 1999, ISPRS J PHOTOGRAMM, V54, P325, DOI 10.1016/S0924-2716(99)00028-3; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Thonicke K, 2006, NAT HAZARDS, V38, P283, DOI 10.1007/s11069-005-8639-8; Torma M, 2011, P SPIE EARTH RESOURC; Wessels K, 2011, APPL VEG SCI, V14, P49, DOI 10.1111/j.1654-109X.2010.01100.x; White MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021961; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	59	59	59	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119811	10.1371/journal.pone.0119811	http://dx.doi.org/10.1371/journal.pone.0119811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822505	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700046
J	Ikeda, M; Ide, T; Fujino, T; Arai, S; Saku, K; Kakino, T; Tyynismaa, H; Yamasaki, T; Yamada, K; Kang, DC; Suomalainen, A; Sunagawa, K				Ikeda, Masataka; Ide, Tomomi; Fujino, Takeo; Arai, Shinobu; Saku, Keita; Kakino, Takamori; Tyynismaa, Henna; Yamasaki, Toshihide; Yamada, Ken-ichi; Kang, Dongchon; Suomalainen, Anu; Sunagawa, Kenji			Overexpression of TFAM or Twinkle Increases mtDNA Copy Number and Facilitates Cardioprotection Associated with Limited Mitochondrial Oxidative Stress	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR-A; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; CARDIAC MYOCYTES; DNA DAMAGE; NITROXIDE SWITCH; VOLUME OVERLOAD; MICE; DYSFUNCTION; CARDIOMYOPATHY	Background Mitochondrial DNA (mtDNA) copy number decreases in animal and human heart failure (HF), yet its role in cardiomyocytes remains to be elucidated. Thus, we investigated the cardioprotective function of increased mtDNA copy number resulting from the overexpression of human transcription factor A of mitochondria (TFAM) or Twinkle helicase in volume overload (VO)-induced HF. Methods and Results Two strains of transgenic (TG) mice, one overexpressing TFAM and the other overexpressing Twinkle helicase, exhibit an approximately 2-fold equivalent increase in mtDNA copy number in heart. These TG mice display similar attenuations in eccentric hypertrophy and improved cardiac function compared to wild-type (WT) mice without any deterioration of mitochondrial enzymatic activities in response to VO, which was accompanied by a reduction in matrix-metalloproteinase (MMP) activity and reactive oxygen species after 8 weeks of VO. Moreover, acute VO-induced MMP-2 and MMP-9 upregulation was also suppressed at 24 h in both TG mice. In isolated rat cardiomyocytes, mitochondrial reactive oxygen species (mitoROS) upregulated MMP-2 and MMP-9 expression, and human TFAM (hTFAM) overexpression suppressed mitoROS and their upregulation. Additionally, mitoROS were equally suppressed in H9c2 rat cardiomyoblasts that overexpress hTFAM or rat Twinkle, both of which exhibit increased mtDNA copy number. Furthermore, mitoROS and mitochondrial protein oxidation from both TG mice were suppressed compared to WT mice. Conclusions The overexpression of TFAM or Twinkle results in increased mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress. Our findings suggest that increasing mtDNA copy number could be a useful therapeutic strategy to target mitoROS in HF.	[Ikeda, Masataka; Ide, Tomomi; Fujino, Takeo; Arai, Shinobu; Saku, Keita; Kakino, Takamori; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Helsinki, Helsinki, Finland; [Yamasaki, Toshihide; Yamada, Ken-ichi] Kyushu Univ, Fac Pharmaceut Sci, Dept Biofunct Sci, Fukuoka 812, Japan; [Kang, Dongchon] Kyushu Univ, Dept Clin Chem & Lab Med, Grad Sch Med Sci, Fukuoka 812, Japan	Kyushu University; University of Helsinki; Kyushu University; Kyushu University	Ide, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan.	tomomi_i@cardiol.med.kyushu-u.ac.jp	Saku, Keita/AAE-8639-2021; Yamada, Ken-ichi/E-6318-2012	Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Yamada, Ken-ichi/0000-0003-2100-8477; Tyynismaa, Henna/0000-0002-2493-2422	JSPS KAKENHI [23220013, 23591084, 50163043]; Ministry of Culture, Sports, Sciences and Technology; Ministry of Health, Labour, and Welfare of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Culture, Sports, Sciences and Technology; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by JSPS KAKENHI Grant Number 23220013, 23591084, 50163043, and the Strategic Funds for the Promotion of Science and Technology from Ministry of Culture, Sports, Sciences and Technology. This work was also supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fujino T, 2012, MITOCHONDRION, V12, P449, DOI 10.1016/j.mito.2012.06.002; GARCIA R, 1990, CARDIOVASC RES, V24, P430, DOI 10.1093/cvr/24.5.430; Gladden JD, 2011, FREE RADICAL BIO MED, V51, P1975, DOI 10.1016/j.freeradbiomed.2011.08.022; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Li HZ, 2012, ADV EXP MED BIOL, V942, P39, DOI 10.1007/978-94-007-2869-1_2; Matsuoka Y, 2012, FREE RADICAL BIO MED, V53, P2112, DOI 10.1016/j.freeradbiomed.2012.09.032; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Mishra PK, 2010, AM J PHYSIOL-HEART C, V298, pH451, DOI 10.1152/ajpheart.00682.2009; Mito F, 2011, FREE RADICAL RES, V45, P1103, DOI 10.3109/10715762.2011.595410; Moshal KS, 2005, AM J PHYSIOL-HEART C, V288, pH2770, DOI 10.1152/ajpheart.01146.2004; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011; Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020; Ovechkin AV, 2005, J APPL PHYSIOL, V99, P2398, DOI 10.1152/japplphysiol.00442.2005; Pohjoismaki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067642; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163	39	87	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119687	10.1371/journal.pone.0119687	http://dx.doi.org/10.1371/journal.pone.0119687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822152	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700043
J	Stuby, FM; Dobele, S; Schaffer, SD; Mueller, S; Ateschrang, A; Baumann, M; Zieker, D				Stuby, Fabian M.; Doebele, Stefan; Schaeffer, Susanne-Dorothea; Mueller, Simon; Ateschrang, Atesch; Baumann, Matthias; Zieker, Derek			Early Functional Postoperative Therapy of Distal Radius Fracture with a Dynamic Orthosis: Results of a Prospective Randomized Cross-Over Comparative Study	PLOS ONE			English	Article							BRIDGING EXTERNAL FIXATION; VOLAR LOCKING PLATE; REDISPLACED UNSTABLE FRACTURES; CONTROLLED-TRIAL; SURGICAL-TREATMENT; EPIDEMIOLOGY; QUESTIONNAIRE; PLASTER; FOREARM; SYSTEM	Introduction This study was conducted according to GCP criteria as a prospective randomized crossover study. The primary goal of the study was to determine clinical findings and patient satisfaction with postoperative treatment. 29 patients with a distal radius fracture that was surgically stabilized from volar and who met the inclusion criteria were enrolled over a 12-month period. Each patient randomly received either a dorsal plaster splint or a vacuum-fit flexible but blocked orthosis applied postoperatively in the operating theatre to achieve postoperative immobilization. After one week all patients were crossed over to the complementary device maintaining the immobilization until end of week 2. After week 2 both groups were allowed to exercise wrist mobility with a physiotherapist, in the orthosis group the device was deblocked, thus allowing limited wrist mobility. After week 4 the devices were removed in both groups. Follow-up exams were performed after postoperative weeks 1, 2, 4 and 12. Results and Discussion Results were determined after week 1 and 2 using SF 36 and a personally compiled questionnaire; after weeks 4 and 12 with a clinical check-up, calculation of ROM and the DASH Score. Comparison of the two groups showed a significant difference in ROM for volar flexion after 4 weeks, but no significant differences in DASH Score, duration of disability or x-ray findings. With regard to satisfaction with comfort and hygiene, patients were significantly more satisfied with the dynamic orthosis, and 23 of the 29 patients would prefer the flexible vacuum orthosis in future.	[Stuby, Fabian M.; Doebele, Stefan; Schaeffer, Susanne-Dorothea; Ateschrang, Atesch] Univ Tubingen, BG Trauma Ctr, D-72076 Tubingen, Germany; [Mueller, Simon] Muon Stat Stat Serv, D-70197 Stuttgart, Germany; [Baumann, Matthias] Paracelsus Hosp Ruit, D-73760 Ostfildern, Germany; [Zieker, Derek] Univ Tubingen, Dept Gen Surg, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Dobele, S (corresponding author), Univ Tubingen, BG Trauma Ctr, Schnarrenbergstr 95, D-72076 Tubingen, Germany.	Sdoebele@bgu-tuebingen.de		Dobele, Stefan/0000-0002-8827-043X	OPED GmbH, Germany	OPED GmbH, Germany	The study was financed by a grant from OPED GmbH Medizinpark 1, D-83626 Valley, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khudairy Ammar, 2013, Eur J Orthop Surg Traumatol, V23, P647, DOI 10.1007/s00590-012-1042-8; Arora R, 2011, J BONE JOINT SURG AM, V93A, P2146, DOI 10.2106/JBJS.J.01597; Atroshi I, 2006, ACTA ORTHOP, V77, P445, DOI 10.1080/17453670610046389; Berner SH, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-53; Chen NC, 2007, J BONE JOINT SURG AM, V89A, P2051, DOI 10.2106/JBJS.G.00020; Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322; Collinge C, 2007, J ORTHOP TRAUMA, V21, P355, DOI 10.1097/BOT.0b013e3180ca83c7; Cui Z, 2012, INJURY, V43, P1006, DOI 10.1016/j.injury.2011.11.018; de Putter CE, 2013, INJURY, V44, P421, DOI 10.1016/j.injury.2012.10.025; Egol KA, 2004, J ORTHOP TRAUMA, V18, P488, DOI 10.1097/00005131-200409000-00003; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Fowler JR, 2013, J HAND SURG-AM, V38A, P2198, DOI 10.1016/j.jhsa.2013.08.116; Gummesson C, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-11; Hayes AJ, 2008, ACTA ORTHOP, V79, P540, DOI 10.1080/17453670710015553; Hove LM, 2010, J BONE JOINT SURG AM, V92A, P1687, DOI 10.2106/JBJS.H.01236; Inglis M, 2013, BONE JOINT J, V95B, P1285, DOI 10.1302/0301-620X.95B9.30666; Jakubietz MG, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-8; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jongs RA, 2012, J PHYSIOTHER, V58, P173, DOI 10.1016/S1836-9553(12)70108-X; Karantana A, 2013, J BONE JOINT SURG AM, V95A, P1737, DOI 10.2106/JBJS.L.00232; Kock H, 2005, Handchir Mikrochir Plast Chir, V37, P303, DOI 10.1055/s-2005-865897; Krishnan J, 2003, J HAND SURG-BRIT EUR, V28B, P417, DOI 10.1016/S0266-7681(03)00083-4; Loveridge J, 2013, J HAND SURG-ASIAN-PA, V18, P159, DOI 10.1142/S0218810413500184; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P404, DOI 10.1302/0301-620X.78B3.0780404; McQueen MM, 1998, J BONE JOINT SURG BR, V80B, P665, DOI 10.1302/0301-620X.80B4.8150; Mehling I, 2012, HANDCHIR MIKROCHIR P, V44, P300, DOI 10.1055/s-0032-1323761; O'Connor D, 2003, J HAND SURG-BRIT EUR, V28B, P50, DOI 10.1054/jhsb.2002.0864; Osada D, 2008, J HAND SURG-AM, V33A, P691, DOI 10.1016/j.jhsa.2008.01.024; Osti M, 2012, ORTHOPEDICS, V35, pE1613, DOI 10.3928/01477447-20121023-18; Protopsaltis TS, 2008, J HAND SURG-AM, V33A, P958, DOI 10.1016/j.jhsa.2008.04.018; SOMMERKAMP TG, 1994, J BONE JOINT SURG AM, V76A, P1149, DOI 10.2106/00004623-199408000-00005; Stockle U, 2000, UNFALLCHIRURG, V103, P215, DOI 10.1007/s001130050525; Uchikura C, 2004, J ORTHOP SCI, V9, P560, DOI 10.1007/s00776-004-0828-x; Wilcke MKT, 2013, ACTA ORTHOP, V84, P292, DOI 10.3109/17453674.2013.792035	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117720	10.1371/journal.pone.0117720	http://dx.doi.org/10.1371/journal.pone.0117720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822197	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700013
J	Wang, Z; Maity, A; Hsiao, CK; Voora, D; Kaddurah-Daouk, R; Tzeng, JY				Wang, Zhi; Maity, Arnab; Hsiao, Chuhsing Kate; Voora, Deepak; Kaddurah-Daouk, Rima; Tzeng, Jung-Ying			Module-Based Association Analysis for Omics Data with Network Structure	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; SACCHAROMYCES-CEREVISIAE; GENOME; CONSERVATION; SIMILARITY; CENTRALITY; REGRESSION; SERTRALINE; BIOLOGY	Module-based analysis (MBA) aims to evaluate the effect of a group of biological elements sharing common features, such as SNPs in the same gene or metabolites in the same pathways, and has become an attractive alternative to traditional single bio-element approaches. Because bio-elements regulate and interact with each other as part of network, incorporating network structure information can more precisely model the biological effects, enhance the ability to detect true associations, and facilitate our understanding of the underlying biological mechanisms. How-ever, most MBA methods ignore the network structure information, which depicts the interaction and regulation relationship among basic functional units in biology system. We construct the con-nectivity kernel and the topology kernel to capture the relationship among bio-elements in a mod-ule, and use a kernel machine framework to evaluate the joint effect of bio-elements. Our proposed kernel machine approach directly incorporates network structure so to enhance the study effi-ciency; it can assess interactions among modules, account covariates, and is computational effi-cient. Through simulation studies and real data application, we demonstrate that the proposed network-based methods can have markedly better power than the approaches ignoring network information under a range of scenarios.	[Wang, Zhi; Tzeng, Jung-Ying] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Maity, Arnab; Tzeng, Jung-Ying] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Voora, Deepak] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Kaddurah-Daouk, Rima] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Tzeng, Jung-Ying] Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Taiwan University; Duke University; Duke University; National Cheng Kung University	Tzeng, JY (corresponding author), N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.	jytzeng@stat.ncsu.edu	yuan, tao/Q-3137-2016; Maity, Arnab/M-8142-2016	yuan, tao/0000-0002-0904-9770; Maity, Arnab/0000-0002-3364-8933; Kaddurah-Daouk, Rima/0000-0003-1858-5732; hsiao, chuhsing kate/0000-0003-4905-8484	National Institutes of Health (NIH) [R00 ES017744, NIH R01 MH084022, P01 CA142538]; Ministry of Science and Technology (MOST) Taiwan [MOST 103-2314-B-002-039-MY3]; NIH [RC1 GM091083, RC2 M092729]; NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) [R00 ES017744 to AM, NIH R01 MH084022 to JYT, P01 CA142538 to JYT] and by the Ministry of Science and Technology (MOST) Taiwan [MOST 103-2314-B-002-039-MY3 to CKH]. The sample collection was supported by NIH [RC1 GM091083]; Pharmacometabolomics Research Network was supported by NIH [RC2 M092729].	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Aluru M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks904; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001353; Chen XH, 2006, BIOINFORMATICS, V22, P2952, DOI 10.1093/bioinformatics/btl491; Cristianini N, 2000, INTRO SUPPORT VECTOR; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Fisher R., 1970, STAT METHODS RES WOR; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Guaderman WJ, 2007, GENET EPIDEMIOL, V32, P108; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaddurah-Daouk R, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.142; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lagarde M, 2010, PROSTAG LEUKOTR ESS, V82, P227, DOI 10.1016/j.plefa.2010.02.017; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li F, 2010, J AM STAT ASSOC, V105, P491; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Monni S, 2010, UPENN BIOSTATISTICS; Nariai N, 2005, BIOINFORMATICS, V21, P206, DOI 10.1093/bioinformatics/bti1133; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; SILVER MJ, 1973, PROSTAGLANDINS, V4, P863, DOI 10.1016/0090-6980(73)90121-4; Snoep JL, 2005, TOP CURR GENET, V13, P13, DOI 10.1007/b106456; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Tai F, 2009, BAYESIAN VARIABLE SE; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Tzeng JY, 2011, AM J HUM GENET, V89, P277, DOI 10.1016/j.ajhg.2011.07.007; Voora D, 2013, J AM COLL CARDIOL, V62, P1267, DOI 10.1016/j.jacc.2013.05.073; Voora D, 2012, J THROMB THROMBOLYS, V33, P246, DOI 10.1007/s11239-012-0683-0; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang Z, 2015, GENET EPIDEMIOL, V39, P122, DOI 10.1002/gepi.21877; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Wikoff WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057639; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068283; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122309	10.1371/journal.pone.0122309	http://dx.doi.org/10.1371/journal.pone.0122309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822417	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700164
J	Moss, CX; Brown, E; Hamilton, A; Van der Veken, P; Augustyns, K; Mottram, JC				Moss, Catherine X.; Brown, Elaine; Hamilton, Alana; Van der Veken, Pieter; Augustyns, Koen; Mottram, Jeremy C.			An Essential Signal Peptide Peptidase Identified in an RNAi Screen of Serine Peptidases of Trypanosoma brucei	PLOS ONE			English	Article							OLIGOPEPTIDASE-B; PROLYL OLIGOPEPTIDASE; DIPEPTIDYL PEPTIDASE-8; AFRICAN TRYPANOSOME; CELL INVASION; BLOOD-STREAM; INHIBITORS; CRUZI; INTERFERENCE; ISOINDOLINE	The serine peptidases of Trypanosoma brucei have been viewed as potential drug targets. In particular, the S9 prolyl oligopeptidase subfamily is thought to be a good avenue for drug discovery. This is based on the finding that some S9 peptidases are secreted and active in the mammalian bloodstream, and that they are a class of enzyme against which drugs have successfully been developed. We collated a list of all serine peptidases in T. brucei, identifying 20 serine peptidase genes, of which nine are S9 peptidases. We screened all 20 serine peptidases by RNAi to determine which, if any, are essential for bloodstream form T. brucei survival. All S9 serine peptidases were dispensable for parasite survival in vitro, even when pairs of similar genes, coding for oligopeptidase B or prolyl oligopeptidase, were targeted simultaneously. We also found no effect on parasite survival in an animal host when the S9 peptidases oligopeptidase B, prolyl oligopeptidase or dipeptidyl peptidase 8 were targeted. The only serine peptidase to emerge from the RNAi screen as essential was a putative type-I signal peptide peptidase (SPP1). This gene was essential for parasite survival both in vitro and in vivo. The growth defect conferred by RNAi depletion of SPP1 was rescued by expression of a functional peptidase from an RNAi resistant SPP1 gene. However, expression of catalytically inactive SPP1 was unable to rescue cells from the SPP1 depleted phenotype, demonstrating that SPP1 serine peptidase activity is necessary for T. brucei survival.	[Moss, Catherine X.; Brown, Elaine; Hamilton, Alana; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Van der Veken, Pieter; Augustyns, Koen] Univ Antwerp, Dept Pharmaceut Sci, Med Chem UAMC, B-2020 Antwerp, Belgium	University of Glasgow; University of Antwerp	Moss, CX (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	catherinexmoss@gmail.com	Augustyns, Koen/ABG-2306-2020; Augustyns, Koen/C-1102-2008; Van der Veken, Pieter/P-5819-2016	Augustyns, Koen/0000-0002-5203-4339; Augustyns, Koen/0000-0002-5203-4339; Van der Veken, Pieter/0000-0003-1208-3571; Mottram, Jeremy/0000-0001-5574-3766; Brown, Elaine/0000-0002-6360-9118	Wellcome Trust [WT091117MA, 085349]; Medical Research Council [G0700127]; Beit Memorial Fellowship for Medical Research; MRC [G0700127] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Beit Memorial Fellowship for Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust Grant WT091117MA www.wellcome.ac.uk. The Wellcome Trust Core Funding Grant 085349 www.wellcome.ac.uk. The Medical Research Council Grant G0700127 (to JCM) www.mrc.ac.uk. CXM was supported by a Beit Memorial Fellowship for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Bastos IMD, 2013, CURRENT MED CHEM; Bastos IMD, 2010, MICROBES INFECT, V12, P457, DOI 10.1016/j.micinf.2010.02.007; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Durand-Dubief M, 2003, MOL BIOCHEM PARASIT, V129, P11, DOI 10.1016/S0166-6851(03)00071-9; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Gilbert IH, 2014, PARASITOLOGY; Grellier P, 2001, J BIOL CHEM, V276, P47078, DOI 10.1074/jbc.M106017200; Hackett F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002704; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kangethe RT, 2012, MOL BIOCHEM PARASIT, V182, P7, DOI 10.1016/j.molbiopara.2011.11.007; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 2001, INFECT IMMUN, V69, P2757, DOI 10.1128/IAI.69.4.2757-2761.2001; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Santos JM, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI 10.1016/j.molbiopara.2011.11.010; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Tomita T, 2013, J BIOL CHEM, V288, P14673, DOI 10.1074/jbc.R113.463281; Troeberg L, 1996, EUR J BIOCHEM, V238, P728, DOI 10.1111/j.1432-1033.1996.0728w.x; Van der Veken P, 2008, BIOORG MED CHEM LETT, V18, P4154, DOI 10.1016/j.bmcl.2008.05.080; Van der Veken P, 2007, J MED CHEM, V50, P5568, DOI 10.1021/jm701005a; Van der Veken P, 2007, CURR TOP MED CHEM, V7, P621, DOI 10.2174/156802607780091046; Van Goethem S, 2008, BIOORG MED CHEM LETT, V18, P4159, DOI 10.1016/j.bmcl.2008.05.079; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; World Health Organization, 2021, HUM AFR TRYP MIAS SL	36	10	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123241	10.1371/journal.pone.0123241	http://dx.doi.org/10.1371/journal.pone.0123241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816352	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600207
J	Zhang, YJ; Zheng, SH; Geng, YY; Xue, J; Wang, ZS; Xie, XX; Wang, JR; Zhang, SY; Hou, YL				Zhang, Yujiao; Zheng, Shaohua; Geng, Yangyang; Xue, Jiao; Wang, Zhongsu; Xie, Xinxing; Wang, Jiangrong; Zhang, Shuyu; Hou, Yinglong			MicroRNA Profiling of Atrial Fibrillation in Canines: MiR-206 Modulates Intrinsic Cardiac Autonomic Nerve Remodeling by Regulating SOD1	PLOS ONE			English	Article							NEUROMUSCULAR SYNAPSES; OXIDATIVE STRESS; EXPRESSION; MIRNAS; RADIOSENSITIVITY; IDENTIFICATION; REGENERATION; CONTRIBUTES; CELLS; MODEL	Background A critical mechanism in atrial fibrillation (AF) is cardiac autonomic nerve remodeling (ANR). MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. Numerous miRNAs are involved in diseases of the nervous and cardiovascular systems. Objective We aimed to assess the underlying role of miRNAs in regulating cardiac ANR in AF by right atrial tachypacing (A-TP) in canines. Methods and Results Following 4-week A-TP, the superior left ganglionated plexuses (SLGPs), which are embedded in the fat pads of the left atrium, were subjected to miRNA expression profiling to screen preferentially expressed miRNAs. Sixteen miRNAs showed significantly differential expression between the control and A-TP groups, including miR-206, miR-203, miR-224 and miR-137. In particular, we focused on miR-206, which was elevated similar to 10-fold in A-TP dogs. Forced expression of miR-206 through lentiviral infection based on A-TP in vivo significantly shortened the atrial effective refractory period (AERP) (81 +/- 7 vs. 98 +/- 7 ms, P < 0.05). Immunohistochemical analysis showed that the regeneration of nerves increased more than 2-fold by miR-206 overexpression (P < 0.01). The expression of superoxide dismutase 1 (SOD1) was repressed by miR-206 overexpression by Western blot and luciferase assay, indicative of SOD1 as a direct target of miR-206. Overexpression of miR-206 increased reactive oxygen species (ROS) levels in vitro and in vivo, whereas miR-206 silencing attenuated irradiation- or A-TP-induced ROS. Knockdown of SOD1 effectively abolished ROS reduction caused by miR-206 silencing. Conclusions Our results found the differential expression of miRNAs in response to ANR in AF and elucidated the important role of miR-206 by targeting SOD1. The study illustrated the novel molecular mechanism of ANR and indicated a potential therapeutic target for AF.	[Zhang, Yujiao; Zheng, Shaohua; Wang, Zhongsu; Xie, Xinxing; Wang, Jiangrong; Hou, Yinglong] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250014, Peoples R China; [Zhang, Yujiao; Zheng, Shaohua] Shandong Univ, Sch Med, Jinan 250012, Peoples R China; [Geng, Yangyang; Xue, Jiao; Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou 215123, Peoples R China; [Geng, Yangyang; Xue, Jiao; Zhang, Shuyu] Soochow Univ, Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiat Med, Suzhou 215123, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Soochow University - China; Soochow University - China	Zhang, SY (corresponding author), Soochow Univ, Sch Radiat Med & Protect, 199 Renai Rd, Suzhou 215123, Peoples R China.	zhang.shuyu@hotmail.com; houyinglong2013@hotmail.com			National Natural Science Foundation of China [81270237]; specialized research fund for the doctoral program of higher education [20110131110063]; Natural Science Foundation of Shandong Province [2012ZRB14226]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized research fund for the doctoral program of higher education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81270237), the specialized research fund for the doctoral program of higher education (20110131110063), the Natural Science Foundation of Shandong Province (2012ZRB14226) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardell, 1994, NEUROCARDIOLOGY, P95; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Arora RC, 2003, ANAT REC PART A, V271A, P249, DOI 10.1002/ar.a.10030; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Chang CM, 2001, CIRCULATION, V103, P22; Feng HJ, 2014, BRAZ J MED BIOL RES, V47, P361, DOI 10.1590/1414-431X20142937; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; Gao Z, 2008, FREE RADICAL BIO MED, V45, P1501, DOI 10.1016/j.freeradbiomed.2008.08.009; Goette A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00236; Goette A, 2012, INT J CARDIOL, V154, P141, DOI 10.1016/j.ijcard.2010.09.004; Goldsmit Y, 2001, CELL MOL NEUROBIOL, V21, P753, DOI 10.1023/A:1015108306171; Grist CG, 2010, CELL METAB, V12, P425, DOI 10.1016/j.cmet.2010.10.007; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085639; Kennedy KAM, 2012, CELL MOL LIFE SCI, V69, P215, DOI 10.1007/s00018-011-0807-2; Kennedy KAM, 2010, J BIOL CHEM, V285, P17974, DOI 10.1074/jbc.M109.084616; Lenaerts I, 2013, EUROPACE, V15, P754, DOI 10.1093/europace/eut012; Lin N, 2010, NEUROSURGERY, V66, pN19, DOI 10.1227/01.neu.0000369898.34291.27; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Maciotta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043464; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Murphy NF, 2007, HEART, V93, P606, DOI 10.1136/hrt.2006.107573; Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16; Ferreira LRP, 2014, INT J CARDIOL, V175, P409, DOI 10.1016/j.ijcard.2014.05.019; Rajan S, 2003, BASIC RES CARDIOL, V98, P39, DOI 10.1007/s00395-003-0382-2; Rossi L, 2000, INT J CANCER, V85, P667, DOI 10.1002/(SICI)1097-0215(20000301)85:5<667::AID-IJC12>3.0.CO;2-1; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wu ZY, 2014, INT J MOL SCI, V15, P9531, DOI 10.3390/ijms15069531; Yu Fu-sheng, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P644; Yu LL, 2012, HEART RHYTHM, V9, P804, DOI 10.1016/j.hrthm.2011.12.023; YUAN BX, 1994, ANAT REC, V239, P75, DOI 10.1002/ar.1092390109; Yue JQ, 2013, LAB INVEST, V93, P748, DOI 10.1038/labinvest.2013.63; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zheng S, 2013, PACING CLIN ELECTROP, V37, P745, DOI [10.1111/pace, DOI 10.1111/PACE]	46	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122674	10.1371/journal.pone.0122674	http://dx.doi.org/10.1371/journal.pone.0122674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816284	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600189
J	Cleveland, AA; Harrison, LH; Farley, MM; Hollick, R; Stein, B; Chiller, TM; Lockhart, SR; Park, BJ				Cleveland, Angela Ahlquist; Harrison, Lee H.; Farley, Monica M.; Hollick, Rosemary; Stein, Betsy; Chiller, Tom M.; Lockhart, Shawn R.; Park, Benjamin J.			Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008-2013: Results from Population-Based Surveillance	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; SUSCEPTIBILITY; GLABRATA; TRENDS; ECHINOCANDINS; MUTATIONS; HOSPITALS; CLSI	Background Recent reports have demonstrated a decline in bacterial bloodstream infections (BSIs) following adherence to central line insertion practices; however, declines have been less evident for BSIs due to Candida species. Methods We conducted active, population-based laboratory surveillance for candidemia in metropolitan Atlanta, GA and Baltimore, MD over a 5-year period. We calculated annual candidemia incidence and antifungal drug resistance rates. Results We identified 3,848 candidemia cases from 2008-2013. Compared with 2008, candidemia incidence per 100,000 person-years decreased significantly by 2013 in both locations (GA: 14.1 to 9.5, p< 0.001; MD: 30.9 to 14.4, p< 0.001). A total of 3,255 cases (85%) had a central venous catheter (CVC) in place within 2 days before the BSI culture date. In both locations, the number of CVC-associated cases declined (GA: 473 to 294; MD: 384 to 151). Candida albicans (CA, 36%) and Candida glabrata (CG, 27%) were the most common species recovered. In both locations, the proportion of cases with fluconazole resistance decreased (GA: 8.0% to 7.1%, -10%; MD: 6.6% to 4.9%, -25%), while the proportion of cases with an isolate resistant to an echinocandin increased (GA: 1.2% to 2.9%, +147%; MD: 2.0% to 3.5%, +77%). Most (74%) echinocandin-resistant isolates were CG; 17 (< 1%) isolates were resistant to both drug categories (multidrug resistant [MDR], 16/17 were CG). The proportion of CG cases with MDR Candida increased from 1.8% to 2.6%. Conclusions We observed a significant decline in the incidence of candidemia over a five-year period, and increases in echinocandin-resistant and MDR Candida. Efforts to strengthen infection control practices may be preventing candidemia among high-risk patients. Further surveillance for resistant Candida is warranted.	[Cleveland, Angela Ahlquist; Chiller, Tom M.; Lockhart, Shawn R.; Park, Benjamin J.] Ctr Dis Control & Prevent, Mycot Dis Branch, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Farley, Monica M.; Stein, Betsy] Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Georgia Emerging Infect Program, Atlanta, GA USA; [Farley, Monica M.; Stein, Betsy] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Cleveland, AA (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	ara0@cdc.gov	Cleveland, Angela Ahlquist/Q-2778-2019	Cleveland, Angela Ahlquist/0000-0003-1375-8964				Alexander BD, 2013, CLIN INFECT DIS, V56, P1724, DOI 10.1093/cid/cit136; [Anonymous], 2012, MAR VIT STAT ANN REP; [Anonymous], 2012, US RESIDENT POPULATI; Cleveland AA, 2012, CLIN INFECT DIS, V55, P1352, DOI 10.1093/cid/cis697; Dixon-Woods M, 2013, INFECT CONT HOSP EP, V34, P555, DOI 10.1086/670630; Espinel-Ingroff A, 2013, ANTIMICROB AGENTS CH, V57, P5836, DOI 10.1128/AAC.01519-13; Fagan RP, 2013, INFECT CONT HOSP EP, V34, P893, DOI 10.1086/671724; Hammarskjold F, 2013, J HOSP INFECT, V85, P60, DOI 10.1016/j.jhin.2013.06.002; Institute CaLS, 2008, M27A3 I CALS CLIN LA, Vthird; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Lee GM, 2012, NEW ENGL J MED, V367, P1428, DOI 10.1056/NEJMsa1202419; Lewis James S 2nd, 2013, Antimicrob Agents Chemother, V57, P4559, DOI 10.1128/AAC.01144-13; Lockhart SR, 2012, J CLIN MICROBIOL, V50, P3435, DOI 10.1128/JCM.01283-12; Marcos M, 2011, J ANTIMICROB CHEMOTH, V66, P2119, DOI 10.1093/jac/dkr231; Ong A, 2011, ARCH SURG-CHICAGO, V146, P302, DOI 10.1001/archsurg.2011.9; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Peasah Samuel K, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.03.a08; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Pham CD, 2014, J CLIN MICROBIOL, V52, P790, DOI 10.1128/JCM.03378-13; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; REAGAN DR, 1990, J CLIN MICROBIOL, V28, P2733, DOI 10.1128/JCM.28.12.2733-2738.1990; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; US Department of Health and Human Services (USDHHS), 2010, NAT ACT PLAN RED HEA; Wise ME, 2013, INFECT CONT HOSP EP, V34, P547, DOI 10.1086/670629; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	29	177	188	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120452	10.1371/journal.pone.0120452	http://dx.doi.org/10.1371/journal.pone.0120452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822249	gold, Green Published			2022-12-27	WOS:000352134700064
J	Crowell, J; Wiley, JA; Bessen, RA				Crowell, Jenna; Wiley, James A.; Bessen, Richard A.			Lesion of the Olfactory Epithelium Accelerates Prion Neuroinvasion and Disease Onset when Prion Replication Is Restricted to Neurons	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; TRANSMISSIBLE MINK ENCEPHALOPATHY; RECEPTOR NEURONS; CELL-DEATH; DOSE-RESPONSE; LYMPHORETICULAR-SYSTEM; GASTROINTESTINAL-TRACT; DISTINCT STRAINS; LYMPHOID-TISSUES; NATURAL SCRAPIE	Natural prion diseases of ruminants are moderately contagious and while the gastrointestinal tract is the primary site of prion agent entry, other mucosae may be entry sites in a subset of infections. In the current study we examined prion neuroinvasion and disease induction following disruption of the olfactory epithelium in the nasal mucosa since this site contains environmentally exposed olfactory sensory neurons that project directly into the central nervous system. Here we provide evidence for accelerated prion neuroinvasion and clinical onset from the olfactory mucosa after disruption and regeneration of the olfactory epithelium and when prion replication is restricted to neurons. In transgenic mice with neuron restricted replication of prions, there was a reduction in survival when the olfactory epithelium was disrupted prior to intranasal inoculation and there was >25% decrease in the prion incubation period. In a second model, the neurotropic DY strain of transmissible mink encephalopathy was not pathogenic in hamsters by the nasal route, but 50% of animals exhibited brain infection and/or disease when the olfactory epithelium was disrupted prior to intranasal inoculation. A time course analysis of prion deposition in the brain following loss of the olfactory epithelium in models of neuron-restricted prion replication suggests that neuroinvasion from the olfactory mucosa is via the olfactory nerve or brain stem associated cranial nerves. We propose that induction of neurogenesis after damage to the olfactory epithelium can lead to prion infection of immature olfactory sensory neurons and accelerate prion spread to the brain.	[Crowell, Jenna; Bessen, Richard A.] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wiley, James A.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Colorado State University; Montana State University System; Montana State University Bozeman	Bessen, RA (corresponding author), Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Richard.Bessen@colostate.edu			Public Health Service from the National Institutes of Health [R01 AI055043]; United States Department of Agriculture [2006-35201-16626]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055043] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01 AI055043 from the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) and United States Department of Agriculture grant 2006-35201-16626 (http://www.csrees.usda.gov/funding/nri/nri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2005, IMMUNITY, V22, P145, DOI 10.1016/j.immuni.2004.12.007; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Bahrami F, 2000, CHEM-BIOL INTERACT, V128, P97, DOI 10.1016/S0009-2797(00)00187-3; Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Bartz JC, 2004, J GEN VIROL, V85, P265, DOI 10.1099/vir.0.19394-0; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bartz JC, 2002, J VIROL, V76, P5759, DOI 10.1128/JVI.76.11.5759-5768.2002; Bergman U, 1999, TOXICOL APPL PHARM, V155, P190, DOI 10.1006/taap.1998.8590; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Bessen RA, 2012, J VIROL, V86, P1777, DOI 10.1128/JVI.06626-11; Bessen RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028026; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; Bessen RA, 2009, J VIROL, V83, P6435, DOI 10.1128/JVI.00018-09; Blanco-Hernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046338; BRITTEBO EB, 1995, PHARMACOL TOXICOL, V76, P76, DOI 10.1111/j.1600-0773.1995.tb00107.x; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Corona C, 2009, J VIROL, V83, P3657, DOI 10.1128/JVI.01966-08; Corps KN, 2010, TOXICOL PATHOL, V38, P429, DOI 10.1177/0192623310364026; Cummings DM, 2000, J COMP NEUROL, V421, P362; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Denkers ND, 2011, J VIROL, V85, P1396, DOI 10.1128/JVI.01655-10; Epstein VA, 2008, OTOLARYNG HEAD NECK, V138, P334, DOI 10.1016/j.otohns.2007.11.029; FARBMAN AI, 1990, TRENDS NEUROSCI, V13, P362, DOI 10.1016/0166-2236(90)90017-5; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Franzen A, 2003, TOXICOL PATHOL, V31, P364, DOI 10.1080/01926230390201075; Fryer HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023664; Ge Y, 2002, CHEM SENSES, V27, P521, DOI 10.1093/chemse/27.6.521; GENTER MB, 1995, TOXICOL PATHOL, V23, P477, DOI 10.1177/019262339502300404; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2008, VET PATHOL, V45, P7, DOI 10.1354/vp.45-1-7; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Harnir AN, 2008, CAN J VET RES, V72, P63; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Heggebo R, 2000, J GEN VIROL, V81, P2327, DOI 10.1099/0022-1317-81-9-2327; Heggebo R, 2003, J COMP PATHOL, V128, P172, DOI 10.1053/jcpa.2002.0625; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; MARSH RF, 1994, PHILOS T R SOC B, V343, P413, DOI 10.1098/rstb.1994.0037; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McBride PA, 2001, J VIROL, V75, P9320, DOI 10.1128/JVI.75.19.9320-9327.2001; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Sakamoto T, 2007, J NEUROSCI RES, V85, P548, DOI 10.1002/jnr.21155; Sam Z, 2006, ENVIRON HEALTH PERSP, V114, P1099, DOI 10.1289/ehp.8854; Sbriccoli M, 2009, ACTA NEUROPATHOL, V117, P175, DOI 10.1007/s00401-008-0474-z; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Shearin H, 2014, J VIROL, V88, P8640, DOI 10.1128/JVI.00378-14; SHIROOZU A, 1986, J CLIN ENDOCR METAB, V63, P125, DOI 10.1210/jcem-63-1-125; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Siso Silvia, 2010, Interdiscip Perspect Infect Dis, V2010, P747892, DOI 10.1155/2010/747892; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; Wagner JG, 2002, TOXICOL SCI, V67, P284, DOI 10.1093/toxsci/67.2.284; Walter BA, 2006, NEUROPATH APPL NEURO, V32, P388, DOI 10.1111/j.1365-2990.2006.00737.x; Wells GAH, 2007, J GEN VIROL, V88, P1363, DOI 10.1099/vir.0.82421-0; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yagi S, 2007, ACTA OTO-LARYNGOL, V127, P748, DOI 10.1080/00016480601002062; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043	71	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119863	10.1371/journal.pone.0119863	http://dx.doi.org/10.1371/journal.pone.0119863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822718	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700048
J	Lee, H; Kim, BJ; Kim, BR; Kook, YH; Kim, BJ				Lee, Hyungki; Kim, Byoung-Jun; Kim, Bo-Ram; Kook, Yoon-Hoh; Kim, Bum-Joon			The Development of a Novel Mycobacterium-Escherichia coli Shuttle Vector System Using pMyong2, a Linear Plasmid from Mycobacterium yongonense DSM 45126(T)	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CLASS-I PRESENTATION; BOVIS BCG; TUBERCULOSIS; SMEGMATIS; MACROPHAGES; VACCINES; AVIUM; GENE; EFFICACY	The Mycobacterium-Escherichia coli shuttle vector system, equipped with the pAL5000 replicon, is widely used for heterologous gene expression and gene delivery in mycobacteria. Despite its extensive use, this system has certain limitations, which has led to the development of alternative mycobacterial vector systems. The present study describes the molecular structure and expression profiles of a novel 18-kb linear plasmid, pMyong2, from Mycobacterium yongonense. Sixteen open reading frames and a putative origin of replication were identified, and the compatibility of the pMyong2 and pAL5000 vector systems was demonstrated. In recombinant Mycobacterium smegmatis (rSmeg), the pMyong2 vector system showed a copy number that was approximately 37 times greater than that of pAL5000. Furthermore, pMyong2 increased the mRNA and protein expression of the human macrophage migration inhibitory factor (hMIF) over pAL5000 levels by approximately 10-fold and 50-fold, respectively, demonstrating the potential utility of the pMyong2 vector system in heterologous gene expression in mycobacteria. Successful delivery of the EGFP gene into mammalian cells via rSmeg carrying the pMyong2 vector system was also observed, demonstrating the feasibility of this system for DNA delivery. In conclusion, the pMyong2 vector system could be effectively used not only for the in vivo delivery of recombinant protein and DNA but also for mycobacterial genetic studies as an alternative or a complement to the pAL5000 vector system.	[Kim, Bum-Joon] Seoul Natl Univ, Liver Res Inst, Dept Microbiol & Immunol, Biomed Sci, Seoul, South Korea; Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Liver Res Inst, Dept Microbiol & Immunol, Biomed Sci, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare Family Affairs [HI13C15620000]; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2013R1A2A2A05005810]	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare Family Affairs; National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported through a grant (Grant No., HI13C15620000) from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs (www.htdream.kr) and a National Research Foundation of Korea (NRF) grant funded through the Korean government (MEST; Grant no., NRF-2013R1A2A2A05005810) (ernd.nrf.re.kr), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8; Alonso-Hearn M, 2008, INFECT IMMUN, V76, P170, DOI 10.1128/IAI.01913-06; AVERILL LE, 1993, RES MICROBIOL, V144, P349, DOI 10.1016/0923-2508(93)90192-5; Bachrach G, 2000, MICROBIOL-UK, V146, P297, DOI 10.1099/00221287-146-2-297; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; BOSE M, 1993, NUCLEIC ACIDS RES, V21, P2529, DOI 10.1093/nar/21.10.2529; Bourn WR, 2007, TUBERCULOSIS, V87, P481, DOI 10.1016/j.tube.2007.08.003; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Cheadle EJ, 2005, INFECT IMMUN, V73, P784, DOI 10.1128/IAI.73.2.784-794.2005; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; Daudel D, 2007, EXPERT REV VACCINES, V6, P97, DOI 10.1586/14760584.6.1.97; DAVISON A, 1995, NUCLEOS NUCLEOT, V14, P1049, DOI 10.1080/15257779508012531; Dominguez Jose, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 9, P33, DOI 10.1016/S0213-005X(08)76539-X; Dos Vultos T, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-47; Esumi N, 1998, MAMM GENOME, V9, P753, DOI 10.1007/s003359900858; Gupta UD, 2007, VACCINE, V25, P3742, DOI 10.1016/j.vaccine.2007.01.112; Hess J, 1996, P NATL ACAD SCI USA, V93, P1458, DOI 10.1073/pnas.93.4.1458; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2005, MICROBES INFECT, V7, P947, DOI 10.1016/j.micinf.2005.04.002; Joseph J, 2006, EXPERT REV VACCINES, V5, P827, DOI 10.1586/14760584.5.6.827; Kim BJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00604-13; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Kirby C, 2002, MOL MICROBIOL, V43, P173, DOI 10.1046/j.1365-2958.2002.02729.x; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; Madalinski K, 2004, MED SCI MONITOR, V10, pPI10; Matsuo Kazuhiro, 2011, Tuberc Res Treat, V2011, P574591, DOI 10.1155/2011/574591; Medeiros MA, 2002, MICROBIOL-SGM, V148, P1999, DOI 10.1099/00221287-148-7-1999; Michelon A, 2006, VACCINE, V24, P6332, DOI 10.1016/j.vaccine.2006.05.028; Mo Y, 2007, INFECT IMMUN, V75, P4804, DOI 10.1128/IAI.01877-06; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Palffy R, 2006, GENE THER, V13, P101, DOI 10.1038/sj.gt.3302635; Picardeau M, 1996, MICROBIOL-UK, V142, P2453, DOI 10.1099/00221287-142-9-2453; Picardeau M, 2000, MICROBIOL-UK, V146, P305, DOI 10.1099/00221287-146-2-305; Picardeau M, 1998, MICROBIOL-UK, V144, P1981, DOI 10.1099/00221287-144-7-1981; Picardeau M, 1997, J BACTERIOL, V179, P2753, DOI 10.1128/jb.179.8.2753-2756.1997; Rovert J., 2004, Hone (2004) Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same, Patent No. [PCT/US1996/005326, 1996005326]; Rowland R, 2011, EXPERT REV VACCINES, V10, P645, DOI [10.1586/ERV.11.28, 10.1586/erv.11.28]; Sable SB, 2011, PLOS ONE, V6; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Walker K B, 2010, Vaccine, V28, P2259, DOI 10.1016/j.vaccine.2009.12.083; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037; Zhang R, 2006, APPL ENVIRON MICROB, V72, P5728, DOI 10.1128/AEM.00707-06	55	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122897	10.1371/journal.pone.0122897	http://dx.doi.org/10.1371/journal.pone.0122897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822634	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700207
J	Mahapa, A; Mandal, S; Biswas, A; Jana, B; Polley, S; Sau, S; Sau, K				Mahapa, Avisek; Mandal, Sukhendu; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Subrata; Sau, Keya			Chemical and Thermal Unfolding of a Global Staphylococcal Virulence Regulator with a Flexible C-Terminal End	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; BACILLUS-STEAROTHERMOPHILUS; GENE-REGULATION; LIGAND-BINDING; AUREUS; PROTEIN; DENATURATION; SARA; UREA; ENZYME	SarA, a Staphylococcus aureus-specific dimeric protein, modulates the expression of numerous proteins including various virulence factors. Interestingly, S. aureus synthesizes multiple SarA paralogs seemingly for optimizing the expression of its virulence factors. To understand the domain structure/flexibility and the folding/unfolding mechanism of the SarA protein family, we have studied a recombinant SarA (designated rSarA) using various in vitro probes. Limited proteolysis of rSarA and the subsequent analysis of the resulting protein fragments suggested it to be a single-domain protein with a long, flexible C-terminal end. rSarA was unfolded by different mechanisms in the presence of different chemical and physical denaturants. While urea-induced unfolding of rSarA occurred successively via the formation of a dimeric and a monomeric intermediate, GdnCl-induced unfolding of this protein proceeded through the production of two dimeric intermediates. The surface hydrophobicity and the structures of the intermediates were not identical and also differed significantly from those of native rSarA. Of the intermediates, the GdnCl-generated intermediates not only possessed a molten globule-like structure but also exhibited resistance to dissociation during their unfolding. Compared to the native rSarA, the intermediate that was originated at lower GdnCl concentration carried a compact shape, whereas, other intermediates owned a swelled shape. The chemical-induced unfolding, unlike thermal unfolding of rSarA, was completely reversible in nature.	[Mahapa, Avisek; Sau, Keya] Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India; [Mandal, Sukhendu; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India	Haldia Institute of Technology; Department of Science & Technology (India); Bose Institute	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@yahoo.co.in; keya_sau@yahoo.co.in	Mandal, Sukhendu/AAX-6423-2021; jana, biswanath/AAC-7540-2022	Mandal, Sukhendu/0000-0002-7752-0982; Biswas, Anindya/0000-0003-1645-2856; Polley, Soumitra/0000-0002-6337-7935; Jana, Biswanath/0000-0002-6464-7570	Council of Scientific and Industrial Research (Government of India); Department of Atomic Energy (Government of India); CSIR, Government of India [37 (1529)/12/EMR-II]; BRNS/DAE, Government of India [2013/37B/25/BRNS]	Council of Scientific and Industrial Research (Government of India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Atomic Energy (Government of India)(Department of Atomic Energy (DAE)); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); BRNS/DAE, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	Mr. A. Mahapa received a Junior Research Fellowship from the Council of Scientific and Industrial Research (Government of India). Mr. S. Mandal and Mr. S. Polley received Senior Research Fellowships from the Council of Scientific and Industrial Research (Government of India). Mr. A. Biswas and Mr. B. Jana received Senior Research Fellowships from the Department of Atomic Energy (Government of India)". This work was supported by grants from CSIR, Government of India [37 (1529)/12/EMR-II] and BRNS/DAE, Government of India (2013/37B/25/BRNS) to KS and SS, respectively. Funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Arya R, 2013, FUTURE MICROBIOL, V8, P1339, DOI 10.2217/fmb.13.92; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Ballal A, 2009, MICROBIOL-SGM, V155, P2342, DOI 10.1099/mic.0.027417-0; Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Biswas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095012; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; de Brevern AG, 2012, NUCLEIC ACIDS RES, V40, pW317, DOI 10.1093/nar/gks482; Del Vecchio P, 2002, BIOCHEMISTRY-US, V41, P1364, DOI 10.1021/bi011146t; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Liu CP, 2005, BIOCHIMIE, V87, P1023, DOI 10.1016/j.biochi.2005.03.017; Liu YF, 2006, P NATL ACAD SCI USA, V103, P2392, DOI 10.1073/pnas.0510439103; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Mahendrarajah K, 2011, ANAL BIOCHEM, V411, P155, DOI 10.1016/j.ab.2010.12.001; MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609; Merlino A, 2012, BIOCHIMIE, V94, P768, DOI 10.1016/j.biochi.2011.11.008; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Morris ER, 2012, CURR PROTOC PROTEIN, pChapter 28; Morrison JM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00026; NANDI PK, 1984, BIOCHEMISTRY-US, V23, P6661, DOI 10.1021/bi00321a058; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Pace CN, 2000, PROTEINS, P1; Pal A, 2008, J BIOMOL STRUCT DYN, V26, P339, DOI 10.1080/07391102.2008.10507249; Park YC, 1998, J BIOL CHEM, V273, P18052, DOI 10.1074/jbc.273.29.18052; Pica A, 2012, BBA-PROTEINS PROTEOM, V1824, P571, DOI 10.1016/j.bbapap.2012.01.014; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Polley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102891; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Rashid F, 2005, PROTEIN J, V24, P283, DOI 10.1007/s10930-005-6749-5; Rechtin TM, 1999, MOL MICROBIOL, V33, P307, DOI 10.1046/j.1365-2958.1999.01474.x; Righetti PG, 2001, ELECTROPHORESIS, V22, P2359, DOI 10.1002/1522-2683(200107)22:12<2359::AID-ELPS2359>3.0.CO;2-8; Riley PW, 2007, J MOL BIOL, V367, P558, DOI 10.1016/j.jmb.2006.12.066; Sambrook J., 2001, MOL CLONING LAB MANU; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; Shah MA, 2011, EUR BIOPHYS J BIOPHY, V40, P877, DOI 10.1007/s00249-011-0706-3; Singh AR, 2010, EUR BIOPHYS J BIOPHY, V39, P289, DOI 10.1007/s00249-009-0539-5; Stryjewski ME, 2009, CURR OPIN CRIT CARE, V15, P403, DOI 10.1097/MCC.0b013e32832f0a74; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Sun F, 2011, CHEM BIOL, V18, P1032, DOI 10.1016/j.chembiol.2011.05.014; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang TF, 2014, J BIOL PHYS, V40, P25, DOI 10.1007/s10867-013-9332-x; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhu YW, 2014, ACTA CRYSTALLOGR D, V70, P2467, DOI 10.1107/S1399004714015326; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	67	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122168	10.1371/journal.pone.0122168	http://dx.doi.org/10.1371/journal.pone.0122168			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822635	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700157
J	Massalski, C; Bloch, J; Zebisch, M; Steinebrunner, I				Massalski, Carolin; Bloch, Jeannine; Zebisch, Matthias; Steinebrunner, Iris			The Biochemical Properties of the Arabidopsis Ecto-Nucleoside Triphosphate Diphosphohydrolase AtAPY1 Contradict a Direct Role in Purinergic Signaling	PLOS ONE			English	Article							EXTRACELLULAR NUCLEOTIDES; GUANOSINE DIPHOSPHATASE; ATP-DIPHOSPHOHYDROLASE; STRUCTURAL INSIGHT; GOLGI VESICLES; APYRASE ATAPY1; PURIFICATION; PROTEIN; GLYCOSYLATION; MEMBRANE	The Arabidopsis E-NTPDase (ecto-nucleoside triphosphate diphosphohydrolase) AtAPY1 was previously shown to be involved in growth and development, pollen germination and stress responses. It was proposed to perform these functions through regulation of extracellular ATP signals. However, a GFP-tagged version was localized exclusively in the Golgi and did not hydrolyze ATP. In this study, AtAPY1 without the bulky GFP-tag was biochemically characterized with regard to its suggested role in purinergic signaling. Both the full-length protein and a soluble form without the transmembrane domain near the N-terminus were produced in HEK293 cells. Of the twelve nucleotide substrates tested, only three GDP, IDP and UDP - were hydrolyzed, confirming that ATP was not a substrate of AtAPY1. In addition, the effects of pH, divalent metal ions, known E-NTPDase inhibitors and calmodulin on AtAPY1 activity were analyzed. AtAPY1-GFP extracted from transgenic Arabidopsis seedlings was included in the analyses. All three AtAPY1 versions exhibited very similar biochemical properties. Activity was detectable in a broad pH range, and Ca2+, Mg2+ and Mn2+ were the three most efficient cofactors. Of the inhibitors tested, vanadate was the most potent one. Surprisingly, sulfonamide-based inhibitors shown to inhibit other E-NTPDases and presumed to inhibit AtAPY1 as well were not effective. Calmodulin stimulated the activity of the GFP-tagless membranous and soluble AtAPY1 forms about five-fold, but did not alter their substrate specificities. The apparent Km values obtained with AtAPY1-GFP indicate that AtAPY1 is primarily a GDPase. A putative three-dimensional structural model of the ecto-domain is presented, explaining the potent inhibitory potential of vanadate and predicting the binding mode of GDP. The found substrate specificity classifies AtAPY1 as a nucleoside diphosphatase typical of N-terminally anchored Golgi E-NTPDases and negates a direct function in purinergic signaling.	[Massalski, Carolin; Bloch, Jeannine; Steinebrunner, Iris] Tech Univ Dresden, Dept Biol, D-01062 Dresden, Germany; [Zebisch, Matthias] Univ Oxford, Div Struct Biol, Oxford, England	Technische Universitat Dresden; University of Oxford	Steinebrunner, I (corresponding author), Tech Univ Dresden, Dept Biol, D-01062 Dresden, Germany.	Iris.Steinebrunner@tu-dresden.de			German Research Foundation [STE 1455/2-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the grant STE 1455/2-1 from the German Research Foundation (http://www.dfg.de) awarded to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Biederbick A, 1999, J CELL SCI, V112, P2473; Braun N, 2000, BIOCHEM J, V351, P639, DOI 10.1042/0264-6021:3510639; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Caldwell JH, 2008, NAT CELL BIOL, V10, P1125, DOI 10.1038/ncb1008-1125; CHEN YR, 1987, J BIOL CHEM, V262, P10689; Chiu TY, 2012, PLANT CELL PHYSIOL, V53, P1913, DOI 10.1093/pcp/pcs131; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clark G, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26093; Clark G, 2011, PLANT PHYSIOL, V156, P1740, DOI 10.1104/pp.111.174466; Clark G, 2010, PLANT MOL BIOL, V74, P423, DOI 10.1007/s11103-010-9683-7; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clark G, 2009, PLANT SCI, V177, P239, DOI 10.1016/j.plantsci.2009.05.004; Clark GB, 2014, PLANT SCI, V225, P107, DOI 10.1016/j.plantsci.2014.06.002; D'Alessio C, 2003, J BIOL CHEM, V278, P22379, DOI 10.1074/jbc.M300892200; Demidchik V, 2003, PLANT PHYSIOL, V133, P456, DOI 10.1104/pp.103.024091; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Gao XD, 1999, J BIOL CHEM, V274, P21450, DOI 10.1074/jbc.274.30.21450; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Herrero AB, 2002, EUKARYOT CELL, V1, P420, DOI 10.1128/EC.1.3.420-431.2002; Hicks-Berger CA, 2000, J BIOL CHEM, V275, P34041, DOI 10.1074/jbc.M004723200; Ikura M, 2002, BINDING SITE SEARCH; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Knowles AF, 2011, PURINERG SIGNAL, V7, P21, DOI 10.1007/s11302-010-9214-7; Krug U, 2012, J BIOL CHEM, V287, P3051, DOI 10.1074/jbc.M111.294348; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim MH, 2014, PLANT PHYSIOL, V164, P2054, DOI 10.1104/pp.113.233429; Liu X, 2012, PLANT PHYSIOL, V160, P1985, DOI 10.1104/pp.112.202887; Lopez-Avalos MD, 2001, GLYCOBIOLOGY, V11, P413, DOI 10.1093/glycob/11.5.413; Matoba K, 2010, ACTA CRYSTALLOGR F, V66, P1445, DOI [10.1107/S1744309110032136, 10.1107/S17443091100321]; Mikami S, 2001, PLANT BIOTECHNOL, V18, P259; MITSUI T, 1994, PLANT PHYSIOL, V106, P119, DOI 10.1104/pp.106.1.119; Mohlmann T, 2014, PROG BOT, V75, P119, DOI 10.1007/978-3-642-38797-5_4; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Neckelmann G, 1998, PLANT PHYSIOL, V117, P1007, DOI 10.1104/pp.117.3.1007; Nikolovski N, 2014, LABEL FREE PROTEIN Q, DOI [10.1104/pp.114.245589, DOI 10.1104/PP.114.245589]; Nishiwaki K, 2004, NAT CELL BIOL, V6, P31, DOI 10.1038/ncb1079; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Pichler G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036967; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Sanchez R, 2003, FEMS MICROBIOL LETT, V228, P33, DOI 10.1016/S0378-1097(03)00698-0; Schiller M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-123; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Steinebrunner I, 2003, PLANT PHYSIOL, V131, P1638, DOI 10.1104/pp.102.014308; Steinebrunner I, 2000, PLANT PHYSIOL BIOCH, V38, P913, DOI 10.1016/S0981-9428(00)01209-2; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Tanaka K, 2011, PLANT PHYSIOL, V155, P1988, DOI 10.1104/pp.110.170910; TOGNOLI L, 1981, BIOCHIM BIOPHYS ACTA, V642, P1, DOI 10.1016/0005-2736(81)90132-2; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Uccelletti D, 2004, J BIOL CHEM, V279, P27390, DOI 10.1074/jbc.M402624200; Uccelletti D, 2007, FEMS YEAST RES, V7, P731, DOI 10.1111/j.1567-1364.2007.00229.x; UniProt Consortium, 2002, UNIPROT KNOWLEDGEBAS; Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139; Vivian JP, 2010, STRUCTURE, V18, P228, DOI 10.1016/j.str.2009.11.014; Wang QL, 2009, J BIOL CHEM, V284, P12000, DOI 10.1074/jbc.M808028200; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Windsor B, 2000, THESIS; Windsor JB, 2002, BIOTECHNIQUES, V33, P1024, DOI 10.2144/02335st02; Wolf C, 2007, PLANT MOL BIOL, V64, P657, DOI 10.1007/s11103-007-9184-5; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wujak M, 2013, PHYTOCHEMISTRY, V93, P8, DOI 10.1016/j.phytochem.2013.03.014; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351; Yang J, 2013, PLANT PHYSIOL BIOCH, V69, P62, DOI 10.1016/j.plaphy.2013.04.022; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zebisch M, 2008, P NATL ACAD SCI USA, V105, P6882, DOI 10.1073/pnas.0802535105; Zebisch M, 2013, STRUCTURE, V21, P1460, DOI 10.1016/j.str.2013.05.016; Zebisch M, 2013, ACTA CRYSTALLOGR F, V69, P257, DOI 10.1107/S1744309113001504; Zebisch M, 2012, J MOL BIOL, V415, P288, DOI 10.1016/j.jmb.2011.10.050; Zhong XT, 1999, J BIOL CHEM, V274, P32704, DOI 10.1074/jbc.274.46.32704; Zimmermann H., 2000, ECTO ATPASES RELATED, P1; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	83	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0115832	10.1371/journal.pone.0115832	http://dx.doi.org/10.1371/journal.pone.0115832			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822168	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700003
J	Shin, J; Kim, G; Kabir, MH; Park, SJ; Lee, ST; Lee, C				Shin, Jihye; Kim, Gamin; Kabir, Mohammad Humayun; Park, Seong Jun; Lee, Seoung Taek; Lee, Cheolju			Use of Composite Protein Database including Search Result Sequences for Mass Spectrometric Analysis of Cell Secretome	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; SERUM; IDENTIFICATIONS; SENSITIVITY	Mass spectrometric (MS) data of human cell secretomes are usually run through the conventional human database for identification. However, the search may result in false identifications due to contamination of the secretome with fetal bovine serum (FBS) proteins. To overcome this challenge, here we provide a composite protein database including human as well as 199 FBS protein sequences for MS data search of human cell secretomes. Searching against the human-FBS database returned more reliable results with fewer false-positive and false-negative identifications compared to using either a human only database or a human-bovine database. Furthermore, the improved results validated our strategy without complex experiments like SILAC. We expect our strategy to improve the accuracy of human secreted protein identification and to also add value for general use.	[Shin, Jihye; Kim, Gamin; Kabir, Mohammad Humayun; Park, Seong Jun; Lee, Cheolju] Korea Inst Sci & Technol, BRI, Ctr Theragnosis, Seoul 136791, South Korea; [Shin, Jihye; Lee, Seoung Taek] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Kim, Gamin] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea; [Lee, Cheolju] Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea	Korea Institute of Science & Technology (KIST); Yonsei University; Yonsei University; Yonsei University Health System	Lee, C (corresponding author), Korea Inst Sci & Technol, BRI, Ctr Theragnosis, Seoul 136791, South Korea.	clee270@kist.re.kr		Lee, Seung-Taek/0000-0001-7300-9784	National Research Foundation (Proteogenomics programs) - Korean Ministry of Science, ICT and Future Planning [2012M3A9B9036679, 2013M3A9B9044846]; National Research Foundation (Next-Generation Applied Omics program) - Korean Ministry of Science, ICT and Future Planning [2013M3A9B6076414]; Korea Health Industry Development Institute (Research Hospital program) - Korean Ministry of Health Welfare [HR14C0008]; intramural program of the Korea Institute of Science and Technology	National Research Foundation (Proteogenomics programs) - Korean Ministry of Science, ICT and Future Planning; National Research Foundation (Next-Generation Applied Omics program) - Korean Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute (Research Hospital program) - Korean Ministry of Health Welfare; intramural program of the Korea Institute of Science and Technology	The study was supported by grants from the National Research Foundation (Proteogenomics programs: 2012M3A9B9036679 and 2013M3A9B9044846; Next-Generation Applied Omics program: 2013M3A9B6076414) funded by the Korean Ministry of Science, ICT and Future Planning, and a grant from the Korea Health Industry Development Institute (Research Hospital program: HR14C0008) funded by the Korean Ministry of Health & Welfare. The study was also supported by an intramural program of the Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2010, MOL CELLS, V29, P123, DOI 10.1007/s10059-010-0008-0; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; Bunkenborg J, 2010, PROTEOMICS, V10, P3040, DOI 10.1002/pmic.201000103; Cargile BJ, 2004, J PROTEOME RES, V3, P1082, DOI 10.1021/pr049946o; Colzani M, 2009, J PROTEOME RES, V8, P4779, DOI 10.1021/pr900476b; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Jagtap P, 2013, PROTEOMICS, V13, P1352, DOI 10.1002/pmic.201200352; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Pellitteri-Hahn MC, 2006, J PROTEOME RES, V5, P2861, DOI 10.1021/pr060287k; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Villarreal L, 2013, MOL CELL PROTEOMICS, V12, P1046, DOI 10.1074/mcp.M112.021618; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52	15	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121692	10.1371/journal.pone.0121692	http://dx.doi.org/10.1371/journal.pone.0121692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822838	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700119
J	Spiro, Z; Gonczy, P				Spiro, Zoltan; Goenczy, Pierre			Polarity-Dependent Asymmetric Distribution and MEX-5/6-Mediated Translational Activation of the Era-1 mRNA in C. elegans Embryos	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN; MEX-5; EXPRESSION; GERMLINE; ESTABLISHMENT; EMBRYOGENESIS; BLASTOMERE; DIVISION; POS-1	The early C. elegans embryo is an attractive model system to investigate fundamental developmental processes. With the exception of mex-3 mRNA, maternally contributed mRNAs are thought to be distributed uniformly in the one-cell embryo. Here, we report and characterize the striking distribution of the mRNA encoding the novel protein ERA-1. We found that era-1 mRNA is enriched in the anterior of the one-cell embryo and present solely in anterior blastomeres thereafter. Although era-1 is not an essential gene, we uncovered that era-1 null mutant embryos are sensitive to slight impairment of embryonic polarity. We found that the asymmetric distribution of era-1 mRNA depends on anterior-posterior polarity cues and on the era-1 3'UTR. Similarly to the era-1 mRNA, the YFP-ERA-1 protein is enriched in anterior blastomeres. Interestingly, we found that the RNA-binding protein MEX-5 is required for era-1 mRNA asymmetry. Furthermore, we show that MEX-5, together with its partially redundant partner MEX-6, are needed to activate era-1 mRNA translation in anterior blastomeres. These findings lead us to propose that MEX-5/6-mediated regulation of era-1 mRNA contributes to robust embryonic development.	[Spiro, Zoltan; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Gonczy, P (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland.	Pierre.Gonczy@epfl.ch		Gonczy, Pierre/0000-0002-6305-6883	Swiss National Science Foundation [3100A0-122500/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by a grant from the Swiss National Science Foundation (grant number: 3100A0-122500/1, website: http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2010, DEVELOPMENT, V137, P2579, DOI 10.1242/dev.051326; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gonczy Pierre, 2005, WormBook, P1; Griffin EE, 2011, CELL, V146, P954, DOI 10.1016/j.cell.2011.08.012; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hwang SY, 2010, BMB REP, V43, P69, DOI 10.5483/BMBRep.2010.43.2.069; Kumano G, 2012, DEV GROWTH DIFFER, V54, P1, DOI 10.1111/j.1440-169X.2011.01301.x; Lasko P, 2012, COLD SPRING HARBOR P, V4; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Motohashi Tomoko, 2006, WormBook, P1; Ogura K, 2003, DEVELOPMENT, V130, P2495, DOI 10.1242/dev.00469; Oldenbroek M, 2012, DEV BIOL, V363, P388, DOI 10.1016/j.ydbio.2012.01.002; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pichler S, 2000, DEVELOPMENT, V127, P2063; Portman Douglas S, 2006, WormBook, P1; Praitis V, 2001, GENETICS, V157, P1217; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tabara H, 1999, DEVELOPMENT, V126, P1; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858	31	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120984	10.1371/journal.pone.0120984	http://dx.doi.org/10.1371/journal.pone.0120984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821955	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700082
J	Zhang, YQ; Zhou, L; Liu, XY; Liu, L; Wu, YZ; Zhao, ZW; Yi, DL; Yi, D				Zhang, Yanqi; Zhou, Liang; Liu, Xiaoyu; Liu, Ling; Wu, Yazhou; Zhao, Zengwei; Yi, Dali; Yi, Dong			The Effectiveness of the Problem-Based Learning Teaching Model for Use in Introductory Chinese Undergraduate Medical Courses: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PERFORMANCE; EDUCATION; STUDENTS; PBL	Background Although the problem-based learning (PBL) emerged in 1969 and was soon widely applied internationally, the rapid development in China only occurred in the last 10 years. This study aims to compare the effect of PBL and lecture-based learning (LBL) on student course examination results for introductory Chinese undergraduate medical courses. Methods Randomized and nonrandomized controlled trial studies on PBL use in Chinese undergraduate medical education were retrieved through PubMed, the Excerpta Medica Database (EMBASE), Chinese National Knowledge Infrastructure (CNKI) and VIP China Science and Technology Journal Database (VIP-CSTJ) with publication dates from 1st January 1966 till 31 August 2014. The pass rate, excellence rate and examination scores of course examination were collected. Methodological quality was evaluated based on the modified Jadad scale. The I-square statistic and Chi-square test of heterogeneity were used to assess the statistical heterogeneity. Overall RRs or SMDs with their 95% CIs were calculated in meta-analysis. Meta-regression and subgroup meta-analyses were also performed based on comparators and other confounding factors. Funnel plots and Egger's tests were performed to assess degrees of publication bias. Results The meta-analysis included 31studies and 4,699 subjects. Fourteen studies were of high quality with modified Jadad scores of 4 to 6, and 17 studies were of low quality with scores of 1 to 3. Relative to the LBL model, the PBL model yielded higher course examination pass rates [RR = 1.09, 95% CI (1.03, 1.17)], excellence rates [RR = 1.66, 95% CI (1.33, 2.06)] and examination scores [SMD = 0.82, 95% CI (0.63, 1.01)]. The meta-regression results show that course type was the significant confounding factor that caused heterogeneity in the examination-score meta-analysis (t = 0.410, P< 0.001). The examination score SMD in "laboratory course" subgroup [SMD = 2.01, 95% CI: (1.50, 2.52)] was higher than that in "theory course" subgroup [SMD = 0.72, 95% CI: (0.56, 0.89)]. Conclusions PBL teaching model application in introductory undergraduate medical courses can increase course examination excellence rates and scores in Chinese medical education system. It is more effective when applied to laboratory courses than to theory-based courses.	[Zhang, Yanqi; Zhou, Liang; Liu, Xiaoyu; Liu, Ling; Wu, Yazhou; Zhao, Zengwei; Yi, Dali; Yi, Dong] Third Mil Med Univ, Coll Prevent Med, Dept Hlth Stat, Chongqing, Peoples R China	Army Medical University	Yi, D (corresponding author), Third Mil Med Univ, Coll Prevent Med, Dept Hlth Stat, Chongqing, Peoples R China.	yd_house@hotmail.com			Natural Science Foundation of China [81202286]; Research Projects of Teaching Reform of Postgraduate Education in Chongqing, China [yjg123101]; Research Projects of Teaching Reform of Higher Education in Chongqing, China [133118]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Projects of Teaching Reform of Postgraduate Education in Chongqing, China; Research Projects of Teaching Reform of Higher Education in Chongqing, China	This study was supported by Natural Science Foundation of China (No. 81202286), Research Projects of Teaching Reform of Postgraduate Education in Chongqing, China (No. yjg123101) and Research Projects of Teaching Reform of Higher Education in Chongqing, China (No. 133118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RR, 2008, ADV PHYSIOL EDUC, V32, P35, DOI 10.1152/advan.00063.2007; ALBANESE MA, 1993, ACAD MED, V68, P52, DOI 10.1097/00001888-199301000-00012; Antepohl W, 1999, MED EDUC, V33, P106, DOI 10.1046/j.1365-2923.1999.00289.x; Chen R, 2006, J SHANXI MED U PRECL, V8, P633; Chen SG, 2006, J XIANGNAN U MED SCI, V8, P71; Chou FH, 2009, KAOHSIUNG J MED SCI, V25, P258, DOI 10.1016/S1607-551X(09)70071-3; Cui BQ, 2007, CHINA HIGHER MED ED, V1, P7; Cui GZ, NATL MED FRONTIERS C, V201, P90; Dai XW, 2009, MODERN J INTEGRATED, V18, P4459; Deng AM, 2009, RES MED ED, V8, P1127; Dochy F, 2003, LEARN INSTR, V13, P533, DOI 10.1016/S0959-4752(02)00025-7; Enarson C, 2001, MED EDUC, V35, P1050, DOI 10.1046/j.1365-2923.2001.01058.x; Farrow R, 2003, MED EDUC, V37, P1131, DOI 10.1046/j.1365-2923.2003.01725.x; Frambach JM, 2012, MED EDUC, V46, P738, DOI 10.1111/j.1365-2923.2012.04290.x; Guo WC, 2009, J BAOTOU MED COLL, V25, P90; He Z, 2014, GUANGDONG CHEM IND, V41, P189; Huang XP, 2011, CHINESE MED MODERN D, V9, P53; Iputo JE, 2005, MED EDUC, V39, P388, DOI 10.1111/j.1365-2929.2005.02106.x; Jones RW, 2006, ANAESTH INTENS CARE, V34, P485, DOI 10.1177/0310057X0603400417; Kinkade S, 2005, ACAD MED, V80, P300, DOI 10.1097/00001888-200503000-00021; Koh GCH, 2008, CAN MED ASSOC J, V178, P34, DOI 10.1503/cmaj.070565; Liu T, 2008, J MATH MED, V21, P636; Liu XC, 2011, CHINA MODERN MED, V18, P128; Liu Y, 2007, J LIAONING MED U SOC, V5, P33; Lu XM, 2007, CHINA J MODERN MED, V13, P2430; Luo XJ, 2009, RES MED ED, V8, P74; Lv L, 2006, CHINA HIGHER MED ED, V10, P65; Ma SF, 2005, RES MED ED, V4, P155; Mahdizadeh M, 2008, IRAN J MED ED, V2, P379; Maudsley G, 1999, ACAD MED, V74, P178, DOI 10.1097/00001888-199902000-00016; McParland M, 2004, MED EDUC, V38, P859, DOI 10.1111/j.1365-2929.2004.01818.x; Norman GR, 2000, MED EDUC, V34, P721, DOI 10.1046/j.1365-2923.2000.00749.x; Oremus M, 2001, DEMENT GERIATR COGN, V12, P232, DOI 10.1159/000051263; Qi YF, 2007, J HEZE MED COLL, V19, P95; Qin W, 2007, MODERN MED HLTH, V10, P23; Qiu GR, 2014, ED TEACHING FORUM, V15, P81; Ren XF, 2008, MED TEACH, V30, P667, DOI 10.1080/01421590802155100; Schmidt HG, 2009, MED EDUC, V43, P211, DOI 10.1111/j.1365-2923.2008.03287.x; Shen W, 2009, J SHANXI MED U PRECL, V11, P270; Song XL., 2011, CHINESE MED MODERN D, V9, P82, DOI DOI 10.3969/J.ISSN.1672-2779.2011.11.055; Tavakol M, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-66; [田金徽 Tian Jinhui], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P39; VERNON DTA, 1993, ACAD MED, V68, P550, DOI 10.1097/00001888-199307000-00015; Wang PY, 2008, RES MED ED, V7, P932; Wang ZY, 2001, CHINA HIGHER MED ED, V5, P80; Wu JL, 2013, CBE-LIFE SCI EDUC, V12, P460, DOI 10.1187/cbe.12-09-0168; Wu YS, 2011, GUIDE CHINA MED, V9, P333; Xing Y, 2011, J QIQIHAR U MED, V49, P83; Xu AF, 2009, CHINA HIGHER MED ED, V2, P114; Yan C, 2013, HLTH VOCATIONAL ED, V31, P112; Yang J, 2012, CHINA HIGHER MED ED, V12, P104; Yin G, 2014, J ED I LILIN PROVINC, V30, P38; Zha GY, 2012, CHINA HIGHER MED ED, V1, P110; Zhang HF, 2005, NW MED ED, V13, P415, DOI DOI 10.3969/J.ISSN.1006-2769.2005.04.041; Zhang YQ, 2010, RES MED ED, V9, P1697; Zhao W, 2014, CHINA MED HERALD, V11, P135; Zhou B, 2009, RES MED ED, V8, P7	57	47	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120884	10.1371/journal.pone.0120884	http://dx.doi.org/10.1371/journal.pone.0120884			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822653	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700078
J	Burks, SR; Legenzov, EA; Martin, EW; Li, CQ; Lu, WY; Kao, JPY				Burks, Scott R.; Legenzov, Eric A.; Martin, Erik W.; Li, Changqing; Lu, Wuyuan; Kao, Joseph P. Y.			Co-Encapsulating the Fusogenic Peptide INF7 and Molecular Imaging Probes in Liposomes Increases Intracellular Signal and Probe Retention	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; INFLUENZA-VIRUS; PROLONGED CIRCULATION; SURFACE-CHARGE; GENE-TRANSFER; LOW PH; CELLS; DELIVERY; ENDOCYTOSIS; FATE	Liposomes are promising vehicles to deliver diagnostic and therapeutic agents to cells in vivo. After uptake into cells by endocytosis, liposomes are degraded in the endolysosomal system. Consequently, the encapsulated cargo molecules frequently remain sequestered in endosomal compartments; this limits their usefulness in many applications (e.g. gene delivery). To overcome this, various fusogenic peptides have been developed to facilitate delivery of liposomally-encapsulated molecules into the cytosol. One such peptide is the pH-sensitive influenza-derived peptide INF7. Liposomal delivery of imaging agents is an attractive approach for enabling cell imaging and cell tracking in vivo, but can be hampered by inadequate intracellular accumulation and retention of probes caused by exocytosis (and possible degradation) of endosome-entrapped probes. Such signal loss could be minimized by facilitating escape of probe molecules from endolysosomal compartments into the cytosol. We investigated the ability of co-encapsulated INF7 to release liposomally-delivered rhodamine fluorophores into the cytosol after endosomal acidification/maturation. We co-encapsulated INF7 and fluorescent rhodamine derivatives having vastly different transport properties to show that after endocytosis by CV1 cells, the INF7 peptide is activated by acidic endosomal pH and facilitates efficient release of the fluorescent tracers into the cytosol. Furthermore, we show that INF7-facilitated escape from endosomes markedly enhanced retention of tracers that cannot be actively extruded from the cytosol. Minimizing loss of intracellular probes improves cellular imaging by increasing the signal-to-noise ratio of images and lengthening the time window that imaging can be performed. In particular, this will enhance in vivo electron paramagnetic resonance imaging, an emergent magnetic resonance imaging modality requires exogenous paramagnetic imaging agents and is highly promising for cellular and molecular imaging.	[Burks, Scott R.; Legenzov, Eric A.; Martin, Erik W.; Kao, Joseph P. Y.] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Burks, Scott R.; Legenzov, Eric A.; Martin, Erik W.; Kao, Joseph P. Y.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Li, Changqing; Lu, Wuyuan] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Li, Changqing; Lu, Wuyuan] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kao, JPY (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	jkao@umaryland.edu	Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; Burks, Scott/0000-0003-2030-3845; Kao, Joseph/0000-0002-8875-2180; Martin, Erik/0000-0003-3979-2378	National Institutes of Health [GM056481, AI061482]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants GM056481 (JPYK) and AI061482 (WL).	ABRAHAM I, 1984, BIOPHARM DRUG DISPOS, V5, P387, DOI 10.1002/bdd.2510050409; BLUME G, 1990, BIOCHIM BIOPHYS ACTA, V1029, P91, DOI 10.1016/0005-2736(90)90440-Y; Burks SR, 2010, IFMBE PROC, V32, P466, DOI 10.1007/978-3-642-14998-6_119; Burks SR, 2011, DRUG METAB DISPOS, V39, P1961, DOI 10.1124/dmd.111.039636; Burks SR, 2010, BREAST CANCER RES TR, V124, P121, DOI 10.1007/s10549-009-0715-4; Burks SR, 2009, BBA-BIOMEMBRANES, V1788, P2301, DOI 10.1016/j.bbamem.2009.08.007; Erdogan S, 2009, J BIOMED NANOTECHNOL, V5, P141, DOI 10.1166/jbn.2009.1016; GABIZON A, 1988, P NATL ACAD SCI USA, V85, P6949, DOI 10.1073/pnas.85.18.6949; GREGORIADIS G, 1975, BIOCHEM SOC T, V3, P613, DOI 10.1042/bst0030613; HEATH TD, 1980, SCIENCE, V210, P539, DOI 10.1126/science.7423203; HEATH TD, 1985, BIOCHIM BIOPHYS ACTA, V820, P74, DOI 10.1016/0005-2736(85)90217-2; HUANG SK, 1992, CANCER RES, V52, P5135; Immordino ML, 2006, INT J NANOMED, V1, P297; Kaufmann AM, 2008, MOL PHARMACEUT, V5, P787, DOI 10.1021/mp8000205; KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521; Lane MC, 2004, METH MOLEC MED, V105, P137; LEE RJ, 1994, J BIOL CHEM, V269, P3198; Lopez-Barcons LA, 2004, J BIOMED MATER RES A, V69A, P155, DOI 10.1002/jbm.a.20235; Mastrobattista E, 2002, J BIOL CHEM, V277, P27135, DOI 10.1074/jbc.M200429200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; PLANK C, 1994, J BIOL CHEM, V269, P12918; Rosen GM, 2005, ORG BIOMOL CHEM, V3, P645, DOI 10.1039/B415586F; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SENIOR J, 1985, BIOCHIM BIOPHYS ACTA, V839, P1, DOI 10.1016/0304-4165(85)90174-6; STEGMANN T, 1987, J BIOL CHEM, V262, P17744; STRAUBINGER RM, 1983, CELL, V32, P1069, DOI 10.1016/0092-8674(83)90291-X; STRAUBINGER RM, 1990, BIOCHEMISTRY-US, V29, P4929, DOI 10.1021/bi00472a025; TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P181, DOI 10.1016/0005-2736(94)90025-6; Torchilin VP, 1996, MOL MED TODAY, V2, P242, DOI 10.1016/1357-4310(96)88805-8; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; VIDAL M, 1985, EMBO J, V4, P2461, DOI 10.1002/j.1460-2075.1985.tb03957.x; WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934; WHITE J, 1982, EMBO J, V1, P217, DOI 10.1002/j.1460-2075.1982.tb01150.x; Whiteman KR, 2001, J LIPOSOME RES, V11, P153, DOI 10.1081/LPR-100108459; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zhang WQ, 2013, ACS APPL MATER INTER, V5, P9856, DOI 10.1021/am4033857	36	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120982	10.1371/journal.pone.0120982	http://dx.doi.org/10.1371/journal.pone.0120982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816348	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600054
J	Martinez, L				Martinez, Leandro			Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; LIGAND-BINDING	The analysis of structural mobility in molecular dynamics plays a key role in data interpretation, particularly in the simulation of biomolecules. The most common mobility measures computed from simulations are the Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuations (RMSF) of the structures. These are computed after the alignment of atomic coordinates in each trajectory step to a reference structure. This rigid-body alignment is not robust, in the sense that if a small portion of the structure is highly mobile, the RMSD and RMSF increase for all atoms, resulting possibly in poor quantification of the structural fluctuations and, often, to overlooking important fluctuations associated to biological function. The motivation of this work is to provide a robust measure of structural mobility that is practical, and easy to interpret. We propose a Low-Order-Value-Optimization (LOVO) strategy for the robust alignment of the least mobile substructures in a simulation. These substructures are automatically identified by the method. The algorithm consists of the iterative superposition of the fraction of structure displaying the smallest displacements. Therefore, the least mobile substructures are identified, providing a clearer picture of the overall structural fluctuations. Examples are given to illustrate the interpretative advantages of this strategy. The software for performing the alignments was named MDLovoFit and it is available as free-software at: http://leandro.iqm.unicamp.br/mdlovofit	Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil	Universidade Estadual de Campinas	Martinez, L (corresponding author), Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil.	leandro@iqm.unicamp.br	UNICAMP, CCES -/J-7787-2015; Martinez, Leandro/B-3792-2008	Martinez, Leandro/0000-0002-6857-1884	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brasil) [2010/16947-9, 2011/51348-1, 2013/05475-7]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil) [304058/2013-0, 470374/2013-6]; Faepex (Fundo de Apoio a Pesquisa, Ensino e a Extensao, Universidade Estadual de Campinas) [596/13]	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brasil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faepex (Fundo de Apoio a Pesquisa, Ensino e a Extensao, Universidade Estadual de Campinas)	Funding: This work was supported by Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brasil)-Grants 2010/16947-9, 2011/51348-1, and 2013/05475-7, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil)-Grants 304058/2013-0 and 470374/2013-6 and Faepex (Fundo de Apoio a Pesquisa, Ensino e a Extensao, Universidade Estadual de Campinas)-Grant 596/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani R, 2009, J GLOBAL OPTIM, V43, P1, DOI 10.1007/s10898-008-9280-3; Andreani R, 2008, MATH PROGRAM, V112, P93, DOI 10.1007/s10107-006-0091-3; Balsera MA, 2006, J PHYS CHEM B, V100, P2567; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KEARSLEY SK, 1989, ACTA CRYSTALLOGR A, V45, P208, DOI 10.1107/S0108767388010128; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c; Martinez L, 2010, J PHYS CHEM B, V114, P1529, DOI 10.1021/jp911554p; Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mezzetti A, 2005, CHEM BIOL, V12, P427, DOI 10.1016/j.chembiol.2005.01.016; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neubert KD, 1998, DR DOBBS J, V23, P123; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Silveira RL, 2012, J PHYS CHEM B, V116, P5671, DOI 10.1021/jp3017858; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	20	158	158	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119264	10.1371/journal.pone.0119264	http://dx.doi.org/10.1371/journal.pone.0119264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816325	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600014
J	Ring, P; Kaernbach, C				Ring, Patrick; Kaernbach, Christian			Sensitivity towards Fear of Electric Shock in Passive Threat Situations	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; DECISION-MAKING; PREFRONTAL CORTEX; HEART RATE; RISK; EMOTION; OUTCOMES; AROUSAL; DAMAGE; REAL	Human judgment and decision-making (JDM) requires an assessment of different choice options. While traditional theories of choice argue that cognitive processes are the main driver to reach a decision, growing evidence highlights the importance of emotion in decision-making. Following these findings, it appears relevant to understand how individuals asses the attractiveness or riskiness of a situation in terms of emotional processes. The following study aims at a better understanding of the psychophysiological mechanisms underlying threat sensitivity by measuring skin conductance responses (SCRs) in passive threat situations. While previous studies demonstrate the role of magnitude on emotional body reactions preceding an outcome, this study focuses on probability. In order to analyze emotional body reactions preceding negative events with varying probability of occurrence, we have our participants play a two-stage card game. The first stage of the card game reveals the probability of receiving an unpleasant electric shock. The second stage applies the electric shock with the previously announced probability. For the analysis, we focus on the time interval between the first and second stage. We observe a linear relation between SCRs in anticipation of receiving an electric shock and shock probability. This finding indicates that SCRs are able to code the likelihood of negative events. We outline how this coding function of SCRs during the anticipation of negative events might add to an understanding of human JDM.	[Ring, Patrick] Kiel Inst World Econ, Kiel, Germany; [Ring, Patrick; Kaernbach, Christian] Univ Kiel, Dept Psychol, Kiel, Germany	Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel	Ring, P (corresponding author), Kiel Inst World Econ, Kiel, Germany.	Patrick.Ring@ifw-kiel.de	Ring, Patrick/K-6881-2019	Ring, Patrick/0000-0002-2214-3139	Leibniz Association [SAW-2013-IfW-2]	Leibniz Association	The study is part of the project "Neurobiological Foundations of Economic Decision Making under Uncertainty and Excessive Risk Taking" which is supported by the Leibniz Association (SAW-2013-IfW-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; [Anonymous], 1915, BODILY CHANGES PAIN; Bankart PC, 1974, PSYCHOPHYSIOLOGY, V11, P160, DOI [10.1111/j.1469-8986.1974.tb00836.x, DOI 10.1111/J.1469-8986.1974.TB00836.X]; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Benedek M, 2011, BIOL PSYCHOL, V86, P320, DOI 10.1016/j.biopsycho.2010.12.012; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Berns GS, 2008, ADV HEALTH ECON HEAL, V20, P1, DOI 10.1016/S0731-2199(08)20001-4; Boucsein W., 2012, ELECTRODERMAL ACTIVI, DOI DOI 10.1007/978-1-4614-1126-0; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; BOWERS KS, 1971, CAN J PSYCHOLOGY, V25, P175, DOI 10.1037/h0082379; Chandrasekhar PVS, 2008, NEUROIMAGE, V39, P1472, DOI 10.1016/j.neuroimage.2007.10.027; CURTIS RC, 1979, PSYCHOL REP, V44, P247, DOI 10.2466/pr0.1979.44.1.247; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; EPSTEIN S, 1970, J PERS SOC PSYCHOL, V16, P20, DOI 10.1037/h0029786; Figner B., 2011, HDB PROCESS TRACING, P163, DOI DOI 10.4324/9780203875292-18/USING-SKIN-CONDUCTANCE-JUDGMENT-DECISION-MAKING-RESEARCH-MICHAEL-SCHULTE-MECKLENBECK-ANTON-KUEHBERGER-JOSEPH-JOHNSON-JOSEPH-JOHNSON; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Gill D, 2012, AM ECON REV, V102, P469, DOI 10.1257/aer.102.1.469; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MEAD JD, 1977, J RES PERS, V11, P443, DOI 10.1016/0092-6566(77)90005-8; Ochsner KN, 2007, TRENDS COGN SCI, V11, P317, DOI 10.1016/j.tics.2007.06.008; Phelps EA, 2014, ANNU REV NEUROSCI, V37, P263, DOI 10.1146/annurev-neuro-071013-014119; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; SHEFRIN H, 1985, J FINANC, V40, P777, DOI 10.2307/2327802; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Venables Peter H, 1980, TECHNIQUES PSYCHOPHY, V54, P3	31	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120989	10.1371/journal.pone.0120989	http://dx.doi.org/10.1371/journal.pone.0120989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816373	gold, Green Submitted, Green Published			2022-12-27	WOS:000352133600055
J	Warris, S; Yalcin, F; Jackson, KJL; Nap, JP				Warris, Sven; Yalcin, Feyruz; Jackson, Katherine J. L.; Nap, Jan Peter			Flexible, Fast and Accurate Sequence Alignment Profiling on GPGPU with PaSWAS	PLOS ONE			English	Article							SMITH-WATERMAN; GRAPHICS PROCESSORS; TOOL	Motivation To obtain large-scale sequence alignments in a fast and flexible way is an important step in the analyses of next generation sequencing data. Applications based on the Smith-Waterman (SW) algorithm are often either not fast enough, limited to dedicated tasks or not sufficiently accurate due to statistical issues. Current SW implementations that run on graphics hardware do not report the alignment details necessary for further analysis. Results With the Parallel SW Alignment Software (PaSWAS) it is possible (a) to have easy access to the computational power of NVIDIA-based general purpose graphics processing units (GPGPUs) to perform high-speed sequence alignments, and (b) retrieve relevant information such as score, number of gaps and mismatches. The software reports multiple hits per alignment. The added value of the new SW implementation is demonstrated with two test cases: (1) tag recovery in next generation sequence data and (2) isotype assignment within an immunoglobulin 454 sequence data set. Both cases show the usability and versatility of the new parallel Smith-Waterman implementation.	[Warris, Sven; Nap, Jan Peter] Hanze Univ Appl Sci Groningen, Inst Life Sci & Technol, NL-9747 AS Groningen, Netherlands; [Warris, Sven; Nap, Jan Peter] Hanze Univ Appl Sci Groningen, Hanze Res Ctr Energy, NL-9747 AS Groningen, Netherlands; [Yalcin, Feyruz] KeyGene NV, NL-6708 PW Wageningen, Netherlands; [Jackson, Katherine J. L.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Keygene N.V.; University of New South Wales Sydney	Nap, JP (corresponding author), Hanze Univ Appl Sci Groningen, Inst Life Sci & Technol, Zernikepl 11, NL-9747 AS Groningen, Netherlands.	j.p.h.nap@pl.hanze.nl	Jackson, Katherine/AAE-4326-2019	Jackson, Katherine/0000-0002-9952-7069	SIA/Raak-PRO; Hanze University of Applied Sciences Groningen	SIA/Raak-PRO; Hanze University of Applied Sciences Groningen	This work was supported by the SIA/Raak-PRO (http://www.innovatie-alliantie.nl/stimuleringsregeling/regeling/item/56-raak-pro.html) grant [BioCOMP] and a Hanze University of Applied Sciences Groningen (http://www.hanze.nl) PhD research grant (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chan EY, 2009, METHODS MOL BIOL, V578, P95, DOI 10.1007/978-1-60327-411-1_5; Collins AM, 2003, PHARMACOL THERAPEUT, V100, P157, DOI 10.1016/j.pharmthera.2003.07.002; Dahlke I, 2006, J ALLERGY CLIN IMMUN, V117, P1477, DOI 10.1016/j.jaci.2005.12.1359; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Emde AK, 2010, BIOINFORMATICS, V26, P123, DOI 10.1093/bioinformatics/btp601; Farber RM, 2011, J MOL GRAPH MODEL, V30, P82, DOI 10.1016/j.jmgm.2011.06.007; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khajeh-Saeed A, 2010, J COMPUT PHYS, V229, P4247, DOI 10.1016/j.jcp.2010.02.009; Korpar M, 2013, BIOINFORMATICS, V29, P2494, DOI 10.1093/bioinformatics/btt410; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Y, 2006, LECT NOTES COMPUT SC, V3994, P188; Liu Yongchao, 2009, BMC Res Notes, V2, P73, DOI 10.1186/1756-0500-2-73; Manavski SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S10; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Naqvi AR, 2009, INT J BIOL SCI, V5, P97; NVIDIA, 2011, NVIDIA CUDA C PROGR; Sandes EFD, 2013, IEEE T PARALL DISTR, V24, P1009, DOI 10.1109/TPDS.2012.194; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122524	10.1371/journal.pone.0122524	http://dx.doi.org/10.1371/journal.pone.0122524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830241	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600114
J	Hepponstall, M; Ignjatovic, V; Binos, S; Attard, C; Karlaftis, V; d'Udekem, Y; Monagle, P; Konstantinov, IE				Hepponstall, Michele; Ignjatovic, Vera; Binos, Steve; Attard, Chantal; Karlaftis, Vasiliki; d'Udekem, Yves; Monagle, Paul; Konstantinov, Igor E.			Remote Ischemic Preconditioning (RIPC) Modifies the Plasma Proteome in Children Undergoing Repair of Tetralogy of Fallot: A Randomized Controlled Trial	PLOS ONE			English	Article							ALPHA-TRYPSIN INHIBITOR; BYPASS GRAFT-SURGERY; CARDIAC-SURGERY; GENE-EXPRESSION; INJURY; COMPLEMENT; HEART; MYOCARDIUM; DEFICIENCY; BINDING	Background Remote ischemic preconditioning (RIPC) has been applied in paediatric cardiac surgery. We have demonstrated that RIPC induces a proteomic response in plasma of healthy volunteers. We tested the hypothesis that RIPC modifies the proteomic response in children undergoing Tetralogy of Fallot (TOF) repair. Methods and Results Children (n=40) were randomized to RIPC and control groups. Blood was sampled at baseline, after cardiopulmonary bypass (CPB) and 6, 12 and 24h post-CPB. Plasma was analysed by liquid chromatography mass spectrometry (LC-MS) in an untargeted approach. Peptides demonstrating differential expression (p<0.01) were subjected to tandem LC-MS/MS and protein identification. Corresponding proteins were identified using the NCBI protein database. There was no difference in age (7.3 +/- 3.5vs6.8 +/- 3.6 months)(p=0.89), weight (7.7 +/- 1.8vs7.5 +/- 1.9 kg)(p=0.71), CPB time (104 +/- 7vs94 +/- 7min)(p=0.98) or aortic cross-clamp time (83 +/- 22vs75 +/- 20 min)(p=0.36). No peptides were differentially expressed at baseline or immediately after CPB. There were 48 peptides with higher expression in the RIPC group 6h post-CPB. This was no longer evident at 12 or 24h, with one peptide down-regulated in the RIPC group. The proteins identified were: inter-alpha globulin inhibitor (42.0 +/- 11.8 vs 820.8 +/- 181.1, p=0.006), fibrinogen preproprotein (59.3 +/- 11.2 vs 1192.6 +/- 278.3, p=0.007), complement-C3 precursor (391.2 +/- 160.9 vs 5385.1 +/- 689.4, p=0.0005), complement C4B (151.5 +/- 17.8 vs 4587.8 +/- 799.2, p=0.003), apolipoprotein B100 (53.4 +/- 8.3 vs 1364.5 +/- 278.2, p=0.005) and urinary proteinase inhibitor (358.6 +/- 74.9 vs 5758.1 +/- 1343.1, p=0.009). These proteins are involved in metabolism, haemostasis, immunity and inflammation. Conclusions We provided the first comprehensive analysis of RIPC-induced proteomic changes in children undergoing surgery. The proteomic changes peak 6h post-CPB and return to baseline within 24h of surgery.	[Hepponstall, Michele; Ignjatovic, Vera; Attard, Chantal; Karlaftis, Vasiliki; d'Udekem, Yves; Monagle, Paul; Konstantinov, Igor E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hepponstall, Michele; d'Udekem, Yves; Konstantinov, Igor E.] Royal Childrens Hosp, Cardiac Surg Unit & Cardiol, Melbourne, Vic, Australia; [Hepponstall, Michele; Ignjatovic, Vera; Monagle, Paul; Konstantinov, Igor E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Hepponstall, Michele; Binos, Steve] Dept Environm & Primary Ind, Biosci Res Div, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Hepponstall, M (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	igor.konstantinov@rch.org.au	Attard, Chantal/AAB-8406-2019; d'Udekem, Yves/AAS-9642-2021	Attard, Chantal/0000-0002-4428-1663; Ignjatovic, Vera/0000-0002-5548-5813; Monagle, Paul/0000-0002-3970-8984; D'UDEKEM D'ACOZ, YVES/0000-0003-1851-7836; Karlaftis, Vasiliki/0000-0002-1443-2352	National Health and Medical Research Council (NHMRC) [628756]; NHMRC postgraduate scholarship [1017734]; Victorian Governments's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Governments's Operational Infrastructure Support Program	The project was funded by the National Health and Medical Research Council (NHMRC) grant (#628756) and NHMRC postgraduate scholarship (#1017734). The study was supported by the Victorian Governments's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Barnouin K, 2011, AMINO ACIDS, V40, P259, DOI 10.1007/s00726-010-0750-9; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Crass T, 1999, J BIOL CHEM, V274, P8367, DOI 10.1074/jbc.274.13.8367; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Hibert P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085669; Hibert P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077211; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; HUTADILOK N, 1988, ANN RHEUM DIS, V47, P377, DOI 10.1136/ard.47.5.377; Inoue K, 2008, J CLIN BIOCHEM NUTR, V43, P139, DOI 10.3164/jcbn.2008059; Ji Q, 2011, INT HEART J, V52, P312, DOI 10.1536/ihj.52.312; Jones BC, 2013, NEUROTOXICOLOGY, V38, P146, DOI 10.1016/j.neuro.2013.05.017; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, J THORAC CARDIOV SUR, V127, P746, DOI 10.1016/j.jtcvs.2003.08.056; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Lee SH, 2012, KOREAN J ANESTHESIOL, V63, P540, DOI 10.4097/kjae.2012.63.6.540; Li Bei, 2009, Interact Cardiovasc Thorac Surg, V8, P17, DOI 10.1510/icvts.2008.189373; Linden MD, 2006, J THROMB HAEMOST, V4, P2670, DOI 10.1111/j.1538-7836.2006.02228.x; Lokki ML, 1999, J IMMUNOL, V162, P3687; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P296, DOI 10.1097/ALN.0b013e318242349a; Luo WJ, 2007, J THORAC CARDIOV SUR, V133, P1373, DOI 10.1016/j.jtcvs.2007.01.028; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Murray I, 1999, BIOCHEM J, V342, P41, DOI 10.1042/0264-6021:3420041; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pang T, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/859056; Pepe S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000095; PRATT CW, 1989, J LEUKOCYTE BIOL, V45, P1; Rivo J, 2006, ANESTHESIOLOGY, V105, P65, DOI 10.1097/00000542-200607000-00014; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Warzecha Z, 2007, J PHYSIOL PHARMACOL, V58, P303; WILSON WA, 1988, J RHEUMATOL, V15, P1855; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yasin NABHM, 2014, J SURG RES, V186, P207, DOI 10.1016/j.jss.2013.09.006; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	40	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122778	10.1371/journal.pone.0122778	http://dx.doi.org/10.1371/journal.pone.0122778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826479	gold, Green Published			2022-12-27	WOS:000352084800091
J	Kim, J; Wang, S; Hyun, J; Choi, SS; Cha, H; Ock, M; Jung, Y				Kim, Jieun; Wang, Sihyung; Hyun, Jeongeun; Choi, Steve S.; Cha, Heejae; Ock, Meesun; Jung, Youngmi			Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver	PLOS ONE			English	Article							HEDGEHOG PATHWAY ACTIVATION; MESENCHYMAL TRANSITIONS; PROMOTES; CULTURE; METASTASIS; MIGRATION; FIBROSIS; SURVIVAL; ACTIN; RNA	Although the various biological roles of thymosin beta 4 (T beta 4) have been studied widely, the effect of T beta 4 and T beta 4-expressing cells in the liver remains unclear. Therefore, we investigated the expression and function of T beta 4 in chronically damaged livers. CCl4 was injected into male mice to induce a model of chronic liver disease. Mice were sacrificed at 6 and 10 weeks after CCl4 treatment, and the livers were collected for biochemical analysis. The activated LX-2, human hepatic stellate cell (HSC) line, were transfected with T beta 4-specific siRNA and activation markers of HSCs were examined. Compared to HepG2, higher expression of T beta 4 in RNA and protein levels was detected in the activated LX-2. In addition, T beta 4 was up-regulated in human liver with advanced liver fibrosis. The expression of T beta 4 increased during mouse HSC activation. T beta 4 was also up-regulated and T beta 4-positive cells were co-localized with a-smooth muscle actin (alpha-SMA) in the livers of CCl4-treated mice, whereas such cells were rarely detected in the livers of corn-oil treated mice. The suppression of T beta 4 in LX-2 cells by siRNA induced the down-regulation of HSC activation-related genes, tgf-beta, alpha-sma, collagen, and vimentin, and up-regulation of HSC inactivation markers, ppar-. and gfap. Immunofluorescent staining detected rare co-expressing cells with T beta 4 and alpha-SMA in T beta 4 siRNA-transfected cells. In addition, cytoplasmic lipid droplets were observed in T beta 4 siRNA-treated cells. These results demonstrate that activated HSCs expressed T beta 4 in chronically damaged livers, and this endogenous expression of T beta 4 influenced HSC activation, indicating that T beta 4 might contribute to liver fibrosis by regulating HSC activation.	[Kim, Jieun; Wang, Sihyung; Hyun, Jeongeun; Jung, Youngmi] Pusan Natl Univ, Dept Integrated Biol Sci, Pusan 609735, South Korea; [Jung, Youngmi] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Choi, Steve S.] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Cha, Heejae; Ock, Meesun] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea	Pusan National University; Pusan National University; Duke University	Jung, Y (corresponding author), Pusan Natl Univ, Dept Integrated Biol Sci, Pusan 609735, South Korea.	y.jung@pusan.ac.kr	Choi, Steve/GZH-1598-2022		National Research Foundation (NRF) of Korea - Korea government (MEST) [2014M2B2A90333]	National Research Foundation (NRF) of Korea - Korea government (MEST)	This work was supported by the National Research Foundation (NRF) of Korea funded by the Korea government (MEST) (2014M2B2A90333) to YJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnaeva E, 2007, ANN NY ACAD SCI, V1112, P154, DOI 10.1196/annals.1415.035; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Chen YW, 2010, J HEPATOL, V53, P528, DOI 10.1016/j.jhep.2010.03.027; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Han T, 2010, WORLD J GASTROENTERO, V16, P625, DOI 10.3748/wjg.v16.i5.625; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji YI, 2013, PATHOL ONCOL RES, V19, P237, DOI 10.1007/s12253-012-9574-0; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Larsson LI, 2007, HUM PATHOL, V38, P114, DOI 10.1016/j.humpath.2006.06.025; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Myohanen TT, 2008, HISTOCHEM CELL BIOL, V130, P993, DOI 10.1007/s00418-008-0468-x; Nemolato S, 2011, EUR J HISTOCHEM, V55, P131, DOI 10.4081/ejh.2011.e25; Paulussen M, 2009, PEPTIDES, V30, P1822, DOI 10.1016/j.peptides.2009.07.010; Reyes-Gordillo K, 2012, ANN NY ACAD SCI, V1269, P61, DOI 10.1111/j.1749-6632.2012.06728.x; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Santelli G, 1999, AM J PATHOL, V155, P799, DOI 10.1016/S0002-9440(10)65178-4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Xiao YT, 2014, CELL PHYSIOL BIOCHEM, V34, P356, DOI 10.1159/000363005; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zuo YQ, 2013, KIDNEY INT, V84, P1166, DOI 10.1038/ki.2013.209	34	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122758	10.1371/journal.pone.0122758	http://dx.doi.org/10.1371/journal.pone.0122758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826335	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800089
J	Nguyen, V; Pearson, K; Kim, JH; Kamdar, K; DePaolo, RW				Nguyen, Vivien; Pearson, Kandyce; Kim, Jee-Hyun; Kamdar, Karishma; DePaolo, R. William			Retinoic Acid Can Exacerbate T Cell Intrinsic TLR2 Activation to Promote Tolerance	PLOS ONE			English	Article							VITAMIN-A SUPPLEMENTATION; DENDRITIC CELLS; REGULATORY RESPONSES; BETA-CATENIN; DIFFERENTIATION; GENERATION; INDUCTION; MORTALITY; IMMUNITY; INFLAMMATION	The contribution of vitamin A to immune health has been well established. However, recent evidence indicates that its active metabolite, retinoic acid (RA), has the ability to promote both tolerogenic and inflammatory responses. While the outcome of RA-mediated immunity is dependent upon the immunological status of the tissue, the contribution of specific innate signals influencing this response have yet to be delineated. Here, we found that treatment with RA can dampen inflammation during intestinal injury. Importantly, we report a novel and unexpected requirement for TLR2 in RA-mediated suppression. Our data demonstrate that RA treatment enhances TLR2-dependent IL-10 production from T cells and this, in turn, potentiates T regulatory cell (T-REG) generation without the need for activation of antigen presenting cells. These data also suggest that combinatorial therapy using RA and TLR2 ligands may be advantageous in the design of therapies to treat autoimmune or inflammatory disease.	[Nguyen, Vivien] Childrens Hosp Los Angeles, Dept Pediat Gastroenterol & Nutr, Los Angeles, CA 90027 USA; [Pearson, Kandyce; Kim, Jee-Hyun; Kamdar, Karishma; DePaolo, R. William] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of Southern California	DePaolo, RW (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	depaolo@usc.edu		DePaolo, William/0000-0002-3880-4544	National Institute of Digestive Disease and Kidney Research of the National Institutes of Health [K01DK082725]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082725] Funding Source: NIH RePORTER	National Institute of Digestive Disease and Kidney Research of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by National Institute of Digestive Disease and Kidney Research of the National Institutes of Health under award number K01DK082725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri RH, 2013, J PEDIATR GASTR NUTR, V56, P89, DOI 10.1097/MPG.0b013e31826a105d; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Eksteen B, 2009, GASTROENTEROLOGY, V137, P320, DOI 10.1053/j.gastro.2009.02.046; Ey B, 2013, J IMMUNOL, V190, P5676, DOI 10.4049/jimmunol.1201592; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kang SG, 2011, MUCOSAL IMMUNOL, V4, P66, DOI 10.1038/mi.2010.42; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; MCDERMOTT MR, 1982, IMMUNOLOGY, V45, P1; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Semba RD, 2005, NUTRITION, V21, P25, DOI 10.1016/j.nut.2004.10.004; SIRISINHA S, 1980, CLIN EXP IMMUNOL, V40, P127; SOMMER A, 1986, LANCET, V1, P1169; SOMMER A, 1983, LANCET, V2, P585; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wang SZ, 2011, J PHYS CHEM LETT, V2, P1, DOI 10.1021/jz101423s; WIEDERMANN U, 1993, IMMUNOLOGY, V80, P581; Wolf G, 1996, FASEB J, V10, P1102, DOI 10.1096/fasebj.10.9.8801174; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0118875	10.1371/journal.pone.0118875	http://dx.doi.org/10.1371/journal.pone.0118875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826367	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800008
J	Antoine, EE; Vlachos, PP; Rylander, MN				Antoine, Elizabeth E.; Vlachos, Pavlos P.; Rylander, Marissa N.			Tunable Collagen I Hydrogels for Engineered Physiological Tissue Micro-Environments	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MATRIX STIFFNESS; CELL-CULTURE; GELS; VITRO; PH; POLYMERIZATION; DIFFUSION; IMPACT	Collagen I hydrogels are commonly used to mimic the extracellular matrix (ECM) for tissue engineering applications. However, the ability to design collagen I hydrogels similar to the properties of physiological tissues has been elusive. This is primarily due to the lack of quantitative correlations between multiple fabrication parameters and resulting material properties. This study aims to enable informed design and fabrication of collagen hydrogels in order to reliably and reproducibly mimic a variety of soft tissues. We developed empirical predictive models relating fabrication parameters with material and transport properties. These models were obtained through extensive experimental characterization of these properties, which include compression modulus, pore and fiber diameter, and diffusivity. Fabrication parameters were varied within biologically relevant ranges and included collagen concentration, polymerization pH, and polymerization temperature. The data obtained from this study elucidates previously unknown fabrication-property relationships, while the resulting equations facilitate informed a priori design of collagen hydrogels with prescribed properties. By enabling hydrogel fabrication by design, this study has the potential to greatly enhance the utility and relevance of collagen hydrogels in order to develop physiological tissue microenvironments for a wide range of tissue engineering applications.	[Antoine, Elizabeth E.; Rylander, Marissa N.] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Vlachos, Pavlos P.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Rylander, Marissa N.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA	Virginia Polytechnic Institute & State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Austin	Antoine, EE (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	elizabeth.antoine@ladhyx.polytechnique.fr	; Vlachos, Pavlos P/G-3779-2010	Antoine, Elizabeth/0000-0001-8116-9585; Vlachos, Pavlos P/0000-0002-8040-9257	National Science Foundation [CBET 0955072]; National Institute of Health [IR21CA158454-01A1]; Virginia Tech AEThER Lab; Virginia Tech Tissue Engineering, Nanotechnology, and Cancer Research Lab; MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS); NATIONAL CANCER INSTITUTE [R21CA158454] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech AEThER Lab; Virginia Tech Tissue Engineering, Nanotechnology, and Cancer Research Lab; MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this project was provided by a National Science Foundation Early CAREER Award CBET 0955072 and a National Institute of Health Grant IR21CA158454-01A1. The authors gratefully acknowledge support provided by the Virginia Tech AEThER Lab, the Virginia Tech Tissue Engineering, Nanotechnology, and Cancer Research Lab, and the MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078; Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664; Antoine EE, 2014, TISSUE ENG PART B-RE, V20, P683, DOI [10.1089/ten.teb.2014.0086, 10.1089/ten.TEB.2014.0086]; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Garcia D, 2010, IMAGE SEGMENTATION U, P26532; Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265; Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047; Hwang YJ, 2011, ANAL METHODS-UK, V3, P529, DOI 10.1039/c0ay00381f; Kreger ST, 2010, BIOPOLYMERS, V93, P690, DOI 10.1002/bip.21431; Kroon D-J, 2009, HESSIAN BASED FRANGI, P24409; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Naciri M, 2008, CYTOTECHNOLOGY, V57, P245, DOI 10.1007/s10616-008-9160-1; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006; Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998; ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5; Seiffert S, 2005, J MICROSC-OXFORD, V220, P20, DOI 10.1111/j.1365-2818.2005.01512.x; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035	33	73	73	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122500	10.1371/journal.pone.0122500	http://dx.doi.org/10.1371/journal.pone.0122500			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822731	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700178
J	Donovan, C; Royce, SG; Vlahos, R; Bourke, JE				Donovan, Chantal; Royce, Simon G.; Vlahos, Ross; Bourke, Jane E.			Lipopolysaccharide Does Not Alter Small Airway Reactivity in Mouse Lung Slices	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTOXIN EXPOSURE; RECEPTOR 4; MICE; CONTRACTION; HYPERRESPONSIVENESS; ROSIGLITAZONE; ACTIVATION; BRADYKININ; INDUCTION	The bacterial endotoxin, lipopolysaccharide (LPS) has been associated with occupational airway diseases with asthma-like symptoms and in acute exacerbations of COPD. The direct and indirect effects of LPS on small airway reactivity have not been fully elucidated. We tested the hypothesis that both in vitro and in vivo LPS treatment would increase contraction and impair relaxation of mouse small airways. Lung slices were prepared from naive Balb/C mice and cultured in the absence or presence of LPS (10 mu g/ml) for up to 48 h for measurement of TNF alpha levels in conditioned media. Alternatively, mice were challenged with PBS or LPS in vivo once a day for 4 days for preparation of lung slices or for harvest of lungs for Q-PCR analysis of gene expression of pro-inflammatory cytokines and receptors involved in airway contraction. Reactivity of small airways to contractile agonists, methacholine and serotonin, and bronchodilator agents, salbutamol, isoprenaline and rosiglitazone, were assessed using phase-contrast microscopy. In vitro LPS treatment of slices increased TNFa release 6-fold but did not alter contraction or relaxation to any agonists tested. In vivo LPS treatment increased lung gene expression of TNF alpha, IL-1 beta and ryanodine receptor isoform 2 more than 5-fold. However there were no changes in reactivity in lung slices from these mice, even when also incubated with LPS ex vivo. Despite evidence of LPS-induced inflammation, neither airway hyperresponsiveness or impaired dilator reactivity were evident. The increase in ryanodine receptor isoform 2, known to regulate calcium signaling in vascular smooth muscle, warrants investigation. Since LPS failed to elicit changes in small airway reactivity in mouse lung slices following in vitro or in vivo treatment, alternative approaches are required to define the potential contribution of this endotoxin to altered small airway reactivity in human lung diseases.	[Donovan, Chantal; Royce, Simon G.; Vlahos, Ross; Bourke, Jane E.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia; [Royce, Simon G.; Bourke, Jane E.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Vlahos, Ross] RMIT Univ Bundoora, Hlth Innovat Res Inst, Sch Hlth Sci, Bundoora, Vic, Australia	University of Melbourne; Monash University; Royal Melbourne Institute of Technology (RMIT)	Bourke, JE (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia.	jane.bourke@monash.edu	Vlahos, Ross/AAM-3837-2020; Bourke, Jane E/K-2596-2019	Vlahos, Ross/0000-0001-8443-7071; Bourke, Jane E/0000-0001-7314-9234	National Health and Medical Research Council (Australia) [1041575, 1027112]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Funding was received from the National Health and Medical Research Council (Australia) 1041575, 1027112 http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Balzary RW, 2006, J PHARMACOL EXP THER, V317, P806, DOI 10.1124/jpet.105.097634; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; Belvisi MG, 1997, BRIT J PHARMACOL, V120, P910, DOI 10.1038/sj.bjp.0700963; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Bourke JE, 2014, AM J RESP CELL MOL, V50, P748, DOI 10.1165/rcmb.2013-0247OC; Bozinovski S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033172; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; Donovan C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-29; Donovan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074101; FitzPatrick M, 2014, PULM PHARMACOL THER, V28, P68, DOI 10.1016/j.pupt.2013.11.005; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Henjakovic M, 2008, TOXICOL APPL PHARM, V231, P68, DOI 10.1016/j.taap.2008.04.003; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liberati TA, 2010, EXPERT REV MOL DIAGN, V10, P501, DOI [10.1586/erm.10.21, 10.1586/ERM.10.21]; Luo SF, 2000, BRIT J PHARMACOL, V130, P1799, DOI 10.1038/sj.bjp.0703489; McSharry C, 2014, J ALLERGY CLIN IMMUN, V134, P1068, DOI 10.1016/j.jaci.2014.08.022; MICHEL O, 1991, CLIN EXP ALLERGY, V21, P441, DOI 10.1111/j.1365-2222.1991.tb01684.x; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Postma DS, 2014, CLIN CHEST MED, V35, P143, DOI 10.1016/j.ccm.2013.09.010; Radon K, 2006, OCCUP ENVIRON MED, V63, P73, DOI 10.1136/oem.2004.017616; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; Sanderson MJ, 2010, ADV EXP MED BIOL, V661, P77, DOI 10.1007/978-1-60761-500-2_5; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Starkhammar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032110; Sukkar M B, 2001, Respirology, V6, P199, DOI 10.1046/j.1440-1843.2001.00334.x; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Xu Y, 2014, AM J RESP CELL MOL, V51, P370, DOI 10.1165/rcmb.2013-0409OC	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122069	10.1371/journal.pone.0122069	http://dx.doi.org/10.1371/journal.pone.0122069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822969	Green Published, gold			2022-12-27	WOS:000352134700150
J	Fu, YF; Pan, LF; Sun, Q; Zhu, WP; Zhu, LY; Ye, CC; Xue, CY; Wang, YP; Liu, Q; Ma, P; Qiu, HF				Fu, Yifei; Pan, Lifeng; Sun, Qiao; Zhu, Weiping; Zhu, Linying; Ye, Chuchu; Xue, Caoyi; Wang, Yuanping; Liu, Qing; Ma, Ping; Qiu, Huifang			The Clinical and Etiological Characteristics of Influenza-Like Illness (ILI) in Outpatients in Shanghai, China, 2011 to 2013	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; HOSPITALIZED CHILDREN; VIRAL-INFECTIONS; TRACT INFECTIONS; YOUNG-CHILDREN; MULTIPLEX PCR; SURVEILLANCE; DIAGNOSIS; ADULTS; ASSAY	Introduction Clinical and etiological characteristics of influenza-like illness (ILI) in outpatients is poorly understood in the southern temperate region of China. We conducted laboratory-based surveillance of viral etiology for ILI outpatients in Shanghai from January 2011 to December 2013. Materials and Methods Clinical and epidemiological data from ILI outpatients, both children and adults, were collected. A total of 1970 nasopharyngeal swabs were collected and tested for 12 respiratory viruses using multiplex RT-PCR, and the data were analyzed anonymously. Results All 12 respiratory viruses were detected in the specimens. At least one virus was detected in 32.4% of 1970 specimens analyzed, with 1.1% showing co-infections. The most frequently detected agents were influenza A (11.7%), influenza B (9.6%), and rhinoviruses (3.1%). Other viruses were present at a frequency less than 3.0%. We observed a winter peak in the detection rate in ILI patients during 3 years of surveillance and a summer peak in 2012. HCoV, HADV, and HMPV were detected more frequently in children than in adults. Patients infected with influenza virus experienced higher temperatures, more coughs, running noses, headaches and fatigue than patients infected with other viruses and virus-free patients (p< 0.001). Conclusions The spectrum, seasonality, age distribution and clinical associations of respiratory virus infections in children and adults with influenza-like illness were analyzed in this study for the first time. To a certain extent, the findings can provide baseline data for evaluating the burden of respiratory virus infection in children and adults in Shanghai. It will also provide clinicians with helpful information about the etiological patterns of outpatients presenting with complaints of acute respiratory syndrome, but further studies should be conducted, and longer-term laboratory-based surveillance would give a better picture of the etiology of ILI.	[Fu, Yifei; Sun, Qiao; Zhu, Weiping; Ye, Chuchu; Xue, Caoyi; Wang, Yuanping] Shanghai Pudong New Area Ctr Dis Control & Preven, Res Base, Key Lab Surveillance & Early Warning Infect Dis C, Shanghai, Peoples R China; [Pan, Lifeng; Zhu, Linying; Liu, Qing; Ma, Ping; Qiu, Huifang] Shanghai Pudong New Area Ctr Dis Control & Preven, Dept Microbiol Lab, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Sun, Q (corresponding author), Shanghai Pudong New Area Ctr Dis Control & Preven, Res Base, Key Lab Surveillance & Early Warning Infect Dis C, Shanghai, Peoples R China.	qsun@pdcdc.sh.cn	Ye, Chuchu/Y-6147-2019	Ye, Chuchu/0000-0003-4461-4111; Pan, Lifeng/0000-0001-9482-3275	National Science and Technology Key Projects [2012ZX10004201]; Scientific Research Project of Ministry of Health, China [201202006]; Shanghai Overseas Talent Training Project [GWHW201220]	National Science and Technology Key Projects; Scientific Research Project of Ministry of Health, China; Shanghai Overseas Talent Training Project	This work was supported in part by National Science and Technology Key Projects (No. 2012ZX10004201, http://www.most.gov.cn), Scientific Research Project of Ministry of Health, China (No. 201202006, http://www.nhfpc.gov.cn) and Shanghai Overseas Talent Training Project (GWHW201220, http://www.wsjsw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CTR DIS CONTROL PREV, V2014; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Chinese National Influenza Center (CNIC), 2011, CHIN FLU WEEKL REP, V2014; Deng Jikui, 2013, Virologica Sinica, V28, P97, DOI 10.1007/s12250-013-3312-y; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Friedman MJ, 2004, ARCH PEDIAT ADOL MED, V158, P391, DOI 10.1001/archpedi.158.4.391; Frobert E, 2011, J MED VIROL, V83, P150, DOI 10.1002/jmv.21932; Hasman H, 2009, J MED MICROBIOL, V58, P408, DOI 10.1099/jmm.0.006098-0; Heijnen M.L.A., 1999, Euro Surveill, V4, P81; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Ju X, 2014, ARCH VIROL; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Laguna-Torres VA, 2011, INFLUENZA OTHER RESP, V5, P123, DOI 10.1111/j.1750-2659.2010.00182.x; Larcher C, 2006, EUR J CLIN MICROBIOL, V25, P681, DOI 10.1007/s10096-006-0214-z; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Li H, 2013, VIROL J, V10, P143, DOI DOI 10.1186/1743-422X-10-143; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Murata Y, 2008, CURR OPIN PULM MED, V14, P235, DOI 10.1097/MCP.0b013e3282f79651; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Nichols WG, 2008, CLIN MICROBIOL REV, V21, P274, DOI 10.1128/CMR.00045-07; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Ranmuthugala G, 2011, COMMUN DIS INTELL, V35, P177; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288; WANER JL, 1994, CLIN MICROBIOL REV, V7, P143, DOI 10.1128/CMR.7.2.143-151.1994; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028786; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568	41	12	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119513	10.1371/journal.pone.0119513	http://dx.doi.org/10.1371/journal.pone.0119513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822885	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700040
J	Pinto, TJP; Farias, DR; Rebelo, F; Lepsch, J; Vaz, JS; Moreira, JD; Cunha, GM; Kac, G				Pinto, Thatiana J. P.; Farias, Dayana R.; Rebelo, Fernanda; Lepsch, Jaqueline; Vaz, Juliana S.; Moreira, Julia D.; Cunha, Geraldo M.; Kac, Gilberto			Lower Inter-Partum Interval and Unhealthy Life-Style Factors Are Inversely Associated with n-3 Essential Fatty Acids Changes during Pregnancy: A Prospective Cohort with Brazilian Women	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; DOCOSAHEXAENOIC ACID; PLASMA; SERUM; CONSUMPTION; STABILITY; BIOMARKER; BLOOD; FISH; PUFA	Objective To analyze serum fatty acids concentrations during healthy pregnancy and evaluate whether socioeconomic, demographic, obstetric, nutritional, anthropometric and lifestyle factors are associated with their longitudinal changes. Study design A prospective cohort of 225 pregnant women was followed in the 5th-13th, 20th-26th and 30th-36th weeks of gestation. Serum samples were collected in each trimester of pregnancy and analyzed to determine the fatty acids composition using a high-throughput robotic direct methylation method coupled with fast gas-liquid chromatography. The independent variables comprised the subjects' socioeconomic and demographic status, obstetric history, early pregnancy body mass index (BMI), dietary and lifestyle parameters. Analyses were performed using linear mixed-effects models. Results The overall absolute concentrations of fatty acids increased from the 1st to the 2nd trimester and slightly increased from the 2nd to the 3rd trimester. Early pregnancy BMI, inter-partum interval and weekly fish intake were the factors associated with changes in eicosapentaenoic + docosahexaenoic acids (EPA+DHA) and total n-3 polyunsaturated fatty acids (PUFAs). Early pregnancy BMI, age and monthly per-capita income were inversely associated with the changes in the n-6/n-3 ratio. Alcohol consumption was positively associated with the n-6/n-3 ratio. Conclusion Early pregnancy BMI was positively associated with EPA+DHA and total n-3 PUFAs, while presenting a reduced weekly fish intake and a lower inter-partum interval were associated with lower levels of n-3 PUFAs. A lower per-capita family income and a drinking habit were factors that were positively associated with a higher n-6/n-3 ratio.	[Pinto, Thatiana J. P.; Farias, Dayana R.; Rebelo, Fernanda; Lepsch, Jaqueline; Vaz, Juliana S.; Kac, Gilberto] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, Brazil; [Pinto, Thatiana J. P.; Farias, Dayana R.; Lepsch, Jaqueline; Kac, Gilberto] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Grad Program Nutr, Rio De Janeiro, RJ, Brazil; [Rebelo, Fernanda] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Grad Program Epidemiol Publ Hlth, Rio De Janeiro, RJ, Brazil; [Vaz, Juliana S.] Univ Fed Pelotas, Fac Nutr, Capao Do Leao, RS, Brazil; [Moreira, Julia D.] Univ Fed Santa Catarina, Dept Nutr, Florianopolis, SC, Brazil; Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Epidemiol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal de Pelotas; Universidade Federal de Santa Catarina (UFSC); Fundacao Oswaldo Cruz	Kac, G (corresponding author), Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, Brazil.	gilberto.kac@gmail.com	Kac, Gilberto/H-6862-2012; Rebelo, Fernanda/AAN-5125-2020; Moreira, Julia D/D-1564-2012; Moreira, Júlia Dubois/ABH-6056-2020; Vaz, Juliana/A-5645-2012	Kac, Gilberto/0000-0001-8603-9077; Moreira, Júlia Dubois/0000-0002-2256-7222; Rebelo, Fernanda/0000-0001-6207-5161; Farias, Dayana/0000-0003-0278-8375; Vaz, Juliana/0000-0002-2880-767X	National Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ); FAPERJ; National School of Public Health/ Oswaldo Cruz Foundation; CNPq	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National School of Public Health/ Oswaldo Cruz Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the National Council for Scientific and Technological Development (CNPq) and the Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ). TJPP received scholarship from FAPERJ. FR received scholarship from National School of Public Health/ Oswaldo Cruz Foundation. GK received scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Astorg P, 2008, EUR J CLIN NUTR, V62, P1155, DOI 10.1038/sj.ejcn.1602836; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Chien KL, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-23; Cohen BE, 2008, J NUTR, V138, P1135, DOI 10.1093/jn/138.6.1135; Coletta Jaclyn M, 2010, Rev Obstet Gynecol, V3, P163; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gil-Sanchez A, 2012, CURR OPIN CLIN NUTR, V15, P265, DOI 10.1097/MCO.0b013e3283523b6e; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hodge AM, 2007, NUTR METAB CARDIOVAS, V17, P415, DOI 10.1016/j.numecd.2006.04.005; Hodson L, 2002, CLIN CHIM ACTA, V321, P63, DOI 10.1016/S0009-8981(02)00100-6; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2014, J NUTR, V144, P33, DOI 10.3945/jn.113.183749; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Joint FAO/WHO Expert Consultation on Fats and Oils in Human Nutrition, 1993, FATS OILS HUM NUTR R; Kendall-Tackett K, 2010, J MIDWIFERY WOM HEAL, V55, P561, DOI 10.1016/j.jmwh.2010.02.014; Klebanoff MA, 2011, OBSTET GYNECOL, V117, P1071, DOI 10.1097/AOG.0b013e31821645dc; Lepsch J, 2015, J HUM NUTR DIET, V28, P85, DOI 10.1111/jhn.12225; Leung CW, 2012, AM J CLIN NUTR, V96, P977, DOI 10.3945/ajcn.112.040014; Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003; Lin YH, 2012, LIPIDS, V47, P527, DOI 10.1007/s11745-012-3661-6; Martin Clayton Antunes, 2006, Rev. Nutr., V19, P761, DOI 10.1590/S1415-52732006000600011; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Matthan NR, 2010, J LIPID RES, V51, P2826, DOI 10.1194/jlr.D007534; McNaughton SA, 2007, BRIT J NUTR, V97, P561, DOI 10.1017/S0007114507381385; Miyake Y, 2013, J PSYCHIATR RES, V47, P572, DOI 10.1016/j.jpsychires.2013.01.012; NAKAMURA MT, 1994, J CLIN INVEST, V93, P450, DOI 10.1172/JCI116981; NEPA, 2011, TAB BRAS COMP AL; Nutrient Data Laboratory (U.S.), 2011, USDA NAT NUTR DAT ST; Otto SJ, 1997, EUR J CLIN NUTR, V51, P232, DOI 10.1038/sj.ejcn.1600390; Ozias MK, 2007, J NUTR, V137, P125, DOI 10.1093/jn/137.1.125; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Sichieri R, 1998, NUTR RES, V18, P1649, DOI 10.1016/S0271-5317(98)00151-1; Steer CD, 2013, AM J CLIN NUTR, V98, P1575, DOI 10.3945/ajcn.112.051524; Stewart F, 2007, LIPIDS, V42, P335, DOI 10.1007/s11745-006-3005-5; Strain JJ, 2008, NEUROTOXICOLOGY, V29, P776, DOI 10.1016/j.neuro.2008.06.002; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; Vaz JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067671; Vaz JS, 2014, J AFFECT DISORDERS, V152, P76, DOI 10.1016/j.jad.2013.04.045; What You Need to Know About Mercury in Fish and Shellfish, 2004, 2004 EPA FDA ADV WOM	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121151	10.1371/journal.pone.0121151	http://dx.doi.org/10.1371/journal.pone.0121151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822204	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700093
J	Roca, P; Mellerio, C; Chassoux, F; Riviere, D; Cachia, A; Charron, S; Lion, S; Mangin, JF; Devaux, B; Meder, JF; Oppenheim, C				Roca, Pauline; Mellerio, Charles; Chassoux, Francine; Riviere, Denis; Cachia, Arnaud; Charron, Sylvain; Lion, Stephanie; Mangin, Jean-Francois; Devaux, Bertrand; Meder, Jean-Francois; Oppenheim, Catherine			Sulcus-Based MR Analysis of Focal Cortical Dysplasia Located in the Central Region	PLOS ONE			English	Article							GENETIC CLASSIFICATION; SURGICAL OUTCOMES; MALFORMATIONS; IMPROVES; RECOGNITION; DISORDERS; LESIONS; SIGN	Objective Focal cortical dysplasias (FCDs) are mainly located in the frontal region, with a particular tropism for the central sulcus. Up to 30% of lesions are undetected (magnetic resonance [MR]-negative FCD patients) or belatedly diagnosed by visual analysis of MR images. We propose an automated sulcus-based method to analyze abnormal sulcal patterns associated with central FCD, taking into account the normal interindividual sulcal variability. Methods We retrospectively studied 29 right-handed patients with FCD in the central region (including 12 MR negative histologically-confirmed cases) and 29 right-handed controls. The analysis of sulcal abnormalities from T1-weighted MR imaging (MRI) was performed using a graph-based representation of the cortical folds and an automated sulci recognition system, providing a new quantitative criterion to describe sulcal patterns, termed sulcus energy. Results Group analysis showed that the central sulcus in the hemisphere ipsilateral to the FCD exhibited an abnormal sulcal pattern compared with controls (p = 0.032). FCDs were associated with abnormal patterns of the central sulci compared with controls (p = 0.006), a result that remained significant when MR-negative and MR-positive patients were considered separately, while the effects of sex, age and MR-field were not significant. At the individual level, sulcus energy alone failed to detect the FCD lesion. We found, however, a significant association between maximum z-scores and the site of FCD (p = 0.0046) which remained significant in MR-negative (p = 0.024) but not in MR-positive patients (p = 0.058). The maximum z-score pointed to an FCD sulcus in four MR-negative and five MR-positive patients. Conclusions We identified abnormal sulcal patterns in patients with FCD of the central region compared with healthy controls. The abnormal sulcal patterns ipsilateral to the FCD and the link between sulcus energy and the FCD location strengthen the interest of sulcal abnormalities in FCD patients.	[Roca, Pauline; Mellerio, Charles; Charron, Sylvain; Lion, Stephanie; Meder, Jean-Francois; Oppenheim, Catherine] Univ Paris 05, Ctr Psychiat & Neurosci, UMR INSERM 894, Dept Neuroimaging,St Anne Hosp Ctr,Sorbonne Paris, Paris, France; [Chassoux, Francine; Devaux, Bertrand] Univ Paris 05, Dept Neurosurg, St Anne Hosp Ctr, Sorbonne Paris Cite, Paris, France; [Riviere, Denis; Mangin, Jean-Francois] CEA, Neurospin, UNATI, Saclay, France; [Cachia, Arnaud] Univ Paris 05, Ctr Psychiat & Neurosci, St Anne Hosp Ctr, UMR INSERM 894, Paris, France; [Cachia, Arnaud] Univ Paris 05, Sorbonne Paris Cite, UMR CNRS 8240, Lab Psychol Child Dev & Educ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; CEA; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Roca, P (corresponding author), Univ Paris 05, Ctr Psychiat & Neurosci, UMR INSERM 894, Dept Neuroimaging,St Anne Hosp Ctr,Sorbonne Paris, Paris, France.	p.roca@ch-sainte-anne.fr	Mangin, Jean-Francois/AAI-8983-2020; Oppenheim, Catherine/N-1635-2018	Cachia, Arnaud/0000-0003-2125-4985; MELLERIO, Charles/0000-0002-9987-9101; Meder, Jean-Francois/0000-0002-0898-0133; Oppenheim, Catherine/0000-0003-3410-0862				Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Barkovich AJ, 2004, NEUROIMAG CLIN N AM, V14, P231, DOI 10.1016/j.nic.2004.03.003; Bernasconi A, 2001, ANN NEUROL, V49, P770, DOI 10.1002/ana.1013; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Bronen RA, 2000, RADIOLOGY, V214, P657, DOI 10.1148/radiology.214.3.r00mr40657; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Chen J, 2012, ANN NEUROL, V72, P881, DOI 10.1002/ana.23795; Colliot O, 2006, NEUROIMAGE, V29, P162, DOI 10.1016/j.neuroimage.2005.07.021; Colombo N, 2012, NEURORADIOLOGY, V54, P1065, DOI 10.1007/s00234-012-1049-1; Colombo N, 2009, EPILEPTIC DISORD, V11, P194, DOI 10.1684/epd.2009.0262; Duchesnay E, 2007, IEEE T MED IMAGING, V26, P553, DOI 10.1109/TMI.2007.892501; Fillard P, 2007, NEUROIMAGE, V34, P639, DOI 10.1016/j.neuroimage.2006.09.027; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; House PM, 2013, EPILEPSY RES, V106, P403, DOI 10.1016/j.eplepsyres.2013.06.016; Kassubek J, 2002, EPILEPSIA, V43, P596, DOI 10.1046/j.1528-1157.2002.41401.x; Kim DW, 2009, NEUROLOGY, V72, P211, DOI 10.1212/01.wnl.0000327825.48731.c3; Lefevre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000749; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Mangin JF, 2004, IEEE T MED IMAGING, V23, P968, DOI 10.1109/TMI.2004.831204; Mellerio C, 2012, AM J NEURORADIOL, V33, P1932, DOI 10.3174/ajnr.A3081; Mellerio C, 2015, RADIOLOGY, V274, P500, DOI 10.1148/radiol.14140773; Mellerio C, 2014, EPILEPSIA, V55, P117, DOI 10.1111/epi.12464; Ono M, 1990, ATLAS CEREBRAL SULCI; Oster JM, 2012, ARCH NEUROL-CHICAGO, V69, P257, DOI 10.1001/archneurol.2011.1002; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Rajan J, 2009, COMPUT MED IMAG GRAP, V33, P553, DOI 10.1016/j.compmedimag.2009.05.004; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Razek AAKA, 2009, AM J NEURORADIOL, V30, P4, DOI 10.3174/ajnr.A1223; Regis J, 2011, NEUROSURGERY, V69, P80, DOI 10.1227/NEU.0b013e318212bb1a; Rettmann ME, 2006, CEREB CORTEX, V16, P1584, DOI 10.1093/cercor/bhj095; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Sun ZY, 2012, NEUROIMAGE, V60, P332, DOI 10.1016/j.neuroimage.2011.12.050; Thesen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016430; Toro R, 2005, CEREB CORTEX, V15, P1900, DOI 10.1093/cercor/bhi068; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204; Winston GP, 2014, EPILEPSY RES, V108, P336, DOI 10.1016/j.eplepsyres.2013.11.004	43	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122252	10.1371/journal.pone.0122252	http://dx.doi.org/10.1371/journal.pone.0122252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822985	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700160
J	Avalos, E; Catanzaro, D; Catanzaro, A; Ganiats, T; Brodine, S; Alcaraz, J; Rodwell, T				Avalos, Elisea; Catanzaro, Donald; Catanzaro, Antonino; Ganiats, Theodore; Brodine, Stephanie; Alcaraz, John; Rodwell, Timothy			Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium tuberculosis Isolates: A Systematic Review	PLOS ONE			English	Article							LINE PROBE ASSAY; EXTENSIVE DRUG-RESISTANCE; MOLECULAR CHARACTERIZATION; RAPID DETECTION; DNA GYRASE; FUNCTIONAL-ANALYSIS; PCR-RFLP; STRAINS; SUSCEPTIBILITY; MOXIFLOXACIN	Background The detection of mutations in the gyrA and gyrB genes in the Mycobacterium tuberculosis genome that have been demonstrated to confer phenotypic resistance to fluoroquinolones is the most promising technology for rapid diagnosis of fluoroquinolone resistance. Methods In order to characterize the diversity and frequency of gyrA and gyrB mutations and to describe the global distribution of these mutations, we conducted a systematic review, from May 1996 to April 2013, of all published studies evaluating Mycobacterium tuberculosis mutations associated with resistance to fluoroquinolones. The overall goal of the study was to determine the potential utility and reliability of these mutations as diagnostic markers to detect phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis and to describe their geographic distribution. Results Forty-six studies, covering four continents and 18 countries, provided mutation data for 3,846 unique clinical isolates with phenotypic resistance profiles to fluoroquinolones. The gyrA mutations occurring most frequently in fluoroquinolone-resistant isolates, ranged from 21-32% for D94G and 13-20% for A90V, by drug. Eighty seven percent of all strains that were phenotypically resistant to moxifloxacin and 83% of ofloxacin resistant isolates contained mutations in gyrA. Additionally we found that 83% and 80% of moxifloxacin and ofloxacin resistant strains respectively, were observed to have mutations in the gyrA codons interrogated by the existing MTBDRsl line probe assay. In China and Russia, 83% and 84% of fluoroquinolone resistant strains respectively, were observed to have gyrA mutations in the gene regions covered by the MTBDRsl assay. Conclusions Molecular diagnostics, specifically the Genotype MTBDRsl assay, focusing on codons 8894 should have moderate to high sensitivity in most countries. While we did observe geographic differences in the frequencies of single gyrA mutations across countries, molecular diagnostics based on detection of all gyrA mutations demonstrated to confer resistance should have broad and global utility.	[Avalos, Elisea; Ganiats, Theodore] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Catanzaro, Donald] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Catanzaro, Antonino] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Brodine, Stephanie; Alcaraz, John] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Rodwell, Timothy] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Rodwell, T (corresponding author), Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA.	trodwell@ucsd.edu	Catanzaro, Donald/AAA-4932-2019	Catanzaro, Donald/0000-0003-1760-0574	National Institutes of Health, National Institute of Allergy and Infectious Disease [U01 AI0822229-05, R01 AI 111435-01, R01 AI 105185-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082229, R01AI111435, P30AI036214, R01AI105185] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: AC and DC are funded by National Institutes of Health, National Institute of Allergy and Infectious Disease, grant #U01 AI0822229-05. TR is funded by National Institutes of Health, National Institute of Allergy and Infectious Disease, grants: # U01 AI0822229-05, R01 AI 111435-01 and R01 AI 105185-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairi Noura M, 2011, BMC Res Notes, V4, P123, DOI 10.1186/1756-0500-4-123; ALANGADEN GJ, 1995, ANTIMICROB AGENTS CH, V39, P1700, DOI 10.1128/AAC.39.8.1700; Ali A, 2011, ANTIMICROB AGENTS CH, V55, P5654, DOI 10.1128/AAC.05101-11; An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; Anand RS, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-47; Ando H, 2011, J MED MICROBIOL, V60, P184, DOI 10.1099/jmm.0.024729-0; Antonova OV, 2008, B EXP BIOL MED+, V145, P108, DOI 10.1007/s10517-008-0034-5; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Barnard M, 2012, AM J RESP CRIT CARE, V186, P1298, DOI 10.1164/rccm.201205-0960OC; Bravo LTC, 2009, J CLIN MICROBIOL, V47, P3985, DOI 10.1128/JCM.01229-09; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Chen J, 2012, BRAZ J INFECT DIS, V16, P136, DOI [10.1016/S1413-8670(12)70294-5, 10.1590/S1413-86702012000200005]; Chernyaeva E, 2013, TUBERCULOSIS, V93, P291, DOI 10.1016/j.tube.2013.02.005; Cui ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-78; Devasia R, 2012, J CLIN MICROBIOL, V50, P1390, DOI 10.1128/JCM.05286-11; El Sahly HM, 2011, J CLIN MICROBIOL, V49, P2942, DOI 10.1128/JCM.00231-11; Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769; Feng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055292; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Giannoni F, 2005, ANTIMICROB AGENTS CH, V49, P2928, DOI 10.1128/AAC.49.7.2928-2933.2005; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Hu Y, 2011, TUBERCULOSIS, V91, P238, DOI 10.1016/j.tube.2011.03.001; Huang TS, 2005, J ANTIMICROB CHEMOTH, V56, P1058, DOI 10.1093/jac/dki353; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Jeon CY, 2011, INT J TUBERC LUNG D, V15, P77; Jnawali HN, 2013, DIAGN MICR INFEC DIS, V76, P187, DOI 10.1016/j.diagmicrobio.2013.02.035; Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7; Kontsevaya I, 2011, J CLIN MICROBIOL, V49, P2832, DOI 10.1128/JCM.01889-10; Lau RWT, 2011, ANTIMICROB AGENTS CH, V55, P608, DOI 10.1128/AAC.00920-10; Lee Ann S. G., 2002, International Journal of Infectious Diseases, V6, P48, DOI 10.1016/S1201-9712(02)90136-0; Long QX, 2012, INT J ANTIMICROB AG, V39, P486, DOI 10.1016/j.ijantimicag.2012.02.015; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Mokrousov I, 2008, ANTIMICROB AGENTS CH, V52, P2937, DOI 10.1128/AAC.00036-08; Nosova EY, 2013, J MED MICROBIOL, V62, P108, DOI 10.1099/jmm.0.046821-0; Pantel A, 2012, ANTIMICROB AGENTS CH, V56, P1990, DOI 10.1128/AAC.06272-11; Pantel A, 2011, ANTIMICROB AGENTS CH, V55, P4524, DOI 10.1128/AAC.00707-11; Perdigao J, 2010, J ANTIMICROB CHEMOTH, V65, P224, DOI 10.1093/jac/dkp452; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Poudel A, 2013, TUBERCULOSIS, V93, P84, DOI 10.1016/j.tube.2012.10.007; Prammananan T, 2011, INT J ANTIMICROB AG, V37, P84, DOI 10.1016/j.ijantimicag.2010.09.005; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Sekiguchi J, 2011, ANTIMICROB AGENTS CH, V55, P3958, DOI 10.1128/AAC.00417-10; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Singh M, 2011, INDIAN J MED RES, V133, P535; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; Soudani A, 2010, CLIN MICROBIOL INFEC, V16, P1454, DOI [10.1111/j.1469-0691.2010.03087.x, 10.1111/j.1469-0691.2009.03087.x]; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Sulochana S, 2007, J CHEMOTHERAPY, V19, P166, DOI 10.1179/joc.2007.19.2.166; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; Surcouf C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-255; Suzuki Y, 2012, INT J ANTIMICROB AG, V39, P435, DOI 10.1016/j.ijantimicag.2012.01.007; Tahmasebi P, 2012, IRAN J MICROBIOL, V4, P165; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; van Doorn HR, 2008, INT J TUBERC LUNG D, V12, P736; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Wang JY, 2007, J ANTIMICROB CHEMOTH, V59, P860, DOI 10.1093/jac/dkm061; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; *WHO, 2008, ANT DRUG RES WORLD; Williams KJ, 1996, J ANTIMICROB CHEMOTH, V37, P1032, DOI 10.1093/jac/37.5.1032; World Health Organization (WHO), 2013, US MOL LIN PROB ASS; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Yin XM, 2010, J INFECTION, V61, P150, DOI 10.1016/j.jinf.2010.05.001; Yuan XL, 2012, J CLIN MICROBIOL, V50, P2404, DOI 10.1128/JCM.06860-11; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P364, DOI 10.1128/AAC.01228-13; Zhao LL, 2012, J MICROBIOL METH, V88, P175, DOI 10.1016/j.mimet.2011.10.015; Zhu CY, 2012, DIAGN MICR INFEC DIS, V73, P260, DOI 10.1016/j.diagmicrobio.2012.03.025	74	87	91	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120470	10.1371/journal.pone.0120470	http://dx.doi.org/10.1371/journal.pone.0120470			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816236	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600037
J	Martemyanov, VV; Pavlushin, SV; Dubovskiy, IM; Belousova, IA; Yushkova, YV; Morosov, SV; Chernyak, EI; Glupov, VV				Martemyanov, Vyacheslav V.; Pavlushin, Sergey V.; Dubovskiy, Ivan M.; Belousova, Irina A.; Yushkova, Yuliya V.; Morosov, Sergey V.; Chernyak, Elena I.; Glupov, Victor V.			Leaf Surface Lipophilic Compounds as One of the Factors of Silver Birch Chemical Defense against Larvae of Gypsy Moth	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; JUVENILE-HORMONE; IMMUNE DEFENSE; GLANDULAR TRICHOMES; DIET CHOICE; 20-HYDROXYECDYSONE; HERBIVORES; RESISTANCE; HEMOLYMPH; RESPONSES	Plant chemical defense against herbivores is a complex process which involves a number of secondary compounds. It is known that the concentration of leaf surface lipophilic compounds (SLCs), particularly those of flavonoid aglycones are increased with the defoliation treatment of silver birch Betula pendula. In this study we investigated how the alteration of SLCs concentration in the food affects the fitness and innate immunity of the gypsy moth Lymantria dispar. We found that a low SLCs concentrations in consumed leaves led to a rapid larval development and increased females' pupae weight (=fecundity) compared to larvae fed with leaves with high SLCs content. Inversely, increasing the compounds concentration in an artificial diet produced the reverse effects: decreases in both larval weight and larval survival. Low SLCs concentrations in tree leaves differently affected larval innate immunity parameters. For both sexes, total hemocytes count in the hemolymph increased, while the activity of plasma phenoloxidase decreased when larvae consume leaves with reduced content of SLCs. Our results clearly demonstrate that the concentration of SLCs in silver birch leaves affects not only gypsy moth fitness but also their innate immune status which might alter the potential resistance of insects against infections and/or parasitoids.	[Martemyanov, Vyacheslav V.; Pavlushin, Sergey V.; Dubovskiy, Ivan M.; Belousova, Irina A.; Glupov, Victor V.] Inst Systemat & Ecol Anim SB RAS, Lab Insect Pathol, Novosibirsk 630091, Russia; [Yushkova, Yuliya V.; Morosov, Sergey V.; Chernyak, Elena I.] Novosibirsk Inst Organ Chem SB RAS, Lab Ecol Res & Chromatog Anal, Novosibirsk 630090, Russia	Russian Academy of Sciences; Vorozhtsov Novosibirsk Institute of Organic Chemistry	Martemyanov, VV (corresponding author), Inst Systemat & Ecol Anim SB RAS, Lab Insect Pathol, Frunze Str 11, Novosibirsk 630091, Russia.	martemyanov79@yahoo.com	Pavlushin, Sergey/AAH-5329-2019; Chernyak, Elena/S-9957-2017; Glupov, Viktor/N-7706-2014; Dubovskiy, Ivan/B-8252-2008; Belousova, Irina A/L-3280-2017; Martemyanov, Vyacheslav/Q-7466-2016	Pavlushin, Sergey/0000-0002-4210-0662; Chernyak, Elena/0000-0002-1669-7864; Dubovskiy, Ivan/0000-0001-9691-3960; 	Federal Fundamental Scientific Research Programme [VI.51.1.5.]; RF [MK-2984.2013.4]	Federal Fundamental Scientific Research Programme; RF	The purchasing of supplies needed for this work was supported by the Federal Fundamental Scientific Research Programme for 2013-2020 (VI.51.1.5.), the grant of president RF (MK-2984.2013.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JH, 1995, LIPIDS, V30, P257, DOI 10.1007/BF02537830; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Broderick Nichole A., 2009, P13; Bukovinszky T, 2009, OECOLOGIA, V160, P299, DOI 10.1007/s00442-009-1308-y; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; Duffey S.S., 1986, P151; Felton G. W., 1996, P373; Ferreres F, 2008, J AGR FOOD CHEM, V56, P844, DOI 10.1021/jf072657a; Ferreres F, 2007, PHYTOCHEMISTRY, V68, P361, DOI 10.1016/j.phytochem.2006.10.020; Franssens V, 2006, DEV COMP IMMUNOL, V30, P735, DOI 10.1016/j.dci.2005.10.010; Hirayama C, 2008, PHYTOCHEMISTRY, V69, P1141, DOI 10.1016/j.phytochem.2007.11.009; Hoover K, 1998, J CHEM ECOL, V24, P1949, DOI 10.1023/A:1020777407980; Il'inykh AV, 1996, BIOTECHNOL, V7, P42; Kapari L, 2006, ECOLOGY, V87, P291, DOI 10.1890/05-0362; KEATING ST, 1989, J INVERTEBR PATHOL, V54, P165, DOI 10.1016/0022-2011(89)90026-8; Khafagi WE, 2001, J INSECT PHYSIOL, V47, P1249, DOI 10.1016/S0022-1910(01)00110-X; Lahtinen M, 2004, J CHEM ECOL, V30, P2257, DOI 10.1023/B:JOEC.0000048787.34388.dd; Larsson S, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P1, DOI 10.1007/0-306-47596-0_1; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Leonard D.E., 1981, B US DEP AGR, V1584, P9; Martemyanov VV, 2013, ECOL PARASITOL IMMUN, V2, DOI [10.4303/epi/235550, DOI 10.4303/epi/235550]; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; Martemyanov VV, 2012, J CHEM ECOL, V38, P295, DOI 10.1007/s10886-012-0090-1; Medeiros PM, 2007, J CHROMATOGR A, V1141, P271, DOI 10.1016/j.chroma.2006.12.017; Meselhy KM, 2012, LIFE SCI J, V9, P830; Miller William E., 2005, Journal of the Lepidopterists' Society, V59, P143; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Ojala K, 2005, EVOL ECOL RES, V7, P1153; Pokhilo, 1988, CHEM NAT COMPD, V24, P273, DOI [10.1007/BF00598568, DOI 10.1007/BF00598568]; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Rantala MJ, 2003, P ROY SOC B-BIOL SCI, V270, P2257, DOI 10.1098/rspb.2003.2472; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Ruuhola T, 2007, J CHEM ECOL, V33, P1160, DOI 10.1007/s10886-007-9308-z; Slama K., 1974, INSECT HORMONES BIOA; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Smilanich AM, 2011, J CHEM ECOL, V37, P239, DOI 10.1007/s10886-011-9924-5; Smith C. Michael, 2005, P1; STOCKHOFF BA, 1993, J INSECT PHYSIOL, V39, P677, DOI 10.1016/0022-1910(93)90073-Z; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Valkama E, 2005, OECOLOGIA, V146, P385, DOI 10.1007/s00442-005-0216-z; Valkama E, 2005, TREES-STRUCT FUNCT, V19, P191, DOI 10.1007/s00468-004-0380-5; Vihakas M, 2012, J CHEM ECOL, V38, P538, DOI 10.1007/s10886-012-0113-y; Vihakas MA, 2010, J CHEM ECOL, V36, P864, DOI 10.1007/s10886-010-9822-2; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220	47	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121917	10.1371/journal.pone.0121917	http://dx.doi.org/10.1371/journal.pone.0121917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816371	Green Published, gold			2022-12-27	WOS:000352133600127
J	Palma, J; Maebe, K; Guedes, JVC; Smagghe, G				Palma, Janine; Maebe, Kevin; Carus Guedes, Jerson Vanderlei; Smagghe, Guy			Molecular Variability and Genetic Structure of Chrysodeixis includens (Lepidoptera: Noctuidae), an Important Soybean Defoliator in Brazil	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; LOOPER LEPIDOPTERA; ANTICARSIA-GEMMATALIS; PYRETHROID RESISTANCE; POPULATION-STRUCTURE; ISSR; FLOW; DIVERSITY; EVOLUTION; SOFTWARE	This study provides the first genetic characterization of the soybean looper, Chrysodeixis includens (Walker, 1857), an important defoliating pest species of soybean crops in Brazil. Population genetic variability and the genetic structure of C. includens populations were evaluated by using ISSR markers with samples from the major soybean producing regions in Brazil in the growing seasons 2011/2012. Seven different primers were applied for population characterization of the molecular variability and genetic structure of 8 soybean looper populations from 8 states of Brazil. The seven ISSR loci generated 247 bands in 246 individuals of C. includens sampled. The expected heterozygosity (H-E) in the populations varied between 0.093 and 0.106, while the overall H-E was 0.099, indicating low genetic diversity. The analysis of molecular variance indicated that 98% of the variability was expressed among individuals within populations (F-ST = 0.021, p = 0.001). The low level of polymorphism over all populations, the high levels of gene flow, and the low genetic structure are indicatives of the exchange of genetic information between the different sampled regions. Population structuring suggests the presence of two major groups which do not correlate with their geographic sampling location in Brazil. These results may indicate recent recolonization of C. includens in Brazil or migration patterns following source-sink dynamics. Furthermore, the presence of two groups within C. includens suggests that a study on development of resistance or any other genetic-based trait needs to be evaluated on both groups, and pest management in soybean fields should be aware that differences may come to the control strategies they use.	[Palma, Janine; Carus Guedes, Jerson Vanderlei] Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, BR-97119900 Santa Maria, RS, Brazil; [Palma, Janine; Maebe, Kevin; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium	Universidade Federal de Santa Maria (UFSM); Ghent University	Palma, J (corresponding author), Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, BR-97119900 Santa Maria, RS, Brazil.	janine.palma@gmail.com; jerson.guedes@gmail.com	Guedes, Jerson/AAD-2483-2020; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Maebe, Kevin/0000-0002-3741-2143	Graduate Program in Agronomy, Federal University of Santa Maria [030086]; University of Ghent through a PhD sandwich; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Graduate Program in Agronomy, Federal University of Santa Maria; University of Ghent through a PhD sandwich; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Graduate Program in Agronomy, Federal University of Santa Maria (Project 030086), and by University of Ghent through a PhD sandwich. The scholarship was provided by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Angulo AO, 1975, ESTADOS INMADUROS LE; Arias RS, 2011, ANN ENTOMOL SOC AM, V104, P576, DOI 10.1603/AN10135; Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Beroiz B, 2012, SPAN J AGRIC RES, V10, P815, DOI 10.5424/sjar/2012103-694-11; CAB International, 2014, CROP PROT COMP; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073017; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; Czepak C, 2014, CULTIV GD CULT, V178, P20; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eichlin T. D., 1975, GUIDE ADULT LARVAL P; Eichlin TD, 1978, PLUSIINAE LEPIDOPTER, DOI 10.22004/ag.econ.158098; Embrapa, 2003, TECN PROD SOJ REG CE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Ferreira ME, 1998, INTRO AO USO MARCADO; GUEDES J.V.C., 2010, CULTIVAR GRANDES CUL, V12, P24; Hendrichs J., 2007, P3; Herzog D.C., 1980, Springer Series in Experimental Entomology, P141; Hundsdoerfer AK, 2005, Z NATURFORSCH C, V60, P618; Barrionuevo MJ, 2012, FLA ENTOMOL, V95, P944, DOI 10.1653/024.095.0419; Jost DJ, 2002, J ECON ENTOMOL, V95, P286, DOI 10.1603/0022-0493-95.2.286; KOGAN M, 1974, ANN ENTOMOL SOC AM, V67, P66, DOI 10.1093/aesa/67.1.66; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Luque C, 2002, HEREDITAS, V136, P251, DOI 10.1034/j.1601-5223.2002.1360312.x; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Marsaro Junior A. L., 2010, Revista Academica Ciencias Agrarias e Ambientais, V8, P71; MARTIN PB, 1976, ENVIRON ENTOMOL, V5, P878, DOI 10.1093/ee/5.5.878; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Mendki MJ, 2011, ASIAN PAC J TROP MED, V4, P357, DOI 10.1016/S1995-7645(11)60103-X; Moscardi F., 2012, SOJA MANEJO INTEGRAD, P214; Papa G, 2007, LAGARTAS NA SOJA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Portillo HE, 1997, J AGR ENTOMOL, V14, P9; Pritchard JK, 2000, GENETICS, V155, P945; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; Shouhani Hossein, 2014, Journal of Bioscience and Biotechnology, V3, P127; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sosa-Gomez DR, 2004, GENET MOL BIOL, V27, P378, DOI 10.1590/S1415-47572004000300012; Souza Giselle Anselmo de, 2008, Pesq. agropec. bras., V43, P843, DOI 10.1590/S0100-204X2008000700008; Specht A, 2004, REV BRASILEIRA AGROC, V4, P389; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Thomas JD, 1996, PESTIC BIOCHEM PHYS, V55, P1, DOI 10.1006/pest.1996.0029; TINGLE F C, 1977, Florida Entomologist, V60, P115, DOI 10.2307/3494389; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhu Xun, 2012, Acta Entomologica Sinica, V55, P981	54	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121260	10.1371/journal.pone.0121260	http://dx.doi.org/10.1371/journal.pone.0121260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816220	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600076
J	Minton, DR; Fu, LP; Chen, QY; Robinson, BD; Gross, SS; Nanus, DM; Gudas, LJ				Minton, Denise R.; Fu, Leiping; Chen, Qiuying; Robinson, Brian D.; Gross, Steven S.; Nanus, David M.; Gudas, Lorraine J.			Analyses of the Transcriptome and Metabolome Demonstrate That HIF1 alpha Mediates Altered Tumor Metabolism in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; GENE-EXPRESSION; COPY-NUMBER; GROWTH; SURVIVAL; ALPHA; HIF-1; CARBOXYLATION; SUPPRESSION; INHIBITION	Hypoxia inducible factor 1 alpha (HIF1 alpha) is a transcription factor that is frequently stabilized and active in human clear cell renal cell carcinoma (ccRCC). We have found that constitutively active HIF1 alpha is sufficient to cause neoplastic transformation in a murine model of ccRCC termed the TRACK model. RNA sequencing (RNAseq) and untargeted metabolomics analyses of samples from TRACK kidneys demonstrate that HIF1 alpha activates the transcription of genes that cause increased glucose uptake, glycolysis, and lactate production, as well as a decrease in the flux of pyruvate entering the tricarboxylic acid (TCA) cycle and a decrease in oxidative phosphorylation; these changes are identical to those observed in human ccRCC samples. These studies show that a constitutively active HIF1 alpha promotes tumorigenesis in TRACK mice by mediating a metabolic switch to aerobic glycolysis, i.e., the Warburg effect, and suggest that TRACK mice are a valid model to test novel therapies targeting metabolic changes to inhibit human ccRCC.	[Minton, Denise R.; Fu, Leiping; Chen, Qiuying; Gross, Steven S.; Gudas, Lorraine J.] Weill Cornell Grad Sch Med Sci, Dept Pharmacol, New York, NY 10065 USA; [Robinson, Brian D.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Nanus, David M.; Gudas, Lorraine J.] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY USA; [Nanus, David M.; Gudas, Lorraine J.] Weill Cornell Med Coll, Weill Cornell Meyer Canc Ctr, New York, NY USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Gudas, LJ (corresponding author), Weill Cornell Grad Sch Med Sci, Dept Pharmacol, New York, NY 10065 USA.	ljgudas@med.cornell.edu			WCMC; Turobiner Kidney Cancer Research Fund; Genitourinary Oncology Research Fund; NIH T32 Training Grant [5T32CA062948, CA062948]; Robert H. McCooey Genitourinary Oncology Research Fellowship; NIH [R37 HL087062, PO1 HD067244]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL087062] Funding Source: NIH RePORTER	WCMC; Turobiner Kidney Cancer Research Fund; Genitourinary Oncology Research Fund; NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. McCooey Genitourinary Oncology Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by WCMC, the Turobiner Kidney Cancer Research Fund, and the Genitourinary Oncology Research Fund. DRM was supported by the NIH T32 Training Grant (5T32CA062948). LF holds the Robert H. McCooey Genitourinary Oncology Research Fellowship and was supported in part by the NIH T32 Training Grant (CA062948). SSG was supported by NIH grants R37 HL087062 and PO1 HD067244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chiavarina B, 2012, CELL CYCLE, V11, P3280, DOI 10.4161/cc.21643; Chintala S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-293; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Fu LP, 2013, CANCER RES, V73, P2916, DOI 10.1158/0008-5472.CAN-12-3983; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gudas LJ, 2014, J MOL MED BERL; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Rexhepaj R, 2006, FASEB J, V20, P2214, DOI 10.1096/fj.05-5676com; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ricketts CJ, 2014, NAT GENET, V46, P214, DOI 10.1038/ng.2904; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Sandlund J, 2007, BJU INT, V100, P556, DOI 10.1111/j.1464-410X.2007.07006.x; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schietke RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031034; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; SHUIN T, 1994, CANCER RES, V54, P2852; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zimmer M, 2004, MOL CANCER RES, V2, P89	44	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120649	10.1371/journal.pone.0120649	http://dx.doi.org/10.1371/journal.pone.0120649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830305	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600036
J	Kinkhabwala, A				Kinkhabwala, Ali			Implications of Network Topology on Stability	PLOS ONE			English	Article							MULTIPLE STEADY-STATES; SYSTEMS; OSCILLATIONS; PROOF	In analogy to chemical reaction networks, I demonstrate the utility of expressing the governing equations of an arbitrary dynamical system (interaction network) as sums of real functions (generalized reactions) multiplied by real scalars (generalized stoichiometries) for analysis of its stability. The reaction stoichiometries and first derivatives define the network's "influence topology", a signed directed bipartite graph. Parameter reduction of the influence topology permits simplified expression of the principal minors (sums of products of non-overlapping bipartite cycles) and Hurwitz determinants (sums of products of the principal minors or the bipartite cycles directly) for assessing the network's steady state stability. Visualization of the Hurwitz determinants over the reduced parameters defines the network's stability phase space, delimiting the range of its dynamics (specifically, the possible numbers of unstable roots at each steady state solution). Any further explicit algebraic specification of the network will project onto this stability phase space. Stability analysis via this hierarchical approach is demonstrated on classical networks from multiple fields.	Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany	Max Planck Society	Kinkhabwala, A (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	alikink@gmail.com			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	AK was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1928, REV GEN ELECTR, DOI DOI 10.1007/S00221-011-2827-4; Banaji M, 2009, COMMUN MATH SCI, V7, P867; Banaji M, 2010, ADV APPL MATH, V44, P168, DOI 10.1016/j.aam.2009.07.003; BANKS HT, 1978, J THEOR BIOL, V74, P323, DOI 10.1016/0022-5193(78)90079-6; Belousov BP, 1959, SB REF RADIATS MED, V1, P145; Clarke B. L., 1980, ADV CHEM PHYS, V43, P1; CLARKE BL, 1974, J CHEM PHYS, V60, P1481, DOI 10.1063/1.1681221; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Cvetkovic D, 1995, SPECTRA OF GRAPHS TH; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; Feinberg M, 1995, ARCH RATION MECH AN, V132, P371, DOI 10.1007/BF00375615; Gantmacher F, 1959, APPLICATIONS OF THE; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Heinrich R., 1996, THE REGULATION OF CE; Hermite C., 1856, J REINE ANGEW MATH, V52, P39, DOI [10.1515/crll.1856.52.39, DOI 10.1515/CRLL.1856.52.39]; Hill A.V., 1910, J PHYSL, V40, pi, DOI DOI 10.1113/JPHYSIOL.1910.SP191040SUPPLTOC; Hurwitz A., 1895, MATH ANN, V46, P273, DOI 10.1007/BF01446812; Jury EI., 1996, ISNM INTERNATIONAL S, P53; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lienard A., 1928, REV GENERALE ELECTR, V23, P946, DOI DOI 10.1016/J.JWEIA.2013.09.002; Lienard A., 1914, J MATH PURE APPL, V10, P291; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; Lyapunov AM, 1966, THESIS; Maxwell J.C., 1868, PROC RS, V16, P270, DOI [DOI 10.1098/RSPL.1867.0055, 10.1098/rspl.1867.0055]; MEINSMA G, 1995, SYST CONTROL LETT, V25, P237, DOI 10.1016/0167-6911(94)00089-E; Mincheva M, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2397073; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Orlando L, 1911, MATH ANN, V71, P233, DOI [10.1007/BF01456650, DOI 10.1007/BF01456650]; PARKS PC, 1966, IEEE T AUTOMAT CONTR, VAC11, P334, DOI 10.1109/TAC.1966.1098340; PARKS PC, 1962, P CAMB PHILOS SOC, V58, P694, DOI 10.1017/S030500410004072X; Pease MC, 1964, METHODS OF MATRIX AL; PRIGOGIN.I, 1968, J CHEM PHYS, V48, P1695, DOI 10.1063/1.1668896; Routh E.J., 1877, TREATISE STABILITY G; SCHUSTER S, 1995, J PHYS CHEM-US, V99, P8017, DOI 10.1021/j100020a026; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; SMITH H, 1987, J MATH BIOL, V25, P169, DOI 10.1007/BF00276388; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Strogatz S.H., 1994, NONLINEAR DYNAMICS A; van der Pol B, 1926, PHILOS MAG, V2, P978; Volterra V., 1928, Journal du Conseil Copenhague, P3; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; Wilhelm T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011911; ZHABOTINSKII A. M., 1964, BIOFIZIKA, V9, P306	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122150	10.1371/journal.pone.0122150	http://dx.doi.org/10.1371/journal.pone.0122150			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826219	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800059
J	Romero-Gomez, M; Turnes, J; Ampuero, J; Oyaguez, I; Cuenca, B; Gonzalez-Garcia, J; Munoz-Molina, B; Aguilar, R; Leal, S; Planas, R; Garcia-Samaniego, J; Diago, M; Crespo, J; Calleja, JL; Casado, MA; Sola, R				Romero-Gomez, Manuel; Turnes, Juan; Ampuero, Javier; Oyagueez, Itziar; Cuenca, Beatriz; Gonzalez-Garcia, Juan; Munoz-Molina, Belen; Aguilar, Rocio; Leal, Sandra; Planas, Ramon; Garcia-Samaniego, Javier; Diago, Moises; Crespo, Javier; Luis Calleja, Jose; Angel Casado, Miguel; Sola, Ricard			Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study	PLOS ONE			English	Article							RIBAVIRIN; GENOTYPE; FIBROSIS; IDENTIFICATION; BOCEPREVIR; TELAPREVIR; ALPHA-2A; IMPACT	Background Virological response to peginterferon + ribavirin (P+ R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline < 1log(10) IU/ml HCVRNA (D1L) should have treatment discontinued due to low SVR rate. Aim To develop a tool to predict first 4 weeks' viral response in patients with hepatitis C genotype 1& 4 treated with P+ R. Methods In this prospective and multicenter study, HCV mono-infected (n= 538) and HCV/HIV co-infected (n= 186) patients were included. To develop and validate a prognostic tool to detect RVR and D1L, we segregated the patients as an estimation cohort (to construct the model) and a validation cohort (to validate the model). Results D1L was reached in 509 (80.2%) and RVR in 148 (22.5%) patients. Multivariate analyses demonstrated that HIV co-infection, Forns' index, LVL, IL28B-CC and Genotype-1 were independently related to RVR as well as D1L. Diagnostic accuracy (AUROC) for D1L was: 0.81 (95% CI: 0.76-0.86) in the estimation cohort and 0.71 (95% CI: 0.62-0.79) in the validation cohort; RVR prediction: AUROC 0.83 (95% CI: 0.78-0.88) in the estimation cohort and 0.82 (95% CI: 0.76-0.88) in the validation cohort. Cost-analysis of standard 48-week treatment indicated a saving of 30.3% if the prognostic tool is implemented. Conclusions The combination of genetic (IL28B polymorphism) and viral genotype together with viral load, HIV co-infection and fibrosis stage defined a tool able to predict RVR and D1L at week 4. Using this tool would be a cost-saving strategy compared to universal triple therapy for hepatitis C.	[Romero-Gomez, Manuel; Ampuero, Javier] Valme Univ Hosp, UCM Digest Dis, Seville, Spain; [Romero-Gomez, Manuel; Ampuero, Javier] Valme Univ Hosp, Ciberehd, Seville, Spain; [Turnes, Juan] Complejo Hosp Pontevedra, Pontevedra, Spain; [Oyagueez, Itziar; Angel Casado, Miguel] Pharmacoecon & Outcomes Res Iberia, Madrid, Spain; [Cuenca, Beatriz] Hosp Infanta Cristina, Madrid, Spain; [Gonzalez-Garcia, Juan] Hosp Univ La Paz, Madrid, Spain; [Munoz-Molina, Belen] Roche Farma, Unidad Hepatol, Madrid, Spain; [Aguilar, Rocio; Leal, Sandra] FISEVI, Seville, Spain; [Planas, Ramon] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Planas, Ramon] Ciberehd, Barcelona, Spain; [Garcia-Samaniego, Javier] Hosp Carlos III, Madrid, Spain; [Garcia-Samaniego, Javier] Ciberehd, Madrid, Spain; [Diago, Moises] Hosp Gen Valencia, Valencia, Spain; [Crespo, Javier] Hosp Marques Valdecilla, Santander, Spain; [Luis Calleja, Jose] Hosp Puerta Hierro, Madrid, Spain; [Sola, Ricard] IMIM, Hosp Mar, Barcelona, Spain	Hospital Valme; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme; Complexo Hospitalario Universitario de Pontevedra; Hospital Infanta Cristina; Hospital Universitario La Paz; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Puerta de Hierro-Majadahonda; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Romero-Gomez, M (corresponding author), Valme Univ Hosp, UCM Digest Dis, Seville, Spain.	mromerogomez@us.es	IBIS, DIGESTIVAS/O-1913-2015; Oyagüez, Itziar/L-2185-2019; Panero, Jose Luis Calleja/A-5351-2010; DIAGO, MOISES/AAH-5364-2019; Romero-Gomez, Manuel/L-8030-2014; Ampuero, Javier/AAI-2582-2019	Oyagüez, Itziar/0000-0002-3047-6152; Panero, Jose Luis Calleja/0000-0002-2265-6591; Romero-Gomez, Manuel/0000-0001-8494-8947; Ampuero, Javier/0000-0002-8332-2122; Turnes Vazquez, Juan/0000-0001-8426-6145; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Garcia-Samaniego, Javier/0000-0002-9974-0855; Leal, Sandra/0000-0002-2318-0863; Crespo, Javier/0000-0001-8248-0172	Roche Farma (Spain)	Roche Farma (Spain)	The study was funded by an unrestricted grant from Roche Farma (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Itziar Oyaguez and Miguel Angel Casado are employed by Pharmacoeconomics & Outcomes Research Iberia. Pharmacoeconomics & Outcomes Research Iberia provided support in the form of salaries for authors IO and MAC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ESA, 2011, J VIRAL HEPATITIS, V18, pe52, DOI 10.1111/j.1365-2893.2010.01358.x; Bichoupan K, 2013, HEPATOLOGY, pA244; Bruno S, 2013, J HEPATOL, V58, P479, DOI 10.1016/j.jhep.2012.11.020; Eslam M, 2011, ALIMENT PHARM THER, V34, P297, DOI 10.1111/j.1365-2036.2011.04716.x; Fernandez-Rodriguez A, 2013, AIDS, V27, P163, DOI 10.1097/QAD.0b013e32835c11e8; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lindh M, 2011, J VIRAL HEPATITIS, V18, P400, DOI 10.1111/j.1365-2893.2010.01323.x; Marcellin P, 2012, J HEPATOL, V56, P1276, DOI 10.1016/j.jhep.2011.12.026; Martinez-Bauer E, 2006, HEPATOLOGY, V43, P72, DOI 10.1002/hep.21002; MCHUTCHISON JG, 2009, NEW ENGL J MED, V361, P580, DOI DOI 10.1056/NEJM0A0808010; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Thompson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103370; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122613	10.1371/journal.pone.0122613	http://dx.doi.org/10.1371/journal.pone.0122613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826755	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800084
J	Alonso, RS; McClintock, BT; Lyren, LM; Boydston, EE; Crooks, KR				Alonso, Robert S.; McClintock, Brett T.; Lyren, Lisa M.; Boydston, Erin E.; Crooks, Kevin R.			Mark-Recapture and Mark-Resight Methods for Estimating Abundance with Remote Cameras: A Carnivore Case Study	PLOS ONE			English	Article							AUTOMATICALLY TRIGGERED CAMERAS; CAPTURE-RECAPTURE; HABITAT FRAGMENTATION; SOUTHERN CALIFORNIA; HOME-RANGE; POPULATION; DENSITY; MODELS; BOBCATS; INFERENCE	Abundance estimation of carnivore populations is difficult and has prompted the use of non-invasive detection methods, such as remotely-triggered cameras, to collect data. To analyze photo data, studies focusing on carnivores with unique pelage patterns have utilized a mark-recapture framework and studies of carnivores without unique pelage patterns have used a mark-resight framework. We compared mark-resight and mark-recapture estimation methods to estimate bobcat (Lynx rufus) population sizes, which motivated the development of a new "hybrid" mark-resight model as an alternative to traditional methods. We deployed a sampling grid of 30 cameras throughout the urban southern California study area. Additionally, we physically captured and marked a subset of the bobcat population with GPS telemetry collars. Since we could identify individual bobcats with photos of unique pelage patterns and a subset of the population was physically marked, we were able to use traditional mark-recapture and mark-resight methods, as well as the new "hybrid" mark-resight model we developed to estimate bobcat abundance. We recorded 109 bobcat photos during 4,669 camera nights and physically marked 27 bobcats with GPS telemetry collars. Abundance estimates produced by the traditional mark-recapture, traditional mark-resight, and "hybrid" mark-resight methods were similar, however precision differed depending on the models used. Traditional mark-recapture and mark-resight estimates were relatively imprecise with percent confidence interval lengths exceeding 100% of point estimates. Hybrid mark-resight models produced better precision with percent confidence intervals not exceeding 57%. The increased precision of the hybrid mark-resight method stems from utilizing the complete encounter histories of physically marked individuals (including those never detected by a camera trap) and the encounter histories of naturally marked individuals detected at camera traps. This new estimator may be particularly useful for estimating abundance of uniquely identifiable species that are difficult to sample using camera traps alone.	[Alonso, Robert S.; Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Alonso, Robert S.] US Geol Survey, Western Ecol Res Ctr, Biol Resources Discipline, Thousand Oaks, CA USA; [McClintock, Brett T.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Seattle, WA 98115 USA; [Lyren, Lisa M.] US Geol Survey, Western Ecol Res Ctr, Biol Resources Discipline, Carlsbad, CA USA	Colorado State University; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey	Crooks, KR (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	kevin.crooks@colostate.edu			Nature Conservancy; Irvine Company; National Science Foundation Ecology of Infectious Disease research program [NSF-EF 0723676, NSF-DEB 1413925]; Direct For Biological Sciences [1413925] Funding Source: National Science Foundation	Nature Conservancy; Irvine Company; National Science Foundation Ecology of Infectious Disease research program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding support was provided by The Nature Conservancy, The Irvine Company, the Transportation Corridor Agencies, and the National Science Foundation Ecology of Infectious Disease research program (NSF-EF 0723676; NSF-DEB 1413925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; BOWDEN DC, 1995, J WILDLIFE MANAGE, V59, P840, DOI 10.2307/3801965; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Heilbrun RD, 2003, WILDLIFE SOC B, V31, P748; Heilbrun RD, 2006, WILDLIFE SOC B, V34, P69, DOI 10.2193/0091-7648(2006)34[69:EBAUAT]2.0.CO;2; Bonner S, 2013, BIOMETRICS, V69, P766, DOI 10.1111/biom.12045; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Larrucea ES, 2007, WEST N AM NATURALIST, V67, P538, DOI 10.3398/1527-0904(2007)67[538:CBURC]2.0.CO;2; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Lyren L. M., 2006, CARNIVORE ACTIVITY M; Mccallum J, 2013, MAMMAL REV, V43, P196, DOI 10.1111/j.1365-2907.2012.00216.x; McClintock BT, 2014, ANN APPL STAT, V8, P2461, DOI 10.1214/14-AOAS783; McClintock BT, 2013, ECOLOGY, V94, P1464, DOI 10.1890/12-1613.1; McClintock BT, 2012, J ORNITHOL, V152, pS641, DOI 10.1007/s10336-010-0524-x; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; Moruzzi TL, 2002, WILDLIFE SOC B, V30, P380; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; OTIS DL, 1978, WILDLIFE MONOGR, P1; Powell RA, 2000, METH C CONS, P65; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Ruell EW, 2009, J MAMMAL, V90, P129, DOI 10.1644/07-MAMM-A-249.1; SCAG, 2005, LAND US DAT ORG COUN; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2013, ECOLOGY, V94, P553, DOI 10.1890/12-1256.1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; White Gary C., 2001, P329, DOI 10.1016/B978-012497781-5/50014-1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zielinski WJ, 1995, AM MARTEN FISHER LYN, P17; Zimmermann F, 2013, INTEGR ZOOL, V8, P232, DOI 10.1111/1749-4877.12017	45	30	31	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123032	10.1371/journal.pone.0123032	http://dx.doi.org/10.1371/journal.pone.0123032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822245	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700214
J	Bao, HJ; Yu, XX; Xu, C; Li, X; Li, ZY; Wei, DJ; Liu, YD				Bao, Huijing; Yu, Xiaoxu; Xu, Chen; Li, Xue; Li, Zhaoyang; Wei, Dianjun; Liu, Yunde			New Toxicity Mechanism of Silver Nanoparticles: Promoting Apoptosis and Inhibiting Proliferation	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; CELL-DEATH; SURFACE	Silver nanoparticles are increasingly recognized for their utility in biological applications, especially antibacterial effects. Herein, we confirmed the antibacterial effect of silver nanoparticles on Escherichia coli using the conventional optical density (OD) and colony-forming units (CFU) method and used flow cytometry (FC), TEM and BrdU ELISA to investigate the mechanisms of this effect. From the results, we conclude that AgNPs can simultaneously induce apoptosis and inhibit new DNA synthesis in the cells in a positive concentration-dependent manner. This study presents the first induction of apoptosis in these bacteria by AgNPs in this field. Our findings may provide a new strategy for the use of silver nanoparticles in antibacterial applications.	[Bao, Huijing; Yu, Xiaoxu; Li, Xue; Liu, Yunde] Tianjin Med Univ, Sch Lab Sci, Tianjin, Peoples R China; [Xu, Chen] 4th Cent Hosp, Tianjin, Peoples R China; [Li, Zhaoyang] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China; [Wei, Dianjun] Tianjin Med Univ, Hosp 2, Dept Lab Sci, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University; Tianjin Medical University	Wei, DJ (corresponding author), Tianjin Med Univ, Hosp 2, Dept Lab Sci, Tianjin, Peoples R China.	weidianjun@163.com; yundeliu@126.com	鲍, 会静/T-2678-2019	鲍, 会静/0000-0001-8719-0457	key discipline of Tianjin medical funding [201301]; Tianjin medical university [2011KY42]	key discipline of Tianjin medical funding; Tianjin medical university	This work was supported by the key discipline of Tianjin medical funding (201301), Tianjin medical university funding (2011KY42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MW, 2011, INT J NANOMED, V6, P2873, DOI 10.2147/IJN.S23945; Choi OK, 2009, WATER SCI TECHNOL, V59, P1699, DOI 10.2166/wst.2009.205; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Dorsey-Oresto A, 2013, CELL REP, V3, P528, DOI 10.1016/j.celrep.2013.01.026; Dwyer Daniel J, 2013, Methods Mol Biol, V1004, P145, DOI 10.1007/978-1-62703-383-1_11; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; He TT, 2014, BIOMETALS, V27, P673, DOI 10.1007/s10534-014-9756-1; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Liang HW, 2011, ACS NANO, V5, P8148, DOI 10.1021/nn202789f; Lu L, 2008, ANTIVIR THER, V13, P253; Madhumathi K, 2010, J MATER SCI-MATER M, V21, P807, DOI 10.1007/s10856-009-3877-z; Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030; Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w; You CG, 2012, MOL BIOL REP, V39, P9193, DOI 10.1007/s11033-012-1792-8; Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040	23	52	54	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122535	10.1371/journal.pone.0122535	http://dx.doi.org/10.1371/journal.pone.0122535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822182	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700183
J	Bates, MN; Crane, J; Balmes, JR; Garrett, N				Bates, Michael N.; Crane, Julian; Balmes, John R.; Garrett, Nick			Investigation of Hydrogen Sulfide Exposure and Lung Function, Asthma and Chronic Obstructive Pulmonary Disease in a Geothermal Area of New Zealand	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; ROTORUA; HEALTH; GAS; SPIROMETRY; POLLUTION; SYMPTOMS; INJURY; VALUES; FIELD	Background Results have been conflicting whether long-term ambient hydrogen sulfide (H2S) affects lung function or is a risk factor for asthma or chronic obstructive pulmonary disease (COPD). Rotorua city, New Zealand, has the world's largest population exposed to ambient H2S-from geothermal sources. Objectives We investigated associations of H2S with lung function, COPD and asthma in this population. Methods 1,204 of 1,639 study participants, aged 18-65 years during 2008-2010, provided satisfactory spirometry results. Residences, workplaces and schools over the last 30 years were geo-coded. Exposures were estimated from data collected by summer and winter H2S monitoring networks across Rotorua. Four metrics for H2S exposure, representing both current and long-term (last 30 years) exposure, and also time-weighted average and peak exposures, were calculated. Departures from expected values for pre-bronchodilator lung function, calculated from prediction equations, were outcomes for linear regression models using quartiles of the H2S exposure metrics. Separate models examined participants with and without evidence of asthma or COPD, and never-and ever-smokers. Logistic regression was used to investigate associations of COPD (a post-bronchodilator FEV1/FVC <70% of expected) and asthma (doctor-diagnosed or by FEV1 response to bronchodilator) with H2S exposure quartiles. Results None of the exposure metrics produced evidence of lung function decrement. The logistic regression analysis showed no evidence that long-term H2S exposure at Rotorua levels was associated with either increased COPD or asthma risk. Some results suggested that recent ambient H2S exposures were beneficially associated with lung function parameters. Conclusions The study found no evidence of reductions in lung function, or increased risk of COPD or asthma, from recent or long-term H2S exposure at the relatively high ambient concentrations found in Rotorua. Suggestions of improved lung function associated with recent ambient H2S exposures require confirmation in other studies.	[Bates, Michael N.; Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Crane, Julian] Univ Otago, Sch Med & Hlth Sci, Wellington, New Zealand; [Garrett, Nick] Auckland Univ Technol, Fac Hlth, Auckland, New Zealand	University of California System; University of California Berkeley; University of Otago; Auckland University of Technology	Bates, MN (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	m_bates@berkeley.edu	Balmes, John/L-6281-2019; Bates, Michael/ABC-2050-2021		National Institute of Environmental Health Sciences of the National Institutes of Health [R01ES014038]; New Zealand Regional Councils Environment Bay of Plenty and Environment Waikato; Berkeley Research Impact Initative (BRII) - UC Berkeley Library; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014038] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New Zealand Regional Councils Environment Bay of Plenty and Environment Waikato; Berkeley Research Impact Initative (BRII) - UC Berkeley Library; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health (grant number R01ES014038). Support for the study was also provided by the New Zealand Regional Councils Environment Bay of Plenty and Environment Waikato. Publication made possible in part by support from the Berkeley Research Impact Initative (BRII) sponsored by the UC Berkeley Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2013, ENVIRON RES, V122, P81, DOI 10.1016/j.envres.2013.02.002; Bates MN, 1997, AUST NZ J PUBL HEAL, V21, P581, DOI 10.1111/j.1467-842X.1997.tb01759.x; Bates MN, 2002, ARCH ENVIRON HEALTH, V57, P405, DOI 10.1080/00039890209601428; Bates MN, 1998, INT J EPIDEMIOL, V27, P10, DOI 10.1093/ije/27.1.10; Buick JB, 2000, AM J IND MED, V37, P296, DOI 10.1002/(SICI)1097-0274(200003)37:3<296::AID-AJIM8>3.0.CO;2-2; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Castro-Piedras I, 2013, J PHYSIOL-LONDON, V591, P5999, DOI 10.1113/jphysiol.2013.257790; Chen YH, 2011, CYTOKINE, V53, P334, DOI 10.1016/j.cyto.2010.12.006; Chen YH, 2012, RESP PHYSIOL NEUROBI, V184, P130, DOI 10.1016/j.resp.2012.03.009; DALES RE, 1989, AM REV RESPIR DIS, V139, P595, DOI 10.1164/ajrccm/139.3.595; Durand M, 2006, ENVIRON RES, V101, P238, DOI 10.1016/j.envres.2005.08.006; Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Fink JW, 2011, NEW ZEAL MED J, V124, P52; Fitzgerald R, 2014, BIOCHEM BIOPH RES CO, V446, P393, DOI 10.1016/j.bbrc.2014.02.129; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Guidotti TL, 2010, INT J TOXICOL, V29, P569, DOI 10.1177/1091581810384882; Han WH, 2011, ANTIOXID REDOX SIGN, V15, P2121, DOI 10.1089/ars.2010.3821; Horwell CJ, 2005, J VOLCANOL GEOTH RES, V139, P259, DOI 10.1016/j.jvolgeores.2004.08.010; Huang JH, 2014, EUR J PHARMACOL, V741, P55, DOI 10.1016/j.ejphar.2014.07.004; International Programme on Chemical Safety, 1981, HYDR SULF; JAPPINEN P, 1990, BRIT J IND MED, V47, P824; Kilburn KH, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/565690; Mannetje A, 2011, AUST NZ J PUBL HEAL, V35, P256, DOI 10.1111/j.1753-6405.2011.00703.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mostaghni AA, 2000, ARCH ENVIRON HEALTH, V55, P297, DOI 10.1080/00039890009604020; Otulakowski G, 2010, ANESTHESIOLOGY, V113, P4, DOI 10.1097/ALN.0b013e3181dec00e; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Reed BR, 2014, NEUROTOXICOL TERATOL, V42, P68, DOI 10.1016/j.ntt.2014.02.002; RICHARDSON DB, 1995, AM J IND MED, V28, P99, DOI 10.1002/ajim.4700280109; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b	31	47	47	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122062	10.1371/journal.pone.0122062	http://dx.doi.org/10.1371/journal.pone.0122062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822819	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700149
J	Chiang, CY; Bai, KJ; Lin, HH; Chien, ST; Lee, JJ; Enarson, DA; Lee, TI; Yu, MC				Chiang, Chen Yuan; Bai, Kuan Jen; Lin, Hsien Ho; Chien, Shun Tien; Lee, Jen Jyh; Enarson, Donald A.; Lee, Ting-I; Yu, Ming-Chih			The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis	PLOS ONE			English	Article							PROSPECTIVE COHORT; MELLITUS; IMPACT; MANIFESTATIONS; ASSOCIATION; OUTCOMES; SMOKING; CELLS; RISK	Background To assess the influence of diabetes mellitus (DM), glycemic control, and diabetes-related comorbidities on manifestations and outcome of treatment of pulmonary tuberculosis (TB). Methodology/Principal Findings Culture positive pulmonary TB patients notified to health authorities in three hospitals in Taiwan from 2005-2010 were investigated. Glycemic control was assessed by glycated haemoglobin A1C (HbA1C) and diabetic patients were categorized into 3 groups: HbA1C< 7%, HbA1C 7-9%, HbA1C> 9%. 1,473 (705 with DM and 768 without DM) patients were enrolled. Of the 705 diabetic patients, 82 (11.6%) had pretreatment HbA1C< 7%, 152 (21.6%) 7%-9%, 276 (39.2%) > 9%, and 195 (27.7%) had no information of HbA1C. The proportions of patients with any symptom, cough, hemoptysis, tiredness and weight loss were all highest in diabetic patients with HbA1C> 9%. In multivariate analysis adjusted for age, sex, smoking, and drug resistance, diabetic patients with HbA1C> 9% (adjOR 3.55, 95% CI 2.40-5.25) and HbA1C 7-9% (adjOR 1.62, 95% CI 1.07-2.44) were significantly more likely to be smear positive as compared with non-diabetic patients, but not those with HbA1C< 7% (adjOR 1.16, 95% CI 0.70-1.92). The influence of DM on outcome of TB treatment was not proportionately related to HbA1C, but mainly mediated through diabetes-related comorbidities. Patients with diabetes-related comorbidities had an increased risk of unfavorable outcome (adjOR 3.38, 95% CI 2.19-5.22, p< 0.001) and one year mortality (adjOR 2.80, 95% CI 1.89-4.16). However, diabetes was not associated with amplification of resistance to isoniazid (p = 0.363) or to rifampicin (p = 0.344). Conclusions/Significance Poor glycemic control is associated with poor TB treatment outcome and improved glycemic control may reduce the influence of diabetes on TB.	[Chiang, Chen Yuan; Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen Yuan; Bai, Kuan Jen; Yu, Ming-Chih] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Bai, Kuan Jen; Yu, Ming-Chih] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Lin, Hsien Ho] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chien, Shun Tien] Chest Hosp, Dept Hlth, Taipei, Tainan County, Taiwan; [Lee, Jen Jyh] Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen Jyh] Tzu Chi Univ, Hualien, Taiwan; [Lee, Ting-I] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Lee, Ting-I] Taipei Med Univ, Coll Med, Sch Med, Dept Gen Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Yu, MC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.	mingchih@w.tmu.edu.tw	Lee, Ting-I/I-3377-2019	LIN, HSIEN-HO/0000-0002-7481-6016	Taiwan Centers of Disease Control [DOH101-DC-1103]	Taiwan Centers of Disease Control	The work was supported by Taiwan Centers of Disease Control [grant number a research grant DOH101-DC-1103]. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; Babalik A, 2013, ANTIMICROB AGENTS CH, V57, P5740, DOI 10.1128/AAC.01345-13; Baker MA, 2011, BMC MED, p[1741, 9, 81]; Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Faurholt-Jepsen D, 2013, TROP MED INT HEALTH, V18, P822, DOI 10.1111/tmi.12120; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Hsu AH, 2013, INT J TUBERC LUNG D, V17, P354, DOI 10.5588/ijtld.11.0670; Interdepartmental Water Quality Training Board, 2011, WORLD EN OUTL 2011 A, P1; International Diabetes Foundation, 2021, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Khanna A, 2013, PUBLIC HEALTH ACTION, V3, pS48, DOI 10.5588/pha.13.0025; Kumar NP, 2015, IMMUNOLOGY, V144, P677, DOI 10.1111/imm.12421; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Leung CC, 2003, INT J TUBERC LUNG D, V7, P980; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Nandakumar KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076275; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Podell BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046824; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2014, DIABETES RES CLIN PR, V106, P191, DOI 10.1016/j.diabres.2014.06.011; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2005, INT J TUBERC LUNG D, V9, P777	37	70	72	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121698	10.1371/journal.pone.0121698	http://dx.doi.org/10.1371/journal.pone.0121698			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822974	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700120
J	Cruz, Y; Lorea, J; Mestre, H; Kim-Lee, JH; Herrera, J; Mellado, R; Galvez, V; Cuellar, L; Musri, C; Ibarra, A				Cruz, Yolanda; Lorea, Jonathan; Mestre, Humberto; Hyuna Kim-Lee, Jennifer; Herrera, Judith; Mellado, Raul; Galvez, Vanesa; Cuellar, Leopoldo; Musri, Carolina; Ibarra, Antonio			Copolymer-1 Promotes Neurogenesis and Improves Functional Recovery after Acute Ischemic Stroke in Rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; GLATIRAMER ACETATE; T-CELLS; ADULT NEUROGENESIS; MULTIPLE-SCLEROSIS; BRAIN; NEUROPROTECTION; INFLAMMATION; EXPRESSION; THERAPY	Stroke triggers a systemic inflammatory response that exacerbates the initial injury. Immunizing with peptides derived from CNS proteins can stimulate protective autoimmunity (PA). The most renowned of these peptides is copolymer-1 (Cop-1) also known as glatiramer acetate. This peptide has been approved for use in the treatment of multiple sclerosis. Cop-1-specific T cells cross the blood-brain barrier and secrete neurotrophins and anti-inflammatory cytokines that could stimulate proliferation of neural precursor cells and recruit them to the injury site; making it an ideal therapy for acute ischemic stroke. The aim of this work was to evaluate the effect of Cop-1 on neurogenesis and neurological recovery during the acute phase (7 days) and the chronic phase of stroke (60 days) in a rat model of transient middle cerebral artery occlusion (tMCAo). BDNF and NT-3 were quantified and infarct volumes were measured. We demonstrated that Cop-1 improves neurological deficit, enhances neurogenesis (at 7 and 60 days) in the SVZ, SGZ, and cerebral cortex through an increase in NT-3 production. It also decreased infarct volume even at the chronic phase of tMCAo. The present manuscript fortifies the support for the use of Cop-1 in acute ischemic stroke.	[Cruz, Yolanda; Lorea, Jonathan; Mestre, Humberto; Hyuna Kim-Lee, Jennifer; Herrera, Judith; Mellado, Raul; Galvez, Vanesa; Cuellar, Leopoldo; Musri, Carolina; Ibarra, Antonio] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico; [Ibarra, Antonio] Ctr Invest Proyecto CAMINA AC, Distrito Fed, Mexico	Universidad Anahuac	Ibarra, A (corresponding author), Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico.	iantonio65@yahoo.com	Cruz, Yolanda/GPT-1412-2022; Mestre, Humberto/AAO-5848-2020	Mestre, Humberto/0000-0001-5876-5397; Cruz, Yolanda/0000-0001-5559-2339; /0000-0002-4030-3749	CONACyT [57204]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This publication was funded by the CONACyT (Grant #57204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Del Rayo Garrido M, 2012, BASIC CLIN PHARMACOL, V5, P314; Dell Ralph B, 2002, ILAR J, V43, P207; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Famakin BM, 2014, AGING DIS, V5, P307, DOI 10.14336/AD.2014.0500307; Garcia E, 2012, J NEUROSCI RES, V90, P656, DOI 10.1002/jnr.22771; Go AS, 2013, CIRCULATION, V128; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Ibarra A, 2007, NEUROSCI LETT, V425, P110, DOI 10.1016/j.neulet.2007.08.038; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Kraft P, 2014, EXP TRANSL STROKE ME, V6, P1, DOI [10.1186/2040-7378-6-1, DOI 10.1186/2040-7378-6-1]; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Poittevin M, 2013, J NEUROIMMUNOL, V254, P55, DOI 10.1016/j.jneuroim.2012.09.009; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Stern JNH, 2008, P NATL ACAD SCI USA, V105, P5172, DOI 10.1073/pnas.0712131105; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yang BB, 2010, J OCUL PHARMACOL TH, V26, P11, DOI 10.1089/jop.2009.0037; Ziemssen T, 2002, BRAIN, V125, P2381, DOI 10.1093/brain/awf252; Ziv Y, 2007, STROKE, V38, P774, DOI 10.1161/01.STR.0000255784.27298.23	30	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121854	10.1371/journal.pone.0121854	http://dx.doi.org/10.1371/journal.pone.0121854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821957	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700132
J	Davis, RVN; Lamont, SJ; Rothschild, MF; Persia, ME; Ashwell, CM; Schmidt, CJ				Davis, Richard V. N.; Lamont, Susan J.; Rothschild, Max F.; Persia, Michael E.; Ashwell, Chris M.; Schmidt, Carl J.			Transcriptome Analysis of Post-Hatch Breast Muscle in Legacy and Modern Broiler Chickens Reveals Enrichment of Several Regulators of Myogenic Growth	PLOS ONE			English	Article							FED TYPICAL 1957; SUCCINYL-COA SYNTHETASES; MYOSTATIN GENE CAUSES; SKELETAL-MUSCLE; MESSENGER-RNA; COACTIVATOR PGC-1-ALPHA; INSULIN-RECEPTOR; FEED CONVERSION; EXPRESSION; PROTEIN	Agriculture provides excellent model systems for understanding how selective pressure, as applied by humans, can affect the genomes of plants and animals. One such system is modern poultry breeding in which intensive genetic selection has been applied for meat production in the domesticated chicken. As a result, modern meat-type chickens (broilers) exhibit enhanced growth, especially of the skeletal muscle, relative to their legacy counterparts. Comparative studies of modern and legacy broiler chickens provide an opportunity to identify genes and pathways affected by this human-directed evolution. This study used RNA-seq to compare the transcriptomes of a modern and a legacy broiler line to identify differentially enriched genes in the breast muscle at days 6 and 21 post-hatch. Among the 15,945 genes analyzed, 10,841 were expressed at greater than 0.1 RPKM. At day 6 post-hatch 189 genes, including several regulators of myogenic growth and development, were differentially enriched between the two lines. The transcriptional profiles between lines at day 21 post-hatch identify 193 genes differentially enriched and still include genes associated with myogenic growth. This study identified differentially enriched genes that regulate myogenic growth and differentiation between the modern and legacy broiler lines. Specifically, differences in the ratios of several positive (IGF1, IGF1R, WFIKKN2) and negative (MSTN, ACE) myogenic growth regulators may help explain the differences underlying the enhanced growth characteristics of the modern broilers.	[Davis, Richard V. N.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Lamont, Susan J.; Rothschild, Max F.; Persia, Michael E.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Ashwell, Chris M.] N Carolina State Univ, Dept Poultry Sci, Raleigh, NC 27695 USA; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA	University of Delaware; Iowa State University; University of North Carolina; North Carolina State University; University of Delaware	Schmidt, CJ (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.	schmidtc@udel.edu	Ashwell, Christopher/N-1332-2016	Ashwell, Christopher/0000-0002-8190-1147; Schmidt, Carl/0000-0002-8386-4781	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture [2011-67003-30228]; College of Agriculture and Life Sciences; State of Iowa; Hatch	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture; College of Agriculture and Life Sciences; State of Iowa; Hatch(United States Department of Agriculture (USDA))	This project was supported by Agriculture and Food Research Initiative Competitive Grant 2011-67003-30228 from the United States Department of Agriculture National Institute of Food and Agriculture received by CJS, SJL, MFR, MEP and CMA. Activities at Iowa State University were also supported by the College of Agriculture and Life Sciences, State of Iowa and Hatch funding received by SJL and MFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chang YF, 2012, FEBS LETT, V586, P3111, DOI 10.1016/j.febslet.2012.07.068; Choi RCY, 2001, J NEUROSCI, V21, P9224, DOI 10.1523/JNEUROSCI.21-23-09224.2001; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Duclos M J, 2005, J Physiol Pharmacol, V56 Suppl 3, P25; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; GRIFFIN HD, 1994, INT J BIOCHEM, V26, P19, DOI 10.1016/0020-711X(94)90190-2; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Guo J, ANIMAL, P20121; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1785, DOI 10.3382/ps.0731785; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1795, DOI 10.3382/ps.0731795; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Konarzewski M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P237, DOI 10.1086/316729; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lavine LC, 2013, ARCH INSECT BIOCHEM, V82, P43, DOI 10.1002/arch.21072; Lee RM, 1999, GENE DEV, V13, P718, DOI 10.1101/gad.13.6.718; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu C, 2010, AM J PHYSIOL-CELL PH, V298, pC1100, DOI 10.1152/ajpcell.00553.2009; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Monestier O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-541; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; ONO Y, 1993, POULTRY SCI, V72, P568, DOI 10.3382/ps.0720568; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Price ER, 2011, J EXP BIOL, V214, P2823, DOI 10.1242/jeb.057620; Puntschart A, 1998, AM J PHYSIOL-CELL PH, V274, pC129, DOI 10.1152/ajpcell.1998.274.1.C129; QURESHI MA, 1994, POULTRY SCI, V73, P1805, DOI 10.3382/ps.0731805; R Core Team, 2021, R LANGUAGE ENV STAT; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sakakima H, 2006, ACTA HISTOCHEM, V108, P357, DOI 10.1016/j.acthis.2006.04.003; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SMITH JH, 1963, POULTRY SCI, V42, P283, DOI 10.3382/ps.0420283; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Szabo G, 1998, MAMM GENOME, V9, P671, DOI 10.1007/s003359900843; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Tajika Y, 2007, CELL TISSUE RES, V328, P573, DOI 10.1007/s00441-006-0376-0; THOMAS CH, 1958, POULTRY SCI, V37, P862, DOI 10.3382/ps.0370862; Tudor CO, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-418; WARREN DC, 1958, POULTRY SCI, V37, P3, DOI 10.3382/ps.0370003; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Xu XW, 2010, MOL BIOL REP, V37, P451, DOI 10.1007/s11033-009-9632-1; Yang W, 2005, BIOCHEM BIOPH RES CO, V326, P660, DOI 10.1016/j.bbrc.2004.11.096; Ye XH, 2007, GENET SEL EVOL, V39, P73, DOI 10.1051/gse:2006029; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236	70	25	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122525	10.1371/journal.pone.0122525	http://dx.doi.org/10.1371/journal.pone.0122525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821972	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700182
J	Wu, WX; Liu, XD; Chaftari, P; Teresa, M; Carreras, C; Gonzalez, C; Viets-Upchurch, J; Merriman, K; Tu, SM; Dalal, S; Yeung, SCJ				Wu, Weixin; Liu, Xiandong; Chaftari, Patrick; Teresa, Maria; Carreras, Cruz; Gonzalez, Carmen; Viets-Upchurch, Jayne; Merriman, Kelly; Tu, Shi-Ming; Dalal, Shalini; Yeung, Sai-Ching J.			Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review	PLOS ONE			English	Review							ANDROGEN-DEPRIVATION THERAPY; MASS INDEX; RADICAL PROSTATECTOMY; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; DOSE CALCULATION; SKELETAL-MUSCLE; BREAST-CANCER; SURFACE-AREA; OBESITY	Background Docetaxel, a lipophilic drug, is indicated for castration-resistant metastatic prostate cancer. Most men with such disease would have had androgen-deprivation therapy, which decreases muscle and increases body fat. Obesity and body composition changes may influence the outcomes of docetaxel therapy. Methods We conducted a retrospective review of 333 patients with metastatic prostate cancer treated with docetaxel at a comprehensive cancer center between October 7, 2004 and December 31, 2012. Body composition parameters were measured based on the areas of muscle and adipose tissues in the visceral and subcutaneous compartments on CT images at L3-4 levels. Dose calculations, toxicity and adverse reaction profiles, and overall survival were analyzed. Results Obese patients were younger at the diagnosis of prostate cancer and had a shorter duration from diagnosis to docetaxel therapy. Analysis of body composition found that a high visceral fat-to-subcutaneous fat area ratio (VSR) was associated with poor prognosis but a high visceral fat-to-muscle area ratio (VMR) and high body mass index were associated with increased duration from starting docetaxel to death, allowing such men to catch up with patients with normal body mass index in overall survival from cancer diagnosis to death. Cox proportional hazard regression showed that age >= 65 years, high VSR, abnormal serum alkaline phosphatase, and >10% reduction of initial dosage were significant predictors of shorter time between starting docetaxel and death, and that high VMR, obesity, and weekly regimens were significant predictors of longer survival after docetaxel. Conclusion Obese and overweight patients may benefit more from weekly docetaxel regimens using the reference dosage of 35 mg/m(2) without empirical dosage reduction.	[Wu, Weixin; Liu, Xiandong; Chaftari, Patrick; Teresa, Maria; Carreras, Cruz; Gonzalez, Carmen; Viets-Upchurch, Jayne; Merriman, Kelly; Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Tu, Shi-Ming] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Dalal, Shalini] Univ Texas MD Anderson Canc Ctr, Dept Symptoms Control & Support Care, Houston, TX 77030 USA; [Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA.	syeung@mdanderson.org	Yeung, Sai-Ching/AAP-8079-2020; Yeung, Sai-Ching/AAI-6178-2021	Yeung, Sai-Ching/0000-0001-5170-0822; Cruz Carreras, Maria/0000-0002-2019-5322	Department of Health of Fujian Province, China; Xiamen Public Health Bureau for Science and Technology Project [3502z20077042, WQK0605]; National Institutes of Health Cancer Center Support Grant [CA16672]; Department of Health of Shandong Province, China; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Department of Health of Fujian Province, China; Xiamen Public Health Bureau for Science and Technology Project; National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health of Shandong Province, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W. Wu was supported by a Health Professional Training Grant from the Department of Health of Fujian Province, China, and a grant from the Xiamen Public Health Bureau for Science and Technology Project (3502z20077042 and WQK0605). The University of Texas MD Anderson Cancer Center was supported by a National Institutes of Health Cancer Center Support Grant (CA16672). X. Liu was supported by a Health Professional Training Grant from the Department of Health of Shandong Province, China. No funding was specific for this work.	Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; Baker SD, 2002, JNCI-J NATL CANCER I, V94, P1883, DOI 10.1093/jnci/94.24.1883; Baker SD, 2006, CLIN PHARMACOKINET, V45, P235, DOI 10.2165/00003088-200645030-00002; Baker SD, 2004, CLIN CANCER RES, V10, P1976, DOI 10.1158/1078-0432.CCR-0842-03; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Berry W, 2001, SEMIN ONCOL, V28, P8, DOI 10.1053/sonc.2001.26893; BLOUIN RA, 1987, CLIN PHARMACY, V6, P706; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark W, 2013, J AM COLL SURGEONS, V216, P1070, DOI 10.1016/j.jamcollsurg.2013.01.007; Cushen S, 2014, ANN ONCOLOGY S4, V25, piv255, DOI [10.1093/annonc/mdu336, DOI 10.1093/ANNONC/MDU336]; Del Fabbro E, 2012, ONCOLOGIST, V17, P1240, DOI 10.1634/theoncologist.2012-0169; DUBOIS D, 1989, NUTRITION, V5, P303; Ferrero JM, 2004, ONCOLOGY-BASEL, V66, P281, DOI 10.1159/000078328; Gouerant S, 2013, ANTICANCER RES, V33, P5655; Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436; Gurney H, 2007, J CLIN ONCOL, V25, P4703, DOI 10.1200/JCO.2007.13.1078; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Hurria A, 2006, CLIN CANCER RES, V12, P6100, DOI 10.1158/1078-0432.CCR-06-0200; Kellokumpu-Lehtinen PL, 2013, LANCET ONCOL, V14, P117, DOI 10.1016/S1470-2045(12)70537-5; Kim HS, 2011, BJU INT, V107, P924, DOI 10.1111/j.1464-410X.2010.09679.x; Lyman GH, 2013, NAT REV CLIN ONCOL, V10, DOI [10.1038/nrclinonc.2013.108-c2, 10.1038/nrclinonc.2013.108]; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Moul JW, 1996, J UROLOGY, V155, P1667, DOI 10.1016/S0022-5347(01)66160-3; Pazdur R, FDA APPROVAL DOCETAX; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Prado CMM, 2007, CLIN CANCER RES, V13, P3264, DOI 10.1158/1078-0432.CCR-06-3067; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Rickles AS, 2013, J GASTROINTEST SURG, V17, P133, DOI 10.1007/s11605-012-2045-9; Sandhu G, 2014, CLIN PHARMACOL THER, V95, P356, DOI 10.1038/clpt.2014.3; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Sparreboom A, 2007, J CLIN ONCOL, V25, P4707, DOI 10.1200/JCO.2007.11.2938; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thompson F., 2014, OVERCOMING OBESITY I; Thompson LA, 2010, J ONCOL PRACT, V6, P141, DOI 10.1200/JOP.200016; Vacca A, 2002, J HEMATOTH STEM CELL, V11, P103, DOI 10.1089/152581602753448577	40	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122047	10.1371/journal.pone.0122047	http://dx.doi.org/10.1371/journal.pone.0122047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822612	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700147
J	Yang, CX; Pan, HP; Liu, Y; Zhou, XG				Yang, Chunxiao; Pan, Huipeng; Liu, Yong; Zhou, Xuguo			Stably Expressed Housekeeping Genes across Developmental Stages in the Two-Spotted Spider Mite, Tetranychus urticae	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE PCR; RT-PCR; SELECTION	Quantitative real-time PCR (qRT-PCR) is a reliable and reproducible technique for measuring mRNA expression. To facilitate gene expression studies and obtain more accurate qRT-PCR analysis, normalization relative to stable housekeeping genes is mandatory. In this study, ten housekeeping genes, including beta-actin (Actin), elongation factor 1 alpha (EF1A), glyceralde hyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein L13 (RPL13), ribosomal protein 49 (RP49), alpha-tubulin (Tubulin), vacuolar-type H+-ATPase (v-ATPase), succinate dehydrogenase subunit A (SDHA), 28S ribosomal RNA (28S), and 18S ribosomal RNA (18S) from the two-spotted spider mite, Tetranychus urticae, were selected as the candidate reference genes. Four algorithms, geNorm, Normfinder, BestKeeper, and the Delta C-t method, were used to evaluate the performance of these candidates as endogenous controls across different developmental stages. In addition, RefFinder, which integrates the above-mentioned software tools, provided the overall ranking of the stability/suitability of these candidate reference genes. Among them, PRL13 and v-ATPase were the two most stable housekeeping genes across different developmental stages. This work is the first step toward establishing a standardized qRT-PCR analysis in T. urticae following the MIQE guideline. With the recent release of the T. urticae genome, results from this study provide a critical piece for the subsequent genomics and functional genomics research in this emerging model system.	[Yang, Chunxiao; Liu, Yong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China; [Yang, Chunxiao; Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Academy of Agricultural Sciences; University of Kentucky	Liu, Y (corresponding author), Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China.	haoasliu@163.com; xuguozhou@uky.edu			University of Kentucky; USDA BRAG [3048108827]; Special Fund for Agroscience Research in the Public Interest [201303028]	University of Kentucky; USDA BRAG; Special Fund for Agroscience Research in the Public Interest	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ, and a Special Fund for Agroscience Research in the Public Interest (Award Agreement No.: 201303028) to YL. These agencies had no role in study design, data collection/analysis, manuscript preparation, or the decision to publish.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fasulo Thomas R., 2009, 2 SPOTTED SPIDER MIT; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kwon DH, 2013, PESTIC BIOCHEM PHYS, V105, P69, DOI 10.1016/j.pestbp.2012.12.001; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Niu JZ, 2012, MOL BIOL REP, V39, P5841, DOI 10.1007/s11033-011-1394-x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Yue Xiu-li, 2013, Scientia Agricultura Sinica, V46, P4542; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	30	43	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120833	10.1371/journal.pone.0120833	http://dx.doi.org/10.1371/journal.pone.0120833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822495	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700076
J	Zhang, ZH; Ni, HY				Zhang, Zhongheng; Ni, Hongying			Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							REGRESSION-MODELS; CLINICAL-TRIAL; MORTALITY; PRESSURE; SURVIVAL; ARDS; DEFINITIONS; ASSOCIATION; OUTCOMES; DEATH	Background and objectives Acute respiratory distress syndrome (ARDS) is a major cause respiratory failure in intensive care unit (ICU). Early recognition of patients at high risk of death is of vital importance in managing them. The aim of the study was to establish a prediction model by using variables that were readily available in routine clinical practice. Methods The study was a secondary analysis of data obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center. Patients were enrolled between August 2007 and July 2008 from 33 hospitals. Demographics and laboratory findings were extracted from dataset. Univariate analyses were performed to screen variables with p< 0.3. Then these variables were subject to automatic stepwise forward selection with significance level of 0.1. Interaction terms and fractional polynomials were examined for variables in the main effect model. Multiple imputations and bootstraps procedures were used to obtain estimations of coefficients with better external validation. Overall model fit and logistic regression diagnostics were explored. Main result A total of 282 ARDS patients were included for model development. The final model included eight variables without interaction terms and non-linear functions. Because the variable coefficients changed substantially after exclusion of most poorly fitted and influential subjects, we estimated the coefficient after exclusion of these outliers. The equation for the fitted model was: g(X)= 0.06xage(in years)+2.23(if on vasopressor)+1.37xpotassium (mmol/l)-0.007xplatelet count (x10(9))+0.03xheart rate (/min)-0.29xHb(g/dl)-0.67xT(degrees C) +0.01xPaO_2+13, and the probability of death Pi(X)= e(g(X))/(1+e(g(X))). Conclusion The study established a prediction model for ARDS patients requiring mechanical ventilation. The model was examined with rigorous methodology and can be used for risk stratification in ARDS patients.	[Zhang, Zhongheng; Ni, Hongying] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Zhang, Zhongheng/0000-0002-2336-5323				Abel SJC, 1998, THORAX, V53, P292, DOI 10.1136/thx.53.4.292; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Baldwin MR, 2013, CHEST, V143, P910, DOI 10.1378/chest.12-1668; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; CLARK JG, 1995, ANN INTERN MED, V122, P17, DOI 10.7326/0003-4819-122-1-199501010-00003; Gajic O, 2007, CRIT CARE, V11, DOI 10.1186/cc5909; Greenland S, 2007, INT J EPIDEMIOL, V36, P195, DOI 10.1093/ije/dyl289; HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630; Hsieh YZ, 2014, COMPUT BIOL MED, V47, P13, DOI 10.1016/j.compbiomed.2013.12.012; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; Khandelwal N, 2014, CRIT CARE MED, V42, P1610, DOI 10.1097/CCM.0000000000000322; Krafft P, 1996, INTENS CARE MED, V22, P519, DOI 10.1007/s001340050125; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; Loekito E, 2013, RESUSCITATION, V84, P280, DOI 10.1016/j.resuscitation.2012.07.025; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Panwar R, 2013, J CRIT CARE, V28, P816, DOI 10.1016/j.jcrc.2013.05.009; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Royston P, 2005, METHOD INFORM MED, V44, P561; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shekar K, 2014, INTENS CARE MED, V40, P1184, DOI 10.1007/s00134-014-3386-5; Sulzer JK, 2013, J TRAUMA ACUTE CARE, V74, P196, DOI 10.1097/TA.0b013e31826fc747; Tang SSK, 2008, EUR J CARDIO-THORAC, V34, P898, DOI 10.1016/j.ejcts.2008.06.020; Tonelli AR, 2014, INTENS CARE MED, V40, P769, DOI 10.1007/s00134-014-3272-1; Villar J, 2014, CRITICAL CARE MEDICI; Villar J, 2014, INTENS CARE MED, V40, P900, DOI 10.1007/s00134-014-3288-6; Villar J, 2011, RESP CARE, V56, P420, DOI 10.4187/respcare.00811; Zhang Z, 2014, J CRITICAL CARE; Zhang ZH, 2014, J NEPHROL, V27, P65, DOI 10.1007/s40620-013-0024-1; Zhu HT, 2012, ANN STAT, V40, P785, DOI 10.1214/12-AOS978	34	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120641	10.1371/journal.pone.0120641	http://dx.doi.org/10.1371/journal.pone.0120641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822778	Green Submitted, gold, Green Published			2022-12-27	WOS:000352134700069
J	Galban, CJ; Ma, B; Malyarenko, D; Pickles, MD; Heist, K; Henry, NL; Schott, AF; Neal, CH; Hylton, NM; Rehemtulla, A; Johnson, TD; Meyer, CR; Chenevert, TL; Turnbull, LW; Ross, BD				Galban, Craig J.; Ma, Bing; Malyarenko, Dariya; Pickles, Martin D.; Heist, Kevin; Henry, Norah L.; Schott, Anne F.; Neal, Colleen H.; Hylton, Nola M.; Rehemtulla, Alnawaz; Johnson, Timothy D.; Meyer, Charles R.; Chenevert, Thomas L.; Turnbull, Lindsay W.; Ross, Brian D.			Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; EARLY SURROGATE MARKER; HIGH-GRADE GLIOMA; IMAGING BIOMARKER; THERAPEUTIC-EFFICACY; PARAMETRIC RESPONSE; WEIGHTED MRI; PREOPERATIVE CHEMOTHERAPY; EARLY PREDICTION; PROSTATE-CANCER	Purpose To evaluate diffusion weighted MRI (DW-MR) as a response metric for assessment of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using prospective multi-center trials which provided MR scans along with clinical outcome information. Materials and Methods A total of 39 patients with locally advanced breast cancer accrued from three different prospective clinical trials underwent DW-MR examination prior to and at 3-7 days (Hull University), 8-11 days (University of Michigan) and 35 days (NeoCOMICE) post-treatment initiation. Thirteen patients, 12 of which participated in treatment response study, from UM underwent short interval (< 1hr) MRI examinations, referred to as "test-retest" for examination of repeatability. To further evaluate stability in ADC measurements, a thermally controlled diffusion phantom was used to assess repeatability of diffusion measurements. MRI sequences included contrast-enhanced T1-weighted, when appropriate, and DW images acquired at b-values of 0 and 800 s/mm(2). Histogram analysis and a voxel-based analytical technique, the Parametric Response Map (PRM), were used to derive diffusion response metrics for assessment of treatment response prediction. Results Mean tumor apparent diffusion coefficient (ADC) values generated from patient test-retest examinations were found to be very reproducible (vertical bar Delta ADC vertical bar<0.1x10(-3)mm(2)/s). This data was used to calculate the 95% CI from the linear fit of tumor voxel ADC pairs of co-registered examinations (+/- 0.45x10(-3)mm(2)/s) for PRM analysis of treatment response. Receiver operating characteristic analysis identified the PRM metric to be predictive of outcome at the 8-11 (AUC = 0.964, p = 0.01) and 35 day (AUC = 0.770, p = 0.05) time points (p<.05) while whole-tumor ADC changes where significant at the later 35 day time interval (AUC = 0.825, p = 0.02). Conclusion This study demonstrates the feasibility of performing a prospective analysis of DW-MRI as a predictive biomarker of NAC in breast cancer patients. In addition, we provide experimental evidence supporting the use of sensitive analytical tools, such as PRM, for evaluating ADC measurements.	[Galban, Craig J.; Ma, Bing; Malyarenko, Dariya; Heist, Kevin; Neal, Colleen H.; Meyer, Charles R.; Chenevert, Thomas L.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Henry, Norah L.; Schott, Anne F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Pickles, Martin D.; Turnbull, Lindsay W.] Univ Hull, Hull York Med Sch, Ctr MR Invest, Kingston Upon Hull HU6 7RX, N Humberside, England; [Hylton, Nola M.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hull; University of York - UK; University of California System; University of California San Francisco	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu	Hylton, Nola/AAF-7861-2019; Schott, Anne/AAD-1902-2019	Chenevert, Thomas/0000-0003-1476-4274	NIH [U01CA151235, U01CA166104, P01CA087634]; Yorkshire Cancer Research to establish and fund the Hull MRI Centre and Cancer Research UK; NATIONAL CANCER INSTITUTE [U01CA151235, P01CA087634, U01CA166104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yorkshire Cancer Research to establish and fund the Hull MRI Centre and Cancer Research UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funds were provided by NIH grants U01CA151235, U01CA166104 and P01CA087634 as well as Yorkshire Cancer Research to establish and fund the Hull MRI Centre and Cancer Research UK who funded the NeoComice study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Atuegwu NC, 2013, TRANSL ONCOL, V6, P256, DOI 10.1593/tlo.13130; Atuegwu NC, 2011, MAGN RESON MED, V66, P1689, DOI 10.1002/mrm.23203; Baba S, 2014, J NUCL MED; Baum M, 1998, LANCET, V352, P1554, DOI 10.1016/S0140-6736(05)60364-9; Boes JL, 2014, TRANSL ONCOL, V7, P101, DOI 10.1593/tlo.14121; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Chenevert TL, 2014, TRANSL ONCOL, V7, P65, DOI 10.1593/tlo.13811; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; Chenevert TL, 2009, NEUROIMAG CLIN N AM, V19, P559, DOI 10.1016/j.nic.2009.08.009; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellingson BM, 2011, MAGN RESON MED, V65, P1132, DOI 10.1002/mrm.22688; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Galons Jean-Philippe, 1999, Neoplasia (New York), V1, P113, DOI 10.1038/sj.neo.7900009; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hahn SY, 2014, EUR J RADIOL, V83, P283, DOI 10.1016/j.ejrad.2013.10.023; HAJNAL JV, 1991, J COMPUT ASSIST TOMO, V15, P1, DOI 10.1097/00004728-199101000-00001; Hall DE, 2004, CLIN CANCER RES, V10, P7852, DOI 10.1158/1078-0432.CCR-04-1218; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Hamstra DA, 2004, MOL THER, V10, P916, DOI 10.1016/j.ymthe.2004.07.022; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Hamstra DA, 2008, TRANSL ONCOL, V1, P187, DOI 10.1593/tlo.08166; Helvie MA, 1996, RADIOLOGY, V198, P327, DOI 10.1148/radiology.198.2.8596826; Hiramatsu R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-192; Huang W, 2014, TRANSL ONCOL, V7, P153, DOI 10.1593/tlo.13838; Iwasa H, 2014, ONCOL REP, V31, P1555, DOI 10.3892/or.2014.3025; Jensen LR, 2011, J MAGN RESON IMAGING, V34, P1099, DOI 10.1002/jmri.22726; Lang P, 1998, RADIOLOGY, V206, P227, DOI 10.1148/radiology.206.1.9423677; Le Bihan D, 1991, Magn Reson Q, V7, P1; Le Bihan D, 2014, EMBO MOL MED; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1992, INVEST RADIOL, V27, pS6, DOI 10.1097/00004424-199212002-00002; Lee KC, 2007, NEOPLASIA, V9, P1003, DOI 10.1593/neo.07954; Lee KC, 2007, CANCER RES, V67, P3524, DOI 10.1158/0008-5472.CAN-06-4236; Lee KC, 2007, CLIN CANCER RES, V13, P443, DOI 10.1158/1078-0432.CCR-06-1888; Li X, 2014, TRANSL ONCOL, V7, P14, DOI 10.1593/tlo.13748; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Newman LA, 2002, ANN SURG ONCOL, V9, P228, DOI 10.1245/aso.2002.9.3.228; Pickles MD, 2006, MAGN RESON IMAGING, V24, P843, DOI 10.1016/j.mri.2005.11.005; Poptani H, 1998, CANCER GENE THER, V5, P101; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross Brian D, 1994, Q Magn Reson Biol Med, V1, P89; Saibara T, 1998, LANCET, V352, P404, DOI 10.1016/S0140-6736(05)60502-8; Stegman LD, 2000, GENE THER, V7, P1005, DOI 10.1038/sj.gt.3301199; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Valero V, 2002, CLIN BREAST CANC S2, V3, P63; Vinnicombe SJ, 1996, RADIOLOGY, V198, P333, DOI 10.1148/radiology.198.2.8596827; Weis JA, 2013, PHYS MED BIOL, V58, P5851, DOI 10.1088/0031-9155/58/17/5851; Whisenant JG, 2014, MAGN RESON IMAGING, V32, P245, DOI 10.1016/j.mri.2013.10.013; Wu LM, 2012, BREAST CANCER RES TR, V135, P17, DOI 10.1007/s10549-012-2033-5	65	45	47	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122151	10.1371/journal.pone.0122151	http://dx.doi.org/10.1371/journal.pone.0122151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816249	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600149
J	Gao, XL; Zhuang, W; Chen, CTA; Zhang, Y				Gao, Xuelu; Zhuang, Wen; Chen, Chen-Tung Arthur; Zhang, Yong			Sediment Quality of the SW Coastal Laizhou Bay, Bohai Sea, China: A Comprehensive Assessment Based on the Analysis of Heavy Metals	PLOS ONE			English	Article							ACID-VOLATILE SULFIDE; SIMULTANEOUSLY EXTRACTED METALS; SURFACE SEDIMENTS; PHYSICOCHEMICAL PROPERTIES; ENVIRONMENTAL-QUALITY; POLLUTION STATUS; TRACE-METALS; CONTAMINATION; SPECIATION; ESTUARY	Historically, the Bohai Sea is one of the most important fishing grounds in China. Yet, surrounded by one of the biggest economic rims of China, its ecological functions have been declining rapidly in recent two decades under the heavy anthropogenic impacts. The Laizhou Bay is the smallest one of the three main bays in the Bohai Sea. Owing to the rich brine deposits, chemical industries using brine as raw materials are booming in the southern coast of the Laizhou Bay, the scale of which ranks as the largest one in China. In order to monitor and assess the environmental quality, surface sediments were collected from the coastal waters of southwestern Laizhou Bay and the rivers it connects with during summer and autumn in 2012, and analyzed for heavy metals. Several widely adopted methods were used in the overall assessment of heavy metal pollution status and potential ecological risks in these sediments, and the data were analyzed to infer the main sources of the pollutants. The results showed that the remarkably high concentrations of heavy metals were almost all recorded in a small number of riverine sites. Cr, Cu, Ni and Zn were the main environmental threat according to the sediment quality guidelines. The marine area was generally in good condition with no or low risk from the studied metals and adverse effects on biota could hardly occur. Natural sources dominated the concentrations and distributions of Cu, Ni, Pb and Zn in the marine area. Our results indicated that heavy metal pollution was not a main cause of the ecological degradation of the Laizhou Bay at present.	[Gao, Xuelu; Zhuang, Wen; Zhang, Yong] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China; [Gao, Xuelu; Chen, Chen-Tung Arthur] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Zhuang, Wen] Zaozhuang Univ, Coll City & Architecture Engn, Zaozhuang, Shandong, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; National Sun Yat Sen University; Zaozhuang University	Gao, XL (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China.	xlgao@yic.ac.cn	Chen, Chen-Tung Arthur/C-8901-2011; chen, chen/GRY-7085-2022; CHEN, CHEN/HDM-6657-2022	Chen, Chen-Tung Arthur/0000-0002-5170-6471; 	National Natural Science Foundation of China [41376083]; Department of Science and Technology of Shandong Province [2012GHY11535]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shandong Province	This study was co-supported by the National Natural Science Foundation of China (41376083) and the Department of Science and Technology of Shandong Province (2012GHY11535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CR, 1993, ESTUARIES, V16, P627, DOI 10.2307/1352800; Bastami KD, 2012, MAR POLLUT BULL, V64, P2877, DOI 10.1016/j.marpolbul.2012.08.015; Beck M, 2013, MAR POLLUT BULL, V70, P100, DOI 10.1016/j.marpolbul.2013.02.017; Cai LM, 2012, ECOTOX ENVIRON SAFE, V78, P2, DOI 10.1016/j.ecoenv.2011.07.004; Carr RS, 1996, ENVIRON TOXICOL CHEM, V15, P1218, DOI 10.1002/etc.5620150730; Duan LQ, 2010, J HAZARD MATER, V183, P155, DOI 10.1016/j.jhazmat.2010.07.005; Duran I, 2012, MAR ENVIRON RES, V77, P43, DOI 10.1016/j.marenvres.2012.02.001; Fan Wen-hong, 2009, Asian Journal of Ecotoxicology, V4, P544; Fujita M, 2014, CHEMOSPHERE, V95, P628, DOI 10.1016/j.chemosphere.2013.10.023; Gao XL, 2008, MAR POLLUT BULL, V56, P786, DOI 10.1016/j.marpolbul.2008.01.004; Gao XL, 2014, ENVIRON INT, V62, P12, DOI 10.1016/j.envint.2013.09.019; Gao XL, 2013, MAR POLLUT BULL, V72, P281, DOI 10.1016/j.marpolbul.2013.02.007; Gao XL, 2012, MAR POLLUT BULL, V64, P1529, DOI 10.1016/j.marpolbul.2012.04.026; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Gao XL, 2010, ESTUAR COAST SHELF S, V86, P369, DOI 10.1016/j.ecss.2009.10.012; GILLIAM FS, 1988, J SOIL SCI, V39, P209, DOI 10.1111/j.1365-2389.1988.tb01207.x; Gomes FD, 2009, MAR POLLUT BULL, V59, P123, DOI 10.1016/j.marpolbul.2009.03.015; Gonzalez-Perez JA, 2008, ENVIRON CHEM LETT, V6, P41, DOI 10.1007/s10311-007-0107-0; Han Yousong, 1994, Studia Marina Sinica, V35, P87; Hjorth T, 2004, ANAL CHIM ACTA, V526, P95, DOI 10.1016/j.aca.2004.08.007; Horowitz AJ, 1988, ASTM STP, P114; Howari FM, 2001, WATER AIR SOIL POLL, V132, P43, DOI 10.1023/A:1012062814873; Hu BQ, 2013, ENVIRON SCI POLLUT R, V20, P4099, DOI 10.1007/s11356-012-1332-z; Hu BQ, 2013, ENVIRON MONIT ASSESS, V185, P5071, DOI 10.1007/s10661-012-2926-0; [胡宁静 Hu Ningjing], 2011, [海洋科学进展, Advances in Marine Science], V29, P63; Huang P, 2014, CONT SHELF RES, V73, P1, DOI 10.1016/j.csr.2013.11.014; Jiang Xia, 2010, Research of Environmental Sciences, V23, P1151; Karbassi A. R., 2005, International Journal of Environmental Science and Technology, V1, P307, DOI 10.1007/BF03325847; Larrose A, 2010, APPL GEOCHEM, V25, P1912, DOI 10.1016/j.apgeochem.2010.10.007; Li GG, 2013, MAR POLLUT BULL, V76, P420, DOI 10.1016/j.marpolbul.2013.08.032; Li XD, 2000, APPL GEOCHEM, V15, P567, DOI 10.1016/S0883-2927(99)00072-4; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Liu Y.H., 2011, PROG FISH SCI, V32, P1; Long ER, 2000, ENVIRON TOXICOL CHEM, V19, P2598, DOI 10.1002/etc.5620191028; [罗先香 Luo Xianxiang], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P262; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Pekey H, 2013, MICROCHEM J, V106, P233, DOI 10.1016/j.microc.2012.07.007; Perin G., 1985, HEAVY METALS TOXIC E, V2, P454, DOI DOI 10.1016/J.MEX.2018.03.005; Prica M, 2008, SCI TOTAL ENVIRON, V389, P235, DOI 10.1016/j.scitotenv.2007.09.006; Qiao YM, 2013, MAR POLLUT BULL, V68, P140, DOI 10.1016/j.marpolbul.2012.12.003; RAPIN F, 1986, ENVIRON SCI TECHNOL, V20, P836, DOI 10.1021/es00150a014; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Sakan SM, 2009, J ENVIRON MANAGE, V90, P3382, DOI 10.1016/j.jenvman.2009.05.013; SALOMONS W, 1980, ENVIRON TECHNOL LETT, V1, P506, DOI 10.1080/09593338009384007; SEPA (State Environmental Protection Administration of China), 2002, 186682002 SEPA, DOI [10.1371/journal.pone.0039690, DOI 10.1371/JOURNAL.PONE.0039690]; Soares HMVM, 1999, ENVIRON POLLUT, V105, P311, DOI 10.1016/S0269-7491(99)00048-2; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; van den Berg GA, 1999, WATER AIR SOIL POLL, V116, P567, DOI 10.1023/A:1005146927718; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Wang Kunshan, 2010, Marine Geology & Quaternary Geology, V30, P1, DOI 10.3724/SP.J.1140.2010.06001; Wang SC, 2007, GRAND PROSPECT THIS; Wright D. A., 1994, Environmental Reviews, V2, P187; [夏斌 XIA Bin], 2009, [渔业科学进展, Progress in Fishery Sciences], V30, P103; Xu S.S., 2011, THESIS GRADUATE U CH; Yu Y, 2013, MAR POLLUT BULL, V68, P157, DOI 10.1016/j.marpolbul.2012.11.043; Yuan HM, 2012, MAR POLLUT BULL, V64, P2151, DOI 10.1016/j.marpolbul.2012.07.040; Zhang R, 2013, MAR POLLUT BULL, V74, P403, DOI 10.1016/j.marpolbul.2013.06.019; Zhang WG, 2009, ENVIRON POLLUT, V157, P1533, DOI 10.1016/j.envpol.2009.01.007; Zhuang W, 2014, MAR POLLUT BULL, V83, P343, DOI 10.1016/j.marpolbul.2014.03.040; Zhuang W, 2014, MAR POLLUT BULL, V83, P352, DOI 10.1016/j.marpolbul.2014.03.039; Zhuang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094145; Zhuang W, 2013, MAR POLLUT BULL, V76, P128, DOI 10.1016/j.marpolbul.2013.09.016	65	31	31	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122190	10.1371/journal.pone.0122190	http://dx.doi.org/10.1371/journal.pone.0122190			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816338	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600151
J	Hess, SY; Abbeddou, S; Jimenez, EY; Some, JW; Vosti, SA; Ouedraogo, ZP; Guissou, RM; Ouedraogo, JB; Brown, KH				Hess, Sonja Y.; Abbeddou, Souheila; Jimenez, Elizabeth Yakes; Some, Jerome W.; Vosti, Stephen A.; Ouedraogo, Zinewende P.; Guissou, Rosemonde M.; Ouedraogo, Jean-Bosco; Brown, Kenneth H.			Small-Quantity Lipid-Based Nutrient Supplements, Regardless of Their Zinc Content, Increase Growth and Reduce the Prevalence of Stunting and Wasting in Young Burkinabe Children: A Cluster-Randomized Trial	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HOME-FORTIFICATION; MICRONUTRIENT SUPPLEMENTS; COMPLEMENTARY FOODS; MALARIA; METAANALYSIS; SPRINKLES; DIARRHEA; INFANTS; IRON	Small-quantity lipid-based nutrient supplements (SQ-LNS) are promising home fortification products, but the optimal zinc level needed to improve growth and reduce morbidity is uncertain. We aimed to assess the impact of providing SQ-LNS with varied amounts of zinc, along with illness treatment, on zinc-related outcomes compared with standard care. In a placebo-controlled, cluster-randomized trial, 34 communities were stratified to intervention (IC) or nonintervention cohorts (NIC). 2435 eligible IC children were randomly assigned to one of four groups: 1) SQ-LNS without zinc, placebo tablet; 2) SQ-LNS containing 5mg zinc, placebo tablet; 3) SQ-LNS containing 10mg zinc, placebo tablet; or 4) SQ-LNS without zinc and 5mg zinc tablet from 9-18 months of age. During weekly morbidity surveillance, oral rehydration salts were provided for reported diarrhea and antimalarial therapy for confirmed malaria. Children in NIC (n = 785) did not receive SQ-LNS, tablets, illness surveillance or treatment. At 9 and 18 months, length, weight and hemoglobin were measured in all children. Reported adherence was 97 +/- 6% for SQ-LNS and tablets. Mean baseline hemoglobin was 89 +/- 15g/L. At 18 months, change in hemoglobin was greater in IC than NIC (+8 vs -1g/L, p<0.0001), but 79.1% of IC were still anemic (vs. 91.1% in NIC). Final plasma zinc concentration did not differ by group. During the 9-month observation period, the incidence of diarrhea was 1.10 +/- 1.03 and of malaria 0.54 +/- 0.50 episodes per 100 child-days, and did not differ by group. Length at 18 months was significantly greater in IC compared to NIC (77.7 +/- 3.0 vs. 76.9 +/- 3.4cm; p<0.001) and stunting prevalence was significantly lower in IC (29.3%) than NIC (39.3%; p<0.0001), but did not differ by intervention group within IC. Wasting prevalence was also significantly lower in IC (8.7%) than in NIC (13.5%; p = 0.0003). Providing SQ-LNS daily with or without zinc, along with malaria and diarrhea treatment, significantly increased growth and reduced stunting, wasting and anemia prevalence in young children.	[Hess, Sonja Y.; Abbeddou, Souheila; Some, Jerome W.; Brown, Kenneth H.] Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, Davis, CA 95616 USA; [Jimenez, Elizabeth Yakes] Univ New Mexico, Dept Individual Family & Community Educ, Nutr Program, Albuquerque, NM 87131 USA; [Some, Jerome W.; Ouedraogo, Zinewende P.; Guissou, Rosemonde M.; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Vosti, Stephen A.] Univ Calif Davis, Agr & Resource Econ, Davis, CA 95616 USA	University of California System; University of California Davis; University of New Mexico; University of California System; University of California Davis	Hess, SY (corresponding author), Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, Davis, CA 95616 USA.	syhess@ucdavis.edu		Ouedraogo, Jean Bosco/0000-0003-0412-8733; Abbeddou, Souheila/0000-0002-1363-0170; Hess, Sonja/0000-0002-4661-277X; Yakes Jimenez, Elizabeth/0000-0003-0315-7022	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The project was funded by a grant from the Bill & Melinda Gates Foundation to the University of California, Davis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeddou S, 2015, MATERN CHILD NUTR, V11, P90, DOI 10.1111/mcn.12162; Adu-Afarwuah S, 2008, AM J CLIN NUTR, V87, P929, DOI 10.1093/ajcn/87.4.929; Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; [Anonymous], 2010, FOOD AGR ORG FATS FA; Arimond M, 2015, MATERN CHILD NUTR, V11, P31, DOI 10.1111/mcn.12049; Becquey E, 2013, FASEB J, V27; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bisimwa G, 2012, AM J CLIN NUTR, V95, P1157, DOI 10.3945/ajcn.111.028704; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown KH, 2009, FOOD NUTR BULL, V30, pS12, DOI 10.1177/15648265090301S103; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hess SY, 2011, MATERN CHILD NUTR, V7, P357, DOI 10.1111/j.1740-8709.2010.00287.x; Iannotti LL, 2014, AM J CLIN NUTR, V99, P198, DOI 10.3945/ajcn.113.063883; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Jack SJ, 2012, ARCH PEDIAT ADOL MED, V166, P842, DOI 10.1001/archpediatrics.2012.1003; Kang H, 2013, INT J EPIDEMIOL, V42, P1390, DOI 10.1093/ije/dyt116; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kuusipalo H, 2006, J PEDIATR GASTR NUTR, V43, P525, DOI 10.1097/01.mpg.0000235981.26700.d3; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Macro International Inc, MEASURE DHS STATCOMP; Mangani C, 2015, MATERN CHILD NUTR, V11, P132, DOI 10.1111/mcn.12068; Mayo-Wilson E, 2014, COCHRANE DB SYST REV, V5; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Padonou G, 2014, T ROY SOC TROP MED H, V108, P77, DOI 10.1093/trstmh/trt099; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Richard SA, 2013, AM J EPIDEMIOL, V178, P1129, DOI 10.1093/aje/kwt094; Roth DE, 2010, INT J EPIDEMIOL, V39, P795, DOI 10.1093/ije/dyp391; Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22; Samadpour K, 2011, EUR J CLIN NUTR, V65, P1287, DOI 10.1038/ejcn.2011.124; Some JW, 2015, FASEB J IN PRESSS; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Troesch B, 2011, J NUTR, V141, P237, DOI 10.3945/jn.110.129247; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; W.H.O, 1983, MEAS CHANG NUTR STAT; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wessells KR, 2012, J PEDIATR-US, V160, P129, DOI 10.1016/j.jpeds.2011.06.051; *WHO, 2006, WHO GROWTH STAND LEN; WHO, 2004, VIT MIN REQ HUM NUTR, V2nd; Williams TN, 1997, QJM-INT J MED, V90, P751; World Health Organization, 1995, TECHN RES SER WHO, V854; World Health Organization, 2011, US MULT MICR POWD HO; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Zlotkin S, 2003, J NUTR, V133, P1075, DOI 10.1093/jn/133.4.1075	51	98	98	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122242	10.1371/journal.pone.0122242	http://dx.doi.org/10.1371/journal.pone.0122242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816354	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600159
J	Jiao, HP; Tang, P; Zhang, YL				Jiao, Huipeng; Tang, Peng; Zhang, Yongliang			MAP Kinase Phosphatase 2 Regulates Macrophage-Adipocyte Interaction	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; FREE FATTY-ACIDS; ADIPOSE-TISSUE; INFLAMMATORY CHANGES; GLUCOSE-HOMEOSTASIS; IMMUNE-RESPONSES; EXPRESSION; JNK	Objective Inflammation is critical for the development of obesity-associated metabolic disorders. This study aims to investigate the role of mitogen-activated protein kinase phosphatase 2 (MKP2) in inflammation during macrophage-adipocyte interaction. Methods White adipose tissues (WAT) from mice either on a high-fat diet (HFD) or normal chow (NC) were isolated to examine the expression of MKP-2. Murine macrophage cell line RAW264.7 stably expressing MKP-2 was used to study the regulation of MKP-2 in macrophages in response to saturated free fatty acid (FFA) and its role in macrophage M1/M2 activation. Macrophage-adipocyte co-culture system was employed to investigate the role of MKP-2 in regulating inflammation during adipocyte-macrophage interaction. c-Jun N-terminal kinase (JNK)-and p38-specific inhibitors were used to examine the mechanisms by which MKP-2 regulates macrophage activation and macrophage-adipocytes interaction. Results HFD changed the expression of MKP-2 in WAT, and MKP-2 was highly expressed in the stromal vascular cells (SVCs). MKP-2 inhibited the production of proinflammatory cytokines in response to FFA stimulation in macrophages. MKP-2 inhibited macrophage M1 activation through JNK and p38. In addition, overexpression of MKP-2 in macrophages suppressed inflammation during macrophage-adipocyte interaction. Conclusion MKP-2 is a negative regulator of macrophage M1 activation through JNK and p38 and inhibits inflammation during macrophage-adipocyte interaction.	[Jiao, Huipeng; Tang, Peng; Zhang, Yongliang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Jiao, Huipeng; Tang, Peng; Zhang, Yongliang] Natl Univ Singapore, Inst Life Sci, Program Immunol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Zhang, YL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore.	miczy@nus.edu.sg		Jiao, Huipeng/0000-0001-9632-6176	Office of Deputy President, National University of Singapore; Ministry of Education [MOE2010-T2-1-079]; National Medical Research Council [IRG10nov091, CBRG11nov101]; National Research Foundation of Singapore [NRF-CRP7-2010-03]	Office of Deputy President, National University of Singapore(National University of Singapore); Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Singapore(National Research Foundation, Singapore)	This study was supported by grants from the Office of Deputy President, National University of Singapore (www.nus.edu.sg), the Ministry of Education (MOE2010-T2-1-079; http://www.moe.gov.sg/), the National Medical Research Council (IRG10nov091 and CBRG11nov101; http://www.nmrc.gov.sg/) and the National Research Foundation (NRF-CRP7-2010-03; http://www.nrf.gov.sg/) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hernandez ED, 2014, CELL METAB, V20, P499, DOI 10.1016/j.cmet.2014.06.008; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawan A, 2011, J BIOL CHEM, V286, P12933, DOI 10.1074/jbc.M110.181370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yamashita A, 2008, INT J OBESITY, V32, P1725, DOI 10.1038/ijo.2008.153; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	41	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120755	10.1371/journal.pone.0120755	http://dx.doi.org/10.1371/journal.pone.0120755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816341	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600046
J	Kushida, N				Kushida, Noriyuki			Condition Number Estimation of Preconditioned Matrices	PLOS ONE			English	Article								The present paper introduces a condition number estimation method for preconditioned matrices. The newly developed method provides reasonable results, while the conventional method which is based on the Lanczos connection gives meaningless results. The Lanczos connection based method provides the condition numbers of coefficient matrices of systems of linear equations with information obtained through the preconditioned conjugate gradient method. Estimating the condition number of preconditioned matrices is sometimes important when describing the effectiveness of new preconditionerers or selecting adequate preconditioners. Operating a preconditioner on a coefficient matrix is the simplest method of estimation. However, this is not possible for large-scale computing, especially if computation is performed on distributed memory parallel computers. This is because, the preconditioned matrices become dense, even if the original matrices are sparse. Although the Lanczos connection method can be used to calculate the condition number of preconditioned matrices, it is not considered to be applicable to large-scale problems because of its weakness with respect to numerical errors. Therefore, we have developed a robust and parallelizable method based on Hager's method. The feasibility studies are curried out for the diagonal scaling preconditioner and the SSOR preconditioner with a diagonal matrix, a tri-daigonal matrix and Pei's matrix. As a result, the Lanczos connection method contains around 10% error in the results even with a simple problem. On the other hand, the new method contains negligible errors. In addition, the newly developed method returns reasonable solutions when the Lanczos connection method fails with Pei's matrix, and matrices generated with the finite element method.	Comprehens Nucl Test Ban Treaty Org, Preparatory Commiss, Int Data Ctr, Vienna, Austria		Kushida, N (corresponding author), Comprehens Nucl Test Ban Treaty Org, Preparatory Commiss, Int Data Ctr, Vienna, Austria.	noriyuki.kushida@ctbto.org						Balay S., 2014, PETSC USERS MANUAL; Barrett Richard, 1994, TEMPLATES SOLUTION L; Eaton J. W., 2009, GNU OCTAVE VERSION 3; Garatani K, 1999, LECT NOTES COMPUT SC, V1593, P133; Golub GH., 2013, MATRIX COMPUTATIONS; HAGER WW, 1984, SIAM J SCI STAT COMP, V5, P311, DOI 10.1137/0905023; HIGHAM NJ, 1988, ACM T MATH SOFTWARE, V14, P381, DOI 10.1145/50063.214386; Kushida N., 2008, J COMPUT SCI TECHNOL, V2, P81, DOI [DOI 10.1299/JCST.2.81, 10.1299/jcst.2.81]; Kushida N, 2007, J COMPUTATIONAL SCI, V1, P2; Kushida N, 2015, MODIFIED HAGERS METH; Meurant G., 2006, SOFTWARE ENV TOOLS; PEI ML, 1962, COMMUN ACM, V5, P508, DOI 10.1145/368959.368975; Saad Y., 2003, ITERATIVE METHODS SP; Tatebe O., 1996, MGCG METHOD ROBUST H	14	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122331	10.1371/journal.pone.0122331	http://dx.doi.org/10.1371/journal.pone.0122331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816331	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600167
J	Li, TX; He, XH; Thomas, JM; Yang, DJ; Zhong, SJ; Xue, FT; Smith, WW				Li, Tianxia; He, Xinhua; Thomas, Joseph M.; Yang, Dejun; Zhong, Shijun; Xue, Fengtian; Smith, Wanli W.			A Novel GTP-Binding Inhibitor, FX2149, Attenuates LRRK2 Toxicity in Parkinson's Disease Models	PLOS ONE			English	Article							KINASE 2 LRRK2; MICE	Leucine-rich repeat kinase-2 (LRRK2), a cytoplasmic protein containing both GTP binding and kinase activities, has emerged as a highly promising drug target for Parkinson's disease (PD). The majority of PD-linked mutations in LRRK2 dysregulate its GTP binding and kinase activities, which may contribute to neurodegeneration. While most known LRRK2 inhibitors are developed to target the kinase domain, we have recently identified the first LRRK2 GTP binding inhibitor, 68, which not only inhibits LRRK2 GTP binding and kinase activities with high potency in vitro, but also reduces neurodegeneration. However, the in vivo effects of 68 are low due to its limited brain penetration. To address this problem, we reported herein the design and synthesis of a novel analog of 68, FX2149, aimed at increasing the in vivo efficacy. Pharmacological characterization of FX2149 exhibited inhibition of LRRK2 GTP binding activity by similar to 90% at a concentration of 10 nM using in vitro assays. Furthermore, FX2149 protected against mutant LRRK2-induced neurodegeneration in SH-SY5Y cells at 50-200 nM concentrations. Importantly, FX2149 at 10 mg/kg (i.p.) showed significant brain inhibition efficacy equivalent to that of 68 at 20 mg/kg (i.p.), determined by mouse brain LRRK2 GTP binding and phosphorylation assays. Furthermore, FX2149 at 10 mg/kg (i.p.) attenuated lipopolysaccharide (LPS)-induced microglia activation and LRRK2 upregulation in a mouse neuroinflammation model comparable to 68 at 20 mg/kg (i.p.). Our results highlight a novel GTP binding inhibitor with better brain efficacy, which represents a new lead compound for further understanding PD pathogenesis and therapeutic studies.	[Li, Tianxia; He, Xinhua; Thomas, Joseph M.; Yang, Dejun; Xue, Fengtian; Smith, Wanli W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [He, Xinhua] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Zhong, Shijun] Dalian Univ Technol, Sch Life Sci & Biotechnol, Liaoning, Peoples R China	University System of Maryland; University of Maryland Baltimore; Academy of Military Medical Sciences - China; Dalian University of Technology	Xue, FT (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	fxue@rx.umaryland.edu; wsmith@rx.umaryland.edu	Yang, Dejun/L-9865-2016	Yang, Dejun/0000-0001-5118-0652; He, Xinhua/0000-0001-7826-2973	University of Maryland	University of Maryland	This work is supported by internal fund from University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng XM, 2012, EXPERT OPIN THER PAT, V22, P1415, DOI 10.1517/13543776.2012.729041; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Geldenhuys WJ, 2013, CURR MED CHEM, V20, P1662; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Lee BD, 2012, TRENDS PHARMACOL SCI, V33, P365, DOI 10.1016/j.tips.2012.04.001; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li TX, 2014, HUM MOL GENET, V23, P6212, DOI 10.1093/hmg/ddu341; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu M, 2010, ANAL BIOCHEM, V404, P186, DOI 10.1016/j.ab.2010.05.033; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tan EK, 2011, EUR J NEUROL, V18, P545, DOI 10.1111/j.1468-1331.2010.03305.x; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zhao LL, 2013, J MED CHEM, V56, P3833, DOI 10.1021/jm301793a	25	62	64	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122461	10.1371/journal.pone.0122461	http://dx.doi.org/10.1371/journal.pone.0122461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816252	gold, Green Submitted, Green Published			2022-12-27	WOS:000352133600181
J	Salo, J; Jaatinen, A; Soderstrom, M; Viljanen, MK; Hytonen, J				Salo, Jemiina; Jaatinen, Annukka; Soderstrom, Mirva; Viljanen, Matti K.; Hytonen, Jukka			Decorin Binding Proteins of Borrelia burgdorferi Promote Arthritis Development and Joint Specific Post-Treatment DNA Persistence in Mice	PLOS ONE			English	Article							LYME-DISEASE; INFECTED MICE; DBPA; PROTEOGLYCANS; MECHANISMS; VIRULENCE; ADHESION; DEFECT	Decorin binding proteins A and B (DbpA and B) of Borrelia burgdorferi are of critical importance for the virulence of the spirochete. The objective of the present study was to further clarify the contribution of DbpA and B to development of arthritis and persistence of B. burgdorferi after antibiotic treatment in a murine model of Lyme borreliosis. With that goal, mice were infected with B. burgdorferi strains expressing either DbpA or DbpB, or both DbpA and B, or with a strain lacking the adhesins. Arthritis development was monitored up to 15 weeks after infection, and bacterial persistence was studied after ceftriaxone and immunosuppressive treatments. Mice infected with the B. burgdorferi strain expressing both DbpA and B developed an early and prominent joint swelling. In contrast, while strains that expressed DbpA or B alone, or the strain that was DbpA and B deficient, were able to colonize mouse joints, they caused only negligible joint manifestations. Ceftriaxone treatment at two or six weeks of infection totally abolished joint swelling, and all ceftriaxone treated mice were B. burgdorferi culture negative. Antibiotic treated mice, which were immunosuppressed by anti-TNF-alpha, remained culture negative. Importantly, among ceftriaxone treated mice, B. burgdorferi DNA was detected by PCR uniformly in joint samples of mice infected with DbpA and B expressing bacteria, while this was not observed in mice infected with the DbpA and B deficient strain. In conclusion, these results show that both DbpA and B adhesins are crucial for early and prominent arthritis development in mice. Also, post-treatment borrelial DNA persistence appears to be dependent on the expression of DbpA and B on B. burgdorferi surface. Results of the immunosuppression studies suggest that the persisting material in the joints of antibiotic treated mice is DNA or DNA containing remnants rather than live bacteria.	[Salo, Jemiina; Jaatinen, Annukka; Viljanen, Matti K.; Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Salo, Jemiina] Turku Doctoral Programme Biomed Sci, TuBS, Turku, Finland; [Jaatinen, Annukka] Univ Turku, Turku Doctoral Programme Mol Med, Turku, Finland; [Soderstrom, Mirva] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Soderstrom, Mirva] Univ Turku, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Salo, J (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland.	jemiina.salo@utu.fi		Hytonen, Jukka/0000-0002-0585-9338; Pietikainen, Annukka/0000-0003-3554-0683	Academy of Finland [265098]; Special Governmental Fund for University Hospitals (EVO), Turku, Finland [E3010, E 3011]; Turku Graduate School for Biomedical Sciences, Turku, Finland; Turku University Foundation, Turku, Finland [7595]	Academy of Finland(Academy of Finland); Special Governmental Fund for University Hospitals (EVO), Turku, Finland; Turku Graduate School for Biomedical Sciences, Turku, Finland; Turku University Foundation, Turku, Finland	This work was supported by Academy of Finland (Decision number 265098), www.aka.fi, JH; the Special Governmental Fund for University Hospitals (EVO), Turku, Finland (Decision numbers E3010 and E 3011), JH and JS; Turku Graduate School for Biomedical Sciences, Turku, Finland, www.tubs.utu.fi, JS; the Turku University Foundation, Turku, Finland (Decision number 7595), www.utu.fi/fi/yksikot/yliopistosaatio, JS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Antonara S, 2011, ADV EXP MED BIOL, V715, P35, DOI 10.1007/978-94-007-0940-9_3; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Benoit VM, 2011, INFECT IMMUN, V79, P3501, DOI 10.1128/IAI.00163-11; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bockenstedt LK, 2002, J INFECT DIS, V186, P1430, DOI 10.1086/345284; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Fortune DE, 2014, INFECT IMMUN, V82, P3186, DOI 10.1128/IAI.02036-14; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hodzic E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086907; Imai DM, 2013, INFECT IMMUN, V81, P1663, DOI 10.1128/IAI.01359-12; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Ivacic L, 2007, DIAGN MICR INFEC DIS, V57, P137, DOI 10.1016/j.diagmicrobio.2006.08.005; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Lin YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004238; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Salo J, 2011, J INFECT DIS, V204, P65, DOI 10.1093/infdis/jir207; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005; Yang XL, 2013, J INFECT DIS, V207, P907, DOI 10.1093/infdis/jis930; Yrjanainen H, 2007, J INFECT DIS, V195, P1489, DOI 10.1086/513873; Yrjanainen H, 2010, APMIS, V118, P665, DOI 10.1111/j.1600-0463.2010.02615.x	32	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121512	10.1371/journal.pone.0121512	http://dx.doi.org/10.1371/journal.pone.0121512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816291	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600102
J	van den Broek, AJ; Schmidt, MK; van 't Veer, LJ; Tollenaar, RAEM; van Leeuwen, FE				van den Broek, Alexandra J.; Schmidt, Marjanka K.; van 't Veer, Laura J.; Tollenaar, Rob A. E. M.; van Leeuwen, Flora E.			Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							GERMLINE BRCA1 MUTATIONS; POPULATION-BASED COHORT; TUMOR CHARACTERISTICS; OVARIAN-CANCER; CONSERVING TREATMENT; SURVIVAL ANALYSIS; FOLLOW-UP; THERAPY; WOMEN; GENE	Objective Conflicting conclusions have been published regarding breast cancer survival of BRCA1/2 mutation carriers. Here we provide an evidence-based systematic literature review. Methods Eligible publications were observational studies assessing the survival of breast cancer patients carrying a BRCA1/2 mutation compared to non-carriers or the general breast cancer population. We performed meta-analyses and best-evidence syntheses for survival outcomes taking into account study quality assessed by selection bias, misclassification bias and confounding. Results Sixty-six relevant studies were identified. Moderate evidence for a worse unadjusted recurrence-free survival for BRCA1 mutation carriers was found. For BRCA1 and BRCA2 there was a tendency towards a worse breast cancer-specific and overall survival, however, results were heterogeneous and the evidence was judged to be indecisive. Surprisingly, only 8 studies considered adjuvant treatment as a confounder or effect modifier while only two studies took prophylactic surgery into account. Adjustment for tumour characteristics tended to shift the observed risk estimates towards a relatively more favourable survival. Conclusions In contrast to currently held beliefs of some oncologists, current evidence does not support worse breast cancer survival of BRCA1/2 mutation carriers in the adjuvant setting; differences if any are likely to be small. More well-designed studies are awaited.	[van den Broek, Alexandra J.; Schmidt, Marjanka K.; van Leeuwen, Flora E.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Schmidt, Marjanka K.; van 't Veer, Laura J.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Tollenaar, Rob A. E. M.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schmidt, MK (corresponding author), Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.	mk.schmidt@nki.nl	Schmidt, Marjanka K/G-9058-2011	Schmidt, Marjanka K/0000-0002-2228-429X	Dutch Cancer Society [DCS-NKI 2007-3839, DCS-NKI 2009-4363]	Dutch Cancer Society(KWF Kankerbestrijding)	Funding: This work was supported by the Dutch Cancer Society grant numbers DCS-NKI 2007-3839 and DCS-NKI 2009-4363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansquer Y, 1998, LANCET, V352, P541, DOI 10.1016/S0140-6736(05)79248-5; Arun B, 2011, J CLIN ONCOL, V29, P3739, DOI 10.1200/JCO.2011.35.2682; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Bonadona V, 2007, BREAST CANCER RES TR, V101, P233, DOI 10.1007/s10549-006-9288-7; Bordeleau L, 2010, BREAST CANCER RES TR, V119, P13, DOI 10.1007/s10549-009-0566-z; Brekelmans CTM, 2007, EUR J CANCER, V43, P867, DOI 10.1016/j.ejca.2006.12.009; Budroni M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-62; Carroll PA, 2011, BREAST, V20, P419, DOI 10.1016/j.breast.2011.04.005; Chappuis PO, 2005, ANN ONCOL, V16, P735, DOI 10.1093/annonc/mdi149; Chappuis PO, 2000, J CLIN ONCOL, V18, P4045, DOI 10.1200/JCO.2000.18.24.4045; Chiappetta G, 2010, EUR J CANCER, V46, P332, DOI 10.1016/j.ejca.2009.10.015; Cortesi L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-90; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eccles D, 2001, Fam Cancer, V1, P65, DOI 10.1023/A:1013867917101; Eerola H, 2001, INT J CANCER, V93, P368, DOI 10.1002/ijc.1341; Einbeigi Z, 2001, EUR J CANCER, V37, P1904, DOI 10.1016/S0959-8049(01)00223-4; El-Tamer M, 2004, ANN SURG ONCOL, V11, P157, DOI 10.1245/ASO.2004.05.018; Ellberg C, 2010, FAM CANCER, V9, P525, DOI 10.1007/s10689-010-9355-4; Foulkes WD, 1997, CLIN CANCER RES, V3, P2465; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Gaffney DK, 1998, RADIOTHER ONCOL, V47, P129, DOI 10.1016/S0167-8140(98)00023-1; Goffin JR, 2003, BRIT J CANCER, V89, P1031, DOI 10.1038/sj.bjc.6601195; Goffin JR, 2003, CANCER-AM CANCER SOC, V97, P527, DOI 10.1002/cncr.11080; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Goode EL, 2002, CANCER RES, V62, P3052; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Hagen AI, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-7; Hamann U, 2000, BREAST CANCER RES TR, V59, P185, DOI 10.1023/A:1006350518190; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Huzarski T, 2013, J CLIN ONCOL; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Kirova YM, 2010, BREAST CANCER RES TR, V120, P119, DOI 10.1007/s10549-009-0685-6; Lee EH, 2010, BREAST CANCER RES TR, V122, P11, DOI 10.1007/s10549-010-0859-2; Lee JS, 1999, JNCI-J NATL CANCER I, V91, P259, DOI 10.1093/jnci/91.3.259; Lee LJ, 2011, CANCER-AM CANCER SOC, V117, P3093, DOI 10.1002/cncr.25911; Loman N, 2000, EUR J CANCER, V36, P1365, DOI 10.1016/S0959-8049(00)00098-8; Moller P, 2002, INT J CANCER, V101, P555, DOI 10.1002/ijc.10641; Moller P, 2007, INT J CANCER, V121, P1017, DOI 10.1002/ijc.22789; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Musolino A, 2007, BREAST, V16, P280, DOI 10.1016/j.breast.2006.12.003; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nisman B, 2010, CANCER BIOMARK, V7, P65, DOI 10.3233/CBM-2010-0148; Phillips KA, 2001, INTERN MED J, V31, P349, DOI 10.1046/j.1445-5994.2001.00075.x; Pierce LJ, 2006, J CLIN ONCOL, V24, P2437, DOI 10.1200/JCO.2005.02.7888; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Plakhins G, 2013, FAM CANC; Plakhins G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-147; PORTER DE, 1994, BRIT J SURG, V81, P1512, DOI 10.1002/bjs.1800811038; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Rijnsburger AJ, 2010, J CLIN ONCOL, V28, P5265, DOI 10.1200/JCO.2009.27.2294; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Robson M, 1999, JNCI-J NATL CANCER I, V91, P2112, DOI 10.1093/jnci/91.24.2112; Robson Mark E, 2002, Cancer Control, V9, P457; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Seynaeve C, 2004, EUR J CANCER, V40, P1150, DOI 10.1016/j.ejca.2004.01.017; Soumittra N, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-13; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Tryggvadottir L, 2013, BREAST CANCER RES TR, V140, P375, DOI 10.1007/s10549-013-2637-4; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; Veronesi A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-70; Vinodkumar B, 2007, J EXP CLIN CANC RES, V26, P329; Wagner TMU, 1998, INT J CANCER, V77, P354, DOI 10.1002/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.0.CO;2-N; Xu J, 2012, MOL BIOL REP, V39, P3097, DOI 10.1007/s11033-011-1073-y	66	57	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120189	10.1371/journal.pone.0120189	http://dx.doi.org/10.1371/journal.pone.0120189			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816289	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600030
J	Huynh, HTT; Pignoly, M; Nkamga, VD; Drancourt, M; Aboudharam, G				Huynh, Hong T. T.; Pignoly, Marion; Nkamga, Vanessa D.; Drancourt, Michel; Aboudharam, Gerard			The Repertoire of Archaea Cultivated from Severe Periodontitis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; METHANOGENIC ARCHAEA; METHANOBREVIBACTER-ORALIS; QUANTITATIVE-ANALYSIS; GENE ANALYSIS; MCRA GENE; DIVERSITY; IDENTIFICATION; PREVALENCE; BACTERIA	In previous studies, the abundance and diversity of methanogenic archaea in the dental microbiota have been analysed by the detection of specific DNA sequences by PCR-based investigations and metagenomic studies. Few data issued regarding methanogens actually living in dental plaque. We collected dental plaque specimens in 15 control individuals and 65 periodontitis patients. Dental plaque specimens were cultured in an anoxic liquid medium for methanogens in the presence of negative control tubes. Dental plaque methanogens were cultured from 1/15 (6.67%) control and 36/65 (55.38%) periodontitis patient samples (p<0.001). The cultures yielded Methanobrevibacter oralis in one control and thirty-one patients, Methanobrevibacter smithii in two patients and a potential new species named Methanobrevibacter sp. strain N13 in three patients with severe periodontitis. Our observations of living methanogens, strengthen previous observations made on DNA-based studies regarding the role of methanogens, in periodontitis.	[Huynh, Hong T. T.; Pignoly, Marion; Aboudharam, Gerard] Aix Marseille Univ, Fac Dent, Marseille, France; [Huynh, Hong T. T.; Nkamga, Vanessa D.; Drancourt, Michel; Aboudharam, Gerard] Fac Med, INSERM 1095, IRD 198, UMR CNRS 7278,URMITE, Marseille 5, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Drancourt, M (corresponding author), Fac Med, INSERM 1095, IRD 198, UMR CNRS 7278,URMITE, 27 Blvd Jean Moulin, Marseille 5, France.	michel.drancourt@univ-amu.fr			Unite de Recherches sur les Maladies Infectieuses Tropicales Emergentes	Unite de Recherches sur les Maladies Infectieuses Tropicales Emergentes	Funding for this work came from Unite de Recherches sur les Maladies Infectieuses Tropicales Emergentes.	Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; Bringuier A, 2013, J CLIN MICROBIOL, V51, P993, DOI 10.1128/JCM.02863-12; Chandra R Viswa, 2007, Oral Health Prev Dent, V5, P39; Faveri M, 2011, J PERIODONTAL RES, V46, P338, DOI 10.1111/j.1600-0765.2011.01347.x; FERRARI A, 1994, CURR MICROBIOL, V29, P7, DOI 10.1007/BF01570184; Horz H.P., 2011, J ORAL MICROBIOL, V3, P5940, DOI DOI 10.3402/JOM.V3I0.5940; Horz HP, 2012, ANAEROBE, V18, P373, DOI 10.1016/j.anaerobe.2012.04.006; Hungate R. E., 1973, "Modern Methods in the Study of Microbial Ecology". Bulletins from the Ecological Research Committee, Sweden, V17, P123; Khelaifia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061563; Kulik EM, 2001, FEMS MICROBIOL LETT, V196, P129, DOI 10.1111/j.1574-6968.2001.tb10553.x; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Li CL, 2009, ORAL MICROBIOL IMMUN, V24, P343, DOI 10.1111/j.1399-302X.2009.00514.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Matarazzo F, 2011, J CLIN PERIODONTOL, V38, P621, DOI 10.1111/j.1600-051X.2011.01734.x; Miller TL, 2002, INT J SYST EVOL MICR, V52, P819, DOI 10.1099/ijs.0.02022-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tung NH, 2013, APMIS, V121, P467, DOI 10.1111/apm.12015; Vianna ME, 2008, J BACTERIOL, V190, P3779, DOI 10.1128/JB.01861-07; Vianna ME, 2009, ORAL MICROBIOL IMMUN, V24, P417, DOI 10.1111/j.1399-302X.2009.00539.x; Wright ADG, 2003, J MICROBIOL METH, V55, P337, DOI 10.1016/S0167-7012(03)00169-6	21	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121565	10.1371/journal.pone.0121565	http://dx.doi.org/10.1371/journal.pone.0121565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830311	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600075
J	Mejdoubi, J; van den Heijkant, SCCM; van Leerdam, FJM; Heymans, MW; Crijnen, A; Hirasing, RA				Mejdoubi, Jamila; van den Heijkant, Silvia C. C. M.; van Leerdam, Frank J. M.; Heymans, Martijn W.; Crijnen, Alfons; Hirasing, Remy A.			The Effect of VoorZorg, the Dutch Nurse-Family Partnership, on Child Maltreatment and Development: A Randomized Controlled Trial	PLOS ONE			English	Article							HOME VISITATION; PREVENTION; ABUSE; PREVALENCE; PREGNANCY; VIOLENCE; NEGLECT; IMPACT; CARE	Background Child maltreatment is a great public health concern that has long-term mental and physical health consequences and can result in death. We studied the effect of a nurse home visiting program on child maltreatment among young disadvantaged families in the Netherlands. This study is the first to investigate the effects of this program outside of the United States. Methods We conducted a single blind, parallel-group, randomized controlled trial that compared usual care with the nurse home visitation program, which began during pregnancy and continued until the children's second birthdays, in 460 disadvantaged women who were pregnant for the first time and <26 years of age. The primary outcome was the existence of a report about the child from a child protecting services agency (CPS reports). Secondary outcome measures included home environment and child behavior. Results Two hundred twenty-three participants were assigned to the control group, and 237 were assigned to the intervention group. Three years after birth, 19% of the children in the control group had a CPS report. The 11 percent of children in the intervention group with CPS files was significantly lower (relative risk 0.91, p-value 0.04). At 24 months, the intervention group scored significantly better on the IT-HOME. At 24 months after birth, the children in the intervention group exhibited a significant improvement in internalizing behavior (relative risk 0.56, p-value 0.04) but no evidence of a difference from the control group in externalizing behavior (relative risk 0.71, p-value 0.12). Conclusion The number of CPS reports for the intervention group was significantly lower than that of the control group. Additionally, the long-term home environments were improved and internalizing behaviors of the children were lower in the intervention group.	[Mejdoubi, Jamila; van den Heijkant, Silvia C. C. M.; Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van Leerdam, Frank J. M.] Dutch Hlth Care Inspectorate, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Crijnen, Alfons] Ctr Forens Serv, De Waag, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Crijnen, A (corresponding author), Ctr Forens Serv, De Waag, Amsterdam, Netherlands.	crijnen@xs4all.nl		Heymans, Martijn/0000-0002-3889-0921	Netherlands Organization for Health Research and Development (ZonMw) - Dutch government [100001015, 71300002]; Youth Health Care organizations; city councils	Netherlands Organization for Health Research and Development (ZonMw) - Dutch government; Youth Health Care organizations; city councils	The conduct of the RCT was funded by the Netherlands Organization for Health Research and Development (ZonMw), which is the funding organization from the Dutch government (http://www.zonmw.nl/nl/), grant numbers: 100001015 and 71300002. Participating Youth Health Care organizations and participating city councils provided funding for the implementation of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 1983, CHILD BEHAV CHECKLIS; Achenbach T. M, 1999, CHILD BEHAV CHECKLIS; AMK, 2012, UTRECHT JEUGDZORG NE; Bruijn DR, 2012, HANDLEIDING; Chaffin M, 2006, CHILD MALTREATMENT, V11, P301, DOI 10.1177/1077559506291261; Euser EM, 2010, CHILD MALTREATMENT, V15, P5, DOI 10.1177/1077559509345904; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Gijzen S, 2014, J PUBLIC HEALTH POL, V35, P43, DOI 10.1057/jphp.2013.41; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Ginsburg GS, 2006, J AM ACAD CHILD PSY, V45, P1179, DOI 10.1097/01.chi.0000231974.43966.6e; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Kooijman K, 2012, HANDLEIDING; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; Manly JT, 2001, DEV PSYCHOPATHOL, V13, P759, DOI 10.1017/S0954579401004023; McFarlane JM, 2005, PUBLIC HEALTH NURS, V22, P98, DOI 10.1111/j.0737-1209.2005.220203.x; Mejdoubi J, 2013, JEUGDGEZONDSZORG TIJ, V45, P26, DOI [10.1007/s12452-013-0007, DOI 10.1007/S12452-013-0007]; Mejdoubi J, 2013, MIDWIFERY; Mejdoubi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078185; Mejdoubi J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-823; Mikton C, 2009, B WORLD HEALTH ORGAN, V87, P353, DOI 10.2471/BLT.08.057075; Olds DL, 2006, INFANT MENT HEALTH J, V27, P5, DOI 10.1002/imhj.20077; OLDS DL, 1986, PEDIATRICS, V77, P16; OLDS DL, 1986, PEDIATRICS, V78, P65; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Reynolds AJ, 2009, CHILD MALTREATMENT, V14, P182, DOI 10.1177/1077559508326223; Salazar M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-350; Schoonenberg NJ, 2013, MEDISCH HDB KINDERMI, P447; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Turnell A., 1999, SIGNS OF SAFETY; Wekerle C, 2009, CHILD ABUSE NEGLECT, V33, P45, DOI 10.1016/j.chiabu.2008.12.006; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zielinski DS, 2009, DEV PSYCHOPATHOL, V21, P441, DOI 10.1017/S0954579409000248; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	38	58	59	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120182	10.1371/journal.pone.0120182	http://dx.doi.org/10.1371/journal.pone.0120182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830242	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600024
J	Schwarz, K; Fragkias, M; Boone, CG; Zhou, WQ; McHale, M; Grove, JM; O'Neil-Dunne, J; McFadden, JP; Buckley, GL; Childers, D; Ogden, L; Pincetl, S; Pataki, D; Whitmer, A; Cadenasso, ML				Schwarz, Kirsten; Fragkias, Michail; Boone, Christopher G.; Zhou, Weiqi; McHale, Melissa; Grove, J. Morgan; O'Neil-Dunne, Jarlath; McFadden, Joseph P.; Buckley, Geoffrey L.; Childers, Dan; Ogden, Laura; Pincetl, Stephanie; Pataki, Diane; Whitmer, Ali; Cadenasso, Mary L.			Trees Grow on Money: Urban Tree Canopy Cover and Environmental Justice	PLOS ONE			English	Article							RACIAL-INEQUALITY; HAZARDOUS-WASTE; LOS-ANGELES; LAND-COVER; VEGETATION; MODELS; EQUITY; BALTIMORE; PATTERNS; CRIME	This study examines the distributional equity of urban tree canopy (UTC) cover for Baltimore, MD, Los Angeles, CA, New York, NY, Philadelphia, PA, Raleigh, NC, Sacramento, CA, and Washington, D.C. using high spatial resolution land cover data and census data. Data are analyzed at the Census Block Group levels using Spearman's correlation, ordinary least squares regression (OLS), and a spatial autoregressive model (SAR). Across all cities there is a strong positive correlation between UTC cover and median household income. Negative correlations between race and UTC cover exist in bivariate models for some cities, but they are generally not observed using multivariate regressions that include additional variables on income, education, and housing age. SAR models result in higher r-square values compared to the OLS models across all cities, suggesting that spatial autocorrelation is an important feature of our data. Similarities among cities can be found based on shared characteristics of climate, race/ethnicity, and size. Our findings suggest that a suite of variables, including income, contribute to the distribution of UTC cover. These findings can help target simultaneous strategies for UTC goals and environmental justice concerns.	[Schwarz, Kirsten] No Kentucky Univ, Dept Biol, Highland Hts, KY 41076 USA; [Fragkias, Michail] Boise State Univ, Dept Econ, Coll Business & Econ COBE, Boise, ID 83725 USA; [Boone, Christopher G.; Childers, Dan] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Zhou, Weiqi] Chinese Acad Sci, Ctr Ecoenvironm Sci, Beijing, Peoples R China; [McHale, Melissa] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA; [Grove, J. Morgan] USDA, Forest Serv, No Res Stn, Baltimore, MD USA; [O'Neil-Dunne, Jarlath] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [O'Neil-Dunne, Jarlath] Spatial Anal Lab, Burlington, VT USA; [McFadden, Joseph P.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Buckley, Geoffrey L.] Ohio Univ, Dept Geog, Clippinger Labs 109, Athens, OH 45701 USA; [Ogden, Laura] Florida Int Univ, Dept Global & Sociocultural Studies, Miami, FL 33199 USA; [Pincetl, Stephanie] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA; [Pataki, Diane] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Whitmer, Ali] Georgetown Univ, Washington, DC USA; [Cadenasso, Mary L.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Northern Kentucky University; Idaho; Boise State University; Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service; University of Vermont; University of California System; University of California Santa Barbara; University System of Ohio; Ohio University; State University System of Florida; Florida International University; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; Georgetown University; University of California System; University of California Davis	Schwarz, K (corresponding author), No Kentucky Univ, Dept Biol, Highland Hts, KY 41076 USA.	schwarzk1@nku.edu	Zhou, Weiqi/G-2427-2010; McHale, Melissa/AIA-0220-2022; Fragkias, Michail/B-5785-2008	McHale, Melissa/0000-0001-7300-2988; Pataki, Diane/0000-0001-7209-514X; Grove, J. Morgan/0000-0002-7803-074X; Boone, Christopher/0000-0001-7643-0806; Childers, Daniel/0000-0003-3904-0803	National Center for Ecological Analysis and Synthesis, Project [12575]; Division Of Behavioral and Cognitive Sci [1229429] Funding Source: National Science Foundation; Division Of Environmental Biology [0844778, 1027188] Funding Source: National Science Foundation	National Center for Ecological Analysis and Synthesis, Project; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Center for Ecological Analysis and Synthesis, Project 12575 (http://www.nceas.ucsb.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson Joni, 2002, ENV JUSTICE READER P; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anselin, 2005, EXPLORING SPATIAL DA; Anselin L, 2001, AM J AGR ECON, V83, P705, DOI 10.1111/0002-9092.00194; Anselin L., 1999, GEOGRAPHIC INFORM SC, V5, P67, DOI DOI 10.1080/10824009909480516; Battaglia MJ, 2010, MULTIMETHODS APPROAC; Bell JF, 2008, AM J PREV MED, V35, P547, DOI 10.1016/j.amepre.2008.07.006; Bezak P, 2008, ENVIRON SCI-TOKYO, V5, P161, DOI [DOI 10.1080/15693430802055524, 10.1080/15693430802055524]; Bigsby KM, 2014, ECOSYSTEMS, V17, P212, DOI 10.1007/s10021-013-9718-4; Boone CG, 2002, URBAN GEOGR, V23, P581, DOI 10.2747/0272-3638.23.6.581; Boone Christopher G., 2010, Urban Ecosystems, V13, P255, DOI 10.1007/s11252-009-0118-7; Boone CG, 2008, ENVIRON JUSTICE, V1, P149, DOI 10.1089/env.2008.0530; Boone CG, 2009, ANN ASSOC AM GEOGR, V99, P767, DOI 10.1080/00045600903102949; Bullard R.D., 2000, DUMPING DIXIE RACE C, VThird edition; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Cutter SL, 1996, RISK ANAL, V16, P517, DOI 10.1111/j.1539-6924.1996.tb01097.x; Cutts BB, 2009, SOC SCI MED, V69, P1314, DOI 10.1016/j.socscimed.2009.08.020; Downey L, 2007, URBAN STUD, V44, P953, DOI 10.1080/00420980701256013; Downey L, 2006, SOC FORCES, V85, P771, DOI 10.1353/sof.2007.0003; Dwyer J. F., 1992, Journal of Arboriculture, V18, P227; Gillespie TW, 2012, URBAN ECOSYST, V15, P233, DOI 10.1007/s11252-011-0183-6; Grove JM, 2006, ECOSYSTEMS, V9, P578, DOI 10.1007/s10021-006-0116-z; Harlan SL, 2006, SOC SCI MED, V63, P2847, DOI 10.1016/j.socscimed.2006.07.030; Heynen N, 2006, URBAN AFF REV, V42, P3, DOI 10.1177/1078087406290729; Holtan MT, 2014, SOCIAL LIFE COVER TR; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Kaplan R, 1989, EXPERIENCE NATURE PS; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo Frances E., 2003, Journal of Arboriculture, V29, P148; Landry SM, 2009, ENVIRON PLANN A, V41, P2651, DOI 10.1068/a41236; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Low Setha, 2005, RETHINKING URBAN PAR; McPherson E. Gregory, 1993, Journal of Arboriculture, V19, P321; McPherson EG, 2011, LANDSCAPE URBAN PLAN, V99, P40, DOI 10.1016/j.landurbplan.2010.08.011; McPherson GE, 1995, URBAN FOREST LANDSCA, P180; McPherson GE, 1996, P ANN M AM SOC LANDS, P27; Mennis JL, 2005, ANN ASSOC AM GEOGR, V95, P249, DOI 10.1111/j.1467-8306.2005.00459.x; Mohai P, 2007, SOC PROBL, V54, P343, DOI 10.1525/sp.2007.54.3.343; Moskal LM, 2011, SEATTLE HYPERSPECTRA; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Pedlowski M.A., 2002, URBAN ECOSYST, V6, P9, DOI [DOI 10.1023/A:1025910528583, 10.1023/A:1025910528583]; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Pickett STA, 2004, LANDSCAPE URBAN PLAN, V69, P369, DOI 10.1016/j.landurbplan.2003.10.035; Pincetl S, 2013, GEOJOURNAL, V78, P475, DOI 10.1007/s10708-012-9446-x; Pincetl S, 2012, LANDSCAPE URBAN PLAN, V107, P193, DOI 10.1016/j.landurbplan.2012.06.006; Pincetl S, 2010, ENVIRON MANAGE, V45, P227, DOI 10.1007/s00267-009-9412-7; Saha R, 2005, SOC PROBL, V52, P618, DOI 10.1525/sp.2005.52.4.618; Su JG, 2010, GEOJOURNAL, V75, P595, DOI 10.1007/s10708-009-9269-6; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tooke TR, 2010, ENVIRON PLANN B, V37, P1040, DOI 10.1068/b36044; Troy A, 2012, LANDSCAPE URBAN PLAN, V106, P262, DOI 10.1016/j.landurbplan.2012.03.010; Troy AR, 2007, ENVIRON MANAGE, V40, P394, DOI 10.1007/s00267-006-0112-2; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Westphal Lynne M., 2003, Journal of Arboriculture, V29, P137; Wolch J, 2005, URBAN GEOGR, V26, P4, DOI 10.2747/0272-3638.26.1.4; Wolf KL, 2010, EMERGING ISSUES URBA, P45; Xiao Qingfu, 2002, Urban Ecosystems, V6, P291, DOI 10.1023/B:UECO.0000004828.05143.67; Xiao Qingfu, 1998, Journal of Arboriculture, V24, P235	63	257	267	10	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122051	10.1371/journal.pone.0122051	http://dx.doi.org/10.1371/journal.pone.0122051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830303	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600096
J	Chen, Z; Schlipalius, D; Opit, G; Subramanyam, B; Phillips, TW				Chen, Zhaorigetu; Schlipalius, David; Opit, George; Subramanyam, Bhadriraju; Phillips, Thomas W.			Diagnostic Molecular Markers for Phosphine Resistance in US Populations of Tribolium castaneum and Rhyzopertha dominica	PLOS ONE			English	Article							LESSER GRAIN BORER; COLEOPTERA; ALLELE	Stored product beetles that are resistant to the fumigant pesticide phosphine (hydrogen phosphide) gas have been reported for more than 40 years in many places worldwide. Traditionally, determination of phosphine resistance in stored product beetles is based on a discriminating dose bioassay that can take up to two weeks to evaluate. We developed a diagnostic cleaved amplified polymorphic sequence method, CAPS, to detect individuals with alleles for strong resistance to phosphine in populations of the red flour beetle, Tribolium castaneum, and the lesser grain borer, Rhyzopertha dominica, according to a single nucleotide mutation in the dihydrolipoamide dehydrogenase (DLD) gene. We initially isolated and sequenced the DLD genes from susceptible and strongly resistant populations of both species. The corresponding amino acid sequences were then deduced. A single amino acid mutation in DLD in populations of T. castaneum and R. dominica with strong resistance was identified as P45S in T. castaneum and P49S in R. dominica, both collected from northern Oklahoma, USA. PCR products containing these mutations were digested by the restriction enzymes MboI and BstNI, which revealed presence or absence, respectively of the resistant (R) allele and allowed inference of genotypes with that allele. Seven populations of T. castaneum from Kansas were subjected to discriminating dose bioassays for the weak and strong resistance phenotypes. Application of CAPS to these seven populations confirmed the R allele was in high frequency in the strongly resistant populations, and was absent or at a lower frequency in populations with weak resistance, which suggests that these populations with a low frequency of the R allele have the potential for selection of the strong resistance phenotype. CAPS markers for strong phosphine resistance will help to detect and confirm resistant beetles and can facilitate resistance management actions against a given pest population.	[Chen, Zhaorigetu; Phillips, Thomas W.] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Schlipalius, David] Agri Sci Queensland, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia; [Opit, George] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Subramanyam, Bhadriraju] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Chen, Zhaorigetu; Schlipalius, David; Subramanyam, Bhadriraju; Phillips, Thomas W.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia	Kansas State University; Queensland Department of Agriculture & Fisheries; Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University	Phillips, TW (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	twp1@ksu.edu			Kansas State University; Oklahoma State University; Agri-Science Queensland; Australian Government's Plant Biosecurity Cooperative Research Centre Program	Kansas State University; Oklahoma State University; Agri-Science Queensland; Australian Government's Plant Biosecurity Cooperative Research Centre Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by Kansas State University, Oklahoma State University, Agri-Science Queensland and the Australian Government's Plant Biosecurity Cooperative Research Centre Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acda MA, 2000, LIFE SCI, V9, P103; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; [Anonymous], KSRE PUBL S; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Daglish GJ, 1999, STORED PRODUCT PROTE, P584; Emery R. N., 2011, Stewart Postharvest Review, V7, P6, DOI 10.2212/spr.2011.3.8; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kaur R, 2013, PEST MANAG SCI, V69, P685, DOI 10.1002/ps.3514; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Opit GP, 2012, J ECON ENTOMOL, V105, P1107, DOI 10.1603/EC12064; Opit G. P., 2012, STORED PRODUCT PROTE, VS156, P352; RAJENDRAN S, 1992, B ENTOMOL RES, V82, P119, DOI 10.1017/S000748530005152X; REN YL, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P173; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2012, SCIENCE, V338, P807, DOI 10.1126/science.1224951; Schlipalius DI, 2002, GENETICS, V161, P773; Sehgal B, 2013, J ECON ENTOMOL, V106, P1911, DOI 10.1603/EC13083; Tyler P. S., 1983, International Pest Control, V25, P10; Yeam I, 2005, THEOR APPL GENET, V112, P178, DOI 10.1007/s00122-005-0120-2; ZETTLER JL, 1990, J ECON ENTOMOL, V83, P1677, DOI 10.1093/jee/83.5.1677	21	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121343	10.1371/journal.pone.0121343	http://dx.doi.org/10.1371/journal.pone.0121343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826251	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800042
J	Egge, JJD; Hagbo, TJ				Egge, Jacob J. D.; Hagbo, Taylor J.			Comparative Phylogeography of Mississippi Embayment Fishes	PLOS ONE			English	Article							CYTOCHROME-B; INTRASPECIFIC PHYLOGEOGRAPHY; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; CATFISHES SILURIFORMES; BULLHEAD CATFISHES; UNITED-STATES; NORTH-AMERICA; TELEOSTEI; DIVERSIFICATION	The Mississippi Embayment is a prominent physiographic feature of eastern North America consisting of primarily lowland aquatic habitats and a fish fauna that is largely distinct from nearby highland regions. Numerous studies have demonstrated that both pre-Pleistocene and Pleistocene events have had a strong influence on the distributions and relationships of highland fishes in eastern North America. However, the extent to which these same events affected Embayment distributed taxa remains largely unexplored. The purpose of this study was to investigate the relative roles of pre-Pleistocene and Pleistocene events in shaping phylogeographic relationships of four stream dwelling fishes in the Mississippi Embayment. Molecular genetic analyses of the mitochondrial gene cytochrome b were performed for three ictalurid catfish species (Noturus miurus, n = 67; Noturus hildebrandi, n = 93, and Noturus phaeus, n = 44) and one minnow species (Cyprinella camura, n = 78), all distributed in tributary streams of the Mississippi Embayment. Phylogenetic relationships and divergence times among haplotypes for each species were estimated using maximum likelihood and Bayesian methods. Phylogenetic analyses recovered 6 major haplotype clades within N. miurus, 5 within N. hildbrandi, 8 within N. phaeus, and 8 within C. camura. All three Noturus species show a high degree of isolation by drainage, which is less evident in C. camura. A clade of haplotypes from tributaries in the southern portion of the Mississippi Embayment was consistently recovered in all four species. Divergence times among clades spanned the Pleistocene, Pliocene, and Miocene. Novel relationships presented here for C. camura and N. phaeus suggest the potential for cryptic species. Pre-Pleistocene and Pleistocene era sea level fluctuations coincide with some divergence events, but no single event explains any common divergence across all taxa. Like their highland relatives, a combination of both pre-Pleistocene and Pleistocene era events have driven divergences among Embayment lineages.	[Egge, Jacob J. D.; Hagbo, Taylor J.] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA	Pacific Lutheran University	Egge, JJD (corresponding author), Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA.	eggejj@plu.edu			M. J. Murdock College Research Program for Life Sciences [2008358:JVZ:2/26/2009]; Pacific Lutheran University Division of Natural Sciences Undergraduate Research Program	M. J. Murdock College Research Program for Life Sciences; Pacific Lutheran University Division of Natural Sciences Undergraduate Research Program	Funding for this project was provided by a grant from the M. J. Murdock College Research Program for Life Sciences (2008358:JVZ:2/26/2009) to JJDE. Additional funding for JJDE and TJH was provided by the Pacific Lutheran University Division of Natural Sciences Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; BENNETT D K, 1979, Transactions of the Kansas Academy of Science, V82, P146, DOI 10.2307/3627406; Berendzen PB, 2010, J FISH BIOL, V77, P1114, DOI 10.1111/j.1095-8649.2010.02769.x; Berendzen PB, 2008, J FISH BIOL, V73, P2021, DOI 10.1111/j.1095-8649.2008.02046.x; Berendzen PB, 2003, J BIOGEOGR, V30, P1139, DOI 10.1046/j.1365-2699.2003.00888.x; Blanton RE, 2013, MOL PHYLOGENET EVOL, V66, P679, DOI 10.1016/j.ympev.2012.10.022; Blum M, 2014, GEOLOGY, V42, P607, DOI 10.1130/G35513.1; Burr B.M., 1986, P287; Chakona A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070953; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cox RT, 1997, ENG GEOL, V46, P201, DOI 10.1016/S0013-7952(97)00003-3; Cox RT, 2002, J GEODYN, V34, P163, DOI 10.1016/S0264-3707(02)00019-4; Divay JD, 2013, J VERTEBR PALEONTOL, V33, P1269, DOI 10.1080/02724634.2013.773334; Dowling TE, 2002, COPEIA, P665, DOI 10.1643/0045-8511(2002)002[0665:EROTPT]2.0.CO;2; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Egge JJD, 2015, J FISH BIOL, V86, P493, DOI 10.1111/jfb.12574; Egge JJD, 2009, ZOOL J LINN SOC-LOND, V155, P60, DOI 10.1111/j.1096-3642.2008.00432.x; Etnier DA, 2001, FISHES OF TENNESSEE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fisk H.N., 1944, GEOLOGICAL INVESTIGA; Halas D, 2014, MOL PHYLOGENET EVOL, V70, P13, DOI 10.1016/j.ympev.2013.08.014; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hardman M, 2004, MOL PHYLOGENET EVOL, V30, P395, DOI 10.1016/S1055-7903(03)00203-3; Hardman M, 2003, COPEIA, P20, DOI 10.1643/0045-8511(2003)003[0020:PRABCO]2.0.CO;2; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; Hocutt C.H., 1986, P161; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Ketmaier V, 2004, MOL PHYLOGENET EVOL, V32, P1061, DOI 10.1016/j.ympev.2004.04.008; Knouft JH, 2011, J BIOGEOGR, V38, P2259, DOI 10.1111/j.1365-2699.2011.02567.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lang NJ, 2011, SOUTHEAST NAT, V10, P133, DOI 10.1656/058.010.0111; Lundberg J.G., 1975, U MICHIGAN MUSEUM PA, V11, P1; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; Martin H, 2008, COPEIA, P579, DOI 10.1643/CG-06-291; MAYDEN RL, 1988, SYST ZOOL, V37, P329, DOI 10.2307/2992197; Miller M.A., 2010, P GAT COMP ENV WORKS; Nagle BC, 2012, MOL PHYLOGENET EVOL, V63, P639, DOI 10.1016/j.ympev.2012.02.013; Near TJ, 2004, EVOLUTION, V58, P2798; Near TJ, 2003, EVOLUTION, V57, P1610; Near TJ, 2001, MOL ECOL, V10, P2235, DOI 10.1046/j.1365-294X.2001.01362.x; Neff N.A., 1975, U MICHIGAN PAPERS PA, V12, P39; Ossian CR, 1973, MICHIGAN STATE U PAL, V1, P101; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Pflieger W.L., 1971, University of Kansas Publications of the Museum of Natural History, V20, P225; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Potter P.E., 2006, BRINGH YOUNG UNIV GE, V48, P1; Powers SL, 2003, COPEIA, P576, DOI 10.1643/CI-02-121R2; Powers SL, 2009, COPEIA, P523, DOI 10.1643/CI-08-047; Ray JM, 2006, J BIOGEOGR, V33, P1550, DOI 10.1111/j.1365-2699.2006.01540.x; RIGGS SR, 1984, SCIENCE, V223, P123, DOI 10.1126/science.223.4632.123; Robison H.W., 1986, P267; Ross ST, 2001, INLAND FISHES MISSIS; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Simons AM, 2003, ZOOL J LINN SOC-LOND, V139, P63, DOI 10.1046/j.1096-3642.2003.00076.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Swartz ER, 2007, J BIOGEOGR, V34, P2086, DOI 10.1111/j.1365-2699.2007.01768.x; Swift C.C., 1986, P213; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; Webb SA, 1998, THESIS U MICHIGAN; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545; Zwickl D.J., 2006, THESIS	69	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0116719	10.1371/journal.pone.0116719	http://dx.doi.org/10.1371/journal.pone.0116719			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826456	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084800001
J	Zhang, Q; Liu, HW; Sun, GL; Wilson, IW; Wu, JQ; Hoffman, A; Cheng, JW; Qiu, DY				Zhang, Qian; Liu, Hongwei; Sun, Guiling; Wilson, Iain W.; Wu, Jianqiang; Hoffman, Angela; Cheng, Junwen; Qiu, Deyou			Baseline Survey of Root-Associated Microbes of Taxus chinensis (Pilger) Rehd	PLOS ONE			English	Article							TAXOL-PRODUCING FUNGUS; ENDOPHYTIC FUNGI; BACTERIAL DIVERSITY; TAXANE PRODUCTION; X-MEDIA; PACLITAXEL; YEW; BIODIVERSITY; RHIZOSPHERE; CULTURES	Taxol (paclitaxel) a diterpenoid is one of the most effective anticancer drugs identified. Biosynthesis of taxol was considered restricted to the Taxus genera until Stierle et al. discovered that an endophytic fungus isolated from Taxus brevifolia could independently synthesize taxol. Little is known about the mechanism of taxol biosynthesis in microbes, but it has been speculated that its biosynthesis may differ from plants. The microbiome from the roots of Taxus chinensis have been extensively investigated with culture-dependent methods to identify taxol synthesizing microbes, but not using culture independent methods., Using bar-coded high-throughput sequencing in combination with a metagenomics approach, we surveyed the microbial diversity and gene composition of the root-associated microbiomefrom Taxus chinensis (Pilger) Rehd. High-throughput amplicon sequencing revealed 187 fungal OTUs which is higher than any previously reported fungal number identified with the culture-dependent method, suggesting that T. chinensis roots harbor novel and diverse fungi. Some operational taxonomic units (OTU) identified were identical to reported microbe strains possessing the ability to synthesis taxol and several genes previously associated with taxol biosynthesis were identified through metagenomics analysis.	[Zhang, Qian; Liu, Hongwei; Qiu, Deyou] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China; [Sun, Guiling; Wu, Jianqiang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming 650201, Peoples R China; [Wilson, Iain W.] CSIRO, Agr Flagship, Canberra, ACT 2001, Australia; [Hoffman, Angela] Univ Portland, Dept Chem, Portland, OR 97203 USA; [Cheng, Junwen] Zhejiang Forestry Acad, Key Lab Biol & Chem Utilizat Forest Resources, Hangzhou 310023, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Portland	Qiu, DY (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China.	peterqdy@aliyun.com	Wu, Jianqiang/A-7169-2019; Wilson, Iain/D-4839-2009	Wu, Jianqiang/0000-0002-7726-6216; Wilson, Iain/0000-0002-4626-8059	NSFC [31300105];  [CAFYBB2012042];  [2013SY17]	NSFC(National Natural Science Foundation of China (NSFC)); ; 	This work was supported by a grant for National non-profit Research Institutions of Chinese Academy of Forestry (CAFYBB2012042), NSFC grant 31300105 and a grant for the cooperation between Zhejiang Forrestry Academy and Chinese Academy of Forestry (2013SY17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARBUCK SG, 1995, TAXOL SCI APPL, P379; Axelrood PE, 2002, CAN J MICROBIOL, V48, P655, DOI [10.1139/w02-059, 10.1139/W02-059]; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caruso M, 2000, ANN MICROBIOL, V50, P3; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Filion M, 2004, APPL ENVIRON MICROB, V70, P3541, DOI 10.1128/AEM.70.6.3541-3551.2004; Flores-Bustamante ZR, 2010, J ANTIBIOT, V63, P460, DOI 10.1038/ja.2010.83; Hanson RL, 1997, BIOTECHNOL APPL BIOC, V26, P153; Hao DC, 2008, FEMS MICROBIOL LETT, V284, P204, DOI 10.1111/j.1574-6968.2008.01201.x; Huang WY, 2009, FUNGAL DIVERS, V36, P69; Kai Z, 2008, SCI CHINA SER C, V51, P222, DOI 10.1007/s11427-008-0037-5; Kang JiChuan, 2011, Mycosystema, V30, P168; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Kumaran RS, 2010, J BIOSCI BIOENG, V110, P541, DOI 10.1016/j.jbiosc.2010.06.007; Li JY, 1998, MYCOL RES, V102, P461, DOI 10.1017/S0953756297005078; Li YC, 2009, CELL BIOL INT, V33, P106, DOI 10.1016/j.cellbi.2008.10.007; Lin X, 2010, FUNGAL DIVERS, V41, P41, DOI 10.1007/s13225-010-0017-5; Liu KH, 2009, J IND MICROBIOL BIOT, V36, P1171, DOI 10.1007/s10295-009-0598-8; Lou Jing, 2011, Mycosystema, V30, P158; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Malik S, 2011, PROCESS BIOCHEM, V46, P23, DOI 10.1016/j.procbio.2010.09.004; Miao Z, 2009, APPL BIOCHEM MICRO+, V45, P81, DOI 10.1134/S0003683809010141; Mirjalili MH, 2012, FEMS MICROBIOL LETT, V328, P122, DOI 10.1111/j.1574-6968.2011.02488.x; Rivera-Orduna FN, 2011, FUNGAL DIVERS, V47, P65, DOI 10.1007/s13225-010-0045-1; Soliman SSM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-93; Soliman SSM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00003; Staniek A, 2009, PLANT MED, V75, P1; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel GA, 1996, J IND MICROBIOL BIOT, V17, P417, DOI 10.1007/BF01574772; Suffness M, 1995, TAXOL SCI APPL, P3; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; WALL ME, 1995, ACS SYM SER, V583, P18; Wang YC, 2007, FEMS MICROBIOL LETT, V273, P253, DOI 10.1111/j.1574-6968.2007.00801.x; Wang YT, 2008, BOT STUD, V49, P39; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Yang YF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-69; Zhang P, 2008, BIOTECHNOL LETT, V30, P2119, DOI 10.1007/s10529-008-9801-7; Zhang P, 2009, CURR MICROBIOL, V59, P227, DOI 10.1007/s00284-008-9270-1; Zhang P, 2009, FEMS MICROBIOL LETT, V293, P155, DOI 10.1111/j.1574-6968.2009.01481.x; Zhou X, 2007, APPL BIOCHEM MICRO+, V43, P439, DOI 10.1134/S000368380704014X; [No title captured], Patent No. 5561055	43	13	14	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123026	10.1371/journal.pone.0123026	http://dx.doi.org/10.1371/journal.pone.0123026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821956	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700212
J	Berl, REW; Hewlett, BS				Berl, Richard E. W.; Hewlett, Barry S.			Cultural Variation in the Use of Overimitation by the Aka and Ngandu of the Congo Basin	PLOS ONE			English	Article							MODEL-BASED BIASES; YOUNG-CHILDREN; NICHE CONSTRUCTION; PYGMY PHENOTYPE; OVER-IMITATION; TOOL USE; TRANSMISSION; EVOLUTION; KNOWLEDGE; AFRICAN	Studies in Western cultures have observed that both children and adults tend to overimitate, copying causally irrelevant actions in the presence of clear causal information. Investigation of this feature in non-Western groups has found little difference cross-culturally in the frequency or manner with which individuals overimitate. However, each of the non-Western populations studied thus far has a history of close interaction with Western cultures, such that they are now far removed from life in a hunter-gatherer or other small-scale culture. To investigate overimitation in a context of limited Western cultural influences, we conducted a study with the Aka hunter-gatherers and neighboring Ngandu horticulturalists of the Congo Basin rainforest in the southern Central African Republic. Aka children, Ngandu children, and Aka adults were presented with a reward retrieval task similar to those performed in previous studies, involving a demonstrated sequence of causally relevant and irrelevant actions. Aka children were found not to overimitate as expected, instead displaying one of the lowest rates of overimitation seen under similar conditions. Aka children copied fewer irrelevant actions than Aka adults, used a lower proportion of irrelevant actions than Ngandu children and Aka adults, and had less copying fidelity than Aka adults. Measures from Ngandu children were intermediate between the two Aka groups. Of the participants that succeeded in retrieving the reward, 60% of Aka children used emulation rather than imitation, compared to 15% of Ngandu children, 11% of Aka adults, and 0% of Western children of similar age. From these results, we conclude that cross-cultural variation exists in the use of overimitation during childhood. Further study is needed under a more diverse representation of cultural and socioeconomic groups in order to investigate the cognitive underpinnings of overimitation and its possible influences on social learning and the biological and cultural evolution of our species.	[Berl, Richard E. W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Hewlett, Barry S.] Washington State Univ, Dept Anthropol, Vancouver, WA USA	Washington State University; Washington State University	Berl, REW (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	richard.berl@wsu.edu	Berl, Richard/AAF-6172-2021	Berl, Richard/0000-0002-4154-1319	Washington State University NSF IGERT Program in Evolutionary Modeling; Japan Society for the Promotion of Science; College of Arts and Sciences at Washington State University, Vancouver; Grants-in-Aid for Scientific Research [22101003] Funding Source: KAKEN	Washington State University NSF IGERT Program in Evolutionary Modeling; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); College of Arts and Sciences at Washington State University, Vancouver; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: Work by REWB was funded through a fellowship with the Washington State University NSF IGERT Program in Evolutionary Modeling (http://ipem.anth.wsu.edu/). Work by BSH was funded by the Japan Society for the Promotion of Science (PI: Hideaki Terashima, Kobe Gakuin University; https://www.jsps.go.jp/english/). Funding for publication was provided by the College of Arts and Sciences at Washington State University, Vancouver (http://cas.vancouver.wsu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Levitt KM, 2003, LOCAL MEANINGS, GLOBAL SCHOOLING: ANTHROPOLOGY AND WORLD CULTURE THEORY, P1; Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; BAHUCHET S, 1993, MAN BIOSPH, V13, P37; Bauchet S., 2014, HUNTER GATHERERS CON, P1; Berndt RM, 1988, THE WORLD OF THE FIR; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Buchsbaum D, 2011, COGNITION, V120, P331, DOI 10.1016/j.cognition.2010.12.001; Buttelmann D, 2013, CHILD DEV, V84, P422, DOI 10.1111/j.1467-8624.2012.01860.x; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Carpenter M, 1998, INFANT BEHAV DEV, V21, P315, DOI 10.1016/S0163-6383(98)90009-1; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Flynn E, 2008, PHILOS T R SOC B, V363, P3541, DOI 10.1098/rstb.2008.0136; Flynn E, 2012, SOC PSYCHOL-GERMANY, V43, P185, DOI 10.1027/1864-9335/a000119; Gardiner AK, 2011, J COGN DEV, V12, P355, DOI 10.1080/15248372.2010.542216; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hewlett B. S., 1996, CULTURAL DIVERSITY 2, P215; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; HEWLETT BS, 1986, AM ANTHROPOL, V88, P922; Hewlett BS, 1998, DEV PSYCHOL, V34, P653, DOI 10.1037/0012-1649.34.4.653; HEWLETT BS, 1991, J ANTHROPOL RES, V47, P1; Hewlett BS, 2014, HUNTER GATHERERS OF; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Joiris D. V., 2003, AFRICAN STUDY MONOGR, P57; Laland KN, 2004, LEARN BEHAV, V32, P4; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lancy D. F., 2010, CHILDHOOD INT J, V3, P79, DOI 10.1179/cip.2010.3.1.79; Lancy DF, 2011, HUM NATURE-INT BIOS, V22, P281, DOI 10.1007/s12110-011-9117-5; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; Lyons DE, 2011, PHILOS T R SOC B, V366, P1158, DOI 10.1098/rstb.2010.0335; McGuigan N, 2007, COGNITIVE DEV, V22, P353, DOI 10.1016/j.cogdev.2007.01.001; McGuigan N, 2013, J EXP CHILD PSYCHOL, V116, P962, DOI 10.1016/j.jecp.2013.05.004; McGuigan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050863; McGuigan N, 2012, J COMP PSYCHOL, V126, P150, DOI 10.1037/a0025525; McGuigan N, 2011, BRIT J PSYCHOL, V102, P1, DOI 10.1348/000712610X493115; McGuigan N, 2009, J EXP CHILD PSYCHOL, V104, P367, DOI 10.1016/j.jecp.2009.07.001; Mesoudi A., 2011, CULTURAL EVOLUTION H, V6, P20; Mesoudi A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2209; Migliano AB, 2013, HUM BIOL, V85, P251, DOI 10.3378/027.085.0313; Nielsen M., 2010, DEV PSYCHOL, P153; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Nielsen M, 2014, CHILD DEV, V85, P2169, DOI 10.1111/cdev.12265; Nielsen M, 2012, J COMP PSYCHOL, V126, P170, DOI 10.1037/a0025168; Nielsen M, 2012, J EXP CHILD PSYCHOL, V112, P73, DOI 10.1016/j.jecp.2012.01.001; Nielsen M, 2011, DEV PSYCHOL, V47, P1050, DOI 10.1037/a0023866; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Nurse D, 2003, THE BANTU LANGUAGES; OGBU JU, 1993, INT J BEHAV DEV, V16, P483, DOI 10.1177/016502549301600307; OGBU JU, 1982, ANTHROPOL EDUC QUART, V13, P290, DOI 10.1525/aeq.1982.13.4.05x1505w; Over H, 2012, J COMP PSYCHOL, V126, P182, DOI 10.1037/a0024555; Partanen E, 2013, P NATL ACAD SCI USA, V110, P15145, DOI 10.1073/pnas.1302159110; Perry GH, 2014, P NATL ACAD SCI USA, V111, pE3596, DOI 10.1073/pnas.1402875111; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rendell L, 2011, TRENDS COGN SCI; Richerson P. J., 2005, NOT BY GENES ALONE H; Robins S, 2001, J S AFR STUD, V27, P833, DOI 10.1080/03057070120090763; Robins S, 2001, CONTRACT NO 2; Robins S, 2003, CURR ANTHROPOL, V44, P398; Shweder R.A., 1998, HDB CHILD PSYCHOL, V1, P865, DOI DOI 10.1002/9780470147658.CHPSY0113; Spindler GD., 1974, ED CULTURAL PROCESS, P279; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; WATSONGEGEO KA, 1992, ANTHROPOL EDUC QUART, V23, P10, DOI 10.1525/aeq.1992.23.1.05x1101i; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1998, J COMP PSYCHOL, V112, P270, DOI 10.1037/0735-7036.112.3.270; Whiten A., 2013, NAVIGATING SOCIAL WO, P150; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wood LA, 2013, DEV REV, V33, P341, DOI 10.1016/j.dr.2013.08.002; Wood LA, 2012, EVOL HUM BEHAV, V33, P387, DOI 10.1016/j.evolhumbehav.2011.11.010; Zmyj N, 2013, INFANT CHILD DEV, V22, P622, DOI 10.1002/icd.1811	75	66	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120180	10.1371/journal.pone.0120180	http://dx.doi.org/10.1371/journal.pone.0120180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816230	Green Published, gold			2022-12-27	WOS:000352133600029
J	Kasteridis, P; Mason, AR; Goddard, MK; Jacobs, R; Santos, R; McGonigal, G				Kasteridis, Panagiotis; Mason, Anne R.; Goddard, Maria K.; Jacobs, Rowena; Santos, Rita; McGonigal, Gerard			The Influence of Primary Care Quality on Hospital Admissions for People with Dementia in England: A Regression Analysis	PLOS ONE			English	Article							PERFORMANCE; PAY; UK; ASSOCIATION; MANAGEMENT; DISEASE	Objectives To test the impact of a UK pay-for-performance indicator, the Quality and Outcomes Framework (QOF) dementia review, on three types of hospital admission for people with dementia: emergency admissions where dementia was the primary diagnosis; emergency admissions for ambulatory care sensitive conditions (ACSCs); and elective admissions for cataract, hip replacement, hernia, prostate disease, or hearing loss. Methods Count data regression analyses of hospital admissions from 8,304 English general practices from 2006/7 to 2010/11. We identified relevant admissions from national Hospital Episode Statistics and aggregated them to practice level. We merged these with practice-level data on the QOF dementia review. In the base case, the exposure measure was the reported QOF register. As dementia is commonly under-diagnosed, we tested a predicted practice register based on consensus estimates. We adjusted for practice characteristics including measures of deprivation and uptake of a social benefit to purchase care services (Attendance Allowance). Results In the base case analysis, higher QOF achievement had no significant effect on any type of hospital admission. However, when the predicted register was used to account for underdiagnosis, a one-percentage point improvement in QOF achievement was associated with a small reduction in emergency admissions for both dementia (-0.1%; P=0.011) and ACSCs (-0.1%; P=0.001). In areas of greater deprivation, uptake of Attendance Allowance was consistently associated with significantly lower emergency admissions. In all analyses, practices with a higher proportion of nursing home patients had significantly lower admission rates for elective and emergency care. Conclusion In one of three analyses at practice level, the QOF review for dementia was associated with a small but significant reduction in unplanned hospital admissions. Given the rising prevalence of dementia, increasing pressures on acute hospital beds and poor outcomes associated with hospital stays for this patient group, this small change may be clinically and economically relevant.	[Kasteridis, Panagiotis; Mason, Anne R.; Goddard, Maria K.; Jacobs, Rowena; Santos, Rita] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [McGonigal, Gerard] York Teaching Hosp NHS Fdn Trust, Dept Med Elderly, York, N Yorkshire, England	University of York - UK	Kasteridis, P (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	panos.kasteridis@york.ac.uk		Mason, Anne/0000-0002-5823-3064; Santos, Rita/0000-0001-7953-1960; Goddard, Maria Karen/0000-0002-1517-7461; Jacobs, Rowena/0000-0001-5225-6321	Department of Health (England, UK) [103/0001]; National Institute for Health Research [PDA/02/06/038] Funding Source: researchfish	Department of Health (England, UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the Department of Health (England, UK) to the Policy Research Unit in the Economics of Social and Health Care [103/0001]. The funders have approved the manuscript for submission but had no role in the design or conduct of the study. The views expressed are those of the authors and not necessarily those of the funders.	Audit Commission, 2000, FORG ME NOT MENT HLT; Banerjee S, 2003, J NEUROL NEUROSUR PS, V74, P1315, DOI 10.1136/jnnp.74.9.1315; Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Bliss RL, 2012, MED CARE, V50, P99, DOI 10.1097/MLR.0b013e31822944d1; Bottle A, 2008, J GEN INTERN MED, V23, P135, DOI 10.1007/s11606-007-0390-2; Bottle A, 2008, J AMBUL CARE MANAG, V31, P226, DOI 10.1097/01.JAC.0000324668.83530.6d; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Cameron A., 1998, ECONOMETRIC SOC MONO; Care Quality Commission, 2013, STAT HLTH CAR AD SOC; Care Services Improvement Partnership, 2005, EV BUS INT MENT HLTH; Department of Health, 2013, DEM STAT NAT REP DEM; Department of Health, 2012, PRIM MIN CHALL DEM D; Department of Health, 2009, LIVING WELL DEMENTIA; Department of Health, 2011, OP FRAM NHS 2012 13; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Downing A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-166; Dusheiko M, 2009, GISRUK 2009 P GIS RE, P1; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Forder J, 2009, HEALTH ECON, V18, P1322, DOI 10.1002/hec.1438; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Gravelle H, 2010, ECON J, V120, pF129, DOI 10.1111/j.1468-0297.2009.02340.x; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; HSCIC Clinical Indicators Team, 2014, NHS OUTC FRAM 2014 1; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Knapp Martin, 2007, DEMENTIA UK; Lakey L., 2009, COUNTING COST CARING; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; National Institute for Health and Care Excellence, 2013, Q30 QUAL STAND SUPP; NHS England Urgent and Emergency Care Review Team, 2014, TRANSF URG EM CAR SE; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Purdy S, 2011, PUBLIC HEALTH, V125, P46, DOI 10.1016/j.puhe.2010.07.006; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Purdy S, 2010, AVOIDING HOSPITAL AD; Royal College of Psychiatrists, 2013, REP NAT AUD DEM CAR; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shohet C, 2007, SEIZURE-EUR J EPILEP, V16, P351, DOI 10.1016/j.seizure.2007.02.005; Soljak M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613142; Toot S, 2013, J AM MED DIR ASSOC, V14, P463, DOI 10.1016/j.jamda.2013.01.011; Vroomen JM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-10; World Health Organization Alzheimer's Disease International, 2012, ALZH DIS INT DEM PUB, DOI [10.1186/alzrt143, DOI 10.1186/ALZRT143]	42	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121506	10.1371/journal.pone.0121506	http://dx.doi.org/10.1371/journal.pone.0121506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816231	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600101
J	Liu, YY; Li, CP; Huai, MS; Fu, XM; Cui, Z; Fan, LL; Zhang, S; Liu, Y; Ma, J; Li, G; Shen, ZY				Liu, Yuan-Yuan; Li, Chang-Ping; Huai, Ming-Sheng; Fu, Xiao-Meng; Cui, Zhuang; Fan, Lin-Lin; Zhang, Shu; Liu, Yuan; Ma, Jun; Li, Guang; Shen, Zhong-Yang			Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ORGAN-TRANSPLANTATION; TUMOR RECURRENCE; RISK-FACTORS; GRAFT LOSS; TACROLIMUS; SIROLIMUS; IMPACT; BASILIXIMAB; WITHDRAWAL	The different choices of immunosuppression (IS) regimens influenced the outcomes of liver transplantation. Steroid was applied as a standard IS to prevent and treat rejections. However, steroid-related complications were increasingly prominent. This study compared the efficacy and safety of standard IS regimens with the efficacy and safety of steroid-free IS regimen and induction IS regimen in Chinese liver transplantation recipients for hepatocellular carcinoma (HCC). A total of 329 patients who underwent liver transplantation from January 2008 to December 2012 were retrospectively reviewed. Three different groups of patients received standard triple-drug IS regimen of steroid, tacrolimus (TAC) and mycophenolate mofetil (MMF) (triple-drug regimen group; n=57), induction-contained IS regimen of basiliximab, steroid, TAC and MMF (BS group; n=241), and induction-contained and steroid-free regimen of basiliximab, TAC and MMF (SF group; n=31), respectively. There were no significant differences in terms of patient, tumor-free and graft survival rates. The acute rejection rate and rejection time were equivalent in different groups. But compared with BS group, higher incidences of biliary complications (11.52% vs. 30.77%, p=0.013) and graft dysfunction (0.48% vs. 13.64%, p=0.003) were observed in SF group. Furthermore, compared with the two groups, incidence of pleural effusion was also higher in SF group (15.79%, 11.96% vs. 45.45%, respectively, both p<0.01). And a trend towards less proportion of De novo diabetes was revealed in SF group. Although it was found that patient, tumor-free and graft survival rates were equivalent among three IS regimens, higher incidences of complications were demonstrated in steroid-free regimen in patients for HCC. These findings suggested that steroid-free IS regimen has no clear advantages in comparison with standard IS regimens for liver transplant recipients with HCC and the postoperative complications should be treated with concentrated attention.	[Liu, Yuan-Yuan; Li, Chang-Ping; Fu, Xiao-Meng; Cui, Zhuang; Fan, Lin-Lin; Zhang, Shu; Ma, Jun] Tianjin Med Univ, Sch Publ Hlth, Dept Hlth Stat, Tianjin 300070, Peoples R China; [Huai, Ming-Sheng; Shen, Zhong-Yang] Tianjin First Ctr Hosp, Dept Transplantat, Tianjin 300192, Peoples R China; [Liu, Yuan] Tianjin First Ctr Hosp, Follow Up Ctr, Dept Transplantat, Tianjin 300192, Peoples R China; [Li, Guang] Tianjin Med Univ, Sch Basic Med, Dept Biol, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University	Ma, J (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Dept Hlth Stat, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	junma@tijmu.edu.cn; lig@tijmu.edu.cn	liu, yuanyuan/GWZ-5838-2022		National High Technology Research and Development Program of China [2012AA021003]; National Natural Science Foundation of China [71373175]; National Public Health Grand Research Foundation [201202017]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation	This study was supported by the National High Technology Research and Development Program of China (grant number: 2012AA021003), the National Natural Science Foundation of China (grant number: 71373175), and the National Public Health Grand Research Foundation (grant number: 201202017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex Bishop G, BEST PRACT RES CL GA, V26, P73; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Cai JC, 2010, TRANSPLANTATION, V90, P1511, DOI 10.1097/TP.0b013e3181fecfcb; Chan HLY, 2006, SEMIN LIVER DIS, V26, P153, DOI 10.1055/s-2006-939753; Chinnakotla S, 2009, LIVER TRANSPLANT, V15, P1834, DOI 10.1002/lt.21953; De Ruvo N, TRANSPLANT P, V37, P2607; Decaens T, 2006, WORLD J GASTROENTERO, V12, P7319, DOI 10.3748/wjg.v12.i45.7319; Demetris AJ, 1997, HEPATOLOGY, V25, P658; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geissler EK, 2008, AM J TRANSPLANT, V8, P2212, DOI 10.1111/j.1600-6143.2008.02391.x; Gras JM, 2008, LIVER TRANSPLANT, V14, P469, DOI 10.1002/lt.21397; Henry SD, 2007, ANN NY ACAD SCI, V1110, P439, DOI 10.1196/annals.1423.046; Klintmalm GB, 2011, LIVER TRANSPLANT, V17, P1394, DOI 10.1002/lt.22417; Liu CL, 2004, LIVER TRANSPLANT, V10, P728, DOI 10.1002/lt.20144; Llado L, 2008, LIVER TRANSPLANT, V14, P1752, DOI 10.1002/lt.21629; Lupo L, 2008, TRANSPLANTATION, V86, P925, DOI 10.1097/TP.0b013e318186b8a3; Miyagi S, 2012, TRANSPL P, V44, P797, DOI 10.1016/j.transproceed.2012.01.012; Opelz G, 2006, TRANSPLANTATION, V81, P1227, DOI 10.1097/01.tp.0000219817.18049.36; Pageaux GP, 2004, LIVER TRANSPLANT, V10, P1454, DOI 10.1002/lt.20291; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Ramirez CB, 2013, CLIN TRANSPLANT, V27, P463, DOI 10.1111/ctr.12119; Rodriguez-Peralvarez M, 2013, J HEPATOL, V59, P1193, DOI 10.1016/j.jhep.2013.07.012; SAAG KG, 1994, AM J MED, V96, P115, DOI 10.1016/0002-9343(94)90131-7; Sanchez-Fueyo A, 2011, LIVER TRANSPLANT, V17, pS69, DOI 10.1002/lt.22421; Scherer MN, 2007, LANGENBECK ARCH SURG, V392, P511, DOI 10.1007/s00423-007-0188-z; Schnitzbauer AA, 2011, TRANSPLANTATION, V91, P1173, DOI 10.1097/TP.0b013e318215e72b; Schnitzbauer AA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-190; STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009; Toso C, 2010, HEPATOLOGY, V51, P1237, DOI 10.1002/hep.23437; Turner AP, 2013, TRANSPL INT, V26, P673, DOI 10.1111/tri.12100; Uemura T, 2011, TRANSPL INT, V24, P640, DOI 10.1111/j.1432-2277.2011.01250.x; Vestergaard P, 2005, J INTERN MED, V257, P374, DOI 10.1111/j.1365-2796.2005.01467.x; Vivarelli M, 2005, LIVER TRANSPLANT, V11, P497, DOI 10.1002/lt.20391; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Vivarelli M, 2010, TRANSPLANTATION, V89, P227, DOI 10.1097/TP.0b013e3181c3c540; Watt KD, 2012, LIVER TRANSPLANT, V18, P1029, DOI 10.1002/lt.23479; Webster AC, 2010, COCHRANE DB SYST REV, V20; Xing TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071251; Chen ZS, 2007, WORLD J GASTROENTERO, V13, P5273, DOI 10.3748/wjg.v13.i39.5273; Zhou J, 2008, TRANSPL P, V40, P3548, DOI 10.1016/j.transproceed.2008.03.165	42	6	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120939	10.1371/journal.pone.0120939	http://dx.doi.org/10.1371/journal.pone.0120939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816221	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600052
J	Kwon, H; Crisostomo, AC; Smalls, HM; Finke, JM				Kwon, Hyewon; Crisostomo, Amanda C.; Smalls, Hayley Marie; Finke, John M.			Anti-A beta Oligomer IgG and Surface Sialic Acid in Intravenous Immunoglobulin: Measurement and Correlation with Clinical Outcomes in Alzheimer's Disease Treatment	PLOS ONE			English	Article							NATURALLY-OCCURRING AUTOANTIBODIES; FC-GAMMA-FRAGMENTS; AMYLOID-BETA; ANTIINFLAMMATORY ACTIVITY; BIOSENSOR TECHNOLOGY; PLASMON RESONANCE; HUMAN-ANTIBODIES; DOUBLE-BLIND; MOUSE MODEL; PROTEIN-A	The fraction of IgG antibodies with anti-oligomeric A beta affinity and surface sialic acid was compared between Octagam and Gammagard intravenous immunoglobulin (IVIG) using two complementary surface plasmon resonance methods. These comparisons were performed to identify if an elevated fraction existed in Gammagard, which reported small putative benefits in a recent Phase III clinical trial for Alzheimer's Disease. The fraction of anti-oligomeric A beta IgG was found to be higher in Octagam, for which no cognitive benefits were reported. The fraction and location of surface-accessible sialic acid in the Fab domain was found to be similar between Gammagard and Octagam. These findings indicate that anti-oligomeric A beta IgG and total surface sialic acid alone cannot account for reported clinical differences in the two IVIG products. A combined analysis of sialic acid in anti-oligomeric A beta IgG did reveal a notable finding that this subgroup exhibited a high degree of surface sialic acid lacking the conventional alpha 2,6 linkage. These results demonstrate that the IVIG antibodies used to engage oligomeric A beta in both Gammagard and Octagam clinical trials did not possess alpha 2,6-linked surface sialic acid at the time of administration. Anti-oligomeric A beta IgG with alpha 2,6 linkages remains untested as an AD treatment.	[Kwon, Hyewon] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Crisostomo, Amanda C.; Smalls, Hayley Marie; Finke, John M.] Univ Washington, Div Sci & Math, Tacoma, WA 98402 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Tacoma	Finke, JM (corresponding author), Univ Washington, Div Sci & Math, Tacoma, WA 98402 USA.	jfinke@u.washington.edu			M. J. Murdock Charitable Trust; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases	M. J. Murdock Charitable Trust; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported in part by a Partners in Science grant from the M. J. Murdock Charitable Trust (awarded to ACC and JMF) and a STEP-UP Fellowship from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (awarded to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anumula KR, 2012, J IMMUNOL METHODS, V382, P167, DOI 10.1016/j.jim.2012.05.022; Bacher M, 2009, NEUROSCI LETT, V449, P240, DOI 10.1016/j.neulet.2008.08.083; Balakrishnan K, 2010, J ALZHEIMERS DIS, V20, P135, DOI 10.3233/JAD-2010-1353; Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bee C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080501; Bee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036261; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Christensen LLH, 1997, ANAL BIOCHEM, V249, P153, DOI 10.1006/abio.1997.2182; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; DAS C, 1985, ANAL BIOCHEM, V145, P27, DOI 10.1016/0003-2697(85)90322-7; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2013, LANCET NEUROL, V12, P233, DOI 10.1016/S1474-4422(13)70014-0; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; HANSON DC, 1984, J IMMUNOL, V132, P1386; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Jendeberg L, 1997, J IMMUNOL METHODS, V201, P25, DOI 10.1016/S0022-1759(96)00215-3; Kasermann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037243; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kingwell Katie, 2011, Nat Rev Neurol, V7, P359, DOI 10.1038/nrneurol.2011.95; Klaver AC, 2013, IMMUNOL LETT, V154, P7, DOI 10.1016/j.imlet.2013.07.008; Klaver AC, 2010, J NEUROSCI METH, V187, P263, DOI 10.1016/j.jneumeth.2010.01.018; Klaver AC, 2010, INT IMMUNOPHARMACOL, V10, P115, DOI 10.1016/j.intimp.2009.10.005; Kyhos B, 2013, GAP 18 MONTH STUDY R; Lemere CA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-36; Linman MJ, 2008, ANAL CHEM, V80, P4007, DOI 10.1021/ac702566e; Loeffler DA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-70; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Ogata S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081448; Perdivara I, 2009, GLYCOBIOLOGY, V19, P958, DOI 10.1093/glycob/cwp038; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; RichaletSecordel PM, 1997, ANAL BIOCHEM, V249, P165, DOI 10.1006/abio.1997.2183; Rogez-Florent T, 2014, J MOL RECOGNIT, V27, P46, DOI 10.1002/jmr.2330; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Sigmundsson K, 2002, BIOCHEMISTRY-US, V41, P8263, DOI 10.1021/bi020099h; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Szabo P, 2010, J NEUROIMMUNOL, V227, P167, DOI 10.1016/j.jneuroim.2010.06.010; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler M, 2010, GERONTOLOGIST, V50, P449; Wu AM, 2007, GLYCOCONJUGATE J, V24, P591, DOI 10.1007/s10719-007-9063-y; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	66	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120420	10.1371/journal.pone.0120420	http://dx.doi.org/10.1371/journal.pone.0120420			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826319	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800016
J	Tritto, P; Palumbo, V; Micale, L; Marzulli, M; Bozzetti, MP; Specchia, V; Palumbo, G; Pimpinelli, S; Berloco, M				Tritto, Patrizia; Palumbo, Valeria; Micale, Lucia; Marzulli, Marco; Bozzetti, Maria Pia; Specchia, Valeria; Palumbo, Gioacchino; Pimpinelli, Sergio; Berloco, Maria			Loss of Pol32 in Drosophila melanogaster Causes Chromosome Instability and Suppresses Variegation	PLOS ONE			English	Article							DNA-POLYMERASE-DELTA; POSITION-EFFECT VARIEGATION; TRANSLESION SYNTHESIS; ACCESSORY SUBUNITS; CATALYTIC SUBUNIT; EXCISION-REPAIR; ABASIC SITES; ZETA; GENE; MUTATIONS	Pol32 is an accessory subunit of the replicative DNA Polymerase delta and of the translesion Polymerase zeta. Pol32 is involved in DNA replication, recombination and repair. Pol32's participation in high-and low-fidelity processes, together with the phenotypes arising from its disruption, imply multiple roles for this subunit within eukaryotic cells, not all of which have been fully elucidated. Using pol32 null mutants and two partial loss-of-function alleles pol32(rd1) and pol32(rds) in Drosophila melanogaster, we show that Pol32 plays an essential role in promoting genome stability. Pol32 is essential to ensure DNA replication in early embryogenesis and it participates in the repair of mitotic chromosome breakage. In addition we found that pol32 mutantssuppress position effect variegation, suggesting a role for Pol32 in chromatin architecture.	[Tritto, Patrizia; Palumbo, Gioacchino; Berloco, Maria] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Palumbo, Valeria] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Micale, Lucia] IRCCS Casa Sollievo Sofferenza, I-71013 San Giovanni Rotondo, Italy; [Marzulli, Marco] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Bozzetti, Maria Pia; Specchia, Valeria] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy; [Pimpinelli, Sergio] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Pimpinelli, Sergio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Salento; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Berloco, M (corresponding author), Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy.	mariafrancesca.berloco@uniba.it	Micale, Lucia/K-3909-2016; Specchia, Valeria/AAS-8179-2020	Specchia, Valeria/0000-0002-1051-6014; Berloco, Maria/0000-0003-3826-8427; Palumbo, Valeria/0000-0002-7758-9891; Micale, Lucia/0000-0003-3604-194X	Universita degli Studi di Bari; Ministero dell'istruzione, dell'Universita e della ricerca; Epigenomics Flagship Project EpiGen, of the Italian National Research Council	Universita degli Studi di Bari; Ministero dell'istruzione, dell'Universita e della ricerca(Ministry of Education, Universities and Research (MIUR)); Epigenomics Flagship Project EpiGen, of the Italian National Research Council	This work was supported by leftover of grants from Universita degli Studi di Bari and Ministero dell'istruzione, dell'Universita e della ricerca. This work was also supported by the Epigenomics Flagship Project EpiGen, of the Italian National Research Council (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, GENE DISRUPTION PROJ; AOYAGI N, 1994, J BIOL CHEM, V269, P6045; Ashburner M, 1999, GENETICS, V153, P179; Auerbach PA, 2010, MUTAGENESIS, V25, P63, DOI 10.1093/mutage/gep045; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Chan K, 2013, DNA REPAIR, V12, P878, DOI 10.1016/j.dnarep.2013.07.008; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; DIMITRI P, 1989, GENETICS, V122, P793; Doheny JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003864; Dronamraju R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025439; Eeken JCJ, 2001, MUTAT RES-DNA REPAIR, V485, P237, DOI 10.1016/S0921-8777(01)00062-3; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; GEHRING WJ, 1984, EMBO J, V3, P2077, DOI 10.1002/j.1460-2075.1984.tb02094.x; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; Gray FC, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-21; Hanna M, 2007, MUTAT RES-FUND MOL M, V625, P164, DOI 10.1016/j.mrfmmm.2007.06.008; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HAWLEY RS, 1983, GENETICS, V104, P63; HAWLEY RS, 1985, P NATL ACAD SCI USA, V82, P8095, DOI 10.1073/pnas.82.23.8095; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; HENIKOFF S, 1989, P NATL ACAD SCI USA, V86, P6704, DOI 10.1073/pnas.86.17.6704; Houseley J, 2011, NUCLEIC ACIDS RES, V39, P8778, DOI 10.1093/nar/gkr589; Huang ME, 2002, GENETICS, V160, P1409; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kanel DP, 2012, PLOS GENET, V8, P447, DOI 10.1371/journal.pgen.1002659; Langston LD, 2012, P NATL ACAD SCI USA, V109, P12268, DOI 10.1073/pnas.1209533109; Lawrence CW, 1996, CANCER SURV, V28, P21; Lindsley DL, 1992, THE GENOME OF DROSOP; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Lynch CJ, 1919, GENETICS, V4, P501; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Mintseris J, 2009, DPIM THE DROSOPHILA; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; MOHAN J, 1970, DEV BIOL, V22, P495, DOI 10.1016/0012-1606(70)90165-X; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; PALUMBO G, 1994, GENETICS, V138, P1181; Polo SE, 2007, M S-MED SCI, V23, P29, DOI 10.1051/medsci/200723129; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prindle MJ, 2012, ENVIRON MOL MUTAGEN, V53, P666, DOI 10.1002/em.21745; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Reynolds N, 1999, GENE, V230, P15, DOI 10.1016/S0378-1119(99)00058-X; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 1989, MOLECULAR CLONING A; SINCLAIR DAR, 1989, MOL GEN GENET, V216, P328, DOI 10.1007/BF00334372; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Spofford J., 1976, GENET BIOL DROSOPHIL, VVolume 1, P955; STELLER H, 1986, MOL CELL BIOL, V6, P1640, DOI 10.1128/MCB.6.5.1640; Takeuchi R, 2006, J BIOL CHEM, V281, P11577, DOI 10.1074/jbc.M512959200; Tosal L, 2001, MOL GENET GENOMICS, V265, P327, DOI 10.1007/s004380000419; Uchimura A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004184; Vincent S, 1996, DEVELOPMENT, V122, P131; VOGEL E, 1979, MUTAT RES, V62, P51, DOI 10.1016/0027-5107(79)90223-9; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Zuo SJ, 1997, P NATL ACAD SCI USA, V94, P11244, DOI 10.1073/pnas.94.21.11244	66	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120859	10.1371/journal.pone.0120859	http://dx.doi.org/10.1371/journal.pone.0120859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826374	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000352084800027
J	Ahmad, F; Ding, WM; Qishuo, DS; Hussain, M; Jabran, K				Ahmad, Fiaz; Ding Weimin; Ding Qishuo; Hussain, Mubshar; Jabran, Khawar			Forces and Straw Cutting Performance of Double Disc Furrow Opener in No-Till Paddy Soil	PLOS ONE			English	Article							WHEAT; SEED; RESIDUE; DRILL; MANAGEMENT; COULTERS; FAILURE; IMPACTS; SYSTEMS; DRAFT	Conservation tillage is an energy efficient and low cost tillage system to improve soil environment compared with conventional tillage systems. However, the rice residue management becomes an "impossible to achieve" task due to high soil moisture content at harvest time and the thickness of rice straw. Disc type furrow openers are used for both seed drilling as well as straw cutting during no tillage sowing. A study was conducted to evaluate the draft requirement and straw cutting performances of different sized furrow openers in no-till paddy soil conditions. Double disc furrow opener was tested on an in-field traction bench for three working depths, i.e. 30, 60 and 90 mm, and three forwarding speeds, i.e. 0.1, 0.2 and 0.3 m/s. The draft and vertical forces on the disc were recorded with load cells. These sensors were connected to a data acquisition system developed with hardware and software. The results revealed that the size of the furrow opener, operating depth and the forwarding speed had significant effects (P< 0.05) on the horizontal and vertical forces, and the straw cutting performance. Mean values of the draft were 648.9, 737.2 and 784.6 N for the opener with diameters of 330, 450 and 600 mm respectively, and the vertical forces for similar openers were 904.7, 1553.9 and 1620.4 N, respectively. Furthermore, the mean straw cutting efficiencies for the double disc opener with diameters of 330, 450 and 600 mm were 39.36, 78.47 and 65.46%, respectively. The opener with 450 mm diameter provided higher straw cutting efficiency as compared to 600 mm diameter disc, while lowest straw cutting efficiency was observed with 330 mm diameter disc. The 450 mm diameter opener provided the highest straw cutting efficiency (88.6%) at 90 mm working depth and expressed optimum performance compared with other furrow openers.	[Ahmad, Fiaz; Ding Weimin; Ding Qishuo] Nanjing Agr Univ, Coll Engn, Key Lab Intelligent Agr Equipment Jiangsu Prov, Nanjing 210031, Jiangsu, Peoples R China; [Ahmad, Fiaz; Hussain, Mubshar] Bahauddin Zakeriya Univ, Coll Agr, Multan, Pakistan; [Jabran, Khawar] Adnan Menderes Univ, Dept Plant Protect, Aydin, Turkey; [Jabran, Khawar] Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan	Nanjing Agricultural University; Adnan Menderes University; University of Agriculture Faisalabad	Ding, WM (corresponding author), Nanjing Agr Univ, Coll Engn, Key Lab Intelligent Agr Equipment Jiangsu Prov, Nanjing 210031, Jiangsu, Peoples R China.	wmding@njau.edu.cn	Hussain, Mubshar/O-7848-2017; Jabran, Khawar/B-4679-2012; AHMAD, FIAZ/Z-1307-2019	Jabran, Khawar/0000-0001-8512-3330; Ahmad, Fiaz/0000-0002-3304-8663	HEC, Pakistan; National Science and Technology Support Program [2013BAD08B04]; National Natural Science Foundation of China [41371238]	HEC, Pakistan(Higher Education Commission of Pakistan); National Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This manuscript represents a portion of a PhD research by the first author. Thanks to the HEC, Pakistan for providing PhD Scholarship to the first author. Additionally, the work was sponsored by the National Science and Technology Support Program (2013BAD08B04) and the National Natural Science Foundation of China (Grant No. 41371238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altikat S, 2013, SOIL TILL RES, V126, P72, DOI 10.1016/j.still.2012.07.013; Baker CJ, 1996, CAB INT, V1937, P245; Bianchini A, 2008, BIOSYST ENG, V100, P370, DOI 10.1016/j.biosystemseng.2008.04.012; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Bouyoucos GJ, 1927, SOIL SCI, V23, P343, DOI 10.1097/00010694-192705000-00002; Bowman G. M., 2002, Soil physical measurement and interpretation for land evaluation, P224; CARTER MR, 1994, SOIL TILL RES, V31, P289, DOI 10.1016/0167-1987(94)90037-X; Carter MR, 2002, AGRON J, V94, P38, DOI 10.2134/agronj2002.0038; Chaudhuri D, 2001, J AGR ENG RES, V79, P125, DOI 10.1006/jaer.2000.0688; Chen Y, 2004, SOIL TILL RES, V77, P147, DOI 10.1016/j.still.2003.12.001; CHOI CH, 1986, T ASAE, V29, P1530; DARMORA DP, 1995, SOIL TILL RES, V34, P127, DOI 10.1016/0167-1987(94)00452-K; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Doan V., 2005, Canadian Biosystems Engineering, V47; Doan V., 2005, Canadian Biosystems Engineering, V47; Endrerud HC, 1999, J AGR ENG RES, V74, P391, DOI 10.1006/jaer.1999.0477; Erenstein O, 2008, SOIL TILL RES, V100, P1, DOI 10.1016/j.still.2008.05.001; Erenstem O, 2008, FIELD CROP RES, V105, P240, DOI 10.1016/j.fcr.2007.10.010; Farooq M, 2011, SOIL TILL RES, V117, P172, DOI 10.1016/j.still.2011.10.001; Farooq M, 2008, P 14 AUSTR AGR C GLO; Farooq M, 2014, SOIL TILL RES, V141, P1, DOI 10.1016/j.still.2014.03.012; Farooq M, 2008, PADDY WATER ENVIRON, V6, P397, DOI 10.1007/s10333-008-0138-6; Fredlund D.G., 2002, SOIL SCI SOC AM BOOK, V5, P329; Godwin RJ, 2007, SOIL TILL RES, V97, P331, DOI 10.1016/j.still.2006.06.010; Gupta R, 2007, CROP PROT, V26, P436, DOI 10.1016/j.cropro.2006.04.030; Hasimu A, 2014, SOIL TILL RES, V140, P48, DOI 10.1016/j.still.2014.02.011; Hemmat A, 2008, SOIL TILL RES, V98, P150, DOI 10.1016/j.still.2007.11.003; Iqbal M, 2012, INT J AGRIC BIOL, V14, P633; Janelle L, 1995, 931561 ASAE; Karayel D, 2007, SOIL TILL RES, V95, P69, DOI 10.1016/j.still.2006.11.001; Karayel D., 2011, Zemes Ukio Inzinerija, Mokslo Darbai, V43, P16; Kukal SS, 2003, SOIL TILL RES, V72, P1, DOI 10.1016/S0167-1987(03)00093-X; KUSHWAHA RL, 1986, CAN AGR ENG, V28, P85; Lal R, 2004, SOIL SCI, V304, P1613; Magalhaes PSG, 2007, BIOSYST ENG, V96, P193, DOI 10.1016/j.biosystemseng.2006.10.014; Magana SGC, 1994, 941009 ASAE; McKyes E., 1985, Soil cutting and tillage., p217pp; Mohanty M, 2007, SOIL TILL RES, V92, P243, DOI 10.1016/j.still.2006.03.005; Munir MA, 2012, PAK J AGR SCI, V49, P349; Parent G, 1993, 931562 ASAE; Rajaram G, 1987, THESIS ASIAN I TECHN; Sahu RK, 2006, SOIL TILL RES, V90, P144, DOI 10.1016/j.still.2005.08.015; Sarauskis E., 2013, Bulgarian Journal of Agricultural Science, V19, P620; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Tagar AA, 2014, SOIL TILL RES, V137, P58, DOI 10.1016/j.still.2013.12.001; Vamerali T, 2006, SOIL TILL RES, V89, P196, DOI 10.1016/j.still.2005.07.011	46	13	21	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119648	10.1371/journal.pone.0119648	http://dx.doi.org/10.1371/journal.pone.0119648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822984	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700041
J	Asikainen, S; Heikkinen, L; Juhila, J; Holm, F; Weltner, J; Trokovic, R; Mikkola, M; Toivonen, S; Balboa, D; Lampela, R; Icay, K; Tuuri, T; Otonkoski, T; Wong, G; Hovatta, O				Asikainen, Suvi; Heikkinen, Liisa; Juhila, Juuso; Holm, Frida; Weltner, Jere; Trokovic, Ras; Mikkola, Milla; Toivonen, Sanna; Balboa, Diego; Lampela, Riina; Icay, Katherine; Tuuri, Timo; Otonkoski, Timo; Wong, Garry; Hovatta, Outi			Selective MicroRNA-Offset RNA Expression in Human Embryonic Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MOUSE; DISCOVERY; MIRNAS; DICER; PLURIPOTENCY; NANOG; FIBROBLASTS; METASTASIS; TRANSITION	Small RNA molecules, including microRNAs (miRNAs), play critical roles in regulating pluri-potency, proliferation and differentiation of embryonic stem cells. miRNA-offset RNAs (moRNAs) are similar in length to miRNAs, align to miRNA precursor (pre-miRNA) loci and are therefore believed to derive from processing of the pre-miRNA hairpin sequence. Recent next generation sequencing (NGS) studies have reported the presence of moRNAs in human neurons and cancer cells and in several tissues in mouse, including pluripotent stem cells. In order to gain additional knowledge about human moRNAs and their putative development-related expression, we applied NGS of small RNAs in human embryonic stem cells (hESCs) and fibroblasts. We found that certain moRNA isoforms are notably expressed in hESCs from loci coding for stem cell-selective or cancer-related miRNA clusters. In contrast, we observed only sparse moRNAs in fibroblasts. Consistent with earlier findings, most of the observed moRNAs derived from conserved loci and their expression did not appear to correlate with the expression of the adjacent miRNAs. We provide here the first report of moRNAs in hESCs, and their expression profile in comparison to fibroblasts. Moreover, we expand the repertoire of hESC miRNAs. These findings provide an expansion on the known repertoire of small non-coding RNA contents in hESCs.	[Asikainen, Suvi; Holm, Frida; Lampela, Riina; Hovatta, Outi] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden; [Asikainen, Suvi; Juhila, Juuso; Weltner, Jere; Trokovic, Ras; Mikkola, Milla; Toivonen, Sanna; Balboa, Diego; Icay, Katherine; Tuuri, Timo; Otonkoski, Timo] Univ Helsinki, Mol Neurol & Biomedicum Stem Cell Ctr, Res Programs Unit, Helsinki 00014, Finland; [Heikkinen, Liisa; Wong, Garry] Univ Eastern Finland, AI Virtanen Inst, Kuopio 70211, Finland; [Heikkinen, Liisa] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Otonkoski, Timo] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki 00029, Finland; [Wong, Garry] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Karolinska Institutet; University of Helsinki; University of Eastern Finland; University of Jyvaskyla; University of Helsinki; Helsinki University Central Hospital; University of Macau	Asikainen, S (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, S-17177 Stockholm, Sweden.	suvi.asikainen@helsinki.fi	Trokovic, Ras/AAC-7309-2022	Trokovic, Ras/0000-0002-3065-6663; Asikainen, Suvi/0000-0002-2558-3711; Balboa, Diego/0000-0002-4784-5452	Academy of Finland; Biocenter Finland; Sigrid Juselius Foundation; Swedish Research Council	Academy of Finland(Academy of Finland); Biocenter Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by Academy of Finland, SA GW TO (http://www.aka.fi/ENG); Biocenter Finland, LH (http://www.biocenter.fi/); Sigrid Juselius Foundation, SA TO (http://www.sigridjuselius.fi/foundation); Swedish Research Council, OH (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ando Y, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-6; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen Z, 2013, J CLIN INVEST, V123, P1057, DOI 10.1172/JCI65344; Ding Y, 2012, ONCOL LETT, V3, P35, DOI 10.3892/ol.2011.438; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gaffo E, 2014, ANIM GENET, V45, P685, DOI 10.1111/age.12192; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laningschror P, 2013, BBA-MOL CELL RES, V1833, P1894, DOI 10.1016/j.bbamcr.2013.03.025; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li SC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S14; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Unger C, 2008, CURRENT PROTOCOLS IN, V1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	78	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0116668	10.1371/journal.pone.0116668	http://dx.doi.org/10.1371/journal.pone.0116668			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822230	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700004
J	Han, Y; Li, YJ; Xie, J; Qiu, ZF; Li, YL; Song, XJ; Zhu, T; Li, TS				Han, Yang; Li, Yijia; Xie, Jing; Qiu, Zhifeng; Li, Yanling; Song, Xiaojing; Zhu, Ting; Li, Taisheng			Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; RENAL-FUNCTION; INFECTED INDIVIDUALS; REGIMEN; MONOTHERAPY; RITONAVIR; TRANSMISSION; MULTICENTER; SUBTYPE; SAFETY	Background Tenofovir (TDF) and ritonavir-boosted lopinavir (LPV/r) were not introduced to China as second-line medications until 2009. The efficacy and safety of TDF/3TC/LPV/r based second-line regimen have not been evaluated in Chinese HIV patients who failed first-line regimens. Methods This was a multicenter cohort study recruiting patients from Beijing, Shanghai, Guangdong, and Henan provinces between November 2008 and January 2010. Eighty HIV infected patients failing first-line regimens with serum creatinine lower than 1.5 times the upper limit of normal received TDF+ lamivudine (3TC)+ LPV/r were followed up for 120 weeks. CD4 cell count, viral load, and estimated glomerular filtration rate (eGFR) were monitored at each visit. Results At baseline, 31.2% and 48.8% of patients had moderate/high-level resistance to TDF and 3TC, respectively; while 2.5% of patients had only low-level resistance to LPV/r. During 120 weeks of follow-up, virological suppression rate reached over 70% (< 40 copies/ml) and 90% (< 400 copies/ml), and median CD4 cell count increased from 157 cells/mu L at baseline to 307 cells/mu L at week 120. Baseline drug-resistance mutations had no impact on the efficacy of second-line antiretroviral therapy. Median eGFR dropped from 104.7 ml/min/1.73m(2) at baseline to 95.6 ml/min/1.73m(2) at week 24 and then recovered after week 96. Conclusion This study for the first time demonstrated that TDF+ 3TC+ LPV/r was efficacious as second-line regimen with acceptable nephrotoxicity profiles in patients who failed zidovudine or stavudine based first-line regimens in China.	[Han, Yang; Li, Yijia; Xie, Jing; Qiu, Zhifeng; Li, Yanling; Song, Xiaojing; Zhu, Ting; Li, Taisheng] Beijing Union Med Coll Hosp, Dept Infect Dis, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, TS (corresponding author), Beijing Union Med Coll Hosp, Dept Infect Dis, Beijing, Peoples R China.	litsh@263.net	li, yan/GTI-4638-2022; Li, Yijia/AAD-6744-2022; han, yang/GRS-2388-2022	Li, Yijia/0000-0001-5300-0571; Li, Yijia/0000-0003-0513-1950	National Natural Science Foundation of China [81071372]; National Key Technologies R&D Program for the 12th Five-year Plan [2012ZX10001003-001]; Ministry of Health; Chinese Ministry of Human Resources and Social Security	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for the 12th Five-year Plan; Ministry of Health; Chinese Ministry of Human Resources and Social Security	Taisheng Li is currently receiving grants from National Natural Science Foundation of China [grant 81071372], National Key Technologies R&D Program for the 12th Five-year Plan [grant 2012ZX10001003-001], and Key Clinical Program of the Ministry of Health [2010-2012]; Jing Xie is currently receiving Grant of Chinese Ministry of Human Resources and Social Security [2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Campo RE, 2005, AIDS, V19, P447, DOI 10.1097/01.aids.0000161777.38438.ed; Cao Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-301; Ferradini L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-14; Fisher M, 2009, JAIDS-J ACQ IMM DEF, V51, P562, DOI 10.1097/QAI.0b013e3181ae2eb9; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Jotwani V, 2012, AM J KIDNEY DIS, V59, P628, DOI 10.1053/j.ajkd.2011.10.050; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li TS, 2014, CHINESE MED J-PEKING, V127, P59, DOI 10.3760/cma.j.issn.0366-6999.20132557; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Li Y, 2014, J ACQUIR IMMUNE DEFI; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Lipscomb JT, 2014, J INFECT DIS, V210, P1827, DOI 10.1093/infdis/jiu333; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Martin M, 2014, CLIN INFECT DIS, V59, P716, DOI 10.1093/cid/ciu355; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Schooley RT, 2002, AIDS, V16, P1257, DOI 10.1097/00002030-200206140-00008; Solomon MM, 2014, AIDS, V28, P851, DOI 10.1097/QAD.0000000000000156; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; von Hentig N, 2012, EXPERT REV CLIN PHAR, V5, P557, DOI [10.1586/ECP.12.45, 10.1586/ecp.12.45]; WHO, 2010, ANT THER HIV INF AD; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	29	3	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120705	10.1371/journal.pone.0120705	http://dx.doi.org/10.1371/journal.pone.0120705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821963	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700072
J	Surkan, PJ; Charles, MK; Katz, J; Siegel, EH; Khatry, SK; LeClerq, SC; Stoltzfus, RJ; Tielsch, JM				Surkan, Pamela J.; Charles, Mary Katherine; Katz, Joanne; Siegel, Emily H.; Khatry, Subarna K.; LeClerq, Steven C.; Stoltzfus, Rebecca J.; Tielsch, James M.			The Role of Zinc and Iron-Folic Acid Supplementation on Early Child Temperament and Eating Behaviors in Rural Nepal: A Randomized Controlled Trial	PLOS ONE			English	Article							MATERNAL FEEDING PRACTICES; PRESCHOOL-CHILDREN; DEFICIENCY ANEMIA; SCHOOL-AGE; INFANTS; WEIGHT; POPULATION; PREGNANCY; GROWTH	Child eating behaviors play an important role in nutrient intake, ultimately affecting child growth and later outcomes in adulthood. The study assessed the effects of iron-folic acid and zinc supplementation on child temperament and child eating behaviors in rural Nepal. Children (N = 569) aged 4-17 months in Sarlahi district, southern Nepal were randomized to receive daily supplements of placebo, iron-folic acid, zinc, or zinc plus iron-folic acid and followed for approximately 1 year. At baseline and four follow-up visits mothers completed questionnaires including information on demographic characteristics and child temperament and eating behaviors. The main effects of zinc and iron-folic acid supplementation on temperament and eating behaviors were assessed through crude and adjusted differences in mean cumulative score changes between visits 1 and 5. The adjusted rate-of-change for these outcomes was modeled using generalized estimating equations. Mean changes in temperament scores and in eating behavior scores between visits 1 and 5 were not significant in either the zinc or non-zinc group. Children in the iron-folic acid group increased temperament scores by 0.37 points over 5 visits (95% CI 0.02, 0.7), which was not significant after adjustment. Neither the adjusted rate-of-change in temperament scores between zinc and non-zinc (beta = -0.03, 95% CI -0.3, 0.2) or iron-folic acid and non-iron-folic acid (beta = 0.08, 95% CI -0.2, 0.3) were significantly different. Adjusted rate of change analysis showed no significant difference between zinc and non-zinc (beta = -0.14, 95% CI -0.3, 0.04) or between iron and non-iron eating behavior scores (beta = -0.11, 95% CI -0.3, 0.1). Only among children with iron-deficiency anemia at baseline was there a significant decrease in eating behavior score, indicating better eating behaviors, when supplemented with zinc (beta = -0.3, 95% CI -0.6, -0.01), Ultimately, this effect of zinc on eating behaviors was the only effect we observed after approximately one year of micronutrient supplementation.	[Surkan, Pamela J.; Charles, Mary Katherine; Katz, Joanne; Siegel, Emily H.; Khatry, Subarna K.; LeClerq, Steven C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Charles, Mary Katherine] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Khatry, Subarna K.; LeClerq, Steven C.; Stoltzfus, Rebecca J.] Nepal Nutr Intervent Project Sarlahi, Hariaun, Nepal; [Stoltzfus, Rebecca J.] Cornell Univ, Program Int Nutr, Div Nutr Sci, Ithaca, NY USA; [Tielsch, James M.] George Washington Univ, Sch Publ Hlth, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; Cornell University; George Washington University	Surkan, PJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	psurkan@jhu.edu	Mireku, Michael/D-5262-2016	Katz, Joanne/0000-0002-5997-7823	National Institutes of Health, Bethesda, Maryland, United States of America [HD 38753]; Bill and Melinda Gates Foundation, Seattle, Washington, United States of America [810-2054]; Johns Hopkins University [HRN-A-00 -97-00015 -00]; Office of Health and Nutrition, United States Agency for International Development, Washington, District of Columbia, United States of America [HRN-A-00 -97-00015 -00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038753] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bill and Melinda Gates Foundation, Seattle, Washington, United States of America; Johns Hopkins University(Johns Hopkins University); Office of Health and Nutrition, United States Agency for International Development, Washington, District of Columbia, United States of America(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this study was received from grants from the National Institutes of Health, Bethesda, Maryland, United States of America (HD 38753), http://www.nih.gov/, Bill and Melinda Gates Foundation, Seattle, Washington, United States of America (810-2054), http://www.gatesfoundation.org/ and A Cooperative Agreement between Johns Hopkins University and the Office of Health and Nutrition, United States Agency for International Development, Washington, District of Columbia, United States of America (HRN-A-00 -97-00015 -00). The study sponsors did not have a role in study design, data collection, analysis, interpretation, or the writing of this report.	[Anonymous], 2008, J AM DIET ASSOC, V108, P1038, DOI 10.1016/j.jada.2008.04.005; Armony-Sivan R, 2010, J DEV BEHAV PEDIATR, V31, P326, DOI 10.1097/DBP.0b013e3181dc525d; Ashworth A, 1998, EUR J CLIN NUTR, V52, P223, DOI 10.1038/sj.ejcn.1600553; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Bentley ME, 1997, J NUTR, V127, P1333, DOI 10.1093/jn/127.7.1333; Benton D, 2008, EUR J NUTR, V47, P38, DOI 10.1007/s00394-008-3004-9; BITHONEY WG, 1987, J DEV BEHAV PEDIATR, V8, P32; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; CAREY WB, 1985, J DEV BEHAV PEDIATR, V6, P128; Corapci F, 2006, J DEV BEHAV PEDIATR, V27, P371, DOI 10.1097/00004703-200610000-00001; DiGirolamo AM, 2010, AM J CLIN NUTR, V92, P1241, DOI 10.3945/ajcn.2010.29686; Dongre AR, 2011, FOOD NUTR BULL, V32, P315, DOI 10.1177/156482651103200402; Dubois L, 2007, EUR J CLIN NUTR, V61, P846, DOI 10.1038/sj.ejcn.1602586; Georgieff MK, 2011, NUTR REV, V69, pS43, DOI 10.1111/j.1753-4887.2011.00432.x; Gupta S, 1999, PREV MED, V29, P152, DOI 10.1006/pmed.1999.0522; HAMBIDGE KM, 1972, PEDIATR RES, V6, P868, DOI 10.1203/00006450-197212000-00003; Haycraft E, 2011, APPETITE, V56, P689, DOI 10.1016/j.appet.2011.02.005; Hurley KM, 2011, HDB GROWTH MONITORIN; Khan Y, 2010, PEDIATR CLIN N AM, V57, P1409, DOI 10.1016/j.pcl.2010.09.016; KIRKSEY A, 1991, AM J CLIN NUTR, V54, P657, DOI 10.1093/ajcn/54.4.657; Lozoff B, 1987, Hematol Oncol Clin North Am, V1, P449; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff B, 2007, J NUTR, V137, P683, DOI 10.1093/jn/137.3.683; NAKAO H, 1990, APPETITE, V14, P45, DOI 10.1016/0195-6663(90)90053-B; OSKI FA, 1979, AM J DIS CHILD, V133, P315, DOI 10.1001/archpedi.1979.02130030091017; Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359; POLLITT E, 1976, J PEDIATR-US, V88, P372, DOI 10.1016/S0022-3476(76)80250-8; POLLITT E, 1986, AM J CLIN NUTR, V43, P555, DOI 10.1093/ajcn/43.4.555; Powell FC, 2011, APPETITE, V57, P683, DOI 10.1016/j.appet.2011.08.011; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; Sazawal S, 1996, PEDIATRICS, V98, P1132; Siegel EH, 2006, EUR J CLIN NUTR, V60, P228, DOI 10.1038/sj.ejcn.1602306; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Vaghri Z, 2011, BIOL TRACE ELEM RES, V143, P1398, DOI 10.1007/s12011-011-8999-8; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; Wachs TD, 2006, ANN NY ACAD SCI, V1094, P28, DOI 10.1196/annals.1376.004	38	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0114266	10.1371/journal.pone.0114266	http://dx.doi.org/10.1371/journal.pone.0114266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821959	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700002
J	Tahtouh, R; Azzi, AS; Alaaeddine, N; Chamat, S; Bouharoun-Tayoun, H; Wardi, L; Raad, I; Sarkis, R; Abou Antoun, N; Hilal, G				Tahtouh, Roula; Azzi, Anne-Sophie; Alaaeddine, Nada; Chamat, Soulaima; Bouharoun-Tayoun, Hasnaa; Wardi, Layal; Raad, Issam; Sarkis, Riad; Abou Antoun, Najibe; Hilal, George			Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study	PLOS ONE			English	Article							CATALYTIC SUBUNIT; CLINICAL-SIGNIFICANCE; TRANSCRIPTION FACTOR; OVER-EXPRESSION; ACIDIC PROTEIN; LIVER-DISEASE; ACTIVATION; GENE; CANCER; MIGRATION	Alpha-fetoprotein (AFP) is a diagnostic marker for hepatocellular carcinoma (HCC). A direct relationship between poor prognosis and the concentration of serum AFP has been observed. Telomerase, an enzyme that stabilizes the telomere length, is expressed by 90% of HCC. The aim of this study was to investigate the effect of telomerase inhibition on AFP secretion and the involvement of the PI3K/Akt/mTOR signaling pathway. Proliferation and viability tests were performed using tetrazolium salt. Apoptosis was determined through the Annexin V assay using flow cytometry. The concentrations of AFP were measured using ELISA kits. The AFP mRNA expression was evaluated using RTPCR, and cell migration was evaluated using a Boyden chamber assay. The in vivo effect of costunolide on AFP production was tested in NSG mice. Telomerase inhibition by costunolide and BIBR 1532 at 5 and 10 mu M decreased AFP mRNA expression and protein secretion by HepG2/C3A cells. The same pattern was obtained with cells treated with hTERT siRNA. This treatment exhibited no apoptotic effect. The AFP mRNA expression and protein secretion by PLC/PRF/5 was decreased after treatment with BIBR1532 at 10 mu M. In contrast, no effect was obtained for PLC/PRF/5 cells treated with costunolide at 5 or 10 mu M. Inhibition of the PI3K/Akt/mTOR signaling pathway decreased the AFP concentration. In contrast, the MAPK/ERK pathway appeared to not be involved in HepG2/C3A cells, whereas ERK inhibition decreased the AFP concentration in PLC/PRF/5 cells. Modulation of the AFP concentration was also obtained after the inhibition or activation of PKC. Costunolide (30 mg/kg) significantly decreased the AFP serum concentration of NSG mice bearing HepG2/C3A cells. Both the inhibition of telomerase and the inhibition of the PI3K/Akt/mTOR signaling pathway decreased the AFP production of HepG2/C3A and PLC/PRF/5 cells, suggesting a relationship between telomerase and AFP expression through the PI3K/Akt/mTOR pathway	[Tahtouh, Roula; Azzi, Anne-Sophie; Wardi, Layal; Hilal, George] St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon; [Alaaeddine, Nada] St Joseph Univ, Regenerat Med Lab, Fac Med, Beirut, Lebanon; [Chamat, Soulaima; Bouharoun-Tayoun, Hasnaa; Abou Antoun, Najibe] Lebanese Univ, Fac Hlth Sci, Fanar, Lebanon; [Raad, Issam] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Sarkis, Riad] St Joseph Univ, Fac Med, Beirut, Lebanon; [Sarkis, Riad] Hotel Dieu France, Dept Surg, Beirut, Lebanon	Lebanese University; University of Texas System; UTMD Anderson Cancer Center; American University of Beirut	Hilal, G (corresponding author), St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon.	george.hilal@usj.edu.lb	Tahtouh, Roula/ABD-4322-2020		Research Council of Saint-Joseph University; Lebanese National Council for Scientific Research (CNRS)	Research Council of Saint-Joseph University; Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported, in whole or in part, by the Research Council of Saint-Joseph University and the Lebanese National Council for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Akiyama M, 2002, CANCER RES, V62, P3876; Akiyama M, 1999, CANCER LETT, V142, P23, DOI 10.1016/S0304-3835(99)00109-3; Alava MA, 1999, TUMOR BIOL, V20, P52, DOI 10.1159/000056521; Alpert E., 1971, SERUM ALPHA FETOPROT; Apergis GA, 1998, J BIOL CHEM, V273, P2917, DOI 10.1074/jbc.273.5.2917; Bayati N, 1998, AM J GASTROENTEROL, V93, P2452, DOI 10.1111/j.1572-0241.1998.00703.x; Beaman JM, 2001, J MED SCREEN, V8, P128, DOI 10.1136/jms.8.3.128; BELAYEW A, 1982, MOL CELL BIOL, V2, P1427, DOI 10.1128/MCB.2.11.1427; Bialecki Eldad S, 2005, HPB (Oxford), V7, P26, DOI 10.1080/13651820410024049; BOISJOYEUX B, 1994, BIOCHEM J, V301, P49, DOI 10.1042/bj3010049; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Chang JT, 2006, BRIT J CANCER, V94, P870, DOI 10.1038/sj.bjc.6603008; Chen LT, 2009, J CLIN ONCOL, V27, pe271, DOI 10.1200/JCO.2009.23.8311; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Christiansen M, 2001, SCAND J CLIN LAB INV, V61, P205; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; CUCKLE HS, 1984, LANCET, V1, P926; Dessain SK, 2000, CANCER RES, V60, P537; Diamandis EP, 2002, TUMOR MARKERS PRIMAR, P269; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Gavory G, 2000, PNA OLIGONUCLEOTIDE; George J, 2010, INT J BIOCHEM CELL B, V42, P1164, DOI 10.1016/j.biocel.2010.04.002; Ghous Z, 2008, ANTICANCER RES, V28, P3757; GITLIN D, 1972, CANCER RES, V32, P979; Gregory JJ, 1999, DRUGS, V57, P463, DOI 10.2165/00003495-199957040-00001; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Hu KQ, 2004, AM J GASTROENTEROL, V99, P860, DOI 10.1111/j.1572-0241.2004.04152.x; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; KONDO F, 1989, HEPATOLOGY, V9, P751, DOI 10.1002/hep.1840090516; Kumar M, 2013, INT J CANCER, V132, P2032, DOI 10.1002/ijc.27880; Lee YS, 1998, ONCOL REP, V5, P1441; Li C, 1996, DNA CELL BIOL, V15, P955, DOI 10.1089/dna.1996.15.955; Li H, 1997, J BIOL CHEM, V272, P16729, DOI 10.1074/jbc.272.27.16729; Li MS, 2004, WORLD J GASTROENTERO, V10, P819; Li MS, 2011, INT J CANCER, V128, P524, DOI 10.1002/ijc.25373; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Miura N, 2003, ONCOLOGY-BASEL, V64, P430, DOI 10.1159/000070303; Mizejewski Gerald J, 2002, Expert Rev Anticancer Ther, V2, P709, DOI 10.1586/14737140.2.6.709; Mizejewski GJ, 2004, EXP BIOL MED, V229, P439, DOI 10.1177/153537020422900602; Mizejewski GJ, 2003, OBSTET GYNECOL SURV, V58, P804, DOI 10.1097/01.OGX.0000099770.97668.18; Mizejewski GJ, 2003, MOL CANCER THER, V2, P1243; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; Mottok A, 2007, BLOOD, V110, P3387, DOI 10.1182/blood-2007-03-082511; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; Page JM, 2009, CLIN LIVER DIS, V13, P631, DOI 10.1016/j.cld.2009.07.007; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Parvin Mehdipour, 2012, TELOMERE TERRITORY A; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Qu Y, 2008, MOL CELL BIOCHEM, V313, P45, DOI 10.1007/s11010-008-9740-6; Renne C, 2007, LEUKEMIA, V21, P780, DOI 10.1038/sj.leu.2404594; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Sato N, 2001, CANCER, V91, P496, DOI 10.1002/1097-0142(20010201)91:3<496::AID-CNCR1028>3.0.CO;2-0; Semenkova L, 2003, EUR J BIOCHEM, V270, P4388, DOI 10.1046/j.1432-1033.2003.03836.x; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Soresi M, 2003, ANTICANCER RES, V23, P1747; Terasaki M, 1999, INT J ONCOL, V14, P63; Torzilli Guido, 2004, Liver Transpl, V10, pS1, DOI 10.1002/lt.20032; Vaira V, 2011, AM J PATHOL, V178, P2478, DOI 10.1016/j.ajpath.2011.02.028; Vakharia D, 2000, BREAST CANCER RES TR, V63, P41, DOI 10.1023/A:1006484223325; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vo BT, 2013, ENDOCRINOLOGY, V154, P1768, DOI 10.1210/en.2012-2074; Vora SR, 2009, ONCOLOGIST, V14, P717, DOI 10.1634/theoncologist.2009-0038; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; WEN P, 1994, MOL CELL BIOL, V14, P6616, DOI 10.1128/MCB.14.10.6616; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xiao X, 2002, LEUKEMIA, V16, P1877, DOI 10.1038/sj.leu.2402607; Zheng L, 2014, TUMOR BIOL, V35, P4095, DOI 10.1007/s13277-013-1535-z	85	12	14	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119512	10.1371/journal.pone.0119512	http://dx.doi.org/10.1371/journal.pone.0119512			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822740	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700039
J	Zhang, XM; Wang, S; Li, S; Luo, C; Li, YX; Zhang, F				Zhang, Xiao-Man; Wang, Su; Li, Shu; Luo, Chen; Li, Yuan-Xi; Zhang, Fan			Comparison of the Antennal Sensilla Ultrastructure of Two Cryptic Species in Bemisia tabaci	PLOS ONE			English	Article							TRIALEURODES-VAPORARIORUM WESTWOOD; ALEYRODES PROLETELLA LINNAEUS; HYMENOPTERA; WHITEFLIES; HOMOPTERA; GENNADIUS; HEMIPTERA; BIOTYPES	Bemisia tabaci is an important agricultural pest with worldwide distribution and host preference. Therefore, understanding the biology of this pest is important to devise specific pest control strategies. The antennae of herbivorous insects play an important role in the identification of hosts using plant volatiles. To understand the features of antennae in B. tabaci MEAM 1(formerly known as biotype 'B') and MED (formerly known as biotype 'Q'), the morphology and distribution of the antennal sensilla were examined using scanning electron micrographs. The results showed that the average antennae length in MEAM 1 was longer than MED. No differences were observed in the number and distribution of antennal sensilla in MEAM 1 and MED antennae; each antenna had nine different types of sensilla. Both cryptic species possessed Microtrichia, Grooved surface trichodea sensilla, Chaetae sensilla, Coeloconic sensillaIandII, Basiconic sensilla I, II and III and Finger-like sensilla. This is the first report of Grooved surface trichodea sensilla and Basiconic sensilla II on B. tabaci flies. The numbers of Chaetae sensilla were different in the females and males of MEAM 1 and MED, which females having 5 and males containing 7. The surface structure of Basiconic sensilla I was different with MEAM 1 showing a multiple-pitted linen surface and MED showing a multiple-pitted pocking surface. Basiconic sensillaII were double in one socket with the longer one having a multiple-pitted surface and the shorter one with a smooth surface. Basiconic III and Finger-like sensillae were longer in MEAM 1 antennae than in MED antennae. Our results are expected to further the studies that link morphological characteristics to insect behavior and help devise strategies to control insect pests.	[Zhang, Xiao-Man; Wang, Su; Li, Shu; Luo, Chen; Zhang, Fan] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Zhang, Xiao-Man; Li, Yuan-Xi] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pest, Nanjing, Jiangsu, Peoples R China	Beijing Academy of Agriculture & Forestry; Nanjing Agricultural University	Luo, C (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	Luochen1010@126.com; Yxli@njau.edu.cn	wang, su/AAC-6313-2019		National Basic Research Program of China [2013CB127605]; National Natural Science Foundation of China [31471773]; earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System [blvt-13]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System	This study was supported partly by research grants from National Basic Research Program of China (2013CB127605), National Natural Science Foundation of China (31471773) and the earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System(blvt-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljunid SF, 1985, SAINS MALAYS, V14, P309; BEDFORD ID, 1994, ANN APPL BIOL, V125, P311, DOI 10.1111/j.1744-7348.1994.tb04972.x; Bink-Moenen R.M., 1983, Monografieen van de Nederlandse Entomologische Vereniging, V10, P1; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Domenichini G, 1982, MEM SOC ENTOMOL ITAL, V60, P169; Frazier J.L., 1985, P287; GILL RJ, 1990, WHITEFLIES : THEIR BIONOMICS, PEST STATUS AND MANAGEMENT, P13; GUPTA P C, 1972, Zoologische Beitraege, V18, P1; HALLBERG E, 1994, TISSUE CELL, V26, P489, DOI 10.1016/0040-8166(94)90002-7; HARBACH R E, 1976, International Journal of Insect Morphology and Embryology, V5, P23, DOI 10.1016/0020-7322(76)90019-2; HILL B G, 1969, Phytophylactica, V1, P127; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Hunger T, 1998, TISSUE CELL, V30, P14, DOI 10.1016/S0040-8166(98)80003-7; Isidoro N., 1996, Journal of Hymenoptera Research, V5, P206; Keil T.A., 1984, P477; Kireger J, 1999, SCIENCE, V283, P785; Li Zhu, 2010, Entomotaxonomia, V32, P113; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; Lin Kejian, 2007, Acta Phytophylacica Sinica, V34, P379; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; LOFTUS R, 1976, J COMP PHYSIOL, V111, P153, DOI 10.1007/BF00605530; Luo Chen, 2006, Shengwu Duoyangxing, V14, P333, DOI 10.1360/biodiv.050276; MELLOR HE, 1995, INT J INSECT MORPHOL, V24, P133, DOI 10.1016/0020-7322(94)00021-H; MELLOR HE, 1995, INT J INSECT MORPHOL, V24, P145, DOI 10.1016/0020-7322(95)93340-I; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Pophof B, 1997, PHYSIOL ENTOMOL, V22, P239, DOI 10.1111/j.1365-3032.1997.tb01164.x; Rebora M, 2008, ARTHROPOD STRUCT DEV, V37, P504, DOI 10.1016/j.asd.2008.03.003; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SLIFER ELEANOR H., 1957, J MORPH, V101, P359, DOI 10.1002/jmor.1051010207; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; Togni PHB, 2010, ENTOMOL EXP APPL, V136, P164, DOI 10.1111/j.1570-7458.2010.01010.x; VANVEEN JC, 1985, Z ANGEW ENTOMOL, V99, P511; VENARD R, 1991, J INSECT BEHAV, V4, P683, DOI 10.1007/BF01052225; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Zhang XM, 2014, MICRON, V67, P132, DOI 10.1016/j.micron.2014.07.011; Zhou H, 2013, MICRON, V44, P365, DOI 10.1016/j.micron.2012.09.001	40	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121820	10.1371/journal.pone.0121820	http://dx.doi.org/10.1371/journal.pone.0121820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822843	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700129
J	Barbany, M; Meyer, T; Hospital, A; Faustino, I; D'Abramo, M; Morata, J; Orozco, M; de la Cruz, X				Barbany, Montserrat; Meyer, Tim; Hospital, Adam; Faustino, Ignacio; D'Abramo, Marco; Morata, Jordi; Orozco, Modesto; de la Cruz, Xavier			Molecular Dynamics Study of Naturally Existing Cavity Couplings in Proteins	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; N-TERMINAL RESIDUES; CONFORMATIONAL STABILITY; HUMAN LYSOZYME; CRYSTAL-STRUCTURE; ALLOSTERIC REGULATION; LIGAND; RECOGNITION; SIMULATION; MOTIONS	Couplings between protein sub-structures are a common property of protein dynamics. Some of these couplings are especially interesting since they relate to function and its regulation. In this article we have studied the case of cavity couplings because cavities can host functional sites, allosteric sites, and are the locus of interactions with the cell milieu. We have divided this problem into two parts. In the first part, we have explored the presence of cavity couplings in the natural dynamics of 75 proteins, using 20 ns molecular dynamics simulations. For each of these proteins, we have obtained two trajectories around their native state. After applying a stringent filtering procedure, we found significant cavity correlations in 60% of the proteins. We analyze and discuss the structure origins of these correlations, including neighbourhood, cavity distance, etc. In the second part of our study, we have used longer simulations (>= 100ns) from the MoDEL project, to obtain a broader view of cavity couplings, particularly about their dependence on time. Using moving window computations we explored the fluctuations of cavity couplings along time, finding that these couplings could fluctuate substantially during the trajectory, reaching in several cases correlations above 0.25/0.5. In summary, we describe the structural origin and the variations with time of cavity couplings. We complete our work with a brief discussion of the biological implications of these results.	[Barbany, Montserrat; de la Cruz, Xavier] Vall dHebron Res Inst VHIR, Translat Bioinformat Neurosci, Barcelona, Spain; [Meyer, Tim] Max Planck Inst Biophys Chem, Theoret & Comp Gestutzte Biophys, D-37077 Gottingen, Germany; [Hospital, Adam; Faustino, Ignacio; Orozco, Modesto] BSC, Joint IRB Inst Res Biomed, Program Computat Biol, Barcelona, Spain; [D'Abramo, Marco] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Morata, Jordi] CRAG, Barcelona, Spain; [Orozco, Modesto] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [de la Cruz, Xavier] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Max Planck Society; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Sapienza University Rome; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; University of Barcelona; ICREA	de la Cruz, X (corresponding author), Vall dHebron Res Inst VHIR, Translat Bioinformat Neurosci, Barcelona, Spain.	xavier.delacruz@vhir.org	D'Abramo, Marco/B-7035-2008; Faustino, Ignacio/C-2545-2013; Meyer, Tim/ABC-1340-2020	D'Abramo, Marco/0000-0001-6020-8581; Faustino, Ignacio/0000-0002-7732-1692; Orozco Lopez, Modesto/0000-0002-8608-3278; De la Cruz Montserrat, Fco. Xavier/0000-0002-9738-8472; Meyer, Tim/0000-0002-0521-6711	Spanish Ministerio de Ciencia e Innovacion [BFU2009-11527]; Consejo Superior de Investigaciones Cientificas (CSIC) [200420E578]; Ministerio de Economia y Competitividad [BIO2012-40133, BIO2012-32868]; ScalaLife European Project; Spanish Red de Supercomputacion [BCV-2008-1-0012, BCV-2009-10003]; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (Spain) [CD08/00241]; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Economia y Competitividad(Spanish Government); ScalaLife European Project; Spanish Red de Supercomputacion; Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (Spain); ICREA(ICREA)	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for this work came from the Spanish Ministerio de Ciencia e Innovacion (grant BFU2009-11527), Consejo Superior de Investigaciones Cientificas (CSIC, grant 200420E578; www.csic.es), and Ministerio de Economia y Competitividad (BIO2012-40133 and BIO2012-32868; www.mineco.es). MO acknowledges economical support from the ScalaLife European Project (www.scalalife.eu). XD acknowledges support from the Spanish Red de Supercomputacion (www.bsc.es, projects BCV-2008-1-0012 and BCV-2009-10003). MB is the recipient of a Sara Borrell postdoctoral contract from the Ministerio de Sanidad y Consumo, Fondo de Investigacion Sanitaria (fellowship: CD08/00241, Spain). MO is an ICREA Academia Fellow (www.icrea.cat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2004, BIOCHEMISTRY-US, V43, P10605, DOI 10.1021/bi0495228; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Almeida PFF, 2005, BIOCHEMISTRY-US, V44, P10905, DOI 10.1021/bi050474g; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Amin EA, 2004, BIOPOLYMERS, V73, P205, DOI 10.1002/bip.10551; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barbany M, 2012, PROTEINS; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2005, CR BIOL, V328, P882, DOI 10.1016/j.crvi.2005.06.001; Bossa C, 2005, BIOPHYS J, V89, P465, DOI 10.1529/biophysj.104.055020; Boutard N, 2011, J PEPT SCI, V17, P288, DOI 10.1002/psc.1337; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Fenwick RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5070; Byrne SL, 2010, BIOCHEMISTRY-US, V49, P4200, DOI 10.1021/bi1003519; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chau PL, 1999, J COMPUT AID MOL DES, V13, P11, DOI 10.1023/A:1008099903676; CHIADMI M, 1993, STRUCTURE, V1, P283, DOI 10.1016/0969-2126(93)90016-A; Coiro VM, 2004, PROTEIN SCI, V13, P2979, DOI 10.1110/ps.04863104; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Coward P, 2009, ANAL BIOCHEM, V384, P312, DOI 10.1016/j.ab.2008.09.051; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Darbellay GA, 2000, ICA 2000, P69; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELACRUZ X, 1994, J MOL BIOL, V236, P1186, DOI 10.1016/0022-2836(94)90020-5; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Epps DE, 1997, CYTOKINE, V9, P149, DOI 10.1006/cyto.1996.0149; Falconi M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-73; Fernandez-Recio J, 2011, WIRES COMPUT MOL SCI, V1, P680, DOI 10.1002/wcms.45; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Funahashi J, 1999, PROTEIN ENG, V12, P841, DOI 10.1093/protein/12.10.841; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; Goda S, 2000, PROTEIN ENG, V13, P299, DOI 10.1093/protein/13.4.299; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harris WR, 2012, BBA-GEN SUBJECTS, V1820, P348, DOI 10.1016/j.bbagen.2011.07.017; HEYDUK T, 1991, J BIOL CHEM, V266, P15650; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Kortagere S, 2009, TRENDS PHARMACOL SCI, V30, P138, DOI 10.1016/j.tips.2008.12.001; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Lois S, 2010, EPIGENETICS-US, V5, P137, DOI 10.4161/epi.5.2.11079; Long D, 2012, J PHYS CHEM LETT, V3, P1722, DOI 10.1021/jz300488e; Lv MS, 2012, BIOCHEM BIOPH RES CO, V425, P938, DOI 10.1016/j.bbrc.2012.08.014; Marek T, 2008, ESTIMATION MUTUAL IN; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Meng WS, 2000, INT IMMUNOL, V12, P949, DOI 10.1093/intimm/12.7.949; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Montalvao RW, 2012, J BIOMOL NMR, V53, P281, DOI 10.1007/s10858-012-9644-3; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Muraki M, 1996, BIOCHEMISTRY-US, V35, P13562, DOI 10.1021/bi9613180; Noy A, 2006, J BIOMOL STRUCT DYN, V23, P447, DOI 10.1080/07391102.2006.10507070; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; Page RDM, 2002, MOL EVOLUTION PHYLOG; Panjkovich A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-273; Panjkovich A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-9; Perutz MF, 1992, PROTEIN STRUCTURE NE; Pesce A, 2008, METHOD ENZYMOL, V436, P303, DOI 10.1016/S0076-6879(08)36017-0; Piedra D, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-2; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002537; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; ROPP PA, 1991, J BIOL CHEM, V266, P7682; ROPP PA, 1991, ARCH BIOCHEM BIOPHYS, V288, P614, DOI 10.1016/0003-9861(91)90244-D; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Sygusch J, 1997, BIOCHEM J, V327, P717, DOI 10.1042/bj3270717; Takano K, 2000, BIOCHEMISTRY-US, V39, P12375, DOI 10.1021/bi000849s; Takano K, 1997, J MOL BIOL, V274, P132, DOI 10.1006/jmbi.1997.1365; Takano K, 1998, J MOL BIOL, V280, P749, DOI 10.1006/jmbi.1998.1906; Takano K, 1999, BIOCHEMISTRY-US, V38, P6623, DOI 10.1021/bi9901228; Takano K, 1999, PROTEIN ENG, V12, P663, DOI 10.1093/protein/12.8.663; Takano K, 1999, EUR J BIOCHEM, V266, P675, DOI 10.1046/j.1432-1327.1999.00918.x; Takano K, 2000, BIOCHEMISTRY-US, V39, P8655, DOI 10.1021/bi9928694; Turnay J, 2009, PROTEIN SCI, V18, P1095, DOI 10.1002/pro.119; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vasko RC, 2010, ACS MED CHEM LETT, V1, P4, DOI 10.1021/ml900003t; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Xu GZ, 2005, MOL CELL PROTEOMICS, V4, P1959, DOI 10.1074/mcp.M500095-MCP200	100	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119978	10.1371/journal.pone.0119978	http://dx.doi.org/10.1371/journal.pone.0119978			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816327	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600023
J	Chen, M; Zhu, Z; Huang, F; Liu, DL; Zhang, TG; Ying, D; Wu, J; Xu, WB				Chen, Meng; Zhu, Zhen; Huang, Fang; Liu, Donglei; Zhang, Tiegang; Ying, Deng; Wu, Jiang; Xu, Wenbo			Adenoviruses Associated with Acute Respiratory Diseases Reported in Beijing from 2011 to 2013	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BUENOS-AIRES; INFECTION; CHILDREN; EVOLUTION; IDENTIFICATION; RECOMBINATION; EMERGENCE; OUTBREAK; STRAINS	Background Adenovirus is one of the most common causes of viral acute respiratory infections. To identify the types of human adenoviruses (HAdVs) causing respiratory illness in Beijing, a sentinel surveillance project on the viral aetiology of acute respiratory infection was initiated in 2011. Principal findings Through the surveillance project, 4617 cases of respiratory infections were identified during 2011-2013. Throat swabs (pharynx and tonsil secretions) were collected from all the patients, and 15 different respiratory viruses were screened by multiplex one-step PCR method. 45 were identified as adenovirus-positive from sporadic and outbreak cases of respiratory infection by a multiplex one-step RT-PCR method, and a total of 21 adenovirus isolates were obtained. Five HAdV types among three species, including HAdV-3 (species HAdV-B), HAdV-4 (species HAdV-E), HAdV-7 (species HAdV-B), HAdV-55 (species HAdV-B), and an undefined HAdV type (species HAdV-C) were identified. The comparison results of the penton base, hexon, and fiber gene sequences of the Beijing HAdV-3, HAdV-4, HAdV-7, and HAdV-55 strains in this study and those from the GenBank database indicated significant spatial and temporal conservation and stability of sequences within the genome; however, the phylogenetic relationship indicated that both strain BJ04 and strain BJ09 isolated in 2012 and 2013, respectively, may have recombined between HAdV-1 genome and HAdV-2 genome within species HAdV-C, indicating intraspecies recombination. Conclusions This study confirmed that at least 5 HAdV types including HAdV-3, HAdV-4, HAdV-7, HAdV-55 and an undefined HAdV type were co-circulating and were the causative agents of respiratory tract infections in recent years in Beijing. HAdV-3, HAdV-4, HAdV-7, and HAdV-55 showed the apparent stability of the genomes, while intraspecies recombination was identified in strain BJ04 and BJ09. The recombinants carrying penton base gene of HAdV-1 as well as hexon and fiber genes of HAdV-2 might be a novel type of HAdV worthy of further study.	[Chen, Meng; Huang, Fang; Liu, Donglei; Zhang, Tiegang; Ying, Deng; Wu, Jiang] Beijing Ctr Dis Control & Prevent, Beijing 100013, Peoples R China; [Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wu, J (corresponding author), Beijing Ctr Dis Control & Prevent, 16 Hepingli Middle St, Beijing 100013, Peoples R China.	wj81732@yahoo.com.cn; wenbo_xu1@aliyun.com			Key Technologies R&D Program of the National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003, 2012ZX10004-206]	Key Technologies R&D Program of the National Ministry of Science	This work was supported by the Key Technologies R&D Program of the National Ministry of Science (2013ZX10004-202, 2012ZX10004201-003, and 2012ZX10004-206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Benko M., 2000, 7 INT COMM TAX VIR, P227; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Echavarria M, 2003, J CLIN MICROBIOL, V41, P810, DOI 10.1128/JCM.41.2.810-812.2003; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Hiroi S, 2013, JPN J INFECT DIS, V66, P436, DOI 10.7883/yoken.66.436; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Jin Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-271; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kajon AE, 2013, J CLIN VIROL, V58, P4, DOI 10.1016/j.jcv.2013.06.030; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; Lukashev AN, 2008, J GEN VIROL, V89, P380, DOI 10.1099/vir.0.83057-0; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Mahadevan P, 2010, VIROLOGY, V397, P113, DOI 10.1016/j.virol.2009.10.052; Matsushima Y, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00068-12; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Purkayastha A, 2005, J CLIN MICROBIOL, V43, P3083, DOI 10.1128/JCM.43.7.3083-3094.2005; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto J, 2010, VIROLOGY, V404, P180, DOI 10.1016/j.virol.2010.05.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Washington C, 2010, J CLIN MICROBIOL, V48, P2217, DOI 10.1128/JCM.00029-10; Yang ZH, 2009, J CLIN MICROBIOL, V47, P3082, DOI 10.1128/JCM.00282-09; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	32	36	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121375	10.1371/journal.pone.0121375	http://dx.doi.org/10.1371/journal.pone.0121375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816320	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600086
J	Li, DL; Li, CR; Wang, ZX; Lau, JTF				Li, Dongliang; Li, Chunrong; Wang, Zixin; Lau, Joseph T. F.			Prevalence and Associated Factors of Unprotected Anal Intercourse with Regular Male Sex Partners among HIV Negative Men Who Have Sex with Men in China: A Cross-Sectional Survey	PLOS ONE			English	Article							YOUNG GAY MEN; RISK BEHAVIOR; DYADIC TRUST; CONDOM USE; POSITIVE MEN; SAFER SEX; HONG-KONG; INFECTION; INTIMACY; BELIEFS	The HIV prevalence and incidence among men who have sex with men (MSM) in China are high. Unprotected anal intercourse (UAI) with a regular male sex partner (RP), a significant predictor of HIV sero-conversion, was high yet under-emphasized among MSM having RP (MSMRP). The present cross-sectional survey interviewed 307 HIV negative MSMRP recruited through convenient sampling from multiple sources, including venue-based out-reaching, online recruitment, and referrals made by peers, in Beijing and Chengdu, China. Among MSMRP, the prevalence of UAI with RP in the last three months was 52.4%. The results of the multivariate analysis showed that trust and intimacy within the relationship with RP and presence of clinical depression symptoms were positively associated with UAI with RP in the last three months. Other associated scalar factors derived from the Theory of Planned Behavior were related to perceptions on condom use, including positive attitudes toward condom use (a negative association), subjective norm of the perception that MSM do not usually use condoms during anal intercourse with RP (a positive association), perceived behavioral control over condom use with RP (a negative association), and behavioral intention to use condoms with RP in the coming three months (a negative association). It is seen that MSMRP were at high risk of HIV/STD transmission. The associated factors hence involved those related to perceptions about condom use, mental health, and interpersonal relationship. Future interventions should take these multi-dimensional factors into account. In particular, future research to test the efficacy of couple-based interventions that include mental health elements needs to be conducted, as trust and intimacy within the relationship were associated with UAI among MSMRP, and mental health problems may exist for both the MSMRP and their RP.	[Li, Dongliang] Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Chunrong; Wang, Zixin; Lau, Joseph T. F.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Wang, Zixin; Lau, Joseph T. F.] CUHK Shenzhen Res Inst SZRI, Shenzhen, Peoples R China; [Lau, Joseph T. F.] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022	Li, Chunrong/0000-0002-5128-0132	Ministry of Science and Technology of China [2012ZX10004-904]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Funding: Funding of this study was provided by Ministry of Science and Technology of China (2012ZX10004-904). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095572; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Althoff MD, 2013, AIDS BEHAV, V17, P2416, DOI 10.1007/s10461-012-0315-x; Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Appleby PR, 1999, PERS RELATIONSHIP, V6, P81, DOI 10.1111/j.1475-6811.1999.tb00212.x; Aral Sevgi O, 2010, Curr Infect Dis Rep, V12, P134, DOI 10.1007/s11908-010-0087-2; Bickham PJ, 2007, ARCH SEX BEHAV, V36, P724, DOI 10.1007/s10508-007-9220-1; BOULTON M, 1995, AIDS CARE, V7, P619, DOI 10.1080/09540129550126263; Brennan D. J., 2011, International Journal of Men's Health, V10, P253, DOI 10.3149/jmh.1003.253; Cai Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-205; Chengdu Gay Care Organization, 2010, CHENGD GAY CAR ORG C; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Corcoran K., 2000, MEASURES CLIN PRACTI, V2; Davidovich U, 2006, J APPL SOC PSYCHOL, V36, P22, DOI 10.1111/j.0021-9029.2006.00002.x; Davidovich U, 2000, AIDS, V14, P701, DOI 10.1097/00002030-200004140-00009; Davidovich U, 2004, AIDS EDUC PREV, V16, P304, DOI 10.1521/aeap.16.4.304.40398; Davidovich U, 2001, AIDS, V15, P1303, DOI 10.1097/00002030-200107060-00013; Ding XianBin, 2011, Journal of Tropical Medicine (Guangzhou), V11, P689; Elford J, 1999, AIDS, V13, P1407, DOI 10.1097/00002030-199907300-00019; FITZPATRICK R, 1990, GENITOURIN MED, V66, P346; FOLKMAN S, 1992, HEALTH PSYCHOL, V11, P218, DOI 10.1037/0278-6133.11.4.218; Gass K, 2012, AIDS CARE, V24, P1255, DOI 10.1080/09540121.2012.656571; GOLD RS, 1992, AIDS, V6, P1021, DOI 10.1097/00002030-199209000-00017; Goldberg AE, 2011, J COUNS PSYCHOL, V58, P139, DOI 10.1037/a0021684; Haning RV, 2007, J SEX MARITAL THER, V33, P93, DOI 10.1080/00926230601098449; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Hays RB, 1997, AIDS EDUC PREV, V9, P314; Hoff CC, 2010, ARCH SEX BEHAV, V39, P774, DOI 10.1007/s10508-008-9393-2; Huebner DM, 2001, ANN BEHAV MED, V23, P304, DOI 10.1207/S15324796ABM2304_10; HUNT AJ, 1992, BRIT MED J, V305, P561, DOI 10.1136/bmj.305.6853.561; Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y; Johnston SG, 1996, PSYCHOL REP, V78, P387, DOI 10.2466/pr0.1996.78.2.387; Jones R, 2004, RES NURS HEALTH, V27, P185, DOI 10.1002/nur.20016; Joseph HA, 2010, AIDS CARE, V22, P29, DOI 10.1080/09540120903012627; Kalichman SC, 2007, J BEHAV MED, V30, P497, DOI 10.1007/s10865-007-9123-6; KELLY JA, 1990, AM J PUBLIC HEALTH, V80, P416, DOI 10.2105/AJPH.80.4.416; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Kong TSK, 2012, AIDS CARE, V24, P517, DOI 10.1080/09540121.2011.617411; LARZELERE RE, 1980, J MARRIAGE FAM, V42, P595, DOI 10.2307/351903; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; Araujo MAL, 2009, AIDS PATIENT CARE ST, V23, P663, DOI 10.1089/apc.2008.0123; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Mayne TJ, 1998, HEALTH PSYCHOL, V17, P403, DOI 10.1037/0278-6133.17.5.403; McLean J., 1994, AIDS Care, V6, P331, DOI 10.1080/09540129408258645; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Mimiaga MJ, 2010, AIDS PATIENT CARE ST, V24, P659, DOI 10.1089/apc.2010.0071; Mitchell JW, 2013, AIDS BEHAV, V17, P1329, DOI 10.1007/s10461-012-0255-5; Moosavi SF, 2012, INT RES J APPL BASIC, V3, P2015; Moreau-Gruet F, 2001, AIDS, V15, P1025, DOI 10.1097/00002030-200105250-00011; O'Cleirigh C, 2009, J BEHAV MED, V32, P466, DOI 10.1007/s10865-009-9217-4; Parsons JT, 2003, AIDS EDUC PREV, V15, P383, DOI 10.1521/aeap.15.6.383.24043; Perdue T, 2003, AIDS EDUC PREV, V15, P81, DOI 10.1521/aeap.15.1.81.23842; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Prieur A, 1990, AIDS Educ Prev, V2, P109; REMIEN RH, 1995, AIDS CARE, V7, P429, DOI 10.1080/09540129550126380; Rosalba R LP, 2012, B PSICOLOGIA APPL, P264; SILVESTRE AJ, 1989, AIDS, V3, P647, DOI 10.1097/00002030-198910000-00005; Song DD, 2013, AIDS BEHAV, V17, P2395, DOI 10.1007/s10461-012-0334-7; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STALL R, 1992, J ACQ IMMUN DEF SYND, V5, P682; van Gemert C, 2014, AIDS BEHAV, V18, P2040, DOI 10.1007/s10461-014-0791-2; van Griensven F, 2005, AIDS, V19, P521, DOI 10.1097/01.aids.0000162341.50933.e8; WALKER AJ, 1983, J MARRIAGE FAM, V45, P841, DOI 10.2307/351796; Wang ZX, 2013, AIDS CARE, V25, P1010, DOI 10.1080/09540121.2012.748166; [魏莎莉 Wei Shachi], 2005, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V30, P679; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yu J, 2013, CHINESE J AIDS HIV, V19, P244; Zeng YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498987; Zeng ZL, 2008, CHINESE J NATURAL ME, V10, P241; Zhan WH, 2012, J PSYCHOSOM RES, V72, P371, DOI 10.1016/j.jpsychores.2012.01.015; Zhang B, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P337; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang Bei-chuan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P32; Zhang M, 2011, AIDS RES HUM RETROV, V27, P1139, DOI 10.1089/aid.2010.0356; Zhang X, 2011, AIDS BEHAV, V17, P1129; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; [周振海 ZHOU Zhen-hai], 2010, [中华流行病学杂志, Chinese Journal of Epidemiology], V31, P273	80	35	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119977	10.1371/journal.pone.0119977	http://dx.doi.org/10.1371/journal.pone.0119977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816292	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600022
J	Zou, QH; Yuan, BK; Gu, H; Liu, DQ; Wang, DJJ; Gao, JH; Yang, YH; Zang, YF				Zou, Qihong; Yuan, Bin-Ke; Gu, Hong; Liu, Dongqiang; Wang, Danny J. J.; Gao, Jia-Hong; Yang, Yihong; Zang, Yu-Feng			Detecting Static and Dynamic Differences between Eyes-Closed and Eyes-Open Resting States Using ASL and BOLD fMRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LOW-FREQUENCY FLUCTUATION; HUMAN VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; DEFAULT MODE; AMPLITUDE; SCHIZOPHRENIA; SIGNALS; NETWORK	Resting-state fMRI studies have increasingly focused on multi-contrast techniques, such as BOLD and ASL imaging. However, these techniques may reveal different aspects of brain activity (e.g., static vs. dynamic), and little is known about the similarity or disparity of these techniques in detecting resting-state brain activity. It is therefore important to assess the static and dynamic characteristics of these fMRI techniques to guide future applications. Here we acquired fMRI data while subjects were in eyes-closed (EC) and eyes-open (EO) states, using both ASL and BOLD techniques, at two research centers (NIDA and HNU). Static brain activity was calculated as voxel-wise mean cerebral blood flow (CBF) using ASL, i.e., CBF-mean, while dynamic activity was measured by the amplitude of low frequency fluctuations (ALFF) of BOLD, i.e., BOLD-ALFF, at both NIDA and HNU, and CBF, i.e., CBF-ALFF, at NIDA. We showed that mean CBF was lower under EC than EO in the primary visual cortex, while BOLD-ALFF was higher under EC in the primary somatosensory cortices extending to the primary auditory cortices and lower in the lateral occipital area. Interestingly, mean CBF and BOLD-ALFF results overlapped at the visual cortex to a very small degree. Importantly, these findings were largely replicated by the HNU dataset. State differences found by CBF-ALFF were located in the primary auditory cortices, which were generally a subset of BOLD-ALFF and showed no spatial overlap with CBF-mean. In conclusion, static brain activity measured by mean CBF and dynamic brain activity measured by BOLD-and CBF-ALFF may reflect different aspects of resting-state brain activity and a combination of ASL and BOLD may provide complementary information on the biophysical and physiological processes of the brain.	[Zou, Qihong; Gao, Jia-Hong] Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China; [Zou, Qihong; Gao, Jia-Hong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Zou, Qihong; Gu, Hong; Yang, Yihong] NIDA, Neuroimaging Res Branch, NIH, Baltimore, MD USA; [Yuan, Bin-Ke; Liu, Dongqiang; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Yuan, Bin-Ke; Liu, Dongqiang; Zang, Yu-Feng] Hangzhou Normal Univ, Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Wang, Danny J. J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Hangzhou Normal University; Hangzhou Normal University; University of California System; University of California Los Angeles; Peking University	Zang, YF (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	yihongyang@intra.nida.nih.gov; zangyf@gmail.com	Wang, Danny JJ/O-2482-2018; ZANG, Yu-Feng/J-1558-2012	Wang, Danny JJ/0000-0002-0840-7062; ZANG, Yu-Feng/0000-0003-1833-8010	Intramural Research Program of NIDA, NIH; Natural Science Foundation of China [81201142, 81020108022, 81271652]; China's National Strategic Basic Research Program (973) [2015CB856400, 2012CB720700]; "Qian Jiang Distinguished Professor" program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000469] Funding Source: NIH RePORTER	Intramural Research Program of NIDA, NIH; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's National Strategic Basic Research Program (973); "Qian Jiang Distinguished Professor" program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Intramural Research Program of NIDA, NIH, the Natural Science Foundation of China (81201142, 81020108022, and 81271652), and China's National Strategic Basic Research Program (973) (2015CB856400 and 2012CB720700). YFZ is partly supported by the "Qian Jiang Distinguished Professor" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Berger H., 1929, ARCH PSYCHIAT NERVEN, V87, P44; Berger H., 1930, J PSYCHOL NEUROL, V40, P20; Bianciardi M, 2011, J CEREBR BLOOD F MET, V31, P401, DOI 10.1038/jcbfm.2010.164; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Dong ZY, 2012, NEUROSCI BULL, V28, P456, DOI 10.1007/s12264-012-1254-2; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Jao T, 2013, NEUROIMAGE, V69, P21, DOI 10.1016/j.neuroimage.2012.12.007; Kindler J, 2013, SCHIZOPHR B; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang XY, 2014, NEUROIMAGE, V87, P265, DOI 10.1016/j.neuroimage.2013.11.013; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Lin AL, 2009, NEUROIMAGE, V44, P16, DOI 10.1016/j.neuroimage.2008.08.029; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Liu TT, 2005, NEUROIMAGE, V24, P207, DOI 10.1016/j.neuroimage.2004.09.047; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Ye FQ, 1997, MAGN RESON MED, V37, P226, DOI 10.1002/mrm.1910370215; Ye FQ, 2000, MAGNET RESON MED, V44, P450, DOI 10.1002/1522-2594(200009)44:3<450::AID-MRM16>3.0.CO;2-0; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	53	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121757	10.1371/journal.pone.0121757	http://dx.doi.org/10.1371/journal.pone.0121757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816237	gold, Green Published			2022-12-27	WOS:000352133600117
J	Rangan, H; Bell, KL; Baum, DA; Fowler, R; McConvell, P; Saunders, T; Spronck, S; Kull, CA; Murphy, DJ				Rangan, Haripriya; Bell, Karen L.; Baum, David A.; Fowler, Rachael; McConvell, Patrick; Saunders, Thomas; Spronck, Stef; Kull, Christian A.; Murphy, Daniel J.			New Genetic and Linguistic Analyses Show Ancient Human Influence on Baobab Evolution and Distribution in Australia	PLOS ONE			English	Article							ADANSONIA-DIGITATA L.; PALEOENVIRONMENTAL CHANGE; ARID ZONE; PATTERNS; MONSOON; PLANT; WEST; TREE; BIOGEOGRAPHY; DISTANCES	This study investigates the role of human agency in the gene flow and geographical distribution of the Australian baobab, Adansonia gregorii. The genus Adansonia is a charismatic tree endemic to Africa, Madagascar, and northwest Australia that has long been valued by humans for its multiple uses. The distribution of genetic variation in baobabs in Africa has been partially attributed to human-mediated dispersal over millennia, but this relationship has never been investigated for the Australian species. We combined genetic and linguistic data to analyse geographic patterns of gene flow and movement of word-forms for A. gregorii in the Aboriginal languages of northwest Australia. Comprehensive assessment of genetic diversity showed weak geographic structure and high gene flow. Of potential dispersal vectors, humans were identified as most likely to have enabled gene flow across biogeographic barriers in northwest Australia. Genetic-linguistic analysis demonstrated congruence of gene flow patterns and directional movement of Aboriginal loanwords for A. gregorii. These findings, along with previous archaeobotanical evidence from the Late Pleistocene and Holocene, suggest that ancient humans significantly influenced the geographic distribution of Adansonia in northwest Australia.	[Rangan, Haripriya; Bell, Karen L.; Fowler, Rachael; Kull, Christian A.] Monash Univ, Ctr Geog & Environm Sci, Melbourne, Vic 3800, Australia; [Bell, Karen L.; Fowler, Rachael; Murphy, Daniel J.] Royal Bot Gardens Melbourne, South Yarra, Vic 3141, Australia; [Baum, David A.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [McConvell, Patrick] Australian Natl Univ, Sch Language Studies, Canberra, ACT 0200, Australia; [Spronck, Stef] Australian Natl Univ, Sch Culture Hist & Language, Linguist, Canberra, ACT 0200, Australia; [Spronck, Stef] Katholieke Univ Leuven, Linguist, B-3000 Louvain, Belgium; [Kull, Christian A.] Univ Lausanne, Inst Geog & Durabil, CH-1015 Lausanne, Switzerland	Monash University; University of Wisconsin System; University of Wisconsin Madison; Australian National University; Australian National University; KU Leuven; University of Lausanne	Rangan, H (corresponding author), Monash Univ, Ctr Geog & Environm Sci, Melbourne, Vic 3800, Australia.	haripriya.rangan@monash.edu	Bell, Karen/A-4190-2009; Spronck, Stef/AAC-2237-2020; Murphy, Daniel/C-3781-2008	Bell, Karen/0000-0002-4445-4026; Spronck, Stef/0000-0003-2891-0092; Kull, Christian/0000-0002-7516-7898; Murphy, Daniel/0000-0002-8358-363X; Rangan, Haripriya/0000-0003-4238-2353	Australian Research Council grant [DP1093100]; Kimberley Foundation Australia; US NSF Grant [HSD 902114]; AIATSIS grant [G2011/76]	Australian Research Council grant(Australian Research Council); Kimberley Foundation Australia; US NSF Grant(National Science Foundation (NSF)); AIATSIS grant	The genetics and biogeographic research in this paper was funded by an Australian Research Council grant (DP1093100, awarded to Rangan, Kull, and Murphy); the linguistic research was supported by a grant from the Kimberley Foundation Australia (awarded to McConvell), a US NSF Grant (HSD 902114, awarded to Bowern, et al., including McConvell), and an AIATSIS grant (G2011/76, awarded to Spronck).	Adanson M, 1771, MEMOIRES ACAD ROYALE, V161, P218; Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; Armstrong, 1979, INT C IND OC STUD PE, P1; Assogbadjo AE, 2010, NOT BOT HORTI AGROBO, V38, P136; Barker G., 2006, AGR REVOLUTION PREHI; BAUM DA, 1995, ANN MO BOT GARD, V82, P322, DOI 10.2307/2399883; BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Baum DA, 1990, BOAD TREE ADAN UNPUB; Bean AR, 2007, AUST SYST BOT, V20, P1, DOI 10.1071/SB06030; BEARD JS, 1967, J ECOL, V55, P271, DOI 10.2307/2257877; Bell KL, 2014, AUST J BOT, V62, P164, DOI 10.1071/BT13209; Bellwood Peter, 2005, 1 FARMERS; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bird RB, 2008, P NATL ACAD SCI USA, V105, P14796, DOI 10.1073/pnas.0804757105; Blench R.M., 2007, FIELDS CHANGE PROGR, V5, P1; BOLAND DJ, 1985, FOREST TREES AUSTR; Bostoen K, 2013, CR GEOSCI, V345, P336, DOI 10.1016/j.crte.2013.03.005; Bowern C., 2004, AUSTR LANGUAGES CLAS; Bowler JM, 2001, QUATERN INT, V83-5, P63, DOI 10.1016/S1040-6182(01)00031-3; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Bowman DMJS, 1997, AUST J BOT, V45, P893, DOI 10.1071/BT96092; Brock J, 1988, TOP END NATIVE PLANT; Brockwell S, 2013, AUST ARCHAEOL, P21; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Campbell L., 1999, HIST LINGUISTICS; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Coller M., SAHUL TIME; De Caluwe E, 2009, ACS SYM SER, V1021, P51; De Deckker P, 2003, GLOBAL PLANET CHANGE, V35, P25, DOI 10.1016/S0921-8181(02)00089-9; Denham T, 2009, ANTIQUITY, V83, P634, DOI 10.1017/S0003598X00098884; Denham T, 2009, QUATERN INT, V202, P29, DOI 10.1016/j.quaint.2008.06.018; Donohue M., 2009, ETHNOBOTANY RES APPL, V7, P293, DOI [DOI 10.17348/ERA.7.0.293-332, 10.17348/era.7.0.293-332]; Duvall CS, 2007, J BIOGEOGR, V34, P1947, DOI 10.1111/j.1365-2699.2007.01751.x; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Eldridge MDB, 2011, AUST J ZOOL, V59, P270, DOI 10.1071/ZO12012; Evans N., 2003, NONPAMANYUNNGAN LANG; EXCOFFIER L, 1992, GENETICS, V131, P479; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fitzsimmons KE, 2013, QUATERNARY SCI REV, V74, P78, DOI 10.1016/j.quascirev.2012.09.007; Garcia C, 2007, MOL ECOL, V16, P1947, DOI 10.1111/j.1365-294X.2006.03126.x; Gebauer J, 2002, GARTENBAUWISSENSCHAF, V67, P155; Gillison AN, 1983, ECOSYSTEMS WORLD, V13, P183; Gott B., 1983, AUSTR ABORIGINAL STU, V2, P2; Harvey MD, 2008, CARTOGRAPHER NONPHAM; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; Hill K. D., 1995, Telopea, V6, P185; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES R, 1969, Australian Natural History, V16, P224; Kershaw AP, 1995, ANTIQUITY, V69, P656, DOI 10.1017/S0003598X00082260; Kondo T, 2012, P ROY SOC B-BIOL SCI, V279, P2652, DOI 10.1098/rspb.2012.0103; LEES BG, 1987, RADIOCARBON, V29, P311; Livingstone David, 1861, POPULAR ACCOUNT MISS; Lourandos H., 1997, CONTINENT HUNTER GAT; Lowe P, 1998, THE BOAD TREE; Maddison WP, 2019, MESQUITE MODULAR SYS; McConnell K., 1997, THESIS ANU CANBERRA; McConnell K, 1999, TAPHONOMY ANAL PROCE, P23; McConvell P, 2014, 43 M AUSTR LING SOC; McConvell P, 2004, AUSTR LANGUAGES CLAS; McGregor W, 2009, CANBERRA PACIFIC L L, VL600, P14; McGregor W., 2004, LANGUAGES KIMBERLEY; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mueller Fv, 1893, VICTORIAN NAT, V10, P110; O'Connor S., 1997, AUST ARCHAEOL, V45, P20; O'Connor S, 2014, AUST ARCHAEOL, P10; Oddou-Muratorio S, 2001, EVOLUTION, V55, P1123, DOI 10.1111/j.0014-3820.2001.tb00632.x; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Pettigrew J, 2011, CLIN EXP OPTOM, V94, P403, DOI 10.1111/j.1444-0938.2011.00648.x; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Potter S, 2012, CONSERV GENET, V13, P937, DOI 10.1007/s10592-012-0342-1; Potter S, 2012, MOL ECOL, V21, P2254, DOI 10.1111/j.1365-294X.2012.05523.x; Reeves JM, 2013, QUATERNARY SCI REV, V74, P97, DOI 10.1016/j.quascirev.2012.11.027; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Shulmeister J, 1999, QUATERN INT, V57-8, P81, DOI 10.1016/S1040-6182(98)00052-4; Smith BD, 2011, PHILOS T R SOC B, V366, P836, DOI 10.1098/rstb.2010.0253; SWART ER, 1963, NATURE, V198, P708, DOI 10.1038/198708b0; Takezaki N, 1996, GENETICS, V144, P389; Tsy JMLP, 2009, MOL ECOL, V18, P1707, DOI 10.1111/j.1365-294X.2009.04144.x; Wallis LA, 2001, QUATERN INT, V83-5, P103, DOI 10.1016/S1040-6182(01)00033-7; WICKENS G E, 1982, Kew Bulletin, V37, P173, DOI 10.2307/4109961; Wickens G.E., 2008, BAOBABS PACHYCAULS A, DOI DOI 10.1007/978-1-4020-6431-9; Williams AN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0486; Wyrwoll K-H, 2001, QUATERN INT, V83-85, P87; [No title captured]	86	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119758	10.1371/journal.pone.0119758	http://dx.doi.org/10.1371/journal.pone.0119758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE9AM	25830225	Green Published, gold			2022-12-27	WOS:000352135600014
J	Skop, V; Malinska, H; Trnovska, J; Huttl, M; Cahova, M; Blachnio-Zabielska, A; Baranowski, M; Burian, M; Oliyarnyk, O; Kazdova, L				Skop, Vojtech; Malinska, Hana; Trnovska, Jaroslava; Huettl, Martina; Cahova, Monika; Blachnio-Zabielska, Agnieszka; Baranowski, Marcin; Burian, Martin; Oliyarnyk, Olena; Kazdova, Ludmila			Positive Effects of Voluntary Running on Metabolic Syndrome-Related Disorders in Non-Obese Hereditary Hypertriacylglycerolemic Rats	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; FATTY-ACID-COMPOSITION; SOFT DRINK CONSUMPTION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; EXPERIMENTAL-MODEL; OXIDATIVE STRESS; PHYSICAL-EXERCISE; LIPID-CONTENT; DIACYLGLYCEROL	While metabolic syndrome is often associated with obesity, 25% of humans suffering from it are not obese and the effect of physical activity remains unclear in such cases. Therefore, we used hereditary hypertriaclyglycerolemic (HHTg) rats as a unique model for studying the effect of spontaneous physical activity [voluntary running (VR)] on metabolic syndrome-related disorders, such as dyslipidemia, in non-obese subjects. Adult HHTg males were fed standard (CD) or high-sucrose (HSD) diets ad libitum for four weeks. Within both dietary groups, some of the rats had free access to a running wheel (CD+VR, HSD+VR), whereas the controls (CD, HSD) had no possibility of extra physical activity. At the end of the four weeks, we measured the effects of VR on various metabolic syndrome-associated parameters: (i) biochemical parameters, (ii) the content and composition of triacylglycerols (TAG), diacylglycerols (DAG), ceramides and membrane phospholipids, and (iii) substrate utilization in brown adipose tissue. In both dietary groups, VR led to various positive effects: reduced epididymal and perirenal fat depots; increased epididymal adipose tissue lipolysis; decreased amounts of serum TAG, non-esterified fatty acids and insulin; a higher insulin sensitivity index. While tissue ceramide content was not affected, decreased TAG accumulation resulted in reduced and modified liver, heart and skeletal muscle DAG. VR also had a beneficial effect on muscle membrane phospholipid composition. In addition, compared with the CD group, the CD+VR rats exhibited increased fatty acid oxidation and protein content in brown adipose tissue. Our results confirm that physical activity in a non-obese model of severe dyslipidemia has many beneficial effects and can even counteract the negative effects of sucrose consumption. Furthermore, they suggest that the mechanism by which these effects are modulated involves a combination of several positive changes in lipid metabolism.	[Skop, Vojtech; Malinska, Hana; Trnovska, Jaroslava; Huettl, Martina; Cahova, Monika; Burian, Martin; Oliyarnyk, Olena; Kazdova, Ludmila] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic; [Skop, Vojtech] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic; [Blachnio-Zabielska, Agnieszka; Baranowski, Marcin] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Institute for Clinical & Experimental Medicine (IKEM); University of Chemistry & Technology, Prague; Medical University of Bialystok	Skop, V (corresponding author), Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic.	skov@ikem.cz	Oliyarnyk, Olena/Q-6380-2019; Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Cahova, Monika/Z-1568-2018; Stefanadis, Christodoulos/ABH-2232-2020; Baranowski, Marcin/F-6718-2011	Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Cahova, Monika/0000-0003-2640-5084; Stefanadis, Christodoulos/0000-0001-5974-6454; Baranowski, Marcin/0000-0002-3714-5815; Oliyarnyk, Olena/0000-0002-4912-6187; Trnovska, Jaroslava/0000-0001-6468-8244; Skop, Vojtech/0000-0002-4685-4429	Grant Agency of the Czech Republic [P301/11/2418]; MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM") [IN 0002301]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM")	This work was supported by grant, P301/11/2418, from the Grant Agency of the Czech Republic and grant, MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM, IN 0002301"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright A, 2000, MED SCI SPORT EXER, V32, P1345; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7; Bizeau ME, 2005, METABOLISM, V54, P1189, DOI 10.1016/j.metabol.2005.04.004; Blachnio-Zabielska AU, 2013, J LIPID RES, V54, P1705, DOI 10.1194/jlr.D035006; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096056; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Dawn-Linsley M, 2005, J NEUROSCI METH, V141, P219, DOI 10.1016/j.jneumeth.2004.06.010; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Deivanayagam S, 2008, AM J CLIN NUTR, V88, P257, DOI 10.1093/ajcn/88.2.257; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galbo T, 2013, AGING-US, V5, P582, DOI 10.18632/aging.100585; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; GRONE EF, 1994, ATHEROSCLEROSIS, V107, P1, DOI 10.1016/0021-9150(94)90136-8; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Helge JW, 1999, J NUTR, V129, P1636, DOI 10.1093/jn/129.9.1636; Hulver MW, 2004, P NUTR SOC, V63, P375, DOI 10.1079/PNS2004351; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kahleova H, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.12; Katzmarzyk PT, 2003, MED SCI SPORT EXER, V35, P1703, DOI 10.1249/01.MSS.0000089337.73244.9B; Kazdova L, 1997, ANN NY ACAD SCI, V827, P521, DOI 10.1111/j.1749-6632.1997.tb51863.x; Ke Z, 2011, IEEE ENG MED BIO, P8223, DOI 10.1109/IEMBS.2011.6092028; Klimes Iwar, 1995, Blood Pressure, V4, P137, DOI 10.3109/08037059509077585; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Li G, 2015, PHYSIOL RES, V64, P355, DOI 10.33549/physiolres.932851; Li JY, 2014, J NEUROPHYSIOL, V111, P2061, DOI 10.1152/jn.00475.2013; Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x; Machann J, 2008, EUR J RADIOL, V67, P275, DOI 10.1016/j.ejrad.2008.02.032; Marek G, 2015, DIABETES, V64, P508, DOI 10.2337/db14-0411; Marignani PA, 1996, BIOCHEM BIOPH RES CO, V225, P469, DOI 10.1006/bbrc.1996.1196; MCALLISTER R A, 1969, Journal of Medical Laboratory Technology, V26, P1; Najafian Jamshid, 2014, Niger Med J, V55, P29, DOI 10.4103/0300-1652.128156; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Pelikanova T, 2001, METABOLISM, V50, P1472, DOI 10.1053/meta.2001.27195; Pravenec M, 2008, INT J OBESITY, V32, P1848, DOI 10.1038/ijo.2008.192; Pravenec M, 2011, HYPERTENSION, V57, P731, DOI 10.1161/HYPERTENSIONAHA.110.164350; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rizkalla SW, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-82; Saric M, 2012, CURR CARDIOL REP, V14, P342, DOI 10.1007/s11886-012-0261-2; Sarma S, 2013, CIRC-CARDIOVASC IMAG, V6, P1048, DOI 10.1161/CIRCIMAGING.113.000565; Segawa M, 1998, RES COMMUN MOL PATH, V100, P77; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Slocum N, 2013, EXP TOXICOL PATHOL, V65, P549, DOI 10.1016/j.etp.2012.04.001; Tamura Y, 2008, METABOLISM, V57, P373, DOI 10.1016/j.metabol.2007.10.013; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Trnovska J, 2015, PHYSIOL RES, V64, P51, DOI 10.33549/physiolres.932823; van Hees AMJ, 2011, OBESITY, V19, P1350, DOI 10.1038/oby.2011.10; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; VRANA A, 1993, ANN NY ACAD SCI, V683, P57, DOI 10.1111/j.1749-6632.1993.tb35692.x; VRANA A, 1990, TRANSPLANT P, V22, P2579; YAMASHITA H, 1993, INT J BIOMETEOROL, V37, P61, DOI 10.1007/BF01212769; Zicha J, 2006, PHYSIOL RES, V55, pS49, DOI 10.33549/physiolres.930000.55.S1.49	74	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122768	10.1371/journal.pone.0122768	http://dx.doi.org/10.1371/journal.pone.0122768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830228	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600124
J	Zhao, J; Song, QX; Wang, L; Dong, XY; Yang, XL; Bai, XY; Song, B; Damaser, M; Li, LK				Zhao, Jiang; Song, Qixiang; Wang, Liang; Dong, Xingyou; Yang, Xingliang; Bai, Xinyu; Song, Bo; Damaser, Margot; Li, Longkun			Detrusor Myocyte Autophagy Protects the Bladder Function via Inhibiting the Inflammation in Cyclophosphamide-Induced Cystitis in Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INTERLEUKIN-6; EXPRESSION; APOPTOSIS; CYTOKINES; RAPAMYCIN; GUIDELINES; RECEPTORS; RELEASE; ASSAYS	Autophagy, a highly conserved homeostatic cellular process that removes and recycles damaged proteins and organelles in response to cellular stress, is believed to play a crucial role in the immune response and inflammation. The role of autophagy in bladder cystitis, however, has not well been clarified. Here we investigate the role of detrusor myocytes autophagy (DMA) in cyclophosphamide-induced cystitis animal model. 164 female Sprague-Dawley rats were randomized into three experimental groups and compared to three control groups, respectively. The expressions of microtubule-associated protein 1 light chain 3 (LC3), p-p70s6k (the phosphorylated form of ribosomal protein S6), SOD2 (superoxide dismutase 2) in the bladder muscular layer were measured using western blot. The co-location of LC3, alpha-smooth muscle actin (alpha-SMA), and autophagic vacuoles were investigated with double-labeled immunofluorescence and transmission electron microscopy (TEM). The expression of lL-1 beta, IL-6, IL-8, malondialdehyde (MDA), and glutathione (GSH) in the detrusor layer were analyzed using ELISA. The bladder inflammation and the number of mast cells in the muscular layer were analyzed by histology. The bladder function was evaluated using cystometry. In cyclophosphamide-induced cystitis, autophagy was detected in detrusor myocytes by increased LC3, p-p70s6k expression, and autophagosomes. However, the presence of enhanced inflammation and oxidative stress in the cyclophosphamide-treated group suggest autophagy of detrusor myocytes may not be sufficiently activated. Inflammation and oxidative stress were significantly decreased and the bladder histology and micturition function were significantly improved with rapamycin (RAPA, autophagy agonist) pre-treatment. In contrast, inflammation and oxidative stress were dramatically increased and the bladder histology and function were negatively affected with chloroquine (CQ, autophagy blocker) pre-treated. These findings preferentially provide evidence of the association between DMA and cyclophosphamide-induced cystitis in rats. The autophagy agonist RAPA significantly decreased the inflammation and protected the bladder function, which might be considered as a potential treatment for interstitial cystitis.	[Zhao, Jiang; Wang, Liang; Dong, Xingyou; Yang, Xingliang; Bai, Xinyu; Song, Bo; Li, Longkun] Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China; [Song, Qixiang; Damaser, Margot] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Army Medical University; Cleveland Clinic Foundation	Li, LK (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China.	lilongk@hotmail.com		Dong, Xingyou/0000-0002-0901-8368; Li, Longkun/0000-0003-3939-5647	National Natural Science Foundation of China [81230017, 81070606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81230017 and 81070606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Bouchelouche K, 2006, J UROLOGY, V175, P760, DOI 10.1016/S0022-5347(05)00167-9; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Chen W, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.08.019; Chuang YC, 2009, EUR UROL, V56, P159, DOI 10.1016/j.eururo.2008.05.007; Dasgupta J, 2009, MATURITAS, V64, P212, DOI 10.1016/j.maturitas.2009.09.016; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Ghavami S, 2012, AM J PHYSIOL-LUNG C, V302, pL420, DOI 10.1152/ajplung.00312.2011; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; He CY, 2013, AM J PATHOL, V183, P626, DOI 10.1016/j.ajpath.2013.04.028; Helmer H, 2002, J SOC GYNECOL INVEST, V9, P15, DOI 10.1016/S1071-5576(01)00142-3; Humphrey L, 2012, EUR UROL, V61, P271, DOI 10.1016/j.eururo.2011.10.004; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Jo EK, 2012, MICROBES INFECT, V14, P119, DOI 10.1016/j.micinf.2011.08.014; Juszczak K, 2010, J PHYSIOL PHARMACOL, V61, P477; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li LK, 2007, AM J PHYSIOL-CELL PH, V293, pC1627, DOI 10.1152/ajpcell.00122.2007; Mangieri LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093257; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nasrin S, 2013, J UROLOGY, V189, P1123, DOI 10.1016/j.juro.2012.09.054; Nickel JC, 2010, J UROLOGY, V183, P167, DOI 10.1016/j.juro.2009.08.133; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Shie JH, 2012, UROL SCI, V23, P107, DOI 10.1016/j.urols.2012.10.003; Starkman JS, 2008, J UROLOGY, V179, P2440, DOI 10.1016/j.juro.2008.01.082; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Zhang MG, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.02.045	34	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122597	10.1371/journal.pone.0122597	http://dx.doi.org/10.1371/journal.pone.0122597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830308	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600116
J	Bermudo, C; Martin, F; Martin, MJ; Sevilla, L				Bermudo, Carolina; Martin, Francisco; Jesus Martin, Maria; Sevilla, Lorenzo			Experimental Validation of the New Modular Application of the Upper Bound Theorem in Indentation	PLOS ONE			English	Article							UBET ANALYSIS; PARAMETERS; EXTRUSION	Nowadays, thanks to the new manufacturing processes, indentation is becoming an essential part of the new arising processes such as the Incremental Forming Processes. This work presents the experimental validation of the analytical model developed for an indentation-based process. The analytical model is originated from the Upper Bound Theorem application by means of its new modular distribution. The modules considered are composed of two Triangular Rigid Zones each. The experimental validation is performed through a series of indentation tests with work-pieces of annealed aluminium EN AW-2030 and punches of steel AISI 304, under plane strain conditions. The results are compared with the ones obtained from the application of this new modular distribution of the Upper Bound Theorem, showing a good approximation and suitability of the model developed for an indentation-based process.	[Bermudo, Carolina; Martin, Francisco; Jesus Martin, Maria; Sevilla, Lorenzo] Univ Malaga, Dept Civil Mat & Mfg Engn, E-29071 Malaga, Spain	Universidad de Malaga	Bermudo, C (corresponding author), Univ Malaga, Dept Civil Mat & Mfg Engn, E-29071 Malaga, Spain.	bgamboa@uma.es	Hurtado, Lorenzo Sevilla/M-1155-2014; Bermudo, Carolina/M-1814-2018	Hurtado, Lorenzo Sevilla/0000-0002-2236-5807; Bermudo, Carolina/0000-0002-2580-5708	FPU program of the Ministry of Education; University of Malaga - Andalucia Tech Campus of International Excellence	FPU program of the Ministry of Education; University of Malaga - Andalucia Tech Campus of International Excellence	This work was supported by FPU program of the Ministry of Education and University of Malaga - Andalucia Tech Campus of International Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfozan A., 2002, Journal of Manufacturing Processes, V4, P97, DOI 10.1016/S1526-6125(02)70136-9; Allwood JM, 2006, INT J MACH TOOL MANU, V46, P1939, DOI 10.1016/j.ijmachtools.2006.01.034; Altinbalik T, 2013, T NONFERR METAL SOC, V23, P1098, DOI 10.1016/S1003-6326(13)62571-6; [Anonymous], 2005, 5733 UNE EN; [Anonymous], 2003, 66040 UNE AENOR; [Anonymous], 2007, E67600 ASTM INT; [Anonymous], 2010, 68921 UNE EN ISO; Bagudanch I, 2013, PROCEDIA ENGINEER, V63, P346, DOI 10.1016/j.proeng.2013.08.208; Bermudo C, 2013, PROCEDIA ENGINEER, V63, P388, DOI 10.1016/j.proeng.2013.08.210; Bernal C, 2013, INT J ADV MANUF TECH, V69, P2091, DOI 10.1007/s00170-013-5164-x; Bernal C, 2012, APPL MECH MATER, V217-219, P2351, DOI 10.4028/www.scientific.net/AMM.217-219.2351; Camacho AM, 2012, MATER SCI FORUM, V713, P19, DOI 10.4028/www.scientific.net/MSF.713.19; Chakrabarty J., 2006, THEORY PLASTICITY; Groche P, 2007, CIRP ANN-MANUF TECHN, V56, P635, DOI 10.1016/j.cirp.2007.10.006; Hirt G, 2007, CIRP ANN-MANUF TECHN, V56, P313, DOI 10.1016/j.cirp.2007.05.072; Hwang BC, 2003, J MATER PROCESS TECH, V139, P547, DOI 10.1016/S0924-0136(03)00523-5; Hwang BC, 2001, J MATER PROCESS TECH, V111, P135, DOI 10.1016/S0924-0136(01)00539-8; Johnson W, 1983, ENG PLASTICITY; Khoddam S, 2011, MECH MATER, V43, P684, DOI 10.1016/j.mechmat.2011.07.009; Martin F, 2009, AIP CONF PROC, V1181, P455, DOI 10.1063/1.3273663; Martin F, 2013, MATER MANUF PROCESS, V28, P282, DOI 10.1080/10426914.2012.718478; Nowak J, 2010, INT J MATER FORM, V3, P931, DOI 10.1007/s12289-010-0921-y; Parvizi A, 2014, INT J MECH SCI, V79, P176, DOI 10.1016/j.ijmecsci.2013.12.012; Rowe G, 1971, INTRO PRINCIPLES MET; Rubio EM, 2004, J MATER PROCESS TECH, V155, P1220, DOI 10.1016/j.jmatprotec.2004.04.349; Topcu N, 2005, THESIS MIDLLE E TU T; Wang JM, 2011, INT J ADV MANUF TECH, V56, P571, DOI 10.1007/s00170-011-3193-x	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122790	10.1371/journal.pone.0122790	http://dx.doi.org/10.1371/journal.pone.0122790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826738	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800093
J	Blouw, B; Patel, M; Iizuka, S; Abdullah, C; You, WK; Huang, X; Li, JL; Diaz, B; Stallcup, WB; Courtneidge, SA				Blouw, Barbara; Patel, Manishha; Iizuka, Shinji; Abdullah, Christopher; You, Weon Kyoo; Huang, Xiayu; Li, Jian-Liang; Diaz, Begona; Stallcup, William B.; Courtneidge, Sara A.			The Invadopodia Scaffold Protein Tks5 Is Required for the Growth of Human Breast Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; PODOSOME FORMATION; TRANSFORMED-CELLS; INVASION; EXPRESSION; MEMBRANE; ANGIOGENESIS; PROTRUSIONS; PROGRESSION; METASTASIS	The ability of cancer cells to invade underlies metastatic progression. One mechanism by which cancer cells can become invasive is through the formation of structures called invadopodia, which are dynamic, actin-rich membrane protrusions that are sites of focal extracellular matrix degradation. While there is a growing consensus that invadopodia are instrumental in tumor metastasis, less is known about whether they are involved in tumor growth, particularly in vivo. The adaptor protein Tks5 is an obligate component of invadopodia, and is linked molecularly to both actin-remodeling proteins and pericellular proteases. Tks5 appears to localize exclusively to invadopodia in cancer cells, and in vitro studies have demonstrated its critical requirement for the invasive nature of these cells, making it an ideal surrogate to investigate the role of invadopodia in vivo. In this study, we examined how Tks5 contributes to human breast cancer progression. We used immunohistochemistry and RNA sequencing data to evaluate Tks5 expression in clinical samples, and we characterized the role of Tks5 in breast cancer progression using RNA interference and orthotopic implantation in SCID-Beige mice. We found that Tks5 is expressed to high levels in approximately 50% of primary invasive breast cancers. Furthermore, high expression was correlated with poor outcome, particularly in those patients with late relapse of stage I/II disease. Knockdown of Tks5 expression in breast cancer cells resulted in decreased growth, both in 3D in vitro cultures and in vivo. Moreover, our data also suggest that Tks5 is important for the integrity and permeability of the tumor vasculature. Together, this work establishes an important role for Tks5 in tumor growth in vivo, and suggests that invadopodia may play broad roles in tumor progression.	[Blouw, Barbara; Patel, Manishha; Iizuka, Shinji; Abdullah, Christopher; You, Weon Kyoo; Huang, Xiayu; Li, Jian-Liang; Diaz, Begona; Stallcup, William B.; Courtneidge, Sara A.] NCI, Tumor Microenvironm & Metastasis Program, Ctr Canc, Sanford Burnham Med Res Inst, La Jolla, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute	Courtneidge, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.	courtneidge@ohsu.edu	Li, Jian-Liang/AAE-9315-2019; Li, J L/E-6100-2018	Li, Jian-Liang/0000-0002-6487-081X; Li, J L/0000-0002-6487-081X; Diaz, Begona/0000-0002-7892-6319	NIH [5 U42 RR006042]; California Breast Cancer Research Program; FRSQ Postdoctoral Fellowship from Quebec, Canada; National Cancer Institute [CA129686, CA154002, RO1 CA095287]; NATIONAL CANCER INSTITUTE [R01CA129686, R01CA095287, R01CA154002, P30CA030199] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Program; FRSQ Postdoctoral Fellowship from Quebec, Canada; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the use of tissues procured by the National Disease Research Interchange with support from NIH grant 5 U42 RR006042. Barbara Blouw was supported by a postdoctoral fellowship from the California Breast Cancer Research Program. Manishha Patel was supported by a FRSQ Postdoctoral Fellowship from Quebec, Canada. This work was supported in part by grants CA129686 and CA154002 (Sara A. Courtneidge) and RO1 CA095287 (William B. Stallcup) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Cejudo-Martin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107674; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dunphy KA, 2010, J VIS EXP; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Stylli SS, 2012, J CLIN NEUROSCI, V19, P436, DOI 10.1016/j.jocn.2011.11.013; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; You WK, 2012, AM J PATHOL, V180, P1145, DOI 10.1016/j.ajpath.2011.11.006	31	46	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121003	10.1371/journal.pone.0121003	http://dx.doi.org/10.1371/journal.pone.0121003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826475	Green Published, gold			2022-12-27	WOS:000352084800029
J	Gu, NY; Yao, X; Shi, HF; Chen, JJ; Chen, M				Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min			The Role of Macrophage Migration Inhibitory Factor in Mast Cell-Stimulated Fibroblast Proliferation and Collagen Production	PLOS ONE			English	Article							GROWTH-FACTOR; UP-REGULATION; I COLLAGEN; FACTOR MIF; HUMAN-SKIN; FIBROSIS; EXPRESSION; LUNG; SCLERODERMA; CHYMASE	Current clinical and translational studies have shown that mast cell plays a pivotal role in multiple fibrotic diseases including scleroderma. However, the lack of mature human mast cell culture model exhibits a major obstacle for further dissection of cytokines and signaling molecules required for mast cell mediated fibrosis in various diseases. Macrophage Migration Inhibitory Factor is a mast cell released pro-inflammatory cytokine which is deregulated in scleroderma patients and is also involved in non-scleroderma related fibrosis. In the current study, we successfully generated a practical and reliable human mast cell culture system with bone marrow CD34+ hematopietic precursors. The derivative mast cell is normal in terms of both morphology and function as manifested by normal degranulation. More importantly, we were able to show mast cell conditioned medium as well as MIF supplementation augments fibroblast proliferation and collagen synthesis. This positive regulatory effect of mast cell conditioned medium can be dampened by MIF antibody. In addition, MIF-knockdown significantly inhibits pro-fibrotic activities of CD34+ hematopietic precursor derived mast cells. These data strongly suggest that mast cell released MIF is required for mast cell mediated fibrogenic activities. The current manuscript seems to be the first mechanistic report showing the significance of MIF in mast cell mediated fibrosis, which may pave the way for the development of potential MIF-targeted therapy for fibrotic diseases to a further extent. Moreover, we strongly believe mast cell culture and differentiation model as well as corresponding genetic manipulation methodology will be helpful in characterizing novel mast cell based therapeutic targets.	[Gu Ningyan; Yao Xu; Chen Jingjing; Chen Min] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Gu Ningyan; Yao Xu; Chen Jingjing; Chen Min] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Shi Hongfei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing University	Chen, M (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.	chenminderma@126.com			Jiangsu Key Laboratory of Molecular Biology for Skin Diseases; STIs (China) [BM2012107]	Jiangsu Key Laboratory of Molecular Biology for Skin Diseases; STIs (China)	This work was supported by the grants from Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs (China, BM2012107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, EUR J DERMATOL, V12, P340; Atamas SP, 2003, CYTOKINE GROWTH F R, V14, P537, DOI 10.1016/S1359-6101(03)00060-1; Bargagli E, 2009, RESP PHYSIOL NEUROBI, V167, P261, DOI 10.1016/j.resp.2009.05.004; Becker H, 2008, CLIN RHEUMATOL, V27, P1307, DOI 10.1007/s10067-008-0960-7; Beghdadi W, 2013, KIDNEY INT, V84, P317, DOI 10.1038/ki.2013.98; Bossini-Castillo L, 2011, RHEUMATOLOGY, V50, P1976, DOI 10.1093/rheumatology/ker259; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Garbuzenko E, 2002, CLIN EXP ALLERGY, V32, P237, DOI 10.1046/j.1365-2222.2002.01293.x; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Heneberg P, 2011, CURR PHARM DESIGN, V17, P3741, DOI 10.2174/138161211798357818; Hori Y, 2003, EUR J HISTOCHEM, V47, P317; IRANI AMA, 1992, ARTHRITIS RHEUM, V35, P933, DOI 10.1002/art.1780350813; ISHIZAKA T, 1983, J IMMUNOL, V130, P2357; Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141; Kakizoe E, 2001, J INVEST DERMATOL, V116, P118, DOI 10.1046/j.1523-1747.2001.00165.x; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kanbe N, 2000, J ALLERGY CLIN IMMUN, V106, pS85, DOI 10.1067/mai.2000.106777; Kovarova Martina, 2012, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f10s97; Kovarova M, 2010, BLOOD, V115, P3695, DOI 10.1182/blood-2009-08-237206; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metcalfe D D, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0725s01; Mirzahosseini A, 2013, CELL IMMUNOL, V283, P38, DOI 10.1016/j.cellimm.2013.05.006; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; NISHIOKA K, 1987, ARCH DERMATOL, V123, P205, DOI 10.1001/archderm.123.2.205; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; OKAYAMA Y, 1992, CLIN EXP ALLERGY, V22, P401, DOI 10.1111/j.1365-2222.1992.tb03102.x; Ozbilgin MK, 2003, CLIN RHEUMATOL, V22, P189, DOI 10.1007/s10067-003-0706-5; Pawankar R, 2001, CURR OPIN ALLERGY CL, V1, P3, DOI 10.1097/01.all.0000010977.11360.f4; POSTLETHWAITE AE, 1984, J IMMUNOL, V132, P2470; Radinger Madeleine, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0737s90; Reber LL, 2014, J IMMUNOL, V192, P1847, DOI 10.4049/jimmunol.1300875; SAITO H, 1988, P NATL ACAD SCI USA, V85, P2288, DOI 10.1073/pnas.85.7.2288; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Selvi E, 2003, ANN RHEUM DIS, V62, P460, DOI 10.1136/ard.62.5.460; Shiota N, 2005, BRIT J PHARMACOL, V145, P424, DOI 10.1038/sj.bjp.0706209; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Tanino Y, 2002, AM J PHYSIOL-LUNG C, V283, pL156, DOI 10.1152/ajplung.00155.2001; Tas J, 1977, Acta Histochem Suppl, VSuppl 18, P95; Taylor JA, 2006, AM J PHYSIOL-RENAL, V291, pF1343, DOI 10.1152/ajprenal.00144.2006; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Walls Andrew F, 2014, Methods Mol Biol, V1192, P117, DOI 10.1007/978-1-4939-1173-8_9; Wang HW, 2005, EXP DERMATOL, V14, P295, DOI 10.1111/j.0906-6705.2005.00315.x; Wu SP, 2006, ARTHRITIS RHEUM-US, V54, P3661, DOI 10.1002/art.22179; Yukawa Sonosuke, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P81	51	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122482	10.1371/journal.pone.0122482	http://dx.doi.org/10.1371/journal.pone.0122482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826375	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800072
J	Miya, S; Takahashi, H; Nakagawa, M; Kuda, T; Igimi, S; Kimura, B				Miya, Satoko; Takahashi, Hajime; Nakagawa, Miku; Kuda, Takashi; Igimi, Shizunobu; Kimura, Bon			Genetic Characteristics of Japanese Clinical Listeria monocytogenes Isolates	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; LOCUS VARIABLE-NUMBER; FIELD GEL-ELECTROPHORESIS; FOOD-BORNE PATHOGEN; MULTISTATE OUTBREAK; SEAFOOD PRODUCTS; UNITED-STATES; TYPING METHOD; VIRULENCE; STRAINS	Listeria monocytogenes causes foodborne illnesses through consumption of ready-to-eat foods. Although 135-201 annual listeriosis cases have been estimated in Japan, the details regarding the clinical isolates such as infection source, virulence level, and other genetic characteristics, are not known. In order to uncover the trends of listeriosis in Japan and use the knowledge for prevention measures to be taken, the genetic characteristics of the past human clinical isolates needs to be elucidated. For this purpose, multilocus tandem-repeat sequence analysis (MLTSA) and multi-virulence-locus sequence typing (MVLST) were used in this study. The clinical isolates showed a variety of genetically distant genotypes, indicating they were from sporadic cases. However, the MVLST profiles of 7 clinical isolates were identical to those of epidemic clone (EC) I isolates, which have caused several serious outbreaks in other countries, suggesting the possibility that they have strong virulence potential and originated from a single outbreak. Moreover, 6 Japanese food isolates shared their genotypes with ECI isolates, indicating that there may be risks for listeriosis outbreak in Japan. This is the first investigational study on genetic characteristics of Japanese listeriosis isolates. The listeriosis cases happened in the past are presumably sporadic, but it is still possible that some isolates with strong virulence potential have caused listeriosis outbreaks, and future listeriosis risks also exist.	[Miya, Satoko; Takahashi, Hajime; Nakagawa, Miku; Kuda, Takashi; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Tokyo, Japan; [Igimi, Shizunobu] Natl Inst Hlth Sci, Div Biomed Food Res, Tokyo, Japan	Tokyo University of Marine Science & Technology; National Institute of Health Sciences - Japan	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Tokyo, Japan.	hajime@kaiyodai.ac.jp	KUDA, Takashi/O-1974-2014; Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343	Ministry of Education, Science, Sports and Culture of Japan [B 24380115]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a grant-in-aid for Scientific Research (B 24380115) from the Ministry of Education, Science, Sports and Culture of Japan, (http://www.jsps.go.jp/english/index.html) given to BK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2005, J CLIN MICROBIOL, V43, P5291, DOI 10.1128/JCM.43.10.5291-5294.2005; Chenal-Francisque V, 2013, J CLIN MICROBIOL, V51, P1868, DOI 10.1128/JCM.00606-13; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Franciosa G, 2001, APPL ENVIRON MICROB, V67, P1793, DOI 10.1128/AEM.67.4.1793-1799.2001; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Gray MJ, 2004, APPL ENVIRON MICROB, V70, P5833, DOI 10.1128/AEM.70.10.5833-5841.2004; Handa S, 2005, J FOOD PROTECT, V68, P411, DOI 10.4315/0362-028X-68.2.411; Handa-Miya S, 2007, INT J FOOD MICROBIOL, V117, P312, DOI 10.1016/j.ijfoodmicro.2007.05.003; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jeffers GT, 2001, MICROBIOL-SGM, V147, P1095, DOI 10.1099/00221287-147-5-1095; Kathariou S, 2006, FOODBORNE PATHOG DIS, V3, P292, DOI 10.1089/fpd.2006.3.292; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Lindstedt BA, 2008, J MICROBIOL METH, V72, P141, DOI 10.1016/j.mimet.2007.11.012; Liu DY, 2006, J CLIN MICROBIOL, V44, P4229, DOI 10.1128/JCM.01032-06; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Makino SI, 2005, INT J FOOD MICROBIOL, V104, P189, DOI 10.1016/j.ijfoodmicro.2005.02.009; Miya S, 2008, INT J FOOD MICROBIOL, V124, P239, DOI 10.1016/j.ijfoodmicro.2008.03.023; Miya S, 2012, J MICROBIOL METH, V90, P285, DOI 10.1016/j.mimet.2012.05.023; Miya S, 2010, APPL ENVIRON MICROB, V76, P3383, DOI 10.1128/AEM.01456-09; Murphy M, 2007, INT J FOOD MICROBIOL, V115, P187, DOI 10.1016/j.ijfoodmicro.2006.10.022; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Norton DM, 2001, APPL ENVIRON MICROB, V67, P646, DOI 10.1128/AEM.67.2.646-653.2001; Okutani A, 2004, EPIDEMIOL INFECT, V132, P769, DOI 10.1017/S0950268804001967; Olsen SJ, 2005, CLIN INFECT DIS, V40, P962, DOI 10.1086/428575; RASMUSSEN OF, 1995, MICROBIOL-SGM, V141, P2053, DOI 10.1099/13500872-141-9-2053; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; SCHUCHAT A, 1991, CLIN MICROBIOL REV, V4, P169, DOI 10.1128/CMR.4.2.169-183.1991; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Takahashi H, 2007, INT J FOOD MICROBIOL, V118, P274, DOI 10.1016/j.ijfoodmicro.2007.07.047; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; Wiedmann M, 1997, INFECT IMMUN, V65, P2707, DOI 10.1128/IAI.65.7.2707-2716.1997; Yamane K, 2012, INFECT AGENTS SURVEI, V33, P247; Yde M, 2010, EUROSURVEILLANCE, V15, P21; Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004	38	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122902	10.1371/journal.pone.0122902	http://dx.doi.org/10.1371/journal.pone.0122902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826318	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800097
J	dos Santos, CMM; Sato, FT; Cury-Boaventura, MF; Guirado-Rodrigues, SH; Cacula, KG; Santos, CCG; Hatanaka, E; de Oliveira, HH; Santos, VC; Murata, G; Borges-Silva, CN; Hirabara, SM; Pithon-Curi, TC; Gorjao, R				Momesso dos Santos, Cesar Miguel; Sato, Fabio Takeo; Cury-Boaventura, Maria Fernanda; Guirado-Rodrigues, Silvia Helena; Cacula, Kim Guimaraes; Goncalves Santos, Cristiane Cassoni; Hatanaka, Elaine; de Oliveira, Heloisa Helena; Santos, Vinicius Coneglian; Murata, Gilson; Borges-Silva, Cristina Neves; Hirabara, Sandro Massao; Pithon-Curi, Tania Cristina; Gorjao, Renata			Effect of Regular Circus Physical Exercises on Lymphocytes in Overweight Children	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; T-CELLS; TNF-ALPHA; WEIGHT-LOSS; OBESITY; INFLAMMATION; EXPRESSION; ADIPONECTIN; ACTIVATION	Obesity associated with a sedentary lifestyle can lead to changes in the immune system balance resulting in the development of inflammatory diseases. The aim of this study was to compare lymphocyte activation mechanisms between overweight children practicing regular circus physical exercises with non-exercised children. The study comprised 60 pubescent children randomly divided into 4 groups: Overweight Children (OWC) (10.67 +/- 0.22 years old), Overweight Exercised Children (OWE) (10.00 +/- 0.41 years old), Eutrophic Children (EC) (11.00 +/- 0.29 years old) and Eutrophic Exercised Children (EE) (10.60 +/- 0.29 years old). OWE and EE groups practiced circus activities twice a week, for 4.3 +/- 0.5 and 4.4 +/- 0.5 months, respectively. Percentage of T regulatory cells (Treg) and the expression of CD95 and CD25 in CD4(+) lymphocytes were evaluated by flow cytometry. Lymphocyte proliferation capacity was measured by [C-14]-thymidine incorporation and mRNA expression of IL-35, TGF-beta, IL-2 and IL-10 by real-time PCR. Lymphocyte proliferation was higher in OWC and OWE groups compared with the EC (3509 +/- 887; 2694 +/- 560, and 1768 +/- 208 cpm, respectively) and EE (2313 +/- 111 cpm) groups. CD95 expression on lymphocytes was augmented in the EC (953.9 +/- 101.2) and EE groups (736.7 +/- 194.6) compared with the OWC (522.1 +/- 125.2) and OWE groups (551.6 +/- 144.5). CTLA-4 expression was also lower in the OWC and OWE groups compared with the EC and EE groups. Percentage of Treg, IL-35, and IL-10 mRNA expression were lower in the OWC and OWE groups compared with the EC and EE groups. In conclusion, overweight children present altered immune system balance characterized by elevated lymphocyte proliferation due to a decrease in T regulatory cell percentage. These effects were partially reverted by moderate physical exercise, as demonstrated by decreased lymphocyte proliferation.	[Momesso dos Santos, Cesar Miguel; Cury-Boaventura, Maria Fernanda; Guirado-Rodrigues, Silvia Helena; Cacula, Kim Guimaraes; Goncalves Santos, Cristiane Cassoni; Hatanaka, Elaine; de Oliveira, Heloisa Helena; Borges-Silva, Cristina Neves; Hirabara, Sandro Massao; Pithon-Curi, Tania Cristina; Gorjao, Renata] Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil; [Sato, Fabio Takeo; Hatanaka, Elaine; Santos, Vinicius Coneglian; Murata, Gilson; Pithon-Curi, Tania Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade Cruzeiro do Sul; Universidade de Sao Paulo	Gorjao, R (corresponding author), Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil.	renata.gorjao@cruzeirodosul.edu.br	Hirabara, Sandro Massao/C-4014-2012; Hatanaka Dermargos, Elaine/HHZ-1180-2022; Cury-Boaventura, Maria Fernanda MF/B-3945-2012; Hatanaka, Elaine/AFL-1791-2022; Gorjão, Renata/D-4130-2013; Pithon-Curi, Tania Cristina/AAB-9436-2021; Sato, Fabio Takeo/AAS-6614-2020; Hatanaka, Elaine/D-6337-2012; Momesso, Cesar Miguel/D-3281-2012	Hirabara, Sandro Massao/0000-0002-7392-0444; Cury-Boaventura, Maria Fernanda MF/0000-0002-1596-0624; Hatanaka, Elaine/0000-0002-9716-1163; Momesso, Cesar Miguel/0000-0001-6448-6028; Gorjao, Renata/0000-0002-9655-1477; Sato, Fabio Takeo/0000-0002-9863-4364; de Oliveira Alves, Heloisa Helena/0000-0002-5378-4510; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Center of Lipid Education and Research (CLEaR); National Institute of Science and Technology in Obesity and Diabetes (INOD); Nucleus of Lipid Studies (NEL); Dean's Office for Research/University of Sao Paulo; Dean's Office for PostGraduate and Research/Cruzeiro do Sul University	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center of Lipid Education and Research (CLEaR); National Institute of Science and Technology in Obesity and Diabetes (INOD); Nucleus of Lipid Studies (NEL); Dean's Office for Research/University of Sao Paulo; Dean's Office for PostGraduate and Research/Cruzeiro do Sul University	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Center of Lipid Education and Research (CLEaR), National Institute of Science and Technology in Obesity and Diabetes (INOD), Nucleus of Lipid Studies (NEL), Dean's Office for Research/University of Sao Paulo, and Dean's Office for PostGraduate and Research/Cruzeiro do Sul University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; Breslin WL, 2012, PEDIATRICS, V129, pE1180, DOI 10.1542/peds.2011-2477; Chan EYT, 1996, J CLIN PATHOL, V49, P660, DOI 10.1136/jcp.49.8.660; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dandona P, 2007, AM J CARDIOL, V99, p15B, DOI 10.1016/j.amjcard.2006.11.003; Darvall KAL, 2007, EUR J VASC ENDOVASC, V33, P223, DOI 10.1016/j.ejvs.2006.10.006; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Ginaldi L, 2004, IMMUNOL RES, V30, P81, DOI 10.1385/IR:30:1:081; Gong LY, 2014, J PEDIATR-US, V164, P795, DOI 10.1016/j.jpeds.2013.12.004; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hosick P, 2013, PEDIATR EXERC SCI, V25, P238, DOI 10.1123/pes.25.2.238; Izadpanah A, 2012, AM J PHYSIOL-ENDOC M, V303, pE542, DOI 10.1152/ajpendo.00190.2012; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Karman J, 2012, J BIOL CHEM, V287, P11098, DOI 10.1074/jbc.M111.283705; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; KIMURA GM, 1981, PEDIATR RES, V15, P1271, DOI 10.1203/00006450-198109000-00009; Koistinen HA, 2000, EUR J CLIN INVEST, V30, P302; Kraszula L, 2012, NEUROL NEUROCHIR POL, V46, P22, DOI 10.5114/ninp.2012.27211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; MARSHALL WA, 1969, DEV MED CHILD NEUROL, V11, P517; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; MATSUDO SMM, 1994, AM J HUM BIOL, V6, P451, DOI 10.1002/ajhb.1310060406; McFarlin BK, 2013, MATERN CHILD NUTR, V9, P524, DOI 10.1111/j.1740-8709.2011.00398.x; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; ORR DP, 1988, J ADOLESCENT HEALTH, V9, P273, DOI 10.1016/0197-0070(88)90249-5; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; PAULI RM, 1973, EXP CELL RES, V82, P357, DOI 10.1016/0014-4827(73)90353-4; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Volp ACP, 2008, ARQ BRAS ENDOCRINOL, V52, P537, DOI 10.1590/S0004-27302008000300015; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rolland C, 2011, DIABETES METAB SYNDR, V4, P315, DOI 10.2147/DMSO.S22788; Russell M, 2009, J CLIN ENDOCR METAB, V94, P2864, DOI 10.1210/jc.2009-0380; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; Sanchez J, 2010, BEHAV BRAIN RES, V213, P183, DOI 10.1016/j.bbr.2010.04.051; Schwarzenberg SJ, 2006, PAEDIATR RESPIR REV, V7, P239, DOI 10.1016/j.prrv.2006.08.002; Shimizu K, 2008, EXERC IMMUNOL REV, V14, P24; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tattersfield AE, 2002, LANCET, V360, P1313, DOI 10.1016/S0140-6736(02)11312-2; Timmons BW, 2007, BRAIN BEHAV IMMUN, V21, P442, DOI 10.1016/j.bbi.2006.11.007; Tokano Y, 1997, SCAND J RHEUMATOL, V26, P37, DOI 10.3109/03009749709065662; Tu WZ, 2011, HYPERTENSION, V58, P818, DOI 10.1161/HYPERTENSIONAHA.111.175695; Wu JT, 2006, CLIN CHIM ACTA, V366, P74, DOI 10.1016/j.cca.2005.10.016; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Yuksel H, 2012, ALLERGY ASTHMA IMMUN, V4, P98, DOI 10.4168/aair.2012.4.2.98	55	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120262	10.1371/journal.pone.0120262	http://dx.doi.org/10.1371/journal.pone.0120262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826263	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800015
J	Wang, XX; Feng, J; Yu, CH; Shen, QWW; Wang, YZ				Wang, Xinxia; Feng, Jie; Yu, Caihua; Shen, Qingwu W.; Wang, Yizhen			Alterations in Oral [1-C-14] 18:1n-9 Distribution in Lean Wild-Type and Genetically Obese (ob/ob) Mice	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; ACYL-COA SYNTHETASE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; BINDING; METABOLISM; OXIDATION; PROTEIN; ALPHA; DEFICIENCY	Obesity may result from altered fatty acid (FA) disposal. Altered FA distribution in obese individuals is poorly understood. Lean wild-type C57BL/6J and obese C57BL/6J(ob/ob) mice received an oral dose of [1-C-14] 18:1n-9 (oleic acid), and the radioactivity in tissues was evaluated at various time points. The C-14 concentration decreased rapidly in gastrointestinal tract but gradually increased and peaked at 96 h in adipose tissue, muscle and skin in lean mice. The C-14 concentration was constant in adipose tissue and muscle of obese mice from 4h to 168h. C-14-label content in adipose tissue was significantly affected by genotype, whereas muscle 14C-label content was affected by genotype, time and the interaction between genotype and time. There was higher total C-14 retention (47.7%) in obese mice than in lean mice (9.0%) at 168 h (P< 0.05). The C-14 concentrations in the soleus and gastrocnemius muscle were higher in obese mice than in lean mice (P< 0.05). Perirenal adipose tissue contained the highest C-14 content in lean mice, whereas subcutaneous adipose tissue (SAT) had the highest C-14 content and accounted for the largest proportion of total radioactivity among fat depots in obese mice. More lipid radioactivity was recovered as TAG in SAT from obese mice than from lean mice (P< 0.05). Gene expression suggested acyl CoA binding protein and fatty acid binding protein are important for FA distribution in adipose tissue and muscle. The FA distribution in major tissues was altered in ob/ob mice, perhaps contributing to obesity. Understanding the disparity in FA disposal between lean and obese mice may reveal novel targets for the treatment and prevention of obesity.	[Wang, Xinxia; Feng, Jie; Yu, Caihua; Wang, Yizhen] Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Zhejiang Prov Lab Feed & Anim Nutr, Coll Anim Sci,Minist Educ,Minist Agr,Key Lab Mol, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Qingwu W.] Northwest A&F Univ, Dept Anim Sci, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Northwest A&F University - China	Shen, QWW (corresponding author), Northwest A&F Univ, Dept Anim Sci, Yangling, Shaanxi, Peoples R China.	yaoyao3153@aliyun.com; yzwang@zju.edu.cn		wang, yizhen/0000-0002-3908-7102	National Basic Research Program of China (973 Program) [2012CB124705]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by a grant from National Basic Research Program of China (973 Program) (No. 2012CB124705); http://program.most.gov.cn/; XW and YW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bonen A, 1998, AM J PHYSIOL-ENDOC M, V275, pE471, DOI 10.1152/ajpendo.1998.275.3.E471; Breslow MJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE443, DOI 10.1152/ajpendo.1999.276.3.E443; Budohoski L, 1996, AM J PHYSIOL-ENDOC M, V271, pE574, DOI 10.1152/ajpendo.1996.271.3.E574; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coburn CT, 2001, J MOL NEUROSCI, V16, P117, DOI 10.1385/JMN:16:2-3:117; Cunnane SC, 1996, CAN J PHYSIOL PHARM, V74, P629, DOI 10.1139/cjpp-74-6-629; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu Z, 2001, LIPIDS, V36, P255, DOI 10.1007/s11745-001-0715-7; Glatz JFC, 2002, MOL CELL BIOCHEM, V239, P3, DOI 10.1023/A:1020529918782; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Jensen MD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1282, DOI 10.1152/ajpendo.00220.2003; KNUDSEN J, 1990, MOL CELL BIOCHEM, V98, P217; Koutsari C, 2008, DIABETES, V57, P1186, DOI 10.2337/db07-0664; LEYTON J, 1987, BRIT J NUTR, V57, P383, DOI 10.1079/BJN19870046; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121; PAGLIASSOTTI MJ, 1995, OBES RES, V3, P459, DOI 10.1002/j.1550-8528.1995.tb00175.x; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rinaldo P, 2001, SEMIN LIVER DIS, V21, P489, DOI 10.1055/s-2001-19037; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; Turcotte LP, 2001, DIABETES, V50, P1389, DOI 10.2337/diabetes.50.6.1389; Turcotte LP, 2000, MOL CELL BIOCHEM, V210, P53, DOI 10.1023/A:1007046929776; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]	32	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122028	10.1371/journal.pone.0122028	http://dx.doi.org/10.1371/journal.pone.0122028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826747	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800057
J	Anitua, E; Zalduendo, M; Troya, M; Padilla, S; Orive, G				Anitua, Eduardo; Zalduendo, Mar; Troya, Maria; Padilla, Sabino; Orive, Gorka			Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN GINGIVAL FIBROBLASTS; GROWTH-FACTORS; PORPHYROMONAS-GINGIVALIS; MATRIX METALLOPROTEINASE-1; MAXILLOFACIAL SURGERY; TISSUE REGENERATION; CURRENT KNOWLEDGE; CYTOKINES; EXPRESSION	One of the main differences among platelet-rich plasma (PRP) products is the inclusion of leukocytes that may affect the biological efficacy of these autologous preparations. The purpose of this study was to evaluate whether the addition of leukocytes modified the morphological, biomechanical and biological properties of PRP under normal and inflammatory conditions. The release of pro-inflammatory cytokines from plasma rich in growth factors (PRGF) and leukocyte-platelet rich plasma (L-PRP) scaffolds was determined by enzymelinked immunosorbent assay (ELISA) and was significantly increased under an inflammatory condition when leukocytes were included in the PRP. Fibroblasts and osteoblasts treated with L-PRP, under an inflammatory situation, underwent a greater activation of NF kappa B pathway, proliferated significantly less and secreted a higher concentration of pro-inflammatory cytokines. These cellular events were assessed through Western blot and fluorimetric and ELISA methods, respectively. Therefore, the inclusion of leukocytes induced significantly higher pro-inflammatory conditions.	[Anitua, Eduardo; Orive, Gorka] Fdn Eduardo Anitua, Vitoria, Spain; [Anitua, Eduardo; Zalduendo, Mar; Troya, Maria; Padilla, Sabino] Biotechnol Inst BTI, Lab Regenerat Med, Vitoria, Spain		Orive, G (corresponding author), Fdn Eduardo Anitua, Vitoria, Spain.	gorka.orive@ehu.es	Anitua, Eduardo/O-1154-2018; Zalduendo, Mar/N-7896-2018; Troya, Maria/N-7897-2018	Anitua, Eduardo/0000-0002-8386-5303; Zalduendo, Mar/0000-0001-8458-6042; ORIVE, GORKA/0000-0002-0773-300X; Troya, Maria/0000-0002-5308-0505	Bioperio Saiotek project (Basque Government)	Bioperio Saiotek project (Basque Government)(Basque Government)	This study was funded by Bioperio Saiotek project (Basque Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23; Anitua E, 2006, J BIOMED MATER RES A, V77A, P285, DOI 10.1002/jbm.a.30585; Anitua E, 2014, J BIOMED MAT RES A; Anitua E., 2013, J TISSUE ENG REGEN M; Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; Anitua E, 2013, INT J ORAL MAX IMPL, V28, P1338, DOI 10.11607/jomi.3137; Anitua E, 2013, J PERIODONTOL, V84, P1180, DOI 10.1902/jop.2012.120292; Anitua E, 2012, OPER TECH ORTHOP, V22, P25, DOI 10.1053/j.oto.2012.01.004; Anitua E, 2012, J PERIODONTOL, V83, P1028, DOI 10.1902/jop.2011.110505; Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Belibasakis GN, 2011, MICROB PATHOGENESIS, V50, P6, DOI 10.1016/j.micpath.2010.11.002; Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004; Del Corso M, 2012, CURR PHARM BIOTECHNO, V13, P1207, DOI 10.2174/138920112800624391; Domeij H, 2006, J PERIODONTAL RES, V41, P108, DOI 10.1111/j.1600-0765.2005.00840.x; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ginty PJ, 2011, REGEN MED, V6, P241, DOI 10.2217/RME.10.89; Giovanini AF, 2013, J CRANIO MAXILL SURG, V41, pE180, DOI 10.1016/j.jcms.2013.01.003; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Humes HD, 2005, J LAB CLIN MED, V146, P51, DOI 10.1016/j.lab.2005.03.012; Imatani T, 2001, ORAL MICROBIOL IMMUN, V16, P65, DOI 10.1034/j.1399-302x.2001.016002065.x; Kishuku M, 2009, J IMMUNOL, V183, P8176, DOI 10.4049/jimmunol.0803849; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Li JP, 2012, J PERIODONTOL, V83, P816, DOI 10.1902/jop.2011.110458; McCarrel T, 2009, J ORTHOP RES, V27, P1033, DOI 10.1002/jor.20853; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Muto T, 2013, J ORTHOP RES, V31, P976, DOI 10.1002/jor.22301; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pillitteri D, 2007, PLATELETS, V18, P119, DOI 10.1080/09537100600800792; Portela GS, 2013, INT J ORAL MAXILLOFA; Redler LH, 2011, PHYSICIAN SPORTSMED, V39, P42, DOI 10.3810/psm.2011.02.1861; Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006; Sanchez M, 2007, AM J SPORT MED, V35, P245, DOI 10.1177/0363546506294078; Scheres N, 2011, MICROB PATHOGENESIS, V51, P149, DOI 10.1016/j.micpath.2011.04.006; Scott A, 2004, BRIT J SPORT MED, V38, P372, DOI 10.1136/bjsm.2004.011312; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c; Simonpieri A, 2012, CURR PHARM BIOTECHNO, V13, P1231, DOI 10.2174/138920112800624472; Sundararaj KP, 2009, J BIOL CHEM, V284, P13714, DOI 10.1074/jbc.M806573200; Sundman EA, 2011, AM J SPORT MED, V39, P2135, DOI 10.1177/0363546511417792; Tang L, 2011, ARCH ORAL BIOL, V56, P1064, DOI 10.1016/j.archoralbio.2011.02.020; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang PL, 2000, BIOCHEM BIOPH RES CO, V273, P1161, DOI 10.1006/bbrc.2000.3060; Wasterlain AS, 2012, OPER TECH ORTHOP, V22, P33, DOI 10.1053/j.oto.2011.11.001; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wroblewski AP, 2010, OPER TECH ORTHOP, V20, P98, DOI 10.1053/j.oto.2009.10.006; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003	59	92	92	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121713	10.1371/journal.pone.0121713	http://dx.doi.org/10.1371/journal.pone.0121713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823008	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700121
J	Arab, HH; Salama, SA; Omar, HA; Arafa, ESA; Maghrabi, IA				Arab, Hany H.; Salama, Samir A.; Omar, Hany A.; Arafa, El-Shaimaa A.; Maghrabi, Ibrahim A.			Diosmin Protects against Ethanol-Induced Gastric Injury in Rats: Novel Anti-Ulcer Actions	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; OXIDATIVE STRESS; MUCOSAL INJURY; PROSTAGLANDIN E-2; ULCER; ANTIOXIDANT; MODULATION; SUCRALFATE; EXPRESSION	Alcohol consumption has been commonly associated with gastric mucosal lesions including gastric ulcer. Diosmin (DIO) is a natural citrus flavone with remarkable antioxidant and anti-inflammatory features that underlay its protection against cardiac, hepatic and renal injuries. However, its impact on gastric ulcer has not yet been elucidated. Thus, the current study aimed to investigate the potential protective effects of DIO against ethanol-induced gastric injury in rats. Pretreatment with DIO (100 mg/kg p.o.) attenuated the severity of ethanol gastric mucosal damage as evidenced by lowering of ulcer index (UI) scores, area of gastric lesions, histopathologic aberrations and leukocyte invasion. These actions were analogous to those exerted by the reference antiulcer sucralfate. DIO suppressed gastric inflammation by curbing of myeloperoxidase (MPO) and tumor necrosis factor-alpha (TNF-alpha) levels along with nuclear factor kappa B (NF-kappa B) p65 expression. It also augmented the anti-inflammatory interleukin-10 (IL-10) levels. Meanwhile, DIO halted gastric oxidative stress via inhibition of lipid peroxides with concomitant enhancement of glutathione (GSH), glutathione peroxidase (GPx) and the total antioxidant capacity (TAC). With respect to gastric mucosal apoptosis, DIO suppressed caspase-3 activity and cytochrome C (Cyt C) with enhancement of the anti-apoptotic B cell lymphoma-2 (Bcl-2) in favor of cell survival. These favorable actions were associated with upregulation of the gastric cytoprotective prostaglandin E-2 (PGE(2)) and nitric oxide (NO). Together, these findings accentuate the gastroprotective actions of DIO in ethanol gastric injury which were mediated via concerted multi-pronged actions, including suppression of gastric inflammation, oxidative stress and apoptosis besides boosting of the antioxidant and the cytoprotective defenses.	[Arab, Hany H.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo 11562, Egypt; [Arab, Hany H.; Salama, Samir A.] Taif Univ, Div Biochem, Fac Pharm, Dept Pharmacol & Toxicol, At Taif 21974, Saudi Arabia; [Arab, Hany H.; Salama, Samir A.] Taif Univ, GTMR Unit, Fac Pharm, Dept Pharmacol & Toxicol, At Taif 21974, Saudi Arabia; [Salama, Samir A.] Al Azhar Univ, Fac Pharm, Dept Biochem, Cairo 11751, Egypt; [Omar, Hany A.; Arafa, El-Shaimaa A.] Beni Suef Univ, Fac Pharm, Dept Pharmacol, Bani Suwayf 62514, Egypt; [Omar, Hany A.] Univ Sharjah, Sharjah Inst Med Res, Coll Pharm, Sharjah 27272, U Arab Emirates; [Maghrabi, Ibrahim A.] Taif Univ, Fac Pharm, Dept Clin Pharm, At Taif 21974, Saudi Arabia	Egyptian Knowledge Bank (EKB); Cairo University; Taif University; Taif University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Beni Suef University; University of Sharjah; Taif University	Arab, HH (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo 11562, Egypt.	hany.arab@pharma.cu.edu.eg	Arab, Hany/AAF-3652-2020; Salama, Samir/B-8153-2013; Omar, Hany/B-7440-2013; Arafa, El-Shaimaa A/C-4777-2013; Arafa, Elshaimaa/Q-1316-2019	Arab, Hany/0000-0002-4195-6901; Salama, Samir/0000-0002-5210-1781; Omar, Hany/0000-0002-4670-8149; Arafa, El-Shaimaa A/0000-0002-9034-6624; Arafa, Elshaimaa/0000-0002-9034-6624				Abdallah DM, 2010, EUR J PHARMACOL, V627, P276, DOI 10.1016/j.ejphar.2009.10.037; Abdelwahab SI, 2013, INT IMMUNOPHARMACOL, V16, P296, DOI 10.1016/j.intimp.2013.04.005; Al Batran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064751; Al Moutaery M, 2012, EXP TOXICOL PATHOL, V64, P233, DOI 10.1016/j.etp.2010.08.012; Campanero MA, 2010, J PHARMACEUT BIOMED, V51, P875, DOI 10.1016/j.jpba.2009.09.012; Antonisamy P, 2014, CHEM-BIOL INTERACT, V224, P157, DOI 10.1016/j.cbi.2014.09.020; Arab HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097193; Arab HH, 2014, FOOD CHEM TOXICOL, V69, P294, DOI 10.1016/j.fct.2014.04.032; Augusto AC, 2007, CLIN BIOCHEM, V40, P615, DOI 10.1016/j.clinbiochem.2007.03.014; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Buege J A, 1978, Methods Enzymol, V52, P302; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Crow J P, 1995, Adv Pharmacol, V34, P17; El-Abhar HS, 2010, EUR J PHARMACOL, V649, P314, DOI 10.1016/j.ejphar.2010.09.012; Franke A, 2005, DIGEST DIS, V23, P204, DOI 10.1159/000090167; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/974185; GUSLANDI M, 1987, Digestive Diseases, V5, P21, DOI 10.1159/000171159; Halabi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095908; Handa O, 2004, J PHARMACOL EXP THER, V309, P670, DOI 10.1124/jpet.103.062216; Hasgul R, 2014, TOXICOL IND HEALTH, V30, P888, DOI 10.1177/0748233712466134; Heeba GH, 2009, EUR J PHARMACOL, V607, P188, DOI 10.1016/j.ejphar.2009.02.008; Khan AQ, 2012, TOXICOLOGY, V302, P266, DOI 10.1016/j.tox.2012.08.008; KONTUREK SJ, 1995, SCAND J GASTROENTERO, V30, P22, DOI 10.3109/00365529509090264; LAINE L, 1988, GASTROENTEROLOGY, V94, P1254, DOI 10.1016/0016-5085(88)90661-0; Li WF, 2013, TOXICOL APPL PHARM, V272, P21, DOI 10.1016/j.taap.2013.05.035; Liu Y, 2012, ENVIRON TOXICOL PHAR, V34, P280, DOI 10.1016/j.etap.2012.04.009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo XJ, 2013, ALCOHOL, V47, P481, DOI 10.1016/j.alcohol.2013.05.005; Lyseng-Williamson KA, 2003, DRUGS, V63, P71, DOI 10.2165/00003495-200363010-00005; Mei XT, 2012, CHEM-BIOL INTERACT, V197, P31, DOI 10.1016/j.cbi.2012.03.006; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nagy L, 2007, WORLD J GASTROENTERO, V13, P2053, DOI 10.3748/wjg.v13.i14.2053; Nartey ET, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-65; Nwafor PA, 2000, J ETHNOPHARMACOL, V72, P421, DOI 10.1016/S0378-8741(00)00261-0; Pan JS, 2008, WORLD J GASTROENTERO, V14, P5857, DOI 10.3748/wjg.14.5857; Pari L, 2010, BIOMED PHARMACOTHER, V64, P477, DOI 10.1016/j.biopha.2010.02.001; Park SW, 2008, J GASTROEN HEPATOL, V23, P976, DOI 10.1111/j.1440-1746.2008.05333.x; Queenthy SS, 2013, EUR J PHARMACOL, V718, P213, DOI 10.1016/j.ejphar.2013.08.031; Rehman MU, 2013, BRIT J NUTR, V110, P699, DOI 10.1017/S0007114512005752; Sacanella E, 1999, ALCOHOL ALCOHOLISM, V34, P678, DOI 10.1093/alcalc/34.5.678; Salga MS, 2012, CHEM-BIOL INTERACT, V195, P144, DOI 10.1016/j.cbi.2011.11.008; Sangiovanni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071762; Santos FA, 2001, DIGEST DIS SCI, V46, P331, DOI 10.1023/A:1005604932760; SHEADONOHUE T, 1986, GASTROENTEROLOGY, V91, P660, DOI 10.1016/0016-5085(86)90636-0; Sheng HM, 1998, CANCER RES, V58, P362; Silambarasan T, 2012, EUR J PHARMACOL, V679, P81, DOI 10.1016/j.ejphar.2011.12.040; Slomiany BL, 1999, SCAND J GASTROENTERO, V34, P459, DOI 10.1080/003655299750026164; Srinivasan S, 2012, CHEM-BIOL INTERACT, V195, P43, DOI 10.1016/j.cbi.2011.10.003; SZABO S, 1992, CLIN CHIM ACTA, V206, P95, DOI 10.1016/0009-8981(92)90010-N; Tahir M, 2013, TOXICOL LETT, V220, P205, DOI 10.1016/j.toxlet.2013.04.004; Tahir M, 2013, ALCOHOL, V47, P131, DOI 10.1016/j.alcohol.2012.12.010; Takeuchi K, 2000, ALIMENT PHARM THERAP, V14, P125, DOI 10.1046/j.1365-2036.2000.014s1125.x; Wada K, 1997, PHARMACOLOGY, V54, P57, DOI 10.1159/000139470; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Yadav SK, 2012, FREE RADICAL BIO MED, V52, P1175, DOI 10.1016/j.freeradbiomed.2011.12.023; Yamamoto S, 2012, AM J PHYSIOL-GASTR L, V302, pG773, DOI 10.1152/ajpgi.00324.2011; Ye HH, 2013, CLIN RES HEPATOL GAS, V37, pE3, DOI 10.1016/j.clinre.2012.03.004; Zhang L, 2012, CURR MED CHEM, V19, P63, DOI 10.2174/092986712803413926	60	148	150	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122417	10.1371/journal.pone.0122417	http://dx.doi.org/10.1371/journal.pone.0122417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821971	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700172
J	Fausther, M; Goree, JR; Lavoie, EG; Graham, AL; Sevigny, J; Dranoff, JA				Fausther, Michel; Goree, Jessica R.; Lavoie, Elise G.; Graham, Alicia L.; Sevigny, Jean; Dranoff, Jonathan A.			Establishment and Characterization of Rat Portal Myofibroblast Cell Lines	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER FIBROSIS; FIBROBLASTS; FIBROGENESIS; EXPRESSION; ORIGIN; BETA	The major sources of scar-forming myofibroblasts during liver fibrosis are activated hepatic stellate cells (HSC) and portal fibroblasts (PF). In contrast to well-characterized HSC, PF remain understudied and poorly defined. This is largely due to the facts that isolation of rodent PF for functional studies is technically challenging and that PF cell lines had not been established. To address this, we have generated two polyclonal portal myofibroblast cell lines, RGF and RGF-N2. RGF and RGF-N2 were established from primary PF isolated from adult rat livers that underwent culture activation and subsequent SV40-mediated immortalization. Specifically, Ntpdase2/Cd39l1-sorted primary PF were used to generate the RGF-N2 cell line. Both cell lines were functionally characterized by RT-PCR, immunofluorescence, immunoblot and bromodeoxyuridine-based proliferation assay. First, immortalized RGF and RGF-N2 cells are positive for phenotypic myofibroblast markers alpha smooth muscle actin, type I collagen alpha-1, tissue inhibitor of metalloproteinases-1, PF-specific markers elastin, type XV collagen alpha-1 and Ntpdase2/Cd39l1, and mesenchymal cell marker ecto-5'-nucleotidase/Cd73, while negative for HSC-specific markers desmin and lecithin retinol acyltransferase. Second, both RGF and RGF-N2 cell lines are readily transfectable using standard methods. Finally, RGF and RGF-N2 cells attenuate the growth of Mz-ChA-1 cholangiocarcinoma cells in co-culture, as previously demonstrated for primary PF. Immortalized rat portal myofibroblast RGF and RGF-N2 cell lines express typical markers of activated PF-derived myofibroblasts, are suitable for DNA transfection, and can effectively inhibit cholangiocyte proliferation. Both RGF and RGF-N2 cell lines represent novel in vitro cellular models for the functional studies of portal (myo) fibroblasts and their contribution to the progression of liver fibrosis.	[Fausther, Michel; Goree, Jessica R.; Lavoie, Elise G.; Graham, Alicia L.; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA; [Fausther, Michel; Goree, Jessica R.; Lavoie, Elise G.; Dranoff, Jonathan A.] Cent Arkansas VA Healthcare Syst, Res Serv, Little Rock, AR USA; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Sevigny, Jean] CHU Quebec, Ctr Rech, Charlesbourg, PQ, Canada	University of Arkansas System; University of Arkansas Medical Sciences; Laval University	Fausther, M (corresponding author), Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA.	mfausther@uams.edu	Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012	Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Fausther, Michel/0000-0002-5673-9360	Gilead Sciences Research Scholars Program in Liver Disease Award (UAMS) [271G141616-01]; Canadian Institutes of Health Research [MOP-102472]; National Institutes of Health (NIH)-National Institute of Diabetes and Digestive and Kidney Diseases (NIH/R01) [DK070849]; NIH National Center for Research Resources-University of Arkansas for Medical Sciences Institutional Support [UL1TR000039]; NIH National Center for Advancing Translational Sciences-University of Arkansas for Medical Sciences Institutional Support [UL1TR000039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER	Gilead Sciences Research Scholars Program in Liver Disease Award (UAMS); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)-National Institute of Diabetes and Digestive and Kidney Diseases (NIH/R01); NIH National Center for Research Resources-University of Arkansas for Medical Sciences Institutional Support; NIH National Center for Advancing Translational Sciences-University of Arkansas for Medical Sciences Institutional Support; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by Gilead Sciences Research Scholars Program in Liver Disease Award (UAMS#271G141616-01) to MF, www.gilead.com; Canadian Institutes of Health Research (#MOP-102472) to JS, www.cihr-irsc.gc.ca; National Institutes of Health (NIH)-National Institute of Diabetes and Digestive and Kidney Diseases (NIH/R01#DK070849) to JAD, http://www.niddk.nih.gov/Pages/default.aspx; and NIH National Center for Research Resources and National Center for Advancing Translational Sciences (#UL1TR000039)-University of Arkansas for Medical Sciences Institutional Support, www.ncats.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosselut N, 2010, PROTEOMICS, V10, P1017, DOI 10.1002/pmic.200900257; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Dezso K, 2007, AM J PATHOL, V171, P1529, DOI 10.2353/ajpath.2007.070273; Dranoff JA, 2002, HEPATOLOGY, V36, P1135, DOI 10.1053/jhep.2002.36823; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Fausther Michel, 2013, Curr Pathobiol Rep, V1, P225; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; GREENWEL P, 1991, LAB INVEST, V65, P644; Guo JS, 2010, J BIOL CHEM, V285, P5428, DOI 10.1074/jbc.M109.035295; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2012, Proc Am Thorac Soc, V9, P137, DOI 10.1513/pats.201202-017AW; Ijzer Jooske, 2006, Comp Hepatol, V5, P7, DOI 10.1186/1476-5926-5-7; Iwaisako Keiko, 2014, Curr Pathobiol Rep, V2, P209; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Jhandier MN, 2005, J BIOL CHEM, V280, P22986, DOI 10.1074/jbc.M412371200; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kruglov EA, 2002, J INVEST MED, V50, P179, DOI 10.2310/6650.2002.33431; Lemoinne S, 2014, HEPATOLOGY; Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Mezaki Y, 2013, ACTA HISTOCHEM CYTOC, V46, P137, DOI 10.1267/ahc.13007; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Ramadori G, 2004, LAB INVEST, V84, P153, DOI 10.1038/labinvest.3700030; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Tateaki Y, 2004, HISTOCHEM CELL BIOL, V122, P41, DOI 10.1007/s00418-004-0666-0; Vogel S, 2000, J LIPID RES, V41, P882; Wells Rebecca G, 2014, Curr Pathobiol Rep, V2, P185; Wells RG, 2014, GASTROENTEROLOGY, V147, P41, DOI 10.1053/j.gastro.2014.05.001; Wen JW, 2012, JOVE-J VIS EXP, DOI 10.3791/3669; Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	38	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121161	10.1371/journal.pone.0121161	http://dx.doi.org/10.1371/journal.pone.0121161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822334	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700094
J	Hao, YP; Ma, XJ; Luo, YQ; Xu, YT; Xiong, Q; Zhu, JA; Bao, YQ; Jia, WP				Hao, Yaping; Ma, Xiaojing; Luo, Yuqi; Xu, Yiting; Xiong, Qin; Zhu, Jiaan; Bao, Yuqian; Jia, Weiping			Inverse Association of Serum Vitamin D in Relation to Carotid Intima-Media Thickness in Chinese Postmenopausal Women	PLOS ONE			English	Article							D DEFICIENCY; OSTEOCALCIN LEVELS; D INADEQUACY; RISK; PREVALENCE; FAT; ATHEROSCLEROSIS; ESTROGEN; DISEASE	Objective This study aimed to investigate the relationship between serum vitamin D level and carotid intima-media thickness (C-IMT) in Chinese postmenopausal women. Methods Nine hundred and twenty six Chinese postmenopausal women without carotid artery plaque or history of cardiovascular disease were selected for analysis. Measurements of serum 25 hydroxyvitamin D-3 (25(OH)D-3) concentration and C-IMT were made by electrochemiluminescence immunoassay and B-mode ultrasound, respectively. Trend analysis was conducted according to tertiles of C-IMT. Results The median serum 25(OH)D-3 level was 11.03 ng/mL, with an interquartile range of 8.22-14.70. A decreasing trend of serum 25(OH)D-3 level was accompanied by increased C-IMT tertiles (P for trend = 0.001). Correlation analysis found an inverse relationship between serum 25(OH) D-3 level and C-IMT (r = -0.113, P = 0.001). After adjustment for confounding factors, multiple regression analysis showed that serum 25(OH) D-3 level independently and negatively associated with C-IMT (Standard beta = -0.112, P < 0.001). Moreover, the inverse correlation of serum 25(OH) D-3 with C-IMT was also found in a subgroup of women with normal glucose tolerance, blood pressure and body mass index, and without undergoing lipid-lowering therapy (standard beta = -0.140, P = 0.018). Conclusions Serum 25(OH)D-3 level was inversely correlated with C-IMT in Chinese postmenopausal women.	[Hao, Yaping; Ma, Xiaojing; Luo, Yuqi; Xu, Yiting; Xiong, Qin; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai Clin Ctr Diabet,Shanghai Key Clin Ctr Me, Shanghai 200233, Peoples R China; [Zhu, Jiaan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Inst Ultrasound Med, Dept Ultrasound, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai Clin Ctr Diabet,Shanghai Key Clin Ctr Me, Shanghai 200233, Peoples R China.	byq522@163.com			973 Program of China [2013CB530606]; National Key Technology R&D Program of China [2012BAI02B03]; Project of National Natural Science Foundation of China [81100563]; Key Project of Science and Technology of Shanghai [13XD1403000]; Shanghai Health and Family Planning Commission [2013ZYJB1001]	973 Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Shanghai Health and Family Planning Commission	This work was funded by 973 Program of China (2013CB530606), National Key Technology R&D Program of China (2012BAI02B03), Project of National Natural Science Foundation of China (81100563), Key Project of Science and Technology of Shanghai (13XD1403000), and Grant from Shanghai Health and Family Planning Commission (2013ZYJB1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri P, 2013, EUR J ENDOCRINOL, V169, P767, DOI 10.1530/EJE-13-0510; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Noncommunicable Disease Surveillance, 1999, REP WHO CONS DEF DIA; Dong JH, 2013, KIDNEY INT, V84, P54, DOI 10.1038/ki.2013.12; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Knox S, 2012, ATHEROSCLEROSIS, V223, P437, DOI 10.1016/j.atherosclerosis.2012.05.001; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lim SK, 2008, CURR MED RES OPIN, V24, P99, DOI 10.1185/030079908X253429; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Looker AC, 2005, J CLIN ENDOCR METAB, V90, P635, DOI 10.1210/jc.2004-1765; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Paschoalin RP, 2012, TRANSPL P, V44, P2588, DOI 10.1016/j.transproceed.2012.09.049; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SALONEN JT, 1993, CIRCULATION, V87, P56; Schierbeck LL, 2012, EUR J ENDOCRINOL, V167, P553, DOI 10.1530/EJE-12-0283; Sibal L, 2011, DIABET METAB SYND OB, V4, P23, DOI 10.2147/DMSO.S8540; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Targher G, 2006, CLIN ENDOCRINOL, V65, P593, DOI 10.1111/j.1365-2265.2006.02633.x; Truesdell D, 2011, J WOMENS HEALTH, V20, P1341, DOI 10.1089/jwh.2010.2599; Wang Y, 2012, INT J OBESITY, V36, P1203, DOI 10.1038/ijo.2011.222; Wat WZM, 2007, ANN NUTR METAB, V51, P59, DOI 10.1159/000100822; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang R, 2013, MENOPAUSE, V20, P1194, DOI [10.1097/gme.0b013e31828aa32d, 10.1097/GME.0b013e31828aa32d]	31	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122803	10.1371/journal.pone.0122803	http://dx.doi.org/10.1371/journal.pone.0122803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822845	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700199
J	Kirk, ER; van Kessel, C; Horwath, WR; Linquist, BA				Kirk, Emilie R.; van Kessel, Chris; Horwath, William R.; Linquist, Bruce A.			Estimating Annual Soil Carbon Loss in Agricultural Peatland Soils Using a Nitrogen Budget Approach	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; SAN-JOAQUIN DELTA; FERTILIZER NITROGEN; USE EFFICIENCY; SUBSIDENCE RATES; RICE FIELDS; STRAW; MINERALIZATION; CALIFORNIA; NITRATE	Around the world, peatland degradation and soil subsidence is occurring where these soils have been converted to agriculture. Since initial drainage in the mid-1800s, continuous farming of such soils in the California Sacramento-San Joaquin Delta (the Delta) has led to subsidence of up to 8 meters in places, primarily due to soil organic matter (SOM) oxidation and physical compaction. Rice (Oryza sativa) production has been proposed as an alternative cropping system to limit SOM oxidation. Preliminary research on these soils revealed high N uptake by rice in N fertilizer omission plots, which we hypothesized was the result of SOM oxidation releasing N. Testing this hypothesis, we developed a novel N budgeting approach to assess annual soil C and N loss based on plant N uptake and fallow season N mineralization. Through field experiments examining N dynamics during growing season and winter fallow periods, a complete annual N budget was developed. Soil C loss was calculated from SOM-N mineralization using the soil C:N ratio. Surface water and crop residue were negligible in the total N uptake budget (3-4 % combined). Shallow groundwater contributed 24-33 %, likely representing subsurface SOM-N mineralization. Assuming 6 and 25 kg N ha-1 from atmospheric deposition and biological N2 fixation, respectively, our results suggest 77-81% of plant N uptake (129-149 kg N ha(-1)) was supplied by SOM mineralization. Considering a range of N uptake efficiency from 50-70 %, estimated net C loss ranged from 1149-2473 kg C ha(-1). These findings suggest that rice systems, as currently managed, reduce the rate of C loss from organic delta soils relative to other agricultural practices.	[Kirk, Emilie R.; van Kessel, Chris; Linquist, Bruce A.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kirk, ER (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	erkirk@ucdavis.edu			U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2011-67003-30371]; University of California, Davis Department of Plant Sciences Graduate Student Research Assistantship	U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative; University of California, Davis Department of Plant Sciences Graduate Student Research Assistantship(University of California System)	This work was supported by the U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative. Award #2011-67003-30371, http://www.nifa.usda.gov/ to WRH and the University of California, Davis Department of Plant Sciences Graduate Student Research Assistantship, http://www.plantsciences.ucdavis.edu/plantsciences/ to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich S, 2013, AGR ECOSYST ENVIRON, V171, P124, DOI 10.1016/j.agee.2013.03.017; Andersen R, 2013, SOIL BIOL BIOCHEM, V64, P37, DOI 10.1016/j.soilbio.2013.04.004; ARMENTANO TV, 1980, BIOSCIENCE, V30, P825, DOI 10.2307/1308375; Bird JA, 2003, SOIL SCI SOC AM J, V67, P806, DOI 10.2136/sssaj2003.0806; Bird JA, 2001, SOIL SCI SOC AM J, V65, P1143, DOI 10.2136/sssaj2001.6541143x; BROADBENT FE, 1971, SOIL SCI SOC AM PRO, V35, P922, DOI 10.2136/sssaj1971.03615995003500060023x; Bronson KF, 2000, SOIL SCI SOC AM J, V64, P235, DOI 10.2136/sssaj2000.641235x; Buresh R.J., 2008, NITROGEN AGR SYSTEMS, V49, P401; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P63, DOI 10.2136/sssaj1993.03615995005700010012x; California Dept. of Food and Agriculture, 2014, CAL AGR STAT REV 201; CASSMAN KG, 1993, PLANT SOIL, V155, P359, DOI 10.1007/BF00025057; CIMIS (California Irrigation Management Information System), WEATH STAT 140; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Deverel S, 2010, SAN FRANCISCO ESTUAR, V8, P1, DOI [10.15447/sfews.2010v8iss2art1, DOI 10.15447/SFEWS.2010V8ISS2ART1]; Deverel SJ, 1996, WATER RESOUR RES, V32, P2359, DOI 10.1029/96WR01338; Deverel SJ, 2007, SAN FRANCISCO ESTUAR, V5, P1; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobermann A., 2000, RICE NUTR DISORDERS; Dourado Neto D, 2010, SOIL SCI SOC AM J, V74, P139, DOI 10.2136/sssaj2009.0192; Drexler JZ, 2009, WETLANDS, V29, P372, DOI 10.1672/08-97.1; Eagle AJ, 2001, AGRON J, V93, P1346, DOI 10.2134/agronj2001.1346; Eagle AJ, 2000, AGRON J, V92, P1096, DOI 10.2134/agronj2000.9261096x; Espe MB, 2015, SOIL SCI SOC AM J, V79, P569, DOI 10.2136/sssaj2014.08.0328; Ewing JM, 2006, WETLANDS, V26, P119, DOI 10.1672/0277-5212(2006)26[119:EPASSI]2.0.CO;2; FAO, 2006, WORLD REF BAS SOIL R, P132, DOI DOI 10.1017/S0014479706394902; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Forster J.C., 1995, METHODS APPL SOIL MI, P79, DOI DOI 10.1016/B978-012513840-6/50023-9; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; Gronlund A, 2008, NUTR CYCL AGROECOSYS, V81, P157, DOI 10.1007/s10705-008-9171-5; Hatala JA, 2012, AGR ECOSYST ENVIRON, V150, P1, DOI 10.1016/j.agee.2012.01.009; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Hooijer A, 2012, BIOGEOSCIENCES, V9, P1053, DOI 10.5194/bg-9-1053-2012; Kasimir-Klemedtsson A, 1997, SOIL USE MANAGE, V13, P245, DOI 10.1111/j.1475-2743.1997.tb00595.x; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Ladha JK, 2000, SOIL SCI SOC AM J, V64, P1993, DOI 10.2136/sssaj2000.6461993x; Lal D, 2012, USCID WAT MAN C P AU; Liang XQ, 2014, J ENVIRON QUAL, V43, P881, DOI 10.2134/jeq2013.10.0402; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Lindberg V, 2000, UNCERTAINTIES ERROR; Linquist BA, 2006, AGRON J, V98, P1050, DOI 10.2134/agronj2005.0350; Linquist BA, 2009, AGRON J, V101, P906, DOI 10.2134/agronj2008.0230x; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; Miller R., 2008, SAN FRANC ESTUARYWAT, V6, DOI [10.15447/sfews.2008v6iss3art1, DOI 10.15447/SFEWS.2008V6ISS3ART1]; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; Dong NM, 2012, SOIL BIOL BIOCHEM, V47, P166, DOI 10.1016/j.soilbio.2011.12.028; Olk DC, 2007, EUR J SOIL SCI, V58, P270, DOI 10.1111/j.1365-2389.2006.00836.x; Olk DC, 2009, SOIL SCI SOC AM J, V73, P952, DOI 10.2136/sssaj2008.0069; Pronger J, 2014, J ENVIRON QUAL, V43, P1442, DOI 10.2134/jeq2013.12.0505; Querner EP, 2012, J HYDROL, V446, P59, DOI 10.1016/j.jhydrol.2012.04.029; REDDY KR, 1975, SOIL BIOL BIOCHEM, V7, P87, DOI 10.1016/0038-0717(75)90004-8; ROGER PA, 1992, PLANT SOIL, V141, P41, DOI 10.1007/BF00011309; ROJSTACZER S, 1993, GEOPHYS RES LETT, V20, P1383, DOI 10.1029/93GL01339; Schipper LA, 2002, SOIL USE MANAGE, V18, P91, DOI [10.1079/SUM2001106, 10.1111/j.1475-2743.2002.tb00225.x]; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Stephens JC, 1984, REV ENG GEOLOGY, VVI; Strack M., 2008, PEATLANDS CLIMATE CH; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Taggart MJ, 2011, GEODERMA, V163, P238, DOI 10.1016/j.geoderma.2011.04.020; Teh YA, 2011, ECOSYSTEMS, V14, P311, DOI 10.1007/s10021-011-9411-4; van den Akker JJH, 2010, GEODERMA, V154, P171, DOI 10.1016/j.geoderma.2009.11.001; Van den Akker JJH, 2008, P 13 INT PEAT C WIS, V1; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Vitoria L, 2004, ENVIRON SCI TECHNOL, V38, P3254, DOI 10.1021/es0348187; WEIR WALTER W., 1950, HILGARDIA, V20, P37; Wosten JHM, 1997, GEODERMA, V78, P25, DOI 10.1016/S0016-7061(97)00013-X; YU ZC, 2010, GEOPHYS RES LETT, V37, DOI DOI 10.1029/2010GL043584	68	12	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121432	10.1371/journal.pone.0121432	http://dx.doi.org/10.1371/journal.pone.0121432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822494	gold, Green Published			2022-12-27	WOS:000352134700106
J	Wang, XC; Zhang, JY; Liang, JP; Zhang, Y; Teng, XD; Yuan, XF; Fan, XL				Wang, Xiaochun; Zhang, Jingyan; Liang, Jinping; Zhang, Ying; Teng, Xindong; Yuan, Xuefeng; Fan, Xionglin			Protection against Mycobacterium tuberculosis Infection Offered by a New Multistage Subunit Vaccine Correlates with Increased Number of IFN-gamma+IL-2(+) CD4(+) and IFN-gamma(+) CD8(+) T Cells	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; GENE-EXPRESSION; POLYFUNCTIONAL CD4(+); GAMMA-INTERFERON; BCG VACCINATION; FUSION PROTEIN; HSPX PROTEIN; DOSR REGULON; ANTIGENS; RESPONSES	Protein subunit vaccines present a compelling new area of research for control of tuberculosis (TB). Based on the interaction between Mycobacterium tuberculosis and its host, five stage-specific antigens of M. tuberculosis that participate in TB pathogenesis-Rv1813, Rv2660c, Ag85B, Rv2623, and HspX-were selected. These antigens were verified to be recognized by T cells from a total of 42 whole blood samples obtained from active TB patients, patients with latent TB infections (LTBIs), and healthy control donors. The multistage polyprotein A1D4 was developed using the selected five antigens as a potentially more effective novel subunit vaccine. The immunogenicity and protective efficacy of A1D4 emulsified in the adjuvant MTO [ monophosphoryl lipid A (MPL), trehalose-6,6'-dibehenate (TDB), components of MF59] was compared with Bacillus Calmette-Guerin (BCG) in C57BL/6 mice. Our results demonstrated that A1D4/MTO could provide more significant protection against M. tuberculosis infection than the PBS control or MTO adjuvant alone judging from the A1D4-specific Th1-type immune response; however, its efficacy was inferior to BCG as demonstrated by the bacterial load in the lung and spleen, and by the pathological changes in the lung. Antigen-specific single IL-2-secreting cells and different combinations with IL-2-secreting CD4(+) T cells were beneficial and correlated with BCG vaccine-induced protection against TB. Antigen-specific IFN-gamma+IL-2(+) CD4(+) T cells were the only effective biomarker significantly induced by A1D4/MTO. Among all groups, A1D4/MTO immunization also conferred the highest number of antigen-specific single IFN-gamma(+) and IFN-gamma+TNF-alpha(+) CD4(+) T cells, which might be related to the antigen load in vivo, and single IFN-gamma(+) CD8(+) T cells by mimicking the immune patterns of LTBIs or curable TB patients. Our strategy seems promising for the development of a TB vaccine based on multistage antigens, and subunit antigen A1D4 suspended in MTO adjuvant warrants preclinical evaluation in animal models of latent infection and may boost BCG vaccination.	[Wang, Xiaochun; Zhang, Jingyan; Liang, Jinping; Teng, Xindong; Yuan, Xuefeng; Fan, Xionglin] Huazhong Univ Sci & Technol, Dept Pathogen Biol, Sch Basic Med, Wuhan 430074, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fan, XL (corresponding author), Huazhong Univ Sci & Technol, Dept Pathogen Biol, Sch Basic Med, Wuhan 430074, Peoples R China.	xlfan@hust.edu.cn	Fan, Xionglin/E-2747-2015	Fan, Xionglin/0000-0001-9754-372X	National Mega-projects of Science Research for the 12th Five-year Plan of China [2012ZX10003008-005]	National Mega-projects of Science Research for the 12th Five-year Plan of China	This work was supported by a grant of the National Mega-projects of Science Research for the 12th Five-year Plan of China (No. 2012ZX10003008-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Fan XL, 2006, ACTA BIOCH BIOPH SIN, V38, P683, DOI 10.1111/j.1745-7270.2006.00217.x; Fu RL, 2009, CLIN VACCINE IMMUNOL, V16, P686, DOI 10.1128/CVI.00486-08; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Geluk A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00256; Geluk A, 2012, VACCINE, V30, P7513, DOI 10.1016/j.vaccine.2012.10.045; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lange S, 2014, J PROTEOMICS, V97, P235, DOI 10.1016/j.jprot.2013.06.036; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lu J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/617892; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mollenkopf HJ, 2004, INFECT IMMUN, V72, P6471, DOI 10.1128/IAI.72.11.6471-6479.2004; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Sable SB, 2007, CLIN IMMUNOL, V122, P239, DOI 10.1016/j.clim.2006.10.010; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Selvaraj S, 2012, GENE, V506, P233, DOI 10.1016/j.gene.2012.06.033; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vasudeva-Rao HM, 2008, INFECT IMMUN, V76, P2478, DOI 10.1128/IAI.01443-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wang CC, 2013, RESPIROLOGY, V18, P412, DOI 10.1111/resp.12052; Wang C, 2011, MED MICROBIOL IMMUN, V200, P165, DOI 10.1007/s00430-011-0188-z; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; Xin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072745; Young SL, 2002, INT IMMUNOL, V14, P793, DOI 10.1093/intimm/dxf050	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122560	10.1371/journal.pone.0122560	http://dx.doi.org/10.1371/journal.pone.0122560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822536	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700187
J	Hu, CY; Jia, JY; Dong, K; Luo, LD; Wu, K; Mehta, R; Peng, J; Ren, Y; Gross, A; Yu, H				Hu, Chaoying; Jia, Jingying; Dong, Kelly; Luo, Linda; Wu, Kai; Mehta, Rashmi; Peng, Jack; Ren, Yan; Gross, Annette; Yu, Hui			Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; SAFETY	Inhaled umeclidinium (UMEC) and the combination of inhaled UMEC with vilanterol (UMEC/VI) are approved maintenance treatments for chronic obstructive pulmonary disease in the US and EU. This was a randomized, open-label, three-period crossover, single- and repeat-dose study to assess the pharmacokinetics (PK), safety, and tolerability of inhaled UMEC/VI 62.5/25 mu g (delivering 55/22 mu g) and UMEC/VI 125/25 mu g (delivering 113/22 mu g) compared with their monotherapy components (UMEC 62.5 mu g, UMEC 125 mu g and, VI 25 mu g [delivering 55, 113, and 22 mu g, respectively]) in healthy Chinese subjects (n=20). UMEC and VI were rapidly absorbed following single and repeat dosing (time to maximum plasma concentration [t(max)]: UMEC = 5 min; VI = 5 min). The median t(last) was 2-4 h for UMEC and 1-2 h for VI following single doses of UMEC/VI and UMEC monotherapy (both doses). UMEC reached steady-state prior to Day 10; steady-state for VI could not be assessed. UMEC accumulation following repeat dosing was 11-34% based on C-max and 19-59% based on area under the concentration-time curve from time zero to 2 h (AUC((0-2))). VI accumulation following repeat dosing was 25-66% based on Cmax and 17-43% based on AUC(0-2). The evidence was not sufficient to suggest that systemic exposure was substantially different between UMEC/VI combination therapy and the constituent monotherapies following single or repeat dosing. Following both single-and repeat-dose administration, the inter-subject coefficient of variation for all UMEC PK parameter estimates ranged from 12% to 165% for all treatments, indicating a wide range of variability in inhaled PK parameters. Twelve subjects experienced >= 1 adverse event (AE). Six subjects experienced >= 1 treatment-related AE; the most commonly reported treatment-related AE was chest discomfort (n=3 [15%]). No clinically important changes in vital signs or electrocardiogram parameters were reported. These data suggest that single-and repeat-dose administration of UMEC/VI combination therapy in healthy Chinese subjects did not result in substantial differences in systemic exposure compared with UMEC and VI as monotherapies.	[Hu, Chaoying; Jia, Jingying] Shanghai Xuhui Cent Hosp, Phase Clin Res Unit 1, Shanghai, Peoples R China; [Dong, Kelly] GlaxoSmithKline Res & Dev Ltd, PTS China, Shanghai, Peoples R China; [Luo, Linda; Peng, Jack] GlaxoSmithKline Res & Dev Ltd, Stat Program & Data Management, Shanghai, Peoples R China; [Wu, Kai; Ren, Yan] GlaxoSmithKline Res & Dev Ltd, Clin Pharmacol Modelling & Simulat, Shanghai, Peoples R China; [Mehta, Rashmi] GlaxoSmithKline Res & Dev Ltd, Clin Pharmacol Modelling & Simulat, Res Triangle Pk, NC USA; [Gross, Annette] GlaxoSmithKline Res & Dev Ltd, Clin Pharmacol Modelling & Simulat, Ermington, Australia; [Yu, Hui] GlaxoSmithKline Res & Dev Ltd, Clin Med Dev, Shanghai, Peoples R China	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Jia, JY (corresponding author), Shanghai Xuhui Cent Hosp, Phase Clin Res Unit 1, Shanghai, Peoples R China.	jyjia@shxh-centerlab.com		Gross, Annette/0000-0001-9567-0127; Jia, Jingying/0000-0002-2492-3219	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline. GlaxoSmithKline was responsible for the study design, and the collection, analysis and interpretation of data (Clinicaltrials.gov: NCT01899638; Protocol Number: DB2115380).	Allen A, 2014, BRIT J CLIN PHARMACO, V77, P808, DOI 10.1111/bcp.12263; Barnes PJ, 2004, AM J MED, V117, p24S, DOI 10.1016/j.amjmed.2004.10.018; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; Cazzola M, 2010, PULM PHARMACOL THER, V23, P257, DOI 10.1016/j.pupt.2010.03.003; Celli B, 2014, CHEST; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Church A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-2; Donohue JF, 2013, RESP MED, V107, P1538, DOI 10.1016/j.rmed.2013.06.001; Donohue JF, 2012, RESP MED, V106, P970, DOI 10.1016/j.rmed.2012.03.012; Feldman G, 2012, PULM PHARMACOL THER, V25, P465, DOI 10.1016/j.pupt.2012.08.007; GlaxoSmithKline, 2014, AN ELL; GlaxoSmithKline, 2014, AN ELL SUMM PROD CHA; Goyal N, 2014, CLIN PHARMACOKINET, V53, P637, DOI 10.1007/s40262-014-0143-4; Hanania NA, 2012, CHEST, V142, P119, DOI 10.1378/chest.11-2231; Kelleher D, 2013, AM J RESP CRIT CARE, V187; KELLEHER DL, 2012, PLOS ONE, V0007; Kempsford R, 2013, PULM PHARMACOL THER, V26, P256, DOI 10.1016/j.pupt.2012.12.001; Mehta R, 2015, INT J CHRONIC OBSTR, V10, P15, DOI 10.2147/COPD.S68094; Mehta R, 2014, CLIN THER, V36, P1016, DOI 10.1016/j.clinthera.2014.05.002; Mehta R, 2013, INT J CHRONIC OBSTR, V8, P159, DOI 10.2147/COPD.S40859; Nakahara N, 2012, AM J RESP CRIT CARE, V185, pA2915; NICE, 2010, CHRON OBSTR PULM DIS; Tal-Singer R, 2013, EUR J PHARMACOL, V701, P40, DOI 10.1016/j.ejphar.2012.12.019; Trivedi R, 2014, EUR RESPIR J, V43, P72, DOI 10.1183/09031936.00033213; World Medical Association, 2008, WMA DECL HELS ETH PR	25	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121264	10.1371/journal.pone.0121264	http://dx.doi.org/10.1371/journal.pone.0121264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816315	Green Submitted, Green Published, gold			2022-12-27	WOS:000352133600078
J	Ng, CS; Toh, MPHS; Ko, Y; Lee, JYC				Ng, Charmaine Shuyu; Toh, Matthias Paul Han Sim; Ko, Yu; Lee, Joyce Yu-Chia			Direct Medical Cost of Type 2 Diabetes in Singapore	PLOS ONE			English	Article							HEALTH-CARE COSTS; OF-ILLNESS; MELLITUS; ADHERENCE; DISEASE	Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p< 0.001) and the combination of both oral medications and insulin (p= 0.047) as well as having complications such as cerebrovascular disease (p< 0.001), cardiovascular disease (p= 0.002), peripheral vascular disease (p= 0.001), and nephropathy (p= 0.041). In this study, the cost of DM treatments and DM-related complications were found to be strong determinants of costs. This finding suggests an imperative need to address the economic burden associated with diabetes with urgency and to reorganise resources required to improve healthcare costs.	[Ng, Charmaine Shuyu; Lee, Joyce Yu-Chia] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [Toh, Matthias Paul Han Sim] Natl Healthcare Grp, Cent Reg Hlth Off, Informat Management, Singapore, Singapore; [Toh, Matthias Paul Han Sim] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Toh, Matthias Paul Han Sim] Natl Univ Hlth Syst, Singapore, Singapore; [Ko, Yu] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan	National University of Singapore; National University of Singapore; National University of Singapore; Taipei Medical University	Toh, MPHS (corresponding author), Natl Healthcare Grp, Cent Reg Hlth Off, Informat Management, Singapore, Singapore.	matthias_toh@nhg.com.sg; phalycj@nus.edu.sg	Lee, Joyce/H-6838-2015		MOH Health Services Research Competitive Research Grant [HSRG/0027/2012]	MOH Health Services Research Competitive Research Grant	This work was supported by a MOH Health Services Research Competitive Research Grant (HSRG/0027/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadri A.O., 2009, SOC ECON STUD, V58, P175; Amos AF, 1997, DIABET MED S5, V14, P1; [Anonymous], 2013, DIABETES ATLAS; Arauz-Pacheco Carlos, 2003, Diabetes Care, V26 Suppl 1, pS80; Asi T, 2011, CLIN NEUROL NEUROSUR, V113, P111, DOI 10.1016/j.clineuro.2010.09.014; Bahia LR, 2011, VALUE HEALTH, V14, pS137, DOI 10.1016/j.jval.2011.05.009; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Cheng SH, 2013, AM J MANAG CARE, V19, P662; Clarke P, 2003, DIABETIC MED, V20, P442, DOI 10.1046/j.1464-5491.2003.00972.x; Diringer MN, 1999, STROKE, V30, P724, DOI 10.1161/01.STR.30.4.724; Eaddy Michael T, 2012, P T, V37, P45; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Ettaro L, 2004, PHARMACOECONOMICS, V22, P149, DOI 10.2165/00019053-200422030-00002; Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128; FUJIMOTO WY, 1992, DIABETES RES CLIN PR, V15, P167, DOI 10.1016/0168-8227(92)90022-J; Grover S, 2008, CAN J CARDIOL, V24, P891, DOI 10.1016/S0828-282X(08)70695-0; Health Promotion Board, 2011, INF PAP DIAB SING; International Diabetes Federation, 2006, DIAB ATL BRUSS; International Diabetes Federation, 2010, IDF GLOB DIAB PLAN 2; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Johnson R., 2007, APPL MULTIVARIATE ST; Koenig L, 2003, AM J MANAG CARE, V9, pSP34; Koster I, 2011, EXP CLIN ENDOCR DIAB, V119, P377, DOI 10.1055/s-0030-1269847; Leong H, 2010, DIABETES MELLITUS; Leung G. M., 2000, Hong Kong Medical Journal, V6, P61; Ministry of Health Singapore, 2014, DIS BURD; Ministry of Health Singapore, 2006, CLIN PRACT GUID DIAB; Nasseh K, 2012, AM J PHARM BENEFITS, V4, pe41; OANDA Corporation, 2014, CURR CONV; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Solli O, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-15; Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Tharkar S, 2010, DIABETES RES CLIN PR, V89, P334, DOI 10.1016/j.diabres.2010.05.009; Toh MPHS, 2009, ANN ACAD MED SINGAP, V38, P546; Tunceli O, 2010, CURR MED RES OPIN, V26, P1827, DOI 10.1185/03007995.2010.488544; Wang WB, 2009, AM J MANAG CARE, V15, P593; World Health Organization, 2004, DIAB ACT NOW IN WHO; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2006, BMI CLASSIFICATION; Wu CX, 2012, J DIABETES COMPLICAT, V26, P107, DOI 10.1016/j.jdiacomp.2012.02.004; Wu CX, 2012, J ENDOCRINOL METAB, V2, P88, DOI 10.4021/jem67w; Yeo D., 2013, COPING LIFELONG DIS; Zhuo XH, 2013, AM J PREV MED, V45, P253, DOI 10.1016/j.amepre.2013.04.017	45	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122795	10.1371/journal.pone.0122795	http://dx.doi.org/10.1371/journal.pone.0122795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816299	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600198
J	Sumra, MK; Schillaci, MA				Sumra, Monika K.; Schillaci, Michael A.			Stress and the Multiple-Role Woman: Taking a Closer Look at the "Superwoman"	PLOS ONE			English	Article							CORTISOL-LEVELS; ROLE STRAIN; HAIR CORTISOL; MENTAL-HEALTH; SOCIAL ROLES; ROLE QUALITY; WOMENS WORK; SATISFACTION; SYMPTOMS; MIDLIFE	In the academic literature there is debate as to whether women who engage in multiple social roles experience more or less stress than women in fewer roles. For the present research we examined the relationship between levels of engagement in seven distinct roles and perceived stress and life satisfaction in a small non-random sample of women in North America (N = 308). We did not find a significant correlation between role engagement and perceived stress, though we did find a small but significant positive correlation between role engagement and life satisfaction. Similarly, in a subset of the participants (N = 31), there was not a significant relationship between the level of role engagement and physiological stress as measured by hair or urinary cortisol levels. We found a significant negative correlation between perceived stress and life satisfaction, and role satisfaction. The results from multiple regression models did not identify the level of role engagement as a significant predictor of either perceived stress or life satisfaction. Role satisfaction in addition to several life style variables such as the frequency of sex and exercise were identified as significant predictors of both outcome variables. We also examined the popularized notion of the "superwoman", which we defined as women who fell within the 4th quartile of role engagement, or those engaged in the wife/mother/worker/homemaker role combination. Based on popular discourses surrounding the superwoman we expected that superwomen would exhibit higher levels of perceived stress. Our results revealed that superwomen do not experience a significantly higher level of perceived stress than non-superwomen. The results of our study therefore suggest that multiple role engagement in women, even at a relatively high level as experienced by "superwomen", is not associated with significantly higher stress, or reduced life satisfaction.	[Sumra, Monika K.; Schillaci, Michael A.] Univ Toronto Scarborough, Dept Anthropol, Toronto, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough	Sumra, MK (corresponding author), Univ Toronto Scarborough, Dept Anthropol, Toronto, ON M1C 1A4, Canada.	monika.sumra@mail.utoronto.ca						Ahrens CJC, 2006, SEX ROLES, V55, P801, DOI 10.1007/s11199-006-9134-8; Albar WF, 2013, CLIN INVEST MED, V36, pE312; Anderson J, 1997, HEALTH, V1, P57, DOI DOI 10.1177/136345939700100103; [Anonymous], 1998, WOMEN HLTH, V8, P69; Barn R, 2008, INT J SOC PSYCHIATR, V54, P69, DOI 10.1177/0020764007082528; Barnett RC, 2005, ANN BEHAV MED, V30, P36, DOI 10.1207/s15324796abm3001_5; Barnett RC, 2004, HARVARD REV PSYCHIAT, V12, P158, DOI 10.1080/10673220490472418; Barnett RC., 1997, MULTIPLE PATHS MIDLI, P324; BARUCH GK, 1986, J PERS SOC PSYCHOL, V51, P578, DOI 10.1037/0022-3514.51.3.578; Becker D, 2010, FEM PSYCHOL, V20, P36, DOI 10.1177/0959353509348215; Black AR, 2009, WOMEN HEALTH, V49, P144, DOI 10.1080/03630240902915051; Blanchflower DG, 2004, SCAND J ECON, V106, P393, DOI 10.1111/j.0347-0520.2004.00369.x; Braiker H, 2002, TYPE E WOMAN OVERCOM, P5; Bratberg E, 2002, EUR SOCIOL REV, V18, P233, DOI 10.1093/esr/18.2.233; Brody S, 2010, J SEX MED, V7, P1336, DOI 10.1111/j.1743-6109.2009.01677.x; Brody S, 2009, J SEX MED, V6, P1947, DOI 10.1111/j.1743-6109.2009.01303.x; Brooks L, 1978, COUNSELING WOMEN MON, P219; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Chen N, 2007, WOMENS EARNING POWER; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Cone EJ, 1996, THER DRUG MONIT, V18, P438, DOI 10.1097/00007691-199608000-00022; Corrin C, 1992, SUPERWOMEN DOUBLE BU, P16; Corrin C., 1992, SUPERWOMEN DOUBLE BU, P8; Crago M, 1996, SEX ROLES, V35, P801, DOI 10.1007/BF01544093; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dettenborn L, 2010, FORENSIC SCI INT, V196, P32, DOI [10.1016/j.forsciint.2009.12.040, DOI 10.1016/J.FORSCIINT.2009.12.040]; ELY RJ, 1994, ADMIN SCI QUART, V39, P203, DOI 10.2307/2393234; Erdwins CJ, 2001, FAM RELAT, V50, P230, DOI 10.1111/j.1741-3729.2001.00230.x; Esser I., 2010, FAMILY POLICY PERCEI; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Evandrou M, 2004, AGEING SOC, V24, P771, DOI 10.1017/S0144686X04002545; Evolahti A, 2006, J PSYCHOSOM RES, V61, P645, DOI 10.1016/j.jpsychores.2006.07.022; Gallagher-Thompson D, 2006, AM J GERIAT PSYCHIAT, V14, P334, DOI 10.1097/01.JGP.0000206485.73618.87; Genuth S.M., 1993, PHYSIOLOGY, V3rd, P949; Hart K, 1997, SEX ROLES, V36, P461, DOI 10.1007/BF02766684; Hervey T, 1989, J EURO SOC POL, V8, P43; Hintze J., 2004, NCSS PASS NUMBER CRU; Humphrey AK, 2006, THESIS MISSISSIPPI S; Ice GH, 2012, SOC SCI MED, V74, P2020, DOI 10.1016/j.socscimed.2012.02.018; Jacques HAK, 2008, YOUNG WOMEN CONSTRUC; Janssen I, 2012, ANN BEHAV MED, V43, P39, DOI 10.1007/s12160-011-9307-8; Johner R., 2008, Pimatisiwin - A Journal of Aboriginal and Indigenous Community Health, V6, P137; Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986; Karraker A, 2011, J GERONTOL B-PSYCHOL, V66, P502, DOI 10.1093/geronb/gbr058; Klag S, 2004, BRIT J HEALTH PSYCH, V9, P137, DOI 10.1348/135910704773891014; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Kunz-Ebrecht SR, 2004, SOC SCI MED, V58, P1523, DOI 10.1016/s0277-9536(03)00347-2; Kurina LM, 2004, STRESS HEALTH, V20, P53, DOI 10.1002/smi.998; Lakey B, 2000, MEASURING INTERVENIN, P29, DOI [10.1093/med:psych/9780195126709.003.0002, DOI 10.1093/MED:PSYCH/9780195126709.003.0002]; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lenaghan J.A., 2007, J BEHAV APPL MANAGEM, V9, P88, DOI 10.21818/001c.16780; Lengacher C A, 1997, J Nurs Meas, V5, P139; Levit RD, 2011, CARDIOL REV, V19, P60, DOI 10.1097/CRD.0b013e31820987b5; Luecken LJ, 1997, PSYCHOSOM MED, V59, P352, DOI 10.1097/00006842-199707000-00003; Lundberg U, 1999, J Occup Health Psychol, V4, P142, DOI 10.1037/1076-8998.4.2.142; LUTTER JM, 1994, CLIN SPORT MED, V13, P263; Maclean H, 2004, BMC WOMEN HLTH, V4, P1; Manenschijn L, 2013, J CLIN ENDOCR METAB, V98, P2078, DOI 10.1210/jc.2012-3663; MARKS SR, 1977, AM SOCIOL REV, V42, P921, DOI 10.2307/2094577; Marshall K., 2006, CONVERGING GENDER RO; Martire LM, 2000, PSYCHOL AGING, V15, P148, DOI 10.1037/0882-7974.15.1.148; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; MOEN P, 1992, AM J SOCIOL, V97, P1612, DOI 10.1086/229941; Muhammad A, 2010, J HEALTH PSYCHOL, V15, P315, DOI 10.1177/1359105309353216; Murphy L, 2010, STRESS, V13, P366, DOI 10.3109/10253891003615473; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; Nepomnaschy PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018242; Nordenmark, 2002, GENDER WORK ORGAN, V9, P125, DOI [DOI 10.1111/1468-0432.00152, 10.1111/1468-0432.00152]; PEARLIN LI, 1975, AM SOCIOL REV, V40, P344, DOI 10.2307/2094462; Pereg D, 2011, STRESS, V14, P73, DOI 10.3109/10253890.2010.511352; Rani K., 2012, EJBM, V4, P11; Ray E., 1994, J APPL BEHAV SCI, V30, P357, DOI [10.1177/0021886394303007, DOI 10.1177/0021886394303007]; Reid J, 1999, J GERONTOL B-PSYCHOL, V54, pS329, DOI 10.1093/geronb/54B.6.S329; Rothbard NP, 2001, ADMIN SCI QUART, V46, P655, DOI 10.2307/3094827; Rudzik AEF, 2014, AM J HUM BIOL, V26, P43, DOI 10.1002/ajhb.22489; Salvante KG, 2012, AM J HUM BIOL, V24, P81, DOI 10.1002/ajhb.21229; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Saxbe DE, 2008, HEALTH PSYCHOL, V27, P15, DOI 10.1037/0278-6133.27.1.15; SAXENA BN, 1974, J OBSTET GYN BR COMM, V81, P563; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Shaevitz MH, 1984, SUPERWOMEN SYNDROME, P6; SIEBER SD, 1974, AM SOCIOL REV, V39, P567, DOI 10.2307/2094422; SIMON RW, 1992, J HEALTH SOC BEHAV, V33, P25, DOI 10.2307/2136855; Sjostrom-Strand A, 2007, INT J NURS, P2; Smolak L, 2001, EATING DISORDERS: INNOVATIVE DIRECTIONS IN RESEARCH AND PRACTICE, P91, DOI 10.1037/10403-005; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; STEINERADAIR C, 1986, J AM ACAD PSYCHOAN, V14, P95, DOI 10.1521/jaap.1.1986.14.1.95; STEPHENS MAP, 1994, PSYCHOL AGING, V9, P45; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; THOITS PA, 1983, AM SOCIOL REV, V48, P174, DOI 10.2307/2095103; Thoits PA, 1987, SPOUSE PARENT WORKER, P11; Thompson MK, 1989, THESIS U LOUISVILLE, P149; THORNTON B, 1991, SEX ROLES, V25, P469, DOI 10.1007/BF00292535; TIEDJE LB, 1990, J MARRIAGE FAM, V52, P63, DOI 10.2307/352838; TIMKO C, 1987, INT J EAT DISORDER, V6, P701, DOI 10.1002/1098-108X(198711)6:6<701::AID-EAT2260060603>3.0.CO;2-D; van Holland BJ, 2012, INT ARCH OCC ENV HEA, V85, P849, DOI 10.1007/s00420-011-0727-3; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; VANMETER MJS, 1982, FAM RELAT, V31, P131; VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961; Verbrugge M, 1996, WOMEN HLTH, V7, P262; Verhoef M J, 1994, Health Care Women Int, V15, P297; VERHOEF MJ, 1992, WOMEN HEALTH, V19, P15, DOI 10.1300/J013v19n04_02; WARE NC, 1992, PSYCHOSOM MED, V54, P546, DOI 10.1097/00006842-199209000-00003; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Williams K, 2002, CLIN OBSTET GYNECOL, V45, P1099, DOI 10.1097/00003081-200212000-00018; Woods-Giscombe CL, 2010, QUAL HEALTH RES, V20, P668, DOI 10.1177/1049732310361892	112	30	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120952	10.1371/journal.pone.0120952	http://dx.doi.org/10.1371/journal.pone.0120952			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816317	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600053
J	Baldini, R				Baldini, Ryan			The Importance of Population Growth and Regulation in Human Life History Evolution	PLOS ONE			English	Article							DENSITY; RATES; INTELLIGENCE; RECRUITMENT; DYNAMICS	Explaining the evolution of human life history traits remains an important challenge for evolutionary anthropologists. Progress is hindered by a poor appreciation of how demographic factors affect the action of natural selection. I review life history theory showing that the quantity maximized by selection depends on whether and how population growth is regulated. I show that the common use of R, a strategy's expected lifetime number of offspring, as a fitness maximand is only appropriate under a strict set of conditions, which are apparently unappreciated by anthropologists. To concretely show how demography-free life history theory can lead to errors, I reanalyze an influential model of human life history evolution, which investigated the coevolution of a long lifespan and late age of maturity. I show that the model's conclusions do not hold under simple changes to the implicitly assumed mechanism of density dependence, even when stated assumptions remain unchanged. This analysis suggests that progress in human life history theory requires better understanding of the demography of our ancestors.	Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA	Stanford University	Baldini, R (corresponding author), Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA.	ryanbaldini@gmail.com						ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; CHARNOV EL, 1986, OIKOS, V47, P129, DOI 10.2307/3566037; Charnov Eric L., 1993, P1; Eshel Ilan, 2001, P161, DOI 10.1017/CBO9780511609084.006; Fowler C.W., 1987, Current Mammalogy, V1, P401; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hill Kim, 1993, Evolutionary Anthropology, V2, P78, DOI 10.1002/evan.1360020303; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H. S., 2005, HDB EVOLUTIONARY PSY, P68, DOI DOI 10.1002/9780470939376.CH2; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Roff Derek, 2002, pi; Roff Derek A., 1992; Stearns S.C., 1992, pi; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; TURELLI M, 1980, P NATL ACAD SCI-BIOL, V77, P7501, DOI 10.1073/pnas.77.12.7501; WOOD JW, 1982, AM J PHYS ANTHROPOL, V58, P403, DOI 10.1002/ajpa.1330580408	25	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0119789	10.1371/journal.pone.0119789	http://dx.doi.org/10.1371/journal.pone.0119789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830310	gold, Green Submitted, Green Published			2022-12-27	WOS:000352135600015
J	Snell, RR				Snell, Richard R.			Menage a Quoi? Optimal Number of Peer Reviewers	PLOS ONE			English	Article							GRANT APPLICATIONS; BIAS; RELIABILITY; PROPOSALS; ASSESSMENTS; SELECTION; VALIDITY; CHANCE; PANEL	Peer review represents the primary mechanism used by funding agencies to allocate financial support and by journals to select manuscripts for publication, yet recent Cochrane reviews determined literature on peer review best practice is sparse. Key to improving the process are reduction of inherent vulnerability to high degree of randomness and, from an economic perspective, limiting both the substantial indirect costs related to reviewer time invested and direct administrative costs to funding agencies, publishers and research institutions. Use of additional reviewers per application may increase reliability and decision consistency, but adds to overall cost and burden. The optimal number of reviewers per application, while not known, is thought to vary with accuracy of judges or evaluation methods. Here I use bootstrapping of replicated peer review data from a Post-doctoral Fellowships competition to show that five reviewers per application represents a practical optimum which avoids large random effects evident when fewer reviewers are used, a point where additional reviewers at increasing cost provides only diminishing incremental gains in chance-corrected consistency of decision outcomes. Random effects were most evident in the relative mid-range of competitiveness. Results support aggressive high-and low-end stratification or triaging of applications for subsequent stages of review, with the proportion and set of mid-range submissions to be retained for further consideration being dependent on overall success rate.	Canadian Inst Hlth Res, Res Knowledge Translat & Eth Portfolio, Ottawa, ON, Canada	Institute for Work & Health	Snell, RR (corresponding author), Canadian Inst Hlth Res, Res Knowledge Translat & Eth Portfolio, Ottawa, ON, Canada.	richard.snell@cihr-irsc.gc.ca		Snell, Richard/0000-0001-9184-8063				Abdoul H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046054; [Anonymous], 2014, R LANG ENV STAT COMP; Benda WGG, 2011, INT J FORECASTING, V27, P166, DOI 10.1016/j.ijforecast.2010.03.003; Birukou A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00056; Bollen J, 2014, EMBO REP, V15, P131, DOI 10.1002/embr.201338068; Bornmann L, 2004, BIF FUTURA, V19, P7; Bornmann L, 2006, RES EVALUAT, V15, P209, DOI 10.3152/147154406781775850; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Buffin-Belanger T, 2005, GEOMORPHOLOGY, V68, P77, DOI 10.1016/j.geomorph.2004.09.032; Canadian Institutes of Health Research, 2012, DES FUT NEW OP SUIT; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Demicheli V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000003.pub2; Fogelholm M, 2012, J CLIN EPIDEMIOL, V65, P47, DOI 10.1016/j.jclinepi.2011.05.001; Graves N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4797; Guthrie S., 2013, ALTERNATIVES PEER RE; Hodgson C, 1997, J CLIN EPIDEMIOL, V50, P1189, DOI 10.1016/S0895-4356(97)00167-4; Holbrook JB, 2011, RES EVALUAT, V20, P239, DOI 10.3152/095820211X12941371876788; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Kaplan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002761; Koehler E, 2009, AM STAT, V63, P155, DOI 10.1198/tast.2009.0030; Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langfeldt L, 2006, RES EVALUAT, V15, P31, DOI 10.3152/147154406781776039; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Lipworth WL, 2011, SOC SCI MED, V72, P1056, DOI 10.1016/j.socscimed.2011.02.002; Luukkonen T, 2012, RES EVALUAT, V21, P48, DOI 10.1093/reseval/rvs001; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Mayo NE, 2006, J CLIN EPIDEMIOL, V59, P842, DOI 10.1016/j.jclinepi.2005.12.007; Obrecht M, 2007, RES EVALUAT, V16, P79; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Roebber PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018680; ROY R, 1985, SCI TECHNOL HUM VAL, P73; Schroter S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-62; Squazzoni F, 2013, RES POLICY, V42, P287, DOI 10.1016/j.respol.2012.04.014; Tite L, 2007, J EPIDEMIOL COMMUN H, V61, P9, DOI 10.1136/jech.2006.049817; van Arensbergen P, 2012, HIGH EDUC POLICY, V25, P381, DOI 10.1057/hep.2012.15; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1	38	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120838	10.1371/journal.pone.0120838	http://dx.doi.org/10.1371/journal.pone.0120838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AM	25830238	Green Submitted, Green Published, gold			2022-12-27	WOS:000352135600044
J	Chang, WT; Lai, TH; Chyan, YJ; Yin, SY; Chen, YH; Wei, WC; Yang, NS				Chang, Wei Ting; Lai, Tzung Hsien; Chyan, Yau Jan; Yin, Shu Yi; Chen, Yung Hsiang; Wei, Wen Chi; Yang, Ning-Sun			Specific Medicinal Plant Polysaccharides Effectively Enhance the Potency of a DC-Based Vaccine against Mouse Mammary Tumor Metastasis	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; DENDRITIC CELLS; SHENQI FUZHENG; HOST-DEFENSE; CANCER; CHEMOKINES; HELPER; IMMUNOTHERAPY; RECEPTORS; MIGRATION	Dendritic cell (DC) vaccines are a newly emerging immunotherapeutic approach for the treatment and prevention of cancer, but major challenges still remain particularly with respect to clinical efficacy. Engineering and optimization of adjuvant formulations for DC-based vaccines is one strategy through which more efficacious treatments may be obtained. In this study, we developed a new ex vivo approach for DC vaccine preparation. We evaluated two highly purified mixed polysaccharide fractions from the root of Astragalus membranaceus and Codonopsis pilosulae, named Am and Cp, for their use in enhancing the efficiency of a DC-based cancer vaccine against metastasis of 4T1 mammary carcinoma in mice. Mixed lymphocyte reaction showed all Am-, Cp-and [Am+Cp]-treated DCs enhanced mouse CD4(+) and CD8(+) -cell proliferation. [Am+Cp]-treated DCs exhibited the strongest anti-4T1 metastasis activity in test mice. Treatments with Am, Cp and [Am+Cp] also resulted in augmented expression of CD40, CD80 and CD86 markers in test DCs. Bioinformatics analysis of the cytokine array data from treated DCs identified that [Am+Cp] is efficacious in activation of specific immune functions via mediating the expression of cytokines/chemokines involved in the recruitment and differentiation of defined immune cells. Biochemical analysis revealed that Am and Cp are composed mainly of polysaccharides containing a high level (70-95%) glucose residues, but few or no (< 1%) mannose residues. In summary, our findings suggest that the specific plant polysaccharides Am and Cp extracted from traditional Chinese medicines can be effectively used instead of bacterial LPS as a potent adjuvant in the formulation of a DC-based vaccine for cancer immunotherapies.	[Chang, Wei Ting] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chang, Wei Ting; Yin, Shu Yi; Chen, Yung Hsiang; Wei, Wen Chi; Yang, Ning-Sun] Acad Sinica, Inst Agr Biotechnol, Res Ctr, Taipei 115, Taiwan; [Lai, Tzung Hsien; Chyan, Yau Jan] Dev Ctr Biotechnol, New Taipei City, Taiwan	Providence University - Taiwan; Academia Sinica - Taiwan	Yang, NS (corresponding author), Acad Sinica, Inst Agr Biotechnol, Res Ctr, Taipei 115, Taiwan.	nsyang@gate.sinica.edu.tw			National Science Council of Taiwan [NSC 101-2325-B-001-027]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a National Science Council of Taiwan grant (NSC 101-2325-B-001-027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Ben-Eliyahu S, 2003, BRAIN BEHAV IMMUN, V17, pS27; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Breckpot Karine, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P328; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Carter D, 2010, CURR OPIN HIV AIDS, V5, P409, DOI 10.1097/COH.0b013e32833d2cdb; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cataldi TRI, 1998, ANAL CHEM, V70, P3940, DOI 10.1021/ac9803582; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chang WT, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1007/S13042-013-0195-Z; Chen HM, 2012, CANCER IMMUNOL IMMUN, V61, P1989, DOI 10.1007/s00262-012-1258-9; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Cho WCS, 2007, CANCER LETT, V252, P43, DOI 10.1016/j.canlet.2006.12.001; Cintolo JA, 2012, FUTURE ONCOL, V8, P1273, DOI [10.2217/fon.12.125, 10.2217/FON.12.125]; Dell'Agnola C, 2007, EXPERT REV VACCINES, V6, P267, DOI 10.1586/14760584.6.2.267; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Dong J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-137; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; El Enshasy HA, 2013, TRENDS BIOTECHNOL, V31, P668, DOI 10.1016/j.tibtech.2013.09.003; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hatfield P, 2008, J IMMUNOTHER, V31, P620, DOI 10.1097/CJI.0b013e31818213df; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Hu JM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-34; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin ML, 2014, INT J BIOL MACROMOL, V64, P257, DOI 10.1016/j.ijbiomac.2013.12.002; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu SH, 2012, J ETHNOPHARMACOL, V140, P614, DOI 10.1016/j.jep.2012.01.047; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Nergard CS, 2005, CARBOHYD RES, V340, P115, DOI 10.1016/j.carres.2004.10.023; O'Neill DW, 2004, BLOOD, V104, P2235, DOI 10.1182/blood-2003-12-4392; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Park JW, 2007, J CLIN ONCOL, V25, P3680, DOI 10.1200/JCO.2006.10.5718; Pavelko KD, 2008, CANCER RES, V68, P2471, DOI 10.1158/0008-5472.CAN-07-5937; Pufnock JS, 2011, BLOOD, V117, P6542, DOI 10.1182/blood-2010-11-317966; Pyz E, 2006, ANN MED, V38, P242, DOI 10.1080/07853890600608985; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Ridolfi R, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-36; Roberts NJ, 2011, ONCOTARGET, V2, P739; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rockwell S, 2013, INT J RADIAT BIOL, V89, P16, DOI 10.3109/09553002.2012.717733; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Toes REM, 1998, SEMIN IMMUNOL, V10, P443, DOI 10.1006/smim.1998.0147; van der Bij GJ, 2009, ANN SURG, V249, P727, DOI 10.1097/SLA.0b013e3181a3ddbd; van Duikeren S, 2012, J IMMUNOL, V189, P3397, DOI 10.4049/jimmunol.1201540; Vulink A, 2008, ADV CANCER RES, V99, P363, DOI 10.1016/S0065-230X(07)99006-5; Wang JX, 2012, J ETHNOPHARMACOL, V139, P788, DOI 10.1016/j.jep.2011.12.019; Xu C, 2012, INT J BIOL MACROMOL, V50, P891, DOI 10.1016/j.ijbiomac.2012.01.013; Yin SY, 2011, EXP CELL RES, V317, P2210, DOI 10.1016/j.yexcr.2011.06.013; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Zheng YS, 2014, SHOCK, V41, P250, DOI 10.1097/SHK.0000000000000091	72	33	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122374	10.1371/journal.pone.0122374	http://dx.doi.org/10.1371/journal.pone.0122374			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825910	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800067
J	Desolneux, G; Maziere, C; Vara, J; Brouste, V; Fonck, M; Bechade, D; Becouarn, Y; Evrard, S				Desolneux, Gregoire; Maziere, Camille; Vara, Jeremy; Brouste, Veronique; Fonck, Marianne; Bechade, Dominique; Becouarn, Yves; Evrard, Serge			Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; RANDOMIZED-TRIAL; CARCINOMATOSIS; CANCER; STANDARD; ORIGIN; MANAGEMENT; SURVIVAL; CARE	Background Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) has long been considered the standard treatment for colorectal peritoneal metastases (CPM). However, although efficacy of surgery has been demonstrated, evidence supporting HIPEC's role is less certain. Method Overall survival (OS), progression-free survival (PFS) and morbidity were analysed retrospectively for fifty consecutively included patients treated for colorectal CPM with complete CRS and systemic chemotherapy only. Results Median peritoneal cancer index (PCI) was 8 (range 1-24). 23 patients had liver or lung metastases (LLM). 22 patients had synchronous CPM. 27 complications occurred (12 Grade 1/2, 14 Grade 3, 1 Grade 4a, 0 Grade 5). Median follow-up was 62.5 months (95 % CI 45.481.3), median survival 32.4 months (21.5-41.7). Three-and 5-year OS were 45.5% (0.31-0.59) and 29.64% (0.17-0.44) respectively. Presence of LLMs associated with peritoneal carcinomatosis was significantly associated with poorer prognosis, with survival at 5 years of 13.95% (95 % CI 2.9-33.6) vs. 43.87% (22.2-63.7) when no metastases were present (P=0.018). Median PFS was 9.5 months (95 % CI 6.2-11.1). Conclusion With an equivalent PCI range and despite one of the highest rates of LLM in the literature, our survival data of CRS + systemic chemotherapy only compare well with results reported after additional HIPEC. Tolerance was better with acceptable morbidity without any mortality. Extra-hepatic metastasis (LLM) is a strong factor of poor prognosis. Awaiting the results of the randomized PRODIGE trial, these results indicate that CRS + systemic chemotherapy only is a robust hypothesis to treat colorectal CPM.	[Desolneux, Gregoire; Maziere, Camille; Vara, Jeremy; Evrard, Serge] Inst Bergonie, Digest Tumours Unit, Bordeaux, France; [Brouste, Veronique; Fonck, Marianne; Bechade, Dominique; Becouarn, Yves] Inst Bergonie, Clin & Epidemiol Res Unit, Bordeaux, France; [Evrard, Serge] Univ Bordeaux, Bordeaux, France	UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux	Evrard, S (corresponding author), Inst Bergonie, Digest Tumours Unit, Bordeaux, France.	s.evrard@bordeaux.unicancer.fr		EVRARD, Serge/0000-0003-1063-6822				[Anonymous], 2013, ANN SURG; Beaujard AC, 2000, CANCER-AM CANCER SOC, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J; Bijelic L, 2007, ANN SURG ONCOL, V14, P2281, DOI 10.1245/s10434-007-9410-z; Brouquet A, 2009, ANN SURG ONCOL, V16, P2744, DOI 10.1245/s10434-009-0611-5; Cavaliere F, 2003, Tumori, V89, P21; Chua TC, 2009, EJSO-EUR J SURG ONC, V35, P1299, DOI 10.1016/j.ejso.2009.07.005; Chua TC, 2009, ANN SURG, V249, P900, DOI 10.1097/SLA.0b013e3181a45d86; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Elias D, 2000, Int J Surg Investig, V1, P431; Elias D, 2004, ANN SURG ONCOL, V11, P518, DOI 10.1245/ASO.2004.09.008; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Elias D, 2009, J CLIN ONCOL, V27, P681, DOI 10.1200/JCO.2008.19.7160; Esquivel J, 2007, ANN SURG ONCOL, V14, P128, DOI 10.1245/s10434-006-9185-7; Esquivel J, 2008, J SURG ONCOL, V98, P263, DOI 10.1002/jso.21053; Evrard S, 2014, PLOS ONE IN PRESS; Evrard S, 2012, LANCET ONCOL, V13, pE462, DOI 10.1016/S1470-2045(12)70448-5; Folprecht G, 2007, Cancer Treat Res, V134, P425; Franko J, 2010, CANCER-AM CANCER SOC, V116, P3756, DOI 10.1002/cncr.25116; Fuzun Mehmet, 2006, Acta Chir Iugosl, V53, P17; Gilly FN, 2006, EJSO-EUR J SURG ONC, V32, P648, DOI 10.1016/j.ejso.2006.03.030; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Glehen O, 2009, J CLIN ONCOL, V27; Glehen Olivier, 2003, Surg Oncol Clin N Am, V12, P729, DOI 10.1016/S1055-3207(03)00044-9; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Khatri VP, 2010, J CLIN ONCOL, V28, P5, DOI 10.1200/JCO.2009.24.8500; Kianmanesh R, 2007, ANN SURG, V245, P597, DOI 10.1097/01.sla.0000255561.87771.11; Mahteme H, 2004, BRIT J CANCER, V90, P403, DOI 10.1038/sj.bjc.6601586; Piso P, 2007, INT J COLORECTAL DIS, V22, P1295, DOI 10.1007/s00384-007-0313-z; Scaringi S, 2009, HEPATO-GASTROENTEROL, V56, P650; SPRATT JS, 1980, CANCER RES, V40, P256; Sugarbaker PH, 2012, LANCET ONCOL, V13, pE362, DOI 10.1016/S1470-2045(12)70210-3; SUGARBAKER PH, 1989, SEMIN ONCOL, V16, P83; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Venook AP, 2014, J CLIN ONCOL S, V32, p5S, DOI DOI 10.1200/JCO.2014.32.18_SUPPL.LBA3; Verwaal VJ, 2008, ANN SURG ONCOL, V15, P2426, DOI 10.1245/s10434-008-9966-2; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187; Yan TD, 2008, ANN SURG, V248, P829, DOI 10.1097/SLA.0b013e31818a15b5; Yan TD, 2006, ANN SURG, V244, P632, DOI 10.1097/01.sla.0000239629.96036.cd; Yan TD, 2010, WORLD J GASTRO ONCOL, V2, P109, DOI 10.4251/wjgo.v2.i2.109	39	35	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122816	10.1371/journal.pone.0122816	http://dx.doi.org/10.1371/journal.pone.0122816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825874	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800094
J	Kerfahi, D; Tripathi, BM; Singh, D; Kim, H; Lee, S; Lee, J; Adams, JM				Kerfahi, Dorsaf; Tripathi, Binu M.; Singh, Dharmesh; Kim, Hyoki; Lee, Sujin; Lee, Junghoon; Adams, Jonathan M.			Effects of Functionalized and Raw Multi-Walled Carbon Nanotubes on Soil Bacterial Community Composition	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY; POTENTIAL RELEASE; DIVERSITY; NANOPARTICLES; NANOMATERIALS; IMPACT; BEHAVIOR; CYTOTOXICITY; ECOTOXICITY	Carbon nanotubes (CNTs) are widely used in industry, but their environmental impacts on soil microbial communities are poorly known. In this paper, we compare the effect of both raw and acid treated or functionalized (fCNTs) multi-walled carbon nanotubes (MWCNTs) on soil bacterial communities, applying different concentrations of MWCNTs (0 mu g/g, 50 mu g/g, 500 mu g/g and 5000 mu g/g) to a soil microcosm system. Soil DNA was extracted at 0, 2 and 8 weeks and the V3 region of the 16S rRNA gene was PCR-amplified and sequenced using paired-end Illumina bar-coded sequencing. The results show that bacterial diversity was not affected by either type of MWCNT. However, overall soil bacterial community composition, as illustrated by NMDS, was affected only by fMWCNT at high concentrations. This effect, detectable at 2 weeks, remained equally strong by 8 weeks. In the case of fMWCNTs, overall changes in relative abundance of the dominant phyla were also found. The stronger effect of fMWCNTs could be explained by their intrinsically acidic nature, as the soil pH was lower at higher concentrations of fMWCNTs. Overall, this study suggests that fMWCNTs may at least temporarily alter microbial community composition on the timescale of at least weeks to months. It appears, by contrast, that raw MWCNTs do not affect soil microbial community composition.	[Kerfahi, Dorsaf; Tripathi, Binu M.; Singh, Dharmesh; Adams, Jonathan M.] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kerfahi, Dorsaf; Lee, Junghoon] Seoul Natl Univ, Sch Chem & Biol Engn, Interdisciplinary Program Bioengn, Seoul, South Korea; [Kim, Hyoki] Celemics Inc, Avison Biomed Res Ctr 612, Yonsei Med Ctr, Seoul, South Korea; [Lee, Sujin; Lee, Junghoon] Seoul Natl Univ, Interdisciplinary Program Bioengn, Sch Mech & Aerosp Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, J (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Interdisciplinary Program Bioengn, Seoul, South Korea.	jleenano@snu.ac.kr; foundinkualalumpur@yahoo.com	Tripathi, Binu M/J-3075-2015	Tripathi, Binu M/0000-0002-7848-0206; Singh, Dharmesh/0000-0002-4251-6617; Adams, Jonathan/0000-0001-7954-8332	Global Frontier Project, Center of Integrated Smart Sensors, Ministry of Education, Science, and Technology, Korea [2012M3A6A6054201]; Korean Government Scholarship Program, Ministry of Education, Science, and Technology, South Korea	Global Frontier Project, Center of Integrated Smart Sensors, Ministry of Education, Science, and Technology, Korea; Korean Government Scholarship Program, Ministry of Education, Science, and Technology, South Korea	We gratefully acknowledge funding from the Global Frontier Project, Center of Integrated Smart Sensors, Ministry of Education, Science, and Technology, Korea (2012M3A6A6054201). DK is supported by the Korean Government Scholarship Program, Ministry of Education, Science, and Technology, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2011, CARBON, V49, P3663, DOI 10.1016/j.carbon.2011.05.002; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Dong LF, 2009, NANOSCALE RES LETT, V4, P1517, DOI 10.1007/s11671-009-9429-0; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003; Freeman KR, 2009, ENVIRON MICROBIOL, V11, P674, DOI 10.1111/j.1462-2920.2008.01844.x; Ghafari P, 2008, NAT NANOTECHNOL, V3, P347, DOI 10.1038/nnano.2008.109; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Goyal D, 2010, LETT APPL MICROBIOL, V51, P428, DOI 10.1111/j.1472-765X.2010.02913.x; Han L, 2004, LANGMUIR, V20, P6019, DOI 10.1021/la0497907; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jackson P, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-154; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Jin L, 2013, ECOTOX ENVIRON SAFE, V88, P9, DOI 10.1016/j.ecoenv.2012.10.031; Johansen A, 2008, ENVIRON TOXICOL CHEM, V27, P1895, DOI 10.1897/07-375.1; Kang S, 2008, ENVIRON SCI TECHNOL, V42, P7528, DOI 10.1021/es8010173; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r; Kang S, 2009, ENVIRON SCI TECHNOL, V43, P2648, DOI 10.1021/es8031506; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Kim B, 2010, J PHYS CHEM C, V114, P15223, DOI 10.1021/jp105498d; Kim YJ, 2005, CARBON, V43, P23, DOI 10.1016/j.carbon.2004.08.015; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kohler AR, 2008, J CLEAN PROD, V16, P927, DOI 10.1016/j.jclepro.2007.04.007; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Liu SB, 2009, ACS NANO, V3, P3891, DOI 10.1021/nn901252r; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Osorio AG, 2008, APPL SURF SCI, V255, P2485, DOI 10.1016/j.apsusc.2008.07.144; Parish A., 2011, PRODUCTION APPL CARB; Park S, 2010, DIAM RELAT MATER, V19, P942, DOI 10.1016/j.diamond.2010.02.041; Petersen EJ, 2011, ENVIRON SCI TECHNOL, V45, P9837, DOI 10.1021/es201579y; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Rodrigues DF, 2013, ENVIRON SCI TECHNOL, V47, P625, DOI 10.1021/es304002q; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P926, DOI 10.1016/j.soilbio.2010.02.009; Saito T, 2002, PHYSICA B, V323, P280, DOI 10.1016/S0921-4526(02)00999-7; Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah V, 2010, ENVIRON TOXICOL CHEM, V29, P2389, DOI 10.1002/etc.320; Shi W, 2002, APPL ENVIRON MICROB, V68, P3859, DOI 10.1128/AEM.68.8.3859-3866.2002; Shrestha B, 2013, J HAZARD MATER, V261, P188, DOI 10.1016/j.jhazmat.2013.07.031; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tong ZH, 2007, ENVIRON SCI TECHNOL, V41, P2985, DOI 10.1021/es061953l; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Vivas A, 2008, J ENVIRON MONITOR, V10, P1287, DOI 10.1039/b808567f; Yang CN, 2010, LANGMUIR, V26, P16013, DOI 10.1021/la103110g; Yang YG, 2006, CHEMOSPHERE, V63, P1942, DOI 10.1016/j.chemosphere.2005.10.009; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; Yousuf B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-150; Yousuf B, 2012, GENE, V506, P18, DOI 10.1016/j.gene.2012.06.083; Yue GZ, 2002, APPL PHYS LETT, V81, P355, DOI 10.1063/1.1492305; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2004, APPL ENVIRON MICROB, V70, P1723, DOI 10.1128/AEM.70.3.1723-1734.2004	70	37	37	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0123042	10.1371/journal.pone.0123042	http://dx.doi.org/10.1371/journal.pone.0123042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825905	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800103
J	Makusha, T; Knight, L; Taegtmeyer, M; Tulloch, O; Davids, A; Lim, J; Peck, R; van Rooyen, H				Makusha, Tawanda; Knight, Lucia; Taegtmeyer, Miriam; Tulloch, Olivia; Davids, Adlai; Lim, Jeanette; Peck, Roger; van Rooyen, Heidi			HIV Self-Testing Could "Revolutionize Testing in South Africa, but It Has Got to Be Done Properly": Perceptions of Key Stakeholders	PLOS ONE			English	Article							CAPE-TOWN; ACCEPTABILITY; INFECTION; URBAN; RISK; MEN	South Africa bears the world's largest burden of HIV with over 6.4 million people living with the virus. The South African government's response to HIV has yielded remarkable results in recent years; over 13 million South Africans tested in a 2012 campaign and over 2 million people are on antiretroviral treatment. However, with an HIV & AIDS and STI National Strategic Plan aiming to get 80 percent of the population to know their HIV status by 2016, activists and public health policy makers argue that non-invasive HIV self-testing should be incorporated into the country HIV Counseling and Testing [HCT] portfolios. In-depth qualitative interviews (N = 12) with key stakeholders were conducted from June to July 2013 in South Africa. These included two government officials, four non-governmental stakeholders, two donors, three academic researchers, and one international stakeholder. All stakeholders were involved in HIV prevention and treatment and influenced HCT policy and research in South Africa and beyond. The interviews explored: interest in HIV self-testing; potential distribution channels for HIV self-tests to target groups; perception of requirements for diagnostic technologies that would be most amenable to HIV self-testing and opinions on barriers and opportunities for HIV-linkage to care after receiving positive test results. While there is currently no HIV self-testing policy in South Africa, and several barriers exist, participants in the study expressed enthusiasm and willingness for scale-up and urgent need for further research, planning, establishment of HIV Self-testing policy and programming to complement existing facility-based and community-based HIV testing systems. Introduction of HIV self-testing could have far-reaching positive effects on holistic HIV testing uptake, giving people autonomy to decide which approach they want to use for HIV testing, early diagnosis, treatment and care for HIV particularly among hard-to reach groups, including men.	[Makusha, Tawanda; Davids, Adlai; van Rooyen, Heidi] Human Sci Res Council, Durban, South Africa; [Taegtmeyer, Miriam; Tulloch, Olivia] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Knight, Lucia] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Lim, Jeanette; Peck, Roger] PATH, Seattle, WA USA	Human Sciences Research Council-South Africa; Liverpool School of Tropical Medicine; University of Liverpool; University of the Western Cape	Makusha, T (corresponding author), Human Sci Res Council, Durban, South Africa.	tmakusha@hsrc.ac.za	Makusha, Tawanda/AAE-5356-2022	Knight, Lucia/0000-0001-9938-6887; Davids, Adlai/0000-0001-6898-2344; Taegtmeyer, Miriam/0000-0002-5377-2536; Makusha, Tawanda/0000-0003-2120-8989; Van Rooyen, Heidi/0000-0002-6502-6098	Bill & Melinda Gates Foundation [OPP1045125]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation under grant OPP1045125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Brown AN, 2014, AIDS BEHAV, V18, pS445, DOI 10.1007/s10461-014-0831-y; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Dong M, 2014, 20 INT AIDS C 2014 J; Ferrand RA, 2011, AM J PUBLIC HEALTH, V101, P2325, DOI 10.2105/AJPH.2011.300250; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Ganguli Ishani, 2009, Curr HIV/AIDS Rep, V6, P217, DOI 10.1007/s11904-009-0029-5; Gardner J, 2012, S AFR J BIOETH LAW, V5, P15; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Green J., 2018, QUALITATIVE METHODS, VFourth; Kalibala S, 2011, KNOWING MYSELF 1 FEA; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kumwenda M, 2014, AIDS BEHAV, V18, pS396, DOI 10.1007/s10461-014-0817-9; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Merson MH, 1997, LANCET, V349, P352, DOI 10.1016/S0140-6736(96)08260-8; Myers JE, 2013, AIDS, V27, P1687, DOI 10.1097/QAD.0b013e32835fd7a0; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Patton M. Q., 1980, QUALITATIVE EVALUATI; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Richter ML, 2012, S AFR J HIV MED, P186, DOI 10.7196/SAJHIVMED.858; Richter M, 2010, SAMJ S AFR MED J, V100, P636, DOI 10.7196/SAMJ.4198; Shisana O, 2014, S AFRICAN NATL HIV P; Silverman D., 2010, DOING QUALITATIVE RE, V3; South African National AIDS Council, 2011, HIV AIDS STI NAT STR; Southern African AIDS Trust, 2014, MULT REV LEG ISS SUR; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; van Rooyen H, 2013, AIDS BEHAV, V17, P2946, DOI 10.1007/s10461-012-0368-x; van Rooyen H, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P165, DOI 10.1007/978-1-4419-0306-8_12; [WHO WHO UNAIDS Brocher Foundation Liverpool School of Tropical Mediciine], 2013, 1 INT S SELF TEST HI; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wong V, 2014, AIDS BEHAV, V18, pS415, DOI 10.1007/s10461-014-0825-9; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	37	69	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122783	10.1371/journal.pone.0122783	http://dx.doi.org/10.1371/journal.pone.0122783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826655	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352084800092
J	Malik, A; Jamasbi, RJ; Kondratov, RV; Geusz, ME				Malik, Astha; Jamasbi, Roudabeh J.; Kondratov, Roman V.; Geusz, Michael E.			Development of Circadian Oscillators in Neurosphere Cultures during Adult Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; GENE-EXPRESSION; OLFACTORY-BULB; CLOCK GENES; NEURONAL DIFFERENTIATION; RHYTHM GENERATION; PROGENITOR CELLS; MOUSE; NUCLEUS; ACID	Circadian rhythms are common in many cell types but are reported to be lacking in embryonic stem cells. Recent studies have described possible interactions between the molecular mechanism of circadian clocks and the signaling pathways that regulate stem cell differentiation. Circadian rhythms have not been examined well in neural stem cells and progenitor cells that produce new neurons and glial cells during adult neurogenesis. To evaluate circadian timing abilities of cells undergoing neural differentiation, neurospheres were prepared from the mouse subventricular zone (SVZ), a rich source of adult neural stem cells. Circadian rhythms in mPer1 gene expression were recorded in individual spheres, and cell types were characterized by confocal immunofluorescence microscopy at early and late developmental stages in vitro. Circadian rhythms were observed in neurospheres induced to differentiate into neurons or glia, and rhythms emerged within 3-4 days as differentiation proceeded, suggesting that the neural stem cell state suppresses the functioning of the circadian clock. Evidence was also provided that neural stem progenitor cells derived from the SVZ of adult mice are self-sufficient clock cells capable of producing a circadian rhythm without input from known circadian pacemakers of the organism. Expression of mPer1 occurred in high frequency oscillations before circadian rhythms were detected, which may represent a role for this circadian clock gene in the fast cycling of gene expression responsible for early cell differentiation.	[Malik, Astha; Jamasbi, Roudabeh J.; Geusz, Michael E.] Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA; [Jamasbi, Roudabeh J.] Bowling Green State Univ, Dept Publ & Allied Hlth, Bowling Green, OH 43403 USA; [Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	University System of Ohio; Bowling Green State University; University System of Ohio; Bowling Green State University; University System of Ohio; Cleveland State University	Geusz, ME (corresponding author), Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA.	mgeusz@bgsu.edu	Malik, Astha/AAH-2431-2020	Malik, Astha/0000-0001-6957-8044; Kondratov, Roman/0000-0003-3449-745X	JP Scott Center for Neuroscience, Mind, and Behavior; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER	JP Scott Center for Neuroscience, Mind, and Behavior; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors received no specific funding for this work other than from sources internal to Bowling Green State University (BGSU), such as the JP Scott Center for Neuroscience, Mind, and Behavior.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Ahn JM, 2008, EUR ARCH OTO-RHINO-L, V265, P429, DOI 10.1007/s00405-007-0487-6; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Beaule C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007476; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Curto GG, 2014, STEM CELLS DEV, V23, P2813, DOI 10.1089/scd.2014.0058; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duhart JM, 2013, J IMMUNOL, V191, P4656, DOI 10.4049/jimmunol.1300450; Gan QN, 2014, STEM CELLS, V32, P45, DOI 10.1002/stem.1561; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; Hiler DJ, 2008, BRAIN RES, V1214, P84, DOI 10.1016/j.brainres.2008.03.041; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kageyama R, 2007, COLD SPRING HARB SYM, V72, P451, DOI 10.1101/sqb.2007.72.012; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kimiwada T, 2009, NEUROCHEM INT, V54, P277, DOI 10.1016/j.neuint.2008.12.005; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Konefal S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00021; Kowalska E, 2010, J BIOL RHYTHM, V25, P442, DOI 10.1177/0748730410385281; Lim DA, 2014, TRENDS NEUROSCI, V37, P563, DOI 10.1016/j.tins.2014.08.006; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Marshall GP, 2007, CURR PHARM BIOTECHNO, V8, P141; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morgan R, 2004, DEV DYNAM, V230, P643, DOI 10.1002/dvdy.20097; Moriya T, 2007, NEUROSCIENCE, V146, P494, DOI 10.1016/j.neuroscience.2007.02.018; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Ng FS, 2011, CURR BIOL, V21, P625, DOI 10.1016/j.cub.2011.03.027; Nolasco N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047779; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Sharma VP, 2014, CANCER LETT, V345, P65, DOI 10.1016/j.canlet.2013.11.009; Silvestroff L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033937; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019745; Sun W, 2010, ANAT CELL BIOL, V43, P269, DOI 10.5115/acb.2010.43.4.269; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Theocharatos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054809; Torrado EF, 2014, INT J DEV NEUROSCI, V37, P94, DOI 10.1016/j.ijdevneu.2014.07.001; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Trounson Alan, 2002, Reprod Biomed Online, V4 Suppl 1, P58; Ueshima T, 2012, GENE, V510, P118, DOI 10.1016/j.gene.2012.08.022; Vik-Mo EO, 2011, EXP CELL RES, V317, P1049, DOI 10.1016/j.yexcr.2010.12.022; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wreschnig D, 2014, J BIOL RHYTHM, V29, P299, DOI 10.1177/0748730414545086; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yokoyama TK, 2011, NEURON, V71, P883, DOI 10.1016/j.neuron.2011.05.046	70	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122937	10.1371/journal.pone.0122937	http://dx.doi.org/10.1371/journal.pone.0122937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826427	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800100
J	Ong, CT; Sheu, SM; Tsai, CF; Wong, YS; Chen, SCC				Ong, Cheung-Ter; Sheu, Shew-Meei; Tsai, Ching-Fang; Wong, Yi-Sin; Chen, Solomon Chih-Cheng			Age-Dependent Sex Difference of the Incidence and Mortality of Status Epilepticus: A Twelve Year Nationwide Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							CONVULSIVE STATUS EPILEPTICUS; EPIDEMIOLOGY; MINNESOTA; ROCHESTER; PROGNOSIS; DATABASE; THERAPY; ADULTS	Status epilepticus (SE) is a serious neurologic emergency associated with a significant mortality. The objective of this study is to investigate its epidemiology in terms of age-and sex-specific incidences and mortality. By using the Taiwan National Health Insurance Research Database during 2000 to 2011, we identified hospitalized patients with a discharged diagnosis of SE and calculated the incidence and in-hospital mortality of SE with respect to age and sex. The overall incidence of SE was 4.61 per 100,000 person-years, which displayed a "J-shaped" distribution by age with a little higher under the age of 5 and highest over 60 years. The male-to-female rate ratio was 1.57 and it demonstrated a "mountain-shape" across ages with the peak at 45 to 49 years old. The in-hospital mortality was significantly lower in males (7.38%) than in females (11.12%) with an odds ratio of 0.64 (95% CI 0.56-.72). Notably, the in-hospital mortality for females increased rapidly after the age of 40 to 45 years. The multivariate analysis found males had a significantly lower risk of mortality than females after, but not before, 45 years of age with an odds ratio of 0.56 (95% CI 0.49-0.65). Sex and age are crucial factors associated with the incidence and in-hospital mortality of SE. The females over 45 years of age have a higher risk of occurrence and mortality from SE. The underlying mechanism deserves further study.	[Ong, Cheung-Ter] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Neurol, Chiayi, Taiwan; [Ong, Cheung-Ter] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan; [Sheu, Shew-Meei; Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Wong, Yi-Sin] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Family Med, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Sch Med, Dept Pediat, Taipei, Taiwan	Taipei Medical University	Chen, SCC (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan.	solomon.ccc@gmail.com						Cascino GD, 1998, EPILEPSIA, V39, P829, DOI 10.1111/j.1528-1157.1998.tb01176.x; Chen SCC, 2010, PEDIATR NEONATOL, V51, P285, DOI 10.1016/S1875-9572(10)60055-1; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng TM, 2010, SIX COUNTRIES SIX RE, P171; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dham BS, 2014, NEUROCRIT CARE, V20, P476, DOI 10.1007/s12028-013-9935-x; Erel T, 2011, ARCH GYNECOL OBSTET, V284, P749, DOI 10.1007/s00404-011-1936-4; Fountain NB, 2000, EPILEPSIA, V41, pS23, DOI 10.1111/j.1528-1157.2000.tb01521.x; Harden CL, 1999, EPILEPSIA, V40, P1402, DOI 10.1111/j.1528-1157.1999.tb02012.x; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Leong MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019404; Lin KL, 2009, PEDIATR NEUROL, V41, P413, DOI 10.1016/j.pediatrneurol.2009.06.004; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Menon Ramshekar, 2013, J Assoc Physicians India, V61, P58; Peebles CT, 2000, ANN PHARMACOTHER, V34, P1028; Rosenow F, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01359.x; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Stevens SJ, 2011, CURR NEUROL NEUROSCI, V11, P435, DOI 10.1007/s11910-011-0196-9; Tiamkao S, 2014, INT J NEUROSCI, V124, P416, DOI 10.3109/00207454.2013.850084; Veliskova J, 2013, HORM BEHAV, V63, P267, DOI 10.1016/j.yhbeh.2012.03.018; Vignatelli L, 2005, EUR J NEUROL, V12, P897, DOI 10.1111/j.1468-1331.2005.01073.x; Vignatelli L, 2003, EPILEPSIA, V44, P964, DOI 10.1046/j.1528-1157.2003.63702.x; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070	26	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122350	10.1371/journal.pone.0122350	http://dx.doi.org/10.1371/journal.pone.0122350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826701	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800066
J	Xia, LL; Wang, XJ; Xu, TY; Zhang, XH; Zhu, ZW; Qin, L; Zhang, X; Fang, C; Zhang, MG; Zhong, S; Shen, ZJ				Xia, Leilei; Wang, Xianjin; Xu, Tianyuan; Zhang, Xiaohua; Zhu, Zhaowei; Qin, Liang; Zhang, Xiang; Fang, Chen; Zhang, Minguang; Zhong, Shan; Shen, Zhoujun			Robotic versus Open Radical Cystectomy: An Updated Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; LEARNING-CURVE; PERIOPERATIVE OUTCOMES; BLADDER-CANCER; PELVIC LYMPHADENECTOMY; EARLY COMPLICATIONS; SURGICAL MARGINS; TIME; CYSTOPROSTATECTOMY	Objective To critically review the currently available evidence of studies comparing robot-assisted radical cystectomy (RARC) with open radical cystectomy (ORC). Methods A comprehensive review of the literature from Pubmed, Web of Science and Scopus was performed in April 2014. All relevant studies comparing RARC with ORC were included for further screening. A pooled meta-analysis of all comparative studies was performed and publication bias was assessed by a funnel plot. Results Nineteen studies were included for the analysis, including a total of 1779 patients (787 patients in the RARC group and 992 patients in the ORC group). Although RARC was associated with longer operative time (p <0.0001), patients in this group might benefit from significantly lower overall perioperative complication rates within 30 days and 90 days (p = 0.005 and 0.0002, respectively), more lymph node yields (p = 0.009), less estimated blood loss (p <0.00001), lower need for perioperative and intraoperative transfusions (p <0.0001 and <0.0001, respectively), and shorter postoperative length of stay (p = 0.0002). There was no difference between two groups regarding positive surgical margin rates (p = 0.19). Conclusions RARC appears to be an efficient alternative to ORC with advantages of less perioperative complications, more lymph node yields, less estimated blood loss, lower need for transfusions, and shorter postoperative length of stay. Further studies should be performed to compare the long-term oncologic outcomes between RARC and ORC.	[Xia, Leilei; Wang, Xianjin; Xu, Tianyuan; Zhang, Xiaohua; Zhu, Zhaowei; Qin, Liang; Zhang, Xiang; Fang, Chen; Zhang, Minguang; Zhong, Shan; Shen, Zhoujun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200030, Peoples R China.	shzj6@sina.com			National Natural Science Foundation of China [81270695, 81472379]; Science and Technology Commission of Shanghai Municipality [12140901200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (grants 81270695 and 81472379), Science and Technology Commission of Shanghai Municipality (grant 12140901200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza R, 2012, J UROLOGY, V187, P1200, DOI 10.1016/j.juro.2011.11.092; Aboumohamed AA, 2014, UROLOGY, V83, P1300, DOI 10.1016/j.urology.2014.02.024; Abraham JBA, 2007, J ENDOUROL, V21, P1473, DOI 10.1089/end.2007.0095; Ahdoot M, 2014, WORLD J UROL, V32, P1441, DOI 10.1007/s00345-014-1242-4; Azzouni F, 2013, EXPERT REV ANTICANC, V13, P681, DOI [10.1586/ERA.13.59, 10.1586/era.13.59]; Bostrom PJ, 2009, BJU INT, V103, P191, DOI 10.1111/j.1464-410X.2008.07889.x; Casey KNA, 2010, EUR UROL, V57, P274, DOI 10.1016/j.eururo.2009.06.001; Chang SS, 2002, J UROLOGY, V167, P2012, DOI 10.1016/S0022-5347(05)65074-4; Coward RM, 2011, UROLOGY, V77, P1111, DOI 10.1016/j.urology.2010.07.510; Davis JW, 2011, J UROLOGY, V185, P79, DOI 10.1016/j.juro.2010.09.031; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dotan ZA, 2007, J UROLOGY, V178, P2308, DOI 10.1016/j.juro.2007.08.023; Galich Anton, 2006, JSLS, V10, P145; Gondo T, 2012, JPN J CLIN ONCOL, V42, P625, DOI 10.1093/jjco/hys062; Guillotreau J, 2012, UROLOGY, V79, P585, DOI 10.1016/j.urology.2011.11.042; Guru Khurshid A, 2007, Can J Urol, V14, P3753; Guru KA, 2009, JSLS-J SOC LAPAROEND, V13, P509, DOI 10.4293/108680809X12589998404128; Hadjizacharia P, 2009, WORLD J UROL, V27, P33, DOI 10.1007/s00345-008-0345-1; Hayn MH, 2010, EUR UROL, V58, P197, DOI 10.1016/j.eururo.2010.04.024; Hellenthal NJ, 2011, BJU INT, V107, P642, DOI 10.1111/j.1464-410X.2010.09473.x; Hellenthal NJ, 2010, J UROLOGY, V184, P87, DOI 10.1016/j.juro.2010.03.037; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johar RS, 2013, EUR UROL, V64, P52, DOI 10.1016/j.eururo.2013.01.010; Kader AK, 2013, BJU INT, V112, pE290, DOI 10.1111/bju.12167; Kauffman EC, 2010, BJU INT, V105, P520, DOI 10.1111/j.1464-410X.2009.08843.x; Khan MS, 2012, INT J CLIN PRACT, V66, P656, DOI 10.1111/j.1742-1241.2011.02888.x; Khan MS, 2013, EUR UROL, V64, P219, DOI 10.1016/j.eururo.2013.01.006; Knox ML, 2013, J ENDOUROL, V27, P40, DOI 10.1089/end.2012.0168; Lawrentschuk N, 2010, EUR UROL, V57, P983, DOI 10.1016/j.eururo.2010.02.024; Lee R, 2011, BJU INT, V108, P1886, DOI 10.1111/j.1464-410X.2011.10114.x; Li KW, 2013, CANCER TREAT REV, V39, P551, DOI 10.1016/j.ctrv.2012.11.007; Marshall SJ, 2013, BJU INT, V111, P1075, DOI 10.1111/j.1464-410X.2012.11583.x; Martin AD, 2011, UROLOGY, V77, P621, DOI 10.1016/j.urology.2010.07.502; Menon M, 2003, BJU INT, V92, P232, DOI 10.1046/j.1464-410X.2003.04329.x; Messer JC, 2014, BJU INT, V114, P896, DOI 10.1111/bju.12818; Mmeje CO, 2013, CURR UROL REP, V14, P26, DOI 10.1007/s11934-012-0292-7; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monn MF, 2014, UROL ONCOL-SEMIN ORI, V32, P785, DOI 10.1016/j.urolonc.2014.04.007; Musch M, 2014, BJU INT, V113, P458, DOI 10.1111/bju.12374; Nepple KG, 2013, UROL ONCOL-SEMIN ORI, V31, P894, DOI 10.1016/j.urolonc.2011.06.009; Nix J, 2010, EUR UROL, V57, P196, DOI 10.1016/j.eururo.2009.10.024; Novara G, 2010, J UROLOGY, V183, P2165, DOI 10.1016/j.juro.2010.02.021; Parekh DJ, 2013, J UROLOGY, V189, P474, DOI 10.1016/j.juro.2012.09.077; Phillips B, LEVELS OF EVIDENCE A; Phillips EA, 2014, J ENDOUROL, V28, P219, DOI 10.1089/end.2013.0159; Pruthi RS, 2007, J UROLOGY, V178, P814, DOI 10.1016/j.juro.2007.05.040; Pruthi RS, 2008, J ENDOUROL, V22, P2469, DOI 10.1089/end.2008.0320; Richards KA, 2011, J ENDOUROL, V25, P1553, DOI 10.1089/end.2010.0630; Richards KA, 2010, UROLOGY, V76, P1400, DOI 10.1016/j.urology.2010.01.019; Smith A, 2010, J UROLOGY, V183, P505, DOI 10.1016/j.juro.2009.09.081; Snow-Lisy DC, 2014, EUR UROL, V65, P193, DOI 10.1016/j.eururo.2013.08.021; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Sterrett S, 2007, WORLD J UROL, V25, P193, DOI 10.1007/s00345-006-0140-9; Styn NR, 2012, UROLOGY, V79, P1303, DOI 10.1016/j.urology.2012.01.055; Sung HH, 2012, J ENDOUROL, V26, P670, DOI 10.1089/end.2011.0372; Wang GJ, 2008, BJU INT, V101, P89, DOI 10.1111/j.1464-410X.2007.07212.x; Wells GA, THE NEWCASTLE OTTAWA, DOI [10.1371/journal.pntd.0002195, DOI 10.1371/JOURNAL.PNTD.0002195]	60	55	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121032	10.1371/journal.pone.0121032	http://dx.doi.org/10.1371/journal.pone.0121032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825873	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800031
J	Jung, SY; Vitolins, MZ; Fenton, J; Frazier-Wood, AC; Hursting, SD; Chang, SN				Jung, Su Yon; Vitolins, Mara Z.; Fenton, Jenifer; Frazier-Wood, Alexis C.; Hursting, Stephen D.; Chang, Shine			Risk Profiles for Weight Gain among Postmenopausal Women: A Classification and Regression Tree Analysis Approach	PLOS ONE			English	Article							BODY-MASS INDEX; BREAST-CANCER; PHYSICAL-ACTIVITY; LIFE-STYLE; OBESITY; HEALTH; FAT; SMOKING; DIET; MENOPAUSE	Purpose Risk factors for obesity and weight gain are typically evaluated individually while "adjusting for" the influence of other confounding factors, and few studies, if any, have created risk profiles by clustering risk factors. We identified subgroups of postmenopausal women homogeneous in their clustered modifiable and non-modifiable risk factors for gaining >= 3% weight. Methods This study included 612 postmenopausal women 50-79 years old, enrolled in an ancillary study of the Women's Health Initiative Observational Study between February 1995 and July 1998. Classification and regression tree and stepwise regression models were built and compared. Results Of 27 selected variables, the factors significantly related to >= 3% weight gain were weight change in the past 2 years, age at menopause, dietary fiber, fat, alcohol intake, and smoking. In women younger than 65 years, less than 4 kg weight change in the past 2 years sufficiently reduced risk of >= 3% weight gain. Different combinations of risk factors related to weight gain were reported for subgroups of women: women 65 years or older (essential factor: < 9.8 g/day dietary factor), African Americans (essential factor: currently smoking), and white women (essential factor: >= 5 kg weight change for the past 2 years). Conclusions Our findings suggest specific characteristics for particular subgroups of postmenopausal women that may be useful for identifying those at risk for weight gain. The study results may be useful for targeting efforts to promote strategies to reduce the risk of obesity and weight gain in subgroups of postmenopausal women and maximize the effect of weight control by decreasing obesity-relevant adverse health outcomes.	[Jung, Su Yon; Chang, Shine] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Nursing, Translat Sci Sect, Los Angeles, CA 90024 USA; [Vitolins, Mara Z.] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Fenton, Jenifer] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Frazier-Wood, Alexis C.] Baylor Coll Med, Dept Pediat, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Wake Forest University; Michigan State University; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Texas System; University of Texas Austin	Jung, SY (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Nursing, Translat Sci Sect, Los Angeles, CA 90024 USA.	sjung@sonnet.ucla.edu	Wood, Lekki/B-8053-2010	Wood, Lekki/0000-0001-7616-2119; Jung, Su Yon/0000-0002-0513-1830; Chang, Shine/0000-0003-3804-9697	NCI [R21 CA086036]; NATIONAL CANCER INSTITUTE [R21CA086036, P30CA016672] Funding Source: NIH RePORTER; ARS [ARS-0426345] Funding Source: Federal RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by an NCI grant (R21 CA086036; J.H. Grudo, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar FS, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-40; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Astrup A, 2010, ANN NY ACAD SCI, V1190, P25, DOI 10.1111/j.1749-6632.2009.05272.x; BeLue R, 2009, J ADOLESCENT HEALTH, V45, P517, DOI 10.1016/j.jadohealth.2009.03.010; Berk, 2009, CLASSIFICATION REGRE; BURNAM MA, 1988, MED CARE, V26, P775, DOI 10.1097/00005650-198808000-00004; Carmelli D, 1997, EPIDEMIOLOGY, V8, P378, DOI 10.1097/00001648-199707000-00005; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Dubnov G, 2003, MATURITAS, V44, P89, DOI 10.1016/S0378-5122(02)00328-6; Dubnov-Raz G, 2007, CLIMACTERIC, V10, P38, DOI 10.1080/13697130701586428; Farrell RT, 2008, J BURN CARE RES, V29, P102, DOI 10.1097/BCR.0b013e31815f5984; Gomez-Cabello A, 2012, NUTR HOSP, V27, P865, DOI 10.3305/nh.2012.27.3.5668; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HIGGINS M, 1993, ANN INTERN MED, V119, P758, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00025; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Jenkins DJA, 2000, CURR OPIN LIPIDOL, V11, P49, DOI 10.1097/00041433-200002000-00008; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; Kristensen M, 2012, J NUTR, V142, P710, DOI 10.3945/jn.111.142315; Kristensen M, 2011, APPETITE, V56, P65, DOI 10.1016/j.appet.2010.11.147; Lambrinoudaki I, 2010, MATURITAS, V66, P323, DOI 10.1016/j.maturitas.2010.03.025; Lee S, 2011, ASIA PAC J CLIN NUTR, V20, P563; Lee YC, 2009, HEPATO-GASTROENTEROL, V56, P1745; Ma YS, 2013, AM J PUBLIC HEALTH, V103, pE34, DOI 10.2105/AJPH.2013.301394; McCrone S, 2000, J WOMEN HEALTH GEN-B, V9, P1007, DOI 10.1089/15246090050200042; McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Nakata Y, 2009, PREV MED, V48, P351, DOI 10.1016/j.ypmed.2009.01.013; Navarro Rodriguez Mary Carmen, 2009, Endocrinol Nutr, V56, P227, DOI 10.1016/S1575-0922(09)71405-6; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Nishida N, 2005, J PERIODONTOL, V76, P923, DOI 10.1902/jop.2005.76.6.923; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; REUBINOFF BE, 1995, FERTIL STERIL, V64, P963, DOI 10.1016/S0015-0282(16)57910-2; Senechal M, 2011, CLIN INTERV AGING, V6, P221, DOI 10.2147/CIA.S23574; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Thomson CA, 2012, INT J OBESITY, V36, P1158, DOI 10.1038/ijo.2012.84; Thomson CA, 2012, NUTR CLIN PRACT, V27, P636, DOI 10.1177/0884533612454302; Wasserman L, 2004, INT J OBESITY, V28, P49, DOI 10.1038/sj.ijo.0802481; Wee CC, 2001, ARCH INTERN MED, V161, P546, DOI 10.1001/archinte.161.4.546; WING RR, 1983, J CONSULT CLIN PSYCH, V51, P153, DOI 10.1037/0022-006X.51.1.153; Xiao Q, 2013, AM J EPIDEMIOL, V178, P1600, DOI 10.1093/aje/kwt180; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179	43	23	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121430	10.1371/journal.pone.0121430	http://dx.doi.org/10.1371/journal.pone.0121430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822239	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700104
J	Meier, SR; Lancaster, JL; Starobin, JM				Meier, Stephen R.; Lancaster, Jarrett L.; Starobin, Joseph M.			Bursting Regimes in a Reaction-Diffusion System with Action Potential-Dependent Equilibrium	PLOS ONE			English	Article							NEURON MODEL; REFLECTION; MECHANISM; DYNAMICS; SPIKING; STATES	The equilibrium Nernst potential plays a critical role in neural cell dynamics. A common approximation used in studying electrical dynamics of excitable cells is that the ionic concentrations inside and outside the cell membranes act as charge reservoirs and remain effectively constant during excitation events. Research into brain electrical activity suggests that relaxing this assumption may provide a better understanding of normal and pathophysiological functioning of the brain. In this paper we explore time-dependent ionic concentrations by allowing the ion-specific Nernst potentials to vary with developing transmembrane potential. As a specific implementation, we incorporate the potential-dependent Nernst shift into a one-dimensional Morris-Lecar reaction-diffusion model. Our main findings result from a region in parameter space where self-sustaining oscillations occur without external forcing. Studying the system close to the bifurcation boundary, we explore the vulnerability of the system with respect to external stimulations which disrupt these oscillations and send the system to a stable equilibrium. We also present results for an extended, one-dimensional cable of excitable tissue tuned to this parameter regime and stimulated, giving rise to complex spatiotemporal pattern formation. Potential applications to the emergence of neuronal bursting in similar two-variable systems and to pathophysiological seizure-like activity are discussed.	[Meier, Stephen R.; Lancaster, Jarrett L.; Starobin, Joseph M.] Univ N Carolina, Dept Neurosci, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Lancaster, JL (corresponding author), Univ N Carolina, Dept Neurosci, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA.	jllancas@uncg.edu		Lancaster, Jarrett/0000-0002-7984-3240				Abbasian AH, 2013, BIOL CYBERN, V107, P465, DOI 10.1007/s00422-013-0559-1; Abramowitz M., 1964, HDB MATH FUNCTIONS F; Aslanidi OV, 1999, J BIOL PHYS, V25, P149, DOI 10.1023/A:1005119218136; Aslanidi OV, 1997, JETP LETT+, V65, P579, DOI 10.1134/1.567398; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Breedlove SM, 2001, BIOL PSYCHOL INTRO B; Cressman JR, 2011, J COMPUT NEUROSCI, V30, P781, DOI 10.1007/s10827-011-0333-0; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Del Negro CA, 1998, BIOPHYS J, V75, P174, DOI 10.1016/S0006-3495(98)77504-6; DUAN LX, 2011, DISCRETE CONT S SEP, P391; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Forrest MD, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00086; Forrest MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068765; Goltsev AV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061921; Gonzalez-Perez A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031047; GUTTMAN R, 1980, J PHYSIOL-LONDON, V305, P377, DOI 10.1113/jphysiol.1980.sp013370; Hampson RE, 2012, IEEE T NEUR SYS REH, V20, P510, DOI 10.1109/TNSRE.2012.2190942; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich E. M., 2010, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Keener JP, 2009, MATH PHYSL; LECAR H, 1975, ANN NY ACAD SCI, V264, P304, DOI 10.1111/j.1749-6632.1975.tb31491.x; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Mornev OA, 1996, DOKL AKAD NAUK+, V347, P123; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; PINSKY PF, 1995, J COMPUT NEUROSCI, V2, P275, DOI 10.1007/BF00961439; Plonsey R., 2007, BIOELECTRICITY QUANT; Press W. H., 1992, NUMERICAL RECIPES FO, V77; Rambidi NG, 1998, ADV MATER OPT ELECTR, V8, P163, DOI 10.1002/(SICI)1099-0712(1998070)8:4<163::AID-AMO347>3.0.CO;2-A; REUTER H, 1969, SCIENCE, V163, P399, DOI 10.1126/science.163.3865.399; RINZEL J, 1980, MATH BIOSCI, V49, P27, DOI 10.1016/0025-5564(80)90109-1; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Tuckwell HC, 2011, J COMPUT NEUROSCI, V30, P361, DOI 10.1007/s10827-010-0260-5; Tuckwell HC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000794; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6	44	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122401	10.1371/journal.pone.0122401	http://dx.doi.org/10.1371/journal.pone.0122401			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823018	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700171
J	Pongkan, W; Chattipakorn, SC; Chattipakorn, N				Pongkan, Wanpitak; Chattipakorn, Siriporn C.; Chattipakorn, Nipon			Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HEART-RATE-VARIABILITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; SEX STEROIDS; CARDIOMYOCYTE CA2+; AIR-POLLUTION; CELL-DEATH	Background Although testosterone deficiency is associated with increased risks of heart disease, the benefits of testosterone therapy are controversial. Moreover, current understanding on the cardiac effect of testosterone during cardiac ischemia-reperfusion (I/R) periods is unclear. We tested the hypothesis that testosterone replacement attenuates the impairment of left ventricular (LV) function and heart rate variability (HRV), and reduces the infarct size and arrhythmias caused by I/R injury in orchiectomized (ORX) rats. Methodology ORX or sham-operated male Wistar rats (n = 24) were randomly divided and received either testosterone (2 mg/kg, subcutaneously administered) or the vehicle for 8 weeks. The ejection fraction (EF) and HRV were determined at baseline and the 4th and 8th week. I/R was performed by left anterior descending coronary artery ligation for 30 minutes, followed by a 120-minute reperfusion. LV pressure, arrhythmia scores, infarct size and cardiac mitochondrial function were determined. Results Prior to I/R, EF and HRV were impaired in the ORX group, but were restored in the testoster-one-treated group. During I/R, arrhythmia scores and the infarct size were greater, and cardiac mitochondrial function was impaired, whereas the time to 1st VT/VF onset and the LV end-systolic pressure were decreased in the ORX group when compared to the sham group. Testosterone replacement attenuated the impairment of these parameters in ORX rats during I/R injury, but did not show any benefit or adverse effect in non-ORX rats. Conclusions Testosterone replacement restores cardiac function and autonomic regulation, and exerts cardioprotective effects during the I/R period via mitochondrial protection in ORX rats.	[Pongkan, Wanpitak; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand; [Pongkan, Wanpitak; Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Unit, Dept Physiol, Fac Med, Chiang Mai 50000, Thailand; [Chattipakorn, Siriporn C.] Chiang Mai Univ, Fac Dent, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand; [Pongkan, Wanpitak; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand.	nchattip@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021; Pongkan, Wanpitak/N-8420-2018	Pongkan, Wanpitak/0000-0001-6788-7740; Chattipakorn, Nipon/0000-0003-3026-718X	NSTDA Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund [RTA5580006, BRG5780016]; Royal Golden Jubilee PhD program; Faculty of Medicine Endowment Fund; Chiang Mai University Center of Excellence Award	NSTDA Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee PhD program(Thailand Research Fund (TRF)); Faculty of Medicine Endowment Fund; Chiang Mai University Center of Excellence Award	This work was supported by a NSTDA Research Chair Grant from the National Science and Technology Development Agency (NC), grants from the Thailand Research Fund RTA5580006 (NC) and BRG5780016 (SC), the Royal Golden Jubilee PhD program (NC and WP), Faculty of Medicine Endowment Fund (NC), and the Chiang Mai University Center of Excellence Award (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Apaijai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102374; Bell JR, 2011, CLIN EXP PHARMACOL P, V38, P717, DOI 10.1111/j.1440-1681.2011.05567.x; Borst SE, 2010, HORM METAB RES, V42, P122, DOI 10.1055/s-0029-1241843; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Chen YP, 2012, EUR J PHARMACOL, V684, P116, DOI 10.1016/j.ejphar.2012.03.032; Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c; Chinda K, 2014, DIABETES VASC DIS RE, V11, P75, DOI 10.1177/1479164113516134; Corona G, 2013, WORLD J MENS HEALTH, V31, P103, DOI 10.5534/wjmh.2013.31.2.103; Crisostomo PR, 2006, AM J PHYSIOL-REG I, V290, pR1168, DOI 10.1152/ajpregu.00833.2005; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Curl CL, 2009, PHYSIOL RES, V58, P293, DOI 10.33549/physiolres.931460; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Lima AHRD, 2011, ARQ BRAS CARDIOL, V96, P498; Foley PL, 2005, COMMON SURG PROCEDUR; Glos M, 2007, P ANN INT IEEE EMBS, P263, DOI 10.1109/IEMBS.2007.4352274; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Haring R, 2010, EUR HEART J, V31, P1494, DOI 10.1093/eurheartj/ehq009; HASCHE ET, 1995, CIRCULATION, V92, P710, DOI 10.1161/01.CIR.92.4.710; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Huang CY, 2010, J SURG RES, V164, pE1, DOI 10.1016/j.jss.2010.07.041; Hwang TIS, 2011, ASIAN J ANDROL, V13, P432, DOI 10.1038/aja.2010.159; Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582; Klapcinska B, 2008, J PHYSIOL SCI, V58, P173, DOI 10.2170/physiolsci.RP002208; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Latchman PL, 2011, CLIN AUTON RES, V21, P319, DOI 10.1007/s10286-011-0116-8; Marin DP, 2010, CELL BIOCHEM FUNCT, V28, P394, DOI 10.1002/cbf.1669; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; Nam UH, 2007, J SURG RES, V142, P113, DOI 10.1016/j.jss.2006.11.019; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Palee S, 2013, EXP PHYSIOL, V98, P1028, DOI 10.1113/expphysiol.2012.070433; Saad F, 2012, DIABETES-METAB RES, V28, P52, DOI 10.1002/dmrr.2354; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sripetchwandee J, 2013, ACTA PHYSL OXF; Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1; Thummasorn S, 2011, MITOCHONDRION, V11, P457, DOI 10.1016/j.mito.2011.01.008; Traish AM, 2011, ATHEROSCLEROSIS, V214, P244, DOI 10.1016/j.atherosclerosis.2010.08.078; Tsang S, 2008, BRIT J PHARMACOL, V153, P693, DOI 10.1038/sj.bjp.0707624; Tsang Sharon, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P119; Uyanik BS, 1997, JPN HEART J, V38, P73; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Wang J, 2010, CELL PROLIFERAT, V43, P103, DOI 10.1111/j.1365-2184.2009.00659.x; Wang MJ, 2009, SURGERY, V146, P138, DOI 10.1016/j.surg.2009.03.035; Weiss EP, 2012, AGING CELL, V11, P876, DOI 10.1111/j.1474-9726.2012.00852.x; Witayavanitkul N, 2013, AM J PHYSIOL-HEART C, V304, pH465, DOI 10.1152/ajpheart.00555.2012; Wranicz JK, 2004, ANN NONINVAS ELECTRO, V9, P156, DOI 10.1111/j.1542-474X.2004.92539.x; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097/MED.0b013e3283383031; Yildirir A, 2001, EUR HEART J, V22, P612, DOI 10.1053/euhj.2000.2365	53	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122503	10.1371/journal.pone.0122503	http://dx.doi.org/10.1371/journal.pone.0122503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822979	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700180
J	Voss, A; Schroeder, R; Heitmann, A; Peters, A; Perz, S				Voss, Andreas; Schroeder, Rico; Heitmann, Andreas; Peters, Annette; Perz, Siegfried			Short-Term Heart Rate Variability-Influence of Gender and Age in Healthy Subjects	PLOS ONE			English	Article							RISK-STRATIFICATION; NONLINEAR DYNAMICS; POINCARE PLOT; COMPRESSION ENTROPY; PERIOD VARIABILITY; GENERAL-POPULATION; SPECTRAL-ANALYSIS; SEX-DIFFERENCES; COMPLEXITY; TIME	In the recent years, short-term heart rate variability (HRV) describing complex variations of beat-to-beat interval series that are mainly controlled by the autonomic nervous system (ANS) has been increasingly analyzed to assess the ANS activity in different diseases and under various conditions. In contrast to long-term HRV analysis, short-term investigations (<30 min) provide a test result almost immediately. Thus, short-term HRV analysis is suitable for ambulatory care, patient monitoring and all those applications where the result is urgently needed. In a previous study, we could show significant variations of 5-min HRV indices according to age in almost all domains (linear and nonlinear) in 1906 healthy subjects from the KORA S4 cohort. Based on the same group of subjects, general gender-related influences on HRV indices are to be determined in this study. Short-term 5-min HRV indices from linear time and frequency domain and from nonlinear methods (compression entropy, detrended fluctuation analysis, traditional and segmented Poincare plot analysis, irreversibility analysis, symbolic dynamics, correlation and mutual information analysis) were determined from 782 females and 1124 males. First, we examined the gender differences in two age clusters (25-49 years and 50-74 years). Secondly, we investigated the gender-specific development of HRV indices in five age decade categories, namely for ages 25-34, 35-44, 45-54, 55-64 and 65-74 years. In this study, significant modifications of the indices according to gender could be obtained, especially in the frequency domain and correlation analyses. Furthermore, there were significant modifications according to age in nearly all of the domains. The gender differences disappeared within the last two age decades and the age dependencies disappeared in the last decade. To summarize gender and age influences need to be considered when performing HRV studies even if these influences only partly differ.	[Voss, Andreas; Schroeder, Rico; Heitmann, Andreas] Univ Appl Sci Jena, Dept Med Engn & Biotechnol, Jena, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany; [Perz, Siegfried] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, German Res Ctr Environm Hlth, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Voss, A (corresponding author), Univ Appl Sci Jena, Dept Med Engn & Biotechnol, Jena, Germany.	andreas.voss@fh-jena.de	Peters, Annette/A-6117-2011	Peters, Annette/0000-0001-6645-0985; Voss, Andreas/0000-0002-0236-0830	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Deutsche Forschungsgemeinschaft [DFG-VO 505/8-2]; Thuringian Ministry of Economy, Labor and Technology [TMBWAT/TAB 2011FE9092]; European Regional Development Fund EFRE	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thuringian Ministry of Economy, Labor and Technology; European Regional Development Fund EFRE(European Commission)	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) (where required: and the MONICA Augsburg studies) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. This study was partly supported by grants from the Deutsche Forschungsgemeinschaft (DFG-VO 505/8-2) and by grants from the Thuringian Ministry of Economy, Labor and Technology (TMBWAT/TAB 2011FE9092) and European Regional Development Fund EFRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-24; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Baumert M, 2004, METHOD INFORM MED, V43, P202, DOI 10.1055/s-0038-1633859; Beckers F, 2006, AM J PHYSIOL-HEART C, V290, pH2560, DOI 10.1152/ajpheart.00903.2005; BIGGER JT, 1995, CIRCULATION, V91, P1936, DOI 10.1161/01.CIR.91.7.1936; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Britton A, 2007, AM J CARDIOL, V100, P524, DOI 10.1016/j.amjcard.2007.03.056; Camm AJ, 1996, CIRCULATION, V93, P1043; Corrales MM, 2012, HEALTH-LONDON, V04, P377, DOI [10.4236/health.2012.47060, DOI 10.4236/OJAPPS.2022.127074, DOI 10.4236/health.2012.47060]; Dantas EM, 2012, COMPUT BIOL MED, V42, P164, DOI 10.1016/j.compbiomed.2011.11.004; Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063; Ehlers CL, 1998, J NEUROSCI, V18, P7474; Fagard RH, 1999, J HYPERTENS, V17, P1589, DOI 10.1097/00004872-199917110-00013; Ferrari Alberto U, 2002, Am J Geriatr Cardiol, V11, P30; Fukusaki C, 2000, CLIN AUTON RES, V10, P123, DOI 10.1007/BF02278016; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; GRIBBIN B, 1971, CIRC RES, V29, P424, DOI 10.1161/01.RES.29.4.424; Guzik P, 2006, BIOMED TECH, V51, P272, DOI 10.1515/BMT.2006.054; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Heitmann A, 2011, MED BIOL ENG COMPUT, V49, P41, DOI 10.1007/s11517-010-0719-6; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huikuri HV, 2009, PHILOS T R SOC A, V367, P1223, DOI 10.1098/rsta.2008.0294; Huikuri HV, 2003, J ELECTROCARDIOL, V36, P95, DOI 10.1016/j.jelectrocard.2003.09.021; Huikuri HV, 1996, CIRCULATION, V94, P122, DOI 10.1161/01.CIR.94.2.122; JensenUrstad K, 1997, ACTA PHYSIOL SCAND, V160, P235, DOI 10.1046/j.1365-201X.1997.00142.x; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; LIAO DP, 1995, AM J CARDIOL, V76, P906, DOI 10.1016/S0002-9149(99)80260-4; Maestri R, 2007, PHYSIOL MEAS, V28, P1067, DOI 10.1088/0967-3334/28/9/008; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Moodithaya Shailaja S, 2009, Indian J Physiol Pharmacol, V53, P227; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PICCIRILLO G, 1995, INT J CARDIOL, V50, P117, DOI 10.1016/0167-5273(95)93680-Q; Pikkujamsa S., 1999, HEART RATE VARIABILI; Pikkujamsa SM, 2001, AM J PHYSIOL-HEART C, V280, pH1400, DOI 10.1152/ajpheart.2001.280.3.H1400; Pompe B, 1998, IEEE ENG MED BIOL, V17, P32, DOI 10.1109/51.731318; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A., 2006, COMPUTING CARDIOLOGY, V33, P77; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; RYAN SM, 1994, J AM COLL CARDIOL, V24, P1700, DOI 10.1016/0735-1097(94)90177-5; Schroder R, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P530, DOI 10.1515/bmte.2002.47.s1b.530; Schulz S, 2010, PHYSIOL MEAS, V31, P303, DOI 10.1088/0967-3334/31/3/003; Schwab JO, 2003, HEART, V89, P337, DOI 10.1136/heart.89.3.337; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sloan RP, 2008, AUTON NEUROSCI-BASIC, V139, P78, DOI 10.1016/j.autneu.2008.01.006; Sloan RP, 2005, INT J EPIDEMIOL, V34, P309, DOI 10.1093/ije/dyh381; Snieder H, 2007, TWIN RES HUM GENET, V10, P364, DOI 10.1375/twin.10.2.364; Stein PK, 2009, AGE AGEING, V38, P212, DOI 10.1093/ageing/afn292; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Truebner S, 2006, BIOMED TECH, V51, P77, DOI 10.1515/BMT.2006.014; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Valencia JF, 2009, IEEE ENG MED BIOL, V28, P72, DOI 10.1109/MEMB.2009.934621; VANHOOGENHUYZE D, 1991, AM J CARDIOL, V68, P1668, DOI 10.1016/0002-9149(91)90327-H; Voss A, 1996, CARDIOVASC RES, V31, P419; Voss A, 2012, PHYSIOL MEAS, V33, P1289, DOI 10.1088/0967-3334/33/8/1289; Voss A, 2010, METHOD INFORM MED, V49, P511, DOI 10.3414/ME09-02-0050; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Wessel N., 2000, HERZSCHRITTMACHERTHE, V11, P159, DOI [10.1007/s003990070035, DOI 10.1007/S003990070035]; Yukishita T., 2010, J ANTI-AGING MED, V7, P94, DOI DOI 10.3793/JAAM.7.94; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	72	211	217	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118308	10.1371/journal.pone.0118308	http://dx.doi.org/10.1371/journal.pone.0118308			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822720	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700018
J	Zhang, ZH; Ni, HY				Zhang, Zhongheng; Ni, Hongying			Normalized Lactate Load Is Associated with Development of Acute Kidney Injury in Patients Who Underwent Cardiopulmonary Bypass Surgery	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; FLUID BALANCE; RISK-FACTORS; CLEARANCE; MORTALITY; MODELS; PREDICTION; BIOMARKERS; CHILDREN	Background and Objective Cardiac surgery associated acute kidney injury is a major postoperative complication and has long been associated with adverse outcomes. However, the association of lactate and AKI has not been well established. The study aimed to explore the association of normalized lactate load with AKI in patients undergoing cardiac surgery. Methods This was a prospective observational cohort study conducted in a 47-bed ICU of a tertiary academic teaching hospital from July 2012 to January 2014. All patients undergoing cardiopulmonary bypass surgery were included. Normalized lactate load (L) was calculated by the equation: L = 1/2x(t(n)-t(0)) Sigma(n)(i=0)(v(i) + v(i+1)) x (t(i+1)-t(i)), where t(i) was time point for lactate measurement and v(i) was the value of lactate. L was transformed by natural log (L-ln) to improve its normality. Logistic regression model was fitted by using stepwise method. Scale of L-ln was examined by using fractional polynomial approach and potential interaction terms were explored. Results A total of 117 patients were included during study period, including 17 AKI patients and 100 non-AKI patients. In univariate analysis L-ln was significantly higher in AKI as compared with non-AKI group (1.43 +/- 0.38 vs 1.01 +/- 0.45, p = 0.0005). After stepwise selection of covariates, the main effect logistic model contained variables of L-ln (odds ratio: 11.1, 95% CI: 1.22-101.6), gender, age, baseline serum creatinine and fluid balance on day 0. Although the two-term fractional polynomial model was the best-fitted model, it was not significantly different from the linear model (Deviance difference = 6.09, p = 0.107). There was no significant interaction term between L-ln and other variables in the main effect model. Conclusions Our study demonstrates that L-ln is independently associated with postoperative AKI in patients undergoing CPB. There is no significant interaction with early postoperative fluid balance.	[Zhang, Zhongheng; Ni, Hongying] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com; nihongying2@163.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Zhang, Zhongheng/0000-0002-2336-5323	Science and Technology Foundation of Jinhua city [2013-3-008]	Science and Technology Foundation of Jinhua city	The study was funded by the Science and Technology Foundation of Jinhua city (approval No. 2013-3-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Bakker J., 1999, CURR OPIN CRIT CARE, V5, P234; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; COHEN RD, 1983, DIABETES, V32, P181, DOI 10.2337/diab.32.2.181; de Vries HM, 2014, J TRAUMA ACUTE CARE, V77, P183, DOI 10.1097/TA.0000000000000252; Englberger L, 2013, EUR J CARDIO-THORAC, V43, P993, DOI 10.1093/ejcts/ezs515; Englberger L, 2011, CRIT CARE, V15, DOI 10.1186/cc9960; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hajjar LA, 2013, J THORAC CARDIOV SUR, V146, P455, DOI 10.1016/j.jtcvs.2013.02.003; Hassinger AB, 2014, PEDIATR CRIT CARE ME, V15, P131, DOI 10.1097/PCC.0000000000000043; Jabbari A, 2013, CASP J INTERN MED, V4, P624; Jones AE, 2009, CRIT CARE CLIN, V25, P769, DOI 10.1016/j.ccc.2009.06.003; Kalyanaraman M, 2008, PEDIATR CRIT CARE ME, V9, P285, DOI 10.1097/PCC.0b013e31816c6f31; Kambhampati G, 2013, J CARDIOVASC SURG, V54, P639; Kellum J, 1999, CURR OPIN CRIT CARE, V5, P429; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Long J, 2010, BRIT J MATH STAT PSY, V63, P177, DOI 10.1348/000711009X431509; Lopez-Delgado JC, 2013, CRIT CARE, V17, DOI 10.1186/cc13159; Maarslet L, 2012, ACTA ANAESTH SCAND, V56, P459, DOI 10.1111/j.1399-6576.2011.02588.x; Mao H, 2013, CARDIORENAL MED, V3, P178, DOI 10.1159/000353134; Nick Todd G., 2007, V404, P273, DOI 10.1007/978-1-59745-530-5_14; O'Connor E, 2012, ANAESTH INTENS CARE, V40, P598, DOI 10.1177/0310057X1204000404; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Patel UD, 2012, CIRCULATION, V125, P1347, DOI 10.1161/CIRCULATIONAHA.111.029686; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Prowle JR, 2014, NAT REV NEPHROL, V10, P37, DOI 10.1038/nrneph.2013.232; Prowle JR, 2012, CRIT CARE, V16, DOI 10.1186/cc11345; Raper RF, 1997, CRIT CARE MED, V25, P46, DOI 10.1097/00003246-199701000-00011; RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714; Royston P, 2005, METHOD INFORM MED, V44, P561; Royston P, 2010, STAT MED, V29, P2508, DOI 10.1002/sim.3994; Schmidt CO, 2013, INT J PUBLIC HEALTH, V58, P157, DOI 10.1007/s00038-012-0362-0; Shaw A, 2011, CONTRIB NEPHROL, V174, P156, DOI 10.1159/000329387; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405; Zhang ZH, 2014, J THORAC DIS, V6, P995, DOI 10.3978/j.issn.2072-1439.2014.07.01; Zhang ZH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004752; Zhang ZH, 2011, AM J KIDNEY DIS, V58, P356, DOI 10.1053/j.ajkd.2011.02.389	41	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120466	10.1371/journal.pone.0120466	http://dx.doi.org/10.1371/journal.pone.0120466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822369	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700065
J	Hamid, AAA; Hamid, THTA; Wahab, RA; Omar, MSS; Huyop, F				Hamid, Azzmer Azzar Abdul; Hamid, Tengku Haziyamin Tengku Abdul; Wahab, Roswanira Abdul; Omar, Mohd. Shahir Shamsir; Huyop, Fahrul			An S188V Mutation Alters Substrate Specificity of Non- Stereospecific alpha-Haloalkanoic Acid Dehalogenase E (DehE)	PLOS ONE			English	Article							PSEUDOMONAS SP; DL-2-HALOACID DEHALOGENASE; MOLECULAR-DYNAMICS; RHIZOBIUM SP; 3-HYDROXYPROPIONIC ACID; 3-CHLOROPROPIONIC ACID; NONPOLAR RESIDUES; ESCHERICHIA-COLI; ACTIVE-SITE; PURIFICATION	The non-stereospecific alpha-haloalkanoic acid dehalogenase E (DehE) degrades many halogenated compounds but is ineffective against beta-halogenated compounds such as 3-chloropropionic acid (3CP). Using molecular dynamics (MD) simulations and site-directed mutagenesis we show here that introducing the mutation S188V into DehE improves substrate specificity towards 3CP. MD simulations showed that residues W34, F37, and S188 of DehE were crucial for substrate binding. DehE showed strong binding ability for D-2-chloropropionic acid (D-2CP) and L-2-chloropropionic acid (L-2CP) but less affinity for 3CP. This reduced affinity was attributed to weak hydrogen bonding between 3CP and residue S188, as the carboxylate of 3CP forms rapidly interconverting hydrogen bonds with the backbone amide and side chain hydroxyl group of S188. By replacing S188 with a valine residue, we reduced the inter-molecular distance and stabilised bonding of the carboxylate of 3CP to hydrogens of the substrate-binding residues. Therefore, the S188V can act on 3CP, although its affinity is less strong than for D-2CP and L-2CP as assessed by K-m. This successful alteration of DehE substrate specificity may promote the application of protein engineering strategies to other dehalogenases, thereby generating valuable tools for future bioremediation technologies.	[Hamid, Azzmer Azzar Abdul; Hamid, Tengku Haziyamin Tengku Abdul] IIUM, Fac Sci, Dept Biotechnol, Kuantan 25200, Pahang, Malaysia; [Wahab, Roswanira Abdul] Univ Teknol Malaysia, Fac Sci, Dept Chem, Utm Johor Bahru 81310, Johor, Malaysia; [Omar, Mohd. Shahir Shamsir] Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Biosci & Hlth Sci, Utm Johor Bahru 81310, Johor, Malaysia; [Huyop, Fahrul] Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Biotechnol & Med Engn, Utm Johor Bahru 81310, Johor, Malaysia	International Islamic University Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Wahab, RA (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Chem, Utm Johor Bahru 81310, Johor, Malaysia.	roswanira@kimia.fs.utm.my; fzhutm@gmail.com	Wahab, Roswanira Abdul/ABF-7351-2020; Wahab, Roswanira Abdul/AAB-6983-2020; Shamsir, Mohd Shahir/AAG-1097-2021; Hamid, Tengku Haziyamin Tengku Abdul/AAX-4401-2020; Huyop, Fahrul Zaman/H-4287-2018	Wahab, Roswanira Abdul/0000-0002-9982-6587; Shamsir, Mohd Shahir/0000-0002-1191-1294; Hamid, Tengku Haziyamin Tengku Abdul/0000-0001-8223-481X; Huyop, Fahrul Zaman/0000-0003-3978-4087	University Research Grant [Q.J130000.2545.04H01, Q.J130000.2535.03H01]	University Research Grant	This work was supported by University Research Grant Q.J130000.2545.04H01 (FH) and Q.J130000.2535.03H01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ADV BIOSCI BIOTECHNO, DOI DOI 10.4236/ABB.2012.32024; Bagherbaigi S, 2013, ANN MICROBIOL, V63, P1363, DOI 10.1007/s13213-012-0595-4; BERGMANN JG, 1957, ANAL CHEM, V29, P241, DOI 10.1021/ac60122a018; BERRY EKM, 1979, J GEN MICROBIOL, V110, P39, DOI 10.1099/00221287-110-1-39; Brokamp A, 1997, BIODEGRADATION, V7, P383, DOI 10.1007/BF00056422; Budiman C, 2012, FEBS J, V279, P976, DOI 10.1111/j.1742-4658.2012.08483.x; Cairns SS, 1996, EUR J BIOCHEM, V235, P744, DOI 10.1111/j.1432-1033.1996.t01-1-00744.x; Cuff AL, 2006, BIOINFORMATICS, V22, P1464, DOI 10.1093/bioinformatics/btl120; Fahrul Huyop, 2010, African Journal of Microbiology Research, V4, P2836; Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hamid AAA, 2015, J BASIC MICROB, V55, P324, DOI [10.1002/jobm.201300526, 10.1002/jobm.201570031]; Hamid AAA, 2013, BIOTECHNOL BIOTEC EQ, V27, P3725, DOI 10.5504/BBEQ.2012.0142; Hamid THTA, 2011, AFR J BIOTECHNOL, V10, P610; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hayashi S, 2011, BIOCHEMISTRY-US, V50, P8583, DOI 10.1021/bi200925f; Huang YN, 2012, BIORESOURCE TECHNOL, V103, P351, DOI 10.1016/j.biortech.2011.10.022; Hughes S, 1988, THESIS U WALES; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huyop F., 2004, ASIA PAC J MOL BIOL, V12, P15; Jing NH, 2009, RES J MICROBIOL, V3, P482; Kokkinidis M, 2012, ADV PROTEIN CHEM STR, V87, P181, DOI 10.1016/B978-0-12-398312-1.00007-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEIGH JA, 1988, FEMS MICROBIOL LETT, V49, P353, DOI 10.1111/j.1574-6968.1988.tb02756.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; McGuire R, 2009, THESIS RICE U; Mesri S, 2009, ANN MICROBIOL, V59, P447, DOI 10.1007/BF03175129; MOTOSUGI K, 1982, J BACTERIOL, V150, P522, DOI 10.1128/JB.150.2.522-527.1982; Nakamura T, 2009, J COMPUT CHEM, V30, P2625, DOI 10.1002/jcc.21273; Nardi-Dei V, 1999, J BIOL CHEM, V274, P20977, DOI 10.1074/jbc.274.30.20977; Nishioka T, 2012, FEBS J, V279, P3264, DOI 10.1111/j.1742-4658.2012.08713.x; Parisini E, 2011, CHEM SOC REV, V40, P2267, DOI 10.1039/c0cs00177e; Park C, 2003, J MOL CATAL B-ENZYM, V23, P329, DOI 10.1016/S1381-1177(03)00096-1; Petsko G., 2004, PROTEIN STRUCTURE FU; Raj SM, 2008, PROCESS BIOCHEM, V43, P1440, DOI 10.1016/j.procbio.2008.04.027; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Schmidberger JW, 2008, J MOL BIOL, V378, P284, DOI 10.1016/j.jmb.2008.02.035; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Stringfellow JM, 1997, EUR J BIOCHEM, V250, P789, DOI 10.1111/j.1432-1033.1997.00789.x; Svendsen A, 2003, ENZYME FUNCTIONALITY; Tan YeaYusn, 2009, Biotechnology, V8, P385, DOI 10.3923/biotech.2009.385.388; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; WEIGHTMAN AJ, 1982, J GEN MICROBIOL, V128, P1755	46	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121687	10.1371/journal.pone.0121687	http://dx.doi.org/10.1371/journal.pone.0121687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816329	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600111
J	Garcia, DV; Casteels, C; Schwarz, AJ; Dierckx, RAJO; Koole, M; Doorduin, J				Garcia, David Vallez; Casteels, Cindy; Schwarz, Adam J.; Dierckx, Rudi A. J. O.; Koole, Michel; Doorduin, Janine			A Standardized Method for the Construction of Tracer Specific PET and SPECT Rat Brain Templates: Validation and Implementation of a Toolbox (vol 10, e0122363, 2015)	PLOS ONE			English	Correction													García, David Vállez/N-2348-2015	García, David Vállez/0000-0003-3308-3167; Koole, Michel/0000-0001-5862-640X; Doorduin, Janine/0000-0003-2925-9959				Vallez Garcia D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122363, 10.1371/journal.pone.0143900]	1	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143900	10.1371/journal.pone.0143900	http://dx.doi.org/10.1371/journal.pone.0143900			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	25823005	Green Published, Green Submitted, gold			2022-12-27	WOS:000365862600126
J	Jaballah, M; Mohamed, IA; Alemrayat, B; Al-Sulaiti, F; Mlih, M; Mraiche, F				Jaballah, Maiy; Mohamed, Iman A.; Alemrayat, Bayan; Al-Sulaiti, Fatima; Mlih, Mohamed; Mraiche, Fatima			Na+/H+ Exchanger Isoform 1 Induced Cardiomyocyte Hypertrophy Involves Activation of p90 Ribosomal S6 Kinase	PLOS ONE			English	Article							SODIUM-HYDROGEN EXCHANGE; CARDIAC-HYPERTROPHY; PROTEIN-KINASES; HEART-FAILURE; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; PHOSPHORYLATION; STRESS; PHENYLEPHRINE	Studies using pharmacological and genetic approaches have shown that increased activity/ expression of the Na+/ H+ exchanger isoform 1 (NHE1) play a critical role in the pathogenesis of cardiac hypertrophy. Despite the importance of NHE1 in cardiac hypertrophy, severe cerebrovascular side effects were associated with the use of NHE1 inhibitors when administered to patients with myocardial infarctions. p90 ribosomal S6 Kinase (RSK), a downstream regulator of the mitogen-activated protein kinase pathway, has also been implicated in cardiac hypertrophy. We hypothesized that RSK plays a role in the NHE1 induced cardiomyocyte hypertrophic response. Infection of H9c2 cardiomyoblasts with the active form of the NHE1 adenovirus induced hypertrophy and was associated with an increase in the phosphorylation of RSK (P<0.05). Parameters of hypertrophy such as cell area, protein content and atrial natriuretic mRNA expression were significantly reduced in H9c2 cardiomyoblasts infected with active NHE1 in the presence of dominant negative RSK (DN-RSK) (P<0.05). These results confirm that NHE1 lies upstream of RSK. Increased phosphorylation and activation of GATA4 at Ser(261) was correlated with increased RSK phosphorylation. This increase was reversed upon inhibition of RSK or NHE1. These findings demonstrate for the first time that the NHE1 mediated hypertrophy is accounted for by increased activation and phosphorylation of RSK, which subsequently increased the phosphorylation of GATA4; eventually activating fetal gene transcriptional machinery.	[Jaballah, Maiy; Mohamed, Iman A.; Alemrayat, Bayan; Al-Sulaiti, Fatima; Mlih, Mohamed; Mraiche, Fatima] Qatar Univ, Coll Pharm, Doha, Qatar	Qatar University	Mraiche, F (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.	fatima.mraiche@qu.edu.qa	Mlih, Mohamed/O-4834-2019; Al-Sulaiti, Fatima Khalifa/S-7807-2019	Mlih, Mohamed/0000-0003-3491-9616; Al-Sulaiti, Fatima Khalifa/0000-0002-4305-9614; Fillmore, Natasha/0000-0002-6723-0869	Qatar University Internal Grant [QUUG-CPH-CPH-11/12-1]; Undergraduate Research Experience Program provided by the Qatar National Research Fund, Doha, Qatar [UREP11-027-3-005]	Qatar University Internal Grant(Qatar National Research Fund (QNRF)); Undergraduate Research Experience Program provided by the Qatar National Research Fund, Doha, Qatar(Qatar National Research Fund (QNRF))	This work was supported by a Qatar University Internal Grant (QUUG-CPH-CPH-11/12-1) and by the Undergraduate Research Experience Program (UREP11-027-3-005) provided by the Qatar National Research Fund, Doha, Qatar (http://www.qnrf.org). Lead principal investigator (PI): FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2000, CIRC RES, V86, P607, DOI 10.1161/01.RES.86.6.607; Amirak E, 2013, BIOCHEM J, V450, P351, DOI 10.1042/BJ20121371; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Baartscheer A, 2003, CARDIOVASC RES, V57, P1015, DOI 10.1016/S0008-6363(02)00809-X; Chen SL, 2007, DIABETES-METAB RES, V23, P356, DOI 10.1002/dmrr.689; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Fang L, 2007, LIFE SCI, V80, P2154, DOI 10.1016/j.lfs.2007.04.003; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Gan XT, 2010, CARDIOVASC RES, V85, P79, DOI 10.1093/cvr/cvp283; Garciarena CD, 2013, J MOL CELL CARDIOL, V61, P51, DOI 10.1016/j.yjmcc.2013.04.008; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Huber JD, 2012, J MED CHEM, V55, P7114, DOI 10.1021/jm300601d; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; JACOB R, 1991, BASIC RES CARDIOL, V86, P113; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Karmazyn M, 2001, BASIC RES CARDIOL, V96, P325, DOI 10.1007/s003950170040; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Li T, 2012, BBA-MOL CELL RES, V1823, P582, DOI 10.1016/j.bbamcr.2011.12.009; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Marian AJ, 2007, CARDIAC HYPERTROPHY, P1177; Merten KE, 2006, J PHARMACOL EXP THER, V319, P934, DOI 10.1124/jpet.106.108845; Motte S, 2006, PHARMACOL THERAPEUT, V110, P386, DOI 10.1016/j.pharmthera.2005.08.012; Mraiche F, 2011, MOL CELL BIOCHEM, V358, P179, DOI 10.1007/s11010-011-0933-z; Mraiche F, 2011, BASIC RES CARDIOL, V106, P603, DOI 10.1007/s00395-011-0161-4; Mukhin YV, 2004, J BIOL CHEM, V279, P1845, DOI 10.1074/jbc.M304907200; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Le NT, 2012, CIRC RES, V110, P536, DOI 10.1161/CIRCRESAHA.111.254730; Pedersen SF, 2007, ARCH BIOCHEM BIOPHYS, V462, P195, DOI 10.1016/j.abb.2006.12.001; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sapkota GP, BIOCH J, V4012007, P29; Seko Y, 1996, CIRC RES, V78, P82, DOI 10.1161/01.RES.78.1.82; Shibata M, 2011, AM J PHYSIOL-HEART C, V301, pH2154, DOI 10.1152/ajpheart.00483.2011; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Snabaitis AK, 2002, CARDIOVASC RES, V53, P470, DOI 10.1016/S0008-6363(01)00464-3; Suzuki YJ, 2011, CELL SIGNAL, V23, P1094, DOI 10.1016/j.cellsig.2011.02.007; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Takeishi Y, 1999, CIRC RES, V85, P1164; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; TAKEWAKI S, 1995, J MOL CELL CARDIOL, V27, P729, DOI 10.1016/S0022-2828(08)80063-6; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Voelkl J, 2013, CELL PHYSIOL BIOCHEM, V32, P25, DOI 10.1159/000350120; Voelkl J, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0236-2; Xue J, 2010, PHYSIOL GENOMICS, V42, P374, DOI 10.1152/physiolgenomics.00064.2010; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430; Yamazaki T, 1996, MOL CELL BIOCHEM, V164, P197, DOI 10.1007/BF00408658; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yoshida H, 2000, AM J PHYSIOL-HEART C, V278, pH300, DOI 10.1152/ajpheart.2000.278.1.H300; Young M, 2003, ENDOCRINOLOGY, V144, P3848, DOI 10.1210/en.2003-0039; Zhang Z, 2013, J MOL CELL CARDIOL, V59, P139, DOI 10.1016/j.yjmcc.2013.03.006; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	63	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122230	10.1371/journal.pone.0122230	http://dx.doi.org/10.1371/journal.pone.0122230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830299	Green Published, gold, Green Submitted			2022-12-27	WOS:000352135600105
J	Jeon, CY; Pandol, SJ; Wu, BC; Cook-Wiens, G; Gottlieb, RA; Merz, NB; Goodman, MT				Jeon, Christie Y.; Pandol, Stephen J.; Wu, Bechien; Cook-Wiens, Galen; Gottlieb, Roberta A.; Merz, Noel Bairey; Goodman, Marc T.			The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; AUTOPHAGY; METASTASIS; THERAPY	Background Pancreatic cancer has poor prognosis and existing interventions provide a modest benefit. Statin has anti-cancer properties that might enhance survival in pancreatic cancer patients. We sought to determine whether statin treatment after cancer diagnosis is associated with longer survival in those with pancreatic ductal adenocarcinoma (PDAC). Methods We analyzed data on 7813 elderly patients with PDAC using the linked Surveillance, Epidemiology, and End Results (SEER) - Medicare claims files. Information on the type, intensity and duration of statin use after cancer diagnosis was extracted from Medicare Part D. We treated statin as a time-dependent variable in a Cox regression model to determine the association with overall survival adjusting for follow-up, age, sex, race, neighborhood income, stage, grade, tumor size, pancreatectomy, chemotherapy, radiation, obesity, dyslipidemia, diabetes, chronic pancreatitis and chronic obstructive pulmonary disease (COPD). Results Overall, statin use after cancer diagnosis was not significantly associated with survival when all PDAC patients were considered (HR = 0.94, 95% CI 0.89, 1.01). However, statin use after cancer diagnosis was associated with a 21% reduced hazard of death (Hazard ratio = 0.79, 95% confidence interval (CI) 0.67, 0.93) in those with grade I or II PDAC and to a similar extent in those who had undergone a pancreatectomy, in those with chronic pancreatitis and in those who had not been treated with statin prior to cancer diagnosis. Conclusions We found that statin treatment after cancer diagnosis is associated with enhanced survival in patients with low-grade, resectable PDAC.	[Jeon, Christie Y.; Pandol, Stephen J.; Goodman, Marc T.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Jeon, Christie Y.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Jeon, Christie Y.; Pandol, Stephen J.; Gottlieb, Roberta A.; Merz, Noel Bairey; Goodman, Marc T.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Pandol, Stephen J.] Dept Vet Affairs, Los Angeles, CA USA; [Wu, Bechien] Kaiser Permanente Angeles Med Ctr, Dept Gastroenterol, Los Angeles, CA USA; [Cook-Wiens, Galen] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Gottlieb, Roberta A.; Merz, Noel Bairey] Heart Inst Cedars Sinai, Barbra Streisand Womens Heart Ctr, Los Angeles, CA USA; [Pandol, Stephen J.; Merz, Noel Bairey; Goodman, Marc T.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Kaiser Permanente; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Jeon, CY (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	christie.jeon@cshs.org		Goodman, Marc/0000-0002-4839-3021	National Cancer Institute [P01CA163200]; Cedars-Sinai Donna and Jesse Garber Award; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cedars-Sinai Donna and Jesse Garber Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant P01CA163200, and the Cedars-Sinai Donna and Jesse Garber Award for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, pv; *APPL RES PROGR DO, 2013, PROC COD SEER MED AN; Araki M, 2012, EUR J PHARMACOL, V674, P95, DOI 10.1016/j.ejphar.2011.10.044; Bolego C, 2002, CURR OPIN LIPIDOL, V13, P637, DOI 10.1097/00041433-200212000-00007; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Deramaudt T, 2005, BBA-REV CANCER, V1756, P97, DOI 10.1016/j.bbcan.2005.08.003; DeVita VT, 2011, DEVITA HELLMAN ROSEN, P677; Franks P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-68; Gronich N, 2013, NAT REV CLIN ONCOL, V10, P625, DOI 10.1038/nrclinonc.2013.169; Hashimoto D, 2014, EUR J CANCER, V50, P1382, DOI 10.1016/j.ejca.2014.01.011; Hong JY, 2014, CANCER CHEMOTH PHARM, V73, P125, DOI 10.1007/s00280-013-2328-1; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ko YH, 2013, PANCREAS, V42, P829, DOI 10.1097/MPA.0b013e318279d0dc; Kusama T, 2002, GASTROENTEROLOGY, V122, P308, DOI 10.1053/gast.2002.31093; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Matrisian LM, 2012, ALARMING RISE PANCRE; Mayo SC, 2012, J AM COLL SURGEONS, V214, P33, DOI 10.1016/j.jamcollsurg.2011.09.022; Nakai Y, 2013, PANCREAS, V42, P202, DOI 10.1097/MPA.0b013e31825de678; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Stone NJ, 2013, J AM COLL CARDIOLOGY; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Warren JL, 2002, MED CARE, V40, P3; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P745, DOI 10.1016/j.biocel.2012.11.001	23	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121783	10.1371/journal.pone.0121783	http://dx.doi.org/10.1371/journal.pone.0121783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830309	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600085
J	Pena, N; Carrillo, D; Munoz, JP; Chnaiderman, J; Urzua, U; Leon, O; Tornesello, ML; Corvalan, AH; Soto-Rifo, R; Aguayo, F				Pena, Nelson; Carrillo, Diego; Munoz, Juan P.; Chnaiderman, Jonas; Urzua, Ulises; Leon, Oscar; Tornesello, Maria L.; Corvalan, Alejandro H.; Soto-Rifo, Ricardo; Aguayo, Francisco			Tobacco Smoke Activates Human Papillomavirus 16 p97 Promoter and Cooperates with High-Risk E6/E7 for Oxidative DNA Damage in Lung Cells	PLOS ONE			English	Article							TYPE-16 E6; TRANSCRIPTION; CANCER; ONCOPROTEINS; CARCINOMAS; EXPRESSION; MUTATION; VIRUS; P53	We have previously shown a functional interaction between human papillomavirus type 16 (HPV-16) E6 and E7 oncoproteins and cigarette smoke condensate (CSC) in lung cells suggesting cooperation during carcinogenesis. The molecular mechanisms of such interaction, however, remain to be elucidated. Here we first present evidence showing that cigarette smoke condensate (CSC) has the ability to activate the HPV-16 p97 promoter by acting on the long control region (LCR) in lung epithelial cells. Interestingly, we observed that CSC-induced p97 promoter activation occurs in a dose-dependent manner in both tumor A-549 (lung adenocarcinoma), H-2170 (bronchial carcinoma), SiHa or Hela (cervical carcinoma) cells but not in non-tumor BEAS-2B (bronchial) or NL-20 (alveolar) lung cells unless they ectopically expressed the HPV-16 E6 and E7 oncogenes. In addition, we also observed a significant increase of primary DNA damage in tumor and non-tumor CSC-treated lung cells expressing HPV-16 E6 and E7 oncogenes suggesting a cooperative effect in this process, even though the contribution of E7 was significantly higher. Taken together, our results strongly suggest that tobacco smoke is able to induce the activation of the HPV-16 p97 promoter in cooperation with HPV-16 E6 and E7 oncogenes that, in turn, sensitize lung cells to tobacco smoke-induced DNA damage.	[Pena, Nelson; Carrillo, Diego; Munoz, Juan P.; Chnaiderman, Jonas; Leon, Oscar; Soto-Rifo, Ricardo; Aguayo, Francisco] Univ Chile, Fac Med, Inst Biomed Sci, Virol Program, Santiago 7, Chile; [Urzua, Ulises] Univ Chile, Fac Med, Inst Biomed Sci, Cellular & Mol Biol Program, Santiago 7, Chile; [Tornesello, Maria L.] Ist Nazl Tumori, Fdn G Pascale IRCCS, Mol Biol & Viral Oncol Unit, Naples, Italy; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, UC Ctr Invest Oncol CITO, Santiago, Chile	Universidad de Chile; Universidad de Chile; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Aguayo, F (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Virol Program, Santiago 7, Chile.	faguayo@med.uchile.cl	Muñoz, Juan P/GSJ-1484-2022; Tornesello, Maria Lina/A-1964-2008; Urzua, Ulises/AAK-8708-2021; Soto, Ricardo/AAJ-5510-2021; Aguayo, Francisco/I-2851-2013; Urzua, Ulises/A-3982-2013; Soto Rifo, Ricardo/I-2850-2013	Tornesello, Maria Lina/0000-0002-3523-3264; Urzua, Ulises/0000-0003-0522-5754; Corvalan, Alejandro/0000-0001-5492-3853; Soto Rifo, Ricardo/0000-0003-0945-2970	Fondo Nacional de Ciencia y Tecnologia (Fondecyt) [1120248, 11121339]; Fondap [15130011]	Fondo Nacional de Ciencia y Tecnologia (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondap	This study was funded by Fondo Nacional de Ciencia y Tecnologia (Fondecyt) (1120248 to F.A., 11121339 to R.SR.) and Fondap 15130011 to A.H.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2007, BRIT J CANCER, V97, P85, DOI 10.1038/sj.bjc.6603848; Alam S, 2008, J VIROL, V82, P1053, DOI 10.1128/JVI.01813-07; Alam S, 2010, J VIROL, V84, P4630, DOI 10.1128/JVI.02431-09; Alloul N, 1999, J GEN VIROL, V80, P2461, DOI 10.1099/0022-1317-80-9-2461; Anantharaman D, 2014, CANCER RES, V74, P3525, DOI 10.1158/0008-5472.CAN-13-3548; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Castillo A, 2006, ONCOL REP, V15, P883; CHAN WK, 1990, NUCLEIC ACIDS RES, V18, P763, DOI 10.1093/nar/18.4.763; Chen B, 2009, CELL CYCLE, V8, P1775, DOI 10.4161/cc.8.11.8724; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Ciotti M, 2006, ONCOL REP, V16, P183; Duensing S, 2002, CANCER RES, V62, P7075; Fontaine V, 2000, VIROLOGY, V272, P40, DOI 10.1006/viro.2000.0363; Geisen C, 1996, J GEN VIROL, V77, P2193, DOI 10.1099/0022-1317-77-9-2193; Lace MJ, 2009, J GEN VIROL, V90, P2402, DOI 10.1099/vir.0.012708-0; Li YJ, 2009, SEMIN ONCOL, V36, P542, DOI 10.1053/j.seminoncol.2009.10.002; Liang FX, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/263216; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Moktar A, 2011, INT J ONCOL, V39, P941, DOI 10.3892/ijo.2011.1106; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Ndisang D, 2010, ONCOGENE, V29, P2701, DOI 10.1038/onc.2010.33; Omland T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099114; Munoz JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038178; Park JW, 2014, ONCOGENE, V33, P3383, DOI 10.1038/onc.2013.327; Rady PL, 1998, LARYNGOSCOPE, V108, P735, DOI 10.1097/00005537-199805000-00021; Ragin C, 2014, CARCINOGENESIS, V35, P1267, DOI 10.1093/carcin/bgu038; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shin KH, 2006, INT J ONCOL, V28, P209; Sichero L, 2012, J INFECT DIS, V206, P867, DOI 10.1093/infdis/jis430; Soto-Rifo R, 2012, NUCLEIC ACIDS RES, V40, P2653, DOI 10.1093/nar/gkr1093; Struyk L, 2000, MOL CARCINOGEN, V28, P42, DOI 10.1002/(SICI)1098-2744(200005)28:1<42::AID-MC6>3.0.CO;2-8; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Syrjanen K, 2012, ANTICANCER RES, V32, P3235; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Wei LL, 2014, CARCINOGENESIS, V35, P2373, DOI 10.1093/carcin/bgu156; Williams VM, 2014, J VIROL, V88, P6751, DOI 10.1128/JVI.03355-13; zur Hausen H, 2009, INDIAN J MED RES, V130, P209	41	20	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123029	10.1371/journal.pone.0123029	http://dx.doi.org/10.1371/journal.pone.0123029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830243	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600134
J	Kvestad, I; Taneja, S; Hysing, M; Kumar, T; Bhandari, N; Strand, TA				Kvestad, Ingrid; Taneja, Sunita; Hysing, Mari; Kumar, Tivendra; Bhandari, Nita; Strand, Tor A.			Diarrhea, Stimulation and Growth Predict Neurodevelopment in Young North Indian Children	PLOS ONE			English	Article							EARLY-CHILDHOOD DIARRHEA; DEVELOPING-COUNTRIES; COGNITIVE FUNCTION; SUPPLEMENTATION; INFECTIONS; BEHAVIOR; IRON; RISK	Background and Objective Infants and young children in low to middle-income countries are at risk for adverse neurodevelopment due to multiple risk factors. In this study, we sought to identify stimulation and learning opportunities, growth, and burden of respiratory infections and diarrhea as predictors for neurodevelopment. Methods We visited 422 North Indian children 6 to 30 months old weekly for six months. Childhood illnesses were assessed biweekly. At end study, we assessed neurodevelopment using the Ages and Stages Questionnaire 3rd ed. (ASQ-3) and gathered information on stimulation and learning opportunities. We identified predictors for ASQ-3 scores in multiple linear and logistic regression models. Results We were able to explain 30.5% of the variation in the total ASQ-3 score by the identified predictors. When adjusting for child characteristics and annual family income, stimulation and learning opportunities explained most of the variation by 25.1%. Height for age (standardized beta: 0.12, p<. 05) and weight for height z-scores (std. beta: 0.09, p<. 05) were positively associated with the total ASQ-3 score, while number of days with diarrhea was negatively associated with these scores (std. beta: -0.13, p< 0.01). Conclusion Our results support the importance of early child stimulation and general nutrition for child development. Our study also suggests that diarrhea is an additional risk factor for adverse neurodevelopment in vulnerable children.	[Kvestad, Ingrid] Univ Bergen, Fac Psychol, Dept Biol & Med Psychol, Bergen, Norway; [Kvestad, Ingrid; Hysing, Mari] Uni Res Hlth, Ctr Child & Youth Mental Hlth & Child Welf, Bergen, Norway; [Taneja, Sunita; Bhandari, Nita] Soc Appl studies, New Delhi, India; [Kumar, Tivendra] Soc Essential Hlth Act & Training, New Delhi, India; [Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Dept Lab Med, Lillehammer, Norway	University of Bergen; University of Bergen; Innlandet Hospital Trust	Strand, TA (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	Tor.Strand@cih.uib.no	Strand, Tor/D-9836-2016; Kvestad, Ingrid/D-9939-2016	Strand, Tor/0000-0002-4038-151X; Hysing, Mari/0000-0001-5303-8879	Thrasher Research Fund [02827]; Research Council of Norway [172226]	Thrasher Research Fund; Research Council of Norway(Research Council of Norway)	This study was funded by Thrasher Research Fund (grant no 02827) and the Research Council of Norway (project no. 172226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud FE, 2011, PEDIATRICS, V127, pE1191, DOI 10.1542/peds.2010-2160; Acock A.C., 2012, GENTLE INTRO STATA, V3rd; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Black MM, 2011, J NUTR, V141, P490, DOI 10.3945/jn.110.129973; Black MM, 2004, AM J CLIN NUTR, V80, P903, DOI 10.1093/ajcn/80.4.903; Bradley RH, 2005, INT J BEHAV DEV, V29, P468, DOI 10.1080/01650250500146925; Crosby L, 2013, FOOD THOUGHT TACLING; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; Handal AJ, 2007, REV PANAM SALUD PUBL, V21, P292, DOI 10.1590/S1020-49892007000400004; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Juneja M, AGES STAGES QUESTION; Kvestad I, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-50; Limbos MM, 2011, J DEV BEHAV PEDIATR, V32, P499, DOI 10.1097/DBP.0b013e31822552e9; Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; Oria RB, 2009, MED HYPOTHESES, V73, P682, DOI 10.1016/j.mehy.2009.05.013; Patrick PD, 2005, CHILD NEUROPSYCHOL, V11, P233, DOI 10.1080/092970490911252; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Santos DN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-202; Squire J, 2009, ASQ 3 USERS GUIDE; Squires J, 2009, AGES STAGES QUESTION; Taneja S, 2013, AM J CLIN NUTR, V98, P731, DOI 10.3945/ajcn.113.059592; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047908; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2	29	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121743	10.1371/journal.pone.0121743	http://dx.doi.org/10.1371/journal.pone.0121743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826376	Green Published, gold			2022-12-27	WOS:000352084800053
J	Li, YH; Wang, XQ; Li, MX; Pan, J; Jin, MF; Wang, J; Li, XZ; Feng, X				Li, Yanhong; Wang, Xueqin; Li, Mengxia; Pan, Jian; Jin, Meifang; Wang, Jian; Li, Xiaozhong; Feng, Xing			Long Non-Coding RNA Expression Profile in the Kidneys of Male, Low Birth Weight Rats Exposed to Maternal Protein Restriction at Postnatal Day 1 and Day 10	PLOS ONE			English	Article							GLOMERULAR NUMBER; NEPHRON NUMBER; HYPERTENSION; DISEASE; RISK	Background Long non-coding RNAs (lncRNAs), which are involved in a variety of biological functions and aberrantly expressed in many types of diseases, are required for postnatal development. In this study, we aimed to investigate the lncRNA profiles in low birth weight (LBW) rats with reduced nephron endowment induced by the restriction of maternal protein intake. LBW by reduced nephron endowment is a risk factor for hypertension and end-stage renal disease in adulthood. Methods Kidneys were obtained from LBW rats fed a low-protein diet throughout gestation and lactation as well as from normal control rats born from dams fed normal protein diets at postnatal day 1 (p1) and 10 (p10). The total number of glomeruli in the kidneys was counted at p10. LncRNA expression profiles were analyzed by sequencing and screening using the Agilent Rat lncRNA Array. Quantitative real-time PCR (qRT-PCR) analysis of these lncRNAs confirmed the identity of some genes. Results The total number of glomeruli per kidney at p10 was significantly lower in LBW rats than in controls. A total of 42 lncRNAs were identified to be significantly differentially expressed, with fold-changes >= 2.0, between the two groups. According to correlation analysis between the differentially expressed lncRNAs and mRNAs involved in kidney development, we randomly selected a number of lncRNAs for comparison analysis between LBW and control kidneys at the two time-points, p1 and p10, using qRT-PCR. Three lncRNAs (TCONs_00014139, TCONS_00014138, and TCONS_00017119), which were significantly correlated with the mRNA expression of mitogen-activated protein kinase 4, were aberrantly expressed in LBW rats, compared with controls, at both p1 and p10. Conclusions LncRNAs are aberrantly expressed in the kidneys of LBW rats, compared with controls, during nephron development, which indicates that lncRNAs might be involved in impaired nephron endowment.	[Li, Yanhong; Wang, Xueqin; Li, Mengxia; Li, Xiaozhong] Soochow Univ, Childrens Hosp, Dept Nephrol, Suzhou, Peoples R China; [Li, Yanhong; Pan, Jian; Jin, Meifang; Wang, Jian] Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou, Peoples R China; [Feng, Xing] Soochow Univ, Childrens Hosp, Dept Neonatol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Li, YH (corresponding author), Soochow Univ, Childrens Hosp, Dept Nephrol, Suzhou, Peoples R China.	lyh072006@hotmail.com	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81370773]; Natural Science Foundation of Jiangsu Province [BK2012604]; Natural Science Foundation for Research Projects in the Colleges and Universities of Jiangsu Province [12KJB320006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Research Projects in the Colleges and Universities of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (81370773), the Natural Science Foundation of Jiangsu Province (BK2012604), and the Natural Science Foundation for Research Projects in the Colleges and Universities of Jiangsu Province (12KJB320006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 2004, PEDIATR NEPHROL, V19, P1319, DOI 10.1007/s00467-004-1643-5; [Anonymous], 2014, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2013.10.007; Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245; Boubred F, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/346067; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Kanwar YS, 2003, KIDNEY INT, V63, P1658, DOI 10.1046/j.1523-1755.2003.00905.x; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Liu HL, 2013, CELL PHYSIOL BIOCHEM, V32, P1497, DOI 10.1159/000356586; Tomat AL, 2013, NUTRITION, V29, P568, DOI 10.1016/j.nut.2012.09.008; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Omori S, 2000, KIDNEY INT, V58, P27, DOI 10.1046/j.1523-1755.2000.00137.x; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schreuder MF, 2005, J AM SOC NEPHROL, V16, P2913, DOI 10.1681/ASN.2004100875; Schreuder MF, 2006, AM J PHYSIOL-RENAL, V291, pF1104, DOI 10.1152/ajprenal.00158.2006; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; Zhu JG, 2014, J CELL BIOCHEM, V115, P910, DOI 10.1002/jcb.24733	28	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121587	10.1371/journal.pone.0121587	http://dx.doi.org/10.1371/journal.pone.0121587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826617	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800048
J	Mielcarek, A; Blauenburg, B; Miethke, M; Marahiel, MA				Mielcarek, Andreas; Blauenburg, Bastian; Miethke, Marcus; Marahiel, Mohamed A.			Molecular Insights into Frataxin-Mediated Iron Supply for Heme Biosynthesis in Bacillus subtilis	PLOS ONE			English	Article							SULFUR CLUSTER BIOSYNTHESIS; HIGH-AFFINITY; CONFORMATIONAL-CHANGES; BINDING-PROPERTIES; 2FE-2S CLUSTERS; FERROCHELATASE; PROTEIN; BACTERIAL; CYAY; BIOGENESIS	Iron is required as an element to sustain life in all eukaryotes and most bacteria. Although several bacterial iron acquisition strategies have been well explored, little is known about the intracellular trafficking pathways of iron and its entry into the systems for co-factor biogenesis. In this study, we investigated the iron-dependent process of heme maturation in Bacillus subtilis and present, for the first time, structural evidence for the physical interaction of a frataxin homologue (Fra), which is suggested to act as a regulatory component as well as an iron chaperone in different cellular pathways, and a ferrochelatase (HemH), which catalyses the final step of heme b biogenesis. Specific interaction between Fra and HemH was observed upon co-purification from crude cell lysates and, further, by using the recombinant proteins for analytical size-exclusion chromatography. Hydrogen-deuterium exchange experiments identified the landscape of the Fra/HemH interaction interface and revealed Fra as a specific ferrous iron donor for the ferrochelatase HemH. The functional utilisation of the in vitro-generated heme b co-factor upon Fra-mediated iron transfer was confirmed by using the B. subtilis nitric oxide synthase bsNos as a metabolic target enzyme. Complementary mutational analyses confirmed that Fra acts as an essential component for maturation and subsequent targeting of the heme b co-factor, hence representing a key player in the iron-dependent physiology of B. subtilis.	[Mielcarek, Andreas; Blauenburg, Bastian; Miethke, Marcus; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, Marburg, Germany; [Miethke, Marcus] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	Philipps University Marburg; University of California System; University of California Los Angeles	Miethke, M (corresponding author), Univ Marburg, Dept Chem Biochem, Marburg, Germany.	miethke@chem.ucla.edu; marahiel@staff.uni-marburg.de			collaborative research center of the Deutsche Forschungsgemeinschaft (DFG) [SFB 987]; LOEWE Center for Synthetic Microbiology (SYNMIKRO)	collaborative research center of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology (SYNMIKRO)	The authors acknowledge the collaborative research center SFB 987 of the Deutsche Forschungsgemeinschaft (DFG) and the LOEWE Center for Synthetic Microbiology (SYNMIKRO) for financial support (AM, BB, MAM). URL: http://www.dfg.de/en/index.jsp, http://www.sfb987.de, http://www.synmikro.com/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bosello M, 2012, BIOCHEMISTRY-US, V51, P3059, DOI 10.1021/bi201837f; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Busi MV, 2012, IUBMB LIFE, V64, P56, DOI 10.1002/iub.577; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Espinas NA, 2012, PLANT CELL PHYSIOL, V53, P1344, DOI 10.1093/pcp/pcs067; Gentry LE, 2013, BIOCHEMISTRY-US, V52, P6085, DOI 10.1021/bi400443n; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; KLEIN C, 1992, APPL ENVIRON MICROB, V58, P132, DOI 10.1128/AEM.58.1.132-142.1992; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Maliandi MV, 2011, FEBS J, V278, P470, DOI 10.1111/j.1742-4658.2010.07968.x; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027; Miethke M, 2013, FEBS LETT, V587, P206, DOI 10.1016/j.febslet.2012.11.027; Miethke M, 2013, METALLOMICS, V5, P15, DOI 10.1039/c2mt20193c; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Napoli E, 2007, BBA-MOL BASIS DIS, V1772, P773, DOI 10.1016/j.bbadis.2007.04.001; Napoli E, 2006, ANTIOXID REDOX SIGN, V8, P506, DOI 10.1089/ars.2006.8.506; Nunoshiba T, 1999, J BIOL CHEM, V274, P34832, DOI 10.1074/jbc.274.49.34832; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Qi WB, 2010, CHEM COMMUN, V46, P719, DOI 10.1039/b911975b; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Salard-Arnaud I, 2012, J INORG BIOCHEM, V106, P164, DOI 10.1016/j.jinorgbio.2011.10.003; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Subramanian P, 2011, CURR OPIN CHEM BIOL, V15, P312, DOI 10.1016/j.cbpa.2011.01.003; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	50	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122538	10.1371/journal.pone.0122538	http://dx.doi.org/10.1371/journal.pone.0122538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826316	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800079
J	Vik, FN; Lien, N; Berntsen, S; De Bourdeaudhuij, I; Grillenberger, M; Manios, Y; Kovacs, E; Chinapaw, MJM; Brug, J; Bere, E				Vik, Froydis N.; Lien, Nanna; Berntsen, Sveinung; De Bourdeaudhuij, Ilse; Grillenberger, Monika; Manios, Yannis; Kovacs, Eva; Chinapaw, Mai J. M.; Brug, Johannes; Bere, Elling			Evaluation of the UP4FUN Intervention: A Cluster Randomized Trial to Reduce and Break Up Sitting Time in European 10-12-Year-Old Children	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; EXCESSIVE WEIGHT-GAIN; SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; HEALTH INDICATORS; SCREEN TIME; MEDIA USE; YOUTH; IMPLEMENTATION; SCHOOLCHILDREN	Background The UP4FUN intervention is a family-involved school-based intervention aiming at reducing and breaking up sitting time at home (with special emphasis on screen time), and breaking up sitting time in school among 10-12 year olds in Europe. The purpose of the present paper was to evaluate its short term effects. Methodology/Principal Findings A total of 3147 pupils from Belgium, Germany, Greece, Hungary and Norway participated in a school-randomized controlled trial. The intervention included 1-2 school lessons per week for a period of six weeks, along with assignments for the children and their parents. Screen time and breaking up sitting time were registered by self-report and total sedentary time and breaking up sitting time by accelerometry. The effect of the intervention on these behaviors was evaluated by multilevel regression analyses. All analyses were adjusted for baseline values and gender. Significance level was p <= 0.01. No significant intervention effects were observed, neither for self-reported TV/DVD or computer/game console time, nor for accelerometer-assessed total sedentary time and number of breaks in sitting time. The intervention group, however, reported more positive attitudes towards (beta = 0.25 (95% CI 0.11, 0.38)) and preferences/liking for (beta = 0.20 (95% CI 0.08, 0.32)) breaking up sitting time than the control group. Conclusions/Significance No significant intervention effect on self-reported screen time or accelerometer-assessed sedentary time or breaks in sitting time was observed, but positive effects on beliefs regarding breaking up sitting time were found in favor of the intervention group. Overall, these results do not warrant wider dissemination of the present UP4FUN intervention.	[Vik, Froydis N.; Berntsen, Sveinung; Bere, Elling] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Lien, Nanna] Univ Oslo, Dept Nutr, Oslo, Norway; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Grillenberger, Monika] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Nutr Behav, Karlsruhe, Germany; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Kovacs, Eva] Univ Pecs, Dept Pediat, Pecs, Hungary; [Chinapaw, Mai J. M.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Chinapaw, Mai J. M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Brug, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	University of Agder; University of Oslo; Ghent University; Harokopio University Athens; University of Pecs; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Vik, FN (corresponding author), Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway.	froydis.n.vik@uia.no	Manios, Yannis/AAM-8953-2021; Paw, Mai Chin A/N-1665-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Brug, Johannes/A-8242-2018	Manios, Yannis/0000-0001-6486-114X; Paw, Mai Chin A/0000-0001-6259-2441; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Brug, Johannes/0000-0002-1904-7349	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B) [223254]	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-B)	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; ActiGraph, ACT 5 US MAN; Autho, 2012, REPORT FINDINGS EVAL; Bartholomew L., 2006, PLANNING HLTH PROMOT; Bessems KMHH, 2013, PUBLIC HEALTH NUTR, V16, P1273, DOI 10.1017/S1368980012003618; Biddle SJH, 2011, BRIT J SPORT MED, V45, P937, DOI 10.1136/bjsports-2011-090205; Brug Johannes, 2005, Int J Behav Nutr Phys Act, V2, P2, DOI 10.1186/1479-5868-2-2; Brug Johannes, 2010, BMC Public Health, V10, P276, DOI 10.1186/1471-2458-10-276; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Chinapaw MJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111205; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kwon S, 2012, MED SCI SPORT EXER, V44, P1075, DOI 10.1249/MSS.0b013e318245ca20; Lien N, 2014, 165 U AGD; Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x; Magnusson MB, 2011, PREV MED, V53, P402, DOI 10.1016/j.ypmed.2011.09.019; Maniccia DM, 2011, PEDIATRICS, V128, pE193, DOI 10.1542/peds.2010-2353; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; RICKHAM PP, 1964, BRIT MED J, V2, P173; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Salmon J, 2011, AM J PREV MED, V41, P197, DOI 10.1016/j.amepre.2011.05.001; Salmon J, 2010, J PHYS ACT HEALTH, V7, pS299, DOI 10.1123/jpah.7.s3.s299; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079143; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Verloigne M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-805; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Wind M, 2008, HEALTH EDUC RES, V23, P997, DOI 10.1093/her/cym078; Yildirim M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-182	41	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122612	10.1371/journal.pone.0122612	http://dx.doi.org/10.1371/journal.pone.0122612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826704	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800083
J	Boliar, S; Das, S; Bansal, M; Shukla, BN; Patil, S; Shrivastava, T; Samal, S; Goswami, S; King, CR; Bhattacharya, J; Chakrabarti, BK				Boliar, Saikat; Das, Supratik; Bansal, Manish; Shukla, Brihaspati N.; Patil, Shilpa; Shrivastava, Tripti; Samal, Sweety; Goswami, Sandeep; King, C. Richter; Bhattacharya, Jayanta; Chakrabarti, Bimal K.			An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies	PLOS ONE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; ENVELOPE GLYCOPROTEIN TRIMERS; MONOCLONAL-ANTIBODIES; CYTOPLASMIC DOMAIN; DEPENDENT EPITOPE; BROAD; GP41; MACAQUES; CONFORMATION; TRUNCATION	An ideal HIV-1 Env immunogen is expected to mimic the native trimeric conformation for inducing broadly neutralizing antibody responses. The native conformation is dependent on efficient cleavage of HIV-1 Env. The clade B isolate, JRFL Env is efficiently cleaved when expressed on the cell surface. Here, for the first time, we report the identification of a native clade C Env, 4-2.J41 that is naturally and efficiently cleaved on the cell surface as confirmed by its biochemical and antigenic characteristics. In addition to binding to several conformation-dependent neutralizing antibodies, 4-2.J41 Env binds efficiently to the cleavage-dependent antibody PGT151; thus validating its native cleaved conformation. In contrast, 4-2.J41 Env occludes non-neutralizing epitopes. The cytoplasmic-tail of 4-2.J41 Env plays an important role in maintaining its conformation. Furthermore, codon optimization of 4-2.J41 Env sequence significantly increases its expression while retaining its native conformation. Since clade C of HIV-1 is the prevalent subtype, identification and characterization of this efficiently cleaved Env would provide a platform for rational immunogen design.	[Boliar, Saikat; Das, Supratik; Bansal, Manish; Shukla, Brihaspati N.; Patil, Shilpa; Shrivastava, Tripti; Samal, Sweety; Goswami, Sandeep; Bhattacharya, Jayanta; Chakrabarti, Bimal K.] Translat Hlth Sci & Technol Inst, THSTI IAVI HIV Vaccine Design Program, Gurgaon 122016, Haryana, India; [King, C. Richter] IAVI Vaccine Design, New York, NY USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; International AIDS Vaccine Initiative	Chakrabarti, BK (corresponding author), Translat Hlth Sci & Technol Inst, THSTI IAVI HIV Vaccine Design Program, 496 Udyog Vihar,Phase 3, Gurgaon 122016, Haryana, India.	bchakrabarti@iavi.org	SAMAL, SWEETY/GQS-6704-2022	Boliar, Saikat/0000-0002-3340-5368	THSTI-IAVI	THSTI-IAVI	Funds for research was provided by THSTI-IAVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chakrabarti BK, 2005, VACCINE, V23, P3434, DOI 10.1016/j.vaccine.2005.01.099; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Murphy MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003173; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; ZINGLER K, 1993, J VIROL, V67, P2824, DOI 10.1128/JVI.67.5.2824-2831.1993	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122443	10.1371/journal.pone.0122443	http://dx.doi.org/10.1371/journal.pone.0122443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822521	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700176
J	Camacho, A; Funck-Brentano, T; Simao, M; Cancela, L; Ottaviani, S; Cohen-Solal, M; Richette, P				Camacho, Antonio; Funck-Brentano, Thomas; Simao, Marcio; Cancela, Leonor; Ottaviani, Sebastien; Cohen-Solal, Martine; Richette, Pascal			Effect of C282Y Genotype on Self-Reported Musculoskeletal Complications in Hereditary Hemochromatosis	PLOS ONE			English	Article							JOINT REPLACEMENT SURGERY; GENETIC HEMOCHROMATOSIS; IRON-OVERLOAD; HFE GENE; FERRITIN CONCENTRATIONS; INCREASED RISK; BONE; ARTHROPATHY; OSTEOARTHRITIS; MUTATIONS	Objective Arthropathy that mimics osteoarthritis (OA) and osteoporosis (OP) is considered a complication of hereditary hemochromatosis (HH). We have limited data comparing OA and OP prevalence among HH patients with different hemochromatosis type 1 (HFE) genotypes. We investigated the prevalence of OA and OP in patients with HH by C282Y homozygosity and compound heterozygosity (C282Y/H63D) genotype. Methods A total of 306 patients with HH completed a questionnaire. Clinical and demographic characteristics and presence of OA, OP and related complications were compared by genotype, adjusting for age, sex, body mass index (BMI), current smoking and menopausal status. Results In total, 266 of the 306 patients (87%) were homozygous for C282Y, and 40 (13%) were compound heterozygous. The 2 groups did not differ by median age [60 (interquartile range [IQR] 53 to 68) vs. 61 (55 to 67) years, P=0.8], sex (female: 48.8% vs. 37.5%, P=0.18) or current smoking habits (12.4% vs. 10%, P=0.3). As compared with compound heterozygous patients, C282Y homozygous patients had higher median serum ferritin concentration at diagnosis [1090 (IQR 610 to 2210) vs. 603 (362 to 950) mu g/L, P<0.001], higher median transferrin saturation [80% (IQR 66 to 91%) vs. 63% (55 to 72%), P<0.001]) and lower median BMI [24.8 (22.1 to 26.9) vs. 26.2 (23.5 to 30.3) kg/m2, P<0.003]. The overall prevalence of self-reported OA was significantly higher with C282Y homozygosity than compound heterozygosity (53.4% vs. 32.5%; adjusted odds ratio [aOR] 2.4 [95% confidence interval 1.2-5.0]), as was self-reported OP (25.6% vs. 7.5%; aOR 3.5 [1.1-12.1]). Conclusion Patients with C282Y homozygosity may be at increased risk of musculoskeletal complications of HH.	[Camacho, Antonio] Ctr Hosp Lisboa Cent, Dept Orthoped, Lisbon, Portugal; [Camacho, Antonio; Simao, Marcio; Cancela, Leonor] Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal; [Camacho, Antonio; Simao, Marcio; Cancela, Leonor] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Funck-Brentano, Thomas; Ottaviani, Sebastien] Univ Paris Diderot, Hop Bichat, AP HP, Serv Rhumatol, Paris, France; [Funck-Brentano, Thomas; Cohen-Solal, Martine; Richette, Pascal] Hop Lariboisiere, INSERM, U1132, F-75475 Paris, France; [Cohen-Solal, Martine; Richette, Pascal] Univ Paris Diderot, Hop Lariboisiere, AP HP, Federat Rhumatol, Paris 10, France	Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade do Algarve; Universidade do Algarve; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Richette, P (corresponding author), Hop Lariboisiere, INSERM, U1132, F-75475 Paris, France.	pascal.richette@lrb.aphp.fr	Funck-Brentano, Thomas/Q-5736-2016; Simão, Márcio/AAC-3877-2019; Funck-Brentano, Thomas/AAS-7201-2020; Cohen-Solal, Martine/P-7808-2017	Funck-Brentano, Thomas/0000-0001-7684-2405; Simão, Márcio/0000-0001-9658-0895; Funck-Brentano, Thomas/0000-0001-7684-2405; Richette, Pascal/0000-0003-2132-4074; Brito Camacho, Antonio/0000-0002-7914-4538; Cancela, M. Leonor/0000-0003-3114-6662; Cohen-Solal, Martine/0000-0002-8582-8258	Association Rhumatisme et Travail (Centre Viggo Petersen, Hospital Lariboisiere, Paris)	Association Rhumatisme et Travail (Centre Viggo Petersen, Hospital Lariboisiere, Paris)	The Association Rhumatisme et Travail (Centre Viggo Petersen, Hospital Lariboisiere, Paris) funded copyediting (Laura Smales, BioMedEditing) of this report. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 1996, J RHEUMATOL, V23, P707; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Allen KJ, 2010, HEPATOLOGY, V52, P925, DOI 10.1002/hep.23786; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; BYWATERS EG, 1971, ANN RHEUM DIS, V30, P453, DOI 10.1136/ard.30.5.453; Carroll GJ, 2012, ARTHRIT CARE RES, V64, P9, DOI 10.1002/acr.20501; Carroll GJ, 2010, SCAND J RHEUMATOL, V39, P413, DOI 10.3109/03009741003677449; Elmberg M, 2013, ARTHRIT CARE RES, V65, P678, DOI 10.1002/acr.21883; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Gurrin LC, 2009, HEPATOLOGY, V50, P94, DOI 10.1002/hep.22972; Heiland GR, 2010, ANN RHEUM DIS, V69, P1214, DOI 10.1136/ard.2009.120204; Husar-Memmer E, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0393-4; Nell-Duxneuner V, 2013, ANN RHEUM DIS, V72, P2006, DOI 10.1136/annrheumdis-2012-202800; Richette P, 2010, J RHEUMATOL, V37, P2145, DOI 10.3899/jrheum.100234; Sahinbegovic E, 2010, ARTHRITIS RHEUM-US, V62, P3792, DOI 10.1002/art.27712; Sahinbegovic E, 2010, AM J MED, V123, P659, DOI 10.1016/j.amjmed.2010.01.024; Saliou P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081128; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Valenti L, 2008, J RHEUMATOL, V35, P153; Waalen J, 2002, MAYO CLIN PROC, V77, P522, DOI 10.4065/77.6.522; Wang Y, 2012, SEMIN ARTHRITIS RHEU, V41, P872, DOI 10.1016/j.semarthrit.2011.11.003	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122817	10.1371/journal.pone.0122817	http://dx.doi.org/10.1371/journal.pone.0122817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822977	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700200
J	Gardner, PP; Fasold, M; Burge, SW; Ninova, M; Hertel, J; Kehr, S; Steeves, TE; Griffiths-Jones, S; Stadler, PF				Gardner, Paul P.; Fasold, Mario; Burge, Sarah W.; Ninova, Maria; Hertel, Jana; Kehr, Stephanie; Steeves, Tammy E.; Griffiths-Jones, Sam; Stadler, Peter F.			Conservation and Losses of Non-Coding RNAs in Avian Genomes	PLOS ONE			English	Article							ANDROGEN RECEPTOR; DICTYOSTELIUM-DISCOIDEUM; EVOLUTION; GENE; EXPRESSION; IDENTIFICATION; MICRORNAS; SEQUENCE; HOMOLOGY; REVEALS	Here we present the results of a large-scale bioinformatics annotation of non-coding RNA loci in 48 avian genomes. Our approach uses probabilistic models of hand-curated families from the Rfam database to infer conserved RNA families within each avian genome. We supplement these annotations with predictions from the tRNA annotation tool, tRNAscan-SE and microRNAs from miRBase. We identify 34 lncRNA-associated loci that are conserved between birds and mammals and validate 12 of these in chicken. We report several intriguing cases where a reported mammalian lncRNA, but not its function, is conserved. We also demonstrate extensive conservation of classical ncRNAs (e.g., tRNAs) and more recently discovered ncRNAs (e.g., snoRNAs and miRNAs) in birds. Furthermore, we describe numerous "losses" of several RNA families, and attribute these to either genuine loss, divergence or missing data. In particular, we show that many of these losses are due to the challenges associated with assembling avian microchromosomes. These combined results illustrate the utility of applying homology-based methods for annotating novel vertebrate genomes.	[Gardner, Paul P.; Steeves, Tammy E.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Gardner, Paul P.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Fasold, Mario; Hertel, Jana; Kehr, Stephanie; Stadler, Peter F.] Univ Leipzig, Bioinformat Grp, Dept Comp Sci, D-04107 Leipzig, Germany; [Fasold, Mario; Hertel, Jana; Kehr, Stephanie; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Fasold, Mario] EcSeq Bioinformat, D-04275 Leipzig, Germany; [Burge, Sarah W.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Ninova, Maria; Griffiths-Jones, Sam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Stadler, Peter F.] Max Planck Inst Math Sci, D-04103 Leipzig, Germany; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, A-1090 Vienna, Austria; [Stadler, Peter F.] Univ Copenhagen, Ctr RNA Technol & Hlth, Frederiksberg C, Denmark; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Stadler, Peter F.] German Ctr Integrat Biodivers Res iDiv, Halle, Germany	University of Canterbury; University of Canterbury; Leipzig University; Leipzig University; European Molecular Biology Laboratory (EMBL); University of Manchester; Max Planck Society; Fraunhofer Gesellschaft; University of Vienna; University of Copenhagen; The Santa Fe Institute	Gardner, PP (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	paul.gardner@canterbury.ac.nz	Schor, Jana/F-8503-2017; Gardner, Paul P./B-1978-2009; Ninova, Maria/AAG-9476-2021; Stadler, Peter F. F/L-7857-2015; Griffiths-Jones, Sam/H-2998-2014	Schor, Jana/0000-0003-1200-6234; Gardner, Paul P./0000-0002-7808-1213; Ninova, Maria/0000-0001-5051-5502; Stadler, Peter F. F/0000-0002-5016-5191; Griffiths-Jones, Sam/0000-0001-6043-807X; Burge, Sarah/0000-0002-2506-927X; Kehr, Stephanie/0000-0001-8461-5763	Rutherford Discovery Fellowship	Rutherford Discovery Fellowship	PPG is supported by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NONCODING RNA ANNOTA; Avesson L, 2012, RNA, V18, P1771, DOI 10.1261/rna.033175.112; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartschat S, 2014, PREPRINT; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan AS, 2002, ONCOGENE, V21, P3029, DOI 10.1038/sj.onc.1205460; Chan PP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r38; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Diederichs S, 2014, TRENDS GENETICS; Douaud M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-129; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Ferreira LB, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-507; Floutsakou I, 2013, GENOME RES, V23, P2003, DOI 10.1101/gr.157941.113; Freyhult EK, 2007, GENOME RES, V17, P117, DOI 10.1101/gr.5890907; Fuxjager MJ, 2012, ENDOCRINOLOGY, V153, P3780, DOI 10.1210/en.2012-1313; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, P5845, DOI 10.1093/nar/gkr168; Gardner Paul P., 2010, Journal of Biology (London), V8, P4, DOI 10.1186/jbiol211; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2005, BIOINFORMATICS, V21, P257, DOI 10.1093/bioinformatics/bth489; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Hertel J, 2012, RNA BIOL IN PRESS; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Hoeppner MP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002752; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Howard J, 2013, GIGASCIENCE DATABASE; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kolbe DL, 2009, BIOINFORMATICS, V25, P1236, DOI 10.1093/bioinformatics/btp154; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lai LB, 2010, P NATL ACAD SCI USA, V107, P22493, DOI 10.1073/pnas.1013969107; Lambert A, 2002, BIOCHIMIE, V84, P953, DOI 10.1016/S0300-9084(02)01441-4; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Leska A, 2012, GEN COMP ENDOCR, V179, P63, DOI 10.1016/j.ygcen.2012.07.026; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Li J, 2014, GENOMES 2 ANTA UNPUB; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin BY, 2000, CANCER RES, V60, P858; Lopez MD, 2008, NUCLEIC ACIDS RES, V36, P3001, DOI 10.1093/nar/gkn142; Lopez MD, 2008, RNA, V14, P1, DOI 10.1261/rna.782308; Lopez MD, 2009, RNA BIOL, V6, P208, DOI 10.4161/rna.6.3.8584; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mao CH, 2009, RNA BIOL, V6, P355, DOI 10.4161/rna.6.4.9172; Marz M, 2011, RNA BIOL, V8, P938, DOI 10.4161/rna.8.6.16603; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; Menzel P, 2009, RNA, V15, P2075, DOI 10.1261/rna.1556009; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Mosig A, 2007, THEOR BIOSCI, V126, P9, DOI 10.1007/s12064-007-0003-y; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nawrocki EP, 2014, NUCL ACIDS RES; Nawrocki EP, 2014, METHODS MOL BIOL, V1097, P163, DOI 10.1007/978-1-62703-709-9_9; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pascual-Anaya J, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-26; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rivas E, 2000, BIOINFORMATICS, V16, P583, DOI 10.1093/bioinformatics/16.7.583; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; SAKAKIBARA Y, 1994, NUCLEIC ACIDS RES, V22, P5112, DOI 10.1093/nar/22.23.5112; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Shao P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-86; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Smith J, BIORXIV 2014; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Solinhac R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-616; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Stevens SG, 2011, RNA BIOL, V8, P792, DOI 10.4161/rna.8.5.16037; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; The Avian Genome Consortium, PHYL AN BIRDS WEBS; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Xu CF, 1997, HUM MOL GENET, V6, P1057, DOI 10.1093/hmg/6.7.1057; YOSHIMURA Y, 1993, GEN COMP ENDOCR, V91, P81, DOI 10.1006/gcen.1993.1107; Yu HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-251; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang GJ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-26; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	113	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121797	10.1371/journal.pone.0121797	http://dx.doi.org/10.1371/journal.pone.0121797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822729	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700128
J	Nguyen, T; Khosravi, A; Creighton, D; Nahavandi, S				Thanh Nguyen; Khosravi, Abbas; Creighton, Douglas; Nahavandi, Saeid			Hierarchical Gene Selection and Genetic Fuzzy System for Cancer Microarray Data Classification	PLOS ONE			English	Article							PREDICTION; SETS; TOOL	This paper introduces a novel approach to gene selection based on a substantial modification of analytic hierarchy process (AHP). The modified AHP systematically integrates outcomes of individual filter methods to select the most informative genes for microarray classification. Five individual ranking methods including t-test, entropy, receiver operating characteristic (ROC) curve, Wilcoxon and signal to noise ratio are employed to rank genes. These ranked genes are then considered as inputs for the modified AHP. Additionally, a method that uses fuzzy standard additive model (FSAM) for cancer classification based on genes selected by AHP is also proposed in this paper. Traditional FSAM learning is a hybrid process comprising unsupervised structure learning and supervised parameter tuning. Genetic algorithm (GA) is incorporated in-between unsupervised and supervised training to optimize the number of fuzzy rules. The integration of GA enables FSAM to deal with the high-dimensional-low-sample nature of microarray data and thus enhance the efficiency of the classification. Experiments are carried out on numerous microarray datasets. Results demonstrate the performance dominance of the AHP-based gene selection against the single ranking methods. Furthermore, the combination of AHP-FSAM shows a great accuracy in microarray data classification compared to various competing classifiers. The proposed approach therefore is useful for medical practitioners and clinicians as a decision support system that can be implemented in the real medical practice.	[Thanh Nguyen; Khosravi, Abbas; Creighton, Douglas; Nahavandi, Saeid] Deakin Univ, Ctr Intelligent Syst Res, Geelong, Vic 3216, Australia	Deakin University	Nguyen, T (corresponding author), Deakin Univ, Ctr Intelligent Syst Res, Geelong Waurn Ponds Campus, Geelong, Vic 3216, Australia.	thanh.nguyen@deakin.edu.au	Khosravi, Abbas/AAQ-8102-2021; Nahavandi, Saeid/AAE-5536-2022	Nguyen, Thanh Thi/0000-0001-9709-1663	Australian Research Council [DP120102112]; Centre for Intelligent Systems Research (CISR) at Deakin University	Australian Research Council(Australian Research Council); Centre for Intelligent Systems Research (CISR) at Deakin University	This research is supported by the Australian Research Council (Discovery Grant DP120102112) and the Centre for Intelligent Systems Research (CISR) at Deakin University.	Basford KE, 2013, BRIEF BIOINFORM, V14, P402, DOI 10.1093/bib/bbs056; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bicego M, 2012, IEEE ACM T COMPUT BI, V9, P1831, DOI 10.1109/TCBB.2012.121; Bolon-Canedo V, 2012, PATTERN RECOGN, V45, P531, DOI 10.1016/j.patcog.2011.06.006; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Deng L., 2004, P 10 ASS COMPUTING M, P410, DOI DOI 10.1145/1014052.1014099; Dickerson JA, 1996, IEEE T SYST MAN CY B, V26, P542, DOI 10.1109/3477.517030; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Du DJ, 2014, NEUROCOMPUTING, V133, P446, DOI 10.1016/j.neucom.2013.12.012; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Giugno R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069873; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hong JH, 2009, PATTERN RECOGN, V42, P1761, DOI 10.1016/j.patcog.2009.01.006; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kohane I. S., 2002, MICROARRAYS INTEGRAT; KOSKO B, 1994, IEEE T COMPUT, V43, P1329, DOI 10.1109/12.324566; Kosko B., 1996, FUZZY ENG; Kumar PG, 2012, EXPERT SYST APPL, V39, P1811, DOI 10.1016/j.eswa.2011.08.069; Leung Y, 2010, IEEE ACM T COMPUT BI, V7, P108, DOI 10.1109/TCBB.2008.46; Liu HW, 2010, PATTERN RECOGN, V43, P2763, DOI 10.1016/j.patcog.2010.02.008; Liu HW, 2010, J BIOMED INFORM, V43, P81, DOI 10.1016/j.jbi.2009.08.010; Mitaim S, 2001, IEEE T FUZZY SYST, V9, P637, DOI 10.1109/91.940974; Mitaim S, 1996, FUZZ-IEEE '96 - PROCEEDINGS OF THE FIFTH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P1237, DOI 10.1109/FUZZY.1996.552354; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Orsenigo C, 2013, EXPERT SYST APPL, V40, P2189, DOI 10.1016/j.eswa.2012.10.044; Pique-Regi R., 2005, 2005 IEEE Computational Systems Bioinformatics Conference Workshops and Poster Abstracts, P112, DOI 10.1109/CSBW.2005.124; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Ramakrishnan K, 2013, INT J ADV MED SCI, V1, P19; Reboiro-Jato M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-31; REEVES CR, 2002, GENETIC ALGORITHMS P; Saaty T.L., 2013, GROUP DECISION MAKIN; Saaty T.L., 1980, ANAL HIERARCHY PROCE, DOI DOI 10.1016/0305-0483(87)90016-8; Nguyen TT, 2012, IEEE T FUZZY SYST, V20, P666, DOI 10.1109/TFUZZ.2011.2181520; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang XS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-391; Wang Z, 2008, MACHINE LEARNING BIO; Wang ZY, 2006, 2006 INTERNATIONAL SYMPOSIUM ON EVOLVING FUZZY SYSTEMS, PROCEEDINGS, P241, DOI 10.1109/ISEFS.2006.251144; Wu MY, 2012, IEEE ACM T COMPUT BI, V9, P1649, DOI 10.1109/TCBB.2012.105; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Yu HL, 2013, NEUROCOMPUTING, V101, P309, DOI 10.1016/j.neucom.2012.08.018	43	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120364	10.1371/journal.pone.0120364	http://dx.doi.org/10.1371/journal.pone.0120364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823003	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700061
J	Swanepoel, W; Le Roux, MM; Wojciechowski, MF; van Wyk, AE				Swanepoel, Wessel; le Roux, M. Marianne; Wojciechowski, Martin F.; van Wyk, Abraham E.			Oberholzeria (Fabaceae subfam. Faboideae), a New Monotypic Legume Genus from Namibia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; LEGUMINOSAE; CROTALARIA; SEQUENCES; RBCL; DNA	Oberholzeria etendekaensis, a succulent biennial or short-lived perennial shrublet is described as a new species, and a new monotypic genus. Discovered in 2012, it is a rare species known only from a single locality in the Kaokoveld Centre of Plant Endemism, northwestern Namibia. Phylogenetic analyses of molecular sequence data from the plastid matK gene resolves Oberholzeria as the sister group to the Genisteae clade while data from the nuclear rDNA ITS region showed that it is sister to a clade comprising both the Crotalarieae and Genisteae clades. Morphological characters diagnostic of the new genus include: 1) succulent stems with woody remains; 2) pinnately trifoliolate, fleshy leaves; 3) monadelphous stamens in a sheath that is fused above; 4) dimorphic anthers with five long, basifixed anthers alternating with five short, dorsifixed anthers, and 5) pendent, membranous, oneseeded, laterally flattened, slightly inflated but indehiscent fruits.	[Swanepoel, Wessel; van Wyk, Abraham E.] Univ Pretoria, Dept Plant Sci, HGWJ Schweickerdt Herbarium, ZA-0002 Pretoria, South Africa; [le Roux, M. Marianne] Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, South Africa; [Wojciechowski, Martin F.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	University of Pretoria; University of Johannesburg; Arizona State University; Arizona State University-Tempe		wessel@kaokosafari.com	van Wyk, Abraham/A-2181-2008	van Wyk, Abraham/0000-0002-0437-3272	South African National Research Foundation; University of Pretoria; University of Johannesburg; Arizona State University	South African National Research Foundation(National Research Foundation - South Africa); University of Pretoria; University of Johannesburg; Arizona State University	This work was funded in part by research grants from the South African National Research Foundation and University of Pretoria to AEVW. MMLR received financial support from the University of Johannesburg. MFW was funded by the Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ADV LEGUME SYSTEMATI; Bentham G., 1865, GENERA PLANTARUM EXE, P478; Boatwright JS, 2008, SYST BOT, V33, P752, DOI 10.1600/036364408786500271; Cardoso D, 2013, AM J BOT, V100, P403, DOI 10.3732/ajb.1200276; Crisp MD, 2000, ADV LEGUME SYSTEMATI, V9, P249; De Candolle AP, 1825, MEMOIRES FAMILLE LEG, V35, P201; Doyle J. J., 2000, ADV LEGUME SYSTEMATI, V9, P1; Ecklon CF, 1836, ENUMERATIO PLANTARUM, P184; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Germishuizen G., 2003, STRELITZIA, V14, P1231, DOI DOI 10.1049/IP-NBT:20031080; Kajita T, 2001, SYST BOT, V26, P515; Kass E, 1997, MOL PHYLOGENET EVOL, V8, P65, DOI 10.1006/mpev.1997.0410; le Roux MM, 2013, TAXON, V62, P957, DOI 10.12705/625.1; Le Roux MM, 2012, FLORA, V207, P414, DOI 10.1016/j.flora.2012.02.005; Linnaeus C, 1753, SPECIES PLANTARUM, P385; Mendelsohn J, 2002, ATLAS NAMIBIA PORTRA, P1; Meyer PG, 1966, MITT BOT STAATSSAML, V6, P245; Moteetee A, 2006, S AFR J BOT, V72, P51, DOI 10.1016/j.sajb.2005.05.004; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Polhill R.M., 2005, LEGUMES WORLD, P283; Polhill RM, 1982, CROTALARIA AFRICA MA, P1; POLHILL RM, 1976, BOTANICAL SYSTEMATIC, V1, P143; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schrire B. D., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P375; Schrire BD, 2009, AM J BOT, V96, P816, DOI 10.3732/ajb.0800185; SCHUTTE AL, 1988, S AFR J BOT, V54, P182, DOI 10.1016/S0254-6299(16)31348-5; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Van Wyk AE, 2001, REGIONS FLORISTIC EN, P1; Van Wyk B-E, 1991, CONTR BOLUS HERB, V13, P265, DOI DOI 10.2307/4110360; VANWYK BE, 1995, ADV LEGUM SYSTEMAT, P283; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122080	10.1371/journal.pone.0122080	http://dx.doi.org/10.1371/journal.pone.0122080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816251	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600141
J	Garcia-Miralles, M; Coomaraswamy, J; Habig, K; Herzig, MC; Funk, N; Gillardon, F; Maisel, M; Jucker, M; Gasser, T; Galter, D; Biskup, S				Garcia-Miralles, Marta; Coomaraswamy, Janaky; Haebig, Karina; Herzig, Martin C.; Funk, Natalja; Gillardon, Frank; Maisel, Martina; Jucker, Mathias; Gasser, Thomas; Galter, Dagmar; Biskup, Saskia			No Dopamine Cell Loss or Changes in Cytoskeleton Function in Transgenic Mice Expressing Physiological Levels of Wild Type or G2019S Mutant LRRK2 and in Human Fibroblasts	PLOS ONE			English	Article							PARKINSONS-DISEASE; MODELS; INHIBITION; ADHESION	Mutations within the LRRK2 gene have been identified in Parkinson's disease (PD) patients and have been implicated in the dysfunction of several cellular pathways. Here, we explore how pathogenic mutations and the inhibition of LRRK2 kinase activity affect cytoskeleton dynamics in mouse and human cell systems. We generated and characterized a novel transgenic mouse model expressing physiological levels of human wild type and G2019S-mutant LRRK2. No neuronal loss or neurodegeneration was detected in midbrain dopamine neurons at the age of 12 months. Postnatal hippocampal neurons derived from transgenic mice showed no alterations in the seven parameters examined concerning neurite outgrowth sampled automatically on several hundred neurons using high content imaging. Treatment with the kinase inhibitor LRRK2-IN-1 resulted in no significant changes in the neurite outgrowth. In human fibroblasts we analyzed whether pathogenic LRRK2 mutations change cytoskeleton functions such as cell adhesion. To this end we compared the adhesion characteristics of human skin fibroblasts derived from six PD patients carrying one of three different pathogenic LRRK2 mutations and from four age-matched control individuals. The mutant LRRK2 variants as well as the inhibition of LRRK2 kinase activity did not reveal any significant cell adhesion differences in cultured fibroblasts. In summary, our results in both human and mouse cell systems suggest that neither the expression of wild type or mutant LRRK2, nor the inhibition of LRRK2 kinase activity affect neurite complexity and cellular adhesion.	[Garcia-Miralles, Marta; Funk, Natalja; Maisel, Martina; Gasser, Thomas; Biskup, Saskia] German Ctr Neurodegenerat Dis, Dept Neurodegenerat, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Garcia-Miralles, Marta; Coomaraswamy, Janaky; Herzig, Martin C.; Funk, Natalja; Maisel, Martina; Jucker, Mathias; Gasser, Thomas; Biskup, Saskia] German Ctr Neurodegenerat Dis, DZNE, D-72076 Tubingen, Germany; [Coomaraswamy, Janaky; Herzig, Martin C.; Jucker, Mathias] German Ctr Neurodegenerat Dis, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Haebig, Karina] Univ Tubingen, Dept Med Genet & Appl Genom, Inst Human Genet, D-72076 Tubingen, Germany; [Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, D-88397 Biberach, Germany; [Galter, Dagmar] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Boehringer Ingelheim; Karolinska Institutet	Biskup, S (corresponding author), German Ctr Neurodegenerat Dis, Dept Neurodegenerat, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	saskia.biskup@medizin.uni-tuebingen.de	Herzig, Martin/R-4601-2016; Galter, Dagmar/C-4826-2011; Gasser, Thomas/GNH-5293-2022	Herzig, Martin/0000-0002-0500-353X; Galter, Dagmar/0000-0001-6485-6244; Gasser, Thomas/0000-0002-1069-1146; Garcia Miralles, Marta/0000-0001-7250-5778	German Research Foundation DFG; Swedish Brain Power; Swedish Research Council; Boehringer Ingelheim Pharma GmbH Co; Novartis Pharma AG; H. Lundbeck A/S	German Research Foundation DFG(German Research Foundation (DFG)); Swedish Brain Power; Swedish Research Council(Swedish Research CouncilEuropean Commission); Boehringer Ingelheim Pharma GmbH Co(Boehringer Ingelheim); Novartis Pharma AG; H. Lundbeck A/S	This work was supported by the German Research Foundation DFG, the Swedish Brain Power, and the Swedish Research Council. Boehringer Ingelheim Pharma GmbH & Co provided support in the form of salaries for author FG and Novartis Pharma AG and H. Lundbeck A/S provided support in the form of salaries for author MCH. Boehringer Ingelheim Pharma GmbH & Co and Novartis Pharma AG and H. Lundbeck A/S did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Belin AC, 2008, FEBS J, V275, P1377, DOI 10.1111/j.1742-4658.2008.06301.x; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dachsel JC, 2010, PARKINSONISM RELAT D, V16, P650, DOI 10.1016/j.parkreldis.2010.08.018; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gasser T, 2011, MOVEMENT DISORD, V26, P1042, DOI 10.1002/mds.23637; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Kett LR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009407; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S146239941100192X; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Luerman GC, 2014, J NEUROCHEM, V128, P561, DOI 10.1111/jnc.12483; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Parisiadou Loukia, 2010, Commun Integr Biol, V3, P396, DOI 10.4161/cib.3.5.12286; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sepulveda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061986; Stacey NC, 2000, NEUROSCIENCE, V98, P397, DOI 10.1016/S0306-4522(00)00149-4; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; TAKEDA M, 1990, ACTA NEUROL SCAND, V82, P238; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Xu Qing, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS186, DOI 10.1016/S1353-8020(11)70058-X; Yue ZY, 2011, MOVEMENT DISORD, V26, P1386, DOI 10.1002/mds.23737	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0118947	10.1371/journal.pone.0118947	http://dx.doi.org/10.1371/journal.pone.0118947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830304	Green Published, Green Submitted, gold			2022-12-27	WOS:000352135600006
J	Xia, M; Chen, DX; Endresz, V; Lantos, I; Szabo, A; Kakkar, V; Lu, XJ				Xia, Min; Chen, Daxin; Endresz, Valeria; Lantos, Ildiko; Szabo, Andrea; Kakkar, Vijay; Lu, Xinjie			Modulation of Recombinant Antigenic Constructs Containing Multi-Epitopes towards Effective Reduction of Atherosclerotic Lesion in B6; 129S-Ldlr(tm1Her)Apob(tm2Sgy)/J Mice	PLOS ONE			English	Article							ADHESION MOLECULE-1 EXPRESSION; DENDRITIC CELLS; TNF-ALPHA; T-CELLS; MATRIX METALLOPROTEINASES; REDUCES ATHEROSCLEROSIS; COMBINATION; VACCINATION; IMMUNE; ATHEROGENESIS	Atherosclerosis is increasingly recognized as a complex chronic inflammatory disease. Many more studies have extended vaccination against atherosclerosis by using epitopes from self-antigens or beyond and demonstrated that vaccination with antigens or derivatives could reduce the extent of the lesions in atherosclerosis-prone mice. Our previous study has demonstrated that construct AHHC [ApoB100(688-707) + hHSP60(303-312) + hHSP60(153-163) + Cpn derived peptide (C)] significantly reduced atherosclerotic lesion. The aim of this study was to investigate whether AHHC can be modulated towards increased lesion reduction in mice by creating two other derivatives with a sequential epitope-substitution named RHHC in which A was replaced by an "R" (C5aR(1-31)) and RPHC with a further "H" (hHSP60(303-312)) conversion into "P" (protease-activated receptor-1(42-55)) in mice. Antigenic epitopes were incorporated into a dendroaspin scaffold. Immunization of B6; 129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice with three constructs elicited production of high levels of antibodies against each epitope (apart from hHSP60(153-163) and P which induced a low antibody response). Histological analyses demonstrated that the mice immunized with either RPHC or RHHC showed significant reductions in the size of atherosclerostic lesions compared to those with AHHC (69.5 +/- 1.1% versus 55.7 +/- 3.4%, P < 0.01 or 65.6 +/- 1.3% versus 55.7 +/- 3.4%, P < 0.01). Reduction of plaque size in the aortic sinus and descending aorta correlated with alterations in cellular immune responses when compared with controls. We conclude that a recombinant construct RPHC may provide new antigenic and structural features which are favorable for significant reduction in atherosclerotic lesion formation. This approach offers a novel strategy for developing anti-atherosclerotic agents.	[Xia, Min; Chen, Daxin; Kakkar, Vijay; Lu, Xinjie] Thrombosis Res Inst, Mary & Garry Weston Mol Immunol Lab, London SW3 6LR, England; [Chen, Daxin] Kings Coll London, MRC Ctr Transplantat, London, England; [Endresz, Valeria; Lantos, Ildiko] Univ Szeged, Dept Med Microbiol & Immunobiol, Szeged, Hungary; [Szabo, Andrea] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Kakkar, Vijay] Thrombosis Res Inst, Bangalore, Karnataka, India	Thrombosis Research Institute; University of London; King's College London; Szeged University; Szeged University	Lu, XJ (corresponding author), Thrombosis Res Inst, Mary & Garry Weston Mol Immunol Lab, London SW3 6LR, England.	xlu@tri-london.ac.uk	Szabó, Andrea/AAC-4691-2019	Szabo, Andrea/0000-0003-3139-0235	Trustees of the Thrombosis Research Institutes in London and in Bangalore; Garfield Weston Foundation, UK; Tata Social Welfare Trust;  [TAMOP-4.2.2.A-11-1-KONV-2012-0035]	Trustees of the Thrombosis Research Institutes in London and in Bangalore; Garfield Weston Foundation, UK; Tata Social Welfare Trust; 	This study was supported by the Trustees of the Thrombosis Research Institutes in London and in Bangalore, The Garfield Weston Foundation, UK, and the Tata Social Welfare Trust. Valeria Endresz and Ildiko Lantos were supported by a grant from Hungary (TAMOP-4.2.2.A-11-1-KONV-2012-0035). The sponsors did not participate in the design, conduct, sample collection, analysis or interpretation of the data, or in the preparation, review or approval of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arnold-Schrauf C, 2015, EUR J IMMUNOL, V45, P32, DOI 10.1002/eji.201444747; Azuma K, 2009, BIOCHEM BIOPH RES CO, V380, P620, DOI 10.1016/j.bbrc.2009.01.135; Barks JL, 1997, J IMMUNOL, V159, P4532; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Chintala M, 2010, ARTERIOSCL THROM VAS, V30, P2143, DOI 10.1161/ATVBAHA.110.203414; Chyu Kuang-Yuh, 2007, Curr Atheroscler Rep, V9, P104, DOI 10.1007/s11883-007-0005-8; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; EMESON EE, 1993, AM J PATHOL, V142, P1906; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Foteinos G, 2009, AUTOIMMUNITY, V42, P627, DOI 10.1080/08916930903002529; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; George J, 1999, CIRCULATION, V99, P2227, DOI 10.1161/01.CIR.99.17.2227; GORDON S, 1995, CURR OPIN IMMUNOL, V7, P24, DOI 10.1016/0952-7915(95)80025-5; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Habets KLL, 2010, CARDIOVASC RES, V85, P622, DOI 10.1093/cvr/cvp338; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Huo Y, 2001, ACTA PHYSIOL SCAND, V173, P35, DOI 10.1046/j.1365-201X.2001.00882.x; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin JT, 2014, CURR DRUG TARGETS, V15, P442, DOI 10.2174/1389450115666140211115805; Lu XJ, 2012, ATHEROSCLEROSIS, V225, P56, DOI 10.1016/j.atherosclerosis.2012.07.021; Lu XJ, 2012, ARTERIOSCL THROM VAS, V32, P2358, DOI 10.1161/ATVBAHA.112.253179; Lu XJ, 2010, ATHEROSCLEROSIS, V212, P472, DOI 10.1016/j.atherosclerosis.2010.06.007; Matsuura E, 2012, AUTOIMMUN REV, V12, P241, DOI 10.1016/j.autrev.2012.04.003; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; van Wanrooij EJA, 2008, CARDIOVASC RES, V78, P590, DOI 10.1093/cvr/cvn025; Wagsater D, 2011, INT J MOL MED, V28, P247, DOI 10.3892/ijmm.2011.693; Wang F, 2006, J INVEST DERMATOL, V126, P1590, DOI 10.1038/sj.jid.5700310; Xia M, 2015, VACCINATION WITH PEP; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhou X, 1999, SCAND J IMMUNOL, V50, P25	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123393	10.1371/journal.pone.0123393	http://dx.doi.org/10.1371/journal.pone.0123393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830298	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000352135600145
J	Bae, IS; Chung, KY; Yi, J; Kim, TI; Choi, HS; Cho, YM; Choi, I; Kim, SH				Bae, In-Seon; Chung, Ki Yong; Yi, Jongmin; Kim, Tae Il; Choi, Hwa-Sik; Cho, Young-Moo; Choi, Inho; Kim, Sang Hoon			Identification of Reference Genes for Relative Quantification of Circulating MicroRNAs in Bovine Serum	PLOS ONE			English	Article							QRT-PCR; RT-PCR; BIOMARKERS; EXPRESSION; PLASMA; NORMALIZATION; TISSUES; CANCER; MECHANISM; DISEASES	Circulating microRNAs in body fluids have been implicated as promising biomarkers for physiopathology disorders. Currently, the expression levels of circulating microRNAs are estimated by reverse transcription quantitative real-time polymerase chain reaction. Use of appropriate reference microRNAs for normalization is critical for accurate microRNA expression analysis. However, no study has systematically investigated reference genes for evaluating circulating microRNA expression in cattle. In this study, we describe the identification and characterization of appropriate reference microRNAs for use in the normalization of circulating microRNA levels in bovine serum. We evaluated the expression stability of ten candidate reference genes in bovine serum by using reverse transcription quantitative real-time polymerase chain reaction. Data were analyzed using geNorm, NormFinder, and Best-Keeper statistical algorithms. The results consistently showed that a combination of miR-93 and miR-127 provided the most stably expressed reference. The suitability of these microRNAs was validated, and even when compared among different genders or breeds, the combination of miR-93 and miR-127 was ranked as the most stable microRNA reference. Therefore, we conclude that this combination is the optimal endogenous reference for reverse transcription quantitative real-time polymerase chain reaction-based detection of microRNAs in bovine serum. The data presented in this study are crucial to successful biomarker discovery and validation for the diagnosis of physiopathological conditions in cattle.	[Bae, In-Seon; Yi, Jongmin; Kim, Sang Hoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Chung, Ki Yong; Kim, Tae Il; Cho, Young-Moo] Natl Inst Anim Sci, RDA, Pyeongchang, Gangwon, South Korea; [Choi, Hwa-Sik] Shinhan Univ, Dept Biomed Lab Sci, Uijongbu, Gyeonggi, South Korea; [Choi, Inho] Yeungnam Univ, Sch Biotechnol, Bovine Genome Resources Bank, Gyongsan, Gyeongbuk, South Korea	Kyung Hee University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Yeungnam University	Kim, SH (corresponding author), Kyung Hee Univ, Dept Biol, Seoul, South Korea.	shkim@khu.ac.kr	Kim, Sang Hoon/AAJ-7334-2020	Kim, Sanghoon/0000-0002-4078-6269	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea [PJ008191]	Next-Generation BioGreen 21 program, Rural Development Administration, Republic of Korea	This research was supported by a grant from the Next-Generation BioGreen 21 program (No. PJ008191), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstaett OL, 2010, VET IMMUNOL IMMUNOP, V137, P201, DOI 10.1016/j.vetimm.2010.05.006; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Brym P, 2013, VET IMMUNOL IMMUNOP, V153, P302, DOI 10.1016/j.vetimm.2013.03.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mi QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031278; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wong CH, 2006, PLAST RECONSTR SURG, V117, P1206, DOI 10.1097/01.prs.0000200070.66604.1e	35	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122554	10.1371/journal.pone.0122554	http://dx.doi.org/10.1371/journal.pone.0122554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826387	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084800080
J	Kelly, CL; Suenram-Lea, SI; Crawford, TJ				Kelly, Claire L.; Suenram-Lea, Sandra I.; Crawford, Trevor J.			The Role of Motivation, Glucose and Self-Control in the Antisaccade Task	PLOS ONE			English	Article							EXTRACELLULAR GLUCOSE; STRENGTH MODEL; COGNITIVE-PROCESSES; EGO-DEPLETION; BRAIN; BLOOD; FLUCTUATIONS; INHIBITION; MODULATION; WILLPOWER	Research shows that self-control is resource limited and there is a gradual weakening in consecutive self-control task performance akin to muscle fatigue. A body of evidence suggests that the resource is glucose and consuming glucose reduces this effect. This study examined the effect of glucose on performance in the antisaccade task - which requires self-control through generating a voluntary eye movement away from a target - following self-control exertion in the Stroop task. The effects of motivation and individual differences in self-control were also explored. In a double-blind design, 67 young healthy adults received a 25g glucose or inert placebo drink. Glucose did not enhance antisaccade performance following self-control exertion in the Stroop task. Motivation however, predicted performance on the antisaccade task; more specifically high motivation ameliorated performance decrements observed after initial self-control exertion. In addition, individuals with high levels of self-control performed better on certain aspects of the antisaccade task after administration of a glucose drink. The results of this study suggest that the antisaccade task might be a powerful paradigm, which could be used as a more objective measure of self-control. Moreover, the results indicate that level of motivation and individual differences in self-control should be taken into account when investigating deficiencies in self-control following prior exertion.	[Kelly, Claire L.; Suenram-Lea, Sandra I.; Crawford, Trevor J.] Univ Lancaster, Dept Psychol, Fylde Coll, Lancaster LA1 4YF, England	Lancaster University	Kelly, CL (corresponding author), Univ Lancaster, Dept Psychol, Fylde Coll, Lancaster LA1 4YF, England.	c.kelly1@lancaster.ac.uk	Sünram-Lea, Sandra I/AAW-2324-2021; Crawford, Trevor J/N-4237-2015	Sünram-Lea, Sandra I/0000-0001-9889-9867; Crawford, Trevor J/0000-0001-5928-7307	Economic and Social Research Council [ESRC NWDTC 13.14]; Economic and Social Research Council [1402992] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council [grant number ESRC NWDTC 13.14]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister RF, NEUROPSYCHO IN PRESS; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Baumeister RF, 2012, PSYCHOLOGIST, V25, P112; Beedie CJ, 2012, PERS SOC PSYCHOL REV, V16, P143, DOI 10.1177/1088868311419817; Blascovich J, 1996, ADV EXP SOC PSYCHOL, V28, P1, DOI 10.1016/S0065-2601(08)60235-X; Brewer GA, 2011, PSYCHON B REV, V18, P923, DOI 10.3758/s13423-011-0130-9; Chambers ES, 2009, J PHYSIOL-LONDON, V587, P1779, DOI 10.1113/jphysiol.2008.164285; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; Dalsgaard MK, 2001, J CEREBRAL BLOOD FLO, V27, P1137; de Vries MG, 2003, DIABETES, V52, P2767, DOI 10.2337/diabetes.52.11.2767; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Dvorak RD, 2009, PERS SOC PSYCHOL B, V35, P572, DOI 10.1177/0146167208330855; Dye L, 2010, BRIT J NUTR, V103, P134, DOI 10.1017/S0007114509991504; Ettinger U, 2005, NEUROIMAGE, V24, P487, DOI 10.1016/j.neuroimage.2004.08.019; EVANS WJ, 1986, J APPL PHYSIOL, V61, P1864, DOI 10.1152/jappl.1986.61.5.1864; Fairclough SH, 2004, BIOL PSYCHOL, V66, P177, DOI 10.1016/j.biopsycho.2003.10.001; FELLOWS LK, 1993, BRAIN RES, V604, P225, DOI 10.1016/0006-8993(93)90373-U; Friese M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060385; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; GOLD PE, 1986, BEHAV NEURAL BIOL, V45, P342, DOI 10.1016/S0163-1047(86)80022-X; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Healthy Meals Resources System, 2013, SENS AV FORM; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Kuhn S, 2009, HUM BRAIN MAPP, V30, P2834, DOI 10.1002/hbm.20711; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; Lange F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00572; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Li W, 2004, THESIS LOUISIANA STA; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; LUNDANDERSEN H, 1979, PHYSIOL REV, V59, P305, DOI 10.1152/physrev.1979.59.2.305; MADSEN PL, 1995, J CEREBR BLOOD F MET, V15, P485, DOI 10.1038/jcbfm.1995.60; Masicampo EJ, 2014, SOC PERSONAL PSYCHOL, V8, P638, DOI 10.1111/spc3.12139; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McNay EC, 1999, J NEUROCHEM, V72, P785, DOI 10.1046/j.1471-4159.1999.720785.x; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Miller EK, 2009, ENCY NEUROSCIENCE, V4, P199; Molden DC, 2012, PSYCHOL SCI, V23, P1137, DOI 10.1177/0956797612439069; Moller AC, 2006, PERS SOC PSYCHOL B, V32, P1024, DOI 10.1177/0146167206288008; Muraven M, 2005, PSYCHOL ADDICT BEHAV, V19, P140, DOI 10.1037/0893-164X.19.2.140; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rebel Annette, 2012, J Diabetes Sci Technol, V6, P396; Reivich M, 1983, Hum Neurobiol, V2, P25; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Sanders MA, 2012, PSYCHOL SCI, V23, P1470, DOI 10.1177/0956797612450034; Scholey AB, 2001, PHYSIOL BEHAV, V73, P585, DOI 10.1016/S0031-9384(01)00476-0; Scholey AB, 2009, NEUROSCIENCE BEHAV R, V33, P394; SILVER IA, 1994, J NEUROSCI, V14, P5068; Smith MA, 2011, NEUROSCI BIOBEHAV R, V35, P770, DOI 10.1016/j.neubiorev.2010.09.008; Sunram-Lea SI, 2011, J PSYCHOPHARMACOL, V25, P1076, DOI 10.1177/0269881110367725; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Wallace HM, 2002, SELF IDENTITY, V1, P35, DOI 10.1080/152988602317232786	64	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122218	10.1371/journal.pone.0122218	http://dx.doi.org/10.1371/journal.pone.0122218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826334	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000352084800061
J	Metson, GS; Bennett, EM				Metson, Genevieve S.; Bennett, Elena M.			Phosphorus Cycling in Montreal's Food and Urban Agriculture Systems	PLOS ONE			English	Article							EUTROPHICATION; LITTER	Cities are a key system in anthropogenic phosphorus (P) cycling because they concentrate both P demand and waste production. Urban agriculture (UA) has been proposed as a means to improve P management by recycling cities' P-rich waste back into local food production. However, we have a limited understanding of the role UA currently plays in the P cycle of cities or its potential to recycle local P waste. Using existing data combined with surveys of local UA practitioners, we quantified the role of UA in the P cycle of Montreal, Canada to explore the potential for UA to recycle local P waste. We also used existing data to complete a substance flow analysis of P flows in the overall food system of Montreal. In 2012, Montreal imported 3.5 Gg of P in food, of which 2.63 Gg ultimately accumulated in landfills, 0.36 Gg were discharged to local waters, and only 0.09 Gg were recycled through composting. We found that UA is only a small sub-system in the overall P cycle of the city, contributing just 0.44% of the P consumed as food in the city. However, within the UA system, the rate of recycling is high: 73% of inputs applied to soil were from recycled sources. While a Quebec mandate to recycle 100% of all organic waste by 2020 might increase the role of UA in P recycling, the area of land in UA is too small to accommodate all P waste produced on the island. UA may, however, be a valuable pathway to improve urban P sustainability by acting as an activity that changes residents' relationship to, and understanding of, the food system and increases their acceptance of composting.	[Metson, Genevieve S.; Bennett, Elena M.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Bennett, Elena M.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada	McGill University; McGill University	Metson, GS (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.	genevieve.metson@mail.mcgill.ca	Metson, Genevieve/J-7791-2019; Bennett, Elena/A-9553-2008	Metson, Genevieve/0000-0002-8081-2126; Bennett, Elena/0000-0003-3944-2925	National Science and Engineering Research Council; National Science and Engineering Research Council [RGPIN 327077]	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Research Council Alexander Graham Bell scholarship (http://www.nserc-crsng.gc.ca/students-etudiants/pg-cs/bellandpostgrad-belletsuperieures_eng.asp) to GSM and National Science and Engineering Research Council Discovery grant (RGPIN 327077, http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) to EMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Kubi, 2011, POTENTIAL URBAN AGR; Adhikari BK, 2012, ENVIRON TECHNOL, V33, P2383, DOI 10.1080/09593330.2012.670267; Anderson T., 2006, FOCUS FORAGE, V1, P1; [Anonymous], SASK AGR FOOD NUTR V; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Butterfield B., 2009, IMPACT HOME COMMUNIT; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; catalog Wf, 2010, PHOSPH CONT FOODS ST; City of Montreal, 2013, SONDAGE AUPRES POPUL; Cogger C, 2002, FERTILIZING YARD TRI; Cogger C, 2014, WSU PUYLLUP COMPOST; Communaute metropolitaine de Montreal (CMM), 2002, CAR BIL MAT RES; Communaute Urbaine de Montreal, 1996, OCC DU SOL; Conference regionale des elus de Montreal, 2014, PLAN DEV SYST AL EQ; Cooper J, 2011, RESOUR CONSERV RECY, V57, P78, DOI 10.1016/j.resconrec.2011.09.009; Cordell D, 2011, CHEMOSPHERE, V84, P747, DOI 10.1016/j.chemosphere.2011.02.032; Cordell D, 2010, STORY PHOSPHORUS SUS, P1; Cordell D, 2011, SUSTAINABILITY-BASEL, V3, P2027, DOI 10.3390/su3102027; COTE B, 1994, CAN J FOREST RES, V24, P192, DOI 10.1139/x94-027; de Montreal Ville, 2013, PORTR 2012 MAT RES A; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Drangert JO, 1998, WATER SA, V24, P157; Drechsel P., 2007, IWMI RES REPORT SERI; Duchemin E., 2013, AGR URBAINE AMENAGER, P394; Duchemin E., 2008, FIELD ACTIONS SCI RE, V1, P43, DOI [DOI 10.5194/FACTS-2-1-2009, DOI 10.5194/facts-2-1-2009]; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Florida R., 2003, CITY COMMUNITY, P3, DOI [DOI 10.1111/1540-6040.00034, 10.1111/1540-6040.00034.URL]; Food and Agriculture Oganizating of the United Nations (FAO), 2004, WAYS IMPR AGR EFF PH; Godden B, 2007, VALORISATION BOIS RA; Gooch M, 2010, FOOD WASTE IN CANADA; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Haberman D, 2014, ISPRS INT J GEO-INF, V3, P1101, DOI 10.3390/ijgi3031101; Hodgson K., 2011, URBAN AGR GROWING HL; International Fertilizer Industry Association International Ferlilizer Development Center Food and Agriculture Organization, 2002, FERT US CROP; Jasinski SM, 2011, PHOSPHATE ROCK; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Lerner AM, 2011, GEOGR J, V177, P311, DOI 10.1111/j.1475-4959.2010.00394.x; Lovell S. T., 2010, Sustainability, V2, P2499, DOI 10.3390/su2082499; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; McClintock N, 2013, LANDSCAPE URBAN PLAN, V111, P46, DOI 10.1016/j.landurbplan.2012.12.009; Metson G, 2012, J IND ECOL, V16, P914, DOI 10.1111/j.1530-9290.2012.00554.x; Metson GS, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044043; Mitchell RG, 2014, ENVIRON POLLUT, V187, P162, DOI 10.1016/j.envpol.2014.01.007; Moniovitch A, 2013, MARIAGE CIVIL LIBAN; Mougeot LJ, 2000, URBAN AGR DEFINITION, P1; Office de consultation publique de Montreal, 2012, ET AGR URB MONTR RAP, P157; Papargyropoulou E, 2014, J CLEANER PRODUCTION; Perron V, 2007, VECTEUR ENV, V40, P48; Pilote I, 2011, RAPPORT ANN 2010 ANA; Redden RR, 2012, FEEDING STRAW; Rosen CJ, 2005, NUTR MANAGEMENT FRUI; Satistics Canada, 2013, POP EST; Satistics Canada, 2009, HUM ACT ENV ANN STAT; Savoie P, 2002, GUIDE PRODUCTION FOI; Singh A, 2013, WASTE MANAGE, V33, P1113, DOI 10.1016/j.wasman.2013.01.022; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Smit J., 1992, Environment and Urbanization, V4, P141, DOI 10.1177/095624789200400214; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Solinov, 2012, ET POT MAT ORG PROV; Thibert J, 2012, J PLAN EDUC RES, V32, P349, DOI 10.1177/0739456X11431692; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tiquia SM, 2002, PROCESS BIOCHEM, V37, P869, DOI 10.1016/S0032-9592(01)00274-6; U.S. Department of Agriculture (USDA), 2009, SDA NAT NUTR DAT STA; University of Maryland Extension, 2013, SOIL AM FERT FERT GU; US Composting Council, 2001, FIELD GUID COMP US; US Environmental Protection Agency (EPA), STAND VOL TO WEIGHT; Vaccari DA, 2011, CHEMOSPHERE, V84, P735, DOI 10.1016/j.chemosphere.2011.06.050; Van Kauwenbergh S. J., 2010, WORLD PHOSPHATE ROCK, P1; von Hoffen LP, 2014, ECOTOX ENVIRON SAFE, V101, P233, DOI 10.1016/j.ecoenv.2013.11.023; WHITE LM, 1981, AGRON J, V73, P117, DOI 10.2134/agronj1981.00021962007300010026x; Wyant KA., 2013, PHOSPHORUS FOOD OUR, DOI 10.1093/acprof:osobl/9780199916832.001.0001; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed	73	39	40	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120726	10.1371/journal.pone.0120726	http://dx.doi.org/10.1371/journal.pone.0120726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826256	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800024
J	Tzivian, L; Friger, M; Kushnir, T				Tzivian, Lilian; Friger, Michael; Kushnir, Talma			Associations between Stress and Quality of Life: Differences between Owners Keeping a Living Dog or Losing a Dog by Euthanasia	PLOS ONE			English	Article							COMPANION ANIMAL DEATH; PET OWNERSHIP; HUMAN HEALTH; ATTACHMENT; BEREAVEMENT; CLIENTS; GRIEF	Objectives The loss of a pet may be stressful to the owner. The main objectives of this study were to compare the levels of stress and to explore the correlates of QOL of healthy adults who currently own or who have just lost their dog. Methods The study sample contained 110 current, and 103 bereaved dog owners, all females, who lost their dogs due to euthanasia. QOL was assessed with the WHOQOL-BREF questionnaire and divided into four major domains-Physical, Psychological, Relationship, and Environmental. Demographic variables, stress, health behaviors, and social support from family, friends, and significant other were included in multivariate analysis. Results Stress levels were significantly higher in bereaved owners. QOL in three of the four domains (Physical, Psychological, and Relationship) of current owners were significantly better than among bereaved owners. Stress was significantly associated with these three domains of QOL. Quality of life was found to be positively associated with social support. Age was related directly only to current owners' QOL. Conclusions The results suggest that a loss of a dog is associated with stress for the bereaved owner and reduced physical, psychological, and relationship QOL. Lack of social support in the case of death of a companion animal has a strong effect on owners' grief reactions.	[Tzivian, Lilian; Friger, Michael; Kushnir, Talma] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University	Tzivian, L (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel.	lili66@smile.net.il	Tzivian, Lilian/AAM-5799-2020	Tzivian, Lilian/0000-0001-6253-9130; Kushnir, Talma/0000-0002-7494-6777				Adams CL, 1999, CAN VET J, V40, P33; Adams CL, 2000, J AM VET MED ASSOC, V217, P1303, DOI 10.2460/javma.2000.217.1303; Adrian JAL, 2009, B MENNINGER CLIN, V73, P176, DOI 10.1521/bumc.2009.73.3.176; ARCHER J, 1994, BRIT J PSYCHOL, V85, P259, DOI 10.1111/j.2044-8295.1994.tb02522.x; BARKER SB, 1989, COMPANION ANIM PRACT, V19, P3; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dunn KL, 2005, SOC WORK HEALTH CARE, V41, P59, DOI 10.1300/J010v41n02_04; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edenburg N, 1992, TIJDSCHR DIERGENEESK, V117, P56; Feldmann BM, 2000, J AM VET MED ASSOC, V217, P1473, DOI 10.2460/javma.2000.217.1473; Field NP, 2009, DEATH STUD, V33, P334, DOI 10.1080/07481180802705783; Fogle B., 1992, Anthrozoos, V3, P143, DOI 10.2752/089279390787057568; Frid MH, 2007, J VET BEHAV, V2, P35, DOI 10.1016/j.jveb.2007.02.001; Garrity TF., 1989, ANTHROZOOS, V3, P35, DOI DOI 10.2752/089279390787057829; Graf S, 1996, PSYCHOL REP, V78, P467; HANCOCK G, 1989, VET CLIN N AM-SMALL, V19, P187, DOI 10.1016/S0195-5616(89)50013-5; HART LA, 1990, J AM VET MED ASSOC, V197, P1292; Hawley DR, 1996, FAM PROCESS, V35, P283, DOI 10.1111/j.1545-5300.1996.00283.x; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Headey B, 2003, MED J AUSTRALIA, V179, P460, DOI 10.5694/j.1326-5377.2003.tb05646.x; Kaufman KR, 2009, DEATH STUD, V30, P61; KEDDIE KMG, 1977, BRIT J PSYCHIAT, V131, P21, DOI 10.1192/bjp.131.1.21; Kellehear A, 1996, OMEGA-J DEATH DYING, V34, P191, DOI 10.2190/3Q32-2FH7-JMG6-M1DN; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Knight S, 2008, J AGING HEALTH, V20, P437, DOI 10.1177/0898264308315875; Kolodny S W, 1991, Probl Vet Med, V3, P1; Kurdek LA, 2008, J SOC PERS RELAT, V25, P247, DOI 10.1177/0265407507087958; Kurdek LA, 2009, ANTHROZOOS, V22, P359, DOI 10.2752/089279309X12538695316149; Kushnir T, 2009, ASS PRIMARY PHYS BUR; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Lewis A., 2009, ELECT J APPL PSYCHOL, V5, P96, DOI [DOI 10.7790/ejap.v5i1.138, 10.7790/ejap.v5i1.138, DOI 10.7790/EJAP.V5I1.138]; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Nieburg HA, 1982, PET LOSS THOUGHTFUL; NUCKOLLS KB, 1972, AM J EPIDEMIOL, V95, P431, DOI 10.1093/oxfordjournals.aje.a121410; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Planchon LA, 1996, ANTHROZOOS, V9, P107, DOI 10.2752/089279396787001491; RAJARAM SS, 1993, ANTHROZOOS, V6, P8, DOI 10.2752/089279393787002349; ROSENBERG MA, 1981, CANINE PRACT, V8, P6; Schmaltz HN, 2007, J GEN INTERN MED, V22, P572, DOI 10.1007/s11606-007-0106-7; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; SHIRLEY VA, 1983, GERONTOLOGIST, V23, P276; STEWART CS, 1985, DEATH STUD, V9, P383, DOI 10.1080/07481188508252532; Stroebe W, 1987, BEREAVEMENT HLTH; Tzivian L, 2014, DEATH STUD, V38, P109, DOI 10.1080/07481187.2012.738764; Walsh F, 2009, FAM PROCESS, V48, P481, DOI 10.1111/j.1545-5300.2009.01297.x; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wilson C. C, 1998, COMPANION ANIMALS HU; Winius EED, 1996, TIJDSCHR DIERGENEESK, V121, P250; Wrobel TA, 2003, OMEGA-J DEATH DYING, V47, P385, DOI 10.2190/QYV5-LLJ1-T043-U0F9; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	50	10	10	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121081	10.1371/journal.pone.0121081	http://dx.doi.org/10.1371/journal.pone.0121081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25826295	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800034
J	Chen, ACH; Martin, ML; Lourie, R; Rogers, GB; Burr, LD; Hasnain, SZ; Bowler, SD; McGuckin, MA; Serisier, DJ				Chen, Alice C. -H.; Martin, Megan L.; Lourie, Rohan; Rogers, Geraint B.; Burr, Lucy D.; Hasnain, Sumaira Z.; Bowler, Simon D.; McGuckin, Michael A.; Serisier, David J.			Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation	PLOS ONE			English	Article							LONG-TERM; INTERLEUKIN-17; INFLAMMATION; NEUTROPHILS; DISEASE; EXACERBATIONS; MACROPHAGES; EXPRESSION; IL-17A; CELLS	Background Non-cystic fibrosis (CF) bronchiectasis is characterised by chronic airway infection and neutrophilic inflammation, which we hypothesised would be associated with Th17 pathway activation. Methods Th17 pathway cytokines were quantified in bronchoalveolar lavage fluid (BALF), and gene expression of IL-17A, IL-1 beta, IL-8 and IL-23 determined from endobronchial biopsies (EBx) in 41 stable bronchiectasis subjects and 20 healthy controls. Relationships between IL-17A levels and infection status, important clinical measures and subsequent Pseudomonas aeruginosa infection were determined. Results BALF levels of all Th17 cytokines (median (IQR) pg/mL) were significantly higher in bronchiectasis than control subjects, including IL-17A (1.73 (1.19, 3.23) vs. 0.27 (0.24, 0.35), 95% CI 1.05 to 2.21, p<0.0001) and IL-23 (9.48 (4.79, 15.75) vs. 0.70 (0.43, 1.79), 95% CI 4.68 to 11.21, p<0.0001). However, BALF IL-17A levels were not associated with clinical measures or airway microbiology, nor predictive of subsequent P. aeruginosa infection. Furthermore, gene expression of IL-17A in bronchiectasis EBx did not differ from control. In contrast, gene expression (relative to medians of controls) in bronchiectasis EBx was significantly higher than control for IL1 beta (4.12 (1.24, 8.05) vs 1 (0.13, 2.95), 95% CI 0.05 to 4.07, p = 0.04) and IL-8 (3.75 (1.64, 11.27) vs 1 (0.54, 3.89), 95% CI 0.32 to 4.87, p = 0.02) and BALF IL-8 and IL-1 alpha levels showed significant relationships with clinical measures and airway microbiology. P. aeruginosa infection was associated with increased levels of IL-8 while Haemophilus influenzae was associated with increased IL-1 alpha. Conclusions and Clinical Relevance Established adult non-CF bronchiectasis is characterised by luminal Th17 pathway activation, however this pathway may be relatively less important than activation of non-antigenspecific innate neutrophilic immunity.	[Chen, Alice C. -H.; Lourie, Rohan; Burr, Lucy D.; Hasnain, Sumaira Z.; McGuckin, Michael A.; Serisier, David J.] Univ Qld, Mater Res, Immun Infect & Inflammat Program, Translat Res Inst, Woolloongabba, Qld, Australia; [Martin, Megan L.; Burr, Lucy D.; Bowler, Simon D.; Serisier, David J.] Mater Adult Hosp, Dept Resp Med, South Brisbane, Qld, Australia; [Lourie, Rohan] Mater Hlth Serv, Dept Anat Pathol, South Brisbane, Qld, Australia; [Rogers, Geraint B.] South Australia Hlth & Med Res Inst, Infect & Immun Theme, Adelaide, SA, Australia; [Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [McGuckin, Michael A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Mater Research; University of Queensland; Mater Health Services; Flinders University South Australia; University of Queensland	Serisier, DJ (corresponding author), Univ Qld, Mater Res, Immun Infect & Inflammat Program, Translat Res Inst, Woolloongabba, Qld, Australia.	david.serisier@mater.org.au	Hasnain, Sumaira Z/N-3412-2014; McGuckin, Michael/G-2310-2010; Bowler, Simon/AAE-1630-2019; Rogers, Geraint/AAD-1011-2020; Burr, Lucy/F-8296-2015; Rogers, Geraint/N-1957-2013	Hasnain, Sumaira Z/0000-0001-8577-8628; McGuckin, Michael/0000-0002-8375-2675; Burr, Lucy/0000-0003-4010-3787; Lourie, Rohan/0000-0002-0093-911X; Rogers, Geraint/0000-0003-4054-1947	Mater Adult Respiratory Research Trust Fund; NHMRC (National Health and Medical Research Council) Senior Research Fellowship	Mater Adult Respiratory Research Trust Fund; NHMRC (National Health and Medical Research Council) Senior Research Fellowship	This study was internally funded by the Mater Adult Respiratory Research Trust Fund. MAM is supported by a NHMRC (National Health and Medical Research Council) Senior Research Fellowship. No pharmaceutical company or other agency (including medical writers) had any role in this study. DJS had full access to all study data, vouches for the integrity of the data and its presentation and had final responsibility for the decision to submit for publication.	Angrill J, 2001, AM J RESP CRIT CARE, V164, P1628, DOI 10.1164/ajrccm.164.9.2105083; Brodlie M, 2012, AM J RESP CRIT CARE, V185, P108, DOI 10.1164/ajrccm.185.1.108a; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; COLE PJ, 1986, EUR J RESPIR DIS, V69, P6; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Decraene A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-177; Fouka E, 2014, LUNG, V192, P849, DOI 10.1007/s00408-014-9619-0; Gaga M, 1998, THORAX, V53, P685, DOI 10.1136/thx.53.8.685; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; O'Brien C, 2000, THORAX, V55, P635, DOI 10.1136/thorax.55.8.635; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Serisier DJ, 2011, RESP MED, V105, P946, DOI 10.1016/j.rmed.2011.01.009; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tan HL, 2012, AM J RESP CRIT CARE, V185, P109, DOI 10.1164/ajrccm.185.1.109; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; Tsang KW, 2009, RESPIROLOGY, V14, P637, DOI 10.1111/j.1440-1843.2009.01569.x; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zheng L, 2002, EUR RESPIR J, V20, P170, DOI 10.1183/09031936.02.00282402; Zheng L, 2001, RESP MED, V95, P792, DOI 10.1053/rmed.2001.1155	29	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0119325	10.1371/journal.pone.0119325	http://dx.doi.org/10.1371/journal.pone.0119325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822228	Green Published, gold			2022-12-27	WOS:000352134700034
J	Dow, AL; Lin, TV; Chartoff, EH; Potter, D; McPhie, DL; Van't Veer, AV; Knoll, AT; Lee, KN; Neve, RL; Patel, TB; Ongur, D; Cohen, BM; Carlezon, WA				Dow, Antonia L.; Lin, Tiffany V.; Chartoff, Elena H.; Potter, David; McPhie, Donna L.; Van't Veer, Ashlee V.; Knoll, Allison T.; Lee, Kristen N.; Neve, Rachael L.; Patel, Tarun B.; Ongur, Dost; Cohen, Bruce M.; Carlezon, William A., Jr.			Sprouty2 in the Dorsal Hippocampus Regulates Neurogenesis and Stress Responsiveness in Rats	PLOS ONE			English	Article							OPIOID RECEPTOR ANTAGONISTS; MEDIATED GENE-TRANSFER; CELL-PROLIFERATION; ANIMAL-MODEL; ADULT; FEAR; PROTEINS; NEURONS; FLUOXETINE; DISORDER	Both the development and relief of stress-related psychiatric conditions such as major depression (MD) and post-traumatic stress disorder (PTSD) have been linked to neuroplastic changes in the brain. One such change involves the birth of new neurons (neurogenesis), which occurs throughout adulthood within discrete areas of the mammalian brain, including the dorsal hippocampus (HIP). Stress can trigger MD and PTSD in humans, and there is considerable evidence that it can decrease HIP neurogenesis in laboratory animals. In contrast, antidepressant treatments increase HIP neurogenesis, and their efficacy is eliminated by ablation of this process. These findings have led to the working hypothesis that HIP neurogenesis serves as a biomarker of neuroplasticity and stress resistance. Here we report that local alterations in the expression of Sprouty2 (SPRY2), an intracellular inhibitor of growth factor function, produces profound effects on both HIP neurogenesis and behaviors that reflect sensitivity to stressors. Viral vector-mediated disruption of endogenous Sprouty2 function (via a dominant negative construct) within the dorsal HIP of adult rats stimulates neurogenesis and produces signs of stress resilience including enhanced extinction of conditioned fear. Conversely, viral vector-mediated elevation of SPRY2 expression intensifies the behavioral consequences of stress. Studies of these manipulations in HIP primary cultures indicate that SPRY2 negatively regulates fibroblast growth factor-2 (FGF2), which has been previously shown to produce antidepressant-and anxiolytic-like effects via actions in the HIP. Our findings strengthen the relationship between HIP plasticity and stress responsiveness, and identify a specific intracellular pathway that could be targeted to study and treat stress-related disorders.	[Dow, Antonia L.; Lin, Tiffany V.; Chartoff, Elena H.; Potter, David; Van't Veer, Ashlee V.; Knoll, Allison T.; Lee, Kristen N.; Ongur, Dost; Cohen, Bruce M.; Carlezon, William A., Jr.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; [Neve, Rachael L.] MIT, Viral Gene Transfer Core Facil, Cambridge, MA 02139 USA; [Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol, Maywood, IL USA	Harvard University; McLean Hospital; Massachusetts Institute of Technology (MIT); Loyola University Chicago	Carlezon, WA (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA.	bcarlezon@mclean.harvard.edu	Van't Veer, Ashlee/GOV-5648-2022; Cohen, Bruce M./AAZ-4986-2020	Van't Veer, Ashlee/0000-0003-4920-447X; /0000-0002-4162-3947; Lee, Kristen/0000-0001-7326-9973	National Alliance for Research on Schizophrenia and Depression (NARSAD); Frazier Research Institute at McLean Hospital	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Frazier Research Institute at McLean Hospital	This research was funded by an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) (to WC) and the Frazier Research Institute at McLean Hospital (to BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2003, METH MOLEC MED, V79, P331; Carlezon WA, 2000, CRIT REV NEUROBIOL, V14, P47; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Eren-Kocak E, 2011, BIOL PSYCHIAT, V69, P534, DOI 10.1016/j.biopsych.2010.11.020; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Jedynak P, 2014, J PSYCHIATR RES, V56, P106, DOI 10.1016/j.jpsychires.2014.05.009; Keller MC, 2007, AM J PSYCHIAT, V164, P1521, DOI 10.1176/appi.ajp.2007.06091564; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; Lyons DM, 2010, P NATL ACAD SCI USA, V107, P14823, DOI 10.1073/pnas.0914568107; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Ongur D, 2007, BIOL PSYCHIAT, V62, P505, DOI 10.1016/j.biopsych.2006.11.014; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prudic J, 1996, AM J PSYCHIAT, V153, P985; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simonato M, 2000, TRENDS NEUROSCI, V23, P183, DOI 10.1016/S0166-2236(99)01539-8; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; van Hooijdonk LWA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437	53	2	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120693	10.1371/journal.pone.0120693	http://dx.doi.org/10.1371/journal.pone.0120693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822989	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700071
J	Wei, MY; Xue, L; Tan, L; Sai, WB; Liu, XC; Jiang, QJ; Shen, JH; Peng, YB; Zhao, P; Yu, MF; Chen, WW; Ma, LQ; Zhai, K; Zou, CB; Guo, DL; Qin, GJ; Zheng, YM; Wang, YX; Ji, GJ; Liu, QH				Wei, Ming-Yu; Xue, Lu; Tan, Li; Sai, Wen-Bo; Liu, Xiao-Cao; Jiang, Qiu-Ju; Shen, Jinhua; Peng, Yong-Bo; Zhao, Ping; Yu, Meng-Fei; Chen, Weiwei; Ma, Li-Qun; Zhai, Kui; Zou, Chunbin; Guo, Donglin; Qin, Gangjian; Zheng, Yun-Min; Wang, Yong-Xiao; Ji, Guangju; Liu, Qing-Hua			Involvement of Large-Conductance Ca2+-Activated K+ Channels in Chloroquine-Induced Force Alterations in Pre-Contracted Airway Smooth Muscle	PLOS ONE			English	Article							TASTANT-INDUCED BRONCHODILATION; BK CHANNELS; POTASSIUM CHANNELS; ACTIVATION; RECEPTORS; RELAXATION; SPARKS; CELLS	The participation of large-conductance Ca2+ activated K+ channels (BKs) in chloroquine (chloro)-induced relaxation of precontracted airway smooth muscle (ASM) is currently undefined. In this study we found that iberiotoxin (IbTx, a selective inhibitor of BKs) and chloro both completely blocked spontaneous transient outward currents (STOCs) in single mouse tracheal smooth muscle cells, which suggests that chloro might block BKs. We further found that chloro inhibited Ca2+ sparks and caffeine-induced global Ca2+ increases. Moreover, chloro can directly block single BK currents completely from the intracellular side and partially from the extracellular side. All these data indicate that the chloro-induced inhibition of STOCs is due to the blockade of chloro on both BKs and ryanodine receptors (RyRs). We also found that low concentrations of chloro resulted in additional contractions in tracheal rings that were precontracted by acetylcholine (ACH). Increases in chloro concentration reversed the contractile actions to relaxations. In the presence of IbTx or paxilline (pax), BK blockers, chloro-induced contractions were inhibited, although the high concentrations of chloro-induced relaxations were not affected. Taken together, our results indicate that chloro blocks BKs and RyRs, resulting in abolishment of STOCs and occurrence of contraction, the latter will counteract the relaxations induced by high concentrations of chloro.	[Wei, Ming-Yu; Xue, Lu; Tan, Li; Sai, Wen-Bo; Liu, Xiao-Cao; Jiang, Qiu-Ju; Shen, Jinhua; Peng, Yong-Bo; Zhao, Ping; Yu, Meng-Fei; Chen, Weiwei; Ma, Li-Qun; Liu, Qing-Hua] South Cent Univ Nationalities, Coll Life Sci, Inst Med Biol, Wuhan 430074, Peoples R China; [Wei, Ming-Yu; Xue, Lu; Tan, Li; Sai, Wen-Bo; Liu, Xiao-Cao; Jiang, Qiu-Ju; Shen, Jinhua; Peng, Yong-Bo; Zhao, Ping; Yu, Meng-Fei; Chen, Weiwei; Ma, Li-Qun; Liu, Qing-Hua] South Cent Univ Nationalities, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan 430074, Peoples R China; [Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zou, Chunbin] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Guo, Donglin] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Guo, Donglin] Main Line Hlth Heart Ctr, Wynnewood, PA 19096 USA; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Dept Med Cardiol, Chicago, IL 60611 USA; [Zheng, Yun-Min; Wang, Yong-Xiao] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	South Central Minzu University; South Central Minzu University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lankenau Medical Center; Lankenau Institute for Medical Research; Northwestern University; Feinberg School of Medicine; Albany Medical College	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	gj28@ibp.ac.cn; qinghualiu@mail.scuec.edu.cn	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726; Ji, Guangju/0000-0001-8626-3490; Zhai, Kui/0000-0003-4725-190X	Ministry of Science and Technology of China [2011CB809100]; National Natural Science Foundation of China [31140087, 30971514, 31101047]; Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China; Natural Science Foundation of Hubei Province, China [2014CFB232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122865, R01HL108232] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China; Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Contract grant sponsor: Ministry of Science and Technology of China. http://www.most.gov.cn/eng/. Contract grant number: 2011CB809100 to QHL and GJ; Contract grant sponsor: National Natural Science Foundation of China. http://www.nsfc.gov.cn/. Contract grant numbers: 31140087 and 30971514 to QHL; 31101047 to LX. Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China (www.mohrss.gov.cn) (to JS) and Natural Science Foundation of Hubei Province, China (http://www.hbstd.gov.cn/) (2014CFB232 to LX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; An SS, 2012, NAT MED, V18, P650, DOI 10.1038/nm.2734; ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Hou PP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01666; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Lifshitz LM, 2011, J GEN PHYSIOL, V138, P195, DOI 10.1085/jgp.201110626; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Malysz J, 2013, PFLUG ARCH EUR J PHY, V465, P965, DOI 10.1007/s00424-012-1214-8; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Sai WB, 2014, CLIN EXP PHARMACOL P, V41, P301, DOI 10.1111/1440-1681.12217; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Semenov I, 2014, J PHYSL, V589, P1803; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Tuo QR, 2013, BIOCHEM BIOPH RES CO, V434, P498, DOI 10.1016/j.bbrc.2013.03.102; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang CH, 2012, NAT MED, V18, P648, DOI 10.1038/nm.2733; Zhang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101578; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	20	10	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121566	10.1371/journal.pone.0121566	http://dx.doi.org/10.1371/journal.pone.0121566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822280	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000352134700114
J	Wylie, SJ; Zhang, C; Long, V; Roossinck, MJ; Koh, SH; Jones, MGK; Iqbal, S; Li, H				Wylie, Stephen J.; Zhang, Chao; Long, Vicki; Roossinck, Marilyn J.; Koh, Shu Hui; Jones, Michael G. K.; Iqbal, Sadia; Li, Hua			Differential Responses to Virus Challenge of Laboratory and Wild Accessions of Australian Species of Nicotiana, and Comparative Analysis of RDR1 Gene Sequences	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; MOSAIC-VIRUS; TERRESTRIAL ORCHIDS; MOTTLE VIRUS; PLANT; BENTHAMIANA; SOLANACEAE; TOBAMOVIRUS; PROTEINS; RESISTANCE	Nicotiana benthamiana is a model plant utilised internationally in plant virology because of its apparent hyper-susceptibility to virus infection. Previously, others showed that all laboratory accessions of N. benthamiana have a very narrow genetic basis, probably originating from a single source. It is unknown if responses to virus infection exhibited by the laboratory accession are typical of the species as a whole. To test this, 23 accessions of N. benthamiana were collected from wild populations and challenged with one to four viruses. Additionally, accessions of 21 other Nicotiana species and subspecies from Australia, one from Peru and one from Namibia were tested for susceptibility to the viruses, and for the presence of a mutated RNA-dependent RNA polymerase I allele (Nb-RDR1m) described previously from a laboratory accession of N. benthamiana. All Australian Nicotiana accessions tested were susceptible to virus infections, although there was symptom variability within and between species. The most striking difference was that plants of a laboratory accession of N. benthamiana (RA-4) exhibited hypersensitivity to Yellow tailflower mild mottle tobamovirus infection and died, whereas plants of wild N. benthamiana accessions responded with non-necrotic symptoms. Plants of certain N. occidentalis accessions also exhibited initial hypersensitivity to Yellow tailflower mild mottle virus resembling that of N. benthamiana RA-4 plants, but later recovered. The mutant Nb-RDR1m allele was identified from N. benthamiana RA-4 but not from any of 51 other Nicotiana accessions, including wild accessions of N. benthamiana, demonstrating that the accession of N. benthamiana used widely in laboratories is unusual.	[Wylie, Stephen J.; Roossinck, Marilyn J.; Koh, Shu Hui; Jones, Michael G. K.; Li, Hua] Murdoch Univ, Plant Biotechnol Res Grp Virol, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia; [Zhang, Chao] Northwest Agr & Forestry Univ, Coll Plant Protect, Yangling, Shaanxi Provinc, Peoples R China; [Long, Vicki] Astron Environm Serv, Karratha, WA, Australia; [Wylie, Stephen J.; Koh, Shu Hui; Jones, Michael G. K.; Iqbal, Sadia; Li, Hua] Murdoch Univ, Plant Biotechnol Res Grp Pests, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia; [Roossinck, Marilyn J.] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Roossinck, Marilyn J.] Penn State Univ, Dept Environm Microbiol, University Pk, PA 16802 USA; [Roossinck, Marilyn J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Murdoch University; Northwest A&F University - China; Murdoch University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wylie, SJ (corresponding author), Murdoch Univ, Plant Biotechnol Res Grp Virol, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia.	s.wylie@murdoch.edu.au	Iqbal, Sadia/Y-2222-2019; Jones, Michael G.K./M-5932-2013; Wylie, Stephen/M-5910-2013	Iqbal, Sadia/0000-0002-6744-8999; Jones, Michael G.K./0000-0001-5002-0227; Wylie, Stephen/0000-0002-5639-7460; Li, Hua/0000-0002-0973-5762	Murdoch University	Murdoch University	Murdoch University provided MJR with an adjunct professorial position and scholarship to collect the plant samples described here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Angel CA, 2011, MOL PLANT MICROBE IN, V24, P91, DOI 10.1094/MPMI-04-10-0089; Bewley JD., 2012, SEEDS PHYSL DEV GERM; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; BURBIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P342, DOI 10.1071/BT9600342; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; CLELAND J. B., 1939, Transactions of the Royal Society of South Australia, V63, P22; Clemente T, 2006, METH MOL B, V343, P143; Coutts BA, 2011, ARCH VIROL, V156, P1757, DOI 10.1007/s00705-011-1046-4; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Fraile A, 1997, J VIROL, V71, P8316, DOI 10.1128/JVI.71.11.8316-8320.1997; Fukuta S, 2004, J VIROL METHODS, V121, P49, DOI 10.1016/j.jviromet.2004.05.016; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; HORTON P, 1981, Journal of the Adelaide Botanic Gardens, V3, P1; HORVATH J, 1993, ACTA PHYTOPATHOL HUN, V28, P355; Hunter LJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066530; Johnston TH, 1933, OCEANIA, V4, P201, DOI 10.1002/j.1834-4461.1933.tb00101.x; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kryszczuk A, 2000, PHYTOPATHOLOGIA POLO, V20, P165; Latz Peter, 1995, BUSHFIRES BUSHTUCKER; Leone G, 1991, 15 INT S SMALL FRIUT, V308, P121; Lowery DT, 2005, PLANT DIS, V89, P205, DOI 10.1094/PD-89-0205A; Luo H, 2011, ANN APPL BIOL, V159, P339, DOI 10.1111/j.1744-7348.2011.00496.x; Marks CE, 2011, AUST SYST BOT, V24, P61, DOI 10.1071/SB11006; Marks CE, 2011, GENET RESOUR CROP EV, V58, P797, DOI 10.1007/s10722-011-9724-3; MCKINNEY HH, 1945, J HERED, V36, P323, DOI 10.1093/oxfordjournals.jhered.a105433; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; Naim F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052717; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Ratsch A, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-26; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Srivastava S, 2012, PHYTOCHEMISTRY, V80, P8, DOI 10.1016/j.phytochem.2012.05.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Meer FA, 1998, 5 INT S SMALL FRUIT, P236; VANDIJK P, 1987, NETH J PLANT PATHOL, V93, P73; Verbeek M, 2008, ARCH VIROL, V153, P127, DOI 10.1007/s00705-007-1076-0; Verbeek M, 2014, ARCH VIROL, V159, P801, DOI 10.1007/s00705-013-1835-z; Verhoeven J. T. J., 2000, Bulletin OEPP, V30, P463, DOI 10.1111/j.1365-2338.2000.tb00930.x; WALTON NJ, 1988, PLANT CELL REP, V7, P115, DOI 10.1007/BF00270118; Wang NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-177; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Wei K, 2012, AUSTRALAS PLANT DIS, V7, P59, DOI 10.1007/s13314-012-0048-8; Wunschova A, 2009, BIOLOGIA, V64, P705, DOI 10.2478/s11756-009-0064-0; WYLIE S, 1993, AUST J AGR RES, V44, P41, DOI 10.1071/AR9930041; Wylie SJ, 2011, ARCH VIROL, V156, P1287, DOI 10.1007/s00705-011-1002-3; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie S, 2011, ARCH VIROL, V156, P1245, DOI 10.1007/s00705-011-0963-6; Wylie SJ, 2014, ARCH VIROL, V159, P791, DOI 10.1007/s00705-013-1891-4; Wylie SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079587; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/s00705-012-1452-2; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Wylie SJ, 2011, ARCH VIROL, V156, P479, DOI 10.1007/s00705-010-0845-3; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206	64	30	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121787	10.1371/journal.pone.0121787	http://dx.doi.org/10.1371/journal.pone.0121787			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822508	gold, Green Published			2022-12-27	WOS:000352134700126
J	Zhang, PW; Chen, L; Huang, T; Zhang, N; Kong, XY; Cai, YD				Zhang, Pei-Wei; Chen, Lei; Huang, Tao; Zhang, Ning; Kong, Xiang-Yin; Cai, Yu-Dong			Classifying Ten Types of Major Cancers Based on Reverse Phase Protein Array Profiles	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; MALIGNANT PHENOTYPE; SIGNALING COMPLEX; DRUG-TARGET; KINASE; ALPHA; RECEPTOR; PEA-15; RNA	Gathering vast data sets of cancer genomes requires more efficient and autonomous procedures to classify cancer types and to discover a few essential genes to distinguish different cancers. Because protein expression is more stable than gene expression, we chose reverse phase protein array (RPPA) data, a powerful and robust antibody-based high-throughput approach for targeted proteomics, to perform our research. In this study, we proposed a computational framework to classify the patient samples into ten major cancer types based on the RPPA data using the SMO (Sequential minimal optimization) method. A careful feature selection procedure was employed to select 23 important proteins from the total of 187 proteins by mRMR (minimum Redundancy Maximum Relevance Feature Selection) and IFS (Incremental Feature Selection) on the training set. By using the 23 proteins, we successfully classified the ten cancer types with an MCC (Matthews Correlation Coefficient) of 0.904 on the training set, evaluated by 10-fold cross-validation, and an MCC of 0.936 on an independent test set. Further analysis of these 23 proteins was performed. Most of these proteins can present the hallmarks of cancer; Chk2, for example, plays an important role in the proliferation of cancer cells. Our analysis of these 23 proteins lends credence to the importance of these genes as indicators of cancer classification. We also believe our methods and findings may shed light on the discoveries of specific biomarkers of different types of cancers.	[Cai, Yu-Dong] Shanghai Univ, Coll Life Sci, Shanghai, Peoples R China; [Zhang, Pei-Wei; Huang, Tao; Kong, Xiang-Yin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tianjin University; Shanghai Maritime University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	tohuangtao@126.com; zhni@tju.edu.cn; xykong@sibs.ac.cn; cai_yud@126.com	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Natural Science Foundation of China [31371335, 81171342, 81201148, 61401302]; Shanghai Municipal Education Commission [12ZZ087]; The First-class Discipline of Universities in Shanghai; Tianjin Research Program of Application Foundation and Advanced Technology [14JCQNJC09500]; National Research Foundation for the Doctoral Program of Higher Education of China [20130032120070, 20120032120073]; Independent Innovation Foundation of Tianjin University [60302064, 60302069]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); The First-class Discipline of Universities in Shanghai; Tianjin Research Program of Application Foundation and Advanced Technology; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Tianjin University	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), and National Natural Science Foundation of China (31371335, 81171342, 81201148, 61401302), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai", Tianjin Research Program of Application Foundation and Advanced Technology(14JCQNJC09500), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073) and the Independent Innovation Foundation of Tianjin University (60302064, 60302069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bae DH, 2013, J CLIN PATHOL, V66, P911, DOI 10.1136/jclinpath-2013-201692; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Dai D, 2002, CANCER RES, V62, P881; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Gundisch S, 2013, J PROTEOME RES, V12, P4424, DOI 10.1021/pr400451z; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hastie T, 1998, ADV NEUR IN, V10, P507; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudler P, 2014, THE SCIENTIFIC WORLD, V2014; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Jiang YZ, 2014, CANCER; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; LI BS, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0033393; Li J, 2013, NATURE METHODS; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Liu HA, 1998, APPL INTELL, V9, P217, DOI 10.1023/A:1008363719778; Lountos GT, 2011, J STRUCT BIOL, V176, P292, DOI 10.1016/j.jsb.2011.09.008; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Masuda T, 2002, CANCER RES, V62, P3819; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mazumder A, 2008, VALIDATION INTEGRATI; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Moore JD, 2013, NAT REV CANCER, V13, P201, DOI 10.1038/nrc3468; Nozoe T, 2002, CLIN CANCER RES, V8, P817; Pasquier E, 2008, IUBMB LIFE, V60, P165, DOI 10.1002/iub.25; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Singh M, 2007, GYNECOL ONCOL, V106, P325, DOI 10.1016/j.ygyno.2007.03.042; Sonntag J., 2014, TRANSL PROTEOMICS, V2, P52, DOI DOI 10.1016/j.trprot.2014.02.001; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Taylor RP, 2014, MOL PHARMACOL, V86, P485, DOI 10.1124/mol.114.092684; Ting KM, 1997, FOURTEENTH INTERNATI; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Vaughan TY, 2011, AM J BLOOD RES, V1, P130; Viet CT, 2010, HEAD NECK-J SCI SPEC, V32, P1246, DOI 10.1002/hed.21358; Weber K, 1997, FEBS LETT, V419, P87, DOI 10.1016/S0014-5793(97)01436-1; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Xu ZB, 2009, IEEE T SYST MAN CY B, V39, P1292, DOI 10.1109/TSMCB.2009.2015672; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005	75	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0123147	10.1371/journal.pone.0123147	http://dx.doi.org/10.1371/journal.pone.0123147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822500	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700216
J	Zheleznyakova, GY; Nilsson, EK; Kiselev, AV; Maretina, MA; Tishchenko, LI; Fredriksson, R; Baranov, VS; Schioth, HB				Zheleznyakova, Galina Yu; Nilsson, Emil K.; Kiselev, Anton V.; Maretina, Marianna A.; Tishchenko, Lyudmila I.; Fredriksson, Robert; Baranov, Vladislav S.; Schioeth, Helgi B.			Methylation Levels of SLC23A2 and NCOR2 Genes Correlate with Spinal Muscular Atrophy Severity	PLOS ONE			English	Article							DNA-METHYLATION; TRANSCRIPTION; MUSCLE; SMRT; SMN; PCR	Spinal muscular atrophy (SMA) is a monogenic neurodegenerative disorder subdivided into four different types. Whole genome methylation analysis revealed 40 CpG sites associated with genes that are significantly differentially methylated between SMA patients and healthy individuals of the same age. To investigate the contribution of methylation changes to SMA severity, we compared the methylation level of found CpG sites, designed as "targets", as well as the nearest CpG sites in regulatory regions of ARHGAP22, CDK2AP1, CHML, NCOR2, SLC23A2 and RPL9 in three groups of SMA patients. Of notable interest, compared to type I SMA male patients, the methylation level of a target CpG site and one nearby CpG site belonging to the 5'UTR of SLC23A2 were significantly hypomethylated 19-22% in type III-IV patients. In contrast to type I SMA male patients, type III-IV patients demonstrated a 16% decrease in the methylation levels of a target CpG site, belonging to the 5'UTR of NCOR2. To conclude, this study validates the data of our previous study and confirms significant methylation changes in the SLC23A2 and NCOR2 regulatory regions correlates with SMA severity.	[Zheleznyakova, Galina Yu; Nilsson, Emil K.; Fredriksson, Robert; Schioeth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Zheleznyakova, Galina Yu; Kiselev, Anton V.; Maretina, Marianna A.; Baranov, Vladislav S.] St Petersburg State Univ, Fac Biol, St Petersburg 199034, Russia; [Zheleznyakova, Galina Yu; Kiselev, Anton V.; Maretina, Marianna A.; Baranov, Vladislav S.] RAMS, DO Ott Res Inst Obstet & Gynecol, Lab Prenatal Diagnost Inherited Dis, St Petersburg 199034, Russia	Uppsala University; Saint Petersburg State University; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology	Zheleznyakova, GY (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	galina.zheleznyakova@neuro.uu.se	Baranov, Vladislav/AAB-4953-2020; Kiselev, Anton/K-9379-2013; Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019; Maretina, Marianna A/H-4895-2017	Baranov, Vladislav/0000-0002-6518-1207; Kiselev, Anton/0000-0002-2487-2423; Fredriksson, Robert/0000-0002-2810-3226; Zheleznyakova, Galina/0000-0003-4660-4523	Swedish Research Council; Swedish Institute Baltic Sea Region Exchange Program; Russian President Scholarship for study abroad; Saint-Petersburg city administration; Novo Nordisk Fonden [NNF12OC1016287, NNF13OC0005723, NNF15OC0016184] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute Baltic Sea Region Exchange Program; Russian President Scholarship for study abroad; Saint-Petersburg city administration; Novo Nordisk Fonden(Novo Nordisk Foundation)	HS is supported by the Swedish Research Council. GYZ is supported by the scholarship within the Swedish Institute Baltic Sea Region Exchange Program and Russian President Scholarship for study abroad. Funding from a Saint-Petersburg city administration is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai SX, 2012, INT J NEUROSCI, V122, P165, DOI 10.3109/00207454.2011.637654; Alrfaei BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080865; Baranov VS, 2008, RUSS J GENET+, V44, P1148, DOI 10.1134/S1022795408100049; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Biros I, 1999, J MED GENET, V36, P1; Bowerman M, 2009, MOL CELL NEUROSCI, V42, P66, DOI 10.1016/j.mcn.2009.05.009; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Cusco I, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-005-0912-y; Darbar IA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-36; David Allis C., 2007, EPIGENETICS-US; Domschke K, 2013, PROG NEURO-PSYCHOPH, V46, P189, DOI 10.1016/j.pnpbp.2013.07.014; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hauke J, 2009, HUM MOL GENET, V18, P304, DOI 10.1093/hmg/ddn357; Heberlein A, 2013, ADDICT BIOL, V18, P508, DOI 10.1111/j.1369-1600.2010.00307.x; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jiang Q, 2001, CYTOGENET CELL GENET, V92, P217, DOI 10.1159/000056906; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; May James M, 2012, Subcell Biochem, V56, P85, DOI 10.1007/978-94-007-2199-9_6; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Pendina AA, 2011, CYTOGENET GENOME RES, V132, P1, DOI 10.1159/000318673; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Spruijt CG, 2014, NAT STRUCT MOL BIOL, V21, P949, DOI 10.1038/nsmb.2910; Wong DTW, 2012, J DENT RES, V91, P235, DOI 10.1177/0022034511420723; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zheleznyakova GY, 2013, EUR J HUM GENET, V21, P988, DOI 10.1038/ejhg.2012.293; Zheleznyakova GY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-96; Zou JH, 2004, J BIOL CHEM, V279, P14922, DOI 10.1074/jbc.M309218200	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121964	10.1371/journal.pone.0121964	http://dx.doi.org/10.1371/journal.pone.0121964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25821969	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700142
J	Goyvaerts, L; Lemaire, K; Arijs, I; Auffret, J; Granvik, M; Van Lommel, L; Binart, N; Veld, PI; Schuit, F; Schraenen, A				Goyvaerts, Lotte; Lemaire, Katleen; Arijs, Ingrid; Auffret, Julien; Granvik, Mikaela; Van Lommel, Leentje; Binart, Nadine; Veld, Peter In't; Schuit, Frans; Schraenen, Anica			Prolactin Receptors and Placental Lactogen Drive Male Mouse Pancreatic Islets to Pregnancy-Related mRNA Changes	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; NORMAL GLUCOSE-HOMEOSTASIS; BETA-CELL PROLIFERATION; GROWTH-HORMONE; PRL RECEPTOR; EXPRESSION; PROTEIN; MICE; RAT; LANGERHANS	Pregnancy requires a higher functional beta cell mass and this is associated with profound changes in the gene expression profile of pancreatic islets. Taking Tph1 as a sensitive marker for pregnancy-related islet mRNA expression in female mice, we previously identified prolactin receptors and placental lactogen as key signalling molecules. Since beta cells from male mice also express prolactin receptors, the question arose whether male and female islets have the same phenotypic resilience at the mRNA level during pregnancy. We addressed this question in vitro, by stimulating cultured islets with placental lactogen and in vivo, by transplanting male or female islets into female acceptor mice. Additionally, the islet mRNA expression pattern of pregnant prolactin receptor deficient mice was compared with that of their pregnant wild-type littermates. When cultured with placental lactogen, or when transplanted in female recipients that became pregnant (day 12.5), male islets induced the 'islet pregnancy gene signature', which we defined as the 12 highest induced genes in non-transplanted female islets at day 12.5 of pregnancy. In addition, serotonin immunoreactivity and beta cell proliferation was also induced in these male transplanted islets at day 12.5 of pregnancy. In order to further investigate the importance of prolactin receptors in these mRNA changes we used a prolactin receptor deficient mouse model. For the 12 genes of the signature, which are highly induced in control pregnant mice, no significant induction of mRNA transcripts was found at day 9.5 of pregnancy. Together, our results support the key role of placental lactogen as a circulating factor that can trigger the pregnancy mRNA profile in both male and female beta cells.	[Goyvaerts, Lotte; Lemaire, Katleen; Arijs, Ingrid; Granvik, Mikaela; Van Lommel, Leentje; Schuit, Frans; Schraenen, Anica] Katholieke Univ Leuven, Gene Express Unit, Dept Cellular & Mol Med, Leuven, Belgium; [Arijs, Ingrid] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Clin & Expt Med, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [Auffret, Julien; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, INSERM, U693, Le Kremlin Bicetre, France; [Veld, Peter In't] Vrije Univ Brussel, Dept Pathol, Jette, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Brussel	Schuit, F (corresponding author), Katholieke Univ Leuven, Gene Express Unit, Dept Cellular & Mol Med, Leuven, Belgium.	Frans.Schuit@med.kuleuven.be; Anica.Schraenen@med.kuleuven.be	Binart, Nadine/F-2949-2013; Arijs, Ingrid/AAJ-3163-2020; Goyvaerts, Lotte/AAP-9125-2020; In't Veld, Peter/E-3624-2013	Binart, Nadine/0000-0002-5606-3866; In't Veld, Peter/0000-0001-5596-7129; Arijs, Ingrid/0000-0002-9415-083X	Juvenile Diabetes Research Foundation (JDRF) [1-2010-393]; Research Foundation - Flanders (FWO) [G.0672.12N]; University of Leuven (KU Leuven) [GOA/14/010, GOA/12/016]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Research Foundation - Flanders (FWO)(FWO); University of Leuven (KU Leuven)(KU Leuven)	This work was financially supported by the Juvenile Diabetes Research Foundation (JDRF grant 1-2010-393; http://jdrf.org/grant-center/), the Research Foundation - Flanders (FWO - project nr. G.0672.12N and postdoctoral fellowships to AS and IA; http://www.fwo.be/en/) and the University of Leuven (KU Leuven GOA/14/010 and GOA/12/016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffret J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1309, DOI 10.1152/ajpendo.00636.2012; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Bengtsson H., 2008, AROMA AFFYMETRIX GEN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Binart N, 2000, ENDOCRINOLOGY, V141, P2691, DOI 10.1210/en.141.7.2691; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bonanno JA, 1997, EXP EYE RES, V64, P953, DOI 10.1006/exer.1997.0290; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; BRELJE TC, 1988, ENDOCRINOLOGY, V123, P1582, DOI 10.1210/endo-123-3-1582; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; Delmeire D, 2004, BIOCHEM PHARMACOL, V68, P33, DOI 10.1016/j.bcp.2004.02.035; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dif F, 2001, ENDOCRINOLOGY, V142, P5286, DOI 10.1210/en.142.12.5286; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Huang C, 2013, J PHYSIOL-LONDON, V591, P1325, DOI 10.1113/jphysiol.2012.244830; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Kasayama S, 2000, CLIN ENDOCRINOL, V52, P549, DOI 10.1046/j.1365-2265.2000.00986.x; KELLY PA, 1974, ENDOCRINOLOGY, V95, P532, DOI 10.1210/endo-95-2-532; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; MOLDRUP A, 1993, ENDOCRINOLOGY, V133, P1165, DOI 10.1210/en.133.3.1165; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polonsky KS, 2000, INT J OBESITY, V24, pS29, DOI 10.1038/sj.ijo.0801273; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schrader J, 2007, DIABETOLOGIA, V50, P1243, DOI 10.1007/s00125-007-0672-6; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Sharma S, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/2042-6410-5-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; SORENSON RL, 1987, PANCREAS, V2, P283, DOI 10.1097/00006676-198705000-00006; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Toffoli B, 2011, MOL CELL ENDOCRINOL, V331, P136, DOI 10.1016/j.mce.2010.08.019; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724	54	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121868	10.1371/journal.pone.0121868	http://dx.doi.org/10.1371/journal.pone.0121868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816302	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600125
J	Freitas, ACO; Souza, CF; Monzani, PS; Garcia, W; de Almeida, AAF; Costa, MGC; Pirovani, CP				Oliveira Freitas, Ana Camila; Souza, Cristiane Ferreira; Monzani, Paulo Sergio; Garcia, Wanius; Furtado de Almeida, Alex Alan; Cardoso Costa, Marcio Gilberto; Pirovani, Carlos Priminho			The Activity of TcCYS4 Modified by Variations in pH and Temperature Can Affect Symptoms of Witches' Broom Disease of Cocoa, Caused by the Fungus Moniliophthora perniciosa	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; PROGRAMMED CELL-DEATH; THEOBROMA-CACAO; CYSTATIN-C; INVOLVEMENT; PLANT; EXPRESSION; GROWTH; GENES; AGENT	The phytocystatins regulate various physiological processes in plants, including responses to biotic and abiotic stresses, mainly because they act as inhibitors of cysteine proteases. In this study, we have analyzed four cystatins from Theobroma cacao L. previously identified in ESTs libraries of the interaction with the fungus Moniliophthora perniciosa and named TcCYS1, TcCYS2, TcCYS3 and TcCYS4. The recombinant cystatins were purified and subjected to the heat treatment, at different temperatures, and their thermostabilities were monitored using their ability to inhibit papain protease. TcCYS1 was sensitive to temperatures above 50 degrees C, while TcCYS2, TcCYS3, and TcCYS4 were thermostable. TcCYS4 presented a decrease of inhibitory activity when it was treated at temperatures between 60 and 70 degrees C, with the greater decrease occurring at 65 degrees C. Analyses by native gel electrophoresis and size-exclusion chromatography showed that TcCYS4 forms oligomers at temperatures between 60 and 70 degrees C, condition where reduction of inhibitory activity was observed. TcCYS4 oligomers remain stable for up to 20 days after heat treatment and are undone after treatment at 80 degrees C. TcCYS4 presented approximately 90% of inhibitory activity at pH values between 5 and 9. This protein treated at temperatures above 45 degrees C and pH 5 presented reduced inhibitory activity against papain, suggesting that the pH 5 enhances the formation of TcCYS4 oligomers. A variation in the titratable acidity was observed in tissues of T. cacao during the symptoms of witches' broom disease. Our findings suggest that the oligomerization of TcCYS4, favored by variations in pH, is an endergonic process. We speculate that this process can be involved in the development of the symptoms of witches' broom disease in cocoa.	[Oliveira Freitas, Ana Camila; Souza, Cristiane Ferreira; Furtado de Almeida, Alex Alan; Cardoso Costa, Marcio Gilberto; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [Monzani, Paulo Sergio] Unive Norte Parana, Ctr Biol & Ciencais Saude, Londrina, Parana, Brazil; [Garcia, Wanius] Univ Fed Abc, CCNH, Santo Andre, SP, Brazil	Universidade Estadual de Santa Cruz; University Norte Parana; Universidade Federal do ABC (UFABC)	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	pirovani@uesc.br	Costa, Marcio/AAG-3285-2020; Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019; Silva, Wanius J. G./L-3948-2016	Costa, Marcio/0000-0002-4358-5489; Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069; Monzani, Paulo Sergio/0000-0003-4001-3431	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305309/2012-9]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); CNPq (PRONEM) [PNE0005/2011]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq (PRONEM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	ACOF was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CPP was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br, Process number 305309/2012-9). The authors thank Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (http://www.fapesb.ba.gov.br/) and the and CNPq (PRONEM, Process number PNE0005/2011) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; Aime MC, 2005, MYCOLOGY, V97; Andebrhan T, 1999, EUR J PLANT PATHOL, V105, P167, DOI 10.1023/A:1008716000479; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camillo LR, 2013, PLANT PHYSIOL BIOCH, V73, P254, DOI 10.1016/j.plaphy.2013.10.009; Cappello F, 2004, EXP CELL RES, V297, P607, DOI 10.1016/j.yexcr.2004.03.048; Ceita GD, 2007, PLANT SCI, V173, P106, DOI 10.1016/j.plantsci.2007.04.006; Dias CV, 2011, PLANT PHYSIOL BIOCH, V49, P917, DOI 10.1016/j.plaphy.2011.05.004; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; EVANS HC, 1980, T BRIT MYCOL SOC, V74, P515, DOI 10.1016/S0007-1536(80)80051-9; Fabrick J, 2002, INSECT BIOCHEM MOLEC, V32, P405, DOI 10.1016/S0965-1748(01)00117-5; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kilaru A, 2007, FEMS MICROBIOL LETT, V274, P238, DOI 10.1111/j.1574-6968.2007.00837.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Margis R, 1998, ARCH BIOCHEM BIOPHYS, V359, P24, DOI 10.1006/abbi.1998.0875; Martinez M, 2007, FEBS LETT, V581, P2914, DOI 10.1016/j.febslet.2007.05.042; Meinhardt LW, 2008, MOL PLANT PATHOL, V9, P577, DOI 10.1111/J.1364-3703.2008.00496.X; Mondego JMC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-548; Nandy SK, 2013, J BIOMOL STRUCT DYN, V31, P649, DOI 10.1080/07391102.2012.706403; Ohtsubo S, 2007, J AGR FOOD CHEM, V55, P1762, DOI 10.1021/jf062637t; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; Pirovani CP, 2010, PLANTA, V232, P1485, DOI 10.1007/s00425-010-1272-0; Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573; RASKIN I, 1989, P NATL ACAD SCI USA, V86, P2214, DOI 10.1073/pnas.86.7.2214; Rincones J, 2008, MOL PLANT MICROBE IN, V21, P891, DOI 10.1094/MPMI-21-7-0891; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Scarpari LM, 2005, J EXP BOT, V56, P865, DOI 10.1093/jxb/eri079; Siriphanisc J, 1993, J AM SOC HORTIC SC, V111, P73; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Vain P, 1998, THEOR APPL GENET, V96, P266, DOI 10.1007/s001220050735; Valadares NAF, 2013, FEBS J, V280, P1028, DOI 10.1111/febs.12095; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; Varoquaux P, 1994, MINIMALLY PROCESSED, P251, DOI [10.1021/jf900541r, DOI 10.1021/JF900541R]; Villela-Dias C, 2014, PHYSIOL PLANTARUM, V150, P1, DOI 10.1111/ppl.12061; Yang SC, 2005, J MOL BIOL, V352, P202, DOI 10.1016/j.jmb.2005.06.062; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x	41	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121519	10.1371/journal.pone.0121519	http://dx.doi.org/10.1371/journal.pone.0121519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830226	gold, Green Published, Green Submitted			2022-12-27	WOS:000352135600074
J	Vaz, PG; Kebreab, E; Hung, SSO; Fadel, JG; Lee, S; Fangue, NA				Vaz, Pedro G.; Kebreab, Ermias; Hung, Silas S. O.; Fadel, James G.; Lee, Seunghyung; Fangue, Nann A.			Impact of Nutrition and Salinity Changes on Biological Performances of Green and White Sturgeon	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; GLOBAL CLIMATE-CHANGE; ACIPENSER-MEDIROSTRIS; OCEAN ACIDIFICATION; GROWTH-PERFORMANCE; FOOD-DEPRIVATION; COMPENSATORY GROWTH; METABOLIC-RESPONSES; ATPASE ACTIVITY; FEEDING RATE	Green and white sturgeon are species of high conservational and economic interest, particularly in the San Francisco Bay Delta (SFBD) for which significant climate change-derived alterations in salinity and nutritional patterns are forecasted. Although there is paucity of information, it is critical to test the network of biological responses underlying the capacity of animals to tolerate current environmental changes. Through nutrition and salinity challenges, climate change will likely have more physiological effect on young sturgeon stages, which in turn may affect growth performance. In this study, the two species were challenged in a multiple-factor experimental setting, first to levels of feeding rate, and then to salinity levels for different time periods. Data analysis included generalized additive models to select predictors of growth performance ( measured by condition factor) among the environmental stressors considered and a suite of physiological variables. Using structural equation modeling, a path diagram is proposed to quantify the main linkages among nutrition status, salinity, osmoregulation variables, and growth performances. Three major trends were anticipated for the growth performance of green and white sturgeon in the juvenile stage in the SFBD: (i) a decrease in prey abundance will be highly detrimental for the growth of both species; (ii) an acute increase in salinity within the limits studied can be tolerated by both species but possibly the energy spent in osmoregulation may affect green sturgeon growth within the time window assessed; (iii) the mechanism of synergistic effects of nutrition and salinity changes will be more complex in green sturgeon, with condition factor responding nonlinearly to interactions of salinity and nutrition status or time of salinity exposure. Green sturgeon merits special scientific attention and conservation effort to offset the effects of feed restriction and salinity as key environmental stressors in the SFBD.	[Vaz, Pedro G.; Kebreab, Ermias; Hung, Silas S. O.; Fadel, James G.; Lee, Seunghyung] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Fangue, Nann A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Vaz, PG (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	pgvaz@ucdavis.edu	Vaz, Pedro Gonçalves/C-6718-2008; /AAL-3738-2021; Kebreab, Ermias/E-9113-2012	Vaz, Pedro Gonçalves/0000-0002-2321-1287; Kebreab, Ermias/0000-0002-0833-1352; Lee, Seunghyung/0000-0003-0914-9613	California Department of Fish and Wildlife, Ecosystem Restoration Program [E1183017]	California Department of Fish and Wildlife, Ecosystem Restoration Program	This study was funded by the California Department of Fish and Wildlife, Ecosystem Restoration Program under the contract number E1183017 (http://www.dfg.ca.gov/erp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Allen PJ, 2007, ENVIRON BIOL FISH, V79, P211, DOI 10.1007/s10641-006-9049-9; Allen PJ, 2011, J COMP PHYSIOL B, V181, P1045, DOI 10.1007/s00360-011-0592-0; Allen PJ, 2009, J COMP PHYSIOL B, V179, P903, DOI 10.1007/s00360-009-0372-2; Amiri BM, 2009, AQUACULTURE, V286, P121, DOI 10.1016/j.aquaculture.2008.08.037; Arbuckle J. L., 2010, AMOS VERSION 27 0; Auad G, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003219; Beatty SJ, 2014, GLOBAL CHANGE BIOL, V20, P1794, DOI 10.1111/gcb.12444; Bizzi S, 2013, RIVER RES APPL, V29, P743, DOI 10.1002/rra.2563; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; Cataldi E, 1999, J APPL ICHTHYOL, V15, P57, DOI 10.1111/j.1439-0426.1999.tb00207.x; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cloern JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023321; Clough Y, 2012, ECOLOGY, V93, P1809, DOI 10.1890/11-1899.1; CNDDB (California Natural Diversity Database), 2009, DAT CAL NAT DIV DAT; Cooke SJ, 2008, BIOSCIENCE, V58, P957, DOI 10.1641/B581009; Cui Y, 1996, J FISH BIOL, V49, P863, DOI 10.1111/j.1095-8649.1996.tb00085.x; Cui Y, 1996, J APPL AQUACULTURE, V5, P25; Cui YB, 1997, PROG FISH CULT, V59, P31, DOI 10.1577/1548-8640(1997)059&lt;0031:GPOJWS&gt;2.3.CO;2; De Riu N, 2012, AQUACULT NUTR, V18, P290, DOI 10.1111/j.1365-2095.2011.00895.x; Deng DF, 2003, AQUACULTURE, V217, P589, DOI 10.1016/S0044-8486(02)00461-1; FIELDS PA, 1993, TRENDS ECOL EVOL, V8, P361, DOI 10.1016/0169-5347(93)90220-J; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Haller LY, 2015, PHYSIOL BIOCHEM ZOOL, V88, P22, DOI 10.1086/679519; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; HUNG SSO, 1989, AQUACULTURE, V80, P147, DOI 10.1016/0044-8486(89)90280-9; Hung SSO, 1997, AQUACULTURE, V151, P357, DOI 10.1016/S0044-8486(96)01506-2; Imsland AK, 2003, AQUACULTURE, V218, P671, DOI 10.1016/S0044-8486(02)00423-4; Imsland AK, 2011, AQUAC RES, V42, P469, DOI 10.1111/j.1365-2109.2010.02640.x; inger TD, 2002, STURGEONS PADDLEFISH, P167; IPCC, 2013, WORKING GROUP I CONT; Israel JA, 2009, LIFE HIST CONCEPTUAL; Jarvis PL, 2003, AQUACULTURE, V219, P891, DOI 10.1016/S0044-8486(03)00063-2; Jarvis PL, 2001, N AM J AQUACULT, V63, P272, DOI 10.1577/1548-8454(2001)063&lt;0272:TIOSOT&gt;2.0.CO;2; Jenkins Wallace E., 1993, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V47, P476; Jensen MK, 1998, J EXP ZOOL, V282, P290, DOI 10.1002/(SICI)1097-010X(19981015)282:3<290::AID-JEZ2>3.0.CO;2-H; Jones CE, 1984, OFFICIAL METHODS ANA, P152; Knowles N, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000360; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Knowles N, 2004, CLIMATIC CHANGE, V62, P319, DOI 10.1023/B:CLIM.0000013696.14308.b9; Kogut NJ, 2008, CALIF FISH GAME, V94, P143; Krayushkina LS, 2006, J APPL ICHTHYOL, V22, P182, DOI 10.1111/j.1439-0426.2007.00948.x; KRAYUSHKINA L S, 1974, Journal of Ichthyology, V14, P971; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lee S, 2014, AQUACULTURE, V433, P411, DOI 10.1016/j.aquaculture.2014.06.007; Linville RG, 2002, AQUAT TOXICOL, V57, P51, DOI 10.1016/S0166-445X(01)00265-X; Martinez-Alvarez RM, 2002, J EXP BIOL, V205, P3699; MCENROE M, 1985, ENVIRON BIOL FISH, V14, P23, DOI 10.1007/BF00001573; McKenzie DJ, 2001, CAN J FISH AQUAT SCI, V58, P1113, DOI 10.1139/cjfas-58-6-1113; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Moyle P.B., 2002, INLAND FISHES CALIFO; National Marine Fisheries Service (NMFS), 2006, FED REGISTER, P17757; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polakof S, 2006, J COMP PHYSIOL B, V176, P441, DOI 10.1007/s00360-006-0065-z; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; Rodriguez A, 2002, FISH PHYSIOL BIOCHEM, V26, P345, DOI 10.1023/B:FISH.0000009263.83075.68; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Sardella BA, 2014, PHYSIOL BIOCHEM ZOOL, V87, P456, DOI 10.1086/675494; Sardella BA, 2009, J COMP PHYSIOL B, V179, P383, DOI 10.1007/s00360-008-0321-5; Sarkar UK, 2013, J ENVIRON BIOL, V34, P951; Schulte PM, 2014, J EXP BIOL, V217, P23, DOI 10.1242/jeb.089722; Silvestre F, 2010, SCI TOTAL ENVIRON, V408, P3176, DOI 10.1016/j.scitotenv.2010.04.005; Sokal R.R.., 2009, INTRO BIOSTATISTICS, Vsecond, P365; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stefansson SO, 2009, AQUACULTURE, V290, P243, DOI 10.1016/j.aquaculture.2009.02.024; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Triebenbach SP, 2009, N AM J AQUACULT, V71, P384, DOI 10.1577/A08-035.1; Van Eenennaam JP, 2012, J APPL ICHTHYOL, V28, P505, DOI 10.1111/j.1439-0426.2012.02012.x; Van Eenennaam JP, 2008, N AM J AQUACULT, V70, P434, DOI 10.1577/A07-073.1; Wheeler R. E., 2010, IMPERM PERMUTATION T; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2013, BIOMETRIKA, V100, P1005, DOI 10.1093/biomet/ast038; Wood SN, 2013, BIOMETRIKA, V100, P221, DOI 10.1093/biomet/ass048; Xin D, 2002, AM FISH S S, V28, P237; Yarmohammadi M, 2012, J APPL ICHTHYOL, V28, P692, DOI 10.1111/j.1439-0426.2012.01969.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	92	9	9	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122029	10.1371/journal.pone.0122029	http://dx.doi.org/10.1371/journal.pone.0122029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25830227	gold, Green Published			2022-12-27	WOS:000352135600094
J	Dirks, JAMC; Wolffs, PFG; Dukers-Muijrers, NHTM; Brink, AATP; Speksnijder, AGCL; Hoebe, CJPA				Dirks, Jeanne A. M. C.; Wolffs, Petra F. G.; Dukers-Muijrers, Nicole H. T. M.; Brink, Antoinette A. T. P.; Speksnijder, Arjen G. C. L.; Hoebe, Christian J. P. A.			Chlamydia trachomatis Load in Population-Based Screening and STI-Clinics: Implications for Screening Policy	PLOS ONE			English	Article							VIRUS LOAD; VIRAL LOAD; INFECTION; MEN; NETHERLANDS; COMMUNITY; WOMEN; SUSCEPTIBILITY; PATHOGENESIS; PERSISTENCE	Objectives If the Chlamydia trachomatis (CT) bacterial load is higher in high-risk populations than in the general population, this negatively affects the efficacy of CT screening incentives. In the largest retrospective study to date, we investigated the CT load in specimens collected from 2 cohorts: (1) attendants of a sexually transmitted infection (STI)-clinic and (2) participants of the Dutch population-based screening (PBS). Methods CT load was determined using quantitative PCR in CT-positive male urine and female cervicovaginal swabs. CT loads were converted into tertiles. Using multinominal logistic regression, independent association of cohort, symptoms, risk behaviour and human cell count on load were assessed. Results CT loads were determined in 889 CT-positives from PBS (n = 529; 71.8% female) and STI-clinics (n = 360; 61.7% female). In men, STI-clinic-cohort, human cell count and urethral discharge were positively associated with CT load. In women, PBS-cohort and cell count were positively associated with CT load. Both cohorts had the same range in CT load. Conclusions The general population has a similar range of bacterial CT load as a high-risk population, but a different distribution for cohort and gender, highlighting the relevance of population-based CT-screening. When CT loads are similar, possibly the chances of transmission and sequelae are too.	[Dirks, Jeanne A. M. C.; Wolffs, Petra F. G.; Dukers-Muijrers, Nicole H. T. M.; Brink, Antoinette A. T. P.; Hoebe, Christian J. P. A.] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Dirks, Jeanne A. M. C.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] Publ Hlth Serv South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Speksnijder, Arjen G. C. L.] Publ Hlth Serv Amsterdam, Med Microbiol Lab, Amsterdam, Netherlands	Maastricht University; Public Health Service Amsterdam	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	p.wolffs@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014; Speksnijder, Arjen/M-3406-2017	Speksnijder, Arjen/0000-0002-1966-7265; Wolffs, Petra/0000-0002-5326-3985; Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X	Dutch organisation for Health Research and Development (ZonMW) [12.400.001]	Dutch organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The Dutch organisation for Health Research and Development (ZonMW, project number 12.400.001) funded the Chlamydia Screening Implementation study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Althaus CL, 2012, SEX TRANSM DIS, V39, P402, DOI 10.1097/OLQ.0b013e318248a550; [Anonymous], 2013, INC PREV COST SEX TR; Bender N, 2011, SEX TRANSM INFECT, V87, P601, DOI 10.1136/sextrans-2011-050205; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Buhrer-Skinner M, 2013, SEX HEALTH, V10, P32, DOI 10.1071/SH11065; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P576, DOI 10.1111/j.1600-0897.2010.00819.x; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Christerson L, 2011, SEX TRANSM DIS, V38, P490, DOI 10.1097/OLQ.0b013e31820b8be0; Gillespie CW, 2013, SEX TRANSM DIS, V40, P271, DOI 10.1097/OLQ.0b013e31827c9e42; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gotz H, 2002, SCAND J INFECT DIS, V34, P28, DOI 10.1080/00365540110077001; Grabowski MK, 2014, SEX TRANSM INFECT, V90, P337, DOI 10.1136/sextrans-2013-051230; Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Horner PJ, 2002, INT J STD AIDS, V13, P667, DOI 10.1258/095646202760326408; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Lorimer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-794; Low N, 2007, BMJ-BRIT MED J, V334, P725, DOI 10.1136/bmj.39154.378079.BE; Michel CEC, 2007, J CLIN MICROBIOL, V45, P1395, DOI 10.1128/JCM.00100-07; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; Pal S, 2001, INFECT IMMUN, V69, P5203, DOI 10.1128/IAI.69.8.5203-5206.2001; Pal S, 1998, J MED MICROBIOL, V47, P599, DOI 10.1099/00222615-47-7-599; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rasmussen SJ, 1998, CURR OPIN INFECT DIS, V11, P37, DOI 10.1097/00001432-199802000-00009; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soetens LC, 2013, SEXUALLY TRANSMITTTE; Stamm WE, 1999, J INFECT DIS, V179, pS380, DOI 10.1086/513844; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Trienekens Suzan, 2012, SEXUALLY TRANSMITTED; Twin J, 2011, SEX TRANSM DIS, V38, P279, DOI 10.1097/OLQ.0b013e3181fc6944; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; van den Broek IVF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-39; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; Verweij SP, 2013, EPIDEMIOLOGY INFECT, P1; Vliegen I, 2004, MICROBES INFECT, V6, P1056, DOI 10.1016/j.micinf.2004.05.020; Vodstrcil LA, 2014, J INFECT DIS; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0; Wiggins R, 2009, J CLIN MICROBIOL, V47, P1824, DOI 10.1128/JCM.00005-09; Wiggins Rebecca, 2009, BMC Res Notes, V2, P139, DOI 10.1186/1756-0500-2-139; Wilson DP, 2009, J INFECT DIS, V199, P1780, DOI 10.1086/599093; Wisniewski CA, 2008, J CLIN MICROBIOL, V46, P1466, DOI 10.1128/JCM.02241-07	51	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0121433	10.1371/journal.pone.0121433	http://dx.doi.org/10.1371/journal.pone.0121433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826298	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084800043
J	Iwata, H; Ebana, K; Uga, Y; Hayashi, T				Iwata, Hiroyoshi; Ebana, Kaworu; Uga, Yusaku; Hayashi, Takeshi			Genomic Prediction of Biological Shape: Elliptic Fourier Analysis and Kernel Partial Least Squares (PLS) Regression Applied to Grain Shape Prediction in Rice (Oryza sativa L.)	PLOS ONE			English	Article							WIDE ASSOCIATION; QUANTITATIVE-EVALUATION; GENETIC ARCHITECTURE; MILLING QUALITY; IMAGE-ANALYSIS; SELECTION; MORPHOLOGY; POPULATION; GENOTYPE; ACCURACY	Shape is an important morphological characteristic both in animals and plants. In the present study, we examined a method for predicting biological contour shapes based on genome-wide marker polymorphisms. The method is expected to contribute to the acceleration of genetic improvement of biological shape via genomic selection. Grain shape variation observed in rice (Oryza sativa L.) germplasms was delineated using elliptic Fourier descriptors (EFDs), and was predicted based on genome-wide single nucleotide polymorphism (SNP) genotypes. We applied four methods including kernel PLS (KPLS) regression for building a prediction model of grain shape, and compared the accuracy of the methods via cross-validation. We analyzed multiple datasets that differed in marker density and sample size. Datasets with larger sample size and higher marker density showed higher accuracy. Among the four methods, KPLS showed the highest accuracy. Although KPLS and ridge regression (RR) had equivalent accuracy in a single dataset, the result suggested the potential of KPLS for the prediction of high-dimensional EFDs. Ordinary PLS, however, was less accurate than RR in all datasets, suggesting that the use of a non-linear kernel was necessary for accurate prediction using the PLS method. Rice grain shape can be predicted accurately based on genome-wide SNP genotypes. The proposed method is expected to be useful for genomic selection in biological shape.	[Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Uga, Yusaku] Natl Inst Agrobiol Sci, Agron Res Ctr, Tsukuba, Ibaraki, Japan; [Hayashi, Takeshi] Natl Agr & Food Res Org, Natl Agr Res Ctr, Agroinformat Div, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp			MEXT [25252002]; Ministry of Agriculture, Forestry, and Fisheries of Japan; Grants-in-Aid for Scientific Research [25252002] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research (A), MEXT, No. 25252002, and by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, NGB2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; FURUTA N, 1995, BREEDING SCI, V45, P315; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2014, THEOR APPL GENET, V127, P463, DOI 10.1007/s00122-013-2231-5; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H, 2002, BREEDING SCI, V52, P243, DOI 10.1270/jsbbs.52.243; Iwata H, 2011, BIOLOGICAL SHAPE ANALYSIS, PROCEEDINGS OF THE 1ST INTERNATIONAL SYMPOSIUM, P50; Iwata H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-81; Iwata H, 2013, BREEDING SCI, V63, P125, DOI 10.1270/jsbbs.63.125; Iwata H, 2011, CROP SCI, V51, P1915, DOI 10.2135/cropsci2010.12.0732; Iwata H, 2010, CROP SCI, V50, P1269, DOI 10.2135/cropsci2009.08.0434; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jongkaewwattana S, 2001, J AGRON CROP SCI, V187, P223, DOI 10.1046/j.1439-037X.2001.00521.x; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lestrel P, 2011, BIOL SHAP AN P 1 INT; Lestrel PE, 2013, BIOL SHAPE ANAL; Liu J, 1996, GENETICS, V142, P1129; Lootens P, 2007, COMPUT ELECTRON AGR, V58, P164, DOI 10.1016/j.compag.2007.03.014; Mebatsion HK, 2012, COMPUT ELECTRON AGR, V80, P63, DOI 10.1016/j.compag.2011.10.016; Meuwissen THE, 2001, GENETICS, V157, P1819; Oka A, 2007, GENETICS, V175, P185, DOI 10.1534/genetics.106.062976; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Redona ED, 1998, THEOR APPL GENET, V96, P957, DOI 10.1007/s001220050826; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Rosipal R, 2002, J MACH LEARN RES, V2, P97, DOI 10.1162/15324430260185556; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tan YF, 2001, THEOR APPL GENET, V103, P1037, DOI 10.1007/s001220100665; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Uga Y, 2003, THEOR APPL GENET, V107, P218, DOI 10.1007/s00122-003-1227-y; Unnevehr L. J., 1992, CONSUMER DEMAND RICE; Viscosi V, 2011, NORD J BOT, V29, P632, DOI 10.1111/j.1756-1051.2011.01098.x; Wang CR, 2011, THEOR APPL GENET, V122, P905, DOI 10.1007/s00122-010-1497-0; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61; Zeng ZB, 2000, GENETICS, V154, P299; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zheng TQ, 2007, PLANT BREEDING, V126, P158, DOI 10.1111/j.1439-0523.2007.01357.x	56	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0120610	10.1371/journal.pone.0120610	http://dx.doi.org/10.1371/journal.pone.0120610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25825876	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084800022
J	Nakajima, NI; Hagiwara, Y; Oike, T; Okayasu, R; Murakami, T; Nakano, T; Shibata, A				Nakajima, Nakako Izumi; Hagiwara, Yoshihiko; Oike, Takahiro; Okayasu, Ryuichi; Murakami, Takeshi; Nakano, Takashi; Shibata, Atsushi			Pre-Exposure to Ionizing Radiation Stimulates DNA Double Strand Break End Resection, Promoting the Use of Homologous Recombination Repair	PLOS ONE			English	Article							G(2)/M CHECKPOINT ARREST; PATHWAY CHOICE; CELL-CYCLE; ADAPTIVE RESPONSE; HUMAN-LYMPHOCYTES; GAMMA-H2AX FOCI; G2 PHASE; ATM; REVEALS; DAMAGE	The choice of DNA double strand break (DSB) repair pathway is determined at the stage of DSB end resection. Resection was proposed to control the balance between the two major DSB repair pathways, homologous recombination (HR) and non-homologous end joining (NHEJ). Here, we examined the regulation of DSB repair pathway choice at two-ended DSBs following ionizing radiation (IR) in G2 phase of the cell cycle. We found that cells pre-exposed to low-dose IR preferred to undergo HR following challenge IR in G2, whereas NHEJ repair kinetics in G1 were not affected by pre-IR treatment. Consistent with the increase in HR usage, the challenge IR induced Replication protein A (RPA) foci formation and RPA phosphorylation, a marker of resection, were enhanced by pre-IR. However, neither major DNA damage signals nor the status of core NHEJ proteins, which influence the choice of repair pathway, was significantly altered in pre-IR treated cells. Moreover, the increase in usage of HR due to pre-IR exposure was prevented by treatment with ATM inhibitor during the incubation period between pre-IR and challenge IR. Taken together, the results of our study suggest that the ATM-dependent damage response after pre-IR changes the cellular environment, possibly by regulating gene expression or post-transcriptional modifications in a manner that promotes resection.	[Hagiwara, Yoshihiko; Shibata, Atsushi] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Nakajima, Nakako Izumi; Okayasu, Ryuichi; Murakami, Takeshi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Nakajima, Nakako Izumi; Okayasu, Ryuichi; Murakami, Takeshi] Natl Inst Radiol Sci, Int Open Lab, Chiba 260, Japan; [Oike, Takahiro; Nakano, Takashi] Gunma Univ, Dept Radiat Oncol, Maebashi, Gunma, Japan	Gunma University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Gunma University	Shibata, A (corresponding author), Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan.	shibata.at@gunma-u.ac.jp	Shibata, Atsushi/AAX-1283-2021	Shibata, Atsushi/0000-0001-8912-6977	Great Britain Sasakawa Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Program for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Grants-in-Aid for Scientific Research [24390288, 26670549] Funding Source: KAKEN	Great Britain Sasakawa Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Great Britain Sasakawa Foundation, the Takeda Science Foundation, the Suzuken Memorial Foundation, the Uehara Memorial Foundation, Japan Society for the Promotion of Science, and the Program for Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation. The author(s) received no specific funding for this work.	Azzam EI, 1996, RADIAT RES, V146, P369, DOI 10.2307/3579298; Beucher A, 2011, RADIOTHER ONCOL, V101, P46, DOI 10.1016/j.radonc.2011.05.043; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhattacharjee D, 1996, MUTAT RES-FUND MOL M, V358, P231, DOI 10.1016/S0027-5107(96)00125-X; Brunton H, 2011, MOL CELL BIOL, V31, P4022, DOI 10.1128/MCB.05289-11; Chan N, 2010, CANCER RES, V70, P8045, DOI 10.1158/0008-5472.CAN-10-2352; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Cramers P, 2005, RADIAT RES, V164, P383, DOI 10.1667/RR3430.1; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Eschrich SA, 2009, INT J RADIAT ONCOL, V75, P489, DOI 10.1016/j.ijrobp.2009.06.014; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Innes CL, 2006, MOL CANCER RES, V4, P197, DOI 10.1158/1541-7786.MCR-05-0154; Jeggo P, 2009, INT J RADIAT BIOL, V85, P1061, DOI 10.3109/09553000903261263; Kakarougkas A, 2013, NUCLEIC ACIDS RES, V41, P9719, DOI 10.1093/nar/gkt729; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; Loser DA, 2010, MOL CANCER THER, V9, P1775, DOI 10.1158/1535-7163.MCT-09-1027; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Rigaud O, 1996, MUTAT RES-FUND MOL M, V358, P127, DOI 10.1016/S0027-5107(96)00113-3; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shibata A, 2014, CLIN ONCOL R COLL RA; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Wakeford R, 2004, ONCOGENE, V23, P6404, DOI 10.1038/sj.onc.1207896; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yamaoka K, 1998, BBA-GEN SUBJECTS, V1381, P265, DOI 10.1016/S0304-4165(98)00021-X; Yatagai F, 2008, RADIAT ENVIRON BIOPH, V47, P439, DOI 10.1007/s00411-008-0179-7	45	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122582	10.1371/journal.pone.0122582	http://dx.doi.org/10.1371/journal.pone.0122582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826455	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084800081
J	Sui, JM; Wang, Y; Wang, P; Qiao, LX; Sun, SM; Hu, XH; Chen, J; Wang, JS				Sui, Jiongming; Wang, Ya; Wang, Peng; Qiao, Lixian; Sun, Shimeng; Hu, Xiaohui; Chen, Jing; Wang, Jingshan			Generation of Peanut Drought Tolerant Plants by Pingyangmycin-Mediated In Vitro Mutagenesis and Hydroxyproline-Resistance Screening	PLOS ONE			English	Article							TISSUE-CULTURE; STRESS; SELECTION	In order to enlarge the potential resources of drought-tolerant peanuts, we conducted in vitro mutagenesis with Pingyangmycin (PYM) as the mutagen as well as directed screening on a medium supplemented with Hydroxyproline (HYP). After being extracted from mature seeds (cv. Huayu 20), the embryonic leaflets were cultured on somatic embryogenesis-induction medium with 4 mg/L PYM and the generated embryos were successively transferred to a germination medium with 4 and then 8 mmol/L HYP to screen HYP-tolerant plantlets. After that, these plantlets were grafted and transplanted to the experimental field. In the next generation, all seeds were sown in the field, and phenotype variation and trait segregation can be observed in most of the offspring (M-2 generation). The M-3 generation individuals were subjected to drought stress at the seedling stages. The activities of SOD and POD were substantially increased in eight offspring of 11 HYP-tolerant, regenerated plants than in their mutagenic parents. To determine the correlation between mutant phenotypes and genomic modification, we carried out a comparison of the DNA polymorphisms between the mutagenic parents and 13 M3 generation individuals from different HYP-tolerant, regenerated plants with SSR primers. Results showed that most mutants and parent plants had signs of polymorphisms. Under drought stress, some M-3 generation individuals of 10 original HYP-tolerant, regenerated plants produced more pods than the mutagenic parent; twenty individuals among them produced >60 g pods/plant. M-4-generation seeds were tested for quality characteristics by Near Infrared Spectroscopy (NIS) and nine individuals with higher protein content (>30%) and 21 individuals with higher oil content (>58%) were screened. We concluded that the use of PYM-based in vitro mutagenesis in combination with directed screening with HYP is effective for the creation of potential drought-tolerant mutants of peanut.	[Sui, Jiongming; Wang, Ya; Wang, Peng; Qiao, Lixian; Sun, Shimeng; Wang, Jingshan] Qingdao Agr Univ, Coll Life Sci, Key Lab Qingdao Major Crop Germplasm Resource Inn, Key Lab Plant Biotechnol Univ Shandong, Qingdao, Peoples R China; [Hu, Xiaohui; Chen, Jing] Shandong Acad Agr Sci, Peanut Res Inst, Qingdao, Peoples R China	Qingdao Agricultural University; Shandong Academy of Agricultural Sciences	Wang, JS (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Qingdao Major Crop Germplasm Resource Inn, Key Lab Plant Biotechnol Univ Shandong, Qingdao, Peoples R China.	jswang319@126.com	peanut, QTL identification for seed weight and size based on a high-density SLAF-seq genetic map in/AAK-2918-2021		National Natural Science Foundation of the P. R. China [31301356, 31471542]; Shandong Province Germplasm Innovation and Utilization Project; Shandong Province science and technology development plan Project [2014GNC110002]; Natural Science Foundation of Shandong [ZR2012CM014]	National Natural Science Foundation of the P. R. China(National Natural Science Foundation of China (NSFC)); Shandong Province Germplasm Innovation and Utilization Project; Shandong Province science and technology development plan Project; Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This study was financially supported by the National Natural Science Foundation of the P. R. China (31301356 and 31471542), Shandong Province Germplasm Innovation and Utilization Project, the Shandong Province science and technology development plan Project (2014GNC110002) and the Natural Science Foundation of Shandong (ZR2012CM014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahloowalia BS, 1998, CROP PRODUCTIVITY AND SUSTAINABILITY: SHAPING THE FUTURE, P405; [Anonymous], 2007, BIOL PLANTARUM; Cao BH, 2001, J ACTA AGR BOREALL S, V16, P62; Dita MA, 2006, EUPHYTICA, V147, P1, DOI 10.1007/s10681-006-6156-9; Fuller MP, 2006, PLANT CELL TISS ORG, V86, P239, DOI 10.1007/s11240-006-9112-4; Hao SJ, 2010, J QINGDAO AGR U, V27, P110; Jain SM, 2001, EUPHYTICA, V118, P153, DOI 10.1023/A:1004124519479; Jiang HuiFang, 2004, Acta Agronomica Sinica, V30, P169; Lee JH, 2002, PLANT CELL TISS ORG, V71, P165, DOI 10.1023/A:1019957606600; Li Hong, 2008, Pratacultural Science, V25, P29; Liu JinPing, 2004, Acta Agriculturae Shanghai, V20, P19; Luan YS, 2007, PLANT CELL TISS ORG, V88, P77, DOI 10.1007/s11240-006-9183-2; Milla SR, 2005, GENOME, V48, P1, DOI [10.1139/g04-089, 10.1139/G04-089]; PATADE VY, 2009, SUGAR TECH, V11, P246, DOI DOI 10.1007/s12355-009-0042-4; Predieri S, 2001, PLANT CELL TISS ORG, V64, P185, DOI 10.1023/A:1010623203554; Qiao LX, 2012, J FOOD AGRIC ENVIRON, V10, P639; Qu W G, 2005, J CHINA AGR, V21, P197; Rai MK, 2011, ENVIRON EXP BOT, V71, P89, DOI 10.1016/j.envexpbot.2010.10.021; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Sui JM, 2013, EUPHYTICA, V189, P161, DOI 10.1007/s10681-012-0739-4; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Venkatachalam P, 1996, APPL BIOCHEM BIOTECH, V61, P351; Wang Hong, 2007, Journal of Nanjing Agricultural University, V30, P39; Wang Xi, 2009, Journal of Hebei University of Technology, V38, P5; Wu GT, 1997, J ZHEJIANG AGR U, V23, P1; Wu YX, 2002, ENVIRON POLLUT, V116, P37, DOI 10.1016/S0269-7491(01)00174-9; Zhang DL, 2008, J HUBEI AGR SCI, V47, P805; Zhang LJ, 2005, BIOTECHNOLOGY, V1, P31; [张秋英 Zhang Qiuying], 2002, [麦类作物学报, Journal of triticeae crops], V22, P66; Zhang XT, J CHINESE AGR SCI B, V27, P36; Zhao MX, 2013, EUPHYTICA, V193, P89, DOI 10.1007/s10681-013-0956-5; Zhao MX, 2007, J NUCL AGR SCI, V25	32	7	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0119240	10.1371/journal.pone.0119240	http://dx.doi.org/10.1371/journal.pone.0119240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IF	25826431	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800010
J	Chapman, AR; He, Z; Lu, SJ; Yong, J; Tan, LZ; Tang, FC; Xie, XS				Chapman, Alec R.; He, Zi; Lu, Sijia; Yong, Jun; Tan, Longzhi; Tang, Fuchou; Xie, X. Sunney			Single Cell Transcriptome Amplification with MALBAC	PLOS ONE			English	Article							MESSENGER-RNA-SEQ; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; STEM-CELLS; GASTRULATION; SMART-SEQ2; LANDSCAPE	Recently, Multiple Annealing and Looping-Based Amplification Cycles (MALBAC) has been developed for whole genome amplification of an individual cell, relying on quasilinear instead of exponential amplification to achieve high coverage. Here we adapt MALBAC for single-cell transcriptome amplification, which gives consistently high detection efficiency, accuracy and reproducibility. With this newly developed technique, we successfully amplified and sequenced single cells from 3 germ layers from mouse embryos in the early gastrulation stage, and examined the epithelial-mesenchymal transition (EMT) program among cells in the mesoderm layer on a single-cell level.	[Chapman, Alec R.; He, Zi; Lu, Sijia; Tan, Longzhi; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Yong, Jun; Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China	Harvard University; Harvard University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu		Tan, Longzhi/0000-0002-5618-1299	NIH/NCI [5DP1CA186693, 5R33CA174560]; Molecular Biophysics Training Grant Agency, National Institutes of Health (NIH)/National Institute of General Medical Sciences [T32 GM008313]; NATIONAL CANCER INSTITUTE [DP1CA186693, R33CA174560] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Biophysics Training Grant Agency, National Institutes of Health (NIH)/National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH/NCI grants 5DP1CA186693 and 5R33CA174560. ARC was supported by Molecular Biophysics Training Grant Agency, National Institutes of Health (NIH)/National Institute of General Medical Sciences Grant T32 GM008313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Topalidou I, 2011, P NATL ACAD SCI USA, V108, P4063, DOI 10.1073/pnas.1101329108; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	38	32	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120889	10.1371/journal.pone.0120889	http://dx.doi.org/10.1371/journal.pone.0120889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822772	Green Published, Green Submitted, gold			2022-12-27	WOS:000352134700079
J	Chendamarai, E; Ganesan, S; Abu Alex, A; Kamath, V; Nair, SC; Nellickal, AJ; Janet, NB; Srivastava, V; Lakshmi, KM; Viswabandya, A; Abraham, A; Aiyaz, M; Mullapudi, N; Mugasimangalam, R; Padua, RA; Chomienne, C; Chandy, M; Srivastava, A; George, B; Balasubramanian, P; Mathews, V				Chendamarai, Ezhilarasi; Ganesan, Saravanan; Abu Alex, Ansu; Kamath, Vandana; Nair, Sukesh C.; Nellickal, Arun Jose; Janet, Nancy Beryl; Srivastava, Vivi; Lakshmi, Kavitha M.; Viswabandya, Auro; Abraham, Aby; Aiyaz, Mohammed; Mullapudi, Nandita; Mugasimangalam, Raja; Padua, Rose Ann; Chomienne, Christine; Chandy, Mammen; Srivastava, Alok; George, Biju; Balasubramanian, Poonkuzhali; Mathews, Vikram			Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance	PLOS ONE			English	Article							EVOLUTION; AS2O3	There is limited data on the clinical, cellular and molecular changes in relapsed acute promyeloytic leukemia (RAPL) in comparison with newly diagnosed cases (NAPL). We undertook a prospective study to compare NAPL and RAPL patients treated with arsenic trioxide (ATO) based regimens. 98 NAPL and 28 RAPL were enrolled in this study. RAPL patients had a significantly lower WBC count and higher platelet count at diagnosis. IC bleeds was significantly lower in RAPL cases (P=0.022). The ability of malignant promyelocytes to concentrate ATO intracellularly and their in-vitro IC50 to ATO was not significantly different between the two groups. Targeted NGS revealed PML B2 domain mutations in 4 (15.38%) of the RAPL subset and none were associated with secondary resistance to ATO. A microarray GEP revealed 1744 genes were 2 fold and above differentially expressed between the two groups. The most prominent differentially regulated pathways were cell adhesion (n=92), cell survival (n=50), immune regulation (n=74) and stem cell regulation (n=51). Consistent with the GEP data, immunophenotyping revealed significantly increased CD34 expression (P=0.001) in RAPL cases and there was in-vitro evidence of significant microenvironment mediated innate resistance (EM-DR) to ATO. Resistance and relapse following treatment with ATO is probably multi-factorial, mutations in PML B2 domain while seen only in RAPL may not be the major clinically relevant cause of subsequent relapses. In RAPL additional factors such as expansion of the leukemia initiating compartment along with EM-DR may contribute significantly to relapse following treatment with ATO based regimens.	[Chendamarai, Ezhilarasi; Ganesan, Saravanan; Abu Alex, Ansu; Janet, Nancy Beryl; Lakshmi, Kavitha M.; Viswabandya, Auro; Abraham, Aby; Chandy, Mammen; Srivastava, Alok; George, Biju; Balasubramanian, Poonkuzhali; Mathews, Vikram] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Kamath, Vandana; Nair, Sukesh C.] Christian Med Coll & Hosp, Dept Transfus Med & Immunohaematol, Vellore, Tamil Nadu, India; [Nellickal, Arun Jose] Christian Med Coll & Hosp, Dept Biochem, Vellore, Tamil Nadu, India; [Srivastava, Vivi] Christian Med Coll & Hosp, Cytogenet Unit, Vellore, Tamil Nadu, India; [Aiyaz, Mohammed; Mullapudi, Nandita; Mugasimangalam, Raja] Genotyp Technol, Bengaluru, India; [Padua, Rose Ann; Chomienne, Christine] Hop St Louis, Inst Hematol, UMR 1131, F-75010 Paris, France	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Mathews, V (corresponding author), Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India.	vikram@cmcvellore.ac.in	Niranjan, Vidya/O-6464-2016; PADUA, Rose Ann/E-8621-2019; ganesan, saravanan/AAA-3775-2019; Padua, Rose Ann/GVT-5961-2022; Niranjan, Vidya/AAF-5553-2019	Niranjan, Vidya/0000-0001-9187-7753; PADUA, Rose Ann/0000-0001-9964-7864; Niranjan, Vidya/0000-0001-9187-7753; Mathews, Vikram/0000-0001-9417-2353; Ganesan, Saravanan/0000-0002-5773-1715; CHOMIENNE, Christine/0000-0001-5513-5752; Abraham, Aby/0000-0002-2596-4434	Department of Biotechnology, New Delhi, India [BT/PR7513/MED/12/287/2006]; Senior Fellowship Program of Wellcome DBT India Alliance, New Delhi, India [IA/S/11/2500267]; Council for Scientific and Industrial Research (CSIR), New Delhi, India; Genotypic Technology	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Senior Fellowship Program of Wellcome DBT India Alliance, New Delhi, India(Wellcome Trust DBT India Alliance); Council for Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Genotypic Technology	1. Department of Biotechnology, New Delhi, India, BT/PR7513/MED/12/287/2006, 2. Senior Fellowship Program of Wellcome DBT India Alliance, New Delhi, India, IA/S/11/2500267. SG is supported by senior Research fellowship from Council for Scientific and Industrial Research (CSIR), New Delhi, India. Genotypic Technology provided support in the form of salaries for authors [MA, NM and RM; employed by the company], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BREITMAN TR, 1981, BLOOD, V57, P1000; Chen GQ, 1997, BLOOD, V89, P3345; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Goto E, 2011, BLOOD, V118, P1600, DOI 10.1182/blood-2011-01-329433; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; LANOTTE M, 1991, BLOOD, V77, P1080; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F., 2006, HEMATOL-AM SOC HEMAT, V156-61, P514, DOI DOI 10.1182/ASHEDUCATI0N-2006.1.156; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Mathews V, 2005, BLOOD; Mathews V, 2010, J CLIN ONCOL, V28, P3866, DOI 10.1200/JCO.2010.28.5031; Morelli E, 2005, BIOMETALS, V18, P587, DOI 10.1007/s10534-005-2998-1; Sahu GR, 2005, AM J HEMATOL, V78, P113, DOI 10.1002/ajh.20235; Sanz MA, 2005, HAEMATOLOGICA, V90, P1231; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Tallman MS, 2007, BEST PRACT RES CL HA, V20, P57, DOI 10.1016/j.beha.2006.11.002; Tallman Martin S, 2010, Clin Adv Hematol Oncol, V8, P89; Thirugnanam R, 2009, BIOL BLOOD MARROW TR, V15, P1479, DOI 10.1016/j.bbmt.2009.07.010; Wojiski S, 2009, LEUKEMIA, V23, P1462, DOI 10.1038/leu.2009.63; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu HH, 2014, NEW ENGL J MED, V370, P1864, DOI 10.1056/NEJMc1316382	27	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121912	10.1371/journal.pone.0121912	http://dx.doi.org/10.1371/journal.pone.0121912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822503	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700136
J	Fu, X; Feng, JF				Fu, Xiang; Feng, Jufu			Minutia Tensor Matrix: A New Strategy for Fingerprint Matching	PLOS ONE			English	Article								Establishing correspondences between two minutia sets is a fundamental issue in fingerprint recognition. This paper proposes a new tensor matching strategy. First, the concept of minutia tensor matrix (simplified as MTM) is proposed. It describes the first-order features and second-order features of a matching pair. In the MTM, the diagonal elements indicate similarities of minutia pairs and non-diagonal elements indicate pairwise compatibilities between minutia pairs. Correct minutia pairs are likely to establish both large similarities and large compatibilities, so they form a dense sub-block. Minutia matching is then formulated as recovering the dense sub-block in the MTM. This is a new tensor matching strategy for fingerprint recognition. Second, as fingerprint images show both local rigidity and global nonlinearity, we design two different kinds of MTMs: local MTM and global MTM. Meanwhile, a two-level matching algorithm is proposed. For local matching level, the local MTM is constructed and a novel local similarity calculation strategy is proposed. It makes full use of local rigidity in fingerprints. For global matching level, the global MTM is constructed to calculate similarities of entire minutia sets. It makes full use of global compatibility in fingerprints. Proposed method has stronger description ability and better robustness to noise and nonlinearity. Experiments conducted on Fingerprint Verification Competition databases (FVC2002 and FVC2004) demonstrate the effectiveness and the efficiency.	[Fu, Xiang; Feng, Jufu] Peking Univ, Key Lab Machine Percept MOE, Dept Machine Intelligence, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China	Peking University	Fu, X (corresponding author), Peking Univ, Room 2112,Sci Bldg 2, Beijing 100871, Peoples R China.	fuxiangpku@163.com			National 973 project in China [61333015, 2011CB302400]	National 973 project in China(National Basic Research Program of China)	The study was granted by National 973 project (No. 61333015, No. 2011CB302400) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Medina-Perez MA, 2012, SENSORS-BASEL, V12, P3418, DOI 10.3390/s120303418; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Cao J, 2009, 6 INT S MULT IM PROC; Cappelli R, 2006, IEEE T PATTERN ANAL, V28, P3, DOI 10.1109/TPAMI.2006.20; Cappelli R, 2010, IEEE T PATTERN ANAL, V32, P2128, DOI 10.1109/TPAMI.2010.52; Chen XJ, 2004, LECT NOTES COMPUT SC, V3211, P360; Chikkerur S, 2006, LECT NOTES COMPUT SC, V3832, P309; Choi H, 2011, IEEE T INF FOREN SEC, V6, P338, DOI 10.1109/TIFS.2010.2103940; Chongjin Liu, 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P3201, DOI 10.1109/ICIP.2011.6116349; Duchenne O, 2011, IEEE T PATTERN ANAL, V33, P2383, DOI 10.1109/TPAMI.2011.110; Feng YS, 2006, INT C PATT RECOG, P374; Fu X, 2012, INT C PATT RECOG, P1743; Fu XJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/159157; HORAUD R, 1989, IEEE T PATTERN ANAL, V11, P1168, DOI 10.1109/34.42855; Izadi M. H., 2012, 2012 IEEE Fifth International Conference On Biometrics: Theory, Applications And Systems (BTAS 2012), P353, DOI 10.1109/BTAS.2012.6374600; Jain AK, 2007, IEEE T PATTERN ANAL, V29, P15, DOI 10.1109/TPAMI.2007.250596; Jea TY, 2005, PATTERN RECOGN, V38, P1672, DOI 10.1016/j.patcog.2005.03.016; Leordeanu M, 2005, IEEE I CONF COMP VIS, P1482; Li J., 2008, BMVC, P1, DOI DOI 10.1109/OCEANSKOBE.2008.4530947; Maio D, 2002, INT C PATT RECOG, P811, DOI 10.1109/ICPR.2002.1048144; Maltoni D., 2009, HDB FINGERPRINT RECO; Thuy NTH, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTING, MANAGEMENT AND TELECOMMUNICATIONS (COMMANTEL), P334, DOI 10.1109/ComManTel.2013.6482416; Ratha NK, 2000, FIFTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P29; Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920; Wen W, 2013, 2013 SECOND IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION (ACPR 2013), P201, DOI 10.1109/ACPR.2013.43; Xu WQ, 2007, LECT NOTES COMPUT SC, V4642, P134	26	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118910	10.1371/journal.pone.0118910	http://dx.doi.org/10.1371/journal.pone.0118910			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822489	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700026
J	Kenchington, EL; Nakashima, BS; Taggart, CT; Hamilton, LC				Kenchington, Ellen L.; Nakashima, Brian S.; Taggart, Christopher T.; Hamilton, Lorraine C.			Genetic Structure of Capelin (Mallotus villosus) in the Northwest Atlantic Ocean	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; CIRCUMPOLAR MARINE FISH; POPULATION DIFFERENTIATION; MICROSATELLITE LOCUS; CONFIDENCE-INTERVALS; COMPLEX EVOLUTION; SCOTIAN SHELF; SIZE; NEWFOUNDLAND; INFERENCE	Capelin (Mallotus villosus) is a commercially exploited, key forage-fish species found in the boreal waters of the North Pacific and North Atlantic Oceans. We examined the population structure of capelin throughout their range in the Canadian northwest Atlantic Ocean using genetic-based methods. Capelin collected at ten beach and five demersal spawning locations over the period 2002 through 2008 (N = 3,433 fish) were genotyped using six polymorphic microsatellite loci. Temporally distinct samples were identified at three beach spawning locations: Chance Cove, Little Lawn and Straitsview, Newfoundland. Four capelin stocks are assumed for fisheries management in the northwest Atlantic Ocean based on meristics, morphometrics, tag returns, and seasonal distribution patterns. Our results suggested groupings that were somewhat different than the assumed structure, and indicate at least seven genetically defined populations arising from two ancestral populations. The spatial mosaic of capelin from each of the two basal cluster groups explains much of the observed geographic variability amongst neighbouring samples. The genetic-defined populations were resolved at Jost's D-est >= 0.01 and were composed of fish collected 1) in the Gulf of St. Lawrence, 2) along the south and east coasts of Newfoundland, 3) along coastal northern Newfoundland and southern Labrador, 4) along coastal northern Labrador, 5) near the Saguenay River, and at two nearshore demersal spawning sites, 6) one at Grebes Nest off Bellevue Beach on the east coast of Newfoundland, and 7) one off the coast of Labrador at Domino Run. Moreover, the offshore demersal spawners on the Scotian Shelf and Southeast Shoal appeared to be related to the inshore demersal spawners at Grebes Nest and in Domino Run and to beach spawners from the Gulf of St. Lawrence.	[Kenchington, Ellen L.; Hamilton, Lorraine C.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada; [Nakashima, Brian S.] Northwest Atlantic Fisheries Ctr, Dept Fisheries & Oceans, St John, NF, Canada; [Taggart, Christopher T.] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Dalhousie University	Kenchington, EL (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca			Canadian Biotechnology Strategy; Oceans Genomics Research and Development Initiative; Natural Sciences and Engineering Council of Canada; Canadian Council for Human Resources in the Environment Industry	Canadian Biotechnology Strategy; Oceans Genomics Research and Development Initiative; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Council for Human Resources in the Environment Industry	This work was supported by Canadian Biotechnology Strategy funds to BN, EK, and CT (http://www.hc-sc.gc.ca/sr-sr/biotech/role/strateg-eng.php), Oceans Genomics Research and Development Initiative funds to EK (http://grdi-irdg.collaboration.gc.ca/eng/about), and Natural Sciences and Engineering Council of Canada and Canadian Council for Human Resources in the Environment Industry (http://thegreenpages.ca/ca/2002/06/13/cchrei_the_canadian_council_fo/) funding to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 1997, MOL BIOL EVOL, V14, P230, DOI 10.1093/oxfordjournals.molbev.a025759; Bekkevold D, 2005, EVOLUTION, V59, P2656; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Birt TP, 1995, MOL ECOL, V4, P771, DOI 10.1111/j.1365-294X.1995.tb00278.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bull LN, 1999, GENOME RES, V9, P830, DOI 10.1101/gr.9.9.830; Campbell JS, 1973, ICNAF REDBOOK, V1973, P137; Carscadden JE, 2002, ICES J MAR SCI, V59, P863, DOI 10.1006/jmsc.2002.1283; Carscadden JE, 2001, CAN J FISH AQUAT SCI, V58, P73, DOI 10.1139/cjfas-58-1-73; CARSCADDEN JE, 1989, CAN J FISH AQUAT SCI, V46, P1743, DOI 10.1139/f89-221; Carscadden JE, 1997, FORAGE FISHES MARINE, P437; Carscadden JE., 1984, FAO FISH REP, V291, P789; Chao A, 2010, PROGRAM USERS GUIDE; Colbeck GJ, 2011, MOL ECOL, V20, P1976, DOI 10.1111/j.1365-294X.2011.05069.x; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Davoren GK, 2006, CAN J FISH AQUAT SCI, V63, P268, DOI 10.1139/F05-204; DODSON JJ, 1991, MAR ECOL PROG SER, V76, P103, DOI 10.3354/meps076103; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; ESTOUP A, 1995, MOL BIOL EVOL, V12, P1074; Flynn SR, 2001, J MAR BIOL ASSOC UK, V81, P307, DOI 10.1017/S0025315401003782; Frank KT, 1996, CAN J FISH AQUAT SCI, V53, P1473, DOI 10.1139/f96-078; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gardner MJ, 1984, CONFIDENCE INTERVALS, P15; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gordos K, 2005, MOL ECOL NOTES, V5, P220, DOI 10.1111/j.1471-8286.2004.00882.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hammill M.O., 2000, Journal of Northwest Atlantic Fishery Science, V26, P1, DOI 10.2960/J.v26.a1; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Liu JX, 2009, J FISH BIOL, V75, P442, DOI 10.1111/j.1095-8649.2009.02340.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; McPherson AA, 2004, T AM FISH SOC, V133, P434, DOI 10.1577/02-106; McPherson AA, 2003, MAR ECOL PROG SER, V247, P303, DOI 10.3354/meps247303; MISRA R K, 1984, Journal of Northwest Atlantic Fishery Science, V5, P199; MISRA RK, 1987, J CONSEIL, V43, P99; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Nakashima BS, 2002, ICES J MAR SCI, V59, P909, DOI 10.1006/jmsc.2002.1261; Nakashima BS, 2002, ICES J MAR SCI, V59, P897, DOI 10.1006/jmsc.2002.1260; NAKASHIMA BS, 1992, CAN J FISH AQUAT SCI, V49, P2423, DOI 10.1139/f92-268; NYHOLMEN O, 1988, J CONSEIL, V44, P264; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Praebel K, 2008, MAR ECOL PROG SER, V360, P189, DOI 10.3354/meps07363; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Regular PM, 2009, ENVIRON MONIT ASSESS, V156, P293, DOI 10.1007/s10661-008-0484-2; Reiss CS, 2000, FISH OCEANOGR, V9, P195; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROBY D, 1991, CAN J FISH AQUAT SCI, V48, P2040, DOI 10.1139/f91-243; Roed KH, 2003, MAR ECOL PROG SER, V262, P299, DOI 10.3354/meps262299; Rose GA, 2002, ICES J MAR SCI, V59, P1018, DOI 10.1006/jmsc.2002.1252; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SHACKELL NL, 1994, CAN J FISH AQUAT SCI, V51, P642, DOI 10.1139/f94-065; Sim J, 1999, PHYS THER, V79, P186, DOI 10.1093/ptj/79.2.186; Skurikhina LA, 2008, RUSS J GENET+, V44, P808, DOI 10.1134/S1022795408070089; Szpiech Z., 2008, ADZE ALLELIC DIVERSI; Templeman W., 1948, B NEWFOUNDLAND GOV L; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	67	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122315	10.1371/journal.pone.0122315	http://dx.doi.org/10.1371/journal.pone.0122315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822621	gold, Green Published			2022-12-27	WOS:000352134700166
J	Manson, KF; Levy, I				Manson, Kirk F.; Levy, Ifat			"Selling" Value: The Influence of Language on Willingness-to-Accept	PLOS ONE			English	Article							ENDOWMENT; CONSUMER; EMOTIONS	In behavioral economics, the "endowment effect" describes the robust finding that prices people are willing to accept (WTA) for a good exceed prices people are willing to pay (WTP) for the same good. The increase in WTA values is often explained by the sellers' negative hedonic response to losing their item. Recent studies, however, show that subtle cues may change participants' perspective, influencing their valuations. We hypothesized that implicit connotations of instructional language may be one of those cues. To test this hypothesis we manipulated the wording of instructions in two conditions: in the Sell condition, subjects were endowed with a set of pens and asked to select an amount of money for which they would sell the pens back and in the Take condition, subjects were endowed with the pens and asked to select an amount of money they would take for the pens. Participants in each condition also estimated the market value of the pens. Consistent with our hypothesis, WTA in the Sell condition was higher than in the Take condition, though there were no differences in market values between conditions. These findings show that instructional language does influence participant valuations. Furthermore, we suggest that those being asked to "sell" use their market estimations as the salient reference point in the transaction.	[Manson, Kirk F.; Levy, Ifat] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Levy, Ifat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University	Levy, I (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA.	Ifat.Levy@yale.edu			NIH [R01AG033406]; Yale University; NATIONAL INSTITUTE ON AGING [R01AG033406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by NIH grant R01AG033406 to IL and by IL's start-up funds from Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2005, J MARKETING RES, V42, P134, DOI 10.1509/jmkr.42.2.134.62283; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Brown TC, 2005, J ECON BEHAV ORGAN, V57, P367, DOI 10.1016/j.jebo.2003.10.010; Carmon Z, 2000, J CONSUM RES, V27, P360, DOI 10.1086/317590; Chartrand TL, 2008, J CONSUM RES, V35, P189, DOI 10.1086/588685; Dijksterhuis A, 2005, J CONSUM PSYCHOL, V15, P193, DOI 10.1207/s15327663jcp1503_3; Franciosi R, 1996, J ECON BEHAV ORGAN, V30, P213, DOI 10.1016/S0167-2681(96)00858-X; Horowitz JK, 2002, J ENVIRON ECON MANAG, V44, P426, DOI 10.1006/jeem.2001.1215; Johnson EJ, 2007, J EXP PSYCHOL LEARN, V33, P461, DOI 10.1037/0278-7393.33.3.461; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lerner JS, 2004, PSYCHOL SCI, V15, P337, DOI 10.1111/j.0956-7976.2004.00679.x; Mandel DR, 2002, ORGAN BEHAV HUM DEC, V88, P737, DOI 10.1016/S0749-5978(02)00013-4; Nayakankuppam D, 2005, J CONSUM RES, V32, P390, DOI 10.1086/497550; Pachur T, 2012, J EXP PSYCHOL LEARN, V38, P1108, DOI 10.1037/a0027637; Plott CR, 2007, AM ECON REV, V97, P1449, DOI 10.1257/aer.97.4.1449; Simonson I, 2004, J CONSUM RES, V31, P681, DOI 10.1086/425103; Simonson I, 2005, SSRN WEBSITE, DOI [10.2139/ssrn.678321, DOI 10.2139/SSRN.678321]; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tom G, 2006, PSYCHOL MARKET, V23, P1, DOI 10.1002/mar.20107; Tom G, 2004, J PSYCHOL, V138, P160, DOI 10.3200/JRLP.138.2.160-170; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Weaver R, 2012, J MARKETING RES, V49, P696, DOI 10.1509/jmr.09.0103; Zhang Y, 2005, J CONSUM PSYCHOL, V15, P316, DOI 10.1207/s15327663jcp1504_6	23	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0120292	10.1371/journal.pone.0120292	http://dx.doi.org/10.1371/journal.pone.0120292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AD	25822825	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700059
J	Marsh, AK; Ambagala, AP; Perciani, CT; Russell, JNH; Chan, JK; Janes, M; Antony, JM; Pilon, R; Sandstrom, P; Willer, DO; MacDonald, KS				Marsh, Angie K.; Ambagala, Aruna P.; Perciani, Catia T.; Russell, Justen N. Hoffman; Chan, Jacqueline K.; Janes, Michelle; Antony, Joseph M.; Pilon, Richard; Sandstrom, Paul; Willer, David O.; MacDonald, Kelly S.			Examining the Species-Specificity of Rhesus Macaque Cytomegalovirus (RhCMV) in Cynomolgus Macaques	PLOS ONE			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; VARICELLA-ZOSTER-VIRUS; COMPLETE DNA-SEQUENCE; HERPES-SIMPLEX-VIRUS; T-CELL RESPONSES; MACACA-FASCICULARIS; GENOME; INFECTION; STRAINS; SUPERINFECTION	Cytomegalovirus (CMV) is a highly species-specific virus that has co-evolved with its host over millions of years and thus restricting cross-species infection. To examine the extent to which host restriction may prevent cross-species research between closely related non-human primates, we evaluated experimental infection of cynomolgus macaques with a recombinant rhesus macaque-derived CMV (RhCMV-eGFP). Twelve cynomolgus macaques were randomly allocated to three groups: one experimental group (RhCMV-eGFP) and two control groups (UV-inactivated RhCMV-eGFP or media alone). The animals were given two subcutaneous inoculations at week 0 and week 8, and a subset of animals received an intravenous inoculation at week 23. No overt clinical or haematological changes were observed and PBMCs isolated from RhCMV-eGFP inoculated animals had comparable eGFP- and IE-1-specific cellular responses to the control animals. Following inoculation with RhCMV-eGFP, we were unable to detect evidence of infection in any blood or tissue samples up to 4 years post-inoculation, using sensitive viral co-culture, qPCR, and Western blot assays. Co-culture of urine and saliva samples demonstrated the presence of endogenous cynomolgus CMV (CyCMV) cytopathic effect, however no concomitant eGFP expression was observed. The absence of detectable RhCMV-eGFP suggests that the CyCMV-seropositive cynomolgus macaques were not productively infected with RhCMV-eGFP under these inoculation conditions. In a continued effort to develop CMV as a viral vector for an HIV/SIV vaccine, these studies demonstrate that CMV is highly restricted to its host species and can be highly affected by laboratory cell culture. Consideration of the differences between lab-adapted and primary viruses with respect to species range and cell tropism should be a priority in evaluating CMV as vaccine vector for HIV or other pathogens at the preclinical development stage.	[Marsh, Angie K.; Perciani, Catia T.; Russell, Justen N. Hoffman; MacDonald, Kelly S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ambagala, Aruna P.; Chan, Jacqueline K.; Antony, Joseph M.; Willer, David O.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Janes, Michelle; Pilon, Richard; Sandstrom, Paul] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Ambagala, Aruna P.; Willer, David O.; MacDonald, Kelly S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Public Health Agency of Canada; University of Toronto	MacDonald, KS (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	kelly.macdonald@utoronto.ca	Perciani, Catia/S-9093-2019; MacDonald, Kelly S/L-3315-2019	Russell, Justen/0000-0002-5275-0116; Perciani, Catia/0000-0003-0377-1778	Canadian Institutes of Health Research (CIHR) Doctoral Research Award; Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN); Vanier Scholarship; OHTN; CIHR [107743]	Canadian Institutes of Health Research (CIHR) Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN); Vanier Scholarship; OHTN; CIHR(Canadian Institutes of Health Research (CIHR))	AKM was supported by the Canadian Institutes of Health Research (CIHR) Doctoral Research Award. DOW was supported by a Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN). CTP is the recipient of the Vanier Scholarship. APA and KSM also received funding from the OHTN as a postdoctoral fellowship and career scientist award, respectively. This research was funded in part by the OHTN. This work was supported by CIHR Grant # 107743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2006, BRIT J DERMATOL, V154, P365, DOI 10.1111/j.1365-2133.2005.06936.x; Ambagala AP, 2013, ARCH VIROL, V158, P955, DOI 10.1007/s00705-012-1568-4; Ambagala APN, 2011, VIROLOGY, V412, P125, DOI 10.1016/j.virol.2010.12.049; Andrade MR, 2003, AM J PRIMATOL, V59, P123, DOI 10.1002/ajp.10069; ASANO Y, 1984, J MED VIROL, V14, P305, DOI 10.1002/jmv.1890140403; ASHER DM, 1974, P SOC EXP BIOL MED, V145, P794; Assaf BT, 2012, J VIROL, V86, P6354, DOI 10.1128/JVI.00607-12; Bahr U, 2001, J VIROL, V75, P4854, DOI 10.1128/JVI.75.10.4854-4870.2001; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Beyari MM, 2003, J INFECT DIS, V188, P678, DOI 10.1086/377504; Blewett EL, 2001, ARCH VIROL, V146, P1723, DOI 10.1007/s007050170059; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Brooks JI, 2007, TRANSFUSION, V47, P162, DOI 10.1111/j.1537-2995.2007.01079.x; CHANDLER SH, 1987, J INFECT DIS, V155, P655, DOI 10.1093/infdis/155.4.655; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chang WLW, 2002, J VIROL, V76, P9493, DOI 10.1128/JVI.76.18.9493-9504.2002; Chang WLW, 2002, J VIROL METHODS, V104, P135, DOI 10.1016/S0166-0934(02)00060-5; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Cicin-Sain L, 2011, J IMMUNOL, V187, P1722, DOI 10.4049/jimmunol.1100560; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; DREW WL, 1984, J INFECT DIS, V150, P952, DOI 10.1093/infdis/150.6.952; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Ebeling M, 2011, GENOME RES, V21, P1746, DOI 10.1101/gr.123117.111; FIORETTI A, 1973, J VIROL, V11, P998, DOI 10.1128/JVI.11.6.998-1003.1973; Gerardo Abenes, 2008, [Virologica Sinica, 中国病毒学], V23, P438, DOI 10.1007/s12250-008-3003-2; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hansen SG, 2003, J VIROL, V77, P6620, DOI 10.1128/JVI.77.12.6620-6636.2003; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Kanai K, 2011, J GEN VIROL, V92, P1005, DOI 10.1099/vir.0.027789-0; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Kaur A, 2003, J VIROL, V77, P5749, DOI 10.1128/JVI.77.10.5749-5758.2003; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Lockridge KM, 1999, J VIROL, V73, P9576, DOI 10.1128/JVI.73.11.9576-9583.1999; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marsh AK, 2011, J VIROL, V85, P12995, DOI 10.1128/JVI.05840-11; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Meyer-Konig U, 1998, LANCET, V352, P1280, DOI 10.1016/S0140-6736(05)70487-6; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07; Oxford KL, 2011, J VIROL, V85, P5105, DOI 10.1128/JVI.02631-10; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Remeijer L, 2002, INVEST OPHTH VIS SCI, V43, P358; Rivailler P, 2006, J VIROL, V80, P4179, DOI 10.1128/JVI.80.8.4179-4182.2006; SAKAOKA H, 1995, J MED VIROL, V46, P387, DOI 10.1002/jmv.1890460416; Schleiss MR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-139; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; SPECTOR SA, 1984, J INFECT DIS, V150, P953, DOI 10.1093/infdis/150.6.953; SWINKELS BW, 1984, ARCH VIROL, V82, P125, DOI 10.1007/BF01309376; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; TAYLOR DL, 1988, EPIDEMIOL INFECT, V101, P483, DOI 10.1017/S095026880002937X; Trask JAS, 2013, AM J PRIMATOL, V75, P135, DOI 10.1002/ajp.22091; Vink C, 2000, J VIROL, V74, P7656, DOI 10.1128/JVI.74.16.7656-7665.2000; Voevodin AF, 2009, SIMIAN VIROLOGY, P217; Walling DM, 2003, J VIROL, V77, P6546, DOI 10.1128/JVI.77.11.6546-6550.2003; Willer DO, 2012, J VIROL, V86, P3626, DOI 10.1128/JVI.06264-11; Willer DO, 2010, J VIROL, V84, P2304, DOI 10.1128/JVI.01995-09; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992	72	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121339	10.1371/journal.pone.0121339	http://dx.doi.org/10.1371/journal.pone.0121339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822981	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700100
J	Meza, R; Meernik, C; Jeon, J; Cote, ML				Meza, Rafael; Meernik, Clare; Jeon, Jihyoun; Cote, Michele L.			Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973-2010	PLOS ONE			English	Article							CIGARETTE-SMOKING; AFRICAN-AMERICANS; RISK; ADENOCARCINOMA; EPIDEMIOLOGY; RATES; SURVEILLANCE; POPULATION; MORTALITY; PATTERNS	Background Lung cancer (LC) incidence in the United States (US) continues to decrease but with significant differences by histology, gender and race. Whereas squamous, large and small cell carcinoma rates have been decreasing since the mid-80s, adenocarcinoma rates remain stable in males and continue to increase in females, with large racial disparities. We analyzed LC incidence trends by histology in the US with an emphasis on gender and racial differences. Methods LC incidence rates from 1973-2010 were obtained from the SEER cancer registry. Age-adjusted incidence trends of five major histological types by gender and race were evaluated using joinpoint regression. Trends of LC histology and stage distributions from 2005-2010 were analyzed. Results US LC incidence varies by histology. Squamous, large and small cell carcinoma rates continue to decrease for all gender/race combinations, whereas adenocarcinoma rates remain relatively constant in males and increasing in females. An apparent recent increase in the incidence of squamous cell carcinoma and adenocarcinoma since 2005 can be explained by a concomitant decrease in the number of cases classified as other non-small cell carcinoma. Black males continue to be disproportionally affected by squamous LCs, and blacks continue to be diagnosed with more advanced cancers than whites. Conclusions LC incidence by histology continues to change over time. Additional variations are expected as screening becomes disseminated. It is important to continue to monitor LC rates to evaluate the impact of screening on current trends, assess the continuing benefits of tobacco control, and focus efforts on reducing racial disparities.	[Meza, Rafael; Meernik, Clare] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Jeon, Jihyoun] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Cote, Michele L.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Wayne State University	Meza, R (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	rmeza@umich.edu	Meernik, Clare/O-2995-2016	Meernik, Clare/0000-0002-8564-1266	Cancer Intervention and Modeling Network (CISNET); National Cancer Institute through National Cancer Institute [U01-CA152956]; National Cancer Institute through Centers for Disease Control and Prevention [U01-CA152956-3S2]; NATIONAL CANCER INSTITUTE [U01CA152956] Funding Source: NIH RePORTER	Cancer Intervention and Modeling Network (CISNET); National Cancer Institute through National Cancer Institute; National Cancer Institute through Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RM received funding from the Cancer Intervention and Modeling Network (CISNET) award, National Cancer Institute U01-CA152956 through an interagency agreement between the National Cancer Institute (http://www.cancer.gov/) and the Centers for Disease Control and Prevention (http://www.cdc.gov/) (U01-CA152956-3S2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; American Cancer Society, 2014, CANC FACTS FIG AFR A; Burns DM, 2011, CANCER CAUSE CONTROL, V22, P389, DOI 10.1007/s10552-010-9708-1; Burns DM, 2011, CANCER CAUSE CONTROL, V22, P13, DOI 10.1007/s10552-010-9660-0; Conde E, 2013, CLIN TRANSL ONCOL, V15, P503, DOI 10.1007/s12094-012-0983-z; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Egevad L, 2008, IARC SCI PUBLICATION, V160; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; Janssen-Heijnen MLG, 2001, LUNG CANCER, V31, P123, DOI 10.1016/S0169-5002(00)00197-5; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Khuder SA, 2001, CHEST, V120, P1577, DOI 10.1378/chest.120.5.1577; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Li X, 2001, EUR J CANCER PREV, V10, P227, DOI 10.1097/00008469-200106000-00005; Ma JM, 2013, CANCER-AM CANCER SOC, V119, P1381, DOI 10.1002/cncr.27813; Makitaro R, 1999, EUR RESPIR J, V13, P436, DOI 10.1034/j.1399-3003.1999.13b36.x; McCarthy WJ, 2012, RISK ANAL, V32, pS69, DOI 10.1111/j.1539-6924.2012.01768.x; MORABIA A, 1991, CANCER, V68, P2074, DOI 10.1002/1097-0142(19911101)68:9<2074::AID-CNCR2820680939>3.0.CO;2-X; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Pinsky PF, 2006, CANCER CAUSE CONTROL, V17, P1017, DOI 10.1007/s10552-006-0038-2; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spitz MR, 2013, J THORAC ONCOL, V8, P391, DOI 10.1097/JTO.0b013e318283da29; Surveillance E and End Results (SEER) Program, 2012, SEER STAT DAT INC SE; Surveillance Research Program National Cancer Institute, SEER STAT SOFTW VERS; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; Travis WD, 1996, CANCER-AM CANCER SOC, V77, P2464, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2464::AID-CNCR8>3.0.CO;2-M; Tse LA, 2009, LUNG CANCER, V66, P22, DOI 10.1016/j.lungcan.2008.12.023; U. S. Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE, P139; Yoshimi I, 2003, JPN J CLIN ONCOL, V33, P98, DOI 10.1093/jjco/hyg019; Yun YH, 2005, CANCER EPIDEM BIOMAR, V14, P2125, DOI 10.1158/1055-9965.EPI-05-0236	42	207	217	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121323	10.1371/journal.pone.0121323	http://dx.doi.org/10.1371/journal.pone.0121323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822850	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700099
J	Page, SK; Parker, DM; Peinke, DM; Davies-Mostert, HT				Page, Samantha K.; Parker, Daniel M.; Peinke, Dean M.; Davies-Mostert, Harriet T.			Assessing the Potential Threat Landscape of a Proposed Reintroduction Site for Carnivores	PLOS ONE			English	Article							AFRICAN WILD DOGS; FISH RIVER RESERVE; LYCAON-PICTUS; LIVESTOCK PREDATION; BLACK RHINOCEROS; PROTECTED AREAS; ATTITUDES; CONFLICT; COMMUNITIES; POPULATION	This study provides a framework to assess the feasibility of reintroducing carnivores into an area, using African wild dogs (Lycaon pictus) as an example. The Great Fish River Nature Reserve in the Eastern Cape Province, South Africa, has been identified as a potential reserve to reintroduce wild dogs, and we applied this framework to provide a threat assessment of the surrounding area to determine potential levels of human-wildlife conflict. Although 56% of neighbouring landowners and local communities were positive about a wild dog reintroduction, data collected from questionnaire surveys revealed that human-wild dog conflict is a potential threat to wild dog survival in the area. Additional potential threats include diseases, snaring, poaching and hunting wild dogs for the use of traditional medicine. A threat index was developed to establish which properties harboured the greatest threats to wild dogs. This index was significantly influenced by the respondent's first language (isiXhosa had more positive indices), education level (poorer education was synonymous with more positive threat indices), land use (wildlife ranching being the most negative) and land tenure (community respondents had more positive indices than private landowners). Although threats are present, they can be effectively mitigated through strategies such as carnivore education programs, vaccination campaigns and anti-snare patrols to promote a successful reintroduction of this endangered canid.	[Page, Samantha K.; Parker, Daniel M.] Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa; [Page, Samantha K.; Davies-Mostert, Harriet T.] Endangered Wildlife Trust, Johannesburg, South Africa; [Peinke, Dean M.] Eastern Cape Parks & Tourism Agcy, East London, South Africa	Rhodes University	Page, SK (corresponding author), Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa.	samkpage23@gmail.com	Parker, Daniel/J-2649-2019	Parker, Daniel/0000-0001-7555-5674; Davies-Mostert, Harriet/0000-0001-7824-4863	Eastern Cape Parks & Tourism Agency and Wildlife; Reserve Management Group (Rhodes University); South African National Research Foundation (NRF)	Eastern Cape Parks & Tourism Agency and Wildlife; Reserve Management Group (Rhodes University); South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The Eastern Cape Parks & Tourism Agency and Wildlife (http://www.visiteasterncape.co.za/) and Reserve Management Group (Rhodes University - http://www.wrmrg.co.za/) provided funding for the collection of surveys for the study (i.e. data design, data collection, decision to publish, hosting workshops, petrol costs, printing costs etc). The South African National Research Foundation (NRF - http://www.nrf.ac.za/) awarded SKP a personal Scholarship for her masters degree to allow for this study. However, the NRF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Anthony B, 2007, ENVIRON CONSERV, V34, P236, DOI 10.1017/S0376892907004018; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cocks ML, 2012, S AFR J SCI, V108, P52, DOI 10.4102/sajs.v108i5/6.880; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 1998, ANIM CONSERV, V1, P1, DOI 10.1111/j.1469-1795.1998.tb00220.x; Davies HT, 2004, ORYX, V38, P32, DOI 10.1017/S0030605304000067; Davies-Mostert H., 2009, MANAGED METAPOPULATI; Davies-Mostert HT, 2013, J APPL ECOL, V50, P1358, DOI 10.1111/1365-2664.12129; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Eastern Cape Parks Tourism Agency, 2012, STRAT MAN PLAN UNPUB; Estes, 1993, SAFARI COMPANION GUI; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fitzpatrick MC, 2012, PLOS NEGLECT TROP D, V6, P1; Fitzsimons FW, 1919, NATURAL HIST S AFRIC; Ganqa NM, 2005, S AFR J WILDL RES, V35, P77; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Gusset M, 2006, J ZOOL, V270, P502, DOI 10.1111/j.1469-7998.2006.00168.x; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; IUCN, 2014, RED LIST THREAT SPEC; IUCN/SSC Reintroduction Specialist Group, 2013, GUID REINTR OTH CONS; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Leigh KA., 2005, THESIS U SYDNEY SYDN; Lent PC, 2003, S AFR J WILDL RES, V33, P109; Lindsey P, 2004, S AFR J WILDL RES, V34, P143; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; Lindsey PA, 2009, NAT CONS ACT PLANN W, P1; Mills MGL, 2014, POPULATION HABITAT V; Minutes WAG-SA, 2014, END WILDL TRUST; Motulsky H., 2014, INTUITIVE BIOSTATIST, P203; NIEMANN SM, 2010, THESIS U KWAZULU NAT; Nilsen EB, 2007, P ROY SOC B-BIOL SCI, V274, P995, DOI 10.1098/rspb.2006.0369; Nyhus P.J., 2003, CONSERV PRACT, V4, P37, DOI DOI 10.1111/J.1526-4629.2003.TB00061.X; Page S.K., 2014, THESIS RHODES U S AF; Parker Daniel M., 2014, Human Dimensions of Wildlife, V19, P512, DOI 10.1080/10871209.2014.926575; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prager KC, 2012, BIOL CONSERV, V150, P15, DOI 10.1016/j.biocon.2012.03.005; Rodriguez M, 2003, WILDLIFE SOC B, V31, P971; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Schumann B, 2012, ORYX, V46, P604, DOI 10.1017/S0030605311000779; Smithers RHN, 1983, MAMMALS SO AFRICAN S; Spiliotopoulou G, 2009, AUST OCCUP THER J, V56, P150, DOI 10.1111/j.1440-1630.2009.00785.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thorn M, 2013, BIODIVERS CONSERV, V22, P1715, DOI 10.1007/s10531-013-0508-2; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Trollope WSW, 2004, P 2004 THICK FOR, p[91, 112]; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Whittington-Jones BM, 2014, S AFR J WILDL RES, V44, P135, DOI 10.3957/056.044.0201; Woodroffe R, 2005, BIOL CONSERV, V124, P225, DOI 10.1016/j.biocon.2005.01.028; Woodroffe R., 2012, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2012.RLTS.T12436A16711116.en; Woodroffe R, 2007, ORYX, V41, P215, DOI 10.1017/S0030605307001809; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992	57	5	5	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0122782	10.1371/journal.pone.0122782	http://dx.doi.org/10.1371/journal.pone.0122782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822468	Green Published, gold, Green Submitted			2022-12-27	WOS:000352134700195
J	Ruiz-Miyazawa, KW; Zarpelon, AC; Pinho-Ribeiro, FA; Pavao-de-Souza, GF; Casagrande, R; Verri, WA				Ruiz-Miyazawa, Kenji W.; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Pavao-de-Souza, Gabriela F.; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Vinpocetine Reduces Carrageenan-Induced Inflammatory Hyperalgesia in Mice by Inhibiting Oxidative Stress, Cytokine Production and NF-kappa B Activation in the Paw and Spinal Cord	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NEUTROPHIL RECRUITMENT; SODIUM-CHANNELS; VALPROIC ACID; FORMALIN TEST; TNF-ALPHA; RAT; PAIN; STIMULATION; EXPRESSION	Vinpocetine is a safe nootropic agent used for neurological and cerebrovascular diseases. The anti-inflammatory activity of vinpocetine has been shown in cell based assays and animal models, leading to suggestions as to its utility in analgesia. However, the mechanisms regarding its efficacy in inflammatory pain treatment are still not completely understood. Herein, the analgesic effect of vinpocetine and its anti-inflammatory and antioxidant mechanisms were addressed in murine inflammatory pain models. Firstly, we investigated the protective effects of vinpocetine in overt pain-like behavior induced by acetic acid, phenyl-p-benzoquinone (PBQ) and formalin. The intraplantar injection of carrageenan was then used to induce inflammatory hyperalgesia. Mechanical and thermal hyperalgesia were evaluated using the electronic von Frey and the hot plate tests, respectively, with neutrophil recruitment to the paw assessed by a myeloperoxidase activity assay. A number of factors were assessed, both peripherally and in the spinal cord, including: antioxidant capacity, reduced glutathione (GSH) levels, superoxide anion, tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) levels, as well as nuclear factor kappa B (NF-kappa B) activation. Vinpocetine inhibited the overt pain-like behavior induced by acetic acid, PBQ and formalin (at both phases), as well as the carrageenan-induced mechanical and thermal hyperalgesia and associated neutrophil recruitment. Both peripherally and in the spinal cord, vinpocetine also inhibited: antioxidant capacity and GSH depletion; increased superoxide anion; IL-1 beta and TNF-alpha levels; and NF-kappa B activation. As such, vinpocetine significantly reduces inflammatory pain by targeting oxidative stress, cytokine production and NF-kappa B activation at both peripheral and spinal cord levels.	[Ruiz-Miyazawa, Kenji W.; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Dept Ciencias Patol, Londrina, Parana, Brazil; [Pavao-de-Souza, Gabriela F.; Casagrande, Rubia] Univ Estadual Londrina Londrina, Dept Ciencias Farmaceut, Univ Hosp, Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Londrina, Parana, Brazil.	waverri@uel.br	de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; WA, Verri/I-1330-2013; Miyazawa, Kenji/AAS-5833-2020; Casagrande, Rubia/U-6019-2019; Casagrande, Rubia/I-1377-2013	de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; WA, Verri/0000-0003-2756-9283; Miyazawa, Kenji/0000-0002-5792-2175; Casagrande, Rubia/0000-0002-2296-1668; 	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/ Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/ Fundacao Araucaria; Parana State Government	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/ Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/ Fundacao Araucaria; Parana State Government	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/Fundacao Araucaria, and Parana State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2011, NEUROCHEM RES, V36, P1062, DOI 10.1007/s11064-011-0450-1; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; BALESTRERI R, 1987, J AM GERIATR SOC, V35, P425, DOI 10.1111/j.1532-5415.1987.tb04664.x; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Bonoczk P, 2000, BRAIN RES BULL, V53, P245, DOI 10.1016/S0361-9230(00)00354-3; Borghi SM, 2014, PHYSIOL BEHAV, V128, P277, DOI 10.1016/j.physbeh.2014.01.023; Borghi SM, 2013, J NAT PROD, V76, P1141, DOI 10.1021/np400222v; BRADLEY PP, 1982, BLOOD, V60, P618; Burnouf C, 2002, CURR PHARM DESIGN, V8, P1255, DOI 10.2174/1381612023394665; Cai YJ, 2013, BIOCHEM BIOPH RES CO, V434, P439, DOI 10.1016/j.bbrc.2013.03.092; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; Campanini MZ, 2013, J PHOTOCH PHOTOBIO B, V127, P153, DOI 10.1016/j.jphotobiol.2013.08.007; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Csillik B, 2008, ANN ANAT, V190, P140, DOI 10.1016/j.aanat.2007.10.002; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2007, EUR J PHARMACOL, V573, P221, DOI 10.1016/j.ejphar.2007.07.007; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; De Stefano D, 2013, AM J RESP CELL MOL, V49, P288, DOI 10.1165/rcmb.2012-0473OC; DERRIEN M, 1993, NEUROSCI LETT, V160, P193, DOI 10.1016/0304-3940(93)90411-D; DUARTE IDG, 1992, EUR J PHARMACOL, V221, P171, DOI 10.1016/0014-2999(92)90789-7; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dunkern TR, 2007, FEBS J, V274, P4812, DOI 10.1111/j.1742-4658.2007.06001.x; DUTOV AA, 1991, ZH NEVROPATOL PSIKH, V91, P21; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; Ei-Laithy HM, 2011, EUR J PHARM BIOPHARM, V77, P43, DOI 10.1016/j.ejpb.2010.10.011; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Gomez CD, 2014, J NEUROCHEM, V130, P770, DOI 10.1111/jnc.12784; Gulyas B, 2002, ACTA NEUROL SCAND, V106, P325, DOI 10.1034/j.1600-0404.2002.01302.x; Gulyas B, 2002, EUR J NUCL MED MOL I, V29, P1031, DOI 10.1007/s00259-002-0823-4; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hendrich J, 2013, PAIN, V154, P2207, DOI 10.1016/j.pain.2013.07.004; Herrera-Mundo N, 2013, J NEUROCHEM, V124, P233, DOI 10.1111/jnc.12082; Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046; Horvath S, 2001, Orv Hetil, V142, P383; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Janes K, 2012, BBA-MOL BASIS DIS, V1822, P815, DOI 10.1016/j.bbadis.2011.12.008; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kassuya CAL, 2007, BRIT J PHARMACOL, V150, P727, DOI 10.1038/sj.bjp.0707149; Kernacki KA, 2000, J IMMUNOL, V164, P1037, DOI 10.4049/jimmunol.164.2.1037; Khanna D, 2007, AM J MANAG CARE, V13, pS218; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Liu RZT, 2014, EXP EYE RES, V127, P49, DOI 10.1016/j.exer.2014.07.003; LOHMANN A, 1992, ARZNEIMITTEL-FORSCH, V42-2, P914; Manson SC, 2009, RESP MED, V103, P975, DOI 10.1016/j.rmed.2009.01.003; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MOLNAR P, 1995, EUR J PHARMACOL, V273, P303, DOI 10.1016/0014-2999(94)00755-V; Motoyoshi S, 2014, BIOCHEM J, V463, P75, DOI 10.1042/BJ20140084; Navarro SA, 2013, PHARMACOL BIOCHEM BE, V105, P183, DOI 10.1016/j.pbb.2013.02.018; NOSALOVA V, 1993, ARZNEIMITTELFORSCH, V43-2, P981; Ojha D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104939; Otroshchenko N P, 2000, Lik Sprava, P8; Parada CA, 2005, PAIN, V113, P185, DOI 10.1016/j.pain.2004.10.021; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Salam OMEA, 2006, PHARMACOL REP, V58, P680; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Sitges M, 2005, NEUROCHEM INT, V46, P533, DOI 10.1016/j.neuint.2005.02.001; Sitges M, 2011, EPILEPSY RES, V96, P257, DOI 10.1016/j.eplepsyres.2011.06.006; Sitges M, 1999, NEUROCHEM RES, V24, P1585, DOI 10.1023/A:1021164418478; Sitges M, 2007, NEUROPHARMACOLOGY, V53, P854, DOI 10.1016/j.neuropharm.2007.08.016; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; SUBHAN Z, 1985, EUR J CLIN PHARMACOL, V28, P567, DOI 10.1007/BF00544068; Suleyman H, 2007, PHARMACOL REP, V59, P247; Suzumura A, 2000, MULT SCLER, V6, P56, DOI 10.1191/135245800678827455; Szatmari S Z, 2003, Cochrane Database Syst Rev, pCD003119, DOI 10.1002/14651858.CD003119; Tabeeva GR, 2012, ZH NEVROL PSIKHIATR, V112, P20; Tassorelli C, 2004, J CHEM NEUROANAT, V27, P23, DOI 10.1016/j.jchemneu.2003.08.006; Valerio DA, 2009, J NAT PROD, V72, P1975, DOI 10.1021/np900259y; van Staveren WCG, 2001, BRAIN RES, V888, P275, DOI 10.1016/S0006-8993(00)03081-X; Verri Jr. Waldiceu A., 2007, Rev. Bras. Reumatol., V47, P341, DOI 10.1590/S0482-50042007000500009; Verri WA, 2008, EUR J PHARMACOL, V588, P207, DOI 10.1016/j.ejphar.2008.04.010; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Wang HX, 2014, NEUROSCI LETT, V566, P247, DOI 10.1016/j.neulet.2014.02.045; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Ward PA, 1996, ANN NY ACAD SCI, V796, P104, DOI 10.1111/j.1749-6632.1996.tb32572.x; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu SN, 2001, BIOCHEM PHARMACOL, V61, P877, DOI 10.1016/S0006-2952(01)00553-6; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zelles T, 2001, NEUROCHEM RES, V26, P1095, DOI 10.1023/A:1012365408215; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129; Zhou X, J PHARM EXP THER, V306, P498; Zhuang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082509	90	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0118942	10.1371/journal.pone.0118942	http://dx.doi.org/10.1371/journal.pone.0118942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822523	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700027
J	Wang, YY; Wang, K; Li, HM; Wang, JF; Wang, L; Dai, JP; Jiang, T; Ma, J				Wang, Yinyan; Wang, Kai; Li, Hongming; Wang, Jiangfei; Wang, Lei; Dai, Jianping; Jiang, Tao; Ma, Jun			Identifying the Association of Contrast Enhancement with Vascular Endothelia Growth Factor Expression in Anaplastic Gliomas: A Volumetric Magnetic Resonance Imaging Analysis	PLOS ONE			English	Article							GASTRIC-CANCER PATIENTS; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; MICROVESSEL DENSITY; POOR-PROGNOSIS; FACTOR VEGF; ANGIOGENESIS; SURVIVAL; GLIOBLASTOMA; MARKER	Contrast enhancement is a crucial radiologic feature of malignant brain tumors, which are associated with genetic changes of the tumor. The purpose of the current study was to investigate the potential relationship among tumor contrast enhancement with MR imaging, vascular endothelial growth factor (VEGF) expression, and survival outcome in anaplastic gliomas. MR images from 240 patients with histologically confirmed anaplastic gliomas were retrospectively analyzed. The volumes of T2 hyperintense, contrast enhanced regions and necrotic regions on postcontrast T1-weighted images were measured. The ratio of the enhanced volume to necrotic volume was compared between patients with high versus low levels of VEGF expression and was further used in the survival analysis. The volumetric ratio of enhancement to necrosis was significantly higher in patients with low VEGF expression than in those with high VEGF expression (Mann-Whitney, p = 0.009). In addition, the enhancement/necrosis ratio was identified as a significant predictor of progression-free survival (Cox regression model, p = 0.004) and overall survival (Cox regression model, p = 0.006) in the multivariate analysis. These results suggest that the volumetric ratio of enhancement to necrosis could serve as a noninvasive radiographic marker associated with VEGF expression and that this ratio is an independent predictor for progression-free survival and overall survival in patients with anaplastic gliomas.	[Wang, Yinyan; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Wang, Yinyan; Wang, Jiangfei; Wang, Lei; Jiang, Tao] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Kai; Dai, Jianping; Ma, Jun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Li, Hongming] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Wang, Lei; Ma, Jun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Jiang, Tao] Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.	taojiang1964@163.com; dr_ma@sina.com	jiang, tao/GWC-7108-2022; Wang, Yinyan/AAJ-1160-2020; Wang, Kai/AAF-6821-2019	Wang, Kai/0000-0002-2471-5460	National Natural Science Foundation of China [81371610]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	Funding for this project came from The National Natural Science Foundation of China (81371610, http://www.nsfc.gov.cn), and The National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03, http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko J, 2014, NEURO-ONCOLOGY, V16, P81, DOI 10.1093/neuonc/not159; Burel-Vandenbos F, 2013, NEURO-ONCOLOGY, V15, P1278, DOI 10.1093/neuonc/not094; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; Chen J, 2014, TUMOR BIOL, V35, P2513, DOI 10.1007/s13277-013-1332-8; Conway AE, 2014, NEURORADIOLOGY, V56, P405, DOI 10.1007/s00234-014-1348-9; DeAngelis LM, 2009, J CLIN ONCOL, V27, P5861, DOI 10.1200/JCO.2009.24.5985; Donahue B, 1997, INT J RADIAT ONCOL, V38, P911, DOI 10.1016/S0360-3016(97)00126-0; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Hong HS, 2013, YONSEI MED J, V54, P123, DOI 10.3349/ymj.2013.54.1.123; Ino Y, 2000, J NEUROSURG, V92, P983, DOI 10.3171/jns.2000.92.6.0983; Inoue H, 2013, J PHARMACOL SCI, V122, P158, DOI 10.1254/jphs.13033SC; Inoue K, 2012, CLIN CANCER RES, V18, P3924, DOI 10.1158/1078-0432.CCR-11-2041; Jensen RL, 2014, NEURO-ONCOLOGY, V16, P280, DOI 10.1093/neuonc/not148; Kim JW, 2011, J NEUROL NEUROSUR PS, V82, P224, DOI 10.1136/jnnp.2009.178806; Kwak BK, 2001, J KOREAN MED SCI, V16, P83, DOI 10.3346/jkms.2001.16.1.83; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Lin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094871; Lin Y, 2013, NEURO-ONCOLOGY, V15, P1008, DOI 10.1093/neuonc/not042; Liu Jinkang, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P406; Liu XG, 2014, WSPOLCZESNA ONKOL, V18, P334, DOI 10.5114/wo.2014.45308; Lote K, 1998, J NEURO-ONCOL, V40, P161, DOI 10.1023/A:1006106708606; Lu XW, 2008, BREAST J, V14, P308, DOI 10.1111/j.1524-4741.2008.00583.x; Nam DH, 2004, ONCOL REP, V11, P863; Qi ST, 2014, ONCOL LETT, V7, P1895, DOI 10.3892/ol.2014.2013; Roberts WG, 1997, CANCER RES, V57, P765; SHAW EG, 1994, NEUROSURGERY, V34, P577, DOI 10.1227/00006123-199404000-00002; SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768; Sjostrom S, 2011, J NEURO-ONCOL, V104, P523, DOI 10.1007/s11060-010-0504-2; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Tomita T, 2013, BRAIN TUMOR PATHOL; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; Vidal O, 2008, J GASTROINTEST SURG, V12, P1005, DOI 10.1007/s11605-007-0336-3; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7; Wei X, 2014, TUMOR BIOL, V35, P6521, DOI 10.1007/s13277-014-1868-2; WINGER MJ, 1989, J NEUROSURG, V71, P487, DOI 10.3171/jns.1989.71.4.0487; Zhang SJ, 2013, ASIAN PAC J CANCER P, V14, P3937, DOI 10.7314/APJCP.2013.14.6.3937	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121380	10.1371/journal.pone.0121380	http://dx.doi.org/10.1371/journal.pone.0121380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823012	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700101
J	Zhai, YF; Ao, LH; Cleveland, JC; Zeng, QC; Reece, TB; Fullerton, DA; Meng, XZ				Zhai, Yufeng; Ao, Lihua; Cleveland, Joseph C.; Zeng, Qingchun; Reece, T. Brett; Fullerton, David A.; Meng, Xianzhong			Toll-like Receptor 4 Mediates the Inflammatory Responses and Matrix Protein Remodeling in Remote Non-Ischemic Myocardium in a Mouse Model of Myocardial Ischemia and Reperfusion	PLOS ONE			English	Article							METALLOPROTEINASE INHIBITION; CARDIAC DYSFUNCTION; TOLL-LIKE-RECEPTOR-4; EXPRESSION; INJURY; INFARCTION; SHOCK; MACROPHAGES; MONOCYTES; PROFILE	The signaling mechanism that mediates inflammatory responses in remote non-ischemic myocardium following regional ischemia/reperfusion (I/R) remains incompletely understood. Myocardial Toll-like receptor 4 (TLR4) can be activated by multiple proteins released from injured cells and plays a role in myocardial inflammation and injury expansion. We tested the hypothesis that TLR4 occupies an important role in mediating the inflammatory responses and matrix protein remodeling in the remote non-ischemic myocardium following regional I/R injury. Methods and results: TLR4-defective (C3H/HeJ) and TLR4-competent (C3H/HeN) mice were subjected to coronary artery ligation (30 min) and reperfusion for 1, 3, 7 or 14 days. In TLR4-competent mice, levels of monocyte chemoattractant protein -1 (MCP-1), keratinocyte chemoattractant (KC), intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) were elevated in the remote non-ischemic myocardium at day 1, 3, and 7 of reperfusion. Levels of collagen I, collagen IV, matrix metalloproteinase (MMP) 2 and MMP 9 were increased in the remote non-ischemic myocardium at day 7 and 14 of reperfusion. MMP 2 and MMP 9 activities were also increased. TLR4 deficiency resulted in a moderate reduction in myocardial infarct size. However, it markedly downgraded the changes in the levels of chemokines, adhesion molecules and matrix proteins in the remote non-ischemic myocardium. Further, left ventricular function at day 14 was significantly improved in TLR4-defective mice. In conclusion, TLR4 mediates the inflammatory responses and matrix protein remodeling in the remote non-ischemic myocardium following regional myocardial I/R injury and contributes to the mechanism of adverse cardiac remodeling.	[Zhai, Yufeng; Ao, Lihua; Cleveland, Joseph C.; Zeng, Qingchun; Reece, T. Brett; Fullerton, David A.; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80204 USA; [Zeng, Qingchun] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Medical University - China	Meng, XZ (corresponding author), Univ Colorado Denver, Dept Surg, Aurora, CO 80204 USA.	xianzhong.meng@ucdenver.edu			National Institute on Aging grant [AG039545]; Academic Enrichment Fund of Department of Surgery, University of Colorado Denver; NATIONAL INSTITUTE ON AGING [R01AG039545] Funding Source: NIH RePORTER	National Institute on Aging grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Academic Enrichment Fund of Department of Surgery, University of Colorado Denver; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging grant AG039545 and the Academic Enrichment Fund of Department of Surgery, University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Apple KA, 2006, J CARDIOVASC PHARM, V47, P228, DOI 10.1097/01.fjc.0000200989.23987.b8; Cha J, 2008, ANN THORAC SURG, V85, P1678, DOI 10.1016/j.athoracsur.2008.01.043; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Ding HS, 2013, GENE; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; FUENTES ME, 1995, J IMMUNOL, V155, P5769; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Kaczorowski DJ, 2007, TRANSPLANTATION, V84, P1279, DOI 10.1097/01.tp.0000287597.87571.17; Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Norman MU, 2008, J LEUKOCYTE BIOL, V84, P68, DOI 10.1189/jlb.1107796; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Polyakova V, 2011, INT J CARDIOL, V151, P18, DOI 10.1016/j.ijcard.2010.04.053; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Su X, 2010, CYTOKINE, V51, P60, DOI 10.1016/j.cyto.2010.04.014; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tessone A, 2005, CARDIOVASC DRUG THER, V19, P383, DOI 10.1007/s10557-005-5201-6; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tsuda T, 2003, CARDIOVASC RES, V59, P926, DOI 10.1016/S0008-6363(03)00519-4; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353; WELGUS HG, 1985, J CLIN INVEST, V76, P219, DOI 10.1172/JCI111949; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	38	11	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121853	10.1371/journal.pone.0121853	http://dx.doi.org/10.1371/journal.pone.0121853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25823011	gold, Green Submitted, Green Published			2022-12-27	WOS:000352134700131
J	Zhang, YJ; Liang, CZ; Tao, YQ; Zhou, XP; Li, H; Li, FC; Chen, QX				Zhang, Yujie; Liang, Chengzhen; Tao, Yiqing; Zhou, Xiaopeng; Li, Hao; Li, Fangcai; Chen, Qixin			Cervical Total Disc Replacement is Superior to Anterior Cervical Decompression and Fusion: A Meta-Analysis of Prospective Randomized Controlled Trials	PLOS ONE			English	Article							ADJACENT-SEGMENT DISEASE; INVESTIGATIONAL-DEVICE-EXEMPTION; CONTROLLED CLINICAL-TRIAL; TERM-FOLLOW-UP; PRODISC-C; RADIOGRAPHIC OUTCOMES; ARTHROPLASTY; DISKECTOMY; MULTICENTER; SPINE	Background Despite being considered the standard surgical procedure for symptomatic cervical disc disease, anterior cervical decompression and fusion invariably accelerates adjacent segment degeneration. Cervical total disc replacement is a motion-preserving procedure developed as a substitute to fusion. Whether cervical total disc replacement is superior to fusion remains unclear. Methods We comprehensively searched PubMed, EMBASE, Medline, and the Cochrane Library in accordance with the inclusion criteria to identify possible studies. The retrieved results were last updated on December 12, 2014. We classified the studies as short-term and midterm follow-up. Results Nineteen randomized controlled trials involving 4516 cases were identified. Compared with anterior cervical decompression and fusion, cervical total disc replacement had better functional outcomes (neck disability index [NDI], NDI success, neurological success, neck pain scores reported on a numerical rating scale [NRS], visual analog scales scores and overall success), greater segmental motion at the index level, fewer adverse events and fewer secondary surgical procedures at the index and adjacent levels in short-term follow-up (P < 0.05). With midterm follow-up, the cervical total disc replacement group indicated superiority in the NDI, neurological success, pain assessment (NRS), and secondary surgical procedures at the index level (P < 0.05). The Short Form 36 (SF-36) and segmental motion at the adjacent level in the short-term follow-up showed no significant difference between the two procedures, as did the secondary surgical procedure rates at the adjacent level with midterm follow-up (P > 0.05). Conclusions Cervical total disc replacement presented favorable functional outcomes, fewer adverse events, and fewer secondary surgical procedures. The efficacy and safety of cervical total disc replacement are superior to those of fusion. Longer-term, multicenter studies are required for a better evaluation of the long-term efficacy and safety of the two procedures.	[Zhang, Yujie; Liang, Chengzhen; Tao, Yiqing; Zhou, Xiaopeng; Li, Hao; Li, Fangcai; Chen, Qixin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University	Chen, QX (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jie Fang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zrcqx@zju.edu.cn			National Nature Science Foundation of China [81401822, 81171756]; key Science and Technology Planning Project [2012C13G2010083, 2012C33121]; Nature Science Foundation of ZhejiangProvince [Q14H060007, Y13H060001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Science and Technology Planning Project; Nature Science Foundation of ZhejiangProvince(Natural Science Foundation of Zhejiang Province)	This study was partly supported by a grant from the National Nature Science Foundation of China (81401822 and 81171756), and the key Science and Technology Planning Project (2012C13G2010083) and (2012C33121) and Nature Science Foundation (Q14H060007 and Y13H060001) of ZhejiangProvince (http://www.nsfc.gov.cn/, http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anakwenze OA, 2009, SPINE, V34, P2001, DOI 10.1097/BRS.0b013e3181b03fe6; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Bartels RHMA, 2010, NEUROSURGERY, V66, P1153, DOI 10.1227/01.NEU.0000369189.09182.5F; Buchowski JM, 2009, J BONE JOINT SURG AM, V91A, P223, DOI 10.2106/JBJS.I.00564; Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513; Cason GW, 2013, J BONE JOINT SURG AM, V95A, P279, DOI [10.2106/JBJS.L.01568, 10.2106/JBJS.J.01042]; Cheng L, 2011, CLIN ORTHOP RELAT R, V469, P3408, DOI 10.1007/s11999-011-2039-z; Coric D, 2012, SPINE, P348, DOI [10.3171/2012.6.SPINE11867, DOI 10.3171/2012.6.SPINE11867]; Coric D, 2013, J NEUROSURG-SPINE, V18, P36, DOI 10.3171/2012.9.SPINE12555; Coric D, 2010, J NEUROSURG-SPINE, V13, P715, DOI 10.3171/2010.5.SPINE09852; Davis RJ, 2013, J NEUROSURG-SPINE, V19, P532, DOI 10.3171/2013.6.SPINE12527; Davis RJ, 2013, SPINE J, V13, pS164; Delamarter RB, 2013, SPINE, V38, P711, DOI 10.1097/BRS.0b013e3182797592; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gao Y, 2013, J BONE JOINT SURG AM, V95A, P555, DOI 10.2106/JBJS.K.00599; Grunert P, 2014, J NEUROSURG-SPINE, V20, P443, DOI 10.3171/2013.12.SPINE13112; Heller JG, 2009, SPINE, V34, P101, DOI 10.1097/BRS.0b013e31818ee263; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Malham GM, 2014, J CLIN NEUROSCI, V21, P949, DOI 10.1016/j.jocn.2013.09.013; McAfee PC, 2012, SPINE, V37, P943, DOI 10.1097/BRS.0b013e31823da169; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; Mummaneni PV, 2007, J NEUROSURG-SPINE, V6, P198, DOI 10.3171/spi.2007.6.3.198; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Murrey D, 2009, SPINE J, V9, P275, DOI 10.1016/j.spinee.2008.05.006; Nabhan A, 2007, J Long Term Eff Med Implants, V17, P229; Nanda A, 2013, WORLD NEUROSURG; Nunley PD, 2012, SPINE, V37, P445, DOI 10.1097/BRS.0b013e31822174b3; Palit M, 1999, SPINE, V24, P2224, DOI 10.1097/00007632-199911010-00009; Phillips FM, 2013, SPINE, V38, pE907, DOI 10.1097/BRS.0b013e318296232f; Pickett GE, 2006, J NEUROSURG-SPINE, V4, P98, DOI 10.3171/spi.2006.4.2.98; Rao RD, 2007, J BONE JOINT SURG AM, V89A, P1360; Riina Joseph, 2008, Am J Orthop (Belle Mead NJ), V37, pE71; Robertson JT, 2005, J NEUROSURG-SPINE, V3, P417, DOI 10.3171/spi.2005.3.6.0417; Rozankovic M, 2014, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e3182a180fc, DOI 10.1097/BSD.0B013E3182A180FC]; Sasso RC, 2011, J BONE JOINT SURG AM, V93A, P1684, DOI [10.2106/JBJS.J.00476, 10.2106/JBJSJ.00476]; Vaccaro A, 2013, SPINE, V38, P2227, DOI 10.1097/BRS.0000000000000031; Verma K, 2013, SPINE, V38, P2253, DOI 10.1097/BRS.0000000000000052; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Virk SS, 2014, ORTHOPEDICS, V37, P547, DOI 10.3928/01477447-20140728-08; WHO, 1979, WHO HDB REP RES CANC; Yin S, 2013, CLIN ORTHOP RELAT R, V471, P1904, DOI 10.1007/s11999-013-2830-0; Yu L, 2011, ORTHOPEDICS, V34, pE651, DOI 10.3928/01477447-20110826-09; Yue WM, 2005, SPINE, V30, P2138, DOI 10.1097/01.brs.0000180479.63092.17; Zechmeister I, 2011, EUR SPINE J, V20, P177, DOI 10.1007/s00586-010-1583-7; Zhang XS, 2012, SPINE, V37, P433, DOI 10.1097/BRS.0b013e31822699fa; Zhang Zhenxiang, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS275, DOI 10.1007/s00590-014-1424-1; Zigler JE, 2013, SPINE, V38, P203, DOI 10.1097/BRS.0b013e318278eb38	49	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0117826	10.1371/journal.pone.0117826	http://dx.doi.org/10.1371/journal.pone.0117826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822465	gold, Green Published, Green Submitted			2022-12-27	WOS:000352134700015
J	Zhao, ZQ; Wang, LJ; Sun, XW; Zhang, JJ; Zhao, YJ; Na, RS; Zhang, JH				Zhao, Zhong Quan; Wang, Li Juan; Sun, Xiao Wei; Zhang, Jiao Jiao; Zhao, Yong Ju; Na, Ri Su; Zhang, Jia Hua			Transcriptome Analysis of the Capra hircus Ovary	PLOS ONE			English	Article							OOCYTE MATURATION; RNA-SEQ; CUMULUS CELLS; BLACK GOAT; IN-VITRO; MOUSE; GENE; IDENTIFICATION; EMBRYOS; CYCLE	Background Capra hircus is an important economic livestock animal, and therefore, it is necessary to discover transcriptome information about their reproductive performance. In this study, we performed de novo transcriptome sequencing to produce the first transcriptome dataset for the goat ovary using high-throughput sequencing technologies. The result will contribute to research on goat reproductive performance. Method and Results RNA-seq analysis generated more than 38.8 million clean paired end (PE) reads, which were assembled into 80,069 unigenes (mean size = 619 bp). Based on sequence similarity searches, 64,824 (60.6%) genes were identified, among which 29,444 and 11,271 unigenes were assigned to Gene Ontology (GO) categories and Clusters of Orthologous Groups (COG), respectively. Searches in the Kyoto Encyclopedia of Genes and Genomes pathway database (KEGG) showed that 27,766 (63.4%) unigenes were mapped to 258 KEGG pathways. Furthermore, we investigated the transcriptome differences of goat ovaries at two different ages using a tag-based digital gene expression system. We obtained a sequencing depth of over 5.6 million and 5.8 million tags for the two ages and identified a large number of genes associated with reproductive hormones, ovulatory cycle and follicle. Moreover, many antisense transcripts and novel transcripts were found; clusters with similar differential expression patterns, enriched GO terms and metabolic pathways were revealed for the first time with regard to the differentially expressed genes. Conclusions The transcriptome provides invaluable new data for a functional genomic resource and future biological research in Capra hircus, and it is essential for the in-depth study of candidate genes in breeding programs.	[Zhao, Zhong Quan; Wang, Li Juan; Sun, Xiao Wei; Zhao, Yong Ju; Na, Ri Su; Zhang, Jia Hua] Southwest Univ, Chongqing Engn Res Ctr Herbivores Resource Protec, Chongqing, Peoples R China; [Zhang, Jiao Jiao] Jeju Natl Univ, Genet Engn & Stem Cell Biol Lab, Dept Anim Biotechnol, Fac Biotechnol, Jeju, South Korea	Southwest University - China; Jeju National University	Zhang, JH (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Herbivores Resource Protec, Chongqing, Peoples R China.	jhzhang007@aliyun.com	Zhang, Jiao Jiao/V-8705-2018	Zhang, Jiao Jiao/0000-0002-2699-6729	Chongqing Municipal Natural Science Foundation [cstc2012jjA80016]; Fundamental Research Funds for the Central Universities [XDJK 2013B024]	Chongqing Municipal Natural Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was founded by Chongqing Municipal Natural Science Foundation project cstc2012jjA80016 and the Fundamental Research Funds for the Central Universities (XDJK 2013B024).	Ahn YK, 2014, GENE, V533, P494, DOI 10.1016/j.gene.2013.09.095; Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R; Alldinger S, 2006, DEUT TIERARZTL WOCH, V113, P151; Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245; Bent ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077834; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Lanes CFC, 2013, MAR BIOTECHNOL, V15, P677, DOI 10.1007/s10126-013-9527-y; Chavan SS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S4; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chitwood JL, 2014, REPROD FERT DEVELOP, V26, P179; Chow RWY, 2010, ENDOCRINOLOGY, V151, P2411, DOI 10.1210/en.2009-1456; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Faustino LR, 2013, SMALL RUMINANT RES, V114, P112, DOI 10.1016/j.smallrumres.2013.05.002; Fisch KM, 2013, ARTHRITIS RHEUM-US, V65, pS807; Fournier A, 2013, J AGR FOOD CHEM, V61, P7156, DOI 10.1021/jf401048j; Ganguly A, 2013, RES VET SCI, V95, P374, DOI 10.1016/j.rvsc.2013.03.013; Garcia A, 2013, HISTOL HISTOPATHOL, V28, P1369, DOI 10.14670/HH-28.1369; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Harding LB, 2013, AQUAT TOXICOL, V142, P146, DOI 10.1016/j.aquatox.2013.07.020; HARROUK W, 1995, MOL REPROD DEV, V41, P29, DOI 10.1002/mrd.1080410106; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; He QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081357; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Igwebuike UM, 2013, VET ARHIV, V83, P313; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Lin XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079258; Ma H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-152; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Metcalfe NB, 2013, TRENDS ECOL EVOL, V28, P347, DOI 10.1016/j.tree.2013.01.015; Pashaj A, 2013, PHYSIOL GENOMICS, V45, P1136, DOI 10.1152/physiolgenomics.00138.2013; Peng JY, 2013, GENE, V524, P105, DOI 10.1016/j.gene.2013.04.054; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ranjan R, 2013, BIOCHEM GENET, V51, P944, DOI 10.1007/s10528-013-9619-4; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sharma RK, 2013, SCANNING, V35, P344, DOI 10.1002/sca.21073; Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wang LB, 2011, MOL BIOL REP, V38, P1621, DOI 10.1007/s11033-010-0272-2; Wang PQ, 2011, GENET MOL RES, V10, P731, DOI 10.4238/vol10-2gmr1091; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718; Zhang Chao, 2011, Yichuan, V33, P607, DOI 10.3724/SP.J.1005.2011.00607; Zhao ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080146; Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282; Zi XD, 2013, GEN COMP ENDOCR, V187, P1, DOI 10.1016/j.ygcen.2013.03.023	53	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121586	10.1371/journal.pone.0121586	http://dx.doi.org/10.1371/journal.pone.0121586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	25822507	Green Submitted, Green Published, gold			2022-12-27	WOS:000352134700116
J	Asfaw, A; Ali, D; Eticha, T; Alemayehu, A; Alemayehu, M; Kindeya, F				Asfaw, Addisu; Ali, Dagim; Eticha, Tadele; Alemayehu, Adissu; Alemayehu, Mussie; Kindeya, Filmon			CD4 Cell Count Trends after Commencement of Antiretroviral Therapy among HIV-Infected Patients in Tigray, Northern Ethiopia: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INITIATION; AFRICA; MORTALITY; CD4+COUNT; RECOVERY; OUTCOMES	Background The rate and extent of CD4 cell recovery varies widely among HIV-infected patients with different baseline CD4 cell count strata. The objective of the study was to assess trends in CD4 cell counts in HIV-infected patients after initiation of antiretroviral therapy in Tigray, Northern Ethiopia. Methods A retrospective cross-sectional study was conducted by reviewing medical records of HIV patients who received antiretroviral treatment at twenty health centers in Tigray region during 2008-2012. Multi-stage cluster sampling technique was employed to collect data, and the data were analyzed using SPSS version 20.0 software. Results The median change from baseline to the most recent CD4 cell count was +292 cells/mu l. By 5 years, the overall median (inter-quartile range, IQR) CD4 cell count was 444(263-557) cells/mu l while the median (IQR) CD4 cell count was 342(246-580) cells/mu l among patients with baseline CD4 cell counts <= 200 cells/mu l, 500(241-557) cells/mu l among those with baseline CD4 cell counts of 201-350 cells/mu l, and 652(537-767) cells/mu l among those with baseline CD4 cell counts >350 cells/mu l. Higher baseline CD4 cell counts and being male were independently associated with the risk of immunological non-response at 12 months. Furthermore, it was also investigated that these factors were significant predictors of subsequent CD4 cell recovery. Conclusions Patients with higher baseline CD4 cell stratum returned to normal CD4 Cell counts though they had an increased risk of immunological non-response at 12 months compared to those with the least baseline CD4 cell stratum. The findings suggest that consideration be given to initiation of HAART at a CD4 cell count >350 cells/mu l to achieve better immune recovery, and to HIV-infected male patients to improve their health seeking behavior.	[Asfaw, Addisu; Ali, Dagim; Eticha, Tadele; Alemayehu, Adissu] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia; [Alemayehu, Mussie] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Kindeya, Filmon] Tigray Reg Hlth Bur, Social Mobilizat, Advocacy & Commun HIV Div, Mekelle, Ethiopia	Mekelle University; Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	td.eticha@gmail.com	Alemayehu, Mussie/AAH-3016-2019	Alemayehu, Mussie/0000-0002-0035-631X	MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme	MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme(United States Agency for International Development (USAID))	This study was funded by MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Fox M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069300; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kilaru KR, 2006, HIV MED, V7, P99, DOI 10.1111/j.1468-1293.2006.00347.x; Kyaw NL, 2013, SE ASIAN J TROP MED, V44, P232; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; Malaza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070126; Michael CG, 2002, SCAND J INFECT DIS, V34, P45, DOI 10.1080/00365540110076930; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Rajasekaran S, 2009, J POSTGRAD MED, V55, P261, DOI 10.4103/0022-3859.58929; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Shastri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072188; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; WHO, 2010, ANT THER HIV INF AD	23	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122583	10.1371/journal.pone.0122583	http://dx.doi.org/10.1371/journal.pone.0122583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816222	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600188
J	Chavan, SG; Deobagkar, DD				Chavan, Sonali Gopichand; Deobagkar, Deepti Dileep			An In Silico Insight into Novel Therapeutic Interaction of LTNF Peptide-LT10 and Design of Structure Based Peptidomimetics for Putative Anti-Diabetic Activity	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; TYPE-2 DIABETES-MELLITUS; STRUCTURE PREDICTION; ACCURATE DOCKING; FORCE-FIELD; PEP-FOLD; PROTEIN; DYNAMICS; GLIDE; DEGRADATION	Lethal Toxin Neutralizing Factor (LTNF) obtained from Opossum serum (Didephis virginiana) is known to exhibit toxin-neutralizing activity for envenomation caused by animals, plants and bacteria. Small synthetic peptide-LT10 (10mer) derived from N-terminal fraction of LTNF exhibit similar anti-lethal and anti-allergic property. In our in silico study, we identified Insulin Degrading Enzyme (IDE) as a potential target of LT10 peptide followed by molecular docking and molecular dynamic (MD) simulation studies which revealed relatively stable interaction of LT10 peptide with IDE. Moreover, their detailed interaction analyses dictate IDE-inhibitory interactions of LT10 peptide. This prediction ofLT10 peptide as a novel putative IDE-inhibitor suggests its possible role in anti-diabetic treatment since IDE-inhibitors are known to assist treatment of Diabetes mellitus by enhancing insulin signalling. Furthermore, series of structure based peptidomimetics were designed from LT10 peptide and screened for their inhibitory interactions which ultimately led to a small set of peptidomimetic inhibitors of IDE. These peptidomimetic thus might provide a new class of IDE-inhibitors, those derived from LT10 peptide.	[Chavan, Sonali Gopichand; Deobagkar, Deepti Dileep] Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India; [Deobagkar, Deepti Dileep] Univ Pune, Dept Zool, Ctr Adv Studies, Pune, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Deobagkar, DD (corresponding author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.	deepti.deobagkar@gmail.com			DST-PURSE	DST-PURSE	Funding for this work was provided by DST-PURSE (http://www.fist-dst.org/html-flies/purse.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Chavan S, 2014, SILICO MOL INTERACTI; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1981, ENDOCR REV, V2, P210, DOI 10.1210/edrv-2-2-210; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Giugliano D, 2009, ACTA DIABETOL, V46, P173, DOI 10.1007/s00592-009-0134-3; Goede A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-11; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hulse RE, 2009, VITAM HORM, V80, P635, DOI 10.1016/S0083-6729(08)00622-5; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kinnings SL, 2011, J CHEM INF MODEL, V51, P624, DOI 10.1021/ci1003174; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; LIPPS B., 2000, J VENOM ANIM TOXINS, V6, P77; LIPPS B. V., 2002, J. Venom. Anim. Toxins, V8, P214, DOI 10.1590/S0104-79302002000200003; Lipps B.V., 1999, J VENOM ANIM TOXINS, V5, P56, DOI [10.1590/S0104-79301999000100005, DOI 10.1590/S0104-79301999000100005]; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; MIRSKY IA, 1957, RECENT PROG HORM RES, V13, P429; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Ver Lipps B, FOOD POISONING TOXIN; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121860	10.1371/journal.pone.0121860	http://dx.doi.org/10.1371/journal.pone.0121860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816209	Green Published, Green Submitted, gold			2022-12-27	WOS:000352133600124
J	Li, YQ; He, QM; Ren, XY; Tang, XR; Xu, YF; Wen, X; Yang, XJ; Ma, J; Liu, N				Li, Ying-Qin; He, Qing-Mei; Ren, Xian-Yue; Tang, Xin-Ran; Xu, Ya-Fei; Wen, Xin; Yang, Xiao-Jing; Ma, Jun; Liu, Na			MiR-145 Inhibits Metastasis by Targeting Fascin Actin-Bundling Protein 1 in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CANCER METASTASIS; MICRORNA; EXPRESSION; INVASION; RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; GROWTH; FSCN1	Background Based on our recent microarray analysis, we found that miR-145 was obviously down-regulated in nasopharyngeal carcinoma (NPC) tissues. However, little is known about its function and mechanism involving in NPC development and progression. Methods Quantitative RT-PCR was used to detect miR-145 expression in NPC cell lines and clinical samples. Wound healing, Transwell migration and invasion, three-dimension spheroid invasion assays, and lung metastasis model were performed to test the migratory, invasive, and metastatic ability of NPC cells. Luciferase reporter assay, quantitative RT-PCR, and Western blotting were used to verify the target of miR-145. Results MiR-145 was obviously decreased in NPC cell lines and clinical samples (P<0.01). Ectopic overexpression of miR-145 significantly inhibited the migratory and invasive ability of SUNE-1 and CNE-2 cells. In addition, stably overexpressing of miR-145 in SUNE-1 cells could remarkably restrain the formation of metastatic nodes in the lungs of mice. Furthermore, fascin actin-bundling protein 1 (FSCN1) was verified as a target of miR-145, and silencing FSCN1 with small RNA interfering RNA could suppress NPC cell migration and invasion. Conclusions Our findings demonstrated that miR-145 function as a tumor suppressor in NPC development and progression via targeting FSCN1, which could sever as a potential novel therapeutic target for patients with NPC.	[Li, Ying-Qin; He, Qing-Mei; Ren, Xian-Yue; Tang, Xin-Ran; Xu, Ya-Fei; Wen, Xin; Yang, Xiao-Jing; Ma, Jun; Liu, Na] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Liu, N (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn; liun1@sysucc.org.cn		Liu, Na/0000-0001-8654-3636; ren, xianyue/0000-0002-1845-0814	National Natural Science Foundation of China [81402516]; Pearl River Science and Technology New Star of Guangzhou, China; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B10]; Health & Medical Collaborative Innovation Project of Guangzhou City [201400000001]; Key Laboratory Construction Project of Guangzhou City [121800085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River Science and Technology New Star of Guangzhou, China; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; Health & Medical Collaborative Innovation Project of Guangzhou City; Key Laboratory Construction Project of Guangzhou City	This work was supported by grants from the National Natural Science Foundation of China (81402516; NL), the Pearl River Science and Technology New Star of Guangzhou, China (2015; NL), the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B10; JM), the Health & Medical Collaborative Innovation Project of Guangzhou City (201400000001; JM), and the Key Laboratory Construction Project of Guangzhou City (121800085; JM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen Y, 2008, INT J RADIAT ONCOL, V71, P1356, DOI 10.1016/j.ijrobp.2007.12.028; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chua DTT, 2005, J CLIN ONCOL, V23, P1118, DOI 10.1200/JCO.2005.12.081; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hart M, 2013, FEBS J, V280, P2105, DOI 10.1111/febs.12236; Hu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045965; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Liu N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-123; Liu N, 2013, CANCER LETT, V329, P181, DOI 10.1016/j.canlet.2012.10.032; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lyu XM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-51; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Peng XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-186; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wu D, 2010, ANN ONCOL, V21, P589, DOI 10.1093/annonc/mdp333; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211	35	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122228	10.1371/journal.pone.0122228	http://dx.doi.org/10.1371/journal.pone.0122228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816323	Green Published, gold, Green Submitted			2022-12-27	WOS:000352133600158
J	Paz-Zulueta, M; Llorca, J; Sarabia-Lavin, R; Bolumar, F; Rioja, L; Delgado, A; Santibanez, M				Paz-Zulueta, Maria; Llorca, Javier; Sarabia-Lavin, Raquel; Bolumar, Francisco; Rioja, Luis; Delgado, Abraham; Santibanez, Miguel			The Role of Prenatal Care and Social Risk Factors in the Relationship between Immigrant Status and Neonatal Morbidity: A Retrospective Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NORTH-AFRICAN IMMIGRANTS; PSYCHOSOCIAL STRESS; PERINATAL OUTCOMES; REPORTED HEALTH; PRETERM BIRTH; SPAIN; WOMEN; DISPARITIES; ETHNICITY	Background and Aim Literature evaluating association between neonatal morbidity and immigrant status presents contradictory results. Poorer compliance with prenatal care and greater social risk factors among immigrants could play roles as major confounding variables, thus explaining contradictions. We examined whether prenatal care and social risk factors are confounding variables in the relationship between immigrant status and neonatal morbidity. Methods Retrospective cohort study: 231 pregnant African immigrant women were recruited from 2007-2010 in northern Spain. A Spanish population sample was obtained by simple random sampling at 1: 3 ratio. Immigrant status (Spanish, Sub-Saharan and Northern African), prenatal care (Kessner Index adequate, intermediate or inadequate), and social risk factors were treated as independent variables. Low birth weight (LBW < 2500 grams) and preterm birth (< 37 weeks) were collected as neonatal morbidity variables. Crude and adjusted odds ratios (OR) were estimated by unconditional logistic regression with 95% confidence intervals (95% CI). Results Positive associations between immigrant women and higher risk of neonatal morbidity were obtained. Crude OR for preterm births in Northern Africans with respect to nonimmigrants was 2.28 (95% CI: 1.04-5.00), and crude OR for LBW was 1.77 (95% CI: 0.74-4.22). However, after adjusting for prenatal care and social risk factors, associations became protective: adjusted OR for preterm birth = 0.42 (95% CI: 0.14-1.32); LBW = 0.48 (95% CI: 0.15-1.52). Poor compliance with prenatal care was the main independent risk factor associated with both preterm birth (adjusted OR inadequate care = 17.05; 95% CI: 3.92-74.24) and LBW (adjusted OR inadequate care = 6.25; 95% CI: 1.28-30.46). Social risk was an important independent risk factor associated with LBW (adjusted OR = 5.42; 95% CI: 1.58-18.62). Conclusions Prenatal care and social risk factors were major confounding variables in the relationship between immigrant status and neonatal morbidity.	[Paz-Zulueta, Maria; Sarabia-Lavin, Raquel] Univ Cantabria, Dept Enfermeria, E-39005 Santander, Spain; [Llorca, Javier; Santibanez, Miguel] Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain; [Llorca, Javier; Santibanez, Miguel] Inst Invest Marques Valdecilla IDIVAL, Santander, Spain; [Llorca, Javier; Bolumar, Francisco] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Madrid, Spain; [Bolumar, Francisco] CUNY, Sch Publ Hlth, Hunter Coll, Epidemiol & Biostat Program, New York, NY 10021 USA; [Bolumar, Francisco] Univ Alcala de Henares, Dept Salud Publ, Madrid, Spain; [Rioja, Luis; Delgado, Abraham] Serv Cantabro Salud, Gerencia Atenc Primaria, Santander, Spain	Universidad de Cantabria; Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; City University of New York (CUNY) System; Hunter College (CUNY); Universidad de Alcala	Santibanez, M (corresponding author), Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain.	maria.paz@unican.es; santibanezm@unican.es	Santibanez, Miguel/L-3323-2017; Llorca, Javier/F-7371-2011	Santibanez, Miguel/0000-0003-2634-615X; Llorca, Javier/0000-0001-8569-861X; Sarabia-Lavin, Raquel/0000-0003-3679-4327; Francisco, Bolumar Montrull/0000-0001-8007-3231	secondary award for the best investigation protocol presented to the 12th edition of the National nursing research awards; IFIMAV	secondary award for the best investigation protocol presented to the 12th edition of the National nursing research awards; IFIMAV	This work was partially supported by the secondary award for the best investigation protocol presented to the 12th edition of the National nursing research awards. In addition, Maria Paz-Zulueta was the recipient of a grant from IFIMAV for the best investigation protocol elaborated during the 5th course of methodology of investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Suarez AA, 2009, REV ESP SALUD PUBLIC, V83, P331, DOI [10.1590/S1135-57272009000200015, 10.1590/s1135-57272009000200015]; ALEXANDER GR, 1987, AM J PREV MED, V3, P254; Bollini P, 2009, SOC SCI MED, V68, P452, DOI 10.1016/j.socscimed.2008.10.018; Borrell C, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2006.055269; Buekens P, 1998, AM J PUBLIC HEALTH, V88, P808, DOI 10.2105/AJPH.88.5.808; Cacciani L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-294; Castello A, 2012, ANN EPIDEMIOL, V22, P175, DOI 10.1016/j.annepidem.2011.12.005; Collins JW, 1997, J NATL MED ASSOC, V89, P198; Comas M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-77; Delgado-Rodriguez M, 1997, Gac Sanit, V11, P136; Dunn JR, 2000, SOC SCI MED, V51, P1573, DOI 10.1016/S0277-9536(00)00053-8; Fernandez Miguel Angel Luque, 2011, Eur J Public Health, V21, P104, DOI 10.1093/eurpub/ckp224; Gagnon AJ, 2011, PAEDIATR PERINAT EP, V25, P575, DOI 10.1111/j.1365-3016.2011.01230.x; Garcia-Subirats I, 2011, MATERN CHILD HLTH J, V15, P561, DOI 10.1007/s10995-010-0614-7; Goedhart G, 2008, BJOG-INT J OBSTET GY, V115, P710, DOI 10.1111/j.1471-0528.2008.01682.x; Gould JB, 2003, PEDIATRICS, V111, pE676, DOI 10.1542/peds.111.6.e676; Guendelman S, 1999, Matern Child Health J, V3, P177, DOI 10.1023/A:1022328020935; Herbst MA, 2003, AM J OBSTET GYNECOL, V189, P930, DOI 10.1067/S0002-9378(03)01055-X; Kessner DM, 1973, INFANT DEATH ANAL MA, P50; Malin M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-84; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; McGlade MS, 2004, AM J PUBLIC HEALTH, V94, P2062, DOI 10.2105/AJPH.94.12.2062; MURRAY JL, 1988, NEW ENGL J MED, V319, P1385, DOI 10.1056/NEJM198811243192105; National Collaborating Centre for Women's and Children's Health, 2008, ANT CAR ROUT CAR HLT; National Institute of Statistics, 2013, BAS DEM IND SER 2002; Paul K, 2008, SOC SCI MED, V67, P824, DOI 10.1016/j.socscimed.2008.05.017; Sola CP, 2008, GAC SANIT, V22, P555, DOI 10.1016/S0213-9111(08)75354-8; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P298, DOI 10.1136/jech.52.5.298; Rich-Edwards JW, 2005, AM J OBSTET GYNECOL, V192, pS30, DOI 10.1016/j.ajog.2005.01.072; Rio I, 2010, EUR J PUBLIC HEALTH, V20, P524, DOI 10.1093/eurpub/ckq067; Rio I, 2010, GAC SANIT, V24, P123, DOI 10.1016/j.gaceta.2009.09.014; RODRIGUEZ C, 1995, J EPIDEMIOL COMMUN H, V49, P38, DOI 10.1136/jech.49.1.38; Spanish Society of Gynaecology and Obstetrics, 2010, NORM PREGN PREN CAR; Sparks PJ, 2009, SOC SCI MED, V68, P1667, DOI 10.1016/j.socscimed.2009.02.026; Vahratian A, 2004, EUR J PUBLIC HEALTH, V14, P381, DOI 10.1093/eurpub/14.4.381; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Villar J., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000934; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; World Health Organization. Department of Reproductive Health and Research, 2003, RAND TRIAL WHO ANT C; Zeitlin J, 2004, BJOG-INT J OBSTET GY, V111, P849, DOI 10.1111/j.1471-0528.2004.00184.x	40	8	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120765	10.1371/journal.pone.0120765	http://dx.doi.org/10.1371/journal.pone.0120765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816369	Green Published, gold			2022-12-27	WOS:000352133600047
J	Richter, E; Harms, M; Ventz, K; Gierok, P; Chilukoti, RK; Hildebrandt, JP; Mostertz, J; Hochgrafe, F				Richter, Erik; Harms, Manuela; Ventz, Katharina; Gierok, Philipp; Chilukoti, Ravi Kumar; Hildebrandt, Jan-Peter; Mostertz, Joerg; Hochgraefe, Falko			A Multi-Omics Approach Identifies Key Hubs Associated with Cell Type-Specific Responses of Airway Epithelial Cells to Staphylococcal Alpha-Toxin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; AUREUS; HEMOLYSIN; ACTIVATION; ADHESION; EXPRESSION; KINASE; ADAM10	Responsiveness of cells to alpha-toxin (Hla) from Staphylococcus aureus appears to occur in a cell-type dependent manner. Here, we compare two human bronchial epithelial cell lines, i.e. Hla-susceptible 16HBE14o-and Hla-resistant S9 cells, by a quantitative multi-omics strategy for a better understanding of Hla-induced cellular programs. Phosphoproteomics revealed a substantial impact on phosphorylation-dependent signaling in both cell models and highlights alterations in signaling pathways associated with cell-cell and cell-matrix contacts as well as the actin cytoskeleton as key features of early rHla-induced effects. Along comparable changes in down-stream activity of major protein kinases significant differences between both models were found upon rHla-treatment including activation of the epidermal growth factor receptor EGFR and mitogen-activated protein kinases MAPK1/3 signaling in S9 and repression in 16HBE14o-cells. System-wide transcript and protein expression profiling indicate induction of an immediate early response in either model. In addition, EGFR and MAPK1/3-mediated changes in gene expression suggest cellular recovery and survival in S9 cells but cell death in 16HBE14o-cells. Strikingly, inhibition of the EGFR sensitized S9 cells to Hla indicating that the cellular capacity of activation of the EGFR is a major protective determinant against Hla-mediated cytotoxic effects.	[Richter, Erik; Harms, Manuela; Ventz, Katharina; Mostertz, Joerg; Hochgraefe, Falko] Ernst Moritz Arndt Univ Greifswald, Jr Res Grp Pathoprote, Competence Ctr Funct Genom, D-17489 Greifswald, Germany; [Gierok, Philipp] Ernst Moritz Arndt Univ Greifswald, Dept Biochem, D-17487 Greifswald, Germany; [Chilukoti, Ravi Kumar] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17489 Greifswald, Germany; [Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Inst Zool, Anim Physiol & Biochem, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Hochgrafe, F (corresponding author), Ernst Moritz Arndt Univ Greifswald, Jr Res Grp Pathoprote, Competence Ctr Funct Genom, D-17489 Greifswald, Germany.	falko.hochgraefe@uni-greifswald.de	Richter, Erik A./Y-8131-2019; Westhoff, Philipp/AAV-1542-2020; Chilukoti, Ravi Kumar/A-9657-2012	Richter, Erik A./0000-0002-6850-3056; Westhoff, Philipp/0000-0002-3494-9420; Chilukoti, Ravi Kumar/0000-0003-1699-0355; Hildebrandt, Jan-Peter/0000-0001-7827-8481	Bundesministerium fur Bildung und Forschung [03Z1CN21]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by funds from the Bundesministerium fur Bildung und Forschung (http://www.unternehmen-region.de/) to FH (03Z1CN21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Amanchy Ramars, 2005, Sci STKE, V2005, ppl2, DOI 10.1126/stke.2672005pl2; Becker REN, 2014, J INNATE IMMUN, V6, P619, DOI 10.1159/000360006; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Below S, 2009, AM J PHYSIOL-LUNG C, V296, pL470, DOI 10.1152/ajplung.90498.2008; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Eichstaedt S, 2008, J RECEPT SIG TRANSD, V28, P591, DOI 10.1080/10799890802407120; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Frank KM, 2012, INFECT IMMUN, V80, P3161, DOI 10.1128/IAI.00191-12; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gierok P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094818; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Hermann I, 2015, AM J RESP CELL MOL, V52, P14, DOI 10.1165/rcmb.2014-0082OC; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Kwak YK, 2012, INFECT IMMUN, V80, P1670, DOI 10.1128/IAI.00001-12; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Naik MU, 2014, BLOOD, V123, P1393, DOI 10.1182/blood-2013-04-496232; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rath S, 2013, CELL MICROBIOL, V15, P1253, DOI 10.1111/cmi.12113; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; WALEV I, 1994, MICROB PATHOGENESIS, V17, P187, DOI 10.1006/mpat.1994.1065; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; White SR, 1999, AM J RESP CELL MOL, V20, P787, DOI 10.1165/ajrcmb.20.4.3318; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	73	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122089	10.1371/journal.pone.0122089	http://dx.doi.org/10.1371/journal.pone.0122089			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816343	gold, Green Published, Green Submitted			2022-12-27	WOS:000352133600143
J	Van Dyck, D; Teychenne, M; McNaughton, SA; De Bourdeaudhuij, I; Salmon, J				Van Dyck, Delfien; Teychenne, Megan; McNaughton, Sarah A.; De Bourdeaudhuij, Ilse; Salmon, Jo			Relationship of the Perceived Social and Physical Environment with Mental Health-Related Quality of Life in Middle-Aged and Older Adults: Mediating Effects of Physical Activity	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; NEIGHBORHOOD CHARACTERISTICS; DETERMINANTS; ASSOCIATIONS; ENGAGEMENT; MULTILEVEL; RESIDENTS; SUPPORT; ANXIETY; CRIME	Background Mental health conditions are among the leading non-fatal diseases in middle-aged and older adults in Australia. Proximal and distal social environmental factors and physical environmental factors have been associated with mental health, but the underlying mechanisms explaining these associations remain unclear. The study objective was to examine the contribution of different types of physical activity in mediating the relationship of social and physical environmental factors with mental health-related quality of life in middle-aged and older adults. Methods Baseline data from the Wellbeing, Eating and Exercise for a Long Life (WELL) study were used. WELL is a prospective cohort study, conducted in Victoria, Australia. Baseline data collection took place in 2010. In total, 3,965 middle-aged and older adults (55-65 years, 47.4% males) completed the SF-36 Health Survey, the International Physical Activity Questionnaire, and a questionnaire on socio-demographic, social and physical environmental attributes. Mediation analyses were conducted using the MacKinnon product-of-coefficients test. Results Personal safety, the neighbourhood physical activity environment, social support for physical activity from family or friends, and neighbourhood social cohesion were positively associated with mental health-related quality of life. Active transportation and leisure-time physical activity mediated 32.9% of the association between social support for physical activity from family or friends and mental health-related quality of life. These physical activity behaviours also mediated 11.0%, 3.4% and 2.3% respectively, of the relationship between the neighbourhood physical activity environment, personal safety and neighbourhood social cohesion and mental health-related quality of life. Conclusions If these results are replicated in future longitudinal studies, tailored interventions to improve mental health-related quality of life in middle-aged and older adults should use a combined strategy, focusing on increasing physical activity as well as social and physical environmental attributes.	[Van Dyck, Delfien] Res Fdn Flanders, B-1000 Brussels, Belgium; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, B-90000 Ghent, Belgium; [Teychenne, Megan; McNaughton, Sarah A.; Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia	Ghent University; Deakin University	Van Dyck, D (corresponding author), Res Fdn Flanders, Egmontstr 5, B-1000 Brussels, Belgium.	delfien.vandyck@ugent.be	Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; McNaughton, Sarah A/B-2075-2012; Van Dyck, Delfien/AAO-8981-2020; Salmon, Jo/C-1226-2009	Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; McNaughton, Sarah A/0000-0001-5936-9820; Salmon, Jo/0000-0002-4734-6354; Teychenne, Megan/0000-0002-7293-8255; Van Dyck, Delfien/0000-0003-1783-9075; Cardon, Greet/0000-0003-4983-6557	Research Foundation Flanders (FWO); Australian Research Council [FT100100581, DP1095595]; NHMRC [ID1026216]; Diabetes Australia Research Trust; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]	Research Foundation Flanders (FWO)(FWO); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; Marie Curie Actions(European Commission)	DVD is supported by the Research Foundation Flanders (FWO; post doctoral research mandate). SAM is supported by an Australian Research Council Future Fellowship (FT100100581). JS is supported by a NHMRC Senior Research Fellowship (ID1026216). The WELL study was awarded funding from the Diabetes Australia Research Trust and the Australian Research Council (Project Grant ID: DP1095595). Analyses for the current paper were part of the MeMo International Exchange programme funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; [Anonymous], 1978, MAIL TELEPHONE SURVE; [Anonymous], 2002, ETHNIC DIS; Asztalos M, 2009, J SCI MED SPORT, V12, P468, DOI 10.1016/j.jsams.2008.06.009; Australian Bureau of Statistics, 2003, CRIT FACT SUCC R D I, P1; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Beard JR, 2009, AM J PUBLIC HEALTH, V99, P1308, DOI 10.2105/AJPH.2007.125104; Berke EM, 2007, J AM GERIATR SOC, V55, P526, DOI 10.1111/j.1532-5415.2007.01108.x; Biddle SJH, 2007, PHYS ACTIVITY PSYCHO; Blazer DG, 2005, PSYCHOL MED, V35, P1421; Brown SC, 2009, J AGING HEALTH, V21, P431, DOI 10.1177/0898264308328976; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Croezen S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-65; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; DISHMAN RK, 1992, MED SCI SPORT EXER, V24, P904; Edwards R, 2007, COCHRANE DB SYST REV, V2; Friedman D, 2012, QUAL LIFE RES, V21, P123, DOI 10.1007/s11136-011-9923-6; Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020; Giles-Corti B, 2003, AM J PUBLIC HEALTH, V93, P1583, DOI 10.2105/AJPH.93.9.1583; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; GREIST JH, 1979, COMPR PSYCHIAT, V20, P41, DOI 10.1016/0010-440X(79)90058-0; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P145; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Leach LS, 2013, SOC PSYCH PSYCH EPID, V48, P417, DOI 10.1007/s00127-012-0559-9; Li F, 2005, JIAOYU KEXUE LUNTAN, V12, P45; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mackinaw-Koons B, 2009, APPL PREVENTIVE PSYC, V9, P191; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mair C, 2009, ANN EPIDEMIOL, V19, P49, DOI 10.1016/j.annepidem.2008.10.002; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; McNaughton SA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-109; Melchior M, 2003, SOC SCI MED, V56, P1817, DOI 10.1016/S0277-9536(02)00181-8; Modie-Moroka T, 2009, J HEALTH POPUL NUTR, V27, P462, DOI 10.3329/jhpn.v27i4.3390; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RANSFORD CP, 1982, MED SCI SPORT EXER, V14, P1, DOI 10.1249/00005768-198201000-00001; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schieman S, 2004, J GERONTOL B-PSYCHOL, V59, pS89, DOI 10.1093/geronb/59.2.S89; Scott KM, 2014, CURR OPIN PSYCHIATR, V27, P289, DOI 10.1097/YCO.0000000000000067; Sniehotta FF, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-106; Stafford M, 2008, EUR J PUBLIC HEALTH, V18, P604, DOI 10.1093/eurpub/ckn091; Stafford M, 2007, AM J PUBLIC HEALTH, V97, P2076, DOI 10.2105/AJPH.2006.097154; Stafford M, 2011, AGEING SOC, V31, P893, DOI 10.1017/S0144686X10001236; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Teychenne M, 2010, HEALTH EDUC RES, V25, P632, DOI 10.1093/her/cyq008; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034; World Health Organisation, 2006, HLTH TOP AG LIF COUR; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93, DOI 10.1093/geronb/58.2.S93	62	63	66	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120475	10.1371/journal.pone.0120475	http://dx.doi.org/10.1371/journal.pone.0120475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799269	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300148
J	Van Dyck, D; Cardon, G; Deforche, B; De Bourdeaudhuij, I				Van Dyck, Delfien; Cardon, Greet; Deforche, Benedicte; De Bourdeaudhuij, Ilse			The Contribution of Former Work-Related Activity Levels to Predict Physical Activity and Sedentary Time during Early Retirement: Moderating Role of Educational Level and Physical Functioning	PLOS ONE			English	Article							TELEVISION VIEWING TIME; TRANSITION; BEHAVIOR	Background The transition to retirement introduces a decline in total physical activity and an increase in TV viewing time. Nonetheless, as more time becomes available, early retirement is an ideal stage to implement health interventions. Therefore, knowledge on specific determinants of physical activity and sedentary time is needed. Former work-related physical activity has been proposed as a potential determinant, but concrete evidence is lacking. The aim of this study was to examine if former work-related sitting, standing, walking or vigorous activities predict physical activity and sedentary time during early retirement. Additionally, moderating effects of educational level and physical functioning were examined. Methods In total, 392 recently retired Belgian adults (> 6 months, < 5 years) completed the International Physical Activity Questionnaire, the SF-36 Health Survey and a questionnaire on sociodemographics and former work-related activities. Generalized linear regression analyses were conducted in R. Moderating effects were examined by adding cross-products to the models. Results More former work-related sitting was predictive of more screen time during retirement. Lower levels of former work-related vigorous activities and higher levels of former work-related walking were associated with respectively more cycling for transport and more walking for transport during retirement. None of the predictors significantly explained passive transportation, cycling and walking for recreation, and leisure-time moderate-to-vigorous physical activity during retirement. Several moderating effects were found, but the direction of the interactions was not univocal. Conclusions Former-work related behaviors are of limited importance to explain physical activity during early retirement, so future studies should focus on other individual, social and environmental determinants. Nonetheless, adults who previously had a sedentary job had higher levels of screen time during retirement, so this is an important subgroup to focus on during interventions. Because of the inconsistent moderating effects of educational level and physical functioning, no clear recommendations can be formulated.	[Van Dyck, Delfien] Res Fdn Flanders, Brussels, Belgium; [Van Dyck, Delfien; Cardon, Greet; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Ghent University; Ghent University	Van Dyck, D (corresponding author), Res Fdn Flanders, Brussels, Belgium.	delfien.vandyck@ugent.be	Salmon, Jo/X-2630-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; McNaughton, Sarah A/B-2075-2012; Van Dyck, Delfien/AAO-8981-2020; Salmon, Jo/C-1226-2009	Salmon, Jo/0000-0002-4734-6354; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; McNaughton, Sarah A/0000-0001-5936-9820; Salmon, Jo/0000-0002-4734-6354; Teychenne, Megan/0000-0002-7293-8255; Van Dyck, Delfien/0000-0003-1783-9075; Cardon, Greet/0000-0003-4983-6557	Research Foundation Flanders [FWO12/PDO/158]	Research Foundation Flanders(FWO)	DVD is supported by the Research Foundation Flanders (FWO12/PDO/158; post doctoral research mandate). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnett I, 2011, J EPIDEMIOL COMMUN H, V65, pA34, DOI 10.1136/jech.2011.143586.76; Barnett I, 2014, J EPIDEMIOL COMMUN H, V68, P747, DOI 10.1136/jech-2013-203225; Barnett I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-97; Barnett I, 2012, AM J PREV MED, V43, P329, DOI 10.1016/j.amepre.2012.05.026; Beck F, 2010, BRIT J HEALTH PSYCH, V15, P663, DOI 10.1348/135910709X479096; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Chung S, 2009, AM J PREV MED, V36, P422, DOI 10.1016/j.amepre.2009.01.026; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Evenson KR, 2002, AM J EPIDEMIOL, V155, P692, DOI 10.1093/aje/155.8.692; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Jackman S., 2012, PSCL CLASSES METHODS; Lahti J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-36; Landi F, 2010, BIOGERONTOLOGY, V11, P537, DOI 10.1007/s10522-010-9296-1; Lang IA, 2007, AGE AGEING, V36, P638, DOI 10.1093/ageing/afm119; Mein GK, 2005, EUR J PUBLIC HEALTH, V15, P317, DOI 10.1093/eurpub/cki087; Organization for Economic Cooperation and Development, 2006, STUD PROJ GROW PRESS; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Slingerland AS, 2007, AM J EPIDEMIOL, V165, P1356, DOI 10.1093/aje/kwm053; Touvier M, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-14; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; U.S. Department of Health and Human Services, 2008, ODPHP PUBL U; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, 2006, HLTH TOP AG LIF COUR; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	30	63	66	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2015	10	3							e0122522	10.1371/journal.pone.0122522	http://dx.doi.org/10.1371/journal.pone.0122522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IF	25799269	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084800077
